RESULT_COUNT: 4470,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
PFE,PFE:US,BBG000BR2B91,Healthcare ETF (VHT) Hits New 52-Week High,2017-10-21 00:59:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2tlHrzgFpGo/healthcare-etf-vht-hits-new-52-week-high-cm863015,Investors seeking momentum may have Vanguard Healthcare ETF VHT on radar now The fund recently hit a new 52 week high Shares of VHT are up approximately 29 2 from the 52 week low of 120 38 share But could there be more gains ahead for this ETF Let s take a look at the fund and
PFE,PFE:US,BBG000BR2B91,Glaxo (GSK) Q3 Earnings: Will it Deliver a Beat Yet Again?,2017-10-20 14:55:02 +0000,https://finance.yahoo.com/news/glaxo-gsk-q3-earnings-deliver-145502766.html?.tsrc=rss,"The performance of GlaxoSmithKline plc&apos;s (GSK) new products is likely to be good. Vaccines acquired from Novartis are likely to drive revenues and ease the impact of the loss of key drug, Advair ."
PFE,PFE:US,BBG000BR2B91,3 High-Yield Pharmaceutical Stocks,2017-10-20 14:00:00 +0000,https://finance.yahoo.com/news/3-high-yield-pharmaceutical-stocks-140000362.html?.tsrc=rss,"High-yield pharma stocks are rare, but these three offer comparatively fat payouts."
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-10-20 12:00:41 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120041039.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,What’s Driving Economic Moats,2017-10-20 11:45:09 +0000,http://finance.yahoo.com/r/cc0078a0-0663-385f-a85a-4cffc9c9193f/whats-driving-economic-moats?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"""How Moats Translate into Sustainable Competitive Advantages"" is a five-part moat investing education series that explores the primary sources of economic moats."
PFE,PFE:US,BBG000BR2B91,"Senate OKs Budget Resolution, The Easy Part Of Passing Trump Tax Cuts",2017-10-20 02:47:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UQVRwpyY2Lo/senate-oks-budget-resolution-the-easy-part-of-passing-trump-tax-cuts-cm861774,The GOP led Senate late Thursday approved a budget resolution that sets aside room for a net 1 5 trillion tax cut over the coming decade The 51 49 vote is important because it will allow the GOP to pass tax cuts with just 50 votes plus Vice President Pence With the exception
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Oct 19, 2017 :  V, AAPL, CMCSA, BABA, PYPL, PFE, T, KW, GE, QQQ, ADBE, GILD",2017-10-19 21:03:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZzMMDVC77zk/after-hours-most-active-for-oct-19-2017-v-aapl-cmcsa-baba-pypl-pfe-t-kw-ge-qqq-adbe-gild-cm862301,The NASDAQ 100 After Hours Indicator is up 4 29 to 6 096 91 The total After hours volume is currently 41 037 723 shares traded The following are the most active stocks for the after hours session Visa Inc V is unchanged at 107 02 with 3 415 192 shares traded V
PFE,PFE:US,BBG000BR2B91,Healthcare ETFs Head to Head: XLV vs. VHT,2017-10-19 19:20:07 +0000,https://finance.yahoo.com/news/healthcare-etfs-head-head-xlv-192007798.html?.tsrc=rss,"Head to head comparison of two Healthcare ETFs, XLV and VHT."
PFE,PFE:US,BBG000BR2B91,Healthcare ETFs in Focus on Johnson & Johnson Q3 Earnings,2017-10-19 18:48:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NyBI3s61Wpk/healthcare-etfs-in-focus-on-johnson-johnson-q3-earnings-cm862185,Earnings and Revenue Beat Shares of Johnson amp Johnson JNJ increased 3 5 at market close on Oct 17 2017 after beating the Zacks Consensus Estimate on both earnings and revenues The company s revenues of 19 7 billion increased 10 3 in third quarter 2017 on a year over year basis
PFE,PFE:US,BBG000BR2B91,3 Reasons to Stay Away From Valeant Pharmaceuticals Intl Inc Stock,2017-10-19 15:47:35 +0000,https://finance.yahoo.com/news/3-reasons-stay-away-valeant-154735608.html?.tsrc=rss,"During the past six months or so, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has been regaining some of its footing.  CEO Joe Papa has wasted little time in cutting costs, streamlining the business and unloading of VRX stock’s assets.  Since April, VRX stock has rallied from $8.60 to $12.81."
PFE,PFE:US,BBG000BR2B91,Conatus Entrusts Keith W. Marshall With Key Management Roles,2017-10-19 13:36:01 +0000,https://finance.yahoo.com/news/conatus-entrusts-keith-w-marshall-133601849.html?.tsrc=rss,"Conatus Pharmaceuticals (CNAT) announced the appointment of Keith W. Marshall as executive vice president, chief operating officer and chief financial officer."
PFE,PFE:US,BBG000BR2B91,Trump Tax Cuts Clear First Hurdle; Now Comes A Wrestling Match,2017-10-19 12:44:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VAxJAs0FZD0/trump-tax-cuts-clear-first-hurdle-now-comes-a-wrestling-match-cm861774,Senate Republicans on Wednesday kicked off debate on a budget resolution that would set aside room for a net 1 5 trillion tax cut over the coming decade The vote is important because it would allow the GOP to pass tax cuts with just 50 votes plus Vice President Pence and
PFE,PFE:US,BBG000BR2B91,"Howe & Rusling Inc Buys DowDuPont Inc, JPMorgan Chase, iShares Intermediate ...",2017-10-19 12:43:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vOpGREevup8/howe-rusling-inc-buys-dowdupont-inc-jpmorgan-chase-ishares-intermediate-cm861813,Howe Rusling Inc New Purchases DWDP GVI IEFA MKC YUM APH CLX ROP HCN UNP Added Positions JPM UNH AVGO TJX VCSH STZ UL AAPL MSFT HD Reduced Positions HAS INTC CSCO ADBE LMT AMAT ABBV RTN DPS FB Sold Out DD AIV CAJ
PFE,PFE:US,BBG000BR2B91,4 Cheap Stock Picks for the Impatient,2017-10-19 12:37:00 +0000,http://finance.yahoo.com/r/8061b19f-0679-3dac-9318-79d3d324cb38/4-cheap-stock-picks-for-the-impatient-1508416634?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"General Motors stock has a rare combination of a breakdown valuation and zippy price momentum. That is, it trades at eight times forward earnings estimates, making it less than half as expensive as the ..."
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-10-19 12:00:38 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120038652.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,Inside Pfizer’s Performance in 3Q17,2017-10-19 11:39:48 +0000,http://finance.yahoo.com/r/9d247e34-8b4d-3ca1-aa71-375e98c1586f/inside-pfizers-performance-in-3q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,PFE stock rose ~7.3% in 3Q17 and has risen ~11.3% YTD (year-to-date) as of October 16.
PFE,PFE:US,BBG000BR2B91,2 Great Stocks For Retirees,2017-10-19 10:11:00 +0000,https://finance.yahoo.com/news/2-great-stocks-retirees-101100541.html?.tsrc=rss,Find out what makes this pair of big pharma stocks a perfect fit for recent retirees looking to bolster their income.
PFE,PFE:US,BBG000BR2B91,3 High-Yield Stocks for Conservative Investors,2017-10-19 10:08:00 +0000,https://finance.yahoo.com/news/3-high-yield-stocks-conservative-100800442.html?.tsrc=rss,These solid businesses with great dividend yields hit the sweet spot for conservative investors.
PFE,PFE:US,BBG000BR2B91,[$$] Reckitt Makeover Clears Way for Pfizer Bid,2017-10-19 04:03:24 +0000,http://finance.yahoo.com/r/afe6a754-aefb-329e-9b29-cf2bd96b121d/reckitt-makeover-clears-way-for-pfizer-bid-1508331531?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,The London-listed consumer group is doing what activist Nelson Peltz wants Procter & Gamble to do—but M&A may be an ulterior motive.
PFE,PFE:US,BBG000BR2B91,"5 Blue-Chip Stocks That “Dow 23,000” Left in the Dust",2017-10-18 23:49:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_sRUFGiSwhg/5-blue-chip-stocks-that-dow-23000-left-in-the-dust-cm861677,InvestorPlace Stock Market News Stock Advice amp Trading Tips The bulls are parading around Wall Street on Wednesday as better than expected earnings from International Business Machines Corp NYSE IBM sent shares soaring to their best gain in eight years never mind the
PFE,PFE:US,BBG000BR2B91,What to Expect from Big Pharmas After J&J's Solid Q3 Results?,2017-10-18 22:52:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e4YHAAqtt4s/what-to-expect-from-big-pharmas-after-jjs-solid-q3-results-cm861641,Johnson amp Johnson JNJ was the first large cap pharma stock to report its earnings results for this season on Oct 17 J amp J beat the Zacks Consensus Estimate for both earnings and revenues in the third quarter and also raised its 2017 sales and profit outlook Shares of J amp J were up
PFE,PFE:US,BBG000BR2B91,What to Expect from Big Pharmas After J&J&apos;s Solid Q3 Results?,2017-10-18 20:21:08 +0000,https://finance.yahoo.com/news/expect-big-pharmas-j-j-202108992.html?.tsrc=rss,"Large-cap pharmas are expected to report encouraging third-quarter results, following J&J&apos;s earnings beat. Five out of the six companies are expected to deliver earnings beat this quarter."
PFE,PFE:US,BBG000BR2B91,Here's Why Ignyta Stock Soared as Much as 27.5% Today,2017-10-18 18:50:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8rS2tntZzF4/heres-why-ignyta-stock-soared-as-much-as-275-today-cm861481,What happened Shares of pre revenue biopharma Ignyta NASDAQ RXDX jumped over 27 Wednesday morning after it announced promising interim results from an ongoing phase 2 3 clinical trial investigating the potential of its lead drug candidate entrectinib to treat patients with
PFE,PFE:US,BBG000BR2B91,"Sabal Trust CO Buys United Parcel Service Inc, Bristol-Myers Squibb Company, Hanesbrands Inc, ...",2017-10-18 18:50:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MAoZ_UglJ20/sabal-trust-co-buys-united-parcel-service-inc-bristol-myers-squibb-company-hanesbrands-inc-cm861549,Sabal Trust CO New Purchases UPS HBI CIU PSA MDT CME SBUX UNP TWX UTX Added Positions BMY T PFE ENB GPC XOM CVS QCOM SO CSCO Reduced Positions GE SON SYY INTC AAPL JNJ BA ABBV MSFT MMM Sold Out AGN AXP EFX DD F CRM
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson Posts Solid Q3 Numbers Led By Ramp Up In Oncology Drugs,2017-10-18 18:19:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/npnvZ8Q0_ro/johnson-johnson-posts-solid-q3-numbers-led-by-ramp-up-in-oncology-drugs-cm861520,Johnson amp Johnson s 160 JNJ stock increased by over 3 following its Q3 2017 earnings announcement effectively adding 13 billion in market cap The results were largely in line with expectations with a ramp up in key oncology drug sales benefits from the Actelion acquisition
PFE,PFE:US,BBG000BR2B91,Here&apos;s Why Ignyta Stock Soared as Much as 27.5% Today,2017-10-18 17:35:57 +0000,https://finance.yahoo.com/news/apos-why-ignyta-stock-soared-173557344.html?.tsrc=rss,The biopharma&apos;s lead drug candidate has strong potential based on a sneak peek at midstage trial data.
PFE,PFE:US,BBG000BR2B91,"Dow Jones Industrial Average Hits 23,000. Now What?",2017-10-18 16:30:21 +0000,https://finance.yahoo.com/news/dow-jones-industrial-average-hits-163021422.html?.tsrc=rss,"On Oct. 18, the Dow Jones Industrial Average hit a new all-time intraday high of 23,145 as of this writing. Investors who aren&#8217;t playing the indices can gain exposure to the Dow Jones today through the SPDR Dow Jones Industrial Average ETF (NYSEARCA:DIA). With the index up 16.3% in 2017, though, how much longer can this rally&#160;continue?"
PFE,PFE:US,BBG000BR2B91,Biogen (BIIB) Q3 Earnings: Will it Deliver a Beat Again?,2017-10-18 15:55:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xEoN8X6b7Z8/biogen-biib-q3-earnings-will-it-deliver-a-beat-again-cm861331,We expect Biogen Inc BIIB a well known name in the multiple sclerosis MS market to beat expectations when it reports third quarter 2017 results on Oct 24 before the market opens Last quarter the company delivered a positive earnings surprise of 15 60 Biogen s shares have risen 21
PFE,PFE:US,BBG000BR2B91,Reckitt to reshape as sales growth evaporates,2017-10-18 14:04:43 +0000,https://finance.yahoo.com/news/reckitt-reshape-sales-growth-evaporates-140443550.html?.tsrc=rss,"Britain's Reckitt Benckiser will split its business into two divisions -- consumer healthcare and home and hygiene products -- to try to revive sales that are set to stall this year.  It hopes to improve performance in its newly expanded health business, while bringing greater focus and accountability to its slower-growth home and hygiene business.  Reckitt, whose products range from Durex condoms to Lysol disinfectant, has blamed fallout from a cyber attack, a failed product launch and a safety scandal in South Korea for its lacklustre sales."
PFE,PFE:US,BBG000BR2B91,Eli Lilly (LLY) to Report Q3 Earnings: What's in Store?,2017-10-18 13:54:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5bnIzrtRjhE/eli-lilly-lly-to-report-q3-earnings-whats-in-store-cm861192,Eli Lilly and Company LLY will report third quarter 2017 results on Oct 24 before the market opens Last quarter the company delivered a positive earnings surprise of 6 73 Lilly s shares have risen 17 this year so far while the industry recorded an increase of 18 2 Lilly
PFE,PFE:US,BBG000BR2B91,[$$] Reckitt Benckiser: fission for compliments,2017-10-18 13:12:00 +0000,"http://finance.yahoo.com/r/1bd026a3-4a7d-3083-930f-780870b60a69/95974e64-b3f1-11e7-aa26-bb002965bce8,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","In the physics of business, the entropic forces that break down a system can also liberate energy. Hidden value is meant to be released from spin-offs and the like, especially when profit growth slows. ..."
PFE,PFE:US,BBG000BR2B91,[$$] Reckitt Makeover Clears Way for Pfizer Bid,2017-10-18 12:58:55 +0000,http://finance.yahoo.com/r/afe6a754-aefb-329e-9b29-cf2bd96b121d/reckitt-makeover-clears-way-for-pfizer-bid-1508331531?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,The London-listed consumer group is doing what activist Nelson Peltz wants Procter & Gamble to do—but M&A may be an ulterior motive.
PFE,PFE:US,BBG000BR2B91,Reckitt to reshape as sales growth evaporates,2017-10-18 11:51:45 +0000,https://finance.yahoo.com/news/reckitt-restructure-sales-growth-evaporates-092238751.html?.tsrc=rss,Britain's Reckitt Benckiser will split its business into two divisions -- consumer healthcare and home and hygiene products -- to try to revive sales that are set to stall this year. The change follows ...
PFE,PFE:US,BBG000BR2B91,Pfizer's Advil May Be Just the Thing for Sickly Reckitt,2017-10-18 11:03:36 +0000,http://finance.yahoo.com/r/2bc51a22-7ec8-35e3-a6bd-9e66e93dbbd1/pfizer-s-advil-may-be-just-the-thing-for-sickly-reckitt?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,The problem is getting shareholders to back a cash call to pay for it.
PFE,PFE:US,BBG000BR2B91,Reckitt Benckiser to form two business units for better focus,2017-10-18 06:24:50 +0000,https://finance.yahoo.com/news/reckitt-benckiser-form-two-business-060440835.html?.tsrc=rss,"Reckitt Benckiser (RB.L) plans to reorganise its business into two distinct units, one for health and the other for hygiene and home products, as it tries to improve its flagging performance.  The maker of Durex condoms, Nurofen tablets and Dettol cleaners announced the restructuring on Wednesday, along with its third-quarter sales figures.  The British company made the decision to restructure after its June acquisition of U.S. baby formula maker Mead Johnson, which will account for roughly half of the larger health unit's sales."
PFE,PFE:US,BBG000BR2B91,"Reckitt CEO Focuses on Health, Looking Beyond Worst Year",2017-10-18 06:14:57 +0000,http://finance.yahoo.com/r/76095c16-709f-3022-bbe8-75966e9f6dec/reckitt-benckiser-sales-miss-estimates-as-it-lowers-forecast?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Reckitt Benckiser Group Plc separated its home-care and health businesses, sharpening its focus on brands such as Durex condoms and Enfamil baby formula after a second cut in the sales forecast this year...."
PFE,PFE:US,BBG000BR2B91,Tiny Ignyta's Lung Cancer Drug Bested Pfizer's. Probably. Will We Ever Know For Sure?,2017-10-18 02:55:00 +0000,http://finance.yahoo.com/r/64269cce-e9be-3602-ae25-6d479a5835e2/tiny-ignytas-lung-cancer-drug-bests-pfizers-we-think-but-we-may-never-know-for-sure?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Results of a 32-patient study of a drug made by Ignyta Pharmaceuticals, a San Diego-based drugmaker, are a best case scenario for the company. The drug shrank tumors in 79% of patients and kept workingabout 10 months longer than the current drug, Pfizer’s Xalkori, did in earlier clinical trials."
PFE,PFE:US,BBG000BR2B91,Aerie (AERI) Up on FDA Review Committee Result for Rhopressa,2017-10-17 23:49:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fp2mfwN6_Eg/aerie-aeri-up-on-fda-review-committee-result-for-rhopressa-cm861041,Shares of Aerie Pharmaceuticals Inc AERI have moved up 15 8 in the last one week on positive news for its lead drug Rhopressa In fact Aerie s stock has surged 71 4 year to date compared with the industry s gain of 3 4 On Oct 13 the Dermatologic and Ophthalmic
PFE,PFE:US,BBG000BR2B91,Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks,2017-10-17 22:52:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G3L8_TQwCK8/innovative-pipelines-regulatory-catalysts-to-drive-pharma-stocks-cm861063,Although pharma and biotech stocks had gone through a rough patch due to the drug pricing controversy the sector is showing signs of recovery with investors being more comfortable with the drug pricing scenario and focusing on the fundamentals of the sector instead Innovation mergers
PFE,PFE:US,BBG000BR2B91,Aerie (AERI) Up on FDA Review Committee Result for Rhopressa,2017-10-17 21:59:09 +0000,https://finance.yahoo.com/news/aerie-aeri-fda-review-committee-215909645.html?.tsrc=rss,"Shares of Aerie Pharmaceuticals, Inc. (AERI) have moved up 15.8% in the last week on positive news for its lead drug, Rhopressa."
PFE,PFE:US,BBG000BR2B91,This hot trade is about to get even hotter: Trader,2017-10-17 21:00:00 +0000,https://finance.yahoo.com/video/hot-trade-even-hotter-trader-210000526.html?.tsrc=rss,The “Fast Money” traders discuss the health care sector seeing a pop and where it could go from here.
PFE,PFE:US,BBG000BR2B91,"J&J (JNJ) Beats on Q3 Earnings, Actelion Buyout Drives Sales",2017-10-17 16:54:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h7HtgTXv1iI/jj-jnj-beats-on-q3-earnings-actelion-buyout-drives-sales-cm860808,Johnson amp Johnson JNJ reported better than expected third quarter 2017 results beating the Zacks Consensus Estimate for both earnings and sales The drug and consumer products giant raised its 2017 sales and profit outlook which sent shares up 1 5 in pre market trading In fact
PFE,PFE:US,BBG000BR2B91,"Notable ETF Outflow Detected - XLV, JNJ, PFE, CELG",2017-10-17 16:52:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RRLKbaw6vLA/notable-etf-outflow-detected-xlv-jnj-pfe-celg-cm860795,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Health Care Select Sector SPDR Fund Symbol XLV where we have detected an approximate 155 9 million dollar outflow that s a 0 9 decrease week over week
PFE,PFE:US,BBG000BR2B91,"Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen",2017-10-17 15:56:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z_aPJlshdXE/zacks-industry-outlook-highlights-gilead-teva-pfizer-and-amgen-cm860679,For Immediate Release Chicago IL October 17 2017 Today Zacks Equity Research discusses the Industry Pharmaceuticals Part 1 including Gilead 160 Nasdaq GILD 160 Free Report Teva NYSE TEVA Free Report Pfizer NYSE PFE Free Report and
PFE,PFE:US,BBG000BR2B91,3 Dividend Healthcare Stocks,2017-10-17 15:51:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wVL2vNb4zjM/3-dividend-healthcare-stocks-cm860621,Healthcare stocks have been extremely fertile ground for dividend investors over the last few years thanks in large part to the aging global population that s presently driving a surge in demand for medical products and healthcare services Best of all this rising tide is showing
PFE,PFE:US,BBG000BR2B91,"J&J (JNJ) Beats on Q3 Earnings, Actelion Buyout Drives Sales",2017-10-17 14:37:02 +0000,https://finance.yahoo.com/news/j-j-jnj-beats-q3-143702932.html?.tsrc=rss,J&J (JNJ) reported better-than-expected third-quarter 2017 results and raised its 2017 sales and profit outlook.
PFE,PFE:US,BBG000BR2B91,"Clark Estates Inc Buys Fluor Corp, Allergan PLC, GlaxoSmithKline PLC, Sells Scripps Networks ...",2017-10-17 13:49:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a6OLw6zfXJo/clark-estates-inc-buys-fluor-corp-allergan-plc-glaxosmithkline-plc-sells-scripps-networks-cm860505,Clark Estates Inc New Purchases FLR AGN GSK SJM AMN ABC JNPR FL LCI SP Added Positions CTL T LB FOXA VZ DFIN OMC FTD IBM EAT Reduced Positions SNI CVS MSFT OI PFE BEN AAN ETSY JPM CAH Sold Out NWSA TRK LUV UAL CBZ
PFE,PFE:US,BBG000BR2B91,"Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen",2017-10-17 13:44:01 +0000,https://finance.yahoo.com/news/zacks-industry-outlook-highlights-gilead-134401197.html?.tsrc=rss,"Zacks Industry Outlook Highlights: Gilead, Teva, Pfizer and Amgen"
PFE,PFE:US,BBG000BR2B91,The Blockbuster That Wasn't -- A CETP Inhibitor Post-Mortem,2017-10-17 12:09:00 +0000,http://finance.yahoo.com/r/8f533772-8533-305d-8c23-8f9c1f169074/the-blockbuster-that-wasnt-a-cetp-inhibitor-post-mortem?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,The quest for the “holy grail” of cardiovascular therapy - a drug that dramatically lowered LDL-c and raised HDL-c and which would hopefully reverse atherosclerosis - has ended ignominiously.
PFE,PFE:US,BBG000BR2B91,Pharma Industry Outlook - October 2017,2017-10-16 19:59:07 +0000,https://finance.yahoo.com/news/pharma-industry-outlook-october-2017-195907438.html?.tsrc=rss,Pharma Industry Outlook - October 2017
PFE,PFE:US,BBG000BR2B91,How Stock Investors Can Profit Big From Spinoffs,2017-10-16 18:00:00 +0000,http://finance.yahoo.com/r/d1953b9c-2789-3c62-8f95-73f68e0ada94/how-stock-investors-can-profit-big-spinoffs?partner=YahooSA&yptr=yahoo&.tsrc=rss,Spinning Rich Profits: Spinoffs as a group have posted total returns of nearly 300% over 10 years
PFE,PFE:US,BBG000BR2B91,The Cost Of Developing Drugs Is Insane. That Paper That Says Otherwise Is Insanely Bad,2017-10-16 14:58:00 +0000,http://finance.yahoo.com/r/f26f5cf6-5eba-3c51-bb21-d0403b473077/the-cost-of-developing-drugs-is-insane-a-paper-that-argued-otherwise-was-insanely-bad?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"The pharmaceutical industry puts the cost of bringing a medicine from invention to pharmacy shelves at $2.7 billion. A new paper says it is 'just' $648 million. Unfortunately for pharmaceutical investors and people fighting to control drug prices, alike, the new number doesn’t stand up scrutiny."
PFE,PFE:US,BBG000BR2B91,Pfizer Presents Full Results from Phase 2 Study of Next-Generation Investigational ALK-Inhibitor Lorlatinib in ALK-Positive and ROS1-Positive Advanced Non-Small Cell Lung Cancer,2017-10-16 11:00:00 +0000,https://finance.yahoo.com/news/pfizer-presents-full-results-phase-110000785.html?.tsrc=rss,"Pfizer Inc. today announced full results from the Phase 2 clinical trial of the investigational, next-generation tyrosine kinase inhibitor lorlatinib that exhibited clinically meaningful activity against lung tumors and brain metastases in a range of patients with ALK-positive and ROS1-positive advanced non-small cell lung cancer , including those who were heavily pretreated."
PFE,PFE:US,BBG000BR2B91,[$$] Drugstore Favorites May Be Catching the Common Consumer Cold,2017-10-16 10:49:33 +0000,http://finance.yahoo.com/r/8ee64cac-650a-3227-99aa-16d8ef897988/drugstore-favorites-may-be-catching-the-common-consumer-cold-1508149810?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Customers may be starting to shop for over-the-counter drugs in the same way they shop for groceries—with a keener eye for cost and content—and this could be painful for consumer-health companies.
PFE,PFE:US,BBG000BR2B91,Pfizer: Trial Of ALK-Inhibitor Lorlatinib Shows Clinically Meaningful Activity,2017-10-16 07:29:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/so3UIveMI4E/pfizer-trial-of-alkinhibitor-lorlatinib-shows-clinically-meaningful-activity-20171016-00379,Pfizer: Trial Of ALK-Inhibitor Lorlatinib Shows Clinically Meaningful Activity
PFE,PFE:US,BBG000BR2B91,Pfizer Consumer Unit Worth as Much as $14 Billion,2017-10-15 20:40:00 +0000,http://finance.yahoo.com/r/de606440-5e1a-39c6-bcff-63d3c0817df0/what-pfizer-consumer-unit-is-worth.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,A deal would give the company capital to do more deals but the decision also keeps the company's recently scratched plans to split into two separate companies alive. The division itself had about $3.4 ...
PFE,PFE:US,BBG000BR2B91,Pfizer Says It's Pondering a Big Sale,2017-10-14 05:16:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d7UBuKEDdEE/pfizer-says-its-pondering-a-big-sale-cm859769,In this Market Foolery podcast and with the big news coming out of healthcare host Chris Hill calls upon the expert insight of Industry Focus Healthcare host Kristine Harjes In this segment they consider the word that giant Pfizer NYSE PFE 160 is
PFE,PFE:US,BBG000BR2B91,Earnings Season Preview: 2 Things to Watch For in Healthcare,2017-10-14 05:15:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uRL3zkps6c8/earnings-season-preview-2-things-to-watch-for-in-healthcare-cm859768,In this Market Foolery podcast and with the big news coming out of healthcare host Chris Hill calls upon the expert insight of Industry Focus Healthcare host Kristine Harjes In this segment they look ahead to earnings season and Kristine tells us a couple of
PFE,PFE:US,BBG000BR2B91,Earnings Season Preview: 2 Things to Watch For in Healthcare,2017-10-14 04:10:00 +0000,https://finance.yahoo.com/news/earnings-season-preview-2-things-041000444.html?.tsrc=rss,"J&J is the lead-off hitter, and its Remicade results will tell us a lot. So will the biosimilar numbers from Pfizer."
PFE,PFE:US,BBG000BR2B91,Pfizer Says It&apos;s Pondering a Big Sale,2017-10-14 04:05:00 +0000,https://finance.yahoo.com/news/pfizer-says-apos-pondering-big-040500903.html?.tsrc=rss,The pharmaceutical major announced it&apos;s thinking about finding a buyer for its consumer healthcare unit.
PFE,PFE:US,BBG000BR2B91,This No. 1-Ranked Medical Stock Is Breaking Out With Q3 Earnings Due,2017-10-13 22:18:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qvoNs6oKnLM/this-no-1-ranked-medical-stock-is-breaking-out-with-q3-earnings-due-cm858615,When biotech companies like Celgene CELG Biogen BIIB and Gilead Sciences GILD 160 put their drugs through extensive trials to gain FDA approval they turn to clinical research firms like PRA Health Sciences PRAH ibd display
PFE,PFE:US,BBG000BR2B91,4 Blue-Chip Stocks to Sell and 4 Stocks to Buy Right Now,2017-10-13 20:20:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8tC97ZiWjA0/4-blue-chip-stocks-to-sell-and-4-stocks-to-buy-right-now-cm859697,InvestorPlace Stock Market News Stock Advice amp Trading Tips One of the tricky things about investing in this market is that many safe stocks or blue chip stocks are neither The notion that a stock is safe because it is a legacy name or it has carried the moniker blue chip
PFE,PFE:US,BBG000BR2B91,5 Large-Cap Drug Stocks Well Poised to Beat on Q3 Earnings,2017-10-13 20:14:08 +0000,https://finance.yahoo.com/news/5-large-cap-drug-stocks-201408113.html?.tsrc=rss,The pharma/biotech sector has a number of things going in its favor.
PFE,PFE:US,BBG000BR2B91,Spin-Off ETF: Can the Outperformance Continue?,2017-10-13 18:12:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mh597pGmTWI/spin-off-etf-can-the-outperformance-continue-cm859574,Spin off activities have stepped up lately with biggies like Honeywell International HON and Pfizer PFE being the most active ones Lately the industrial giant Honeywell announced plans of spinning off its homes and global distribution units and its transportation systems unit into two
PFE,PFE:US,BBG000BR2B91,Spin-Off ETF: Can the Outperformance Continue?,2017-10-13 16:20:04 +0000,https://finance.yahoo.com/news/spin-off-etf-outperformance-continue-162004619.html?.tsrc=rss,Spin-off activities picked up pace in the United States.
PFE,PFE:US,BBG000BR2B91,Behind Eli Lilly’s October Analyst Recommendations,2017-10-13 15:42:53 +0000,http://finance.yahoo.com/r/fa09096b-4083-327b-94d1-3541f5315994/behind-eli-lillys-october-analyst-recommendations?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"So far in October, of the 22 analysts covering Eli Lilly (LLY), four have suggested a “strong buy,” while ten analysts have suggested a “buy.”"
PFE,PFE:US,BBG000BR2B91,"Gilead Sciences, Inc. (GILD) Stock Is Primed After Kite Pharma Buy",2017-10-13 15:17:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8ZXZD2fPjSc/gilead-sciences-inc-gild-stock-is-primed-after-kite-pharma-buy-cm859490,InvestorPlace Stock Market News Stock Advice amp Trading Tips Markets barely reacted when Gilead Sciences Inc NASDAQ GILD announced on Sept 14 that it would buy Kite Pharma Inc for 11 9 billion The lack of a reaction is understandable Kite may not bring it the growth
PFE,PFE:US,BBG000BR2B91,Pharma Sales Could Be Chilled by Hurricane Damage,2017-10-13 14:47:00 +0000,http://finance.yahoo.com/r/80513b76-7385-34fb-a754-e197acb48f9f/pharma-sales-could-be-chilled-by-hurricane-damage-1507906049?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Pharmaceutical third-quarter earnings are nearly upon us, and Guggenheim's Tony Butler and Allen Cha provide their thoughts on the upcoming results. Butler and Cha write that the hurricanes are a factor ..."
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Pfizer Mulls Options for Consumer Healthcare, LLY's Pipeline Setback",2017-10-13 14:20:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o-6IHur8DDQ/pharma-stock-roundup-pfizer-mulls-options-for-consumer-healthcare-llys-pipeline-setback-cm859307,Companies like Pfizer PFE Merck MRK and Eli Lilly LLY were in the news this week while Pfizer is mulling strategic options for its Consumer Healthcare business Merck said that it will not file its CETP inhibitor Recap of the Week s Most Important Stories Pfizer to
PFE,PFE:US,BBG000BR2B91,"Koshinski Asset Management, Inc. Buys PowerShares S&P 500 Low Volatility Portfolio, Pfizer ...",2017-10-13 14:10:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/berbi55cLZA/koshinski-asset-management-inc-buys-powershares-sp-500-low-volatility-portfolio-pfizer-cm859319,Koshinski Asset Management Inc New Purchases SPLV ITA DWDP AGN VMW MTK MGA PFF FMAO KBWB Added Positions PFE CRM BA UNH AMAT ADBE RYT AMZN RTN JPM Reduced Positions AVK AVK TSLA DON IBB MCD NXP NXP SPY AET Sold Out
PFE,PFE:US,BBG000BR2B91,Pfizer: Could a Big Merger Move the Needle?,2017-10-13 13:32:00 +0000,http://finance.yahoo.com/r/a3eb8da7-a748-3723-b9f2-e39ef917b99a/pfizer-could-a-big-merger-move-the-needle-1507901532?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"T here’s been speculation about whether or not Pfizer (PFE) is planning to make a large acquisition, and Guggenheim’s Tony Butler takes on the question, writing that a smart deal could expand the pharma giant’s multiple.  Butler notes that Pfizer’s management has stated that it’s aware of the need to create shareholder value, and he believes that the outcome hinges on a number of factors, including any potential tax reform/cash repatriation holiday, as well as clinical trial results.  At the moment, Pfizer has a joint venture with Merck (MRK) to develop Bavencio, a PD-L1 antibody, but Butler wonders if it might be willing to step back if the data isn’t supportive, and if it might be willing to acquire a company with a different, PD-1 antibody—again if the data bears it out."
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Pfizer Mulls Options for Consumer Healthcare, LLY&apos;s Pipeline Setback",2017-10-13 12:06:12 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-pfizer-mulls-120612619.html?.tsrc=rss,Pfizer (PFE) is looking at strategic options for its Consumer Healthcare business while Merck announced that it won&apos;t be seeking approval for its CETP inhibitor.
PFE,PFE:US,BBG000BR2B91,"Gilead Sciences, Inc. (GILD) Stock Is Primed After Kite Pharma Buy",2017-10-13 11:02:23 +0000,https://finance.yahoo.com/news/gilead-sciences-inc-gild-stock-110223682.html?.tsrc=rss,"Markets barely reacted when Gilead Sciences Inc. (NASDAQ:GILD) announced on Sept. 14 that it would buy Kite Pharma, Inc. for $11.9 billion.  The slowdown in Gilead’s HCV business is starting to come to an end.  The HCV segment will continue adding meaningfully to Gilead’s cash flow, which is money it needs to fund the Kite acquisition."
PFE,PFE:US,BBG000BR2B91,2 Reasons Pfizer Is on Our Minds Today,2017-10-13 07:15:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pH3XSn1htwo/2-reasons-pfizer-is-on-our-minds-today-cm859178,In this Market Foolery podcast and with the big news coming out of healthcare host Chris Hill calls upon the expert insight of Industry Focus Healthcare host Kristine Harjes First they consider the word that giant Pfizer NYSE PFE is considering
PFE,PFE:US,BBG000BR2B91,2 Reasons Pfizer Is on Our Minds Today,2017-10-13 05:35:00 +0000,https://finance.yahoo.com/news/2-reasons-pfizer-minds-today-053500683.html?.tsrc=rss,"First, it raised some spinoff speculation. Second, it&apos;s in an intriguing tussle with J&J that could affect the biosimilars market for everyone."
PFE,PFE:US,BBG000BR2B91,"ONCE Sparkles, BDSI Makes Peace, Coming Event Casts Its Shadow Before ATRS",2017-10-13 02:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ez3wUSPO7sc/once-sparkles-bdsi-makes-peace-coming-event-casts-its-shadow-before-atrs-20171013-00034,"ONCE Sparkles, BDSI Makes Peace, Coming Event Casts Its Shadow Before ATRS"
PFE,PFE:US,BBG000BR2B91,Breakout Watch: No. 1-Ranked Medical Research Stock Tests Buy Zone,2017-10-12 21:13:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-Xd_oTTuuOw/breakout-watch-no-1-ranked-medical-research-stock-tests-buy-zone-cm858615,When biotech and Big Pharma companies like Celgene CELG Biogen BIIB Gilead Sciences GILD and Pfizer PFE put their drugs through extensive and costly trials to gain FDA approval they turn to clinical research firms like PRA
PFE,PFE:US,BBG000BR2B91,Merck Will Not Seek Approval for CETP Inhibitor Anacetrapib,2017-10-12 21:12:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qr7zJU-LYcg/merck-will-not-seek-approval-for-cetp-inhibitor-anacetrapib-cm859055,Merck amp Co Inc MRK announced that it is not going ahead with filing the regulatory applications seeking approval for anacetrapib a cholesteryl ester transfer protein CETP inhibitor that it had developed for cholesterol management The stock was down more than 1 on Wednesday Merck
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer Seen Mulling Options,2017-10-12 15:04:00 +0000,http://finance.yahoo.com/r/5f7de100-d4af-387d-9c54-882548c31680/pfizer-seen-mulling-options-1507820698?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Credit Suisse  We are not surprised by Pfizer’s announcement [Tuesday] morning that they are exploring strategic options for their Consumer Healthcare business.  Based on our recent conversations with the company, it had become clear to us that Pfizer (PFE) management does not see this business as part of their long-term innovative core.  After speaking with the company again today and based on their previous transactions, we assume Pfizer will take their usual time and care in exploring all options."
PFE,PFE:US,BBG000BR2B91,Pres Trump believes he has the cure for Obamacare,2017-10-12 14:31:44 +0000,https://finance.yahoo.com/video/pres-trump-believes-cure-obamacare-143144493.html?.tsrc=rss,"President Trump's healthcare bill may have died in Congress, but that's not stopping him from making changes to Obamacare. Later today, the president is expected to  sign an executive order that would let Americans buy insurance across state lines. Yahoo Finance’s Alexis Christoforous and Editor-in-Chief Andy Serwer figure out if the the president’s move will help lower premiums."
PFE,PFE:US,BBG000BR2B91,U.S. FDA Approves LYRICA® CR (pregabalin) Extended-Release Tablets CV,2017-10-12 12:00:00 +0000,https://finance.yahoo.com/news/u-fda-approves-lyrica-cr-120000933.html?.tsrc=rss,Pfizer Inc. announced today that the United States Food and Drug Administration has approved LYRICA® CR extended-release tablets CV as once-daily therapy for the management of neuropathic pain associated with diabetic peripheral neuropathy and the management of postherpetic neuralgia .
PFE,PFE:US,BBG000BR2B91,Corporate News Blog - Pharma Giant Pfizer Mulling Divestment of Consumer Healthcare Business,2017-10-12 11:20:00 +0000,https://finance.yahoo.com/news/corporate-news-blog-pharma-giant-112000403.html?.tsrc=rss,"LONDON, UK / ACCESSWIRE / October 12, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Pfizer Inc. (NYSE: PFE ), following which we have published a ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Announces FDA Approval Of LYRICA CR Extended-release Tablets CV,2017-10-12 08:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dwXaTE9Uu-c/pfizer-announces-fda-approval-of-lyrica-cr-extendedrelease-tablets-cv-20171012-00510,Pfizer Announces FDA Approval Of LYRICA CR Extended-release Tablets CV
PFE,PFE:US,BBG000BR2B91,Is Pfizer the Best Dividend Stock in Healthcare?,2017-10-11 22:12:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gE78FZWtaeE/is-pfizer-the-best-dividend-stock-in-healthcare-cm858474,Pfizer Inc s NYSE PFE sales have fallen sharply since its top selling Lipitor lost patent protection back in 2012 However steps management has taken to control costs and invest in cancer drugs and biosimilar drug development may position it perfectly for future growth In
PFE,PFE:US,BBG000BR2B91,Is Pfizer the Best Dividend Stock in Healthcare?,2017-10-11 20:48:00 +0000,https://finance.yahoo.com/news/pfizer-best-dividend-stock-healthcare-204800020.html?.tsrc=rss,A push into cancer drugs and biosimilars could make this a good time to buy Pfizer’s shares.
PFE,PFE:US,BBG000BR2B91,"Pfizer considers selling unit that includes Advil, ChapStick",2017-10-11 19:05:09 +0000,http://finance.yahoo.com/r/ab9e7a2d-9646-32c8-9009-66c0ac006e5c/pfizer-considers-selling-unit-that-includes-advil.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Pharmaceutical giant Pfizer Inc. is reviewing a sale process for its consumer healthcare business.  A spin-off is also possible, Pfizer (PFE) noted.  The segment is touted as one of the largest over-the-counter health care products businesses in the world, consisting of well-known products that include dietary supplement Emergen-C, Advil, Thermacare, Robitussin and ChapStick."
PFE,PFE:US,BBG000BR2B91,"Three blue-chip US companies are on the verge of breaking apart, prodded by short-term investors",2017-10-11 19:03:00 +0000,http://finance.yahoo.com/r/406d4e0c-fa52-3b11-b116-ad6d721b673c/procter-gamble-honeywell-and-pfizer-all-fear-the-power-of-short-term-investors-pg-hon-pfe?utm_source=YPL&yptr=yahoo&.tsrc=rss,"The CEOs of Procter & Gamble, Honeywell, and Pfizer are all under pressure to split up their companies. The reasons are different but root cause is the same: the rapacious hunger of short-term investors. Procter & Gamble, seller of toothpaste and toilet paper, drew headlines this week by narrowly winning a proxy battle with Nelson…"
PFE,PFE:US,BBG000BR2B91,"Boltwood Capital Management Buys DowDuPont Inc, iShares Intermediate Credit Bond ETF, iShares ...",2017-10-11 18:10:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1TYi-APF2Lg/boltwood-capital-management-buys-dowdupont-inc-ishares-intermediate-credit-bond-etf-ishares-cm858366,Boltwood Capital Management New Purchases DWDP CIU BA PCAR EEM SCHM Added Positions CMF XLB SCHF PFE VCIT SCHE MUB SCHA SCHB XLF Reduced Positions VTI EFA CSJ ABBV WMT PEP MSFT JWN XLK GE Sold Out DD NUE WFM CB New
PFE,PFE:US,BBG000BR2B91,Pfizer: Who Will Pay $14B for Advil?,2017-10-11 17:40:00 +0000,http://finance.yahoo.com/r/5ed16c9b-f11f-3338-9f9e-665f609089ee/pfizer-who-will-pay-14b-for-advil-1507743616?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Just imagine if Pfizer (PFE) is able to sell its consumer products business?  In a note published today, Credit Suisse’s Vamil Divan believes that either a sale or a spinoff is a sure thing on the heels of the pharmaceutical giant’s announcement Tuesday that it was weighing options for the business.  It was barely a year ago that Pfizer abandoned the long-debated notion of breaking itself up into two separate companies."
PFE,PFE:US,BBG000BR2B91,Lilly's (LLY) Verzenio Fails in Phase III Lung Cancer Study,2017-10-11 17:13:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nWsQzJD0NC0/lillys-lly-verzenio-fails-in-phase-iii-lung-cancer-study-cm858308,The series of setbacks continues for Eli Lilly and Company LLY as the company announced that its phase III JUNIPER study failed to meet the primary endpoint The study was evaluating Verzenio in advanced non small lung cancer NSCLC with KRAS mutation Shares fell 1 on Tuesday after
PFE,PFE:US,BBG000BR2B91,"Stock Market News For Oct 11, 2017",2017-10-11 16:17:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0KBeVk5a3vQ/stock-market-news-for-oct-11-2017-cm858238,The Dow notched up another record close on Tuesday following a surge in shares of Wal Mart The departmental store reaffirmed its guidance for fiscal 2018 and also a share repurchase of 20 billion Such announcements from the company sent the consumer staples sector higher Meanwhile the
PFE,PFE:US,BBG000BR2B91,Pfizer Considering Sale/Spin-Off of Consumer Healthcare Unit,2017-10-11 16:14:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mQoBBF_KP3c/pfizer-considering-salespin-off-of-consumer-healthcare-unit-cm858185,Pfizer Inc PFE said it is exploring strategic alternatives for its Consumer Healthcare segment including a partial or a full separation through a spin off sale or other transaction A decision regarding the same is expected to be made next year and it may ultimately opt to retain the
PFE,PFE:US,BBG000BR2B91,Pfizer Considering Sale/Spin-Off of Consumer Healthcare Unit,2017-10-11 14:22:02 +0000,https://finance.yahoo.com/news/pfizer-considering-sale-spin-off-142202171.html?.tsrc=rss,"Pfizer (PFE) is exploring strategic alternatives for its Consumer Healthcare segment including a partial or a full separation through a spin-off, sale or other transaction."
PFE,PFE:US,BBG000BR2B91,"Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for October 12, 2017",2017-10-11 13:23:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n4hRpSFzS84/abbott-laboratories-abt-ex-dividend-date-scheduled-for-october-12-2017-cm858066,Abbott Laboratories ABT will begin trading ex dividend on October 12 2017 A cash dividend payment of 0 265 per share is scheduled to be paid on November 15 2017 Shareholders who purchased ABT prior to the ex dividend date are eligible for the cash dividend payment This marks the
PFE,PFE:US,BBG000BR2B91,"AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for October 12, 2017",2017-10-11 13:20:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ifJ0_BoTq5k/abbvie-inc-abbv-ex-dividend-date-scheduled-for-october-12-2017-cm857986,AbbVie Inc ABBV will begin trading ex dividend on October 12 2017 A cash dividend payment of 0 64 per share is scheduled to be paid on November 15 2017 Shareholders who purchased ABBV prior to the ex dividend date are eligible for the cash dividend payment This marks the 4th
PFE,PFE:US,BBG000BR2B91,3 Reasons Why Pfizer Investors Will Win With a Consumer Business Sale or Spinoff,2017-10-11 13:14:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_f1hn1GrP-o/3-reasons-why-pfizer-investors-will-win-with-a-consumer-business-sale-or-spinoff-cm857940,Nearly a year ago reports surfaced that Pfizer NYSE PFE was considering selling or spinning off its consumer healthcare business But those were just reports Nothing happened until now On Tuesday Pfizer officially announced that it was reviewing strategic
PFE,PFE:US,BBG000BR2B91,"$100 Billion Question: Will Trump Let Alphabet, Pfizer Keep Tax Havens?",2017-10-11 13:11:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_yAFAKO0eyM/100-billion-question-will-trump-let-alphabet-pfizer-keep-tax-havens-cm857937,Tech companies like Alphabet GOOGL and Apple AAPL and drugmakers like Pfizer PFE that have amassed piles of cash to avoid paying high domestic tax rates on profits earned overseas have been singled out as big potential winners under Trump s tax
PFE,PFE:US,BBG000BR2B91,3 Reasons Why Pfizer Investors Will Win With a Consumer Business Sale or Spinoff,2017-10-11 12:04:00 +0000,https://finance.yahoo.com/news/3-reasons-why-pfizer-investors-120400803.html?.tsrc=rss,Could good news be on the way for Pfizer shareholders?
PFE,PFE:US,BBG000BR2B91,"$100 Billion Question: Will Trump Let Alphabet, Pfizer Keep Tax Havens?",2017-10-11 11:45:14 +0000,http://finance.yahoo.com/r/df172fa9-c8d1-3ae3-a371-1b52891b905a/will-trump-let-alphabet-pfizer-keep-tax-havens?src=A00220&yptr=yahoo&.tsrc=rss,Tax reform may not be as great as expected for companies with low international tax rates.
PFE,PFE:US,BBG000BR2B91,[$$] The Reason Investors Love Spinoffs: Juicier Returns,2017-10-11 07:02:07 +0000,http://finance.yahoo.com/r/94b84941-ae8e-37f4-a474-7bf441a289b2/the-reason-investors-love-spinoffs-juicier-returns-1507681008?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Pfizer and Honeywell announced plans to hive off major business units, a reminder that spinoffs remain popular with executives as well as investors, who appreciate their long history of outperforming the ..."
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer Considers a Sale or Spinoff of Its Consumer Healthcare Business,2017-10-11 07:00:27 +0000,http://finance.yahoo.com/r/1d1bc299-6d11-3062-ae63-3beee9c6c054/pfizer-reviews-consumer-healthcare-business-options-could-include-spinoff-or-sale-1507634886?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Pfizer is exploring a sale or spin-off of its consumer-health business, the pharmaceutical company’s latest move to double down on prescription-drug sales and a potential prelude to more deal-making."
PFE,PFE:US,BBG000BR2B91,Asian shares higher after Wall Street sets new record high,2017-10-11 04:19:48 +0000,https://finance.yahoo.com/news/us-stocks-rise-forecasts-wal-mart-airlines-141751300--finance.html?.tsrc=rss,Asian stocks advanced Wednesday after Wall Street's main index closed at a fresh record high and Spain's Catalonia crisis eased after an independence leader backed away from plans to break away immediately. ...
PFE,PFE:US,BBG000BR2B91,The Pharma Chief Who Sees Profit Where Skeptics See Lousy Odds,2017-10-11 04:00:16 +0000,http://finance.yahoo.com/r/3e9cb734-fa57-3b50-aa0d-59f990780465/the-pharma-chief-who-sees-profit-where-skeptics-see-lousy-odds?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,AstraZeneca boss Pascal Soriot has long embraced risky bets.
PFE,PFE:US,BBG000BR2B91,Asian shares higher after Wall Street sets new record high,2017-10-11 03:27:03 +0000,http://finance.yahoo.com/r/f62b36e8-a63b-33b3-b4b4-8ad16fc5226e/us-stocks-rise-forecasts-wal-mart-airlines-141751300--finance.html?.tsrc=rss,HONG KONG (AP) — Asian stocks advanced Wednesday after Wall Street's main index closed at a fresh record high and Spain's Catalonia crisis eased after an independence leader backed away from plans to break away immediately.
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. (PFE) May Spin Off Consumer Health Biz,2017-10-11 03:10:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QxTbPrFp5EM/pfizer-inc-pfe-may-spin-off-consumer-health-biz-cm857886,InvestorPlace Stock Market News Stock Advice amp Trading Tips Pfizer Inc NYSE PFE is considering spinning off its consumer health business according to sources close to the matter The combination of these brands is worth a reported
PFE,PFE:US,BBG000BR2B91,[$$] Spinoffs Juice Investor Returns,2017-10-11 00:00:44 +0000,http://finance.yahoo.com/r/1b21bceb-e1e1-3680-8a7f-f0aa029da980/SB21791610971150393684804583445552940427508.html?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Among corporate executives, spinoffs of divisions have come in and out of favor over the years, but with one group they have been a steady crowd-pleaser: investors."
PFE,PFE:US,BBG000BR2B91,10 Best Stocks to Buy and Hold for the Next Decade,2017-10-10 22:10:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OQkRqLCNXSU/10-best-stocks-to-buy-and-hold-for-the-next-decade-cm857835,InvestorPlace Stock Market News Stock Advice amp Trading Tips Long term investing seems more difficult now than it has ever been and finding stocks to buy and hold for years seems like a tough task Source Shutterstock Consumer tastes are moving away from dominant brands
PFE,PFE:US,BBG000BR2B91,Business Highlights,2017-10-10 21:18:22 +0000,https://finance.yahoo.com/news/business-highlights-211822145.html?.tsrc=rss,"___ P&G, in early vote, fends off activist investor Nelson Peltz Initial voting results show that Procter & Gamble successfully fended off an attempt activist investor Nelson Peltz to capture a seat on ..."
PFE,PFE:US,BBG000BR2B91,Pfizer considers consumer business sale,2017-10-10 21:11:25 +0000,https://finance.yahoo.com/news/pfizer-considers-consumer-business-sale-125008631.html?.tsrc=rss,"Pfizer may be done selling ChapStick, Advil, Robitussin and other brands that people can buy without a prescription. The pharmaceutical giant is weighing options for its consumer health care business. ..."
PFE,PFE:US,BBG000BR2B91,Dow Component Pfizer Mulls Over-The-Counter Spinoff Or Sale,2017-10-10 21:11:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ez4VmRxOD0c/dow-component-pfizer-mulls-over-the-counter-spinoff-or-sale-cm857733,Dow component Pfizer PFE said Tuesday it s considering selling or spinning off its over the counter business which includes Advil Centrum and a number of other heavy sales hitters ibd display video id 2345591 width 50 float left autostart true The Consumer
PFE,PFE:US,BBG000BR2B91,Dow Component Pfizer Mulls Over-The-Counter Spinoff Or Sale,2017-10-10 21:03:17 +0000,http://finance.yahoo.com/r/9aaaed45-56c6-3cb0-8f56-1bdfc143707b/dow-component-pfizer-mulls-over-the-counter-spinoff-or-sale?src=A00220&yptr=yahoo&.tsrc=rss,"Pfizer said Tuesday it&apos;s considering selling or spinning off its over-the-counter business, which includes Advil, Centrum and a major bolus of other heavy sales hitters."
PFE,PFE:US,BBG000BR2B91,Wal-Mart and United climb while Procter & Gamble slumps,2017-10-10 20:54:10 +0000,https://finance.yahoo.com/news/wal-mart-united-climb-while-205410450.html?.tsrc=rss,"Stocks that moved substantially or traded heavily Tuesday: Wal-Mart Stores Inc., up $3.60 to $84.13 The retailer said it expects its online sales to jump 40 percent next year. United Continental Holdings ..."
PFE,PFE:US,BBG000BR2B91,Pfizer considers consumer business sale,2017-10-10 20:14:30 +0000,http://finance.yahoo.com/r/250570df-1f78-3e50-80be-6563efa020b4/pfizer-considers-consumer-business-sale-125008631.html?.tsrc=rss,"NEW YORK (AP) — Pfizer may be done selling ChapStick, Advil, Robitussin and other brands that people can buy without a prescription."
PFE,PFE:US,BBG000BR2B91,Healthcare: Are These the Best Dividend Stocks to Buy Now?,2017-10-10 19:13:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3dl4uBTjG88/healthcare-are-these-the-best-dividend-stocks-to-buy-now-cm857738,Demand in the healthcare sector isn t tied as closely to the state of the economy as it is in most other sectors Because of that dividend paying healthcare stocks may offer income investors some insulation against market declines Is this a good time to consider adding Johnson
PFE,PFE:US,BBG000BR2B91,Going Long Pfizer Inc. (PFE) Stock Is an Easy Pill to Swallow,2017-10-10 19:10:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w8_BUpbZIQk/going-long-pfizer-inc-pfe-stock-is-an-easy-pill-to-swallow-cm857748,InvestorPlace Stock Market News Stock Advice amp Trading Tips Pfizer Inc NYSE PFE has had a decent year rising 11 year to date and 8 in the past 12 months But it still trails the iShares NASDAQ Biotechnology Index ETF NASDAQ IBB which is up 28 160 in
PFE,PFE:US,BBG000BR2B91,Pfizer weighing sale of consumer health care business,2017-10-10 18:07:00 +0000,https://finance.yahoo.com/video/pfizer-weighing-sale-consumer-health-180700933.html?.tsrc=rss,CNBC's Meg Tirrell reports Pfizer may be looking to spin off its consumer health business.
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. -- Moody's: Sale of Pfizer consumer products would be positive for liquidity,2017-10-10 17:35:07 +0000,http://finance.yahoo.com/r/05168c99-85c3-34af-b069-f6f6c0a3b287/viewresearchdoc.aspx?docid=PR_373803&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20171010_PR_373803&yptr=yahoo&.tsrc=rss,"Announcement: Moody's: Sale of Pfizer consumer products would be positive for liquidity. Global Credit Research- 10 Oct 2017. New York, October 10, 2017-- Moody's Investors Service commented that a sale ..."
PFE,PFE:US,BBG000BR2B91,Healthcare: Are These the Best Dividend Stocks to Buy Now?,2017-10-10 17:30:00 +0000,https://finance.yahoo.com/news/healthcare-best-dividend-stocks-buy-173000677.html?.tsrc=rss,"In today&apos;s episode, we offer up some insights into the risks and rewards associated with owning pharmaceutical dividend darlings Johnson & Johnson, AbbVie, and Pfizer."
PFE,PFE:US,BBG000BR2B91,Healthcare: Are These the Best Dividend Stocks to Buy Now?,2017-10-10 17:30:00 +0000,http://finance.yahoo.com/r/a107354a-7c0d-32f6-ad1a-09499095e94d/healthcare-are-these-the-best-dividend-stocks-to-b.aspx?yptr=yahoo&.tsrc=rss,"In today&apos;s episode, we offer up some insights into the risks and rewards associated with owning pharmaceutical dividend darlings Johnson & Johnson, AbbVie, and Pfizer."
PFE,PFE:US,BBG000BR2B91,Pfizer weighs $15 billion sale of consumer healthcare business,2017-10-10 17:07:25 +0000,https://finance.yahoo.com/news/pfizer-weighs-15-billion-sale-170725400.html?.tsrc=rss,"The move comes as Germany's Merck KGaA is also looking to divest its non-prescription products, including brands such as Seven Seas vitamins, which could be worth around $4.5 billion.  As ageing populations and health-conscious consumers drive demand for self-medication, the fragmented consumer health sector has proved a fertile ground for deal-making in recent years.  Pfizer's consumer healthcare business, whose brands include painkiller Advil and lip balm Chapstick, had revenue of about $3.4 billion in 2016."
PFE,PFE:US,BBG000BR2B91,Pfizer weighs $15 billion sale of consumer healthcare business,2017-10-10 16:58:14 +0000,https://finance.yahoo.com/news/pfizer-mulling-sale-consumer-healthcare-110043219.html?.tsrc=rss,"The move comes as Germany's Merck KGaA (MRCG.DE) is also looking to divest its non-prescription products, including brands such as Seven Seas vitamins, which could be worth around $4.5 billion.  As ageing populations and health-conscious consumers drive demand for self-medication, the fragmented consumer health sector has proved a fertile ground for deal-making in recent years.  Pfizer's consumer healthcare business, whose brands include painkiller Advil and lip balm Chapstick, had revenue of about $3.4 billion in 2016."
PFE,PFE:US,BBG000BR2B91,Pfizer weighs $15 bln sale of consumer healthcare business,2017-10-10 16:57:59 +0000,https://finance.yahoo.com/news/pfizer-mulling-sale-consumer-healthcare-110030355.html?.tsrc=rss,"The move comes as Germany's Merck KGaA (MRCG.DE) is also looking to divest its non-prescription products, including brands such as Seven Seas vitamins, which could be worth around $4.5 billion.  As ageing populations and health-conscious consumers drive demand for self-medication, the fragmented consumer health sector has proved a fertile ground for deal-making in recent years.  Pfizer's consumer healthcare business, whose brands include painkiller Advil and lip balm Chapstick, had revenue of about $3.4 billion in 2016."
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer: shelf medication,2017-10-10 16:52:56 +0000,"http://finance.yahoo.com/r/c2271787-4498-3983-873b-1968516027e6/78cdbb2c-adcc-11e7-beba-5521c713abf4,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Non-prescription medicines are financially better for investors than customers, who often buy hurriedly when their decision making is impaired. The flu-struck and the inflamed reach reflexively for Robitussin ..."
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer Reviews Options for Consumer Healthcare Business,2017-10-10 16:43:27 +0000,http://finance.yahoo.com/r/1d1bc299-6d11-3062-ae63-3beee9c6c054/pfizer-reviews-consumer-healthcare-business-options-could-include-spinoff-or-sale-1507634886?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Pfizer is exploring a sale or spin-off of its consumer-health business, the pharmaceutical company’s latest move to double down on prescription-drug sales and a potential prelude to more deal-making."
PFE,PFE:US,BBG000BR2B91,5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings,2017-10-10 16:17:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wP2vD6cg5FA/5-pharma-biotech-stocks-that-could-be-big-winners-in-q3-earnings-cm857590,Pharma and biotech stocks started 2017 on a strong note with this part of the market remaining in favor as the year progresses So far this year the Nasdaq Biotechnology Index and the NYSE ARCA Pharmaceutical Index are up 25 6 and 14 6 respectively With investors being more
PFE,PFE:US,BBG000BR2B91,This Pfizer Disposal Won't Leave Investors Hanging,2017-10-10 15:43:11 +0000,http://finance.yahoo.com/r/4cc9ea98-4e79-31e9-8b2d-b03e00a15d3c/pfizer-consumer-health-disposal-won-t-leave-us-hanging?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Selling its consumer unit is an easy call, unlike its four-year split-up indecision."
PFE,PFE:US,BBG000BR2B91,"Stocks Climb; Wal-Mart Takes Buy Point, Tesla Gets Price Hike",2017-10-10 15:15:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GCvwmt7nCuc/stocks-climb-wal-mart-takes-buy-point-tesla-gets-price-hike-cm857355,Stocks opened to solid gains Tuesday as Wal Mart WMT hauled the Dow to a new high and a rallying American Airlines Group AAL helped the Nasdaq to new high ground ibd display video id 2345165 width 50 float left autostart true The Nasdaq leapt 0 3 at the start
PFE,PFE:US,BBG000BR2B91,Honeywell To Spin Off 2 Units; Pfizer Mulls Consumer Sale; P&G-Peltz Proxy Fight Today,2017-10-10 15:15:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MTPmZLIvuaU/honeywell-to-spin-off-2-units-pfizer-mulls-consumer-sale-pg-peltz-proxy-fight-today-cm857336,Honeywell HON confirmed Tuesday that it would split two noncore units into separately traded companies by the end of next year but hold onto its big aerospace assets Meanwhile Pfizer PFE said it may sell or spin off its consumer health unit Procter amp
PFE,PFE:US,BBG000BR2B91,Going Long Pfizer Inc. (PFE) Stock Is an Easy Pill to Swallow,2017-10-10 14:57:03 +0000,https://finance.yahoo.com/news/going-long-pfizer-inc-pfe-145703514.html?.tsrc=rss,"Pfizer Inc. (NYSE:PFE) has had a decent year, rising 11% year-to-date and 8% in the past 12 months.  Fundamentally, PFE stock could play catch up since its value is mid-range compared to its competitors.  Today’s trade is bullish PFE stock."
PFE,PFE:US,BBG000BR2B91,5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings,2017-10-10 14:01:02 +0000,https://finance.yahoo.com/news/5-pharma-biotech-stocks-could-140102820.html?.tsrc=rss,Here is a look at 5 pharma and biotech stocks including Pfizer (PFE) that are expected to post a positive earnings surprise in Q3.
PFE,PFE:US,BBG000BR2B91,News Update – Market Open,2017-10-10 13:59:00 +0000,https://finance.yahoo.com/video/news-market-open-135900030.html?.tsrc=rss,"CNBC brings you fast, accurate, and actionable business news and market updates."
PFE,PFE:US,BBG000BR2B91,Honeywell To Spin Off 2 Units; Pfizer Mulls Consumer Sale; P&G-Peltz Proxy Fight Today,2017-10-10 13:45:40 +0000,http://finance.yahoo.com/r/573bd85e-86c6-3750-bd45-4ad51f2ea799/honeywell-to-spin-off-2-units-pfizer-mulls-consumer-sale-pg-peltz-proxy-fight-today?src=A00220&yptr=yahoo&.tsrc=rss,"Honeywell confirmed it will split some noncore assets into two separately traded firms. Pfizer may divest its consumer health unit, while P&G&apos;s proxy showdown is here."
PFE,PFE:US,BBG000BR2B91,"Stocks Climb; Wal-Mart Takes Buy Point, Tesla Gets Price Hike",2017-10-10 13:44:24 +0000,http://finance.yahoo.com/r/a3993ee9-790e-3794-89b5-fc38eae6af1f/stock-futures-rise-pfizer-to-divide-tesla-gets-price-hike?src=A00220&yptr=yahoo&.tsrc=rss,Stocks opened to solid gains Tuesday as Wal-Mart hauled the Dow to a new high and a rallying American Airlines Group helped the Nasdaq to new high ground.
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 10/10/2017: JNJ, PFE, ABT, MRK, AMGN, ANAB, VICL, LLY",2017-10-10 13:30:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ujNZcgS0zlI/health-care-sector-update-for-10102017-jnj-pfe-abt-mrk-amgn-anab-vicl-lly-cm857376,Top Health Care Stocks Top Health Care Stocks JNJ flatJNJ flat PFE 1 1 PFE 1 1 ABT flatABT flat MRK 0 6 MRK 0 6 AMGN flatAMGN flat Health care shares were mostly flat in pre market trade Tuesday Health care shares were mostly flat in pre market trade Tuesday In sector
PFE,PFE:US,BBG000BR2B91,"Stocks to Watch: AIG, Wal-Mart, Honeywell, Pfizer, P&G, United Continental, Microsoft",2017-10-10 13:23:30 +0000,http://finance.yahoo.com/r/24ea3462-4674-3c83-ba24-d7f0090cd533/stocks-to-watch-aig-wal-mart-honeywell-pfizer-p-g-united-continental-microsoft-1507641808?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Among the companies with shares expected to trade actively in Tuesday's session are American International Group, Wal-Mart, Honeywell, Pfizer and Procter & Gamble."
PFE,PFE:US,BBG000BR2B91,Pfizer's Divestiture Plan No Big Deal,2017-10-10 13:00:00 +0000,https://finance.yahoo.com/news/pfizers-divestiture-plan-no-big-130000551.html?.tsrc=rss,"The wide-moat drugmaker's plan to divest its consumer business will likely create only a minor level of value-creation for shareholders, at best."
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer weighs sale of consumer health business,2017-10-10 12:30:02 +0000,"http://finance.yahoo.com/r/4210cc8c-b149-3886-acaf-8b1054ca066c/8b98ede6-adb1-11e7-aab9-abaa44b1e130,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss",Pfizer said it was looking to sell or spin off its consumer healthcare business in a move that could fetch up to $14bn of cash for the pharmaceuticals group and set off a flurry of dealmaking. The drugmaker ...
PFE,PFE:US,BBG000BR2B91,"Stocks making the biggest moves premarket: HON, PFE, WMT, AIG, MSFT & more",2017-10-10 12:15:28 +0000,http://finance.yahoo.com/r/3d7e2576-e4da-39cf-9686-50fc3f6e9876/104763053?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104763053&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
PFE,PFE:US,BBG000BR2B91,Pfizer Pops in Pre-Market After Group Considers Consumer Healthcare Sale,2017-10-10 12:14:00 +0000,http://finance.yahoo.com/r/abd0cee6-1e55-344c-bda6-a83abd7ccdbc/pfizer-mulls-consumer-healthcare-spin-off.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Pfizer's consumer healthcare division has 10 brands, including Advil and Centrum, that had $100 million or more in sales last year."
PFE,PFE:US,BBG000BR2B91,Pfizer Could Fall By 9% Or More,2017-10-10 12:07:00 +0000,http://finance.yahoo.com/r/987cd55b-3672-3fd8-9904-c96ad45cbc22/pfizer-could-fall-9-or-more?partner=YahooSA&yptr=yahoo&.tsrc=rss,Pfizer shares could dip further as Wall Street slashes its revenue and earnings projections.
PFE,PFE:US,BBG000BR2B91,3 Healthcare Dividend Stocks Ideal for Retirees,2017-10-10 11:52:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IkOGUUxUDeQ/3-healthcare-dividend-stocks-ideal-for-retirees-cm857329,What does an ideal investment portfolio look like for retirees The answer to that question varies based on each individual s financial position and goals However nearly every retiree wants to have solid dividend stocks in their portfolios With healthcare making up
PFE,PFE:US,BBG000BR2B91,Pfizer may sell consumer unit,2017-10-10 11:51:51 +0000,https://finance.yahoo.com/news/pfizer-may-sell-consumer-unit-110705896--finance.html?.tsrc=rss,"Pfizer may be done selling ChapStick, Advil, Robitussin and other brands that people can buy without a prescription. The pharmaceutical giant is weighing options for its consumer healthcare business. It ..."
PFE,PFE:US,BBG000BR2B91,"Pfizer to explore potential sale, spinoff of consumer healthcare business",2017-10-10 11:08:56 +0000,http://finance.yahoo.com/r/6917a596-a0bd-3f51-8314-70f7815eb2a2/Story.aspx?guid=4CDE9921-7C61-496A-A042-9937D9084235&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of Pfizer Inc. rallied 1.1% in premarket trade Tuesday, after the drug giant said it was reviewing alternatives for its consumer healthcare business. The company said the alternatives could include ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Is Weighing Sale of $17 Billion Consumer Health Unit,2017-10-10 11:02:10 +0000,http://finance.yahoo.com/r/e0008ac4-d87e-3917-aec1-36bb526c4b19/pfizer-considers-strategic-options-for-consumer-health-business?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Pfizer Inc. is considering offloading its consumer-health division in a sale that could be worth as much as $17 billion after abandoning a plan to split the drug giant in two last year.
PFE,PFE:US,BBG000BR2B91,"Pfizer is exploring sale, spin-off of its consumer health-care business",2017-10-10 10:58:10 +0000,http://finance.yahoo.com/r/50de775d-9ec7-352b-aaf5-0ccfa2ef216c/104762944?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104762944&yptr=yahoo&.tsrc=rss,Pfizer on Tuesday said it is reviewing strategic alternatives for its consumer health-care business.
PFE,PFE:US,BBG000BR2B91,CNBC poll shows 64% of households own Apple products,2017-10-10 10:47:00 +0000,https://finance.yahoo.com/video/cnbc-poll-shows-64-households-104700710.html?.tsrc=rss,"CNBC's Steve Liesman reports two-thirds of the public has an Apple product in their household, according to the latest results from CNBC's exclusive survey."
PFE,PFE:US,BBG000BR2B91,Pfizer Reviewing Strategic Alternatives for Consumer Healthcare Business,2017-10-10 10:45:00 +0000,https://finance.yahoo.com/news/pfizer-reviewing-strategic-alternatives-consumer-104500881.html?.tsrc=rss,"Pfizer Inc. today announced that it is reviewing strategic alternatives for its Consumer Healthcare business. A range of options will be considered, including a full or partial separation of the Consumer Healthcare business from Pfizer through a spin-off, sale or other transaction, and Pfizer may ultimately determine to retain the business."
PFE,PFE:US,BBG000BR2B91,2 Big Safe Havens if the Stock Rally Crashes,2017-10-10 10:32:00 +0000,http://finance.yahoo.com/r/881f5c13-c1cc-3ae6-b2c2-3ccdfa5c3c2c/4-key-drivers-may-boost-microsoft-60?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Bank of America Merrill Lynch says financials and health care will hold up if the current rally crashes, due to cheap valuations and other factors."
PFE,PFE:US,BBG000BR2B91,3 Healthcare Dividend Stocks Ideal for Retirees,2017-10-10 10:04:00 +0000,http://finance.yahoo.com/r/f30fd311-8121-3575-899c-d336ed4507c4/3-healthcare-dividend-stocks-ideal-for-retirees.aspx?yptr=yahoo&.tsrc=rss,"These healthcare stocks provide what every retiree likes: solid, dependable income and good long-term growth prospects."
PFE,PFE:US,BBG000BR2B91,"Pfizer Reviews Strategic Alternatives For Consumer Healthcare Unit, Incl Sale",2017-10-10 07:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fWztyV_sIy0/pfizer-reviews-strategic-alternatives-for-consumer-healthcare-unit-incl-sale-20171010-00326,"Pfizer Reviews Strategic Alternatives For Consumer Healthcare Unit, Incl Sale"
PFE,PFE:US,BBG000BR2B91,AstraZeneca's Tagrisso Gets Breakthrough Therapy Designation,2017-10-09 17:52:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z2kXkA-lhIw/astrazenecas-tagrisso-gets-breakthrough-therapy-designation-cm857089,AstraZeneca AZN announced that the FDA has granted Breakthrough Therapy Designation BTD for Tagrisso osimertinib for the first line treatment of patients with metastatic epidermal growth factor receptor EGFR mutation positive non small cell lung cancer NSCLC Tagrisso is
PFE,PFE:US,BBG000BR2B91,"Forget Teva (TEVA), Buy These 5 Drug Stocks Instead",2017-10-09 16:54:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0y9FQfYMR-A/forget-teva-teva-buy-these-5-drug-stocks-instead-cm857047,Israel based generic drug maker Teva Pharmaceutical Industries Limited TEVA saw its shares decline 9 4 last week with the company suffering a fresh setback in the form of FDA approval of a generic version of the company s top selling branded drug Copaxone multiple sclerosis Mylan NV
PFE,PFE:US,BBG000BR2B91,"Notable ETF Outflow Detected - XLV, JNJ, PFE, MDT",2017-10-09 16:53:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sdR2_DFwPPs/notable-etf-outflow-detected-xlv-jnj-pfe-mdt-cm857072,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Health Care Select Sector SPDR Fund Symbol XLV where we have detected an approximate 402 2 million dollar outflow that s a 2 2 decrease week over week
PFE,PFE:US,BBG000BR2B91,"Investors Are Scooping Up Shares of Apple, Ditching Bristol Myers and Pfizer",2017-10-09 14:35:00 +0000,http://finance.yahoo.com/r/719ce611-33cf-3472-ac0a-7f957d447230/investors-are-scooping-up-shares-of-apple-ditching-bristol-myers-and-pfizer.html?puc=yahoov&cm_ven=YAHOOV&yptr=yahoo&.tsrc=rss,"Investors rolled into shares of Apple in September, according to TD Ameritrade, but took profits on shares of Bristol-Myers and Pfizer shares."
PFE,PFE:US,BBG000BR2B91,"Forget Teva (TEVA), Buy These 5 Drug Stocks Instead",2017-10-09 14:20:02 +0000,https://finance.yahoo.com/news/forget-teva-teva-buy-5-142002954.html?.tsrc=rss,"With another challenge cropping up for Teva (TEVA) in the form of earlier-than-expected generic competition for the 40 mg dose of Copaxone, here is a look at 5 drug stocks that look better-positioned."
PFE,PFE:US,BBG000BR2B91,These 5 Dow Stocks Are Near Buy Zones As Earnings Season Begins,2017-10-09 13:51:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Dw56Wwo3CqI/these-5-dow-stocks-are-near-buy-zones-as-earnings-season-begins-cm856739,Despite retreating on Friday the Dow has been setting record highs But some of those stocks are still near buy points and could get the push they need to enter buy range as earnings season picks up steam 160 Your stocks to watch this week are Wal Mart WMT
PFE,PFE:US,BBG000BR2B91,These 5 Dow Stocks Are Near Buy Zones As Earnings Season Begins,2017-10-09 12:53:46 +0000,http://finance.yahoo.com/r/e11b12c5-0d72-3eb4-9ef4-80c8c0b686c8/dow-stocks-wal-mart-cisco-pfizer-utx-mrk-near-buy-points-as-earnings-season-begins?src=A00220&yptr=yahoo&.tsrc=rss,"The Dow industrials have been setting record highs, but there are still possible buying opportunities for some top blue-chip stocks, including Wal-Mart, Cisco and Pfizer."
PFE,PFE:US,BBG000BR2B91,Analysts’ Recommendations for Amgen in October 2017,2017-10-09 11:44:10 +0000,http://finance.yahoo.com/r/e9811728-6913-3524-8fac-391d802e1e6d/analysts-recommendations-for-amgen-in-october-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Of the 24 analysts tracking Amgen (AMGN) in October 2017, ~42% of the analysts recommended a “buy” rating, and the rest suggested a ”hold.” On October 5, Amgen had a consensus 12-month target price of ..."
PFE,PFE:US,BBG000BR2B91,This Dow stock looks poised to ‘pull an Intel’ and break out to a multi-year high,2017-10-09 11:22:06 +0000,http://finance.yahoo.com/r/96b5ed29-d3b0-33cc-8936-135821ec6b65/Story.aspx?guid=4A0B3720-ACDB-11E7-8FF0-A2F2318D159F&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Another Dow component — Pfizer  — could be following in Intel’s footsteps after the chip giant’s breakout, and traders ought to buy the drugmaker’s shares, says a technical analyst."
PFE,PFE:US,BBG000BR2B91,New Drugs Approved In September,2017-10-09 05:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AMA7U9Q5EXE/new-drugs-approved-in-september-20171009-00181,New Drugs Approved In September
PFE,PFE:US,BBG000BR2B91,3 Blockbuster Drugs That Still Cost More Than They Should,2017-10-07 15:51:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MBhui2fPZXM/3-blockbuster-drugs-that-still-cost-more-than-they-should-cm856667,Asking Is there a generic for that usually saves a bundle when your doctor prescribes an expensive brand name drug If you re one of the thousands of Americans who rely on Humira Enbrel or Remicade though odds are you ll still be paying through the nose for branded versions of
PFE,PFE:US,BBG000BR2B91,3 Blockbuster Drugs That Still Cost More Than They Should,2017-10-07 14:43:00 +0000,http://finance.yahoo.com/r/f4acdecd-5c16-3d8d-8348-3399049df18c/3-blockbuster-drugs-that-will-cost-more-than-they.aspx?yptr=yahoo&.tsrc=rss,The FDA has already approved cheaper biosimilar versions of three drugs that will cost Americans a combined $21 billion this year. Here&apos;s why you probably won&apos;t be able to buy any of them for a long time.
PFE,PFE:US,BBG000BR2B91,FDA: Drug shortages possible due to Puerto Rico power outage,2017-10-06 22:27:58 +0000,http://finance.yahoo.com/r/73f8aa97-d6e4-3121-9d9b-2bf8b6ef12d1/fda-drug-shortages-possible-due-211242921.html?.tsrc=rss,The Food and Drug Administration on Friday warned that U.S. drug shortages are possible because power outages in Puerto Rico have stopped or limited production at many medicine factories there.
PFE,PFE:US,BBG000BR2B91,FDA: Drug shortages possible due to Puerto Rico power outage,2017-10-06 22:27:58 +0000,https://finance.yahoo.com/news/fda-drug-shortages-possible-due-211242921.html?.tsrc=rss,The Food and Drug Administration on Friday warned that U.S. drug shortages are possible because power outages in Puerto Rico have stopped or limited production at many medicine factories there. Nearly ...
PFE,PFE:US,BBG000BR2B91,"Missing Link: Long Capital One, Bristol-Myers",2017-10-06 16:38:00 +0000,https://finance.yahoo.com/video/missing-long-capital-one-bristol-163800826.html?.tsrc=rss,"&quot;Fast Money Halftime Report&quot; trader Stephanie Link talks her new portfolio adds, Capital One and Bristol-Myers."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 10/06/2017: JNJ, PFE, ABT, MRK, AMGN, KDMN",2017-10-06 13:46:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f3nJjiA1Y8c/health-care-sector-update-for-10062017-jnj-pfe-abt-mrk-amgn-kdmn-cm856137,Top Health Care Stocks Top Health Care Stocks JNJ flatJNJ flat PFE flatPFE flat ABT flatABT flat MRK flatMRK flat AMGN flatAMGN flat Health care shares were inactive in pre market trade Friday Health care shares were inactive in pre market trade Friday In sector news Johnson
PFE,PFE:US,BBG000BR2B91,4 Large-Cap Drug Stocks to Buy on Solid Momentum Ahead of Q3,2017-10-05 22:48:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UI_qjrHImVg/4-large-cap-drug-stocks-to-buy-on-solid-momentum-ahead-of-q3-cm856013,The pharmaceutical sector has been grabbing investors attention of late with the NYSE ARCA Pharmaceutical Index gaining 13 1 and the Large Cap Pharmaceuticals 160 industry 20 7 year to date outpacing 14 7 gain for the S amp P 500 New drug approvals and tax reforms are expected to provide
PFE,PFE:US,BBG000BR2B91,4 Large-Cap Drug Stocks to Buy on Solid Momentum Ahead of Q3,2017-10-05 20:37:08 +0000,https://finance.yahoo.com/news/4-large-cap-drug-stocks-203708072.html?.tsrc=rss,"The Large Cap Pharmaceuticals industry has gained 20.7% year to date, outpacing 14.7% gain for the S&P 500."
PFE,PFE:US,BBG000BR2B91,"The 2 Surprising Reasons Exelixis, Inc. Lost 17% in September",2017-10-05 15:48:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7FpgaUqxtks/the-2-surprising-reasons-exelixis-inc-lost-17-in-september-cm855703,What happened Shares of Exelixis NASDAQ EXEL a biotech company focused on the development of therapies to treat cancer plunged 17 during the month of September according to data from S amp P Global Market Intelligence Two factors including new clinical data from
PFE,PFE:US,BBG000BR2B91,"New Research: Key Drivers of Growth for Sprint, Pfizer, Oracle, Chesapeake Energy, Ford, and Verizon - A Look Behind the Scenes at Consolidated Results, Factors of Influence, Major Initiatives and Sustained Production",2017-10-05 15:13:20 +0000,https://finance.yahoo.com/news/research-key-drivers-growth-sprint-151320131.html?.tsrc=rss,"NEW YORK, Oct. 05, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Sprint ..."
PFE,PFE:US,BBG000BR2B91,"The 2 Surprising Reasons Exelixis, Inc. Lost 17% in September",2017-10-05 14:37:00 +0000,http://finance.yahoo.com/r/c97280b3-dbf2-39de-876a-9072bf6b6b31/the-2-surprising-reasons-exelixis-inc-lost-17-in-s.aspx?yptr=yahoo&.tsrc=rss,"Despite a poor showing last month, the outlook for Exelixis&apos; lead drug remains positive."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 10/05/2017: JNJ, PFE, ABT, MRK, AMGN, DXTR, NBIX, RIGL",2017-10-05 13:27:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nhTuk8wztys/health-care-sector-update-for-10052017-jnj-pfe-abt-mrk-amgn-dxtr-nbix-rigl-cm855594,Top Health Care Stocks Top Health Care Stocks JNJ 0 3 JNJ 0 3 PFE 0 1 PFE 0 1 ABT 0 1 ABT 0 1 MRK flatMRK flat AMGN 0 2 AMGN 0 2 Health care shares were mostly higher in pre market trade Thursday Health care shares were mostly higher in pre market trade Thursday In
PFE,PFE:US,BBG000BR2B91,Pfizer Launches Novel Programs to Put Important Support Services at the Fingertips of Cancer Patients,2017-10-05 12:00:00 +0000,https://finance.yahoo.com/news/pfizer-launches-novel-programs-put-120000427.html?.tsrc=rss,"Pfizer today unveils enhanced offerings to help patients manage their life with cancer. Pfizer Oncology Together is a first-of-its-kind program for patients taking Pfizer Oncology medicines that offers dedicated social workers called ‘Care Champions’ to help navigate the complexities that accompany treatment, such as identifying resources to help find emotional support, and workplace transition, transportation ..."
PFE,PFE:US,BBG000BR2B91,"Pensionfund DSM Netherlands Buys General Electric Co, CVS Health Corp, Time Warner Inc, Sells ...",2017-10-05 07:47:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QPzRQzF0-Vs/pensionfund-dsm-netherlands-buys-general-electric-co-cvs-health-corp-time-warner-inc-sells-cm855515,Pensionfund DSM Netherlands New Purchases GE CVS TWX FDX CL CI BK EMR AEP PCG Added Positions SBRA IRM JBGS DLR Reduced Positions HIFR ARE EGP ESRT STAG Sold Out PG PCLN LLY NKE COST ADP WAT COH DRI PH New Purchases
PFE,PFE:US,BBG000BR2B91,3 High-Yield Billionaire Stocks,2017-10-05 00:47:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X1-NhmPvaKA/3-high-yield-billionaire-stocks-cm855497,Billionaire investors know a thing or two about picking stocks That s why we Fools like to scan our favorite investors holdings every couple of months to see what they have been buying and selling With that in mind we asked a team of investors to highlight an income stock that
PFE,PFE:US,BBG000BR2B91,3 High-Yield Billionaire Stocks,2017-10-04 23:30:00 +0000,http://finance.yahoo.com/r/1e46cb10-f5de-374f-aefc-347c69b8cdcf/3-high-yield-billionaire-stocks.aspx?yptr=yahoo&.tsrc=rss,Searching for income? You can follow in the masters&apos; footsteps by checking out these high-yield stocks.
PFE,PFE:US,BBG000BR2B91,"How Mylan's MS-Generic Approval Caused Teva, Momenta To Plunge",2017-10-04 20:32:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RJnO4osjttc/how-mylans-ms-generic-approval-caused-teva-momenta-to-plunge-cm855303,Never count out Mylan MYL an analyst said Wednesday after the Food and Drug Administration approved its generic versions of Teva Pharmaceutical s TEVA Copaxone a multiple sclerosis drug 160 setting shares of the two companies on vastly divergent
PFE,PFE:US,BBG000BR2B91,"S.Africa watchdog drops over-charging probe into Aspen, Equity",2017-10-04 16:12:28 +0000,https://finance.yahoo.com/news/africa-watchdog-drops-over-charging-161228080.html?.tsrc=rss,"In June, the Competition Commission said it would  investigate Aspen, U.S. company Pfizer, Swiss-based  Roche Holding and its subsidiary Genentech, and Equity,  a division of Clinigen South Africa, for suspected  excessive pricing in the provision of specific cancer medicines  in the country.  ""Based on the information gathered to date, the Commission  has decided to drop the investigation against Aspen and Equity  because an excessive pricing case cannot be sustained against  them,"" the agency said in a statement on Wednesday."
PFE,PFE:US,BBG000BR2B91,Allergan's Botox Gets FDA Nod for Forehead Line Treatment,2017-10-04 15:36:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zEQs0CtzZpk/allergans-botox-gets-fda-nod-for-forehead-line-treatment-cm855190,Allergan plc AGN announced that the FDA has approved its Botox Cosmetic product for a third indication temporary improvement of moderate to severe forehead lines in appearance associated with frontalis muscle activity in adults So far this year Allergan s share price has slipped 0
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Pfizer, AT&T, BlackRock U.S. Bancorp and Walt Disney",2017-10-04 14:37:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jcIDdsA6KZk/the-zacks-analyst-blog-highlights-pfizer-att-blackrock-us-bancorp-and-walt-disney-cm855126,For Immediate Release Chicago IL October 04 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the
PFE,PFE:US,BBG000BR2B91,"S.Africa watchdog drops over-charging probe into Aspen, Equity",2017-10-04 14:10:19 +0000,https://finance.yahoo.com/news/africa-watchdog-drops-over-charging-141019999.html?.tsrc=rss,"In June, the Competition Commission said it would  investigate Aspen, U.S. company Pfizer, Swiss-based  Roche Holding and its subsidiary Genentech, and Equity,  a division of Clinigen South Africa, for suspected  excessive pricing in the provision of specific cancer medicines  in the country.  ""Based on the information gathered to date, the Commission  has decided to drop the investigation against Aspen and Equity  because an excessive pricing case cannot be sustained against  them,"" the agency said in a statement on Wednesday."
PFE,PFE:US,BBG000BR2B91,"Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for October 05, 2017",2017-10-04 13:21:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n0qnPsGunXE/bristol-myers-squibb-company-bmy-ex-dividend-date-scheduled-for-october-05-2017-cm855059,Bristol Myers Squibb Company BMY will begin trading ex dividend on October 05 2017 A cash dividend payment of 0 39 per share is scheduled to be paid on November 01 2017 Shareholders who purchased BMY prior to the ex dividend date are eligible for the cash dividend payment This marks
PFE,PFE:US,BBG000BR2B91,Allergan&apos;s Botox Gets FDA Nod for Forehead Line Treatment,2017-10-04 13:15:01 +0000,https://finance.yahoo.com/news/allergan-apos-botox-gets-fda-131501131.html?.tsrc=rss,Allergan (AGN) secures an FDA approval for Botox Cosmetic product for its third indication of forehead line development.
PFE,PFE:US,BBG000BR2B91,Why Pfizer is the 'Top Dividend Stock of the Dow' With 3.5% Yield (PFE),2017-10-04 12:29:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BneqndzKRS4/why-pfizer-is-the-top-dividend-stock-of-the-dow-with-35-yield-pfe-cm854983,Pfizer Inc Symbol PFE has been named as the Top Dividend Stock of the Dow according to Dividend Channel which published its most recent DividendRank report The report noted that among the components of the Dow Jones Industrial Average PFE shares displayed both attractive
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Pfizer, AT&T, BlackRock U.S. Bancorp and Walt Disney",2017-10-04 12:12:12 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-pfizer-121212426.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Pfizer, AT&T, BlackRock U.S. Bancorp and Walt Disney"
PFE,PFE:US,BBG000BR2B91,"Top Research Reports for Pfizer, AT&T & BlackRock",2017-10-03 23:53:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/elariDuUNsA/top-research-reports-for-pfizer-att-blackrock-cm854926,Tuesday October 3 2017 The Zacks Research Daily presents the best research output of our analyst team Today s Research Daily features new research reports on 16 major stocks including Pfizer PFE AT amp T T and BlackRock BLK These research reports have been hand picked from the
PFE,PFE:US,BBG000BR2B91,"Top Research Reports for Pfizer, AT&T & BlackRock",2017-10-03 21:43:09 +0000,https://finance.yahoo.com/news/top-research-reports-pfizer-t-214309552.html?.tsrc=rss,"Top Research Reports for Pfizer, AT&T & BlackRock"
PFE,PFE:US,BBG000BR2B91,Is This How Drugmakers Will Kill Biosimilars?,2017-10-03 14:54:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pHuS60jX2K0/is-this-how-drugmakers-will-kill-biosimilars-cm854486,Pfizer NYSE PFE has filed a lawsuit accusing Johnson amp Johnson NYSE JNJ of strong arming insurers into excluding its Remicade biosimilar Inflectra from their reimbursement lists If drugmakers start to employ this strategy widely it could have big implications on the
PFE,PFE:US,BBG000BR2B91,Is This How Drugmakers Will Kill Biosimilars?,2017-10-03 14:39:00 +0000,http://finance.yahoo.com/r/a625e808-2cdf-39ca-bff2-11aea2b7be7a/is-this-how-drugmakers-will-kill-biosimilars.aspx?yptr=yahoo&.tsrc=rss,"Pfizer is accusing Johnson & Johnson of making unfair deals with insurers to reduce demand for Inflectra, its Remicade biosimilar."
PFE,PFE:US,BBG000BR2B91,[$$] Big Questions for Big Pharma,2017-10-03 14:19:00 +0000,http://finance.yahoo.com/r/e77903f7-eb88-3df7-9671-aba3546ca973/big-questions-for-big-pharma-1507040386?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Credit Suisse  We have spent much of the past several weeks on the road, attending medical conferences and meeting with various companies and investors.  Overall, sentiment on the group remains relatively robust with noise on the U.S. drug pricing side far below what it has been and investors still cautiously optimistic on the possibility of U.S. corporate tax reform coming through in 2018.  What will get Allergan (AGN) turned around?"
PFE,PFE:US,BBG000BR2B91,Gender Focus Proves Rewarding for This ETF,2017-10-03 14:05:00 +0000,http://finance.yahoo.com/r/bf35ade2-e2a9-3688-a863-f769e087aa3b/gender-focus-proves-rewarding-etf?partner=YahooSA&yptr=yahoo&.tsrc=rss,The gender diversity ETF is one to consider for socially conscious investors.
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 10/03/2017: JNJ, PFE, ABT, MRK, AMGN, DMPI, RDHL, RIGL",2017-10-03 13:26:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Artgl5Pwk6o/health-care-sector-update-for-10032017-jnj-pfe-abt-mrk-amgn-dmpi-rdhl-rigl-cm854411,Top Health Care Stocks Top Health Care Stocks JNJ 0 4 JNJ 0 4 PFE 0 03 PFE 0 03 ABT flatABT flat MRK 0 2 MRK 0 2 AMGN flatAMGN flat Health care shares were mostly higher in pre market trade Tuesday Health care shares were mostly higher in pre market trade Tuesday In
PFE,PFE:US,BBG000BR2B91,3 Winning Dividend Strategies To Survive The Next Pullback,2017-10-03 12:36:00 +0000,http://finance.yahoo.com/r/44235074-584d-3260-a3bf-6b4d68ef0ae0/3-winning-dividend-strategies-to-survive-the-next-pullback?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,It’s a question I’m hearing from a lot of investors these days... how should I prepare for the next market crash?
PFE,PFE:US,BBG000BR2B91,Markets Move Higher; Inversion Rules Put Pfizer-Allergan Back In Focus -- ICYMI,2017-10-03 00:28:00 +0000,http://finance.yahoo.com/r/ab7a3ffc-eca2-377c-8b46-6a2c2664f9b9/markets-move-higher-inversion-rules-put-pfizer-allergan-back-in-focus-icymi.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Here's what you need to know now for Monday, Oct. 2."
PFE,PFE:US,BBG000BR2B91,"AbbVie Patent Deal Staves Off Amgen Competition, But Others Lurk",2017-10-02 20:49:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lSO6CNos0QU/abbvie-patent-deal-staves-off-amgen-competition-but-others-lurk-cm854065,AbbVie s ABBV Humira franchise is safe through 2023 after a patent settlement with Amgen AMGN an analyst said Monday as he upgraded AbbVie and predicted that its profits would outgrow other large cap pharmas through 2021 ibd display video id 2325332 width
PFE,PFE:US,BBG000BR2B91,Merck's Keytruda Continues To Roll With Another FDA Approval,2017-10-02 18:48:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wt3hU7DPyRw/mercks-keytruda-continues-to-roll-with-another-fda-approval-cm854145,Merck s 160 MRK Keytruda was recently approved by the U S FDA for gastric cancer Keytruda has been on a strong run in 2017 with a series of approvals Keytruda already had approval for melanoma metastatic non small cell lung cancer head and neck cancer Hodgkin s lymphoma and
PFE,PFE:US,BBG000BR2B91,Interesting November Stock Options for PFE,2017-10-02 17:50:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/38zFpNYGJEU/interesting-november-stock-options-for-pfe-cm854089,Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the November expiration for PFE The put contract
PFE,PFE:US,BBG000BR2B91,"How To Trade The 8 'Dogs Of The Dow,' Which Outperformed The Dow In September",2017-10-02 16:38:00 +0000,http://finance.yahoo.com/r/351b1cee-b1dd-3502-8f2d-5031d67b44aa/the-8-dogs-of-the-dow-outperformed-the-dow-in-september-heres-how-to-trade-them-now?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Investment strategies for the 'Dogs of the Dow,' which include Boeing and Cisco,"
PFE,PFE:US,BBG000BR2B91,"[$$] Lilly Faces Off With Pfizer, Novartis",2017-10-02 15:14:00 +0000,http://finance.yahoo.com/r/46b527a7-d65b-3b7e-af65-f74cade81a5b/lilly-faces-off-with-pfizer-novartis-1506957267?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Credit Suisse  Lilly’s Verzenio (abemaciclib) has obtained Food and Drug Administration approval for use in patients with HR+, HER2- metastatic breast cancer who progressed on prior therapy.  Given the data that we have seen for Lilly’s (LLY) product from the MONARCH-1 and MONARCH-2 studies, we had expected the approval, although it does comes three to four months earlier than we had expected, representing another example of the agency working to get innovative products to the market quickly.  Along with approval for use in combination with fulvestrant, Verzenio has the unique indication (relative to key competitors Pfizer’s (PFE) Ibrance and Novartis’s (NVS) Kisqali) for use as monotherapy after endocrine therapy and chemotherapy in patients with metastatic disease."
PFE,PFE:US,BBG000BR2B91,"Better Buy: Gilead Sciences, Inc. vs. Pfizer",2017-10-02 14:50:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3tzNb5lBpfM/better-buy-gilead-sciences-inc-vs-pfizer-cm853853,The biopharmaceutical industry has been exceptionally kind to investors over the past six years because of the introduction of several new classes of drugs greater insurance coverage for low income individuals in the United States and the aging global population Even so the industry
PFE,PFE:US,BBG000BR2B91,3 Crash-Survival Tips Every Investor Should Know,2017-10-02 13:45:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yX8Z50LHhPg/3-crash-survival-tips-every-investor-should-know-cm853808,By Brett Owens It s a question I m hearing from a lot of investors these days and it just came up again a few days ago How should I prepare for the next market crash It s not hard to see why folks are worried about their nest eggs with the S amp P 500 bubbling along at
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 10/02/2017: JNJ, PFE, ABT, MRK, AMGN, KTOV, MNKD, AEMD",2017-10-02 13:36:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jxgVxaItClU/health-care-sector-update-for-10022017-jnj-pfe-abt-mrk-amgn-ktov-mnkd-aemd-cm853800,Top Health Care Stocks Top Health Care Stocks JNJ 0 2 JNJ 0 2 PFE 0 1 PFE 0 1 ABT flatABT flat MRK flatMRK flat AMGN 0 03 AMGN 0 03 Health care shares were mixed in pre market trade Monday Health care shares were mixed in pre market trade Monday In sector news
PFE,PFE:US,BBG000BR2B91,Quality Dividend ETFs for Turbulent Times,2017-10-02 13:01:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SE5e4AomB1k/quality-dividend-etfs-for-turbulent-times-cm853755,U S equity markets are going through turbulent times There is a lot of volatility and uncertainty owing to rising geopolitical risks and political uncertainty This has increased the appeal of dividend investing Geopolitical Risks Geopolitical risks have been on the rise
PFE,PFE:US,BBG000BR2B91,"Better Buy: Gilead Sciences, Inc. vs. Pfizer",2017-10-02 13:00:00 +0000,http://finance.yahoo.com/r/57f4e08d-c704-335b-b24b-598171e3ff73/better-buy-gilead-sciences-inc-vs-pfizer.aspx?yptr=yahoo&.tsrc=rss,This top pharma stock proves that slow and steady wins the race.
PFE,PFE:US,BBG000BR2B91,"Best Buy: Johnson & Johnson, Pfizer, or Gilead Sciences?",2017-10-02 00:28:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PIw5wnQmjoo/best-buy-johnson-johnson-pfizer-or-gilead-sciences-cm853622,Remember the old game show Let s Make a Deal It was originally hosted by the recently deceased Monty Hall and its current iteration is hosted by comedian Wayne Brady Contestants can choose from one of three doors one of which usually has a nice prize behind it but at least one
PFE,PFE:US,BBG000BR2B91,"Best Buy: Johnson & Johnson, Pfizer, or Gilead Sciences?",2017-10-01 23:03:00 +0000,http://finance.yahoo.com/r/9dc9a026-7c28-3bd6-9e82-8fada667185d/best-buy-johnson-johnson-pfizer-or-gilead-sciences.aspx?yptr=yahoo&.tsrc=rss,"These are three of the biggest and most successful drugmakers on the planet, but which is the best stock for investors right now?"
PFE,PFE:US,BBG000BR2B91,Pfizer Exposes the Sordid Underbelly of Drug Prices,2017-10-01 13:30:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rzkQZlJIZBE/pfizer-exposes-the-sordid-underbelly-of-drug-prices-cm853550,Johnson amp Johnson s NYSE JNJ 160 one of the largest drugmakers in the world and according to a lawsuit Pfizer NYSE PFE has filed it s leveraging its size to negotiate contracts that prevent insurers from paying for cheaper biosimilars to Remicade
PFE,PFE:US,BBG000BR2B91,Pfizer Exposes the Sordid Underbelly of Drug Prices,2017-10-01 11:31:00 +0000,http://finance.yahoo.com/r/d1984c58-052f-3115-a551-49d009d7608f/pfizer-exposes-the-sordid-underbelly-of-drug-price.aspx?yptr=yahoo&.tsrc=rss,"A suit Pfizer filed last week accuses Johnson & Johnson of using anti-competitive tactics to keep insurers from paying for Inflectra, a cheaper alternative to top-selling autoimmune-disease drug Remicade."
PFE,PFE:US,BBG000BR2B91,"XLV, HEWW: Big ETF Outflows",2017-09-29 16:36:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xCJWeV9v0rs/xlv-heww-big-etf-outflows-cm853163,Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel the biggest outflow was seen in the Health Care Select Sector SPDR Fund XLV where 4 750 000 units were destroyed or a 2 1 decrease week over week Among the largest underlying
PFE,PFE:US,BBG000BR2B91,"VYM, PFE, BMY, CB: ETF Outflow Alert",2017-09-29 16:35:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YyG_d6mqO6E/vym-pfe-bmy-cb-etf-outflow-alert-cm853162,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard High Dividend Yield ETF Symbol VYM where we have detected an approximate 85 0 million dollar outflow that s a 0 4 decrease week over week
PFE,PFE:US,BBG000BR2B91,Must-Know Changes to Bristol-Myers Squibb’s Valuation,2017-09-29 14:40:15 +0000,http://finance.yahoo.com/r/5291550d-982b-3297-9fe7-e6b51ab4ffff/must-know-changes-to-bristol-myers-squibbs-valuation?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Bristol-Myers Squibb (BMY), a US pharmaceutical company, includes innovative products from its Cardiovascular, Immunoscience, Neuroscience, Oncology, and Virology franchises."
PFE,PFE:US,BBG000BR2B91,What’s Johnson & Johnson’s Valuation?,2017-09-29 13:08:51 +0000,http://finance.yahoo.com/r/484123c4-4c65-354b-ae39-46b47e5d9aee/whats-johnson-johnsons-valuation?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Johnson & Johnson (JNJ) reported earnings per share (or EPS) of $1.83 on revenues of $18.8 billion in 2Q17.
PFE,PFE:US,BBG000BR2B91,Could Tax Reform Boost the Healthcare Sector?,2017-09-29 12:28:08 +0000,http://finance.yahoo.com/r/b5562161-3edb-3adb-bb7f-77ee583ec519/will-tax-reform-boost-healthcare-sector?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,The healthcare sector remained the second largest gainer of the S&P 500 Index (SPY) so far in 2017 in September.
PFE,PFE:US,BBG000BR2B91,Is Pfizer Inc (PFE) A Buy At Its Current Price?,2017-09-29 00:10:14 +0000,https://finance.yahoo.com/news/pfizer-inc-pfe-buy-current-001014166.html?.tsrc=rss,"Pfizer Inc (NYSE:PFE) trades with a trailing P/E of 25.7x, which is lower than the industry average of 27.5x. Although some investors may jump to the conclusion that this isRead More..."
PFE,PFE:US,BBG000BR2B91,Cramer's lightning round: Re-pounding the table on DowDuP...,2017-09-28 23:08:00 +0000,https://finance.yahoo.com/video/cramers-lightning-round-pounding-table-230800707.html?.tsrc=rss,"Jim Cramer speeds through his take on callers' favorite stocks, including recently merged chemical giant DowDuPont."
PFE,PFE:US,BBG000BR2B91,Cramer's lightning round: Re-pounding the table on DowDuPont,2017-09-28 22:51:56 +0000,http://finance.yahoo.com/r/66c66f01-409d-3566-ae66-8233f82508a2/104738176?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104738176&yptr=yahoo&.tsrc=rss,"Jim Cramer speeds through his take on callers' favorite stocks, including recently merged chemical giant DowDuPont."
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Fourth-Quarter Dividend,2017-09-28 22:26:52 +0000,https://finance.yahoo.com/news/pfizer-announces-fourth-quarter-dividend-221817626.html?.tsrc=rss,Company paying dividend of 32 cents with a forward dividend yield of 3.61%
PFE,PFE:US,BBG000BR2B91,Why Amgen's Drug Win Sent AbbVie Stock Into The Stratosphere,2017-09-28 21:34:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6RgH0tGmS00/why-amgens-drug-win-sent-abbvie-stock-into-the-stratosphere-cm852720,AbbVie ABBV launched to a record high Thursday after it settled a patent dispute with Amgen AMGN that will require the No 1 biotech to pay AbbVie royalties on sales of its Humira copycat ibd display video id 2322998 width 50 float left autostart true By
PFE,PFE:US,BBG000BR2B91,Tax reform could spark a wave of biopharma M&A,2017-09-28 21:27:00 +0000,https://finance.yahoo.com/video/tax-reform-could-spark-wave-212700721.html?.tsrc=rss,CNBC's Meg Tirrell discusses the failed attempts at Pfizer trying to acquire two companies in the past but how the Republican tax reform plan could change that. The “Fast Money” traders weigh in.
PFE,PFE:US,BBG000BR2B91,Eli Lilly wins U.S. approval for breast cancer drug,2017-09-28 20:41:36 +0000,https://finance.yahoo.com/news/eli-lilly-wins-u-approval-183549014.html?.tsrc=rss,"The U.S. Food and Drug Administration  said on Thursday it approved an Eli Lilly and Co drug to  treat advanced breast cancer that has progressed following prior  treatment.  The drug, abemaciclib, which will be sold under the brand  name Verzenio, will carry a list price before any discounts or  rebates of about $10,948 per month, Lilly said.  Verzenio belongs to a newer class of oral medicines called  CDK 4/6 inhibitors that block cancer cells' ability to divide  and proliferate."
PFE,PFE:US,BBG000BR2B91,This Drug Pricing Scheme Could Be Making Your Medicine More Expensive,2017-09-28 19:41:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Nvl8p6ZfiPc/this-drug-pricing-scheme-could-be-making-your-medicine-more-expensive-cm852767,Biosimilars that are as safe and effective as expensive brand name biologics could significantly reduce drug prices and healthcare spending but only if they win support from insurers Unfortunately drugmakers like Johnson amp Johnson NYSE JNJ may be employing tactics to keep
PFE,PFE:US,BBG000BR2B91,This Drug Pricing Scheme Could Be Making Your Medicine More Expensive,2017-09-28 18:27:00 +0000,http://finance.yahoo.com/r/06fdeefa-1d70-3266-a103-dceb2f1ad878/this-drug-pricing-scheme-could-be-making-your-medi.aspx?yptr=yahoo&.tsrc=rss,"Unpacking Axovant Sciences big Alzheimer’s disease disappointment, plus Pfizer accuses Johnson & Johnson of unfairly increasing healthcare costs."
PFE,PFE:US,BBG000BR2B91,Moody's: Biosimilars Market Adoption Faces Hurdles But Development Continues Apace,2017-09-28 15:56:05 +0000,http://finance.yahoo.com/r/51d6ebe7-c909-3ab3-a138-db44d5f6b029/viewresearchdoc.aspx?docid=PR_373317&WT.mc_id=AM~WWFob29fRmluYW5jZTQyX1NCX0NWX1JhdGluZ19OZXdzX0FsbF9Fbmc=~20170928_PR_373317&yptr=yahoo&.tsrc=rss,"Announcement: Moody's: Biosimilars Market Adoption Faces Hurdles But Development Continues Apace. Global Credit Research- 28 Sep 2017. New York, September 28, 2017-- The slow launch of Pfizer's Inflectra ..."
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-09-28 12:00:36 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120036382.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Sep 27, 2017 :  CNDT, AABA, CSCO, QQQ, T, HPQ, MDLZ, IEF, PFE, F, SYF, EBAY",2017-09-27 20:58:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FI4V7yjYz68/after-hours-most-active-for-sep-27-2017-cndt-aaba-csco-qqq-t-hpq-mdlz-ief-pfe-f-syf-ebay-cm852181,The NASDAQ 100 After Hours Indicator is up 47 to 5 938 26 The total After hours volume is currently 51 872 437 shares traded The following are the most active stocks for the after hours session Conduent Incorporated CNDT is 0 13 at 15 50 with 3 682 553 shares
PFE,PFE:US,BBG000BR2B91,3 Dividend Stocks to Buy and Hold Forever,2017-09-27 18:53:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dhvVa62qc7k/3-dividend-stocks-to-buy-and-hold-forever-cm852105,InvestorPlace Stock Market News Stock Advice amp Trading Tips Dividend and growth fanatics have argued tooth and nail about who backs the superior strategy for decades But time and time again deep research shows that investors like you and I that prefer collecting
PFE,PFE:US,BBG000BR2B91,3 High-Yield Stocks to Own in a Market Crash,2017-09-27 16:54:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xH73j1dBosM/3-high-yield-stocks-to-own-in-a-market-crash-cm851944,Even after a six year bull run the broader markets don t appear to be showing any signs of slowing down Even so income seeking investors who have been riding this market to new all time highs may want to start to rotate into a handful of defensive stocks that can withstand any
PFE,PFE:US,BBG000BR2B91,Agilent Boosts Market Share With FDA Nod to New Cancer Test,2017-09-27 15:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CC2GSqFoSRI/agilent-boosts-market-share-with-fda-nod-to-new-cancer-test-cm851856,Agilent Technologies A recently received approval from the Food and Drug Administration FDA for a cancer diagnostic named PD L1 IHC 28 8 pharmDx The test will be used in cases of urothelial carcinoma UC and squamous cell carcinoma of the head and neck SCCHN This is a new step in
PFE,PFE:US,BBG000BR2B91,3 High-Yield Stocks to Own in a Market Crash,2017-09-27 15:00:00 +0000,http://finance.yahoo.com/r/1abeb2da-5fc7-3bf3-96f1-457f8e8f239e/3-high-yield-stocks-to-own-in-a-market-crash.aspx?yptr=yahoo&.tsrc=rss,These three high-yield stocks also double as outstanding defensive plays.
PFE,PFE:US,BBG000BR2B91,Pfizer Declares 32-Cent Fourth-Quarter 2017 Dividend,2017-09-27 12:30:00 +0000,https://finance.yahoo.com/news/pfizer-declares-32-cent-fourth-123000729.html?.tsrc=rss,"The board of directors of Pfizer Inc. today declared a 32-cent fourth-quarter 2017 dividend on the company’s common stock, payable December 1, 2017, to shareholders of record at the close of business on November 10, 2017."
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-09-27 12:00:16 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120016192.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,Bavencio (avelumab) Approved for Merkel Cell Carcinoma in Japan,2017-09-27 08:00:00 +0000,https://finance.yahoo.com/news/bavencio-avelumab-approved-merkel-cell-080000046.html?.tsrc=rss,"DARMSTADT, Germany and NEW YORK , September 27, 2017 /PRNewswire/ -- Not intended for UK-based media     First-ever treatment indicated for curatively unresectable Merkel cell carcinoma (MCC)   and first ..."
PFE,PFE:US,BBG000BR2B91,Wall Street Might Open Higher,2017-09-27 07:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2EB7hWjPKL0/wall-street-might-open-higher-20170927-00390,Wall Street Might Open Higher
PFE,PFE:US,BBG000BR2B91,Bavencio Approved For Merkel Cell Carcinoma In Japan,2017-09-27 04:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qJ51KioEJ4M/bavencio-approved-for-merkel-cell-carcinoma-in-japan-20170927-00153,Bavencio Approved For Merkel Cell Carcinoma In Japan
PFE,PFE:US,BBG000BR2B91,Axovant Sciences' Alzheimer's Disease Trial Comes Up Empty -- What Now?,2017-09-26 23:52:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IQEzQ1sTb28/axovant-sciences-alzheimers-disease-trial-comes-up-empty-what-now-cm851431,Historically 99 of Alzheimer s disease drugs to enter clinical trials have failed yet Axovant Sciences NASDAQ AXON believed it could design a phase 3 trial for its Alzheimer s disease drug intepirdine that could overcome those stiff odds Sadly 160 Axovant Sciences
PFE,PFE:US,BBG000BR2B91,Patti LaBelle and Pfizer Work Together to Educate Baby Boomers About the Risk of Pneumococcal Pneumonia,2017-09-26 13:21:00 +0000,https://finance.yahoo.com/news/patti-labelle-pfizer-together-educate-132100314.html?.tsrc=rss,"Like many Baby Boomers, award-winning entertainer and music icon Patti LaBelle takes steps to stay healthy, including exercising and eating right. Yet, despite being a health-conscious Boomer, LaBelle knows there are diseases that can take her out of her routine: such as pneumococcal pneumonia, a potentially serious bacterial lung disease.1 That’s why LaBelle has joined Pfizer Inc to help launch All ..."
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: J&J Drug Gets CRL, Label Expansion for Merck and BMY Drugs",2017-09-26 12:50:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IavOpd2pqmg/pharma-stock-roundup-jj-drug-gets-crl-label-expansion-for-merck-and-bmy-drugs-cm850815,Key highlights in the pharma sector include a complete response letter CRL from the FDA for Johnson amp Johnson s JNJ investigational rheumatoid arthritis RA treatment and FDA approval for Merck s MRK and Bristol Myers Squibb s BMY cancer drugs Recap of the Week s Most
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Sep 25, 2017 :  T, ON, QQQ, BAC, SBUX, ADP, INTC, IBB, GE, TPRE, PFE, F",2017-09-25 20:57:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/verGKUV4MTE/after-hours-most-active-for-sep-25-2017-t-on-qqq-bac-sbux-adp-intc-ibb-ge-tpre-pfe-f-cm850657,The NASDAQ 100 After Hours Indicator is up 3 92 to 5 871 27 The total After hours volume is currently 68 655 630 shares traded The following are the most active stocks for the after hours session AT amp T Inc T is unchanged at 39 12 with 4 893 350 shares traded T
PFE,PFE:US,BBG000BR2B91,"One Put, One Call Option To Know About for Pfizer",2017-09-25 17:47:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xpWTFEWI-mE/one-put-one-call-option-to-know-about-for-pfizer-cm850497,Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the January 2019 expiration for PFE The put
PFE,PFE:US,BBG000BR2B91,Merck's Keytruda Gets FDA Nod for Advanced Gastric Cancer,2017-09-25 16:52:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U-h_hQ6nFig/mercks-keytruda-gets-fda-nod-for-advanced-gastric-cancer-cm850454,Merck amp Co Inc MRK announced that the FDA has approved its anti PD 1 therapy Keytruda as a monotherapy for third line treatment of advanced gastric or gastroesophageal junction adenocarcinoma Keytruda is already approved for many types of cancers and treatment settings including
PFE,PFE:US,BBG000BR2B91,Pfizer helps pump $103M into startup to develop new cancer therapies,2017-09-25 16:15:08 +0000,http://finance.yahoo.com/r/9e7f5147-958f-3ee9-9709-b1654219123c/pfizer-helps-pump-103m-into-startup-to-develop-new.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"A local startup has been spun-out of Pfizer to develop clinical-stage experimental therapies.  Nascent medicine company SpringWorks Therapeutics completed a $103 million series A round led by the New York-based pharma giant with the help of Bain Capital, OrbiMed and LifeArc (formerly known as MRC Technology).  Pfizer (PFE) granted SpringWorks the rights to help develop four drugs or therapies that treat various conditions, including post-traumatic stress disorder and cancer."
PFE,PFE:US,BBG000BR2B91,Pfizer Channels Its Inner Biotech,2017-09-25 15:03:58 +0000,http://finance.yahoo.com/r/b7f7b013-a67a-3e59-93bf-f945500325be/pfizer-springworks-spinoff-channels-its-inner-biotech?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Four pipeline castoffs should fetch a higher valuation standing alone.
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-09-25 12:00:16 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120016172.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer tests new way of putting more drugs on trial,2017-09-25 11:02:46 +0000,"http://finance.yahoo.com/r/4e35f29e-c90d-36cd-b086-37d19c6bef52/a317c178-9fdc-11e7-8cd4-932067fbf946,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Pfizer has backed a new drug development company with the task of shepherding four of its experimental medicines through clinical trials, in an unusual deal designed to prevent promising products from ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Spins Off New Firm for Some Rare Disease Drugs,2017-09-25 11:00:00 +0000,http://finance.yahoo.com/r/25fdd068-6adf-3238-9551-c5124c1e3a87/pfizer-spins-off-new-company-to-develop-some-rare-disease-drugs?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Pfizer Inc. will spin off four experimental drugs that it had decided to shelve into a new company, called SpringWorks Therapeutics, to give them a better chance to get developed with the backing of outside ..."
PFE,PFE:US,BBG000BR2B91,[$$] Gene Therapy Is Nearing a Major Breakthrough,2017-09-25 04:01:00 +0000,http://finance.yahoo.com/r/0cc44cf1-ce16-3c9e-85bb-26fdfbce3cc5/gene-therapy-is-nearing-a-major-breakthrough-1506140340?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"After decades of research and development, gene therapy is rapidly emerging as one of the most exciting areas in biotechnology—and generating new hope for patients with certain rare and often deadly inherited diseases.  Replacement gene therapy that uses neutered viruses to deliver healthy genes to the body is particularly promising, given its potential to cure a range of disorders with the administration of a single treatment.  The first regulatory approval for this technology could come as soon as January, if the Food and Drug Administration gives the go-ahead to Spark Therapeutics (ONCE) for its one-time treatment that targets a rare, inherited retinal condition leading to blindness."
PFE,PFE:US,BBG000BR2B91,The 6 Medications Being Used to Tackle the Opioid Epidemic,2017-09-23 16:40:00 +0000,http://finance.yahoo.com/r/de6a3b82-f0bf-3b3a-bc1c-83c911b4ddbb/opioid-crisis.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The U.S. opioid crisis rages on. TheStreet takes a look at several drugs being used to help treat people.
PFE,PFE:US,BBG000BR2B91,3 Biotech Stocks That Skyrocketed This Week: Can They Go Higher?,2017-09-23 15:48:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oWzczwlRIWo/3-biotech-stocks-that-skyrocketed-this-week-can-they-go-higher-cm850027,One great thing about the biotech industry is that there are nearly always some winners Regardless of what s going on in the world or in the broader market at least a few biotech stocks are likely to gain momentum week in and week out Three such winners over the past five days
PFE,PFE:US,BBG000BR2B91,This Trial Failure Dropped Versartis Inc 86.6% and Lifted Ascendis Pharma 51.4%,2017-09-22 20:49:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NdN6DlFvjs4/this-trial-failure-dropped-versartis-inc-866-and-lifted-ascendis-pharma-514-cm849813,What happened Shares of biopharma Versartis NASDAQ VSAR crashed nearly 87 Friday after somavaratan the company s lead drug candidate did not meet its primary endpoint in the phase 3 Velocity trial The drug is a recombinant human growth hormone that was being evaluated
PFE,PFE:US,BBG000BR2B91,AstraZeneca Stock Upgraded: What You Need to Know,2017-09-22 19:18:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I9VQ8FwhS0Y/astrazeneca-stock-upgraded-what-you-need-to-know-cm849759,Every day Wall Street analysts upgrade some stocks downgrade others and initiate coverage on a few more But do these analysts even know what they re talking about Today we re taking one high profile Wall Street pick and putting it under the microscope Shares of U
PFE,PFE:US,BBG000BR2B91,Healthcare Stocks Soar After McCain Rejects Obamacare Repeal,2017-09-22 19:17:15 +0000,https://finance.yahoo.com/news/healthcare-stocks-soar-mccain-rejects-191715952.html?.tsrc=rss,"The Graham Cassidy bill appears dead, but the stock market has found new life."
PFE,PFE:US,BBG000BR2B91,This Trial Failure Dropped Versartis Inc 86.6% and Lifted Ascendis Pharma 51.4%,2017-09-22 18:44:00 +0000,http://finance.yahoo.com/r/090c1abd-52f4-363e-9896-ae19640b3f1e/this-trial-failure-dropped-versartis-inc-866-and-l.aspx?yptr=yahoo&.tsrc=rss,One biopharma&apos;s loss is another biopharma&apos;s gain when it comes to rare disease drug trials.
PFE,PFE:US,BBG000BR2B91,AstraZeneca Stock Upgraded: What You Need to Know,2017-09-22 17:08:19 +0000,http://finance.yahoo.com/r/7e1d49e2-80bd-33e4-a0ab-886776a4edf3/astrazeneca-stock-upgraded-what-you-need-to-know.aspx?yptr=yahoo&.tsrc=rss,Bernstein sees opportunity in a buyout target.
PFE,PFE:US,BBG000BR2B91,Pfizer-Merck KGaA Skin Cancer Drug Bavencio Gets EU Approval,2017-09-22 15:39:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_Zff8CgLTYY/pfizer-merck-kgaa-skin-cancer-drug-bavencio-gets-eu-approval-cm849573,Pfizer Inc PFE and German partner Merck KGaA announced that their anti PD L1 monoclonal antibody Bavencio avelumab has been granted marketing authorization in the EU as a monotherapy for treating adult patients with metastatic Merkel cell carcinoma mMCC a rare and aggressive skin
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Pfizer Files Suit against J&J, Supernus Hit by Study Update",2017-09-22 14:40:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aD0-fF1ZJ_8/pharma-stock-roundup-pfizer-files-suit-against-jj-supernus-hit-by-study-update-cm849533,Key highlights this week include a lawsuit filed by Pfizer PFE accusing Johnson amp Johnson JNJ of adopting exclusionary contracts and other anticompetitive practices to prevent biosimilar uptake Meanwhile companies like GlaxoSmithKline GSK and Supernus Pharmaceuticals SUPN were in the
PFE,PFE:US,BBG000BR2B91,"Cancer Space Update: Mixed Week for Pfizer, Roche Falters",2017-09-22 14:39:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2GaW6xvfumQ/cancer-space-update-mixed-week-for-pfizer-roche-falters-cm849500,While last week was eventful with European Society for Medical Oncology ESMO congress taking place this week saw the approval of Pfizer Inc s PFE Bavencio in Europe On the one hand TESARO Inc s TSRO Zejula received positive CHMP opinion in the EU while on the other Pfizer s Sutent
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: BA Wins $600M Air Force Contract, JPM Invests in Bill.com",2017-09-22 14:39:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fjvOLDhBNdQ/dow-30-stock-roundup-ba-wins-600m-air-force-contract-jpm-invests-in-billcom-cm849497,The Dow mopped up gains over the week buoyed by announcements from the Federal Reserve A decline in tensions between the United States and North Korea led to gains for the index on Monday The index moved higher on Tuesday on speculation that the Fed would declare that it would be trimming
PFE,PFE:US,BBG000BR2B91,Pfizer-Merck KGaA Skin Cancer Drug Bavencio Gets EU Approval,2017-09-22 13:58:01 +0000,https://finance.yahoo.com/news/pfizer-merck-kgaa-skin-cancer-135801097.html?.tsrc=rss,Pfizer and German partner Merck KGaA&apos;s Bavencio secures an EU approval for metastatic Merkel cell carcinoma. The company also expects to make the drug commercially available within a month.
PFE,PFE:US,BBG000BR2B91,What Pfizer’s Valuation Changes after 2Q17 Tell Us,2017-09-22 13:07:08 +0000,http://finance.yahoo.com/r/6bceaff1-e2cd-375e-a02e-045881c269e4/what-pfizers-valuation-changes-after-2q17-tell-us?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Analysts estimate that Pfizer (PFE) stock has the potential to return ~5.9% over the next 12 months.
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: BA Wins $600M Air Force Contract, JPM Invests in Bill.com",2017-09-22 12:59:12 +0000,https://finance.yahoo.com/news/dow-30-stock-roundup-ba-125912947.html?.tsrc=rss,"The Dow mopped up gains over the week, buoyed by announcements from the Federal Reserve."
PFE,PFE:US,BBG000BR2B91,"Cancer Space Update: Mixed Week for Pfizer, Roche Falters",2017-09-22 12:58:12 +0000,https://finance.yahoo.com/news/cancer-space-mixed-week-pfizer-125812221.html?.tsrc=rss,Roche again disappointed this week with two studies on Tecentriq being put on partial hold while Pfizer&apos;s Bavencio received approval in Europe. TESARO&apos;s Zejula moved a step closer to approval.
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Pfizer Files Suit against J&J, Supernus Hit by Study Update",2017-09-22 12:42:12 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-pfizer-files-124212253.html?.tsrc=rss,Industry heavyweights like Pfizer (PFE) and Johnson & Johnson were in the news this week related to a lawsuit while Glaxo got FDA approval for a key drug.
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-09-22 12:00:16 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120016367.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,These Pfizer’s Products Are Now Losing Market Share,2017-09-22 11:37:29 +0000,http://finance.yahoo.com/r/aa9d6a7e-5556-3b5f-9696-cb5d5263a880/these-pfizers-products-are-now-losing-market-share?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer's (PFE) Essential Health segment reported a fall in overall revenues in 2Q17, driven by the loss of exclusivity of Celebrex and Zyvox."
PFE,PFE:US,BBG000BR2B91,US Market Indexes Gain on Wednesday,2017-09-22 08:35:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mSn4i4-PdnY/us-market-indexes-gain-on-wednesday-cm849396,U S market indexes were mostly higher on Wednesday The Dow Jones Industrial Average closed at 22 412 59 for a gain of 41 79 points or 0 19 The S amp P 500 closed at 2 508 24 for a gain of 1 59 points or 0 06 The Nasdaq Composite closed at 6 456 04 for a loss of 5 28 points or 0 08 The
PFE,PFE:US,BBG000BR2B91,Versartis Loses VELOCITY - What Other Pharma Stocks Made News This Week?,2017-09-22 00:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2gr6-fmdAYU/versartis-loses-velocity--what-other-pharma-stocks-made-news-this-week-20170922-00016,Versartis Loses VELOCITY - What Other Pharma Stocks Made News This Week?
PFE,PFE:US,BBG000BR2B91,"Versartis growth hormone drug fails key study, shares sink",2017-09-21 21:59:28 +0000,https://finance.yahoo.com/news/versartis-growth-hormone-drug-fails-215928634.html?.tsrc=rss,"Versartis Inc said its experimental drug for the treatment of growth hormone deficiency in children did not meet the main goal of a late-stage study, sending its shares tanking 85 percent. The drug, somavaratan, ..."
PFE,PFE:US,BBG000BR2B91,3 Ways AI Is Changing Medicine,2017-09-21 21:27:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vwlVRRZlSRo/3-ways-ai-is-changing-medicine-cm848878,Recent developments in artificial intelligence AI are turning science fiction into science fact and deep learning is at the heart of these advances These AI systems have the ability to sift through scores of data recognize patterns and detect differences that might be
PFE,PFE:US,BBG000BR2B91,"XLV, JNJ, PFE, MDT: Large Inflows Detected at ETF",2017-09-21 19:39:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GEEFy0_kByc/xlv-jnj-pfe-mdt-large-inflows-detected-at-etf-cm849233,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Health Care Select Sector SPDR Fund Symbol XLV where we have detected an approximate 340 4 million dollar inflow that s a 1 9 increase week over week
PFE,PFE:US,BBG000BR2B91,National Sickle Cell Disease Poll of African Americans Dispels Long-Held Views,2017-09-21 17:41:00 +0000,https://finance.yahoo.com/news/national-sickle-cell-disease-poll-174100468.html?.tsrc=rss,"Pfizer Inc. , the National Newspaper Publishers Association , and scholars from Howard University today announced results from a new national poll designed to deepen understanding and gauge perceptions around sickle cell disease among African Americans."
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer's Underappreciated Global Opportunity,2017-09-21 17:33:00 +0000,http://finance.yahoo.com/r/186afc37-1d22-3a02-9cf6-0ef4b277b63c/pfizers-underappreciated-global-opportunity-1506015197?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Pfizer (PFE: NYSE) By Morgan Stanley ($35.45, Sept. 20) We are upgrading Pfizer stock from Equal-weight to Overweight and raising our price target from $35 to $39. This is a multiple call. Following underperformance, ..."
PFE,PFE:US,BBG000BR2B91,"Stock Market News For Sep 21, 2017",2017-09-21 16:40:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WS3AxXjuwas/stock-market-news-for-sep-21-2017-cm849092,Markets closed mostly higher on Wednesday after the Federal Reserve announced trimming of its balance sheet from October The Fed also decided to keep the benchmark interest rates unchanged but indicated a possible rate hike in December Such statements led to gains for financial shares and
PFE,PFE:US,BBG000BR2B91,"Pfizer Sues J&J, Accuses it of Preventing Inflectra Uptake",2017-09-21 16:40:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vB0Za5HhvrE/pfizer-sues-jj-accuses-it-of-preventing-inflectra-uptake-cm849086,Pfizer Inc PFE has filed a lawsuit in a U S district court alleging that Johnson amp Johnson JNJ is resorting to unfair practices to prevent sale of Inflectra Pfizer s biosimilar version of J amp J and Merck amp Co Inc s MRK blockbuster rheumatoid arthritis drug Remicade Pfizer
PFE,PFE:US,BBG000BR2B91,Can Pfizer (PFE) Prove to be an Apt Value Investment?,2017-09-21 15:40:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_ga8Cq163Ts/can-pfizer-pfe-prove-to-be-an-apt-value-investment-cm848984,Value investing is easily one of the most popular ways to find great stocks in any market environment After all who wouldn t want to find stocks that are either flying under the radar and are compelling buys or offer up tantalizing discounts when compared to fair value One way to find
PFE,PFE:US,BBG000BR2B91,These Key Pfizer Products Contributed to Growth in 2Q17,2017-09-21 14:38:04 +0000,http://finance.yahoo.com/r/ee1f618a-48a3-3d2b-8ae1-7871cb423aaa/these-key-pfizer-products-contributed-to-growth-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer's (PFE) key products contributing to growth include Eliquis, Ibrance, Lyrica, Xalkori, Xeljanz, and Xtandi."
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference,2017-09-21 14:30:00 +0000,https://finance.yahoo.com/news/pfizer-invites-public-listen-webcast-143000394.html?.tsrc=rss,"Pfizer Inc. invites investors and the general public to listen to a discussion with Liz Barrett, Global President, Oncology, and Chris Boshoff, Senior Vice President and Head, Immuno-Oncology, Early Development and Translational Oncology, at the LEERINK Partners Roundtable Series: Rare Disease and Immuno-Oncology on Thursday, September 28, 2017 at 9:00 a.m."
PFE,PFE:US,BBG000BR2B91,"Pfizer Sues J&J, Accuses it of Preventing Inflectra Uptake",2017-09-21 14:25:02 +0000,https://finance.yahoo.com/news/pfizer-sues-j-j-accuses-142502583.html?.tsrc=rss,Pfizer (PFE) filed a lawsuit in a U.S. district court alleging that J&J is resorting to anticompetitive practices to prevent uptake of Inflectra.
PFE,PFE:US,BBG000BR2B91,National Sickle Cell Disease Poll of African Americans Dispels Long-Held Views,2017-09-21 14:00:00 +0000,https://finance.yahoo.com/news/national-sickle-cell-disease-poll-140000075.html?.tsrc=rss,"Pfizer Inc. , the National Newspaper Publishers Association , and scholars from Howard University today announced results from a new national poll designed to deepen understanding and gauge perceptions around sickle cell disease among African Americans."
PFE,PFE:US,BBG000BR2B91,Can Pfizer (PFE) Prove to be an Apt Value Investment?,2017-09-21 13:45:01 +0000,https://finance.yahoo.com/news/pfizer-pfe-prove-apt-value-134501788.html?.tsrc=rss,"Let&apos;s find out if Pfizer, Inc. (PFE) stock is a good choice for value-oriented investors right now"
PFE,PFE:US,BBG000BR2B91,Pharma giants' to clash in court over biosimilar product dispute,2017-09-21 13:35:08 +0000,http://finance.yahoo.com/r/49473313-dce0-3b06-8e4b-79413c9d2c19/pharma-giants-to-clash-in-court-over-biosimilar.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Pfizer Inc. sued Johnson & Johnson Wednesday in the latest twist to the heated and protracted battle over biosimilar competition for a multibillion-dollar blockbuster medicine originally developed by Centocor.  The lawsuit further alleges that Johnson & Johnson’s systematic efforts to maintain its monopoly in connection with Remicade — a product it acquired when it bought Malvern-based Centocor for $4.9 billion in 1999 — violate federal antitrust laws and undermines the principal goals of the U.S. Biologics Price Competition and Innovation Act, which became law 2010."
PFE,PFE:US,BBG000BR2B91,Understanding Pfizer’s Performance in US and International Markets,2017-09-21 13:09:50 +0000,http://finance.yahoo.com/r/d8e917e6-aa76-3574-90f8-e044d599fdf1/understanding-pfizers-performance-in-us-and-international-markets?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"PFE reported revenues of nearly $12.9 billion for 2Q17, including nearly flat revenues at constant exchange, offset by the 2% negative impact of foreign exchange."
PFE,PFE:US,BBG000BR2B91,Assessing Pfizer’s Performance by Business Segment in 2Q17,2017-09-21 11:40:09 +0000,http://finance.yahoo.com/r/72bf0285-4492-3767-b69f-08a8ee6eb92e/assessing-pfizers-performance-by-business-segment-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer’s Innovative Health segment contributed ~59% of PFE's total revenues in 2Q17, and analysts expect the contribution to rise to ~60% in 3Q17."
PFE,PFE:US,BBG000BR2B91,3 Ways AI Is Changing Medicine,2017-09-21 11:37:00 +0000,http://finance.yahoo.com/r/77f2190c-295e-3df2-9c3c-b960b08159d7/3-ways-ai-is-changing-medicine.aspx?yptr=yahoo&.tsrc=rss,Artificial intelligence isn&apos;t just for self-driving cars and virtual assistants. Medicine is finding new uses for the nascent technology.
PFE,PFE:US,BBG000BR2B91,New Global Report Finds Majority of People at High Risk of Stroke Not Being Screened for Common Risk Factors,2017-09-21 10:59:00 +0000,https://finance.yahoo.com/news/global-report-finds-majority-people-105900069.html?.tsrc=rss,"New research released today by The Economist Intelligence Unit , a division of The Economist and a leader in global business intelligence, revealed that on average, more than 75 percent of people aged 65 and older worldwide are not being screened for atrial fibrillation and other common stroke risk factors during routine primary care examinations, even though this population is at high risk for stroke...."
PFE,PFE:US,BBG000BR2B91,This squabble between two big drugmakers could have major implications for the U.S. health care system,2017-09-21 10:48:23 +0000,http://finance.yahoo.com/r/7b211486-40d3-3c33-90b3-68990ad4db39/Story.aspx?guid=18D5EB70-9E15-11E7-8DA8-70A592F3D9E7&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Pfizer is suing Johnson & Johnson, alleging that it set up contracts to leave Pfizer’s Inflectra out in the cold."
PFE,PFE:US,BBG000BR2B91,Big Pharma Turns to Blockchain to Track Meds,2017-09-21 10:00:29 +0000,https://finance.yahoo.com/news/big-pharma-turns-blockchain-track-100029373.html?.tsrc=rss,No more counterfeits?
PFE,PFE:US,BBG000BR2B91,European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma,2017-09-21 07:28:00 +0000,https://finance.yahoo.com/news/european-commission-approves-bavencio-avelumab-072800008.html?.tsrc=rss,"DARMSTADT, Germany , and NEW YORK , Sept. 21, 2017 /PRNewswire/ -- Not intended for US, Canadian and UK-based media      First   approved   immunotherapy   for rare and aggressive skin cancer in the European ..."
PFE,PFE:US,BBG000BR2B91,"Merck KGaA, Pfizer's cancer drug Bavencio gets EU nod",2017-09-21 07:19:24 +0000,https://finance.yahoo.com/news/merck-kgaa-pfizers-cancer-drug-071924697.html?.tsrc=rss,"European regulators on Thursday granted market approval for Merck KGaA and Pfizer's immuno-oncology drug Bavencio to treat a rare and aggressive type of skin cancer called Merkel cell carcinoma. In May, ..."
PFE,PFE:US,BBG000BR2B91,Pfizer is taking its fight with J&J over a blockbuster drug to court,2017-09-21 06:34:00 +0000,https://finance.yahoo.com/news/pfizer-taking-fight-j-j-063400341.html?.tsrc=rss,Two of the world's largest drugmakers are heading to court over a blockbuster arthritis treatment...
PFE,PFE:US,BBG000BR2B91,[$$] The Murky World of Drug Rebates Gets Airing in Lawsuit,2017-09-21 04:44:03 +0000,http://finance.yahoo.com/r/8af8d060-29ee-381b-a54e-353a5b283dda/the-murky-world-of-drug-rebates-gets-airing-in-lawsuit-1505929432?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,The closely guarded world of drug pricing is getting a public airing in a feud between two of the industry’s biggest companies. The attention drawn to rebates could hurt the profits of some very successful ...
PFE,PFE:US,BBG000BR2B91,"[$$] Pfizer Alleges J&J Thwarted Competition to Remicade, in Legal Test of Biotech-Drug Copies",2017-09-21 04:43:54 +0000,http://finance.yahoo.com/r/8cdeb461-4f5e-3138-b8c7-794a2bdb8a65/pfizer-files-antitrust-lawsuit-alleging-j-j-thwarted-use-of-biosimilar-rival-to-remicade-1505913080?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Pfizer filed suit against Johnson & Johnson alleging it has thwarted competition to its arthritis drug Remicade by effectively preventing health insurers, hospitals and clinics from offering Pfizer’s lower-priced ..."
PFE,PFE:US,BBG000BR2B91,PRESS DIGEST - Wall Street Journal - Sept 21,2017-09-21 04:41:51 +0000,https://finance.yahoo.com/news/press-digest-wall-street-journal-044151004.html?.tsrc=rss,The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - Alphabet Inc's Google said it would buy part of Taiwanese smartphone ...
PFE,PFE:US,BBG000BR2B91,"Merck, Pfizer Report EU Marketing Authorization For BAVENCIO - Quick Facts",2017-09-21 03:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/24G1si0EFGE/merck-pfizer-report-eu-marketing-authorization-for-bavencio--quick-facts-20170921-00114,"Merck, Pfizer Report EU Marketing Authorization For BAVENCIO - Quick Facts"
PFE,PFE:US,BBG000BR2B91,Pfizer and Johnson & Johnson's Brewing Brawl Gets Real,2017-09-21 02:35:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GuARMawL1YM/pfizer-and-johnson-johnsons-brewing-brawl-gets-real-cm848786,Pfizer NYSE PFE took direct aim at Johnson amp Johnson NYSE JNJ last year when it won FDA approval for Inflectra a biosimilar to Johnson amp Johnson s multi billion dollar per year autoimmune disease drug Remicade Remicade s market size made Inflectra s
PFE,PFE:US,BBG000BR2B91,Mylan Down 24% Year to Date: What's Troubling the Stock?,2017-09-21 01:34:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uSeKXC7Yeag/mylan-down-24-year-to-date-whats-troubling-the-stock-cm848771,Shares of Mylan N V MYL have declined 24 7 in the last six months compared to the industry s loss of 20 0 Here we analyze the factors that led to the underperformance Mylan is a global pharmaceutical company with a well established generics business as well as a presence
PFE,PFE:US,BBG000BR2B91,"FDA Nod For ABMD, AERI Faces FDA Panel In Oct, IPCI Put On Notice, PFE Sues JNJ",2017-09-21 01:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8sL35mMdux0/fda-nod-for-abmd-aeri-faces-fda-panel-in-oct-ipci-put-on-notice-pfe-sues-jnj-20170921-00016,"FDA Nod For ABMD, AERI Faces FDA Panel In Oct, IPCI Put On Notice, PFE Sues JNJ"
PFE,PFE:US,BBG000BR2B91,Pfizer and Johnson & Johnson&apos;s Brewing Brawl Gets Real,2017-09-21 00:46:00 +0000,http://finance.yahoo.com/r/10022c82-385f-37a4-a7c7-4677823c02f4/pfizer-and-johnson-johnson-brewing-brawl-gets-real.aspx?yptr=yahoo&.tsrc=rss,Pfizer has filed a suit against Johnson & Johnson alleging that it has engaged in anticompetitive behavior to block market demand for Pfizer&apos;s Remicade biosimilar.
PFE,PFE:US,BBG000BR2B91,"[$$] Pfizer Alleges J&J Thwarted Competition to Remicade, in Legal Test of Biotech-Drug Copies",2017-09-20 22:46:51 +0000,http://finance.yahoo.com/r/8cdeb461-4f5e-3138-b8c7-794a2bdb8a65/pfizer-files-antitrust-lawsuit-alleging-j-j-thwarted-use-of-biosimilar-rival-to-remicade-1505913080?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Pfizer filed suit against Johnson & Johnson alleging it has thwarted competition to its arthritis drug Remicade by effectively preventing health insurers, hospitals and clinics from offering Pfizer’s lower-priced ..."
PFE,PFE:US,BBG000BR2B91,Pfizer’s Revenues in Review: PFE’s Quarterly Performance,2017-09-20 21:06:05 +0000,http://finance.yahoo.com/r/69265c8f-ed3d-3a4a-b601-af5e2ed06b71/pfizers-revenues-in-review-pfes-quarterly-performance?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer (PFE) reported revenues of ~$12.9 billion in 2Q17, which was ~2% lower than its revenues of ~$13.2 billion in 2Q16."
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Sep 20, 2017 :  INTC, GE, F, BAC, PFE, ZNGA, AAPL, JPM, CSCO, HPE, QQQ, CDNS",2017-09-20 20:56:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F6DPm7iRLvg/after-hours-most-active-for-sep-20-2017-intc-ge-f-bac-pfe-znga-aapl-jpm-csco-hpe-qqq-cdns-cm848696,The NASDAQ 100 After Hours Indicator is down 1 76 to 5 971 84 The total After hours volume is currently 66 243 783 shares traded The following are the most active stocks for the after hours session Intel Corporation INTC is 0 03 at 37 10 with 3 960 496 shares
PFE,PFE:US,BBG000BR2B91,Pfizer is taking its fight with J&J over a blockbuster drug to court,2017-09-20 19:46:00 +0000,https://finance.yahoo.com/news/pfizer-taking-fight-j-j-164844901.html?.tsrc=rss,Two of the world's largest drugmakers are heading to court over a blockbuster arthritis treatment...
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer takes on J&J with antitrust lawsuit,2017-09-20 19:42:19 +0000,"http://finance.yahoo.com/r/f46605b6-1a7a-3ee4-850d-5c5a04b9b1e6/26a8a0ba-9e12-11e7-9a86-4d5a475ba4c5,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Pfizer has sued Johnson & Johnson for using ""anti-competitive practices"" to stymie a copycat version of its $7bn arthritis drug, opening a new front in the battle over an emerging class of medicines ..."
PFE,PFE:US,BBG000BR2B91,Inside Pfizer’s Post-2Q17 Pipeline Developments,2017-09-20 19:37:53 +0000,http://finance.yahoo.com/r/121543d5-4f39-3764-b91a-f8bda6c9eaf1/inside-pfizers-post-2q17-pipeline-developments?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On September 14, Pfizer (PFE) and Astellas Pharma announced positive top-line results for their Prosper study, a phase-III study evaluating Xtandi with ADT."
PFE,PFE:US,BBG000BR2B91,Pfizer files suit against J&J over Remicade contracts,2017-09-20 19:23:59 +0000,https://finance.yahoo.com/news/pfizer-sues-johnson-johnson-over-134520963.html?.tsrc=rss,"Pfizer said in the suit that J&J is offering discounts on its Remicade treatment in exchange for essentially excluding Pfizer's drug from insurance coverage, keeping it out of the hands of patients.  J&J said in an e-mailed statement that the lawsuit was without merit and that the company is competing on value and price."
PFE,PFE:US,BBG000BR2B91,[$$] Murky World of Drug Rebates Gets Airing in Lawsuit,2017-09-20 18:17:31 +0000,http://finance.yahoo.com/r/8af8d060-29ee-381b-a54e-353a5b283dda/the-murky-world-of-drug-rebates-gets-airing-in-lawsuit-1505929432?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,The closely guarded world of drug pricing is getting a public airing in a feud between two of the industry’s biggest companies. The attention drawn to rebates could hurt the profits of some very successful ...
PFE,PFE:US,BBG000BR2B91,Behind Pfizer’s Product Developments after 2Q17,2017-09-20 17:48:42 +0000,http://finance.yahoo.com/r/cc1bdde2-b8a3-31c7-af4d-b83c86d9b343/behind-pfizers-product-developments-after-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On September 1, 2017, the FDA approved Pfizer's drug Mylotarg (gemtuzumab ozogamicin) for the treatment of CD33-positive acute myeloid leukemia."
PFE,PFE:US,BBG000BR2B91,Pfizer: Is It Time To Buy?,2017-09-20 17:39:00 +0000,http://finance.yahoo.com/r/30fc50e7-b15a-3a71-9f2b-932821303d4a/pfizer-is-it-time-to-buy-1505929141?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Pfizer (PFE) have made quite a run in recent weeks.  Morgan Stanley’s David Risinger says the drug’s giant’s stock should keep rising, perhaps as high as $44 a share.  Earlier today, Risinger upgraded Pfizer from an Equal-weight to an Outperform and set a $39 price target, which is based on a price-to-earnings multiple of 14 times 2018 estimated earnings of $2.76 a share."
PFE,PFE:US,BBG000BR2B91,Dow Analyst Moves: PFE,2017-09-20 17:37:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CCxwhr-9nb4/dow-analyst-moves-pfe-cm848524,The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average Pfizer is the 18 analyst pick Within the broader S amp P 500 when components were ranked in terms of analyst favorites PFE claims the 267
PFE,PFE:US,BBG000BR2B91,Pfizer's Sutent Label Expansion Gets Mixed FDA Committee View,2017-09-20 16:42:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IdUuv4NHi_I/pfizers-sutent-label-expansion-gets-mixed-fda-committee-view-cm848481,Pfizer Inc PFE announced that an FDA advisory committee gave a mixed opinion regarding a regulatory application that was filed to expand the label of its cancer drug Sutent Sutent is presently marketed for the first line treatment of advanced renal cell carcinoma RCC With the
PFE,PFE:US,BBG000BR2B91,"Dow Movers: MMM, PFE",2017-09-20 16:38:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EiQLARSsbmg/dow-movers-mmm-pfe-cm848413,In early trading on Wednesday shares of Pfizer topped the list of the day s best performing Dow Jones Industrial Average components trading up 1 2 Year to date Pfizer registers a 10 4 gain And the worst performing Dow component thus far on the day is MMM trading down 1 4 MMM
PFE,PFE:US,BBG000BR2B91,Pfizer&apos;s Sutent Label Expansion Gets Mixed FDA Committee View,2017-09-20 14:12:02 +0000,https://finance.yahoo.com/news/pfizer-apos-sutent-label-expansion-141202515.html?.tsrc=rss,"Pfizer&apos;s (PFE) cancer drug Sutent gets a mixed opinion from an FDA advisory committee regarding a regulatory application, which was filed to expand its label."
PFE,PFE:US,BBG000BR2B91,US STOCKS-Wall St opens little changed; Fed takes center stage,2017-09-20 13:56:45 +0000,https://finance.yahoo.com/news/us-stocks-wall-st-opens-135645046.html?.tsrc=rss,"Wall Street opened little changed on  Wednesday as investors waited for the conclusion of the two-day  Federal Reserve meeting for indications of a third interest rate  hike this year.  Fed Chair Janet Yellen will hold a  press conference half an hour later, which will be closely  watched for views on inflation."
PFE,PFE:US,BBG000BR2B91,Pfizer's stock jumps to 13-month high to lead Dow gainers after analyst upgrade,2017-09-20 13:52:24 +0000,http://finance.yahoo.com/r/191a41e8-cc19-30ee-8021-19b04e6a4fc7/Story.aspx?guid=4820BF74-E5E1-433A-98B9-80E2FDB1BE97&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of Pfizer Inc. surged 1.3% in morning trade Wednesday toward a 13-month high, after the drug maker was upgraded at Morgan Stanley, which cited valuation following ""a long period of middling ..."
PFE,PFE:US,BBG000BR2B91,"Pfizer Should Outperform, Morgan Stanley Upgrades",2017-09-20 13:45:03 +0000,https://finance.yahoo.com/news/pfizer-outperform-morgan-stanley-upgrades-134503514.html?.tsrc=rss,Analysts at Morgan Stanley turned bullish on Pfizer Inc. (NYSE: PFE ) amid multiple catalysts and accretive M&A opportunities ahead. Analyst David Risinger upgraded Pfizer's stock from Equal-weight to ...
PFE,PFE:US,BBG000BR2B91,"Investors Await Fed Move; Amazon To Link Alexa, Smart Glasses",2017-09-20 13:39:00 +0000,http://finance.yahoo.com/r/a08a105a-33ed-3613-9f18-b0c9d7c909af/stock-futures-flat-ahead-of-fed-china-mining-leader-spikes?src=A00220&yptr=yahoo&.tsrc=rss,"Stock futures traded pancake flat Wednesday, with all eyes turned toward the afternoon&apos;s policy announcement from the Federal Reserve."
PFE,PFE:US,BBG000BR2B91,Pfizer Goes to Court to Allow Competition for Biologics and Expand Options for Patients,2017-09-20 13:10:00 +0000,https://finance.yahoo.com/news/pfizer-goes-court-allow-competition-131000126.html?.tsrc=rss,"To ensure patients and providers have access to important, lower cost biosimilar medicines, Pfizer today filed suit in the U.S. District Court for the Eastern District of Pennsylvania against Johnson & Johnson ."
PFE,PFE:US,BBG000BR2B91,"Early movers: FDX, WMT, AMZN, BBB, PFE, LB & more",2017-09-20 11:52:57 +0000,http://finance.yahoo.com/r/a7e9bdad-d115-3a50-a40a-715cf692cd00/104715717?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104715717&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
PFE,PFE:US,BBG000BR2B91,PFE Claims J&J Engaged In Unlawful Conduct To Stifle Competition From Inflectra,2017-09-20 09:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d-23KFcFJJw/pfe-claims-jj-engaged-in-unlawful-conduct-to-stifle-competition-from-inflectra-20170920-00647,PFE Claims J&J Engaged In Unlawful Conduct To Stifle Competition From Inflectra
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Sep 19, 2017 :  BAC, T, INTC, APD, KEY, Z, PFE, GE, FOXA, BBBY, QQQ, ETFC",2017-09-19 20:56:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3ak5LfU-Zq4/after-hours-most-active-for-sep-19-2017-bac-t-intc-apd-key-z-pfe-ge-foxa-bbby-qqq-etfc-cm848044,The NASDAQ 100 After Hours Indicator is down 3 01 to 5 988 07 The total After hours volume is currently 35 387 874 shares traded The following are the most active stocks for the after hours session Bank of America Corporation BAC is 0 02 at 24 88 with 3 735
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Outcome of FDA Advisory Committee Meeting for SUTENT® in Patients at High Risk of Recurrent Renal Cell Carcinoma after Surgery,2017-09-19 17:15:00 +0000,https://finance.yahoo.com/news/pfizer-announces-outcome-fda-advisory-171500418.html?.tsrc=rss,Pfizer Inc. today announced that the U.S. Food and Drug Administration’s Oncologic Drug Advisory Committee voted 6 in favor and 6 against the benefit-risk profile for SUTENT® as adjuvant treatment of adult patients at high risk of recurrent renal cell carcinoma after nephrectomy .
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public to View and Listen to Webcast of October 31 Conference Call with Analysts,2017-09-19 14:00:00 +0000,https://finance.yahoo.com/news/pfizer-invites-public-view-listen-140000755.html?.tsrc=rss,"Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, October 31, 2017. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Third Quarter 2017 Performance Report, to be issued that morning."
PFE,PFE:US,BBG000BR2B91,3 Stocks to Buy with Dividend Yields Above 3%,2017-09-19 13:38:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DfB2PKQJqpo/3-stocks-to-buy-with-dividend-yields-above-3-cm847596,Sometimes chasing high dividend yields leads to higher risks than many investors are willing to take But for income seeking investors particularly retirees relatively high yields are a must One approach is to look for solid stocks that pay attractive yields of 3 or more instead
PFE,PFE:US,BBG000BR2B91,3 Stocks to Buy with Dividend Yields Above 3%,2017-09-19 11:34:00 +0000,http://finance.yahoo.com/r/36ea752b-eaa9-3ce9-a8ed-4fecc13fb521/3-stocks-to-buy-with-dividend-yields-above-3.aspx?yptr=yahoo&.tsrc=rss,Good things come in threes. Here are three solid stocks in three different industries with greater than 3% yields.
PFE,PFE:US,BBG000BR2B91,3 High-Yield Pharmaceutical Stocks,2017-09-19 08:34:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SlSdUCQj8HQ/3-high-yield-pharmaceutical-stocks-cm847497,It can be tempting to buy stocks based solely on their dividend yield but that can actually be a big mistake However that doesn t mean that all high yield stocks should be avoided So which big dividend payers do we like right now We asked a team of healthcare investors to
PFE,PFE:US,BBG000BR2B91,3 High-Yield Pharmaceutical Stocks,2017-09-19 07:30:00 +0000,http://finance.yahoo.com/r/f2fe1193-d866-3897-938a-a20760110405/3-high-yield-pharmaceutical-stocks.aspx?yptr=yahoo&.tsrc=rss,On the hunt for a fat dividend yield? These three big pharma stocks deliver.
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Sep 18, 2017 :  MSFT, LC, CERN, BAC, MU, PFE, BABA, GE, CPN, AAPL, ISBC, ETFC",2017-09-18 20:56:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P1IWbUpsEMI/after-hours-most-active-for-sep-18-2017-msft-lc-cern-bac-mu-pfe-baba-ge-cpn-aapl-isbc-etfc-cm847419,The NASDAQ 100 After Hours Indicator is up 64 to 5 981 76 The total After hours volume is currently 69 256 099 shares traded The following are the most active stocks for the after hours session Microsoft Corporation MSFT is 0 04 at 75 20 with 5 785 201 shares
PFE,PFE:US,BBG000BR2B91,What Analysts Recommend for Novartis in September 2017,2017-09-18 18:19:40 +0000,http://finance.yahoo.com/r/b2abd793-25e1-39d4-b8dc-faf8e4a167ef/what-analysts-recommend-for-novartis-in-september-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Three analysts were analyzing Novartis in September 2017. One analyst recommended a “strong buy,” while the other two recommended a “hold.”"
PFE,PFE:US,BBG000BR2B91,Interesting October Stock Options for PFE,2017-09-18 17:35:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qMehyokumk0/interesting-october-stock-options-for-pfe-cm847226,Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the October expiration for PFE The put contract
PFE,PFE:US,BBG000BR2B91,Neos Therapeutics ADHD Drug Adzenys Receives Approval in US,2017-09-18 16:41:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AjwgJ0PFHsY/neos-therapeutics-adhd-drug-adzenys-receives-approval-in-us-cm847214,Neos Therapeutics Inc 160 NEOS announced that the FDA has approved its third attention deficit hyperactivity disorder ADHD drug Adzenys ER extended release oral suspension in patients six years and older The drug is approved as a once daily treatment The company s shares were up 2
PFE,PFE:US,BBG000BR2B91,Catalyst (CPRX) Focused on Two Lead Pipeline Candidates,2017-09-18 16:40:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-v4XWh9Yvjw/catalyst-cprx-focused-on-two-lead-pipeline-candidates-cm847180,We issued an updated report on Catalyst Pharmaceuticals Inc CPRX on Sep 15 Catalyst Pharma is a development stage biopharmaceutical company focused on the development and commercialization of therapies targeting rare neurological diseases and disorders such as Lambert Eaton
PFE,PFE:US,BBG000BR2B91,3 High-Yield Healthcare Stocks,2017-09-18 15:40:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/soqTbR9SJd0/3-high-yield-healthcare-stocks-cm847092,One downside to a long lasting bull market is that the market s dividend yield declines That s a big problem for retirees who rely on their portfolio to meet their income needs Even in today s pricey market there are a few high yield stocks still worth buying Want proof We asked
PFE,PFE:US,BBG000BR2B91,3 High-Yield Healthcare Stocks,2017-09-18 14:30:00 +0000,http://finance.yahoo.com/r/6861f713-422b-35b4-9667-ce166b10aab5/3-high-yield-healthcare-stocks.aspx?yptr=yahoo&.tsrc=rss,"GlaxoSmithKline, HCP, and Pfizer all offer their shareholders fat payouts. Here&apos;s why income investors can safely buy each of these stocks today."
PFE,PFE:US,BBG000BR2B91,Buy Bristol-Myers Squibb Co (BMY) Stock With No Fear,2017-09-18 14:19:26 +0000,https://finance.yahoo.com/news/buy-bristol-myers-squibb-co-141926484.html?.tsrc=rss,"Bristol-Myers Squibb Co (NYSE:BMY) stock has had a tumultuous 12-month period. In January, it fell 20% but luckily for the bulls it recovered all of it within five weeks. Since then and after several +/-8% moves, BMY is up 12% in 52 weeks which is decent but still underwhelming relative to the iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) as a whole.Source: A 4 via Flickr"
PFE,PFE:US,BBG000BR2B91,Neos Therapeutics ADHD Drug Adzenys Receives Approval in US,2017-09-18 14:00:02 +0000,https://finance.yahoo.com/news/neos-therapeutics-adhd-drug-adzenys-140002200.html?.tsrc=rss,Neos Therapeutics (NEOS) announced the approval of its third ADHD drug Adzenys for the treatment of six years and older patients.
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-09-18 12:00:38 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120019016.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,10 Rock-Solid Reasons Johnson & Johnson's Near-Term Future Looks Bright,2017-09-17 14:35:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8SW19Elp9fg/10-rock-solid-reasons-johnson-johnsons-near-term-future-looks-bright-cm846807,Johnson amp Johnson NYSE JNJ reported anemic overall sales growth in the first half of 2017 The big healthcare company even saw a decline in year over year earnings during the period Perhaps the most surprising disappointment of all was that pharmaceutical segment revenue was
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. Bristol-Myers Squibb,2017-09-17 12:35:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hyVCSBL6LQA/better-buy-pfizer-inc-vs-bristol-myers-squibb-cm846781,You can call them frenemies Pfizer NYSE PFE and Bristol Myers Squibb NYSE BMY are friends when it comes to blockbuster blood thinner Eliquis But the two big pharma companies are enemies in the oncology and immunology arenas How do these collaborators and
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. Bristol-Myers Squibb,2017-09-17 11:03:00 +0000,http://finance.yahoo.com/r/7e793b44-1a64-36e8-a706-b91b8fb0a997/better-buy-pfizer-inc-vs-bristol-myers-squibb.aspx?yptr=yahoo&.tsrc=rss,It&apos;s a tough decision between these two big pharma stocks.
PFE,PFE:US,BBG000BR2B91,3 Stocks to Buy and Hold for Decades,2017-09-16 20:34:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/asbAQ0a4ibU/3-stocks-to-buy-and-hold-for-decades-cm846748,Trading in and out of stocks may be exciting but it s no way to build wealth Buying shares of high quality companies and holding on for the long haul is a far better alternative We asked three of our Foolish investors to each discuss one stock worthy of being bought and held
PFE,PFE:US,BBG000BR2B91,3 Stocks to Buy and Hold for Decades,2017-09-16 19:25:00 +0000,http://finance.yahoo.com/r/59adf217-243a-378d-849c-5dc7789fdf3b/3-stocks-to-buy-and-hold-for-decades.aspx?yptr=yahoo&.tsrc=rss,These stocks should stand the test of time.
PFE,PFE:US,BBG000BR2B91,"Levin Capital Strategies, L.p. Buys Tyson Foods Inc, General Electric Co, Qualcomm Inc, Sells ...",2017-09-15 19:34:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GA9_ZP0w3dI/levin-capital-strategies-lp-buys-tyson-foods-inc-general-electric-co-qualcomm-inc-sells-cm846509,Levin Capital Strategies L p New Purchases TSN QCOM THS AXL BKU CADE AABA TECK POST SRUN Added Positions GE CVS HES PFE T INTC M NSTG NXPI PF Reduced Positions MCD HPE ZBH PKI APC DD NOK ETN CB GOLF Sold Out WHR SYF
PFE,PFE:US,BBG000BR2B91,Pfizer Xtandi Succeeds in Early Stage Prostate Cancer Study,2017-09-15 16:39:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6yNdIVuxcig/pfizer-xtandi-succeeds-in-early-stage-prostate-cancer-study-cm846359,Pfizer Inc PFE and its Japanese partner Astellas announced that their prostate cancer drug Xtandi met the primary endpoint in a late stage study which can expand the label of the drug to include early stage patients Top line data from the phase III PROSPER study showed that treatment
PFE,PFE:US,BBG000BR2B91,Oncology Space in Focus this Week on ESMO Presentations,2017-09-15 16:38:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vXpy5Y27IW8/oncology-space-in-focus-this-week-on-esmo-presentations-cm846326,Cancer capable of striking fear in even the strongest of hearts is a malignancy characterized by uncontrolled growth of abnormal cells which if not treated can lead to death According to the American Cancer Society there are more than 100 types of cancers the deadliest among them
PFE,PFE:US,BBG000BR2B91,"Dow Movers: GS, BA",2017-09-15 15:38:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yLpjgZ8jU2Y/dow-movers-gs-ba-cm846271,In early trading on Friday shares of Boeing BA topped the list of the day s best performing Dow Jones Industrial Average components trading up 0 7 Year to date Boeing registers a 58 6 gain And the worst performing Dow component thus far on the day is Goldman Sachs Group
PFE,PFE:US,BBG000BR2B91,Oncology Space in Focus this Week on ESMO Presentations,2017-09-15 14:55:02 +0000,https://finance.yahoo.com/news/oncology-space-focus-week-esmo-145502098.html?.tsrc=rss,There were multiple presentations at European Society for Medical Oncology 2017 Congress. AstraZeneca&apos;s lung cancer study data was positive and so was Bristol-Myers&apos;s melanoma candidate.
PFE,PFE:US,BBG000BR2B91,Pfizer Xtandi Succeeds in Early Stage Prostate Cancer Study,2017-09-15 14:36:02 +0000,https://finance.yahoo.com/news/pfizer-xtandi-succeeds-early-stage-143602732.html?.tsrc=rss,"Pfizer&apos;s (PFE) prostate cancer drug Xtandi met the primary endpoint in a late-stage study, which can expand the label of the drug to include early-stage patients."
PFE,PFE:US,BBG000BR2B91,Pfizer Punches Back at Johnson & Johnson in Prostate Cancer,2017-09-15 13:37:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i5JbBL3gr64/pfizer-punches-back-at-johnson-johnson-in-prostate-cancer-cm846169,After winning Food and Drug Administration FDA approval for use in castration resistant metastatic prostate cancer in 2012 Pfizer s NYSE PFE Xtandi quickly gained ground on Johnson amp Johnson s NYSE JNJ multibillion dollar Zytiga However Xtandi s momentum has
PFE,PFE:US,BBG000BR2B91,Pfizer Punches Back at Johnson & Johnson in Prostate Cancer,2017-09-15 12:15:00 +0000,http://finance.yahoo.com/r/22fdf9ff-5556-34b7-a2c0-9d5f1abad177/pfizer-fires-back-at-johnson-johnson-in-prostate-c.aspx?yptr=yahoo&.tsrc=rss,The two companies are battling to expand the use of their cancer drugs in prostate-cancer patients.
PFE,PFE:US,BBG000BR2B91,Dow Jones Closes at New High,2017-09-15 12:02:53 +0000,https://finance.yahoo.com/news/dow-jones-closes-high-215410213.html?.tsrc=rss,US market indexes mostly lower
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-09-15 12:00:24 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120024304.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,Who Will Win the Kidney Cancer Battle Between Bristol-Myers Squibb and Exelixis?,2017-09-15 11:37:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rdOxPWtmZx8/who-will-win-the-kidney-cancer-battle-between-bristol-myers-squibb-and-exelixis-cm846124,A head to head competition for market share in the renal cell carcinoma RCC market appears to be about to intensify In one corner is Bristol Myers Squibb NYSE BMY With a market cap of over 100 billion and a history dating back to 1887 the big pharma has a lot of muscle to
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Achillion Slumps on End of HCV Deal, Teva Gets a New CEO",2017-09-15 10:52:10 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-achillion-slumps-105210457.html?.tsrc=rss,Key highlights this week include Teva&apos;s (TEVA) CEO announcement and the FDA approval of the first cancer biosimilar.
PFE,PFE:US,BBG000BR2B91,"Noteworthy Thursday Option Activity: MCD, MO, PFE",2017-09-14 21:37:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ut4dyjB_BrM/noteworthy-thursday-option-activity-mcd-mo-pfe-cm845984,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in McDonald s Corp Symbol MCD where a total volume of 13 180 contracts has been traded thus far today a contract volume which is representative of approximately 1 3
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 09/14/2017: JNJ, PFE, ABT, MRK, AMGN, EKSO, RARE, CRIS",2017-09-14 20:37:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9k3xvEKIXD8/health-care-sector-update-for-09142017-jnj-pfe-abt-mrk-amgn-ekso-rare-cris-cm845958,Top Health Care Stocks Top Health Care Stocks JNJ 1 2 JNJ 1 2 PFE 1 7 PFE 1 7 ABT 0 8 ABT 0 8 MRK 1 4 MRK 1 4 AMGN 0 1 AMGN 0 1 Health care shares were mostly higher as Thursday s session closed Health care shares were mostly higher as Thursday s session closed In
PFE,PFE:US,BBG000BR2B91,Markets Right Now: Dow ekes out another high in mixed day,2017-09-14 20:11:55 +0000,https://finance.yahoo.com/news/markets-now-tech-health-care-134420158.html?.tsrc=rss,"The latest on developments in financial markets (All times local): 4 p.m. Stocks ended mixed on Wall Street, but a meager gain for the Dow Jones industrial average was enough to mark another record high. ..."
PFE,PFE:US,BBG000BR2B91,How This Dow Component Could Double Its Prostate-Cancer Market,2017-09-14 20:05:37 +0000,http://finance.yahoo.com/r/de5c38f1-e390-332d-98ea-2c1b58639e17/how-this-dow-component-could-double-its-prostate-cancer-market?src=A00220&yptr=yahoo&.tsrc=rss,"Pfizer will net a larger percentage of the prostate-cancer market, an analyst argued Thursday after the Dow component reported the results of a Phase 3 trial."
PFE,PFE:US,BBG000BR2B91,"Dow Posts Fresh Record, Third in a Row, but S&P 500 and Nasdaq Fall",2017-09-14 20:05:00 +0000,http://finance.yahoo.com/r/1f3c5906-f047-35d7-8aa5-8640c0573d5a/dow-posts-fresh-record-third-in-a-row-but-s-amp-p-500-and-nasdaq-fall.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The Dow rises but the rest of the market falters Thursday. Here's where stocks are trading at market close.
PFE,PFE:US,BBG000BR2B91,"Exelixis, Inc. and Bristol-Myers Squibb Co. Gear Up for Round 2 of the Kidney Cancer Drug Battle Royale",2017-09-14 19:19:00 +0000,http://finance.yahoo.com/r/ef330264-d576-3c33-8519-fc4154094353/exelixis-inc-and-bristol-myers-squibb-co-gear-up-f.aspx?yptr=yahoo&.tsrc=rss,"Ironically, round three could have the companies fighting on the same side."
PFE,PFE:US,BBG000BR2B91,"Boeing, United Tech Lead Dow to Records but Rest of Market Flounders",2017-09-14 19:06:00 +0000,http://finance.yahoo.com/r/d4bbee46-8864-31ba-a26a-d3bdba8730d7/energy-again-keeps-market-losses-to-a-minimum-while-dow-reaches-record.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The Dow rises but the rest of the market falters Thursday. Here's where stocks are trading by midday.
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 09/14/2017: JNJ, PFE, ABT, MRK, AMGN, GKOS, PFE, BVXV",2017-09-14 17:16:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yfw5ME1iUNA/health-care-sector-update-for-09142017-jnj-pfe-abt-mrk-amgn-gkos-pfe-bvxv-cm845873,Top Health Care Stocks Top Health Care Stocks JNJ 0 5 JNJ 0 5 PFE 1 4 PFE 1 4 ABT 0 2 ABT 0 2 MRK 1 MRK 1 AMGN 0 1 AMGN 0 1 Health care shares were mainly firmer in mid day trade Thursday Health care shares were mainly firmer in mid day trade Thursday In sector
PFE,PFE:US,BBG000BR2B91,"US stocks are mixed as energy companies rise, retailers dip",2017-09-14 16:20:14 +0000,http://finance.yahoo.com/r/8a8645e4-f46e-3ad9-a35a-5e94b73d42d6/us-stocks-dip-record-run-143116694.html?.tsrc=rss,"NEW YORK (AP) — U.S. stocks are mixed Thursday after finishing at record highs the last two days. Companies that sell everything from clothes to groceries are slipping after the government said prices paid by consumers jumped in August. That could be a sign inflation is increasing, which would push the Federal Reserve to raise interest rates at a faster pace and slow the economy down. Health care and energy companies are rising."
PFE,PFE:US,BBG000BR2B91,Why Did Pfizer (PFE) Stock Pop Today?,2017-09-14 15:51:03 +0000,https://finance.yahoo.com/news/why-did-pfizer-pfe-stock-155103838.html?.tsrc=rss,"Shares of Pfizer (PFE) and Astellas Pharma (ALPMY) moved higher in morning trading Thursday after the companies said their new prostate cancer drug, Xtandi, met the main goal of an important clinical trial."
PFE,PFE:US,BBG000BR2B91,"Pfizer, Astellas prostate cancer drug promising in late-stage trial",2017-09-14 15:29:00 +0000,https://finance.yahoo.com/news/pfizer-astellas-prostate-cancer-drug-152900405.html?.tsrc=rss,"Pfizer Inc and Japan's Astellas  Pharma Inc said on Thursday their blockbuster prostate  cancer drug met the main goal of a key study that tested it for  treating the disease in its early stages.  The positive data sets the stage for an  earlier-than-expected approval of the drug, which is already  cleared to treat metastatic castration-resistant prostate cancer  (CRPC) - where the cancer has spread to other parts of the body."
PFE,PFE:US,BBG000BR2B91,Dow Hits Intraday Record but Rest of Market Falters After Inflation Reading,2017-09-14 14:18:00 +0000,http://finance.yahoo.com/r/76ed638e-5c3b-333d-997d-1dd435f77ea1/stocks-retreat-from-records-after-inflation-data-raises-questions-for-fed.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The Dow rises but the rest of the market falters early Thursday. Here's where stocks are trading.
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Positive Late Stage Trial of Cancer Treatment,2017-09-14 14:18:00 +0000,http://finance.yahoo.com/r/4e8046cb-0052-38c2-8cf6-cad5cd83afe9/pfizer-announces-positive-late-stage-trial-of-cancer-treatment.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Xtandi showed positive signs in its prostate cancer treatment trials.
PFE,PFE:US,BBG000BR2B91,"UPDATE 2-Pfizer, Astellas prostate cancer drug succeeds key trial",2017-09-14 13:51:08 +0000,https://finance.yahoo.com/news/pfizer-astellas-prostate-cancer-drug-101135888.html?.tsrc=rss,"Pfizer Inc and Japan's Astellas  Pharma Inc said on Thursday their prostate cancer drug  met the main goal of a trial testing it for a more common form  of the disease.  The drug, Xtandi, is already approved to treat metastatic  castration-resistant prostate cancer (CRPC) - where the cancer  has spread to other parts of the body - and raked in U.S. sales  of $141 million in the second quarter for Pfizer."
PFE,PFE:US,BBG000BR2B91,Here's Why the Best Is Yet to Come for Opko Health Inc.,2017-09-14 13:41:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rYigOpfqe9E/heres-why-the-best-is-yet-to-come-for-opko-health-inc-cm845538,There s not a whole lot that looks good for Opko Health Inc NASDAQ OPK right now The stock has dropped more than 30 so far in 2017 Several large institutional investors have reduced their positions in Opko Although sales have risen the company continues to lose a lot
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Apple, Pfizer, Carnival, T. Rowe Price and Novo Nordisk",2017-09-14 13:21:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-apple-132101569.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Apple, Pfizer, Carnival, T. Rowe Price and Novo Nordisk"
PFE,PFE:US,BBG000BR2B91,Pfizer shares rise 1.4% after news of positive late-stage cancer trial,2017-09-14 12:16:09 +0000,http://finance.yahoo.com/r/3e3cccb9-9b40-3bdf-bba3-a41b845cfce9/Story.aspx?guid=053C4CAF-7914-49D0-A9B5-3E0FE1555400&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Pfizer Inc. shares rose as much as 1.4% in premarket trade Thursday on news that its late-stage clinical trial examining its key cancer drug Xtandi in non-metastatic castration-resistant prostate cancer ...
PFE,PFE:US,BBG000BR2B91,US STOCKS-Futures flat ahead of key inflation data,2017-09-14 11:40:30 +0000,https://finance.yahoo.com/news/us-stocks-futures-flat-ahead-114030206.html?.tsrc=rss,U.S. stock index futures were little changed on Thursday ahead of key inflation data that could impact the Federal Reserve's decision on the timing of another interest rate hike this year. * A Labor Department ...
PFE,PFE:US,BBG000BR2B91,Here&apos;s Why the Best Is Yet to Come for Opko Health Inc.,2017-09-14 11:32:00 +0000,http://finance.yahoo.com/r/1eb64513-1ef5-3146-b982-54309e677007/heres-why-the-best-is-yet-to-come-for-opko-health.aspx?yptr=yahoo&.tsrc=rss,A rebound could be on the way for the beleaguered healthcare stock.
PFE,PFE:US,BBG000BR2B91,"Pfizer, Astellas prostate cancer drug clears late-stage trial",2017-09-14 09:54:45 +0000,https://finance.yahoo.com/news/pfizer-astellas-prostrate-cancer-drug-093707897.html?.tsrc=rss,"Pfizer Inc and Astellas Pharma  Inc said on Thursday their drug to treat a type of  prostate cancer met the main goal of improving overall survival  in a late-stage trial.  The oral drug, Xtandi, in combination with an anti-hormone  therapy was more successful than an anti-hormone therapy alone  in improving overall survival in men with non-metastatic  castration-resistant prostate cancer.  The drug is already approved to treat metastatic  castration-resistant prostate cancer."
PFE,PFE:US,BBG000BR2B91,Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer,2017-09-14 09:00:00 +0000,https://finance.yahoo.com/news/pfizer-astellas-announce-positive-top-090000228.html?.tsrc=rss,Pfizer Inc. and Astellas Pharma Inc. announced today that the Phase 3 PROSPER trial evaluating XTANDI® plus androgen deprivation therapy versus ADT alone in patients with non-metastatic Castration-Resistant Prostate Cancer met its primary endpoint of improved metastasis-free survival .
PFE,PFE:US,BBG000BR2B91,"Pfizer, Astellas Report Positive Results From XTANDI Phase 3 Trial - Quick Facts",2017-09-14 05:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VZa7Pc5S-HY/pfizer-astellas-report-positive-results-from-xtandi-phase-3-trial--quick-facts-20170914-00188,"Pfizer, Astellas Report Positive Results From XTANDI Phase 3 Trial - Quick Facts"
PFE,PFE:US,BBG000BR2B91,3 Biotech Stocks That Have Already Quadrupled in 2017,2017-09-14 01:36:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uImty3Zy2nI/3-biotech-stocks-that-have-already-quadrupled-in-2017-cm845432,It s been a good year for biotech stocks the iShares Nasdaq Biotechnology index has risen about 26 this year but a handful of companies make the industry tracking index s success seem trivial Investors that began the year with shares of Kite Pharma Inc NASDAQ KITE
PFE,PFE:US,BBG000BR2B91,"Top Analyst Reports for Apple, Pfizer & Carnival",2017-09-13 23:37:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jJV1TpXXdpc/top-analyst-reports-for-apple-pfizer-carnival-cm845427,Wednesday September 13 2017 The Zacks Research Daily presents the best research output of our analyst team Today s Research Daily features new research reports on 16 major stocks including Apple AAPL Pfizer PFE and Carnival CCL These research reports have been hand picked from
PFE,PFE:US,BBG000BR2B91,"Top Analyst Reports for Apple, Pfizer & Carnival",2017-09-13 21:23:09 +0000,https://finance.yahoo.com/news/top-analyst-reports-apple-pfizer-212309141.html?.tsrc=rss,"Top Analyst Reports for Apple, Pfizer & Carnival"
PFE,PFE:US,BBG000BR2B91,"XLV, PFE, MDT, AGN: Large Inflows Detected at ETF",2017-09-13 16:38:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R2xdk-V17YQ/xlv-pfe-mdt-agn-large-inflows-detected-at-etf-cm845174,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Health Care Select Sector SPDR Fund Symbol XLV where we have detected an approximate 316 7 million dollar inflow that s a 1 8 increase week over week
PFE,PFE:US,BBG000BR2B91,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 14, 2017",2017-09-13 13:34:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XFP7-q8G5Pg/merck-company-inc-mrk-ex-dividend-date-scheduled-for-september-14-2017-cm844945,Merck amp Company Inc MRK will begin trading ex dividend on September 14 2017 A cash dividend payment of 0 47 per share is scheduled to be paid on October 06 2017 Shareholders who purchased MRK prior to the ex dividend date are eligible for the cash dividend payment This marks
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-09-13 12:00:23 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120023340.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,US Market Indexes Reach New Highs on Tuesday,2017-09-13 11:59:47 +0000,https://finance.yahoo.com/news/us-market-indexes-reach-highs-215234397.html?.tsrc=rss,"Dow Jones closes at 22,118.86"
PFE,PFE:US,BBG000BR2B91,Teva Pharmaceutical on the Street: Analysts’ Recommendations in September,2017-09-13 11:41:04 +0000,http://finance.yahoo.com/r/406f03bd-ce6c-3b92-a009-6e113ba53e7a/teva-pharmaceutical-on-the-street-analysts-recommendations-in-september?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In August 2017, the FDA approved Teva Pharmaceutical's (TEVA) Austedo for the treatment of adult individuals with tardive dyskinesia."
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Reports Positive Results from Melanoma Study,2017-09-12 23:34:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RKuB-mtpajY/bristol-myers-reports-positive-results-from-melanoma-study-cm844649,Bristol Myers Squibb Company BMY announced encouraging results from a phase III study CheckMate 238 on Opdivo CheckMate 238 is an ongoing phase III randomized double blind study of Opdivo versus Yervoy in patients who have undergone complete resection of stage IIIb c or stage IV
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Reports Positive Results from Melanoma Study,2017-09-12 21:36:09 +0000,https://finance.yahoo.com/news/bristol-myers-reports-positive-results-213609426.html?.tsrc=rss,"Bristol-Myers Squibb Company (BMY) announced encouraging results from a phase III study, CheckMate -238, on Opdivo."
PFE,PFE:US,BBG000BR2B91,Dow Jumps Again; Apple Stock Falls After iPhone X,2017-09-12 21:34:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jAZQuD3GhyE/dow-jumps-again-apple-stock-falls-after-iphone-x-cm844599,The U S stock market rallied once again with the 160 S amp P 500 Index SPX 160 hitting fresh record highs and the 160 Dow Jones Industrial Average DJIA 160 expanding on Monday s huge surge thanks in large part to a bank rally and 160 Pfizer s big day Stocks
PFE,PFE:US,BBG000BR2B91,"Close Update: Wall Street Hits Record Highs as Telecoms, Financials Lead",2017-09-12 20:54:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o0BVbKwD65c/close-update-wall-street-hits-record-highs-as-telecoms-financials-lead-cm844605,Wall Street was in record territory on Tuesday with the S amp P 500 closing at another all time high as gains in financials and telecom stocks helped outweigh declines in real estate and utilities Wall Street was in record territory on Tuesday with the S P 500 closing at another all time high
PFE,PFE:US,BBG000BR2B91,"Market Close Report: Historical high reached as NASDAQ Composite Index closes at 6,454.28.",2017-09-12 20:48:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_1RLeuHpnR0/market-close-report-historical-high-reached-as-nasdaq-composite-index-closes-at-645428-cm844615,Tuesday s session closes with the NASDAQ Composite Index reaching a historical high The index closed at 6 454 28 up 22 02 for the day The index had a previous high 6435 33065 on 09 01 2017 The total shares traded for the NASDAQ was over 1 72 billion Tuesday s session closes with the
PFE,PFE:US,BBG000BR2B91,"Supercharge Your Portfolio With Amgen, Inc. (AMGN) Stock",2017-09-12 19:35:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mn8AD4Do86A/supercharge-your-portfolio-with-amgen-inc-amgn-stock-cm844578,InvestorPlace Stock Market News Stock Advice amp Trading Tips Even though Amgen Inc NASDAQ AMGN stock has one of the best performing charts I ve seen it doesn t get the respect it deserves From a valuation perspective it sells at a sizable discount
PFE,PFE:US,BBG000BR2B91,"Teva Pharma showing strong gains, IQ100 up 22%",2017-09-12 17:11:00 +0000,https://finance.yahoo.com/video/teva-pharma-showing-strong-gains-171100840.html?.tsrc=rss,"The CNBC IQ100 index beating the broader market over one year up 22%. Among today's top gainers Teva Pharma, DowDupont, Micron, International Paper and Pfizer."
PFE,PFE:US,BBG000BR2B91,Pfizer Lung Cancer Drug's Overall Survival Data Unfavorable,2017-09-12 16:39:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L4bkJOC_IbU/pfizer-lung-cancer-drugs-overall-survival-data-unfavorable-cm844436,Pfizer Inc PFE announced final overall survival data from a phase III study PROFILE 1014 evaluating its cancer drug Xalkori for first line treatment of ALK positive non small cell lung cancer NSCLC Xalkori is currently approved for the treatment of ALK or ROS1 positive locally
PFE,PFE:US,BBG000BR2B91,AbbVie's RA Candidate Meets Primary Endpoint in Phase III,2017-09-12 16:38:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dJzLP19PRKo/abbvies-ra-candidate-meets-primary-endpoint-in-phase-iii-cm844374,AbbVie s ABBV shares increased almost 2 after the company announced that its oral JAK 1 selective inhibitor upadacitinib ABT 494 met primary endpoints in a phase III study for treatment of patients with rheumatoid arthritis RA In fact AbbVie s shares have rallied 38 9
PFE,PFE:US,BBG000BR2B91,"Supercharge Your Portfolio With Amgen, Inc. (AMGN) Stock",2017-09-12 15:13:26 +0000,https://finance.yahoo.com/news/supercharge-portfolio-amgen-inc-amgn-151326619.html?.tsrc=rss,"Even though Amgen, Inc. (NASDAQ:AMGN) stock has one of the best-performing charts I&#8217;ve seen, it doesn&#8217;t get the respect it deserves. From a valuation perspective, it sells at a sizable discount to its competitors. Its price-earnings ratio runs at least 40% cheaper than Johnson &#38; Johnson (NYSE:JNJ), Pfizer Inc. (NYSE:PFE), Merck &#38; Co., Inc. (NYSE:MRK) or Celgene Corporation (NASDAQ:CELG)."
PFE,PFE:US,BBG000BR2B91,Is There Now An Opportunity In Pfizer Inc (PFE)?,2017-09-12 14:25:16 +0000,https://finance.yahoo.com/news/now-opportunity-pfizer-inc-pfe-142516728.html?.tsrc=rss,"Pfizer Inc (NYSE:PFE) View our latest analysis for Pfizer What’s the opportunity in PFE? Good news, investors! PFE is still a bargain right now. My valuation model shows that theRead More..."
PFE,PFE:US,BBG000BR2B91,Pfizer Lung Cancer Drug&apos;s Overall Survival Data Unfavorable,2017-09-12 14:15:02 +0000,https://finance.yahoo.com/news/pfizer-lung-cancer-drug-apos-141502220.html?.tsrc=rss,"Pfizer (PFE) announced final overall survival data from a phase III study (PROFILE 1014), evaluating its cancer drug Xalkori for first-line treatment of ALK-positive non-small cell lung cancer (NSCLC)."
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-09-12 12:00:18 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120018956.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,AbbVie says deaths in arthritis trial not linked to drug,2017-09-11 15:16:49 +0000,https://finance.yahoo.com/news/abbvie-reports-two-patient-deaths-133045534.html?.tsrc=rss,"AbbVie Inc said on Monday two  patients died in a late-stage trial of its rheumatoid arthritis  drug but that the deaths were not linked to the drug, which met  the study's main goals.  The trial was evaluating two doses of the drug upadacitinib  - 15 mg and 30 mg - in patients with moderate to severe  rheumatoid arthritis, who did not adequately respond to or were  intolerant to other anti-rheumatic drugs.  Upadacitinib, a once-daily pill, belongs to a class of drugs  known as JAK inhibitors, which block inflammation-causing  enzymes called Janus kinases and are being used to treat  rheumatoid arthritis among other diseases."
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-09-11 14:05:26 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-140526141.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,FDA's Letter To Pfizer Won't Hurt EpiPen Market,2017-09-11 13:55:00 +0000,http://finance.yahoo.com/r/e4b56d14-2e26-384a-9b46-99cd3f24e990/fdas-letter-to-pfizer-wont-hurt-epipen-market-1505138155?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Last week, Pfizer (PFE) received a warning letter from the Food and Drug Administration relating to its manufacturing of EpiPens for Mylan (MYL), which charged that Pfizer did not investigate cases of malfunctioning EpiPens, including those that may have resulted in illness or death.  While that's a worrying charge, Cantor Fitzgerald's Louise Chen and Brandon Folkes argue that that shouldn't affect investors' view of Mylan--they reiterated a Neutral rating on the stock--and they don't think there will be any material change in the EpiPen market near term."
PFE,PFE:US,BBG000BR2B91,"Forward Pharma A/S (FWP) Ex-Dividend Date Scheduled for September 12, 2017",2017-09-11 13:20:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y_C44xs04SI/forward-pharma-as-fwp-ex-dividend-date-scheduled-for-september-12-2017-cm843545,Forward Pharma A S FWP will begin trading ex dividend on September 12 2017 A cash dividend payment of 23 073 per share is scheduled to be paid on September 11 2017 Shareholders who purchased FWP prior to the ex dividend date are eligible for the cash dividend payment At the current
PFE,PFE:US,BBG000BR2B91,Allergan's Patent Loophole Could Be a Huge Gift for Pfizer,2017-09-11 12:51:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/83hKfVQuGsY/allergans-patent-loophole-could-be-a-huge-gift-for-pfizer-cm843496,The tribe has spoken On Friday Allergan NYSE AGN announced that the Saint Regis Mohawk Tribe now owns all patents for blockbuster dry eye disease drug Restatis Both parties should win from the deal The tribe will receive millions of dollars upfront and in annual
PFE,PFE:US,BBG000BR2B91,Featured Company News - Pfizer Receives Warning Letter from FDA Highlighting Manufacturing Defects in the EpiPen Administered for Anaphylaxis,2017-09-11 11:40:00 +0000,https://finance.yahoo.com/news/featured-company-news-pfizer-receives-114000899.html?.tsrc=rss,"Research Desk Line-up: Alliqua BioMedical Post Earnings Coverage LONDON, UK / ACCESSWIRE / September 11, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines ..."
PFE,PFE:US,BBG000BR2B91,Allergan&apos;s Patent Loophole Could Be a Huge Gift for Pfizer,2017-09-11 11:17:00 +0000,http://finance.yahoo.com/r/d5dee9dc-458d-389f-b62a-a3853497559d/allergans-patent-loophole-could-be-a-huge-gift-for.aspx?yptr=yahoo&.tsrc=rss,An announcement from Allergan of a novel way to defend against patent challenges could be just what Pfizer needs.
PFE,PFE:US,BBG000BR2B91,Pfizer Presents Overall Survival Data of XALKORI in Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer,2017-09-11 11:00:00 +0000,https://finance.yahoo.com/news/pfizer-presents-overall-survival-data-110000684.html?.tsrc=rss,Pfizer Inc. today announced final overall survival data from the PROFILE 1014 trial examining XALKORI® in previously untreated patients with ALK-positive advanced non-small cell lung cancer .
PFE,PFE:US,BBG000BR2B91,"New Hope For AZN's Old Drug, More About BMY's Opdivo, IMDZ On Watch",2017-09-11 00:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YSrwGw-FWiI/new-hope-for-azns-old-drug-more-about-bmys-opdivo-imdz-on-watch-20170911-00011,"New Hope For AZN's Old Drug, More About BMY's Opdivo, IMDZ On Watch"
PFE,PFE:US,BBG000BR2B91,"Lilly takes on Pfizer, Novartis with new breast cancer drug data",2017-09-10 08:19:36 +0000,https://finance.yahoo.com/news/lilly-takes-pfizer-novartis-breast-081936133.html?.tsrc=rss,"NEW YORK/MADRID, Sept 10 (Reuters) - Eli Lilly  staked its claim for a slice of sales in a new class of breast  cancer drugs on Sunday as clinical data showed adding its  medicine abemaciclib to standard therapy reduced the risk of  disease progression by 46 percent.  Experts at the European Society for Medical Oncology (ESMO)  congress in Madrid said the experimental drug's efficacy was  comparable to that of rival drugs from Pfizer and  Novartis already on the market."
PFE,PFE:US,BBG000BR2B91,"Pfizer Presents Positive Pivotal Data for PF-05280014, an Investigational Biosimilar to Herceptin® (trastuzumab), at the European Society for Medical Oncology (ESMO) 2017 Congress",2017-09-10 07:15:00 +0000,https://finance.yahoo.com/news/pfizer-presents-positive-pivotal-data-071500263.html?.tsrc=rss,"Pfizer Inc. today announced positive findings from REFLECTIONS B327-02 , a pivotal Phase 3 randomized, double-blind comparative safety and efficacy study of the company’s investigational trastuzumab biosimilar versus Herceptin®1 , at the European Society for Medical Oncology 2017 Congress in Madrid."
PFE,PFE:US,BBG000BR2B91,Lilly Breast Cancer Drug Results May Challenge Pfizer Pill,2017-09-09 22:05:00 +0000,http://finance.yahoo.com/r/ea8fe05b-9e2f-351d-a60c-2390ce60989b/lilly-breast-cancer-drug-results-may-challenge-pfizer-pill?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Eli Lilly & Co.’s experimental breast cancer drug abemaciclib, when combined with standard therapy, slowed the progression of the tumor in patients with an advanced form of the disease."
PFE,PFE:US,BBG000BR2B91,3 Excellent Dividend ETFs for Turbulent Times,2017-09-08 23:51:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wa60L5Va3vY/3-excellent-dividend-etfs-for-turbulent-times-cm843221,U S equity markets are going through turbulent times There is a lot of volatility and uncertainty owing to rising geopolitical risks and political uncertainty This has increased the appeal for dividend investing Geopolitical Risks North Korea conducted its sixth nuclear test
PFE,PFE:US,BBG000BR2B91,Pfizer Accused of Not Investigating EpiPen Failures,2017-09-08 19:54:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vfhCovtrH4A/pfizer-accused-of-not-investigating-epipen-failures-cm843160,InvestorPlace Stock Market News Stock Advice amp Trading Tips The U S Food and Drug Administration FDA is taking Pfizer Inc NYSE PFE to task for allegedly not properly investigating cases of EpiPen failure Source Kojach Via Flickr A letter from the FDA accuses
PFE,PFE:US,BBG000BR2B91,Feds want to deny Martin Shkreli bail,2017-09-08 17:17:55 +0000,https://finance.yahoo.com/video/feds-want-deny-martin-shkreli-171755949.html?.tsrc=rss,"Martin Shkreli, the former hedge fund manager awaiting sentencing for defrauding his investors, has a new headache to deal with. Prosecutors say the Pharma Bro should have his $5 million bail revoked for harassing Hillary Clinton and others.  Yahoo Finance’s Alexis Christoforous, Editor-in-Chief Andy Serwer and Myles Udland figure out if denying Shkreli bail is justified."
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: UTX to Buy Rockwell Collins, Merck Secures EU Keytruda Approval",2017-09-08 15:55:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CCJ5teFosK0/dow-30-stock-roundup-utx-to-buy-rockwell-collins-merck-secures-eu-keytruda-approval-cm842947,The Dow endured significant losses over a holiday shortened trading week Markets were closed on Monday for the Labor Day holiday The index endured its worst one day loss in several weeks on Tuesday following rising tensions over North Korea The index rebounded on Wednesday after President
PFE,PFE:US,BBG000BR2B91,"Bristol-Myers' Opdivo Study Meets Early Success, Stock Up",2017-09-08 15:55:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SVbtogYJDoM/bristol-myers-opdivo-study-meets-early-success-stock-up-cm842946,Shares of Bristol Myers Squibb Company BMY gained about 5 after the company ended its phase III combination study CheckMate 214 earlier than expected after it met its co primary endpoint The phase III study evaluated Opdivo plus Yervoy in patients with previously untreated advanced
PFE,PFE:US,BBG000BR2B91,Pfizer Accused of Not Investigating EpiPen Failures,2017-09-08 15:35:45 +0000,https://finance.yahoo.com/news/pfizer-accused-not-investigating-epipen-153545235.html?.tsrc=rss,"A letter from the FDA accuses Pfizer Inc. of ignoring cases in which EpiPens didn’t operate properly.  The FDA’s letter specifically calls out Pfizer Inc. for not investigating a case of EpiPen failure from back in Feb. 1, 2016."
PFE,PFE:US,BBG000BR2B91,"Stocks to Watch: Equifax, Pfizer, Kroger, Southwest, Kura Oncology, American Outdoor Brands",2017-09-08 13:23:29 +0000,http://finance.yahoo.com/r/11ee9300-2894-32b8-92c4-d31c2c4fa5b2/stocks-to-watch-equifax-pfizer-kroger-southwest-kura-oncology-american-outdoor-brands-1504877007?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Among the companies with shares expected to trade actively in Friday's session are Equifax Inc.. Pfizer Inc., Kroger Co., Southwest Airlines Co. and Kura Oncology Inc."
PFE,PFE:US,BBG000BR2B91,"[$$] Pfizer CEO, CFO Sell $13 Million in Stock",2017-09-08 11:49:00 +0000,http://finance.yahoo.com/r/bc5e3522-425b-34f1-a359-d46198e508a0/pfizer-ceo-cfo-sell-13-million-in-stock-1504871370?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"On Aug. 1, Pfizer reported mixed second-quarter results as revenue was lighter than Wall Street expected while earnings per share topped the consensus forecast.  Some Pfizer (PFE) investors would like to see the pharmaceutical giant make an acquisition.  Such restraint didn’t apply to selling stock, however, as Read, Chief Financial Officer Frank D’Amelio and two executive vice presidents together sold $14.5 million in Pfizer shares over the next 30 days."
PFE,PFE:US,BBG000BR2B91,Understanding Merck’s Valuation after 2Q17,2017-09-08 11:38:13 +0000,http://finance.yahoo.com/r/63146f08-0644-3585-80c9-23825ddc23cc/understanding-mercks-valuation-after-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Merck reported EPS of $1.01 on revenues of ~$9.93 billion for 2Q17, compared with its EPS of $0.93 on revenues of $9.84 billion in 2Q16."
PFE,PFE:US,BBG000BR2B91,FDA warns of serious manufacturing violations in letter to EpiPen manufacturing facility,2017-09-08 10:53:10 +0000,http://finance.yahoo.com/r/c0b4dd0b-846a-3ead-8474-0ae945c218fc/Story.aspx?guid=1791C13E-93F8-11E7-9FD8-05220BAFA418&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"A Pfizer unit that manufactures the EpiPen did not thoroughly investigate issues, including those associated with patient deaths and severe illness, the FDA said."
PFE,PFE:US,BBG000BR2B91,Pfizer’s Meridian Hit With FDA Warning Over EpiPen Flaws,2017-09-08 10:32:33 +0000,https://finance.yahoo.com/news/pfizer-meridian-hit-fda-warning-103233371.html?.tsrc=rss,Warning comes with threat of legal action.
PFE,PFE:US,BBG000BR2B91,"[$$] FDA Warns Pfizer’s Meridian Unit on EpiPen Oversight, Quality Issues",2017-09-08 05:05:00 +0000,http://finance.yahoo.com/r/e2c3c46c-6a08-313f-b959-b43f77ca5e5c/fda-warns-pfizers-meridian-unit-on-epipen-oversight-quality-issues-1504826114?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"The Food and Drug Administration issued a scathing warning letter to a Pfizer unit that manufactures the emergency auto-injector EpiPen, saying the company “failed to thoroughly investigate” product failures ..."
PFE,PFE:US,BBG000BR2B91,PRESS DIGEST- New York Times business news - Sept 8,2017-09-08 04:15:23 +0000,https://finance.yahoo.com/news/press-digest-york-times-business-041523253.html?.tsrc=rss,"The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. - Equifax Inc, one of the three major consumer credit ..."
PFE,PFE:US,BBG000BR2B91,PRESS DIGEST - Wall Street Journal - Sept 8,2017-09-08 03:58:57 +0000,https://finance.yahoo.com/news/press-digest-wall-street-journal-035857908.html?.tsrc=rss,"The following are the top stories in the  Wall Street Journal.  - Amazon.com Inc on Thursday launched an  plan to  establish a second corporate headquarters in North America,  creating up to 50,000 high-paying jobs, many in software  development and most of them new.  - President Donald Trump signaled he was open to making more  deals with Democrats in Congress despite anger from fellow  Republicans over a bipartisan agreement that passed the Senate  Thursday."
PFE,PFE:US,BBG000BR2B91,FDA Warns Of Manufacturing Violations To EpiPen Plant,2017-09-08 00:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-a54NeozLBY/fda-warns-of-manufacturing-violations-to-epipen-plant-20170908-00001,FDA Warns Of Manufacturing Violations To EpiPen Plant
PFE,PFE:US,BBG000BR2B91,"[$$] FDA Warns Pfizer's Meridian Unit on EpiPen Oversight, Quality Issues",2017-09-07 23:15:17 +0000,http://finance.yahoo.com/r/e2c3c46c-6a08-313f-b959-b43f77ca5e5c/fda-warns-pfizers-meridian-unit-on-epipen-oversight-quality-issues-1504826114?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"The Food and Drug Administration issued a scathing warning letter to a Pfizer Inc. unit that manufactures the emergency auto-injector EpiPen, saying the company “failed to thoroughly investigate” product ..."
PFE,PFE:US,BBG000BR2B91,U.S. FDA warns of problems with EpiPen manufacturing plant,2017-09-07 21:20:21 +0000,https://finance.yahoo.com/news/u-fda-warns-problems-epipen-212021065.html?.tsrc=rss,"A U.S. regulator this week told Pfizer  Inc’s Meridian Medical Technologies division, maker of the  EpiPen injector device, that serious component and product  failures have been associated with patient deaths and severe  illness.  Tens of thousands of EpiPens, sold by Mylan NV, were  recalled worldwide in March following two reports of the  life-saving allergy shot failing to work in emergencies.  Pfizer makes EpiPens for Mylan, which has come under fire  for sharply hiking the price of the device."
PFE,PFE:US,BBG000BR2B91,"FDA says there have been 'hundreds of complaints' about EpiPen misfires, some patient deaths followed",2017-09-07 19:32:05 +0000,http://finance.yahoo.com/r/1e0ea8da-f84a-3240-88bc-e7848f838706/104696313?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104696313&yptr=yahoo&.tsrc=rss,"That stunning revelation is in a warning letter the FDA sent to the division of Pfizer, which makes EpiPens for another pharmaceuticals firm, Mylan."
PFE,PFE:US,BBG000BR2B91,EpiPen Maker Neglected ‘Hundreds’ of Complaints About Defects,2017-09-07 19:23:31 +0000,http://finance.yahoo.com/r/4b458c5b-0269-3176-bc5e-f7a26a985adc/epipen-maker-neglected-hundreds-of-complaints-about-defects?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"A Pfizer Inc. unit that makes the life-saving allergy shot EpiPen failed to investigate hundreds of complaints about defects in the auto-injecting pens, including in cases where patients were hurt or died, ..."
PFE,PFE:US,BBG000BR2B91,J&J (JNJ) PAH Drug's U.S. Label Expanded for Pediatric Use,2017-09-07 16:54:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5SdQxROtI-0/jj-jnj-pah-drugs-us-label-expanded-for-pediatric-use-cm842385,Johnson amp Johnson JNJ a healthcare bellwether announced that the FDA has approved a label expansion for its oral pulmonary arterial hypertension PAH medicine Tracleer Consequently a 32 mg tablet of Tracleer is now approved for use in pediatric patients aged three years and
PFE,PFE:US,BBG000BR2B91,Aerie Initiates Phase III Study for Ophthalmic Drug Roclatan,2017-09-07 15:58:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iRa9UBr0-KY/aerie-initiates-phase-iii-study-for-ophthalmic-drug-roclatan-cm842311,Aerie Pharmaceuticals Inc AERI announced the initiation of phase III study Mercury 3 in Europe for its pipeline candidate Roclatan 0 02 0 005 Roclatan is a once daily quadruple action fixed dose combination of Rhopressa and Pfizer s PFE Xalatan iis being evaluated to lower
PFE,PFE:US,BBG000BR2B91,3 Alternative Mutual Funds to Ride Out a Spooky September,2017-09-07 15:43:03 +0000,https://finance.yahoo.com/news/3-alternative-mutual-funds-ride-154303259.html?.tsrc=rss,"Alternative mutual funds are known for their potential to hedge risks, provide unwavering returns particularly in difficult times and a diversified portfolio"
PFE,PFE:US,BBG000BR2B91,3 Top Stocks for Retirees,2017-09-07 13:53:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d8m_U_6Mbow/3-top-stocks-for-retirees-cm842103,When you re retired your investing goals change Growth is still good but it isn t nearly as important as steady and reliable income But what stocks should you choose to provide that steady and reliable income There are plenty of alternatives to consider I like AT amp T NYSE
PFE,PFE:US,BBG000BR2B91,3 Top Stocks for Retirees,2017-09-07 12:04:00 +0000,http://finance.yahoo.com/r/acc2093d-107a-3284-b174-ab143ec87545/3-top-stocks-for-retirees.aspx?yptr=yahoo&.tsrc=rss,"Why AT&T, Intel, and Pfizer look like great stocks for retired investors."
PFE,PFE:US,BBG000BR2B91,New Drugs Approved In August,2017-09-07 05:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZoP1iaTzo4w/new-drugs-approved-in-august-20170907-00189,New Drugs Approved In August
PFE,PFE:US,BBG000BR2B91,Genentech Recalls Three Lots Of Activase (alteplase) 100mg Vials,2017-09-07 01:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MKJbMZGgOj4/genentech-recalls-three-lots-of-activase-alteplase-100mg-vials-20170907-00024,Genentech Recalls Three Lots Of Activase (alteplase) 100mg Vials
PFE,PFE:US,BBG000BR2B91,Here's Why Spark Therapeutics Inc. Surged 23.5% in August,2017-09-06 22:50:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fVnyQ3I0p00/heres-why-spark-therapeutics-inc-surged-235-in-august-cm841959,What happened Shares of Spark Therapeutics Inc NASDAQ ONCE a clinical stage biotech developing gene therapies rose 23 5 in August according to data from S amp P Global Market Intelligence The company pleased investors with clinical trial data for a hemophilia drug
PFE,PFE:US,BBG000BR2B91,4 Drug Stocks Worth a Look on Promising Cancer Pipeline,2017-09-06 16:55:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KlT1ZASm774/4-drug-stocks-worth-a-look-on-promising-cancer-pipeline-cm841764,Cancer is the second most common cause of death in the U S preceded only by heart disease The traditional cancer treatments include surgery radiation and chemotherapy However immunotherapy gene therapy and other new novel therapies are being developed to improve supplement or
PFE,PFE:US,BBG000BR2B91,MEI Pharma-Presage Biosciences on License Deal for Voruciclib,2017-09-06 16:53:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/18_ZlShHWBQ/mei-pharma-presage-biosciences-on-license-deal-for-voruciclib-cm841743,MEI Pharma Inc MEIP announced that it has inked an exclusive license agreement with Presage Biosciences an oncology company for developing its oral and selective cyclin dependent kinase CDK inhibitor voruciclib formerly P1446A for treatment of B cell lymphoma 2 BCL2 Pursuant to
PFE,PFE:US,BBG000BR2B91,Merck's (MRK) Keytruda Gets EU Approval for Bladder Cancer,2017-09-06 16:52:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g6PGdb900_Q/mercks-mrk-keytruda-gets-eu-approval-for-bladder-cancer-cm841692,Merck amp Co Inc MRK announced that its anti PD 1 therapy Keytruda has received approval from the European Commission EC for the first and second line treatment of certain patients with locally advanced or metastatic urothelial carcinoma a type of bladder cancer Keytruda has
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-09-06 14:05:24 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-140524097.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference,2017-09-06 14:00:00 +0000,https://finance.yahoo.com/news/pfizer-invites-public-listen-webcast-140000745.html?.tsrc=rss,"Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Frank D’Amelio, Executive Vice President, Business Operations, and Chief Financial Officer, at the Morgan Stanley 15th Annual Global Healthcare Conference on Wednesday, September 13, 2017 at 9:55 a.m."
PFE,PFE:US,BBG000BR2B91,"Shire plc (SHPG) Ex-Dividend Date Scheduled for September 07, 2017",2017-09-06 13:23:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8CSJj-ejs4s/shire-plc-shpg-ex-dividend-date-scheduled-for-september-07-2017-cm841489,Shire plc SHPG will begin trading ex dividend on September 07 2017 A cash dividend payment of 0 153 per share is scheduled to be paid on October 20 2017 Shareholders who purchased SHPG prior to the ex dividend date are eligible for the cash dividend payment This represents an 80
PFE,PFE:US,BBG000BR2B91,7 Medical Conditions That Will Be Lining Big Pharma's Pockets by 2020,2017-09-06 11:50:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_PMPntqAH_g/7-medical-conditions-that-will-be-lining-big-pharmas-pockets-by-2020-cm841383,Image source Getty Images Imagine a stack of dollar bills reaching from the ground to more than 95 000 miles into the sky nearly four tenths of the way to the moon That stack would total 1 4 trillion 160 It s a staggering number It s also how much will be spent worldwide
PFE,PFE:US,BBG000BR2B91,Health Care Select Sector SPDR Fund Experiences Big Outflow,2017-09-05 16:51:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YLsmQO1Gbgo/health-care-select-sector-spdr-fund-experiences-big-outflow-cm841107,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Health Care Select Sector SPDR Fund Symbol XLV where we have detected an approximate 85 3 million dollar outflow that s a 0 5 decrease week over week
PFE,PFE:US,BBG000BR2B91,Pfizer's Acute Leukemia Drug Mylotarg Approved by the FDA,2017-09-04 15:49:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dUP9K9NnRcE/pfizers-acute-leukemia-drug-mylotarg-approved-by-the-fda-cm840773,Pfizer Inc PFE announced that the FDA has granted approval to Mylotarg for adult patients with newly diagnosed CD33 positive acute myeloid leukemia AML The drug also received approval to treat relapsed or refractory CD33 positive AML in adults as well as children 2 years and older
PFE,PFE:US,BBG000BR2B91,Pfizer&apos;s Acute Leukemia Drug Mylotarg Approved by the FDA,2017-09-04 13:54:01 +0000,https://finance.yahoo.com/news/pfizer-apos-acute-leukemia-drug-135401017.html?.tsrc=rss,Pfizer&apos;s (PFE) Mylotarg received FDA nod as a treatment for new or relapsed CD33-positive acute myeloid leukemia.
PFE,PFE:US,BBG000BR2B91,Key FDA Regulatory Events to Watch Out for in Sep 2017,2017-09-04 13:50:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ytCH56SlVIQ/key-fda-regulatory-events-to-watch-out-for-in-sep-2017-cm840710,The FDA which approved 22 novel drugs last year has given its approval to 31 drugs so far in 2017 including five in August Key approvals this year include Gilead s Vosevi hepatitis C virus Puma s Nerlynx to reduce the risk of breast cancer returning J amp J s Tremfya moderate to
PFE,PFE:US,BBG000BR2B91,What to Expect from Pfizer’s Biosimilars Business,2017-09-04 13:06:07 +0000,http://finance.yahoo.com/r/09195746-b4af-3dcb-b7cb-ac8d071cde40/what-to-expect-from-pfizers-biosimilars-business?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Pfizer’s Inflectra/Remsima reported revenues of ~$94 million compared to $45 million in 2Q16."
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-09-04 12:00:21 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120021631.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,An Update on Pfizer’s Legacy Established Products after 2Q17,2017-09-04 11:36:07 +0000,http://finance.yahoo.com/r/cf9b3b2a-d61f-3ce6-8aaf-66333a1cb58d/an-update-on-pfizers-legacy-established-products-after-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1H17, Zithromax generated revenues of ~$140 million compared to $147 million in 1H16."
PFE,PFE:US,BBG000BR2B91,Here's the Best Dividend Stock in Big Pharma,2017-09-03 12:49:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Oyf-OUR12Pk/heres-the-best-dividend-stock-in-big-pharma-cm840633,Dividends make a huge impact on your overall investing returns They can also provide solid income during your retirement years Historically big pharma stocks have been a great place for investors to turn to for high yields and reliable income But which big pharma stock is the
PFE,PFE:US,BBG000BR2B91,US Market Indexes End the Month Higher,2017-09-02 09:48:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sII4VzTM4U8/us-market-indexes-end-the-month-higher-cm840565,U S market indexes were higher on Thursday For the day the Dow Jones Industrial Average closed at 21 948 10 for a gain of 55 67 points or 0 25 The S amp P 500 closed 2 471 65 for a gain of 14 06 points or 0 57 The Nasdaq Composite closed at 6 428 66 for a gain of 60 35 points or 0 95
PFE,PFE:US,BBG000BR2B91,Pfizer Inc (PFE) Chairman & CEO Ian C Read Sold $6.7 million of Shares,2017-09-02 01:15:03 +0000,https://finance.yahoo.com/news/pfizer-inc-pfe-chairman-ceo-011503029.html?.tsrc=rss,"Chairman & CEO of Pfizer Inc (NYSE:PFE) Ian C Read sold 197,168 shares of PFE on 08/31/2017 at an average price of $34 a share."
PFE,PFE:US,BBG000BR2B91,Cramer's biggest investing mistakes,2017-09-01 23:09:00 +0000,https://finance.yahoo.com/video/cramers-biggest-investing-mistakes-230900720.html?.tsrc=rss,Jim Cramer opens up the lesson book and shares his top blunders made on Wall Street.
PFE,PFE:US,BBG000BR2B91,Cramer admits his biggest investing mistakes,2017-09-01 22:58:00 +0000,https://finance.yahoo.com/video/cramer-admits-biggest-investing-mistakes-225800259.html?.tsrc=rss,Jim Cramer opens up the lesson book and shares his top blunders made on Wall Street.
PFE,PFE:US,BBG000BR2B91,Cramer admits his biggest investing mistakes,2017-09-01 22:44:40 +0000,http://finance.yahoo.com/r/169a94ee-2548-3688-8678-002ac142da63/104686099?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104686099&yptr=yahoo&.tsrc=rss,Jim Cramer opens up the lesson book and shares his top blunders made on Wall Street.
PFE,PFE:US,BBG000BR2B91,Cramer admits his biggest investing mistakes,2017-09-01 22:44:40 +0000,https://finance.yahoo.com/news/cramer-admits-biggest-investing-mistakes-224440271.html?.tsrc=rss,Jim Cramer opens up the lesson book and shares his top blunders made on Wall Street.
PFE,PFE:US,BBG000BR2B91,FDA Approves Pfizer's Leukemia Drug,2017-09-01 20:34:59 +0000,http://finance.yahoo.com/r/591c9032-4793-3fcf-ade5-a5c0e41b5345/fda-approves-pfizers-leukemia-drug-1504298096?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Pfizer is bringing back a cancer drug it pulled from the U.S. market over safety concerns in 2010--but the second iteration carries a higher cost, in the latest sign of the industry’s pricing power."
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. : PFE-US: Dividend Analysis : August 04th, 2017 (record date) : By the numbers : September 1, 2017",2017-09-01 20:30:57 +0000,http://finance.yahoo.com/r/959e1b06-b914-3505-a50a-af230ae4211c/pfizer-inc-pfe-us-dividend-analysis-august-04th-2017-record-date-by-the-numbers-september-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Our analysis is based on comparing Pfizer Inc. with the following peers – Merck & Co., Inc., Johnson & Johnson, Bristol-Myers Squibb Company, Eli Lilly and Company, Novartis AG Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Mylan N.V., Abbott Laboratories and Astrazeneca PLC Sponsored ADR (MRK-US, JNJ-US, BMY-US, LLY-US, NVS-US, ... Read more
<b>(Read more...)</b>"
PFE,PFE:US,BBG000BR2B91,3 Stocks That Pay You,2017-09-01 19:50:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ijChaPPztBo/3-stocks-that-pay-you-cm840444,Other than the obvious reason that investors like the steady stream of income that comes from investing in dividend paying stocks the stability it conveys about a particular business provides a certain peace of mind to income investors Of course companies do get into financial
PFE,PFE:US,BBG000BR2B91,Better Buy: Eli Lilly and Company vs. Pfizer Inc.,2017-09-01 19:49:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v6omtrCe_NM/better-buy-eli-lilly-and-company-vs-pfizer-inc-cm840443,Two of the biggest pharmaceutical companies in the world have been around since the 19th century Eli Lilly and Company NYSE LLY was founded in 1876 while Pfizer Inc NYSE PFE began operations even earlier in 1849 Overall Pfizer stock has been the better investment That
PFE,PFE:US,BBG000BR2B91,FDA approves Pfizer's leukemia drug,2017-09-01 19:21:46 +0000,https://finance.yahoo.com/news/fda-approves-pfizers-leukemia-drug-192146773.html?.tsrc=rss,"The U.S. Food and Drug Administration  (FDA) on Friday approved Pfizer Inc's drug, Mylotarg,  for certain patients with acute myeloid leukemia (AML),  re-clearing a drug that had been pulled off the market in 2010.  The drug was cleared to treat adults with newly diagnosed  AML and tumors expressing the CD33 antigen, as well as patients  aged 2 years and older with CD33-positive AML who have relapsed,  or did not respond to initial treatment.  The FDA said the drug has a boxed warning as it may cause  severe or fatal liver damage, including blockage of veins in the  liver."
PFE,PFE:US,BBG000BR2B91,FDA approves Pfizer's leukemia drug,2017-09-01 19:06:25 +0000,https://finance.yahoo.com/news/fda-approves-pfizers-leukemia-drug-153720561.html?.tsrc=rss,"The drug was cleared to treat adults with newly diagnosed AML whose tumors express the CD33 antigen, as well as patients aged 2 years and older with CD33-positive AML who have relapsed, or did not respond to initial treatment.  The FDA said the drug has a boxed warning as it may cause severe or fatal liver damage, including blockage of veins in the liver.  Mylotarg got accelerated approval in 2000 as a standalone treatment for adult patients with CD33-positive AML who had experienced a relapse, but was voluntarily withdrawn as subsequent confirmatory studies failed to show clinical benefit and had safety concerns, including a high number of deaths."
PFE,PFE:US,BBG000BR2B91,Better Buy: Eli Lilly and Company vs. Pfizer Inc.,2017-09-01 18:41:00 +0000,http://finance.yahoo.com/r/be55ce5f-e0c6-3891-9dbd-6b9b822f9f62/better-buy-eli-lilly-and-company-vs-pfizer.aspx?yptr=yahoo&.tsrc=rss,How do Eli Lilly and Pfizer fare in a head-to-head matchup between the two big pharma stocks?
PFE,PFE:US,BBG000BR2B91,3 Stocks That Pay You,2017-09-01 18:40:00 +0000,http://finance.yahoo.com/r/0ac0854f-0ecc-348d-9f4f-4cb67d91221b/3-stocks-that-pay-you.aspx?yptr=yahoo&.tsrc=rss,"Investing always seems to incur costs, but Darden Restaurants, MasterCard, and Pfizer actually pay you to own their stocks."
PFE,PFE:US,BBG000BR2B91,FDA approves Pfizer's leukemia drug,2017-09-01 15:53:58 +0000,https://finance.yahoo.com/news/fda-approves-pfizers-leukemia-drug-155358928.html?.tsrc=rss,"The U.S. Food and Drug Administration  (FDA) on Friday approved Pfizer Inc's drug, Mylotarg,  for certain patients with acute myeloid leukemia (AML).  The drug was cleared to treat adults with newly diagnosed  AML whose tumors express the CD33 antigen, as well as patients  aged 2 years and older with CD33-positive AML who have relapsed,  or did respond to initial treatment.  The FDA said the drug has a boxed warning as it may cause  severe or fatal liver damage, including blockage of veins in the  liver."
PFE,PFE:US,BBG000BR2B91,Pfizer Receives FDA Approval for MYLOTARG™ (gemtuzumab ozogamicin),2017-09-01 15:38:00 +0000,https://finance.yahoo.com/news/pfizer-receives-fda-approval-mylotarg-153800670.html?.tsrc=rss,"Pfizer Inc. today announced that the U.S. Food and Drug Administration approved MYLOTARG™ for adults with newly diagnosed CD33-positive acute myeloid leukemia , and adults and children 2 years and older with relapsed or refractory CD33-positive AML.1 MYLOTARG is the first therapy with an indication that includes pediatric AML."
PFE,PFE:US,BBG000BR2B91,How Pfizer’s Enbrel and Xeljanz Are Positioned after 2Q17,2017-09-01 14:36:14 +0000,http://finance.yahoo.com/r/c0abc261-9bce-36ac-b9a4-f49314f8550c/how-pfizers-enbrel-and-xeljanz-are-positioned-after-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In August 2017, the Arthritis Advisory Committee of the FDA recommended a positive opinion for the proposed dose of Xeljanz for the treatment of individuals with active psoriatic arthritis."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 09/01/2017: JNJ, PFE, ABT, MRK, AMGN, IOVA, APVO, PGNX",2017-09-01 13:50:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oT2GszJHh7o/health-care-sector-update-for-09012017-jnj-pfe-abt-mrk-amgn-iova-apvo-pgnx-cm840156,Top Health Care Stocks Top Health Care Stocks JNJ 0 02 JNJ 0 02 PFE 0 03 PFE 0 03 ABT flatABT flat MRK flatMRK flat AMGN 0 3 AMGN 0 3 Health care shares were mainly firmer in pre market trade Friday Health care shares were mainly firmer in pre market trade Friday In
PFE,PFE:US,BBG000BR2B91,Pfizer’s Sterile Injection Pharmaceuticals in 2Q17 and 1H17,2017-09-01 13:06:18 +0000,http://finance.yahoo.com/r/224458ea-7da1-3dfa-94c3-e0a12f34d0d0/pfizers-sterile-injection-pharmaceuticals-in-2q17-and-1h17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1H17, Sulperazon reported revenues of ~$232 million for 15% growth on a YoY basis."
PFE,PFE:US,BBG000BR2B91,A Post-2Q17 Look at Pfizer’s Internal Medicines,2017-09-01 11:36:25 +0000,http://finance.yahoo.com/r/efba0b5b-9ddc-392a-b845-51a7eb74e8aa/a-post-2q17-look-at-pfizers-internal-medicines?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Chantix/Champix generated revenues of ~$248 million, which represents ~16% growth on a YoY basis and 4% growth on a quarter-over-quarter basis."
PFE,PFE:US,BBG000BR2B91,Why Is Pfizer (PFE) Up 2.5% Since the Last Earnings Report?,2017-09-01 10:51:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9Esa6k5DyqI/why-is-pfizer-pfe-up-25-since-the-last-earnings-report-cm840084,It has been about a month since the last earnings report for Pfizer Inc PFE Shares have added about 2 5 in that time frame outperforming the market Will the recent positive trend continue leading up to the stock s next earnings release or is it due for a pullback Before we dive into
PFE,PFE:US,BBG000BR2B91,Why Is Pfizer (PFE) Up 2.5% Since the Last Earnings Report?,2017-09-01 08:18:08 +0000,https://finance.yahoo.com/news/why-pfizer-pfe-2-5-081808175.html?.tsrc=rss,Pfizer (PFE) reported earnings about a month ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
PFE,PFE:US,BBG000BR2B91,"Bristol-Myers Squibb, Pfizer, Abbott Are on the Move: Buy These Target Prices",2017-09-01 00:11:00 +0000,http://finance.yahoo.com/r/c1a13695-f358-3adc-9a14-7d7b6a3efea7/eli-lilly-pfizer-abbott-are-big-pharma-on-the-move-buy-these-target-prices.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Check out these three big movers today.
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Aug 31, 2017 :  DOW, DD, SBAC, BAC, QQQ, MSFT, TEVA, PFE, GE, AMAT, GILD, INTC",2017-08-31 20:58:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q4d1DzcEtNI/after-hours-most-active-for-aug-31-2017-dow-dd-sbac-bac-qqq-msft-teva-pfe-ge-amat-gild-intc-cm839965,The NASDAQ 100 After Hours Indicator is down 63 to 5 987 97 The total After hours volume is currently 66 675 731 shares traded The following are the most active stocks for the after hours session Dow Chemical Company The DOW is unchanged at 66 65 with 12 912
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/31/2017: JNJ, PFE, ABT, MRK, AMGN, IPXL, INSY",2017-08-31 20:29:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bVqkDiUQmi4/health-care-sector-update-for-08312017-jnj-pfe-abt-mrk-amgn-ipxl-insy-cm839944,Top Health Care StocksTop Health Care Stocks JNJ 1 JNJ 1 PFE 1 6 PFE 1 6 ABT 1 7 ABT 1 7 MRK 1 1 MRK 1 1 AMGN 2 2 AMGN 2 2 Health care stocks were firmer as Thursday s regular session drew to a close Health care stocks were firmer as Thursday s regular session drew to
PFE,PFE:US,BBG000BR2B91,Changes in GlaxoSmithKline’s Valuation after 2Q17,2017-08-31 16:34:10 +0000,http://finance.yahoo.com/r/1f7978bc-3038-361b-94f4-d8fc6d93e4f0/changes-glaxosmithklines-valuation-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"As of August 30, 2017, GlaxoSmithKline is trading at a forward PE multiple of 13.3x, which is slightly lower than the industry average of 15.5x."
PFE,PFE:US,BBG000BR2B91,The Medicines Company's Infection Drug Vabomere Gets FDA Nod,2017-08-31 15:56:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9iTy3qrahf4/the-medicines-companys-infection-drug-vabomere-gets-fda-nod-cm839749,The Medicines Company MDCO announced that the FDA has granted accelerated approval to its experimental antibiotic Vabomere a combination of meropenem and vaborbactam for treating complicated urinary tract infections cUTI including the pyelonephritis The company expects to make
PFE,PFE:US,BBG000BR2B91,"A Post-2Q17 Update on Pfizer’s Oncology Drugs: Sutent, Xalkori, and Inlyta",2017-08-31 14:36:32 +0000,http://finance.yahoo.com/r/d6106cd0-e43d-35dd-883c-cf349a301c00/a-post-2q17-update-on-pfizers-oncology-drugs-sutent-xalkori-and-inlyta?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Inlyta generated revenues of ~$88 million, which represents an ~19% decline on a YoY basis and ~4% growth on a quarter-over-quarter basis."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/31/2017: JNJ, PFE, MRK, ABT, AMGN, APRI, BVXV, AMGN",2017-08-31 13:29:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UV82YAQ5EBk/health-care-sector-update-for-08312017-jnj-pfe-mrk-abt-amgn-apri-bvxv-amgn-cm839599,Top Health Care Stocks Top Health Care Stocks JNJ flatJNJ flat PFE 0 2 PFE 0 2 ABT flatABT flat MRK 0 3 MRK 0 3 AMGN 0 4 AMGN 0 4 Health care shares were mixed in pre market trade Thursday Health care shares were mixed in pre market trade Thursday In sector news
PFE,PFE:US,BBG000BR2B91,The Medicines Company&apos;s Infection Drug Vabomere Gets FDA Nod,2017-08-31 13:26:01 +0000,https://finance.yahoo.com/news/medicines-company-apos-infection-drug-132601396.html?.tsrc=rss,The Medicines Company&apos;s (MDCO) infection-resistant antibiotic Vabomere secures a fast FDA approval for urinary tract diseases. The drug is likely to hit the market in fourth-quarter 2017.
PFE,PFE:US,BBG000BR2B91,"Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for September 01, 2017",2017-08-31 13:18:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1FhDij6fkAg/phibro-animal-health-corporation-pahc-ex-dividend-date-scheduled-for-september-01-2017-cm839582,Phibro Animal Health Corporation PAHC will begin trading ex dividend on September 01 2017 A cash dividend payment of 0 1 per share is scheduled to be paid on September 27 2017 Shareholders who purchased PAHC prior to the ex dividend date are eligible for the cash dividend payment
PFE,PFE:US,BBG000BR2B91,How Pfizer’s Rare Disease Franchise Stands after 2Q17,2017-08-31 13:06:45 +0000,http://finance.yahoo.com/r/8a87d9f3-5859-3048-87a7-4bac7a92fab7/how-pfizers-rare-disease-franchise-stands-after-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1H17, BeneFix generated revenues of ~$302 million, which reflected an ~18% decline on a YoY basis."
PFE,PFE:US,BBG000BR2B91,"Amyloid Publishes Long-Term Data Analysis from Pfizer Suggesting Tafamidis Delays Progression of TTR-FAP, a Rare Disease",2017-08-31 12:54:00 +0000,https://finance.yahoo.com/news/amyloid-publishes-long-term-data-125400158.html?.tsrc=rss,"Pfizer Inc. announced the publication of a new interim analysis of long-term data from four studies indicating that treatment with tafamidis is associated with delay in disease progression in patients with hereditary transthyretin amyloid polyneuropathy and was well tolerated, with no unexpected side effects."
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-08-31 12:05:24 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120524609.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,How Pfizer’s Prevnar 13 and Lyrica Stand after 2Q17,2017-08-31 11:37:14 +0000,http://finance.yahoo.com/r/3c181ee6-e55d-374e-aec9-da6c75844748/how-pfizers-prevnar-13-and-lyrica-stand-after-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Pfizer's (PFE) Prevnar 13 generated revenues of ~$1.2 billion, which reflected an ~8% decline on a year-over-year basis and an ~17% decline on a quarter-over-quarter basis."
PFE,PFE:US,BBG000BR2B91,"Hospira Recalls 1 Lot Of Vancomycin Hydrochloride For Injection, USP,750 Mg/vial",2017-08-31 03:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ydNXUbKVpuc/hospira-recalls-1-lot-of-vancomycin-hydrochloride-for-injection-usp750-mgvial-20170831-00107,"Hospira Recalls 1 Lot Of Vancomycin Hydrochloride For Injection, USP,750 Mg/vial"
PFE,PFE:US,BBG000BR2B91,5 Greatest Health-Care Stocks of All Time,2017-08-30 20:48:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wWPnuDfM0Qc/5-greatest-health-care-stocks-of-all-time-cm839395,Health care stocks have always benefited from the powerful demographic forces of steady population growth and longer life expectancy Indeed the population of the U S has more than tripled over the past 100 years And the average American can expect to live to the age of 79 up from 51
PFE,PFE:US,BBG000BR2B91,Pfizer's sNDA for Bosulif Accepted in the U.S. and Europe,2017-08-30 15:54:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uq0Y531Kt1M/pfizers-snda-for-bosulif-accepted-in-the-us-and-europe-cm839183,Pfizer Inc PFE and partner Avillion announced that a supplemental New Drug Application sNDA for Bosulif has been accepted and granted priority review by the FDA We remind investors that Bosulif is currently approved for the treatment of chronic accelerated or blast phase
PFE,PFE:US,BBG000BR2B91,Merck: Heartbreak Over A Cholesterol Drug,2017-08-30 15:46:00 +0000,http://finance.yahoo.com/r/c7945d4c-67f3-3280-aac8-18b2e25cb635/merck-heartbreak-over-a-cholesterol-drug-1504108016?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Is it still a good time to buy Merck & Co. (MRK)?  In fact, Merck appears poised to become the leader in the new market for immuno-cancer therapies that use the body’s own defense system to battle malignant cells.  Thanks to underwhelming results from a big study of its experimental cholesterol drug anacetrapib, Merck’s fortunes seem more attached than ever to those cancer drugs."
PFE,PFE:US,BBG000BR2B91,Merck's CETP Inhibitor Reduces Cardiovascular Risk by 9%,2017-08-30 14:52:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bZuu54b7bA4/mercks-cetp-inhibitor-reduces-cardiovascular-risk-by-9-cm839057,Merck amp Co Inc MRK announced detailed data from a large phase III cardiovascular outcomes study REVEAL evaluating anacetrapib a cholesteryl ester transfer protein CETP inhibitor in patients with cardiovascular disease Data from the phase III study showed that anacetrapib and
PFE,PFE:US,BBG000BR2B91,Pfizer’s Ibrance Could See Robust Growth in 2H17,2017-08-30 14:37:15 +0000,http://finance.yahoo.com/r/3d0fe5ba-ba56-340e-865c-41fb69b3b227/pfizers-ibrance-could-see-robust-growth-in-2h17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In the Phase 3 PALOMA-2 trial, Ibrance and letrozole combination therapy demonstrated substantially extended progression-free survival (or PFA) compared to placebo and letrozole treatment."
PFE,PFE:US,BBG000BR2B91,Gilead-Kite: A New Transformative Deal For Biotech,2017-08-30 14:01:00 +0000,http://finance.yahoo.com/r/b2abb760-fa69-3761-beac-10be92400511/gilead-kite-a-new-transformative-deal-and-maybe-the-new-future-of-healthcare-deals?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"The Gilead deal couldn’t have been timed better to help activate M&A activity and continue to spur a biotech bull market. It is, however, a reminder that mega-mergers are a distant memory."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/30/2017: JNJ, PFE, ABT, MRK, AMGN, MDCO, OTIC",2017-08-30 13:29:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9E-EBgE9Rug/health-care-sector-update-for-08302017-jnj-pfe-abt-mrk-amgn-mdco-otic-cm839035,Top Health Care Stocks Top Health Care Stocks JNJ 0 2 JNJ 0 2 PFE flatPFE flat ABT flatABT flat MRK flatMRK flat AMGN 0 3 AMGN 0 3 Health care shares were mainly inactive in pre market trade Wednesday Health care shares were mainly inactive in pre market trade Wednesday In
PFE,PFE:US,BBG000BR2B91,Pfizer&apos;s sNDA for Bosulif Accepted in the U.S. and Europe,2017-08-30 13:17:01 +0000,https://finance.yahoo.com/news/pfizer-apos-snda-bosulif-accepted-131701111.html?.tsrc=rss,Pfizer (PFE) along with Avillion announced that the regulatory authorities in the U.S. and Europe have accepted the application for label expansion of Bosulif to include newly diagnosed patients.
PFE,PFE:US,BBG000BR2B91,Merck&apos;s CETP Inhibitor Reduces Cardiovascular Risk by 9%,2017-08-30 13:13:01 +0000,https://finance.yahoo.com/news/merck-apos-cetp-inhibitor-reduces-131301432.html?.tsrc=rss,"Detailed results from Merck&apos;s (MRK) REVEAL study on anacetrapib, showed that the CETP inhibitor and a statin reduced the risk of major coronary events by 9% relative to placebo."
PFE,PFE:US,BBG000BR2B91,Talazoparib Could Be a Significant Long-Term Growth Driver for Pfizer,2017-08-30 13:08:25 +0000,http://finance.yahoo.com/r/3601024f-13df-3912-a890-8643180c185b/talazoparib-could-be-a-significant-long-term-growth-driver-for-pfizer?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In June 2017, Pfizer (PFE) presented the results from the Phase 2 ABRAZO trial."
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-08-30 12:00:24 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120024664.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,Pfizer’s Immuno-Oncology Clinical Program’s Long-Term Growth Potential,2017-08-30 11:37:38 +0000,http://finance.yahoo.com/r/f5a57543-11f1-3b82-a6e2-e7765aa10f99/pfizers-immuno-oncology-clinical-programs-long-term-growth-potential?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,The success in ongoing clinical trials could help Pfizer and Merck KGaA file for label expansion and approval of the new indications for Bavencio.
PFE,PFE:US,BBG000BR2B91,"APRI Makes 2nd Try, PRQR To Reveal Data On Sep.25, PFE Awaits FDA Decision",2017-08-30 02:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tYljtDA0jSY/apri-makes-2nd-try-prqr-to-reveal-data-on-sep25-pfe-awaits-fda-decision-20170830-00061,"APRI Makes 2nd Try, PRQR To Reveal Data On Sep.25, PFE Awaits FDA Decision"
PFE,PFE:US,BBG000BR2B91,"Why Abeona Therapeutics Inc. (and Maybe Sangamo Therapeutics, Inc.) Jumped Higher Today",2017-08-29 23:49:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XsP2RR7bPv8/why-abeona-therapeutics-inc-and-maybe-sangamo-therapeutics-inc-jumped-higher-today-cm838887,What happened Shares of Abeona Therapeutics NASDAQ ABEO jumped 18 4 on Tuesday while shares of Sangamo Therapeutics NASDAQ SGMO ended up 11 3 The former is clearly because Abeona received a breakthrough therapy BT designation from the U S Food and Drug
PFE,PFE:US,BBG000BR2B91,How Did Pfizer Perform in 2Q17?,2017-08-29 22:06:51 +0000,http://finance.yahoo.com/r/53988d07-b494-3973-a11b-af559e026fff/how-did-pfizer-perform-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1H17, Pfizer generated revenues of ~$25.3 billion, which reflected ~3% growth on a YoY basis."
PFE,PFE:US,BBG000BR2B91,Analysts’ Recommendations for Pfizer in August 2017,2017-08-29 20:14:52 +0000,http://finance.yahoo.com/r/804bdc72-966d-38dd-979e-557a2b4eb7c6/analysts-recommendations-for-pfizer-in-august-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Of the 22 analysts covering Pfizer (PFE) in August 2017, one analyst recommended a “strong buy” and ten analysts recommended a “buy.” On August 26, Pfizer had a consensus 12-month target price of $37.45 ..."
PFE,PFE:US,BBG000BR2B91,"Gilead Sciences, Inc. (GILD) Stock Still Has Room to Grow",2017-08-29 19:50:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FjUvm3feiUQ/gilead-sciences-inc-gild-stock-still-has-room-to-grow-cm838818,InvestorPlace Stock Market News Stock Advice amp Trading Tips For a while Gilead Sciences Inc NASDAQ GILD was too shy to take advantage of its technical opportunities and it had many of them But in late June GILD stock rallied off a good earnings report It finally
PFE,PFE:US,BBG000BR2B91,Biogen Alzheimer's Drug Shows Promise in Long-Term Study,2017-08-29 17:52:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MV4uBZiaT8g/biogen-alzheimers-drug-shows-promise-in-long-term-study-cm838739,Biogen Inc BIIB announced data from a long term study on its Alzheimer s disease AD candidate aducanumab Data from the study showed a continued benefit in the rate of amyloid decline over a two three year period in patients with prodromal or mild Alzheimer s disease when treated
PFE,PFE:US,BBG000BR2B91,Why Catalent Inc. Rose as Much as 17% This Morning,2017-08-29 17:51:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oV3MvA7YOEc/why-catalent-inc-rose-as-much-as-17-this-morning-cm838729,What happened Shares of drug delivery technology specialist Catalent NYSE CTLT jumped as much as 17 Tuesday morning in the wake of the company s 2017 fiscal year earnings report released Monday after the market closed As investors can probably guess it was a pretty good
PFE,PFE:US,BBG000BR2B91,Pfizer Presents Encouraging Eliquis Results in NVAF Patients,2017-08-29 17:51:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u_CNTXBbgbw/pfizer-presents-encouraging-eliquis-results-in-nvaf-patients-cm838728,Pfizer Inc PFE and partner Bristol Myers Squibb Company BMY presented findings from a phase IV study on Eliquis which demonstrated the oral anticoagulation s potential in achieving and maintaining normal heart rhythm cardioversion The study EMANATE compared Eliquis with standard of
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb’s Valuation after 2Q17 Earnings,2017-08-29 17:12:58 +0000,http://finance.yahoo.com/r/6187a854-9ad1-3969-b977-291393c7d80a/bristol-myers-squibbs-valuation-after-2q17-earnings?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Bristol-Myers Squibb (BMY) met Wall Street analysts’ estimate for EPS at $0.74. It also surpassed the estimates for revenues.
PFE,PFE:US,BBG000BR2B91,"David Tepper Reduces General Motors, Allergan Positions, Exits Pfizer",2017-08-29 16:48:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3MHkoDdFYvk/david-tepper-reduces-general-motors-allergan-positions-exits-pfizer-cm838706,Appaloosa Management founder David Tepper Trades Portfolio sold shares of the following stocks during the second quarter Appaloosa Management founderDavid Tepper Trades Portfolio sold shares of the following stocks during the second quarter Tepper reduced his holding
PFE,PFE:US,BBG000BR2B91,Pfizer Presents Encouraging Eliquis Results in NVAF Patients,2017-08-29 15:45:03 +0000,https://finance.yahoo.com/news/pfizer-presents-encouraging-eliquis-results-154503751.html?.tsrc=rss,Pfizer (PFE) and partner Bristol-Myers presented data on Eliquis which showed the potential of the drug in reducing stroke and systemic embolism in NVAF patients undergoing cardioversion.
PFE,PFE:US,BBG000BR2B91,Biogen Alzheimer&apos;s Drug Shows Promise in Long-Term Study,2017-08-29 15:29:03 +0000,https://finance.yahoo.com/news/biogen-alzheimer-apos-drug-shows-152903612.html?.tsrc=rss,"Biogen (BIIB) announced data from a long-term study on its Alzheimer&apos;s disease candidate, aducanumab, which showed continued benefit in the rate of amyloid decline."
PFE,PFE:US,BBG000BR2B91,"Gilead Sciences, Inc. (GILD) Stock Still Has Room to Grow",2017-08-29 14:58:18 +0000,https://finance.yahoo.com/news/gilead-sciences-inc-gild-stock-145818440.html?.tsrc=rss,"For a while, Gilead Sciences, Inc. (NASDAQ:GILD) was too shy to take advantage of its technical opportunities and it had many of them.  Recently, Gilead Sciences mounted a 15% rally off a double bottom.  The technical breakout in GILD stock still has legs, but I don’t want to risk my money without room for error."
PFE,PFE:US,BBG000BR2B91,3 Healthcare Stocks to Buy With Dividends Yielding More Than 3%,2017-08-29 13:51:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9UYyrKLhE1w/3-healthcare-stocks-to-buy-with-dividends-yielding-more-than-3-cm838342,There are fewer healthcare stocks with high yields than you might think At least that s the case depending on your definition of healthcare stocks and high yields If you think a high yield stock should boast a minimum 3 yield and that healthcare stocks should exclude real
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/29/2017: JNJ, PFE, ABT, MRK, AMGN, IMGN, ETRM",2017-08-29 13:29:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GphX7296_ns/health-care-sector-update-for-08292017-jnj-pfe-abt-mrk-amgn-imgn-etrm-cm838370,Top Health Care Stocks Top Health Care Stocks JNJ 0 9 JNJ 0 9 PFE 1 1 PFE 1 1 ABT 1 ABT 1 MRK 0 5 MRK 0 5 AMGN 0 8 AMGN 0 8 Health care shares were weaker in pre market trade Tuesday Health care shares were weaker in pre market trade Tuesday In sector news
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb and Pfizer Alliance Announce Real-World Observational Analysis of the Effectiveness and Safety of Direct Oral Anticoagulants Compared to Warfarin in Elderly Patients with Non-Valvular Atrial Fibrillation,2017-08-29 12:21:00 +0000,https://finance.yahoo.com/news/bristol-myers-squibb-pfizer-alliance-122100205.html?.tsrc=rss,"Bristol-Myers Squibb Company and Pfizer Inc. today announced findings from a real-world data analysis of the U.S. Humana database, in which treatment with Eliquis® was associated with a significantly lower risk of stroke/systemic embolism and lower rates of major bleeding compared to warfarin in patients aged 65 years and older with non-valvular atrial fibrillation ."
PFE,PFE:US,BBG000BR2B91,3 Healthcare Stocks to Buy With Dividends Yielding More Than 3%,2017-08-29 12:03:00 +0000,http://finance.yahoo.com/r/aa846806-91ec-3536-9a77-208088f6841e/3-healthcare-stocks-to-buy-with-dividends-yielding.aspx?yptr=yahoo&.tsrc=rss,"Why AbbVie, Pfizer, and Sanofi are three of the top high-yield healthcare stocks to be found."
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-08-29 12:00:21 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120021084.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer to test drug for liver disease linked to rising obesity,2017-08-29 11:30:33 +0000,"http://finance.yahoo.com/r/8490ef26-f4a5-3812-8c26-82027d5afd8f/4208ac4a-8834-11e7-8bb1-5ba57d47eff7,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Pfizer has started testing an experimental medicine for a deadly liver disease in mid-stage clinical trials, as pharmaceutical companies race to develop new medicines for the untreatable ""silent killer"". ..."
PFE,PFE:US,BBG000BR2B91,U.S. FDA and European Medicines Agency Accept Regulatory Submissions for BOSULIF® (bosutinib) for the Treatment of Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia,2017-08-29 11:00:00 +0000,https://finance.yahoo.com/news/u-fda-european-medicines-agency-110000751.html?.tsrc=rss,Pfizer Inc. and Avillion LLP today announced that a supplemental New Drug Application for BOSULIF® has been accepted for filing and granted Priority Review by the U.S.
PFE,PFE:US,BBG000BR2B91,Medical Journals Have a Fake News Problem,2017-08-29 09:00:15 +0000,http://finance.yahoo.com/r/0e4d66c3-6bba-3c4c-b1d9-2d3df2fb134c/medical-journals-have-a-fake-news-problem?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"With help from drug companies, Omics International is making millions as it roils the scientific community with sketchy publications."
PFE,PFE:US,BBG000BR2B91,Biotech Stocks Facing FDA Decision In September,2017-08-29 08:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eLoYmPQkXWM/biotech-stocks-facing-fda-decision-in-september-20170829-00502,Biotech Stocks Facing FDA Decision In September
PFE,PFE:US,BBG000BR2B91,We Got It Wrong With OPKO Health -- Now What?,2017-08-28 23:45:00 +0000,http://finance.yahoo.com/r/d293cbe8-034e-3e4f-99b9-f95f0eaf9b4b/we-got-it-wrong-with-opko-health-now-what.aspx?yptr=yahoo&.tsrc=rss,"OPKO Health’s been dealt setbacks that have caused its shares to nose-dive, rather than head higher. Is that about to change?"
PFE,PFE:US,BBG000BR2B91,"ETFs with exposure to Pfizer Inc. : August 28, 2017",2017-08-28 22:10:34 +0000,http://finance.yahoo.com/r/6d8a5198-601f-3b3a-849a-ca453b575fa1/etfs-with-exposure-to-pfizer-inc-august-28-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pfizer Inc. Here are 5 ETFs with the largest exposure to PFE-US. Comparing the performance and risk of Pfizer Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
PFE,PFE:US,BBG000BR2B91,3 High-Yield Dividend Aristocrat Stocks,2017-08-28 20:49:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pi8oIvMfTho/3-high-yield-dividend-aristocrat-stocks-cm838159,High yield dividend stocks can produce exceptional returns on capital At the same time these stocks can also present unacceptable levels of risk for average investors One way to lower your exposure to the inherent risks associated with high yielders however is to comb
PFE,PFE:US,BBG000BR2B91,"Dow Movers: TRV, HD",2017-08-28 15:49:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6G6lNxI8MZk/dow-movers-trv-hd-cm837946,In early trading on Monday shares of Home Depot topped the list of the day s best performing Dow Jones Industrial Average components trading up 0 7 Year to date Home Depot registers a 12 4 gain And the worst performing Dow component thus far on the day is Travelers Companies
PFE,PFE:US,BBG000BR2B91,Sangamo Therapeutics Initiates Dosing in Hemophilia A Study,2017-08-28 13:54:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W_dxMDSplT0/sangamo-therapeutics-initiates-dosing-in-hemophilia-a-study-cm837928,Sangamo Therapeutics Inc SGMO and partner Pfizer Inc PFE announced the dosing of first patient in a phase I II study on its gene therapy candidate SB 525 for treating hemophilia A In fact SB 525 is considered to be one of Sangamo s four leading product candidates In May 2017
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/28/2017: JNJ, PFE, ABT, MRK, AMGN, KITE, GILD, AVEO, NVS",2017-08-28 13:29:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JvY3z1YTezU/health-care-sector-update-for-08282017-jnj-pfe-abt-mrk-amgn-kite-gild-aveo-nvs-cm837784,Top Health Care Stocks Top Health Care Stocks JNJ flatJNJ flat PFE 0 8 PFE 0 8 ABT flatABT flat MRK 0 2 MRK 0 2 AMGN 0 7 AMGN 0 7 Health care shares were mixed in pre market trade Monday Health care shares were mixed in pre market trade Monday In sector news Kite Pharma
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. breached its 50 day moving average in a Bullish Manner : PFE-US : August 28, 2017",2017-08-28 13:07:40 +0000,http://finance.yahoo.com/r/befde931-a187-3dd2-adfd-90f2dfc6864e/pfizer-inc-breached-its-50-day-moving-average-in-a-bullish-manner-pfe-us-august-28-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Pfizer Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
PFE,PFE:US,BBG000BR2B91,In Your 60s? 3 Stocks You Might Want to Buy,2017-08-28 12:51:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u1XFqVnGCa4/in-your-60s-3-stocks-you-might-want-to-buy-cm837712,For many Americans reaching their 60s is often the point where they transition out of the labor force and into retirement It means putting that alarm clock to bed for good and putting your feet up on lawn chairs instead However one thing seniors should never consider retiring
PFE,PFE:US,BBG000BR2B91,AstraZeneca's Faslodex Gets FDA Nod in First-Line Setting,2017-08-28 12:50:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7Dn6ynuIzEU/astrazenecas-faslodex-gets-fda-nod-in-first-line-setting-cm837707,AstraZeneca plc AZN announced that Faslodex has received FDA approval for a label extension in the first line monotherapy setting for the treatment of advanced breast cancer Faslodex has 160 been approved as a monotherapy treatment for previously untreated post menopausal women
PFE,PFE:US,BBG000BR2B91,Sangamo Therapeutics Initiates Dosing in Hemophilia A Study,2017-08-28 12:09:12 +0000,https://finance.yahoo.com/news/sangamo-therapeutics-initiates-dosing-hemophilia-120912622.html?.tsrc=rss,"Sangamo Therapeutics (SGMO) and partner Pfizer announced the dosing of first patient in Alta study on Hemophilia A candidate, SB-525."
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-08-28 12:00:30 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120030631.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,In Your 60s? 3 Stocks You Might Want to Buy,2017-08-28 11:33:00 +0000,http://finance.yahoo.com/r/cdc048b6-8660-3c82-9f10-32823ba4f2ad/in-your-60s-3-stocks-you-might-want-to-buy.aspx?yptr=yahoo&.tsrc=rss,"If you&apos;re looking to add high-quality, low-volatility income stocks to your portfolio, these are the companies you should be considering."
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb and Pfizer Present Investigational Eliquis® (apixaban) Data for Patients with Non-Valvular Atrial Fibrillation (NVAF) Undergoing Cardioversion,2017-08-28 09:00:00 +0000,https://finance.yahoo.com/news/bristol-myers-squibb-pfizer-present-090000880.html?.tsrc=rss,"Bristol-Myers Squibb Company and Pfizer Inc. today presented findings from EMANATE , a Phase 4 clinical trial, during a late-breaking hot line presentation at the ESC Congress 2017, organized by the European Society of Cardiology, in Barcelona, Spain."
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb and Pfizer Present Observational Real-World Data Analysis on the Effectiveness and Safety of Eliquis® (apixaban) Compared to Warfarin in Select High-Risk Patients with Non-Valvular Atrial Fibrillation,2017-08-28 06:30:00 +0000,https://finance.yahoo.com/news/bristol-myers-squibb-pfizer-present-063000339.html?.tsrc=rss,Bristol-Myers Squibb Company and Pfizer Inc. today announced results from an analysis of real-world data pooled from four large U.S. insurance claims databases.
PFE,PFE:US,BBG000BR2B91,"Bristol-Myers, Pfizer Report Investigational Eliquis Data - Quick Facts",2017-08-28 05:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DoJufwLqaZo/bristolmyers-pfizer-report-investigational-eliquis-data--quick-facts-20170828-00124,"Bristol-Myers, Pfizer Report Investigational Eliquis Data - Quick Facts"
PFE,PFE:US,BBG000BR2B91,Bristol-Myers: Eliquis Shows Lower Risk Of Stroke In NVAF Patient Subgroups,2017-08-28 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WVwj-8orcAw/bristolmyers-eliquis-shows-lower-risk-of-stroke-in-nvaf-patient-subgroups-20170828-00061,Bristol-Myers: Eliquis Shows Lower Risk Of Stroke In NVAF Patient Subgroups
PFE,PFE:US,BBG000BR2B91,Can Buying Exelixis Stock Still Make You Rich?,2017-08-27 20:48:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pSpoif0i4-k/can-buying-exelixis-stock-still-make-you-rich-cm837666,What were you doing on Friday Jan 2 2015 It s OK if you don t remember I certainly can t But there were some investors who did something on that date who probably recall it with a smile Anyone who bought shares of Exelixis NASDAQ EXEL at the beginning of 2015 and held on
PFE,PFE:US,BBG000BR2B91,Here Are the Big Pharma Stocks to Own Based on R&D Spending,2017-08-27 13:49:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hmb4kHBXMXw/here-are-the-big-pharma-stocks-to-own-based-on-rd-spending-cm837625,Just because a big pharma company is successful today doesn t mean it will be successful in a few years Even the biggest blockbuster drugs eventually lose patent exclusivity or face new and improved competition That s why continued research and development R amp D is a must
PFE,PFE:US,BBG000BR2B91,Here Are the Big Pharma Stocks to Own Based on R&D Spending,2017-08-27 11:47:00 +0000,http://finance.yahoo.com/r/8e381b2f-d9bb-3e0c-a662-f302b29483ec/here-are-the-big-pharma-stocks-to-own-based-on-r-2.aspx?yptr=yahoo&.tsrc=rss,"Roche, Novartis, Pfizer, Johnson & Johnson, and Merck are investing the heaviest in R&D. That could bode well for these big pharma stocks."
PFE,PFE:US,BBG000BR2B91,Is the System Rigged Against Biosimilars?,2017-08-26 17:37:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/atpUwvwykm8/is-the-system-rigged-against-biosimilars-cm837567,If you think prescription drug costs are high now imagine what costs would be without generic drugs Roughly 25 of total prescription drug sales in 2016 were generics But it s a different story altogether for biologics drugs made from living organisms or components of
PFE,PFE:US,BBG000BR2B91,Is the System Rigged Against Biosimilars?,2017-08-26 16:03:00 +0000,http://finance.yahoo.com/r/0e6e65a4-ac92-33af-8df0-3979fd0b5ad6/is-the-system-rigged-against-biosimilars.aspx?yptr=yahoo&.tsrc=rss,Pfizer and Amgen are encountering problems getting traction for their biosimilars. Is the system rigged against them?
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Aug 25, 2017 :  WLL, PFE, ROST, MU, EBAY, QQQ, DAL, KO, CSCO, AXL, CPN, WFM",2017-08-25 20:58:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G0WTg_QV92c/after-hours-most-active-for-aug-25-2017-wll-pfe-rost-mu-ebay-qqq-dal-ko-csco-axl-cpn-wfm-cm837445,The NASDAQ 100 After Hours Indicator is down 17 to 5 822 36 The total After hours volume is currently 41 642 516 shares traded The following are the most active stocks for the after hours session Whiting Petroleum Corporation WLL is 0 03 at 4 44 with 6 915
PFE,PFE:US,BBG000BR2B91,"Noteworthy ETF Inflows: VT, GE, CVX, PFE",2017-08-25 16:45:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9IDK5vV2O1I/noteworthy-etf-inflows-vt-ge-cvx-pfe-cm837270,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard Total World Stock ETF Symbol VT where we have detected an approximate 55 3 million dollar inflow that s a 0 6 increase week over week in
PFE,PFE:US,BBG000BR2B91,"XLV, GNRX: Big ETF Outflows",2017-08-25 16:41:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2PQTW5MLyP8/xlv-gnrx-big-etf-outflows-cm837206,Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel the biggest outflow was seen in the Health Care Select Sector SPDR Fund XLV where 7 100 000 units were destroyed or a 3 2 decrease week over week Among the largest underlying
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/25/2017: JNJ, PFE, ABT, MRK, AMGN, XOMA, VEEV, ADMS, NVS",2017-08-25 13:41:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iqKfuF5RzBk/health-care-sector-update-for-08252017-jnj-pfe-abt-mrk-amgn-xoma-veev-adms-nvs-cm837016,Top Health Care Stocks Top Health Care Stocks JNJ 0 5 JNJ 0 5 PFE flatPFE flat ABT flatABT flat MRK 0 5 MRK 0 5 AMGN 0 4 AMGN 0 4 Health care shares were mixed in pre market trade Friday Health care shares were mixed in pre market trade Friday In sector news
PFE,PFE:US,BBG000BR2B91,Sangamo And Pfizer Announce First Patient Receives Treatment In Phase 1/2 Clinical Trial Evaluating SB-525 Investigational Gene Therapy For Hemophilia A,2017-08-25 12:00:00 +0000,https://finance.yahoo.com/news/sangamo-pfizer-announce-first-patient-120000732.html?.tsrc=rss,"RICHMOND, Calif., Aug. 25, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO) and Pfizer Inc. (PFE) today announced that the first patient received treatment in the Phase 1/2 clinical trial (""the Alta trial"") evaluating SB-525, an investigational gene therapy for patients with Hemophilia A, a rare genetic blood disorder.  ""We are excited to announce the first patient infusion in this initial clinical trial of SB-525.  Gene therapy holds promise as a potential one-time treatment to control Hemophilia A and prevent spontaneous bleeding,"" said Dr. Sandy Macrae, Chief Executive Officer of Sangamo Therapeutics."
PFE,PFE:US,BBG000BR2B91,Florida executes man with drug not previously used in lethal injections,2017-08-24 23:11:52 +0000,https://finance.yahoo.com/news/florida-carry-execution-drug-not-205809774.html?.tsrc=rss,"Florida on Thursday  executed a 53-year-old man convicted of two  1987 murders,  administering a lethal injection that included a drug never  before used in a U.S. execution, state officials said.  The execution was carried out at 6:22 p.m. (2222 GMT) at the  Florida State Prison in Bradford County, about 50 miles (80 km)  southwest of Jacksonville, where the two murders took place.  Mark James Asay was the first white man to be put to death  in Florida for killing a black man since the state reinstated  the death penalty in 1979."
PFE,PFE:US,BBG000BR2B91,Candida Auris: A New Fungal Superbug Emerging As A Global Threat,2017-08-24 17:30:00 +0000,http://finance.yahoo.com/r/104714d4-5ae2-34a3-8d67-f6cd9a69bd2f/candida-auris-a-new-fungal-superbug-emerging-as-a-global-threat?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"For the first time, a new yeast, Candida auris, is found to be spreading from person to person in hospitals."
PFE,PFE:US,BBG000BR2B91,Florida set to carry out execution with drug not previously used in lethal injections,2017-08-24 15:07:32 +0000,https://finance.yahoo.com/news/florida-set-carry-execution-drug-150732504.html?.tsrc=rss,"Florida is  scheduled on Thursday to put to death an inmate by injection  that includes a drug never before used in a U.S. execution.  Mark James Asay, 53, would be the first Florida inmate  executed since January 2016, when the U.S. Supreme Court ruled  the state's death penalty process was unconstitutional because  it gave powers to judges that should be reserved for juries.  Asay would also be the first white man executed for killing  a black man in Florida since the state revived its death penalty  in 1979, according to the Death Penalty Information Center."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/24/2017: JNJ, PFE, ABT, MRK, AMGN, CO, ENZY, MYL",2017-08-24 13:18:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fOojQy_U4PY/health-care-sector-update-for-08242017-jnj-pfe-abt-mrk-amgn-co-enzy-myl-cm836392,Top Health Care Stocks Top Health Care Stocks JNJ 0 2 JNJ 0 2 PFE 0 2 PFE 0 2 ABT flatABT flat MRK 0 6 MRK 0 6 AMGN flatAMGN flat Health care shares were mixed in pre market trade Thursday Health care shares were mixed in pre market trade Thursday In sector news China
PFE,PFE:US,BBG000BR2B91,"Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for August 25, 2017",2017-08-24 13:18:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hA1yJjRGf1M/teva-pharmaceutical-industries-limited-teva-ex-dividend-date-scheduled-for-august-25-2017-cm836404,Teva Pharmaceutical Industries Limited TEVA will begin trading ex dividend on August 25 2017 A cash dividend payment of 0 072 per share is scheduled to be paid on September 14 2017 Shareholders who purchased TEVA prior to the ex dividend date are eligible for the cash dividend
PFE,PFE:US,BBG000BR2B91,"Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 25, 2017",2017-08-24 13:17:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LggFy1Gf3FE/johnson-johnson-jnj-ex-dividend-date-scheduled-for-august-25-2017-cm836394,Johnson amp Johnson JNJ will begin trading ex dividend on August 25 2017 A cash dividend payment of 0 84 per share is scheduled to be paid on September 12 2017 Shareholders who purchased JNJ prior to the ex dividend date are eligible for the cash dividend payment This represents an
PFE,PFE:US,BBG000BR2B91,Pfizer Rare Disease Launches Two First-of-Its-Kind Innovative Technologies for People Living with Hemophilia at National Hemophilia Foundation Annual Meeting,2017-08-24 12:00:00 +0000,https://finance.yahoo.com/news/pfizer-rare-disease-launches-two-120000668.html?.tsrc=rss,"Pfizer Inc. today announced the launch of Hemocraft™, a modification of the popular video game Minecraft®, and the HemMobile® Striiv® Wearable, a custom wristband, to help people living with hemophilia better approach hemophilia education and activity tracking in the US."
PFE,PFE:US,BBG000BR2B91,3 High-Yield Dividend Stocks for Conservative Investors,2017-08-23 23:37:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SexRn2kyprY/3-high-yield-dividend-stocks-for-conservative-investors-cm836252,High yield dividend stocks tend to be particularly risky types of investing vehicles that aren t well suited for conservative individuals Even so there are a handful of rare gems that do in fact offer both an acceptable level of risk and an above average yield Armed with
PFE,PFE:US,BBG000BR2B91,Here's Why Clovis Stock Is Up Almost 60% So Far in 2017,2017-08-23 22:37:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ktsBJoVZK2E/heres-why-clovis-stock-is-up-almost-60-so-far-in-2017-cm836233,Shares of Clovis Oncology Inc CLVS have witnessed a continuous upside this year Shares of this small biotech company are up 62 3 so far this year outperforming the 7 2 increase registered by the industry 160 during this period Let s analyze the factors that have driven the rally so
PFE,PFE:US,BBG000BR2B91,3 High-Yield Dividend Stocks for Conservative Investors,2017-08-23 21:35:00 +0000,http://finance.yahoo.com/r/2521fad5-eb1b-34c5-b403-a454e8937b06/3-high-yield-for-conservative-investors.aspx?yptr=yahoo&.tsrc=rss,These rare gems offer both a high yield and an acceptable level of risk.
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Aug 23, 2017 :  T, QQQ, CAG, PFE, ENZY, CTL, VWR, F, GE, MSFT, MU, CSCO",2017-08-23 20:58:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1ECA6aDxKQY/after-hours-most-active-for-aug-23-2017-t-qqq-cag-pfe-enzy-ctl-vwr-f-ge-msft-mu-csco-cm836231,The NASDAQ 100 After Hours Indicator is down 49 to 5 851 29 The total After hours volume is currently 39 663 716 shares traded The following are the most active stocks for the after hours session AT amp T Inc T is unchanged at 37 92 with 4 246 105 shares
PFE,PFE:US,BBG000BR2B91,30 Great Stocks of All Time,2017-08-23 19:37:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RLMg7vOIajU/30-great-stocks-of-all-time-cm836173,A finance professor made a startling discovery about the stock market Over a 90 year span 96 of all stocks collectively performed no better than risk free 1 month Treasury bills After analyzing the lifetime returns of 25 782 common stocks Hendrik Bessembinder determined that just 1
PFE,PFE:US,BBG000BR2B91,SAC Capital's Martoma fails to overturn U.S. insider trading conviction,2017-08-23 17:38:09 +0000,https://finance.yahoo.com/news/sacs-martoma-fails-overturn-u-145231094.html?.tsrc=rss,"A divided federal appeals court  on Wednesday upheld the insider trading conviction of Mathew  Martoma, a former portfolio manager for billionaire Steven A.  Cohen's SAC Capital Advisors LP, after the U.S. Supreme Court  made such cases easier to pursue.  The 2nd U.S. Circuit Court of Appeals in Manhattan found  ""overwhelming"" evidence that a Michigan doctor received  financial benefits from providing confidential information to  Martoma about a 2008 Alzheimer's drug trial."
PFE,PFE:US,BBG000BR2B91,Pfizer's Ibrance in First-Line Combo Breast Cancer Study,2017-08-23 16:40:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NdRNMYJjTcs/pfizers-ibrance-in-first-line-combo-breast-cancer-study-cm836016,Pfizer Inc PFE and six international cancer research groups are collaborating on a combination study to explore the use of Ibrance for first line treatment of advanced breast cancer The PATINA phase III study will evaluate Ibrance a CDK 4 6 inhibitor in combination with anti HER2
PFE,PFE:US,BBG000BR2B91,Pfizer&apos;s Ibrance in First-Line Combo Breast Cancer Study,2017-08-23 14:10:02 +0000,https://finance.yahoo.com/news/pfizer-apos-ibrance-first-line-141002389.html?.tsrc=rss,"Pfizer, Inc. (PFE) and six international cancer research groups are collaborating on a combination study to explore the use of Ibrance for first-line treatment of advanced breast cancer."
PFE,PFE:US,BBG000BR2B91,U.S. appeals court upholds insider trading conviction of SAC's Martoma,2017-08-23 14:03:42 +0000,https://finance.yahoo.com/news/u-appeals-court-upholds-insider-140342491.html?.tsrc=rss,"A divided federal appeals court on Wednesday upheld the insider trading conviction of Mathew Martoma, a former SAC Capital Advisors LP portfolio manager, rejecting his claims that there was inadequate ..."
PFE,PFE:US,BBG000BR2B91,How Johnson & Johnson Makes Most of Its Money,2017-08-23 13:39:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q96zC83F5go/how-johnson-johnson-makes-most-of-its-money-cm835788,As you might expect Johnson amp Johnson NYSE JNJ makes a lot of money Last year the healthcare giant generated revenue totaling nearly 72 billion Over the past decade J amp J raked in over 668 billion To put that amount into perspective consider that a stack of that many
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/23/2017: JNJ, PFE, ABT, MRK, AMGN, PRTK, NVAX, RARE",2017-08-23 13:18:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2chRtRgE_z8/health-care-sector-update-for-08232017-jnj-pfe-abt-mrk-amgn-prtk-nvax-rare-cm835793,Top Health Care Stocks Top Health Care Stocks JNJ 1 3 JNJ 1 3 PFE 0 5 PFE 0 5 ABT flatABT flat MRK 0 02 MRK 0 02 AMGN 0 1 AMGN 0 1 Health care shares were mostly in the red in pre market trade Wednesday Health care shares were mostly in the red in pre market trade
PFE,PFE:US,BBG000BR2B91,How Allergan’s International Segment Performed in 2Q17,2017-08-23 11:37:09 +0000,http://finance.yahoo.com/r/c09cbf72-70b9-3692-b2d7-35fb6772ed1b/how-allergans-international-segment-performed-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Allergan’s (AGN) international business includes total revenues from the sales of branded products as well as aesthetics products outside the US markets.
PFE,PFE:US,BBG000BR2B91,India grants Pfizer patent on pneumonia vaccine in blow to aid group,2017-08-23 06:21:00 +0000,https://finance.yahoo.com/news/india-grants-pfizer-patent-pneumonia-062100282.html?.tsrc=rss,"India has granted Pfizer Inc  a patent for its powerful pneumonia vaccine Prevenar 13,  in a blow to some health groups that said this would put the  treatment out of reach of thousands in poorer nations.  The decision by India's patent office bars other companies  from making cheaper copies of the vaccine and allows Pfizer to  exclusively sell it in India until 2026."
PFE,PFE:US,BBG000BR2B91,What's Next for Bristol-Myers Squibb After Its Opdivo Setback?,2017-08-22 21:39:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RQM3Xio_2iA/whats-next-for-bristol-myers-squibb-after-its-opdivo-setback-cm835640,The signs were definitely there for a disappointment from Bristol Myers Squibb NYSE BMY Several weeks ago AstraZeneca NYSE AZN reported its checkpoint inhibitor Imfinzi failed to improve progression free survival in a late stage study targeting lung cancer There
PFE,PFE:US,BBG000BR2B91,What&apos;s Next for Bristol-Myers Squibb After Its Opdivo Setback?,2017-08-22 19:47:00 +0000,http://finance.yahoo.com/r/5794cafa-6879-3d7d-a241-59789f1d48ca/whats-next-for-bristol-myers-squibb-after-its-opdi.aspx?yptr=yahoo&.tsrc=rss,Mixed results for a study with Opdivo in treating first-line kidney cancer give reasons for concern. But how worried should investors really be?
PFE,PFE:US,BBG000BR2B91,Immunomedics' Progress in Phase II Cancer Study Encouraging,2017-08-22 16:41:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hkwhwWHIKdg/immunomedics-progress-in-phase-ii-cancer-study-encouraging-cm835421,Immunomedics Inc IMMU announced encouraging interim results from a phase II study on its antibody drug conjugate ADC labetuzumab govitecan IMMU 130 The candidate is being evaluated as a single agent in heavily pretreated patients with metastatic colorectal cancer mCRC
PFE,PFE:US,BBG000BR2B91,Immunomedics&apos; Progress in Phase II Cancer Study Encouraging,2017-08-22 14:44:02 +0000,https://finance.yahoo.com/news/immunomedics-apos-progress-phase-ii-144402166.html?.tsrc=rss,"Immunomedics, Inc. (IMMU) announced encouraging interim results from a phase II study on its cancer candidate, labetuzumab govitecan. Shares were up 7% on Monday in response."
PFE,PFE:US,BBG000BR2B91,India grants Pfizer patent on pneumonia vaccine in blow to aid group,2017-08-22 13:47:07 +0000,https://finance.yahoo.com/news/india-grants-pfizer-patent-pneumonia-134707346.html?.tsrc=rss,"India has granted Pfizer Inc  a patent for its powerful pneumonia vaccine Prevenar 13,  in a blow to some health groups that said this would put the  treatment out of reach of thousands in poorer nations.  The decision by India's patent office bars other companies  from making cheaper copies of the vaccine and allows Pfizer to  exclusively sell it in India until 2026."
PFE,PFE:US,BBG000BR2B91,"Perrigo Company (PRGO) Ex-Dividend Date Scheduled for August 23, 2017",2017-08-22 13:18:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KodoZ-7QzBY/perrigo-company-prgo-ex-dividend-date-scheduled-for-august-23-2017-cm835177,Perrigo Company PRGO will begin trading ex dividend on August 23 2017 A cash dividend payment of 0 16 per share is scheduled to be paid on September 12 2017 Shareholders who purchased PRGO prior to the ex dividend date are eligible for the cash dividend payment This marks the 3rd
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/22/2017: JNJ, PFE, ABT, MRK, AMGN, MTBC, PFE, MDT",2017-08-22 13:18:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f3hGppkhtpU/health-care-sector-update-for-08222017-jnj-pfe-abt-mrk-amgn-mtbc-pfe-mdt-cm835165,Top Health Care Stocks Top Health Care Stocks JNJ 0 5 JNJ 0 5 PFE 0 3 PFE 0 3 ABT 0 2 ABT 0 2 MRK 0 2 MRK 0 2 AMGN flatAMGN flat Health care shares were mostly firmer in pre market trade Tuesday Health care shares were mostly firmer in pre market trade Tuesday In
PFE,PFE:US,BBG000BR2B91,How Allergan’s US Specialized Therapeutics Segment Performed in 2Q17,2017-08-22 13:07:36 +0000,http://finance.yahoo.com/r/9215aa76-8b09-3de4-a49c-1ed56baa2894/how-allergans-us-specialized-therapeutics-segment-performed-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"The US Specialized Therapeutics segment reported revenues of $1.7 billion in 2Q17, a 15.2% increase as compared to $1.5 billion during 2Q16."
PFE,PFE:US,BBG000BR2B91,"Alliance Foundation Trials Opens Global Trial Investigating First-in-Class Palbociclib in HR+, HER2+ Metastatic Breast Cancer",2017-08-22 12:00:00 +0000,https://finance.yahoo.com/news/alliance-foundation-trials-opens-global-120000338.html?.tsrc=rss,"The Alliance Foundation Trials, LLC , in conjunction with Pfizer and six international cancer research groups, today announced the launch of PATINA – a randomized, open-label, Phase 3 clinical study of the cyclin-dependent kinase 4/6 inhibitor palbociclib ."
PFE,PFE:US,BBG000BR2B91,3 High-Yield Pharmaceutical Stocks,2017-08-22 11:38:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rr6cT10nRYo/3-high-yield-pharmaceutical-stocks-cm835100,The pharmaceutical industry is a natural hunting ground for reliable income stocks since people buy drugs in good times and in bad But which high yield dividend stocks are actually worthy of your investment dollars We posed that question to a team of Motley Fool
PFE,PFE:US,BBG000BR2B91,India grants Pfizer patent on pneumonia vaccine in blow to aid group,2017-08-22 11:33:08 +0000,https://finance.yahoo.com/news/india-grants-pfizer-patent-pneumonia-113308395.html?.tsrc=rss,"India has granted Pfizer Inc  a patent for its powerful pneumonia vaccine Prevenar 13,  in a blow to some health groups that said this would put the  treatment out of reach of thousands in poorer nations.  The decision by India's patent office bars other companies  from making cheaper copies of the vaccine and allows Pfizer to  exclusively sell it in India until 2026.  It's a big victory for the U.S. drugmaker in a market that  has the world's largest number of pneumonia cases, a lung  disease that kills nearly a million children a year globally."
PFE,PFE:US,BBG000BR2B91,3 High-Yield Pharmaceutical Stocks,2017-08-22 10:30:00 +0000,http://finance.yahoo.com/r/ca0e67d1-9e3e-3335-94d4-33cad7830214/3-high-yield-pharmaceutical-stocks.aspx?yptr=yahoo&.tsrc=rss,"Pfizer, GlaxoSmithKline, and Novo Nordisk all offer up temptingly high yields. Here&apos;s why they&apos;re worth putting on your radar."
PFE,PFE:US,BBG000BR2B91,3 Dividend Stocks Perfect for Retirement,2017-08-22 01:38:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mHgzKkAJchI/3-dividend-stocks-perfect-for-retirement-cm835050,Preparing your portfolio for retirement is no easy task but investing in quality dividend paying stocks can certainly relieve a lot of the hassle Income plus appreciation is a powerful combination to build your nest egg We asked three Motley Fool investors to identify one stock
PFE,PFE:US,BBG000BR2B91,3 Dividend Stocks Perfect for Retirement,2017-08-21 23:46:00 +0000,http://finance.yahoo.com/r/7ef766f4-1465-35cb-89b2-395f94c3c8b4/3-dividend-stocks-perfect-for-retirement.aspx?yptr=yahoo&.tsrc=rss,"There&apos;s good reason why Pfizer, Cisco Systems, and Diageo can work for you in your retirement."
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Aug 21, 2017 :  GE, INTC, PFE, RAD, CMCSA, TGT, F, BAC, AAPL, QQQ, AMAT, EMB",2017-08-21 20:57:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/veaVWRqwxrA/after-hours-most-active-for-aug-21-2017-ge-intc-pfe-rad-cmcsa-tgt-f-bac-aapl-qqq-amat-emb-cm834997,The NASDAQ 100 After Hours Indicator is down 46 to 5 786 08 The total After hours volume is currently 46 644 922 shares traded The following are the most active stocks for the after hours session General Electric Company GE is 0 005 at 24 49 with 9 803 626
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. :PFE-US: Earnings Analysis: Q2, 2017 By the Numbers : August 21, 2017",2017-08-21 14:37:24 +0000,http://finance.yahoo.com/r/0d283832-768c-3b43-98a4-34edba8b3f23/pfizer-inc-pfe-us-earnings-analysis-q2-2017-by-the-numbers-august-21-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Pfizer Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Pfizer Inc. – Merck & Co., Inc., Johnson & Johnson, Bristol-Myers Squibb Company, Eli Lilly and Company, Novartis AG Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Mylan N.V., ... Read more
<b>(Read more...)</b>"
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/21/2017: JNJ, PFE, ABT, MRK, AMGN, AZN, NVS, TNXP",2017-08-21 13:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JMDRnGRBy90/health-care-sector-update-for-08212017-jnj-pfe-abt-mrk-amgn-azn-nvs-tnxp-cm834518,Top Health Care Stocks Top Health Care Stocks JNJ flatJNJ flat PFE 0 6 PFE 0 6 ABT flatABT flat MRK flatMRK flat AMGN 0 1 AMGN 0 1 Health care shares were mostly flat in pre market trade Monday Health care shares were mostly flat in pre market trade Monday In sector
PFE,PFE:US,BBG000BR2B91,Better Buy: AbbVie Inc. vs. Pfizer Inc.,2017-08-21 12:21:00 +0000,http://finance.yahoo.com/r/c32f8062-2121-3711-b21e-d2d16b9c4c3b/better-buy-abbvie-inc-vs-pfizer-inc.aspx?yptr=yahoo&.tsrc=rss,AbbVie and Pfizer both have great dividends and successful track records over the long run. But which is the better pick now?
PFE,PFE:US,BBG000BR2B91,3 Stocks You Can Safely Own Until 2030,2017-08-20 17:38:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EHOuU8Gl5Xg/3-stocks-you-can-safely-own-until-2030-cm834409,A lot can happen to a company in 13 years It s notoriously difficult many would say impossible to predict a company s path more than a few quarters out Things happen scandals accidents surprise acquisition offers and of course disruption from faster moving new
PFE,PFE:US,BBG000BR2B91,"Here's How Much $10,000 Invested in Pfizer in 1977 Is Worth Now",2017-08-20 13:38:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VPWnM4LVP4E/heres-how-much-10000-invested-in-pfizer-in-1977-is-worth-now-cm834382,Forty years is a long time But it s not an unimaginably long time For many Americans 40 years is roughly the length of time they will spend or have spent in the workforce Those years will end up being much more profitable for those who chose to invest early in their careers That s
PFE,PFE:US,BBG000BR2B91,Pfizer's Besponsa Is Yet Another Win for the Biopharma Giant,2017-08-20 13:37:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g_O9UR4rsuw/pfizers-besponsa-is-yet-another-win-for-the-biopharma-giant-cm834375,Pfizer Inc NYSE PFE scored another cancer drug victory this past week when the FDA green lighted Besponsa a drug that battles back against a rare and deadly type of leukemia The approval adds yet another arrow to Pfizer s quiver of cancer treatments and it could boost
PFE,PFE:US,BBG000BR2B91,Pfizer&apos;s Besponsa Is Yet Another Win for the Biopharma Giant,2017-08-20 12:15:00 +0000,http://finance.yahoo.com/r/dbf1daaa-f402-3e83-bf01-dfc989de7876/pfizers-besponsa-is-yet-another-win-for-the-biopha.aspx?yptr=yahoo&.tsrc=rss,Besponsa&apos;s FDA approval for use in some leukemia patients continues to position the company as a leading player in cancer treatment.
PFE,PFE:US,BBG000BR2B91,"Here&apos;s How Much $10,000 Invested in Pfizer in 1977 Is Worth Now",2017-08-20 11:43:00 +0000,http://finance.yahoo.com/r/ea922d3e-043a-39a7-a852-b40ace998714/heres-how-much-10000-invested-in-pfizer-in-1977-is.aspx?yptr=yahoo&.tsrc=rss,"Pfizer&apos;s last 40 years show what it takes to become a millionaire: Buy, hold, and reinvest."
PFE,PFE:US,BBG000BR2B91,These Stocks Have Tripled This Year,2017-08-19 15:38:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fb-CUfZTOcQ/these-stocks-have-tripled-this-year-cm834302,The stock market has made a lot of people rich since 2009 as several major benchmarks have tripled or even quadrupled during the past eight years Yet for individual stocks gains can come a lot more quickly and a few particularly successful stocks have seen gains of that magnitude
PFE,PFE:US,BBG000BR2B91,[$$] Healthy Dividends,2017-08-19 05:01:00 +0000,http://finance.yahoo.com/r/5123f07f-52df-3290-8699-8acb3892e371/healthy-dividends-1503115243?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"When it comes to health care, pharmaceutical companies get a lot of attention, because many offer attractive yields.  Pfizer’s (PFE), for example, was 3.9% late last week, and Bristol Myers Squibb’s (BMY) was 2.7%."
PFE,PFE:US,BBG000BR2B91,Notable Two Hundred Day Moving Average Cross - PFE,2017-08-18 16:40:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C6dtj1vK2Eo/notable-two-hundred-day-moving-average-cross-pfe-cm833998,In trading on Friday shares of Pfizer Inc Symbol PFE crossed below their 200 day moving average of 32 94 changing hands as low as 32 73 per share Pfizer Inc shares are currently trading down about 0 6 on the day The chart below shows the one year performance of PFE shares versus its
PFE,PFE:US,BBG000BR2B91,Pfizer's (PFE) Besponsa Gets FDA Nod with a Boxed Warning,2017-08-18 15:43:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/osmYZ0u3wdo/pfizers-pfe-besponsa-gets-fda-nod-with-a-boxed-warning-cm833937,Pfizer Inc PFE announced that its leukemia candidate Besponsa inotuzumab ozogamicin has been approved by the FDA though with a boxed warning on the label Pfizer s shares were down more than 1 on Thursday So far this year Pfizer s shares are up 4 5 comparing unfavorably with
PFE,PFE:US,BBG000BR2B91,"The FDA Just Approved a New Pfizer Cancer Drug for a Rare, Vicious Leukemia",2017-08-18 15:35:20 +0000,https://finance.yahoo.com/news/fda-just-approved-pfizer-cancer-153520775.html?.tsrc=rss,"The therapy, Besponsa, treats a rapidly progressing version of the disease."
PFE,PFE:US,BBG000BR2B91,IWX's Underlying Holdings Could Mean 10% Gain Potential,2017-08-18 14:39:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qNArvPtAMi4/iwxs-underlying-holdings-could-mean-10-gain-potential-cm833843,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Multiple Sclerosis Drug Prices in Focus, Mixed Data on BMY's Opdivo",2017-08-18 13:42:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QJF6KhgQNco/pharma-stock-roundup-multiple-sclerosis-drug-prices-in-focus-mixed-data-on-bmys-opdivo-cm833799,Pharmaceutical stocks were in the limelight this week with Merck s MRK CEO Ken Frazier resigning from President Donald Trump s manufacturing council The sector was also in the news with an investigation being launched into the rising prices of multiple sclerosis MS drugs Recap of
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Pfizer, TJX Companies, Honda, American Electric and Novo Nordisk",2017-08-18 13:41:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F_muJ8G-rC4/the-zacks-analyst-blog-highlights-pfizer-tjx-companies-honda-american-electric-and-novo-nordisk-cm833781,For Immediate Release Chicago IL August 18 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
PFE,PFE:US,BBG000BR2B91,Pfizer&apos;s (PFE) Besponsa Gets FDA Nod with a Boxed Warning,2017-08-18 13:18:01 +0000,https://finance.yahoo.com/news/pfizer-apos-pfe-besponsa-gets-131801504.html?.tsrc=rss,"Pfizer, Inc.&apos;s (PFE) leukemia candidate, Besponsa received FDA approval, though with a boxed warning on the label."
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-08-18 12:00:22 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120022319.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Pfizer, TJX Companies, Honda, American Electric and Novo Nordisk",2017-08-18 11:45:11 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-pfizer-114511025.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Pfizer, TJX Companies, Honda, American Electric and Novo Nordisk"
PFE,PFE:US,BBG000BR2B91,Analysts’ Recommendations for Bristol-Myers Squibb in August 2017,2017-08-18 11:39:11 +0000,http://finance.yahoo.com/r/62ccc48c-e2ea-3300-9a0b-da4feab35f38/analysts-recommendations-for-bristol-myers-squibb-in-august-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Of the 23 analysts covering Bristol-Myers Squibb (BMY) in August 2017, six analysts recommended a “strong buy,” and four analysts recommended a “buy.” Ten analysts recommended a “hold,” and three analysts ..."
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Multiple Sclerosis Drug Prices in Focus, Mixed Data on BMY&apos;s Opdivo",2017-08-18 11:09:11 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-multiple-sclerosis-110911289.html?.tsrc=rss,"Key highlights this week in the pharmaceutical sector include the launch of a drug pricing probe, a resignation from the President&apos;s manufacturing council and data on Bristol-Myers&apos; (BMY) Opdivo."
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb and Pfizer to Highlight Commitment to Reducing the Risk of Stroke Caused by Non-Valvular Atrial Fibrillation (NVAF) and Treating Deep Vein Thrombosis/Pulmonary Embolism (DVT/PE) at ESC Congress 2017,2017-08-18 10:59:00 +0000,https://finance.yahoo.com/news/bristol-myers-squibb-pfizer-highlight-105900576.html?.tsrc=rss,"Bristol-Myers Squibb Company and Pfizer Inc. today announced that 15 abstracts have been accepted for presentation at the ESC Congress 2017, organized by the European Society of Cardiology, on August 26-30 in Barcelona, Spain."
PFE,PFE:US,BBG000BR2B91,"Top Analyst Reports for Pfizer, TJX Companies & Honda",2017-08-18 05:37:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9z_O05hWpuQ/top-analyst-reports-for-pfizer-tjx-companies-honda-cm833698,Thursday August 17 2017 The Zacks Research Daily presents the best research output of our analyst team Today s Research Daily features new research reports on 16 major stocks including Pfizer PFE TJX Companies TJX and Honda HMC These research reports have been hand picked from
PFE,PFE:US,BBG000BR2B91,"FDA Nod For PFE, New Use For AZN's Ovarian Cancer Drug, ELGX's LEOPARD Hits Goal",2017-08-18 01:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RDqJJyQPwao/fda-nod-for-pfe-new-use-for-azns-ovarian-cancer-drug-elgxs-leopard-hits-goal-20170818-00018,"FDA Nod For PFE, New Use For AZN's Ovarian Cancer Drug, ELGX's LEOPARD Hits Goal"
PFE,PFE:US,BBG000BR2B91,Exelixis Submits sNDA for Kidney Cancer Drug Cabometyx,2017-08-17 23:38:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y9_Gf8HnLpY/exelixis-submits-snda-for-kidney-cancer-drug-cabometyx-cm833643,Exelixis Inc EXEL announced that it has completed the submission of a supplemental New Drug Application sNDA to the FDA for Cabometyx tablets for patients with previously untreated advanced renal cell carcinoma RCC The sNDA submission was based on positive results from phase II
PFE,PFE:US,BBG000BR2B91,"Top Analyst Reports for Pfizer, TJX Companies & Honda",2017-08-17 21:42:09 +0000,https://finance.yahoo.com/news/top-analyst-reports-pfizer-tjx-214209340.html?.tsrc=rss,"Top Analyst Reports for Pfizer, TJX Companies & Honda"
PFE,PFE:US,BBG000BR2B91,"FDA OKs Pfizer drug for rare, fast-killing type of leukemia",2017-08-17 21:36:35 +0000,https://finance.yahoo.com/news/fda-oks-pfizer-drug-rare-211347105.html?.tsrc=rss,"The Food and Drug Administration has approved a new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed. The agency approved Pfizer Inc.'s Besponsa for ..."
PFE,PFE:US,BBG000BR2B91,"FDA OKs Pfizer drug for rare, fast-killing type of leukemia",2017-08-17 21:36:35 +0000,http://finance.yahoo.com/r/ab6124cb-32e2-38c6-b997-65d116f108b3/fda-oks-pfizer-drug-rare-211347105.html?.tsrc=rss,"TRENTON, N.J. (AP) — The Food and Drug Administration has approved a new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed."
PFE,PFE:US,BBG000BR2B91,Pfizer Gets FDA Approval For Rare Blood Cancer Drug Besponsa,2017-08-17 21:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sbZahqUXfuY/pfizer-gets-fda-approval-for-rare-blood-cancer-drug-besponsa-20170817-01168,Pfizer Gets FDA Approval For Rare Blood Cancer Drug Besponsa
PFE,PFE:US,BBG000BR2B91,FDA approves Pfizer's drug for rare blood cancer,2017-08-17 19:59:14 +0000,https://finance.yahoo.com/news/fda-approves-pfizers-drug-rare-182619411.html?.tsrc=rss,"The U.S. Food and Drug Administration  (FDA) said on Thursday it approved Pfizer Inc's rare  blood cancer drug, Besponsa, with a boxed warning.  Besponsa was approved to treat adults with relapsed or  refractory B-cell precursor acute lymphoblastic leukemia (ALL)."
PFE,PFE:US,BBG000BR2B91,Pfizer Receives U.S. FDA Approval for BESPONSA® (inotuzumab ozogamicin),2017-08-17 17:57:00 +0000,https://finance.yahoo.com/news/pfizer-receives-u-fda-approval-175700917.html?.tsrc=rss,Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved BESPONSA® for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia .1 BESPONSA was reviewed and approved under the FDA’s Breakthrough Therapy designation and Priority Review programs.
PFE,PFE:US,BBG000BR2B91,FDA approves Pfizer's drug for rare blood cancer,2017-08-17 17:48:15 +0000,https://finance.yahoo.com/news/fda-approves-pfizers-drug-rare-174815698.html?.tsrc=rss,"The U.S. Food and Drug Administration said on Thursday it approved Pfizer Inc's treatment for a rare type of blood cancer. The treatment, Besponsa, carries a boxed warning, the agency's severest form of ..."
PFE,PFE:US,BBG000BR2B91,"Notable ETF Inflow Detected - VT, GE, CVX, PFE",2017-08-17 16:34:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oJyr3BJRoV4/notable-etf-inflow-detected-vt-ge-cvx-pfe-cm833347,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard Total World Stock ETF Symbol VT where we have detected an approximate 57 2 million dollar inflow that s a 0 7 increase week over week in
PFE,PFE:US,BBG000BR2B91,Can Pfizer Bank on New Immunotherapy Bavencio for Growth?,2017-08-17 14:06:02 +0000,https://finance.yahoo.com/news/pfizer-bank-immunotherapy-bavencio-growth-140602126.html?.tsrc=rss,"Pfizer, Inc.&apos;s (PFE) newly approved anti-PD-L1 immunotherapy, Bavencio, is being touted as a significant top-line driver for this New York-based pharma giant."
PFE,PFE:US,BBG000BR2B91,How Amgen’s Nephrology Drugs Are Positioned after 2Q17?,2017-08-17 11:36:17 +0000,http://finance.yahoo.com/r/c5fb46d6-d1fc-3426-a9ea-b6cf671e5402/how-amgens-nephrology-drugs-are-positioned-after-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, Amgen’s (AMGN) Aranesp generated revenues of ~$535 million, which represented a 6% year-over-year rise."
PFE,PFE:US,BBG000BR2B91,"First Fiduciary Investment Counsel, Inc. Buys Capital One Financial Corp, Intel Corp, Sells ...",2017-08-16 17:35:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Uqv9x6NBPQk/first-fiduciary-investment-counsel-inc-buys-capital-one-financial-corp-intel-corp-sells-cm832915,First Fiduciary Investment Counsel Inc New Purchases COF Added Positions INTC CSCO GIS JPM MET BK SLB JCI GE UPS Reduced Positions WMT JNJ PG PEP PM MMM NVS HON New Purchases COF New Purchases COF Added
PFE,PFE:US,BBG000BR2B91,The Bull Case for Valeant Pharmaceuticals Intl Inc (VRX) Stock Is Weak,2017-08-16 14:16:55 +0000,https://finance.yahoo.com/news/bull-case-valeant-pharmaceuticals-intl-141655890.html?.tsrc=rss,"Giving credit where credit is due, I do think Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock looks stronger than it did just a couple of quarters ago.  VRX stock has still declined 1.5% so far this year, but the narrative surrounding the company has certainly changed.  On the Q2 conference call, Valeant management made a big deal of the fact that 73% of Q2 revenue came from Bausch & Lomb and the Salix business."
PFE,PFE:US,BBG000BR2B91,"Cypress Capital Management Llc Buys iShares International Select Dividend, SPDR DJ STOXX 50 ...",2017-08-16 13:35:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KXNzEql4yDY/cypress-capital-management-llc-buys-ishares-international-select-dividend-spdr-dj-stoxx-50-cm832682,Cypress Capital Management Llc New Purchases IDV FEU HBI BMY EEM V CMCSA IEFA HSIC IVV Added Positions BRK B VGT DIS JPM PG UNP XOM ANTM PCLN MMM Reduced Positions MSFT BA LEA AAPL WLTW VZ GD WY CAT QQQ Sold Out L LOW
PFE,PFE:US,BBG000BR2B91,"Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for August 17, 2017",2017-08-16 13:17:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p-q9yAhbF6o/novo-nordisk-as-nvo-ex-dividend-date-scheduled-for-august-17-2017-cm832644,Novo Nordisk A S NVO will begin trading ex dividend on August 17 2017 A cash dividend payment of 0 336 per share is scheduled to be paid on August 29 2017 Shareholders who purchased NVO prior to the ex dividend date are eligible for the cash dividend payment This represents an 29
PFE,PFE:US,BBG000BR2B91,"ALXN's Strengthening Patents, FOLD's Fabry Drug Approved In OZ, VBIV Surges",2017-08-16 02:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UPeOCxT4xeY/alxns-strengthening-patents-folds-fabry-drug-approved-in-oz-vbiv-surges-20170816-00044,"ALXN's Strengthening Patents, FOLD's Fabry Drug Approved In OZ, VBIV Surges"
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Aug 15, 2017 :  MSFT, MU, FOXA, URBN, ORCL, WMB, QQQ, PFE, CMCSA, EXC, CHK, XOM",2017-08-15 21:04:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BGPFsqgC1OQ/after-hours-most-active-for-aug-15-2017-msft-mu-foxa-urbn-orcl-wmb-qqq-pfe-cmcsa-exc-chk-xom-cm832476,The NASDAQ 100 After Hours Indicator is down 01 to 5 907 72 The total After hours volume is currently 51 287 979 shares traded The following are the most active stocks for the after hours session Microsoft Corporation MSFT is 0 04 at 73 18 with 4 490 128
PFE,PFE:US,BBG000BR2B91,Catalyst (CPRX) Focused on Development of Pipeline Candidates,2017-08-15 16:39:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pRe6tE-TvEA/catalyst-cprx-focused-on-development-of-pipeline-candidates-cm832307,We issued an updated report on Catalyst Pharmaceuticals Inc CPRX on Aug 14 In fact Catalyst Pharma is a development stage biopharmaceutical company focused on the development and commercialization of therapies targeting rare neurological diseases and disorders such as Lambert
PFE,PFE:US,BBG000BR2B91,"Clovis (CLVS) Focuses on Label Expansion, Rubraca Impresses",2017-08-15 15:42:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XKIdC7gfMzg/clovis-clvs-focuses-on-label-expansion-rubraca-impresses-cm832221,We issued an updated research report on Boulder CO based Clovis Oncology Inc CLVS on Aug 14 Rubraca has shown impressive growth trend in 2017 on the back of the company s commercialization efforts Rubraca sales doubled sequentially in the second quarter Rubraca sales were 14 6 million
PFE,PFE:US,BBG000BR2B91,Pfizer’s Corporate and Pipeline Developments in 2Q17,2017-08-15 14:36:03 +0000,http://finance.yahoo.com/r/0d26c512-8e36-31a6-80f2-6755c64647a5/pfizers-corporate-and-pipeline-developments-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Apart from Pfizer’s (PFE) product developments, let's take a look at some recent pipeline and corporate developments."
PFE,PFE:US,BBG000BR2B91,"Allergan plc. (AGN) Ex-Dividend Date Scheduled for August 16, 2017",2017-08-15 13:16:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3LnzwhS6BoE/allergan-plc-agn-ex-dividend-date-scheduled-for-august-16-2017-cm832073,Allergan plc AGN will begin trading ex dividend on August 16 2017 A cash dividend payment of 0 7 per share is scheduled to be paid on September 15 2017 Shareholders who purchased AGN prior to the ex dividend date are eligible for the cash dividend payment This marks the 3rd quarter
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. breached its 50 day moving average in a Bullish Manner : PFE-US : August 15, 2017",2017-08-15 13:13:27 +0000,http://finance.yahoo.com/r/1aceccca-723f-3b40-921e-aa780a7b9084/pfizer-inc-breached-its-50-day-moving-average-in-a-bullish-manner-pfe-us-august-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Pfizer Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
PFE,PFE:US,BBG000BR2B91,Pfizer’s Important Product Developments in 2Q17,2017-08-15 13:06:11 +0000,http://finance.yahoo.com/r/b82d2fba-b671-3a2f-acd7-05b8c1a5636d/pfizers-important-product-developments-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer’s (PFE) innovative health business and essential health business are focusing on growth. To strengthen the innovative health business, the company is focusing on the development of new drugs…"
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-08-15 12:00:25 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120025047.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,Pfizer’s Declining-Revenue Products in 2Q17,2017-08-15 11:36:43 +0000,http://finance.yahoo.com/r/6a6eb8be-826d-366f-89b1-e22fdcc5e854/pfizers-declining-revenue-products-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,We discussed the products that contribute to the growth of Pfizer’s (PFE) revenues in 2Q17. Let's now take a look at the products that have impacted revenue growth in 2Q17.
PFE,PFE:US,BBG000BR2B91,What’s Harder Than Making Copycat Biotech Drugs? Selling Them,2017-08-15 09:00:00 +0000,http://finance.yahoo.com/r/74730b42-9f11-3839-aa39-3b19ef62633b/what-s-harder-than-making-copycat-biotech-drugs-selling-them?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Big-name drugmakers want to profit from selling lower-priced copies of rivals’ expensive biotechnology drugs. Patients and doctors want to pay less for medicine.
PFE,PFE:US,BBG000BR2B91,"Alnylam Pharmaceuticals, Inc. Earnings: Waiting for Apollo",2017-08-14 19:34:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SLaxo_QUn8I/alnylam-pharmaceuticals-inc-earnings-waiting-for-apollo-cm831838,Alnylam Pharmaceuticals NASDAQ ALNY reported 160 second quarter earnings last week and for the record the company lost 118 4 million but without any products on the market the focus of the earnings call was the biotech s pipeline and the potential for revenue in
PFE,PFE:US,BBG000BR2B91,Pfizer’s Major Growth Drivers in 2Q17,2017-08-14 14:37:38 +0000,http://finance.yahoo.com/r/5469264b-39f1-3d36-90ad-e69f5c1c31c0/pfizers-major-growth-drivers-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Pfizer’s (PFE) growth contributors include products from both the innovative health and essential health businesses.
PFE,PFE:US,BBG000BR2B91,Understanding Pfizer’s Geographical Performance in 2Q17,2017-08-14 13:07:11 +0000,http://finance.yahoo.com/r/68129cf8-3492-3ed5-a7a3-95e110dd988a/understanding-pfizers-geographical-performance-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"As we discussed earlier in this series, Pfizer (PFE) reported a 2% decline in revenues to $12.89 billion in 2Q17, compared to revenues of $13.15 billion in 2Q16."
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-08-14 12:00:22 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120022625.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,Pfizer’s Innovative and Essential Health Businesses in 2Q17,2017-08-14 11:37:44 +0000,http://finance.yahoo.com/r/5be794b7-8c86-37cf-b8a1-84ccea6729e8/pfizers-innovative-and-essential-health-businesses-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer’s (PFE) portfolio includes medicines, vaccines, and consumer healthcare products segregated into two businesses—Innovative Health and Essential Health."
PFE,PFE:US,BBG000BR2B91,Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?,2017-08-13 19:34:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7QOdJOxSe7Y/why-has-2017-been-a-horrible-year-so-far-for-biotech-acquisitions-cm831433,How many big biotech acquisitions can you name that have occurred so far in 2017 Johnson amp Johnson NYSE JNJ spent 30 billion to buy Swiss biotech Actelion That s one Then there s well actually that s it J amp J s acquisition of Actelion is the only truly big
PFE,PFE:US,BBG000BR2B91,Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?,2017-08-13 18:03:00 +0000,http://finance.yahoo.com/r/e70d82fc-ecb3-3f9e-9174-2fb0a879e965/why-has-2017-been-a-horrible-year-so-far-for-biote.aspx?yptr=yahoo&.tsrc=rss,Big biotech deals have been few and far between so far in 2017. But just wait till next year.
PFE,PFE:US,BBG000BR2B91,Video games could soon replace pills in treating Alzheimer's disease and depression,2017-08-12 16:13:17 +0000,http://finance.yahoo.com/r/005afa15-cc5f-3f07-b1df-f5b62843146b/104645902?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104645902&yptr=yahoo&.tsrc=rss,"A company spun out of UCSF's Neuroscape lab is developing video games to treat Alzheimer's, ADHD, depression and other cognitive diseases."
PFE,PFE:US,BBG000BR2B91,See what the IHS Markit Score report has to say about Pfizer Inc.,2017-08-12 12:00:31 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120031567.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,Edited Transcript of PFE earnings conference call or presentation 1-Aug-17 2:00pm GMT,2017-08-12 01:36:08 +0000,https://finance.yahoo.com/news/edited-transcript-pfe-earnings-conference-193526211.html?.tsrc=rss,Q2 2017 Pfizer Inc Earnings Call
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. – Value Analysis (NYSE:PFE) : August 12, 2017",2017-08-12 00:26:36 +0000,http://finance.yahoo.com/r/bdfd1a6d-ac28-3653-b4d2-075f8d04a7ce/pfizer-inc-value-analysis-nysepfe-august-12-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Pfizer Inc. a score of 50. Our analysis is based on comparing Pfizer Inc. with the following peers – Merck & Co., Inc., Johnson & Johnson, Bristol-Myers Squibb Company, Eli Lilly and Company, Novartis AG Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Mylan N.V., Abbott Laboratories ... Read more
<b>(Read more...)</b>"
PFE,PFE:US,BBG000BR2B91,Pfizer’s 2Q17 Earnings: What You Need to Know,2017-08-11 21:35:43 +0000,http://finance.yahoo.com/r/edf44e7e-1645-395b-9010-1b4e333dd62a/pfizers-2q17-earnings-what-you-need-to-know?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer (PFE) reported a 2% decline in its top line for its 2Q17 earnings, which were released on August 1."
PFE,PFE:US,BBG000BR2B91,Pfizer’s Valuation after 2Q17 Earnings,2017-08-11 19:59:09 +0000,http://finance.yahoo.com/r/278f9d57-73ba-3f43-89ae-52dab407cb1b/pfizers-valuation-after-2q17-earnings?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer (PFE) is one of the largest pharmaceutical companies by revenue. It reported a 2% decline in revenues, to $12.89 billion in 2Q17 from $13.15 billion in 2Q16."
PFE,PFE:US,BBG000BR2B91,"On earnings calls, corporate leaders openly bemoan DC's lack of direction",2017-08-11 15:46:28 +0000,http://finance.yahoo.com/r/74e802b4-eedb-3e69-a3af-7a28ae2196c4/104605446?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104605446&yptr=yahoo&.tsrc=rss,Washington's lack of movement on tax reform and health-care policy has corporate executives worried.
PFE,PFE:US,BBG000BR2B91,Luspatercept: Opportunity for Celgene’s Long-Term Growth?,2017-08-11 13:06:04 +0000,http://finance.yahoo.com/r/1273d6bf-e79c-3769-aaf6-35adf89dc808/luspatercept-opportunity-celgenes-long-term-growth?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Celgene and Acceleron are conducting the Phase 3 MEDALIST trial to evaluate the safety and efficacy of luspatercept in individuals with ring sideroblasts.
PFE,PFE:US,BBG000BR2B91,IHS Markit Score Update: Rise in demand for ETFs holding Pfizer Inc is a positive for its shares,2017-08-11 12:00:33 +0000,https://finance.yahoo.com/news/ihs-markit-score-rise-demand-120033478.html?.tsrc=rss,Pfizer Inc NYSE:PFE
PFE,PFE:US,BBG000BR2B91,Pfizer Alum's China Startup Is Said to Select Banks for IPO,2017-08-11 05:51:22 +0000,http://finance.yahoo.com/r/fc49804f-38bf-3eab-83ab-31690185b48d/pfizer-alum-s-china-startup-is-said-to-pick-banks-for-u-s-ipo?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Zai Lab Ltd., a Chinese drug developer working on cancer treatments, has picked banks to arrange a planned U.S. initial public offering that could raise about $150 million, people with knowledge of the ..."
PFE,PFE:US,BBG000BR2B91,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfizer Inc. - PFE,2017-08-11 00:18:00 +0000,https://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-001800882.html?.tsrc=rss,"NEW YORK, Aug. 11, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Pfizer Inc. (""Pfizer"" or the ""Company"") (NYSE:  PFE).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, Ext. 9980.  The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation."
PFE,PFE:US,BBG000BR2B91,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfizer Inc. - PFE,2017-08-10 23:36:00 +0000,https://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-233600639.html?.tsrc=rss,"NEW YORK , Aug. 10, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Pfizer Inc. (""Pfizer"" or the ""Company"") (NYSE:  PFE).   Such investors are advised ..."
PFE,PFE:US,BBG000BR2B91,3 High-Yield Healthcare Stocks,2017-08-10 14:37:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wbd_HysZ_5Y/3-high-yield-healthcare-stocks-cm830108,The healthcare sector is a natural hunting ground for income investors since consumers demand access to high quality healthcare products in good times and bad That fact helps keep many healthcare companies profits and dividend payments flowing even during periods of economic
PFE,PFE:US,BBG000BR2B91,"Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for August 11, 2017",2017-08-10 14:03:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YgcRCna-n-Y/eli-lilly-and-company-lly-ex-dividend-date-scheduled-for-august-11-2017-cm830061,Eli Lilly and Company LLY will begin trading ex dividend on August 11 2017 A cash dividend payment of 0 52 per share is scheduled to be paid on September 08 2017 Shareholders who purchased LLY prior to the ex dividend date are eligible for the cash dividend payment This marks the
PFE,PFE:US,BBG000BR2B91,3 High-Yield Healthcare Stocks,2017-08-10 13:15:00 +0000,http://finance.yahoo.com/r/bcb95228-1cde-3fe7-993e-5f77d582c51b/3-high-yield-healthcare-stocks.aspx?yptr=yahoo&.tsrc=rss,"Looking for income from the healthcare sector? Here&apos;s why you should check out GlaxoSmithKline, Pfizer, and CVS Health. "
PFE,PFE:US,BBG000BR2B91,Short Sellers Hike Bets in Major Pharma,2017-08-10 12:40:22 +0000,https://finance.yahoo.com/news/short-sellers-hike-bets-major-124022255.html?.tsrc=rss,"The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased."
PFE,PFE:US,BBG000BR2B91,Pfizer: Some Near Term Challenges May Mute Positive Triggers,2017-08-09 17:05:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M5c_Ex_3_SE/pfizer-some-near-term-challenges-may-mute-positive-triggers-cm829615,The impact of Pfizer s PFE second quarter results on the company s stock was barely noticeable and this has almost become a norm The company s stock has remained largely rangebound for the last five years despite Pfizer showing a rebound in revenue This is likely because the market
PFE,PFE:US,BBG000BR2B91,Analysts’ Recommendations for Celgene in August 2017,2017-08-09 17:02:23 +0000,http://finance.yahoo.com/r/2d54cc01-3307-30c2-94bb-d9937bd485a9/analysts-recommendations-celgene-august-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Of the 27 analysts covering Celgene (CELG) in August 2017, 12 analysts recommended a “strong buy,” and ten analysts recommended a “buy.”"
PFE,PFE:US,BBG000BR2B91,Vanguard High Dividend Yield ETF Experiences Big Inflow,2017-08-09 16:37:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wK2LP--rGns/vanguard-high-dividend-yield-etf-experiences-big-inflow-cm829535,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard High Dividend Yield ETF Symbol VYM where we have detected an approximate 152 9 million dollar inflow that s a 0 8 increase week over week
PFE,PFE:US,BBG000BR2B91,Mexico watchdog finds big pharma faces no competition on some drugs,2017-08-09 15:47:32 +0000,https://finance.yahoo.com/news/mexico-watchdog-finds-big-pharma-154732888.html?.tsrc=rss,"Pharmaceutical companies  including GlaxoSmithKline, Pfizer and  Sanofi-Aventis face no  competition for certain drugs in Mexico from generics that are  readily available elsewhere, a senior Mexican anti-trust  official said on Wednesday.  The companies have done nothing illegal, Juan Manuel Espino,  Cofece's director of economic studies, said at a presentation of  the body's probe into the Mexican drugs market that found  regulatory failings contributed to a lack of competition.  The report, released by Cofece on Wednesday, found that  pharmaceutical firms use ""legal strategies"" to extend drug  exclusivity after patents expire, blocking competition."
PFE,PFE:US,BBG000BR2B91,Why Vertex Pharmaceuticals Incorporated (VRTX) Will Keep Rolling Higher,2017-08-09 12:34:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JTrmIdq8Eo0/why-vertex-pharmaceuticals-incorporated-vrtx-will-keep-rolling-higher-cm829233,InvestorPlace Stock Market News Stock Advice amp Trading Tips Cystic Fibrosis is one of the scariest diseases you can imagine It s genetic so its victims are children It attacks breathing and digestion Many sufferers don t make it to adulthood although today half of the roughly 70
PFE,PFE:US,BBG000BR2B91,Earnings Review and Free Research Report: Johnson Controls’ Adjusted Net Income Soared 69.4%,2017-08-09 11:00:00 +0000,https://finance.yahoo.com/news/earnings-review-free-research-report-110000274.html?.tsrc=rss,"Research Desk Line-up: Pfizer Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 9, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Johnson Controls International PLC (NYSE: ..."
PFE,PFE:US,BBG000BR2B91,Why Vertex Pharmaceuticals Incorporated (VRTX) Will Keep Rolling Higher,2017-08-09 01:00:38 +0000,https://finance.yahoo.com/news/why-vertex-pharmaceuticals-incorporated-vrtx-010038677.html?.tsrc=rss,"InvestorPlace - Stock Market News, Stock Advice &#38; Trading Tips"
PFE,PFE:US,BBG000BR2B91,[$$] Aclaris Therapeutics Buys Confluence Life Sciences in $100 Million Deal,2017-08-08 22:06:47 +0000,http://finance.yahoo.com/r/197ba86e-4652-3f75-a258-2b1cb8f9d061/aclaris-therapeutics-buys-confluence-life-sciences-in-100-million-deal-1502230004?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Biotechnology startup Confluence Life Sciences Inc. didn’t take a conventional route to its $100 million merger with publicly traded Aclaris Therapeutics Inc.
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Aug 8, 2017 :  BAC, PFE, CMCSA, FIG, APO, DIS, INTC, QCOM, CSCO, MSFT, MRK, QQQ",2017-08-08 21:03:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hmLzX6I3l-w/after-hours-most-active-for-aug-8-2017-bac-pfe-cmcsa-fig-apo-dis-intc-qcom-csco-msft-mrk-qqq-cm829082,The NASDAQ 100 After Hours Indicator is down 13 84 to 5 912 51 The total After hours volume is currently 50 845 154 shares traded The following are the most active stocks for the after hours session Bank of America Corporation BAC is 0 03 at 24 87 with 4 653
PFE,PFE:US,BBG000BR2B91,"Horizon Pharma (HZNP) Q2 Earnings & Sales Top, Raises View",2017-08-08 16:41:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JDki0exwMhU/horizon-pharma-hznp-q2-earnings-sales-top-raises-view-cm828874,Horizon Pharma plc HZNP topped both earnings and sales estimate in second quarter 2017 The company also raised its sales guidance for 2017 The company s shares moved up 4 72 on better than expected second quarter results and increased guidance However Horizon Pharma s stock is
PFE,PFE:US,BBG000BR2B91,Why Martin Shkreli Won’t Be the Last Pharma Bro,2017-08-08 16:37:47 +0000,https://finance.yahoo.com/news/why-martin-shkreli-won-t-163747554.html?.tsrc=rss,Price gouging isn’t going away anytime soon.
PFE,PFE:US,BBG000BR2B91,"Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for August 09, 2017",2017-08-08 13:17:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j2S1VMwnuak/astrazeneca-plc-azn-ex-dividend-date-scheduled-for-august-09-2017-cm828606,Astrazeneca PLC AZN will begin trading ex dividend on August 09 2017 A cash dividend payment of 0 44 per share is scheduled to be paid on September 11 2017 Shareholders who purchased AZN prior to the ex dividend date are eligible for the cash dividend payment This represents an 52
PFE,PFE:US,BBG000BR2B91,"Pfizer investing $100M in Sanford plant expansion, adding jobs",2017-08-08 12:45:11 +0000,http://finance.yahoo.com/r/f8214c4b-10c9-384c-86b1-3d2254e065a3/pfizer-investing-100m-in-sanford-plant-expansion.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Pfizer (PFE) has confirmed plans to invest $100 million in the expansion of its Sanford research and manufacturing plant, further capitalizing on its acquisition of a Chapel Hill gene therapy startup last year.  On Monday, Gov. Roy Cooper announced that Pfizer has been awarded a $250,000 economic development incentive grant from the state’s One North Carolina Fund to help support the expansion that’s expected to create 40 additional high-paying jobs in Lee County.  Cooper had toured the plant with Pfizer officials last week."
PFE,PFE:US,BBG000BR2B91,Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire,2017-08-07 16:13:00 +0000,http://finance.yahoo.com/r/a2dfd6c8-1eeb-3ac3-8204-45395e18e9b5/pfizer-s-poor-earnings-feed-the-allergan-tie-up-fire.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,All eyes are on Pfizer in the months ahead.
PFE,PFE:US,BBG000BR2B91,Q2 Earnings Fail to Impress Pharma ETF,2017-08-07 15:42:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7wKlBEenEnM/q2-earnings-fail-to-impress-pharma-etf-cm828073,Total earnings for 83 3 of the total healthcare market capitalization are up 6 on revenue growth of 4 1 Though earnings growth is weak compared with many other sectors earnings and revenue beat ratios of 85 and 70 respectively are particularly encouraging In fact healthcare is
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Apple, Pfizer, Intel, Chevron and Exxon Mobil",2017-08-07 15:41:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qLZVodtWElg/the-zacks-analyst-blog-highlights-apple-pfizer-intel-chevron-and-exxon-mobil-cm828055,For Immediate Release Chicago IL August 07 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog include
PFE,PFE:US,BBG000BR2B91,"Dow Movers: UTX, MCD",2017-08-07 15:36:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZcaFUAHnLaU/dow-movers-utx-mcd-cm828050,In early trading on Monday shares of McDonald s MCD topped the list of the day s best performing Dow Jones Industrial Average components trading up 1 0 Year to date McDonald s registers a 27 6 gain And the worst performing Dow component thus far on the day is United
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Apple, Pfizer, Intel, Chevron and Exxon Mobil",2017-08-07 13:59:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-apple-135901309.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Apple, Pfizer, Intel, Chevron and Exxon Mobil"
PFE,PFE:US,BBG000BR2B91,Q2 Earnings Fail to Impress Pharma ETF,2017-08-07 13:45:01 +0000,https://finance.yahoo.com/news/q2-earnings-fail-impress-pharma-134501496.html?.tsrc=rss,The string of earnings beat failed to boost pharma ETFs.
PFE,PFE:US,BBG000BR2B91,9 Stocks That Have Paid Dividends for More Than a Century,2017-08-06 05:59:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Iv-euoDgA1c/9-stocks-that-have-paid-dividends-for-more-than-a-century-cm827757,InvestorPlace Stock Market News Stock Advice amp Trading Tips The number of S amp P 500 companies paying a dividend just hit a new all time high As of July 1 84 424 of the S amp P 500 companies paid a dividend up from 74 10 years ago 160 That s an extra 54 dividend payers
PFE,PFE:US,BBG000BR2B91,Earnings Preview: What To Expect From Valeant Pharmaceuticals On Tuesday,2017-08-05 15:52:00 +0000,http://finance.yahoo.com/r/58b4a0bc-7762-35f7-a192-683499f2f23b/earnings-preview-what-to-expect-from-valeant-pharmaceuticals-on-tuesday-2?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Valeant Pharmaceuticals is expected to earn $0.97/share on $2.24 billion in revenue. Meanwhile, the so-called Whisper number is $1.01."
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: Apple Impresses, Pfizer Beats on Earnings",2017-08-04 22:59:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N9VwemXPYAk/dow-30-stock-roundup-apple-impresses-pfizer-beats-on-earnings-cm827595,The Dow breached the psychological 22 000 barrier during a week of strong gains Strong earnings performances were primarily responsible for the index s record run The index also received a boost from falling sovereign bond yields on Monday On Tuesday the index achieved its 31st record
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Aug 4, 2017 :  PFE, QQQ, TWTR, BAC, M, GIS, VZ, GT, AMAT, MDLZ, BRCD, TTPH",2017-08-04 20:58:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1J7NEfRWqSs/after-hours-most-active-for-aug-4-2017-pfe-qqq-twtr-bac-m-gis-vz-gt-amat-mdlz-brcd-ttph-cm827542,The NASDAQ 100 After Hours Indicator is down 1 29 to 5 898 62 The total After hours volume is currently 40 051 554 shares traded The following are the most active stocks for the after hours session Pfizer Inc PFE is 0 04 at 33 60 with 2 805 819 shares traded PFE
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: Apple Impresses, Pfizer Beats on Earnings",2017-08-04 20:45:08 +0000,https://finance.yahoo.com/news/dow-30-stock-roundup-apple-204508046.html?.tsrc=rss,"The Dow breached the psychological 22,000 barrier during a week of strong gains."
PFE,PFE:US,BBG000BR2B91,"Market News For August 04, 2017",2017-08-04 16:04:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VhYj_XHinzg/market-news-for-august-04-2017-cm827234,The blue chip index registered its 33 rd record for 2017 to finish above the 22 000 threshold yet again on a day marked by losses for other benchmarks Further the Dow notched its eighth straight daily rise buoyed by an increase in shares of Pfizer The S amp P 500 ended in the red after
PFE,PFE:US,BBG000BR2B91,"Dow Movers: DIS, JPM",2017-08-04 16:03:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3mqUHaMmjLU/dow-movers-dis-jpm-cm827287,In early trading on Friday shares of JPMorgan Chase JPM topped the list of the day s best performing Dow Jones Industrial Average components trading up 1 4 Year to date JPMorgan Chase registers a 8 7 gain And the worst performing Dow component thus far on the day is Walt
PFE,PFE:US,BBG000BR2B91,"[$$] CVS Formulary Changes Boost JNJ, Pfizer; Hurt Lilly",2017-08-04 15:13:00 +0000,http://finance.yahoo.com/r/a0bb1d20-316b-3806-b496-83916105154f/cvs-formulary-changes-boost-jnj-pfizer-hurt-lilly-1501859632?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Credit Suisse  CVS Health has released its 2018 Formulary Strategy, including the list of drugs that will be removed from the Standard Control Formulary.  As compared to the Express Scripts Holding (ESRX) 2018 National Formulary List that was released earlier this week, the list from CVS (CVS) has some changes that will likely be more impactful to the stocks in our coverage.  The most notable shift we see in CVS’ 2018 formulary is in the diabetes space, where Eli Lilly’s (LLY) SGLT-2 inhibitor Jardiance is being dropped from the Standard Control Formulary and Johnson & Johnson’s (JNJ) Invokana is being added back as a Preferred drug for 2018."
PFE,PFE:US,BBG000BR2B91,"Dow Jones Reaches Another New High, Closes at 22,026.10",2017-08-04 14:55:31 +0000,https://finance.yahoo.com/news/dow-jones-reaches-another-high-220501014.html?.tsrc=rss,Large-cap stocks mostly lower on Thursday
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/04/2017: JNJ, PFE, ABT, MRK, AMGN, MDRX, CFRX",2017-08-04 13:19:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jr7ZN5GxusU/health-care-sector-update-for-08042017-jnj-pfe-abt-mrk-amgn-mdrx-cfrx-cm827085,Top Health Care Stocks Top Health Care Stocks JNJ 0 5 JNJ 0 5 PFE 0 2 PFE 0 2 ABT flatABT flat MRK flatMRK flat AMGN flatAMGN flat Health care shares were mostly flat in pre market trade Friday Health care shares were mostly flat in pre market trade Friday In sector
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Mixed 2Q Results from Pfizer, Bristol-Myers Announces IO Deals",2017-08-04 12:47:12 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-mixed-2q-124712684.html?.tsrc=rss,Pfizer&apos;s (PFE) results were mixed while Teva had a dismal quarter with the company missing estimates as well as cutting its outlook and guidance.
PFE,PFE:US,BBG000BR2B91,"Asian stocks mixed as US jobs, politics in focus",2017-08-04 03:39:42 +0000,http://finance.yahoo.com/r/f0ae2ab0-7504-3282-9b87-92a2d1cc359c/stocks-start-lower-tech-companies-141212136.html?.tsrc=rss,"SEOUL, South Korea (AP) — Most Asian stock markets were mixed Friday as investors awaited the monthly U.S. jobs report and developments in the U.S. probe into President Donald Trump's alleged ties to Russia."
PFE,PFE:US,BBG000BR2B91,"DVAX Plunges On Delay In Approval, FDA Nod For ABBV's HCV Drug, ABIO On Radar",2017-08-04 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5id7u3diVtI/dvax-plunges-on-delay-in-approval-fda-nod-for-abbvs-hcv-drug-abio-on-radar-20170804-00064,"DVAX Plunges On Delay In Approval, FDA Nod For ABBV's HCV Drug, ABIO On Radar"
PFE,PFE:US,BBG000BR2B91,AstraZeneca plc: Buy the Dip?,2017-08-04 01:59:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AwS2Yyo2eXQ/astrazeneca-plc-buy-the-dip-cm826972,AstraZeneca plc NYSE AZN stock tumbled after the company announced the failure of an important clinical trial recently Although the shares have recovered somewhat the stock is still off by about 11 and investors are right to wonder if now is a good time to buy Now that it
PFE,PFE:US,BBG000BR2B91,"Dow bags 7th straight record, but energy slump weighs on broader stock market",2017-08-03 21:19:06 +0000,http://finance.yahoo.com/r/0616704f-17d4-351d-a4bf-13c96aeb9d15/Story.aspx?guid=ACC63BAA-7822-11E7-8BAC-51224A647843&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"The Dow industrials on Thursday log a seventh consecutive all-time high, but the broader market closes lower following a slump in the energy sector."
PFE,PFE:US,BBG000BR2B91,"Momenta (MNTA) Q2 Loss In Line with Estimates, Sales Beat",2017-08-03 21:04:09 +0000,https://finance.yahoo.com/news/momenta-mnta-q2-loss-line-210409973.html?.tsrc=rss,Momenta Pharmaceuticals Inc (MNTA)&apos;s loss per share came in line with estimates in the second quarter of 2017 while sales beat estimates driven by Glatopa 20mg.
PFE,PFE:US,BBG000BR2B91,"Market Close Report: NASDAQ Composite index closes at 6,340.34 down -22.31 points",2017-08-03 20:48:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aaWJc5GZ8Zk/market-close-report-nasdaq-composite-index-closes-at-634034-down-2231-points-cm826859,Thursday s session closes with the NASDAQ Composite Index at 6 340 34 The total shares traded for the NASDAQ was over 2 26 billion Declining stocks led advancers by 1 44 to 1 ratio There were 1214 advancers and 1750 decliners for the day On the NASDAQ Stock Exchange 45 stocks reached a 52
PFE,PFE:US,BBG000BR2B91,FDA Advisory Committee Votes in Favor of XELJANZ® (tofacitinib citrate) for the Treatment of Active Psoriatic Arthritis,2017-08-03 18:10:00 +0000,https://finance.yahoo.com/news/fda-advisory-committee-votes-favor-181000985.html?.tsrc=rss,Pfizer Inc. announced today that the United States Food and Drug Administration’s Arthritis Advisory Committee voted 10 to 1 to recommend approval of the proposed dose of tofacitinib for the treatment of adult patients with active psoriatic arthritis .
PFE,PFE:US,BBG000BR2B91,"Dow Movers: V, PFE",2017-08-03 16:03:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/szvo00dL6tE/dow-movers-v-pfe-cm826548,In early trading on Thursday shares of Pfizer PFE topped the list of the day s best performing Dow Jones Industrial Average components trading up 0 9 Year to date Pfizer registers a 2 2 gain And the worst performing Dow component thus far on the day is Visa V trading
PFE,PFE:US,BBG000BR2B91,"Keystone Financial Planning, Inc. Buys British American Tobacco PLC, Procter & Gamble Co, ...",2017-08-03 15:59:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xhfhEf3X8d4/keystone-financial-planning-inc-buys-british-american-tobacco-plc-procter-gamble-co-cm826593,Keystone Financial Planning Inc New Purchases BTI Added Positions PG GE UPS KO XOM D QCOM RAI PAYX PFE Reduced Positions ABB PM DEO VYM MSFT SNY TOT New Purchases BTI New Purchases BTI Added Positions PG GE
PFE,PFE:US,BBG000BR2B91,Novartis a Top Ranked SAFE Dividend Stock With 3.2% Yield (NVS),2017-08-03 14:01:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ed0zx7ux1iU/novartis-a-top-ranked-safe-dividend-stock-with-32-yield-nvs-cm826310,Novartis Symbol NVS has been named to the Dividend Channel International S A F E 10 list signifying an international stock with above average DividendRank statistics including a strong 3 2 yield as well as a superb track record of at least five years of dividend growth
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/03/2017: JNJ, PFE, ABT, MRK, AMGN, REGN, TEVA",2017-08-03 13:19:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uq0UkLoolAQ/health-care-sector-update-for-08032017-jnj-pfe-abt-mrk-amgn-regn-teva-cm826292,Top Health Care Stocks Top Health Care Stocks JNJ 0 5 JNJ 0 5 PFE 0 03 PFE 0 03 ABT flatABT flat MRK flatMRK flat AMGN flatAMGN flat Health care shares were mostly flat in pre market trade Thursday Health care shares were mostly flat in pre market trade Thursday In sector
PFE,PFE:US,BBG000BR2B91,Today's Research Reports on Stocks to Watch: Pfizer and Procter & Gamble,2017-08-03 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000970.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 3, 2017 / Pfizer shares modestly saw a jump on Wednesday after releasing a favorable guidance looking forward and after a BMO Capitals analyst had optimistic things to ..."
PFE,PFE:US,BBG000BR2B91,Aerie (AERI) Reports Narrower-Than-Expected Loss in Q2,2017-08-02 16:00:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rV6wVStSKyA/aerie-aeri-reports-narrower-than-expected-loss-in-q2-cm825758,Aerie Pharmaceuticals Inc AERI posted second quarter 2017 loss of 82 cents per share including stock based compensation narrower than the Zacks Consensus Estimate of a loss of 84 cents and the year ago loss of 87 cents Being a development stage company Aerie has not generated
PFE,PFE:US,BBG000BR2B91,Wednesday's ETF with Unusual Volume: ACWV,2017-08-02 15:56:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MKHpbFuERw4/wednesdays-etf-with-unusual-volume-acwv-cm825730,The iShares Edge MSCI Min Vol Global ETF ACWV is seeing unusually high volume in afternoon trading Wednesday with over 1 4 million shares traded versus three month average volume of about 225 000 Shares of ACWV were off about 0 1 on the day Components of that ETF with the
PFE,PFE:US,BBG000BR2B91,A Large-Scale Acquisition Is Unlikely for Pfizer Until This Happens,2017-08-02 15:15:00 +0000,http://finance.yahoo.com/r/4edde680-2859-3fb7-842d-e83633ff241a/large-scale-acquisition-is-unlikely-for-pfizer-unt.aspx?yptr=yahoo&.tsrc=rss,"With U.S. lawmakers failing to tackle corporate tax reform, Pfizer&apos;s appetite for a large-scale acquisition appears to be waning."
PFE,PFE:US,BBG000BR2B91,"Company News For August 02, 2017",2017-08-02 14:09:02 +0000,https://finance.yahoo.com/news/company-news-august-02-2017-140902665.html?.tsrc=rss,"Companies in the news are: XRX,ADM,RCL,PFE"
PFE,PFE:US,BBG000BR2B91,"With 22K in the books, here are the stocks Wall Street believes will lead the Dow to 23,000",2017-08-02 14:05:10 +0000,http://finance.yahoo.com/r/b7a5a73b-a186-3be5-a1e7-b8266f8208de/104626522?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104626522&yptr=yahoo&.tsrc=rss,"If the average Wall Street price targets prove accurate, some consumer and technology names could help the Dow Jones industrial average reach 23,000."
PFE,PFE:US,BBG000BR2B91,"With 22K in the books, here are the stocks Wall Street believes will lead the Dow to 23,000",2017-08-02 14:05:10 +0000,https://finance.yahoo.com/news/22k-books-stocks-wall-street-140510703.html?.tsrc=rss,"If the average Wall Street price targets prove accurate, some consumer and technology names could help the Dow Jones industrial average reach 23,000."
PFE,PFE:US,BBG000BR2B91,Can DENTSPLY Sirona (XRAY) Deliver a Beat in Q2 Earnings?,2017-08-02 14:00:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bKWWR-1b90U/can-dentsply-sirona-xray-deliver-a-beat-in-q2-earnings-cm825522,York PA based DENTSPLY Sirona Inc XRAY a dental solutions company is expected to report second quarter 2017 results on Aug 9 DENTSPLY Sirona s track record has been quite impressive with the company beating estimates in three of the trailing four quarters 160 Last quarter it
PFE,PFE:US,BBG000BR2B91,"Pfizer Stock Upgraded at BMO on Attractive Risk/Reward, Growth Outlook",2017-08-02 14:00:00 +0000,http://finance.yahoo.com/r/6ca7247f-8f31-3712-afda-472a22273ef6/pfizer-stock-upgraded-at-bmo-on-attractive-risk-reward-growth-outlook.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Analysts at BMO Capital expect 'positive updates' on the company's pipeline that could improve investors' view on the company.
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/02/2017: JNJ, PFE, ABT, MRK, AMGN, EYES, OCUL",2017-08-02 13:34:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2NE6Hoe507Y/health-care-sector-update-for-08022017-jnj-pfe-abt-mrk-amgn-eyes-ocul-cm825628,Top Health Care Stocks Top Health Care Stocks JNJ 0 2 JNJ 0 2 PFE 0 3 PFE 0 3 ABT flatABT flat MRK flatMRK flat AMGN 0 7 AMGN 0 7 Health care shares were mixed in pre market trade Wednesday Health care shares were mixed in pre market trade Wednesday In sector news Second
PFE,PFE:US,BBG000BR2B91,Pfizer upgraded to outperform at BMO Capital Markets on drug pipeline progress,2017-08-02 13:08:52 +0000,http://finance.yahoo.com/r/0b4c6c20-fd2d-3f68-a46a-8a1617b495da/Story.aspx?guid=6173B174-6F6B-4158-B38C-1112030CB037&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Pfizer Inc. was upgraded to outperform with a $37 price target by BMO Capital Markets early Wednesday. Pfizer shares, which were up 0.6% premarket, closed at $32.76 on Tuesday. BMO Capital Markets analyst ..."
PFE,PFE:US,BBG000BR2B91,Earnings Preview: What To Expect From Regeneron Pharmaceuticals On Thursday,2017-08-02 12:00:00 +0000,http://finance.yahoo.com/r/07e95ea8-26c0-3f0f-aba6-0b9dacd72023/earnings-preview-what-to-expect-from-regeneron-pharmaceuticals-on-thursday?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Regeneron is expected to report earnings of $3.15 per share on $1.36 billion in revenue. Meanwhile, the so-called Whisper number is $3.29."
PFE,PFE:US,BBG000BR2B91,How BMY Is Valued following Its 2Q17 Earnings,2017-08-02 11:37:01 +0000,http://finance.yahoo.com/r/024deee5-cd23-3f8c-8c34-d96b3e1e2b0f/how-bmy-is-valued-following-its-2q17-earnings?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Bristol-Myers Squibb (BMY) met Wall Street analysts’ consensus estimate for earnings per share (or EPS) in 2Q17, reporting EPS of $0.74."
PFE,PFE:US,BBG000BR2B91,Eli Lilly’s Valuation after 2Q17 Earnings Release,2017-08-02 11:35:56 +0000,http://finance.yahoo.com/r/692b92c6-c691-3256-a106-cddd80d7e3ab/eli-lillys-valuation-after-2q17-earnings-release?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"For 2Q17, Eli Lilly (LLY) surpassed analysts’ EPS estimate of $1.05 and reported EPS of $1.11. Analysts are estimating EPS of $1.03 for 3Q17."
PFE,PFE:US,BBG000BR2B91,Merck's Keytruda Plays Catch-Up to Bristol-Myers' Opdivo,2017-08-02 02:54:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YuMZH5KuTe4/mercks-keytruda-plays-catch-up-to-bristol-myers-opdivo-cm825400,Merck amp Co NYSE MRK and Bristol Myers Squibb NYSE BMY are engaged in a battle of sorts The two won FDA approval for new non small cell lung cancer therapies in 2015 that work similarly and ever since they ve been elbowing at one another for market share So
PFE,PFE:US,BBG000BR2B91,Pfizer tops 2Q profit forecasts,2017-08-02 01:33:23 +0000,https://finance.yahoo.com/news/pfizer-tops-2q-profit-forecasts-110852448.html?.tsrc=rss,"The New York-based company said it had profit of 51 cents per share. Earnings, adjusted for one-time gains and costs, came to 67 cents per share. The results beat Wall Street expectations. The average ..."
PFE,PFE:US,BBG000BR2B91,"Dow Enters August With a Bang, New Records for Day Five",2017-08-02 00:00:00 +0000,http://finance.yahoo.com/r/e3e3779c-605a-38cb-9f68-0956f11465da/dow-enters-august-with-a-bang-new-records-for-day-five.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Telecoms rise, autos sink."
PFE,PFE:US,BBG000BR2B91,"How Snap May Have Dashed Uber's IPO Hopes; Intel CEO on Autonomy, Tech Rally -- ICYMI Tuesday",2017-08-01 23:30:00 +0000,http://finance.yahoo.com/r/e7fd2d17-a82a-3c04-804f-b435d427ef0d/how-snap-may-have-dashed-uber-s-ipo-hopes-intel-ceo-on-autonomy-tech-rally-icymi-tuesday.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here's what you need to know now.
PFE,PFE:US,BBG000BR2B91,12 Numbers in Pfizer's Q2 Update More Important Than Its Revenue Decline,2017-08-01 20:55:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ws_MTe_-aK0/12-numbers-in-pfizers-q2-update-more-important-than-its-revenue-decline-cm825276,Pfizer NYSE PFE announced its second quarter results before the market opened on Tuesday And investors yawned at least for the most part Many of the headlines about the big drugmaker s quarterly performance centered on Pfizer s year over year revenue decline The
PFE,PFE:US,BBG000BR2B91,"Pfizer's Weak Viagra, Consumer Sales Drag Down Massive Gains in New Products",2017-08-01 20:30:00 +0000,http://finance.yahoo.com/r/11dfdb14-f5b6-344a-b36b-21ba2d2e4aab/pfizer-stock-slips-after-company-misses-on-revenue-beats-on-profit.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Pfizer post earnings beat.
PFE,PFE:US,BBG000BR2B91,Will Pfizer&apos;s Cancer Drugs Help It Grow Without A Merger?,2017-08-01 20:22:57 +0000,http://finance.yahoo.com/r/8603a1c7-d169-375e-ba49-0dd1af3f6655/will-pfizers-cancer-drugs-help-it-grow-without-a-merger?src=A00220&yptr=yahoo&.tsrc=rss,"Pfizer is awaiting clarification on tax reform before embarking on deal-making, the Dow component said Tuesday."
PFE,PFE:US,BBG000BR2B91,"Generics Chip Away At Dow Stock Pfizer, But Cancer Unit &apos;Stabilizing&apos;",2017-08-01 20:11:48 +0000,http://finance.yahoo.com/r/9d019387-601f-38e4-95e0-8e5a67000d43/pfizer-earnings-top-revenue-misses?src=A00220&yptr=yahoo&.tsrc=rss,"Pfizer reported better-than-expected second-quarter earnings early Tuesday, but revenue came up short."
PFE,PFE:US,BBG000BR2B91,12 Numbers in Pfizer&apos;s Q2 Update More Important Than Its Revenue Decline,2017-08-01 19:02:00 +0000,http://finance.yahoo.com/r/b98df841-648c-3c7b-afc3-5b907035e82a/12-numbers-in-pfizers-q2-update-more-important-tha.aspx?yptr=yahoo&.tsrc=rss,"Sure, Pfizer&apos;s revenue dropped in Q2, but here are a dozen numbers that matter more."
PFE,PFE:US,BBG000BR2B91,Pfizer's New Tax Obsession Shouldn't Paralyze It,2017-08-01 18:32:15 +0000,http://finance.yahoo.com/r/c0dab10f-005d-3254-9a26-936f288153e0/pfizer-earnings-tax-obsession-shouldn-t-paralyze-it?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,It needs growth and can't wait for clarity from the Trump administration.
PFE,PFE:US,BBG000BR2B91,"Dow on Track for Fifth Record Close in a Row, Wall Street Rises",2017-08-01 18:15:00 +0000,http://finance.yahoo.com/r/d02baa04-1d8d-38ce-8942-048ec007ee11/telecoms-drive-wall-street-gains-but-weak-auto-sales-cap-momentum.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Telecoms rise, autos sink."
PFE,PFE:US,BBG000BR2B91,"Q2 Earnings From UA, PFE And ADM",2017-08-01 17:58:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DtU2U2yQktY/q2-earnings-from-ua-pfe-and-adm-cm825176,Though we ve seen plenty of marquee names put out quarterly earnings reports already in this calendar Q2 with Apple AAPL due after the closing bell this afternoon there are still a large amount of well known firms having reported in Tuesday s pre market UnderArmour UAA Pfizer PFE
PFE,PFE:US,BBG000BR2B91,Pfizer delays major M&A as it awaits U.S. tax reform clarity,2017-08-01 17:36:44 +0000,https://finance.yahoo.com/news/pfizer-quarterly-revenue-slips-2-105729493.html?.tsrc=rss,"The largest U.S. drugmaker has been under increasing pressure from investors and Wall Street to pull off a large deal to help reignite growth.  ""There are short-term events in the marketplace, such as tax reform, that may change asset values.  Any focus on (business development) is somewhat delayed by resolution of that,"" CEO Ian Read told analysts."
PFE,PFE:US,BBG000BR2B91,Pfizer Remains Underappreciated,2017-08-01 17:33:07 +0000,https://finance.yahoo.com/video/pfizer-remains-underappreciated-173307297.html?.tsrc=rss,"With a secure wide moat and signs that sales growth will resume next year, investors should take a closer look at Pfizer shares today."
PFE,PFE:US,BBG000BR2B91,Big movers in the blitz,2017-08-01 17:26:00 +0000,https://finance.yahoo.com/video/big-movers-blitz-172600288.html?.tsrc=rss,Big ups and big downs on the first day of August.
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer Waiting for Cues on Tax Reform to Pursue Deals,2017-08-01 17:19:20 +0000,http://finance.yahoo.com/r/18bd490e-865e-3eae-a212-8aada86343ed/pfizer-sales-miss-expectations-on-increased-competition-1501586549?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Pfizer, reporting a drop in second-quarter sales, says it wants to wait to see what happens with tax reform in Washington before deciding on any big mergers or acquisitions"
PFE,PFE:US,BBG000BR2B91,Q2 Earnings Tuesday: Mixed Bag for Most,2017-08-01 17:01:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/irW9c9dIfpU/q2-earnings-tuesday-mixed-bag-for-most-cm824978,Tuesday August 1st 2017 Though we ve seen plenty of marquee names put out quarterly earnings reports already in this calendar Q2 with Apple AAPL due after the closing bell this afternoon there are still a large amount of well known firms having reported in Tuesday s pre
PFE,PFE:US,BBG000BR2B91,Sky-High Boeing Co (BA) Stock Is Bleeding Fuel,2017-08-01 16:53:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dlxrpdaol8I/sky-high-boeing-co-ba-stock-is-bleeding-fuel-cm825102,InvestorPlace Stock Market News Stock Advice amp Trading Tips Boeing Co NYSE BA might just be the hottest Dow Jones Industrial Average stock these days Its ascent has gone from gradual to steep to straight up parabolic However Boeing can t fly forever Even the biggest
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer hits pause on deals amid US tax reform uncertainty,2017-08-01 16:38:47 +0000,"http://finance.yahoo.com/r/d57e7c2f-516b-3524-9869-df98d16f2597/255e274c-76d1-11e7-90c0-90a9d1bc9691,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Pfizer, the biggest US drugmaker by sales, has hit the pause button on large dealmaking pending greater clarity on whether the Trump administration can deliver on its pledge to overhaul the US tax code. ..."
PFE,PFE:US,BBG000BR2B91,Why Garmin Ltd. (GRMN) Stock Should Still Be Avoided,2017-08-01 16:13:20 +0000,https://finance.yahoo.com/news/why-garmin-ltd-grmn-stock-161320779.html?.tsrc=rss,"Back in February, Garmin Ltd. (NASDAQ:GRMN) shares were pushing toward new 52-weeks highs on a stellar fourth-quarter earnings report.  In fact, at $50, GRMN stock sits pretty squarely between its 52-week range of $46 and $56.  Investors want to know which end of the range it may test on Garmin earnings Wednesday morning."
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Surpasses Q2 Earnings Estimates, Misses Sales",2017-08-01 15:58:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XiQvBlCPQbk/pfizer-pfe-surpasses-q2-earnings-estimates-misses-sales-cm824982,Pfizer Inc PFE reported second quarter 2017 adjusted earnings per share of 67 cents which beat the Zacks Consensus Estimate of 65 cents by 3 1 Earnings also rose 5 year over year On the other hand revenues missed expectations The pharma heavyweight delivered revenues of 12 90
PFE,PFE:US,BBG000BR2B91,"Dow Movers: MCD, JPM",2017-08-01 15:55:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v2BPdDKPXFI/dow-movers-mcd-jpm-cm824946,In early trading on Tuesday shares of JPMorgan Chase JPM topped the list of the day s best performing Dow Jones Industrial Average components trading up 1 2 Year to date JPMorgan Chase registers a 7 7 gain And the worst performing Dow component thus far on the day is McDonald
PFE,PFE:US,BBG000BR2B91,The 8 'Dogs Of The Dow' Gained Ground On The Dow 30,2017-08-01 15:54:00 +0000,http://finance.yahoo.com/r/2c5d1954-d88c-3401-9cd7-c9bd877de53d/the-8-dogs-of-the-dow-gained-ground-on-the-dow-30?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,Here's how to trade the 'Dogs of the Dow' now.
PFE,PFE:US,BBG000BR2B91,"Q2 Earnings From UA, PFE And ADM",2017-08-01 15:25:03 +0000,https://finance.yahoo.com/news/q2-earnings-ua-pfe-adm-152503996.html?.tsrc=rss,"Q2 Earnings From UA, PFE And ADM"
PFE,PFE:US,BBG000BR2B91,Pfizer Looks Undervalued,2017-08-01 15:00:00 +0000,https://finance.yahoo.com/news/pfizer-looks-undervalued-150000699.html?.tsrc=rss,We think the market continues to underappreciate both Pfizer’s pipeline and recently launched drugs.
PFE,PFE:US,BBG000BR2B91,"Dow Secures All-Time Trading High, Weak Auto Sales Cap Broader Gains",2017-08-01 14:46:00 +0000,http://finance.yahoo.com/r/9b27f2ab-05ef-37b5-b4c4-a8d8cfb0fe8d/dow-opens-at-all-time-high-nears-22-000-as-wall-street-awaits-apple.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stocks are higher.
PFE,PFE:US,BBG000BR2B91,Pfizer's revenue falls again,2017-08-01 14:36:42 +0000,https://www.yahoo.com/news/pfizers-revenue-falls-again-143642044.html?.tsrc=rss,"Strong competition for biosimilars hurt sales of the drug maker's rheumatoid arthritis treatment, Enbrel. Fred Katayama reports."
PFE,PFE:US,BBG000BR2B91,Eli Lilly’s Major Developments in 2Q17,2017-08-01 14:36:13 +0000,http://finance.yahoo.com/r/1e14b3a0-10f7-3ccf-9ecc-00ae41ea2837/eli-lillys-major-developments-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Eli Lilly repurchased shares worth $200.0 million and distributed dividends of more than $500.0 million to its shareholders in 2Q17.
PFE,PFE:US,BBG000BR2B91,Q2 Earnings Tuesday: Mixed Bag for Most,2017-08-01 14:11:02 +0000,https://finance.yahoo.com/news/q2-earnings-tuesday-mixed-bag-141102726.html?.tsrc=rss,"UnderArmour (UAA), Pfizer (PFE), Archer Daniels Midland (ADM), among others, hit the tape this morning."
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Surpasses Q2 Earnings Estimates, Misses Sales",2017-08-01 14:11:02 +0000,https://finance.yahoo.com/news/pfizer-pfe-surpasses-q2-earnings-141102851.html?.tsrc=rss,"Pfizer, Inc. (PFE) beat expectations for earnings while missing the same for sales in Q2. It raised the lower end of its 2017 adjusted earnings guidance but kept the revenue expectations intact."
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Tops Q2 Earnings Estimates, Misses Sales",2017-08-01 13:59:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lhyX7OQkmbw/pfizer-pfe-tops-q2-earnings-estimates-misses-sales-cm824765,Pfizer Inc s PFE is one of the most well known names in the pharmaceutical sector not just for its medicines and vaccines but also for its consumer healthcare products This New York based company is well known for products like Prevnar Lyrica Lipitor and Celebrex among others However
PFE,PFE:US,BBG000BR2B91,"Becton, Dickinson (BDX) Q2 Earnings: What's in the Cards?",2017-08-01 13:59:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KssO0WSPvLY/becton-dickinson-bdx-q2-earnings-whats-in-the-cards-cm824930,Becton Dickinson and Company BDX is set to report second quarter fiscal 2017 results on Aug 3 Becton Dickinson has an impressive track of comfortably beating estimates in each of the four trailing quarters In the last reported quarter it delivered a positive earnings surprise of 3
PFE,PFE:US,BBG000BR2B91,Key drug sales push Pfizer profit up 50 percent,2017-08-01 13:37:50 +0000,http://finance.yahoo.com/r/ac98b7ba-128d-3d17-a0ad-2371aa33c468/pfizer-tops-2q-profit-forecasts-110852448.html?.tsrc=rss,"Rising sales of most key drugs, lower one-time charges and reduced manufacturing costs helped drive Pfizer's profit up 50 percent in the second quarter."
PFE,PFE:US,BBG000BR2B91,"Stocks to Watch: Sprint, Pfizer, Pandora, Under Armour, Lumber Liquidators",2017-08-01 13:25:20 +0000,http://finance.yahoo.com/r/7fde042d-724b-3f90-8e06-6eab6a84a646/stocks-to-watch-sprint-pfizer-pandora-under-armour-lumber-liquidators-1501593808?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Among the companies with shares expected to trade actively in Monday’s session are Sprint Corp., Pfizer Inc., Pandora Media Inc., Under Armour Inc. and Lumber Liquidators Holdings Inc."
PFE,PFE:US,BBG000BR2B91,"Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for August 02, 2017",2017-08-01 13:15:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_XoWgegzURM/pfizer-inc-pfe-ex-dividend-date-scheduled-for-august-02-2017-cm824832,Pfizer Inc PFE will begin trading ex dividend on August 02 2017 A cash dividend payment of 0 32 per share is scheduled to be paid on September 01 2017 Shareholders who purchased PFE prior to the ex dividend date are eligible for the cash dividend payment This marks the 3rd quarter
PFE,PFE:US,BBG000BR2B91,Dow Set to Open at All-Time High as Wall Street Awaits Apple,2017-08-01 12:41:00 +0000,http://finance.yahoo.com/r/e342df8f-2b73-3c77-9fee-b4b477e6b2b9/dow-set-to-open-at-all-time-high-as-pfizer-beats-and-wall-street-awaits-apple.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Stock futures are higher.
PFE,PFE:US,BBG000BR2B91,"Becton, Dickinson (BDX) Q2 Earnings: What&apos;s in the Cards?",2017-08-01 12:28:12 +0000,https://finance.yahoo.com/news/becton-dickinson-bdx-q2-earnings-122812724.html?.tsrc=rss,"Becton, Dickinson&apos;s (BDX) second-quarter performance faces risks from unfavorable foreign exchange rate."
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Tops Q2 Earnings Estimates, Misses Sales",2017-08-01 12:13:12 +0000,https://finance.yahoo.com/news/pfizer-pfe-tops-q2-earnings-121312294.html?.tsrc=rss,"Pfizer, Inc. (PFE) beat expectations for earnings while missing the same for sales in Q2. It raised the lower end of its 2017 adjusted earnings guidance but kept the revenue expectations intact."
PFE,PFE:US,BBG000BR2B91,"Pfizer revenue misses on lower Prevnar, Enbrel sales",2017-08-01 12:10:46 +0000,https://finance.yahoo.com/news/pfizer-revenue-misses-lower-prevnar-121046200.html?.tsrc=rss,"Pfizer reported a nearly 2 percent drop in revenue, driven by lower demand for its rheumatoid arthritis treatment Enbrel and pneumonia vaccine Prevnar."
PFE,PFE:US,BBG000BR2B91,"Pfizer revenue misses on lower Prevnar, Enbrel sales",2017-08-01 12:10:46 +0000,http://finance.yahoo.com/r/0de97e48-15b7-3f6a-8fdd-075202c0f315/104621425?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104621425&yptr=yahoo&.tsrc=rss,"Pfizer reported a nearly 2 percent drop in revenue, driven by lower demand for its rheumatoid arthritis treatment Enbrel and pneumonia vaccine Prevnar."
PFE,PFE:US,BBG000BR2B91,"3 Stocks to Watch on Tuesday: Snap Inc (SNAP), Pfizer Inc. (PFE) and Texas Roadhouse Inc (TXRH)",2017-08-01 12:10:26 +0000,https://finance.yahoo.com/news/3-stocks-watch-tuesday-snap-121026831.html?.tsrc=rss,"While the Dow Jones Industrial Average hit yet another record high after a 0.3% uptick, the S&P 500 Index slipped by 0.1%, while the Nasdaq Composite fell 0.4%.  Corporate earnings are dominating the headlines once again, with Pfizer Inc. (NYSE:PFE) and Texas Roadhouse Inc (NASDAQ:TXRH) among companies on the move following their most recent financial results.  Fears of the event exacerbated Snap’s selling, with Wall Street fearing that already significant losses since the IPO would prompt insiders to sell like crazy the second they had the opportunity."
PFE,PFE:US,BBG000BR2B91,"Early movers: UAA, PFE, ADM, P, TXRH, AN, HMC, LVS, WYNN, SNAP & more",2017-08-01 12:05:58 +0000,http://finance.yahoo.com/r/9135f146-14f9-3742-ad30-eaa77fc7ed25/104623557?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104623557&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
PFE,PFE:US,BBG000BR2B91,Investor Network: Pfizer Inc. to Host Earnings Call,2017-08-01 12:00:00 +0000,https://finance.yahoo.com/news/investor-network-pfizer-inc-host-120000178.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 1, 2017 / Pfizer Inc. (NYSE: PFE) will be discussing their earnings results in their Q2 Earnings Call to be held on Tuesday, August 01, 2017 at 10:00 AM Eastern Time. ..."
PFE,PFE:US,BBG000BR2B91,Why Pfizer Earnings Aren’t Exciting Investors,2017-08-01 11:55:16 +0000,https://finance.yahoo.com/news/why-pfizer-earnings-aren-t-115516466.html?.tsrc=rss,"Pharmaceuticals maker Pfizer reported second-quarter earnings before markets opened Tuesday, beating profit estimates by a penny a share, but coming up short on revenues."
PFE,PFE:US,BBG000BR2B91,Pfizer on the Street: Analyst Recommendations after 2Q17,2017-08-01 11:41:38 +0000,http://finance.yahoo.com/r/f75ff4ce-16d2-31b1-a86c-a810476f5ef1/pfizer-on-the-street-analyst-recommendations-after-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"As of July 31, 2017, of the 22 analysts tracking Pfizer, ten recommend a “buy” for the stock, while 11 recommend a “hold,” and one recommends a “sell."""
PFE,PFE:US,BBG000BR2B91,US STOCKS-Futures higher on strong earnings season; Apple in focus,2017-08-01 11:32:50 +0000,https://finance.yahoo.com/news/us-stocks-futures-higher-strong-113250067.html?.tsrc=rss,"U.S. stock index futures started the month  on a strong note, with Dow futures surging 100 points on  Tuesday, driven by a set of upbeat earnings reports and ahead of  Apple's quarterly results.  * Shares of Dow-component Apple were up 0.36  percent in premarket trading.  * The Dow industrials hit a record closing high on Monday,  helped by Boeing, while selling in technology companies kept the  S&P 500 in check and pulled the Nasdaq lower."
PFE,PFE:US,BBG000BR2B91,Key FDA Events to Watch Out for in Aug 2017,2017-08-01 11:29:11 +0000,https://finance.yahoo.com/news/key-fda-events-watch-aug-112911630.html?.tsrc=rss,Will the FDA follow the recommendation of its advisory panel and give its nod to Dynavax&apos;s (DVAX) hepatitis B vaccine?
PFE,PFE:US,BBG000BR2B91,"Pfizer reports mixed quarter, increases midrange 2017 EPS...",2017-08-01 11:11:00 +0000,https://finance.yahoo.com/video/pfizer-reports-mixed-quarter-increases-111100892.html?.tsrc=rss,"It is essentially a bond, says Barbara Ryan, Barbara Ryan Advisors, talking about Pfizer's struggle to provide shareholders growth. Eventually they will turn to M&A, says Ryan."
PFE,PFE:US,BBG000BR2B91,Pfizer Sales Shortfall Highlights Pressure to Make a Deal,2017-08-01 11:04:53 +0000,http://finance.yahoo.com/r/5ebf2b44-f430-376c-a3b1-57e9d1ee7d8c/pfizer-revenue-falls-short-as-pressure-mounts-to-make-a-deal?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Pfizer Inc.’s revenue shortfall last quarter may reignite pressure on the New York drugmaker to make deals to return to growth.
PFE,PFE:US,BBG000BR2B91,"Pfizer reports Q2 profit beat, revenue miss",2017-08-01 11:02:40 +0000,http://finance.yahoo.com/r/5f5092f3-6bf8-3696-abcb-59f9b1683bc9/Story.aspx?guid=CDCE3D62-920C-4499-A2D5-764E0D19A4B1&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Pfizer Inc. reported a second-quarter profit beat and revenue miss early Tuesday. Earnings for the latest quarter rose to $3.07 billion, or 51 cents per share, from $2.05 billion, or 33 cents per share. ..."
PFE,PFE:US,BBG000BR2B91,"Earnings Reaction History: Pfizer Inc, 36.4% Follow-Through Indicator, 1.1% Sensitive",2017-08-01 10:54:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Sc4fdFD__tk/earnings-reaction-history-pfizer-inc-364-follow-through-indicator-11-sensitive-cm824679,Expected Earnings Release 08 01 2017 PremarketExpected Earnings Release 08 01 2017 Premarket Avg Extended Hours Dollar Volume 9 524 707Avg Extended Hours Dollar Volume 9 524 707 Pfizer Inc PFE is due to issue its quarterly earnings report in the upcoming extended hours session
PFE,PFE:US,BBG000BR2B91,Pfizer Reports Second-Quarter 2017 Results,2017-08-01 10:45:00 +0000,https://finance.yahoo.com/news/pfizer-reports-second-quarter-2017-104500677.html?.tsrc=rss,"Pfizer Inc. reported financial results for second-quarter 2017, increased the midpoint of its 2017 financial guidance range for Adjusted diluted EPS and reaffirmed its 2017 financial guidance range for Revenues."
PFE,PFE:US,BBG000BR2B91,Pfizer Q2 17 Earnings Conference Call At 10:00 AM ET,2017-08-01 09:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZzG0MzarsUI/pfizer-q2-17-earnings-conference-call-at-1000-am-et-20170801-00867,Pfizer Q2 17 Earnings Conference Call At 10:00 AM ET
PFE,PFE:US,BBG000BR2B91,AstraZeneca a tricky takeover target after big cancer drug blow,2017-08-01 08:34:25 +0000,https://finance.yahoo.com/news/astrazeneca-tricky-takeover-target-big-083425226.html?.tsrc=rss,"Hurdles ranging from existing  commercial tie-ups to politics make drugmaker AstraZeneca  a problematic takeover target in the wake of last week's  big lung cancer setback that hammered the stock and rekindled  takeover talk.  Industry executives and bankers say Pfizer, which  failed to buy it for $118 billion in 2014, is unlikely to  return, while European rivals Novartis, Sanofi  and GlaxoSmithKline are wary of large deals.  AstraZeneca still boasts a pipeline of new drugs that could  lure predators - even after the failure of its immunotherapy  treatment to curb lung cancer as hoped in the closely watched  Mystic trial."
PFE,PFE:US,BBG000BR2B91,"Pfizer Q2 Profit Tops Estimates, Revenues Miss; Lifts FY17 Earnings View",2017-08-01 07:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g8oADPnSmoc/pfizer-q2-profit-tops-estimates-revenues-miss-lifts-fy17-earnings-view-20170801-00511,"Pfizer Q2 Profit Tops Estimates, Revenues Miss; Lifts FY17 Earnings View"
PFE,PFE:US,BBG000BR2B91,Wall Street Aims For A Racing Start,2017-08-01 07:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZBE-O8EldVA/wall-street-aims-for-a-racing-start-20170801-00478,Wall Street Aims For A Racing Start
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. Reports 3% Rise In Q2 Earnings,2017-08-01 06:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8RZLOkX3Wps/pfizer-inc-reports-3%25-rise-in-q2-earnings-20170801-00352,Pfizer Inc. Reports 3% Rise In Q2 Earnings
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. Reports 3% Rise In Q2 Earnings,2017-08-01 06:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wgJDZDbY7c4/pfizer-inc-reports-3-rise-in-q2-earnings-20170801-00352,Pfizer Inc. Reports 3% Rise In Q2 Earnings
PFE,PFE:US,BBG000BR2B91,Why Pfizer Expects Lower Revenues for 2Q17,2017-07-31 22:06:05 +0000,http://finance.yahoo.com/r/b18f2297-f288-3a38-a3f7-4aa3219c37be/why-pfizer-expects-lower-revenues-for-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Analysts expect a 0.5% fall in Pfizer’s (PFE) 2Q17 revenues to $13.08 billion, following a decline in revenues from blockbuster drugs including Celebrex, Zyvox, and Lyrica."
PFE,PFE:US,BBG000BR2B91,Close Update: Dow Closes At Record High While Nasdaq and S&P Struggle Under Tech Losses,2017-07-31 21:14:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rhnXLFNUgoI/close-update-dow-closes-at-record-high-while-nasdaq-and-sp-struggle-under-tech-losses-cm824553,Stocks were mixed into Monday s open with the Dow closing at a record high on both a sustained rally in shares of Boeing BA and gains in the energy sector but the Nasdaq and S amp P 500 weighed down by losses in technology stocks Stocks were mixed into Monday s open with the Dow closing at
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. (PFE) Stock Isn’t the Sexiest, But it’s Worth Checking Out",2017-07-31 20:56:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/li-AiVxSQu4/pfizer-inc-pfe-stock-isnt-the-sexiest-but-its-worth-checking-out-cm824577,InvestorPlace Stock Market News Stock Advice amp Trading Tips Pfizer Inc NYSE PFE isn t the sexiest stock in the market but that doesn t mean investors shouldn t be interested PFE stock is up more than 2 in 2017 but down nearly 10 over the past year Now may be as good
PFE,PFE:US,BBG000BR2B91,Inside Pfizer’s 2Q17 Earnings: Analyst Estimates,2017-07-31 20:24:06 +0000,http://finance.yahoo.com/r/526b40a1-0e01-39a4-ae53-ca6fc9152986/inside-pfizers-2q17-earnings-analyst-estimates?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer (PFE) is set to release its 2Q17 earnings on August 1, 2017. Analysts estimate earnings per share of $0.66 on revenues of ~$13.1 billion for 2Q17."
PFE,PFE:US,BBG000BR2B91,"Pre-Market Earnings Report for August 1, 2017 :  PFE, SPG, PSX, CME, EMR, ECL, ETN, TRI, S, BP, APD, CMI",2017-07-31 20:13:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xc0cez_9qR0/pre-market-earnings-report-for-august-1-2017-pfe-spg-psx-cme-emr-ecl-etn-tri-s-bp-apd-cmi-cm824529,The following companies are expected to report earnings prior to market open on 08 01 2017 Visit our Earnings Calendar for a full list of expected earnings releases Pfizer Inc PFE is reporting for the quarter ending June 30 2017 The large
PFE,PFE:US,BBG000BR2B91,"Pfizer Investors Keep Eyes on Pipeline as Viagra, Lyrica Approach Patent Cliff",2017-07-31 20:03:00 +0000,http://finance.yahoo.com/r/f4e30adf-b930-3c81-8ec8-2fca78c35cdc/pfizer-investors-keep-eyes-on-pipeline-as-viagra-lyrica-approach-patent-cliff.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,A glimpse of what to expect during Tuesday's pre-market.
PFE,PFE:US,BBG000BR2B91,Pfizer Earnings: Drug Growth And Pipeline In Focus For Q2,2017-07-31 17:51:00 +0000,http://finance.yahoo.com/r/9f81c2d2-17b2-374c-b375-b669b395965c/pfizer-earnings-drug-growth-and-pipeline-in-focus-for-q2?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,Pharmaceutical company Pfizer reports second-quarter earnings on August 1. Here’s a look at what might be expected for its Q2 earnings.
PFE,PFE:US,BBG000BR2B91,What's in the Cards for Immune Design (IMDZ) in Q2 Earnings?,2017-07-31 16:58:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TO-o7JS-kis/whats-in-the-cards-for-immune-design-imdz-in-q2-earnings-cm824364,Immune Design Corp IMDZ is scheduled to report second quarter 2017 results on Aug 2 Last quarter Immune Design pulled off a positive earnings surprise of 19 35 TIn fact the company has posted a positive surprise in three of the four trailing quarters bringing the average surprise to 7
PFE,PFE:US,BBG000BR2B91,"Drug Stocks Q2 Earnings Releases on Aug 1: PFE, AERI & INCY",2017-07-31 16:58:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EpIjHOlJH7M/drug-stocks-q2-earnings-releases-on-aug-1-pfe-aeri-incy-cm824357,We have already crossed the halfway mark of the second quarter reporting cycle The earning season has shown broad based growth with record earnings this quarter As of Jul 28 2017 286 S amp P 500 members accounting for 68 8 of the index s total market capitalization reported
PFE,PFE:US,BBG000BR2B91,Allergan (AGN) to Report Q2 Earnings: What's in the Cards?,2017-07-31 16:56:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GRMxqv27mGg/allergan-agn-to-report-q2-earnings-whats-in-the-cards-cm824328,Allergan plc AGN will be reporting second quarter 2017 earnings on Aug 3 before the market opens Last quarter the company delivered a positive earnings surprise of 0 90 Allergan s share price is up 20 5 this year so far outperforming the 0 4 increase witnessed by the
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. (PFE) Stock Isn’t the Sexiest, But it’s Worth Checking Out",2017-07-31 16:20:38 +0000,https://finance.yahoo.com/news/pfizer-inc-pfe-stock-isn-162038282.html?.tsrc=rss,"Pfizer Inc. (NYSE:PFE) isn’t the sexiest stock in the market, but that doesn’t mean investors shouldn’t be interested.  PFE stock is up more than 2% in 2017, but down nearly 10% over the past year.  Pfizer is probably best known for Viagra, but it’s got other brands, too, such as Eliquis, Lipitor and Celebrex, among others."
PFE,PFE:US,BBG000BR2B91,"Apple, Pfizer and Yum Brands are part of Zacks Earnings Preview",2017-07-31 16:01:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fLpEfXGRZlE/apple-pfizer-and-yum-brands-are-part-of-zacks-earnings-preview-cm824234,For Immediate Release Chicago IL July 31 2017 Zacks com releases the list of companies likely to issue earnings surprises This week s list includes Apple NASDAQ AAPL Free Report Pfizer NYSE PFE Free Report and Yum Brands NYSE YUM Free Report To see
PFE,PFE:US,BBG000BR2B91,"Ex-Dividend Reminder: Dominion Energy Midstream Partners LP, CMS Energy Corp and Pfizer",2017-07-31 15:57:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VOSLa--QWm0/ex-dividend-reminder-dominion-energy-midstream-partners-lp-cms-energy-corp-and-pfizer-cm824209,Looking at the universe of stocks we cover at Dividend Channel on 8 2 17 Dominion Energy Midstream Partners LP Symbol DM CMS Energy Corp Symbol CMS and Pfizer Inc Symbol PFE will all trade ex dividend for their respective upcoming dividends Dominion Energy Midstream Partners LP
PFE,PFE:US,BBG000BR2B91,Can Cardinal Health (CAH) Pull a Surprise in Q4 Earnings?,2017-07-31 15:00:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xnYUDNqTScs/can-cardinal-health-cah-pull-a-surprise-in-q4-earnings-cm824098,Dublin OH based Cardinal Health CAH a global player in the healthcare services and products space is set to report fourth quarter fiscal 2017 results on Aug 2 before the bell The company reported adjusted earnings of 1 53 per share in the last reported quarter which beat the
PFE,PFE:US,BBG000BR2B91,Earnings Preview: Pharma Giant Pfizer Reports Q2 Results Tomorrow Morning,2017-07-31 14:46:01 +0000,https://finance.yahoo.com/news/earnings-preview-pharma-giant-pfizer-144601036.html?.tsrc=rss,"Pharmaceutical company Pfizer Inc. (NYSE: PFE ) reports second-quarter earnings on Tuesday, August 1 at 10:00AM ET. For most major pharma companies, analysts and investors appear to be generally focused ..."
PFE,PFE:US,BBG000BR2B91,"Drug Stocks Q2 Earnings Releases on Aug 1: PFE, AERI & INCY",2017-07-31 14:30:02 +0000,https://finance.yahoo.com/news/drug-stocks-q2-earnings-releases-143002654.html?.tsrc=rss,The Medical sector has carried on the momentum of its first quarter performance so far this earnings season but lagged the overall market.
PFE,PFE:US,BBG000BR2B91,"Apple, Pfizer and Yum Brands are part of Zacks Earnings Preview",2017-07-31 14:11:02 +0000,https://finance.yahoo.com/news/apple-pfizer-yum-brands-part-141102308.html?.tsrc=rss,"Apple, Pfizer and Yum Brands are part of Zacks Earnings Preview"
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Q2 Earnings Results from Merck, Lilly, Bristol-Myers & More",2017-07-31 13:58:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6oRUXJ7Xm1g/pharma-stock-roundup-q2-earnings-results-from-merck-lilly-bristol-myers-more-cm824039,Last week several pharma majors reported second quarter results Meanwhile important study data was released by Merck MRK and AstraZeneca AZN Recap of the Week s Most Important Stories A Look at Q2 Earnings Results Big pharma companies like Merck Lilly LLY Glaxo
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Q2 Earnings Results from Merck, Lilly, Bristol-Myers & More",2017-07-31 12:06:12 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-q2-earnings-120612184.html?.tsrc=rss,Companies like AstraZeneca (AZN) and Lilly saw their shares fall after the release of second quarter results.
PFE,PFE:US,BBG000BR2B91,ICU Medical Recalls One Lot Of 0.9% Sodium Chloride Injection,2017-07-31 06:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sNAg2XNNwhs/icu-medical-recalls-one-lot-of-09%25-sodium-chloride-injection-20170731-00295,ICU Medical Recalls One Lot Of 0.9% Sodium Chloride Injection
PFE,PFE:US,BBG000BR2B91,ICU Medical Recalls One Lot Of 0.9% Sodium Chloride Injection,2017-07-31 06:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6wMYTiPxrI8/icu-medical-recalls-one-lot-of-09-sodium-chloride-injection-20170731-00295,ICU Medical Recalls One Lot Of 0.9% Sodium Chloride Injection
PFE,PFE:US,BBG000BR2B91,Biotech Stocks Facing FDA Decision In August,2017-07-31 01:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T6SiGP_nfTo/biotech-stocks-facing-fda-decision-in-august-20170731-00044,Biotech Stocks Facing FDA Decision In August
PFE,PFE:US,BBG000BR2B91,"Apple, Tesla and More Companies Reporting This Week",2017-07-30 14:25:46 +0000,https://finance.yahoo.com/news/apple-tesla-more-companies-reporting-142546738.html?.tsrc=rss,"24/7 Wall St. has put together a quick preview Apple, Pfizer, Tesla and some of the other top companies reporting their latest quarterly results in the coming week."
PFE,PFE:US,BBG000BR2B91,Earnings Preview: What To Expect From Pfizer On Tuesday,2017-07-30 13:05:00 +0000,http://finance.yahoo.com/r/637c22fb-d424-3aea-b854-3af893871899/earnings-preview-what-to-expect-from-pfizer-on-tuesday-2?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Pfizer is expected to report $0.65/share on $13.02 billion in revenue. Meanwhile, the so-called Whisper number is $0.67."
PFE,PFE:US,BBG000BR2B91,3 Things You Can Expect With Pfizer's Q2 Results,2017-07-30 12:54:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zqz_q6_sru0/3-things-you-can-expect-with-pfizers-q2-results-cm823881,There was good news and bad news for Pfizer NYSE PFE the last time it reported quarterly results In May the big drugmaker announced earnings for the first quarter that beat analysts estimates but revenue that fell from the prior year period Pfizer provides its update
PFE,PFE:US,BBG000BR2B91,3 Things You Can Expect With Pfizer&apos;s Q2 Results,2017-07-30 11:43:00 +0000,http://finance.yahoo.com/r/1de00f18-75de-366a-952b-5a22f93dde1f/3-things-you-can-expect-with-pfizers-q2-results.aspx?yptr=yahoo&.tsrc=rss,Here&apos;s what to look for when Pfizer announces its Q2 results on Aug. 1.
PFE,PFE:US,BBG000BR2B91,Company Spotlight: Spark Therapeutics,2017-07-29 23:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vVOhVTN9JY8/company-spotlight-spark-therapeutics-20170729-00008,Company Spotlight: Spark Therapeutics
PFE,PFE:US,BBG000BR2B91,What's Next for AstraZeneca and Its Dividend?,2017-07-29 15:57:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JMuXBPs8nwU/whats-next-for-astrazeneca-and-its-dividend-cm823811,Just over three summers ago AstraZeneca plc NYSE AZN CEO Pascal Soriot convinced shareholders to reject a generous buyout offer from Pfizer with promises that drugs in its pipeline would deliver even greater returns While the company has had some success since then
PFE,PFE:US,BBG000BR2B91,Q2 Earnings Season Past the Halfway Mark,2017-07-28 23:56:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xcVs24epmNY/q2-earnings-season-past-the-halfway-mark-cm823728,The Q2 earnings season which has crossed the half way mark already reconfirms the positive earnings picture that emerged as a result of the preceding reporting cycle The key positive aspects of this earnings season that we have been pointing out all long include broad based growth
PFE,PFE:US,BBG000BR2B91,"Upcoming Earnings Reports to Watch: AAPL, PFE, TWX, KHC",2017-07-28 21:58:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iPpVKt1zfm8/upcoming-earnings-reports-to-watch-aapl-pfe-twx-khc-cm823661,Over the past week several of the Wall Street s most talked about companies have posted their Q2 reports but earnings season is far from over Indeed investors still have the latest reports from several tech giants and major market movers to look forward to which means it s more important
PFE,PFE:US,BBG000BR2B91,"Upcoming Earnings Reports to Watch: AAPL, PFE, TWX, KHC",2017-07-28 20:12:08 +0000,https://finance.yahoo.com/news/upcoming-earnings-reports-watch-aapl-201208121.html?.tsrc=rss,"We are looking ahead to next week to target the most important upcoming reports. Check out the latest on Apple (AAPL), Pfizer (PFE), Time Warner (TWX), and Kraft Heinz (KHC) ahead of their earnings report dates."
PFE,PFE:US,BBG000BR2B91,"Earnings Watch: Apple, Tesla, Pfizer, Activision-Blizzard On Tap For Next Week",2017-07-28 19:45:39 +0000,https://finance.yahoo.com/news/earnings-watch-apple-tesla-pfizer-194539860.html?.tsrc=rss,"UBS keyed into expectations for some of next week’s highest profile earnings reports, providing updated insights for their high-conviction trading ideas. Among the names were Apple Inc. (NASDAQ: AAPL ), ..."
PFE,PFE:US,BBG000BR2B91,"Merck (MRK) Beats on Q2 Earnings and Sales, Keeps 2017 View",2017-07-28 14:54:02 +0000,https://finance.yahoo.com/news/merck-mrk-beats-q2-earnings-145402296.html?.tsrc=rss,"Merck & Co., Inc. (MRK) beat estimates for both earnings and sales in Q2 mainly backed by strong sales of PD-1 inhibitor, Keytruda."
PFE,PFE:US,BBG000BR2B91,3 Value Stocks Senior Citizens Should Consider Buying Today,2017-07-28 14:50:00 +0000,http://finance.yahoo.com/r/8a6bfa6c-4226-35b4-88b7-42faa8b27e86/3-value-stocks-senior-citizens-should-consider-buy.aspx?yptr=yahoo&.tsrc=rss,These brand-name companies offer income and value potential that can&apos;t be ignored.
PFE,PFE:US,BBG000BR2B91,AbbVie Inc (ABBV) Q2 Beat Fueled by Best World’s Best-Selling Drug,2017-07-28 13:48:32 +0000,https://finance.yahoo.com/news/abbvie-inc-abbv-q2-beat-134832500.html?.tsrc=rss,"InvestorPlace - Stock Market News, Stock Advice &#38; Trading Tips"
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 07/28/2017: JNJ, PFE, ABT, MRK, AMGN, ABBV, NUVA",2017-07-28 13:17:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GjB8ZqNE7tg/health-care-sector-update-for-07282017-jnj-pfe-abt-mrk-amgn-abbv-nuva-cm823056,Top Health Care Stocks Top Health Care Stocks JNJ 0 1 JNJ 0 1 PFE 0 3 PFE 0 3 ABT 0 6 ABT 0 6 MRK 3 5 MRK 3 5 AMGN 2 1 AMGN 2 1 Health care shares were mixed in pre market trade Friday Health care shares were mixed in pre market trade Friday In sector news Merck
PFE,PFE:US,BBG000BR2B91,Pfizer on the Street: Inside the Analysts’ Recommendations,2017-07-28 13:06:15 +0000,http://finance.yahoo.com/r/f61ecc0e-052d-339a-8f0b-78e5710d90bf/pfizer-on-the-street-inside-the-analysts-recommendations?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"No analyst has recommended any form of ""sell"" for Pfizer stock."
PFE,PFE:US,BBG000BR2B91,Why Pfizer Inc. (PFE) Might Surprise This Earnings Season,2017-07-28 12:35:12 +0000,https://finance.yahoo.com/news/why-pfizer-inc-pfe-might-123512538.html?.tsrc=rss,Pfizer Inc. (PFE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.
PFE,PFE:US,BBG000BR2B91,Behind Pfizer’s Legacy Established Products Performance in 2017,2017-07-28 11:36:15 +0000,http://finance.yahoo.com/r/8f4df108-63c6-34db-9da9-201002dfbf6d/behind-pfizers-legacy-established-products-performance-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Pfizer’s (PFE) Lipitor reported revenues of ~$1.8 billion, which represented a ~5% YoY (year-over-year) fall."
PFE,PFE:US,BBG000BR2B91,[$$] United Therapeutics in Settlement Talks With Justice Department,2017-07-28 06:04:12 +0000,http://finance.yahoo.com/r/9e1d0324-d7e9-3499-bedc-9599778ce182/united-therapeutics-in-settlement-talks-with-justice-department-1501162542?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,United Therapeutics has set aside $210 million for a possible settlement of a U.S. Justice Department investigation of whether the company’s contributions to patient-assistance charity groups violate federal ...
PFE,PFE:US,BBG000BR2B91,Mighty AstraZeneca Takes a Lickin' on Failed Mystic Trial,2017-07-28 02:58:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o5IpSFfXNhQ/mighty-astrazeneca-takes-a-lickin-on-failed-mystic-trial-cm822958,When AstraZeneca NYSE AZN spurned overtures from Pfizer NYSE PFE to combine in one of the biggest merger deals of all time it told investors not to worry It had plenty of irons in the fire that could fuel significant increases in sales profit and share price
PFE,PFE:US,BBG000BR2B91,Mighty AstraZeneca Takes a Lickin&apos; on Failed Mystic Trial,2017-07-28 01:15:00 +0000,http://finance.yahoo.com/r/7b69796e-fa11-3a00-a7a9-a1e3c1fa3984/mighty-astrazeneca-takes-a-lickin-on-failed-mystic.aspx?yptr=yahoo&.tsrc=rss,AstraZeneca&apos;s attempts to challenge competitors for dominance in treating non-small lung cancer were dashed today when data from a key trial came up short.
PFE,PFE:US,BBG000BR2B91,"Gilead Sciences, Inc. (GILD) Stock Has Tremendous Potential Even Post-Rally",2017-07-27 19:00:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/azk3h1DpzOY/gilead-sciences-inc-gild-stock-has-tremendous-potential-even-post-rally-cm822813,InvestorPlace Stock Market News Stock Advice amp Trading Tips For the past few months Gilead Sciences Inc NASDAQ GILD could not fulfill the technical upside promise It threatened several times to stop its slide but failed But then on June 16 it finally set a low that
PFE,PFE:US,BBG000BR2B91,[$$] United Therapeutics in Settlement Talks With Justice Department,2017-07-27 17:59:11 +0000,http://finance.yahoo.com/r/9e1d0324-d7e9-3499-bedc-9599778ce182/united-therapeutics-in-settlement-talks-with-justice-department-1501162542?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,United Therapeutics has set aside $210 million for a possible settlement of a U.S. Justice Department investigation of whether the company’s contributions to patient-assistance charity groups violate federal ...
PFE,PFE:US,BBG000BR2B91,"Bristol-Myers (BMY) Beats on Q2 Earnings, Tweaks 2017 View",2017-07-27 17:03:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eax5alrMsx0/bristol-myers-bmy-beats-on-q2-earnings-tweaks-2017-view-cm822587,Bristol Myers Squibb Company s BMY second quarter 2017 earnings of 74 cents per share beat the Zacks Consensus Estimate of 73 cents and increased 7 from the year ago period Bristol Myers Squibb Company Price Consensus and EPS Surprise Bristol Myers
PFE,PFE:US,BBG000BR2B91,[$$] AstraZeneca: transcendental agitation,2017-07-27 16:24:47 +0000,"http://finance.yahoo.com/r/fe409344-18fe-3c87-9c88-6c8e10eb0c91/2b7a6e30-72dd-11e7-aca6-c6bd07df1a3c,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss",Philosopher Blaise Pascal never faced proof he was wrong to believe in God. AstraZeneca's Pascal Soriot has discovered his faith in the Mystic cancer drug trial really was misplaced. A failure of a key ...
PFE,PFE:US,BBG000BR2B91,"Gilead Sciences, Inc. (GILD) Stock Has Tremendous Potential Even Post-Rally",2017-07-27 14:07:29 +0000,https://finance.yahoo.com/news/gilead-sciences-inc-gild-stock-140729807.html?.tsrc=rss,"For the past few months, Gilead Sciences, Inc. (NASDAQ:GILD) could not fulfill the technical upside promise.  Last night, GILD report earnings and the stock is spiking toward $76.  Click to Enlarge Coming into the earnings, sentiment had also shifted in favor of better days to come from GILD stock, and I am one who likes to trade with the market sentiment."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 07/27/2017: JNJ, PFE, ABT, MRK, AMGN, BMY, EW, VAR",2017-07-27 13:37:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/q2eeKD4kEYA/health-care-sector-update-for-07272017-jnj-pfe-abt-mrk-amgn-bmy-ew-var-cm822335,Top Health Care Stocks Top Health Care Stocks JNJ 0 6 JNJ 0 6 PFE flatPFE flat ABT 0 2 ABT 0 2 MRK 4 MRK 4 AMGN 2 8 AMGN 2 8 Health care shares were mixed in pre market trade Thursday Health care shares were mixed in pre market trade Thursday In sector news Bristol
PFE,PFE:US,BBG000BR2B91,Alexion Spikes on Q2 Earnings Blowout Providing Positive Signs for Rest of Sector -Biotech Movers,2017-07-27 13:29:00 +0000,http://finance.yahoo.com/r/1f09459a-64f6-36b6-8189-0192129fdf2b/biotech-movers-alexion-spikes-on-38-rise-in-second-quarter-earnings.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Alexion Pharmaceuticals, United Therapeutics and Gilead Sciences were among the biotech stock movers in premarket trading on July 27."
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. breached its 50 day moving average in a Bearish Manner : PFE-US : July 27, 2017",2017-07-27 13:16:03 +0000,http://finance.yahoo.com/r/c7d76ff0-93fe-3795-946f-9bd697b96ffc/pfizer-inc-breached-its-50-day-moving-average-in-a-bearish-manner-pfe-us-july-27-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Pfizer Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
PFE,PFE:US,BBG000BR2B91,What Led the Rise in GE’s Healthcare Revenue in 2Q17?,2017-07-27 13:09:03 +0000,http://finance.yahoo.com/r/8c7a8cf1-9d9a-333b-bf16-9c5303d62648/what-led-the-rise-in-ges-healthcare-revenue-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"GE's Healthcare segment remained a top performer in 2Q17. Revenue-wise, this segment remained the third-largest contributor to GE’s total operating revenue of $28.0 billion."
PFE,PFE:US,BBG000BR2B91,What to Expect from Pfizer’s Rare Disease Franchise in 2017,2017-07-27 13:06:45 +0000,http://finance.yahoo.com/r/d1401604-d903-33d9-a309-ced7d6b9afc7/what-to-expect-from-pfizers-rare-disease-franchise-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Pfizer’s (PFE) BeneFix reported revenues of ~$712 million, which reflected a ~5% YoY (year-over-year) fall."
PFE,PFE:US,BBG000BR2B91,Shares in AstraZeneca dive as key cancer drug trial fails,2017-07-27 12:57:49 +0000,http://finance.yahoo.com/r/94c500ca-96d0-3e08-b216-ffd339cc989a/astrazeneca-revenue-down-key-drugs-073339184.html?.tsrc=rss,LONDON (AP) — Shares in Anglo-Swedish drugmaker AstraZeneca plunged as much as 17 percent Thursday after a new lung cancer treatment proved less successful than the company had hoped.
PFE,PFE:US,BBG000BR2B91,"Argyle Capital Management Inc. Buys DXC Technology Co, CVS Health Corp, C.R. ...",2017-07-27 11:56:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2s3gUfBC6B8/argyle-capital-management-inc-buys-dxc-technology-co-cvs-health-corp-cr-cm822194,Argyle Capital Management Inc New Purchases BCR Added Positions DXC CVS TEVA MCK GE IBM SLB HAL Reduced Positions MMM MSFT DE RTN JPM PPL DD CSCO CAT BAX Sold Out TGNA CARS New Purchases BCR New Purchases BCR
PFE,PFE:US,BBG000BR2B91,Pfizer Sees a Significant Opportunity in This for Revenue Growth,2017-07-27 11:36:11 +0000,http://finance.yahoo.com/r/37e627f9-fd45-302f-ba11-7e541f71b7b5/pfizer-sees-a-significant-opportunity-in-this-for-revenue-growth?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Pfizer’s (PFE) biosimilar business reported revenues of ~$319 million, compared with $63 million in 2015."
PFE,PFE:US,BBG000BR2B91,AstraZeneca's Missing Takeover Defense,2017-07-27 11:10:34 +0000,http://finance.yahoo.com/r/0bb3e5cb-bc6b-374e-8ca6-7559e457fd23/astrazeneca-s-missing-takeover-defense?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Drug trial miss has undermined the CEO's growth vision.
PFE,PFE:US,BBG000BR2B91,AstraZeneca Plunges After Setback in Crucial Lung-Cancer Drug Trial,2017-07-27 06:22:08 +0000,http://finance.yahoo.com/r/bf8c30fc-efa8-3e3e-9207-254a14ba2ba8/astra-s-imfinzi-combination-fails-to-check-lung-tumor-growth?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"AstraZeneca Plc plunged by a record after suffering a setback to its next-generation cancer medicine, hurting Chief Executive Officer Pascal Soriot’s ambition to join the league of the world’s five largest ..."
PFE,PFE:US,BBG000BR2B91,Corning Exceeds Expectations on Optical and Gorilla Glass Strength,2017-07-27 02:57:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UjZa-z821so/corning-exceeds-expectations-on-optical-and-gorilla-glass-strength-cm822146,Corning Incorporated NYSE GLW announced second quarter 2017 results on Wednesday morning easily beating expectations on both the top and bottom lines thanks to strong showings from both its optical communications and specialty materials segments But with shares down more than
PFE,PFE:US,BBG000BR2B91,"Gilead Sciences Has 3 Available Options, but Only 1 Makes Sense",2017-07-27 00:57:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KJ49w7fZD-M/gilead-sciences-has-3-available-options-but-only-1-makes-sense-cm822126,Gilead Sciences NASDAQ GILD is nearing a crossroads of sorts In short AbbVie s NYSE ABBV eight week pan genotypic hepatitis C combo of 160 glecaprevir and pibrentasvir could emerge as a significant competitive threat to the biotech s struggling hep C
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Jul 26, 2017 :  FB, BTI, BAC, T, CSCO, F, AUY, AAPL, MU, PFE, JBLU, WFM",2017-07-26 20:57:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ue6uQ5m6oQg/after-hours-most-active-for-jul-26-2017-fb-bti-bac-t-csco-f-auy-aapl-mu-pfe-jblu-wfm-cm822040,The NASDAQ 100 After Hours Indicator is up 12 11 to 5 962 84 The total After hours volume is currently 48 399 014 shares traded The following are the most active stocks for the after hours session Facebook Inc FB is 3 31 at 168 92 with 5 736 939 shares
PFE,PFE:US,BBG000BR2B91,Corning (GLW) Beats Q2 Earnings Estimates on Strong Revenues,2017-07-26 17:01:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l0nhVcGn0PM/corning-glw-beats-q2-earnings-estimates-on-strong-revenues-cm821838,Corning Inc GLW reported second quarter 2017 adjusted earnings of 42 cents per share beating the Zacks Consensus Estimate by couple of cents Earnings surged 13 5 on a year over year basis and 7 7 sequentially in the reported quarter The year over year growth was driven by improvement
PFE,PFE:US,BBG000BR2B91,PFE Crosses Below Key Moving Average Level,2017-07-26 17:00:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gStcgpYLi_o/pfe-crosses-below-key-moving-average-level-cm821828,In trading on Wednesday shares of Pfizer Inc Symbol PFE crossed below their 200 day moving average of 32 91 changing hands as low as 32 83 per share Pfizer Inc shares are currently trading down about 0 6 on the day The chart below shows the one year performance of PFE shares versus
PFE,PFE:US,BBG000BR2B91,S&P 500 stocks to find value,2017-07-26 16:43:00 +0000,https://finance.yahoo.com/video/p-500-stocks-value-164300855.html?.tsrc=rss,CNBC's Dominic Chu reports on where to find value as the markets reach record highs.
PFE,PFE:US,BBG000BR2B91,Is a Beat in the Cards for Pfizer (PFE) in Q2 Earnings?,2017-07-26 16:04:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eUPDY9U0AQs/is-a-beat-in-the-cards-for-pfizer-pfe-in-q2-earnings-cm821692,We expect Pfizer Inc PFE to beat expectations when it reports second quarter 2017 results on Aug 1 before the market opens Last quarter the company delivered a positive earnings surprise of 2 99 The pharma giant has a mixed record of earnings surprises The company s earnings
PFE,PFE:US,BBG000BR2B91,"Key Takeaways from Lilly's (LLY) Q2 Call: Baricitinib, Cancer Pipeline",2017-07-26 15:04:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sgm9HM4zjag/key-takeaways-from-lillys-lly-q2-call-baricitinib-cancer-pipeline-cm821750,Yesterday big pharma player Eli Lilly and Company LLY reported better than expected second quarter results and raised its outlook for the year However shares were down 3 with investors focusing on the company s update regarding its investigational rheumatoid arthritis RA
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Oracle, Pfizer, Abbott, Alphabet and Schlumberger",2017-07-26 15:03:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nSgNmH4NcV8/the-zacks-analyst-blog-highlights-oracle-pfizer-abbott-alphabet-and-schlumberger-cm821746,For Immediate Release Chicago IL July 26 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
PFE,PFE:US,BBG000BR2B91,Understanding Pfizer’s Sterile Injection Pharmaceuticals Position in 2017,2017-07-26 14:37:03 +0000,http://finance.yahoo.com/r/d7edb172-62ad-3e83-b604-d6093b09ee68/understanding-pfizers-sterile-injection-pharmaceuticals-position-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Pfizer’s (PFE) Medrol reported revenues of ~$450 million, which represented a ~12% rise on a YoY (year-over-year) basis."
PFE,PFE:US,BBG000BR2B91,Is a Beat in the Cards for Pfizer (PFE) in Q2 Earnings?,2017-07-26 14:11:02 +0000,https://finance.yahoo.com/news/beat-cards-pfizer-pfe-q2-141102002.html?.tsrc=rss,"While Pfizer, Inc.&apos;s (PFE) new drugs like Ibrance and acquisitions like Hospira are likely to drive sales in Q2, genericization of key drugs, pricing pressure and rising competition will hurt sales."
PFE,PFE:US,BBG000BR2B91,"Amgen, Inc. (AMGN) Stock Is a Trade for Ailing Portfolios",2017-07-26 14:09:12 +0000,https://finance.yahoo.com/news/amgen-inc-amgn-stock-trade-140912222.html?.tsrc=rss,"InvestorPlace - Stock Market News, Stock Advice &#38; Trading Tips"
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 07/26/2017: JNJ, PFE, ABT, MRK, AMGN, TTPH, BMY, RETA",2017-07-26 13:37:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hOW9nkHEwSU/health-care-sector-update-for-07262017-jnj-pfe-abt-mrk-amgn-ttph-bmy-reta-cm821527,Top Health Care stocks Top Health Care stocks JNJ 0 8 JNJ 0 8 PFE 0 03 PFE 0 03 ABT flatABT flat MRK flatMRK flat AMGN 2 9 AMGN 2 9 Health care shares were mixed in pre market trade Wednesday Health care shares were mixed in pre market trade Wednesday In sector news
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Oracle, Pfizer, Abbott, Alphabet and Schlumberger",2017-07-26 13:30:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-oracle-133001175.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Oracle, Pfizer, Abbott, Alphabet and Schlumberger"
PFE,PFE:US,BBG000BR2B91,"Key Takeaways from Lilly&apos;s (LLY) Q2 Call: Baricitinib, Cancer Pipeline",2017-07-26 13:29:01 +0000,https://finance.yahoo.com/news/key-takeaways-lilly-apos-lly-132901643.html?.tsrc=rss,"Why were Lilly&apos;s (LLY) shares down despite the company delivering a ""beat and raise"" quarter?"
PFE,PFE:US,BBG000BR2B91,How Is Pfizer’s Lyrica Expected to Perform in 2017?,2017-07-26 13:06:55 +0000,http://finance.yahoo.com/r/b862e5af-08bd-3166-b4a9-e486ea0bb8be/how-is-pfizers-lyrica-expected-to-perform-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Pfizer’s (PFE) Lyrica generated revenues of ~$4.96 billion, which reflected a ~3% rise on a YoY (year-over-year) basis."
PFE,PFE:US,BBG000BR2B91,These 2 Pharma Giants May Be on Pfizer's M&A Radar Right Now,2017-07-26 13:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X04rQfJPW80/these-2-pharma-giants-may-be-on-pfizers-ma-radar-right-now-cm821381,Despite overcoming a whopping 23 billion in branded patent expirations over the course of 2011 to 2016 and returning to growth on an operational basis Wall Street thinks Pfizer NYSE PFE still has a lot more to work to do The basic issue is that Pfizer is barreling toward
PFE,PFE:US,BBG000BR2B91,3 Charts Suggesting Traders Are Bullish on Healthcare,2017-07-26 12:11:00 +0000,http://finance.yahoo.com/r/17893afd-3580-3e7a-8b9c-7bd03c9f7eae/3-charts-suggesting-traders-are-bullish-healthcare?partner=YahooSA&yptr=yahoo&.tsrc=rss,Bullish patterns on the charts of key healthcare-related assets suggest that now could be the time to buy.
PFE,PFE:US,BBG000BR2B91,These 2 Pharma Giants May Be on Pfizer&apos;s M&A Radar Right Now,2017-07-26 11:15:00 +0000,http://finance.yahoo.com/r/f909ce03-1adb-30e0-a606-32dab7a5caae/these-2-pharma-giants-may-be-on-pfizers-ma-radar-r.aspx?yptr=yahoo&.tsrc=rss,Pfizer seems to be edging closer to a megadeal.
PFE,PFE:US,BBG000BR2B91,"Top Analyst Reports for Oracle, Pfizer & Abbott",2017-07-26 05:57:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A8UP2_vviwk/top-analyst-reports-for-oracle-pfizer-abbott-cm821327,Tuesday July 25 2017 The Zacks Research Daily presents the best research output of our analyst team Today s Research Daily features new research reports on 16 major stocks including Oracle ORCL Pfizer PFE and Abbott ABT These research reports have been hand picked from the roughly
PFE,PFE:US,BBG000BR2B91,"Top Analyst Reports for Oracle, Pfizer & Abbott",2017-07-25 21:53:09 +0000,https://finance.yahoo.com/news/top-analyst-reports-oracle-pfizer-215309851.html?.tsrc=rss,"Top Analyst Reports for Oracle, Pfizer & Abbott"
PFE,PFE:US,BBG000BR2B91,Adviser charged with insider trading on Pfizer-King deal pleads guilty,2017-07-25 21:36:13 +0000,https://finance.yahoo.com/news/adviser-charged-insider-trading-pfizer-213613905.html?.tsrc=rss,"A Long Island, New York,  investment adviser accused of engaging in insider trading after  being tipped off about Pfizer Inc's $3.6 billion  acquisition of King Pharmaceuticals Inc pleaded guilty on  Tuesday, federal prosecutors said.  Tibor Klein, 43, pleaded guilty to one count of conspiracy  to commit securities fraud before U.S. District Judge Joan  Azrack in federal court in Brooklyn, New York."
PFE,PFE:US,BBG000BR2B91,Why Pfizer’s Sutent Could Witness a Modest Decline in 2017,2017-07-25 14:40:30 +0000,http://finance.yahoo.com/r/d0d25d9f-fb75-3455-b514-7ae5b8cd9ceb/why-pfizers-sutent-could-witness-a-modest-decline-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Pfizer’s (PFE) Sutent reported revenues of ~$1.1 billion, which represented a ~2% decline on a YoY (year-over-year) basis."
PFE,PFE:US,BBG000BR2B91,ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings,2017-07-25 13:56:00 +0000,https://finance.yahoo.com/news/viiv-healthcare-announces-superior-efficacy-135600322.html?.tsrc=rss,ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 07/25/2017: JNJ, PFE, ABT, MRK, AMGN, NVAX, BIIB, LLY",2017-07-25 13:17:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tNM-mFaydcg/health-care-sector-update-for-07252017-jnj-pfe-abt-mrk-amgn-nvax-biib-lly-cm820676,Top Health Care stocks Top Health Care stocks JNJ 0 1 JNJ 0 1 PFE 0 2 PFE 0 2 ABT flatABT flat MRK 0 2 MRK 0 2 AMGN 0 5 AMGN 0 5 Health care shares were mostly higher in pre market trade Tuesday Health care shares were mostly higher in pre market trade Tuesday In
PFE,PFE:US,BBG000BR2B91,How Pfizer’s Vaccine Franchise Is Positioned in 2017,2017-07-25 13:11:41 +0000,http://finance.yahoo.com/r/d1eae663-9001-394e-989e-5b49da53c602/how-pfizers-vaccine-franchise-is-positioned-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Pfizer’s (PFE) Prevnar 13 reported revenues of ~$5.7 billion, which reflected a ~8% decline on a YoY (year-over-year) basis."
PFE,PFE:US,BBG000BR2B91,Why Xeljanz Could Boost Pfizer’s Revenue Growth,2017-07-25 11:40:13 +0000,http://finance.yahoo.com/r/d3c98c01-5f49-3762-a86e-8b47037b0777/why-xeljanz-could-boost-pfizers-revenue-growth?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Pfizer’s (PFE) Xeljanz reported revenues of ~$927 million, which reflected a ~77% growth YoY (year-over-year)."
PFE,PFE:US,BBG000BR2B91,Analysts’ Recommendations for Merck in July 2017,2017-07-25 11:35:43 +0000,http://finance.yahoo.com/r/ec1db567-6e18-392a-8c2e-5dbfe58cf724/analysts-recommendations-merck-july-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Twenty-two analysts covered Merck in July 2017. Four analysts recommended a “strong buy” while ten analysts recommended a “buy.”
PFE,PFE:US,BBG000BR2B91,ViiV Healthcare Reports Positive Interim Results From DAWNING - Quick Facts,2017-07-25 08:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CE4xw8RLK14/viiv-healthcare-reports-positive-interim-results-from-dawning--quick-facts-20170725-00794,ViiV Healthcare Reports Positive Interim Results From DAWNING - Quick Facts
PFE,PFE:US,BBG000BR2B91,GSK : ViiV Healthcare Announces Results From NEAT 022 Study,2017-07-25 08:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6YcQLamzMIU/gsk--viiv-healthcare-announces-results-from-neat-022-study-20170725-00791,GSK : ViiV Healthcare Announces Results From NEAT 022 Study
PFE,PFE:US,BBG000BR2B91,Corning Looks to Sustain Its Momentum,2017-07-25 02:57:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zeNv1GZQk7s/corning-looks-to-sustain-its-momentum-cm820598,Corning Incorporated NYSE GLW is set to announce second quarter 2017 results this Wednesday July 26 2017 With shares trading at a 10 year high after climbing more than 30 year to date as of this writing helped by Corning s strong first quarter report three months ago you
PFE,PFE:US,BBG000BR2B91,Why Ibrance Could Be Pfizer’s Long-Term Growth Driver,2017-07-24 21:35:58 +0000,http://finance.yahoo.com/r/88ef8c7c-2063-3560-8c27-7e7d75e8dc5a/why-ibrance-could-be-pfizers-long-term-growth-driver?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Pfizer (PFE) is extensively conducting clinical trials for the label expansion of Ibrance.
PFE,PFE:US,BBG000BR2B91,Why Ibrance Could Drive Pfizer’s Revenue Growth,2017-07-24 20:06:09 +0000,http://finance.yahoo.com/r/e393f7fe-be3b-3c50-927f-1c6b1b8956b4/why-ibrance-could-drive-pfizers-revenue-growth?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Pfizer’s (PFE) Ibrance reported revenues of ~$2.1 billion, compared with $723 million in 2015."
PFE,PFE:US,BBG000BR2B91,"Merck, Samsung Accelerate a Biosimilar Price War",2017-07-24 18:37:41 +0000,http://finance.yahoo.com/r/21b0ce49-028f-3790-bd15-ca20f74e802b/merck-samsung-remicade-biosimilar-accelerates-price-war?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,The days of high-priced knockoffs of biologic drugs are ending quickly.
PFE,PFE:US,BBG000BR2B91,How Pfizer Is Expected to Perform in 2017,2017-07-24 18:26:49 +0000,http://finance.yahoo.com/r/8f715769-7846-349b-bb68-3ebf80e4aec9/how-pfizer-is-expected-to-perform-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Pfizer (PFE) reported revenues of ~$52.8 billion, which reflected a ~8% growth YoY (year-over-year)."
PFE,PFE:US,BBG000BR2B91,What's in the Cards for Merck KGaA (MKGAF) in Q2 Earnings?,2017-07-24 17:09:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1hsDxTLVVvI/whats-in-the-cards-for-merck-kgaa-mkgaf-in-q2-earnings-cm820316,Merck KGaA MKGAF is scheduled to report second quarter 2017 earnings results on Aug 3 Merck KGaA s share price has increased 10 year to date while the industry gained 6 3 The company reports results under three business sectors Healthcare Life Science and Performance
PFE,PFE:US,BBG000BR2B91,Interesting January 2019 Stock Options for PFE,2017-07-24 17:06:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-8eAsL98e98/interesting-january-2019-stock-options-for-pfe-cm820364,Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the January 2019 expiration for PFE The put
PFE,PFE:US,BBG000BR2B91,Surprise in Store for Healthcare in Q2: Buy Top-Ranked ETFs,2017-07-24 16:10:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZANGpJtUFzw/surprise-in-store-for-healthcare-in-q2-buy-top-ranked-etfs-cm820210,Despite the hurdles in Trump s plans to repeal and replace Obamacare healthcare is the second best performing sector this year lagging technology The optimism comes especially from encouraging industry trends and hopes of a favorable policy environment The Trump administration plans to
PFE,PFE:US,BBG000BR2B91,"Noteworthy ETF Inflows: VYM, PFE, MMM, ABBV",2017-07-24 16:02:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cUYJOLQfq5k/noteworthy-etf-inflows-vym-pfe-mmm-abbv-cm820134,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard High Dividend Yield ETF Symbol VYM where we have detected an approximate 63 6 million dollar inflow that s a 0 3 increase week over week
PFE,PFE:US,BBG000BR2B91,Centene (CNC) to Report Q2 Earnings: What's in the Cards?,2017-07-24 15:11:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OfXl3y36Hc4/centene-cnc-to-report-q2-earnings-whats-in-the-cards-cm820081,Centene Corporation CNC will release second quarter 2017 results on Jul 25 before the market opens Last quarter the company delivered a positive earnings surprise of 5 66 Let s see how things are shaping up for this announcement Factors to be Considered this Quarter The buyout
PFE,PFE:US,BBG000BR2B91,What to Expect from Anthem (ANTM) this Earnings Season?,2017-07-24 15:10:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4fxUmTPIbhg/what-to-expect-from-anthem-antm-this-earnings-season-cm820076,Anthem Inc ANTM will release second quarter 2017 results on Jul 26 before the market opens Last quarter the company pulled off a positive earnings surprise of 21 56 Let s see how things are shaping up for this announcement Factors to be Considered this Quarter Anthem is likely
PFE,PFE:US,BBG000BR2B91,Surprise in Store for Healthcare in Q2: Buy Top-Ranked ETFs,2017-07-24 14:11:02 +0000,https://finance.yahoo.com/news/surprise-store-healthcare-q2-buy-141102443.html?.tsrc=rss,"Though the healthcare sector is expected to post an earnings decline and has a dismal Rank, some surprises may well be in the cards, suggesting upside for healthcare ETFs."
PFE,PFE:US,BBG000BR2B91,Universal Health (UHS) Q2 Earnings: What's in the Cards?,2017-07-24 14:07:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iWu37oyUeDE/universal-health-uhs-q2-earnings-whats-in-the-cards-cm820087,Universal Health Services Inc UHS is set to report second quarter 2017 results on Jul 25 after 160 market close Last quarter the company pulled off a positive earnings surprise of 1 94 Let s see how things are shaping up for this announcement Factors to be Considered this
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 07/24/2017: JNJ, PFE, ABT, MRK, AMGN, WBMD, BMY, SRPT",2017-07-24 14:03:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/okLMzPLMTRw/health-care-sector-update-for-07242017-jnj-pfe-abt-mrk-amgn-wbmd-bmy-srpt-cm820033,Top Health Care stocks Top Health Care stocks JNJ 0 01 JNJ 0 01 PFE 0 1 PFE 0 1 ABT 0 7 ABT 0 7 MRK 0 4 MRK 0 4 AMGN 0 2 AMGN 0 2 Health care shares were mostly higher in pre market trade Monday Health care shares were mostly higher in pre market trade Monday In
PFE,PFE:US,BBG000BR2B91,Centene (CNC) to Report Q2 Earnings: What&apos;s in the Cards?,2017-07-24 13:14:01 +0000,https://finance.yahoo.com/news/centene-cnc-report-q2-earnings-131401458.html?.tsrc=rss,"Centene&apos;s (CNC) second-quarter earnings are likely to be driven by Health Net buyout. However, surging level of SG&A expenses might put pressure on the bottom line."
PFE,PFE:US,BBG000BR2B91,"Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B7391003 Study for PF-06439535, a Potential Biosimilar to Avastin®1 (bevacizumab)",2017-07-24 12:30:00 +0000,https://finance.yahoo.com/news/pfizer-announces-positive-top-line-123000544.html?.tsrc=rss,"Pfizer Inc. today announced that the REFLECTIONS B7391003 study, a comparative, confirmatory safety and efficacy study of PF-06439535 versus Avastin® , met its primary objective."
PFE,PFE:US,BBG000BR2B91,Featured Company News - Pfizer and Merck Announce EMA'S CHMP Positive Opinion for Avelumab,2017-07-24 11:20:00 +0000,https://finance.yahoo.com/news/featured-company-news-pfizer-merck-112000613.html?.tsrc=rss,"MAIN, GERMANY / ACCESSWIRE / July 24, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Pfizer Inc. (NYSE: PFE ), following which we have published a ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Says REFLECTIONS B7391003 Study Met Primary Objective - Quick Facts,2017-07-24 08:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tg37NOjummY/pfizer-says-reflections-b7391003-study-met-primary-objective--quick-facts-20170724-00579,Pfizer Says REFLECTIONS B7391003 Study Met Primary Objective - Quick Facts
PFE,PFE:US,BBG000BR2B91,GlaxoSmithKline: ViiV Healthcare Presents 96-week Data From LATTE-2 Study,2017-07-24 04:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pDY9mC17vUk/glaxosmithkline-viiv-healthcare-presents-96week-data-from-latte2-study-20170724-00138,GlaxoSmithKline: ViiV Healthcare Presents 96-week Data From LATTE-2 Study
PFE,PFE:US,BBG000BR2B91,One Step Closer To EU Approval...,2017-07-23 23:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0Tnuvvu6IN0/one-step-closer-to-eu-approval-20170723-00089,One Step Closer To EU Approval...
PFE,PFE:US,BBG000BR2B91,5 Things You Probably Didn't Know About Pfizer Inc.,2017-07-23 17:04:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S4HDo63wCfM/5-things-you-probably-didnt-know-about-pfizer-inc-cm819880,Many people can name one of Pfizer s NYSE PFE products From over the counter products such as Advil and Robitussin to powerful prescription drugs such as Eliquis and Ibrance Pfizer makes some of the best selling products in the world For investors probably one of the
PFE,PFE:US,BBG000BR2B91,5 Things You Probably Didn&apos;t Know About Pfizer Inc.,2017-07-23 15:01:00 +0000,http://finance.yahoo.com/r/e7dbed69-0cfb-37c6-90f2-22948e7fb2dc/5-things-you-probably-didnt-know-about-pfizer-inc.aspx?yptr=yahoo&.tsrc=rss,Creating tasty tapeworm medicines and helping win World War II? Yep. And there&apos;s more you probably didn&apos;t know about the big drugmaker.
PFE,PFE:US,BBG000BR2B91,Better Buy: AbbVie Inc. vs. Johnson & Johnson,2017-07-22 16:05:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7OnX3oHBJ58/better-buy-abbvie-inc-vs-johnson-johnson-cm819768,U S based pharmaceutical companies are enjoying a much friendlier business environment under President Trump than his predecessor President Trump after all has backed away from the repeated calls for hard caps on prescription drug prices and his administration continues to push
PFE,PFE:US,BBG000BR2B91,Merck's Biosimilar Insulin Gets Tentative FDA Approval,2017-07-21 23:04:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/89oq2wrBoXc/mercks-biosimilar-insulin-gets-tentative-fda-approval-cm819640,Merck MRK announced that the FDA has granted a tentative approval to Lusduna Nexvue the company s biosimilar version of Sanofi s SNY Lantus insulin glargine for treatment of people with type I and type II diabetes Lusduna Nexvue delivers insulin in a pre filled dosing device Note that
PFE,PFE:US,BBG000BR2B91,AbbVie Inc's. (ABBV) Q2 Earnings: Disappointment in Store?,2017-07-21 22:03:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yp8jrvYdNBE/abbvie-incs-abbv-q2-earnings-disappointment-in-store-cm819615,AbbVie Inc ABBV is scheduled to release second quarter 2017 earnings before the opening bell on Jul 28 AbbVie s shares have rallied 18 2 so far this year while the industry has recorded an increase of 13 2 Last quarter the company delivered a positive surprise of 1 59 We
PFE,PFE:US,BBG000BR2B91,HCA Healthcare (HCA) Q2 Earnings: Will it Beat Estimates?,2017-07-21 17:11:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8IpWoM422tk/hca-healthcare-hca-q2-earnings-will-it-beat-estimates-cm819444,HCA Healthcare Inc HCA is scheduled to report second quarter 2017 results on Jul 25 before the market opens Last quarter this hospital company posted in line results It has however surpassed earnings estimates in three out of the last four quarters with an average positive surprise
PFE,PFE:US,BBG000BR2B91,"Capital Insight Partners, Llc Buys LafargeHolcim, NextEra Energy Inc, EQT Corp, Sells Walt ...",2017-07-21 16:02:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RFgQwjeSMI4/capital-insight-partners-llc-buys-lafargeholcim-nextera-energy-inc-eqt-corp-sells-walt-cm819387,Capital Insight Partners Llc New Purchases HCMLF NEE EQT GOOG EGN MCD Added Positions MDT MTU WFC VWR CMCSA PEP MSFT Reduced Positions UL CVX XOM MA JPM EXPGF AAIGF T DEO FRC Sold Out DIS SJW GILD IBM TCEHY New
PFE,PFE:US,BBG000BR2B91,HCA Healthcare (HCA) Q2 Earnings: Will it Beat Estimates?,2017-07-21 14:46:02 +0000,https://finance.yahoo.com/news/hca-healthcare-hca-q2-earnings-144602122.html?.tsrc=rss,"HCA Healthcare&apos;s (HCA) second-quarter earnings are likely to witness equivalent, admission growth and accretion from a number of acquisitions. Commercial business will likely be a dampener."
PFE,PFE:US,BBG000BR2B91,A Look at Johnson & Johnson’s Segment-Wise Performance,2017-07-21 14:41:27 +0000,http://finance.yahoo.com/r/02105a1c-e89b-36da-bf7f-2b294f9af456/a-look-at-johnson-johnsons-segment-wise-performance?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Johnson & Johnson (JNJ) reported a revenue increase of ~2.9% between 2Q16 and 2Q17. The company’s business is broken down into three business segments: Pharmaceuticals, Consumer Products, and Medical Devices. ..."
PFE,PFE:US,BBG000BR2B91,Can Merck (MRK) Pull Off a Surprise this Earnings Season?,2017-07-21 14:10:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kmWAucRLU3g/can-merck-mrk-pull-off-a-surprise-this-earnings-season-cm819281,Merck amp Co Inc MRK will be reporting second quarter 2017 earnings on Jul 28 before market opens Last quarter the company delivered a positive earnings surprise of 6 02 Merck s performance has been pretty impressive with the company exceeding earnings expectations consistently
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 07/21/2017: JNJ, PFE, ABT, MRK, AMGN, AEZS, BCLI, RH",2017-07-21 13:04:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-KJeDi0LQHQ/health-care-sector-update-for-07212017-jnj-pfe-abt-mrk-amgn-aezs-bcli-rh-cm819140,Top Health Care stocks Top Health Care stocks JNJ 0 6 JNJ 0 6 PFE 0 03 PFE 0 03 ABT 0 3 ABT 0 3 MRK flatMRK flat AMGN flatAMGN flat Health care shares were mostly mixed in pre market trade Friday Health care shares were mostly mixed in pre market trade Friday In sector
PFE,PFE:US,BBG000BR2B91,Can Merck (MRK) Pull Off a Surprise this Earnings Season?,2017-07-21 12:52:12 +0000,https://finance.yahoo.com/news/merck-mrk-pull-off-surprise-125212901.html?.tsrc=rss,"Merck & Co., Inc.&apos;s (MRK) new products like Keytruda, Zepatier and Bridion are likely to drive sales in Q2. However, headwinds remain in the form genericization of key drugs and increasing competition."
PFE,PFE:US,BBG000BR2B91,Today's Research Reports on Stocks to Watch: Abbott Laboratories and Pfizer Inc.,2017-07-21 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000536.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 21, 2017 / Abbott Laboratories saw its shares climb higher yesterday after announcing Q2 results that narrowly beat Wall Street's expectations. Shares of Pfizer saw a loss ..."
PFE,PFE:US,BBG000BR2B91,EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma,2017-07-21 11:50:00 +0000,https://finance.yahoo.com/news/emas-chmp-issues-positive-opinion-115000425.html?.tsrc=rss,"DARMSTADT, Germany and NEW YORK , July 20, 2017 /PRNewswire/ -- Not intended for UK-based media     If approved,   avelumab   could   be   the   first   immunotherapy   treatment   indicated   for   this ..."
PFE,PFE:US,BBG000BR2B91,Cleaner Exposure to Value Stocks,2017-07-21 11:00:00 +0000,http://finance.yahoo.com/r/b6359421-72a1-3954-9f04-a9748ea74d00/article.aspx?id=816532&SR=Yahoo&yptr=yahoo&.tsrc=rss,This ETF allows investors to own cheap stocks without the persistent sector bets that most of its peers make.
PFE,PFE:US,BBG000BR2B91,3 Hottest Biotech Stocks of 2017 -- Are They Still Buys Now?,2017-07-21 03:02:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PcU5QIOFpvk/3-hottest-biotech-stocks-of-2017-are-they-still-buys-now-cm819044,Biotechnology s top performing stocks this year have already given investors envy inspiring returns but there s reason to believe that Calithera Biosciences NASDAQ CALA Aurinia Pharmaceuticals NASDAQ AUPH and Esperion Therapeutics NASDAQ ESPR could still go
PFE,PFE:US,BBG000BR2B91,5 New Breast Cancer Treatments That Are Helping to Save Lives,2017-07-20 23:30:00 +0000,http://finance.yahoo.com/r/fa9ce2cc-dc7b-3464-a331-dbc17fc49825/5-new-breast-cancer-treatments-from-lilly-novartis-and-pfizer-that-could-double-sales-by-2021.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"In the U.S., one in eight women will be diagnosed with breast cancer in their lifetime; for men, the risk is one in 1,000."
PFE,PFE:US,BBG000BR2B91,"Tesla Started At Neutral, High Risk; Amazon Gets Price Target Hike",2017-07-20 20:06:15 +0000,http://finance.yahoo.com/r/7355b69c-57c3-3ea4-8dfa-ae6eab250614/tesla-started-at-neutral-high-risk-hp-nike-upgraded-pfizer-cut?src=A00220&yptr=yahoo&.tsrc=rss,Citigroup on Thursday initiated coverage of electric car maker Tesla at neutral/high risk. Analysts also upgraded PC and printer maker HP and athletic apparel vendor Nike.
PFE,PFE:US,BBG000BR2B91,Trump unveils companies' $500 million U.S. drug packaging project,2017-07-20 20:02:40 +0000,https://finance.yahoo.com/news/trump-unveils-companies-500-million-200240244.html?.tsrc=rss,"President Donald Trump on  Thursday announced a $500 million investment that Corning Inc  is making with pharmaceutical giants Merck and  Pfizer to manufacture a new kind of glass for injectable  drug vials.  At a White House event, Trump said the effort will create  nearly 1,000 jobs at facilities in New York and New Jersey and  at a soon-to-be-determined site in the southeastern United  States.  The deal could eventually result in a total investment of $4  billion and create around 4,000 jobs, Trump said, joined by the  CEOs of Corning, Merck and Pfizer."
PFE,PFE:US,BBG000BR2B91,"Merck, Pfizer CEOs talk 'Made in America' week",2017-07-20 19:53:27 +0000,https://finance.yahoo.com/video/merck-pfizer-ceos-talk-made-195327037.html?.tsrc=rss,Merck CEO Kenneth Frazier and Pfizer CEO Ian Read appear with President Trump to address 'Made in America' week.
PFE,PFE:US,BBG000BR2B91,Merck and Pfizer Collaborate with Corning to Modernize Pharmaceutical Glass Packaging,2017-07-20 19:17:00 +0000,https://finance.yahoo.com/news/merck-pfizer-collaborate-corning-modernize-191700566.html?.tsrc=rss,                                              Collaborations result in development of Corning Valor(TM) Glass; drive significant U.S. investment and job creation The White House Office of American Innovation ...
PFE,PFE:US,BBG000BR2B91,What Lies in Store for Glaxo (GSK) this Earnings Season?,2017-07-20 17:04:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rr47N5wiCfs/what-lies-in-store-for-glaxo-gsk-this-earnings-season-cm818776,GlaxoSmithKline plc GSK is scheduled to report second quarter 2017 results on Jul 26 before market opens Last quarter the company delivered in line earnings Glaxo s shares are up 10 1 this year so far underperforming the 11 9 increase witnessed by the Zacks classified Large Cap
PFE,PFE:US,BBG000BR2B91,Pfizer Downgraded on Patent Expiration for Viagra: Credit Suisse,2017-07-20 16:41:00 +0000,http://finance.yahoo.com/r/0a6b61da-7ca8-3860-a163-cf2a91b88941/pfizer-downgraded-patent-expiration-viagra-credit-suisse?partner=YahooSA&yptr=yahoo&.tsrc=rss,Analysts downgrade PFE as they suggest that the big pharma stock has limited drivers of upside.
PFE,PFE:US,BBG000BR2B91,Analyst Prescribes Neutral Rating For Pfizer Shares,2017-07-20 14:57:34 +0000,https://finance.yahoo.com/news/analyst-prescribes-neutral-rating-pfizer-145734288.html?.tsrc=rss,"Previewing second-quarter results of Pfizer Inc. (NYSE: PFE ), Credit Suisse prescribed a Neutral rating for the shares of the company, down from its previous Outperform rating. Pfizer is scheduled to ..."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 07/20/2017: JNJ, PFE, ABT, MRK, AMGN, BVXV, GSK, PFE",2017-07-20 13:43:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3i-qAsgW0qk/health-care-sector-update-for-07202017-jnj-pfe-abt-mrk-amgn-bvxv-gsk-pfe-cm818574,Top Health Care stocks Top Health Care stocks JNJ flatJNJ flat PFE 0 6 PFE 0 6 ABT 0 3 ABT 0 3 MRK flatMRK flat AMGN flatAMGN flat Health care shares were mostly inactive in pre market trade Thursday Health care shares were mostly inactive in pre market trade Thursday In
PFE,PFE:US,BBG000BR2B91,Pfizer: We Still Like You But…,2017-07-20 13:35:00 +0000,http://finance.yahoo.com/r/6200fbec-fbba-37bf-a6c4-0830f1d01ad3/pfizer-we-still-like-you-but-1500557717?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Pfizer (PFE) have gained 5.1% since closing at $32 on June 7, and the stock even looks like it had been making a run for the top of its recent range.  In fact, they call themselves ""long-time supporters"" of the company, and see ""opportunities for upside over the long term."" So why are they downgrading Pfizer?"
PFE,PFE:US,BBG000BR2B91,Pfizer shares downgraded because Viagra patent is expiring later this year,2017-07-20 11:58:51 +0000,http://finance.yahoo.com/r/0bc25b67-1eb9-3715-9e79-de0e51f0b29f/104598133?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104598133&yptr=yahoo&.tsrc=rss,Credit Suisse believes Pfizer will suffer from the patent expirations of its key drugs such as Viagra and Lyrica.
PFE,PFE:US,BBG000BR2B91,Pfizer shares downgraded because Viagra patent is expiring later this year,2017-07-20 11:58:51 +0000,https://finance.yahoo.com/news/pfizer-shares-downgraded-because-viagra-115851462.html?.tsrc=rss,Credit Suisse believes Pfizer will suffer from the patent expirations of its key drugs such as Viagra and Lyrica.
PFE,PFE:US,BBG000BR2B91,"Pfizer Completes License Agreement For The Exclusive Commercialization Rights In Europe For CRESEMBA (isavuconazole), A Novel Treatment For Potentially Life-Threatening Fungal Infections Among Immunocompromised Patients",2017-07-20 05:23:00 +0000,https://finance.yahoo.com/news/pfizer-completes-license-agreement-exclusive-052300692.html?.tsrc=rss,"Pfizer Inc. and Basilea Pharmaceutica Ltd. , an international biopharmaceutical company specializing in the research and development of anti-infective and oncological medicines, today announced they have completed the licensing agreement whereby Pfizer has obtained the exclusive commercialization rights in Europe to CRESEMBA , a novel anti-fungal treatment for adult patients with diagnosed invasive ..."
PFE,PFE:US,BBG000BR2B91,"Basilea announces completion of the license agreement with Pfizer for antifungal Cresemba® for Europe, Russia, Turkey and Israel",2017-07-20 05:17:00 +0000,https://finance.yahoo.com/news/basilea-announces-completion-license-agreement-051700219.html?.tsrc=rss,"Basel, Switzerland, July 20, 2017 - Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that its license agreement with Pfizer Inc. (NYSE: PFE) for Basilea`s antifungal Cresemba (isavuconazole), which ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Obtains Exclusive Commercialization Rights In Europe To CRESEMBA,2017-07-20 01:50:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NCYbUK9FrqY/pfizer-obtains-exclusive-commercialization-rights-in-europe-to-cresemba-20170720-00055,Pfizer Obtains Exclusive Commercialization Rights In Europe To CRESEMBA
PFE,PFE:US,BBG000BR2B91,4 Healthcare Megatrends for Investors,2017-07-20 00:03:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NlzkHuXKlQQ/4-healthcare-megatrends-for-investors-cm818429,When you think about investing to powerfully grow your money into the future what giant long term trends come to mind first Certainly anything on the cutting edge of technology does from mobile the cloud and AI to robotics alternative energy and autonomous cars But do you know
PFE,PFE:US,BBG000BR2B91,Cramer's lightning round: GameStop just can't seem to go ...,2017-07-19 22:59:00 +0000,https://finance.yahoo.com/video/cramers-lightning-round-gamestop-just-225900553.html?.tsrc=rss,"Jim Cramer speeds through his take on callers' favorite stocks, including the stock of a video game retailer."
PFE,PFE:US,BBG000BR2B91,Cramer&apos;s lightning round: GameStop just can&apos;t seem to go higher,2017-07-19 22:48:26 +0000,https://finance.yahoo.com/news/cramer-apos-lightning-round-gamestop-224826550.html?.tsrc=rss,"Jim Cramer speeds through his take on callers&apos; favorite stocks, including the stock of a video game retailer."
PFE,PFE:US,BBG000BR2B91,Cramer's lightning round: GameStop just can't seem to go higher,2017-07-19 22:48:26 +0000,http://finance.yahoo.com/r/b59d050d-c516-324a-8cf6-80246c6390b9/104596183?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104596183&yptr=yahoo&.tsrc=rss,"Jim Cramer speeds through his take on callers' favorite stocks, including the stock of a video game retailer."
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Jul 19, 2017 :  INTC, PFE, QQQ, CAG, T, RF, MGM, KO, ROST, ERIC, TMUS, AAPL",2017-07-19 21:02:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kdeJJAbFQM0/after-hours-most-active-for-jul-19-2017-intc-pfe-qqq-cag-t-rf-mgm-ko-rost-eric-tmus-aapl-cm818357,The NASDAQ 100 After Hours Indicator is down 2 36 to 5 913 8 The total After hours volume is currently 44 088 461 shares traded The following are the most active stocks for the after hours session Intel Corporation INTC is 0 01 at 34 57 with 2 922 913 shares
PFE,PFE:US,BBG000BR2B91,4 Healthcare Megatrends for Investors,2017-07-19 20:58:08 +0000,https://finance.yahoo.com/news/4-healthcare-megatrends-investors-205808245.html?.tsrc=rss,4 Healthcare Megatrends for Investors
PFE,PFE:US,BBG000BR2B91,5 Off-the-Radar Numbers to Take Note of in Johnson & Johnson's Second-Quarter Report,2017-07-19 20:03:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QJzSlT3DeBQ/5-off-the-radar-numbers-to-take-note-of-in-johnson-johnsons-second-quarter-report-cm818279,It s officially earnings season which can only mean one thing Johnson amp Johnson NYSE JNJ is kicking things off for big pharmaceutical companies On Tuesday morning July 18 Johnson amp Johnson released its second quarter earnings results keeping alive a recent trend
PFE,PFE:US,BBG000BR2B91,Can Biogen (BIIB) Keep the Earnings Streak Alive in Q2?,2017-07-19 16:08:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bMMoAQYV5F4/can-biogen-biib-keep-the-earnings-streak-alive-in-q2-cm818132,Biogen Inc BIIB a well known name in the multiple sclerosis MS market will report second quarter 2017 results on Jul 25 before the market opens Last quarter the company delivered a positive earnings surprise of 4 63 Biogen s shares have declined 0 4 this year so far while the
PFE,PFE:US,BBG000BR2B91,Is a Beat in the Cards for Eli Lilly (LLY) in Q2 Earnings?,2017-07-19 15:08:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZLiylOsYHhU/is-a-beat-in-the-cards-for-eli-lilly-lly-in-q2-earnings-cm818012,We expect Eli Lilly and Company LLY to beat expectations when it reports second quarter 2017 results on Jul 25 before the market opens Last quarter the company delivered a positive earnings surprise of 2 08 So far this year Lilly s share price has risen 13 8 compared with an increase
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 07/19/2017: JNJ, PFE, ABT, MRK, AMGN, MDGS, GSK, INO",2017-07-19 13:04:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NEAsZYBSths/health-care-sector-update-for-07192017-jnj-pfe-abt-mrk-amgn-mdgs-gsk-ino-cm817913,Top Health Care stocks Top Health Care stocks JNJ 0 4 JNJ 0 4 PFE 0 8 PFE 0 8 ABT 0 4 ABT 0 4 MRK 0 1 MRK 0 1 AMGN 0 4 AMGN 0 4 Health care shares were mostly higher in pre market trade Wednesday Health care shares were mostly higher in pre market trade Wednesday In
PFE,PFE:US,BBG000BR2B91,Does Puma Biotechnology's Approval Make It Worth More?,2017-07-19 03:02:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ykZb6YCCgws/does-puma-biotechnologys-approval-make-it-worth-more-cm817834,Puma Biotechnology s NASDAQ PBYI roller coaster ride to approval is finally over After fits and starts in clinical trials 160 the FDA gave the company s breast cancer drug Nerlynx a green light clearing the way to its commercialization later this year The decision is
PFE,PFE:US,BBG000BR2B91,"J&J (JNJ) Beats on Q2 Earnings, Lags Sales, Ups 2017 View",2017-07-18 16:08:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4dSHrIxehAw/jj-jnj-beats-on-q2-earnings-lags-sales-ups-2017-view-cm817557,Johnson amp Johnson JNJ reported mixed second quarter 2017 results While earnings beat expectations sales missed the same However the drug and consumer products giant raised its 2017 sales and profit outlook which sent shares up more than 1 in pre market trading This year so
PFE,PFE:US,BBG000BR2B91,Paratek Antibiotic Candidate's Phase III Data Favorable,2017-07-18 14:08:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/97Tm-JpNaHI/paratek-antibiotic-candidates-phase-iii-data-favorable-cm817469,Paratek Pharmaceuticals Inc PRTK announced positive results from a phase III study OASIS 2 comparing its antibiotic candidate omadacycline to Pfizer Inc s PFE Zyvox for the treatment of acute bacterial skin and skin structure infections ABSSSI The study met the key primary and
PFE,PFE:US,BBG000BR2B91,JNJ Named Top 25 SAFE Dividend Stock Increasing Payments For Decades,2017-07-18 13:02:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WSHlEDD7eeQ/jnj-named-top-25-safe-dividend-stock-increasing-payments-for-decades-cm817279,Johnson amp Johnson Symbol JNJ has been named to the Dividend Channel S A F E 25 list signifying a stock with above average DividendRank statistics including a strong 2 5 yield as well as a superb track record of at least two decades of dividend growth according to the
PFE,PFE:US,BBG000BR2B91,How Bayer Is Creating Value through Innovation,2017-07-17 15:26:59 +0000,http://finance.yahoo.com/r/2508cf97-4943-33cb-a49a-ceaac095fa85/bayer-creating-value-innovation?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Bayer owned ~51,000 valid patent applications and patents relating to ~5,000 protected inventions worldwide."
PFE,PFE:US,BBG000BR2B91,How to Identify Economic Moats,2017-07-17 15:26:53 +0000,http://finance.yahoo.com/r/e1a2c664-8cd6-395c-b44a-eeb9ba90af36/identify-economic-moats?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In this series, we’ll discuss how intangible assets can create long-term competitive advantages for companies."
PFE,PFE:US,BBG000BR2B91,3 Small Biotech Stocks Being Run by Proven Winners,2017-07-17 12:49:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZbNbDPfQ970/3-small-biotech-stocks-being-run-by-proven-winners-cm816698,Great leaders are important in any industry but perhaps they re even more valuable in biotech where any number of clinical stage and regulatory obstacles can derail drug research and send share prices reeling For that reason investing in biotech stocks such as Aurinia
PFE,PFE:US,BBG000BR2B91,Roundtable: 1 Stock I'm Never Selling,2017-07-16 22:46:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l_-mfT4cegY/roundtable-1-stock-im-never-selling-cm816629,Stocks that are worth buying and holding for exceptionally long periods of time are far less common than most investors may think 160 Changes in underlying market conditions after all can knock even top performers off their perches Even so our investors think that Pfizer
PFE,PFE:US,BBG000BR2B91,Pfizer Is Set to Lose Its No. 1 Spot Among Drugmakers: Here's Why It Doesn't Matter,2017-07-16 20:45:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pI0eIW1eHvs/pfizer-is-set-to-lose-its-no-1-spot-among-drugmakers-heres-why-it-doesnt-matter-cm816611,Pfizer NYSE PFE stands at the top of the mountain when it comes to prescription drug sales Last year the big pharma company made 45 9 billion from prescription drugs well ahead of runners up Novartis NYSE NVS and Roche NASDAQOTH RHHBY However Pfizer
PFE,PFE:US,BBG000BR2B91,Pfizer Is Set to Lose Its No. 1 Spot Among Drugmakers: Here&apos;s Why It Doesn&apos;t Matter,2017-07-16 19:03:00 +0000,http://finance.yahoo.com/r/15e4a5a2-7249-3d89-9075-298cd19957e3/pfizer-is-set-to-lose-its-no-1-spot-among-drugmake.aspx?yptr=yahoo&.tsrc=rss,Novartis could take the top spot from Pfizer in prescription-drug sales by 2022. So what?
PFE,PFE:US,BBG000BR2B91,Roundtable: 1 Stock I&apos;m Never Selling,2017-07-16 14:45:00 +0000,http://finance.yahoo.com/r/d6e5a8c5-15f7-3d68-9277-2651f6640215/roundtable-1-stock-im-never-selling.aspx?yptr=yahoo&.tsrc=rss,"There aren&apos;t many stocks worth holding onto forever, but our investors think these three names are an exception to the rule."
PFE,PFE:US,BBG000BR2B91,"[$$] ""A Great Time"" to Invest in the Health-Care Sector",2017-07-15 04:01:00 +0000,http://finance.yahoo.com/r/c69dfb06-0329-34c3-b86e-7e67e9632425/a-great-time-to-invest-in-the-health-care-sector-1500092194?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"The future of the U.S. health-care system has engendered fierce debate on both sides of the political aisle.  For example, which drugmakers and medical-device companies are developing breakthrough therapies?  Which companies are developing and using technology to improve how health care is delivered?"
PFE,PFE:US,BBG000BR2B91,"How to Use Technical Analysis to Make Money: Cramer's 'Mad Money' Recap (Friday, 7/14/17)",2017-07-14 23:01:00 +0000,http://finance.yahoo.com/r/f46d09e3-3b4d-3e9b-a807-d73f24054b54/how-to-use-technical-analysis-to-make-money-cramer-s-mad-money-recap-friday-7-14-17.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Why study charts? Because they're like footprints at the scene of a crime, clues to what the big money managers are likely thinking, Jim Cramer says."
PFE,PFE:US,BBG000BR2B91,AbbVie Inc (ABBV) Stock Isn’t Done Charting New Highs Yet,2017-07-14 22:47:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UreQ73baqaU/abbvie-inc-abbv-stock-isnt-done-charting-new-highs-yet-cm816435,InvestorPlace Stock Market News Stock Advice amp Trading Tips AbbVie Inc NYSE ABBV is part of a notoriously volatile sector even under normal circumstances Add to it an election cycle where they ve been the hottest political football and you get a
PFE,PFE:US,BBG000BR2B91,Potential AstraZeneca C-Suite Shuffle Rekindles Takeover Chatter,2017-07-14 20:05:00 +0000,http://finance.yahoo.com/r/2c94c8ae-5002-346b-9f48-f243c2e55439/potential-astrazeneca-c-suite-shuffle-rekindles-takeover-chatter.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,CEO Pascal Soriot may be on his way to Israel's Teva Pharmaceuticals ahead of key drug trial information release.
PFE,PFE:US,BBG000BR2B91,AbbVie Inc (ABBV) Stock Isn’t Done Charting New Highs Yet,2017-07-14 18:07:22 +0000,https://finance.yahoo.com/news/abbvie-inc-abbv-stock-isn-180722747.html?.tsrc=rss,"InvestorPlace - Stock Market News, Stock Advice &#38; Trading Tips"
PFE,PFE:US,BBG000BR2B91,"Notable ETF Inflow Detected - VHT, PFE, MDT, ABBV",2017-07-14 16:47:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gGgfOpn91Bg/notable-etf-inflow-detected-vht-pfe-mdt-abbv-cm816236,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard Health Care ETF Symbol VHT where we have detected an approximate 66 8 million dollar inflow that s a 1 0 increase week over week in outstanding
PFE,PFE:US,BBG000BR2B91,Pfizer Xeljanz Label Expansion Application Accepted by FDA,2017-07-14 16:45:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tBBkoALMuH4/pfizer-xeljanz-label-expansion-application-accepted-by-fda-cm816208,Pfizer Inc s PFE supplemental new drug application sNDA for Xeljanz has been accepted for review by the FDA Xeljanz 5 mg twice daily a JAK inhibitor is presently approved in the U S as a second line treatment for moderate to severely active rheumatoid arthritis RA in patients who
PFE,PFE:US,BBG000BR2B91,"Kevin O'Leary: Own big, quality names",2017-07-14 15:59:00 +0000,https://finance.yahoo.com/video/kevin-oleary-own-big-quality-155900780.html?.tsrc=rss,"Kevin O'Leary, chair Of O'Shares ETF Investments, lists stocks he expects to outperform the S&P into the end of the year."
PFE,PFE:US,BBG000BR2B91,Pfizer Xeljanz Label Expansion Application Accepted by FDA,2017-07-14 14:57:02 +0000,https://finance.yahoo.com/news/pfizer-xeljanz-label-expansion-application-145702758.html?.tsrc=rss,Pfizer Inc.&apos;s (PFE) supplemental new drug application (sNDA) for Xeljanz has been accepted for review by the FDA.
PFE,PFE:US,BBG000BR2B91,Why Healthcare Funds Are Not Sickened By GOP Bid To Kill Obamacare,2017-07-14 13:01:00 +0000,http://finance.yahoo.com/r/a0036f8f-5933-325c-8cd1-98068e7b8456/why-healthcare-funds-are-not-sickened-by-gop-bid-to-kill-obamacare?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Abroad Obamacare, McConnellcare, Ryancare and Trumpcare are just Twitter hashtags. Sales growth overseas could alleviate pain in the U.S. market. Healthcare spending some regions are expected to grow much faster than in the U.S. over the next few years."
PFE,PFE:US,BBG000BR2B91,What Allergan’s Valuation as of July 13 Tells Us,2017-07-14 11:40:11 +0000,http://finance.yahoo.com/r/96c0385a-c5b0-39cc-9bbf-5a5641d2578f/what-allergans-valuation-as-of-july-13-tells-us?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"For 2Q17, Wall Street analysts estimate AGN's EPS (earnings per share) to come in at $3.93, which would be a 17.5% growth over 2Q16."
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: FDA Panel Votes for Novartis CAR-T Drug, SNY to Buy Vaccines Co.",2017-07-14 11:28:11 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-fda-panel-112811804.html?.tsrc=rss,Novartis (NVS) was in the limelight this week with its CAR-T cell therapy receiving the support of an FDA advisory panel.
PFE,PFE:US,BBG000BR2B91,"FDA Panel Backs 2 Biosimilars, ALDR Abuzz, MDXG Q2 Revenue Grows 33%",2017-07-14 02:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7aTL7pt1MeE/fda-panel-backs-2-biosimilars-aldr-abuzz-mdxg-q2-revenue-grows-33-20170714-00061,"FDA Panel Backs 2 Biosimilars, ALDR Abuzz, MDXG Q2 Revenue Grows 33%"
PFE,PFE:US,BBG000BR2B91,Why Are Shares of Exelixis (EXEL) Up 77% So Far in 2017?,2017-07-14 00:45:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W3RpU-720zY/why-are-shares-of-exelixis-exel-up-77-so-far-in-2017-cm815934,Shares of Exelixis Inc EXEL have gained almost 4 68 on Aug 12 The company s shares have rallied a whopping 77 this year so far outperforming the 7 8 increase registered by the Zacks categorized Medical Biomedical and Genetics industry during this period Here we analyze the
PFE,PFE:US,BBG000BR2B91,Clovis (CLVS) Focuses on Rubraca Launch and Label Expansion,2017-07-13 23:47:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xt4N_QITDBw/clovis-clvs-focuses-on-rubraca-launch-and-label-expansion-cm815926,We issued an updated research report on Boulder CO based Clovis Oncology Inc CLVS on Jul 12 Clovis got a huge boost in Dec 2016 when the FDA granted accelerated approval to its PARP inhibitor Rubraca rucaparib for the treatment of advanced ovarian cancer two months earlier than
PFE,PFE:US,BBG000BR2B91,Corcept Therapeutics Focuses on Korlym's Label Expansion,2017-07-13 23:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c6fMnVA1mE0/corcept-therapeutics-focuses-on-korlyms-label-expansion-cm815921,We issued an updated research report on Corcept Therapeutics Inc CORT on Jul 12 Corcept s shares have surged 71 2 year to date comparing favorably with the Zacks classified Medical Drugs industry s gain of 6 3 Currently the company is striving to commercialize
PFE,PFE:US,BBG000BR2B91,Tata Consultancy Profit Misses Estimates,2017-07-13 23:24:45 +0000,https://finance.yahoo.com/video/tata-consultancy-profit-misses-estimates-232445566.html?.tsrc=rss,"Jul.13 -- Lower spending by major IT customers, particularly banks, weighed on the profits of Asia's largest software services provider. Tata Consultancy's net income dropped by nearly 6% in the first quarter. Bloomberg Intelligence's Mandeep Singh discusses the outlook for the company on &quot;Bloomberg Daybreak: Australia.&quot;"
PFE,PFE:US,BBG000BR2B91,3 Dividend Stocks That Are Minting Money,2017-07-13 13:02:00 +0000,http://finance.yahoo.com/r/efcf1936-39de-360d-a53b-ae9b84f8bc55/3-dividend-stocks-that-are-minting-money.aspx?yptr=yahoo&.tsrc=rss,"High dividend yields and huge cash flow? AT&T, Gilead Sciences, and Pfizer have both."
PFE,PFE:US,BBG000BR2B91,Pfizer Announces FDA Accepts Supplemental New Drug Application for XELJANZ® (tofacitinib citrate) for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis,2017-07-13 12:00:00 +0000,https://finance.yahoo.com/news/pfizer-announces-fda-accepts-supplemental-120000006.html?.tsrc=rss,"Pfizer Inc. announced today that the supplemental New Drug Application for XELJANZ® , an investigational oral treatment for adult patients with moderately to severely active ulcerative colitis , has been accepted for filing by the U.S."
PFE,PFE:US,BBG000BR2B91,Pfizer: FDA Accepts SNDA For Xeljanz For Treatment Of Ulcerative Colitis,2017-07-13 08:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9UnV-U2DNp8/pfizer-fda-accepts-snda-for-xeljanz-for-treatment-of-ulcerative-colitis-20170713-00471,Pfizer: FDA Accepts SNDA For Xeljanz For Treatment Of Ulcerative Colitis
PFE,PFE:US,BBG000BR2B91,Pfizer's Mylotarg Recommended by FDA Advisory Committee,2017-07-12 16:48:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/foVV7GO0ATc/pfizers-mylotarg-recommended-by-fda-advisory-committee-cm815128,Pfizer Inc PFE announced that the FDA s Oncologic Drug Advisory Committee ODAC voted in favor of Mylotarg for the treatment of patients with newly diagnosed CD33 positive acute myeloid leukemia AML The committee believes that the ALFA 0701 study investigating Mylotarg provides
PFE,PFE:US,BBG000BR2B91,Amgen Gets FDA Nod to Broaden Leukemia Drug Blincyto's Label,2017-07-12 15:49:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nzwCUwN3YRs/amgen-gets-fda-nod-to-broaden-leukemia-drug-blincytos-label-cm815013,Amgen Inc AMGN announced that its supplemental biologics license application sBLA to convert accelerated approval for leukemia drug Blincyto to regular approval has been accepted by the FDA So far this year Amgen s shares are up 18 5 outperforming the 7 1 increase registered by the
PFE,PFE:US,BBG000BR2B91,J&J (JNJ) to Commence Pharma Q2 Earnings Season: What's Up?,2017-07-12 14:50:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kc_oPzHZQ7Y/jj-jnj-to-commence-pharma-q2-earnings-season-whats-up-cm814994,Johnson amp Johnson JNJ a healthcare bellwether will report second quarter 2017 results on Jul 18 before the opening bell Last quarter the company reported a positive earnings surprise of 3 39 J amp J s shares 160 have gained 13 9 so far this year significantly ahead of the 10
PFE,PFE:US,BBG000BR2B91,Pfizer&apos;s Mylotarg Recommended by FDA Advisory Committee,2017-07-12 14:24:02 +0000,https://finance.yahoo.com/news/pfizer-apos-mylotarg-recommended-fda-142402512.html?.tsrc=rss,Pfizer Inc. (PFE) announced that the FDA&apos;s Oncologic Drug Advisory Committee (ODAC) voted in favor of Mylotarg for the treatment of patients with newly-diagnosed CD33-positive acute myeloid leukemia (AML).
PFE,PFE:US,BBG000BR2B91,Will Pfizer Keep Growing Its Dividend?,2017-07-12 10:33:00 +0000,http://finance.yahoo.com/r/38194e55-5c93-3db2-bfcd-71dadcbf4031/will-pfizer-keep-growing-its-dividend.aspx?yptr=yahoo&.tsrc=rss,The drug company had a long streak of rising dividends that got broken in the financial crisis. Can it get back on the right foot?
PFE,PFE:US,BBG000BR2B91,"ORMP To Meet With FDA, Second Time's No Charm For OCUL, Panel Backs PFE",2017-07-12 01:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uY6ZV1p4Pzo/ormp-to-meet-with-fda-second-times-no-charm-for-ocul-panel-backs-pfe-20170712-00035,"ORMP To Meet With FDA, Second Time's No Charm For OCUL, Panel Backs PFE"
PFE,PFE:US,BBG000BR2B91,3 Top Healthcare Stocks to Buy Today,2017-07-11 22:45:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W5NF9vljQoI/3-top-healthcare-stocks-to-buy-today-cm814762,The healthcare sector is riddled with companies that are long on potential but short on profits For that reason it makes sense to be extremely picky about which stocks you choose to buy So which healthcare stocks do we think are worth the risk right now We asked that very question
PFE,PFE:US,BBG000BR2B91,Exelixis & Bristol-Myers Initiate Trial on Opdivo-Cabometyx,2017-07-11 22:44:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1E9pc97kLoM/exelixis-bristol-myers-initiate-trial-on-opdivo-cabometyx-cm814746,Exelixis Inc EXEL and Bristol Myers Squibb Company BMY announced that they have initiated a phase III trial CheckMate 9ER The trial will evaluate Bristol Myers immuno oncology drug Opdivo in combination with Exelixis Cabometyx or Opdivo and Yervoy in combination with Cabometyx
PFE,PFE:US,BBG000BR2B91,FDA Advisory Committee Votes in Favor of Pfizer’s MYLOTARG (gemtuzumab ozogamicin) for Acute Myeloid Leukemia,2017-07-11 20:32:00 +0000,https://finance.yahoo.com/news/fda-advisory-committee-votes-favor-203200480.html?.tsrc=rss,"Pfizer Inc. today announced that the U.S. Food and Drug Administration’s Oncologic Drug Advisory Committee voted that the results of ALFA-0701 demonstrated a favorable risk:benefit profile for MYLOTARG 3 mg/m2 on days 1, 4 and 7 added to chemotherapy for patients with newly-diagnosed CD33-positive acute myeloid leukemia ."
PFE,PFE:US,BBG000BR2B91,Pfizer's Exit From Brazil Generics Market Is Not Alarming,2017-07-11 18:52:00 +0000,http://finance.yahoo.com/r/28781e08-66af-3bff-87df-deebce31f98d/pfizers-exit-from-brazil-generics-market-is-not-alarming?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Pfizer recently relinquished its stake in Brazilian generics maker Laboratório Teuto Brasileiro for just 30 cents total. In 2010, Pfizer invested nearly $240 million in the company and acquired a 40% stake in the process."
PFE,PFE:US,BBG000BR2B91,"Arena's Ralinepag Positive in Phase II PAH Study, Shares Up",2017-07-11 16:47:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Lar0smuy3Ho/arenas-ralinepag-positive-in-phase-ii-pah-study-shares-up-cm814511,Arena Pharmaceuticals Inc s ARNA shares surged 41 3 in after market trading 160 on Monday after the company announced that a phase II study evaluating its key pipeline candidate ralinepag in pulmonary arterial hypertension PAH met its primary endpoint Also the company plans
PFE,PFE:US,BBG000BR2B91,Lilly's Breast Cancer Drug Gets Priority Review Status by FDA,2017-07-11 15:49:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9YNBGKO0CvQ/lillys-breast-cancer-drug-gets-priority-review-status-by-fda-cm814438,Eli Lilly and Company LLY announced that its new drug application for its pipeline candidate abemaciclib both as a potential monotherapy and combination therapy has been accepted for priority review by the FDA for patients with advanced breast cancer Lilly is looking to get the CDK 4
PFE,PFE:US,BBG000BR2B91,"Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for July 12, 2017",2017-07-11 13:17:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Jl_pJzqXv5I/abbott-laboratories-abt-ex-dividend-date-scheduled-for-july-12-2017-cm814309,Abbott Laboratories ABT will begin trading ex dividend on July 12 2017 A cash dividend payment of 0 265 per share is scheduled to be paid on August 15 2017 Shareholders who purchased ABT prior to the ex dividend date are eligible for the cash dividend payment This marks the 3rd
PFE,PFE:US,BBG000BR2B91,"AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for July 12, 2017",2017-07-11 13:14:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G10H1y3R940/abbvie-inc-abbv-ex-dividend-date-scheduled-for-july-12-2017-cm814262,AbbVie Inc ABBV will begin trading ex dividend on July 12 2017 A cash dividend payment of 0 64 per share is scheduled to be paid on August 15 2017 Shareholders who purchased ABBV prior to the ex dividend date are eligible for the cash dividend payment This marks the 3rd quarter
PFE,PFE:US,BBG000BR2B91,Here’s how much the 10 largest pharmaceutical companies spend on R&D,2017-07-11 13:04:00 +0000,https://finance.yahoo.com/news/much-10-largest-pharmaceutical-companies-130400175.html?.tsrc=rss,"The pharmaceutical industry is among the biggest in the world, containing some of the largest..."
PFE,PFE:US,BBG000BR2B91,"NFL loses Viagra, Cialis advertising: Report",2017-07-11 11:24:00 +0000,https://finance.yahoo.com/video/nfl-loses-viagra-cialis-advertising-112400412.html?.tsrc=rss,CNBC's Meg Tirrell reports the National Football League will have to scout for new advertising dollars after two major erectile dysfunction drugs pull their television advertising.
PFE,PFE:US,BBG000BR2B91,How Portola Is Looking to Change the Anticoagulant Game,2017-07-11 11:18:00 +0000,http://finance.yahoo.com/r/45998dcf-5965-3d57-89bb-6265ea96031a/how-portola-is-looking-to-change-the-anticoagulant.aspx?yptr=yahoo&.tsrc=rss,The biopharma is getting help from some of the biggest players in the drugmaking industry to develop its newest drug.
PFE,PFE:US,BBG000BR2B91,These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now,2017-07-10 21:47:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gUAoYLFTik8/these-5-cancer-drugs-will-be-the-biggest-winners-5-years-from-now-cm814090,Five years fly by quickly In 2022 the landscape for cancer drugs will be different from today but with some familiar players Pharmaceutical market analysis firm EvaluatePharma recently published its report looking at what the biopharmaceutical world might look like five years
PFE,PFE:US,BBG000BR2B91,The 10 largest pharmaceutical companies in the world,2017-07-10 20:44:56 +0000,https://finance.yahoo.com/news/10-largest-pharmaceutical-companies-world-204456951.html?.tsrc=rss,"The pharmaceutical industry is among the biggest in the world, containing some of the largest..."
PFE,PFE:US,BBG000BR2B91,These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now,2017-07-10 20:22:00 +0000,http://finance.yahoo.com/r/0ca6ce6f-5816-30f6-be9e-60b7a94bc2be/these-5-cancer-drugs-will-be-the-biggest-winners-5.aspx?yptr=yahoo&.tsrc=rss,Five cancer drugs that are already successful will become even bigger winners by 2022.
PFE,PFE:US,BBG000BR2B91,Wall Street Opens Without a Clear Direction,2017-07-10 19:47:13 +0000,https://finance.yahoo.com/news/wall-street-opens-without-clear-194713911.html?.tsrc=rss,The market expects more economic data and the appearance of Yellen before Congress
PFE,PFE:US,BBG000BR2B91,Interesting October Stock Options for PFE,2017-07-10 17:47:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a5AUwSkpQf8/interesting-october-stock-options-for-pfe-cm813952,Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the October expiration for PFE The put contract
PFE,PFE:US,BBG000BR2B91,The Worst Place to Invest Now (and 2 Buys for Quick 100%+ Gains),2017-07-10 14:45:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vYySrMDaHS0/the-worst-place-to-invest-now-and-2-buys-for-quick-100-gains-cm813709,By Brett Owens If you re like most folks you re about to put your portfolio on autopilot as the lazy days of summer roll in It s an easy trap to fall into but you must not take the bait as I ll explain in a moment Later on I ll show you two hidden dividend growers that
PFE,PFE:US,BBG000BR2B91,"Boeing Best In Show Among 8 'Dogs Of The Dow,' Here's How To Trade Them Now",2017-07-10 13:38:00 +0000,http://finance.yahoo.com/r/fc45ec5a-0d70-3210-873f-574fecc7f926/boeing-best-in-show-among-8-dogs-of-the-dow-heres-how-to-trade-them-now?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,Boeing is the top performer of the stocks designated as “Dogs of the Dow” this year. Here's how to buy and sell the eight 'dogs' now.
PFE,PFE:US,BBG000BR2B91,How 2Q17 Is Shaping Up for Pfizer,2017-07-10 11:39:04 +0000,http://finance.yahoo.com/r/63dc83a5-9ba5-3c3d-8934-365fa9938ca3/how-2q17-is-shaping-up-for-pfizer?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer (PFE) is one of the largest pharmaceutical companies by revenue. Pfizer’s portfolio, which comprises the Innovative Health and Essential Health segments, includes various medicines, vaccines, and ..."
PFE,PFE:US,BBG000BR2B91,15 Great Dividend Stocks to Own Should the Surging Stock Market Plunge This Summer,2017-07-07 16:05:00 +0000,http://finance.yahoo.com/r/48c7db62-44a6-3ba9-9471-3c6bdd7c2ac8/15-great-dividend-stocks-to-own-should-the-surging-stock-market-plunge-this-summer.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here are the names.
PFE,PFE:US,BBG000BR2B91,Puma (PBYI) Ends Patient Enrollment in Phase III Cancer Trial,2017-07-07 15:51:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yx3osU0wkT4/puma-pbyi-ends-patient-enrollment-in-phase-iii-cancer-trial-cm813044,Puma Biotechnology Inc PBYI announced that it has completed enrollment of patients in a phase III study to evaluate its lead pipeline candidate PB272 neratinib in combination with Roche Holding AG s RHHBY Xeloda capecitabine for treatment of third line HER2 positive metastatic
PFE,PFE:US,BBG000BR2B91,This Biotech Finds Its Stride With Kidney Cancer Treatment,2017-07-07 14:46:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/De3-HLLEvYs/this-biotech-finds-its-stride-with-kidney-cancer-treatment-cm812918,Exelixis EXEL is on a hot streak The South San Francisco based biotech 160 has notched 160 a series of achievements in recent months posting first time operating profit confirming the effectiveness of its breakout compound for treating kidney cancer and retiring
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: MRK's Keytruda MM Combo Studies on Clinical Hold, Bayer to Revise Outlook",2017-07-07 13:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2RgckUoZQQ8/pharma-stock-roundup-mrks-keytruda-mm-combo-studies-on-clinical-hold-bayer-to-revise-outlook-cm812971,Merck s MRK Keytruda has hit a stumbling block with the FDA placing three combination studies on clinical hold Meanwhile Bayer BAYRY said that it will be revising its outlook when it reports second quarter results later this month to reflect inventory issues associated with the Crop
PFE,PFE:US,BBG000BR2B91,"The Cabosun Shone on Exelixis in June, Sending Its Shares Up 32%",2017-07-07 13:47:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0zy3SbC_xiI/the-cabosun-shone-on-exelixis-in-june-sending-its-shares-up-32-cm812851,What happened Shares of Exelixis NASDAQ EXEL a biotech company with a keen focus on developing therapies to treat cancer skyrocketed 32 in June according to data from S amp P Global Market Intelligence The reason for the move can almost entirely be traced to
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 07/07/2017: JNJ, PFE, ABT, MRK, AMGN, NVS, DXTR, CNAT, ADXS",2017-07-07 13:24:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L2Csjw39BOE/health-care-sector-update-for-07072017-jnj-pfe-abt-mrk-amgn-nvs-dxtr-cnat-adxs-cm812890,Top Health Care stocks Top Health Care stocks JNJ 1 1 JNJ 1 1 PFE 0 7 PFE 0 7 ABT flatABT flat MRK flatMRK flat AMGN 0 7 AMGN 0 7 Health care shares were mostly higher in pre market trade Friday Health care shares were mostly higher in pre market trade Friday Dextera
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: MRK&apos;s Keytruda MM Combo Studies on Clinical Hold, Bayer to Revise Outlook",2017-07-07 12:25:12 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-mrk-apos-122512550.html?.tsrc=rss,3 studies on Merck&apos;s (MRK) Keytruda have been put on clinical hold while Bayer said that it expects to revise its 2017 outlook when it reports Q2 results.
PFE,PFE:US,BBG000BR2B91,Pfizer Exits Brazil Venture,2017-07-06 20:14:00 +0000,http://finance.yahoo.com/r/7272ba47-038d-36e6-b917-4d99b13e45db/pfizer-exits-brazil-venture.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"After their failure to find a buyer for their 40% holding in Laboratorio Teuto, Pfizer is now exiting the generic drug making venture for an undisclosed amount."
PFE,PFE:US,BBG000BR2B91,Dow Analyst Moves: PFE,2017-07-06 17:45:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cGW0Mjbw3bQ/dow-analyst-moves-pfe-cm812569,The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average Pfizer PFE is the 20 analyst pick Within the broader S amp P 500 when components were ranked in terms of analyst favorites PFE claims the
PFE,PFE:US,BBG000BR2B91,See How Pfizer Ranks Among Analysts' Top Dow 30 Picks,2017-07-06 17:43:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x920mOkEaJQ/see-how-pfizer-ranks-among-analysts-top-dow-30-picks-cm812560,A study of analyst recommendations at the major brokerages shows that Pfizer Inc Symbol PFE is the 20 broker pick on average out of the 30 stocks making up the Dow Jones Industrial Average according to ETF Channel Within the broader S amp P 500 when components were ranked in terms
PFE,PFE:US,BBG000BR2B91,"IYH, PFE, MDT, CELG: ETF Inflow Alert",2017-07-06 16:47:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wr6gALx2Owk/iyh-pfe-mdt-celg-etf-inflow-alert-cm812534,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares U S Healthcare ETF Symbol IYH where we have detected an approximate 67 0 million dollar inflow that s a 3 4 increase week over week in
PFE,PFE:US,BBG000BR2B91,5 Dow Jones Stocks Every Investor Should Own,2017-07-06 13:30:10 +0000,http://finance.yahoo.com/r/3b068396-6589-374d-a5ad-6db21fbdc421/5-dow-jones-stocks-every-investor-should-own-588818?yptr=yahoo&.tsrc=rss,"If one had to choose several stocks from the Dow Jones Industrial Average, what would be the 5 Dow Jones stocks every investor should own? Ask any investor what the safest stocks to invest in are and they are likely to tell you to go for stocks that are part of the Dow Jones Industrial […]"
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 07/06/2017: JNJ, PFE, ABT, MRK, AMGN, EGLT, TNXP, NVS",2017-07-06 13:24:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TtZ_KkR6Leo/health-care-sector-update-for-07062017-jnj-pfe-abt-mrk-amgn-eglt-tnxp-nvs-cm812275,Top Health Care stocks Top Health Care stocks JNJ 0 3 JNJ 0 3 PFE 0 4 PFE 0 4 ABT 0 7 ABT 0 7 MRK 1 MRK 1 AMGN 0 6 AMGN 0 6 Health care shares were mostly lower in pre market trade Thursday Health care shares were mostly lower in pre market trade Thursday In health
PFE,PFE:US,BBG000BR2B91,"Despite This Happening, Sangamo Therapeutics Inc. Surged 31% in June",2017-07-06 13:22:00 +0000,http://finance.yahoo.com/r/932cbc23-14b7-3549-a70e-4e0d9bece2e8/despite-this-happening-sangamo-therapeutics-inc-su.aspx?yptr=yahoo&.tsrc=rss,Even an $83 million common stock offering can&apos;t stop Sangamo in 2017.
PFE,PFE:US,BBG000BR2B91,In Your 70s? 3 Stocks You Might Want to Buy,2017-07-06 13:11:00 +0000,http://finance.yahoo.com/r/b4ab3a4f-aa67-3d8d-8234-d94a93c3eafd/in-your-70s-3-stocks-you-might-want-to-buy-2.aspx?yptr=yahoo&.tsrc=rss,"Pfizer, STORE Capital, and National Grid all look like timely buys for conservative investors."
PFE,PFE:US,BBG000BR2B91,"Pensionfund Sabic Buys Procter & Gamble Co, McDonald's Corp, PepsiCo Inc, Sells Facebook ...",2017-07-06 08:43:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pstIHNJhccc/pensionfund-sabic-buys-procter-gamble-co-mcdonalds-corp-pepsico-inc-sells-facebook-cm812189,Pensionfund Sabic New Purchases PG MCD PEP PCLN UNP KMB PGR BBY PPL NTAP Added Positions DDR SKT Reduced Positions GOOG MSFT AAPL HCP Sold Out FB INTC ORCL BMY GILD ADI CL SYK ISRG PCG New Purchases PG MCD
PFE,PFE:US,BBG000BR2B91,"Pensionfund DSM Netherlands Buys Procter & Gamble Co, McDonald's Corp, PepsiCo Inc, Sells ...",2017-07-06 07:43:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qm8qtMm98Kw/pensionfund-dsm-netherlands-buys-procter-gamble-co-mcdonalds-corp-pepsico-inc-sells-cm812188,Pensionfund DSM Netherlands New Purchases PG MCD PEP PCLN UNP KMB PGR BBY PPL NTAP Added Positions SKT DDR Reduced Positions GOOG MSFT AAPL CCP HCP Sold Out FB INTC ORCL BMY GILD ADI CL SYK ISRG PCG New Purchases PG
PFE,PFE:US,BBG000BR2B91,"Bank on Gilead Sciences, Inc. (GILD) Stock Getting Its Mojo Back",2017-07-05 14:20:24 +0000,https://finance.yahoo.com/news/bank-gilead-sciences-inc-gild-142024734.html?.tsrc=rss,"For the past 12 months Gilead Sciences, Inc. (NASDAQ:GILD) could have served as the poster-child for a falling knife to avoid.  Finally, GILD stock was able to participate in the biotech sector bounce that happened in June."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 07/05/2017: JNJ, PFE, ABT, MRK, AMGN, MTBC, BGNE, EVHC",2017-07-05 13:24:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wv6hyJkdTYo/health-care-sector-update-for-07052017-jnj-pfe-abt-mrk-amgn-mtbc-bgne-evhc-cm811700,Top Health Care stocks Top Health Care stocks JNJ flatJNJ flat PFE 0 1 PFE 0 1 ABT flatABT flat MRK 0 1 MRK 0 1 AMGN flatAMGN flat Health care shares were mostly quiet in pre market trade Wednesday Health care shares were mostly quiet in pre market trade Wednesday In health
PFE,PFE:US,BBG000BR2B91,"Early movers: VNTV, CAB, PFE, AAPL, INTC, WMT, DIS, BMY & more",2017-07-05 11:59:39 +0000,http://finance.yahoo.com/r/9737cb8c-7071-36c3-942c-4397b6bf0cc3/104567901?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104567901&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
PFE,PFE:US,BBG000BR2B91,"Early movers: VNTV, CAB, PFE, AAPL, INTC, WMT, DIS, BMY & more",2017-07-05 11:59:39 +0000,https://finance.yahoo.com/news/early-movers-vntv-cab-pfe-115939411.html?.tsrc=rss,These are the stocks posting the largest moves before the bell.
PFE,PFE:US,BBG000BR2B91,Mixed open seen as shortened trading week resumes; Fed minutes in focus,2017-07-05 10:21:56 +0000,https://finance.yahoo.com/news/mixed-open-seen-shortened-trading-102156957.html?.tsrc=rss,Traders await the release of the Federal Reserve&apos;s latest meeting minutes.
PFE,PFE:US,BBG000BR2B91,Mixed open seen as shortened trading week resumes; Fed minutes in focus,2017-07-05 10:21:56 +0000,http://finance.yahoo.com/r/809b2316-37f9-318c-ac90-730444f12f6b/104567645?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104567645&yptr=yahoo&.tsrc=rss,Traders await the release of the Federal Reserve's latest meeting minutes.
PFE,PFE:US,BBG000BR2B91,"Pfizer receives token payment to exit Brazil venture, sources say",2017-07-04 17:44:52 +0000,https://finance.yahoo.com/news/pfizer-receives-token-payment-exit-174452337.html?.tsrc=rss,"Pfizer Inc has agreed  to exit Laboratório Teuto Brasileiro SA for a token amount after  failing to find a buyer for the 40 percent stake it held in the  Brazilian generic drugmaking joint venture, two people with  knowledge of the matter said on Tuesday.  According to one of the people, the heirs of Teuto founder  Walterci Melo will pay Pfizer 1 real ($0.30) for the stake  acquired by the U.S. pharmaceutical company seven years ago for  $240 million.  In a statement, Pfizer confirmed the transfer ""after careful  consideration,"" but said the terms of the deal were  confidential."
PFE,PFE:US,BBG000BR2B91,Long-Term Performance of Hedge Funds’ Popular Picks,2017-07-03 15:55:32 +0000,http://finance.yahoo.com/r/51f4ab4f-9bcc-37ba-8f7c-67a58e8b7f5c/long-term-performance-of-hedge-funds-popular-picks-588657?yptr=yahoo&.tsrc=rss,"Despite the recent years of poor performance, hedge funds are still great at picking stocks, as they always have been. Because most hedge funds operate with hundreds of millions of dollars, they can afford to employ resources that are not available to other investors. Moreover, because they usually invest high amounts of money in a […]"
PFE,PFE:US,BBG000BR2B91,Why Investment In Biosimilars Is Important For Pfizer,2017-07-03 15:55:00 +0000,http://finance.yahoo.com/r/71de79a9-591d-3fc5-afdf-fade3971d203/why-investment-in-biosimilars-is-important-for-pfizer?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Pfizer bought Hospira in 2015 to strengthen its generic drugs business, and gain a strong foothold in sterile injectables and the growing biosimilar market. It is Hospira’s biosimilar pipeline that holds to the most promise as far as Pfizer’s upside potential is concerned."
PFE,PFE:US,BBG000BR2B91,Why is Corcept's Stock Up More Than 60% So Far This Year?,2017-07-03 15:49:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/afkyr86r2fw/why-is-corcepts-stock-up-more-than-60-so-far-this-year-cm811198,Shares of Corcept Therapeutics Incorporated CORT has soared 62 5 this year so far massively outperforming the 5 6 increase registered by the Zacks classified Medical Drugs industry during this period Here we analyze the factors that led to the rally Corcept s only marketed
PFE,PFE:US,BBG000BR2B91,Pfizer's (PFE) Leukemia Candidate Receives Approval in EU,2017-07-03 15:48:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YTMfctTU44k/pfizers-pfe-leukemia-candidate-receives-approval-in-eu-cm811163,Pfizer Inc PFE announced that its leukemia candidate Besponsa has been approved by the European Commission The drug is approved as a monotherapy for relapsed or refractory CD22 positive B cell precursor acute lymphoblastic leukemia ALL including patients with either
PFE,PFE:US,BBG000BR2B91,Pfizer&apos;s (PFE) Leukemia Candidate Receives Approval in EU,2017-07-03 14:01:02 +0000,https://finance.yahoo.com/news/pfizer-apos-pfe-leukemia-candidate-140102995.html?.tsrc=rss,"Pfizer Inc. (PFE) announced that its leukemia candidate, Besponsa, has been approved by the European Commission."
PFE,PFE:US,BBG000BR2B91,"Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for July 05, 2017",2017-07-03 13:14:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dy_0dQnsy1o/bristol-myers-squibb-company-bmy-ex-dividend-date-scheduled-for-july-05-2017-cm811075,Bristol Myers Squibb Company BMY will begin trading ex dividend on July 05 2017 A cash dividend payment of 0 39 per share is scheduled to be paid on August 01 2017 Shareholders who purchased BMY prior to the ex dividend date are eligible for the cash dividend payment This marks the
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 07/03/2017: JNJ, PFE, ABT, MRK, AMGN, OPXA, PTCT. KND",2017-07-03 13:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xz5Igml0HKs/health-care-sector-update-for-07032017-jnj-pfe-abt-mrk-amgn-opxa-ptct-knd-cm811036,Top Health Care stocks Top Health Care stocks JNJ flatJNJ flat PFE 0 3 PFE 0 3 ABT flatABT flat MRK 0 1 MRK 0 1 AMGN flatAMGN flat Health care shares were mostly quiet in pre market trade Monday Health care shares were mostly quiet in pre market trade Monday In health care
PFE,PFE:US,BBG000BR2B91,"The CBO Trips Up Trumpcare, Plus a Biotech &quot;Spiffy-Pop",2017-07-02 11:21:00 +0000,http://finance.yahoo.com/r/8cd71da6-345b-381c-9807-e36f98671d07/the-cbo-trips-up-trumpcare-plus-a-biotech-spiffy-p.aspx?yptr=yahoo&.tsrc=rss,"The Congressional Budget Office announces a discouraging outlook for Trumpcare. Meanwhile, Portola Pharmaceuticals&apos; stock price increases more in one day than it cost last November."
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. Eli Lilly and Company,2017-07-01 18:04:00 +0000,http://finance.yahoo.com/r/d34ac086-dfab-3da9-af2d-a35dcf6d26b0/better-buy-pfizer-inc-vs-eli-lilly-and-company.aspx?yptr=yahoo&.tsrc=rss,Which big pharma stock wins in a head-to-head matchup between Pfizer and Lilly?
PFE,PFE:US,BBG000BR2B91,"3 Stocks That Turned $7,000 Into As Much As $37,000 So Far in 2017",2017-06-30 23:42:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hBS_ca0oLG4/3-stocks-that-turned-7000-into-as-much-as-37000-so-far-in-2017-cm810801,With the Dow Jones Industrial Average still trading in nosebleed territory above 21 000 points it s easy to find stocks that are being lifted by the rising tide Yet some companies have risen atop the wave doubling tripling and even quadrupling in value this year Three
PFE,PFE:US,BBG000BR2B91,Arena Ends Study on Extended Release Formulation of PAH Drug,2017-06-30 17:42:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8UuEZ6Hy1m0/arena-ends-study-on-extended-release-formulation-of-pah-drug-cm810652,ARena Pharmaceuticals Inc ARNA announced that it has completed an early stage study comparing the once daily extended release XR formulation of its experimental pulmonary arterial hypertension PAH candidate ralinepag with its twice daily immediate release IR formulation It is to
PFE,PFE:US,BBG000BR2B91,Sarepta Looks to Focus on Exondys 51 & DMD Pipeline in 2017,2017-06-30 16:44:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RMRcr4Eglv4/sarepta-looks-to-focus-on-exondys-51-dmd-pipeline-in-2017-cm810615,We issued an updated research report on Cambridge MA based Sarepta Therapeutics Inc SRPT on Jun 28 Sarepta is a commercial stage biopharmaceutical company that focuses on the discovery and development of RNA based therapeutics targeting rare and infectious diseases especially
PFE,PFE:US,BBG000BR2B91,"Merck’s Valuation on June 28, 2017",2017-06-30 14:39:18 +0000,http://finance.yahoo.com/r/add902ed-6bbf-3110-99e7-4b8e9d222292/mercks-valuation-on-june-28-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Of the 22 analysts covering Merck, 14 analysts recommended a “buy”, seven analysts recommended a “hold,” and one analyst recommended a “sell.”"
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/30/2017: JNJ, PFE, ABT, MRK, AMGN, SKLN, AMGN. CARA",2017-06-30 13:23:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nxjX_aDl5Eg/health-care-sector-update-for-06302017-jnj-pfe-abt-mrk-amgn-skln-amgn-cara-cm810373,Top Health Care stocks Top Health Care stocks JNJ flatJNJ flat PFE 0 2 PFE 0 2 ABT 0 6 ABT 0 6 MRK flatMRK flat AMGN 1 2 AMGN 1 2 Health care shares were mixed in pre market trade Friday Health care shares were mixed in pre market trade Friday In health care stocks
PFE,PFE:US,BBG000BR2B91,InPlay from Briefing.com,2017-06-30 11:43:49 +0000,https://finance.yahoo.com/news/inplay-briefing-com-125529772.html?.tsrc=rss,InPlay from Briefing.com
PFE,PFE:US,BBG000BR2B91,BESPONSA® Approved in the EU for Adult Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia,2017-06-30 11:30:00 +0000,https://finance.yahoo.com/news/besponsa-approved-eu-adult-patients-113000503.html?.tsrc=rss,Pfizer Inc. today announced that the European Commission has approved BESPONSA® as monotherapy for the treatment of adults with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia .
PFE,PFE:US,BBG000BR2B91,The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion),2017-06-30 10:00:00 +0000,http://finance.yahoo.com/r/f27a8ac9-dc1c-3bfe-83da-0f54f2054a92/the-9-best-selling-prescription-drugs-in-2016-each.aspx?yptr=yahoo&.tsrc=rss,These prescription drugs raked in billions of dollars last year. But several of them might not be so lucrative for much longer.
PFE,PFE:US,BBG000BR2B91,Pfizer Reports European Commission's Approval Of BESPONSA - Quick Facts,2017-06-30 07:44:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vmcfc4M51Zc/pfizer-reports-european-commissions-approval-of-besponsa--quick-facts-20170630-00292,Pfizer Reports European Commission's Approval Of BESPONSA - Quick Facts
PFE,PFE:US,BBG000BR2B91,Is It Too Late to Buy Portola Pharmaceuticals Stock?,2017-06-29 22:03:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5Ibp8W6ORvU/is-it-too-late-to-buy-portola-pharmaceuticals-stock-cm810244,Portola Pharmaceuticals NASDAQ PTLA is enjoying the best year ever at least in terms of stock performance After losing more than half of its market cap last year the biotech s share price is up more than 140 so far in 2017 There has been nothing but good news for Portola
PFE,PFE:US,BBG000BR2B91,"M&As, Rich Pipelines & Catalyst Rich 2017 to Drive Pharma Stocks",2017-06-29 22:02:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gIpEven5cMk/mas-rich-pipelines-catalyst-rich-2017-to-drive-pharma-stocks-cm810261,Although pharma and biotech stocks are facing challenges in the form of increasing focus on the high prices of drugs a changing competitive scenario and mixed results the sector s fundamentals remain strong innovation mergers and acquisitions M amp As product approvals and positive
PFE,PFE:US,BBG000BR2B91,"M&As, Rich Pipelines & Catalyst Rich 2017 to Drive Pharma Stocks",2017-06-29 19:53:07 +0000,https://finance.yahoo.com/news/m-rich-pipelines-catalyst-rich-195307641.html?.tsrc=rss,"M&As, Rich Pipelines & Catalyst Rich 2017 to Drive Pharma Stocks"
PFE,PFE:US,BBG000BR2B91,"FDA, Pfizer, Merck join WHO in Memphis for global drug conference",2017-06-29 19:50:11 +0000,http://finance.yahoo.com/r/c2f9c0f2-aa60-3a88-ba33-c4ba6400a272/fda-pfizer-merck-join-who-in-memphis-for-global.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Pharmaceutical industry representatives and regulators from 13 countries were in Memphis this week to discuss safety strategies for global pharmaceutical manufacturing, shipping and delivery.  University of Tennessee Health Science Center (UTHSC) hosted 75 attendees from June 26-29.  “Substandard and counterfeit drugs are a global problem that needs global solutions and global collaboration,"" said Ilisa Bernstein, deputy director of the FDA's Center for Drug Research (CDER) Office of Compliance."
PFE,PFE:US,BBG000BR2B91,"Zacks Industry Outlook Highlights: Johnson & Johnson, Incyte, Pfizer, Novartis and AstraZeneca",2017-06-29 15:08:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kh6QkYi0BYs/zacks-industry-outlook-highlights-johnson-johnson-incyte-pfizer-novartis-and-astrazeneca-cm809831,For Immediate Release Chicago IL June 29 2017 Today Zacks Equity Research discusses the Industry Pharmaceuticals including Johnson amp Johnson NYSE JNJ Free Report Incyte NASDAQ INCY Free Report Pfizer NYSE PFE Free Report Novartis NYSE NVS
PFE,PFE:US,BBG000BR2B91,Merck & Co. Inc.: The Bear Case from a Bull,2017-06-29 15:07:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V9RqASYdJKc/merck-co-inc-the-bear-case-from-a-bull-cm809891,Merck NYSE MRK 160 lays claim to one of the hottest cancer drugs on the market with Keytruda The big pharma company also just announced positive results for its experimental cholesterol drug 160 anacetrapib with significantly reduced cardiovascular risk Perhaps
PFE,PFE:US,BBG000BR2B91,The Real Impact Of The Walgreens And Rite Aid Saga,2017-06-29 14:55:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UHrs85XYGXo/the-real-impact-of-the-walgreens-and-rite-aid-saga-cm809930,"Walgreens (Shutterstock photo)    The story of the proposed merger between Walgreens ( WBA ) and Rite Aid ( RAD ) took another twist this morning. Over the last week or so, the saga has taken on the “will they, won’t they” characteristics of a soap opera romance. Last week stories were circulating saying that the"
PFE,PFE:US,BBG000BR2B91,"Zacks Industry Outlook Highlights: Johnson & Johnson, Incyte, Pfizer, Novartis and AstraZeneca",2017-06-29 13:30:01 +0000,https://finance.yahoo.com/news/zacks-industry-outlook-highlights-johnson-133001328.html?.tsrc=rss,"Zacks Industry Outlook Highlights: Johnson & Johnson, Incyte, Pfizer, Novartis and AstraZeneca"
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/29/2017: JNJ, PFE, ABT, MRK, AMGN, VRX, SRPT, NVS",2017-06-29 13:22:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e_AkNqB2YbI/health-care-sector-update-for-06292017-jnj-pfe-abt-mrk-amgn-vrx-srpt-nvs-cm809780,Top Health Care stocks Top Health Care stocks JNJ 0 1 JNJ 0 1 PFE 0 1 PFE 0 1 ABT flatABT flat MRK 0 1 MRK 0 1 AMGN 0 04 AMGN 0 04 Health care shares were mixed in pre market trade Thursday Health care shares were mixed in pre market trade Thursday In health care
PFE,PFE:US,BBG000BR2B91,Merck & Co. Inc.: The Bear Case from a Bull,2017-06-29 13:03:00 +0000,http://finance.yahoo.com/r/c9e6a446-b3de-31f2-8ab1-400b9b9f9824/merck-co-inc-the-bear-case-from-a-bull.aspx?yptr=yahoo&.tsrc=rss,A pessimistic look at Merck from an optimist.
PFE,PFE:US,BBG000BR2B91,3 Value Stocks Perfect for Retirement,2017-06-29 12:53:00 +0000,http://finance.yahoo.com/r/d8a57137-fb53-35c5-aaa0-c53b1e162667/3-value-stocks-perfect-for-retirement.aspx?yptr=yahoo&.tsrc=rss,"Why Copart, Consolidated Edison, and Pfizer make for great retirement stocks."
PFE,PFE:US,BBG000BR2B91,Alcyone Lifesciences Enters into a Feasibility Study Agreement with Pfizer to Evaluate Alcyone's proprietary Pulsar™ Advanced Intrathecal Precision Delivery Platform Technology for use in Gene Therapy Targeting Central Nervous System Disorders,2017-06-29 12:30:00 +0000,https://finance.yahoo.com/news/alcyone-lifesciences-enters-feasibility-study-123000852.html?.tsrc=rss,"LOWELL, Mass., June 29, 2017 /PRNewswire/ -- Alcyone Lifesciences, Inc., a leader in precision advanced central nervous system (CNS) delivery systems announced that it has entered into a feasibility study agreement with Pfizer Inc. (PFE) in the area of genetic therapy targeting rare and orphan neurological disorders.  The feasibility study combines Alcyone's proprietary PulsarTM Advanced Intrathecal Precision Delivery Platform Technology and Pfizer's Recombinant Adeno-associated Viral Vector (rAAV) gene therapy technology in an effort to develop a method of administering genetic therapies that may address neurological disorders more effectively."
PFE,PFE:US,BBG000BR2B91,Biotech Stocks Facing FDA Decision In July,2017-06-29 00:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pgpziX5aPwc/biotech-stocks-facing-fda-decision-in-july-20170629-00014,Biotech Stocks Facing FDA Decision In July
PFE,PFE:US,BBG000BR2B91,Better Days Ahead for the Pharma Sector?,2017-06-28 22:03:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3MnO6tocceA/better-days-ahead-for-the-pharma-sector-cm809665,We are halfway through 2017 and the pharma and biotech sector has bounced back nicely with the NYSE ARCA Pharmaceutical Index gaining 12 9 while the NASDAQ Biotechnology Index is up 17 2 This is in sharp contrast to 2016 which was a tough year for pharma and biotech stocks with the
PFE,PFE:US,BBG000BR2B91,Is This the Next Home-Run Biotech Stock?,2017-06-28 15:07:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4Eko_I18-4o/is-this-the-next-home-run-biotech-stock-cm809218,Alzheimer s disease is incredibly tough to treat and 99 of Alzheimer s disease drugs to enter clinical trials have failed But Axovant Sciences NYSE AXON thinks it s designed a trial that can pan out and given that its management includes been there and done that leaders it
PFE,PFE:US,BBG000BR2B91,Pfizer’s Profitability in 1Q17,2017-06-28 14:36:01 +0000,http://finance.yahoo.com/r/fca262f0-7aac-3d7f-8edc-d71fa63cfb60/pfizers-profitability-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer's gross margin for 1Q17 was 81.0%, a 0.70% rise compared to 80.3% in 1Q16."
PFE,PFE:US,BBG000BR2B91,Merck's CETP Inhibitor Reduces CV Risk in Phase III Study,2017-06-28 14:06:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3lAgTwR1uBs/mercks-cetp-inhibitor-reduces-cv-risk-in-phase-iii-study-cm809326,Merck amp Co Inc MRK announced that a large late stage cardiovascular outcomes study REVEAL evaluating anacetrapib a cholesterol lowering medicine met the primary endpoint by reducing cardiovascular CV risk Top line data from the phase III study showed that anacetrapib a
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/28/2017: JNJ, PFE, ABT, MRK, AMGN, GMRE, BLUE, FOLD",2017-06-28 13:29:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eL7m3z0Zr1s/health-care-sector-update-for-06282017-jnj-pfe-abt-mrk-amgn-gmre-blue-fold-cm809229,Top Health Care stocks Top Health Care stocks JNJ flatJNJ flat PFE 0 1 PFE 0 1 ABT flatABT flat MRK 0 1 MRK 0 1 AMGN 0 2 AMGN 0 2 Health care shares were mixed in pre market trade Wednesday Health care shares were mixed in pre market trade Wednesday In health care stocks
PFE,PFE:US,BBG000BR2B91,Pfizer’s Geographical Performance in 1Q17,2017-06-28 13:06:20 +0000,http://finance.yahoo.com/r/fe3710e2-6ebb-3743-8f6d-765ec16798da/pfizers-geographical-performance-in-1q17-2?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,The Innovative Health segment reported a 9.0% rise in 1Q17 revenues compared to 1Q16 revenues from sales in the US markets.
PFE,PFE:US,BBG000BR2B91,Pfizer’s Segment Performance in 1Q17,2017-06-28 11:36:35 +0000,http://finance.yahoo.com/r/33cc7b31-a76a-3038-89a9-3d03e83f1671/pfizers-segment-performance-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer Innovative Health contributed $7.4 billion, or about 58.0% of Pfizer's total revenues in 1Q17."
PFE,PFE:US,BBG000BR2B91,[$$] Cancer Drug Startup Vivace Therapeutics Raises $40 Million,2017-06-28 10:15:03 +0000,http://finance.yahoo.com/r/32827687-22b8-339b-93b7-39e628823d1a/cancer-drug-startup-vivace-therapeutics-raises-40-million-1498644900?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Two former executives of successful venture-backed company LEAD Therapeutics are now leaders of Vivace Therapeutics Inc., a cancer drug startup that has raised $40 million in Series A and B financing."
PFE,PFE:US,BBG000BR2B91,[$$] Merck Cholesterol Drug Could Help Unlock Value,2017-06-27 20:03:00 +0000,http://finance.yahoo.com/r/2a6f266a-57eb-37e3-af39-9dd51b843912/merck-cholesterol-drug-could-help-unlock-value-1498593835?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"In the last decade, no fewer than three major pharmaceutical companies have suffered defeat trying to bring a new class of cholesterol-lowering medication to market.s Much to the surprise of investors, Merck & Co. (MRK) could succeed where Pfizer (PFE), Roche (RHHBY) and Eli Lilly & Co. (LLY) have all failed.  Merck has yet to decide if it will seek Food and Drug Administration approval, a sign to some that the company isn’t sure if the study data, though positive, are strong enough to ensure regulatory approval.  Thanks to the growing success of Merck’s immunotherapy cancer drug Keytruda, the shares have gained 19% in the past year to near a 52-week high of $66.80."
PFE,PFE:US,BBG000BR2B91,AstraZeneca's Faslodex Recommended by CHMP for 1st Line Use,2017-06-27 16:52:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fpC77U1mUg8/astrazenecas-faslodex-recommended-by-chmp-for-1st-line-use-cm808905,AstraZeneca PLC AZN announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has adopted a positive opinion recommending the marketing authorisation of Faslodex fulvestrant for 1st line treatment for postmenopausal women with HR
PFE,PFE:US,BBG000BR2B91,Sanofi/Regeneron's Kevzara Gets Marketing Approval in EU,2017-06-27 15:55:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BCQF5SWBwWs/sanofiregenerons-kevzara-gets-marketing-approval-in-eu-cm808820,Sanofi SNY and partner Regeneron Pharmaceuticals Inc REGN announced that the European Commission has granted marketing approval to its rheumatoid arthritis RA drug Kevzara The IL 6R antibody has been approved for the treatment of adult patients in combination with methotrexate MTX
PFE,PFE:US,BBG000BR2B91,A Look at Pfizer’s Revenue for 1Q17,2017-06-27 14:36:38 +0000,http://finance.yahoo.com/r/80d78812-5571-3985-a790-e6decec237af/a-look-at-pfizers-revenue-for-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer (PFE) reported a 2.0% fall in 1Q17 revenues to ~$12.8 billion, with a 1.0% operational fall in revenues and a 1.0% negative impact of foreign exchange."
PFE,PFE:US,BBG000BR2B91,"Pfizer’s Valuation as of June 22, 2017",2017-06-27 13:07:04 +0000,http://finance.yahoo.com/r/ebf7c46d-d6d8-33b3-a8f3-5ab9ea56bd60/pfizers-valuation-as-of-june-22-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer was trading at a forward PE multiple of ~12.8x on June 22, 2017, compared to the industry average of ~16.6x."
PFE,PFE:US,BBG000BR2B91,Shocker: Merck Cholesterol Drug Yields Benefit Where Rivals Failed,2017-06-27 13:03:00 +0000,http://finance.yahoo.com/r/ff629c80-f338-33a6-b051-d22dbf12d3a4/shocker-merck-cholesterol-drug-yields-benefit-where-rivals-failed?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Merck announced this morning that anacetrapib, a cholesterol-lowering medicine, reduced heart problems and strokes in a 30,000-patient clinical trial, giving the drug giant a success where Pfizer, Eli Lilly and Roche have all failed."
PFE,PFE:US,BBG000BR2B91,"Pfizer Breaks Ground on New R&D Facility in Chesterfield, Missouri",2017-06-27 13:00:00 +0000,https://finance.yahoo.com/news/pfizer-breaks-ground-r-d-130000499.html?.tsrc=rss,"Today Pfizer Inc., one of the world’s premier biopharmaceutical companies, broke ground on a state-of-the art Research and Development and process development facility at 875 W."
PFE,PFE:US,BBG000BR2B91,Pfizer a Top 25 Dividend Giant With 3.77% Yield (PFE),2017-06-27 12:50:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XHrEntL03RM/pfizer-a-top-25-dividend-giant-with-377-yield-pfe-cm808472,Pfizer Inc Symbol PFE has been named as a Top 25 Dividend Giant by ETF Channel with a stunning 11 54B worth of stock held by ETFs and above average DividendRank statistics including a strong 3 77 yield according to the most recent Dividend Channel DividendRank report
PFE,PFE:US,BBG000BR2B91,The Forgotten $35 Billion U.S. Healthcare Problem,2017-06-27 12:38:00 +0000,http://finance.yahoo.com/r/07d39e54-4eb1-3e02-ba4f-43b125958718/the-forgotten-35-billion-u-s-health-care-problem?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Each year, more than 23,000 people die in the U.S. as a result of bacterial infections that are resistant to antibiotics – the equivalent of a Boeing 747 crashing each week. Worse, there are at least 2 million people each year who acquire serious infections by bacteria resistant to antibiotics."
PFE,PFE:US,BBG000BR2B91,2 Pharma Buyout Targets That May Surprise You,2017-06-27 12:08:00 +0000,http://finance.yahoo.com/r/843a6f38-6ac1-3950-96fb-797be2623bf5/2-biopharma-buyout-targets-that-may-surprise-you.aspx?yptr=yahoo&.tsrc=rss,"When the M&A bonanza picks up again, Biogen and Bristol-Myers Squibb may be the first to go. Here&apos;s why."
PFE,PFE:US,BBG000BR2B91,Pfizer Fueling Growth Of Competitors' Pipelines,2017-06-27 12:01:00 +0000,http://finance.yahoo.com/r/e9bab4d9-f3c0-3d80-9cc6-742d2f9992b3/pfizer-fueling-growth-of-competitors-pipelines?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,But it would have been nice to have been able to keep these drugs in-house and bring them to market under the Pfizer banner.
PFE,PFE:US,BBG000BR2B91,Tanezumab Receives FDA Fast Track Designation,2017-06-27 11:38:11 +0000,http://finance.yahoo.com/r/81cf0dca-dca0-3413-9a69-2e557d357e85/tanezumab-receives-fda-fast-track-designation?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Tanezumab is an investigational drug co-developed by Pfizer (PFE) and Eli Lilly (LLY) for pain management in chronic pain related to cancer, lower back pain, and osteoarthritis."
PFE,PFE:US,BBG000BR2B91,"How Things Look for Opko Health, Inc. in 3 Charts",2017-06-26 21:50:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FX9p2uqNx5g/how-things-look-for-opko-health-inc-in-3-charts-cm808360,Opko Health Inc NASDAQ OPK has gone through significant changes over the last couple of years It launched 160 secondary hyperparathyroidism drug Rayaldee Opko s partner Tesaro NASDAQ TSRO launched Varubi as a treatment for chemotherapy induced nausea and vomiting
PFE,PFE:US,BBG000BR2B91,"How Things Look for Opko Health, Inc. in 3 Charts",2017-06-26 20:26:00 +0000,http://finance.yahoo.com/r/1f83eda0-7266-3ec7-aed0-35759199342e/how-things-look-for-opko-health-inc-in-3-charts.aspx?yptr=yahoo&.tsrc=rss,"It hasn&apos;t been a great year so far for Opko Health, but the future could be brighter."
PFE,PFE:US,BBG000BR2B91,How to Find Cheap Stocks With 5%+ Dividends,2017-06-26 18:51:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/epMIdw4OBPI/how-to-find-cheap-stocks-with-5-dividends-cm808319,InvestorPlace Stock Market News Stock Advice amp Trading Tips Today I m going to show you 2 easy ways to set yourself up for safe double digit yearly dividend growth and invite quick 100 upside too I ll also reveal a blue chip stock that s delivering both
PFE,PFE:US,BBG000BR2B91,Pfizer Has Received Commercial Rights for Cresemba in Europe,2017-06-26 16:05:43 +0000,http://finance.yahoo.com/r/e4fb5c0d-9429-395e-a71a-9602216f97b6/pfizer-received-commercial-rights-cresemba-europe?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On June 14, 2017, Pfizer (PFE) announced an agreement with Basilea Pharmaceutica for exclusive commercial rights for Cresemba in Europe."
PFE,PFE:US,BBG000BR2B91,Epizyme Progressing Well on Two Lead Pipeline Candidates,2017-06-26 14:55:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sCU3DvRRyTg/epizyme-progressing-well-on-two-lead-pipeline-candidates-cm808031,We issued an updated research report on Epizyme Inc EPZM on Jun 23 2017 Currently Epizyme is a development stage biopharmaceutical company focused on bringing novel epigenetic therapies for the treatment of cancer and other diseases to market Key candidates in Epizyme s pipeline
PFE,PFE:US,BBG000BR2B91,Pfizer Stock Looks Pretty Bullish for the Long Term,2017-06-26 14:50:00 +0000,http://finance.yahoo.com/r/2619f770-2c8e-31c9-87d6-eaa9df2d8af1/pfizer-stock-looks-pretty-bullish-long-term?partner=YahooSA&yptr=yahoo&.tsrc=rss,"After spending much of the last two months in a slow decline, shares of Pfizer have broken out of their downtrend."
PFE,PFE:US,BBG000BR2B91,Pfizer’s Xeljanz: Results from the ORAL Strategy,2017-06-26 14:38:16 +0000,http://finance.yahoo.com/r/45eddca8-a944-3544-aa05-b13392b7ac11/pfizers-xeljanz-results-from-the-oral-strategy?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On June 16, 2017, Pfizer announced detailed results from its ORAL (Oral Rheumatoid Arthritis TriaL) Strategy."
PFE,PFE:US,BBG000BR2B91,After health care gains eight percent in one quarter,2017-06-26 14:24:00 +0000,https://finance.yahoo.com/video/health-care-gains-eight-percent-142400664.html?.tsrc=rss,"According to Kensho, health care gains 8% in one quarter with Merck, Bristol-Myers and Pfizer as some of its outperformers."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/26/2017: JNJ, PFE, ABT, MRK, AMGN",2017-06-26 13:29:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7ENUfsh4DzQ/health-care-sector-update-for-06262017-jnj-pfe-abt-mrk-amgn-cm807970,Top Health Care stocks Top Health Care stocks JNJ 0 5 JNJ 0 5 PFE 0 5 PFE 0 5 ABT 0 2 ABT 0 2 MRK 0 02 MRK 0 02 AMGN 0 5 AMGN 0 5 Health care shares were mainly firmer in pre market trade Monday Health care shares were mainly firmer in pre market trade Monday In
PFE,PFE:US,BBG000BR2B91,Pfizer’s Progress on Its Group B Streptococcus Vaccine,2017-06-26 12:40:31 +0000,http://finance.yahoo.com/r/1ac4710a-2fa7-356a-8eaf-2d41d2046d6e/pfizers-progress-group-b-streptococcus-vaccine?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Pfizer (PFE) has started a Phase 1 clinical trial to evaluate an investigational vaccine for protection against Group B streptococcus in infants younger than three months.
PFE,PFE:US,BBG000BR2B91,Trader shares top health-care play,2017-06-26 11:18:00 +0000,https://finance.yahoo.com/video/trader-shares-top-health-care-111800374.html?.tsrc=rss,"I'm long Pfizer and I plan staying that way, says Jim Iuorio, TJM Institutional Services, sharing his bet in the health-care sector."
PFE,PFE:US,BBG000BR2B91,How To Find Dividend Payers With 100%+ Upside To Boot,2017-06-25 13:32:00 +0000,http://finance.yahoo.com/r/ec4de4a7-5f22-3f1b-a65c-e474d05dc418/how-to-find-dividend-payers-with-100-upside-to-boot?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,Today I’m going to show you 2 easy ways to set yourself up for safe double-digit yearly dividend growth and invite quick 100%+ upside too.
PFE,PFE:US,BBG000BR2B91,3 Stocks to Help You Build Retirement Wealth,2017-06-25 12:50:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d73acg8TXyk/3-stocks-to-help-you-build-retirement-wealth-cm807822,There are plenty of options available for investing your money with retirement in mind Some are definitely better than others though The ideal stocks for retirement are companies with enduring business models that pay solid dividends Three stocks that definitely meet those two
PFE,PFE:US,BBG000BR2B91,3 Stocks to Help You Build Retirement Wealth,2017-06-25 10:48:00 +0000,http://finance.yahoo.com/r/7ed59c23-84a3-36f5-9f74-dd7d43d69dab/3-stocks-to-help-you-build-retirement-wealth.aspx?yptr=yahoo&.tsrc=rss,"Why Cisco Systems, IBM, and Pfizer are great stocks for retirement portfolios."
PFE,PFE:US,BBG000BR2B91,Portola Pharmaceuticals' FDA Nod Could Spark M&A Interest,2017-06-24 13:51:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Dgzi__jOhkk/portola-pharmaceuticals-fda-nod-could-spark-ma-interest-cm807751,Portola Pharmaceuticals NASDAQ PTLA 160 investors who stuck with it after stumbles caused share prices to crash last year are feeling a bit better about their position today On Friday the Food and Drug Administration approved the company s first drug 160 Bevyxxa and
PFE,PFE:US,BBG000BR2B91,Portola Pharmaceuticals&apos; FDA Nod Could Spark M&A Interest,2017-06-24 12:03:00 +0000,http://finance.yahoo.com/r/f4d78d7a-5352-35d8-800c-2acfc9b9fea7/portola-pharmaceuticals-fda-nod-could-spark-ma-int.aspx?yptr=yahoo&.tsrc=rss,"The FDA has approved its first commercial medicine, and because it could reshape a big indication, the company may have just gotten a lot more interesting to suitors."
PFE,PFE:US,BBG000BR2B91,"Greenwich Capital Commercial Funding Corp., 2005-GG3 -- Moody's Affirms Four Classes of GCCFC 2005-GG3",2017-06-23 16:59:08 +0000,http://finance.yahoo.com/r/5a0be947-663c-3f7b-9aec-ca7af4e311e9/viewresearchdoc.aspx?docid=PR_368559&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170623_PR_368559&yptr=yahoo&.tsrc=rss,Rating Action: Moody's Affirms Four Classes of GCCFC 2005- GG3. Global Credit Research- 23 Jun 2017. Approximately $86.3 Million of Structured Securities Affected.
PFE,PFE:US,BBG000BR2B91,Dow 30 Stock Roundup: Boeing Bags Big Orders at Paris Air Show; Wal-Mart to Buy Bonobos,2017-06-23 15:57:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/986DEiAPNWo/dow-30-stock-roundup-boeing-bags-big-orders-at-paris-air-show-wal-mart-to-buy-bonobos-cm807470,The Dow experienced a turbulent week even as the broader market was guided by the fortunes of tech stocks On the first day of the week tech stocks rebounded helping the index move higher However a decline in energy shares led to the blue chip index closing in the red on Tuesday and
PFE,PFE:US,BBG000BR2B91,Healthcare Stocks Make a Dumb Move on ‘Trumpcare’,2017-06-23 14:28:54 +0000,https://finance.yahoo.com/news/healthcare-stocks-dumb-move-trumpcare-142854917.html?.tsrc=rss,"Tenet Healthcare Corp. (NYSE:THC) was up 6.9% on the day; Community Health Systems (NYSE:CYH) was up 5.1%; HCA Healthcare Inc (NYSE:HCA) was up 2.1% and gained another dime per share overnight.  UnitedHealth Group Inc (NYSE:UNH) hit an all-time high, adding almost $3 billion to its market cap.  Hospitals like Tenet were rallying employees against this bill, because they know that."
PFE,PFE:US,BBG000BR2B91,Biotech Movers: Regeneron Slides Back After Big Gains,2017-06-23 14:08:00 +0000,http://finance.yahoo.com/r/e78e2d53-2a2c-3290-8a0f-206fb693b4ab/biotech-movers-regeneron-slides-back-after-big-gains.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The main headwind for Regeneron is that Swiss pharma giant Novartis could soon be a rival to the eye drug that drives most of Regeneron's revenue.
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/23/2017: JNJ, PFE, ABT, MRK, AMGN, CARA, BLCM, NVS",2017-06-23 13:29:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S7NL2Z5KMuk/health-care-sector-update-for-06232017-jnj-pfe-abt-mrk-amgn-cara-blcm-nvs-cm807297,Top Health Care stocks Top Health Care stocks JNJ 0 1 JNJ 0 1 PFE 1 3 PFE 1 3 ABT 0 1 ABT 0 1 MRK flatMRK flat AMGN 0 2 AMGN 0 2 Health care shares were mainly higher in pre market trade Friday Health care shares were mainly higher in pre market trade Friday In health
PFE,PFE:US,BBG000BR2B91,Vertex on the Street: Analysts’ Recommendations in June 2017,2017-06-23 13:06:47 +0000,http://finance.yahoo.com/r/2c134374-b01b-3bf5-af3b-e6eddcdf0b73/vertex-on-the-street-analysts-recommendations-in-june-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Vertex (VRTX) has planned to submit a new drug application to the FDA in 3Q17 for a Tezacaftor-Ivacaftor combination treatment for cystic fibrosis.
PFE,PFE:US,BBG000BR2B91,Novartis breast cancer drug Kisqali wins European panel nod,2017-06-23 09:10:03 +0000,https://finance.yahoo.com/news/novartis-breast-cancer-drug-kisqali-091003898.html?.tsrc=rss,"A European Medicines Agency panel recommended on Friday approving Novartis's Kisqali drug, bolstering the Swiss drugmaker's bid to challenge rival Pfizer's Ibrance against tough-to-treat breast cancer. ..."
PFE,PFE:US,BBG000BR2B91,Stocks to Fight Cancer: Why Immunotherapy Is a Gamechanger,2017-06-22 22:19:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AEaNQnJCSgY/stocks-to-fight-cancer-why-immunotherapy-is-a-gamechanger-cm807149,1 10 What Is the ASCO Conference And Why Is It Important 5 50 What Has Changed In The World Of Oncology Over The Years 9 00 What Cancers Is Immunotherapy Focused On Now 10 55 Incyte INCY Combination Trials 13 15 Are
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. – Value Analysis (NYSE:PFE) : June 22, 2017",2017-06-22 21:05:29 +0000,http://finance.yahoo.com/r/59df73e0-6392-395c-956d-929e5a21f31d/pfizer-inc-value-analysis-nysepfe-june-22-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Pfizer Inc. a score of 50. Our analysis is based on comparing Pfizer Inc. with the following peers – Merck & Co., Inc., Johnson & Johnson, Bristol-Myers Squibb Company, Eli Lilly and Company, Novartis AG Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Mylan N.V., Abbott Laboratories ... Read more
<b>(Read more...)</b>"
PFE,PFE:US,BBG000BR2B91,"3 Big Stock Charts for Thursday: Pfizer Inc. (PFE), Wal-Mart Stores Inc (WMT) and Costco Wholesale Corporation (COST)",2017-06-22 20:22:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6QeyFJoXKtg/3-big-stock-charts-for-thursday-pfizer-inc-pfe-wal-mart-stores-inc-wmt-and-costco-wholesale-corporation-cost-cm807134,InvestorPlace Stock Market News Stock Advice amp Trading Tips The market is seeing some serious splits in performance both at the sector and the stock level This is typical for summer trading as we usually see the environment turn more into a stock pickers game Today
PFE,PFE:US,BBG000BR2B91,Pfizer Declares 32-Cent Third-Quarter 2017 Dividend,2017-06-22 20:05:00 +0000,https://finance.yahoo.com/news/pfizer-declares-32-cent-third-200500741.html?.tsrc=rss,"The board of directors of Pfizer Inc. today declared a 32-cent third-quarter 2017 dividend on the company’s common stock, payable September 1, 2017, to shareholders of record at the close of business on August 4, 2017."
PFE,PFE:US,BBG000BR2B91,Here's Why Sangamo Therapeutics Rose as Much as 11.7% Today,2017-06-22 18:21:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sgVrPrPTIGw/heres-why-sangamo-therapeutics-rose-as-much-as-117-today-cm807032,What happened Shares of biopharmaceutical company Sangamo Therapeutics NASDAQ SGMO rose nearly 12 this morning after a new analyst took over coverage of the stock at Jefferies The analyst said an impressive showing at a recent conference influenced their increased bullishness
PFE,PFE:US,BBG000BR2B91,"Stock Market News for June 22, 2017",2017-06-22 17:21:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GwG9wgbZ-KI/stock-market-news-for-june-22-2017-cm806988,Energy shares continued to decline on Wednesday sending the Dow and the S amp P 500 lower Oil prices dropped as investors remained concerned over global glut in crude production as major oil producing countries increased crude production Financials declined as investors digested several
PFE,PFE:US,BBG000BR2B91,Here&apos;s Why Sangamo Therapeutics Rose as Much as 11.7% Today,2017-06-22 16:33:00 +0000,http://finance.yahoo.com/r/099c0fa8-4aa5-3697-9119-a84b0f5c2d45/heres-why-sangamo-therapeutics-rose-as-much-as-117.aspx?yptr=yahoo&.tsrc=rss,A new analyst took over coverage and released a note to investors.
PFE,PFE:US,BBG000BR2B91,Merck's Keytruda on a Roll: Can it Retain the Momentum?,2017-06-22 16:24:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H4OPfihB4GU/mercks-keytruda-on-a-roll-can-it-retain-the-momentum-cm806927,As demand for immuno oncology drugs and their combinations rises Merck amp Co Inc s MRK anti PD 1 therapy Keytruda is being touted as a significant top line driver for this Kenilworth NJ based pharma giant Keytruda is presently marketed for the treatment of first line as well
PFE,PFE:US,BBG000BR2B91,"3 Big Stock Charts for Thursday: Pfizer Inc. (PFE), Wal-Mart Stores Inc (WMT) and Costco Wholesale Corporation (COST)",2017-06-22 16:04:09 +0000,https://finance.yahoo.com/news/3-big-stock-charts-thursday-160409956.html?.tsrc=rss,"This is typical for summer trading as we usually see the environment turn more into a stock pickers game.  Today’s three big stock charts look at Pfizer Inc. (NYSE:PFE), Wal-Mart Stores Inc (NYSE:WMT) and Costco Wholesale Corporation (NASDAQ:COST) as they are presenting clear technical outlooks that should help traders generate profits.  The pharmaceutical sector is hitting a stride now as the market is feeling like some clarification on healthcare reform."
PFE,PFE:US,BBG000BR2B91,10 Great Dividend Stocks to Own Should the Surging Stock Market Plunge This Summer,2017-06-22 15:27:00 +0000,http://finance.yahoo.com/r/78ed343d-250e-31ae-aaed-9db3728cae07/10-dividend-stocks-for-the-upcoming-crazy-market-swoon-we-might-have.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here are the names.
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/22/2017: JNJ, PFE, ABT, MRK, AMGN, KMDA, NVS, OTIC",2017-06-22 13:20:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x00D-qOQryA/health-care-sector-update-for-06222017-jnj-pfe-abt-mrk-amgn-kmda-nvs-otic-cm806711,Top Health Care stocks Top Health Care stocks JNJ 0 2 JNJ 0 2 PFE 0 6 PFE 0 6 ABT 0 4 ABT 0 4 MRK 0 03 MRK 0 03 AMGN 0 4 AMGN 0 4 Health care shares were higher in pre market trade Thursday Health care shares were higher in pre market trade Thursday In health care
PFE,PFE:US,BBG000BR2B91,"Notable Wednesday Option Activity: WDC, BBY, PFE",2017-06-21 19:21:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dRtblYvdZ00/notable-wednesday-option-activity-wdc-bby-pfe-cm806442,Among the underlying components of the S amp P 500 index we saw noteworthy options trading volume today in Western Digital Corp Symbol WDC where a total of 26 784 contracts have traded so far representing approximately 2 7 million underlying shares That amounts to about 67 5 of WDC
PFE,PFE:US,BBG000BR2B91,Will Pfizer Reexamine a Sale of its Consumer Division?,2017-06-21 18:29:00 +0000,http://finance.yahoo.com/r/6b02b425-8e9b-3f51-8667-a9c200e4e952/pfizer-should-re-examine-a-sale-of-its-consumer-division.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Morgan Stanley analyst David Risinger argued for the drugmaker to part ways with its consumer health division.
PFE,PFE:US,BBG000BR2B91,Dems Roast Trump for Leaving Medicare Out of Drug Price Order,2017-06-21 17:50:00 +0000,http://finance.yahoo.com/r/392080b3-ff85-3ae1-bfa0-d6c5c2a70c93/dems-roast-trump-for-leaving-medicare-out-of-drug-price-order.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The main thrust of the order appears to be easing regulatory hurdles to drug approvals, which could lower the cost of bringing new treatments to market and thus lower prices."
PFE,PFE:US,BBG000BR2B91,Traders take bullish position on Pfizer,2017-06-21 17:29:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kOxOnZEFAP8/traders-take-bullish-position-on-pfizer-cm806415,Option traders are taking bullish positions Pfizer PFE Wednesday Both the Jily 35 and July 37 50 calls have traded in very high volume today The 37 50 has only one trade but that trade was 22 500 contracts against no open interest Since the contract moved for a penny per share it
PFE,PFE:US,BBG000BR2B91,Shire's (SHPG) ADHD Drug Mydayis Receives Approval in US,2017-06-21 17:24:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X1kJvaDIyG4/shires-shpg-adhd-drug-mydayis-receives-approval-in-us-cm806398,Shire Plc SHPG announced that the FDA has approved its new attention deficit hyperactivity disorder ADHD drug Mydayis mixed salts of a single entity amphetamine product in patients 13 years and older The drug is approved as a once daily treatment consisting of three different types
PFE,PFE:US,BBG000BR2B91,Pfizer: Time to Sell the Consumer Biz?,2017-06-21 17:08:00 +0000,http://finance.yahoo.com/r/5cc48119-e78a-3223-8984-b9aa9a2b58bd/pfizer-time-to-sell-the-consumer-biz-1498064909?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Back in November, reports circulated that Pfizer (PFE) was considering selling its consumer business. Then...nothing. Now Morgan Stanley analyst David Risinger and team are out with a note calling for ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Firing on All Cylinders,2017-06-21 16:22:00 +0000,http://finance.yahoo.com/r/279bcefe-8b3b-303e-b160-e2ee9fb46004/pfizer-firing-on-all-cylinders.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Shares of Pfizer are moving well again Tuesday as the stock gains momentum following Monday's trendline break.
PFE,PFE:US,BBG000BR2B91,"Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More",2017-06-21 15:25:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZllTJ5jWXYA/small-cancer-biotech-space-in-focus-3-stocks-up-100-more-cm806187,The oncology space has always been keenly watched by investors interested in the pharma biotech sector Cancer is the second most common cause of death in the U S preceded only by heart disease According to a report by the American Cancer Society almost 1 7 million cancer cases are expected
PFE,PFE:US,BBG000BR2B91,S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017,2017-06-21 14:00:00 +0000,https://finance.yahoo.com/news/p-500-buybacks-fall-17-140000215.html?.tsrc=rss,"- Q1 2017 repurchases is 1.6% less than Q4 2016 and 17.5% less than Q1 2016 - EPS support via share count reduction significantly declines - Cash reserves set new record NEW YORK , June 21, 2017 /PRNewswire/ ..."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/21/2017: JNJ, PFE, ABT, MRK, AMGN, RXII, PSTI, CARA",2017-06-21 13:21:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h3IqUHekGH8/health-care-sector-update-for-06212017-jnj-pfe-abt-mrk-amgn-rxii-psti-cara-cm806085,Top Health Care stocks Top Health Care stocks JNJ 0 2 JNJ 0 2 PFE flatPFE flat ABT flatABT flat MRK 0 1 MRK 0 1 AMGN 0 9 AMGN 0 9 Health care shares were mixed in pre market trade Wednesday Health care shares were mixed in pre market trade Wednesday In health care stocks
PFE,PFE:US,BBG000BR2B91,"3 Stocks to Watch on Wednesday: Carmax, Inc (KMX), Adobe Systems Incorporated (ADBE) and Sangamo Therapeutics Inc (SGMO)",2017-06-21 12:54:02 +0000,https://finance.yahoo.com/news/3-stocks-watch-wednesday-carmax-125402825.html?.tsrc=rss,"As we head into Wednesday’s trade, Adobe Systems Incorporated (NASDAQ:ADBE), CarMax, Inc (NYSE:KMX) and Sangamo Therapeutics Inc (NASDAQ:SGMO) are among a few stocks wrestling for the spotlight.  ADBE stock resumed its red-hot 2017 after reporting its latest batch of quarterly earnings last night."
PFE,PFE:US,BBG000BR2B91,Exelixis's Cabometyx Positive for First-Line Kidney Cancer,2017-06-20 23:19:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hViLhjShXlw/exelixiss-cabometyx-positive-for-first-line-kidney-cancer-cm805981,Exelixis Inc EXEL announced results from an analysis of the data from the phase II trial CABOSUN The study compared Cabometyx to Pfizer s PFE Sutent in the first line treatment of intermediate or poor risk advanced renal cell carcinoma RCC patients We note that Cabometyx tablets
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/20/2017: JNJ, PFE, ABT, MRK, AMGN, NEOS, IMNP, GLPG",2017-06-20 20:20:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vZb2-f7Unfc/health-care-sector-update-for-06202017-jnj-pfe-abt-mrk-amgn-neos-imnp-glpg-cm805917,Top Health Care stocks Top Health Care stocks JNJ 0 2 JNJ 0 2 PFE 1 2 PFE 1 2 ABT 0 04 ABT 0 04 MRK 1 5 MRK 1 5 AMGN 1 2 AMGN 1 2 Health care shares inched higher ahead of the close of Tuesday s regular session Health care shares inched higher ahead of the close
PFE,PFE:US,BBG000BR2B91,"Is Ford Motor Company (F) Stock Undervalued, Or Cheap for a Reason?",2017-06-20 17:35:49 +0000,https://finance.yahoo.com/news/ford-motor-company-f-stock-173549636.html?.tsrc=rss,"Low multiples make Ford Motor Company (NYSE:F) stock look tantalizingly cheap.  You can buy Ford stock for 12 times earnings and only 7 times forward earnings.  Ford stock also trades at 0.29 times sales, 1.45 times book value and 4.8 times free cash flow."
PFE,PFE:US,BBG000BR2B91,Today's iQ100 leaders,2017-06-20 17:26:00 +0000,https://finance.yahoo.com/video/todays-iq100-leaders-172600314.html?.tsrc=rss,"The CNBC iq100 tracks big cap companies that get most of their revenue from their own intellectual property. Some of today's leaders include Oracle, Boeing, Becton Dickinson, American Express, Amazon and Pfizer. For more on the index go to CNBC.com/iq1..."
PFE,PFE:US,BBG000BR2B91,J&J-AbbVie's Imbruvica Positive in Follow-up Lymphoma Study,2017-06-20 17:19:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xMDcyaajMrs/jj-abbvies-imbruvica-positive-in-follow-up-lymphoma-study-cm805751,Johnson amp Johnson JNJ announced a three year follow up data from a late stage study evaluating its cancer drug Imbruvica ibrutinib against Pfizer Inc s PFE Torisel temsirolimus for treatment of patients with relapsed or refractory mantle cell lymphoma MCL Notably Imbruvica
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/20/2017: JNJ, PFE, ABT, MRK, AMGN, EGLT, NVIV, VAR",2017-06-20 16:59:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IC4N-fQ5uv4/health-care-sector-update-for-06202017-jnj-pfe-abt-mrk-amgn-eglt-nviv-var-cm805822,Top Health Care stocks Top Health Care stocks JNJ 0 4 JNJ 0 4 PFE 1 3 PFE 1 3 ABT 0 8 ABT 0 8 MRK 1 7 MRK 1 7 AMGN 2 1 AMGN 2 1 Health care shares were higher in mid day trade Tuesday Health care shares were higher in mid day trade Tuesday In health care stocks
PFE,PFE:US,BBG000BR2B91,"IUSG, PG, PFE, VZ: Large Inflows Detected at ETF",2017-06-20 16:22:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_GNW6P6kjTM/iusg-pg-pfe-vz-large-inflows-detected-at-etf-cm805690,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core S amp P U S Growth ETF Symbol IUSG where we have detected an approximate 125 2 million dollar inflow that s a 5 2 increase week over week
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public To View And Listen To Webcast Of August 1 Conference Call With Analysts,2017-06-20 14:00:00 +0000,https://finance.yahoo.com/news/pfizer-invites-public-view-listen-140000721.html?.tsrc=rss,"Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, August 1, 2017. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Second Quarter 2017 Performance Report, to be issued that morning."
PFE,PFE:US,BBG000BR2B91,Worldwide drug sale forecasts fall as pricing pressures mount,2017-06-20 13:55:50 +0000,https://finance.yahoo.com/news/worldwide-drug-sale-forecasts-fall-135550536.html?.tsrc=rss,"Forecasts for global sales of  pharmaceuticals have declined for the first time in a decade as  continuing pressure on prices in the key U.S. market has caused  analysts to moderate revenue expectations, according to a report  on Tuesday.  Evaluate Pharma, which compiles consensus numbers based on  analysts' forecasts, said worldwide drug sales were now expected  to hit $1.06 trillion in 2022, down from $1.12 trillion  predicted a year ago for the same period.  It is the first time in 10 years that total drug sales have  failed to beat the previous year's forecast level."
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Chevron, Pfizer, Boeing, 3M and Citigroup",2017-06-20 13:30:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-chevron-133001571.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Chevron, Pfizer, Boeing, 3M and Citigroup"
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/20/2017: JNJ, PFE, ABT, MRK, AMGN, LPCN, PRXL, MD",2017-06-20 13:20:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LMglq4DQrPs/health-care-sector-update-for-06202017-jnj-pfe-abt-mrk-amgn-lpcn-prxl-md-cm805474,Top Health Care stocks Top Health Care stocks JNJ flatJNJ flat PFE flatPFE flat ABT flatABT flat MRK flatMRK flat AMGN 1 AMGN 1 Health care shares were mostly lower in pre market trade Tuesday Health care shares were mostly lower in pre market trade Tuesday In health care
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. breached its 50 day moving average in a Bullish Manner : PFE-US : June 20, 2017",2017-06-20 12:28:17 +0000,http://finance.yahoo.com/r/18eee5f1-b7ad-3609-be81-8e9713992a79/pfizer-inc-breached-its-50-day-moving-average-in-a-bullish-manner-pfe-us-june-20-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Pfizer Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
<b>(Read more...)</b>"
PFE,PFE:US,BBG000BR2B91,Regeneron’s Praluent May See Gradual Increase in 2017 Demand,2017-06-20 11:36:13 +0000,http://finance.yahoo.com/r/d2b8fb43-7588-39d3-a9d5-c46273a44bde/praluent-may-witness-gradual-increase-demand-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1Q17, Regeneron (REGN) and Sanofi’s (SNY) Praluent reported global revenues close to $36.0 million, of which $25.0 million were earned from the US market."
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. AbbVie Inc.,2017-06-20 11:11:00 +0000,http://finance.yahoo.com/r/29bc6839-61d8-3d53-b127-2e9388d0687f/better-buy-pfizer-inc-vs-abbvie.aspx?yptr=yahoo&.tsrc=rss,"These two big pharma stocks have a lot in common, but which is the better stock pick right now?"
PFE,PFE:US,BBG000BR2B91,Top 10 Holdings of Our Ultimate Stock-Pickers' Index,2017-06-20 10:00:00 +0000,http://finance.yahoo.com/r/55c4c01e-9679-31be-9037-79029020ade3/article.aspx?id=812931&SR=Yahoo&yptr=yahoo&.tsrc=rss,"While Healthcare names continue to present opportunities, our lists revealed names from other sectors that may be compelling."
PFE,PFE:US,BBG000BR2B91,Can AstraZeneca Thrive on Its Own? Big Test Looms,2017-06-20 04:36:49 +0000,http://finance.yahoo.com/r/e5ef66d9-9962-3349-b7ab-22e23cc643b2/can-astrazeneca-thrive-on-its-own-big-test-looms-1497873600?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"The drug maker hopes the results of a trial for Mystic, a lung-cancer treatment, will prove it was right to fend off a 2014 takeover offer and commit to developing immunotherapy medicines."
PFE,PFE:US,BBG000BR2B91,"Why Exelixis, Inc. Zoomed Higher Today",2017-06-19 23:19:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qFiERU3TZHc/why-exelixis-inc-zoomed-higher-today-cm805394,What happened Exelixis NASDAQ EXEL ended the day up 12 after announcing 160 that the 160 blinded independent radiology review committee confirmed the progression free survival as measured by the investigators of the CABOSUN clinical trial So what CABOSUN was a phase
PFE,PFE:US,BBG000BR2B91,"Top Stock Reports for Chevron, Pfizer & Boeing",2017-06-19 23:19:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x63RiuWUUxk/top-stock-reports-for-chevron-pfizer-boeing-cm805405,Monday June 19 2017 The Zacks Research Daily presents the best research output of our analyst team Today s Research Daily features new research reports on 16 major stocks including Chevron CVX Pfizer PFE and Boeing BA These research reports have been hand picked from the roughly
PFE,PFE:US,BBG000BR2B91,"Why Exelixis, Inc. Zoomed Higher Today",2017-06-19 21:21:00 +0000,http://finance.yahoo.com/r/da3a7824-eac6-3d59-a41c-eb13fc8ca2db/why-exelixis-inc-zoomed-higher-today.aspx?yptr=yahoo&.tsrc=rss,The CABOSUN data is real.
PFE,PFE:US,BBG000BR2B91,"Top Stock Reports for Chevron, Pfizer & Boeing",2017-06-19 21:06:09 +0000,https://finance.yahoo.com/news/top-stock-reports-chevron-pfizer-210609365.html?.tsrc=rss,"Top Stock Reports for Chevron, Pfizer & Boeing"
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Jun 19, 2017 :  AABA, INTC, T, ETE, QQQ, CSCO, PFE, C, BABA, LC, MSFT, AAPL",2017-06-19 20:59:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XvxNULN5YuM/after-hours-most-active-for-jun-19-2017-aaba-intc-t-ete-qqq-csco-pfe-c-baba-lc-msft-aapl-cm805358,The NASDAQ 100 After Hours Indicator is down 84 to 5 771 38 The total After hours volume is currently 57 585 161 shares traded The following are the most active stocks for the after hours session Altaba Inc AABA is 0 03 at 54 43 with 10 842 838 shares
PFE,PFE:US,BBG000BR2B91,Biotech Stocks To Watch And Pharma Industry News,2017-06-19 18:18:44 +0000,http://finance.yahoo.com/r/d95a9140-bcb4-38ab-b942-e0c45662051a/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead?src=A00220&yptr=yahoo&.tsrc=rss,Track the latest trends and leading stocks in the biotech and pharmaceutical industries.
PFE,PFE:US,BBG000BR2B91,3 Biotech Stocks That More than Doubled Year to Date,2017-06-19 15:25:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8kKdR_t4FAE/3-biotech-stocks-that-more-than-doubled-year-to-date-cm805064,We are almost half way through 2017 and the biotech sector which had a rough and challenging 2016 has been showing signs of recovery despite some ups and downs Year to date YTD the NASDAQ Biotechnology Index is up 10 4 providing a glimmer of hope to biotech investors who saw the
PFE,PFE:US,BBG000BR2B91,FDA Grants Fast-Track Designation to Tanezumab,2017-06-19 14:37:08 +0000,http://finance.yahoo.com/r/578c27e0-b2e1-3118-b14b-0c7c6d50f808/fda-grants-fast-track-designation-to-tanezumab?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Tanezumab is an investigational drug co-developed by Eli Lilly (LLY) and Pfizer (PFE).
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/19/2017: JNJ, PFE, ABT, MRK, AMGN, VRX, MACK, MDT",2017-06-19 13:20:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DAH2CNGB5c8/health-care-sector-update-for-06192017-jnj-pfe-abt-mrk-amgn-vrx-mack-mdt-cm804907,Top Health Care stocks Top Health Care stocks JNJ 0 2 JNJ 0 2 PFE 0 3 PFE 0 3 ABT 0 6 ABT 0 6 MRK flatMRK flat AMGN 0 4 AMGN 0 4 Health care shares were mostly firmer in pre market trade Monday Health care shares were mostly firmer in pre market trade Monday In health
PFE,PFE:US,BBG000BR2B91,Eylea Continues to Be a Key Growth Driver for Regeneron in 2017,2017-06-19 13:08:16 +0000,http://finance.yahoo.com/r/1dc6c2e6-273d-3a09-80fd-9c195b6b69ba/eylea-continues-key-growth-driver-regeneron-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1Q17, Regeneron's (REGN) Eylea reported revenues of about $854.0 million in the US market, which is a YoY (year-over-year) rise of about 9.0%."
PFE,PFE:US,BBG000BR2B91,3 Biotech Stocks That More than Doubled Year to Date,2017-06-19 12:53:12 +0000,https://finance.yahoo.com/news/3-biotech-stocks-more-doubled-125312599.html?.tsrc=rss,Here is a look at Puma (PBYI) and two other biotech stocks that have recorded massive gains so far in 2017.
PFE,PFE:US,BBG000BR2B91,[$$] Can AstraZeneca Thrive on Its Own? Big Test Looms,2017-06-19 12:00:05 +0000,http://finance.yahoo.com/r/e5ef66d9-9962-3349-b7ab-22e23cc643b2/can-astrazeneca-thrive-on-its-own-big-test-looms-1497873600?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"The drug maker hopes the results of a trial for Mystic, a lung-cancer treatment, will prove it was right to fend off a 2014 takeover offer and commit to developing immunotherapy medicines."
PFE,PFE:US,BBG000BR2B91,Pfizer Begins Phase 1 Clinical Trial to Evaluate Investigational Group B Streptococcus Vaccine,2017-06-19 12:00:00 +0000,https://finance.yahoo.com/news/pfizer-begins-phase-1-clinical-120000104.html?.tsrc=rss,"Pfizer Inc. today announced that it has started a Phase 1 trial in healthy volunteers of PF-06760805, an investigational vaccine designed to help protect against Group B Streptococcus infection."
PFE,PFE:US,BBG000BR2B91,Could Legalized Marijuana Be Making Big Pharma Nervous?,2017-06-18 19:19:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hJp4i0ldJpI/could-legalized-marijuana-be-making-big-pharma-nervous-cm804826,An effort in Arizona to legalize recreational marijuana failed last year Insys Therapeutics NASDAQ INSY helped make it happen The drugmaker donated 500 000 to an organization that opposed a marijuana legalization proposition It makes sense that Insys would be
PFE,PFE:US,BBG000BR2B91,Could Legalized Marijuana Be Making Big Pharma Nervous?,2017-06-18 18:03:00 +0000,http://finance.yahoo.com/r/9371d718-9d4e-3fc3-bce7-f5da1d89c431/could-legalized-marijuana-be-making-big-pharma-ner.aspx?yptr=yahoo&.tsrc=rss,"A new report says that drugmakers could lose billions of dollars per year if marijuana is legalized throughout the U.S. Should Pfizer, Allergan, and others be nervous?"
PFE,PFE:US,BBG000BR2B91,3 Dividend Stocks for Successful Investors,2017-06-17 15:42:00 +0000,http://finance.yahoo.com/r/7dce4d85-4d98-3324-91d5-efd7dffbc6f2/3-dividend-stocks-for-successful-investors.aspx?yptr=yahoo&.tsrc=rss,"Top dividend-paying stocks Pfizer, Boeing, and JPMorgan Chase have catalysts approaching that could make buying them now smart."
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: GE Appoints Flannery as CEO; UTX, CAT Hike Dividends",2017-06-16 22:19:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tlvsV006zeY/dow-30-stock-roundup-ge-appoints-flannery-as-ceo-utx-cat-hike-dividends-cm804614,The Dow notched up successive record gains during a week marked by grievous losses for tech stocks Concerns about valuations continued to push tech stocks lower on Monday leading to notable losses for the broader markets However the Dow was able to ride the rebound staged on Tuesday
PFE,PFE:US,BBG000BR2B91,"Can AstraZeneca Keep Up As Clovis, Tesaro Unveil Blockbuster Drugs?",2017-06-16 20:41:01 +0000,http://finance.yahoo.com/r/9709ede1-9b26-34d9-a31d-dd6edd399ea2/can-astrazeneca-keep-up-as-clovis-tesaro-unveil-blockbuster-drugs?src=A00220&yptr=yahoo&.tsrc=rss,"Clovis and Tesaro could each deliver blockbuster ovarian cancer drugs and grab takeover interest, an analyst said Friday."
PFE,PFE:US,BBG000BR2B91,2 Incredibly Cheap Biotech Stocks,2017-06-16 17:49:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DCnN66hYRnY/2-incredibly-cheap-biotech-stocks-cm804492,Biotech stocks sport some of the richest valuations in the market today making it hard to suss out any attractive bargains within this high flying group The average forward price to earnings ratio among large cap biotechs after all presently stands at a stately 45 2 Having
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: J&J, Lilly Present Data, Merck Keytruda Study Enrolment Paused",2017-06-16 14:11:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kzkrRPbC_Dg/pharma-stock-roundup-jj-lilly-present-data-merck-keytruda-study-enrolment-paused-cm804262,This week s highlights include data from companies like Johnson amp Johnson JNJ and Lilly LLY while Merck MRK paused new enrolment in a couple of studies being conducted with Keytruda Recap of the Week s Most Important Stories J amp J Presents Data on Invokana Simponi Aria
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/16/2017: JNJ, PFE, ABT, MRK, AMGN, GSK, PFE, LLY",2017-06-16 13:07:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/swpIP_zoMS0/health-care-sector-update-for-06162017-jnj-pfe-abt-mrk-amgn-gsk-pfe-lly-cm804231,Top Health Care stocks Top Health Care stocks JNJ flatJNJ flat PFE flatPFE flat ABT flatABT flat MRK flatMRK flat AMGN flatAMGN flat Health care shares were inactive in pre market trade Friday Health care shares were inactive in pre market trade Friday In health care stocks
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: J&J, Lilly Present Data, Merck Keytruda Study Enrolment Paused",2017-06-16 12:27:12 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-j-j-122712265.html?.tsrc=rss,"Merck (MRK) paused patient enrolment in a couple of studies being conducted with its anti-PD-1 therapy, Keytruda."
PFE,PFE:US,BBG000BR2B91,5 best bets in biotech: Expert,2017-06-16 11:37:00 +0000,https://finance.yahoo.com/video/5-best-bets-biotech-expert-113700943.html?.tsrc=rss,"Merck is our number pick, says Tony Butler, Guggenheim Securities, providing his top plays in the pharma space."
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Results from XELJANZ® (tofacitinib citrate) ORAL Strategy Study Published in The Lancet and Presented at the EULAR Annual Congress,2017-06-16 08:35:00 +0000,https://finance.yahoo.com/news/pfizer-announces-results-xeljanz-tofacitinib-083500557.html?.tsrc=rss,"Pfizer Inc. announced today detailed results from ORAL Strategy, a head-to-head, noninferiority Phase 3b/4 study of XELJANZ® 5 mg twice daily as monotherapy or in combination with methotrexate compared to Humira® plus MTX in the treatment of moderate to severe rheumatoid arthritis ."
PFE,PFE:US,BBG000BR2B91,Pfizer Reports Overall Efficacy In Xeljanz Oral Safety Study,2017-06-16 05:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UBB9s85ZIeI/pfizer-reports-overall-efficacy-in-xeljanz-oral-safety-study-20170616-00108,Pfizer Reports Overall Efficacy In Xeljanz Oral Safety Study
PFE,PFE:US,BBG000BR2B91,Don’t Be Scared of Biogen Inc (BIIB) Stock,2017-06-15 18:11:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cJJTbSsumKs/dont-be-scared-of-biogen-inc-biib-stock-cm804035,InvestorPlace Stock Market News Stock Advice amp Trading Tips Biogen Inc NASDAQ BIIB stock has had a choppy few months It has been ping ponging back and forth by 15 in either direction as political rhetoric weighs on biotechs Politicians have used
PFE,PFE:US,BBG000BR2B91,[$$] European takeover rules merit a sceptical response,2017-06-15 17:08:58 +0000,"http://finance.yahoo.com/r/9de38b04-d8df-343e-9fc7-571dbd58dcfe/ec361c36-51cd-11e7-a1f2-db19572361bb,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","It is still hard for a European politician to call for takeover regulation by appeal to bald protectionism. Marine Le Pen, in her campaign for the French presidency, called for a ""sovereign fund"" ..."
PFE,PFE:US,BBG000BR2B91,Mylan In FDA Limbo On Generic Multiple Sclerosis Drug,2017-06-15 16:15:33 +0000,http://finance.yahoo.com/r/1b17e6af-f9e9-3e7b-80c7-ccedb9c0e28d/mylan-in-fda-limbo-on-generic-version-of-tevas-multiple-sclerosis-drug?src=A00220&yptr=yahoo&.tsrc=rss,Mylan stock fell as the FDA is looking for more information into its generic version of the multiple sclerosis drug Copaxone.
PFE,PFE:US,BBG000BR2B91,3 Stocks With Better Dividends Than CVS Health Corporation,2017-06-15 16:09:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QJHBD_Sl7jo/3-stocks-with-better-dividends-than-cvs-health-corporation-cm803888,Finding stocks with higher dividend yields than CVS Health Corporation NYSE CVS is easy Finding stocks with quantifiably better dividends than the large pharmacy services company is a different story altogether That s especially true if you try to look only at stocks within
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Buys Exclusive EU Rights to Anti-Fungal Drug,2017-06-15 15:12:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d_oycVQ3UDs/pfizer-pfe-buys-exclusive-eu-rights-to-anti-fungal-drug-cm803816,Pfizer Inc PFE announced a deal to buy exclusive EU commercialization rights to an anti fungal treatment Cresemba from Swiss pharma company Basilea Pharmaceutica Ltd Cresemba an intravenous IV and oral azole antifungal for the treatment of two serious infections invasive
PFE,PFE:US,BBG000BR2B91,3 Stocks With Better Dividends Than CVS Health Corporation,2017-06-15 14:43:00 +0000,http://finance.yahoo.com/r/b3e0dc12-a182-3ed4-8459-eedb2b870639/3-stocks-with-better-dividends-than-cvs-health-cor.aspx?yptr=yahoo&.tsrc=rss,"CVS Health is a great dividend stock. AbbVie, Gilead Sciences, and Pfizer are even better."
PFE,PFE:US,BBG000BR2B91,Don’t Be Scared of Biogen Inc (BIIB) Stock,2017-06-15 13:40:48 +0000,https://finance.yahoo.com/news/don-t-scared-biogen-inc-134048063.html?.tsrc=rss,Biogen Inc (NASDAQ:BIIB) stock has had a choppy few months.  It has been ping-ponging back and forth by 15% in either direction as political rhetoric weighs on biotechs.  Politicians have used the sector as a political football.
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/15/2017: JNJ, PFE, ABT, MRK, AMGN, CRBP, LNTH",2017-06-15 13:26:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GSNg36YDlpA/health-care-sector-update-for-06152017-jnj-pfe-abt-mrk-amgn-crbp-lnth-cm803697,Top Health Care stocks Top Health Care stocks JNJ 0 6 JNJ 0 6 PFE flatPFE flat ABT flatABT flat MRK 0 1 MRK 0 1 AMGN 0 5AMGN 0 5 Health care shares were mixed in pre market trade Thursday Health care shares were mixed in pre market trade Thursday In health care stocks
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Buys Exclusive EU Rights to Anti-Fungal Drug,2017-06-15 13:08:01 +0000,https://finance.yahoo.com/news/pfizer-pfe-buys-exclusive-eu-130801188.html?.tsrc=rss,"Pfizer, Inc. (PFE) announced a deal to buy exclusive EU commercialization rights to an anti-fungal treatment, Cresemba from Swiss pharma company, Basilea Pharmaceutica Ltd."
PFE,PFE:US,BBG000BR2B91,"ALDX Down But Not Out, BTX On Track, MNK Exploring New Use For Acthar",2017-06-15 02:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aXMjId0nzxE/aldx-down-but-not-out-btx-on-track-mnk-exploring-new-use-for-acthar-20170615-00053,"ALDX Down But Not Out, BTX On Track, MNK Exploring New Use For Acthar"
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson: The Bear Case From a Bull,2017-06-14 22:07:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S4nOjdqTu8k/johnson-johnson-the-bear-case-from-a-bull-cm803561,You probably couldn t describe me as a raging bull when it comes to Johnson amp Johnson NYSE JNJ stock but I m a bull nonetheless With the healthcare giant s shares at all time highs I still think the stock will go even higher However I can fully understand why some
PFE,PFE:US,BBG000BR2B91,Acceleron (XLRN) Kidney Cancer Candidate Fails in Phase II,2017-06-14 21:09:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HiUGy6unu8Y/acceleron-xlrn-kidney-cancer-candidate-fails-in-phase-ii-cm803508,Acceleron Pharma Inc s XLRN stock had gone down earlier and then regained ground by almost 5 after the company announced disappointing top line results from a phase II DART study evaluating its pipeline candidate dalantercept in combination with Pfizer s PFE Inlyta axitinib for treatment
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson: The Bear Case From a Bull,2017-06-14 20:43:00 +0000,http://finance.yahoo.com/r/81fde1b1-667e-3a0b-94ce-072442b29e4f/johnson-johnson-the-bear-case-from-a-bull.aspx?yptr=yahoo&.tsrc=rss,An investor with a bullish view on Johnson & Johnson gives three bearish arguments against the stock.
PFE,PFE:US,BBG000BR2B91,"Pfizer Receives Exclusive Commercialization Rights in Europe for CRESEMBA, a Novel Treatment for Potentially Life-Threatening Fungal Infections Among Immunocompromised Patients",2017-06-14 17:20:00 +0000,https://finance.yahoo.com/news/pfizer-receives-exclusive-commercialization-rights-172000733.html?.tsrc=rss,"Pfizer Inc. and Basilea Pharmaceutica Ltd. , an international biopharmaceutical company specializing in the research and development of anti-infective and oncological medicines, today announced they have entered into an agreement whereby Pfizer will be granted the exclusive commercialization rights in Europe to CRESEMBA , a novel anti-fungal treatment for adult patients with diagnosed invasive aspergillosis ..."
PFE,PFE:US,BBG000BR2B91,"Basilea announces license agreement with Pfizer for antifungal Cresemba® (isavuconazole) for Europe, Russia, Turkey and Israel",2017-06-14 17:16:02 +0000,https://finance.yahoo.com/news/basilea-announces-license-agreement-pfizer-171602841.html?.tsrc=rss,Basilea receives a CHF 70 million upfront payment and is eligible for additional milestone payments of up to USD 427 million and double-digit royalties on sales Basilea continues to focus on establishing ...
PFE,PFE:US,BBG000BR2B91,Pfizer & Lilly Get Fast Track Designation for Pain Candidate,2017-06-14 17:08:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r96pw6frSEc/pfizer-lilly-get-fast-track-designation-for-pain-candidate-cm803406,Pfizer Inc PFE and Eli Lilly and Company LLY announced that the FDA has granted fast track designation to their pipeline candidate tanezumab for the treatment of chronic pain in patients with osteoarthritis OA and chronic low back pain CLBP We note that the FDA s fast track
PFE,PFE:US,BBG000BR2B91,"Company News for June 14, 2017",2017-06-14 16:09:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VExi_t8Hc20/company-news-for-june-14-2017-cm803302,160 160 160 Shares of Eli Lilly and Company LLY advanced 0 4 after the company declared that the pain drug it has developed with Pfizer Inc PFE has been granted fast track designation by the Food and Drug Administration 160 160 160 The Cheesecake Factory Incorporated s
PFE,PFE:US,BBG000BR2B91,Pfizer & Lilly Get Fast Track Designation for Pain Candidate,2017-06-14 14:57:02 +0000,https://finance.yahoo.com/news/pfizer-lilly-fast-track-designation-145702847.html?.tsrc=rss,"Pfizer Inc. (PFE) and Eli Lilly and Company (LLY) announced that the FDA has granted fast track designation to their pipeline candidate, tanezumab for the treatment of chronic pain in patients with osteoarthritis (OA) and chronic low back pain (CLBP)."
PFE,PFE:US,BBG000BR2B91,"Company News for June 14, 2017",2017-06-14 14:28:02 +0000,https://finance.yahoo.com/news/company-news-june-14-2017-142802499.html?.tsrc=rss,"Companies in the News are: LLY,PFE,CAKE,JW.A,CVCO"
PFE,PFE:US,BBG000BR2B91,Pfizer denies over-charging for cancer drugs in South Africa,2017-06-14 13:59:07 +0000,https://finance.yahoo.com/news/pfizer-denies-over-charging-cancer-135907238.html?.tsrc=rss,"U.S. drugmaker Pfizer has denied  allegations it over-charged for cancer medicines in South Africa  following an investigation launched on Tuesday into three drug  companies by the country's competition watchdog.  The Competition Commission said it would investigate Aspen  Pharmacare, Africa's biggest generic drugmaker, Pfizer  and Swiss-based Roche Holding on suspicion of charging  too much for cancer medicines."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/14/2017: JNJ, PFE, ABT, MRK, AMGN, ALDX, NDRM, LOXO",2017-06-14 13:46:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pi4DyB-FDOY/health-care-sector-update-for-06142017-jnj-pfe-abt-mrk-amgn-aldx-ndrm-loxo-cm803196,Top Health Care stocks Top Health Care stocks JNJ 0 6 JNJ 0 6 PFE flatPFE flat ABT flatABT flat MRK 0 1 MRK 0 1 AMGN flatAMGN flat Health care shares were mostly quiet in pre market trade Wednesday Health care shares were mostly quiet in pre market trade Wednesday In health
PFE,PFE:US,BBG000BR2B91,Pfizer To Participate In Goldman Sachs Healthcare Conference At 11:00 AM ET,2017-06-14 10:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U1ZlQlOFDy0/pfizer-to-participate-in-goldman-sachs-healthcare-conference-at-1100-am-et-20170614-00695,Pfizer To Participate In Goldman Sachs Healthcare Conference At 11:00 AM ET
PFE,PFE:US,BBG000BR2B91,Will Tesaro Be the Focus of the Next Biotech Bidding War?,2017-06-13 22:28:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pYQNQmx2lPE/will-tesaro-be-the-focus-of-the-next-biotech-bidding-war-cm802984,Tesaro NASDAQ TSRO 160 is the latest biotech to see rumors swirl of potential mergers and acquisitions On the heels of launching Zejula earlier this year the company could fetch as much as 10 billion in a deal according to industry watchers Whether this company gets sold
PFE,PFE:US,BBG000BR2B91,Will Tesaro Be the Focus of the Next Biotech Bidding War?,2017-06-13 21:07:00 +0000,http://finance.yahoo.com/r/86903ca0-de94-3093-9e3c-a4fca5fafb6b/will-tesaro-be-the-focus-of-the-next-biotech-biddi.aspx?yptr=yahoo&.tsrc=rss,"Tesaro&apos;s management knows a thing or two about biotech M&A, and they&apos;re entertaining offers."
PFE,PFE:US,BBG000BR2B91,General Electric Company (GE) Stock: Immelt’s Departure Is Just the Start,2017-06-13 19:26:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rDPjv0bZkA4/general-electric-company-ge-stock-immelts-departure-is-just-the-start-cm802913,InvestorPlace Stock Market News Stock Advice amp Trading Tips Wall Street s judgments can be brutal for chief executives Just look at the case of Jeff Immelt now ex CEO of 160 General Electric 160 Company 160 NYSE GE On the news of his departure GE stock popped 3
PFE,PFE:US,BBG000BR2B91,"Pfizer, Roche and Aspen face South African probe into cancer drug prices",2017-06-13 16:27:44 +0000,https://finance.yahoo.com/news/pfizer-roche-aspen-face-south-123759753.html?.tsrc=rss,"South Africa's competition watchdog has launched an investigation into three drug companies accused of over-charging for cancer medicines, the agency's chief said on Tuesday. Tembinkosi Bonakele, head ..."
PFE,PFE:US,BBG000BR2B91,"Pfizer, Eli Lilly Granted Accelerated Review for Non-Opiod Pain Relief Drug",2017-06-13 16:16:00 +0000,http://finance.yahoo.com/r/e35a229f-f444-39f8-9afc-e446418be1a2/pfizer-eli-lilly-granted-fda-accelerated-review-for-non-opiod-pain-relief-drug.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The FDA approval comes amidst America's struggle with an opioid epidemic.
PFE,PFE:US,BBG000BR2B91,General Electric Company (GE) Stock: Immelt’s Departure Is Just the Start,2017-06-13 15:06:46 +0000,https://finance.yahoo.com/news/general-electric-company-ge-stock-150646977.html?.tsrc=rss,"InvestorPlace - Stock Market News, Stock Advice &#38; Trading Tips"
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/13/2017: JNJ, PFE, ABT, MRK, AMGN, CHRS, IMNP",2017-06-13 13:46:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b_eETkWkvKE/health-care-sector-update-for-06132017-jnj-pfe-abt-mrk-amgn-chrs-imnp-cm802613,Top Health Care stocks Top Health Care stocks JNJ 0 1 JNJ 0 1 PFE flatPFE flat ABT flatABT flat MRK 1 2 MRK 1 2 AMGN flatAMGN flat Health care shares were mostly flat in pre market trade Tuesday Health care shares were mostly flat in pre market trade Tuesday In health care
PFE,PFE:US,BBG000BR2B91,Merck: A Speed Bump For Keytruda?,2017-06-13 13:18:00 +0000,http://finance.yahoo.com/r/3a9481fa-28e1-3b22-9b71-281369492229/merck-a-speed-bump-for-keytruda-1497359892?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Shares of Merck (MRK) are falling today after the drug maker announced late Monday that it was hitting the brakes on two late-stage studies involving the use of its immuno-cancer drug Keytruda as a treatment for multiple myeloma.  Merck is investigating increased reports of deaths in the groups using the drug.  Evercore ISI analyst  Umer Raffat has the details.
PFE,PFE:US,BBG000BR2B91,Nearly One in Four New and Expectant Parents Have Never Heard of Invasive Pneumococcal Disease According to a New Survey,2017-06-13 13:00:00 +0000,https://finance.yahoo.com/news/nearly-one-four-expectant-parents-130000708.html?.tsrc=rss,"Pfizer Inc. , in partnership with Parents magazine , announced today the results of a national survey of more than 2,000 new and expectant parents assessing their knowledge of childhood infectious diseases, such as measles, whooping cough and invasive pneumococcal disease , and the measures parents can take to help prevent them."
PFE,PFE:US,BBG000BR2B91,Eli Lilly stock rises 1.5% after pain drug gets fast track designation from FDA,2017-06-13 12:53:50 +0000,http://finance.yahoo.com/r/8f5890bb-88b5-347b-9b4e-9673363d352b/Story.aspx?guid=4160BF6F-1210-479B-8A31-E0F85510A8BF&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Eli Lilly & Co. shares rose 1.5% in premarket trade Tuesday after the company said its pain drug with Pfizer Inc. has received fast track designation from the Food and Drug Administration, which is intended ..."
PFE,PFE:US,BBG000BR2B91,Former Pfizer Scientist Is Resurrecting Projects To Solve The Multidrug Resistant Bacteria Problem,2017-06-13 12:06:00 +0000,http://finance.yahoo.com/r/405bb4b1-d4db-326b-a314-a2e970fad3b9/former-pfizer-scientist-is-resurrecting-projects-to-solve-the-multidrug-resistant-bacteria-problem?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Despite this success, Dr. Dunne wasn’t done with Pfizer and his former anti-infective portfolio."
PFE,PFE:US,BBG000BR2B91,Pfizer and Lilly Receive FDA Fast Track Designation for Tanezumab,2017-06-13 12:00:00 +0000,https://finance.yahoo.com/news/pfizer-lilly-receive-fda-fast-120000341.html?.tsrc=rss,Pfizer Inc. and Eli Lilly and Company today announced that the U.S. Food and Drug Administration has granted Fast Track designation for tanezumab for the treatment of chronic pain in patients with osteoarthritis and chronic low back pain .
PFE,PFE:US,BBG000BR2B91,Apple and Pfizer's Tax Windfall,2017-06-13 10:00:00 +0000,http://finance.yahoo.com/r/cc853049-c09f-321f-b08d-c8a9d5b08aa7/apple-and-pfizers-tax-windfall-aapl-pfe-msft-0?partner=YahooSA&yptr=yahoo&.tsrc=rss,Apple and Pfizer could enjoy multi-billion dollar one-time tax windfalls.
PFE,PFE:US,BBG000BR2B91,Pfizer And Lilly Gets FDA Fast Track Designation For Tanezumab,2017-06-13 08:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wTV0dj6_-zo/pfizer-and-lilly-gets-fda-fast-track-designation-for-tanezumab-20170613-00450,Pfizer And Lilly Gets FDA Fast Track Designation For Tanezumab
PFE,PFE:US,BBG000BR2B91,The Winners of Trump's Offshore Tax Plan,2017-06-12 18:21:31 +0000,https://finance.yahoo.com/video/winners-trumps-offshore-tax-plan-182131934.html?.tsrc=rss,"Jun.12 -- Multinationals are in line for a windfall from President Donald Trump’s call to cut the tax rate on U.S. companies’ stockpiled overseas earnings, but a select few would do better than others. Bloomberg's Lynnley Browning has more on &quot;Bloomberg Markets.&quot;"
PFE,PFE:US,BBG000BR2B91,Interesting March 2018 Stock Options for PFE,2017-06-12 17:27:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ikFLQOrzemQ/interesting-march-2018-stock-options-for-pfe-cm802204,Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the March 2018 expiration for PFE The put contract
PFE,PFE:US,BBG000BR2B91,PFE Makes Bullish Cross Above Critical Moving Average,2017-06-12 16:29:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g8VOn6QHZxI/pfe-makes-bullish-cross-above-critical-moving-average-cm802116,In trading on Monday shares of Pfizer Inc Symbol PFE crossed above their 200 day moving average of 33 03 changing hands as high as 33 12 per share Pfizer Inc shares are currently trading up about 0 9 on the day The chart below shows the one year performance of PFE shares versus its
PFE,PFE:US,BBG000BR2B91,"IVE, PFE, ABT, CVS: Large Outflows Detected at ETF",2017-06-12 16:27:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4a3kBUXWYio/ive-pfe-abt-cvs-large-outflows-detected-at-etf-cm802096,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares S amp P 500 Value ETF Symbol IVE where we have detected an approximate 73 9 million dollar outflow that s a 0 6 decrease week over week
PFE,PFE:US,BBG000BR2B91,Merck's Diabetes Drug Meets Primary Endpoint in Key Studies,2017-06-12 14:32:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4hzgO3Fer1U/mercks-diabetes-drug-meets-primary-endpoint-in-key-studies-cm801963,Merck amp Co Inc MRK and partner Pfizer Inc PFE announced that its pipeline candidate ertugliflozin met primary endpoints in two late stage studies evaluating ertugliflozin in adults with Type 2 diabetes The results were presented at the Scientific Sessions of the American
PFE,PFE:US,BBG000BR2B91,"Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for June 13, 2017",2017-06-12 13:23:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j8ztfGpc7hQ/zoetis-inc-zts-ex-dividend-date-scheduled-for-june-13-2017-cm801929,Zoetis Inc ZTS will begin trading ex dividend on June 13 2017 A cash dividend payment of 0 105 per share is scheduled to be paid on September 01 2017 Shareholders who purchased ZTS prior to the ex dividend date are eligible for the cash dividend payment This marks the 3rd quarter
PFE,PFE:US,BBG000BR2B91,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for June 13, 2017",2017-06-12 13:17:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Lr1pA6G2avE/merck-company-inc-mrk-ex-dividend-date-scheduled-for-june-13-2017-cm801825,Merck amp Company Inc MRK will begin trading ex dividend on June 13 2017 A cash dividend payment of 0 47 per share is scheduled to be paid on July 10 2017 Shareholders who purchased MRK prior to the ex dividend date are eligible for the cash dividend payment This marks the
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/12/2017: JNJ, PFE, ABT, MRK, AMGN,CHRS, NVO, AZN",2017-06-12 13:06:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZCpgJQiVyrY/health-care-sector-update-for-06122017-jnj-pfe-abt-mrk-amgnchrs-nvo-azn-cm801800,Top Health Care stocks Top Health Care stocks JNJ 0 2 JNJ 0 2 PFE 0 3 PFE 0 3 ABT flatABT flat MRK 0 3 MRK 0 3 AMGN 0 9 AMGN 0 9 Health care shares were mostly higher in pre market trade Monday Health care shares were mostly higher in pre market trade Monday In health
PFE,PFE:US,BBG000BR2B91,Merck&apos;s Diabetes Drug Meets Primary Endpoint in Key Studies,2017-06-12 12:43:12 +0000,https://finance.yahoo.com/news/merck-apos-diabetes-drug-meets-124312213.html?.tsrc=rss,"Merck & Co., Inc. (MRK) and partner Pfizer Inc. (PFE) announced that its pipeline candidate, ertugliflozin, met primary endpoints in two late stage studies evaluating ertugliflozin in adults with Type 2 diabetes."
PFE,PFE:US,BBG000BR2B91,"Trump's Offshore Tax Plan May Mean Extra Perk for Apple, Pfizer",2017-06-12 08:00:00 +0000,https://finance.yahoo.com/news/trumps-offshore-tax-plan-may-080000039.html?.tsrc=rss,"Multinationals are in line for a windfall from President Donald Trump’s call to cut the tax rate on U.S. companies’ stockpiled overseas earnings, but a select few would do better than others."
PFE,PFE:US,BBG000BR2B91,[$$] U.S. Probe Sheds Light on Charities’ Role in Boosting Drug Sales,2017-06-12 04:50:21 +0000,http://finance.yahoo.com/r/dd0f2cd0-aef5-346e-b9e1-fca35ba7d595/u-s-probe-sheds-light-on-charities-role-in-boosting-drug-sales-1497000601?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"U.S. sales of blockbuster prostate-cancer drugs have dropped sharply since the start of a federal investigation into charities that help patients pay for these drugs, a sign of how much the pharmaceutical ..."
PFE,PFE:US,BBG000BR2B91,[$$] Big US pharma dealmaking plunges to five-year low,2017-06-12 04:00:42 +0000,"http://finance.yahoo.com/r/a84096d3-ee49-35e8-8569-110b9f1f0d05/cb456228-4d5b-11e7-919a-1e14ce4af89b,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Big dealmaking in the US pharmaceuticals sector has sunk to its lowest level in five years, as companies shy away from large takeovers following President Donald Trump's failure to move ahead with overhauling ..."
PFE,PFE:US,BBG000BR2B91,[$$] Washington turmoil is proving a bitter pill for Pfizer,2017-06-12 04:00:42 +0000,"http://finance.yahoo.com/r/7416a1a6-3102-3150-a1c5-f33a37244c5c/7f1f0d5e-4eb4-11e7-bfb8-997009366969,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Since becoming chief executive of Pfizer in 2010, Ian Read has twice tried to reshape the drugmaker through a transformational acquisition. And twice he has been thwarted by politicians. Now politics is ..."
PFE,PFE:US,BBG000BR2B91,"LXRX Brings Sweet Tidings, PFE's PROSPER Ahead Of Schedule, XBIT Fails To Excite",2017-06-11 21:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HtvGVopioJo/lxrx-brings-sweet-tidings-pfes-prosper-ahead-of-schedule-xbit-fails-to-excite-20170611-00060,"LXRX Brings Sweet Tidings, PFE's PROSPER Ahead Of Schedule, XBIT Fails To Excite"
PFE,PFE:US,BBG000BR2B91,Merck and Pfizer Announce that Investigational SGLT-2 Inhibitor Ertugliflozin Met Primary Endpoint in Two Phase 3 Studies,2017-06-10 17:00:00 +0000,https://finance.yahoo.com/news/merck-pfizer-announce-investigational-sglt-170000556.html?.tsrc=rss,"Merck , known as MSD outside the United States and Canada, in partnership with Pfizer Inc. , today announced that two Phase 3 studies of ertugliflozin, an investigational oral SGLT-2 inhibitor in development to help improve glycemic control in adults with type 2 diabetes, met their primary endpoints."
PFE,PFE:US,BBG000BR2B91,Get Paid While You Wait: 3 Top Dividend Stocks in Big Pharma,2017-06-09 22:28:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mUbsbBzgLjw/get-paid-while-you-wait-3-top-dividend-stocks-in-big-pharma-cm801509,It s a fact Dividend stocks are often the foundation of most retirement portfolios But not all dividend stocks are created equally Income investors are usually on the lookout for stocks with as high a dividend yield as possible but also a yield that ll be sustainable over
PFE,PFE:US,BBG000BR2B91,Dow Jones Industrial Average Nabs Record Close; Nasdaq Retreats as Tech Stocks Spiral,2017-06-09 22:27:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ArrPCABZYgA/dow-jones-industrial-average-nabs-record-close-nasdaq-retreats-as-tech-stocks-spiral-cm801514,The Dow Jones Industrial Average DJIA 160 closed at a record high led by a surge in Pfizer stock and big gains for JPMorgan Chase shares ahead of next week s Fed meeting And while the U K election results drew focus early on it was a dramatic fall from grace for tech
PFE,PFE:US,BBG000BR2B91,"Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 6,207.92",2017-06-09 20:48:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0BoOjBKdYss/market-close-report-nasdaq-trading-volume-joins-the-top-ten-ranking-for-the-year-nasdaq-composite-index-closes-at-620792-cm801490,Today s session closes with the NASDAQ Composite Index volume reaching the 10th place in the top ten list for this year The last time the index closed above 2 49 billion shares was on Jan 17 2017 The total shares traded for the NASDAQ was over 3 13 billion Today s session closes with the
PFE,PFE:US,BBG000BR2B91,Get Paid While You Wait: 3 Top Dividend Stocks in Big Pharma,2017-06-09 20:45:00 +0000,http://finance.yahoo.com/r/2ee72777-339d-3ef7-8524-04abd0a8e13c/get-paid-while-you-wait-3-top-dividend-stocks-in-b.aspx?yptr=yahoo&.tsrc=rss,Good things come to those income investors who wait.
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/09/2017: JNJ, PFE, ABT, MRK, AMGN, ENZ, BNTC, SNSS",2017-06-09 20:06:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ks246xV8Wt4/health-care-sector-update-for-06092017-jnj-pfe-abt-mrk-amgn-enz-bntc-snss-cm801440,Top Health Care stocks Top Health Care stocks JNJ 0 5 JNJ 0 5 PFE 2 8 PFE 2 8 ABT 0 9 ABT 0 9 MRK 1 9 MRK 1 9 AMGN 1 7 AMGN 1 7 Health care shares were higher ahead of the close of Friday s session Health care shares were higher ahead of the close of Friday s session
PFE,PFE:US,BBG000BR2B91,Prostate Cancer Drug Sales Drop as Feds Investigate Charities,2017-06-09 19:32:00 +0000,http://finance.yahoo.com/r/fc6bc8ba-c6b2-3339-92d6-f500b0ba0f86/prostate-cancer-drug-sales-drop-as-feds-investigate-charities.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Prostate cancer drug sales have dropped during a federal investigation of charities that support the industry.
PFE,PFE:US,BBG000BR2B91,Don't Miss These 3 Breakouts; What's Taking Tech Stocks Down?,2017-06-09 19:28:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qAlC5JiUdkM/dont-miss-these-3-breakouts-whats-taking-tech-stocks-down-cm801262,ibd display video id 449449 top true Major U S index tracking ETFs were mixed Friday as Nvidia NVDA sent the chip sector reeling The stock indexes had taken off to early gains after shrugging off the surprise U K election outcome British Prime Minister Theresa May
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/09/2017: JNJ, PFE, ABT, MRK, AMGN, ENDP, LXRX, MBOT",2017-06-09 16:46:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TWpSwQKYtYk/health-care-sector-update-for-06092017-jnj-pfe-abt-mrk-amgn-endp-lxrx-mbot-cm801320,Top Health Care stocks Top Health Care stocks JNJ 0 3 JNJ 0 3 PFE 1 4 PFE 1 4 ABT 0 4 ABT 0 4 MRK 1 34 MRK 1 34 AMGN 1 2 AMGN 1 2 Health care shares were higher in mid day trade Friday Health care shares were higher in mid day trade Friday In health care stocks news
PFE,PFE:US,BBG000BR2B91,"Opioids are ravaging the U.S., but they’re still the best pain drug we’ve got",2017-06-09 12:40:10 +0000,https://finance.yahoo.com/news/opioids-ravaging-u-still-best-200657779.html?.tsrc=rss,The quest has seemed so elusive that it regularly draws comparison to the Holy Grail and unicorns.
PFE,PFE:US,BBG000BR2B91,Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial of enzalutamide in Patients with Non-metastatic Castration-Resistant Prostate Cancer,2017-06-09 12:00:00 +0000,https://finance.yahoo.com/news/astellas-pfizer-announce-amendment-clinical-120000092.html?.tsrc=rss,"Astellas Pharma Inc. and Pfizer Inc. announced today the amendment of the protocol for the registrational PROSPER trial, a multi-national, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of XTANDI® in patients with non-metastatic Castration-Resistant Prostate Cancer ."
PFE,PFE:US,BBG000BR2B91,7 Reasons Why Prescription Drug Prices Are Extremely Expensive,2017-06-09 11:28:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D3tBCPPcZXw/7-reasons-why-prescription-drug-prices-are-extremely-expensive-cm800997,Image source Getty Images Spending on prescription drugs increased by 3 8 in 2016 according 160 to pharmacy benefit manager Express Scripts While that s slower growth than the 5 2 year over year increase experienced in 2015 spending is still headed in the wrong
PFE,PFE:US,BBG000BR2B91,Pfizer  Investor Conference Call At 11:00 AM ET,2017-06-09 10:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zscI-hGe2Hs/pfizer--investor-conference-call-at-1100-am-et-20170609-00496,Pfizer  Investor Conference Call At 11:00 AM ET
PFE,PFE:US,BBG000BR2B91,[$$] U.S. Probe Sheds Light on Charities' Role in Boosting Drug Sales,2017-06-09 09:30:07 +0000,http://finance.yahoo.com/r/dd0f2cd0-aef5-346e-b9e1-fca35ba7d595/u-s-probe-sheds-light-on-charities-role-in-boosting-drug-sales-1497000601?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"U.S. sales of blockbuster prostate-cancer drugs have dropped sharply since the start of a federal investigation into charities that help patients pay for these drugs, a sign of how much the pharmaceutical ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Investor Conference Call At 11:00 AM ET,2017-06-09 07:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cSGhc-8Edso/pfizer-investor-conference-call-at-1100-am-et-20170609-00239,Pfizer Investor Conference Call At 11:00 AM ET
PFE,PFE:US,BBG000BR2B91,Pfizer Becomes Oversold,2017-06-08 21:26:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CD382K8Qi9w/pfizer-becomes-oversold-cm800858,The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important characteristics strong fundamentals and a valuation that looks inexpensive Pfizer
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Jun 8, 2017 :  YHOO, GE, CSCO, BAX, FB, F, AAPL, MU, QQQ, HPQ, PFE, SBGL",2017-06-08 20:56:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iNQyja9DIfE/after-hours-most-active-for-jun-8-2017-yhoo-ge-csco-bax-fb-f-aapl-mu-qqq-hpq-pfe-sbgl-cm800886,The NASDAQ 100 After Hours Indicator is down 32 to 5 884 98 The total After hours volume is currently 61 228 396 shares traded The following are the most active stocks for the after hours session Yahoo Inc YHOO is 0 31 at 55 40 with 11 553 069 shares
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/08/2017: JNJ, PFE, ABT, MRK, AMGN, CYTR, TGTX, QGEN",2017-06-08 16:46:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P9xoga9z-qg/health-care-sector-update-for-06082017-jnj-pfe-abt-mrk-amgn-cytr-tgtx-qgen-cm800717,Top Health Care stocks Top Health Care stocks JNJ 0 1 JNJ 0 1 PFE 0 2 PFE 0 2 ABT 0 2 ABT 0 2 MRK 1 4 MRK 1 4 AMGN 0 8AMGN 0 8 Health care shares were mixed in mid day trade Thursday Health care shares were mixed in mid day trade Thursday In health care stocks news
PFE,PFE:US,BBG000BR2B91,AbbVie (ABBV) Announced Positive Phase III RA Candidate Data,2017-06-08 16:31:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HHwNWDsnVwc/abbvie-abbv-announced-positive-phase-iii-ra-candidate-data-cm800663,AbbVie Inc ABBV announced positive top line results from a phase III study on rheumatoid arthritis candidate upadacitinib ABT 494 Upadacitinib is an investigational oral JAK1 selective inhibitor being studied as a once a day oral therapy AbbVie s shares have rallied 13 2 in the past
PFE,PFE:US,BBG000BR2B91,Why Pfizer’s Products Lost Market Share in 1Q17,2017-06-08 14:36:19 +0000,http://finance.yahoo.com/r/4e8bcad7-ae33-34ff-b479-c57741ab813e/why-pfizers-products-lost-market-share-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,There are a few products in Pfizer’s (PFE) portfolio that are losing market share due to competition.
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. Johnson & Johnson,2017-06-08 14:29:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LIbRbO1WCQs/better-buy-pfizer-inc-vs-johnson-johnson-cm800487,It s a battle of the behemoths In one corner sits Pfizer Inc NYSE PFE America s largest pharmaceutical company In the opposite corner we have Johnson amp Johnson NYSE JNJ the world s largest healthcare company Both would make fine additions to any portfolio
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. Johnson & Johnson,2017-06-08 13:12:00 +0000,http://finance.yahoo.com/r/570beb04-f0b8-3b68-be9a-0e970508d227/better-buy-pfizer-inc-vs-johnson-johnson.aspx?yptr=yahoo&.tsrc=rss,Find out how America&apos;s largest pharma stacks up to the world&apos;s largest healthcare company.
PFE,PFE:US,BBG000BR2B91,What Drove Pfizer in 1Q17?,2017-06-08 13:06:56 +0000,http://finance.yahoo.com/r/db6f75df-14dc-398a-87f4-da5defa90c21/what-drove-pfizer-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Growth drivers for Pfizer (PFE) include products contributing to operational growth, such as BMP2, Celebrex, Ibrance, Lyrica, and Xeljanz."
PFE,PFE:US,BBG000BR2B91,"Pre-Market Most Active for Jun 8, 2017 :  BABA, SMFG, YHOO, GE, MSFT, F, T, PFE, AAPL, CSCO, INTC, CMCSA",2017-06-08 12:56:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sQs8xPwQIFM/pre-market-most-active-for-jun-8-2017-baba-smfg-yhoo-ge-msft-f-t-pfe-aapl-csco-intc-cmcsa-cm800431,The NASDAQ 100 Pre Market Indicator is up 16 47 to 5 894 06 The total Pre Market volume is currently 28 082 992 shares traded The following are the most active stocks for the pre market session Alibaba Group Holding Limited BABA is 16 79 at 142 43 with 5 538
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson’s new prostate cancer advances could signal trouble for Pfizer,2017-06-08 11:46:25 +0000,http://finance.yahoo.com/r/c997677f-660b-38f4-9be0-139eb55491f3/Story.aspx?guid=FAF78E24-49F5-11E7-A1D7-BEF8BED2BE0B&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Two big clinical trials, which have dazzled scientists and Wall Street, are likely to give the company a big leg up."
PFE,PFE:US,BBG000BR2B91,Understanding Pfizer’s 1Q17 Performance by Geography,2017-06-08 11:36:38 +0000,http://finance.yahoo.com/r/ff72bf7c-5930-35c7-9529-9986438b1585/understanding-pfizers-1q17-performance-by-geography?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer (PFE) reported a 2% decline in revenues to ~$12.8 billion for 1Q17, as compared to $13.0 billion in 1Q16."
PFE,PFE:US,BBG000BR2B91,Behind Pfizer’s Business Segments in 1Q17,2017-06-07 21:35:58 +0000,http://finance.yahoo.com/r/1be72d1a-bb51-3009-9abb-3f9de01e0b7f/behind-pfizers-business-segments-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Pfizer's Innovative Health segment contributes ~58% of PFE's total revenues and reported an operational growth of 6% to $7.4 billion for 1Q17.
PFE,PFE:US,BBG000BR2B91,"Dow&apos;s Pfizer Faces Challenges As Roche, J&J, Lilly Loom",2017-06-07 20:25:12 +0000,http://finance.yahoo.com/r/9ac5d74f-6b5b-37f7-86a8-d22fc3e7ed6e/dows-pfizer-faces-challenges-as-roche-jj-lilly-loom?src=A00220&yptr=yahoo&.tsrc=rss,"Roche could displace Dow&apos;s Pfizer in one segment of the lung cancer market, an analyst said Wednesday."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/07/2017: JNJ, PFE, ABT, MRK, AMGN, KMDA, JAZZ, EXAS",2017-06-07 20:06:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DA0HXIlxXR4/health-care-sector-update-for-06072017-jnj-pfe-abt-mrk-amgn-kmda-jazz-exas-cm800241,Top Health Care stocks Top Health Care stocks JNJ 0 1 JNJ 0 1 PFE 0 5 PFE 0 5 ABT 0 5 ABT 0 5 MRK 0 9 MRK 0 9 AMGN 1 2 AMGN 1 2 Health care shares were mixed ahead of the close of Wednesday s session Health care shares were mixed ahead of the close of Wednesday s
PFE,PFE:US,BBG000BR2B91,Inside Pfizer’s 1Q17 Revenues,2017-06-07 20:05:57 +0000,http://finance.yahoo.com/r/c0e61403-3511-3887-9cfd-541129d7f0b3/inside-pfizers-1q17-revenues?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1Q17, Pfizer’s (PFE) revenues fell ~2% to ~$12.8 billion, including a 1% decline in operational revenues and a 1% decline due to foreign exchange."
PFE,PFE:US,BBG000BR2B91,What Happened to Pfizer’s Valuation after 1Q17?,2017-06-07 18:22:31 +0000,http://finance.yahoo.com/r/62519b2e-73aa-3d09-b993-01600e3a7313/what-happened-to-pfizers-valuation-after-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer (PFE), a pharmaceutical giant headquartered in New York City, reported EPS (earnings per share) of $0.69 on revenues of ~$12.8 billion for 1Q17."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/07/2017: JNJ, PFE, ABT, MRK, AMGN, CALA, ALOG, CERS",2017-06-07 16:46:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jZsz3Z8g1Kg/health-care-sector-update-for-06072017-jnj-pfe-abt-mrk-amgn-cala-alog-cers-cm800140,Top Health Care stocks Top Health Care stocks JNJ 0 1 JNJ 0 1 PFE 0 2 PFE 0 2 ABT 0 1 ABT 0 1 MRK 0 6 MRK 0 6 AMGN 0 9AMGN 0 9 Health care shares were mostly lower in mid day trade Wednesday Health care shares were mostly lower in mid day trade Wednesday In health
PFE,PFE:US,BBG000BR2B91,Pfizer's (PFE) Tafamidis Gets Fast Track Status in the U.S.,2017-06-07 15:28:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kn4U35jFoas/pfizers-pfe-tafamidis-gets-fast-track-status-in-the-us-cm800053,Pfizer Inc PFE has been granted with fast track status by FDA for treating patients with transthyretin cardiomyopathy TTR CM This rare disease is associated with progressive heart failure and is universally fatal Currently tafamidis is in phase III study for TTR CM Incidentally in
PFE,PFE:US,BBG000BR2B91,Pfizer&apos;s (PFE) Tafamidis Gets Fast Track Status in the U.S.,2017-06-07 14:16:02 +0000,https://finance.yahoo.com/news/pfizer-apos-pfe-tafamidis-gets-141602999.html?.tsrc=rss,Pfizer Inc. (PFE) has been granted with fast track status by FDA for treating patients with transthyretin cardiomyopathy (TTR-CM).
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference,2017-06-07 14:00:00 +0000,https://finance.yahoo.com/news/pfizer-invites-public-view-listen-140000951.html?.tsrc=rss,"Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Mikael Dolsten, President, Worldwide Research and Development, at the Goldman Sachs 38th Annual Global Healthcare Conference on Wednesday, June 14, 2017 at 8:00 a.m."
PFE,PFE:US,BBG000BR2B91,Sangamo Therapeutics And Pfizer Announce That SB-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency,2017-06-07 11:30:00 +0000,https://finance.yahoo.com/news/sangamo-therapeutics-pfizer-announce-sb-113000434.html?.tsrc=rss,"RICHMOND, Calif., June 7, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO) and Pfizer Inc. (PFE) announced today that the European Medicines Agency (EMA) has granted orphan medicinal product designation (OMPD) to SB-525, a clinical stage cDNA gene therapy candidate for hemophilia A. The EMA's OMPD is granted to medicines intended for the treatment, prevention or diagnosis of life-threatening or chronically debilitating conditions that are rare and affect less than five in 10,000 persons in the European Union (EU).  The designation provides incentives to advance the development and commercialization of orphan medicines, which include access to the EU centralized authorization procedure and potential for market exclusivity for a period of up to ten years."
PFE,PFE:US,BBG000BR2B91,Sangamo: SB-525 Therapy Receives Orphan Medicinal Product Designation From EMA,2017-06-07 07:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e01vzr_Up_k/sangamo-sb525-therapy-receives-orphan-medicinal-product-designation-from-ema-20170607-00322,Sangamo: SB-525 Therapy Receives Orphan Medicinal Product Designation From EMA
PFE,PFE:US,BBG000BR2B91,Merck's Cancer Drug Keytruda Positive in Clinical Studies,2017-06-07 00:18:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UIt4KeuMWh4/mercks-cancer-drug-keytruda-positive-in-clinical-studies-cm799739,Merck amp Co Inc MRK announced positive data from a phase III study KEYNOTE 024 evaluating its anti PD 1 therapy Keytruda pembrolizumab for first line treatment of patients with metastatic non small cell lung cancer NSCLC with high levels of PD L1 In Aug 2016 Keytruda
PFE,PFE:US,BBG000BR2B91,"Roche Announces Data on Perjeta, Alecensa and Tecentriq",2017-06-07 00:16:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JEq-IHdiX2Y/roche-announces-data-on-perjeta-alecensa-and-tecentriq-cm799727,Roche Holdings AG RHHBY announced data from the phase III study APHINITY on breast cancer drug Perjeta The data from the study showed that the combination of Perjeta Herceptin and chemotherapy the Perjeta based regimen significantly reduced the risk of breast cancer recurrence or
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/06/2017: JNJ, PFE, ABT, MRK, AMGN, NOVT, SNOA, EGLT",2017-06-06 20:17:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dHKVaQM5Fzw/health-care-sector-update-for-06062017-jnj-pfe-abt-mrk-amgn-novt-snoa-eglt-cm799638,Top Health Care stocks Top Health Care stocks JNJ 0 4 JNJ 0 4 PFE 0 9 PFE 0 9 ABT 0 4 ABT 0 4 MRK 0 8 MRK 0 8 AMGN 0 1 AMGN 0 1 Most health care shares were on track to close Tuesday s session lower Most health care shares were on track to close Tuesday s session lower
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson's New Prostate Cancer Drug Might Make Pfizer Sick,2017-06-06 18:18:00 +0000,http://finance.yahoo.com/r/2f434016-01b2-38be-90ef-8d81cff3efa8/johnson-amp-johnson-s-new-prostate-cancer-drug-might-make-pfizer-sick.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The companies are competing for approval for drugs that treat prostate cancer, the second most common cancer in men."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/06/2017: JNJ, PFE, ABT, MRK, AMGN, CTIC, PTCT, CLDX",2017-06-06 16:36:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x9zvWTNRaKw/health-care-sector-update-for-06062017-jnj-pfe-abt-mrk-amgn-ctic-ptct-cldx-cm799509,Top Health Care stocks Top Health Care stocks JNJ 0 5 JNJ 0 5 PFE 0 8 PFE 0 8 ABT 0 1 ABT 0 1 MRK 0 3 MRK 0 3 AMGN 0 2 AMGN 0 2 Health care shares were mostly lower in mid day trade Tuesday Health care shares were mostly lower in mid day trade Tuesday In health
PFE,PFE:US,BBG000BR2B91,Pfizer Receives FDA Fast Track Designation for Tafamidis for Transthyretin Cardiomyopathy,2017-06-06 12:00:00 +0000,https://finance.yahoo.com/news/pfizer-receives-fda-fast-track-120000646.html?.tsrc=rss,"Pfizer Inc. announced today that the U.S. Food and Drug Administration granted Fast Track designation to tafamidis, the company’s investigational treatment for transthyretin cardiomyopathy ."
PFE,PFE:US,BBG000BR2B91,Pfizer Gets FDA Fast Track Designation For Tafamidis For TTR-CM,2017-06-06 08:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ed1Dj9UKf6I/pfizer-gets-fda-fast-track-designation-for-tafamidis-for-ttrcm-20170606-00453,Pfizer Gets FDA Fast Track Designation For Tafamidis For TTR-CM
PFE,PFE:US,BBG000BR2B91,Top Stocks Billionaires Are Buying Now,2017-06-05 23:00:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XuQi3nxQFWE/top-stocks-billionaires-are-buying-now-cm799038,Warren Buffett George Soros and Carl Icahn are famous investors worth billions of dollars but these three gurus embrace wildly different investment approaches Buffett buys great stocks at fair prices for the long haul Soros invests opportunistically to benefit from both bull and
PFE,PFE:US,BBG000BR2B91,Tesaro Crashes Despite Beating AstraZeneca With &apos;Stronger&apos; Data,2017-06-05 21:14:00 +0000,http://finance.yahoo.com/r/58a8f9bf-ecf3-3ff4-a2d8-f192d2e8966f/tesaro-crashes-despite-beating-astrazeneca-with-stronger-data?src=A00220&yptr=yahoo&.tsrc=rss,Tesaro stock plunged Monday despite a Sunday presentation during a meeting that showed its Zejula could be stronger than drugs from AstraZeneca in breast cancer.
PFE,PFE:US,BBG000BR2B91,Top Stocks Billionaires Are Buying Now,2017-06-05 20:51:00 +0000,http://finance.yahoo.com/r/24a952fb-658a-3698-afd8-8bb65e9af4ff/top-stocks-billionaires-are-buying-now.aspx?yptr=yahoo&.tsrc=rss,"Here&apos;s why Warren Buffett, George Soros, and Carl Icahn have been buying Apple Inc., Pfizer Inc., and Herbalife."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/05/2017: JNJ, PFE, ABT, MRK, AMGN, NLNK, RDUS, BPMC",2017-06-05 20:01:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/siGngYzEVpA/health-care-sector-update-for-06052017-jnj-pfe-abt-mrk-amgn-nlnk-rdus-bpmc-cm798961,Top Health Care stocks Top Health Care stocks JNJ 0 1 JNJ 0 1 PFE 0 8 PFE 0 8 ABT 0 2 ABT 0 2 MRK 0 8 MRK 0 8 AMGN 0 9 AMGN 0 9 Health care shares were on track to close Monday s session higher Health care shares were on track to close Monday s session higher In
PFE,PFE:US,BBG000BR2B91,Here's Why Opko Health Inc. Slipped 18.8% in May,2017-06-05 17:04:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LahZfUMNkBM/heres-why-opko-health-inc-slipped-188-in-may-cm798805,What happened Shares of Opko Health Inc NASDAQ OPK 160 a company with pharmaceutical and diagnostic operations continued its months long slide following a gloomy first quarter earnings report According to data from S amp P Global Market Intelligence the stock
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 06/05/2017: JNJ, PFE, ABT, MRK, AMGN, CLSN, MBOT, LOXO",2017-06-05 16:40:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rjGBDhdhfMg/health-care-sector-update-for-06052017-jnj-pfe-abt-mrk-amgn-clsn-mbot-loxo-cm798838,Top Health Care stocks Top Health Care stocks JNJ 0 1 JNJ 0 1 PFE 0 8 PFE 0 8 ABT 0 3 ABT 0 3 MRK 1 1 MRK 1 1 AMGN 0 1 AMGN 0 1 Health care shares were mostly higher in mid day trade Monday Health care shares were mostly higher in mid day trade Monday In health
PFE,PFE:US,BBG000BR2B91,Interesting September 2018 Stock Options for PFE,2017-06-05 16:04:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3yWY7N9KwSQ/interesting-september-2018-stock-options-for-pfe-cm798830,Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the September 2018 expiration for PFE The put
PFE,PFE:US,BBG000BR2B91,"How To Trade 'Dogs Of The Dow' Chevron, IBM, Verizon And Exxon In Correction Territory",2017-06-05 15:06:00 +0000,http://finance.yahoo.com/r/a2f30a3c-9daf-3f06-be09-fac8a94be219/how-to-trade-dogs-of-the-dow-chevron-ibm-verizon-and-exxon-in-correction-territory?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,Here's a look at how the eight 'dogs of the Dow' are doing so far this year and how you should trade them now.
PFE,PFE:US,BBG000BR2B91,Pfizer Provides Final Update on Phase II Talazoparib Study,2017-06-05 14:53:02 +0000,https://finance.yahoo.com/news/pfizer-provides-final-phase-ii-145302010.html?.tsrc=rss,"Pfizer Inc. (PFE) announced data from its phase II study, ABRAZO, which is evaluating talazoparib in advanced breast cancer patients with germline BRCA 1/2 positive (gBRCA+) mutations, showing anti-tumor activity"
PFE,PFE:US,BBG000BR2B91,Here's the Best Dividend Stock in Big Pharma,2017-06-05 14:03:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YspTbm6EHi0/heres-the-best-dividend-stock-in-big-pharma-cm798559,Not long ago I labeled Bristol Myers Squibb Co NYSE BMY Eli Lilly and Co NYSE LLY Johnson amp Johnson NYSE JNJ and Pfizer Inc NYSE PFE the best dividend stocks in pharmaceuticals 160 I still believe all four have what it takes to boost
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: General Electric, Walt Disney, Merck, Pfizer and Chevron",2017-06-05 13:30:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-general-133001389.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: General Electric, Walt Disney, Merck, Pfizer and Chevron"
PFE,PFE:US,BBG000BR2B91,Will Pfizer Be Affected By Trump Administration Tax Reform?,2017-06-05 12:52:00 +0000,http://finance.yahoo.com/r/f28c744b-9675-3435-b9f9-69be6b5fee9f/will-pfizer-be-affected-by-trump-administration-tax-reform?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"The Trump administration’s tax reform is eagerly awaited by the corporate world, as it proposes to lower the corporate tax rate to 15%. But for companies such as Pfizer, there may not be much of an impact. This note explains why."
PFE,PFE:US,BBG000BR2B91,Here&apos;s the Best Dividend Stock in Big Pharma,2017-06-05 12:47:00 +0000,http://finance.yahoo.com/r/eca3cdc4-958c-36c8-9ba8-9e9a91956ff7/heres-the-best-dividend-stock-in-big-pharma.aspx?yptr=yahoo&.tsrc=rss,Pharmaceutical industry stocks are famous for fast-growing dividends -- and infamous for cutting them when conditions change.
PFE,PFE:US,BBG000BR2B91,Roche's Alecensa bests Pfizer's Xalkori in lung cancer trial,2017-06-05 11:30:00 +0000,https://finance.yahoo.com/news/roches-alecensa-bests-pfizers-xalkori-113000758.html?.tsrc=rss,"Roche Holding AG's  Alecensa halted the spread of lung cancer for a median of 15  months longer than treatment with rival Pfizer Inc's  Xalkori with fewer side effects, according to trial results  presented on Monday.  Both drugs are designed to treat advanced non-small cell  lung cancer in patients with a mutation of the ALK gene, which  is found in about 5 percent of all NSCLC patients.  About 12,500 Americans are diagnosed with ALK-positive NSCLC  each year, according to the American Society of Clinical  Oncology, which featured the study results at its annual meeting  in Chicago."
PFE,PFE:US,BBG000BR2B91,Pfizer drug delays lung cancer growth longer than Astra's Iressa-study,2017-06-05 11:30:00 +0000,https://finance.yahoo.com/news/pfizer-drug-delays-lung-cancer-113000215.html?.tsrc=rss,"A targeted drug being developed by Pfizer  Inc held advanced lung cancer in check longer than  AstraZeneca's Iressa in newly diagnosed patients, but  with a higher rate of side effects, according to data presented  on Monday.  The late-stage study of 452 patients with EGFR-positive  non-small cell lung cancer (NSCLC) compared Pfizer's next  generation oral drug, dacomitinib, with the older standard  treatment that also targets abnormal epidermal growth factor  receptor genes in advanced lung cancer."
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Down 2.5% Since Earnings Report: Can It Rebound?,2017-06-05 10:01:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KwMhqZwyNaw/pfizer-pfe-down-25-since-earnings-report-can-it-rebound-cm798477,It has been about a month since the last earnings report for Pfizer Inc PFE Shares have lost about 2 5 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a breakout Before we dive
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Down 2.5% Since Earnings Report: Can It Rebound?,2017-06-05 07:18:07 +0000,https://finance.yahoo.com/news/pfizer-pfe-down-2-5-071807955.html?.tsrc=rss,Pfizer (PFE) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
PFE,PFE:US,BBG000BR2B91,InPlay from Briefing.com,2017-06-05 04:57:51 +0000,https://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
PFE,PFE:US,BBG000BR2B91,"AMGN Finds New Use For Old Drug, NLNK Disappointed, ECYT Cuts Workforce",2017-06-05 02:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_X--m_S9v_U/amgn-finds-new-use-for-old-drug-nlnk-disappointed-ecyt-cuts-workforce-20170605-00056,"AMGN Finds New Use For Old Drug, NLNK Disappointed, ECYT Cuts Workforce"
PFE,PFE:US,BBG000BR2B91,Pfizer Presents Final Phase 2 Data on Investigational PARP Inhibitor Talazoparib in Patients with Germline BRCA-Positive Advanced Breast Cancer,2017-06-03 20:30:00 +0000,https://finance.yahoo.com/news/pfizer-presents-final-phase-2-203000370.html?.tsrc=rss,"Pfizer Inc. today announced Phase 2 data showing that its investigational, dual-mechanism poly ADP ribose polymerase inhibitor, talazoparib, demonstrated anti-tumor activity in patients with germline BRCA1/2-positive advanced breast cancer."
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: GE Inks Deals Worth $5.58B in Vietnam, Merck Buys Rights to Alzheimer Antibody",2017-06-02 22:31:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kmSV1zIP388/dow-30-stock-roundup-ge-inks-deals-worth-558b-in-vietnam-merck-buys-rights-to-alzheimer-antibody-cm798273,The Dow suffered across the holiday shortened week buoyed only by encouraging private sector hiring After remaining closed on Monday for a holiday the index slipped on Tuesday dragged down by energy shares Financials weighed on the blue chip index on Wednesday Ultimately strong ADP
PFE,PFE:US,BBG000BR2B91,Pfizer hikes U.S. prices of 91 drugs by average 20 pct in 2017-FT,2017-06-02 18:54:22 +0000,https://finance.yahoo.com/news/pfizer-hikes-u-prices-91-184623517.html?.tsrc=rss,"Pfizer Inc has hiked the price of  nearly a hundred drugs by an average of 20 percent so far this  year in the United States, the Financial Times reported on  Friday.  The U.S drugmaker raised the list price of 91 medicines –  including that of its erectile dysfunction treatment, Viagra,  and its pain drug, Lyrica – on June 1 by 5-13 percent, according  to figures seen by the Financial Times.  Pfizer had also raised prices in January and, including  those hikes, the average price of many of its drugs has risen by  20 percent this year, the FT said."
PFE,PFE:US,BBG000BR2B91,Pfizer defeats appeals linking Zoloft to birth defects,2017-06-02 18:38:36 +0000,https://finance.yahoo.com/news/pfizer-defeats-appeals-over-zoloft-134748740.html?.tsrc=rss,"Pfizer Inc on Friday defeated an  effort to revive more than 300 lawsuits alleging that its  antidepressant Zoloft causes cardiac birth defects in children  when taken by women during early pregnancy.  A panel of the 3rd U.S. Circuit Court of Appeals in  Philadelphia upheld the April 2016 dismissal of the cases by a  lower court judge, who said the plaintiffs had not shown a  plausible scientific link between Zoloft and the birth defects.  The plaintiffs accused New York-based Pfizer of playing down  the risks to boost sales of Zoloft, which topped $3 billion  annually before sales of generic versions began in 2006."
PFE,PFE:US,BBG000BR2B91,Pfizer's Kidney Cancer Drug Gets Acceptance in the U.S. & EU,2017-06-02 17:31:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ga407wuWx7s/pfizers-kidney-cancer-drug-gets-acceptance-in-the-us-eu-cm798076,Pfizer Inc PFE announced encouraging news with the FDA and the European Medicines Agency EMA accepting the company s regulatory submission for label expansion of its cancer drug Sutent sunitinib The company is looking to expand Sutent s label for adjuvant treatment of adult patients
PFE,PFE:US,BBG000BR2B91,Portola Pharmaceuticals Could Be a Great June Trade,2017-06-02 17:27:09 +0000,https://finance.yahoo.com/news/portola-pharmaceuticals-could-great-june-172709450.html?.tsrc=rss,A look at the upcoming FDA decision for 1 of the company's 2 lead assets
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer raises US prices of 91 drugs by 20% in 2017,2017-06-02 16:48:31 +0000,"http://finance.yahoo.com/r/b09d8cbd-79b5-3361-b3bb-46058fe6cccc/b2e0dd80-47ab-11e7-8519-9f94ee97d996,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Pfizer has raised the US price of nearly 100 drugs by an average of 20 per cent so far this year, in a move that threatens to draw anger from politicians at a time of public outcry over the cost of medicines. ..."
PFE,PFE:US,BBG000BR2B91,"ITOT, PG, PFE, MMM: Large Inflows Detected at ETF",2017-06-02 16:32:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VNNXn-KHkTU/itot-pg-pfe-mmm-large-inflows-detected-at-etf-cm798036,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core S amp P Total U S Stock Market ETF Symbol ITOT where we have detected an approximate 79 9 million dollar inflow that s a 0 9 increase week
PFE,PFE:US,BBG000BR2B91,Pfizer&apos;s Kidney Cancer Drug Gets Acceptance in the U.S. & EU,2017-06-02 15:42:03 +0000,https://finance.yahoo.com/news/pfizer-apos-kidney-cancer-drug-154203624.html?.tsrc=rss,"Pfizer Inc. (PFE) announced encouraging news with the FDA and the European Medicines Agency (EMA) accepting the company&apos;s regulatory submission for label expansion of its cancer drug, Sutent (sunitinib)."
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Positive Data from Lilly & Teva, BMY's Deals & More",2017-06-02 14:36:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zyOvflCjBeA/pharma-stock-roundup-positive-data-from-lilly-teva-bmys-deals-more-cm797951,This week there were quite a few regulatory and pipeline updates with Lilly LLY reporting positive results on its cancer drug Cyramza while the FDA expanded the label of Merck s MRK HIV drug Isentress Recap of the Week s Most Important Stories Lilly s Cyramza Hits Primary
PFE,PFE:US,BBG000BR2B91,GSK Reports EU & US Submissions For First HIV Maintenance Regimen - Quick Facts,2017-06-02 02:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R0WVb6nFbiY/gsk-reports-eu--us-submissions-for-first-hiv-maintenance-regimen--quick-facts-20170602-00049,GSK Reports EU & US Submissions For First HIV Maintenance Regimen - Quick Facts
PFE,PFE:US,BBG000BR2B91,"How Clovis, AstraZeneca Could &apos;Muddy&apos; A Potential Deal For Tesaro",2017-06-01 20:07:28 +0000,http://finance.yahoo.com/r/a4d488f1-0e3c-3844-9c15-5dcdb828294c/how-clovis-astrazeneca-could-muddy-a-potential-deal-for-tesaro?src=A00220&yptr=yahoo&.tsrc=rss,"AstraZeneca, Pfizer and Clovis Oncology could slow bidding on Tesaro, an analyst said Thursday."
PFE,PFE:US,BBG000BR2B91,"AT&T, Pfizer, Taiwan Semi Ready to Rip Higher: Must-See Charts",2017-06-01 16:25:00 +0000,http://finance.yahoo.com/r/4c077d88-3b27-3b38-b6f7-94491aa60f5e/at-amp-t-pfizer-taiwan-semi-ready-to-rip-higher-must-see-charts.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,These huge stocks look ready to lead the market to new highs this summer.
PFE,PFE:US,BBG000BR2B91,Icon Plc (ICLR) Stock is Cultivating a Strong Business,2017-06-01 15:35:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h0DoC4zB4QE/icon-plc-iclr-stock-is-cultivating-a-strong-business-cm797515,InvestorPlace Stock Market News Stock Advice amp Trading Tips The biotech sector is rife with hit or miss investments so it s critical that you re very selective when choosing your next buy One under the radar name that recently came across my screen is Icon Plc
PFE,PFE:US,BBG000BR2B91,European Markets Put An End To Their Recent Losing Streak,2017-06-01 12:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/APuwfRRNyp8/european-markets-put-an-end-to-their-recent-losing-streak-20170601-01103,European Markets Put An End To Their Recent Losing Streak
PFE,PFE:US,BBG000BR2B91,European Shares Broadly Higher; Banks Underperform,2017-06-01 05:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZujNXc6P5hY/european-shares-broadly-higher-banks-underperform-20170601-00153,European Shares Broadly Higher; Banks Underperform
PFE,PFE:US,BBG000BR2B91,"Market Close Report: NASDAQ Composite index closes at 6,198.52 down -4.67 points",2017-05-31 20:49:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wxPe6rk4nYw/market-close-report-nasdaq-composite-index-closes-at-619852-down-467-points-cm797117,Wednesday s session closes with the NASDAQ Composite Index at 6 198 52 The total shares traded for the NASDAQ was over 2 23 billion Declining stocks led advancers by 1 04 to 1 ratio There were 1408 advancers and 1468 decliners for the day On the NASDAQ Stock Exchange 64 stocks reached a 52
PFE,PFE:US,BBG000BR2B91,Stocks Close In The Red; Banks Crumble On Slow JPMorgan Trade Revenue,2017-05-31 20:46:03 +0000,http://finance.yahoo.com/r/082864bc-7d96-3b44-8d2d-1d745f2a14ea/stocks-close-in-the-red-banks-crumble-on-jpmorgan-trade-reveal?src=A00220&yptr=yahoo&.tsrc=rss,"The market ended May with a dull thud, running losses of 0.1% across the Nasdaq, S&P 500 and Dow Jones industrial average."
PFE,PFE:US,BBG000BR2B91,3 Top Dividend Stocks in Diabetes Treatment,2017-05-31 19:44:00 +0000,http://finance.yahoo.com/r/8d33268a-71f6-30e9-ace4-82b737807232/3-top-dividend-stocks-in-diabetes-treatment.aspx?yptr=yahoo&.tsrc=rss,"Looking for great dividend stocks of drugmakers with diabetes treatments? Check out AstraZeneca, Pfizer, and Sanofi."
PFE,PFE:US,BBG000BR2B91,Pfizer's Trumenba Vaccine Approved by European Commission,2017-05-31 17:32:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lvvC164hgNA/pfizers-trumenba-vaccine-approved-by-european-commission-cm796942,Pfizer Inc PFE announced that its Trumenba vaccine received approval from the European Commission EC for active immunization of people aged 10 years and older for the prevention of invasive disease caused by Neisseria meningitidis serogroup B MenB Shares of Pfizer have underperformed
PFE,PFE:US,BBG000BR2B91,Pfizer&apos;s Trumenba Vaccine Approved by European Commission,2017-05-31 15:48:03 +0000,https://finance.yahoo.com/news/pfizer-apos-trumenba-vaccine-approved-154803937.html?.tsrc=rss,Pfizer Inc. (PFE) announced that its Trumenba vaccine received approval from the European Commission (EC) for active immunization of people aged 10 years and older for the prevention of invasive disease caused by Neisseria meningitidis serogroup B (MenB).
PFE,PFE:US,BBG000BR2B91,"Dow Movers: GS, PFE",2017-05-31 15:33:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RtVALn_iaPE/dow-movers-gs-pfe-cm796793,In early trading on Wednesday shares of Pfizer PFE topped the list of the day s best performing Dow Jones Industrial Average components trading up 1 3 Year to date Pfizer registers a 0 2 gain And the worst performing Dow component thus far on the day is Goldman Sachs Group
PFE,PFE:US,BBG000BR2B91,"Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for June 01, 2017",2017-05-31 13:22:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o6RzBbuWn1I/teva-pharmaceutical-industries-limited-teva-ex-dividend-date-scheduled-for-june-01-2017-cm796693,Teva Pharmaceutical Industries Limited TEVA will begin trading ex dividend on June 01 2017 A cash dividend payment of 0 289 per share is scheduled to be paid on June 22 2017 Shareholders who purchased TEVA prior to the ex dividend date are eligible for the cash dividend payment
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Acceptance of Regulatory Submissions by U.S. FDA and European Medicines Agency for SUTENT® (sunitinib) for Adjuvant Treatment of Adult Patients at High Risk of Recurrent Renal Cell Carcinoma After Surgery,2017-05-31 12:30:00 +0000,https://finance.yahoo.com/news/pfizer-announces-acceptance-regulatory-submissions-123000100.html?.tsrc=rss,Pfizer Inc. today announced that a supplemental New Drug Application for SUTENT® has been accepted for filing by the U.S. Food and Drug Administration .
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 05/30/2017: PFE,PTGX,JNJ,CYCC",2017-05-30 20:32:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AJbs_RB9Vqs/health-care-sector-update-for-05302017-pfeptgxjnjcycc-cm796451,Top Health Care StocksTop Health Care Stocks JNJ 0 11 JNJ 0 11 PFE 0 02 PFE 0 02 ABT 0 70 ABT 0 70 MRK 0 12 MRK 0 12 AMGN 0 77 AMGN 0 77 Health care stocks were ending little changed this afternoon with the NYSE Health Care Index rising less than 0 1 while shares of health
PFE,PFE:US,BBG000BR2B91,European Commission Approves Pfizer’s TRUMENBA® to Help Prevent Meningococcal Group B Disease in Adolescents and Adults,2017-05-30 14:00:00 +0000,https://finance.yahoo.com/news/european-commission-approves-pfizer-trumenba-140000651.html?.tsrc=rss,Pfizer Inc. announced today that the European Commission has approved TRUMENBA® for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 years of age and older.
PFE,PFE:US,BBG000BR2B91,The 5 Best Dividend Stocks in Cholesterol Drugs,2017-05-30 12:30:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2R9nK9SZcX4/the-5-best-dividend-stocks-in-cholesterol-drugs-cm795970,There s good news bad news and more good news about high cholesterol levels The first good news is that the percentage of Americans with high cholesterol is falling The bad news is that over 73 million Americans still have high bad cholesterol levels What s the other piece of
PFE,PFE:US,BBG000BR2B91,The 5 Best Dividend Stocks in Cholesterol Drugs,2017-05-30 11:23:00 +0000,http://finance.yahoo.com/r/b8a0819f-c871-3045-9a42-f036d61f1f5f/the-5-best-dividend-stocks-in-cholesterol-drugs.aspx?yptr=yahoo&.tsrc=rss,"Looking for great dividend stocks of companies that make cholesterol drugs? Check out Amgen, AstraZeneca, Novartis, Pfizer, and Sanofi."
PFE,PFE:US,BBG000BR2B91,Pfizer: EC Oks TRUMENBA For Prevention Of Invasive Meningococcal Disease,2017-05-30 10:29:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7CotHRnOjVI/pfizer-ec-oks-trumenba-for-prevention-of-invasive-meningococcal-disease-20170530-00751,Pfizer: EC Oks TRUMENBA For Prevention Of Invasive Meningococcal Disease
PFE,PFE:US,BBG000BR2B91,Meet the Cancer Therapy that Could Become the Second Best-Selling Drug in the World by Year's End,2017-05-29 14:33:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mXn-vGo3b2U/meet-the-cancer-therapy-that-could-become-the-second-best-selling-drug-in-the-world-by-years-end-cm795870,The pharmaceutical industry is big business According to the International Trade Administration s Top Markets Report on pharmaceuticals last year the global drug market is expected to grow from about 1 trillion in sales in 2015 to 1 3 trillion by 2020 representing about 5
PFE,PFE:US,BBG000BR2B91,3 Top Dividend Stocks in Cancer Drugs,2017-05-28 16:30:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WGJvmqgs96I/3-top-dividend-stocks-in-cancer-drugs-cm795766,It seems as if nearly every biotech and pharmaceutical on the planet is hard at work developing new cancer drugs That s a good thing for cancer patients And it s good for dividend seeking investors as well since many of the companies in the cancer drug space pay nice dividends
PFE,PFE:US,BBG000BR2B91,3 Top Dividend Stocks in Cancer Drugs,2017-05-28 15:03:00 +0000,http://finance.yahoo.com/r/f72dc220-64a1-3a2d-8d53-5e939a110d13/3-top-dividend-stocks-in-cancer-drugs.aspx?yptr=yahoo&.tsrc=rss,"There are lot of companies focusing on cancer drugs that pay dividends. AbbVie, AstraZeneca, and Pfizer stand at the top of the list."
PFE,PFE:US,BBG000BR2B91,Top Presentations to Look for at ASCO,2017-05-27 12:40:04 +0000,https://finance.yahoo.com/news/top-presentations-look-asco-124004427.html?.tsrc=rss,"The 2017 annual meeting of the American Society of Clinical Oncology (ASCO) runs from June 2 to June 6. The following companies have signaled that they will be presenting data, or data will be presented ..."
PFE,PFE:US,BBG000BR2B91,Which Biotechs Benefit Most Under Trump&apos;s Tax Reform Vision?,2017-05-27 12:00:55 +0000,http://finance.yahoo.com/r/cc324037-f97e-3ba0-8f24-1c7e7820a122/which-biotechs-benefit-most-under-trumps-tax-reform-vision?src=A00220&yptr=yahoo&.tsrc=rss,"Regeneron, Gilead and Biogen will benefit the most among biotechs under Trump&apos;s proposed tax reform, a measure that would cut the corporate tax rate by 20%."
PFE,PFE:US,BBG000BR2B91,3 Top Dividend Stocks in Generic Drugs,2017-05-26 20:31:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qBDKcygCAVo/3-top-dividend-stocks-in-generic-drugs-cm795538,There haven t been too many positive developments in prescription drug price trends However there is at least one 160 Generic drugs now make up nearly eight out of every 10 prescriptions That s good news for payers and patients It s also good news for dividend seeking investors
PFE,PFE:US,BBG000BR2B91,Genvoya Could Drive Gilead Sciences’ Revenue Growth in 2017,2017-05-26 20:23:23 +0000,http://finance.yahoo.com/r/4c319575-b0f7-3987-abab-c59cd9859954/genvoya-could-drive-gilead-sciences-revenue-growth-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 1Q17, Gilead Sciences’ (GILD) Genvoya generated revenues of around $769 million. The drug has seen double-digit sequential sales growth in every quarter since its launch in November 2015."
PFE,PFE:US,BBG000BR2B91,"Are Regeneron, Sanofi Treading On Pfizer In Eczema?",2017-05-26 20:20:20 +0000,http://finance.yahoo.com/r/033c3cb6-3a0d-3014-a3c4-cb7482d11b5e/are-regeneron-sanofi-treading-on-pfizer-in-eczema?src=A00220&yptr=yahoo&.tsrc=rss,Total prescriptions of Pfizer&apos;s eczema drug Eucrisa have flattened out over recent weeks as Regeneron and Sanofi&apos;s Dupixent has picked up steam.
PFE,PFE:US,BBG000BR2B91,"Opioids are ravaging the U.S., but they’re still the best pain drug we’ve got",2017-05-26 20:06:57 +0000,http://finance.yahoo.com/r/8d2f04c5-e160-36ee-baba-572d88c2ae74/Story.aspx?guid=91F0E9FC-4167-11E7-BA12-2EF43906EB08&siteid=yhoof2&yptr=yahoo&.tsrc=rss,The quest has seemed so elusive that it regularly draws comparison to the Holy Grail and unicorns.
PFE,PFE:US,BBG000BR2B91,3 Top Dividend Stocks in Generic Drugs,2017-05-26 19:02:00 +0000,http://finance.yahoo.com/r/c1cdeb46-8ed1-384b-afe0-af26791b8111/3-top-dividend-stocks-in-generic-drugs.aspx?yptr=yahoo&.tsrc=rss,"Why Pfizer, Novartis, and Sanofi rank at the top of all dividend stocks in the generic-drug industry."
PFE,PFE:US,BBG000BR2B91,Celldex's Immuno-Oncology Pipeline Continues to Impress,2017-05-26 15:36:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7SEv5Ovh8Sw/celldexs-immuno-oncology-pipeline-continues-to-impress-cm795268,On May 25 we issued an updated research report on Hampton NJ based Celldex Therapeutics Inc CLDX Celldex is a development stage biopharmaceutical company focused on the development and commercialization of immunotherapy technologies and other cancer targeting biologics So far this
PFE,PFE:US,BBG000BR2B91,Pfizer's Epogen Biosimilar Gets Positive FDA Committee Vote,2017-05-26 15:36:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qfshcdcF5hI/pfizers-epogen-biosimilar-gets-positive-fda-committee-vote-cm795253,Pfizer Inc PFE announced that an FDA advisory committee has recommended approval of its biosimilar version of Amgen Inc s AMGN erythropoiesis stimulating agent ESA Epogen and Procrit The Oncologic Drugs Advisory Committee ODAC recommended approval across all indications of the
PFE,PFE:US,BBG000BR2B91,Pfizer&apos;s Epogen Biosimilar Gets Positive FDA Committee Vote,2017-05-26 13:36:01 +0000,https://finance.yahoo.com/news/pfizer-apos-epogen-biosimilar-gets-133601656.html?.tsrc=rss,"Pfizer, Inc. (PFE) announced that an FDA advisory committee has recommended approval of its biosimilar version of ESA Epogen and Procrit."
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Label Expansion for Merck Drug, Aerie Up On Eye Data",2017-05-26 13:34:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QKdPN0FpI-w/pharma-stock-roundup-label-expansion-for-merck-drug-aerie-up-on-eye-data-cm795202,This week there were quite a few regulatory updates with Merck MRK getting FDA approval for yet another indication for Keytruda while Bristol Myers BMY got priority review for a regulatory application for Opdivo Recap of the Week s Most Important Stories Aerie Soars on Positive
PFE,PFE:US,BBG000BR2B91,Blog Coverage: Pfizer Cautions Shareholders Against Accepting TRC Capital Corporation's Mini-Tender Offer,2017-05-26 12:15:00 +0000,https://finance.yahoo.com/news/blog-coverage-pfizer-cautions-shareholders-121500019.html?.tsrc=rss,"Upcoming AWS Coverage on AbbVie Post-Earnings Results LONDON, UK / ACCESSWIRE / May 26, 2017 / Active Wall St. blog coverage looks at the headline from pharmaceutical giant Pfizer Inc. (NYSE: PFE ) as ..."
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Label Expansion for Merck Drug, Aerie Up On Eye Data",2017-05-26 12:08:12 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-label-expansion-120812582.html?.tsrc=rss,Merck (MRK) got another approval for Keytruda while Aerie shot up on positive data.
PFE,PFE:US,BBG000BR2B91,Changes in Sanofi’s Valuation after Its 1Q17 Earnings,2017-05-26 11:37:49 +0000,http://finance.yahoo.com/r/6c12b624-3c60-3176-8901-153b1c123416/changes-in-sanofis-valuation-after-its-1q17-earnings?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Paris-based Sanofi (SNY) reported revenues of ~8.7 billion euros in 1Q17. Sanofi surpassed analyst estimates, posting EPS of 1.42 euros in 1Q17, compared to estimates of 1.31 euros."
PFE,PFE:US,BBG000BR2B91,The Top 10 S&P 500 Dividend Stocks to Buy Now,2017-05-25 23:32:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uCA24wYAVpE/the-top-10-sp-500-dividend-stocks-to-buy-now-cm794929,InvestorPlace Stock Market News Stock Advice amp Trading Tips The typical income investor who is retired needs dividend stocks that yield at least 3 5 to live off of them Unfortunately the average S amp P 500 stock yields just 1 9 Source Steve Buissinne via Stock Snap Care
PFE,PFE:US,BBG000BR2B91,FDA Panel Recommends Approval Of Epoetin Alfa Biosimilar Across All Indications,2017-05-25 21:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kw0abtAMjlQ/fda-panel-recommends-approval-of-epoetin-alfa-biosimilar-across-all-indications-20170525-01325,FDA Panel Recommends Approval Of Epoetin Alfa Biosimilar Across All Indications
PFE,PFE:US,BBG000BR2B91,Aerie's Ophthalmic Candidate Positive in Registration Trial,2017-05-25 20:32:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2HJ6r5hLjoI/aeries-ophthalmic-candidate-positive-in-registration-trial-cm794820,Aerie Pharmaceuticals Inc AERI announced positive primary efficacy results of the 90 day phase III registration trial Mercury 2 for its pipeline candidate Roclatan We note that Aerie has outperformed the Zacks classified Medical Drugs industry in the last 12 months The stock
PFE,PFE:US,BBG000BR2B91,Aerie&apos;s Ophthalmic Candidate Positive in Registration Trial,2017-05-25 18:13:06 +0000,https://finance.yahoo.com/news/aerie-apos-ophthalmic-candidate-positive-181306598.html?.tsrc=rss,"Aerie Pharmaceuticals, Inc. (AERI) announced positive primary efficacy results of the 90-day phase III registration trial -- Mercury 2 -- for its pipeline candidate Roclatan."
PFE,PFE:US,BBG000BR2B91,TrumpCare isn't moving health care stocks because it won't pass: NYSE trader,2017-05-25 18:01:28 +0000,https://finance.yahoo.com/video/trumpcare-isnt-moving-health-care-180128765.html?.tsrc=rss,"Alan Valdes, director of floor operations for Silverbear, joins Alexis Christoforous from the New York Stock Exchange to discuss the outlook for health care stocks after the CBO scored the latest healthcare bill from President Trump and the Republicans."
PFE,PFE:US,BBG000BR2B91,FDA Advisory Committee Recommends Approval of Pfizer’s Proposed Biosimilar to Epogen®/Procrit® Across All Indications,2017-05-25 17:16:00 +0000,https://finance.yahoo.com/news/fda-advisory-committee-recommends-approval-171600020.html?.tsrc=rss,Pfizer Inc. today announced the United States Food and Drug Administration Oncologic Drugs Advisory Committee recommended approval of the Company’s proposed epoetin alfa biosimilar across all indications.
PFE,PFE:US,BBG000BR2B91,iShares S&P 500 Growth ETF Experiences Big Inflow,2017-05-25 16:32:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lKEEscuCYy8/ishares-sp-500-growth-etf-experiences-big-inflow-cm794630,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares S amp P 500 Growth ETF Symbol IVW where we have detected an approximate 136 8 million dollar inflow that s a 0 8 increase week over week in
PFE,PFE:US,BBG000BR2B91,Drug approvals bounce back as R&D labs churn out new winners,2017-05-25 12:10:37 +0000,https://finance.yahoo.com/news/drug-approvals-bounce-back-r-121037595.html?.tsrc=rss,"The U.S. Food and Drug Administration has already cleared 21  new prescription medicines for sale against 22 in the whole of  2016, and just nine at this stage last year.  The European Medicines Agency has recommended 42 compared  with a 2016 total of 81, and 31 in the first five months of last  year.  Unlike the FDA, the EMA includes generic or non-patented  drugs in its list."
PFE,PFE:US,BBG000BR2B91,Merck’s Immunology and Cardiovascular Franchise in 1Q17,2017-05-25 11:35:53 +0000,http://finance.yahoo.com/r/a2f3e365-8b4f-3686-9f98-c0c22c6765dd/mercks-immunology-and-cardiovascular-franchise-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Remicade, a top-selling drugs for the treatment of inflammatory disorders, is losing market share after the loss of exclusivity in European markets in February 2015."
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for May 24, 2017 :  INTC, PFE, WY, F, WIN, MRO, OAS, JCP, MSFT, IMGN, BRCD, EBAY",2017-05-24 20:59:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eFPIMjGvyD8/after-hours-most-active-for-may-24-2017-intc-pfe-wy-f-win-mro-oas-jcp-msft-imgn-brcd-ebay-cm794215,The NASDAQ 100 After Hours Indicator is up 02 to 5 730 32 The total After hours volume is currently 36 962 220 shares traded The following are the most active stocks for the after hours session Intel Corporation INTC is 0 17 at 35 95 with 2 811 490 shares
PFE,PFE:US,BBG000BR2B91,PFE Crosses Above 4% Yield Territory,2017-05-24 20:32:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FekLSkxUh24/pfe-crosses-above-4-yield-territory-cm794165,Looking at the universe of stocks we cover at Dividend Channel in trading on Wednesday shares of Pfizer Inc Symbol PFE were yielding above the 4 mark based on its quarterly dividend annualized to 1 28 with the stock changing hands as low as 31 97 on the day Dividends are
PFE,PFE:US,BBG000BR2B91,"XLV, ULE: Big ETF Outflows",2017-05-24 16:33:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0bTOtzp9cq8/xlv-ule-big-etf-outflows-cm793952,Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel the biggest outflow was seen in the Health Care Select Sector SPDR Fund XLV where 4 300 000 units were destroyed or a 2 0 decrease week over week Among the largest underlying
PFE,PFE:US,BBG000BR2B91,Performance of Merck’s Diabetes Portfolio in 1Q17,2017-05-24 14:36:50 +0000,http://finance.yahoo.com/r/5b41dfb4-0fd3-3c3f-8287-3b385fc11d87/performance-of-mercks-diabetes-portfolio-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Combined sales for Januvia and Janumet were ~$1.3 billion for 1Q17, a ~5.0% fall from $1.4 billion in 1Q16."
PFE,PFE:US,BBG000BR2B91,"Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 25, 2017",2017-05-24 13:12:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w0z9pxUSxe0/johnson-johnson-jnj-ex-dividend-date-scheduled-for-may-25-2017-cm793738,Johnson amp Johnson JNJ will begin trading ex dividend on May 25 2017 A cash dividend payment of 0 84 per share is scheduled to be paid on June 13 2017 Shareholders who purchased JNJ prior to the ex dividend date are eligible for the cash dividend payment This represents an 5
PFE,PFE:US,BBG000BR2B91,Pfizer Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital Corporation,2017-05-24 10:45:00 +0000,https://finance.yahoo.com/news/pfizer-recommends-shareholders-reject-below-104500509.html?.tsrc=rss,"Pfizer Inc. today announced that it has received notice of an unsolicited mini-tender offer by TRC Capital Corporation of Ontario, Canada to purchase up to 4 million shares of Pfizer common stock at a price of $31.60 per share in cash."
PFE,PFE:US,BBG000BR2B91,Pfizer Recommends Stockholders To Reject TRC Capital's Mini-tender Offer,2017-05-24 07:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a0v1eDMrJGo/pfizer-recommends-stockholders-to-reject-trc-capitals-minitender-offer-20170524-00357,Pfizer Recommends Stockholders To Reject TRC Capital's Mini-tender Offer
PFE,PFE:US,BBG000BR2B91,"Gainers & Losers Of May 23: GLYC, PBYI, SGMO, CERS, AGLE...",2017-05-23 21:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t5IyzUfbJZ8/gainers--losers-of-may-23-glyc-pbyi-sgmo-cers-agle-20170523-01429,"Gainers & Losers Of May 23: GLYC, PBYI, SGMO, CERS, AGLE..."
PFE,PFE:US,BBG000BR2B91,Can These 3 High-Flying Healthcare Stocks Reach the Clouds?,2017-05-23 21:13:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZuQhhgGvf5g/can-these-3-high-flying-healthcare-stocks-reach-the-clouds-cm793564,It s been a pretty good year for healthcare stocks across the board and a handful have soared to all time highs You shouldn t buy stocks just because they re going up but there s a chance Zoetis Inc NYSE ZTS Baxter International Inc NYSE BAX and Intuitive
PFE,PFE:US,BBG000BR2B91,"What's Your Flavor? Don't Worry, There's An ETF For That",2017-05-23 17:14:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uKY5NZ3c338/whats-your-flavor-dont-worry-theres-an-etf-for-that-cm793477,Remember Apple s AAPL popular There s an app for that catchphrase Perhaps the same could be said for exchange traded funds At least the industry appears headed in that direction Whether you support gender diversity prefer religious oriented investments or believe
PFE,PFE:US,BBG000BR2B91,Sanofi/Regeneron's Kevzara Gets FDA Approval for Arthritis,2017-05-23 16:16:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sHv93HGfKWs/sanofiregenerons-kevzara-gets-fda-approval-for-arthritis-cm793282,Sanofi SNY and partner Regeneron Pharmaceuticals Inc REGN announced that the FDA has approved their pipeline candidate sarilumab to be marketed under the trade name of Kevzara Kevzara has been approved for the treatment of moderately to severely active rheumatoid arthritis RA in
PFE,PFE:US,BBG000BR2B91,"NWQ Managers Sells Pfizer, Viacom, Edison",2017-05-23 16:11:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9i0oOjXEsCE/nwq-managers-sells-pfizer-viacom-edison-cm793375,NWQ Managers Trades Portfolio is a value oriented money management firm with several funds products and more than 54 billion under management During the first quarter the guru sold shares in the following stocks NWQ Managers Trades Portfolio is a value oriented money
PFE,PFE:US,BBG000BR2B91,The Current State Of The Breast Cancer Treatment Space,2017-05-23 12:59:04 +0000,https://finance.yahoo.com/news/current-state-breast-cancer-treatment-125904515.html?.tsrc=rss,"Puma Biotechnology Inc (NASDAQ: PBYI ) popped 88 percent Monday on news that its neratinib candidate , an early-stage breast cancer treatment for human epidermal growth factor receptor-2 (HER2) positive ..."
PFE,PFE:US,BBG000BR2B91,Merck & Co Faces Financial Hit From U.K. Regulator Over Drug Pricing,2017-05-23 10:05:00 +0000,http://finance.yahoo.com/r/21650678-aff9-341a-8a22-6613608d82a2/merck-amp-co-faces-financial-hit-from-u-k-regulator-over-drug-pricing.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Merck & Co may face financial penalties from U.K. regulators after the Competition & Markets Authority released provisional findings of a drug pricing investigation into the American drugmaker.
PFE,PFE:US,BBG000BR2B91,"3 Big Stock Charts for Monday: Bristol-Myers Squibb Co (BMY), Pfizer Inc. (PFE) and Amgen, Inc. (AMGN)",2017-05-22 21:12:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LCW1kvwSPio/3-big-stock-charts-for-monday-bristol-myers-squibb-co-bmy-pfizer-inc-pfe-and-amgen-inc-amgn-cm792945,InvestorPlace Stock Market News Stock Advice amp Trading Tips Stocks are ready to continue last week s recovery as traders continue to look for opportunities to buy the short term dip caused by the political headlines from last week While there are some deals to be had
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for May 22, 2017 :  PFE, HPE, QCOM, MSFT, CVS, INTC, BAC, ORCL, FOXA, ETE, CSCO, AAPL",2017-05-22 21:01:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7SqYETHTmLc/after-hours-most-active-for-may-22-2017-pfe-hpe-qcom-msft-cvs-intc-bac-orcl-foxa-ete-csco-aapl-cm792931,The NASDAQ 100 After Hours Indicator is down 15 to 5 699 25 The total After hours volume is currently 46 204 804 shares traded The following are the most active stocks for the after hours session Pfizer Inc PFE is unchanged at 32 12 with 3 395 694 shares
PFE,PFE:US,BBG000BR2B91,"NASDAQ Composite Index closes up 28.57 points for the week, rising for the 3rd straight day",2017-05-22 20:48:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rtwzPrYgiEI/nasdaq-composite-index-closes-up-2857-points-for-the-week-rising-for-the-3rd-straight-day-cm792930,Monday s session closes with the NASDAQ Composite Index 49 92 This is the 3rd straight day of increase for the index The total shares traded for the NASDAQ was over 1 73 billion Monday s session closes with the NASDAQ Composite Index 49 92 This is the 3rd straight day of increase for the
PFE,PFE:US,BBG000BR2B91,"These 3 Biotech Stocks Have Ballooned in 2017, but Will They Pop?",2017-05-22 14:15:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y1YQ3bFaFyo/these-3-biotech-stocks-have-ballooned-in-2017-but-will-they-pop-cm792537,Happy days are here again for biotech stocks The industry tracking iShares Nasdaq Biotechnology Index 160 has risen further than the broad market in 2017 and a handful of companies that suffered in 2016 have bounced back Shares of Regeneron Pharmaceuticals Inc NASDAQ
PFE,PFE:US,BBG000BR2B91,The 3 Best Dividend Stocks in Arthritis Medication,2017-05-22 12:42:00 +0000,http://finance.yahoo.com/r/d45b5c06-9892-3ec1-ada5-83c844af1756/the-3-best-dividend-stocks-in-arthritis-medication.aspx?yptr=yahoo&.tsrc=rss,"Why AbbVie, Pfizer, and Johnson & Johnson rank as the best dividend stocks among arthritis medication companies."
PFE,PFE:US,BBG000BR2B91,Health Care SPDR (ETF) (XLV): The Quick Guide to XLV,2017-05-21 20:11:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sUQzGpcxGVs/health-care-spdr-etf-xlv-the-quick-guide-to-xlv-cm792368,InvestorPlace Stock Market News Stock Advice amp Trading Tips The healthcare sector the third largest sector weight in the S amp P 500 behind technology and financial services can serve a range of investment strategies 160 Scores of exchange traded funds
PFE,PFE:US,BBG000BR2B91,3 Ways Johnson & Johnson's Pharmaceutical Business Plans to Beat the Market,2017-05-21 13:12:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rNQqQjrT4hA/3-ways-johnson-johnsons-pharmaceutical-business-plans-to-beat-the-market-cm792325,Johnson amp Johnson s NYSE JNJ pharmaceutical business segment usually is a bright spot when the company reports its financial results That wasn t the case however in J amp J s first quarter Sales for the pharmaceutical segment increased a dismal 0 8 year over year U
PFE,PFE:US,BBG000BR2B91,3 Ways Johnson & Johnson&apos;s Pharmaceutical Business Plans to Beat the Market,2017-05-21 11:41:00 +0000,http://finance.yahoo.com/r/d2e0f533-6140-3f74-97ec-0b7d55b6448d/3-ways-johnson-johnsons-pharmaceutical-business-pl.aspx?yptr=yahoo&.tsrc=rss,Johnson & Johnson aims to be in the top three among global drugmakers by 2020 and beat the market in growth. Here&apos;s how.
PFE,PFE:US,BBG000BR2B91,3 Stocks to Supplement Your Social Security Income,2017-05-20 11:22:00 +0000,http://finance.yahoo.com/r/8dac596d-40ed-35db-95f6-be5030123341/3-stocks-to-supplement-your-social-security-income.aspx?yptr=yahoo&.tsrc=rss,"Is Social Security not enough? Check out high-yield dividend stocks Brookfield Instrastructure Partners, Pfizer, and Welltower."
PFE,PFE:US,BBG000BR2B91,Shire (SHPG) Up on Positive Phase III Study Data on HAE Drug,2017-05-19 23:11:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DZTC5APUV8Q/shire-shpg-up-on-positive-phase-iii-study-data-on-hae-drug-cm792177,Shire plc SHPG announced positive top line results from the phase III study HELP on pipeline candidate lanadelumab Shire s shares have rallied 10 6 so far this year outperforming the Zacks classified Medical Drugs industry s 7 0 rise The global multi center
PFE,PFE:US,BBG000BR2B91,[$$] Iterum Therapeutics Lines Up Funding Ahead of Trials,2017-05-19 21:47:04 +0000,http://finance.yahoo.com/r/17966c54-d4fa-3ce0-a8da-0b25b3dbf8db/iterum-therapeutics-lines-up-funding-ahead-of-trials-1495230421?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Iterum Therapeutics Ltd., an Irish startup launched less than two years ago, has snared $65 million ahead of plans to seek regulatory approval in 2019 for an antibiotic to treat certain common infections...."
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for May 19, 2017 :  SNAP, PFE, QCOM, CNP, LNT, T, MSFT, QQQ, EGO, CMCSA, HMHC, CBOE",2017-05-19 21:01:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HPAUObVhg24/after-hours-most-active-for-may-19-2017-snap-pfe-qcom-cnp-lnt-t-msft-qqq-ego-cmcsa-hmhc-cboe-cm792153,The NASDAQ 100 After Hours Indicator is down 2 53 to 5 649 03 The total After hours volume is currently 40 066 586 shares traded The following are the most active stocks for the after hours session Snap Inc SNAP is 0 05 at 19 95 with 3 065 443 shares traded SNAP
PFE,PFE:US,BBG000BR2B91,"ETFs with exposure to Pfizer Inc. : May 19, 2017",2017-05-19 18:05:38 +0000,http://finance.yahoo.com/r/2fdbe4f6-ab37-3b32-ba55-c7743fcf2947/etfs-with-exposure-to-pfizer-inc-may-19-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pfizer Inc. Here are 5 ETFs with the largest exposure to PFE-US. Comparing the performance and risk of Pfizer Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
PFE,PFE:US,BBG000BR2B91,Merck's (MRK) Keytruda Gets FDA Nod for Two New Indications,2017-05-19 16:13:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kKAjfHTYVv0/mercks-mrk-keytruda-gets-fda-nod-for-two-new-indications-cm791934,Merck amp Co Inc MRK announced that the FDA has approved two new indications for Keytruda pembrolizumab the company s anti PD 1 therapy 160 The drug is now approved for the first line treatment of patients with locally advanced or metastatic urothelial carcinoma who
PFE,PFE:US,BBG000BR2B91,Billionaire George Soros Is Warming Up to This Big Pharma Stock. Should You?,2017-05-19 16:12:00 +0000,http://finance.yahoo.com/r/103622f1-a816-3388-bd9c-22b8f7fceb02/billionaire-george-soros-is-warming-up-to-this-big.aspx?yptr=yahoo&.tsrc=rss,The Soros Fund appears to be testing the waters with Pfizer.
PFE,PFE:US,BBG000BR2B91,"Merck KGaA (MKGAF) Q1 Earnings Fall Y/Y, Revenues Increase",2017-05-19 15:17:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y91peI6pB8g/merck-kgaa-mkgaf-q1-earnings-fall-yy-revenues-increase-cm791861,Merck KGaA MKGAF reported first quarter 2017 earnings of 1 28 per American Depositary Share 14 7 lower than the year ago figure of 1 50 Net sales in the reported quarter came in at 4 1 billion 3 86 billion up 5 3 Organic sales growth of 3 1 was driven by the Healthcare and
PFE,PFE:US,BBG000BR2B91,CHMP backs Novartis's Zykadia for first-line use in lung cancer,2017-05-19 12:38:44 +0000,https://finance.yahoo.com/news/chmp-backs-novartiss-zykadia-first-123844663.html?.tsrc=rss,Novartis's push to win approval for Zykadia as an initial treatment for a type of lung cancer got a lift on Friday with a positive recommendation from the European Medicines Agency's Committee for Medicinal ...
PFE,PFE:US,BBG000BR2B91,7 Top Dividend Stocks to Buy for Every Kind of Investor,2017-05-19 12:05:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/44l0t4Ntjw4/7-top-dividend-stocks-to-buy-for-every-kind-of-investor-cm791657,InvestorPlace Stock Market News Stock Advice amp Trading Tips The best dividend stocks in the market are truly in the eye of the beholder Yes some companies have multitudes of qualities whereas others are trash but at the end of the day whether a dividend stock or any investment
PFE,PFE:US,BBG000BR2B91,Company Spotlight: GlycoMimetics,2017-05-19 02:28:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d3sB5Haz8Wg/company-spotlight-glycomimetics-20170519-00051,Company Spotlight: GlycoMimetics
PFE,PFE:US,BBG000BR2B91,Endocyte (ECYT) Focused on Two Lead Pipeline Candidates,2017-05-18 23:12:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YDHwneBq65Y/endocyte-ecyt-focused-on-two-lead-pipeline-candidates-cm791611,We issued an updated report on Endocyte Inc ECYT on May 17 Endocyte s share price has increased 10 2 year to date while the Zacks classified Medical Drugs industry gained 4 9 Currently the company is focused on the development of two candidates EC1456 and EC1169 both of
PFE,PFE:US,BBG000BR2B91,Conference Spotlights Drug Giant Donnybrooks In Cancer Treatments,2017-05-18 19:44:45 +0000,http://finance.yahoo.com/r/fe46b8b5-dce5-35cf-9497-7339351dd0e6/conference-spotlights-lilly-pfizer-merck-bristol-donnybrooks-in-cancer?src=A00220&yptr=yahoo&.tsrc=rss,"Preliminary data highlights breast, ovarian, lung and skin cancer data to presented during the American Society of Clinical Oncology meeting next month."
PFE,PFE:US,BBG000BR2B91,J&J (JNJ) Plans to Seek Approval for 10 New Drugs by 2021,2017-05-18 16:14:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VUzGcNXgEBs/jj-jnj-plans-to-seek-approval-for-10-new-drugs-by-2021-cm791262,Johnson amp Johnson Inc JNJ discussed its future plans and showcased a strong pipeline of transformational medicines at a meeting held yesterday with industry analysts J amp J intends to seek approval for 10 new products between 2017 and 2021 The company said that each of these
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. :PFE-US: Earnings Analysis: Q1, 2017 By the Numbers : May 18, 2017",2017-05-18 13:36:41 +0000,http://finance.yahoo.com/r/1a20fddd-bd1a-385b-95d9-65cdb1680c24/pfizer-inc-pfe-us-earnings-analysis-q1-2017-by-the-numbers-may-18-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Pfizer Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Pfizer Inc. – Merck & Co., Inc., Johnson & Johnson, Bristol-Myers Squibb Company, Eli Lilly and Company, Novartis AG Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Mylan N.V., ... Read more
<b>(Read more...)</b>"
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Pfizer, Home Depot, ConocoPhillips, Prudential Financial and Canadian Pacific",2017-05-18 13:30:01 +0000,https://finance.yahoo.com/news/zacks-analyst-blog-highlights-pfizer-133001890.html?.tsrc=rss,"The Zacks Analyst Blog Highlights: Pfizer, Home Depot, ConocoPhillips, Prudential Financial and Canadian Pacific"
PFE,PFE:US,BBG000BR2B91,The Lancet Publishes Phase 2 Results from Shire's Investigational Anti-MAdCAM Antibody Showing Significantly Increased Remission Rates in Patients with Moderate-to-Severe Ulcerative Colitis,2017-05-18 13:00:00 +0000,https://finance.yahoo.com/news/lancet-publishes-phase-2-results-130000826.html?.tsrc=rss,"Shire plc (LSE: SHP, NASDAQ: SHPG), the global leader in rare and specialty diseases, today announced publication in the May 17, 2017 issue of The Lancet the results from a Phase 2 study (NCT01620255) investigating PF-00547659 (now called SHP647), an anti-mucosal addressin cell adhesion molecule 1 (MAdCAM-1) antibody, investigated in the treatment of moderate-to-severe ulcerative colitis in adults.  In this Phase 2 study, called TURANDOT, SHP647, the first anti-MAdCAM antibody in clinical development, met its primary endpoint demonstrating significantly greater remission rates in patients receiving anti-MAdCAM antibody compared to placebo in three of four tested dose groups.  Shire continues to work toward the initiation of a pivotal Phase 3 trial for SHP647 in the second half of 2017."
PFE,PFE:US,BBG000BR2B91,A Doomed Trump Presidency Would Be a Terrifying Development for Pharmaceutical Stocks,2017-05-18 11:37:00 +0000,http://finance.yahoo.com/r/26bb368a-4c48-3841-9a3b-28a4d95540be/a-doomed-trump-presidency-would-be-a-terrifying-de.aspx?yptr=yahoo&.tsrc=rss,Pharmaceutical stocks took a huge hit on Trump&apos;s latest setback. Here&apos;s why.
PFE,PFE:US,BBG000BR2B91,[$$] Some Biotech Companies Making the Cut in Narrower IPO Market,2017-05-18 11:30:16 +0000,http://finance.yahoo.com/r/70b722d7-307d-3131-bf33-c018686c1aa0/some-biotech-companies-making-the-cut-in-narrower-ipo-market-1495107005?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Biotechnology startups are facing a more selective market for initial public offerings, but some are making the cut."
PFE,PFE:US,BBG000BR2B91,Sangamo's (SGMO) Hemophilia A Drug Gets Fast-Track Status,2017-05-18 00:11:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G3rD2wjyHQ0/sangamos-sgmo-hemophilia-a-drug-gets-fast-track-status-cm790949,Sangamo Therapeutics Inc SGMO announced that the FDA has granted fast track designation to pipeline candidate SB 525 Sangamo s shares declined 145 9 year to date compared with the Zacks classified 160 Medical Biomedical and Genetics 160 industry s gain of 2 1 SB 525
PFE,PFE:US,BBG000BR2B91,Pfizer Oncology to Present Data Across 13 Different Types of Cancer at ASCO 2017 Annual Meeting,2017-05-18 00:00:00 +0000,https://finance.yahoo.com/news/pfizer-oncology-present-data-across-000000767.html?.tsrc=rss,"Pfizer Inc. today announced it will present more than 50 abstracts, involving more than 15 clinical-stage assets across solid and hematologic tumors and 12 mechanisms of action, at the 53rd Annual Meeting of the American Society of Clinical Oncology in Chicago from June 2-6, 2017."
PFE,PFE:US,BBG000BR2B91,Astellas Announces Oncology Portfolio Updates,2017-05-18 00:00:00 +0000,https://finance.yahoo.com/news/astellas-announces-oncology-portfolio-updates-000000645.html?.tsrc=rss,"TOKYO, May 17, 2017 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, ""Astellas"") announced today an update regarding the Company's diverse oncology portfolio, ..."
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for May 17, 2017 :  CSCO, ODP, PFE, QQQ, PTEN, CMCSA, MSFT, BAC, RF, UAL, DOW, GE",2017-05-17 21:01:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dk1lwFwOVI8/after-hours-most-active-for-may-17-2017-csco-odp-pfe-qqq-pten-cmcsa-msft-bac-rf-ual-dow-ge-cm790871,The NASDAQ 100 After Hours Indicator is down 4 07 to 5 576 48 The total After hours volume is currently 55 194 060 shares traded The following are the most active stocks for the after hours session Cisco Systems Inc CSCO is 1 93 at 31 89 with 3 565 298
PFE,PFE:US,BBG000BR2B91,Pfizer drug from Medivation deal shows promise in breast cancer -study,2017-05-17 21:00:00 +0000,https://finance.yahoo.com/news/pfizer-drug-medivation-deal-shows-210000940.html?.tsrc=rss,"A breast cancer drug that Pfizer Inc  acquired with its $14 billion purchase of Medivation  showed promising anti-tumor activity following prior treatments  and a modest ability to hold the disease in check, according to  data from a mid-stage study released on Wednesday.  The drug, talazoparib, belongs to a class of medicines  called PARP inhibitors which may induce tumor cell death.  PARP  inhibitors have shown promise in ovarian and breast cancers."
PFE,PFE:US,BBG000BR2B91,"Stock Market Today & Home Depot, Pfizer and ConocoPhillips Research Reports",2017-05-17 20:13:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h3qqNMkMTIo/stock-market-today-home-depot-pfizer-and-conocophillips-research-reports-cm790863,Wednesday May 17 2017 Today s Research Daily features new research reports on 16 major stocks including Pfizer PFE Home Depot HD and ConocoPhillips COP These research reports have been hand picked from the roughly 70 reports published by our analyst team today You can see
PFE,PFE:US,BBG000BR2B91,Vanguard Health Care ETF (VHT): A Healthy Long-Term Investment,2017-05-17 20:13:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uRjBPf5BC8c/vanguard-health-care-etf-vht-a-healthy-long-term-investment-cm790862,InvestorPlace Stock Market News Stock Advice amp Trading Tips Vanguard Health Care ETF NYSEARCA VHT has a mandate to track the MSCI US Investable Market 25 50 Index 160 which is a benchmark that contains large mid and small cap healthcare
PFE,PFE:US,BBG000BR2B91,"Stock Market Today & Home Depot, Pfizer and ConocoPhillips Research Reports",2017-05-17 17:25:05 +0000,https://finance.yahoo.com/news/stock-market-today-home-depot-172505954.html?.tsrc=rss,"Stock Market Today & Home Depot, Pfizer and ConocoPhillips Research Reports"
PFE,PFE:US,BBG000BR2B91,Nasdaq Reports Another New High,2017-05-17 17:11:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/64HteoWH6hM/nasdaq-reports-another-new-high-cm790706,U S market indexes were mixed on Tuesday with the Nasdaq reporting another new high U S market indexes were mixed on Tuesday with the Nasdaq reporting another new high For the day the Dow Jones Industrial Average closed at 20 979 75 for a loss of 2 19 points or 0 01 The Standard amp Poor
PFE,PFE:US,BBG000BR2B91,Eli Lilly: Worries Ahead In Patent Fight,2017-05-17 16:39:00 +0000,http://finance.yahoo.com/r/ad3fe1db-7d9b-3d32-97cd-77f760dd6edc/eli-lilly-but-investors-may-under-appreciate-the-downside-risk-the-company-faces-from-the-ipr-patent-challenge-on-the-cancer-drug-alimta-for-which-a-decision-is-expected-between-now-and-june-3-worries-ahead-in-patent-fight-1495039189?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Bernstein Research warns that Eli Lilly (LLY) could be in for a bumpy ride.  Tim Anderson and his team remain bullish on the stock, with an Outperform rating and a $88 price target, which implies a 12% upside from the $78.68 a share it fetches today.  In a worst-case scenario, Alimta could face generics in 2017, even though it won an earlier appeals court ruling on a more ""traditional"" patent challenge."
PFE,PFE:US,BBG000BR2B91,5 Reasons Why Merck (MRK) is a Good Stock to Buy Now,2017-05-17 16:17:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bcsD2aobtg8/5-reasons-why-merck-mrk-is-a-good-stock-to-buy-now-cm790637,Kenilworth NJ based Merck amp Co Inc MRK is a research driven pharmaceutical company which is a global leader in the discovery and development of vaccines and pharmaceutical drugs The company currently makes noteworthy treatments or vaccines for HPV type 2 diabetes cancer and
PFE,PFE:US,BBG000BR2B91,"IVW, PFE, PG, MMM: ETF Inflow Alert",2017-05-17 16:13:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2T0g2CWyaiI/ivw-pfe-pg-mmm-etf-inflow-alert-cm790603,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares S amp P 500 Growth ETF Symbol IVW where we have detected an approximate 68 1 million dollar inflow that s a 0 4 increase week over week in
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public to View and Listen to Webcast of June 9 Conference Call with Analysts to Review Oncology Business and ASCO Data Presentations,2017-05-17 15:00:00 +0000,https://finance.yahoo.com/news/pfizer-invites-public-view-listen-150000108.html?.tsrc=rss,"Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts on Friday, June 9, 2017 at 11:00 a.m. EDT. The purpose of the call is to provide an update on Pfizer’s oncology business and to review Pfizer’s ASCO data presentations."
PFE,PFE:US,BBG000BR2B91,The Implied Analyst 12-Month Target For PPH,2017-05-17 14:13:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cYEKScf1HTc/the-implied-analyst-12-month-target-for-pph-cm790455,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
PFE,PFE:US,BBG000BR2B91,3 Dividend Stocks Perfect for Senior Citizens,2017-05-17 13:42:00 +0000,http://finance.yahoo.com/r/eff247c4-3ae6-322d-beaf-5a68e2d68f65/3-dividend-stocks-perfect-for-senior-citizens.aspx?yptr=yahoo&.tsrc=rss,These three dividend stocks are reliable sources of income for senior citizens.
PFE,PFE:US,BBG000BR2B91,Today's Research Reports on Stocks to Watch: BlackBerry and Pfizer,2017-05-17 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000831.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 17, 2017 / Continued strength from the technology sector helped push the NASDAQ to a new record high. The NASDAQ has outperformed both the Dow Jones Industrial Average and ..."
PFE,PFE:US,BBG000BR2B91,"Biotech Stock Roundup: Biogen Inks Deal to Boost Pipeline, Sangamo Soars on Pfizer Deal",2017-05-17 11:53:11 +0000,https://finance.yahoo.com/news/biotech-stock-roundup-biogen-inks-115311547.html?.tsrc=rss,Quite a few deals were announced this week including by companies like Biogen (BIIB).
PFE,PFE:US,BBG000BR2B91,Aerie's (AERI) Rhopressa NDA Sufficient for FDA Review,2017-05-17 00:15:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZRwzhXEv7Y4/aeries-aeri-rhopressa-nda-sufficient-for-fda-review-cm790285,Aerie Pharmaceuticals Inc AERI announced that it has received notification from the FDA about the completion of the initial 60 day review of the new drug application NDA for Rhopressa The FDA determined that the application is sufficiently complete and can undergo a substantive
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for May 16, 2017 :  CMCSA, PSXP, BAC, PFE, KEY, KATE, KIM",2017-05-16 21:04:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XAuy7ElpKPE/after-hours-most-active-for-may-16-2017-cmcsa-psxp-bac-pfe-key-kate-kim-cm790212,The NASDAQ 100 After Hours Indicator is down 84 to 5 723 6 The total After hours volume is currently 44 185 748 shares traded The following are the most active stocks for the after hours session Comcast Corporation CMCSA is unchanged at 38 82 with 3 503 794
PFE,PFE:US,BBG000BR2B91,[$$] US retail real estate extends its bruising slide,2017-05-16 20:37:01 +0000,"http://finance.yahoo.com/r/0c4bac80-1c44-3ee8-a727-7ec41d5c64db/f00e6eca-3a4a-11e7-ac89-b01cc67cfeec,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Shares in companies that own and manage US shopping malls and other retail properties dropped on Tuesday, the fourth-straight decline, amid mounting anxiety over disappointing sales at department stores ..."
PFE,PFE:US,BBG000BR2B91,"US STOCKS-S&P 500, Dow end session flat, tech boosts Nasdaq",2017-05-16 20:35:43 +0000,https://finance.yahoo.com/news/us-stocks-p-500-dow-203543446.html?.tsrc=rss,"The S&P 500 and the Dow ended  Tuesday's session flat after mixed economic data and retail  earnings, while the Nasdaq had another record close with help  from technology stocks.  U.S. manufacturing production showed its biggest increase in  more than three years in April, bolstering a view that economic  growth picked up early in the second quarter despite a surprise  decline in homebuilding."
PFE,PFE:US,BBG000BR2B91,"Dow&apos;s Pfizer, Eli Lilly Topple To 3-Month Lows On Downgrades",2017-05-16 20:13:19 +0000,http://finance.yahoo.com/r/732a5799-33ef-3cad-bc6d-702c4cb2f0c6/dows-pfizer-eli-lilly-topple-to-3-month-lows-on-downgrades?src=A00220&yptr=yahoo&.tsrc=rss,Eli Lilly and Pfizer stocks toppled to three-month lows Tuesday after sustaining a pair of downgrades.
PFE,PFE:US,BBG000BR2B91,"Yum Brands, Intuitive Surgical Called Buys; Pfizer Cut To Sell",2017-05-16 20:04:51 +0000,http://finance.yahoo.com/r/9f5e1145-e717-3bbb-b38b-ef6a2adfe456/yum-brands-intuitive-surgical-called-buys-pfizer-cut-to-sell?src=A00220&yptr=yahoo&.tsrc=rss,"Fast-food restaurant operator Yum Brands was upgraded to buy, while drug giant Pfizer was downgraded to sell by Wall Street analysts Tuesday."
PFE,PFE:US,BBG000BR2B91,"US STOCKS-S&P 500 falls on mixed data, Nasdaq helped by tech stocks",2017-05-16 19:05:51 +0000,https://finance.yahoo.com/news/us-stocks-p-500-falls-190551034.html?.tsrc=rss,"The S&P 500 was down slightly  on Tuesday after a slew of mixed economic data and earnings  while the Nasdaq hit another record as it was boosted by gains  in technology stocks.  U.S. manufacturing production showed its biggest increase in  more than three years for April, bolstering a view that economic  growth picked up early in the second quarter despite a surprise  decline in homebuilding.  While home improvement chain Home Depot reported a  better-than-expected first-quarter performance, TJX Cos Inc,  the owner of T.J. Maxx and Marshalls stores, posted  slowing comparable-store sales growth and a disappointing  current-quarter profit forecast."
PFE,PFE:US,BBG000BR2B91,"US STOCKS-Wall St flat after S&P, Nasdaq hit record highs",2017-05-16 17:15:38 +0000,https://finance.yahoo.com/news/us-stocks-wall-st-flat-171538502.html?.tsrc=rss,"U.S. stocks pulled back on Tuesday after  the S&P 500 and the Nasdaq Composite hit record intraday highs  as a decline in healthcare stocks offset gains in technology.  The main indexes have been trading near record levels,  supported largely by strong first-quarter earnings, but global  geopolitical tensions and developments in Washington could  unsettle the market's record-setting spree."
PFE,PFE:US,BBG000BR2B91,Pfizer: Is It Time To Sell?,2017-05-16 17:07:00 +0000,http://finance.yahoo.com/r/49cb4243-7bd7-3941-b7d4-3cb907037066/pfizer-is-it-time-to-sell-1494954450?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Eli Lilly (LLY) isn’t the only Big Pharma name getting pressured by a downgrade. Shares of Pfizer (PFE) fell to a three-month low today after Citigroup turned bearish on the stock. Analyst Andrew Baum ...
PFE,PFE:US,BBG000BR2B91,"Jim Cramer Talks Home Depot, TJX Companies, Ford, Apple, Pfizer, Nike, Target and Alibaba",2017-05-16 16:34:00 +0000,http://finance.yahoo.com/r/3bea97f0-20fd-3521-8e87-d2da226549eb/jim-cramer-talks-home-depot-tjx-companies-ford-apple-pfizer-nike-target-and-alibaba.html?puc=yahoov&cm_ven=YAHOOV&yptr=yahoo&.tsrc=rss,"TheStreet's Jim Cramer weighs in on Home Depot, TJX Companies, Ford, Apple, Pfizer, Nike, Target and Alibaba."
PFE,PFE:US,BBG000BR2B91,"Dow Movers: NKE, HD",2017-05-16 16:19:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YsdMMfRk8gM/dow-movers-nke-hd-cm789981,In early trading on Tuesday shares of Home Depot topped the list of the day s best performing Dow Jones Industrial Average components trading up 1 6 Year to date Home Depot registers a 19 2 gain And the worst performing Dow component thus far on the day is Nike trading down 1 4
PFE,PFE:US,BBG000BR2B91,Eli Lilly: Has This Bloom Begun To Wilt?,2017-05-16 16:17:00 +0000,http://finance.yahoo.com/r/55cd360a-9ebc-3b18-869a-ffe0b69e3995/eli-lilly-has-this-bloom-begun-to-wilt-1494951434?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,Shares of U.S. drug maker Eli Lilly & Co. (LLY) fell to a three-month low after Goldman Sachs pulled the stock off its closely-followed Conviction Buy List. Don’t panic. It isn’t as if Goldman analyst ...
PFE,PFE:US,BBG000BR2B91,"US STOCKS-Wall St retreats after S&P, Nasdaq hit record highs",2017-05-16 15:39:41 +0000,https://finance.yahoo.com/news/us-stocks-wall-st-retreats-153941459.html?.tsrc=rss,"U.S. stocks reversed course as some  investors locked in gains after the S&P 500 and the Nasdaq hit  record highs, with healthcare and industrial stocks leading the  decliners.  Investors turned cautious after reports that President  Donald Trump disclosed highly classified information to Russia's  foreign minister about a planned Islamic State operation."
PFE,PFE:US,BBG000BR2B91,Citi Prefers These 4 Stocks Over Pfizer On Bottom-Line Concerns,2017-05-16 15:15:54 +0000,https://finance.yahoo.com/news/citi-prefers-4-stocks-over-151554227.html?.tsrc=rss,Shares of Pfizer Inc. (NYSE: PFE ) were trading lower by nearly 2 percent Tuesday morning after analysts at Citi downgraded the stock and offered three alternative recommendations. Citi's Andrew Baum downgraded ...
PFE,PFE:US,BBG000BR2B91,Jim Cramer -- Citi's Downgrade of Pfizer Not Totally Reasonable,2017-05-16 14:47:00 +0000,http://finance.yahoo.com/r/be07558f-c2e4-3dae-8a73-77fbfb1c3ed4/jim-cramer-citi-s-downgrade-of-pfizer-not-totally-reasonable.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Citigroup had a 'thoughtful' research piece on Pfizer, but downgrading it partly based on 'transaction risk' seems unreasonable, Cramer said."
PFE,PFE:US,BBG000BR2B91,Pfizer Posting Notable Loss After Downgrade By Citi,2017-05-16 13:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/13N8jSIq19A/pfizer-posting-notable-loss-after-downgrade-by-citi-20170516-01112,Pfizer Posting Notable Loss After Downgrade By Citi
PFE,PFE:US,BBG000BR2B91,"US STOCKS-S&P, Nasdaq hit record highs on gains in tech, consumer staples",2017-05-16 13:48:02 +0000,https://finance.yahoo.com/news/us-stocks-p-nasdaq-hit-134802422.html?.tsrc=rss,"The S&P 500 and the Nasdaq drifted higher  to hit record intraday levels on Tuesday, supported by gains in  technology and consumer staple stocks.  Investors were wary after reports that President Donald  Trump disclosed highly classified information to Russia's  foreign minister about a planned Islamic State operation."
PFE,PFE:US,BBG000BR2B91,"Early movers: HD, PFE, BABA, DKS, YHOO, F, VOD, FB, JNJ & more",2017-05-16 12:13:47 +0000,http://finance.yahoo.com/r/15d086e5-659d-3a1b-b788-593eddf68259/104472873?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104472873&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
PFE,PFE:US,BBG000BR2B91,"Early movers: HD, PFE, BABA, DKS, YHOO, F, VOD, FB, JNJ & more",2017-05-16 12:13:47 +0000,https://finance.yahoo.com/news/early-movers-hd-pfe-baba-121347846.html?.tsrc=rss,These are the stocks posting the largest moves before the bell.
PFE,PFE:US,BBG000BR2B91,Sangamo Receives Fast Track Designation From The FDA For SB-525 Investigational Hemophilia A Gene Therapy,2017-05-16 11:30:00 +0000,https://finance.yahoo.com/news/sangamo-receives-fast-track-designation-113000012.html?.tsrc=rss,"RICHMOND, Calif., May 16, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SB-525, the Company's clinical stage cDNA gene therapy candidate for hemophilia A, which is being developed as part of an exclusive, global collaboration and license agreement with Pfizer Inc. (PFE).  The FDA's Fast Track designation is designed to facilitate the development and expedite the review of drugs and biologics to treat serious conditions and fill an unmet medical need."
PFE,PFE:US,BBG000BR2B91,Sangamo Gets Fast Track Designation For SB-525 Hemophilia A Gene Therapy,2017-05-16 07:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U5HzXKNVSEc/sangamo-gets-fast-track-designation-for-sb525-hemophilia-a-gene-therapy-20170516-00386,Sangamo Gets Fast Track Designation For SB-525 Hemophilia A Gene Therapy
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for May 15, 2017 :  NE, ZNGA, MU, SNAP, PFE, VVV, MGM, DDR, MSFT, YHOO, AGNC, QQQ",2017-05-15 21:04:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0UwEyddCbh8/after-hours-most-active-for-may-15-2017-ne-znga-mu-snap-pfe-vvv-mgm-ddr-msft-yhoo-agnc-qqq-cm789536,The NASDAQ 100 After Hours Indicator is down 1 to 5 703 48 The total After hours volume is currently 69 499 996 shares traded The following are the most active stocks for the after hours session Noble Corporation NE is 0 03 at 4 68 with 26 459 684 shares traded
PFE,PFE:US,BBG000BR2B91,7 Dogs of the Dow to Trade Now for Income,2017-05-15 20:17:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FHHIRs1owBs/7-dogs-of-the-dow-to-trade-now-for-income-cm789533,InvestorPlace Stock Market News Stock Advice amp Trading Tips The Dogs of the Dow investment strategy is typically a year end year beginning phenomenon but today I want to show you how this income centric tactic can do wonders for you as we near 2017 s midway point
PFE,PFE:US,BBG000BR2B91,"Allergan plc. (AGN) Ex-Dividend Date Scheduled for May 16, 2017",2017-05-15 13:17:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4a9O088xn94/allergan-plc-agn-ex-dividend-date-scheduled-for-may-16-2017-cm789113,Allergan plc AGN will begin trading ex dividend on May 16 2017 A cash dividend payment of 0 7 per share is scheduled to be paid on June 15 2017 Shareholders who purchased AGN prior to the ex dividend date are eligible for the cash dividend payment At the current stock price of 230
PFE,PFE:US,BBG000BR2B91,Here's Why the Best Is Yet to Come for Pfizer Inc.,2017-05-14 16:14:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/maVtQTi6CZY/heres-why-the-best-is-yet-to-come-for-pfizer-inc-cm789000,Pfizer Inc NYSE PFE stock is lagging behind the S amp P 500 Index so far in 2017 That s nothing new though Pfizer has underperformed the S amp P 500 over the past year the past three years the past five years and the past decade Despite this less than stellar
PFE,PFE:US,BBG000BR2B91,Here&apos;s Why the Best Is Yet to Come for Pfizer Inc.,2017-05-14 15:01:00 +0000,http://finance.yahoo.com/r/1dc212cc-478d-3aa9-a429-c86de8a373cf/heres-why-the-best-is-yet-to-come-for-pfizer-inc.aspx?yptr=yahoo&.tsrc=rss,Pfizer&apos;s up-and-coming products are just one reason better days are ahead.
PFE,PFE:US,BBG000BR2B91,"Investec Asset Management (PTY) Ltd Buys Microsoft Corp, Alphabet Inc, Bank of Nova Scotia, ...",2017-05-13 09:14:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AJ5byZzWzdo/investec-asset-management-pty-ltd-buys-microsoft-corp-alphabet-inc-bank-of-nova-scotia-cm788861,Investec Asset Management PTY Ltd PTY PTY New Purchases GOOGL BNS CELG LVS ALK MS AMZN FB GOOG NRZ Added Positions MSFT BDX TSM CMCSA AFL EBAY TMO LRCX PEG PYPL Reduced Positions PFE BK CSCO KEY CL HON C PEP PCLN
PFE,PFE:US,BBG000BR2B91,What happens to corporate crime cases with the FBI in flux?,2017-05-12 22:01:53 +0000,https://finance.yahoo.com/news/happens-corporate-crime-cases-fbi-163954552.html?.tsrc=rss,"There's the federal criminal investigation into Wells Fargo's opening of unauthorized client accounts. And the probe of Fox News's business practices. And the investigation of Baxter International, Pfizer ..."
PFE,PFE:US,BBG000BR2B91,Tepper's Appaloosa Trims Bets on Pharmaceuticals,2017-05-12 21:19:38 +0000,http://finance.yahoo.com/r/2dc2a4a8-b255-34e8-8134-364a112f6695/appaloosa0512?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,David Tepper's Appaloosa Management trimmed its wagers on pharmaceutical companies in the first quarter and sold out of retailer J.C. Penney.
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson Analyst Day,2017-05-12 21:00:00 +0000,https://finance.yahoo.com/video/johnson-johnson-analyst-day-210023669.html?.tsrc=rss,"Johnson & Johnson hosts its annual presentation for investors from the company's headquarters in New Brunswick, NJ.  J&J CEO Alex Gorsky will give the keynote address in the morning followed by other J&J executives with new product announcements and vision for the company."
PFE,PFE:US,BBG000BR2B91,Why Sangamo Therapeutics Inc. Jumped Higher Today,2017-05-12 20:31:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UotegqtYj68/why-sangamo-therapeutics-inc-jumped-higher-today-cm788774,What happened Sangamo Therapeutics NASDAQ SGMO ended the day up 16 after catapulting over 60 higher yesterday following the announcement that Pfizer NYSE PFE licensed Sangamo s hemophilia A gene therapy SB 525 So what The partnership came with a 70
PFE,PFE:US,BBG000BR2B91,What's in Store for Merck KGaA (MKGAF) in Q1 Earnings?,2017-05-12 20:25:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2DJMJtDM194/whats-in-store-for-merck-kgaa-mkgaf-in-q1-earnings-cm788724,Merck KGaA MKGAF is scheduled to report first quarter 2017 earnings results on May 18 Merck KGaA s share price has increased 15 5 year to date while the Zacks classified Medical Drugs industry gained 6 5 The company reports results under three business sectors Healthcare
PFE,PFE:US,BBG000BR2B91,Why Sangamo Therapeutics Inc. Jumped Higher Today,2017-05-12 20:20:00 +0000,http://finance.yahoo.com/r/28138258-1510-36e0-8686-d918f720fc0d/why-sangamo-therapeutics-inc-jumped-higher-today.aspx?yptr=yahoo&.tsrc=rss,"A deal with Pfizer, coupled with some likely short-seller covering, has shares headed higher for the second day in a row."
PFE,PFE:US,BBG000BR2B91,These guys put the 'activist' in activist investing,2017-05-12 17:43:59 +0000,http://finance.yahoo.com/r/98c18e50-0143-356d-8c34-ee2484e4c633/104374284?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104374284&yptr=yahoo&.tsrc=rss,"With 230 shares of Canada Goose, PETA increased its stock portfolio, which is built on pushing companies to rethink their use of animals."
PFE,PFE:US,BBG000BR2B91,These guys put the &apos;activist&apos; in activist investing,2017-05-12 17:43:59 +0000,https://finance.yahoo.com/news/guys-put-apos-activist-apos-174359753.html?.tsrc=rss,"With 230 shares of Canada Goose, PETA increased its stock portfolio, which is built on pushing companies to rethink their use of animals."
PFE,PFE:US,BBG000BR2B91,"Boston Financial Mangement Inc  Buys Luxottica Group SpA, Air Products & Chemicals Inc, ...",2017-05-12 17:24:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kkUl9uc6fWg/boston-financial-mangement-inc-buys-luxottica-group-spa-air-products-chemicals-inc-cm788663,Boston Financial Mangement Inc New Purchases ARMK USBPRNCL NTRP 4ETA TIP MDYG MCHP EL CFCPRB AKTS Added Positions LUX APD CPRT CRI CNSWF PFE WBA IJR VRSN WSO Reduced Positions VWO CVS PX GIS UTX VEU AFL CMCSA EEM FTV
PFE,PFE:US,BBG000BR2B91,What happens to corporate crime cases with the FBI in flux?,2017-05-12 16:39:54 +0000,http://finance.yahoo.com/r/918dc045-910a-38ae-b2d6-3966a54f5da9/happens-corporate-crime-cases-fbi-163954552.html?.tsrc=rss,WASHINGTON (AP) — There's the federal criminal investigation into Wells Fargo's opening of unauthorized client accounts.
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses in Pivotal Study",2017-05-12 14:29:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1UT9GD2qCZk/pharma-stock-roundup-mylan-teva-q1-earnings-roche-drug-misses-in-pivotal-study-cm788429,This week companies like Mylan MYL Allergan and Teva TEVA reported earnings results The spotlight also remained on Roche RHHBY which saw its immuno oncology drug fail in a pivotal study 160 Recap of the Week s Most Important Stories A Look at Earnings Results
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses in Pivotal Study",2017-05-12 12:49:12 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-mylan-teva-124912888.html?.tsrc=rss,"While companies like Mylan (MYL), Allergan and Teva reported Q1 results this week, several companies provided updates on their cancer drugs."
PFE,PFE:US,BBG000BR2B91,The 7 Biggest Mergers of All Time (Exxon Didn't Even Make the List),2017-05-12 12:06:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mtt2-n_rh_0/the-7-biggest-mergers-of-all-time-exxon-didnt-even-make-the-list-cm788296,Image source Getty Images Megamergers aren t very common but when they happen the numbers involved are truly massive For example Exxon s 79 billion merger with Mobil doesn t even crack the top seven deals of all time in terms of value Here s a list of the deals that
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for May 11, 2017 :  PFE, SNAP, BAC, JWN, CSCO, ETE, ETP, MSFT, MU, AAPL, ODP, FB",2017-05-11 21:00:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vSzWKixIyXg/after-hours-most-active-for-may-11-2017-pfe-snap-bac-jwn-csco-ete-etp-msft-mu-aapl-odp-fb-cm788166,The NASDAQ 100 After Hours Indicator is down 1 to 5 674 12 The total After hours volume is currently 39 396 910 shares traded The following are the most active stocks for the after hours session Pfizer Inc PFE is 0 06 at 33 10 with 5 581 830 shares traded PFE
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 05/11/2017: CNAT,SGMO,PFE,ITUS",2017-05-11 20:20:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wl8cBCieNt0/health-care-sector-update-for-05112017-cnatsgmopfeitus-cm788139,Top Health Care StocksTop Health Care Stocks JNJ 0 28 JNJ 0 28 PFE 0 03 PFE 0 03 ABT 1 48 ABT 1 48 MRK 0 81 MRK 0 81 AMGN 0 23 AMGN 0 23 Health care stocks resisted the worst of today s broader market declines with the NYSE Health Care Index falling less than 0 1 while shares
PFE,PFE:US,BBG000BR2B91,Here's Why Sangamo Therapeutics Rocketed Up to 56.3% Higher Today,2017-05-11 19:03:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uXrRrQWcTKM/heres-why-sangamo-therapeutics-rocketed-up-to-563-higher-today-cm788065,What happened Shares of genome editing pioneer Sangamo Therapeutics NASDAQ SGMO soared over 56 this morning after the company announced a slew of updates from the first three months of this year and most importantly a new collaboration with Pfizer NYSE PFE in Hemophilia
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 05/11/2017: MNKD,SGMO,PFE,ITUS",2017-05-11 18:01:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f2NnZKacb3U/health-care-sector-update-for-05112017-mnkdsgmopfeitus-cm788043,Top Health Care StocksTop Health Care Stocks JNJ 0 08 JNJ 0 08 PFE 0 21 PFE 0 21 ABT 1 21 ABT 1 21 MRK 0 78 MRK 0 78 AMGN 1 02 AMGN 1 02 Health care stocks were resisting the worst of Thursday s broader market declines with the NYSE Health Care Index falling about 0 2 while
PFE,PFE:US,BBG000BR2B91,Midday Update: Retail Earnings Weigh Down Wall Street,2017-05-11 17:20:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xlp2iEq7cRE/midday-update-retail-earnings-weigh-down-wall-street-cm788013,Led lower by retail and tech stocks the benchmark averages were all trading in the red with the Dow Jones Industrial Average negative for a third consecutive day despite upbeat economic data and higher oil prices Led lower by retail and tech stocks the benchmark averages were all trading
PFE,PFE:US,BBG000BR2B91,Why Sangamo Therapeutics Is Surging,2017-05-11 14:30:38 +0000,http://finance.yahoo.com/news/why-sangamo-therapeutics-surging-143038610.html?.tsrc=rss,Sangamo Therapeutics saw its shares skyrocket early on Thursday after a critical business update.
PFE,PFE:US,BBG000BR2B91,PFE Named 'Top Dividend Stock of the Dow' at Dividend Channel With 3.9% Yield,2017-05-11 13:02:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DR4f4rJeevg/pfe-named-top-dividend-stock-of-the-dow-at-dividend-channel-with-39-yield-cm787679,Pfizer Inc Symbol PFE has been named as the Top Dividend Stock of the Dow according to Dividend Channel which published its most recent DividendRank report The report noted that among the components of the Dow Jones Industrial Average PFE shares displayed both attractive
PFE,PFE:US,BBG000BR2B91,"FDA Nod For MRK's Keytruda, SGMO Soars On Gene Therapy Deal, OMER Catches Eyes",2017-05-11 02:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tOFbP1H8_NU/fda-nod-for-mrks-keytruda-sgmo-soars-on-gene-therapy-deal-omer-catches-eyes-20170511-00093,"FDA Nod For MRK's Keytruda, SGMO Soars On Gene Therapy Deal, OMER Catches Eyes"
PFE,PFE:US,BBG000BR2B91,"Why Roche&apos;s Cancer Failure Might Tank Bristol, Pfizer — But Not Merck",2017-05-10 23:43:31 +0000,http://finance.yahoo.com/r/d8438ad3-d1d8-3c30-8d08-9f6fe97f0e23/why-roches-cancer-failure-might-tank-bristol-pfizer-but-not-merck?src=A00220&yptr=yahoo&.tsrc=rss,The failure of Roche&apos;s Tecentriq in a late-stage bladder cancer trial could bode badly for Bristol and Pfizer while boosting Merck.
PFE,PFE:US,BBG000BR2B91,"Sangamo shares jump on Pfizer collaboration, quarterly results",2017-05-10 21:18:02 +0000,http://finance.yahoo.com/r/70e6e50a-b263-34c0-814b-6bb708fdd358/Story.aspx?guid=A7848EFA-8DA7-4B12-9EFE-222A2DFED4BD&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Sangamo Therapeutics Inc. shares surged after the gene therapy company reported a narrower-than-expected loss for the quarter and a collaboration with pharmaceutical giant Pfizer Inc. . Sangamo shares ...
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for May 10, 2017 :  SNAP, PFE, MT, ETP, EPD, RF, INTC, QQQ, NVDA, RCII, VIAV, AMAG",2017-05-10 21:00:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jwNW_htdGfI/after-hours-most-active-for-may-10-2017-snap-pfe-mt-etp-epd-rf-intc-qqq-nvda-rcii-viav-amag-cm787501,The NASDAQ 100 After Hours Indicator is down 95 to 5 680 73 The total After hours volume is currently 42 477 526 shares traded The following are the most active stocks for the after hours session Snap Inc SNAP is 5 62 at 17 36 with 18 600 872 shares traded
PFE,PFE:US,BBG000BR2B91,"Model N (MODN) Q2 Loss Narrower than Expected, Guides Well",2017-05-10 20:03:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SQgJXGvKIh4/model-n-modn-q2-loss-narrower-than-expected-guides-well-cm787441,Model N Inc MODN reported second quarter 2017 adjusted loss of 25 cents per share which was wider than the year ago quarter s loss of 21 cents However including stock based compensation a loss of 34 cents per share was narrower than the Zacks Consensus Estimate of a loss of 35
PFE,PFE:US,BBG000BR2B91,Sangamo Therapeutics And Pfizer Announce Collaboration For Hemophilia A Gene Therapy,2017-05-10 20:01:00 +0000,http://finance.yahoo.com/news/sangamo-therapeutics-pfizer-announce-collaboration-200100659.html?.tsrc=rss,"RICHMOND, Calif., May 10, 2017 /PRNewswire/ -- Sangamo Therapeutics, Inc. (SGMO) and Pfizer Inc. (PFE) today announced an exclusive, global collaboration and license agreement for the development and commercialization of gene therapy programs for Hemophilia A, including SB-525, one of Sangamo's four lead product candidates, which Sangamo expects will enter the clinic this quarter.  ""Sangamo brings deep scientific and technical expertise across multiple genomic platforms, and we look forward to working together to advance this potentially transformative treatment for patients living with Hemophilia A,"" said Mikael Dolsten, MD, PhD, President of Worldwide Research and Development at Pfizer."
PFE,PFE:US,BBG000BR2B91,"Allergan Starts 'Pivotal' 2017 With a Beat, Plus Jim Cramer's Take",2017-05-10 19:28:00 +0000,http://finance.yahoo.com/r/fd7f886f-c38b-3c85-9bb1-5e72434d3bf3/allergan.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Allergan shares had risen $2.55, or 1.05%, in premarket trading to $244.50."
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. : PFE-US: Dividend Analysis : May 12th, 2017 (record date) : By the numbers : May 10, 2017",2017-05-10 17:01:42 +0000,http://finance.yahoo.com/r/9f2150fe-4e86-3540-8402-a1dabad670fd/pfizer-inc-pfe-us-dividend-analysis-may-12th-2017-record-date-by-the-numbers-may-10-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Our analysis is based on comparing Pfizer Inc. with the following peers – Merck & Co., Inc., Johnson & Johnson, Bristol-Myers Squibb Company, Eli Lilly and Company, Novartis AG Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Mylan N.V., Abbott Laboratories and Astrazeneca PLC Sponsored ADR (MRK-US, JNJ-US, BMY-US, LLY-US, NVS-US, ... Read more
<b>(Read more...)</b>"
PFE,PFE:US,BBG000BR2B91,[$$] Going public benefits workers and investors,2017-05-10 13:30:02 +0000,"http://finance.yahoo.com/r/6072326a-e3a2-34fb-9fef-cd2835a30f3b/9fcfb668-3409-11e7-99bd-13beb0903fa3,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Over the past 10 years the number of initial public offerings in the US, and the total amount of equity raised by them, are way down on historical averages. If these had held there would have been more ..."
PFE,PFE:US,BBG000BR2B91,Why Teva Pharmaceutical Industries is a Top 10 SAFE International Dividend Stock (TEVA),2017-05-10 13:00:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tsBpzn_TVqA/why-teva-pharmaceutical-industries-is-a-top-10-safe-international-dividend-stock-teva-cm787006,Teva Pharmaceutical Industries Ltd Symbol TEVA has been named to the Dividend Channel International S A F E 10 list signifying an international stock with above average DividendRank statistics including a strong 4 4 yield as well as a superb track record of at least five years
PFE,PFE:US,BBG000BR2B91,"Roche's star cancer drug stumbles in study, raising doubts about future",2017-05-10 08:56:16 +0000,http://finance.yahoo.com/news/roches-tecentriq-fails-trial-advanced-061704067.html?.tsrc=rss,"Roche's Tecentriq  immuno-oncology drug failed a late-stage follow-up trial against  advanced bladder cancer, the Swiss drugmaker said on Wednesday,  raising questions about whether regulators could scale back  their approval of the medicine.  Roche, the world's biggest maker of cancer drugs, had won  fast-track approval last May in the United States for Tecentriq  against bladder cancer but full approval hinged on further  trials."
PFE,PFE:US,BBG000BR2B91,Edited Transcript of PFE earnings conference call or presentation 2-May-17 2:00pm GMT,2017-05-10 01:31:06 +0000,http://finance.yahoo.com/news/edited-transcript-pfe-earnings-conference-122104645.html?.tsrc=rss,Q1 2017 Pfizer Inc Earnings Call
PFE,PFE:US,BBG000BR2B91,Pfizer immuno-oncology drug wins U.S. approval for bladder cancer,2017-05-09 21:12:57 +0000,http://finance.yahoo.com/news/pfizer-immuno-oncology-drug-wins-211257427.html?.tsrc=rss,"U.S. health regulators on Tuesday granted  accelerated approval for Pfizer Inc's immuno-oncology  drug Bavencio to treat advanced bladder cancer, marking the  second approval in less than two months for the treatment  developed along with Germany's Merck KGaA.  Bavencio, known chemically as avelumab, was approved for  patients with locally advanced or metastatic bladder cancer  whose disease progressed during or following platinum-containing  chemotherapy or within 12 months of chemotherapy treatment  before or after surgery.  It is the fourth new immunotherapy to  be approved for advanced bladder cancer."
PFE,PFE:US,BBG000BR2B91,Pfizer : FDA Grants BAVENCIO Approval For Common Type Of Advanced Bladder Cancer,2017-05-09 21:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0V72ZypWi-o/pfizer--fda-grants-bavencio-approval-for-common-type-of-advanced-bladder-cancer-20170509-02078,Pfizer : FDA Grants BAVENCIO Approval For Common Type Of Advanced Bladder Cancer
PFE,PFE:US,BBG000BR2B91,FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer,2017-05-09 21:03:00 +0000,http://finance.yahoo.com/news/fda-grants-bavencio-r-avelumab-210300877.html?.tsrc=rss,"DARMSTADT, Germany, and NEW YORK, May 10, 2017 /PRNewswire/ -- Second   approval   for BAVENCIO   in   less than two   months     Advanced urothelial carcinoma   is an aggressive disease with a high rate ..."
PFE,PFE:US,BBG000BR2B91,InPlay from Briefing.com,2017-05-09 19:58:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
PFE,PFE:US,BBG000BR2B91,FDA Grants BAVENCIO® (avelumab) Approval for a Common Type of Advanced Bladder Cancer,2017-05-09 19:53:00 +0000,http://finance.yahoo.com/news/fda-grants-bavencio-avelumab-approval-195300484.html?.tsrc=rss,"ROCKLAND, Mass. and NEW YORK, May 9, 2017 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced ..."
PFE,PFE:US,BBG000BR2B91,"Buy 'repatriation stocks' because that is sure to make the cut in the final tax bill, UBS says",2017-05-09 17:00:23 +0000,http://finance.yahoo.com/r/fcdc1f25-79b0-305f-a4ca-b66765419f02/104455472?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104455472&yptr=yahoo&.tsrc=rss,"One highly anticipated piece of tax reform should support stocks in two industries, UBS analysts say."
PFE,PFE:US,BBG000BR2B91,"Buy &apos;repatriation stocks&apos; because that is sure to make the cut in the final tax bill, UBS says",2017-05-09 17:00:23 +0000,http://finance.yahoo.com/news/buy-apos-repatriation-stocks-apos-170023714.html?.tsrc=rss,"One highly anticipated piece of tax reform should support stocks in two industries, UBS analysts say."
PFE,PFE:US,BBG000BR2B91,Pfizer immuno-oncology drug wins U.S. approval for bladder cancer,2017-05-09 16:47:19 +0000,http://finance.yahoo.com/news/pfizer-immuno-oncology-drug-wins-164719446.html?.tsrc=rss,"U.S. health regulators on Tuesday granted  accelerated approval for Pfizer Inc's immuno-oncology  drug Bavencio to treat advanced bladder cancer, marking the  second approval in less than two months for the treatment  developed along with Germany's Merck KGaA.  Bavencio, known chemically as avelumab, was approved for  patients with locally advanced or metastatic bladder cancer  whose disease progressed during or following platinum-containing  chemotherapy or within 12 months of chemotherapy treatment  before or after surgery.  As a condition of  accelerated approval, the companies may be asked to conduct a  trial to confirm the benefits of the treatment."
PFE,PFE:US,BBG000BR2B91,"IVW, PFE, PG, ACN: ETF Outflow Alert",2017-05-09 16:01:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rPx6aTJUtwM/ivw-pfe-pg-acn-etf-outflow-alert-cm786490,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares S amp P 500 Growth ETF Symbol IVW where we have detected an approximate 162 4 million dollar outflow that s a 0 9 decrease week over week
PFE,PFE:US,BBG000BR2B91,Comparing Pfizer’s Valuation to Peers after 1Q17 Earnings,2017-05-09 13:06:19 +0000,http://finance.yahoo.com/r/db724be5-e2e2-36ea-85de-3b982b20e242/comparing-pfizers-valuation-to-peers-after-1q17-earnings?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer (PFE) reported a 2% decline in revenues to $12.78 billion in 1Q17, compared to $13.00 billion in 1Q16."
PFE,PFE:US,BBG000BR2B91,Pfizer’s Corporate and Pipeline Developments in 1Q17,2017-05-09 11:35:57 +0000,http://finance.yahoo.com/r/ccbe5dc0-835f-3233-a3d1-0fd9beecc755/pfizers-corporate-and-pipeline-developments-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Apart from Pfizer’s (PFE) product developments, let's take a look at a few of the recent pipeline and corporate developments."
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for May 8, 2017 :  XRX, PFE, YHOO, SRC, DDR, KO, JNPR, AAPL, MSFT, MNST, ADI, CSX",2017-05-08 21:00:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QFyVrRdF5c8/after-hours-most-active-for-may-8-2017-xrx-pfe-yhoo-src-ddr-ko-jnpr-aapl-msft-mnst-adi-csx-cm786168,The NASDAQ 100 After Hours Indicator is down 1 53 to 5 657 54 The total After hours volume is currently 49 226 970 shares traded The following are the most active stocks for the after hours session Xerox Corporation XRX is 0 0162 at 7 09 with 4 931 815 shares
PFE,PFE:US,BBG000BR2B91,M&A Talks May Take Center Stage in Allergan's 1Q Earnings Call,2017-05-08 20:00:00 +0000,http://finance.yahoo.com/r/3ae832b5-d779-3907-af52-c63dacf0e93f/m-amp-a-talks-may-take-centerstage-in-allergan-s-1q-earnings-call.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Pfizer CEO Ian Read last week was forced to field questions about M&A and there's a good chance Allergan won't be any different.
PFE,PFE:US,BBG000BR2B91,"Allergan Must Show Mergers, Drug Pipeline Can Make Up For Lost Sales",2017-05-08 19:21:00 +0000,http://finance.yahoo.com/r/5809cb88-0c48-3dd8-9184-7f489652e00a/allergan-must-show-mergers-drug-pipeline-can-make-up-for-lost-sales.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Analysts estimate total revenue will fall 6.9% to $3.53 billion in the quarter due to the loss of patent exclusivity on some drugs and divestitures of major business lines.
PFE,PFE:US,BBG000BR2B91,Interesting June Stock Options for PFE,2017-05-08 18:03:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BJoQBKVf33o/interesting-june-stock-options-for-pfe-cm785998,Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the June expiration for PFE The put contract
PFE,PFE:US,BBG000BR2B91,"Ex-Dividend Reminder: WEC Energy Group, Pfizer and Union Bankshares",2017-05-08 15:02:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wz22eeYNdZg/ex-dividend-reminder-wec-energy-group-pfizer-and-union-bankshares-cm785774,Looking at the universe of stocks we cover at Dividend Channel on 5 10 17 WEC Energy Group Inc Symbol WEC Pfizer Inc Symbol PFE and Union Bankshares Corp Symbol UBSH will all trade ex dividend for their respective upcoming dividends WEC Energy Group Inc will pay its
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Merck, Pfizer Report Q1 Earnings, J&J Talc Powder Lawsuit",2017-05-08 14:48:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8K6xYdrQySI/pharma-stock-roundup-merck-pfizer-report-q1-earnings-jj-talc-powder-lawsuit-cm785710,Last week big names like Merck MRK and Pfizer PFE reported earnings results Johnson amp Johnson JNJ was also in the news related to a jury verdict for its talc powder lawsuit 160 Recap of the Week s Most Important Stories A Look at Earnings Results Two major
PFE,PFE:US,BBG000BR2B91,Pfizer’s Key Product Developments in 1Q17,2017-05-08 14:36:15 +0000,http://finance.yahoo.com/r/d4fbd58e-871a-382f-8415-6951e8f35cbd/pfizers-key-product-developments-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"To strengthen the innovative health business, the company is focusing on the development of new drugs as well as expanding the market reach of existing products."
PFE,PFE:US,BBG000BR2B91,"Collaboration Helps Broaden Access to Pfizer’s Contraceptive, Sayana® Press (medroxyprogesterone acetate), for Women in Some of the World’s Poorest Countries",2017-05-08 14:00:00 +0000,http://finance.yahoo.com/news/collaboration-helps-broaden-access-pfizer-140000942.html?.tsrc=rss,"Pfizer Inc., the Bill & Melinda Gates Foundation, and the Children’s Investment Fund Foundation today announced a multi-year extension of their collaboration to further broaden access to Pfizer’s all-in-one injectable contraceptive, Sayana® Press , for women most in need in some of the world’s poorest countries."
PFE,PFE:US,BBG000BR2B91,J&J: What's In Store At Next Week's Analyst Meeting,2017-05-08 13:34:00 +0000,http://finance.yahoo.com/r/226b7c4c-3ef1-320c-8f8d-069fd79070e0/j-j-whats-in-store-at-next-weeks-analyst-meeting-1494250482?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"The biggest source of revenue for Johnson & Johnson (JNJ) is its famed pharmaceutical business.  It alone generated 46% of the company’s 2016 revenue, and has been a key driver of top line growth over the past few years.  Wells Fargo analyst Larry Biegelsen notes that the unit’s revenue growth is set to slow into the low single digits in the face of several headwinds -- or at least that’s what J&J’s 2017 guidance has implied."
PFE,PFE:US,BBG000BR2B91,Pfizer: Why Revenues Fell in 1Q17 for Some Products,2017-05-08 13:06:28 +0000,http://finance.yahoo.com/r/d2163881-32bf-30a4-8ac3-21750990b892/pfizer-why-revenues-fell-in-1q17-for-some-products?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Pfizer's (PFE) 1Q17 revenues reflected a decrease in revenues in both the Innovative Health and Essential Health segments.
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Merck, Pfizer Report Q1 Earnings, J&J Talc Powder Lawsuit",2017-05-08 12:46:12 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-merck-pfizer-124612890.html?.tsrc=rss,Major pharma companies like Pfizer (PFE) and Merck reported Q1 results last week.
PFE,PFE:US,BBG000BR2B91,Pfizer: Understanding Growth Drivers in 1Q17,2017-05-08 11:37:17 +0000,http://finance.yahoo.com/r/84f1a36c-e1a0-3a44-ae18-cd9b9b3e7be5/pfizer-understanding-growth-drivers-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer’s (PFE) revenues have been driven by growth in the sales of key products including Lyrica, Ibrance, Xalkori, and Xeljanz."
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: Apple, Merck Beat; Pfizer Misses on Revenues",2017-05-05 23:24:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9Fqr_0S2YDc/dow-30-stock-roundup-apple-merck-beat-pfizer-misses-on-revenues-cm785338,The Dow traded inside a tight band during a week marked by key earnings releases and legislative developments The index moved lower on Monday after two of its components released disappointing quarterly results only to rebound on Tuesday following the release of upbeat earnings numbers The
PFE,PFE:US,BBG000BR2B91,Merck vs. Pfizer: Which Stock Looks Better Post-Earnings?,2017-05-05 22:25:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iByom4rNcPE/merck-vs-pfizer-which-stock-looks-better-post-earnings-cm785304,Both Merck amp Co Inc 160 MRK and Pfizer Inc PFE reported upbeat first quarter results earlier this week While Merck posted better than expected earnings and revenues Pfizer managed to outpace its earnings estimate but missed on the top line Both Pfizer and Merck have a Zacks
PFE,PFE:US,BBG000BR2B91,Pfizer’s Geographical Performance in 1Q17,2017-05-05 21:36:10 +0000,http://finance.yahoo.com/r/ff2de4e3-f1a5-3c91-834e-b7819849122b/pfizers-geographical-performance-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"To better understand the factors affecting growth, let's take a look at Pfizer's performance in US markets and beyond in 1Q17."
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: Apple, Merck Beat; Pfizer Misses on Revenues",2017-05-05 21:04:09 +0000,http://finance.yahoo.com/news/dow-30-stock-roundup-apple-210409776.html?.tsrc=rss,The Dow traded inside a tight band during a week marked by key earnings releases and legislative developments.
PFE,PFE:US,BBG000BR2B91,Merck vs. Pfizer: Which Stock Looks Better Post-Earnings?,2017-05-05 20:37:08 +0000,http://finance.yahoo.com/news/merck-vs-pfizer-stock-looks-203708806.html?.tsrc=rss,Pfizer is better positioned than Merck and thus calls for investors&apos; attention post earnings.
PFE,PFE:US,BBG000BR2B91,Pfizer’s 1Q17 Earnings: A Look at Revenues by Segment,2017-05-05 20:05:43 +0000,http://finance.yahoo.com/r/c1bcdc3b-fdf5-362e-8806-ab9a8f738025/pfizers-1q17-earnings-a-look-at-revenues-by-segment?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer’s (PFE) portfolio includes medicines, vaccines, and consumer healthcare products. The company has segregated its operations into two businesses."
PFE,PFE:US,BBG000BR2B91,Deals of the Week: Waiting for Clarity,2017-05-05 19:56:00 +0000,http://finance.yahoo.com/r/2df00f65-a78e-329d-963e-342fe30370ed/deals-of-the-week-waiting-for-clarity.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The week's action suggests other dealmakers may be thinking the same thing as Pfizer CEO Ian Read.
PFE,PFE:US,BBG000BR2B91,U.S. chief justice taps New York judge to handle Puerto Rico bankruptcy,2017-05-05 19:34:56 +0000,http://finance.yahoo.com/news/u-chief-justice-appoints-york-164705485.html?.tsrc=rss,"U.S. Chief Justice John  Roberts on Friday appointed a federal judge based in Manhattan  to oversee Puerto Rico's landmark bankruptcy case two days after  the island's government filed for protection from creditors.  In a brief statement, Roberts said he had designated U.S.  District Judge Laura Taylor Swain of the Southern District of  New York to handle the biggest bankruptcy in the history of the  U.S. municipal debt market."
PFE,PFE:US,BBG000BR2B91,Analyzing Pfizer’s 1Q17 Earnings,2017-05-05 18:17:07 +0000,http://finance.yahoo.com/r/aa1117b4-29ea-309a-8c7d-d6b714a473f0/analyzing-pfizers-1q17-earnings?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer (PFE) reported a 2% fall in its top line for 1Q17 as part of its latest earnings announcement on May 2, 2017."
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for May 4, 2017 :  BAC, JNPR, PFE, GM, FCX, CF, SBUX, CMCSA, YHOO, QCOM, STX, AMAG",2017-05-04 20:59:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6cl2R0yZSW8/after-hours-most-active-for-may-4-2017-bac-jnpr-pfe-gm-fcx-cf-sbux-cmcsa-yhoo-qcom-stx-amag-cm784590,The NASDAQ 100 After Hours Indicator is down 2 08 to 5 624 24 The total After hours volume is currently 26 842 429 shares traded The following are the most active stocks for the after hours session Bank of America Corporation BAC is unchanged at 23 85 with 3 203
PFE,PFE:US,BBG000BR2B91,"BPMX Craters, KPTI Surges On Deal With Anivive, PFE Seeks New Use For Old Drug",2017-05-04 03:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-NgktwpeHyo/bpmx-craters-kpti-surges-on-deal-with-anivive-pfe-seeks-new-use-for-old-drug-20170504-00179,"BPMX Craters, KPTI Surges On Deal With Anivive, PFE Seeks New Use For Old Drug"
PFE,PFE:US,BBG000BR2B91,Phase 3 OCTAVE Studies of Oral Tofacitinib in Ulcerative Colitis Results Published in The New England Journal of Medicine,2017-05-03 21:25:00 +0000,http://finance.yahoo.com/news/phase-3-octave-studies-oral-212500455.html?.tsrc=rss,Pfizer Inc. announced today that detailed results from the Phase 3 Oral Clinical Trials for tofAcitinib in ulceratiVE colitis clinical program were published in The New England Journal of Medicine .
PFE,PFE:US,BBG000BR2B91,"Aerie (AERI) Posts Wider-Than-Expected Q1 Loss, Expenses Up",2017-05-03 20:50:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_0qDJwaJURY/aerie-aeri-posts-wider-than-expected-q1-loss-expenses-up-cm783562,Aerie Pharmaceuticals Inc AERI posted first quarter 2017 loss of 76 cents per share including stock based compensation wider than the Zacks Consensus Estimate of a loss of 74 cents but narrower than the year ago loss of 85 cents Being a development stage company Aerie has not
PFE,PFE:US,BBG000BR2B91,"Bristol-Myers &apos;Too Risky&apos; To Acquire As Merck, Roche Pile On Pressure",2017-05-03 20:31:58 +0000,http://finance.yahoo.com/r/04b8ec2c-5917-3bac-8b82-52541ae31f33/bristol-myers-too-risky-to-acquire-as-merck-roche-pile-on-pressure?src=A00220&yptr=yahoo&.tsrc=rss,"Bristol-Myers is too risky to acquire as Merck and Roche pile on the pressure in immuno-oncology, an analyst argued Wednesday."
PFE,PFE:US,BBG000BR2B91,"Momenta (MNTA) Q1 Loss Narrower than Expected, Sales Beat",2017-05-03 19:51:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h0rkEW3juSU/momenta-mnta-q1-loss-narrower-than-expected-sales-beat-cm783696,Momenta Pharmaceuticals Inc MNTA reported loss of 46 cents per share in the first quarter of 2017 which was narrower than the Zacks Consensus Estimate loss of 1 09 In fact the company posted a loss of 35 cents in the year ago quarter as well But revenues in the quarter surged 34 1 to 26
PFE,PFE:US,BBG000BR2B91,"Advisors Asset Management, Inc. Buys Alpine Total Dynamic Dividend Fund, Colony NorthStar Inc, ...",2017-05-03 19:44:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1UUMKcbwJNg/advisors-asset-management-inc-buys-alpine-total-dynamic-dividend-fund-colony-northstar-inc-cm783476,Advisors Asset Management Inc New Purchases AOD CLNS 4ETA LCII LLL HLT BLUE GPT NTTYY MPLX Added Positions ENB KO KRO QUAD CF FE AGNC GME PBF PBI Reduced Positions JOY OKE HUN TRGP CNP JDD OLN ATI NUS COP Sold Out SE
PFE,PFE:US,BBG000BR2B91,Pfizer Must Learn to Live With Uncertainty,2017-05-03 18:02:28 +0000,http://finance.yahoo.com/r/b360ed62-4ac8-3195-913b-08e6ae9bfd27/pfizer-earnings-deal-fears-must-go?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Finding new growth drivers is risky but necessary.
PFE,PFE:US,BBG000BR2B91,Bristol-Myers: Going Stag to the Ball?,2017-05-03 14:33:00 +0000,http://finance.yahoo.com/r/b14b4c1f-eaba-38e4-987f-4883fde11706/bristol-myers-going-stag-to-the-ball-1493822038?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"When Bristol-Myers Squibb (BMY) tumbled last year following disappointing drug trial data, analysts were quick to talk up a potential acquisition, naming companies like Pfizer (PFE), Gilead Sciences (GILD) ..."
PFE,PFE:US,BBG000BR2B91,"Momenta (MNTA) Q1 Loss Narrower than Expected, Sales Beat",2017-05-03 14:32:02 +0000,http://finance.yahoo.com/news/momenta-mnta-q1-loss-narrower-143202950.html?.tsrc=rss,"Momenta Pharmaceuticals Inc. (MNTA) reported loss of 46 cents per share in the first quarter of 2017,which was narrower than the Zacks Consensus Estimate loss of $1.09. In fact, the company posted a loss of 35 cents in the year-ago quarter as well."
PFE,PFE:US,BBG000BR2B91,"Drug Stock Q1 Earnings Releases on May 4: ZTS, REGN & More",2017-05-03 13:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i9-fy5tld40/drug-stock-q1-earnings-releases-on-may-4-zts-regn-more-cm783421,The Q1 earnings season is past the halfway mark Overall earnings and revenue growth has been better than investors expectations We believe this quarter is on track to see the highest growth in many years According to the Earnings Preview report 288 S amp P 500 members accounting for 63
PFE,PFE:US,BBG000BR2B91,Pfizer Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for XELJANZ® (tofacitinib citrate) for the Treatment of Adult Patients with Active Psoriatic Arthritis,2017-05-03 13:00:00 +0000,http://finance.yahoo.com/news/pfizer-announces-u-fda-filing-130000526.html?.tsrc=rss,Pfizer Inc. announced today that the United States Food and Drug Administration has accepted for review the supplemental New Drug Application for XELJANZ® 5 mg twice daily for the treatment of adult patients with active psoriatic arthritis .
PFE,PFE:US,BBG000BR2B91,Dow Jones Industrial Average And Dow Stocks: News And Analysis,2017-05-03 12:58:29 +0000,http://finance.yahoo.com/r/567315ae-e999-3aac-997c-6bcc3dc55234/dow-jones-industrial-average-and-dow-stocks-news-and-analysis?src=A00220&yptr=yahoo&.tsrc=rss,Get the latest news and analysis on the Dow Jones Industrial Average and its 30 component stocks.
PFE,PFE:US,BBG000BR2B91,5 Best Stocks for Investing in Cancer Treatments,2017-05-03 12:25:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6TLqTkX7nwY/5-best-stocks-for-investing-in-cancer-treatments-cm783238,Medical science hasn t yet won the war on cancer but it is scoring important victories in battles against many forms of the dreaded disease Advances in new treatments have made cancer a hot investing theme over the past 18 months helping to power fresh interest in biotechnology stocks
PFE,PFE:US,BBG000BR2B91,Investors Rest Easy After Pfizer and Merck Release Solid Q1 Earnings Reports,2017-05-03 11:30:00 +0000,http://finance.yahoo.com/news/investors-rest-easy-pfizer-merck-113000465.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 3, 2017 / A bigger than expected profit in the first quarter for Pfizer was driven by higher sales of the company's Ibrance breast cancer drug and its blockbuster pain relief ..."
PFE,PFE:US,BBG000BR2B91,Asian stocks lower ahead of US Federal Reserve meeting,2017-05-03 07:07:11 +0000,http://finance.yahoo.com/news/slowing-auto-sales-weigh-us-144019709.html?.tsrc=rss,"Asian stocks declined Wednesday ahead of a meeting of U.S. Federal Reserve policymakers as markets in Japan and Hong Kong closed for a holiday. KEEPING SCORE: Sydney's S&P-ASX 200 fell 1 percent to 5,892.30 ..."
PFE,PFE:US,BBG000BR2B91,"3 Reasons Pfizer, Inc. Investors Shouldn't Be Concerned About the Q1 Revenue Dip",2017-05-02 22:29:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2rK64CZy-Us/3-reasons-pfizer-inc-investors-shouldnt-be-concerned-about-the-q1-revenue-dip-cm783099,Pfizer Inc NYSE PFE reported its first quarter results before the market opened on Tuesday The big drugmaker s revenue of 12 8 billion reflected a 2 drop from the prior year period Falling sales isn t usually a good sign Should Pfizer investors be concerned Nope Here
PFE,PFE:US,BBG000BR2B91,"Dow&apos;s Pfizer Tops Earnings Views, But Sales Come Up Short",2017-05-02 20:27:58 +0000,http://finance.yahoo.com/r/2eae07a9-fbd1-353c-9555-e00a3f5daddb/pfizer-earnings-top-but-sales-come-up-short?src=A00220&yptr=yahoo&.tsrc=rss,Pfizer on Tuesday reported mixed first-quarter results on declining sales in its what it calls its Essential Health unit.
PFE,PFE:US,BBG000BR2B91,Mid-Afternoon Market Update: Crude Oil Down 2.5%; Chegg Surges Higher,2017-05-02 20:06:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3PI--UNn8Ak/mid-afternoon-market-update-crude-oil-down-25-chegg-surges-higher-cm783007,Toward the end of trading Tuesday the Dow traded up 0 10 percent to 20 935 20 while the NASDAQ declined 0 01 percent to 6 091 05 The S amp P also rose gaining 0 02 percent to 2 388 90 Leading and Lagging Sectors Healthcare sector was the top gainer in the US market on Tuesday
PFE,PFE:US,BBG000BR2B91,Buy Pfizer Inc. (PFE) Stock While Its Dividend Is on Sale,2017-05-02 18:27:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LbMMoO6kbcY/buy-pfizer-inc-pfe-stock-while-its-dividend-is-on-sale-cm782956,InvestorPlace Stock Market News Stock Advice amp Trading Tips Pfizer Inc NYSE PFE is slipping in pre market trading after announcing earnings that beat estimates on the bottom line but missed on the revenue side If you re looking for growth stay
PFE,PFE:US,BBG000BR2B91,"Merck (MRK) Beats on Q1 Earnings & Sales, Ups Annual View",2017-05-02 18:27:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/On3esB0Ln1w/merck-mrk-beats-on-q1-earnings-sales-ups-annual-view-cm782874,Merck amp Co Inc MRK reported first quarter 2017 earnings of 88 cents per share which beat the Zacks Consensus Estimate of 83 cents However earnings declined 1 1 from the year ago period Merck s shares rallied 6 1 so far this year while the Zacks classified Large Cap
PFE,PFE:US,BBG000BR2B91,"Midday Update: Stocks Hold Slim Gains as Wait Begins for FOMC, Apple Results",2017-05-02 17:46:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XKY6gMwIbtQ/midday-update-stocks-hold-slim-gains-as-wait-begins-for-fomc-apple-results-cm782890,The benchmark averages flipped to the plus column as Wall Street struggles for direction ahead of the Federal Open Market Committee meeting conclusion on Wednesday and earnings from Dow component stock Apple AAPL due after Tuesday s close The benchmark averages flipped to the plus column
PFE,PFE:US,BBG000BR2B91,Pfizer and Apple In Focus,2017-05-02 17:29:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2nlUqXO_zco/pfizer-and-apple-in-focus-cm782849,For the Zacks Investment Research analytical team the Strategists and Editors who parse through huge amounts of data to give actionable information on whether a particular stock is worth buying or it isn t trudging through earnings season is both easy pickings and a slog to find the jewels
PFE,PFE:US,BBG000BR2B91,Trump's 'tax holiday' could be a windfall for these stocks,2017-05-02 17:27:29 +0000,http://finance.yahoo.com/news/trump-apos-apos-tax-holiday-172729086.html?.tsrc=rss,"Apple may have the biggest overall stash, but other companies could also stand to save billions on a corporate tax holiday."
PFE,PFE:US,BBG000BR2B91,Trump's 'tax holiday' could be a windfall for these stocks,2017-05-02 17:27:29 +0000,http://finance.yahoo.com/r/cfda30c9-fe1b-3511-8060-d6a75ecec93d/104435811?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104435811&yptr=yahoo&.tsrc=rss,"Apple may have the biggest overall stash, but other companies could also stand to save billions on a corporate tax holiday."
PFE,PFE:US,BBG000BR2B91,Pfizer Enters Oversold Territory,2017-05-02 17:26:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MaW2cOfAiBI/pfizer-enters-oversold-territory-cm782827,The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important characteristics strong fundamentals and a valuation that looks inexpensive Pfizer
PFE,PFE:US,BBG000BR2B91,"Pfizer beats 1Q profit forecasts, but sales slip",2017-05-02 17:06:56 +0000,http://finance.yahoo.com/news/pfizer-beats-1q-profit-forecasts-sales-dip-misses-130029648--finance.html?.tsrc=rss,"Pfizer beat Wall Street expectations for first-quarter profit thanks to reduced spending on operations and legal costs, plus strong sales of key new drugs and longtime blockbuster pain treatment Lyrica. ..."
PFE,PFE:US,BBG000BR2B91,Prescription for growth at Pfizer? Analysts say deals,2017-05-02 16:58:09 +0000,http://finance.yahoo.com/news/pfizers-quarterly-profit-rises-2-110229817.html?.tsrc=rss,"Sales of rheumatoid arthritis drug Xeljanz, prostate cancer treatment Xtandi and pneumonia vaccine Prevnar fell short of analyst estimates.  Sales of breast cancer drug Ibrance, which has just begun to face Novartis AG's (NOVN.S) rival treatment Kisqali, rose more than 58 percent, but just missed expectations.  ""Key franchises came in well below expectations, raising concerns about Pfizer's ability to grow in the absence of M&A,"" Goldman Sachs analysts said."
PFE,PFE:US,BBG000BR2B91,Four CNBC IQ 100 components are down big today,2017-05-02 16:37:00 +0000,http://finance.yahoo.com/video/four-cnbc-iq-100-components-163700274.html?.tsrc=rss,"Several components in the IQ 100, including Advanced Micro Devices, General Motors, Pfizer and Micron Technology are getting hit hard today."
PFE,PFE:US,BBG000BR2B91,On Pfizer and Apple: 2 Titanic Stocks Reporting Earnings Today,2017-05-02 16:31:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rnqRpXWq2zc/on-pfizer-and-apple-2-titanic-stocks-reporting-earnings-today-cm782785,Tuesday May 2nd 2017 For the Zacks Investment Research analytical team the Strategists and Editors who parse through huge amounts of data to give actionable information on whether a particular stock is worth buying or it isn t trudging through earnings season is both easy pickings and
PFE,PFE:US,BBG000BR2B91,Slowing auto sales weigh on US stocks as indexes wobble,2017-05-02 16:02:19 +0000,http://finance.yahoo.com/r/8e9bf7b5-0998-3851-a9ba-65d1f325f1ab/slowing-auto-sales-weigh-us-144019709.html?.tsrc=rss,"NEW YORK (AP) — U.S. stock indexes are little changed Tuesday as weak auto sales drag down car makers even as other companies report strong earnings. Ford, General Motors and Fiat Chrysler are falling as it appears U.S. car sales are slowing down. Industrial companies including engine maker Cummins are rising after posting their first-quarter results."
PFE,PFE:US,BBG000BR2B91,"Patent Losses, Prevnar Weakness Weigh on Pfizer Growth",2017-05-02 16:00:00 +0000,http://finance.yahoo.com/news/patent-losses-prevnar-weakness-weigh-160000447.html?.tsrc=rss,Shares look undervalued amid a steady first quarter.
PFE,PFE:US,BBG000BR2B91,Pfizer: We Could Be Here a While,2017-05-02 15:59:00 +0000,http://finance.yahoo.com/r/fce4ad59-95bb-3791-8818-c5628b9b7b9d/pfizer-we-could-be-here-a-while-1493740792?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Pfizer (PFE) are falling today after the pharmaceutical giant beat earnings forecasts but missed on sales.  Pfizer reported an adjusted profit of 69 cents, beating forecasts for 67 cents, on sales of $12.8 billion, missing expectations for $13.1 billion.  After listening to Pfizer's conference call, Bernstein's Tim Anderson and team wonder what might lift its stock from here: Twice now we have asked Pfizer directly about its commitment to the IO partnership it has with Merck KGaA: as part of Q4 results in January the answer seemed imprecise, but today's answers seemed like a much clearer commitment to the collaboration."
PFE,PFE:US,BBG000BR2B91,Dow Higher On Intel Gain; Apple Q2 Earnings After The Close,2017-05-02 15:58:16 +0000,http://finance.yahoo.com/r/ef331ab8-db5e-3d8b-b27d-7bbed1b336e4/dow-higher-on-intel-gain-apple-q2-earnings-after-the-close?src=A00220&yptr=yahoo&.tsrc=rss,The stock market traded mixed as the Federal Reserve&apos;s two-day meeting interest rate meeting kicked off. The Fed is expected to leave rates unchanged.
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer Revenue Falls as Drugs Lose Exclusivity,2017-05-02 15:37:42 +0000,http://finance.yahoo.com/r/43f975a3-7be5-300f-ba99-6c130048c9a1/pfizer-revenue-falls-as-drugs-lose-exclusivity-1493726019?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Pfizer said revenue fell in its latest quarter as some legacy drugs lost market exclusivity.
PFE,PFE:US,BBG000BR2B91,Mid-Morning Market Update: Markets Mostly Flat; Pfizer Profit Beats Views,2017-05-02 15:36:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7naxwDew4ys/mid-morning-market-update-markets-mostly-flat-pfizer-profit-beats-views-cm782801,Following the market opening Tuesday the Dow traded up 0 03 percent to 20 919 78 while the NASDAQ declined 0 09 percent to 6 085 27 The S amp P also fell dropping 0 04 percent to 2 387 09 Leading and Lagging Sectors Non cyclical consumer goods amp services sector was the
PFE,PFE:US,BBG000BR2B91,"Zacks Investment Ideas feature highlights: Tesla, Pfizer, Apple and Facebook",2017-05-02 15:32:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5nJDjN07h0Y/zacks-investment-ideas-feature-highlights-tesla-pfizer-apple-and-facebook-cm782652,For Immediate Release Chicago IL May 02 2017 Today Zacks Investment Ideas feature highlights Features Tesla NASDAQ TSLA Free Report Pfizer NYSE PFE Free Report Apple NASDAQ AAPL Free Report and Facebook NASDAQ FB Free Report The
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Q1 Earnings Beat, Sales Lag, 2017 View Intact",2017-05-02 15:32:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dmU_YftnQrU/pfizer-pfe-q1-earnings-beat-sales-lag-2017-view-intact-cm782614,Pfizer Inc PFE reported first quarter 2017 adjusted earnings per share of 69 cents which beat the Zacks Consensus Estimate of 67 cents by 3 Earnings also rose 3 year over year as lower costs offset a soft top line performance On the other hand revenues missed expectations
PFE,PFE:US,BBG000BR2B91,"Dow Movers: PFE, AAPL",2017-05-02 15:28:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KzSIjuygPJ8/dow-movers-pfe-aapl-cm782632,In early trading on Tuesday shares of Apple AAPL topped the list of the day s best performing Dow Jones Industrial Average components trading up 0 7 Year to date Apple registers a 27 4 gain And the worst performing Dow component thus far on the day is Pfizer PFE trading
PFE,PFE:US,BBG000BR2B91,Pfizer and Apple In Focus,2017-05-02 15:17:03 +0000,http://finance.yahoo.com/news/pfizer-apple-focus-151703785.html?.tsrc=rss,Pfizer and Apple In Focus
PFE,PFE:US,BBG000BR2B91,Pfizer Sill Desperately Seeking Revenue Growth,2017-05-02 14:48:00 +0000,http://finance.yahoo.com/r/332ab858-1bdb-3732-99bb-9c236f42a43a/pfizer-sill-desperately-seeking-revenue-growth?partner=YahooSA&yptr=yahoo&.tsrc=rss,"With revenue slipping and the pipeline looking a bit thin, Pfizer needs new sources of growth, STAT."
PFE,PFE:US,BBG000BR2B91,On Pfizer and Apple: 2 Titanic Stocks Reporting Earnings Today,2017-05-02 14:20:02 +0000,http://finance.yahoo.com/news/pfizer-apple-2-titanic-stocks-142002369.html?.tsrc=rss,"Instead of another run-down of the high number of companies reporting today, I&apos;d like to focus on one company having reported before the bell and one coming after the close: Pfizer (PFE) and Apple (AAPL)."
PFE,PFE:US,BBG000BR2B91,US STOCKS-Wall St flat as Fed meet kicks off; Nasdaq hits record,2017-05-02 14:03:29 +0000,http://finance.yahoo.com/news/us-stocks-wall-st-flat-140329745.html?.tsrc=rss,"Wall Street was little changed on Tuesday,  with the Nasdaq Composite edging lower after eking out another  record high, as the Federal Reserve's meeting kicks off.  While the Fed is widely expected to stand pat on interest  rates, investors are awaiting the central bank's statement, due  on Wednesday, for clues regarding the future path of rate hikes."
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Q1 Earnings Beat, Sales Lag, 2017 View Intact",2017-05-02 13:41:01 +0000,http://finance.yahoo.com/news/pfizer-pfe-q1-earnings-beat-134101903.html?.tsrc=rss,"Pfizer, Inc. (PFE) reported first-quarter 2017 adjusted earnings per share of 69 cents, which beat the Zacks Consensus Estimate of 67 cents by 3%."
PFE,PFE:US,BBG000BR2B91,"Zacks Investment Ideas feature highlights: Tesla, Pfizer, Apple and Facebook",2017-05-02 13:30:01 +0000,http://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-133001206.html?.tsrc=rss,"Zacks Investment Ideas feature highlights: Tesla, Pfizer, Apple and Facebook"
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Tops Q1 Earnings Estimates, Misses Sales",2017-05-02 13:29:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/epBam4hFUXg/pfizer-pfe-tops-q1-earnings-estimates-misses-sales-cm782591,Pfizer Inc s PFE is one of the most well known names in the pharmaceutical sector not just for its medicines and vaccines but also for its consumer healthcare products This New York based company is well known for products like Prevnar Lyrica Lipitor and Celebrex among others However
PFE,PFE:US,BBG000BR2B91,"Stocks to Watch: Aetna, Pfizer, Apple",2017-05-02 13:18:50 +0000,http://finance.yahoo.com/r/117b6890-5446-300e-b228-54f6e243cbc4/stocks-to-watch-aetna-pfizer-apple?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Among the companies with shares expected to trade actively in Tuesday's session are Aetna Inc., Pfizer Inc. and Apple Inc."
PFE,PFE:US,BBG000BR2B91,Pfizer Sinks on Mixed Q1 Earnings,2017-05-02 12:50:35 +0000,http://finance.yahoo.com/news/pfizer-sinks-mixed-q1-earnings-125035551.html?.tsrc=rss,Pfizer reported mixed first-quarter financial results before the markets opened on Tuesday.
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Tops Q1 Earnings Estimates, Misses Sales",2017-05-02 12:25:12 +0000,http://finance.yahoo.com/news/pfizer-pfe-tops-q1-earnings-122512332.html?.tsrc=rss,PFE beat first quarter earnings which came in at 69 cents while our consensus called for EPS of 67 cents.
PFE,PFE:US,BBG000BR2B91,Pfizer Tops Earnings Estimates but Revenue Misses as Prevnar 13 Sales Slide,2017-05-02 11:14:00 +0000,http://finance.yahoo.com/r/3679bf2c-3af8-3ebb-895e-0c9a4b75ed17/pfizer-tops-earnings-estimates-but-revenue-misses-as-prevnar-13-sales-slide.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Pfizer posts slightly better-than-expected first-quarter earnings but misses analysts' forecasts for revenue amid a slowdown for sales of its key Prevnar 13 vaccine.
PFE,PFE:US,BBG000BR2B91,Pfizer's Lackluster Sales May Fuel Speculation for Deals,2017-05-02 11:11:30 +0000,http://finance.yahoo.com/r/807e74d8-32a2-3c0e-8176-2d122289ddb8/pfizer-s-lackluster-sales-show-need-of-a-deal-to-revive-growth?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Pfizer Inc.’s underwhelming sales for its blockbuster medicines in the first quarter will probably further fuel speculation that the giant drugmaker needs to make a deal to revive growth.
PFE,PFE:US,BBG000BR2B91,Pfizer beats 1Q profit forecasts,2017-05-02 11:06:06 +0000,http://finance.yahoo.com/news/pfizer-beats-1q-profit-forecasts-105123981.html?.tsrc=rss,"Pfizer Inc. is reporting first-quarter net income of $3.12 billion. The New York company had a profit of 51 cents per share. Earnings, adjusted for non-recurring costs, came to 69 cents per share. The ..."
PFE,PFE:US,BBG000BR2B91,"Pfizer reports Q1 profit beat, revenue miss",2017-05-02 11:01:15 +0000,http://finance.yahoo.com/r/3f1e7cdd-6bd6-323d-baf9-2028c6c0b677/Story.aspx?guid=4162B838-0293-43B7-8BFC-D1498B8AA0B8&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Pfizer Inc. reported a first-quarter profit beat and revenue miss early Tuesday. Earnings for the latest quarter rose to $3.12 billion, or 51 cents per share, from $3.04 billion, or 49 cents per share, ..."
PFE,PFE:US,BBG000BR2B91,Pfizer's quarterly profit rises 2.7 pct,2017-05-02 10:55:05 +0000,http://finance.yahoo.com/news/pfizers-quarterly-profit-rises-2-105505045.html?.tsrc=rss,"Drugmaker Pfizer Inc reported a 2.7 percent rise in quarterly profit, helped by higher sales of breast cancer drug Ibrance. The largest U.S. drugmaker's net profit rose to $3.12 billion, or 51 cents per ..."
PFE,PFE:US,BBG000BR2B91,"Earnings Reaction History: Pfizer Inc, 41.7% Follow-Through Indicator, 1.3% Sensitive",2017-05-02 10:46:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KFRBsQHKebs/earnings-reaction-history-pfizer-inc-417-follow-through-indicator-13-sensitive-cm782417,Expected Earnings Release 05 02 2017 PremarketExpected Earnings Release 05 02 2017 Premarket Avg Extended Hours Dollar Volume 9 170 260Avg Extended Hours Dollar Volume 9 170 260 Pfizer Inc PFE is due to issue its quarterly earnings report in the upcoming extended hours session
PFE,PFE:US,BBG000BR2B91,PFIZER REPORTS FIRST-QUARTER 2017 RESULTS,2017-05-02 10:45:00 +0000,http://finance.yahoo.com/news/pfizer-reports-first-quarter-2017-104500029.html?.tsrc=rss,Pfizer Inc. reported financial results for first-quarter 2017 and reaffirmed its 2017 financial guidance.
PFE,PFE:US,BBG000BR2B91,Pfizer Q1 17 Earnings Conference Call At 10:00 AM ET,2017-05-02 09:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7q8osbZG_xc/pfizer-q1-17-earnings-conference-call-at-1000-am-et-20170502-00529,Pfizer Q1 17 Earnings Conference Call At 10:00 AM ET
PFE,PFE:US,BBG000BR2B91,Street Aims For Mixed Opening Ahead Of FOMC Meeting,2017-05-02 07:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sX2u_VwGGlA/street-aims-for-mixed-opening-ahead-of-fomc-meeting-20170502-00500,Street Aims For Mixed Opening Ahead Of FOMC Meeting
PFE,PFE:US,BBG000BR2B91,"Pfizer Q1 Profit Beats Estimates, Revenues Up 1% Excl. HIS; Reaffirms Guidance",2017-05-02 07:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hWX5Jl3x21s/pfizer-q1-profit-beats-estimates-revenues-up-1-excl-his-reaffirms-guidance-20170502-00437,"Pfizer Q1 Profit Beats Estimates, Revenues Up 1% Excl. HIS; Reaffirms Guidance"
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. Q1 Income Advances 0%,2017-05-02 06:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0CN4ITOY9Ew/pfizer-inc-q1-income-advances-0-20170502-00317,Pfizer Inc. Q1 Income Advances 0%
PFE,PFE:US,BBG000BR2B91,Stock Futures: These 10 Big-Cap Earnings Are On Tap Tuesday,2017-05-02 04:47:12 +0000,http://finance.yahoo.com/r/7283958d-637f-3486-9858-e0b3345475a6/dow-futures-rise-10-sp-100-stocks-are-on-tap?src=A00220&yptr=yahoo&.tsrc=rss,"Futures for the Dow Jones industrial average, S&P 500 index and Nasdaq 100 futures rose slightly Monday evening."
PFE,PFE:US,BBG000BR2B91,"Earnings Calendar, Analyst Estimates And Stocks To Watch",2017-05-02 02:28:31 +0000,http://finance.yahoo.com/r/42519aaa-ca3d-3dc0-9c97-5e87379d2ff1/earnings-calendar-analyst-estimates-stocks-to-watch?src=A00220&yptr=yahoo&.tsrc=rss,Build your watch list and action plan with a look at stocks set to report.
PFE,PFE:US,BBG000BR2B91,What To Expect From Merck's Q1 Earnings,2017-05-01 23:28:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k8sj01dxKtI/what-to-expect-from-mercks-q1-earnings-cm782362,Merck MRK will report its Q1 2017 earnings on May 2 160 The primary growth driver is likely to be cancer drug Keytruda along with 160 Hepatitis C drug Zepatier The combined sales of these 2 drugs stood at nearly 1 96 billion in 2016 This year we expect at least 50 growth in
PFE,PFE:US,BBG000BR2B91,Analysts’ Ratings and Recommendations for Pfizer,2017-05-01 20:35:44 +0000,http://finance.yahoo.com/r/3410e5ab-dd54-3203-9e62-631a23e3c397/analysts-ratings-and-recommendations-for-pfizer?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Wall Street analysts expect Pfizer’s (PFE) top line to rise 0.6% to ~$13.1 billion in 1Q17. Its earnings per share are expected to be $0.67 in the quarter.
PFE,PFE:US,BBG000BR2B91,Why Pfizer’s 1Q17 Revenue Is Expected to Rise,2017-05-01 19:05:49 +0000,http://finance.yahoo.com/r/21f86546-e162-33c6-b734-3f16c4528d28/why-pfizers-1q17-revenue-is-expected-to-rise?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Analysts expect a rise of 0.6% in Pfizer’s (PFE) 1Q17 revenue to $13.1 billion following the increased sales of the Prevnar family and its Xalkori, Xeljanz, and legacy Hospira products."
PFE,PFE:US,BBG000BR2B91,Pfizer’s 1Q17 Earnings: Analysts’ Estimates,2017-05-01 17:21:19 +0000,http://finance.yahoo.com/r/e24497a4-209c-32a8-838d-ad5cbd24365e/pfizers-1q17-earnings-analysts-estimates?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Headquartered in New York City, Pfizer (PFE) is one of the largest pharmaceutical companies by revenue. Pfizer is set to release its 1Q17 earnings on May 2, 2017."
PFE,PFE:US,BBG000BR2B91,iShares S&P 500 Growth ETF Experiences Big Inflow,2017-05-01 16:28:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/upwb-7dQBmI/ishares-sp-500-growth-etf-experiences-big-inflow-cm782065,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares S amp P 500 Growth ETF Symbol IVW where we have detected an approximate 201 2 million dollar inflow that s a 1 2 increase week over week in
PFE,PFE:US,BBG000BR2B91,"Drug Stocks Q1 Earnings Slated for May 2: MRK, PFE & GILD",2017-05-01 15:31:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/53GFHnUIF8Q/drug-stocks-q1-earnings-slated-for-may-2-mrk-pfe-gild-cm781951,The Q1 earnings season is in full swing with financial results from 288 S amp P 500 members or 63 8 of the index already out as of Apr 28 2017 according to the latest Earnings Preview report Total earnings for these index members jumped 13 7 from the year ago quarter driven by 8
PFE,PFE:US,BBG000BR2B91,What to Expect From Apple and More Dow Stocks Reporting on Tuesday,2017-05-01 15:30:41 +0000,http://finance.yahoo.com/news/expect-apple-more-dow-stocks-153141344.html?.tsrc=rss,24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results this week.
PFE,PFE:US,BBG000BR2B91,"Earnings Preview: Q1 Results From Pfizer, Merck, And Gilead Sciences This Week",2017-05-01 14:56:05 +0000,http://finance.yahoo.com/news/earnings-preview-q1-results-pfizer-145605559.html?.tsrc=rss,"The week ahead could bring heightened volatility with it. On top of companies releasing first-quarter results, there’s a Fed meeting, monthly jobs data, and Congress keeps working to approve government ..."
PFE,PFE:US,BBG000BR2B91,3 Big Drugmakers That Could Make Billions Under Trump's Tax Plan,2017-05-01 14:30:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zANb-SGK6y8/3-big-drugmakers-that-could-make-billions-under-trumps-tax-plan-cm781922,President Trump s much anticipated tax plan is now on the table or at least a lot of it is Treasury Secretary Steven Mnuchin laid out the primary components of the tax proposal on Wednesday While the changes affect millions of Americans three big drugmakers in particular stand
PFE,PFE:US,BBG000BR2B91,"Drug Stocks Q1 Earnings Slated for May 2: MRK, PFE & GILD",2017-05-01 13:40:01 +0000,http://finance.yahoo.com/news/drug-stocks-q1-earnings-slated-134001897.html?.tsrc=rss,"The Q1 earnings season is in full swing with financial results from 288 S&P 500 members or 63.8% of the index already out as of Apr 28, 2017."
PFE,PFE:US,BBG000BR2B91,"'Dogs Of The Dow' Chevron, Verizon And Exxon Need To Be Rescued By Investors",2017-05-01 13:36:00 +0000,http://finance.yahoo.com/r/829a963d-e91c-3a4e-a70c-ce8187dffe8e/dogs-of-the-dow-chevron-verizon-and-exxon-need-to-be-rescued-by-investors?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"The eight stocks designated as the “Dogs of the Dow” for 2017 have an aggregate gain of just 0.5% year to date at the end of April, underperforming the gain of 6% for the Dow Jones Industrial Average."
PFE,PFE:US,BBG000BR2B91,Earnings Preview: What To Expect From Pfizer On Tuesday,2017-05-01 12:50:00 +0000,http://finance.yahoo.com/r/1eb0338b-c6ec-3d82-8bdd-12eb9072b797/earnings-preview-what-to-expect-from-pfizer-on-tuesday?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Pfizer is expected to report $0.67/share on $13.05 billion in revenue. Meanwhile, the so-called Whisper number is $0.68."
PFE,PFE:US,BBG000BR2B91,3 Big Drugmakers That Could Make Billions Under Trump&apos;s Tax Plan,2017-05-01 12:42:00 +0000,http://finance.yahoo.com/r/e6ac243d-64a7-3a0b-8884-a7604a9ca714/3-big-drugmakers-that-could-make-billions-under-tr.aspx?yptr=yahoo&.tsrc=rss,"Johnson & Johnson, Pfizer, and Gilead Sciences stand to reap huge rewards if President Trump&apos;s tax proposals are implemented."
PFE,PFE:US,BBG000BR2B91,Drug Makers Take Page From Hollywood to Spread the Risk,2017-05-01 04:10:09 +0000,http://finance.yahoo.com/r/36890f02-20a2-379c-b4c8-063f29bb357e/drug-makers-take-page-from-hollywood-to-spread-the-risk-1493557202?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Private-equity firms and other investors are funding late-stage clinical trials, shouldering the risk for pharmaceutical companies like Pfizer in exchange for a share of the upside if a drug succeeds."
PFE,PFE:US,BBG000BR2B91,3 Key Things to Watch in Pfizer's Q1 Results,2017-04-30 13:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qXbuWJUgvYM/3-key-things-to-watch-in-pfizers-q1-results-cm781726,When Pfizer NYSE PFE reported its fourth quarter 2016 performance in January the results weren t all that great The big drugmaker posted earnings per share that came in 0 03 below what Wall Street expected Pfizer provides its first quarter 2017 update on May 2 Will
PFE,PFE:US,BBG000BR2B91,"Facebook, Tesla and More Major Earnings Coming Out This Week",2017-04-30 13:25:50 +0000,http://finance.yahoo.com/news/facebook-tesla-more-major-earnings-132550373.html?.tsrc=rss,"24/7 Wall St. has put together a preview of Apple, Facebook, Pfizer and some of the other top companies reporting their latest results in the coming week."
PFE,PFE:US,BBG000BR2B91,Drug Makers Take Page From Hollywood to Spread the Risk,2017-04-30 13:00:12 +0000,http://finance.yahoo.com/r/36890f02-20a2-379c-b4c8-063f29bb357e/drug-makers-take-page-from-hollywood-to-spread-the-risk-1493557202?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"Private-equity firms and other investors are funding late-stage clinical trials, shouldering the risk for pharmaceutical companies like Pfizer in exchange for a share of the upside if a drug succeeds."
PFE,PFE:US,BBG000BR2B91,3 Key Things to Watch in Pfizer&apos;s Q1 Results,2017-04-30 11:41:00 +0000,http://finance.yahoo.com/r/8617f6f1-a6aa-3710-b64d-cb6c681bebcd/3-key-things-to-watch-in-pfizers-q1-results.aspx?yptr=yahoo&.tsrc=rss,These factors could make the difference in whether Pfizer meets expectations in Q1.
PFE,PFE:US,BBG000BR2B91,"[$$] French back at polls, US pharma results, Fed sets interest rates",2017-04-30 11:08:57 +0000,"http://finance.yahoo.com/r/0e08de27-dd31-320d-80ad-1c966f03b428/8180dd48-2849-11e7-bc4b-5528796fe35c,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss",American manufacturing output US President Donald Trump has made reviving domestic manufacturing a centrepiece of his agenda and this week investors will get an update on how the sector is faring. Manufacturing ...
PFE,PFE:US,BBG000BR2B91,The 3 Best Pharmaceutical Stocks to Buy in 2017,2017-04-29 21:26:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1x9pMmqVuJk/the-3-best-pharmaceutical-stocks-to-buy-in-2017-cm781694,One big benefit that comes from owning pharmaceutical stocks is that their products remain in demand even during periods of economic stress That allows drugmakers to crank out profits even when the economy catches a cold So what pharmaceutical stocks should investors buy this
PFE,PFE:US,BBG000BR2B91,The 3 Best Pharmaceutical Stocks to Buy in 2017,2017-04-29 19:31:00 +0000,http://finance.yahoo.com/r/d001292e-7a4c-327e-9e5f-79cf6d2f8d2f/the-3-best-pharmaceutical-stocks-to-buy-in-2017.aspx?yptr=yahoo&.tsrc=rss,"Here&apos;s why Pfizer, Teligent, and Neurocrine Biosciences are all top pharmaceutical stocks to own this year."
PFE,PFE:US,BBG000BR2B91,Amgen: The Bear Case From a Bull,2017-04-29 19:26:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jtcFdCR3y4k/amgen-the-bear-case-from-a-bull-cm781687,Amgen NASDAQ AMGN is arguably one of the safest bets in the world of large cap biotech stocks Simply put the company has a rock solid balance sheet and an impressive clinical pipeline that s produced several new blockbuster candidates in the past four years 160 Even so Amgen
PFE,PFE:US,BBG000BR2B91,Amgen: The Bear Case From a Bull,2017-04-29 17:41:00 +0000,http://finance.yahoo.com/r/38228757-b3e1-3ec8-b9c6-6a0dbe5a8057/amgen-the-bear-case-from-a-bull.aspx?yptr=yahoo&.tsrc=rss,"Amgen&apos;s top-selling anti-inflammatory drug, Enbrel, may have already hit its high-water mark."
PFE,PFE:US,BBG000BR2B91,"Capital Insight Partners, Llc Buys Medtronic PLC, PepsiCo, Mitsubishi UFJ Financial Group, ...",2017-04-28 19:25:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KNz_iFJLI6I/capital-insight-partners-llc-buys-medtronic-plc-pepsico-mitsubishi-ufj-financial-group-cm781410,Capital Insight Partners Llc New Purchases MDT PEP MTU VWR CMCSA CLS TCEHY Added Positions GSK FDS VNTV PFE VOD MSFT NKE DEO CAPMF MANH Reduced Positions GILD UL NXPI BMLPRH BAC CVS MSPRA PRU STI XOM Sold Out JBL LB
PFE,PFE:US,BBG000BR2B91,"Vertex (VRTX) Q1 Earnings Top, CF Products Sales Strong",2017-04-28 15:31:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K1h58bCz5X4/vertex-vrtx-q1-earnings-top-cf-products-sales-strong-cm781127,Vertex Pharmaceuticals Incorporated VRTX reported first quarter 2017 earnings per share of 13 cents including the impact of stock based compensation expense which beat the Zacks Consensus Estimate of 4 cents Notably the company had posted a loss of 13 cents in the year ago quarter
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Lilly, Bristol-Myers, Novartis Q1 Earnings & More",2017-04-28 14:31:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hbwmZ5eBk3Y/pharma-stock-roundup-lilly-bristol-myers-novartis-q1-earnings-more-cm780993,Earnings season for the pharma sector started in full flow this week with companies like Lilly LLY Novartis NVS Bristol Myers BMY Roche AstraZeneca Glaxo GSK and Sanofi SNY reporting results So far it looks like a mixed quarter for the sector Recap of the Week s Most
PFE,PFE:US,BBG000BR2B91,Should You Buy Pfizer (PFE) Ahead of Earnings?,2017-04-28 14:30:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NEjzX5SaqC4/should-you-buy-pfizer-pfe-ahead-of-earnings-cm781162,Investors are always looking for stocks that are poised to beat at earnings season and Pfizer Inc PFE may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Pfizer is seeing favorable earnings
PFE,PFE:US,BBG000BR2B91,These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016,2017-04-28 13:29:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JG2eDRSt064/these-7-drugmakers-relied-on-price-hikes-for-100-of-their-earnings-growth-in-2016-cm780928,If I told you that drug companies lean on their exceptional pricing power to grow their top and bottom lines it probably wouldn t come as a shock in the least If you ve picked up a prescription from the pharmacy at any point over the past couple of years you re probably well aware of
PFE,PFE:US,BBG000BR2B91,Should You Buy Pfizer (PFE) Ahead of Earnings?,2017-04-28 12:45:12 +0000,http://finance.yahoo.com/news/buy-pfizer-pfe-ahead-earnings-124512261.html?.tsrc=rss,"Pfizer (PFE) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season."
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Lilly, Bristol-Myers, Novartis Q1 Earnings & More",2017-04-28 12:41:12 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-lilly-bristol-124112594.html?.tsrc=rss,Several major pharma companies including Lilly (LLY) and Bristol-Myers reported Q1 results this week.
PFE,PFE:US,BBG000BR2B91,Rutgers All-Stars Round 2 pick: PFE,2017-04-27 18:48:00 +0000,http://finance.yahoo.com/video/rutgers-stars-round-2-pick-184800079.html?.tsrc=rss,"In the 2017 CNBC Stock Draft, The Rugters All-Stars choose their second-round draft pick."
PFE,PFE:US,BBG000BR2B91,"Bristol-Myers (BMY) Beats on Q1 Earnings, Ups 2017 View",2017-04-27 17:31:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UvB3_DUBab0/bristol-myers-bmy-beats-on-q1-earnings-ups-2017-view-cm780504,Bristol Myers Squibb Company s BMY first quarter 2017 earnings of 84 cents per share beat the Zacks Consensus Estimate of 72 cents and surged 14 from the year ago period We note that the bottom line was boosted by an 18 cent contribution from the patent infringement litigation settlement
PFE,PFE:US,BBG000BR2B91,Pfizer Hosts Annual Meeting of Shareholders,2017-04-27 16:30:00 +0000,http://finance.yahoo.com/news/pfizer-hosts-annual-meeting-shareholders-163000095.html?.tsrc=rss,"The board of directors of Pfizer Inc. today declared a 32-cent second-quarter 2017 dividend on the company’s common stock, payable June 1, 2017, to shareholders of record at the close of business on May 12, 2017."
PFE,PFE:US,BBG000BR2B91,"Hamlin Capital Management, LLC Buys Exxon Mobil, American Eagle Outfitters, First American ...",2017-04-27 13:25:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IKCKtgpUEDs/hamlin-capital-management-llc-buys-exxon-mobil-american-eagle-outfitters-first-american-cm780154,Hamlin Capital Management LLC New Purchases FAF Added Positions XOM AEO PFE QCOM RDS B VOD BCE MDC PEG FII Reduced Positions MDP RHP HPT MXIM EMR CNK WRK DOW FNB Sold Out MAT PBCT LAMR SPY New Purchases FAF New
PFE,PFE:US,BBG000BR2B91,InSphero Announces Agreement with Pfizer to Develop Novel Assays for Predicting Drug-induced Liver Injury,2017-04-27 13:08:40 +0000,http://finance.yahoo.com/news/insphero-announces-agreement-pfizer-develop-130840445.html?.tsrc=rss,"InSphero AG, the leading supplier of assay-ready 3D cell culture models for accelerating drug discovery and development, has entered into an agreement with Pfizer Inc. , one of the world's premier biopharmaceutical ..."
PFE,PFE:US,BBG000BR2B91,Will Apple Increase Its Dividend Next Week?,2017-04-27 12:27:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9Il-ITj2WS0/will-apple-increase-its-dividend-next-week-cm780071,Apple NASDAQ AAPL has become one of the best dividend stocks in all of tech 160 Fed by its popular device franchises the Mac maker hauls in a quarterly cash hoard large enough to make Scrooge McDuck blush and the company has in turn lavished capital on its
PFE,PFE:US,BBG000BR2B91,"Pfizer’s Next-Generation ALK/ROS1 Inhibitor, Lorlatinib, Granted Breakthrough Therapy Designation from FDA for ALK-Positive Metastatic Non-Small Cell Lung Cancer",2017-04-27 12:00:00 +0000,http://finance.yahoo.com/news/pfizer-next-generation-alk-ros1-120000233.html?.tsrc=rss,"Pfizer Inc. today announced that its investigational next-generation ALK/ROS1 tyrosine kinase inhibitor, lorlatinib, was granted Breakthrough Therapy designation from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase -positive metastatic non-small cell lung cancer , previously treated with one or more ALK inhibitors."
PFE,PFE:US,BBG000BR2B91,AstraZeneca aims to escape drug sales trough in second half,2017-04-27 11:04:01 +0000,http://finance.yahoo.com/news/astrazeneca-hopes-escape-drug-sales-074321400.html?.tsrc=rss,"AstraZeneca, struggling  with loss of patents on blockbusters like cholesterol pill  Crestor, reported another quarter of falling drug sales on  Thursday as it awaits pivotal clinical trial data that may  revive its fortunes.  Chief Executive Pascal Soriot believes 2017 will mark the  trough for the British group, as it starts to put generic losses  behind it and builds up sales of recently launched and  experimental cancer medicines.  Industry analysts, on average, had forecast revenue of $5.4  billion and earnings of 82 cents, according to Thomson Reuters  data."
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Apr 26, 2017 :  BAC, QQQ, NRG, MPW, GE, PFE, GM, MCHI, GILD, SIRI, MU, MSFT",2017-04-26 20:56:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xM8sE10Mp9M/after-hours-most-active-for-apr-26-2017-bac-qqq-nrg-mpw-ge-pfe-gm-mchi-gild-siri-mu-msft-cm779914,The NASDAQ 100 After Hours Indicator is up 1 59 to 5 542 68 The total After hours volume is currently 47 718 372 shares traded The following are the most active stocks for the after hours session Bank of America Corporation BAC is 0 03 at 23 92 with 3 817 473
PFE,PFE:US,BBG000BR2B91,Roche Should Remain Resilient And Grow Moderately In Q1,2017-04-26 20:46:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7ZtDzjSlD7U/roche-should-remain-resilient-and-grow-moderately-in-q1-cm779779,Roche 160 RHHBY will announce its Q1 2017 results on April 27 We expect Roche s diagnostics division to see mid single digit growth driven by expansion 160 in international markets including China and focus on high throughput laboratories with new products in the Cobas family We
PFE,PFE:US,BBG000BR2B91,"XLV, SVXY: Big ETF Outflows",2017-04-26 16:05:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RXib1UngxA4/xlv-svxy-big-etf-outflows-cm779483,Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel the biggest outflow was seen in the Health Care Select Sector SPDR Fund XLV where 3 100 000 units were destroyed or a 1 4 decrease week over week Among the largest underlying
PFE,PFE:US,BBG000BR2B91,"John G Ullman & Associates Inc Buys Exxon Mobil, Flowserve, Abbott Laboratories, Sells St ...",2017-04-26 16:03:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZT23nQbBNTc/john-g-ullman-associates-inc-buys-exxon-mobil-flowserve-abbott-laboratories-sells-st-cm779620,John G Ullman Associates Inc New Purchases CELG LH NI IXYS PPL Q MU VOO Added Positions XOM FLS ABT GXP WTS AMSWA SLB NYCB CCC EEMV Reduced Positions GLW CHMG MON BRKS PLOW DUK OTTR AMGN GVA SBNY Sold Out STJ AMAT MENT
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Q1 Earnings: Will it Pull Off a Surprise?,2017-04-26 15:09:03 +0000,http://finance.yahoo.com/news/pfizer-pfe-q1-earnings-pull-150903131.html?.tsrc=rss,"Pfizer, Inc. (PFE) will report first-quarter 2017 earnings on May 2, before market open. Last quarter, the company delivered a negative earnings surprise of 6.0%."
PFE,PFE:US,BBG000BR2B91,3 Dividend Stocks That Prove Boring Is Beautiful,2017-04-26 13:25:00 +0000,http://finance.yahoo.com/r/163e14eb-5c0d-3a03-99ec-8a63c6432e46/3-dividend-stocks-that-prove-boring-is-beautiful.aspx?yptr=yahoo&.tsrc=rss,These three dividend stocks may not be exciting but they are proven winners.
PFE,PFE:US,BBG000BR2B91,Tesaro Inc Bulls Need a Reality Check,2017-04-25 19:43:00 +0000,http://finance.yahoo.com/r/f4370afe-e0df-3f41-b158-c2fb70a538d8/tesaro-inc-bulls-need-a-reality-check.aspx?yptr=yahoo&.tsrc=rss,Has the market overestimated the odds of success for Tesaro&apos;s fancy new cancer drug?
PFE,PFE:US,BBG000BR2B91,Chill Pill: Eli Lilly Cuts Guidance with Earnings,2017-04-25 17:00:00 +0000,http://finance.yahoo.com/r/ce30bef7-115c-3462-9d78-b9c57915a070/chill-pill-eli-lilly-cuts-guidance-earnings?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Lilly trimmed its full-year GAAP EPS guidance, dragging shares lower today."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 04/25/2017: BIIB, ESRX, JNJ, PFE, ABT, MRK, AMGN",2017-04-25 13:04:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MHe5sOu469A/health-care-sector-update-for-04252017-biib-esrx-jnj-pfe-abt-mrk-amgn-cm778440,Top Health Care stocks Top Health Care stocks JNJ 01 JNJ 01 PFE 1 PFE 1 ABT 2 5 ABT 2 5 MRK flatMRK flat AMGN 0 8 AMGN 0 8 Health care shares were mostly higher in pre market trade Tuesday Health care shares were mostly higher in pre market trade Tuesday In health
PFE,PFE:US,BBG000BR2B91,America's 12 Most Charitable Companies,2017-04-25 12:04:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FCuYLZ8QIPY/americas-12-most-charitable-companies-cm778395,Image source Getty Images Whether through cash donations or through providing their products and services free of charge to people and nonprofits in need corporations across America are making billions of dollars worth of charitable donations each year Here s the list of
PFE,PFE:US,BBG000BR2B91,3 Reasons Pfizer Is a Better Dividend Stock Than Bristol-Myers Squibb,2017-04-25 12:04:00 +0000,http://finance.yahoo.com/r/2ff76473-dd59-32ee-9387-277a404078f3/3-reasons-pfizer-is-a-better-dividend-stock-than-b.aspx?yptr=yahoo&.tsrc=rss,"Bristol-Myers Squibb might have fast-growing cancer drug Opdivo, but here&apos;s why Pfizer is the better dividend stock."
PFE,PFE:US,BBG000BR2B91,Aquinnah Pharmaceuticals Receives $10 Million Investment from Pfizer and AbbVie to Research Breakthrough Approach to Neurodegenerative Disease,2017-04-25 12:00:00 +0000,http://finance.yahoo.com/news/aquinnah-pharmaceuticals-receives-10-million-120000025.html?.tsrc=rss,"CAMBRIDGE, Mass., April 25, 2017 /PRNewswire/ -- Aquinnah Pharmaceuticals, a privately held biotechnology company focused on RNA binding proteins for neurodegenerative disease, announced today that two additional pharmaceutical companies, Pfizer Inc. (PFE) and AbbVie Inc. (ABBV), have invested in Aquinnah's work to treat ALS (Amyotrophic Lateral Sclerosis), Alzheimer's disease and other neurodegenerative diseases. This $10 million adds to an earlier $5 million investment made by Takeda Pharmaceuticals in December 2015.  ""We are excited to have the support of three world-class pharmaceutical companies to expand our drug development efforts from ALS into new RNA binding proteins known to modulate Tau, one of the hallmark pathological proteins involved in Alzheimer's disease,"" said Glenn Larsen, Ph.D., Aquinnah's President and Chief Executive Officer."
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Apr 24, 2017 :  INTC, F, SBGL, HPE, CMCSA, NKE, GE, PFE, YHOO, AAOI, QCOM, SBUX",2017-04-24 21:03:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mic7zzQsDcI/after-hours-most-active-for-apr-24-2017-intc-f-sbgl-hpe-cmcsa-nke-ge-pfe-yhoo-aaoi-qcom-sbux-cm778263,The NASDAQ 100 After Hours Indicator is down 45 to 5 507 58 The total After hours volume is currently 49 151 056 shares traded The following are the most active stocks for the after hours session Intel Corporation INTC is unchanged at 36 75 with 3 929 232
PFE,PFE:US,BBG000BR2B91,CEO Gassner Makes Sure Veeva Has A 'Second Act'  — And More,2017-04-24 21:02:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/km1ZGjpPSgs/ceo-gassner-makes-sure-veeva-has-a-second-act-and-more-cm776897,When Peter Gassner launched Veeva Systems VEEV in 2007 he didn t expect to outstrip 500 million in revenue watch its stock 160 triple in a span of less than three years or expand its arsenal of products to 23 applications Instead Gassner 160 was in survival
PFE,PFE:US,BBG000BR2B91,"How Lilly&apos;s New Drug Could Spark A Deeper Rivalry With Pfizer, Novartis",2017-04-24 20:14:13 +0000,http://finance.yahoo.com/r/d01069bd-417e-34dd-949c-a3b4a467022d/how-lillys-new-drug-could-spark-a-deeper-rivalry-with-pfizer-novartis?src=A00220&yptr=yahoo&.tsrc=rss,Eli Lilly stock popped Monday after the drugmaker said its breast cancer drug &quot;has the potential to be best in class.&quot;
PFE,PFE:US,BBG000BR2B91,Trump Executive Order Could Revive Allergan-Pfizer Merger,2017-04-24 17:10:00 +0000,http://finance.yahoo.com/news/trump-executive-order-could-revive-200300049.html?.tsrc=rss,The Trump administration's executive order on tax regulations could revive the defunct Allergan-Pfizer merger.
PFE,PFE:US,BBG000BR2B91,Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?,2017-04-24 14:06:02 +0000,http://finance.yahoo.com/news/pain-ahead-healthcare-etfs-weak-140602517.html?.tsrc=rss,"Results from Johnson and Johnson could be a warning sign for other drug makers, which are scheduled to report this week and the next."
PFE,PFE:US,BBG000BR2B91,Better Buy: Amgen Inc. vs. Pfizer,2017-04-24 12:42:00 +0000,http://finance.yahoo.com/r/71904f25-656f-3d03-9d33-65f5411a9a12/better-buy-amgen-inc-vs-pfizer.aspx?yptr=yahoo&.tsrc=rss,How do Amgen and Pfizer stocks stack up against each other?
PFE,PFE:US,BBG000BR2B91,Hiding Data And Other Criticisms Of Big Pharma,2017-04-24 11:58:00 +0000,http://finance.yahoo.com/r/1a450299-392e-3a18-a688-1ef33fa569d6/hiding-data-and-other-criticisms-of-big-pharma?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"However, the pendulum has swung dramatically in recent years, particularly with respect to reporting negative clinical trial results."
PFE,PFE:US,BBG000BR2B91,"Pivotal Phase III Study Underscores Efficacy Of Zavicefta™ (ceftazidime-avibactam) For Treatment Of Hospital-Acquired Pneumonia, A Leading Cause Of Mortality In Hospitals",2017-04-24 09:30:00 +0000,http://finance.yahoo.com/news/pivotal-phase-iii-study-underscores-093000070.html?.tsrc=rss,"Positive results of the REPROVE1 Study showed that patients diagnosed with hospital-acquired pneumonia , treated with Zavicefta, a novel combination antibiotic for the treatment of certain known or suspected Gram-negative bacterial infections, or Meropenem , a broad spectrum carbapenem antibiotic currently considered the standard of care, experienced comparable rates of clinical cure at test-of-cure ..."
PFE,PFE:US,BBG000BR2B91,Street To Open In Greener Zone,2017-04-24 07:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nATuwlD4YsQ/street-to-open-in-greener-zone-20170424-00348,Street To Open In Greener Zone
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Positive Results Of REPROVE Study,2017-04-24 05:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qDQePMNVDIo/pfizer-announces-positive-results-of-reprove-study-20170424-00190,Pfizer Announces Positive Results Of REPROVE Study
PFE,PFE:US,BBG000BR2B91,"If You're in Your 50s, Consider Buying These 3 Stocks",2017-04-23 12:02:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NiQhzXN-8M0/if-youre-in-your-50s-consider-buying-these-3-stocks-cm777557,Balance That s what s required with investing if you re in your fifties You don t want to be too aggressive On the other hand you don t want to be too cautious After all you still have several years to go before you retire With this goal of balance in mind three stocks appear
PFE,PFE:US,BBG000BR2B91,"If You&apos;re in Your 50s, Consider Buying These 3 Stocks",2017-04-23 10:42:00 +0000,http://finance.yahoo.com/r/df7441cb-0462-38ed-96f7-2fd559bf135e/if-youre-in-your-50s-consider-buying-these-3-stock.aspx?yptr=yahoo&.tsrc=rss,"Pfizer, Chevron, and Facebook look to be smart stock picks -- not too risky but not too cautious."
PFE,PFE:US,BBG000BR2B91,Better Buy: AbbVie Inc. vs. Pfizer,2017-04-22 13:48:00 +0000,http://finance.yahoo.com/r/95a45446-37e3-345a-9438-f3b0916d862a/better-buy-abbvie-inc-vs-pfizer.aspx?yptr=yahoo&.tsrc=rss,Is AbbVie or Pfizer the better dividend-paying pharma stock?
PFE,PFE:US,BBG000BR2B91,"Hospira Recalls One Lot Of 25% Dextrose Injection, USP (Infant)",2017-04-22 05:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3Gnqo8wzEEs/hospira-recalls-one-lot-of-25-dextrose-injection-usp-infant-20170422-00007,"Hospira Recalls One Lot Of 25% Dextrose Injection, USP (Infant)"
PFE,PFE:US,BBG000BR2B91,FDA OKs Samsung Bioepis’s Biosimilar Version Of J&J’s Remicade,2017-04-22 04:08:23 +0000,http://finance.yahoo.com/r/789dfa75-2996-3934-98b7-22fd164b8b30/fda-oks-samsung-bioepiss-biosimilar-version-of-j-js-remicade-1492808596?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,Rheumatoid-arthritis drug Renflexis is the South Korean conglomerate’s first biologic to win approval from U.S. regulators.
PFE,PFE:US,BBG000BR2B91,FDA OKs Samsung Bioepis's Biosimilar Version Of J&J's Remicade,2017-04-21 21:03:22 +0000,http://finance.yahoo.com/r/789dfa75-2996-3934-98b7-22fd164b8b30/fda-oks-samsung-bioepiss-biosimilar-version-of-j-js-remicade-1492808596?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Rheumatoid-arthritis drug Renflexis is the South Korean conglomerate’s first biologic to win approval from U.S. regulators
PFE,PFE:US,BBG000BR2B91,Pfizer Receives Positive CHMP Opinion for BESPONSA® (Inotuzumab Ozogamicin) for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia,2017-04-21 19:05:00 +0000,http://finance.yahoo.com/news/pfizer-receives-positive-chmp-opinion-190500225.html?.tsrc=rss,Pfizer Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of BESPONSA® in the European Union as monotherapy for the treatment of adults with relapsed or refractory CD22-positive B-cell precursor Philadelphia chromosome negative acute lymphoblastic leukemia and Philadelphia chromosome positive ...
PFE,PFE:US,BBG000BR2B91,"Hexavest Inc. Buys VanEck Vectors Gold Miners, Ventas, Tyson Foods, Sells Citigroup, Coca-Cola ...",2017-04-21 17:02:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8hZWGIJWK9Y/hexavest-inc-buys-vaneck-vectors-gold-miners-ventas-tyson-foods-sells-citigroup-coca-cola-cm777208,Hexavest Inc New Purchases GDX VTR TSN EWT CERN EVHC MDT ZBH HRL ESRX Added Positions AUY NGD NEM HCP VZ AGI ED SO ABX T Reduced Positions C PNC BBT GS EEM DLTR WFC UTX MFC UFS Sold Out KO BAC MS USB CIFAF CADNF
PFE,PFE:US,BBG000BR2B91,"Noteworthy ETF Inflows: VTV, BAC, PG, PFE",2017-04-21 16:04:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SacfyKhn4Vw/noteworthy-etf-inflows-vtv-bac-pg-pfe-cm777087,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard Value ETF Symbol VTV where we have detected an approximate 86 4 million dollar inflow that s a 0 3 increase week over week in outstanding units
PFE,PFE:US,BBG000BR2B91,Making Drug Manufacturing Great Again,2017-04-21 16:00:26 +0000,http://finance.yahoo.com/r/998e12e5-455f-3a7d-80ac-c67fa4862398/making-drug-manufacturing-great-again?src=A00220&yptr=yahoo&.tsrc=rss,"President Trump wants to lower drug prices and reinvigorate domestic pharmaceutical manufacturing.  Bravo. But standing in the way is the inside-the-Beltway gospel that preaches that regulators love ambiguity. As a former FDA associate commissioner, I can affirm that&apos;s true. Vagueness gives the agency almost unlimited authority to do whatever it wants. But, when it comes to the FDA, it&apos;s predictability..."
PFE,PFE:US,BBG000BR2B91,"Pfizer Unveils ATLAS®, An Interactive, User-Friendly Website That Provides Global Antibiotic Resistance Surveillance Data Across 60 Countries",2017-04-21 12:36:00 +0000,http://finance.yahoo.com/news/pfizer-unveils-atlas-interactive-user-123600187.html?.tsrc=rss,"Pfizer Inc. today announced the launch of the company’s Antimicrobial Testing Leadership and Surveillance website, which is designed to provide physicians and the global health community with easy access to critical data on the efficacy of various antibiotic treatments and emerging resistance patterns across more than 60 countries."
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public To Listen To Webcast Of April 27 Annual Meeting Of Shareholders,2017-04-20 19:00:00 +0000,http://finance.yahoo.com/news/pfizer-invites-public-listen-webcast-190000925.html?.tsrc=rss,"Pfizer Inc. invites investors and the general public to listen to a webcast of the Annual Meeting of Shareholders at 9:00 a.m. on Thursday, April 27, 2017. To pre-register and access the live audio webcast, visit www.pfizer.com/proxy and click on the “Annual Meeting Webcast” button."
PFE,PFE:US,BBG000BR2B91,AbbVie's (ABBV) Cancer Candidate Fails in Phase III Studies,2017-04-20 16:05:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mgECiojt0b0/abbvies-abbv-cancer-candidate-fails-in-phase-iii-studies-cm776431,AbbVie Inc ABBV recently announced disappointing top line results from two phase III studies evaluating its PARP inhibitor veliparib in combination with chemotherapy such as carboplatin and paclitaxel for treatment of patients with squamous non small cell lung cancer NSCLC and
PFE,PFE:US,BBG000BR2B91,3 Top High-Yield Dividend Stocks to Buy Now,2017-04-20 16:05:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/glVQsrFUKH8/3-top-high-yield-dividend-stocks-to-buy-now-cm776463,In today s low interest rate environment many investors are turning to the stock market in order to generate yield However not every dividend paying stock is worth owning so investors need to be choosy about which companies they buy So which high yield stocks do I think can be
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb Co: Buy the Dip?,2017-04-20 16:04:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BRvkgIz74YY/bristol-myers-squibb-co-buy-the-dip-cm776435,Shares of Bristol Myers Squibb NYSE BMY have slipped about 30 since the company announced a surprising setback for its lead growth driver Opdivo last August More recent missteps in skin and brain cancer trials have analysts scrambling to adjust their peak sales targets for
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb Co: Buy the Dip?,2017-04-20 14:47:00 +0000,http://finance.yahoo.com/r/fe6e15fa-8ccf-3f55-ac1d-4d4b5638cc84/bristol-myers-squibb-co-buy-the-dip.aspx?yptr=yahoo&.tsrc=rss,The reaction to Opdivo’s recent shortcomings seem overblown. Is Bristol-Myers Squibb stock a buy right now?
PFE,PFE:US,BBG000BR2B91,3 Top High-Yield Dividend Stocks to Buy Now,2017-04-20 13:55:00 +0000,http://finance.yahoo.com/r/9882f958-966d-381e-9950-3b47160d3f91/3-top-high-yield-dividend-stocks-to-buy-now.aspx?yptr=yahoo&.tsrc=rss,"Pfizer, National Grid, and Retail Opportunity Investments all look like timely buys for income-focused investors."
PFE,PFE:US,BBG000BR2B91,Pfizer subpoenaed in U.S. intravenous saline solution probe,2017-04-20 01:13:21 +0000,http://finance.yahoo.com/news/pfizer-subpoenaed-u-intravenous-saline-011321158.html?.tsrc=rss,"Pfizer Inc has received  grand jury subpoenas from the U.S. Justice Department in  connection with an antitrust investigation focusing on  drugmakers that market intravenous saline solutions.  The drugmaker disclosed the subpoenas in a statement on  Wednesday after ICU Medical Inc, which recently  acquired Pfizer's global infusion therapy business, and Baxter  International Inc said they received similar subpoenas.  ICU Medical said the probe related to Hospira Infusion  Systems, which it purchased in February from Pfizer, after  Pfizer had acquired it in a merger with Hospira Inc in 2015."
PFE,PFE:US,BBG000BR2B91,Pfizer Gets US DoJ Subpoena In Intravenous Saline Investigation,2017-04-19 23:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KgKGvDaRTso/pfizer-gets-us-doj-subpoena-in-intravenous-saline-investigation-20170419-01469,Pfizer Gets US DoJ Subpoena In Intravenous Saline Investigation
PFE,PFE:US,BBG000BR2B91,Is J&J's Pharma Sales Slowdown a Warning for Other Players?,2017-04-19 22:03:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NtH_GlPPegE/is-jjs-pharma-sales-slowdown-a-warning-for-other-players-cm776123,Johnson amp Johnson JNJ reported mixed first quarter 2017 earnings results on Tuesday While earnings beat the Zacks Consensus Estimate sales missed due to a slowdown in pharmaceutical product sales For the first quarter J amp J s earnings of 1 83 per share beat the Zacks
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Apr 19, 2017 :  GE, EBAY, LC, PFE, SWNC, GIMO, QCOM, WLL, ARRY, YHOO, MSFT, CMCSA",2017-04-19 21:02:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qaUNlOpPGII/after-hours-most-active-for-apr-19-2017-ge-ebay-lc-pfe-swnc-gimo-qcom-wll-arry-yhoo-msft-cmcsa-cm776117,The NASDAQ 100 After Hours Indicator is up 2 62 to 5 402 26 The total After hours volume is currently 28 682 345 shares traded The following are the most active stocks for the after hours session General Electric Company GE is unchanged at 30 00 with 1 569 108
PFE,PFE:US,BBG000BR2B91,"Pfizer Follows Baxter, Gets Slammed With Subpoena Related To Saline Shortage",2017-04-19 21:02:38 +0000,http://finance.yahoo.com/r/452ccc93-507b-37f4-ba98-b198e0f7b722/pfizer-follows-baxter-slammed-with-subpoena-related-to-saline-shortage?src=A00220&yptr=yahoo&.tsrc=rss,Pfizer received subpoenas from the U.S. Justice Department connected to a widespread antitrust investigation into saline fluids.
PFE,PFE:US,BBG000BR2B91,Is J&J&apos;s Pharma Sales Slowdown a Warning for Other Players?,2017-04-19 20:17:08 +0000,http://finance.yahoo.com/news/j-j-apos-pharma-sales-201708420.html?.tsrc=rss,Johnson & Johnson (JNJ) reported mixed first-quarter 2017 earnings results on Tuesday.
PFE,PFE:US,BBG000BR2B91,Pfizer is latest to get Justice Department subpoena in intravenous saline investigation,2017-04-19 20:03:01 +0000,http://finance.yahoo.com/r/5e9bc3f2-bf05-3424-91d0-e2fde42f2ce2/Story.aspx?guid=8420F8DA-0882-41F2-A42F-1CAB7E0C3F69&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Pfizer Inc. has been subpoenaed by the Justice Department as part of an antitrust investigation into intravenous saline sales practices, requests that it is ""evaluating,"" the company said Wednesday. ..."
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson's Pharma Business To See Challenges In The Near Term,2017-04-19 19:33:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0f9ZUxDl9Yo/johnson-johnsons-pharma-business-to-see-challenges-in-the-near-term-cm776054,Johnson amp Johnson 160 JNJ recently reported its Q1 2017 earnings and the stock dropped more than 3 following the announcement of results It is rare for J amp J s fairly stable stock to drop this much in a single day So what went wrong Let s first look at what went according
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. – Value Analysis (NYSE:PFE) : April 19, 2017",2017-04-19 19:13:12 +0000,http://finance.yahoo.com/r/eaa0def7-6e64-3ba9-8a94-b036422fed21/pfizer-inc-value-analysis-nysepfe-april-19-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Pfizer Inc. a score of 50. Our analysis is based on comparing Pfizer Inc. with the following peers – Merck & Co., Inc., Johnson & Johnson, Bristol-Myers Squibb Company, Eli Lilly and Company, Novartis AG Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Mylan N.V., Abbott Laboratories ... Read more
<b>(Read more...)</b>"
PFE,PFE:US,BBG000BR2B91,Pfizer subpoenaed in U.S. intravenous saline solution probe,2017-04-19 19:05:29 +0000,http://finance.yahoo.com/news/pfizer-subpoenaed-u-intravenous-saline-155252390.html?.tsrc=rss,"Pfizer Inc has received  grand jury subpoenas from the U.S. Justice Department in  connection with an antitrust investigation focusing on  drugmakers that market intravenous saline solutions.  The drugmaker disclosed the subpoenas in a statement on  Wednesday after ICU Medical Inc, which recently  acquired Pfizer's global infusion therapy business, and Baxter  International Inc said they received similar subpoenas."
PFE,PFE:US,BBG000BR2B91,Lackluster J&J Q1 Pushes Healthcare ETFs Down,2017-04-19 17:04:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zOFufUVuN3Q/lackluster-jj-q1-pushes-healthcare-etfs-down-cm775934,The Q1 earnings season has kicked in and Johnson amp Johnson JNJ was the first drug company to report earnings on April 18 before the opening bell The world s biggest maker of health care products continued its long streak of earnings beat but lagged our revenue estimate again on sluggish
PFE,PFE:US,BBG000BR2B91,Gilead Sciences: Who's Frustrated Now?,2017-04-19 15:42:00 +0000,http://finance.yahoo.com/r/bda188a0-b14b-3d9a-9c65-d366c2bb23bc/gilead-sciences-whos-frustrated-now?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Last month, I urged investors to stay away from  Gilead Sciences (GILD), arguing that it had, in effect, become a value trap (even if I didn't use those exact words.  Barclays analyst Geoff Meacham and team note that ""investors seem increasingly more frustrated"" with not only Gilead, but with Alexion Pharmaceuticals (ALXN) and Biogen (BIIB) as well."
PFE,PFE:US,BBG000BR2B91,"Billionaires, companies power Trump's record inaugural haul",2017-04-19 15:05:19 +0000,http://finance.yahoo.com/r/8427fac1-1797-3452-94f1-16709bd6b24d/billionaires-companies-power-trumps-record-inaugural-haul-122318155--politics.html?.tsrc=rss,"WASHINGTON (AP) — Billionaires, corporations and NFL owners opened their wallets in a big way to help President Donald Trump raise a record-shattering $107 million for his inaugural festivities, records released by the Federal Election Commission on Wednesday show. The amount about doubled the record set by President Barack Obama eight years ago."
PFE,PFE:US,BBG000BR2B91,Pfizer receives subpoenas in U.S. intravenous saline solution probe,2017-04-19 14:57:09 +0000,http://finance.yahoo.com/news/pfizer-receives-subpoenas-u-intravenous-145709870.html?.tsrc=rss,"Pfizer Inc said on  Wednesday that the company had received grand jury subpoenas  from the U.S. Justice Department amid an antitrust investigation  focused on drugmakers that market intravenous saline solution.  Pfizer disclosed the subpoenas in a statement a day after  ICU Medical Inc, which recently acquired the company's  global infusion therapy business, on Tuesday said it had  received a similar subpoena related to intravenous solutions."
PFE,PFE:US,BBG000BR2B91,Why Is Pfizer (PFE) Up 8.7% Since the Last Earnings Report?,2017-04-19 13:05:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/elZbCrs3PCc/why-is-pfizer-pfe-up-87-since-the-last-earnings-report-cm775670,It has been about a month since the last earnings report for Pfizer Inc PFE Shares have added about 8 7 in that time frame outperforming the market Will the recent positive trend continue leading up to the stock s next earnings release or is it due for a pullback Before we dive into
PFE,PFE:US,BBG000BR2B91,Why Is Pfizer (PFE) Up 8.7% Since the Last Earnings Report?,2017-04-19 11:05:11 +0000,http://finance.yahoo.com/news/why-pfizer-pfe-8-7-110511955.html?.tsrc=rss,Pfizer (PFE) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson Sees Little Impact In Key Area Despite Pfizer Competition,2017-04-18 18:11:00 +0000,http://finance.yahoo.com/r/4b0ab47d-ade1-3354-9245-1b5ce2171ecb/johnson-amp-johnson-saw-little-impact-from-biosimilar-competition-to-remicade-in-u-s.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Pfizer launched a Remicade biosimilar in November.
PFE,PFE:US,BBG000BR2B91,The 4 Best Dividend Stocks in Pharmaceuticals,2017-04-18 17:06:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/epOvHju2R5A/the-4-best-dividend-stocks-in-pharmaceuticals-cm775334,If you re looking for steadily growing income the pharmaceutical industry boasts plenty of dividend paying stocks Not all of them are created equal though and plenty of investors in this space have seen their payouts frozen or slashed in recent years as their leading products
PFE,PFE:US,BBG000BR2B91,Roche's (RHHBY) Cancer Drug Gets FDA Nod for Label Expansion,2017-04-18 17:05:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bz0nLnR3ECk/roches-rhhby-cancer-drug-gets-fda-nod-for-label-expansion-cm775341,Roche Holding AG s RHHBY unit Genentech announced that its drug Tecentriq atezolizumab has received FDA approval on an accelerated basis for initial treatment of people with advanced urothelial carcinoma mUC a form of bladder 160 cancer who are unable to receive initial
PFE,PFE:US,BBG000BR2B91,High-Yield Healthcare Investments You Can Buy Right Now,2017-04-18 17:05:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KfpVhEf9Ohw/high-yield-healthcare-investments-you-can-buy-right-now-cm775299,If you re looking for high yield investments you might want to consider the sector that accounts for nearly one fifth of the nation s economy I m talking about healthcare of course Three healthcare stocks in particular boast high dividend yields and good overall prospects Here s
PFE,PFE:US,BBG000BR2B91,Dow Analyst Moves: PFE,2017-04-18 17:04:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7kEsHvM_M5A/dow-analyst-moves-pfe-cm775336,The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average Pfizer is the 15 analyst pick Within the broader S amp P 500 when components were ranked in terms of analyst favorites PFE claims the 253
PFE,PFE:US,BBG000BR2B91,High-Yield Healthcare Investments You Can Buy Right Now,2017-04-18 15:41:00 +0000,http://finance.yahoo.com/r/4a80e419-618a-3537-a4f2-cfc478d219cc/high-yield-healthcare-investments-you-can-buy-righ.aspx?yptr=yahoo&.tsrc=rss,"Want high dividend yields? Check out healthcare stocks AbbVie, Pfizer, and Novo Nordisk."
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson says pricing competition squeezed 1Q sales,2017-04-18 15:19:31 +0000,http://finance.yahoo.com/r/48599735-9083-3376-91f3-e9b9923f60d2/johnson-johnson-tops-1q-profit-105620623.html?.tsrc=rss,Increased pressure to cut medicine prices and an industry-wide slowdown in consumer health product sales is hurting health care giant Johnson & Johnson.
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson says pricing competition squeezed 1Q sales,2017-04-18 15:19:31 +0000,http://finance.yahoo.com/news/johnson-johnson-tops-1q-profit-105620623.html?.tsrc=rss,"Increased pressure to cut medicine prices and an industry-wide slowdown in consumer health product sales is hurting health care giant Johnson & Johnson. Those factors, along with a bigger tax bill than ..."
PFE,PFE:US,BBG000BR2B91,Did Pharma & Biotech M&As Pick Pace in Q1?,2017-04-18 15:08:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4LF2gJ117OU/did-pharma-biotech-mas-pick-pace-in-q1-cm775180,2016 was not exactly a great year for pharma and biotech stocks with the sector facing a lot of criticism for rising drug prices The year also marked a slowdown in M amp A mergers and acquisitions activity in this sector representing a stark contrast to both 2014 and 2015 which saw several
PFE,PFE:US,BBG000BR2B91,The 4 Best Dividend Stocks in Pharmaceuticals,2017-04-18 15:04:00 +0000,http://finance.yahoo.com/r/c46662c2-0dbb-3e46-b8d2-7d7376f59b9f/the-4-best-dividend-stocks-in-pharmaceuticals.aspx?yptr=yahoo&.tsrc=rss,Find out how these pharma stocks could boost your dividend growth portfolio’s performance.
PFE,PFE:US,BBG000BR2B91,"J&J (JNJ) Q1 Earnings Beat Estimates, Pharma Sales Slow Down",2017-04-18 15:02:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YyGfmAeLTps/jj-jnj-q1-earnings-beat-estimates-pharma-sales-slow-down-cm775222,Johnson amp Johnson JNJ reported mixed first quarter 2017 results While earnings beat expectations sales missed the same due to a slowdown in pharmaceutical product sales The drug and consumer products giant raised its 2017 sales and earnings outlook though only to include the impact of
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. breached its 50 day moving average in a Bullish Manner : PFE-US : April 18, 2017",2017-04-18 12:33:43 +0000,http://finance.yahoo.com/r/cfcbb975-e003-34c1-880e-31366fdd5650/pfizer-inc-breached-its-50-day-moving-average-in-a-bullish-manner-pfe-us-april-18-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Pfizer Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
PFE,PFE:US,BBG000BR2B91,[$$] Papua New Guinea struggles to eradicate yaws disease,2017-04-18 03:56:25 +0000,"http://finance.yahoo.com/r/1de9544f-4232-345c-95d8-3654c1977b74/9b97ee86-ff65-11e6-8d8e-a5e3738f9ae4,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","At first the lump on Timish Ongula's right leg was barely noticeable, but within six weeks it had developed into a painful, golf ball-sized ulcer that oozed pus and blood, making it difficult for the four-year-old ..."
PFE,PFE:US,BBG000BR2B91,"HitGen, Pfizer Enter Research Collaboration & License Agreement - Quick Facts",2017-04-18 03:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m1-vC7VtS0w/hitgen-pfizer-enter-research-collaboration--license-agreement--quick-facts-20170418-00109,"HitGen, Pfizer Enter Research Collaboration & License Agreement - Quick Facts"
PFE,PFE:US,BBG000BR2B91,Roche's Hemophilia A Drug Positive in Second Phase III Study,2017-04-18 00:54:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F6SeWAkQIi8/roches-hemophilia-a-drug-positive-in-second-phase-iii-study-cm774946,Roche Holding AG s RHHBY unit Genentech announced positive interim results from the Phase III HAVEN 2 study evaluating its pipeline candidate emicizumab prophylaxis Emicizumab was being assessed in children less than 12 years of age with hemophilia A and inhibitors to factor VIII 160
PFE,PFE:US,BBG000BR2B91,The makers of a lethal-injection drug have become leaders in Arkansas' death-penalty battle,2017-04-18 00:43:00 +0000,http://finance.yahoo.com/news/big-pharma-become-leader-fight-150106426.html?.tsrc=rss,Arkansas' plan to execute seven men by lethal injection over the course of 10 days in April hit a...
PFE,PFE:US,BBG000BR2B91,5 Stocks To Profit From The Canadian Marijuana Boom,2017-04-18 00:30:00 +0000,http://finance.yahoo.com/news/5-stocks-profit-canadian-marijuana-003000993.html?.tsrc=rss,"Medical marijuana has been legal in Canada for a while, but now the government is looking to legalize recreational marijuana, a multi-billion dollar market is in the making"
PFE,PFE:US,BBG000BR2B91,5 Things You Should Expect When Johnson & Johnson Reports Its Q1 Results Tomorrow,2017-04-17 23:54:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P7FPGkd8RV4/5-things-you-should-expect-when-johnson-johnson-reports-its-q1-results-tomorrow-cm774916,It s officially time once again folks earnings season is under way As per the norm healthcare conglomerate Johnson amp Johnson NYSE JNJ is more or less slated to set the tone for the sector by reporting its first quarter results before the opening bell on Tuesday April
PFE,PFE:US,BBG000BR2B91,5 Things You Should Expect When Johnson & Johnson Reports Its Q1 Results Tomorrow,2017-04-17 22:13:00 +0000,http://finance.yahoo.com/r/7ddffa84-32f2-33d3-9ce8-4578acacde1b/5-things-you-should-expect-when-johnson-johnson-re.aspx?yptr=yahoo&.tsrc=rss,It&apos;s about more than just the headline numbers.
PFE,PFE:US,BBG000BR2B91,How Pfizer Inc. Makes Most of Its Money,2017-04-17 21:54:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4Uj8BwcjllY/how-pfizer-inc-makes-most-of-its-money-cm774875,Pfizer Inc NYSE PFE made a whopping 52 8 billion last year To put that amount into perspective imagine a stack of 1 bills that reaches the height of Mount Everest Then add another 651 stacks of the same height on top of that stack That s how much money Pfizer made in
PFE,PFE:US,BBG000BR2B91,Billion dollar drug bust,2017-04-17 21:43:00 +0000,http://finance.yahoo.com/video/billion-dollar-drug-bust-214300736.html?.tsrc=rss,CNBC's Meg Tirrell takes a look at the next potential blockbuster drugs. With the &quot;Fast Money&quot; traders.
PFE,PFE:US,BBG000BR2B91,How Pfizer Inc. Makes Most of Its Money,2017-04-17 20:22:00 +0000,http://finance.yahoo.com/r/e08e3149-156a-3301-99a6-27153e2ab99d/how-pfizer-inc-makes-most-of-its-money.aspx?yptr=yahoo&.tsrc=rss,Pfizer generates an enormous amount of revenue. Here&apos;s where it comes from.
PFE,PFE:US,BBG000BR2B91,Can Lilly Survive Rheumatoid Arthritis Flop With Breast Cancer Drug?,2017-04-17 20:13:20 +0000,http://finance.yahoo.com/r/6d0ff6dd-72cc-3676-a973-21a9370d3686/can-lilly-survive-rheumatoid-arthritis-flop-on-breast-cancer-diabetes?src=A00220A&yptr=yahoo&.tsrc=rss,AbbVie will get some breathing room in rheumatoid arthritis after Eli Lilly and Incyte&apos;s drug caught an FDA delay.
PFE,PFE:US,BBG000BR2B91,Why Incyte Corporation Stock Is Plunging Today,2017-04-17 16:47:00 +0000,http://finance.yahoo.com/r/40dc06f3-2b78-358a-8787-7a551c52af80/why-incyte-corporation-stock-is-plunging-today.aspx?yptr=yahoo&.tsrc=rss,Shares of Incyte and Eli Lilly are reeling following the FDA&apos;s rejection of their once-daily rheumatoid arthritis pill.
PFE,PFE:US,BBG000BR2B91,5 Drug Stocks That Could Be Big Winners this Earnings Season,2017-04-17 14:58:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QPLo4QQxIuo/5-drug-stocks-that-could-be-big-winners-this-earnings-season-cm774522,The first quarter earnings season is off to a start with results expected to ramp up this week as 177 companies including 61 S amp P 500 members provide numbers While it is still early in the season total Q1 earnings are expected to be up 7 6 on revenue growth of 6 3 This compares
PFE,PFE:US,BBG000BR2B91,Why Shares of Portola Pharmaceuticals Are Up Over 60% in 2017,2017-04-17 14:58:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-AcK9AKShWE/why-shares-of-portola-pharmaceuticals-are-up-over-60-in-2017-cm774581,2017 has been a great year for investors of Portola Pharmaceuticals NASDAQ PTLA with shares up almost 70 year to date The reason for the run A combination one two punch of an FDA resubmission combined with a priority review has led to a substantial rise in the stock So can
PFE,PFE:US,BBG000BR2B91,"Gilead, Pfizer, AbbVie Win From Lilly's Loss",2017-04-17 14:51:00 +0000,http://finance.yahoo.com/r/1ef8ca2d-7983-3fbe-a999-6671c00b9621/gilead-pfizer-abbvie-win-from-lilly-s-loss.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The FDA action was a win for Pfizer because Xeljanz escapes competition for one year or more.
PFE,PFE:US,BBG000BR2B91,"Stocks Open Higher: McDonald&apos;s, Apple Rise On The Dow",2017-04-17 13:46:05 +0000,http://finance.yahoo.com/r/d1dfa7e4-98f1-345d-9b0c-194c111d0f54/stock-futures-positive-alibaba-abbott-labs-lilly-stir-early-trade?src=A00220&yptr=yahoo&.tsrc=rss,"Stocks opened higher Monday, despite a weak reading on New York manufacturing activity in April."
PFE,PFE:US,BBG000BR2B91,"Stocks Open Higher: McDonald&apos;s, Apple Rise On The Dow",2017-04-17 13:46:05 +0000,http://finance.yahoo.com/r/d1dfa7e4-98f1-345d-9b0c-194c111d0f54/stock-futures-positive-alibaba-abbott-labs-lilly-stir-early-trade?src=A00220A&yptr=yahoo&.tsrc=rss,"Stocks opened higher Monday, despite a weak reading on New York manufacturing activity in April."
PFE,PFE:US,BBG000BR2B91,5 Drug Stocks That Could Be Big Winners this Earnings Season,2017-04-17 13:20:01 +0000,http://finance.yahoo.com/news/5-drug-stocks-could-big-132001722.html?.tsrc=rss,Here is a look at five companies including Pfizer (PFE) that sport a favorable Zacks Rank and have a positive earnings ESP.
PFE,PFE:US,BBG000BR2B91,Overcoming Opioids: The quest for less addictive drugs,2017-04-17 07:30:28 +0000,http://finance.yahoo.com/r/b60d7a1b-3a02-3049-932e-3b2c87ec9799/overcoming-opioids-quest-less-addictive-drugs-052128205--finance.html?.tsrc=rss,"Tummy tucks really hurt. Doctors carve from hip to hip, slicing off skin, tightening muscles, tugging at innards. Patients often need strong painkillers for days or even weeks, but Mary Hernandez went home on just over-the-counter ibuprofen."
PFE,PFE:US,BBG000BR2B91,Overcoming Opioids: The quest for less addictive drugs,2017-04-17 07:30:28 +0000,http://finance.yahoo.com/news/overcoming-opioids-quest-less-addictive-drugs-052128205--finance.html?.tsrc=rss,"Tummy tucks really hurt. Doctors carve from hip to hip, slicing off skin, tightening muscles, tugging at innards. Patients often need strong painkillers for days or even weeks, but Mary Hernandez went ..."
PFE,PFE:US,BBG000BR2B91,Lilly and Incyte Fall After FDA Rejects Potential Blockbuster for Rheumatoid Arthritis,2017-04-17 01:33:00 +0000,http://finance.yahoo.com/r/93e8e82a-0218-3aa6-b019-9d60cdbb8caa/gilead-pfizer-abbvie-stand-to-gain-from-lilly-incyte-rheumatoid-arthritis-pill-setback.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Gilead, Pfizer, Abbvie stand to gain from Lilly and Incyte Rheumatoid Arthritis Setback."
PFE,PFE:US,BBG000BR2B91,"Town & Country Bank & Trust CO dba First Bankers Trust CO Buys Enbridge, TJX, Royal ...",2017-04-15 12:53:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SGE6g06Fr8s/town-country-bank-trust-co-dba-first-bankers-trust-co-buys-enbridge-tjx-royal-cm774321,Town Country Bank Trust CO dba First Bankers Trust CO New Purchases ENB TJX Added Positions KO BMY RDS A MDLZ VOD HON PEP RTN DOW PM Reduced Positions PNC JPM WMT WBA JNJ GIS CVX XOM BRK B DIS Sold Out SE WSBC TRV CBRL HUM
PFE,PFE:US,BBG000BR2B91,Analysts Expect 10% Upside For XLV,2017-04-14 14:54:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IzbxQcB32qs/analysts-expect-10-upside-for-xlv-cm774222,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
PFE,PFE:US,BBG000BR2B91,2 firms seek to prevent drugs' use in Arkansas executions,2017-04-14 01:38:38 +0000,http://finance.yahoo.com/r/3a610dff-778b-38c7-9b68-14f9ab8d1bc4/arkansas-judge-rejects-bid-block-inmates-execution-195516341.html?.tsrc=rss,"LITTLE ROCK, Ark. (AP) — Two pharmaceutical companies asked a federal judge Thursday to prevent Arkansas from using their drugs to execute seven inmates by the end of the month, saying they object to their products being used for capital punishment."
PFE,PFE:US,BBG000BR2B91,Pfizer Says Execution Drugs Sold to Arkansas Without Knowing,2017-04-13 22:17:57 +0000,http://finance.yahoo.com/r/34714dad-ab81-3d9c-82e8-0d771b8c12cf/pfizer-says-execution-drugs-sold-to-arkansas-without-it-knowing?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Pfizer Inc. said drugs that can be used to execute inmates by lethal injection were sold to the Arkansas Department of Corrections without its knowledge by the distributor McKesson Corp., in violation ..."
PFE,PFE:US,BBG000BR2B91,"Edge Wealth Management LLC Buys Gilead Sciences, Qualcomm, Apollo Commercial Real Estate ...",2017-04-13 18:53:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gOxYOx9k01E/edge-wealth-management-llc-buys-gilead-sciences-qualcomm-apollo-commercial-real-estate-cm773988,Edge Wealth Management LLC New Purchases CYS RRC AOBC PATK LVS ARR LQD SNAP FRGI AVXL Added Positions GILD QCOM ARI GE CSCO BP CVX IVR GOOGL NLY Reduced Positions LUK MDT SPY EPD PFE AAL PCI EAD TWTR MUJ Sold Out
PFE,PFE:US,BBG000BR2B91,Roche Launches Antibody Test to Diagnose Prostate Cancer,2017-04-13 17:54:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rjC7kZqKhNs/roche-launches-antibody-test-to-diagnose-prostate-cancer-cm773915,Roche Holding AG RHHBY announced that it has launched the anti p504s SP116 Rabbit Monoclonal Primary Antibody for prostate cancer diagnosis on a world wise basis Roche s share price shows that the company has outperformed the Zacks classified industry year to date The stock rallied 12
PFE,PFE:US,BBG000BR2B91,J&J (JNJ) to Kick Off Pharma Q1 Earnings: Will it Beat?,2017-04-13 16:57:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S72ixqilwjg/jj-jnj-to-kick-off-pharma-q1-earnings-will-it-beat-cm773890,We expect Johnson amp Johnson JNJ a healthcare bellwether to beat expectations when it reports first quarter 2017 results on Apr 18 before the opening bell Last quarter the company reported a positive earnings surprise of 1 28 J amp J s share price is up 8 8 so far this
PFE,PFE:US,BBG000BR2B91,"Noteworthy ETF Outflows: IWB, BAC, PG, PFE",2017-04-13 16:55:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lFVLVOOoALw/noteworthy-etf-outflows-iwb-bac-pg-pfe-cm773886,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 ETF Symbol IWB where we have detected an approximate 71 7 million dollar outflow that s a 0 4 decrease week over week from 133 750 000
PFE,PFE:US,BBG000BR2B91,A Direct Approach to Value Stocks,2017-04-13 15:00:00 +0000,http://finance.yahoo.com/r/b19a5db7-7850-3411-9d46-44f4172a8d87/direct-approach-value-stocks-vlue?partner=YahooSA&yptr=yahoo&.tsrc=rss,This ETF uses several metrics to get investors involved with value stocks.
PFE,PFE:US,BBG000BR2B91,J&J (JNJ) to Kick Off Pharma Q1 Earnings: Will it Beat?,2017-04-13 14:22:02 +0000,http://finance.yahoo.com/news/j-j-jnj-kick-off-142202857.html?.tsrc=rss,"We expect Johnson & Johnson (JNJ), a healthcare bellwether, to beat expectations when it reports first-quarter 2017 results on Apr 18, before the opening bell."
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Merck Gets CRL for Label Expansion Effort, Roche Cancer Drug Tops",2017-04-13 13:58:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_GZmu3IDvRI/pharma-stock-roundup-merck-gets-crl-for-label-expansion-effort-roche-cancer-drug-tops-cm773675,It was a relatively slow week with key highlights including a complete response letter CRL for Merck s MRK label expansion efforts for its diabetes drugs and positive data on Roche s RHHBY lung cancer treatment Recap of the Week s Most Important Stories Roche Cancer Drug
PFE,PFE:US,BBG000BR2B91,Aerie Reports Positive Data on Ophthalmic Drug Rhopressa,2017-04-13 13:58:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h2rWdBvCVSY/aerie-reports-positive-data-on-ophthalmic-drug-rhopressa-cm773673,Aerie Pharmaceuticals Inc AERI reported encouraging six month top line safety and efficacy results from the phase III trial ROCKET 4 on lead product candidate Rhopressa We note that Aerie is evaluating Rhopressa a novel once daily eye drop for its ability to lower intraocular
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Apr 12, 2017 :  F, T, INTC, PFE, CSCO, GM, XOM, KO, MAT, QCOM, JD, SIRI",2017-04-12 21:04:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wbkw_7ChTHA/after-hours-most-active-for-apr-12-2017-f-t-intc-pfe-csco-gm-xom-ko-mat-qcom-jd-siri-cm773509,The NASDAQ 100 After Hours Indicator is up 34 to 5 377 37 The total After hours volume is currently 33 293 022 shares traded The following are the most active stocks for the after hours session Ford Motor Company F is unchanged at 11 23 with 6 064 666 shares
PFE,PFE:US,BBG000BR2B91,Here's Why Wave Life Sciences Fell as Much as 12.1% This Morning,2017-04-12 18:55:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KJPUQHOjSZc/heres-why-wave-life-sciences-fell-as-much-as-121-this-morning-cm773412,What happened Shares of pre clinical biopharma Wave Life Sciences NASDAQ WVE fell nearly 12 in early trading Wednesday after the company announced it will offer 4 2 million shares at 24 apiece The net proceeds will be approximately 93 4 million and as is usually the case
PFE,PFE:US,BBG000BR2B91,Healthcare Sector Earnings: Making A Comeback In Q1 2017?,2017-04-12 15:46:38 +0000,http://finance.yahoo.com/news/healthcare-sector-earnings-making-comeback-154638460.html?.tsrc=rss,"In 2016, healthcare was the only sector in the S&P 500 (SPX) that ended the year in the red, declining 2.7% versus a positive 12% return for the SPX. However, things appear to be looking up in 2017 with ..."
PFE,PFE:US,BBG000BR2B91,"Foundation Resource Management Inc Buys Johnson & Johnson, Sells SPDR S&P 500, Vectrus, ...",2017-04-12 14:53:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uQkYenCi3SM/foundation-resource-management-inc-buys-johnson-johnson-sells-spdr-sp-500-vectrus-cm773210,Foundation Resource Management Inc New Purchases JNJ Added Positions DO DVN IBM Reduced Positions PFE BRK B MRK VLO NEM GLW TECK LUK COP PSX Sold Out SPY VEC JOY New Purchases JNJ New Purchases JNJ Added Positions
PFE,PFE:US,BBG000BR2B91,What's Got Axovant Sciences Jumping 10% Today?,2017-04-11 21:54:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ILuflN8UyGU/whats-got-axovant-sciences-jumping-10-today-cm772954,What happened Yesterday shares in Axovant Sciences NYSE AXON 160 shot higher after management announced it has hired former Medivation CEO David Hung to be the company s next CEO Today shares climbed another 10 after the company announced it s shoring up its balance
PFE,PFE:US,BBG000BR2B91,What&apos;s Got Axovant Sciences Jumping 10% Today?,2017-04-11 20:29:00 +0000,http://finance.yahoo.com/r/abd6d4b1-bac1-33f0-b34c-e97a1e58abee/whats-got-axovant-sciences-jumping-10-today.aspx?yptr=yahoo&.tsrc=rss,A new CEO with a proven track record and an equity offering that bolsters its balance sheet are sparking interest in this clinical-stage company.
PFE,PFE:US,BBG000BR2B91,See Which Of The Latest 13F Filers Holds Pfizer,2017-04-11 18:54:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FFRJf2jfo7I/see-which-of-the-latest-13f-filers-holds-pfizer-cm772868,At Holdings Channel we have reviewed the latest batch of the 22 most recent 13F filings for the 03 31 2017 reporting period and noticed that Pfizer Inc Symbol PFE was held by 17 of these funds When hedge fund managers appear to be thinking alike we find it is a good idea to take a
PFE,PFE:US,BBG000BR2B91,"Dynamic Advisors Solutions LLC Buys Ventas, Las Vegas Sands, Crown Castle International, Sells ...",2017-04-11 16:53:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h-8D7wxdc08/dynamic-advisors-solutions-llc-buys-ventas-las-vegas-sands-crown-castle-international-sells-cm772815,Dynamic Advisors Solutions LLC New Purchases VTR LVS CCI EPR IDV SJM BA RDS A INDA TGT Added Positions ABBV PFE GSK TBF PPL MKC PPG QQQ PEP MO Reduced Positions DOG HE GM QCOM ETR BMY SPY PSX XOM UTX Sold Out PBCT CF
PFE,PFE:US,BBG000BR2B91,​Boston biotech Rhythm elevates Genzyme head Meeker to board chairman,2017-04-11 15:45:08 +0000,http://finance.yahoo.com/r/0735f769-463b-3149-b6e8-357e4d798f1b/boston-biotech-rhythm-elevates-genzyme-head.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"A week after announcing that he plans to step down as head of Cambridge-based Sanofi Genzyme, David Meeker has been named chairman of the board at a smaller rare disease biotech.  Boston-based Rhythm Pharmaceuticals, a privately-held company that is developing a drug that targets rare genetic disorders linked to obesity, announced Tuesday that Meeker — who has served on the company’s board since 2015 — will now become chairman.  Meeker is set to leave his post at Sanofi Genzyme , a unit of Sanofi (SNY) that is the state's largest life science employer, at the end of June following a 23-year career during which he oversaw the launch of several rare disease drugs."
PFE,PFE:US,BBG000BR2B91,Jim Cramer -- Eli Lilly Is the New 'Darling' of Big Pharma,2017-04-11 15:09:00 +0000,http://finance.yahoo.com/r/05cd19a8-1f00-3e6a-9769-9d3af3464928/jim-cramer-eli-lilly-is-the-new-darling-of-big-pharma.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Eli Lilly has become the new go-to name in the pharmaceutical space, even over Johnson & Johnson, Cramer said."
PFE,PFE:US,BBG000BR2B91,The 3 Top Dividend Stocks in the Healthcare Sector,2017-04-11 12:08:00 +0000,http://finance.yahoo.com/r/405a0eee-58bb-3de6-b803-f33601855ba1/the-3-top-dividend-stocks-in-the-healthcare-sector.aspx?yptr=yahoo&.tsrc=rss,"Here&apos;s why our team of contributors thinks Pfizer, Welltower, and Amgen are all terrific healthcare dividend stocks to buy right now."
PFE,PFE:US,BBG000BR2B91,"Lawson Kroeker Investment Management Inc Buys Opus Bank, Gilead Sciences, Crimson Wine Group, ...",2017-04-11 11:53:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/krJ9bxEZaPc/lawson-kroeker-investment-management-inc-buys-opus-bank-gilead-sciences-crimson-wine-group-cm772515,Lawson Kroeker Investment Management Inc New Purchases GHC Added Positions OPB GILD CWGL CBI CMP XOM LKQ BUD PSX Reduced Positions BRK B BRK A TPL USB DIS AXP IBM CNI LUK AJRD Sold Out BMY New Purchases GHC New
PFE,PFE:US,BBG000BR2B91,Roche's Lung Cancer Drug Alecensa Meets Primary Endpoint,2017-04-10 23:54:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7yjOjli5UC8/roches-lung-cancer-drug-alecensa-meets-primary-endpoint-cm772430,Roche Holdings RHHBY announced that the global randomized phase III study ALEX on lung cancer drug Alecensa met its primary endpoint as an initial first line treatment Alecensa significantly reduced the risk of disease worsening or death progression free survival PFS compared
PFE,PFE:US,BBG000BR2B91,Roche Cancer Drug Beats Pfizer's Xalkori in Study,2017-04-10 15:37:00 +0000,http://finance.yahoo.com/r/beead736-c3a5-394d-a5af-67511939679c/roche-cancer-drug-beats-pfizers-study-rhhbypfe?partner=YahooSA&yptr=yahoo&.tsrc=rss,Roche said its lung cancer drug Alecensa beat Pfizer's Xalkori in a Phase 3 study.
PFE,PFE:US,BBG000BR2B91,3 Top Dividend Stocks to Put on Your Shopping List,2017-04-10 14:11:00 +0000,http://finance.yahoo.com/r/7ef8ae94-c2ee-36df-8b19-bd293de222ba/47-rt-3-top-dividend-stocks-to-put-on-your-shoppin.aspx?yptr=yahoo&.tsrc=rss,Income investors might find these three dividend stocks top choices to buy.
PFE,PFE:US,BBG000BR2B91,"Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for April 11, 2017",2017-04-10 13:15:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D2Rt51oy6a8/abbott-laboratories-abt-ex-dividend-date-scheduled-for-april-11-2017-cm772006,Abbott Laboratories ABT will begin trading ex dividend on April 11 2017 A cash dividend payment of 0 265 per share is scheduled to be paid on May 15 2017 Shareholders who purchased ABT prior to the ex dividend date are eligible for the cash dividend payment This represents an 1
PFE,PFE:US,BBG000BR2B91,"AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for April 11, 2017",2017-04-10 13:14:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9ZrcVkZmg4c/abbvie-inc-abbv-ex-dividend-date-scheduled-for-april-11-2017-cm771982,AbbVie Inc ABBV will begin trading ex dividend on April 11 2017 A cash dividend payment of 0 64 per share is scheduled to be paid on May 15 2017 Shareholders who purchased ABBV prior to the ex dividend date are eligible for the cash dividend payment This represents an 12 28
PFE,PFE:US,BBG000BR2B91,3 Dividend Stocks That Should Pay for the Rest of Your Life,2017-04-10 12:50:00 +0000,http://finance.yahoo.com/r/9ea5e240-0efd-3521-ba3c-dd90c71776cc/3-dividend-stocks-that-should-pay-for-the-rest-of.aspx?yptr=yahoo&.tsrc=rss,"8Point3 Energy Partners, Lowe&apos;s, and Pfizer are top dividend-paying companies that could produce long-term income for investors."
PFE,PFE:US,BBG000BR2B91,Medivation Founder David Hung Becomes CEO Of Axovant Sciences,2017-04-10 12:15:00 +0000,http://finance.yahoo.com/r/f828b120-837e-32e0-94d0-1d0d7f0a8697/medivation-founder-david-hung-becomes-ceo-of-axovant-sciences?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,One of biotech’s most successful entrepreneurs takes a job from 31-year-old wunderkind Vivek Ramaswamy.
PFE,PFE:US,BBG000BR2B91,How Pfizer Stock Performed in 1Q17,2017-04-10 11:36:42 +0000,http://finance.yahoo.com/r/101f3745-52ca-34f6-8a67-88a3bcd2ddb1/how-pfizer-stock-performed-in-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Pfizer’s stock price rose ~1.7% in 1Q17. On April 6, 2017, the stock's price had risen 5.3% year-to-date (or YTD)."
PFE,PFE:US,BBG000BR2B91,Roche's Alecensa notches trial win against Pfizer's Xalkori,2017-04-10 05:38:51 +0000,http://finance.yahoo.com/news/roches-alecensa-notches-trial-win-053851096.html?.tsrc=rss,"Roche's Alecensa kept  people with a specific lung cancer alive longer without their  disease progressing than Pfizer's Xalkori, the Swiss  drugmaker said on Monday, as it seeks to move in on the U.S.  company's share of early treatment of the disease.  Roche now plans to submit the results of the Phase III study  to global health regulators, it said in its statement.  Alecensa, approved since 2015 in people with advanced  ALK-positive non-small cell lung cancer who have failed on  Xalkori, is now being trialed head-to-head against Pfizer's  medication as an initial treatment."
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: Boeing Bags Air Force Orders, DuPont to Sell Part of Crop Protection Biz",2017-04-07 22:54:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p9NHAG9Zyb0/dow-30-stock-roundup-boeing-bags-air-force-orders-dupont-to-sell-part-of-crop-protection-biz-cm771654,The Dow experienced a relatively quiet week as investors eagerly awaited the outcome of the Trump Xi meeting Markets were especially cautious ahead of crucial payrolls data to be released on Friday Dismal auto sales and manufacturing data shaved a few points off the index on Monday Gains
PFE,PFE:US,BBG000BR2B91,"Boltwood Capital Management Buys iShares Core S&P Small-Cap, Allergan PLC, ...",2017-04-07 16:53:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0qG774u-Xy8/boltwood-capital-management-buys-ishares-core-sp-small-cap-allergan-plc-cm771499,Boltwood Capital Management New Purchases AGN ABC PM MCO RWO FBHS PCAR Added Positions IJR ABT SCHZ SCHF XLK VEU XLI UPS DIS XOM Reduced Positions MRK PFE EFA TIP VTI MSFT CSCO PEP IBM VCIT Sold Out STJ MCK CNDT BIVV CNDT
PFE,PFE:US,BBG000BR2B91,FDA Warns Of Dangerous Hidden Ingredient In 5 OTC Male Sexual Enhancement Supplements,2017-04-07 16:25:07 +0000,http://finance.yahoo.com/news/fda-warns-dangerous-hidden-ingredient-162507597.html?.tsrc=rss,"The U.S. Food and Drug Administration has issued a series of warnings about a handful of over-the-counter male sexual enhancement supplements. According to the FDA, laboratory analysis has identified that ..."
PFE,PFE:US,BBG000BR2B91,How Pharmaceutical ETFs Performed during 1Q17,2017-04-07 15:57:50 +0000,http://finance.yahoo.com/r/924977b2-31cc-3108-a628-72bb26a3622a/how-pharmaceutical-etfs-performed-during-1q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Let's take a look at a handful of different pharmaceutical ETFs and their returns year-to-date (or YTD).
PFE,PFE:US,BBG000BR2B91,Paratek (PRTK) Stock Continues to Rise on Positive Results,2017-04-06 17:53:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9Cj_WY4oBKw/paratek-prtk-stock-continues-to-rise-on-positive-results-cm770913,Paratek Pharmaceuticals Inc s PRTK shares are up more than 22 since it announced positive results from a phase III study of its lead pipeline candidate omadacycline for the treatment of patients with community acquired bacterial pneumonia CABP The study compared omadacycline a
PFE,PFE:US,BBG000BR2B91,Allergan (AGN) Presents Mixed Depression Data on Botox,2017-04-06 17:53:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/elMXlAN1JVg/allergan-agn-presents-mixed-depression-data-on-botox-cm770907,Allergan plc AGN announced mixed top line data from a mid stage study evaluating its key drug Botox for the treatment of major depressive disorder MDD Allergan s share price is up 13 2 this year so far while the Zacks classified Medical Generics Drug industry declined 3 4 Botox
PFE,PFE:US,BBG000BR2B91,3 Top Big Pharma Stocks to Buy Now,2017-04-06 16:56:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4D-Vxrb4z5g/3-top-big-pharma-stocks-to-buy-now-cm770900,Despite the ongoing political storm over U S prescription drug prices major drug manufacturers or Big Pharma remain on balance an attractive group of equities for long term investors The fact of the matter is that major pricing reforms aren t even on the political radar
PFE,PFE:US,BBG000BR2B91,3 Top Big Pharma Stocks to Buy Now,2017-04-06 14:48:00 +0000,http://finance.yahoo.com/r/c0d7e600-674b-3eaa-98b8-8c325cb0acb8/3-top-big-pharma-stocks-to-buy-now.aspx?yptr=yahoo&.tsrc=rss,These three Big Pharma stocks offer compelling valuations and long-term growth trajectories.
PFE,PFE:US,BBG000BR2B91,The 3 Most Important Numbers for Pfizer Inc.,2017-04-05 21:54:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zFJhlhGoTaA/the-3-most-important-numbers-for-pfizer-inc-cm770421,It s not hard to be overwhelmed by the sheer volume of numbers included in Pfizer s NYSE PFE financial reports From the company s accumulated post retirement benefit obligation to Zoloft revenue there are a lot of numbers involved in understanding Pfizer s business But I
PFE,PFE:US,BBG000BR2B91,"DepoMed, Opioid Makers Fall After Trump's FDA Pick Says America's Drug Addiction Is Out of Control",2017-04-05 21:00:00 +0000,http://finance.yahoo.com/r/5ae1b30a-f182-3c45-ba81-2eb869c7721a/shares-of-opiod-makers-fall-after-fda-pick-gottlieb-says-america-s-drug-addiction-is-out-of-control.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Washington needs to do more, Gottlieb says at his confirmation hearing."
PFE,PFE:US,BBG000BR2B91,The 3 Most Important Numbers for Pfizer Inc.,2017-04-05 20:44:00 +0000,http://finance.yahoo.com/r/bd76e244-a6cf-3d5c-81de-9f8bd2705efc/the-3-most-important-numbers-for-pfizer-inc.aspx?yptr=yahoo&.tsrc=rss,"From a big figure to a small one, these three numbers could make the difference for Pfizer&apos;s future."
PFE,PFE:US,BBG000BR2B91,Advertisers flee Bill O'Reilly's show but impact unclear,2017-04-05 19:36:28 +0000,http://finance.yahoo.com/r/be4e6c34-6a56-3afc-a2c7-7fbf94db0da0/advertisers-flee-bill-oreillys-show-193628084.html?.tsrc=rss,"NEW YORK (AP) — More advertisers fled Bill O'Reilly's show on Wednesday, with drugmaker Pfizer and real estate company Coldwell Banker among the latest to distance themselves."
PFE,PFE:US,BBG000BR2B91,Roche Announces Positive Data on Lung Cancer Drug Alecensa,2017-04-05 18:53:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lv_05UbUv18/roche-announces-positive-data-on-lung-cancer-drug-alecensa-cm770325,Roche Holdings AG RHHBY recently announced encouraging results from the phase III study ALUR on lung cancer drug Alecensa The study met its primary endpoint as data from the study demonstrated that Alecensa significantly improved progression free survival PFS in patients Those
PFE,PFE:US,BBG000BR2B91,"IWB, BAC, PFE, C: ETF Outflow Alert",2017-04-05 15:56:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JJIYvqk086w/iwb-bac-pfe-c-etf-outflow-alert-cm770205,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 ETF Symbol IWB where we have detected an approximate 91 8 million dollar outflow that s a 0 5 decrease week over week from 134 450 000
PFE,PFE:US,BBG000BR2B91,What Wall Street Analysts Recommend for Pfizer,2017-04-05 13:06:09 +0000,http://finance.yahoo.com/r/4ac1ed8d-3999-3ab2-9d75-237fe998e809/what-wall-street-analysts-recommend-for-pfizer?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,The strong performance of innovative products and the inclusion of the Hospira business have driven Pfizer’s (PFE) 2016 earnings.
PFE,PFE:US,BBG000BR2B91,Must-Know Corporate and Pipeline Developments for Pfizer,2017-04-05 11:36:02 +0000,http://finance.yahoo.com/r/5220980c-1349-3f58-b3b6-d1d1dc468dee/must-know-corporate-and-pipeline-developments-for-pfizer?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"On February 17, 2017, Pfizer and Celltrion Healthcare released data for a randomized 54-week clinical trial that met its primary endpoint."
PFE,PFE:US,BBG000BR2B91,How Walgreens Boots Alliance Inc (WBA) Stock Will Trade After Earnings,2017-04-04 18:23:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nKX3fKF9ji8/how-walgreens-boots-alliance-inc-wba-stock-will-trade-after-earnings-cm769759,InvestorPlace Stock Market News Stock Advice amp Trading Tips When Walgreens Boots Alliance Inc NASDAQ WBA reports its fiscal second quarter earnings on Wednesday investors won t be focused on the numbers Without much growth projections show just 4 year over year
PFE,PFE:US,BBG000BR2B91,Onconova Reports Positive Data for 2 Cancer Drugs,2017-04-04 16:25:00 +0000,http://finance.yahoo.com/r/30ede9fe-90fe-3895-b111-90a885314d8f/onconova-reports-positive-data-2-cancer-drugs-ontx?partner=YahooSA&yptr=yahoo&.tsrc=rss,Onconova shares surged 29% on positive pre-clinical reports for two of its cancer drugs.
PFE,PFE:US,BBG000BR2B91,There's Value in Healthcare ETFs,2017-04-04 16:24:00 +0000,http://finance.yahoo.com/r/6de7329d-8dc9-3f87-a7f5-5fe6c3b162bd/theres-value-healthcare-etfs-iyh-ihe?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Healthcare ETFs are surging, but investors should be selective when looking for compelling value."
PFE,PFE:US,BBG000BR2B91,These Key Product Developments Could Help Pfizer,2017-04-04 14:36:41 +0000,http://finance.yahoo.com/r/dce150fd-92f0-3f0d-a3cf-4dc87bcd1ed5/these-key-product-developments-could-help-pfizer?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Pfizer’s (PFE) innovative health business and essential health business are focused on growth.
PFE,PFE:US,BBG000BR2B91,"Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for April 05, 2017",2017-04-04 13:16:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OjFnpfmZGl0/bristol-myers-squibb-company-bmy-ex-dividend-date-scheduled-for-april-05-2017-cm769451,Bristol Myers Squibb Company BMY will begin trading ex dividend on April 05 2017 A cash dividend payment of 0 39 per share is scheduled to be paid on May 01 2017 Shareholders who purchased BMY prior to the ex dividend date are eligible for the cash dividend payment This represents
PFE,PFE:US,BBG000BR2B91,Today's Research Reports on Stocks to Watch: Mylan and Pfizer,2017-04-04 13:15:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-131500808.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / April 4, 2017 / Mylan's recent string of bad news continued Monday after it was revealed that the previously announced recall of EpiPens would also include U.S. EpiPen and EpiPen ..."
PFE,PFE:US,BBG000BR2B91,Onconova Therapeutics stock surges 18% on positive pre-clinical data for cancer drugs,2017-04-04 13:08:40 +0000,http://finance.yahoo.com/r/c05f4802-22e3-372f-88a3-6bcda8474bc2/Story.aspx?guid=084E03BF-CFB4-4F66-B239-C010440C1122&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Onconova Therapeutics Inc. stock surged as much as 18% in premarket trade Tuesday after the company said its two cancer drugs had positive pre-clinical results. Onconova shares were valued at $3.01 as ...
PFE,PFE:US,BBG000BR2B91,What’s Pfizer’s Financial Guidance for 2017?,2017-04-04 13:06:40 +0000,http://finance.yahoo.com/r/0b65eac8-fc87-30b8-8709-9d67e68969f6/whats-pfizers-financial-guidance-for-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Pfizer (PFE) reported an increase of ~11% in revenues at constant exchange rates during 2016.
PFE,PFE:US,BBG000BR2B91,Mylan's EpiPen Recall Expanded to U.S.,2017-04-03 19:36:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ym-ndQvvzB8/mylans-epipen-recall-expanded-to-us-cm769211,On Monday Mylan NV s MYL manufacturing partner Meridian Medical Technologies who is a Pfizer PFE subsidiary announced that it will expand its voluntary recall of the EpiPen to the United States after discussing the issue with the Food and Drug Administration FDA This follows Mylan
PFE,PFE:US,BBG000BR2B91,Mylan's EpiPen Recall Expanded to U.S.,2017-04-03 17:38:05 +0000,http://finance.yahoo.com/news/mylans-epipen-recall-expanded-u-173805143.html,Mylan's EpiPen Recall Expanded to U.S.
PFE,PFE:US,BBG000BR2B91,"Monday’s Vital Data: Apple Inc. (AAPL), Amazon.com, Inc. (AMZN) and Comcast Corporation (CMCSA)",2017-04-03 17:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y3doRnDu1dY/mondays-vital-data-apple-inc-aapl-amazoncom-inc-amzn-and-comcast-corporation-cmcsa-cm769182,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are headed for a mixed open this morning as pressure from falling oil prices applies pressure in the first trading day of the second quarter Crude fell in Asian trading due to global
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. (PFE) Stock Could Be a Second-Quarter Star,2017-04-03 16:36:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ib_XOoOi5tQ/pfizer-inc-pfe-stock-could-be-a-second-quarter-star-cm769144,InvestorPlace Stock Market News Stock Advice amp Trading Tips Today we enter a fresh month and a fresh quarter That means it s time to sniff out opportunities in the stock market that might offer great reward for little risk in the second quarter As I look across the
PFE,PFE:US,BBG000BR2B91,Pfizer Gets Regular Approval for Breast Cancer Drug Ibrance,2017-04-03 15:39:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-ChPpBsy4BY/pfizer-gets-regular-approval-for-breast-cancer-drug-ibrance-cm769020,Pfizer Inc PFE announced that its supplemental new drug application sNDA to convert accelerated approval for Ibrance to regular approval has been approved by the FDA Pfizer s shares are up 5 3 so far this year comparing unfavorably with the Zacks classified Large Cap Pharma industry
PFE,PFE:US,BBG000BR2B91,What Contributed to Pfizer’s Growth in 2016?,2017-04-03 14:41:55 +0000,http://marketrealist.com/2017/03/what-contributed-to-pfizers-growth-in-2016/?utm_source=yahoo&utm_medium=feed,What Contributed to Pfizer’s Growth in 2016?
PFE,PFE:US,BBG000BR2B91,Mylan Expands EpiPen Recall,2017-04-03 14:10:00 +0000,https://www.thestreet.com/story/14070089/1/mylan-expands-epipen-recall.html?puc=yahoo&cm_ven=YAHOO,Mylan Expands EpiPen Recall
PFE,PFE:US,BBG000BR2B91,Pfizer Gets Regular Approval for Breast Cancer Drug Ibrance,2017-04-03 13:39:01 +0000,http://finance.yahoo.com/news/pfizer-gets-regular-approval-breast-133901393.html,Pfizer Gets Regular Approval for Breast Cancer Drug Ibrance
PFE,PFE:US,BBG000BR2B91,"Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for April 04, 2017",2017-04-03 13:15:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_-duQ_WnEBM/zoetis-inc-zts-ex-dividend-date-scheduled-for-april-04-2017-cm768914,Zoetis Inc ZTS will begin trading ex dividend on April 04 2017 A cash dividend payment of 0 105 per share is scheduled to be paid on June 01 2017 Shareholders who purchased ZTS prior to the ex dividend date are eligible for the cash dividend payment This represents an 10 53
PFE,PFE:US,BBG000BR2B91,Analyzing Pfizer’s Geographical Performance in 2016,2017-04-03 13:08:10 +0000,http://marketrealist.com/2017/03/analyzing-pfizers-geographical-performance-in-2016/?utm_source=yahoo&utm_medium=feed,Analyzing Pfizer’s Geographical Performance in 2016
PFE,PFE:US,BBG000BR2B91,Pfizer's Ibrance Gets FDA Approval for Breast Cancer,2017-04-03 12:49:00 +0000,http://www.investopedia.com/news/pfizers-ibrance-gets-fda-approval-breast-cancer-pfe/?partner=YahooSA,Pfizer's Ibrance Gets FDA Approval for Breast Cancer
PFE,PFE:US,BBG000BR2B91,How Pfizer’s Innovative and Essential Health Segments Performed,2017-04-03 11:38:04 +0000,http://marketrealist.com/2017/03/how-pfizers-innovative-and-essential-health-segments-performed/?utm_source=yahoo&utm_medium=feed,How Pfizer’s Innovative and Essential Health Segments Performed
PFE,PFE:US,BBG000BR2B91,The cost of cancer: new drugs show success at a steep price,2017-04-03 11:00:00 +0000,http://uk.finance.yahoo.com/news/cost-cancer-drugs-show-success-110000888.html,"[Reuters - UK Focus] - Newer cancer drugs that enlist the body's immune system are improving the odds of survival, but competition between them is not reining in prices that can now top $250,000 a year. The drugs' success for patients is the result of big bets in cancer therapy made by Bristol-Myers Squibb Co, Merck (Jakarta: 28586808.JK - news) & Co Inc and Roche Holding AG (IOB: 0QOK.IL - news) , among others in big pharma. The industry's pipeline of cancer drugs expanded by 63 percent between 2005 and 2015, according to the QuintilesIMS Institute, and a good number are reaching the market."
PFE,PFE:US,BBG000BR2B91,The cost of cancer: new drugs show success at a steep price,2017-04-03 06:00:00 +0000,http://uk.finance.yahoo.com/news/cost-cancer-drugs-show-success-060000160.html,"[Reuters - UK Focus] - Newer cancer drugs that enlist the body's immune system are improving the odds of survival, but competition between them is not reining in prices that can now top $250,000 a year. The drugs' success for patients is the result of big bets in cancer therapy made by Bristol-Myers Squibb Co, Merck (Jakarta: 28586808.JK - news) & Co Inc and Roche Holding AG (IOB: 0QOK.IL - news) , among others in big pharma. The industry's pipeline of cancer drugs expanded by 63 percent between 2005 and 2015, according to the QuintilesIMS Institute, and a good number are reaching the market."
PFE,PFE:US,BBG000BR2B91,"2:05 pm Pfizer confirms that the FDA has approved a supplemental New Drug Application for its first-in-class cyclin dependent kinase 4/6 (CDK 4/6) inhibitor, IBRANCE",2017-04-02 18:05:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#pfe,"2:05 pm Pfizer confirms that the FDA has approved a supplemental New Drug Application for its first-in-class cyclin dependent kinase 4/6 (CDK 4/6) inhibitor, IBRANCE"
PFE,PFE:US,BBG000BR2B91,White House wealth: Trump employees disclose their finances,2017-04-01 07:10:58 +0000,http://sg.finance.yahoo.com/news/white-house-wealth-trump-employees-071058418.html,White House wealth: Trump employees disclose their finances
PFE,PFE:US,BBG000BR2B91,White House wealth: Trump employees disclose their finances,2017-04-01 02:54:59 +0000,http://finance.yahoo.com/news/white-house-wealth-trump-employees-025459886.html,White House wealth: Trump employees disclose their finances
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: Apple Buys Workflow, J&J Wins European Label Expansion",2017-03-31 22:59:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H77z_D4jMtA/dow-30-stock-roundup-apple-buys-workflow-jj-wins-european-label-expansion-cm768589,The Dow experienced a mixed week with most of its gains coming from encouraging economic releases The index moved lower on Monday after the Trump administration failed to pass a new healthcare legislation A surge in consumer confidence helped the index end in the green on Tuesday Broader
PFE,PFE:US,BBG000BR2B91,How Does Pfizer’s Valuation Compare to Peers?,2017-03-31 21:55:08 +0000,http://marketrealist.com/2017/03/how-does-pfizers-valuation-compare-to-peers/?utm_source=yahoo&utm_medium=feed,How Does Pfizer’s Valuation Compare to Peers?
PFE,PFE:US,BBG000BR2B91,3 Attractive Healthy Dividend-Paying Market Gems,2017-03-31 19:32:00 +0000,http://www.forbes.com/sites/genemarcial/2017/03/31/3-attractive-healthy-dividend-paying-market-gems/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,3 Attractive Healthy Dividend-Paying Market Gems
PFE,PFE:US,BBG000BR2B91,Understanding Sanofi’s Valuation Compared to Peers,2017-03-31 19:29:18 +0000,http://marketrealist.com/2017/03/understanding-sanofis-valuation-compared-to-peers/?utm_source=yahoo&utm_medium=feed,Understanding Sanofi’s Valuation Compared to Peers
PFE,PFE:US,BBG000BR2B91,"IBRANCE® (palbociclib) Receives FDA Regular Approval and Expanded Indication for First-Line HR+, HER2- Metastatic Breast Cancer",2017-03-31 18:04:00 +0000,http://finance.yahoo.com/news/ibrance-palbociclib-receives-fda-regular-180400317.html,"[Business Wire] - Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved a supplemental New Drug Application for its first-in-class cyclin dependent kinase 4/6 inhibitor, IBRANCE® , based on the results from the confirmatory Phase 3 trial PALOMA-2."
PFE,PFE:US,BBG000BR2B91,"Merck, Incyte Expand Cancer Collaboration",2017-03-31 16:48:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/31/merck-incyte-expand-cancer-collaboration/?mod=yahoobarrons&ru=yahoo,"Merck, Incyte Expand Cancer Collaboration"
PFE,PFE:US,BBG000BR2B91,Entresto Could See Strong Uptake in European Markets in 2017,2017-03-31 14:35:57 +0000,http://marketrealist.com/2017/03/entresto-expected-witness-strong-uptake-european-markets-2017/?utm_source=yahoo&utm_medium=feed,Entresto Could See Strong Uptake in European Markets in 2017
PFE,PFE:US,BBG000BR2B91,Could Pfizer Buy Esperion Therapeutics?,2017-03-31 14:07:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YY5EhwG5ESk/could-pfizer-buy-esperion-therapeutics-cm768179,Pfizer Inc NYSE PFE is back in growth mode and it has been acquiring smaller companies as part of its effort to boost revenue and profitability Given that it shuttered its research into the PCSK9 cholesterol lowering candidate drug bococizumab last November perhaps the
PFE,PFE:US,BBG000BR2B91,Could Pfizer Buy Esperion Therapeutics?,2017-03-31 12:21:00 +0000,https://www.fool.com/investing/2017/03/31/could-pfizer-buy-esperion-therapeutics.aspx,Could Pfizer Buy Esperion Therapeutics?
PFE,PFE:US,BBG000BR2B91,These 5 Dow Stocks Are Near Buy Points: Investing Action Plan,2017-03-30 20:30:58 +0000,http://www.investors.com/research/investing-action-plan/5-dow-average-stocks-that-are-near-buy-points-investing-action-plan/?src=A00220A,These 5 Dow Stocks Are Near Buy Points: Investing Action Plan
PFE,PFE:US,BBG000BR2B91,Reduced Co-pays May Boost Demand for Entresto,2017-03-30 14:36:43 +0000,http://marketrealist.com/2017/03/reduced-copays-may-boost-demand-entresto-2017/?utm_source=yahoo&utm_medium=feed,Reduced Co-pays May Boost Demand for Entresto
PFE,PFE:US,BBG000BR2B91,Viagra May Be Soon Be Sold Without a Prescription in the UK,2017-03-30 13:16:00 +0000,http://www.investopedia.com/news/viagra-may-be-soon-be-sold-without-prescription-uk-pfe-teva/?partner=YahooSA,Viagra May Be Soon Be Sold Without a Prescription in the UK
PFE,PFE:US,BBG000BR2B91,What Could Boost Medicare Demand for Novartis’s Entresto?,2017-03-30 13:06:41 +0000,http://marketrealist.com/2017/03/improved-formulary-position-may-help-boost-medicare-demand-entresto-2017/?utm_source=yahoo&utm_medium=feed,What Could Boost Medicare Demand for Novartis’s Entresto?
PFE,PFE:US,BBG000BR2B91,Why Entresto Could Become Key Growth Driver for Novartis in 2017,2017-03-30 11:36:52 +0000,http://marketrealist.com/2017/03/heart-failure-drug-entresto-may-become-key-growth-driver-novartis-2017/?utm_source=yahoo&utm_medium=feed,Why Entresto Could Become Key Growth Driver for Novartis in 2017
PFE,PFE:US,BBG000BR2B91,3 Drugmakers With Boatloads of Cash to Spend,2017-03-29 20:59:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sMtQX6SH5cg/3-drugmakers-with-boatloads-of-cash-to-spend-cm767451,Which biopharmaceutical companies are sitting on the largest cash stockpiles Identifying two of the most cash rich drugmakers is easy but there s a catch with one of them Johnson amp Johnson NYSE JNJ Amgen NASDAQ AMGN and Gilead Sciences NASDAQ GILD
PFE,PFE:US,BBG000BR2B91,Eli Lilly’s Valuation Compared to Its Peers’,2017-03-29 20:50:35 +0000,http://marketrealist.com/2017/03/eli-lillys-valuation-compared-to-its-peers/?utm_source=yahoo&utm_medium=feed,Eli Lilly’s Valuation Compared to Its Peers’
PFE,PFE:US,BBG000BR2B91,VBI Vaccines Emerges as Strong Biotech Stock,2017-03-29 20:01:00 +0000,https://www.thestreet.com/story/14064786/1/vbi-vaccines-emerges-as-strong-biotech-stock.html?puc=yahoo&cm_ven=YAHOO,VBI Vaccines Emerges as Strong Biotech Stock
PFE,PFE:US,BBG000BR2B91,3 Drugmakers With Boatloads of Cash to Spend,2017-03-29 19:42:00 +0000,https://www.fool.com/investing/2017/03/29/3-drugmakers-with-boatloads-of-cash-to-spend.aspx,3 Drugmakers With Boatloads of Cash to Spend
PFE,PFE:US,BBG000BR2B91,AstraZeneca's (AZN) Lynparza NDA Accepted for Review by FDA,2017-03-29 17:59:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9LJOp-SNS1k/astrazenecas-azn-lynparza-nda-accepted-for-review-by-fda-cm767346,AstraZeneca plc AZN announced that the FDA has accepted the new drug application NDA for Lynparza 300mg twice daily for the maintenance treatment of patients suffering from platinum sensitive relapsed ovarian cancer with the germline BRCA mutation The drug has also been granted a
PFE,PFE:US,BBG000BR2B91,AstraZeneca's (AZN) Lynparza NDA Accepted for Review by FDA,2017-03-29 15:41:00 +0000,http://www.investopedia.com/partner/zacks/astrazenecas-azn-lynparza-nda-accepted-review-fda/?partner=YahooSA,AstraZeneca's (AZN) Lynparza NDA Accepted for Review by FDA
PFE,PFE:US,BBG000BR2B91,What Wall Street Analysts Recommend for Merck,2017-03-29 11:36:09 +0000,http://marketrealist.com/2017/03/what-wall-street-analysts-recommend-for-merck/?utm_source=yahoo&utm_medium=feed,What Wall Street Analysts Recommend for Merck
PFE,PFE:US,BBG000BR2B91,"First Drug For 2 Forms Of MS Gets FDA Nod, RTTR Abuzz, VRTX Gains On Trial Data",2017-03-29 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ODH4o3dW8uQ/first-drug-for-2-forms-of-ms-gets-fda-nod-rttr-abuzz-vrtx-gains-on-trial-data-20170329-00071,"First Drug For 2 Forms Of MS Gets FDA Nod, RTTR Abuzz, VRTX Gains On Trial Data"
PFE,PFE:US,BBG000BR2B91,Cramer's lightning round: Stick with this 'terrific' defense play,2017-03-28 22:51:16 +0000,http://www.cnbc.com/id/104369203?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104369203,Cramer's lightning round: Stick with this 'terrific' defense play
PFE,PFE:US,BBG000BR2B91,Could Real-World Studies Boost These 3 Big Pharma Stocks' Prospects?,2017-03-28 21:00:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_eS98D7qMGo/could-real-world-studies-boost-these-3-big-pharma-stocks-prospects-cm766869,Pharmaceutical companies rely primarily on rigorous randomized clinical trials to demonstrate efficacy and safety for their prescription drugs However data from real world usage of drugs has become a bigger factor in helping to convince physicians and patients to go with one
PFE,PFE:US,BBG000BR2B91,Could Real-World Studies Boost These 3 Big Pharma Stocks' Prospects?,2017-03-28 19:42:00 +0000,https://www.fool.com/investing/2017/03/28/could-real-world-studies-boost-these-3-big-pharma.aspx,Could Real-World Studies Boost These 3 Big Pharma Stocks' Prospects?
PFE,PFE:US,BBG000BR2B91,Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in Europe,2017-03-28 17:58:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wavdasFhX8I/pfizers-arthritis-drug-xeljanz-gets-marketing-nod-in-europe-cm766760,Pfizer Inc s PFE rheumatoid arthritis RA drug Xeljanz has received marketing approval in Europe The European Commission has approved Xeljanz 5 mg taken twice daily to be used in combination with methotrexate MTX for the treatment of moderate to severely active RA in adult patients
PFE,PFE:US,BBG000BR2B91,"Noteworthy ETF Inflows: IWB, BAC, PG, PFE",2017-03-28 16:59:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XAhT-rPVA6U/noteworthy-etf-inflows-iwb-bac-pg-pfe-cm766726,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 ETF Symbol IWB where we have detected an approximate 52 0 million dollar inflow that s a 0 3 increase week over week in outstanding
PFE,PFE:US,BBG000BR2B91,Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in Europe,2017-03-28 15:49:03 +0000,http://finance.yahoo.com/news/pfizers-arthritis-drug-xeljanz-gets-154903968.html,Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in Europe
PFE,PFE:US,BBG000BR2B91,[$$] Could Pfizer Make Cash Bid for Bristol-Myers?,2017-03-28 15:31:00 +0000,http://www.barrons.com/articles/could-pfizer-make-cash-bid-for-bristol-myers-1490715108?mod=yahoobarrons&ru=yahoo,[$$] Could Pfizer Make Cash Bid for Bristol-Myers?
PFE,PFE:US,BBG000BR2B91,This Is Driving Merck’s Vaccines Business,2017-03-28 13:06:21 +0000,http://marketrealist.com/2017/03/this-is-driving-mercks-vaccines-business/?utm_source=yahoo&utm_medium=feed,This Is Driving Merck’s Vaccines Business
PFE,PFE:US,BBG000BR2B91,How Decline in Remicade Is Affecting Merck’s Immunology Revenues,2017-03-28 11:36:38 +0000,http://marketrealist.com/2017/03/how-decline-in-remicade-is-affecting-mercks-immunology-revenues/?utm_source=yahoo&utm_medium=feed,How Decline in Remicade Is Affecting Merck’s Immunology Revenues
PFE,PFE:US,BBG000BR2B91,"The 'Fearless Girl' Statue Isn't a Symbol, It Is an Advertisement",2017-03-28 02:58:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u3glGglYrBY/the-fearless-girl-statue-isnt-a-symbol-it-is-an-advertisement-cm766282,You probably saw the debut of the Fearless Girl statue in early March in New York City The statue is of a young girl defiantly staring down the Charging Bull and has been heralded by many as a symbol for women everywhere Many are now calling for the statue to be made a permanent fixture
PFE,PFE:US,BBG000BR2B91,3 Top Cancer Drug Stocks to Buy in 2017,2017-03-27 22:00:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qj-329w4NDM/3-top-cancer-drug-stocks-to-buy-in-2017-cm766215,Some of the best performing biopharma stocks in recent years belong to companies developing cancer drugs and it looks as if this trend is going to continue throughout 2017 and into the foreseeable future Estimated global spending for oncology medicines is expected to grow from
PFE,PFE:US,BBG000BR2B91,3 Top Cancer Drug Stocks to Buy in 2017,2017-03-27 20:29:00 +0000,https://www.fool.com/investing/2017/03/27/3-top-cancer-drug-stocks-to-buy-in-2017.aspx,3 Top Cancer Drug Stocks to Buy in 2017
PFE,PFE:US,BBG000BR2B91,Can Pfizer Boost Its Value By $5 Billion By Taking Over Bristol?,2017-03-27 20:13:27 +0000,http://www.investors.com/news/technology/this-drugmaker-could-boost-its-value-by-5-billion-in-a-bristol-takeover/?src=A00220A,Can Pfizer Boost Its Value By $5 Billion By Taking Over Bristol?
PFE,PFE:US,BBG000BR2B91,A.M. Best Affirms Credit Ratings of Blue Whale Re Ltd.,2017-03-27 19:23:00 +0000,http://uk.finance.yahoo.com/news/m-best-affirms-credit-ratings-192300596.html,A.M. Best Affirms Credit Ratings of Blue Whale Re Ltd.
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb's Motivation Behind CytomX Deal,2017-03-27 18:29:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GwWO2psr20Q/bristol-myers-squibbs-motivation-behind-cytomx-deal-cm766125,Bristol Myers Squibb 160 BMY recently extended its collaboration with U S biotech firm CytomX The two companies entered the original contract in 2014 when Bristol Myers Squibb endorsed CytomX s probody platform and made a bet on four oncology candidates Under the new
PFE,PFE:US,BBG000BR2B91,Interesting January 2018 Stock Options for PFE,2017-03-27 18:01:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O1N_7l8shMQ/interesting-january-2018-stock-options-for-pfe-cm766051,Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the January 2018 expiration for PFE The put
PFE,PFE:US,BBG000BR2B91,Pfizer Stock Rises on Bristol-Myers Takeover Talk,2017-03-27 16:55:00 +0000,http://www.investopedia.com/news/pfizer-bristolmyers-takeover-talk-pfe-bmy/?partner=YahooSA,Pfizer Stock Rises on Bristol-Myers Takeover Talk
PFE,PFE:US,BBG000BR2B91,3 Big Pharma Stocks You Don't Have to Babysit,2017-03-27 16:03:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lx4Djo5-l8Y/3-big-pharma-stocks-you-dont-have-to-babysit-cm765944,Big pharma stocks don t wake up in the middle of the night and require feeding or changing like a baby does But some of them can require plenty of attention No babysitting is required however for Johnson amp Johnson NYSE JNJ Pfizer NYSE PFE and Novartis
PFE,PFE:US,BBG000BR2B91,Pfizer Rheumatoid Arthritis Drug Approved in EU,2017-03-27 15:45:00 +0000,http://www.investopedia.com/news/pfizer-rheumatoid-arthritis-drug-approved-eu-pfe/?partner=YahooSA,Pfizer Rheumatoid Arthritis Drug Approved in EU
PFE,PFE:US,BBG000BR2B91,Merck's Ketruda Gets Positive CHMP Opinion for Lymphoma,2017-03-27 15:03:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uQJ_K9N2m6w/mercks-ketruda-gets-positive-chmp-opinion-for-lymphoma-cm765814,Merck amp Co Inc MRK recently announced that its anti PD 1 therapy Keytruda has received positive opinion from the European Medicines Agency s EMA Committee for Medicinal Products for Human Use CHMP for the treatment of patients with relapsed or refractory classical hodgkin
PFE,PFE:US,BBG000BR2B91,Bristol-Myers: Maybe a Pfizer Acquisition Could Makes Sense After All?,2017-03-27 14:22:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/27/bristol-myers-maybe-a-pfizer-acquisition-could-makes-sense-after-all/?mod=yahoobarrons&ru=yahoo,Bristol-Myers: Maybe a Pfizer Acquisition Could Makes Sense After All?
PFE,PFE:US,BBG000BR2B91,3 Big Pharma Stocks You Don't Have to Babysit,2017-03-27 14:02:00 +0000,https://www.fool.com/investing/2017/03/27/3-big-pharma-stocks-you-dont-have-to-babysit.aspx,3 Big Pharma Stocks You Don't Have to Babysit
PFE,PFE:US,BBG000BR2B91,XELJANZ® (tofacitinib citrate) Receives Marketing Authorisation in the European Union for the Treatment of Moderate to Severe Active Rheumatoid Arthritis (RA),2017-03-27 09:00:00 +0000,http://uk.finance.yahoo.com/news/xeljanz-tofacitinib-citrate-receives-marketing-090000730.html,XELJANZ® (tofacitinib citrate) Receives Marketing Authorisation in the European Union for the Treatment of Moderate to Severe Active Rheumatoid Arthritis (RA)
PFE,PFE:US,BBG000BR2B91,Chinese drug approval boosts AstraZeneca's lung cancer hopes,2017-03-27 07:20:52 +0000,http://uk.finance.yahoo.com/news/chinese-drug-approval-boosts-astrazenecas-072052931.html,"[Reuters - UK Focus] - AstraZeneca (NYSE: AZN - news) has won approval for its lung cancer pill Tagrisso in China, a key market for the potential blockbuster medicine. Tagrisso is designed to help cancer patients with certain genetic mutations that are very common in China and the regulatory green light boosts the British drugmaker's prospects in a key therapy area."
PFE,PFE:US,BBG000BR2B91,Pfizer: XELJANZ In Combination With Methotrexate Gets EC Approval For RA,2017-03-27 05:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MHAD1Dw7xqk/pfizer-xeljanz-in-combination-with-methotrexate-gets-ec-approval-for-ra-20170327-00144,Pfizer: XELJANZ In Combination With Methotrexate Gets EC Approval For RA
PFE,PFE:US,BBG000BR2B91,"XENE Loses Face As Acne Trial Flops, NBRV Awaits LEAP Data, Opdivo Scores A Nod",2017-03-26 23:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zUDYgWU4b8M/xene-loses-face-as-acne-trial-flops-nbrv-awaits-leap-data-opdivo-scores-a-nod-20170326-00096,"XENE Loses Face As Acne Trial Flops, NBRV Awaits LEAP Data, Opdivo Scores A Nod"
PFE,PFE:US,BBG000BR2B91,3 Tremendously Promising Diabetes Drugs Potentially on the Way,2017-03-26 14:59:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m6WBcqSId5U/3-tremendously-promising-diabetes-drugs-potentially-on-the-way-cm765661,Here s the scary thing about diabetes Over 30 million Americans have it with an additional 1 4 million new diagnoses each year The disease is the seventh highest cause of death in the U S Those are concerning statistics but there are also some numbers that provide hope Over 170
PFE,PFE:US,BBG000BR2B91,3 Tremendously Promising Diabetes Drugs Potentially on the Way,2017-03-26 13:03:00 +0000,https://www.fool.com/investing/2017/03/26/3-tremendously-promising-diabetes-drugs-potentiall.aspx,3 Tremendously Promising Diabetes Drugs Potentially on the Way
PFE,PFE:US,BBG000BR2B91,Can You Guess Which Drugmaker Has the Most Debt? (Hint: It's Not Valeant),2017-03-25 19:58:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qIyCn2dEt6E/can-you-guess-which-drugmaker-has-the-most-debt-hint-its-not-valeant-cm765623,Which drugmaker do you think has the most debt Some might think the correct answer is Valeant Pharmaceuticals NYSE VRX After all the company is shedding assets to try to reduce its massive debt load However Valeant doesn t have the highest debt among pharmaceutical
PFE,PFE:US,BBG000BR2B91,Can You Guess Which Drugmaker Has the Most Debt? (Hint: It's Not Valeant),2017-03-25 18:01:00 +0000,https://www.fool.com/investing/2017/03/25/can-you-guess-which-drugmaker-has-the-most-debt-hi.aspx,Can You Guess Which Drugmaker Has the Most Debt? (Hint: It's Not Valeant)
PFE,PFE:US,BBG000BR2B91,"Pioneer Investments Exits Wells Fargo, Coca-Cola, Buys Walt Disney",2017-03-25 15:58:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DYGIyApw-P8/pioneer-investments-exits-wells-fargo-coca-cola-buys-walt-disney-cm765608,Pioneer Investment Management operates in wide areas of investment vehicles mutual funds single manager hedge funds funds of hedge funds structured products segregated and managed accounts and institutional funds During the fourth quarter of 2016 the firm traded shares in the
PFE,PFE:US,BBG000BR2B91,1 Top Stock in Big Pharma,2017-03-25 11:58:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jBNf43mshsY/1-top-stock-in-big-pharma-cm765553,Despite the ongoing drug pricing debate that may result in a tectonic shift to a value based purchasing scheme vs unit based pricing the pharmaceutical industry as a whole remains on a solid long term growth trajectory Valuations across the space are poised to continue their
PFE,PFE:US,BBG000BR2B91,1 Top Stock in Big Pharma,2017-03-25 10:43:00 +0000,https://www.fool.com/investing/2017/03/25/1-top-stock-in-big-pharma.aspx,1 Top Stock in Big Pharma
PFE,PFE:US,BBG000BR2B91,Here's how stocks could react now that the GOP health-care bill has been killed,2017-03-24 22:57:41 +0000,http://www.cnbc.com/id/104363719?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104363719,Here's how stocks could react now that the GOP health-care bill has been killed
PFE,PFE:US,BBG000BR2B91,Large-Cap Stocks Mostly Lower With Health Care Vote Uncertainty,2017-03-24 21:47:15 +0000,http://finance.yahoo.com/news/large-cap-stocks-mostly-lower-214715364.html,Large-Cap Stocks Mostly Lower With Health Care Vote Uncertainty
PFE,PFE:US,BBG000BR2B91,"Trump, Ryan Spike Health Care Vote in Setback for President, GOP",2017-03-24 20:51:00 +0000,https://www.thestreet.com/story/14059152/1/gop-spikes-healthcare-vote.html?puc=yahoo&cm_ven=YAHOO,"Trump, Ryan Spike Health Care Vote in Setback for President, GOP"
PFE,PFE:US,BBG000BR2B91,Novartis’s Valuation Compared to Its Peers’,2017-03-24 19:07:07 +0000,http://marketrealist.com/2017/03/novartiss-valuation-compared-to-its-peers/?utm_source=yahoo&utm_medium=feed,Novartis’s Valuation Compared to Its Peers’
PFE,PFE:US,BBG000BR2B91,Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval,2017-03-24 17:00:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OGIHvOR9eis/pfizers-immunotherapy-for-skin-cancer-gets-fda-approval-cm765286,Pfizer Inc PFE and German partner Merck KGaA s investigational cancer treatment avelumab was approved by the FDA for the treatment of metastatic Merkel cell carcinoma MCC a rare and aggressive form of skin cancer Pfizer s shares are up 5 5 so far this year comparing unfavorably
PFE,PFE:US,BBG000BR2B91,Amgen's (AMGN) Humira Biosimilar Receives Approval in EU,2017-03-24 17:00:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RE6mr8HZp-8/amgens-amgn-humira-biosimilar-receives-approval-in-eu-cm765282,Amgen Inc AMGN announced that its biosimilar version of AbbVie Inc s ABBV rheumatoid arthritis RA drug Humira has been approved by the European Commission EC The approval grants marketing rights in 28 member countries of the European Union EU under a unified label of Amgevita
PFE,PFE:US,BBG000BR2B91,US Market Indexes Lower With Losses Led by Energy Stocks,2017-03-24 16:58:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E62W-3ZBSEg/us-market-indexes-lower-with-losses-led-by-energy-stocks-cm765342,U S market indexes were lower Thursday For the day the Dow Jones Industrial Average closed at 20656 58 for a loss of 4 72 points or 0 02 The S amp P 500 closed at 2345 96 for a loss of 2 49 points or 0 11 The Nasdaq Composite closed lower at 5817 69 for a loss of 3 95 points or 0
PFE,PFE:US,BBG000BR2B91,Healthcare: Will They or Won't They?,2017-03-24 16:58:00 +0000,http://blogs.barrons.com/focusonfunds/2017/03/24/healthcare-will-they-or-wont-they/?mod=yahoobarrons&ru=yahoo,Healthcare: Will They or Won't They?
PFE,PFE:US,BBG000BR2B91,"Dow Movers: PFE, INTC",2017-03-24 16:01:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IgL5nrUax9s/dow-movers-pfe-intc-cm765257,In early trading on Friday shares of Intel INTC topped the list of the day s best performing Dow Jones Industrial Average components trading up 1 0 Year to date Intel has lost about 1 8 of its value And the worst performing Dow component thus far on the day is Pfizer
PFE,PFE:US,BBG000BR2B91,Mylan Hit After Abbott Dumps Shares,2017-03-24 15:41:00 +0000,https://www.thestreet.com/story/14058776/1/mylan-hit-after-abbott-dumps-shares.html?puc=yahoo&cm_ven=YAHOO,Mylan Hit After Abbott Dumps Shares
PFE,PFE:US,BBG000BR2B91,Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval,2017-03-24 15:19:03 +0000,http://finance.yahoo.com/news/pfizers-immunotherapy-skin-cancer-gets-151903404.html,Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval
PFE,PFE:US,BBG000BR2B91,Pfizer Receives Positive CHMP Opinion for TRUMENBA® for Prevention of Meningococcal Group B Disease,2017-03-24 14:18:00 +0000,http://uk.finance.yahoo.com/news/pfizer-receives-positive-chmp-opinion-141800880.html,Pfizer Receives Positive CHMP Opinion for TRUMENBA® for Prevention of Meningococcal Group B Disease
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Is Sanofi Buying Flexion? Pfizer, Merck KGaA Drug Approved",2017-03-24 14:01:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_-mL-5KBKeU/pharma-stock-roundup-is-sanofi-buying-flexion-pfizer-merck-kgaa-drug-approved-cm765118,Shortly after the release of the Budget Blueprint for 2018 which could require companies to shell out higher fees for regulatory reviews as well as a reduction of 5 8 billion in the National Institutes of Health s NIH spending the President continued to focus on drug prices at a meeting
PFE,PFE:US,BBG000BR2B91,20 Questions With Tom Vilord of Vilord Wealth Advisors,2017-03-24 11:58:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wJ8HoTl2s-g/20-questions-with-tom-vilord-of-vilord-wealth-advisors-cm765062,1 What is the best investment advice you have ever been given 1 What is the best investment advice you have ever been given 1 What is the best investment advice you have ever been given Do not just buy a great company because you like the products or understand the business Only buy
PFE,PFE:US,BBG000BR2B91,Merck KGaA Shares Spike After FDA Approves Skin Cancer Treatment,2017-03-24 10:46:00 +0000,https://www.thestreet.com/story/14058246/1/merck-kgaa-shares-spike-after-fda-approves-skin-cancer-treatment.html?puc=yahoo&cm_ven=YAHOO,Merck KGaA Shares Spike After FDA Approves Skin Cancer Treatment
PFE,PFE:US,BBG000BR2B91,Pfizer Gets Positive CHMP Opinion For TRUMENBA,2017-03-24 10:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rvedXIv6YPk/pfizer-gets-positive-chmp-opinion-for-trumenba-20170324-00473,Pfizer Gets Positive CHMP Opinion For TRUMENBA
PFE,PFE:US,BBG000BR2B91,"Pfizer, Merck KGaA Get FDA Nod for Skin Cancer Drug (PFE)",2017-03-24 09:50:00 +0000,http://www.investopedia.com/news/pfizer-merck-kgaa-get-fda-nod-skin-cancer-drug-pfe-rhhby/?partner=YahooSA,"Pfizer, Merck KGaA Get FDA Nod for Skin Cancer Drug (PFE)"
PFE,PFE:US,BBG000BR2B91,"Merck KgaA, Pfizer Cancer Drug to Cost $13,000 a Month",2017-03-24 07:40:49 +0000,http://finance.yahoo.com/video/merck-kgaa-pfizer-cancer-drug-074049422.html,"Merck KgaA, Pfizer Cancer Drug to Cost $13,000 a Month"
PFE,PFE:US,BBG000BR2B91,Biotech Stocks Facing FDA Decision In April,2017-03-24 06:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/70ZD2H6sCX8/biotech-stocks-facing-fda-decision-in-april-20170324-00160,Biotech Stocks Facing FDA Decision In April
PFE,PFE:US,BBG000BR2B91,"FDA Approves First-ever Merkel Cell Carcinoma Drug, HTGM Riding High, FLXN Soars",2017-03-24 01:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/owtzTJanL-U/fda-approves-firstever-merkel-cell-carcinoma-drug-htgm-riding-high-flxn-soars-20170324-00018,"FDA Approves First-ever Merkel Cell Carcinoma Drug, HTGM Riding High, FLXN Soars"
PFE,PFE:US,BBG000BR2B91,US Market Indexes Lower With Losses Led by Energy Stocks,2017-03-23 21:56:34 +0000,http://finance.yahoo.com/news/us-market-indexes-lower-losses-215634291.html,US Market Indexes Lower With Losses Led by Energy Stocks
PFE,PFE:US,BBG000BR2B91,"FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma",2017-03-23 21:30:00 +0000,http://finance.yahoo.com/news/fda-grants-approval-bavencio-avelumab-213000232.html,"[PR Newswire] - ROCKLAND, Mass. and NEW YORK, March 23, 2017 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced ..."
PFE,PFE:US,BBG000BR2B91,"Pfizer, Merck KGaA's $13,000-a-Month Cancer Drug Wins Approval",2017-03-23 20:28:21 +0000,https://www.bloomberg.com/news/articles/2017-03-23/pfizer-and-merck-kgaa-s-new-cancer-drug-to-cost-13-000-a-month?cmpid=yhoo.headline,"Pfizer, Merck KGaA's $13,000-a-Month Cancer Drug Wins Approval"
PFE,PFE:US,BBG000BR2B91,"FDA approves Pfizer, German Merck immunotherapy for skin cancer",2017-03-23 19:10:41 +0000,http://finance.yahoo.com/news/fda-approves-pfizer-german-merck-191041816.html,"[Reuters] - U.S. health regulators on Thursday approved a drug developed by Merck KGaA and Pfizer Inc that helps the immune system to fight a rare form of skin cancer once it has spread to other parts of the body. The Food and Drug Administration said it approved Bavencio, known chemically as avelumab, to treat metastatic Merkel cell carcinoma (MCC) in patients 12 years and older. Bavencio belongs to a new class of oncology drugs called PD-L1 inhibitors that block a mechanism tumors use to evade detection from the immune system."
PFE,PFE:US,BBG000BR2B91,Why Teva Pharmaceutical Industries Ltd (ADR) Stock Has Staying Power,2017-03-23 19:02:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AMWBNz3Lx28/why-teva-pharmaceutical-industries-ltd-adr-stock-has-staying-power-cm764877,InvestorPlace Stock Market News Stock Advice amp Trading Tips It s been a rough few years for Teva Pharmaceutical Industries Ltd ADR NYSE TEVA stock TEVA stock has declined by half from mid 2015 levels nearing a three plus year low in the process The loss of patents for
PFE,PFE:US,BBG000BR2B91,Catalyst Pharma (CPRX) Focused on U.S. Approval for Firdapse,2017-03-23 16:02:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gGAzA3iL3kk/catalyst-pharma-cprx-focused-on-us-approval-for-firdapse-cm764693,We issued an updated research report on Catalyst Pharmaceuticals Inc CPRX on Mar 22 Catalyst s share price has increased significantly by 60 year to date compared with the Zacks classified Medical Drugs industry s gain of 2 1 Catalyst has in licensed rights to Firdapse
PFE,PFE:US,BBG000BR2B91,Pfizer’s Lyrica Ineffective for Sciatica Pain (PFE),2017-03-23 12:33:00 +0000,http://www.investopedia.com/news/pfizers-lyrica-ineffective-sciatica-pain-pfe/?partner=YahooSA,Pfizer’s Lyrica Ineffective for Sciatica Pain (PFE)
PFE,PFE:US,BBG000BR2B91,EXCLUSIVE: Advent pulls bid for Pfizer's Brazil venture - sources,2017-03-22 20:01:55 +0000,http://in.finance.yahoo.com/news/exclusive-advent-pulls-bid-pfizers-195300863.html,EXCLUSIVE: Advent pulls bid for Pfizer's Brazil venture - sources
PFE,PFE:US,BBG000BR2B91,Can Abbott Outperform Despite Alere?,2017-03-22 18:47:00 +0000,https://www.thestreet.com/story/14054875/1/abbott-poised-to-perform-well-as-long-as-it-closes-alere-litigation.html?puc=yahoo&cm_ven=YAHOO,Can Abbott Outperform Despite Alere?
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public to View and Listen to Webcast of May 2 Conference Call with Analysts,2017-03-22 14:30:00 +0000,http://finance.yahoo.com/news/pfizer-invites-public-view-listen-143000139.html,"[Business Wire] - Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, May 2, 2017. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s First Quarter 2017 Performance Report, to be issued that morning."
PFE,PFE:US,BBG000BR2B91,"Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for March 23, 2017",2017-03-22 13:16:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Stly6l6hKaw/novo-nordisk-as-nvo-ex-dividend-date-scheduled-for-march-23-2017-cm763967,Novo Nordisk A S NVO will begin trading ex dividend on March 23 2017 A cash dividend payment of 0 474 per share is scheduled to be paid on April 04 2017 Shareholders who purchased NVO prior to the ex dividend date are eligible for the cash dividend payment This represents an 43
PFE,PFE:US,BBG000BR2B91,Japan May Prove to Be Strong Growth Driver for AstraZeneca in 2017,2017-03-21 22:05:43 +0000,http://marketrealist.com/2017/03/japan-may-prove-strong-growth-driver-astrazeneca-2017/?utm_source=yahoo&utm_medium=feed,Japan May Prove to Be Strong Growth Driver for AstraZeneca in 2017
PFE,PFE:US,BBG000BR2B91,Investing Rookie? Start With These 3 Stocks,2017-03-21 18:07:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xilDgla1rEU/investing-rookie-start-with-these-3-stocks-cm763662,Taking control of your stock portfolio can be a daunting task There are literally thousands of publicly traded companies after all So in an effort to help simplify the process for you we asked three of our contributors for stocks they think would be solid first picks for a
PFE,PFE:US,BBG000BR2B91,Is Valeant Pharmaceuticals Intl Inc (VRX) Stock Worth the Risk?,2017-03-21 18:07:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sv693f2ghtw/is-valeant-pharmaceuticals-intl-inc-vrx-stock-worth-the-risk-cm763705,InvestorPlace Stock Market News Stock Advice amp Trading Tips The dust is still settling from this week s announcement that Pershing Square Capital Management LP billionaire and activist investor Bill Ackman s investment firm has eliminated its remaining holding in
PFE,PFE:US,BBG000BR2B91,Nektar's Pain Drug Positive in Phase III Study; Shares Gain,2017-03-21 17:09:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PxmxpyDhFrY/nektars-pain-drug-positive-in-phase-iii-study-shares-gain-cm763605,Nektar Therapeutics NKTR shares surged 42 6 after the company announced positive results from SUMMIT 07 phase III efficacy study evaluating its investigational opioid analgesic candidate NKTR 181 in patients with moderate to severe chronic low back pain The opioid based drug was studied
PFE,PFE:US,BBG000BR2B91,"4 Health Care Charts Signaling Buys: Pfizer, Amgen Included",2017-03-21 16:49:00 +0000,https://www.thestreet.com/story/14052305/1/4-health-care-charts-signaling-buys-pfizer-amgen-included.html?puc=yahoo&cm_ven=YAHOO,"4 Health Care Charts Signaling Buys: Pfizer, Amgen Included"
PFE,PFE:US,BBG000BR2B91,Investing Rookie? Start With These 3 Stocks,2017-03-21 16:43:00 +0000,https://www.fool.com/investing/2017/03/21/investing-rookie-start-with-these-3-stocks.aspx,Investing Rookie? Start With These 3 Stocks
PFE,PFE:US,BBG000BR2B91,7 Pharma Plays With Emerging Market Potential,2017-03-21 16:13:00 +0000,http://blogs.barrons.com/emergingmarketsdaily/2017/03/21/7-pharma-plays-with-emerging-market-potential/?mod=yahoobarrons&ru=yahoo,7 Pharma Plays With Emerging Market Potential
PFE,PFE:US,BBG000BR2B91,Is Pfizer (PFE) a Great Stock for Value Investors?,2017-03-21 16:11:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rO_GNOBejoo/is-pfizer-pfe-a-great-stock-for-value-investors-cm763488,Value investing is easily one of the most popular ways to find great stocks in any market environment After all who wouldn t want to find stocks that are either flying under the radar and are compelling buys or offer up tantalizing discounts when compared to fair value One way to find
PFE,PFE:US,BBG000BR2B91,Nektar's Pain Drug Positive in Phase III Study; Shares Gain,2017-03-21 14:53:02 +0000,http://finance.yahoo.com/news/nektars-pain-drug-positive-phase-145302660.html,Nektar's Pain Drug Positive in Phase III Study; Shares Gain
PFE,PFE:US,BBG000BR2B91,Lilly's Breast Cancer Combo Drug Phase III Results Positive,2017-03-21 14:09:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QSMsf3fTJMs/lillys-breast-cancer-combo-drug-phase-iii-results-positive-cm763321,Eli Lilly and Company LLY recently announced that a phase III combination study evaluating its pipeline candidate abemaciclib in advanced breast cancer met the primary endpoint of progression free survival PFS The double blind MONARCH 2 phase III study evaluated abemaciclib a CDK 4
PFE,PFE:US,BBG000BR2B91,IBM's Watson Is Tackling Medicine's Most Complex Problems,2017-03-21 14:08:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BdCZSI2OcUo/ibms-watson-is-tackling-medicines-most-complex-problems-cm763367,International Business Machines Corporation NYSE IBM 160 has been hard at work in the area of healthcare and CEO Ginni Rometty recently suggested that because of 160 the continuing intersection of technology and medicine 160 medical students would be at a disadvantage if
PFE,PFE:US,BBG000BR2B91,Is Pfizer (PFE) a Great Stock for Value Investors?,2017-03-21 14:00:02 +0000,http://finance.yahoo.com/news/pfizer-pfe-great-stock-value-140002108.html,Is Pfizer (PFE) a Great Stock for Value Investors?
PFE,PFE:US,BBG000BR2B91,[$$] SutroVax Set for Vaccine Trials After $64 Million Financing,2017-03-21 11:30:04 +0000,https://www.wsj.com/articles/sutrovax-set-for-vaccine-trials-after-64-million-financing-1490095800?mod=yahoo_hs,[$$] SutroVax Set for Vaccine Trials After $64 Million Financing
PFE,PFE:US,BBG000BR2B91,Our Ultimate Stock-Pickers' Top 10 Dividend-Yielding Stocks,2017-03-21 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=798740&SR=Yahoo,Our Ultimate Stock-Pickers' Top 10 Dividend-Yielding Stocks
PFE,PFE:US,BBG000BR2B91,[$$] White House Set to Announce Head of Senate Legislative Affairs Team,2017-03-21 01:56:50 +0000,https://www.wsj.com/articles/white-house-to-announce-amy-swonger-as-head-of-senate-legislative-affairs-1490061405?mod=yahoo_hs,[$$] White House Set to Announce Head of Senate Legislative Affairs Team
PFE,PFE:US,BBG000BR2B91,"Anatomy Of A Decision, Part 1: The C-Suite",2017-03-20 20:12:08 +0000,http://finance.yahoo.com/news/anatomy-decision-part-1-c-201208223.html,"Anatomy Of A Decision, Part 1: The C-Suite"
PFE,PFE:US,BBG000BR2B91,Eli Lilly Breast Cancer Combo Does Well In Trial,2017-03-20 17:16:00 +0000,http://www.investopedia.com/news/eli-lilly-breast-cancer-combo-succeeds-llypfe/?partner=YahooSA,Eli Lilly Breast Cancer Combo Does Well In Trial
PFE,PFE:US,BBG000BR2B91,"Noteworthy ETF Inflows: IUSV, CVX, PG, PFE",2017-03-20 16:09:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DBG3NnsUaBQ/noteworthy-etf-inflows-iusv-cvx-pg-pfe-cm762880,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Core S amp P U S Value ETF Symbol IUSV where we have detected an approximate 82 0 million dollar inflow that s a 5 2 increase week over week
PFE,PFE:US,BBG000BR2B91,"Trump, Biogen and Amgen Hammer Healthcare ETFs",2017-03-20 16:08:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a3zCjvZyZTc/trump-biogen-and-amgen-hammer-healthcare-etfs-cm762887,After making a strong comeback in February the U S healthcare sector again witnessed some pain in the last couple of sessions The initial sell off came after Trump s budget blueprint which signaled higher regulatory costs for the sector and a cut in federal funding for medical research
PFE,PFE:US,BBG000BR2B91,Lilly's breast cancer drug combination succeeds key study,2017-03-20 14:07:00 +0000,http://finance.yahoo.com/news/lillys-breast-cancer-drug-combination-112117597.html,"[Reuters] - Eli Lilly and Co's combination of its experimental breast cancer drug and another widely used treatment slowed disease progression in patients who relapsed or did not benefit enough when treated with the anti-estrogen therapy. In August, an independent data monitoring committee recommended the late-stage study continue without modification, even though interim evaluation suggested the combination treatment was not delaying cancer progression. Lilly's drug, abemaciclib, is part of the same new class of breast cancer treatments as Pfizer Inc's Ibrance, and Novartis AG's newly approved Kisqali."
PFE,PFE:US,BBG000BR2B91,"Pfizer, Merck KGaA Delay Lung Cancer Drug Trial Outcome",2017-03-20 13:41:00 +0000,http://www.investopedia.com/news/pfizer-merck-kgaa-delay-lung-cancer-drug-trial-outcome-pfe-mrk/?partner=YahooSA,"Pfizer, Merck KGaA Delay Lung Cancer Drug Trial Outcome"
PFE,PFE:US,BBG000BR2B91,3 Best Stocks for Your Roth IRA,2017-03-19 13:06:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xwabos6_nvo/3-best-stocks-for-your-roth-ira-cm762620,Roth IRAs offer a lot of advantages that make them great investment tools for retirement savings Unlike traditional IRAs they don t require minimum distributions in your golden years and they can provide advantages for legacy planning too Perhaps their biggest advantage however
PFE,PFE:US,BBG000BR2B91,3 Best Stocks for Your Roth IRA,2017-03-19 11:22:00 +0000,https://www.fool.com/investing/2017/03/19/3-best-stocks-for-your-roth-ira.aspx,3 Best Stocks for Your Roth IRA
PFE,PFE:US,BBG000BR2B91,"Cronos Group Execs Talk About Cannabis Co., Recent 'Bought Deal' And Expansion Plans",2017-03-18 22:28:36 +0000,http://finance.yahoo.com/news/cronos-group-execs-talk-cannabis-222836788.html,"Cronos Group Execs Talk About Cannabis Co., Recent 'Bought Deal' And Expansion Plans"
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: Boeing Inks $3.3B U.S. Army Deal, Intel Buys Mobileye",2017-03-17 22:06:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p0cak41ZvBE/dow-30-stock-roundup-boeing-inks-33b-us-army-deal-intel-buys-mobileye-cm762460,The Dow endured a difficult week dominated by the Fed s two day policy meeting A key chipmaker component s decision to buy an autonomous vehicle technology firm led to a decline for the index on Monday even as other benchmarks moved upward A decline in oil prices an effect of
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Mar 17, 2017 :  FTR, DNR, LYG, URBN, RJF, PG, PFE, ARE, TTWO, FSLR, HBAN, SGYP",2017-03-17 21:06:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w6ni4IeK2EU/after-hours-most-active-for-mar-17-2017-ftr-dnr-lyg-urbn-rjf-pg-pfe-are-ttwo-fslr-hban-sgyp-cm762442,The NASDAQ 100 After Hours Indicator is up 85 to 5 409 61 The total After hours volume is currently 388 829 621 shares traded The following are the most active stocks for the after hours session Frontier Communications Corporation FTR is 0 01 at 2 46 with 142 471
PFE,PFE:US,BBG000BR2B91,The Biggest Loser: Amgen Drops 6.4%,2017-03-17 20:59:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/17/the-biggest-loser-amgen-drops-6-4/?mod=yahoobarrons&ru=yahoo,The Biggest Loser: Amgen Drops 6.4%
PFE,PFE:US,BBG000BR2B91,Fired U.S. Attorney Preet Bharara Was Investigating HHS Chief Tom Price - Report,2017-03-17 20:03:00 +0000,https://www.thestreet.com/story/14049570/1/fired-u-s-attorney-preet-bharara-was-investigating-hhs-chief-tom-price-report.html?puc=yahoo&cm_ven=YAHOO,Fired U.S. Attorney Preet Bharara Was Investigating HHS Chief Tom Price - Report
PFE,PFE:US,BBG000BR2B91,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-03-17 18:52:16 +0000,http://biz.yahoo.com/e/170317/pfe8-k.html,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
PFE,PFE:US,BBG000BR2B91,3 Best Pharmaceutical Stocks for Long-Term Investors,2017-03-17 17:06:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lDJ97jD08NA/3-best-pharmaceutical-stocks-for-long-term-investors-cm762299,People needed prescription drugs 20 years ago They need them now They ll need them 20 years from now too Those three statements sum up the argument for long term investors to buy pharmaceutical stocks Three of The Motley Fool s healthcare contributors weighed in on
PFE,PFE:US,BBG000BR2B91,"Amgen Blew It…For Medicines Co., Esperion Too",2017-03-17 17:03:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/17/amgen-blew-it-for-medicines-co-esperion-too/?mod=yahoobarrons&ru=yahoo,"Amgen Blew It…For Medicines Co., Esperion Too"
PFE,PFE:US,BBG000BR2B91,3 Best Pharmaceutical Stocks for Long-Term Investors,2017-03-17 16:03:00 +0000,https://www.fool.com/investing/2017/03/17/3-best-pharmaceutical-stocks-for-long-term-investo.aspx,3 Best Pharmaceutical Stocks for Long-Term Investors
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb and Pfizer Present Large Real-World Observational Analysis of the Effectiveness and Safety of Direct Oral Anticoagulants Compared to Warfarin in Patients with Non-Valvular Atrial Fibrillation,2017-03-17 15:15:00 +0000,http://finance.yahoo.com/news/bristol-myers-squibb-pfizer-present-151500688.html,[Business Wire] - Bristol-Myers Squibb Company and Pfizer Inc. today announced findings from a real-world data analysis of the U.S. Medicare database comparing the risk of stroke or systemic embolism and rate of major bleeding among patients with non-valvular atrial fibrillation who were treated with direct oral anticoagulants versus warfarin.
PFE,PFE:US,BBG000BR2B91,Valeant: It's Not a Game of Chess- Part I,2017-03-17 13:05:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9pQ8wPUK4cE/valeant-its-not-a-game-of-chess-part-i-cm762050,I have always been interested in extreme successes and failures as case studies No doubt Valeant Pharmaceuticals VRX has been the most fascinating story I have followed in the investing world over the past few years What started as a promising business model designed by an ambitious
PFE,PFE:US,BBG000BR2B91,"Final Trade: BAC, COH & more",2017-03-16 21:58:00 +0000,http://finance.yahoo.com/video/final-trade-bac-coh-more-215800936.html,"Final Trade: BAC, COH & more"
PFE,PFE:US,BBG000BR2B91,How to trade deregulation: 6 stocks,2017-03-16 21:00:00 +0000,http://finance.yahoo.com/video/trade-deregulation-6-stocks-210000078.html,How to trade deregulation: 6 stocks
PFE,PFE:US,BBG000BR2B91,"Close Update: Wall Street Posts Mostly Weaker Finish as Utilities, Health Care Lag",2017-03-16 20:45:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/09lbBKMhfac/close-update-wall-street-posts-mostly-weaker-finish-as-utilities-health-care-lag-cm761909,The main U S indices were in mostly negative territory at the close on Thursday as gains made in the financials group a day earlier after the Federal Open Market Committee raised interest rates were overshadowed by weakness in utilities health care and energy The main U S indices were in
PFE,PFE:US,BBG000BR2B91,"Wall Street Poised for Weaker Finish as Utilities, Health Care Lag",2017-03-16 20:25:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p0Hzg2c8J-o/wall-street-poised-for-weaker-finish-as-utilities-health-care-lag-cm761890,The main U S indices were in negative territory near the close on Thursday as gains made in the financials group a day earlier after the Federal Open Market Committee raised interest rates were overshadowed by weakness in utilities health care and energy The main U S indices were in
PFE,PFE:US,BBG000BR2B91,Biogen Inc (BIIB): Profit From the BIIB Stock Bears,2017-03-16 19:07:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zOZiOhal7JE/biogen-inc-biib-profit-from-the-biib-stock-bears-cm761877,InvestorPlace Stock Market News Stock Advice amp Trading Tips Biogen Inc NASDAQ BIIB stock much like the rest of the biotech and healthcare industry has had a tumultuous few months First Hillary Clinton used biotechs as political scapegoats and now President Donald Trump
PFE,PFE:US,BBG000BR2B91,Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in China,2017-03-16 17:07:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jDhSP5QnLgg/pfizers-arthritis-drug-xeljanz-gets-marketing-nod-in-china-cm761771,Pfizer Inc s PFE rheumatoid arthritis RA drug Xeljanz 5 mg taken twice daily has received marketing approval in China to be used in combination with methotrexate MTX or other non biologic disease modifying antirheumatic drugs DMARDs Xeljanz 5 mg twice daily a JAK inhibitor
PFE,PFE:US,BBG000BR2B91,Glaxo Files for Label Expansion of Influenza Vaccine in US,2017-03-16 15:10:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_izUCg5xDV4/glaxo-files-for-label-expansion-of-influenza-vaccine-in-us-cm761595,GlaxoSmithKline plc GSK announced that it has submitted a supplemental Biologics License Application sBLA to the FDA seeking approval to expand the label of Fluarix Quadrivalent an influenza vaccine for infants six months or older At present this vaccine is approved for
PFE,PFE:US,BBG000BR2B91,Roche Holding Ltd. (ADR) (RHHBY) Stock Is Weathering the Healthcare Storm,2017-03-16 15:09:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K5P7FGrSY28/roche-holding-ltd-adr-rhhby-stock-is-weathering-the-healthcare-storm-cm761717,InvestorPlace Stock Market News Stock Advice amp Trading Tips Roche Holding Ltd ADR OTCMKTS RHHBY may not grab your attention like Pfizer Inc NYSE PFE Merck amp Co Inc NYSE MRK or Swiss
PFE,PFE:US,BBG000BR2B91,Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in China,2017-03-16 14:49:02 +0000,http://finance.yahoo.com/news/pfizers-arthritis-drug-xeljanz-gets-144902687.html,Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in China
PFE,PFE:US,BBG000BR2B91,Dividend Stocks Hedge Funds Are Betting On,2017-03-16 12:02:50 +0000,http://www.insidermonkey.com/blog/dividend-stocks-hedge-funds-are-betting-on-566646/,Dividend Stocks Hedge Funds Are Betting On
PFE,PFE:US,BBG000BR2B91,"Pfizer Announces Approval By The China Food And Drug Administration Of XELJANZ®, The First Oral JAK Inhibitor For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis",2017-03-16 01:00:00 +0000,http://finance.yahoo.com/news/pfizer-announces-approval-china-food-010000864.html,"[Business Wire] - Pfizer China announced today that it has received approval from the Chinese Food and Drug Administration to market its oral Janus kinase inhibitor, XELJANZ® , in China for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate ."
PFE,PFE:US,BBG000BR2B91,US Market Indexes Gain and Fed Raises Rate,2017-03-15 22:29:37 +0000,http://finance.yahoo.com/news/us-market-indexes-gain-fed-222937175.html,US Market Indexes Gain and Fed Raises Rate
PFE,PFE:US,BBG000BR2B91,Ex-Oppenheimer adviser gets six months in U.S. insider trading case,2017-03-15 21:46:40 +0000,http://finance.yahoo.com/news/ex-oppenheimer-adviser-gets-six-214640041.html,Ex-Oppenheimer adviser gets six months in U.S. insider trading case
PFE,PFE:US,BBG000BR2B91,Pfizer Receives China Food And Drug Administration Approval To Market Xeljanz,2017-03-15 21:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O01CPtL9_1U/pfizer-receives-china-food-and-drug-administration-approval-to-market-xeljanz-20170315-01413,Pfizer Receives China Food And Drug Administration Approval To Market Xeljanz
PFE,PFE:US,BBG000BR2B91,Will Pfizer's Growth Be Threatened by Novartis' New Cancer Drug?,2017-03-15 21:06:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rERzwFgRhSU/will-pfizers-growth-be-threatened-by-novartis-new-cancer-drug-cm761348,Novartis NYSE NVS announced on Monday that the U S Food and Drug Administration FDA approved Kisqali as a first line treatment for hormone receptor positive 160 human epidermal growth factor receptor 2 negative HR HER2 160 breast cancer 160 Soon stories were
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Mar 15, 2017 :  SNPS, RIG, GEO, KOS, YPF, TNGO, LYG, PFE, MCHI, MSFT, GRPN, AAPL",2017-03-15 21:05:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NAzgbSVHemI/after-hours-most-active-for-mar-15-2017-snps-rig-geo-kos-ypf-tngo-lyg-pfe-mchi-msft-grpn-aapl-cm761363,The NASDAQ 100 After Hours Indicator is up 38 to 5 416 63 The total After hours volume is currently 70 463 657 shares traded The following are the most active stocks for the after hours session Synopsys Inc SNPS is 0 05 at 70 20 with 14 135 762 shares traded
PFE,PFE:US,BBG000BR2B91,Will Pfizer's Growth Be Threatened by Novartis' New Cancer Drug?,2017-03-15 19:41:00 +0000,https://www.fool.com/investing/2017/03/15/will-pfizers-growth-be-threatened-by-novartis-new.aspx,Will Pfizer's Growth Be Threatened by Novartis' New Cancer Drug?
PFE,PFE:US,BBG000BR2B91,Pfizer’s Cash Flow Stamina versus Merck’s Ambitious R&D,2017-03-15 18:13:12 +0000,http://marketrealist.com/2017/03/pfizer-continues-generate-sufficient-cash-flows-dividend-payoffs/?utm_source=yahoo&utm_medium=feed,Pfizer’s Cash Flow Stamina versus Merck’s Ambitious R&D
PFE,PFE:US,BBG000BR2B91,Merck's (MRK) Keytruda Gets FDA Nod for Lymphoma Indication,2017-03-15 17:08:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BCm7XG_r2Sc/mercks-mrk-keytruda-gets-fda-nod-for-lymphoma-indication-cm761201,Merck amp Co Inc MRK announced that it has received FDA approval for its anti PD 1 therapy Keytruda for the treatment of patients with refractory classical Hodgkin lymphoma cHL or who had relapsed after three or more prior lines of therapy This is the first time that Merck has
PFE,PFE:US,BBG000BR2B91,3 Safe Stocks to Invest In for an Aging Bull Market,2017-03-15 17:07:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XlhRD6_0jiA/3-safe-stocks-to-invest-in-for-an-aging-bull-market-cm761204,It s a tricky thing investing for the long term at the very top of what has been an eight year long bull market in stocks Financial advisors tell us to invest and forget but the simple fact of the matter is that historically the market has experienced a drop of at least 20 termed
PFE,PFE:US,BBG000BR2B91,Bernie Sanders Slams Sanofi Zika Vaccine Deal,2017-03-15 16:40:00 +0000,http://www.investopedia.com/news/bernie-sanders-blasts-sanofi-zika-vaccine-deal-sny-pfe/?partner=YahooSA,Bernie Sanders Slams Sanofi Zika Vaccine Deal
PFE,PFE:US,BBG000BR2B91,3 Safe Stocks to Invest In for an Aging Bull Market,2017-03-15 15:07:00 +0000,http://www.fool.com/investing/2017/03/15/3-safe-stocks-to-invest-in-for-aging-bull-market.aspx,3 Safe Stocks to Invest In for an Aging Bull Market
PFE,PFE:US,BBG000BR2B91,David Tepper on Allergan: Does It Look Cheap?,2017-03-15 14:37:17 +0000,http://marketrealist.com/2017/03/david-tepper-allergan-looks-fairly-cheap/?utm_source=yahoo&utm_medium=feed,David Tepper on Allergan: Does It Look Cheap?
PFE,PFE:US,BBG000BR2B91,Turning Pfizer Discards Into Novartis Gold: The Story Of Ziarco,2017-03-15 12:09:00 +0000,http://www.forbes.com/sites/johnlamattina/2017/03/15/turning-pfizer-discards-into-novartis-gold-the-story-of-ziarco/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Turning Pfizer Discards Into Novartis Gold: The Story Of Ziarco
PFE,PFE:US,BBG000BR2B91,Novartis Takes Aim at Pfizer in Breast Cancer,2017-03-14 23:06:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PkhokdKwnmg/novartis-takes-aim-at-pfizer-in-breast-cancer-cm760815,Novartis NYSE NVS has won a speedy approval for Kisqali a new breast cancer drug that pits Novartis head to head against Pfizer s NYSE PFE billion dollar blockbuster drug Ibrance It remains to be seen how Kisqali s launch will reshape the breast cancer market but
PFE,PFE:US,BBG000BR2B91,Unilever CEO urges UK to provide 'level playing field' after Kraft bid,2017-03-14 21:49:51 +0000,http://finance.yahoo.com/news/unilever-ceo-urges-uk-level-165632796.html,"[Reuters] - Fresh from defending Unilever against an unsolicited $143 billion takeover attempt by Kraft Heinz, CEO Paul Polman said the British government should ensure a level playing field for target companies. One key feature of UK takeover rules is that once an expression of interest for a company has been made, suitors have only 28 days in which to make a formal bid, or they must walk away for six months."
PFE,PFE:US,BBG000BR2B91,Novartis Takes Aim at Pfizer in Breast Cancer,2017-03-14 21:41:00 +0000,http://www.fool.com/investing/2017/03/14/novartis-takes-aim-at-pfizer-in-breast-cancer.aspx,Novartis Takes Aim at Pfizer in Breast Cancer
PFE,PFE:US,BBG000BR2B91,Novartis Breast Cancer Drug Just OK'd — And Already Losing?,2017-03-14 20:14:17 +0000,http://www.investors.com/news/technology/novartis-breast-cancer-drug-was-just-okd-and-its-already-losing/?src=A00220A,Novartis Breast Cancer Drug Just OK'd — And Already Losing?
PFE,PFE:US,BBG000BR2B91,AstraZeneca Takes PARP Inhibitor Fight to Rival Tesaro with Strong Ovarian Cancer Study Results,2017-03-14 19:43:00 +0000,https://www.thestreet.com/story/14043007/1/astrazeneca-takes-parp-inhibitor-fight-to-rival-tesaro-with-strong-ovarian-cancer-study-results.html?puc=yahoo&cm_ven=YAHOO,AstraZeneca Takes PARP Inhibitor Fight to Rival Tesaro with Strong Ovarian Cancer Study Results
PFE,PFE:US,BBG000BR2B91,"Pfizer Unveils Zavicefta Antibiotic in Germany, UK",2017-03-14 19:05:00 +0000,http://www.investopedia.com/news/pfizer-launches-zavicefta-germany-and-uk-pfe/?partner=YahooSA,"Pfizer Unveils Zavicefta Antibiotic in Germany, UK"
PFE,PFE:US,BBG000BR2B91,Novartis wins U.S. approval for breast cancer drug; to compete with Pfizer's Ibrance,2017-03-14 14:13:56 +0000,http://finance.yahoo.com/news/novartis-wins-u-approval-breast-141356961.html,"[Reuters] - Novartis has won U.S. Food and Drug Administration approval for Kisqali to treat postmenopausal women who have a difficult-to-treat form of breast cancer, challenging U.S. rival Pfizer's Ibrance. The Swiss company has priced Kisqali to be cheaper than Ibrance, which analysts said could help it win business, though Kisqali's approval includes additional patient monitoring requirements that could work against the new drug."
PFE,PFE:US,BBG000BR2B91,[$$] Don't Expect Pfizer to Make a Mega Acquisition,2017-03-14 12:31:00 +0000,http://www.barrons.com/articles/dont-expect-pfizer-to-make-a-mega-acquisition-1489494702?mod=yahoobarrons&ru=yahoo,[$$] Don't Expect Pfizer to Make a Mega Acquisition
PFE,PFE:US,BBG000BR2B91,"Pfizer Launches Zavicefta™ (ceftazidime-avibactam) in the U.K. and Germany, a New Antibiotic to Treat Complicated Infections Caused by Gram-Negative Bacteria",2017-03-14 09:00:00 +0000,http://uk.finance.yahoo.com/news/pfizer-launches-zavicefta-ceftazidime-avibactam-090000681.html,"Pfizer Launches Zavicefta™ (ceftazidime-avibactam) in the U.K. and Germany, a New Antibiotic to Treat Complicated Infections Caused by Gram-Negative Bacteria"
PFE,PFE:US,BBG000BR2B91,Wall Street Cautious Amid Rate Hike Prospects,2017-03-14 08:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pELF2jS8BcQ/wall-street-cautious-amid-rate-hike-prospects-20170314-00478,Wall Street Cautious Amid Rate Hike Prospects
PFE,PFE:US,BBG000BR2B91,Pfizer Launches Zavicefta In The U.K. & Germany - Quick Facts,2017-03-14 05:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HHfY4XAaqVA/pfizer-launches-zavicefta-in-the-uk--germany--quick-facts-20170314-00149,Pfizer Launches Zavicefta In The U.K. & Germany - Quick Facts
PFE,PFE:US,BBG000BR2B91,Better Buy: Eli Lilly and Company vs. Pfizer,2017-03-13 22:06:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HwQ06e82rD4/better-buy-eli-lilly-and-company-vs-pfizer-cm760238,Two big pharma stocks posted nearly identical gains over the last 12 months Eli Lilly s NYSE LLY share price is up slightly under 15 during the period The same is true for Pfizer NYSE PFE stock But which of these two drug stocks is the better choice for long
PFE,PFE:US,BBG000BR2B91,Better Buy: Eli Lilly and Company vs. Pfizer,2017-03-13 20:23:00 +0000,http://www.fool.com/investing/2017/03/13/better-buy-eli-lilly-and-company-vs-pfizer.aspx,Better Buy: Eli Lilly and Company vs. Pfizer
PFE,PFE:US,BBG000BR2B91,Intrexon executive out less than a year after joining the company,2017-03-13 19:45:02 +0000,http://www.bizjournals.com/washington/news/2017/03/13/intrexons-geno-germano-out-less-than-a-year-after.html?ana=yahoo,Intrexon executive out less than a year after joining the company
PFE,PFE:US,BBG000BR2B91,Why AbbVie Inc Was a Named Top Dividend Stock (ABBV),2017-03-13 19:05:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RaiMW3qXKp4/why-abbvie-inc-was-a-named-top-dividend-stock-abbv-cm760169,InvestorPlace Stock Market News Stock Advice amp Trading Tips AbbVie Inc ABBV has been named to the Dividend Channel S A F E 25 list signifying a stock with above average DividendRank statistics including a strong 3 9 yield as well as
PFE,PFE:US,BBG000BR2B91,Interesting April Stock Options for PFE,2017-03-13 18:06:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dYqsuGs-Qrs/interesting-april-stock-options-for-pfe-cm760113,Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the April expiration for PFE The put contract
PFE,PFE:US,BBG000BR2B91,Trefis Market Diagnosis: What Are Market Participants Thinking About Pfizer?,2017-03-13 17:08:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Px1kCj1NnfA/trefis-market-diagnosis-what-are-market-participants-thinking-about-pfizer-cm760084,Pfizer 160 PFE had a reasonably good 2016 and saw a rebound in its revenue While some drugs are doing well the portfolio in general has matured So what comes next For investors understanding market expectations is one of the most critical tasks and many investors rely on
PFE,PFE:US,BBG000BR2B91,Billionaire David Tepper Makes Huge Investments In These 4 Drug Stocks,2017-03-13 15:18:39 +0000,http://www.insidermonkey.com/blog/billionaire-david-tepper-makes-huge-investments-in-these-4-drug-stocks-565903/,Billionaire David Tepper Makes Huge Investments In These 4 Drug Stocks
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson’s Business Segment Performance,2017-03-13 14:37:11 +0000,http://marketrealist.com/2017/03/johnson-johnsons-business-segment-performance/?utm_source=yahoo&utm_medium=feed,Johnson & Johnson’s Business Segment Performance
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. :PFE-US: Earnings Analysis: Q4, 2016 By the Numbers : March 13, 2017",2017-03-13 14:30:49 +0000,http://www.capitalcube.com/blog/index.php/pfizer-inc-pfe-us-earnings-analysis-q4-2016-by-the-numbers-march-13-2017/,"Pfizer Inc. :PFE-US: Earnings Analysis: Q4, 2016 By the Numbers : March 13, 2017"
PFE,PFE:US,BBG000BR2B91,"Aerie Resubmits Rhopressa NDA, Roclatan Gains Traction",2017-03-13 14:07:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zDIHBZ1JcQI/aerie-resubmits-rhopressa-nda-roclatan-gains-traction-cm759899,We issued an updated research report on Aerie Pharmaceuticals Inc AERI on Mar 10 2016 Aerie Pharmaceuticals is a development stage company focused on the development and commercialization of eye disease therapies including glaucoma and other eye diseases Aerie s two lead
PFE,PFE:US,BBG000BR2B91,The 19 Best-Selling Prescription Drugs of All-Time,2017-03-13 13:53:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kIv3sLiIJ6s/the-19-best-selling-prescription-drugs-of-all-time-cm759885,If you ve picked up a prescription at your pharmacy anytime recently or have been administered prescription medicines in your doctor s office or at a hospital you probably don t need me telling you that they re exceptionally pricey and growing pricier by the year Yet on the
PFE,PFE:US,BBG000BR2B91,"Pre-Market Most Active for Mar 13, 2017 :  MBLY, INTC, MT, STM, GE, MSFT, T, PFE, AAPL, CSCO, CMCSA, ASML",2017-03-13 13:00:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ggf99RTW6hM/pre-market-most-active-for-mar-13-2017-mbly-intc-mt-stm-ge-msft-t-pfe-aapl-csco-cmcsa-asml-cm759824,The NASDAQ 100 Pre Market Indicator is up 3 59 to 5 389 49 The total Pre Market volume is currently 16 327 024 shares traded The following are the most active stocks for the pre market session Mobileye N V MBLY is 14 35 at 61 62 with 3 968 038 shares traded Over
PFE,PFE:US,BBG000BR2B91,The 19 Best-Selling Prescription Drugs of All-Time,2017-03-13 12:41:00 +0000,http://www.fool.com/investing/2017/03/13/the-19-best-selling-prescription-drugs-of-all-time.aspx,The 19 Best-Selling Prescription Drugs of All-Time
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson’s Valuation Compared to Its Peers,2017-03-13 11:37:58 +0000,http://marketrealist.com/2017/03/johnson-johnsons-valuation-compared-to-peers/?utm_source=yahoo&utm_medium=feed,Johnson & Johnson’s Valuation Compared to Its Peers
PFE,PFE:US,BBG000BR2B91,Is this top FTSE 100 income stock a clear takeover candidate?,2017-03-13 11:14:08 +0000,http://uk.finance.yahoo.com/news/top-ftse-100-income-stock-111408370.html,Is this top FTSE 100 income stock a clear takeover candidate?
PFE,PFE:US,BBG000BR2B91,The 10 Most Important Tips for Playing the Stock Market in March,2017-03-12 19:40:00 +0000,https://www.thestreet.com/slideshow/14026153/1/the-10-most-important-tips-for-playing-the-stock-market-in-march.html?puc=yahoo&cm_ven=YAHOO,The 10 Most Important Tips for Playing the Stock Market in March
PFE,PFE:US,BBG000BR2B91,3 Big Pharma Stocks To Buy in Your 401(k),2017-03-12 17:10:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ucYpBWwPwMQ/3-big-pharma-stocks-to-buy-in-your-401k-cm759733,A larger longer living population is going to drive demand for medicine higher and if so then adding top pharmaceuticals stocks Pfizer Inc NYSE PFE Bristol Myers Squibb NYSE BMY and Johnson amp Johnson NYSE JNJ to your 401 k could be smart All three of
PFE,PFE:US,BBG000BR2B91,3 Big Pharma Stocks To Buy in Your 401(k),2017-03-12 15:41:00 +0000,http://www.fool.com/investing/2017/03/12/3-big-pharma-stocks-to-buy-in-your-401k.aspx,3 Big Pharma Stocks To Buy in Your 401(k)
PFE,PFE:US,BBG000BR2B91,The 3 Most Important Numbers for Johnson & Johnson,2017-03-12 14:10:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VCOmsFH8jig/the-3-most-important-numbers-for-johnson-johnson-cm759712,Your eyes would probably gloss over looking at all of the figures Johnson amp Johnson NYSE JNJ 160 puts up From adjusted earnings to Zyrtec sales the healthcare giant generates a massive volume of statistics in managing its global operations Of all the numbers key
PFE,PFE:US,BBG000BR2B91,The 3 Most Important Numbers for Johnson & Johnson,2017-03-12 12:42:00 +0000,http://www.fool.com/investing/2017/03/12/the-3-most-important-numbers-for-johnson-johnson.aspx,The 3 Most Important Numbers for Johnson & Johnson
PFE,PFE:US,BBG000BR2B91,"Better Buy: Myriad Genetics, Inc. vs. Opko Health, Inc.",2017-03-11 19:10:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nTuQIJvT79A/better-buy-myriad-genetics-inc-vs-opko-health-inc-cm759666,It s been a rough 12 months for Myriad Genetics NASDAQ MYGN and Opko Health NASDAQ OPK Myriad lost nearly half of its market cap during the period while Opko stock is down around 20 Could better days be ahead for these two stocks And which is the better pick
PFE,PFE:US,BBG000BR2B91,"Better Buy: Myriad Genetics, Inc. vs. Opko Health, Inc.",2017-03-11 17:04:00 +0000,http://www.fool.com/investing/2017/03/11/better-buy-myriad-genetics-inc-vs-opko-health.aspx,"Better Buy: Myriad Genetics, Inc. vs. Opko Health, Inc."
PFE,PFE:US,BBG000BR2B91,Jobs report beats expectations,2017-03-10 17:36:00 +0000,http://finance.yahoo.com/video/jobs-report-beats-expectations-173600709.html,Jobs report beats expectations
PFE,PFE:US,BBG000BR2B91,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for March 13, 2017",2017-03-10 14:17:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OU0pHPZfinE/merck-company-inc-mrk-ex-dividend-date-scheduled-for-march-13-2017-cm759114,Merck amp Company Inc MRK will begin trading ex dividend on March 13 2017 A cash dividend payment of 0 47 per share is scheduled to be paid on April 07 2017 Shareholders who purchased MRK prior to the ex dividend date are eligible for the cash dividend payment This represents
PFE,PFE:US,BBG000BR2B91,Biogen Spinoff Takes Flight With Focus On Hemophilia Drugs,2017-03-10 13:00:33 +0000,http://www.investors.com/research/the-new-america/biogen-spinoff-takes-flight-with-focus-on-drugs-for-hemophilia/?src=A00220A,Biogen Spinoff Takes Flight With Focus On Hemophilia Drugs
PFE,PFE:US,BBG000BR2B91,The 6 Most Shorted NYSE Stocks,2017-03-10 11:10:39 +0000,http://finance.yahoo.com/news/6-most-shorted-nyse-stocks-111039235.html,The 6 Most Shorted NYSE Stocks
PFE,PFE:US,BBG000BR2B91,"Will Pfizer Take On Celgene, Other Rivals With Leukemia Drug?",2017-03-09 21:03:42 +0000,http://www.investors.com/news/technology/could-this-drugmaker-take-on-celgene-juno-kite-with-leukemia-drug/?src=A00220A,"Will Pfizer Take On Celgene, Other Rivals With Leukemia Drug?"
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Caterpillar, Apple and Pfizer",2017-03-09 16:16:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gq2kf9_Sv-4/the-zacks-analyst-blog-highlights-caterpillar-apple-and-pfizer-cm758465,For Immediate Release Chicago IL March 09 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Caterpillar, Apple and Pfizer",2017-03-09 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-caterpillar-143002093.html,"The Zacks Analyst Blog Highlights: Caterpillar, Apple and Pfizer"
PFE,PFE:US,BBG000BR2B91,Pharma says high prices fund drug development — but this study finds otherwise,2017-03-09 13:59:14 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=547D1EB2-040C-11E7-B423-D9A672D73401&siteid=yhoof2,Pharma says high prices fund drug development — but this study finds otherwise
PFE,PFE:US,BBG000BR2B91,"Retirees, Maximize Your Income From Dividends",2017-03-09 13:12:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8WokHBt4rpE/retirees-maximize-your-income-from-dividends-cm758334,Dividend investing is supposed to be a bit like watching grass grow steady progress few surprises But lately investors holding dividend paying stocks have suffered some jarring setbacks Dividend investing is supposed to be a bit like watching grass grow steady progress few surprises
PFE,PFE:US,BBG000BR2B91,US Indexes Lower on Energy Stock Losses,2017-03-09 08:12:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cKZxeI4Cfho/us-indexes-lower-on-energy-stock-losses-cm758279,U S market indexes were lower Tuesday U S market indexes were lower Tuesday For the day the Dow Jones Industrial Average closed at 20 924 76 for a loss of 29 58 points or 0 14 The Standard amp Poor s 500 closed at 2 368 39 for a loss of 6 92 points or 0 29 The Nasdaq Composite closed
PFE,PFE:US,BBG000BR2B91,Servier and Pfizer Announce FDA Clearance of IND Application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia,2017-03-09 07:00:00 +0000,http://uk.finance.yahoo.com/news/servier-pfizer-announce-fda-clearance-070000417.html,Servier and Pfizer Announce FDA Clearance of IND Application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia
PFE,PFE:US,BBG000BR2B91,"1 Thing About Pfizer, Inc. Stock That You Might Be Overlooking",2017-03-08 23:15:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WbsfdEpd3ZY/1-thing-about-pfizer-inc-stock-that-you-might-be-overlooking-cm758201,There are several things about Pfizer NYSE PFE stock for investors to like Its dividend is a biggie The potential for growth from products such as Ibrance and Xeljanz definitely makes the list So does growth driving newer drugs like Eucrisa But what about Pfizer s
PFE,PFE:US,BBG000BR2B91,Global Blood Therapeutics Shares Jump on Report It Was Approached by Novo Nordisk,2017-03-08 22:39:00 +0000,https://www.thestreet.com/story/14032638/1/global-blood-therapeutics-shares-jump-on-report-it-was-approached-by-novo-nordisk.html?puc=yahoo&cm_ven=YAHOO,Global Blood Therapeutics Shares Jump on Report It Was Approached by Novo Nordisk
PFE,PFE:US,BBG000BR2B91,"Aerie (AERI) Q4 Loss Widens, Rhopressa NDA Resubmitted",2017-03-08 22:13:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mudvyGdh2h4/aerie-aeri-q4-loss-widens-rhopressa-nda-resubmitted-cm758135,Aerie Pharmaceuticals Inc AERI posted fourth quarter 2016 loss of 87 cents per share including stock based compensation wider than both the Zacks Consensus Estimate of a loss of 65 cents and the year ago loss of 76 cents Being a development stage company Aerie has not generated
PFE,PFE:US,BBG000BR2B91,"1 Thing About Pfizer, Inc. Stock That You Might Be Overlooking",2017-03-08 21:23:00 +0000,http://www.fool.com/investing/2017/03/08/1-thing-about-pfizer-inc-stock-that-you-might-be-o.aspx,"1 Thing About Pfizer, Inc. Stock That You Might Be Overlooking"
PFE,PFE:US,BBG000BR2B91,This Pharma Firm Is Beating The Pack In Getting Drugs To Market,2017-03-08 21:22:43 +0000,http://www.investors.com/news/technology/this-small-drugmaker-is-routing-pfizer-merck-bristol-in-rd-bang/?src=A00220A,This Pharma Firm Is Beating The Pack In Getting Drugs To Market
PFE,PFE:US,BBG000BR2B91,Caterpillar Stock Slides After Report Accuses It of Tax Fraud,2017-03-08 21:13:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fpL_YlH_Sbg/caterpillar-stock-slides-after-report-accuses-it-of-tax-fraud-cm758101,On Wednesday shares of manufacturing giant Caterpillar Inc CAT are sliding down about 1 5 in late morning trading after a new report commissioned by the government accused the company of tax and accounting fraud according to The New York Times The report which the Times had
PFE,PFE:US,BBG000BR2B91,Caterpillar Stock Slides After Report Accuses It of Tax Fraud,2017-03-08 18:43:06 +0000,http://finance.yahoo.com/news/caterpillar-stock-slides-report-accuses-184306277.html,Caterpillar Stock Slides After Report Accuses It of Tax Fraud
PFE,PFE:US,BBG000BR2B91,Trump Tweet on Drug Pricing Hits Biotech and Pharma ETFs,2017-03-08 17:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eMS5F9JVygY/trump-tweet-on-drug-pricing-hits-biotech-and-pharma-etfs-cm757946,The pharma and biotech industry has been hit badly by concerns over high drug prices in the past few years The initial panic was triggered in September 2015 when the Democratic presidential candidate Hillary Clinton tweeted about price gouging and laid out a proposal for combating
PFE,PFE:US,BBG000BR2B91,"Merck/Pfizer's Diabetes Drug Accepted for Review by FDA, EMA",2017-03-08 17:14:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uvjdRQbUz3s/merckpfizers-diabetes-drug-accepted-for-review-by-fda-ema-cm757910,Merck amp Co Inc MRK and partner Pfizer Inc PFE announced that the FDA has accepted its new drug applications NDA for its diabetes candidate ertugliflozin as a monotherapy as well as two fixed dose combination tablets The companies had filed three NDAs with the FDA one as
PFE,PFE:US,BBG000BR2B91,"J2 Global, eHealth, Pfizer, Amgen and Mylan highlighted as Zacks Bull and Bear of the Day",2017-03-08 16:16:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qOE4L3BfP-k/j2-global-ehealth-pfizer-amgen-and-mylan-highlighted-as-zacks-bull-and-bear-of-the-day-cm757855,For Immediate Release Chicago IL March 08 2017 Zacks Equity Research highlights J2 Global NASDAQ JCOM Free Report as the Bull of the Day eHealth Inc NASDAQ EHTH Free Report as the Bear of the Day In addition Zacks Equity Research provides analysis on
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. (PFE) Reportedly In Talks To Expand Plant In Lee County,2017-03-08 16:01:02 +0000,http://www.insidermonkey.com/blog/pfizer-inc-pfe-reportedly-in-talks-to-expand-plant-in-lee-county-564616/,Pfizer Inc. (PFE) Reportedly In Talks To Expand Plant In Lee County
PFE,PFE:US,BBG000BR2B91,Chaos Is Biggest Threat to Wednesday's Vote on Repealing Obamacare,2017-03-08 15:46:00 +0000,https://www.thestreet.com/story/14032310/1/chaos-is-biggest-threat-to-wednesday-s-vote-on-repealing-obamacare.html?puc=yahoo&cm_ven=YAHOO,Chaos Is Biggest Threat to Wednesday's Vote on Repealing Obamacare
PFE,PFE:US,BBG000BR2B91,"Merck/Pfizer's Diabetes Drug Accepted for Review by FDA, EMA",2017-03-08 15:30:03 +0000,http://finance.yahoo.com/news/merck-pfizers-diabetes-drug-accepted-153003512.html,"Merck/Pfizer's Diabetes Drug Accepted for Review by FDA, EMA"
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference,2017-03-08 15:00:00 +0000,http://finance.yahoo.com/news/pfizer-invites-public-listen-webcast-150000198.html,"[Business Wire] - Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Frank D’Amelio, Executive Vice President, Business Operations and Chief Financial Officer, at the Barclays Global Healthcare Conference on Wednesday, March 15, 2017 at 1:35 p.m."
PFE,PFE:US,BBG000BR2B91,"J2 Global, eHealth, Pfizer, Amgen and Mylan highlighted as Zacks Bull and Bear of the Day",2017-03-08 14:30:02 +0000,http://finance.yahoo.com/news/j2-global-ehealth-pfizer-amgen-143002721.html,"J2 Global, eHealth, Pfizer, Amgen and Mylan highlighted as Zacks Bull and Bear of the Day"
PFE,PFE:US,BBG000BR2B91,Forget the Distractions: Bristol-Myers Squibb Is a Bargain,2017-03-08 14:13:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d0xsatyXJW8/forget-the-distractions-bristol-myers-squibb-is-a-bargain-cm757714,What will Carl Icahn do Will Bristol Myers Squibb NYSE BMY be acquired How will Opdivo fare against Merck s NYSE MRK Keytruda There are plenty of unanswered questions swirling around about Bristol Myers Squibb BMS these days But as I listened to the company s CEO
PFE,PFE:US,BBG000BR2B91,State Street Calls for More Women on Boards,2017-03-08 13:35:00 +0000,http://finance.yahoo.com/news/video-state-street-calls-more-133500855.html,State Street Calls for More Women on Boards
PFE,PFE:US,BBG000BR2B91,Forget the Distractions: Bristol-Myers Squibb Is a Bargain,2017-03-08 13:04:00 +0000,http://www.fool.com/investing/2017/03/08/forget-the-distractions-bristol-myers-squibb-is-a.aspx,Forget the Distractions: Bristol-Myers Squibb Is a Bargain
PFE,PFE:US,BBG000BR2B91,Are Hedge Funds Turning Bearish on Healthcare Stocks?,2017-03-08 12:25:02 +0000,http://www.insidermonkey.com/blog/are-hedge-funds-turning-bearish-on-healthcare-stocks-562997/,Are Hedge Funds Turning Bearish on Healthcare Stocks?
PFE,PFE:US,BBG000BR2B91,US Indexes Lower on Energy Stock Losses,2017-03-08 11:58:27 +0000,http://finance.yahoo.com/news/us-indexes-lower-energy-stock-115827586.html,US Indexes Lower on Energy Stock Losses
PFE,PFE:US,BBG000BR2B91,"FDA Endorses 3 New Drug Applications (NDAs) From Merck & Co., Inc. (MRK), Pfizer Inc. (PFE)",2017-03-08 10:37:24 +0000,http://www.insidermonkey.com/blog/fda-endorses-3-new-drug-applications-ndas-from-merck-co-inc-mrk-pfizer-inc-pfe-564331/,"FDA Endorses 3 New Drug Applications (NDAs) From Merck & Co., Inc. (MRK), Pfizer Inc. (PFE)"
PFE,PFE:US,BBG000BR2B91,Trump's Twitter tantrums a pharma buying opportunity,2017-03-08 01:25:00 +0000,http://finance.yahoo.com/video/trumps-twitter-tantrums-pharma-buying-012500412.html,Trump's Twitter tantrums a pharma buying opportunity
PFE,PFE:US,BBG000BR2B91,"Stock Market Roundup, March 7: SNAP Falls Again, Drug Stocks Dip",2017-03-08 00:13:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KtjUR0l_pNE/stock-market-roundup-march-7-snap-falls-again-drug-stocks-dip-cm757614,Stocks opened in the red and were down slightly throughout the day on Tuesday The healthcare sector specifically drug stocks witnessed some volatility after the release of the Republican plan to replace Obamacare and President Trump s ensuing tweets while shares of Snap Inc fell another
PFE,PFE:US,BBG000BR2B91,3 Drug Stocks Hit by Trump’s Call for Lower Prices,2017-03-08 00:12:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZP9Qle-HkaA/3-drug-stocks-hit-by-trumps-call-for-lower-prices-cm757633,InvestorPlace Stock Market News Stock Advice amp Trading Tips U S equities are pulling back again on Tuesday pushing the Dow Jones Industrial Average down in what could be the first back to back decline since January Source Shutterstock The tape is heavy as political risk
PFE,PFE:US,BBG000BR2B91,Cramer: Why Trump’s Twitter tantrums on pharma are your b...,2017-03-07 23:41:00 +0000,http://finance.yahoo.com/video/cramer-why-trump-twitter-tantrums-234100646.html,Cramer: Why Trump’s Twitter tantrums on pharma are your b...
PFE,PFE:US,BBG000BR2B91,"Trump's Tweet Hits Pharma Stocks, Promises Decreased Drug Prices",2017-03-07 23:13:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6KGCoVxvdPs/trumps-tweet-hits-pharma-stocks-promises-decreased-drug-prices-cm757605,A President Donald Trump tweet promising to increase competition and decrease prices in the drug industry sent pharmaceutical stocks falling on Tuesday I am working on a new system where there will be competition in the Drug Industry Pricing for the American people will come way
PFE,PFE:US,BBG000BR2B91,Drugmakers fall as investors see pricing threat from Trump,2017-03-07 22:20:06 +0000,http://sg.finance.yahoo.com/news/drugmakers-fall-investors-see-pricing-191801134.html,Drugmakers fall as investors see pricing threat from Trump
PFE,PFE:US,BBG000BR2B91,Close Update: Wall Street Trades Lower as Energy and Healthcare Stocks Wilt,2017-03-07 22:12:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RF1OEuM2_4E/close-update-wall-street-trades-lower-as-energy-and-healthcare-stocks-wilt-cm757579,The major averages all closed lower again Tuesday as lingering concerns about slowing global growth coupled with the likelihood for the Federal Reserve to raise rates next week weighed on Wall Street The major averages all closed lower again Tuesday as lingering concerns about slowing global
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Mar 7, 2017 :  FMBI, XRX, CSCO, SWN, PFE, HBI, F, MSFT, YHOO, FIG, CMCSA, TLT",2017-03-07 22:02:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nwrNp8tHh40/after-hours-most-active-for-mar-7-2017-fmbi-xrx-csco-swn-pfe-hbi-f-msft-yhoo-fig-cmcsa-tlt-cm757580,The NASDAQ 100 After Hours Indicator is down 1 53 to 5 349 75 The total After hours volume is currently 50 613 415 shares traded The following are the most active stocks for the after hours session First Midwest Bancorp Inc FMBI is 0 64 at 23 65 with 12 922
PFE,PFE:US,BBG000BR2B91,"Stocks today: Dow, S&P 500 slip as rally pauses on Obamacare repeal; Trump talks tax cuts right before closing bell",2017-03-07 21:55:44 +0000,http://www.bizjournals.com/phoenix/news/2017/03/07/stocks-today-dow-s-p-500-slip-as-rally-pauses-on.html?ana=yahoo,"Stocks today: Dow, S&P 500 slip as rally pauses on Obamacare repeal; Trump talks tax cuts right before closing bell"
PFE,PFE:US,BBG000BR2B91,Stocks Fall for Day Two as Trump Targets Health Care Sector,2017-03-07 21:05:00 +0000,https://www.thestreet.com/story/14030890/1/stocks-fall-for-day-two-as-trump-targets-health-care-sector.html?puc=yahoo&cm_ven=YAHOO,Stocks Fall for Day Two as Trump Targets Health Care Sector
PFE,PFE:US,BBG000BR2B91,"Chevron, Verizon Sink DJIA on Tuesday",2017-03-07 21:01:54 +0000,http://finance.yahoo.com/news/chevron-verizon-sink-djia-tuesday-210154014.html,"Chevron, Verizon Sink DJIA on Tuesday"
PFE,PFE:US,BBG000BR2B91,"Trump's Tweet Hits Pharma Stocks, Promises Decreased Drug Prices",2017-03-07 20:50:08 +0000,http://finance.yahoo.com/news/trumps-tweet-hits-pharma-stocks-205008778.html,"Trump's Tweet Hits Pharma Stocks, Promises Decreased Drug Prices"
PFE,PFE:US,BBG000BR2B91,Sources: Pfizer considering $100M plant expansion in the Triangle,2017-03-07 20:30:18 +0000,http://www.bizjournals.com/triangle/news/2017/03/07/pfizer-plant-expansion-gene-therapy-sanford-lee.html?ana=yahoo,Sources: Pfizer considering $100M plant expansion in the Triangle
PFE,PFE:US,BBG000BR2B91,Trump's Tax Plans: Biggest Winners and Losers,2017-03-07 18:30:00 +0000,https://www.thestreet.com/story/14029691/1/trump-s-tax-plans-the-biggest-winners-and-losers.html?puc=yahoo&cm_ven=YAHOO,Trump's Tax Plans: Biggest Winners and Losers
PFE,PFE:US,BBG000BR2B91,"Dow Movers: MRK, WMT",2017-03-07 18:14:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E1Dx6_QpdBU/dow-movers-mrk-wmt-cm757321,In early trading on Tuesday shares of Wal Mart Stores topped the list of the day s best performing Dow Jones Industrial Average components trading up 0 4 Year to date Wal Mart Stores registers a 1 5 gain And the worst performing Dow component thus far on the day is Merck trading
PFE,PFE:US,BBG000BR2B91,Midday Update: Wall Street Remains Cautious as Global Growth Weighs,2017-03-07 18:13:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jPReqF40-wo/midday-update-wall-street-remains-cautious-as-global-growth-weighs-cm757377,The major benchmark averages were lower for a second day as caution continued to rip through Wall Street after China lowered growth forecasts and Germany reported a significant drop in factory orders The major benchmark averages were lower for a second day as caution continued to rip through
PFE,PFE:US,BBG000BR2B91,Vertex to Buy Concert's Cystic Fibrosis Candidate for $160M,2017-03-07 18:13:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1nMvaq1SZ6M/vertex-to-buy-concerts-cystic-fibrosis-candidate-for-160m-cm757339,Vertex Pharmaceuticals Incorporated VRTX announced a definitive deal to buy the worldwide development and commercialization rights of Concert Pharmaceuticals CNCE cystic fibrosis CF pipeline candidate CTP 656 for an upfront payment of 160 million in cash Shares of Concert Pharma
PFE,PFE:US,BBG000BR2B91,"Trump Tweets, Drug Stocks Tank",2017-03-07 17:14:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jy6tT1SobGE/trump-tweets-drug-stocks-tank-cm757288,Tuesday March 7 2017 Moments ago President Trump took to his Twitter TWTR account to promise lower drug prices for Americans Saying he s working on a new system to increase competition among drug manufacturers Pricing for the American people will come way down That s not the
PFE,PFE:US,BBG000BR2B91,"GLOBAL MARKETS-Wall Street slips, U.S. dollar firm on Fed outlook",2017-03-07 16:51:54 +0000,http://uk.finance.yahoo.com/news/global-markets-wall-street-slips-165154087.html,"[Reuters - UK Focus] - Wall Street stocks slipped on Tuesday, led by a decline in healthcare stocks after a tweet from U.S. President Donald Trump on the need to lower drug prices, while expectations the Federal Reserve will raise interest rates supported the U.S. dollar. Shares (Berlin: DI6.BE - news) of large U.S. pharmaceutical and biotechnology companies sold off after President Donald Trump said he was working on a ""new system"" to reduce prices in the industry. The U.S. dollar edged up 0.09 percent against a basket of six major trading currencies and gained 0.11 percent against the Japanese yen ahead of the Fed's meeting next week."
PFE,PFE:US,BBG000BR2B91,"Stock market fights for altitude, but health-care, energy slide weigh",2017-03-07 16:37:14 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=7C0CDA80-0312-11E7-AF0E-6FD7C0D42EFF&siteid=yhoof2,"Stock market fights for altitude, but health-care, energy slide weigh"
PFE,PFE:US,BBG000BR2B91,Is Portola Pharmaceuticals Balance Sheet Safe?,2017-03-07 16:14:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VVXHhkI5dqI/is-portola-pharmaceuticals-balance-sheet-safe-cm757227,Portola Pharmaceuticals NASDAQ PTLA 160 could have two commercial stage drugs on the market next year but turning them into top sellers will require a lot of money Is Portola Pharmaceuticals balance sheet flush enough with cash to get its drugs across the finish line What
PFE,PFE:US,BBG000BR2B91,"Ten stocks to watch with focus on Obamacare, drug prices; Dow Jones dips; Snap slides 10 percent early",2017-03-07 15:36:03 +0000,http://www.bizjournals.com/phoenix/news/2017/03/07/ten-stocks-to-watch-with-focus-on-obamacare-drug.html?ana=yahoo,"Ten stocks to watch with focus on Obamacare, drug prices; Dow Jones dips; Snap slides 10 percent early"
PFE,PFE:US,BBG000BR2B91,Trump's Latest Drug Pricing Tweet Hits Biotech Stocks,2017-03-07 14:48:55 +0000,http://blogs.wsj.com/moneybeat/2017/03/07/trumps-latest-drug-pricing-tweet-hits-biotech-stocks/?mod=yahoo_hs,Trump's Latest Drug Pricing Tweet Hits Biotech Stocks
PFE,PFE:US,BBG000BR2B91,Is Portola Pharmaceuticals Balance Sheet Safe?,2017-03-07 14:21:00 +0000,http://www.fool.com/investing/2017/03/07/is-portola-pharmaceuticals-balance-sheet-safe.aspx,Is Portola Pharmaceuticals Balance Sheet Safe?
PFE,PFE:US,BBG000BR2B91,"Shire plc (SHPG) Ex-Dividend Date Scheduled for March 08, 2017",2017-03-07 14:17:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b_Wcf5LIpCw/shire-plc-shpg-ex-dividend-date-scheduled-for-march-08-2017-cm757092,Shire plc SHPG will begin trading ex dividend on March 08 2017 A cash dividend payment of 1 542 per share is scheduled to be paid on April 25 2017 Shareholders who purchased SHPG prior to the ex dividend date are eligible for the cash dividend payment This represents an 1010 15
PFE,PFE:US,BBG000BR2B91,"Early movers: DKS, MIK, NAV, PFE, AET, CSX, & more",2017-03-07 12:54:21 +0000,http://www.cnbc.com/id/104325753?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104325753,"Early movers: DKS, MIK, NAV, PFE, AET, CSX, & more"
PFE,PFE:US,BBG000BR2B91,Pfizer To Present At Cowen And Co Healthcare Conference; Webcast At 11:20 AM ET,2017-03-07 10:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FTmUGp6m1c0/pfizer-to-present-at-cowen-and-co-healthcare-conference-webcast-at-1120-am-et-20170307-00898,Pfizer To Present At Cowen And Co Healthcare Conference; Webcast At 11:20 AM ET
PFE,PFE:US,BBG000BR2B91,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-03-06 22:17:34 +0000,http://biz.yahoo.com/e/170306/pfe8-k.html,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb: Don't Get Your Hopes Up,2017-03-06 18:29:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/03/06/bristol-myers-squibb-dont-get-your-hopes-up/?mod=yahoobarrons&ru=yahoo,Bristol-Myers Squibb: Don't Get Your Hopes Up
PFE,PFE:US,BBG000BR2B91,What's in Store for Merck KGaA (MKGAF) in Q4 Earnings?,2017-03-06 16:17:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k5aEl1tkxCw/whats-in-store-for-merck-kgaa-mkgaf-in-q4-earnings-cm756581,Merck KGaA MKGAF is scheduled to report fourth quarter 2016 earnings results on Mar 9 The company reports results under three business sectors Healthcare Life Science and Performance Materials Strong performance at Life Science which was the catalyst behind sales growth in the last
PFE,PFE:US,BBG000BR2B91,Health Care Sector Update for 03/06/2017: MRK,2017-03-06 14:52:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9yIAqooVoJs/health-care-sector-update-for-03062017-mrk-cm756535,Top Health care stocks Top Health care stocks JNJ 0 6 JNJ 0 6 PFE 0 4 PFE 0 4 ABT 0 1 ABT 0 1 MRK flatMRK flat AMGN 0 2 AMGN 0 2 Health care shares were mixed in pre market trade on Monday Health care shares were mixed in pre market trade on Monday In health care
PFE,PFE:US,BBG000BR2B91,Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here,2017-03-06 14:50:08 +0000,http://finance.yahoo.com/news/where-merck-pfizer-type-2-145008934.html,Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here
PFE,PFE:US,BBG000BR2B91,Germany to scrap plan to lower prices of new drugs-lawmakers,2017-03-06 14:19:17 +0000,http://uk.finance.yahoo.com/news/germany-scrap-plan-lower-prices-141917337.html,"[Reuters - UK Focus] - Germany's ruling coalition will scrap plans announced last year to lower prices of newly launched drugs within the first 12 months should sales exceed 250 million euros , lawmakers told Reuters on Monday. ..."
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb and Pfizer to Present New Analyses of Eliquis™ (apixaban) Clinical and Real-World Data at the American College of Cardiology 2017 Scientific Session,2017-03-06 13:30:00 +0000,http://finance.yahoo.com/news/bristol-myers-squibb-pfizer-present-133000652.html,"[Business Wire] - Bristol-Myers Squibb Company and Pfizer Inc. today announced that eight abstracts have been accepted for presentation at the American College of Cardiology 66th Annual Scientific Session, taking place March 17-19 in Washington, D.C."
PFE,PFE:US,BBG000BR2B91,[$$] AstraZeneca Struggles to Justify Rejection of Pfizer,2017-03-04 05:01:00 +0000,http://www.barrons.com/articles/astrazeneca-struggles-to-justify-rejection-of-pfizer-1488609179?mod=yahoobarrons&ru=yahoo,[$$] AstraZeneca Struggles to Justify Rejection of Pfizer
PFE,PFE:US,BBG000BR2B91,Here's Why Pfizer Rallied 7.7% in February,2017-03-03 21:13:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q_qO_eAjFH0/heres-why-pfizer-rallied-77-in-february-cm756153,What happened According to data from S amp P Global Market Intelligence shares of Pfizer NYSE PFE 160 gained 7 7 in February The move has added more than 11 billion to the pharma giant s market capitalization So what Pfizer showered investors with
PFE,PFE:US,BBG000BR2B91,How Mylan’s Europe Segment Performed,2017-03-03 20:35:43 +0000,http://marketrealist.com/2017/03/how-mylans-europe-segment-performed/?utm_source=yahoo&utm_medium=feed,How Mylan’s Europe Segment Performed
PFE,PFE:US,BBG000BR2B91,Here's Why Pfizer Rallied 7.7% in February,2017-03-03 19:46:00 +0000,http://www.fool.com/investing/2017/03/03/heres-why-pfizer-rallied-77-in-february.aspx,Here's Why Pfizer Rallied 7.7% in February
PFE,PFE:US,BBG000BR2B91,Health Care Dividend Stock Showdown,2017-03-03 17:42:49 +0000,http://finance.yahoo.com/news/health-care-dividend-stock-showdown-174249443.html,Health Care Dividend Stock Showdown
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Mylan, Endo Report 4Q Results, FDA Nod for AZN Diabetes Drug",2017-03-03 15:16:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C6LQDob9yAI/pharma-stock-roundup-mylan-endo-report-4q-results-fda-nod-for-azn-diabetes-drug-cm756013,This week companies like Mylan MYL Endo and Valeant reported earnings results Meanwhile several companies including Roche RHHBY and AstraZeneca AZN provided pipeline regulatory updates Recap of the Week s Most Important Stories A Look at Earnings Results This week
PFE,PFE:US,BBG000BR2B91,70 or Older? 3 Stocks You Should Consider Buying,2017-03-03 14:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U-ClyHL6wX4/70-or-older-3-stocks-you-should-consider-buying-cm755829,Life expectancies have been creeping higher for decades which is wonderful news for humanity However a longer life expectancy also means that many will be dependent on their nest eggs to sustain them for a longer time period That s a big reason why we Fools are firm believers that
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Mylan, Endo Report 4Q Results, FDA Nod for AZN Diabetes Drug",2017-03-03 13:33:01 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-mylan-endo-133301707.html,"Pharma Stock Roundup: Mylan, Endo Report 4Q Results, FDA Nod for AZN Diabetes Drug"
PFE,PFE:US,BBG000BR2B91,Corporates break new ground to cope with negative rates,2017-03-03 13:07:48 +0000,http://finance.yahoo.com/news/corporates-break-ground-cope-negative-130748126.html,"[Reuters] - Coca-Cola and Pfizer broke new ground in the European corporate market this week, pricing the first above par floating-rate notes as the sector adapts to the deeply negative rates sparked by eurozone monetary policy. Coca-Cola priced its FRN on Monday with Pfizer following on Wednesday, in what could trigger a new market trend, bankers say. ""This is the first time we've seen an above par pricing on a public corporate deal, and it's been done by Coca-Cola and Pfizer in a very visible way."
PFE,PFE:US,BBG000BR2B91,70 or Older? 3 Stocks You Should Consider Buying,2017-03-03 12:53:00 +0000,http://www.fool.com/investing/2017/03/03/70-or-older-3-stocks-you-should-consider-buying.aspx,70 or Older? 3 Stocks You Should Consider Buying
PFE,PFE:US,BBG000BR2B91,[$$] The Biotech Stock Safety Net,2017-03-03 05:03:25 +0000,https://www.wsj.com/articles/the-biotech-stock-safety-net-1488476452?ru=yahoo?mod=yahoo_itp,[$$] The Biotech Stock Safety Net
PFE,PFE:US,BBG000BR2B91,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-03-02 22:10:54 +0000,http://biz.yahoo.com/e/170302/pfe8-k.html,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
PFE,PFE:US,BBG000BR2B91,How To Trade The 8 'Dogs Of The Dow',2017-03-02 19:09:00 +0000,http://www.forbes.com/sites/investor/2017/03/02/how-to-trade-the-8-dogs-of-the-dow/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,How To Trade The 8 'Dogs Of The Dow'
PFE,PFE:US,BBG000BR2B91,[$$] The Biotech Stock Safety Net,2017-03-02 18:10:00 +0000,https://www.wsj.com/articles/the-biotech-stock-safety-net-1488476452?mod=yahoo_hs,[$$] The Biotech Stock Safety Net
PFE,PFE:US,BBG000BR2B91,"Dow Movers: AXP, XOM",2017-03-02 17:15:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q_TPy2_hGKQ/dow-movers-axp-xom-cm755493,In early trading on Thursday shares of Exxon Mobil topped the list of the day s best performing Dow Jones Industrial Average components trading up 1 2 Year to date Exxon Mobil has lost about 6 9 of its value And the worst performing Dow component thus far on the day is
PFE,PFE:US,BBG000BR2B91,Don't Be Cowed in the Face of This Bull: Cramer's 'Mad Money' Recap (Wednesday March 1),2017-03-02 11:11:00 +0000,https://www.thestreet.com/story/14022958/1/don-t-be-cowed-in-the-face-of-this-bull-cramer-s-mad-money-recap-wednesday-march-1.html?puc=yahoo&cm_ven=YAHOO,Don't Be Cowed in the Face of This Bull: Cramer's 'Mad Money' Recap (Wednesday March 1)
PFE,PFE:US,BBG000BR2B91,Drug Companies Block Shareholder Votes on Price Transparency Proposals,2017-03-02 05:37:30 +0000,https://www.wsj.com/articles/drug-companies-block-shareholder-votes-on-price-transparency-proposals-1488406027?ru=yahoo?mod=yahoo_itp,Drug Companies Block Shareholder Votes on Price Transparency Proposals
PFE,PFE:US,BBG000BR2B91,[$$] ICU Medical Outlook Misses Wall Street Targets,2017-03-02 02:40:25 +0000,https://www.wsj.com/articles/icu-medical-2017-outlook-falls-short-of-wall-street-estimates-1488404325?mod=yahoo_hs,[$$] ICU Medical Outlook Misses Wall Street Targets
PFE,PFE:US,BBG000BR2B91,Cramer Remix: Investors are too negative about fast-growi...,2017-03-01 23:58:00 +0000,http://finance.yahoo.com/video/cramer-remix-investors-too-negative-235800308.html,Cramer Remix: Investors are too negative about fast-growi...
PFE,PFE:US,BBG000BR2B91,Could pharma sector roar even higher? Cramer checks the c...,2017-03-01 23:47:00 +0000,http://finance.yahoo.com/video/could-pharma-sector-roar-even-234700293.html,Could pharma sector roar even higher? Cramer checks the c...
PFE,PFE:US,BBG000BR2B91,Cramer’s charts uncover 4 pharma stocks ready to explode ...,2017-03-01 23:42:00 +0000,http://finance.yahoo.com/video/cramer-charts-uncover-4-pharma-234200165.html,Cramer’s charts uncover 4 pharma stocks ready to explode ...
PFE,PFE:US,BBG000BR2B91,Cramer’s charts uncover 4 pharma stocks ready to explode higher,2017-03-01 23:36:07 +0000,http://www.cnbc.com/id/104313689?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104313689,Cramer’s charts uncover 4 pharma stocks ready to explode higher
PFE,PFE:US,BBG000BR2B91,"M&As, Pipeline Catalysts to Drive Pharma Sector",2017-03-01 23:14:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N3pJezp3vK8/mas-pipeline-catalysts-to-drive-pharma-sector-cm755151,Although pharma and biotech stocks are facing challenges in the form of increasing focus on the high prices of drugs a changing competitive scenario and mixed results the sector s fundamentals remain strong innovation mergers and acquisitions M amp As product approvals and positive
PFE,PFE:US,BBG000BR2B91,Drugs stocks shrug off Trump warning,2017-03-01 22:15:00 +0000,http://finance.yahoo.com/video/drugs-stocks-shrug-off-trump-221500115.html,Drugs stocks shrug off Trump warning
PFE,PFE:US,BBG000BR2B91,[$$] Drug Companies Block Shareholders' Voting on Price Transparency,2017-03-01 22:07:10 +0000,https://www.wsj.com/articles/drug-companies-block-shareholder-votes-on-price-transparency-proposals-1488406027?mod=yahoo_hs,[$$] Drug Companies Block Shareholders' Voting on Price Transparency
PFE,PFE:US,BBG000BR2B91,Drug Companies Block Shareholder Votes on Price Transparency Proposals,2017-03-01 22:07:00 +0000,http://finance.yahoo.com/news/drug-companies-block-shareholder-votes-220700020.html,Drug Companies Block Shareholder Votes on Price Transparency Proposals
PFE,PFE:US,BBG000BR2B91,"Spark Therapeutics and Pfizer Announce that SPK-9001, an Investigational Hemophilia B Medicine, has been Granted Access to the PRIority MEdicines (PRIME) Program by the European Medicines Agency",2017-03-01 21:15:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-pfizer-announce-spk-211500657.html,"[GlobeNewswire] - PHILADELPHIA and NEW YORK, March 01, 2017-- Spark Therapeutics and Pfizer Inc. announced today that SPK-9001, the lead investigational candidate in the companies' SPK-FIX program has been granted support ..."
PFE,PFE:US,BBG000BR2B91,PFIZER INC Financials,2017-03-01 18:04:11 +0000,http://finance.yahoo.com/q/is?s=pfe,PFIZER INC Financials
PFE,PFE:US,BBG000BR2B91,AstraZeneca’s New Products May Offer 2017 Growth Opportunities,2017-03-01 12:37:46 +0000,http://marketrealist.com/2017/02/new-product-launches-may-offer-solid-growth-opportunity-astrazeneca-2017/?utm_source=yahoo&utm_medium=feed,AstraZeneca’s New Products May Offer 2017 Growth Opportunities
PFE,PFE:US,BBG000BR2B91,Label Expansion Expected to Boost Keytruda’s 2017 Revenue,2017-03-01 12:36:19 +0000,http://marketrealist.com/2017/02/label-expansion-expected-boost-keytrudas-revenues-2017/?utm_source=yahoo&utm_medium=feed,Label Expansion Expected to Boost Keytruda’s 2017 Revenue
PFE,PFE:US,BBG000BR2B91,Analyzing Pfizer’s Estimates for the Future,2017-03-01 12:35:47 +0000,http://marketrealist.com/2017/02/analyzing-pfizers-estimates-for-the-future/?utm_source=yahoo&utm_medium=feed,Analyzing Pfizer’s Estimates for the Future
PFE,PFE:US,BBG000BR2B91,Short Sellers Pile On Pfizer After Buyout Rumors,2017-03-01 11:54:50 +0000,http://finance.yahoo.com/news/short-sellers-pile-pfizer-buyout-115450624.html,Short Sellers Pile On Pfizer After Buyout Rumors
PFE,PFE:US,BBG000BR2B91,[$$] OrbiMed Logs Two Decades of Novel Attacks on Cancer,2017-03-01 00:14:33 +0000,https://www.wsj.com/articles/vc-profile-orbimed-funds-novel-attacks-on-cancer-1488205956?mod=yahoo_hs,[$$] OrbiMed Logs Two Decades of Novel Attacks on Cancer
PFE,PFE:US,BBG000BR2B91,"Pfizer Prices €4,000,000,000 Debt Offering",2017-02-28 23:53:00 +0000,http://finance.yahoo.com/news/pfizer-prices-4-000-000-235300183.html,[Business Wire] - Pfizer Inc. today announced the pricing of a debt offering consisting of four tranches of notes:
PFE,PFE:US,BBG000BR2B91,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-02-28 23:18:44 +0000,http://biz.yahoo.com/e/170228/pfe8-k.html,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
PFE,PFE:US,BBG000BR2B91,Get Paid While You Wait: 3 Top Dividend Stocks in Big Pharma,2017-02-28 22:52:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bzbr4X7SDiY/get-paid-while-you-wait-3-top-dividend-stocks-in-big-pharma-cm754528,Sit back and let the money roll in That s what stocks that pay great dividends allow investors to do Three big pharma stocks boast especially attractive dividends AbbVie NYSE ABBV Pfizer NYSE PFE and Novo Nordisk NYSE NVO 160 These drugmakers should
PFE,PFE:US,BBG000BR2B91,Get Paid While You Wait: 3 Top Dividend Stocks in Big Pharma,2017-02-28 20:42:00 +0000,http://www.fool.com/investing/2017/02/28/get-paid-while-you-wait-3-top-dividend-stocks-in-b.aspx,Get Paid While You Wait: 3 Top Dividend Stocks in Big Pharma
PFE,PFE:US,BBG000BR2B91,FDA warns Pfizer over contaminated drugs at Kansas plant,2017-02-28 19:43:13 +0000,http://finance.yahoo.com/news/fda-warns-pfizer-over-contaminated-194313785.html,"[Reuters] - The U.S. Food and Drug Administration said Pfizer Inc's process for manufacturing sterile injectable drugs at a plant in McPherson, Kansas was ""out of control"" and put patients at risk, according to a warning letter made public on Tuesday. In the Feb. 14 letter, the FDA said that several products were contaminated with multiple foreign particulates and that the injectable antibiotic vancomycin had been compromised by cardboard pieces. The presence of the foreign matter is ""unacceptable"" and suggests ""a significant loss of control in your manufacturing process"" that represents a ""severe risk of harm to patients,"" the FDA wrote."
PFE,PFE:US,BBG000BR2B91,Results In For Pfizer Inc. (PFE) Rheumatoid Arthritis Study,2017-02-28 18:35:48 +0000,http://www.insidermonkey.com/blog/results-in-for-pfizer-inc-pfe-rheumatoid-arthritis-study-562855/,Results In For Pfizer Inc. (PFE) Rheumatoid Arthritis Study
PFE,PFE:US,BBG000BR2B91,Pfizer Gets FDA Warning Over Contaminated Drugs at Hospira Plant,2017-02-28 17:35:25 +0000,https://www.bloomberg.com/news/articles/2017-02-28/pfizer-gets-fda-warning-over-contaminated-drugs-at-hospira-plant?cmpid=yhoo.headline,Pfizer Gets FDA Warning Over Contaminated Drugs at Hospira Plant
PFE,PFE:US,BBG000BR2B91,"Zacks Industry Outlook Highlights: Johnson & Johnson, Pfizer, Glaxo, Amgen's and Lilly",2017-02-28 16:52:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x3veEitpvqg/zacks-industry-outlook-highlights-johnson-johnson-pfizer-glaxo-amgens-and-lilly-cm754237,For Immediate Release Chicago IL February 28 2017 Today Zacks Equity Research discusses the Industry Pharma Part 1 including Johnson amp Johnson NYSE JNJ Free Report Pfizer NYSE PFE Free Report Glaxo NYSE GSK Free Report Amgen s NASDAQ
PFE,PFE:US,BBG000BR2B91,Pfizer’s Recent Corporate and Pipeline Developments,2017-02-28 15:35:59 +0000,http://marketrealist.com/2017/02/pfizers-recent-corporate-and-pipeline-developments/?utm_source=yahoo&utm_medium=feed,Pfizer’s Recent Corporate and Pipeline Developments
PFE,PFE:US,BBG000BR2B91,Eli Lilly & Co.’s Valuation after Its 4Q16 Earnings Report,2017-02-28 15:35:48 +0000,http://marketrealist.com/2017/02/eli-lilly-co-s-valuation-after-its-4q16-earnings-report/?utm_source=yahoo&utm_medium=feed,Eli Lilly & Co.’s Valuation after Its 4Q16 Earnings Report
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference,2017-02-28 15:00:00 +0000,http://finance.yahoo.com/news/pfizer-invites-public-view-listen-150000834.html,"[Business Wire] - Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by John Young, Group President, Pfizer Essential Health, at the Cowen and Company 37th Annual Healthcare Conference on Tuesday, March 7, 2017 at 11:20 a.m."
PFE,PFE:US,BBG000BR2B91,"Zacks Industry Outlook Highlights: Johnson & Johnson, Pfizer, Glaxo, Amgen's and Lilly",2017-02-28 14:30:02 +0000,http://finance.yahoo.com/news/zacks-industry-outlook-highlights-johnson-143002844.html,"Zacks Industry Outlook Highlights: Johnson & Johnson, Pfizer, Glaxo, Amgen's and Lilly"
PFE,PFE:US,BBG000BR2B91,"Perrigo Company (PRGO) Ex-Dividend Date Scheduled for March 01, 2017",2017-02-28 14:20:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k8KDpQaajO0/perrigo-company-prgo-ex-dividend-date-scheduled-for-march-01-2017-cm754058,Perrigo Company PRGO will begin trading ex dividend on March 01 2017 A cash dividend payment of 0 16 per share is scheduled to be paid on March 21 2017 Shareholders who purchased PRGO prior to the ex dividend date are eligible for the cash dividend payment This represents an 10
PFE,PFE:US,BBG000BR2B91,Pfizer’s Major Product Developments in 4Q16,2017-02-28 14:06:24 +0000,http://marketrealist.com/2017/02/pfizers-major-product-developments-in-4q16/?utm_source=yahoo&utm_medium=feed,Pfizer’s Major Product Developments in 4Q16
PFE,PFE:US,BBG000BR2B91,Pfizer Stock History: How the Drugmaker Became an Industry Giant,2017-02-28 13:51:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fJCw4_sT9P4/pfizer-stock-history-how-the-drugmaker-became-an-industry-giant-cm753989,For nearly 170 years Pfizer NYSE PFE 160 has sought to help improve the world Yet it took nearly a century after its 1849 founding before Pfizer started to press forward with large scale production of penicillin which helped redefine the company s future path as
PFE,PFE:US,BBG000BR2B91,"Merck KGaA, Pfizer get priority review for bladder cancer drug",2017-02-28 12:38:38 +0000,http://finance.yahoo.com/news/merck-kgaa-pfizer-priority-review-123838576.html,"[Reuters] - German drugmaker Merck KGaA and U.S. partner Pfizer have been granted priority review status in the United States as they seek to widen the use of immunotherapy drug avelumab to include bladder cancer. The U.S. Food and Drug Administration will review trial data for the drug against locally advanced or metastatic urothelial carcinoma (mUC) which has worsened despite chemotherapy, within six months instead of the usual 10, Merck said in a statement on Tuesday. Avelumab belongs to a new generation of biotech drugs that stop some tumours from hiding from the immune system, similar to Merck & Co's Keytruda or Roche's Tecentriq."
PFE,PFE:US,BBG000BR2B91,Pfizer’s Profitability and Financial Guidance,2017-02-28 12:36:47 +0000,http://marketrealist.com/2017/02/pfizers-profitability-and-financial-guidance-2/?utm_source=yahoo&utm_medium=feed,Pfizer’s Profitability and Financial Guidance
PFE,PFE:US,BBG000BR2B91,Pfizer Stock History: How the Drugmaker Became an Industry Giant,2017-02-28 12:07:05 +0000,http://www.fool.com/investing/2017/02/28/pfizer-stock-history-how-the-drugmaker-became-an-i.aspx,Pfizer Stock History: How the Drugmaker Became an Industry Giant
PFE,PFE:US,BBG000BR2B91,FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review,2017-02-28 12:00:00 +0000,http://finance.yahoo.com/news/fda-accepts-biologics-license-application-120000950.html,"[PR Newswire] - EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, and Pfizer Inc. today announced that the US Food and Drug Administration (FDA) has accepted for Priority Review EMD Serono's Biologics License Application (BLA) for avelumab* as a treatment for patients with locally advanced or metastatic urothelial carcinoma (mUC) with disease progression on or after platinum-based therapy. The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of August 27, 2017, for avelumab in this indication."
PFE,PFE:US,BBG000BR2B91,The 6 Most Shorted NYSE Stocks,2017-02-28 11:15:08 +0000,http://finance.yahoo.com/news/6-most-shorted-nyse-stocks-111508262.html,The 6 Most Shorted NYSE Stocks
PFE,PFE:US,BBG000BR2B91,"Merck KGaA, Pfizer: FDA Accepts For Priority Review BLA For Avelumab - Quick Facts",2017-02-28 11:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Eum71mjDIr4/merck-kgaa-pfizer-fda-accepts-for-priority-review-bla-for-avelumab--quick-facts-20170228-01240,"Merck KGaA, Pfizer: FDA Accepts For Priority Review BLA For Avelumab - Quick Facts"
PFE,PFE:US,BBG000BR2B91,"Merck KGaA, Pfizer: FDA Accepts For Priority Review BLA For Avelumab - Quick Facts",2017-02-28 11:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TtiXr7b_3cc/merck-kgaa-pfizer-fda-accepts-for-priority-review-bla-for-avelumab--quick-facts-20170228-01239,"Merck KGaA, Pfizer: FDA Accepts For Priority Review BLA For Avelumab - Quick Facts"
PFE,PFE:US,BBG000BR2B91,"Merck, Pfizer: FDA Accepts For Priority Review BLA For Avelumab - Quick Facts",2017-02-28 07:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-NF4vbjI4To/merck-pfizer-fda-accepts-for-priority-review-bla-for-avelumab--quick-facts-20170228-00544,"Merck, Pfizer: FDA Accepts For Priority Review BLA For Avelumab - Quick Facts"
PFE,PFE:US,BBG000BR2B91,Pharma Industry Outlook - February/March 2017,2017-02-28 06:50:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JnCkTN4-Fz8/pharma-industry-outlook-februarymarch-2017-cm753953,There is no doubt that 2016 was a tough year for pharma and biotech stocks with the sector facing a lot of criticism for rising drug prices Although shares did rally post election in November on hopes that drug pricing would not be a key focus area under a Trump presidency the rally turned
PFE,PFE:US,BBG000BR2B91,"Drugmakers pledge restraint, but prices will still soar",2017-02-27 22:12:26 +0000,http://finance.yahoo.com/news/drugmakers-pledge-restraint-prices-still-191004283.html,"Drugmakers pledge restraint, but prices will still soar"
PFE,PFE:US,BBG000BR2B91,"Drugmakers pledge restraint, but prices will still soar",2017-02-27 22:12:21 +0000,http://sg.finance.yahoo.com/news/drugmakers-pledge-restraint-prices-still-191004727.html,"Drugmakers pledge restraint, but prices will still soar"
PFE,PFE:US,BBG000BR2B91,"No, Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Isn’t Doomed",2017-02-27 21:50:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tc7pzab88pE/no-teva-pharmaceutical-industries-ltd-adr-teva-stock-isnt-doomed-cm753855,InvestorPlace Stock Market News Stock Advice amp Trading Tips Pharmaceutical giant Teva Pharmaceutical Industries Ltd ADR NYSE TEVA got a much needed break this week Source Open Grid Scheduler Modified After being told in late January the company s patent protection
PFE,PFE:US,BBG000BR2B91,Pfizer Reports Top-Line Results for Rheumatoid Arthritis Treatment Study,2017-02-27 21:46:19 +0000,http://finance.yahoo.com/news/pfizer-reports-top-line-results-214619731.html,Pfizer Reports Top-Line Results for Rheumatoid Arthritis Treatment Study
PFE,PFE:US,BBG000BR2B91,Why You Shouldn't Look Down On Your Depressed Colleagues,2017-02-27 18:22:00 +0000,http://www.forbes.com/sites/simonconstable/2017/02/27/why-you-shouldnt-look-down-on-your-depressed-colleagues/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Why You Shouldn't Look Down On Your Depressed Colleagues
PFE,PFE:US,BBG000BR2B91,"Dow Movers: MSFT, CVX",2017-02-27 16:50:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kM40-0PpcDM/dow-movers-msft-cvx-cm753585,In early trading on Monday shares of Chevron topped the list of the day s best performing Dow Jones Industrial Average components trading up 0 7 Year to date Chevron has lost about 5 8 of its value And the worst performing Dow component thus far on the day is Microsoft trading
PFE,PFE:US,BBG000BR2B91,Pfizer’s Products with Falling Revenues in 4Q16,2017-02-27 15:38:09 +0000,http://marketrealist.com/2017/02/pfizers-products-with-falling-revenues-in-4q16/?utm_source=yahoo&utm_medium=feed,Pfizer’s Products with Falling Revenues in 4Q16
PFE,PFE:US,BBG000BR2B91,"Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for February 28, 2017",2017-02-27 14:19:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CRgO1X5Zv5Y/teva-pharmaceutical-industries-limited-teva-ex-dividend-date-scheduled-for-february-28-2017-cm753442,Teva Pharmaceutical Industries Limited TEVA will begin trading ex dividend on February 28 2017 A cash dividend payment of 0 289 per share is scheduled to be paid on March 20 2017 Shareholders who purchased TEVA prior to the ex dividend date are eligible for the cash dividend payment
PFE,PFE:US,BBG000BR2B91,Understanding Pfizer’s Growth Contributors in 4Q16,2017-02-27 14:08:22 +0000,http://marketrealist.com/2017/02/understanding-pfizers-growth-contributors-in-4q16/?utm_source=yahoo&utm_medium=feed,Understanding Pfizer’s Growth Contributors in 4Q16
PFE,PFE:US,BBG000BR2B91,Pfizer’s Innovative Health and Essential Health in 4Q16,2017-02-27 12:38:10 +0000,http://marketrealist.com/2017/02/pfizers-innovative-health-and-essential-health-in-4q16/?utm_source=yahoo&utm_medium=feed,Pfizer’s Innovative Health and Essential Health in 4Q16
PFE,PFE:US,BBG000BR2B91,Merck & Co.’s Valuation after Its 4Q16 Earnings,2017-02-27 12:35:53 +0000,http://marketrealist.com/2017/02/mercks-valuation-after-its-4q16-earnings/?utm_source=yahoo&utm_medium=feed,Merck & Co.’s Valuation after Its 4Q16 Earnings
PFE,PFE:US,BBG000BR2B91,"Biogen alums team up to launch Waltham biotech, with backing from Henri Termeer",2017-02-27 12:15:08 +0000,http://www.bizjournals.com/boston/news/2017/02/27/biogen-alums-team-up-to-launch-waltham-biotech.html?ana=yahoo,"Biogen alums team up to launch Waltham biotech, with backing from Henri Termeer"
PFE,PFE:US,BBG000BR2B91,Details Still Missing on Republicans' 'Once in a Generation' Tax Plan,2017-02-25 14:25:00 +0000,https://www.thestreet.com/story/14016045/1/details-still-missing-on-republicans-once-in-a-generation-tax-plan.html?puc=yahoo&cm_ven=YAHOO,Details Still Missing on Republicans' 'Once in a Generation' Tax Plan
PFE,PFE:US,BBG000BR2B91,3 Biotech Long Shots: Boom Or Bust?,2017-02-25 00:50:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e4VtaovgNro/3-biotech-long-shots-boom-or-bust-cm753149,The ability to develop game changing new drugs that revolutionize patient care could cause shares in Axovant Sciences NYSE AXON Celldex Therapeutics NASDAQ CLDX and Esperion Therapeutics NASDAQ ESPR to soar However success may be tough to come by and that
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: Wal-Mart, Home Depot Beat on Earnings, Boeing Wins $1.32B Order from Juneyao",2017-02-24 23:49:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MLcEYJe0w8I/dow-30-stock-roundup-wal-mart-home-depot-beat-on-earnings-boeing-wins-132b-order-from-juneyao-cm753126,The Dow notched up a record streak of gains over a holiday shortened week Markets were closed on Monday to commemorate President s Day The index increased on Tuesday after key components posted encouraging earnings results President Trump s comments and his possible policy proposals continued
PFE,PFE:US,BBG000BR2B91,Pfizer subpoenaed in U.S. over patient assistance plans,2017-02-24 23:43:23 +0000,http://in.finance.yahoo.com/news/pfizer-subpoenaed-u-over-patient-234323147.html,Pfizer subpoenaed in U.S. over patient assistance plans
PFE,PFE:US,BBG000BR2B91,Pfizer Subpoenaed in DOJ Investigation of Drugmaker Charity Connections,2017-02-24 22:30:21 +0000,http://finance.yahoo.com/news/pfizer-subpoenaed-doj-investigation-drugmaker-223021879.html,Pfizer Subpoenaed in DOJ Investigation of Drugmaker Charity Connections
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Feb 24, 2017 :  SE, F, CSCO, MT, PFE, MGM, KMI, QQQ, EBAY, ELNK, HOLX, STX",2017-02-24 21:59:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/84W7F2G4lHk/after-hours-most-active-for-feb-24-2017-se-f-csco-mt-pfe-mgm-kmi-qqq-ebay-elnk-holx-stx-cm753087,The NASDAQ 100 After Hours Indicator is down 2 09 to 5 341 22 The total After hours volume is currently 32 579 990 shares traded The following are the most active stocks for the after hours session Spectra Energy Corp SE is unchanged at 40 68 with 13 495 303
PFE,PFE:US,BBG000BR2B91,Pfizer’s Valuation after Its 4Q16 Earnings Release,2017-02-24 21:53:02 +0000,http://marketrealist.com/2017/02/pfizers-valuation-after-its-4q16-earnings-release/?utm_source=yahoo&utm_medium=feed,Pfizer’s Valuation after Its 4Q16 Earnings Release
PFE,PFE:US,BBG000BR2B91,"Pfizer Prices $1,065,000,000 Debt Offering",2017-02-24 18:09:00 +0000,http://finance.yahoo.com/news/pfizer-prices-1-065-000-180900126.html,"[Business Wire] - Pfizer Inc. today announced the pricing of $1,065,000,000 aggregate principal amount of 4.20% notes due 2047. This offering is expected to be sold to professional institutional investors in Taiwan, with application to be made to list the notes on the Taipei Exchange."
PFE,PFE:US,BBG000BR2B91,Novartis Cancer Drug Zykadia Gets Priority Review,2017-02-24 16:05:00 +0000,http://www.investopedia.com/news/novartis-cancer-drug-zykadia-gets-priority-review-nvs/?partner=YahooSA,Novartis Cancer Drug Zykadia Gets Priority Review
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Is BMY the Next Acquisition Target? Priority Review for PFE, Novartis Drugs",2017-02-24 14:54:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IzbzaW6L2ls/pharma-stock-roundup-is-bmy-the-next-acquisition-target-priority-review-for-pfe-novartis-drugs-cm752604,This week focus remained on Bristol Myers BMY with the company making additions to its Board and billionaire activist investor Carl Icahn reportedly acquiring a stake in the company Recap of the Week s Most Important Stories Is Bristol Myers the Next Takeover Target According
PFE,PFE:US,BBG000BR2B91,"Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for February 27, 2017",2017-02-24 14:20:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cApBXD19yWU/phibro-animal-health-corporation-pahc-ex-dividend-date-scheduled-for-february-27-2017-cm752644,Phibro Animal Health Corporation PAHC will begin trading ex dividend on February 27 2017 A cash dividend payment of 0 1 per share is scheduled to be paid on March 22 2017 Shareholders who purchased PAHC prior to the ex dividend date are eligible for the cash dividend payment This
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. -- Moody's assigns A1 to Pfizer's notes; stable outlook,2017-02-24 13:45:03 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_362554&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170224_PR_362554,Pfizer Inc. -- Moody's assigns A1 to Pfizer's notes; stable outlook
PFE,PFE:US,BBG000BR2B91,Performance of Eli Lilly & Co.’s Business Segments in 4Q16,2017-02-24 12:39:01 +0000,http://marketrealist.com/2017/02/performance-of-eli-lilly-co-s-business-segments-in-4q16/?utm_source=yahoo&utm_medium=feed,Performance of Eli Lilly & Co.’s Business Segments in 4Q16
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Is BMY the Next Acquisition Target? Priority Review for PFE, Novartis Drugs",2017-02-24 12:27:12 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-bmy-next-122712720.html,"Pharma Stock Roundup: Is BMY the Next Acquisition Target? Priority Review for PFE, Novartis Drugs"
PFE,PFE:US,BBG000BR2B91,Dow Jones Leads Market Gains on Thursday,2017-02-23 23:29:57 +0000,http://finance.yahoo.com/news/dow-jones-leads-market-gains-232957774.html,Dow Jones Leads Market Gains on Thursday
PFE,PFE:US,BBG000BR2B91,United Therapeutics feels squeeze from increased pulmonary hypertension competition,2017-02-23 22:39:20 +0000,http://www.bizjournals.com/washington/news/2017/02/23/united-therapeutics-feeling-squeeze-from-increased.html?ana=yahoo,United Therapeutics feels squeeze from increased pulmonary hypertension competition
PFE,PFE:US,BBG000BR2B91,"PFIZER INC Files SEC form 8-K, Financial Statements and Exhibits",2017-02-23 22:06:00 +0000,http://biz.yahoo.com/e/170223/pfe8-k.html,"PFIZER INC Files SEC form 8-K, Financial Statements and Exhibits"
PFE,PFE:US,BBG000BR2B91,"PFIZER INC Files SEC form 10-K, Annual Report",2017-02-23 21:54:41 +0000,http://biz.yahoo.com/e/170223/pfe10-k.html,"PFIZER INC Files SEC form 10-K, Annual Report"
PFE,PFE:US,BBG000BR2B91,"Dow logs 10th straight record, but Nasdaq stumbles a second day",2017-02-23 21:36:24 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=F7152726-F9A5-11E6-83E8-CFED21FD304B&siteid=yhoof2,"Dow logs 10th straight record, but Nasdaq stumbles a second day"
PFE,PFE:US,BBG000BR2B91,Ronald E. Blaylock Elected to Pfizer’s Board of Directors,2017-02-23 21:15:00 +0000,http://finance.yahoo.com/news/ronald-e-blaylock-elected-pfizer-211500471.html,"[Business Wire] - Pfizer Inc. today announced the election of Ronald E. Blaylock to its Board of Directors, effective immediately. Mr. Blaylock was also appointed to the Corporate Governance and Science and Technology Committees of Pfizer’s Board."
PFE,PFE:US,BBG000BR2B91,"Johnson & Johnson, Pfizer Lead DJIA Higher on Thursday",2017-02-23 21:01:35 +0000,http://finance.yahoo.com/news/johnson-johnson-pfizer-lead-djia-210135625.html,"Johnson & Johnson, Pfizer Lead DJIA Higher on Thursday"
PFE,PFE:US,BBG000BR2B91,Thursday's ETF with Unusual Volume: PPH,2017-02-23 19:49:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TNx2Z8W2pgo/thursdays-etf-with-unusual-volume-pph-cm752257,The Pharmaceutical ETF PPH is seeing unusually high volume in afternoon trading Thursday with over 2 0 million shares traded versus three month average volume of about 243 000 Shares of PPH were up about 1 1 on the day Components of that ETF with the highest volume on Thursday
PFE,PFE:US,BBG000BR2B91,"Dow Movers: GS, CVX",2017-02-23 16:53:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LmBvh1hXnAs/dow-movers-gs-cvx-cm752059,In early trading on Thursday shares of Chevron CVX topped the list of the day s best performing Dow Jones Industrial Average components trading up 1 0 Year to date Chevron has lost about 5 3 of its value And the worst performing Dow component thus far on the day is Goldman
PFE,PFE:US,BBG000BR2B91,Better Cloud Growth Stock: Twilio Inc. vs. Veeva Systems,2017-02-23 16:53:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NZ-AQ0gGnL4/better-cloud-growth-stock-twilio-inc-vs-veeva-systems-cm752071,The cloud services industry is filled with high growth companies but their stock prices can be highly volatile For example cloud services vendor Twilio NYSE TWLO skyrocketed from its IPO price of 15 to nearly 70 last year but then tumbled back to the lower 30s
PFE,PFE:US,BBG000BR2B91,Seeking Alpha Interviews: Bret Jensen On Promising Drugs And Acquisition Targets,2017-02-23 15:51:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YJer37_PmcE/seeking-alpha-interviews-bret-jensen-on-promising-drugs-and-acquisition-targets-cm752029,By Bret Jensen ByBret Jensen In the fifth episode of Seeking Alpha Interviews Lilamax s Jane King sits down with Bret Jensen to discuss regulatory changes merger activity and drug development affecting action in the biotech sector In the fifth episode of Seeking Alpha Interviews Lilamax
PFE,PFE:US,BBG000BR2B91,Clovis (CLVS) Q4 Loss Wider than Expected; Focus on Rubraca,2017-02-23 14:50:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bfUJNCm_uis/clovis-clvs-q4-loss-wider-than-expected-focus-on-rubraca-cm751913,Clovis Oncology Inc CLVS reported fourth quarter 2016 loss of 1 83 per share wider than the Zacks Consensus Estimate of a loss of 1 65 However the loss was much narrower than the year ago loss of 2 23 per share Clovis did not generate significant revenues in the reported quarter as
PFE,PFE:US,BBG000BR2B91,"Allergan plc. (AGN) Ex-Dividend Date Scheduled for February 24, 2017",2017-02-23 14:20:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WPG3whOyNpQ/allergan-plc-agn-ex-dividend-date-scheduled-for-february-24-2017-cm751848,Allergan plc AGN will begin trading ex dividend on February 24 2017 A cash dividend payment of 0 7 per share is scheduled to be paid on March 28 2017 Shareholders who purchased AGN prior to the ex dividend date are eligible for the cash dividend payment This represents an 1300
PFE,PFE:US,BBG000BR2B91,"Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for February 24, 2017",2017-02-23 14:20:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yAn5XZhkxJE/johnson-johnson-jnj-ex-dividend-date-scheduled-for-february-24-2017-cm751843,Johnson amp Johnson JNJ will begin trading ex dividend on February 24 2017 A cash dividend payment of 0 8 per share is scheduled to be paid on March 14 2017 Shareholders who purchased JNJ prior to the ex dividend date are eligible for the cash dividend payment This marks the
PFE,PFE:US,BBG000BR2B91,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Fading Fast,2017-02-23 08:49:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/okoeyTjuOYg/teva-pharmaceutical-industries-ltd-adr-teva-stock-is-fading-fast-cm751738,InvestorPlace Stock Market News Stock Advice amp Trading Tips Teva Pharmaceutical Industries Ltd ADR NYSE TEVA has enjoyed a solid run during the past week with TEVA stock up more than 12 since Feb 10 A strong showing in the earnings
PFE,PFE:US,BBG000BR2B91,Pfizer's Leukemia Candidate Gets Priority Review in U.S.,2017-02-23 00:50:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M_MRKdPZ84s/pfizers-leukemia-candidate-gets-priority-review-in-us-cm751705,Pfizer Inc PFE announced that its Biologics License Application BLA for leukemia candidate inotuzumab ozogamicin has been accepted for priority review by the FDA Inotuzumab ozogamicin is being evaluated for the treatment of adult patients with relapsed or refractory B cell precursor
PFE,PFE:US,BBG000BR2B91,Who Could Buy Bristol-Myers Squibb?,2017-02-23 00:50:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EhdxWGGKiSc/who-could-buy-bristol-myers-squibb-cm751696,Billionaire activist investor Carl Icahn has reportedly set his sights on Bristol Myers Squibb NYSE BMY a 90 billion market cap biopharma that s carving out an important leadership position in immuno oncology If past is prologue Icahn s about to start advocating for big
PFE,PFE:US,BBG000BR2B91,Who Could Buy Bristol-Myers Squibb?,2017-02-22 23:21:05 +0000,http://www.fool.com/investing/2017/02/22/who-could-buy-bristol-myers-squibb.aspx,Who Could Buy Bristol-Myers Squibb?
PFE,PFE:US,BBG000BR2B91,Pfizer's Leukemia Candidate Gets Priority Review in U.S.,2017-02-22 22:08:10 +0000,http://finance.yahoo.com/news/pfizers-leukemia-candidate-gets-priority-220810266.html,Pfizer's Leukemia Candidate Gets Priority Review in U.S.
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Feb 22, 2017 :  CUZ, VMBS, AAPL, PFE, AMAT, PHM, QQQ, VER, MSFT, SQ, CSX, FCX",2017-02-22 21:58:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mXvD5dkALeU/after-hours-most-active-for-feb-22-2017-cuz-vmbs-aapl-pfe-amat-phm-qqq-ver-msft-sq-csx-fcx-cm751653,The NASDAQ 100 After Hours Indicator is down 2 47 to 5 349 66 The total After hours volume is currently 29 753 761 shares traded The following are the most active stocks for the after hours session Cousins Properties Incorporated CUZ is 0 01 at 8 59 with 2 681
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. (PFE) Invest For Attractive Valuation And The 4% Dividend Yield,2017-02-22 21:41:05 +0000,http://www.insidermonkey.com/blog/pfizer-inc-pfe-invest-for-attractive-valuation-and-the-4-dividend-yield-561556/,Pfizer Inc. (PFE) Invest For Attractive Valuation And The 4% Dividend Yield
PFE,PFE:US,BBG000BR2B91,Manufacturing Delay Of Generic Drug From Pfizer Inc. (PFE) A Relief For Teva Pharmaceutical Industries Ltd (ADR) (TEVA),2017-02-22 19:02:19 +0000,http://www.insidermonkey.com/blog/manufacturing-delay-of-generic-drug-from-pfizer-inc-pfe-a-relief-for-teva-pharmaceutical-industries-ltd-adr-teva-561521/,Manufacturing Delay Of Generic Drug From Pfizer Inc. (PFE) A Relief For Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
PFE,PFE:US,BBG000BR2B91,"Goldman Says Buy Health-Care, Retail Volatility Before Trump Address",2017-02-22 18:51:42 +0000,http://blogs.wsj.com/moneybeat/2017/02/22/goldman-says-buy-health-care-retail-volatility-before-trump-address/?mod=yahoo_hs,"Goldman Says Buy Health-Care, Retail Volatility Before Trump Address"
PFE,PFE:US,BBG000BR2B91,Why Spark's CEO says 2017 may be a 'historic year' for his gene therapy company,2017-02-22 17:25:09 +0000,http://www.bizjournals.com/philadelphia/news/2017/02/22/spark-therapeutics-gene-therapy-final-stages-once.html?ana=yahoo,Why Spark's CEO says 2017 may be a 'historic year' for his gene therapy company
PFE,PFE:US,BBG000BR2B91,Merck & Co.’s Segment-Wise Revenues for 4Q16,2017-02-22 14:08:26 +0000,http://marketrealist.com/2017/02/merck-and-co-s-segment-wise-revenues-for-4q16/?utm_source=yahoo&utm_medium=feed,Merck & Co.’s Segment-Wise Revenues for 4Q16
PFE,PFE:US,BBG000BR2B91,World's Biggest Drugmaker Quits London and Swiss Listings,2017-02-22 13:23:00 +0000,http://www.thestreet.com/video/14010754/world-s-biggest-drugmaker-quits-london-and-swiss-listings.html?puc=yahoov&cm_ven=YAHOOV,World's Biggest Drugmaker Quits London and Swiss Listings
PFE,PFE:US,BBG000BR2B91,"Early movers: TOL, DISH, SIX, TRCO, FSLR, & more",2017-02-22 12:54:03 +0000,http://www.cnbc.com/id/104297209?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104297209,"Early movers: TOL, DISH, SIX, TRCO, FSLR, & more"
PFE,PFE:US,BBG000BR2B91,Viagra maker Pfizer cites poor performance for stock de-listing,2017-02-22 10:39:00 +0000,http://uk.finance.yahoo.com/news/viagra-maker-pfizer-cites-poor-101900975.html,Viagra maker Pfizer cites poor performance for stock de-listing
PFE,PFE:US,BBG000BR2B91,"Pfizer Quits London and Swiss Listings, Says 'Limited Liquidity' in European Trading",2017-02-22 08:33:00 +0000,https://www.thestreet.com/story/14010654/1/pfizer-quits-london-and-swiss-listings-says-limited-liquidity-in-european-trading.html?puc=yahoo&cm_ven=YAHOO,"Pfizer Quits London and Swiss Listings, Says 'Limited Liquidity' in European Trading"
PFE,PFE:US,BBG000BR2B91,Factor Xa's Win Billions of Dollars in Sales From Warfarin,2017-02-22 07:07:45 +0000,http://www.fool.com/investing/2017/02/21/factor-xas-win-billions-of-dollars-in-sales-from-w.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Factor Xa's Win Billions of Dollars in Sales From Warfarin
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. Merck & Co. Inc.,2017-02-22 06:57:19 +0000,http://www.fool.com/investing/2017/02/21/better-buy-pfizer-inc-vs-merck.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Pfizer Inc. vs. Merck & Co. Inc.
PFE,PFE:US,BBG000BR2B91,"Dow Jones Industrial Average Scores New High, 8th Straight Win",2017-02-21 23:06:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zLaNlDIxeHY/dow-jones-industrial-average-scores-new-high-8th-straight-win-cm750934,The 160 Dow Jones Industrial Average DJIA 160 notched its eighth straight win as the Dow S amp P 500 Index SPX and Nasdaq Composite COMP all finished with new record highs Traders applauded a round of earnings from big name retail stocks including blue chips 160 Wal
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Feb 21, 2017 :  ODP, GE, AKS, AAPL, BX, F, PFE, AME, MSFT, INTC, CMCSA, TVIX",2017-02-21 21:56:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8lVeXCzOkMY/after-hours-most-active-for-feb-21-2017-odp-ge-aks-aapl-bx-f-pfe-ame-msft-intc-cmcsa-tvix-cm750925,The NASDAQ 100 After Hours Indicator is down 2 83 to 5 347 9 The total After hours volume is currently 49 943 764 shares traded The following are the most active stocks for the after hours session Office Depot Inc ODP is unchanged at 4 68 with 2 858 700
PFE,PFE:US,BBG000BR2B91,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Still Looks Strong,2017-02-21 19:07:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bcv7XuqV3Qg/teva-pharmaceutical-industries-ltd-adr-teva-stock-still-looks-strong-cm750819,InvestorPlace Stock Market News Stock Advice amp Trading Tips I m a big fan of Israeli stocks First and foremost Israelis are essentially the world s most educated people You can t progress as a society unless rationality and science reigns and they have it in droves I also love
PFE,PFE:US,BBG000BR2B91,Factor Xa's Win Billions of Dollars in Sales From Warfarin,2017-02-21 18:09:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LAwiGRpNWSA/factor-xas-win-billions-of-dollars-in-sales-from-warfarin-cm750728,Similar efficacy and a better safety profile are allowing a new type of anticoagulants known as factor Xa inhibitors to capture billions of dollars in sales away from warfarin a decades old drug that requires frequent testing dose adjustments and dietary changes Bristol Myers
PFE,PFE:US,BBG000BR2B91,"Momenta, Pfizer Give Teva Pharma Breathing Room On Generic MS Drug",2017-02-21 17:37:27 +0000,http://www.investors.com/news/technology/momenta-pfizer-give-teva-pharma-breathing-room-on-generic-ms-drug/,"Momenta, Pfizer Give Teva Pharma Breathing Room On Generic MS Drug"
PFE,PFE:US,BBG000BR2B91,"XLV, PFE, MRK, LLY: ETF Outflow Alert",2017-02-21 17:07:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7ZFL5y8x_II/xlv-pfe-mrk-lly-etf-outflow-alert-cm750661,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Health Care Select Sector SPDR Fund Symbol XLV where we have detected an approximate 18 4 million dollar outflow that s a 0 1 decrease week over week
PFE,PFE:US,BBG000BR2B91,Momenta shares plunge after supplier receives warning letter from FDA on multiple sclerosis drug,2017-02-21 16:35:28 +0000,http://www.cnbc.com/id/104294993?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104294993,Momenta shares plunge after supplier receives warning letter from FDA on multiple sclerosis drug
PFE,PFE:US,BBG000BR2B91,"Here’s What The Latest Pain Therapeutics, Inc. (PTIE) Update Means",2017-02-21 16:11:43 +0000,http://www.insidermonkey.com/blog/heres-what-the-latest-pain-therapeutics-inc-ptie-update-means-561072/,"Here’s What The Latest Pain Therapeutics, Inc. (PTIE) Update Means"
PFE,PFE:US,BBG000BR2B91,"Boeing, GE and Oracle CEOs Support Border Adjustment Tax in Letter to Congress",2017-02-21 15:57:00 +0000,http://www.thestreet.com/video/14009565/boeing-ge-and-oracle-ceos-support-border-adjustment-tax-in-letter-to-congress.html?puc=yahoov&cm_ven=YAHOOV,"Boeing, GE and Oracle CEOs Support Border Adjustment Tax in Letter to Congress"
PFE,PFE:US,BBG000BR2B91,"Execs from Boeing, Pfizer Send Letter Backing House GOP Tax Plan",2017-02-21 15:47:00 +0000,http://finance.yahoo.com/news/execs-boeing-pfizer-send-letter-154700805.html,"Execs from Boeing, Pfizer Send Letter Backing House GOP Tax Plan"
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. Merck & Co. Inc.,2017-02-21 13:53:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DKmbIsEaOz8/better-buy-pfizer-inc-vs-merck-co-inc-cm750343,Investors have really liked Merck NYSE MRK stock over the last 12 months with shares jumping around 30 Pfizer NYSE PFE has performed pretty well also but not nearly at the level of Merck The big drugmaker s stock is up close to 15 But past performance doesn
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Acceptance of Regulatory Submission for Inotuzumab Ozogamicin by the U.S. Food and Drug Administration,2017-02-21 13:00:00 +0000,http://finance.yahoo.com/news/pfizer-announces-acceptance-regulatory-submission-130000287.html,[Business Wire] - Pfizer Inc. today announced that a Biologics License Application for inotuzumab ozogamicin has been accepted for filing and granted Priority Review by the U.S. Food and Drug Administration .
PFE,PFE:US,BBG000BR2B91,Pfizer Says FDA Accepts BLA For Inotuzumab Ozogamicin - Quick Facts,2017-02-21 08:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eM5nKkPLNNg/pfizer-says-fda-accepts-bla-for-inotuzumab-ozogamicin--quick-facts-20170221-00680,Pfizer Says FDA Accepts BLA For Inotuzumab Ozogamicin - Quick Facts
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Feb 17, 2017 :  PFE, NI, HPQ, PGNX, CSCO, QQQ, WFT, ORCL, BAC, SPLS, SBUX, MSFT",2017-02-20 21:52:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1flrDqYbtI0/after-hours-most-active-for-feb-17-2017-pfe-ni-hpq-pgnx-csco-qqq-wft-orcl-bac-spls-sbux-msft-cm750287,The NASDAQ 100 After Hours Indicator is down 3 21 to 5 321 51 The total After hours volume is currently 52 128 827 shares traded The following are the most active stocks for the after hours session Pfizer Inc PFE is 0 09 at 33 53 with 5 298 457 shares traded PFE
PFE,PFE:US,BBG000BR2B91,Collapse of Kraft-Unilever tie-up extends run of failed mega-deals,2017-02-20 19:45:22 +0000,http://sg.finance.yahoo.com/news/collapse-kraft-unilever-tie-extends-194522763.html,Collapse of Kraft-Unilever tie-up extends run of failed mega-deals
PFE,PFE:US,BBG000BR2B91,A Billionaire Recently Bought Pfizer Stock -- and So Did I,2017-02-19 13:52:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6HRS0sgy0N4/a-billionaire-recently-bought-pfizer-stock-and-so-did-i-cm750085,If you combined hedge fund investor David Tepper s net worth with mine you d have around 11 billion Of course Tepper is a multibillionaire ranked as one of the wealthiest people in the U S Let s just say his contribution to our combined net worth is a bit more than mine Tepper
PFE,PFE:US,BBG000BR2B91,A Billionaire Recently Bought Pfizer Stock -- and So Did I,2017-02-19 12:54:19 +0000,http://www.fool.com/investing/2017/02/19/a-billionaire-recently-bought-pfizer-stock-and-so.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,A Billionaire Recently Bought Pfizer Stock -- and So Did I
PFE,PFE:US,BBG000BR2B91,"Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc.",2017-02-18 22:41:56 +0000,http://www.fool.com/investing/2017/02/18/better-buy-gilead-sciences-inc-vs-pfizer.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc."
PFE,PFE:US,BBG000BR2B91,"Better Buy: Gilead Sciences, Inc. vs. Pfizer Inc.",2017-02-18 17:51:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SEnXv6dVtzw/better-buy-gilead-sciences-inc-vs-pfizer-inc-cm750025,Your time horizon is important when comparing the performance of different stocks Gilead Sciences NASDAQ GILD for example handily beat Pfizer NYSE PFE over the past five years But Pfizer is the bigger winner over the last 12 months However when picking a stock
PFE,PFE:US,BBG000BR2B91,The Best Investments for an IRA,2017-02-18 13:52:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PidKP0ndsIU/the-best-investments-for-an-ira-cm749997,An IRA is a fantastic way to build long term wealth but it can be tricky knowing which stocks or ETFs are best to own in one There are thousands of publicly traded companies and ETFs to choose from and they don t all deserve a spot in your portfolio How do you separate the good from
PFE,PFE:US,BBG000BR2B91,The Best Investments for an IRA,2017-02-18 12:01:08 +0000,http://www.fool.com/retirement/2017/02/18/the-best-investments-for-an-ira.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Best Investments for an IRA
PFE,PFE:US,BBG000BR2B91,Roche says Phase II trial supports twin treatment for kidney cancer,2017-02-18 10:53:47 +0000,http://finance.yahoo.com/news/roche-says-phase-ii-trial-105347424.html,"[Reuters] - Swiss pharmaceuticals company Roche said on Saturday that a combination of its immunotherapy drug Tecentriq and its blockbuster cancer drug Avastin had shown encouraging results in a Phase II trial in treating a type of kidney cancer. The study found that the combination had a ""manageable safety profile"" when used for locally advanced or metastatic renal cell carcinoma (mRCC). The tests showed promising effectiveness compared with the standard treatment for mRCC, sunitinib, which is sold by Pfizer under the brand name Sutent."
PFE,PFE:US,BBG000BR2B91,Momenta Pharma shares halted as drug application hits speed bump,2017-02-17 23:41:03 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=DED3AEE5-5260-4152-B455-66BAFB6AE370&siteid=yhoof2,Momenta Pharma shares halted as drug application hits speed bump
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Feb 17, 2017 :  PFE, NI, PGNX, CSCO, ORCL, WFC, SPLS, PEG, QQQ, BAC, SBUX, MSFT",2017-02-17 22:01:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1Fv3I3TCLRA/after-hours-most-active-for-feb-17-2017-pfe-ni-pgnx-csco-orcl-wfc-spls-peg-qqq-bac-sbux-msft-cm749871,The NASDAQ 100 After Hours Indicator is down 2 73 to 5 321 99 The total After hours volume is currently 47 746 501 shares traded The following are the most active stocks for the after hours session Pfizer Inc PFE is unchanged at 33 62 with 5 002 194 shares
PFE,PFE:US,BBG000BR2B91,Trade or fade this week's Dow winners?,2017-02-17 22:01:00 +0000,http://finance.yahoo.com/video/trade-fade-weeks-dow-winners-220100415.html,Trade or fade this week's Dow winners?
PFE,PFE:US,BBG000BR2B91,"AstraZeneca Could Give Pfizer, Tesaro Leg Up In Breast Cancer: Leerink",2017-02-17 21:31:05 +0000,http://www.investors.com/news/technology/astrazeneca-could-give-pfizer-tesaro-leg-up-in-breast-cancer-leerink/,"AstraZeneca Could Give Pfizer, Tesaro Leg Up In Breast Cancer: Leerink"
PFE,PFE:US,BBG000BR2B91,New Data in Crohn’s Disease Patients Shows Similar Efficacy and Safety Profiles for INFLECTRA® and REMICADE®a,2017-02-17 17:00:00 +0000,http://uk.finance.yahoo.com/news/data-crohn-disease-patients-shows-170000120.html,New Data in Crohn’s Disease Patients Shows Similar Efficacy and Safety Profiles for INFLECTRA® and REMICADE®a
PFE,PFE:US,BBG000BR2B91,The Math Shows XLV Can Go To $81,2017-02-17 15:53:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fAvDfh8Ikk4/the-math-shows-xlv-can-go-to-81-cm749537,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
PFE,PFE:US,BBG000BR2B91,Pfizer's Xeljanz Combo Comparable to AbbVie's Humira,2017-02-17 14:58:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c_ZU8zUKY1s/pfizers-xeljanz-combo-comparable-to-abbvies-humira-cm749438,Pfizer Inc PFE announced top line results from a head to head study comparing its rheumatoid arthritis RA drug Xeljanz with AbbVie Inc s ABBV Humira Xeljanz 5 mg twice daily a JAK inhibitor is presently approved as a second line treatment for the treatment of moderate to
PFE,PFE:US,BBG000BR2B91,Pfizer's Xeljanz Combo Comparable to AbbVie's Humira,2017-02-17 13:13:01 +0000,http://finance.yahoo.com/news/pfizers-xeljanz-combo-comparable-abbvies-131301739.html,Pfizer's Xeljanz Combo Comparable to AbbVie's Humira
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Merck's Alzheimer's Study Halted, Allergan to Buy ZELTIQ",2017-02-17 12:21:12 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-mercks-alzheimers-122112453.html,"Pharma Stock Roundup: Merck's Alzheimer's Study Halted, Allergan to Buy ZELTIQ"
PFE,PFE:US,BBG000BR2B91,Santhera opens Mass. office as local Duchenne ecosystem grows,2017-02-17 11:55:07 +0000,http://www.bizjournals.com/boston/news/2017/02/17/santhera-opens-mass-office-as-local-duchenne.html?ana=yahoo,Santhera opens Mass. office as local Duchenne ecosystem grows
PFE,PFE:US,BBG000BR2B91,Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks,2017-02-16 23:55:26 +0000,http://www.fool.com/investing/2017/02/16/why-this-billionaire-just-shelled-out-11-billion-o.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks
PFE,PFE:US,BBG000BR2B91,Bullish Two Hundred Day Moving Average Cross - PFE,2017-02-16 22:54:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WAkdUvu2Fo0/bullish-two-hundred-day-moving-average-cross-pfe-cm749238,In trading on Thursday shares of Pfizer Inc Symbol PFE crossed above their 200 day moving average of 33 61 changing hands as high as 33 88 per share Pfizer Inc shares are currently trading up about 0 3 on the day The chart below shows the one year performance of PFE shares versus its
PFE,PFE:US,BBG000BR2B91,Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks,2017-02-16 21:55:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cLW2Vs0vmNU/why-this-billionaire-just-shelled-out-11-billion-on-4-drug-stocks-cm749190,A billion here a billion there and pretty soon you re talking about real money It s debatable who first uttered that phrase What isn t debatable though is that David Tepper and Appaloosa Management are accustomed to throwing around plenty of real money The multi billion
PFE,PFE:US,BBG000BR2B91,3 Dividend Stocks That Prove Boring Is Beautiful,2017-02-16 20:57:23 +0000,http://www.fool.com/investing/2017/02/15/3-dividend-stocks-that-prove-boring-is-beautiful.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Dividend Stocks That Prove Boring Is Beautiful
PFE,PFE:US,BBG000BR2B91,How Bristol-Myers Squibb and Pfizer Are Winning a Big Brawl in Blood Thinners,2017-02-16 17:55:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/coN6cS4qFbU/how-bristol-myers-squibb-and-pfizer-are-winning-a-big-brawl-in-blood-thinners-cm749029,Warfarin may have dominanted the 10 billion market for anticoagulants for the past 50 or so years but a new class of drugs that works in an entirely new way is quickly relegating warfarin s use to the dustbin Factor Xa inhibitors that keep blood clots from forming without
PFE,PFE:US,BBG000BR2B91,David Tepper Invests Heavily in Pharma in 4th Quarter,2017-02-16 17:06:55 +0000,http://finance.yahoo.com/news/david-tepper-invests-heavily-pharma-170655363.html,David Tepper Invests Heavily in Pharma in 4th Quarter
PFE,PFE:US,BBG000BR2B91,How Bristol-Myers Squibb and Pfizer Are Winning a Big Brawl in Blood Thinners,2017-02-16 16:41:06 +0000,http://www.fool.com/investing/2017/02/16/how-bristol-myers-squibb-and-pfizer-are-winning-a.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,How Bristol-Myers Squibb and Pfizer Are Winning a Big Brawl in Blood Thinners
PFE,PFE:US,BBG000BR2B91,"Procter & Gamble, Pfizer Lead Market Gains",2017-02-16 15:46:52 +0000,http://finance.yahoo.com/news/procter-gamble-pfizer-lead-market-154652474.html,"Procter & Gamble, Pfizer Lead Market Gains"
PFE,PFE:US,BBG000BR2B91,Here Comes Pfizer's Powerful Breakout,2017-02-16 14:19:00 +0000,https://www.thestreet.com/story/14003866/1/pfizer-is-firming-up.html?puc=yahoo&cm_ven=YAHOO,Here Comes Pfizer's Powerful Breakout
PFE,PFE:US,BBG000BR2B91,Washington University to collaborate with Pfizer on drug discovery,2017-02-16 14:00:16 +0000,http://www.bizjournals.com/stlouis/news/2017/02/16/washington-university-to-collaborate-with-pfizer.html?ana=yahoo,Washington University to collaborate with Pfizer on drug discovery
PFE,PFE:US,BBG000BR2B91,Pfizer says rheumatoid arthritis drug is comparable to Humira as combination treatment but not alone,2017-02-16 13:16:19 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=1626ABEA-8C89-408B-89DB-E88AF07848B6&siteid=yhoof2,Pfizer says rheumatoid arthritis drug is comparable to Humira as combination treatment but not alone
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Top-Line Results from the Oral Strategy Trial of XELJANZ® (tofacitinib citrate) Compared to Humira® (adalimumab),2017-02-16 13:00:00 +0000,http://finance.yahoo.com/news/pfizer-announces-top-line-results-130000824.html,"[Business Wire] - Pfizer Inc. announced today top-line results from ORAL Strategy, a Phase 3B/4 study of XELJANZ® 5mg twice daily in the treatment of moderate to severe rheumatoid arthritis ."
PFE,PFE:US,BBG000BR2B91,Pfizer Reports Results From Oral Strategy Trial Of XELJANZ Compared To Humira,2017-02-16 08:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9P2h-DrclAQ/pfizer-reports-results-from-oral-strategy-trial-of-xeljanz-compared-to-humira-20170216-00636,Pfizer Reports Results From Oral Strategy Trial Of XELJANZ Compared To Humira
PFE,PFE:US,BBG000BR2B91,"Ajo, Lp Buys Wal-Mart Stores, Hospitality Properties Trust, Applied Materials, Sells Symantec, ...",2017-02-16 06:53:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wt8CiKsp1sw/ajo-lp-buys-wal-mart-stores-hospitality-properties-trust-applied-materials-sells-symantec-cm748715,Ajo Lp New Purchases AMH CNX SWN NRF TU Y JBLU IWD PJC TECK Added Positions WMT HPT AMAT INTU CFG FDX AES BPOP SAVE HPQ Reduced Positions SYMC TSN GD LUV OII TTWO HII GNW DGX RS Sold Out OHI ACC CONE SBGL PDCO FCE
PFE,PFE:US,BBG000BR2B91,3 Dividend Stocks That Prove Boring Is Beautiful,2017-02-15 22:55:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vaf8-STJ31E/3-dividend-stocks-that-prove-boring-is-beautiful-cm748618,Want income checks rolling in just for sitting tight and doing nothing How about capital gains on top of that One of the best parts about owning high quality stocks that pay regular dividends is their uncanny ability to produce market beating returns due simply to the awesome power
PFE,PFE:US,BBG000BR2B91,Stock Index ETFs Nail Another Gain; Health Stocks Lead,2017-02-15 22:53:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2ODsK86M3E4/stock-index-etfs-nail-another-gain-health-stocks-lead-cm748470,The major stock index ETFs shot to fresh all time highs Wednesday with their strings of gains increasing to the fifth to ninth days SPDR S amp P 500 SPY was up 0 5 Wednesday It s in its seventh day of straight gains having gained 2 since Feb 6 and 5 since the
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Feb 15, 2017 :  CSCO, WFC, XOM, PFE, TMUS, MSFT, VZ, EMR, SXL, QQQ, AMAT, TRIP",2017-02-15 22:03:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lDUpazF0BEg/after-hours-most-active-for-feb-15-2017-csco-wfc-xom-pfe-tmus-msft-vz-emr-sxl-qqq-amat-trip-cm748605,The NASDAQ 100 After Hours Indicator is down 1 64 to 5 300 75 The total After hours volume is currently 36 948 144 shares traded The following are the most active stocks for the after hours session Cisco Systems Inc CSCO is 0 22 at 32 60 with 1 802 587
PFE,PFE:US,BBG000BR2B91,Close Update: Wall Street Sets Records for Fifth Straight Day as Trump Talks Taxes,2017-02-15 21:53:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kEolG5WcHpQ/close-update-wall-street-sets-records-for-fifth-straight-day-as-trump-talks-taxes-cm748586,Stocks in the U S closed at new all time highs for the fifth consecutive day on Wednesday as President Donald Trump s talk on taxes continued to cheer on investors anticipating his pro growth policies Stocks in the U S closed at new all time highs for the fifth consecutive day on Wednesday
PFE,PFE:US,BBG000BR2B91,"Pfizer, Cisco Push DJIA Higher Wednesday",2017-02-15 21:01:35 +0000,http://finance.yahoo.com/news/pfizer-cisco-push-djia-higher-210135147.html,"Pfizer, Cisco Push DJIA Higher Wednesday"
PFE,PFE:US,BBG000BR2B91,5 Ways Allergan Can Keep Up Momentum,2017-02-15 20:03:00 +0000,https://www.thestreet.com/story/14003652/1/5-nbsp-ways-allergan-can-keep-up-momentum.html?puc=yahoo&cm_ven=YAHOO,5 Ways Allergan Can Keep Up Momentum
PFE,PFE:US,BBG000BR2B91,Roche's Herceptin And Perjeta Combination Trials Beg A Larger Question,2017-02-15 19:54:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OTA5-EjkpxA/roches-herceptin-and-perjeta-combination-trials-beg-a-larger-question-cm748501,Roche s RHHBY results from trials of the Herceptin and Perjeta combination therapy for after surgery breast cancer applications 160 are eagerly awaited Why Simply because investors expect Roche to come up with novel combination therapies and make its portfolio resilient
PFE,PFE:US,BBG000BR2B91,Tepper's Appaloosa triples stake in Allergan,2017-02-15 19:18:00 +0000,http://finance.yahoo.com/video/teppers-appaloosa-triples-stake-allergan-191800406.html,Tepper's Appaloosa triples stake in Allergan
PFE,PFE:US,BBG000BR2B91,Wednesday's ETF with Unusual Volume: PPH,2017-02-15 18:53:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aDmPr8O3unk/wednesdays-etf-with-unusual-volume-pph-cm748451,The VanEck Vectors Pharmaceutical ETF is seeing unusually high volume in afternoon trading Wednesday with over 984 000 shares traded versus three month average volume of about 196 000 Shares of PPH were up about 0 8 on the day Components of that ETF with the highest volume on
PFE,PFE:US,BBG000BR2B91,Bristol-Myers: Don't Bet on a Pfizer Acquisition,2017-02-15 17:38:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/15/bristol-myers-dont-bet-on-a-pfizer-acquisition/?mod=yahoobarrons&ru=yahoo,Bristol-Myers: Don't Bet on a Pfizer Acquisition
PFE,PFE:US,BBG000BR2B91,4 High-Yield Dividend Stocks You Don't Have to Babysit,2017-02-15 15:56:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YYPCvuF7cDE/4-high-yield-dividend-stocks-you-dont-have-to-babysit-cm748226,Most income investors are naturally drawn to the stocks that offer up high yields That s understandable but oftentimes a market topping yield can be a sign that a business is in trouble For that reason investors need to be picky about which dividend stocks they choose to
PFE,PFE:US,BBG000BR2B91,Merck (MRK) Halts Late Stage Alzheimer Study; Shares Slip,2017-02-15 14:58:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6x98WYO8uqo/merck-mrk-halts-late-stage-alzheimer-study-shares-slip-cm748187,Merck amp Co Inc MRK announced that it is discontinuing a late stage study evaluating its pipeline candidate verubecestat for the treatment of mild to moderate Alzheimer s disease due to lack of efficacy Shares of Merck declined almost 2 in after hours trading on Tuesday This year
PFE,PFE:US,BBG000BR2B91,4 High-Yield Dividend Stocks You Don't Have to Babysit,2017-02-15 14:25:05 +0000,http://www.fool.com/investing/2017/02/15/4-high-yield-dividend-stocks-you-dont-have-to-baby.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,4 High-Yield Dividend Stocks You Don't Have to Babysit
PFE,PFE:US,BBG000BR2B91,Merck (MRK) Halts Late Stage Alzheimer Study; Shares Slip,2017-02-15 13:06:01 +0000,http://finance.yahoo.com/news/merck-mrk-halts-stage-alzheimer-130601147.html,Merck (MRK) Halts Late Stage Alzheimer Study; Shares Slip
PFE,PFE:US,BBG000BR2B91,"Lord, Abbett & Co. Llc Buys KeyCorp, PowerShares Exchange-Traded Fund Trust, United States ...",2017-02-15 10:17:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x5yqQcpP2j0/lord-abbett-co-llc-buys-keycorp-powershares-exchange-traded-fund-trust-united-states-cm748053,Lord Abbett Co Llc New Purchases BKLN X PM RJF ADM NFLX EVR NBR AME AKS Added Positions KEY WFC ALK APC CMCSA CAT BAC CGNX CB UNH Reduced Positions ALR RAI GRUB TWX ABMD FB MKTX GE ISRG IP Sold Out ELLI PAYC WEC EMR
PFE,PFE:US,BBG000BR2B91,David Tepper Increases Wagers on Drug Companies,2017-02-14 22:32:36 +0000,http://blogs.wsj.com/moneybeat/2017/02/14/david-tepper-increases-wagers-on-drug-companies/?mod=yahoo_hs,David Tepper Increases Wagers on Drug Companies
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb: Takeover Target?,2017-02-14 20:33:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/14/bristol-myers-squibb-takeover-target/?mod=yahoobarrons&ru=yahoo,Bristol-Myers Squibb: Takeover Target?
PFE,PFE:US,BBG000BR2B91,Investing Rookie? Start With These 3 Stocks,2017-02-14 17:49:35 +0000,http://www.fool.com/investing/2017/02/14/investing-rookie-start-with-these-3-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Investing Rookie? Start With These 3 Stocks
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Boeing, Pfizer, Goldman Sachs, NVIDIA and Twitter",2017-02-14 16:21:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nWk7vD1kqf4/the-zacks-analyst-blog-highlights-boeing-pfizer-goldman-sachs-nvidia-and-twitter-cm747607,For Immediate Release Chicago IL February 14 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
PFE,PFE:US,BBG000BR2B91,Three Stocks To Buy For Valentines Day,2017-02-14 15:45:13 +0000,http://www.insidermonkey.com/blog/three-stocks-to-buy-for-valentines-day-551279/,Three Stocks To Buy For Valentines Day
PFE,PFE:US,BBG000BR2B91,Investing Rookie? Start With These 3 Stocks,2017-02-14 15:18:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ruEbgXzdg4E/investing-rookie-start-with-these-3-stocks-cm747526,If you re just getting started investing in individual stocks you re likely wondering what stocks you should buy first We asked our contributors to highlight top stocks that they d recommend for rookie investors and they came back with Pfizer NYSE PFE ExxonMobil NYSE
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Boeing, Pfizer, Goldman Sachs, NVIDIA and Twitter",2017-02-14 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-boeing-143002835.html,"The Zacks Analyst Blog Highlights: Boeing, Pfizer, Goldman Sachs, NVIDIA and Twitter"
PFE,PFE:US,BBG000BR2B91,"Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for February 15, 2017",2017-02-14 14:21:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cf-_USfiOCE/astrazeneca-plc-azn-ex-dividend-date-scheduled-for-february-15-2017-cm747500,Astrazeneca PLC AZN will begin trading ex dividend on February 15 2017 A cash dividend payment of 0 93 per share is scheduled to be paid on March 20 2017 Shareholders who purchased AZN prior to the ex dividend date are eligible for the cash dividend payment This represents an 111
PFE,PFE:US,BBG000BR2B91,Gilead challenges GSK with strong HIV drug data,2017-02-14 08:52:04 +0000,http://sg.finance.yahoo.com/news/gilead-challenges-gsk-strong-hiv-085204001.html,Gilead challenges GSK with strong HIV drug data
PFE,PFE:US,BBG000BR2B91,"Luxury, lingerie and...Viagra?",2017-02-14 05:25:00 +0000,http://finance.yahoo.com/video/luxury-lingerie-viagra-052500395.html,"Luxury, lingerie and...Viagra?"
PFE,PFE:US,BBG000BR2B91,"Allergan To Acquire ZELTIQ in $2.47 Billion Deal, ZELTIQ Shares Pop 13%",2017-02-14 00:17:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l5TdQo_Mv8A/allergan-to-acquire-zeltiq-in-247-billion-deal-zeltiq-shares-pop-13-cm747335,Pharmaceutical giant Allergan AGN announced on Monday they will acquire ZELTIQ Aesthetics ZLTQ in a 2 47 billion deal Allergan expects the deal to close in the latter half of 2017 ZELTIQ a medical technology company focuses on commercializing their proprietary controlled cooling
PFE,PFE:US,BBG000BR2B91,"Q4 Scorecard & Analyst Reports for Pfizer, Boeing & Goldman Sachs",2017-02-13 22:17:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W0aiWDPNSHU/q4-scorecard-analyst-reports-for-pfizer-boeing-goldman-sachs-cm747314,Monday February 13 2017 The Zacks Research Daily features the best research output of our analyst team In today s write up we are featuring analyst reports on 16 major stocks including reports on Boeing BA Pfizer PFE and Goldman Sachs GS These reports have been hand picked
PFE,PFE:US,BBG000BR2B91,"Allergan To Acquire ZELTIQ in $2.47 Billion Deal, ZELTIQ Shares Pop 13%",2017-02-13 22:11:10 +0000,http://finance.yahoo.com/news/allergan-acquire-zeltiq-2-47-221110797.html,"Allergan To Acquire ZELTIQ in $2.47 Billion Deal, ZELTIQ Shares Pop 13%"
PFE,PFE:US,BBG000BR2B91,"Q4 Scorecard & Analyst Reports for Pfizer, Boeing & Goldman Sachs",2017-02-13 19:19:07 +0000,http://finance.yahoo.com/news/q4-scorecard-analyst-reports-pfizer-191907405.html,"Q4 Scorecard & Analyst Reports for Pfizer, Boeing & Goldman Sachs"
PFE,PFE:US,BBG000BR2B91,"Let’s just call it an ‘American Rally,’ OK?",2017-02-13 19:05:53 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=6459F04E-F219-11E6-AE2B-D7ACEC395090&siteid=yhoof2,"Let’s just call it an ‘American Rally,’ OK?"
PFE,PFE:US,BBG000BR2B91,"SSO, BAC, PFE, MRK: Large Outflows Detected at ETF",2017-02-13 17:19:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UJdP1uo2dIo/sso-bac-pfe-mrk-large-outflows-detected-at-etf-cm747110,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the ProShares Ultra S amp P500 Symbol SSO where we have detected an approximate 65 1 million dollar outflow that s a 3 8 decrease week over week from 21 150
PFE,PFE:US,BBG000BR2B91,"XLV, EFU: Big ETF Inflows",2017-02-13 17:19:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bLBK66X8pb4/xlv-efu-big-etf-inflows-cm747105,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the XLV Health Care Select Sector SPDR Fund US Equities XLV which added 14 700 000 units or a 7 4 increase week over week Among the largest
PFE,PFE:US,BBG000BR2B91,"Drug Stocks Earnings Slated for Feb 14: INCY, PRTA & More",2017-02-13 16:22:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pLLVWmpV-n4/drug-stocks-earnings-slated-for-feb-14-incy-prta-more-cm747016,The year 2017 seems to have started on a positive note for investors in the U S Approximately 71 6 of the companies or 358 members in the S amp P 500 Index have reported results so far Per the Earnings Trends an impressive 69 of the companies reported in the index have beaten
PFE,PFE:US,BBG000BR2B91,3 Stocks You Can Still Buy With the Market at Record Highs,2017-02-13 13:00:07 +0000,http://www.fool.com/investing/2017/02/13/3-stocks-you-can-still-buy-with-the-market-at-reco.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Stocks You Can Still Buy With the Market at Record Highs
PFE,PFE:US,BBG000BR2B91,US issuers rush to sell Formosa bonds before rule change,2017-02-13 03:10:03 +0000,http://finance.yahoo.com/news/us-issuers-rush-sell-formosa-031003158.html,"[Reuters] - Three US blue chips headed to Taiwan's Formosa bond market last week in a rush to lock in flexible funding ahead of changes in local regulations and a potential shake-up in US tax rules. Verizon Communications issued a $1.475 billion 30-year non-call three bond at 4.95 percent, the largest Formosa issue of the year so far. Also last week, Apple was rumoured to be sounding investors for a potential $1 billion 30 non-call three, indicated at a yield in the 4.3 percent area, and Pfizer was heard to be eyeing the market, too."
PFE,PFE:US,BBG000BR2B91,"Weighing The Week Ahead: Trump Vs. Yellen, Round One",2017-02-12 09:17:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ba2QFPoCZSw/weighing-the-week-ahead-trump-vs-yellen-round-one-cm746734,By Jeff Miller ByJeff Miller A week featuring the Fed Chair s semi annual Congressional testimony and daily speeches by most of her Fed colleagues would normally represent a commanding first choice for the upcoming theme This time is different Yes I know that you are never supposed
PFE,PFE:US,BBG000BR2B91,Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock: Will the Slump End?,2017-02-11 00:17:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RrWtt2xIKGc/teva-pharmaceutical-industries-ltd-adr-teva-stock-will-the-slump-end-cm746621,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Value investors are familiar with pain They endure pain when the stock hits a low then falls some more The markets are hammering 160 Teva Pharmaceutical Industries Ltd ADR NYSE TEVA because it
PFE,PFE:US,BBG000BR2B91,Here's Why M&A Has Tesaro's Stock Soaring 40% In 2017,2017-02-10 23:18:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i0Wb7IAm9cw/heres-why-ma-has-tesaros-stock-soaring-40-in-2017-cm746593,Hope that a big drugmaker will bid to buy Tesaro NASDAQ TSRO has sent this company s shares skyrocketing 40 this year That s impressive but there could be room to run higher Why Because Tesaro could be about to land its second FDA approval and this next approval could be
PFE,PFE:US,BBG000BR2B91,Is More Downside Ahead For Teva Pharmaceutical?,2017-02-10 17:00:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/10/is-more-downside-ahead-for-teva-pharmaceutical/?mod=yahoobarrons&ru=yahoo,Is More Downside Ahead For Teva Pharmaceutical?
PFE,PFE:US,BBG000BR2B91,Which Of The Latest 13F Filers Holds Pfizer?,2017-02-10 16:19:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eLxOTPiOjyU/which-of-the-latest-13f-filers-holds-pfizer-cm746248,At Holdings Channel we have reviewed the latest batch of the 24 most recent 13F filings for the 12 31 2016 reporting period and noticed that Pfizer Inc Symbol PFE was held by 11 of these funds When hedge fund managers appear to be thinking alike we find it is a good idea to take a
PFE,PFE:US,BBG000BR2B91,Actinium Pharmaceuticals (ATNM) has Considerable Potential in 2017,2017-02-10 16:09:55 +0000,http://ir.baystreet.ca/article.aspx?id=475&1486742995,Actinium Pharmaceuticals (ATNM) has Considerable Potential in 2017
PFE,PFE:US,BBG000BR2B91,"Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for February 13, 2017",2017-02-10 14:23:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tukwV8mTvAQ/eli-lilly-and-company-lly-ex-dividend-date-scheduled-for-february-13-2017-cm746165,Eli Lilly and Company LLY will begin trading ex dividend on February 13 2017 A cash dividend payment of 0 52 per share is scheduled to be paid on March 10 2017 Shareholders who purchased LLY prior to the ex dividend date are eligible for the cash dividend payment This represents an 1
PFE,PFE:US,BBG000BR2B91,Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?,2017-02-10 13:35:53 +0000,http://finance.yahoo.com/news/short-sellers-doubting-trump-hiking-133553363.html,Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Feb 9, 2017 :  F, BAC, MCHP, AAPL, GGB, QQQ, ABEV, NVDA, PFE, FB, STM, ATVI",2017-02-09 21:57:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KgrlQvzCjP0/after-hours-most-active-for-feb-9-2017-f-bac-mchp-aapl-ggb-qqq-abev-nvda-pfe-fb-stm-atvi-cm745872,The NASDAQ 100 After Hours Indicator is down 93 to 5 211 23 The total After hours volume is currently 50 666 419 shares traded The following are the most active stocks for the after hours session Ford Motor Company F is 0 01 at 12 37 with 4 547 566 shares
PFE,PFE:US,BBG000BR2B91,"Academics call time on $100,000 cancer drugs",2017-02-09 17:00:01 +0000,http://finance.yahoo.com/news/academics-call-time-100-000-170001172.html,"[Reuters] - A group of academic researchers has demanded an end to cancer medicines costing more than $100,000 a year and proposed a new model of low-cost drug development that would capitalise on recent advances in science. The spiralling cost of cancer medicines is a growing concern for doctors and their patients, many of whom struggle to pay for new medicines that often cost $10,000 a month. Sky-high prices have made oncology hugely profitable, with IMS Health forecasting global cancer drug sales of at least $150 billion by 2020."
PFE,PFE:US,BBG000BR2B91,10 Best Dividend-Paying Stocks for 2017,2017-02-09 13:50:02 +0000,http://portal.kiplinger.com/slideshow/investing/T018-S001-10-best-dividend-paying-stocks-for-2017/index.html?rid=SYN-yahoo&rpageid=16066,10 Best Dividend-Paying Stocks for 2017
PFE,PFE:US,BBG000BR2B91,Relationship Expert Teams Up with Pfizer to Address Intimacy and Relationship Issues for People Living with Chronic Diseases,2017-02-09 13:30:00 +0000,http://finance.yahoo.com/news/relationship-expert-teams-pfizer-address-133000139.html,"[Business Wire] - Nationally-recognized relationship expert and author, Logan Levkoff, Ph.D., has partnered with Pfizer Inc. to fill a void in information available to people living with chronic diseases: relationship advice."
PFE,PFE:US,BBG000BR2B91,Pfizer Builds Consumer Apps to Improve Patient Care,2017-02-08 23:54:16 +0000,http://blogs.wsj.com/cio/2017/02/08/pfizer-builds-consumer-apps-to-improve-patient-care/?mod=yahoo_hs,Pfizer Builds Consumer Apps to Improve Patient Care
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. – Value Analysis (NYSE:PFE) : February 8, 2017",2017-02-08 19:30:03 +0000,http://www.capitalcube.com/blog/index.php/pfizer-inc-value-analysis-nysepfe-february-8-2017/,"Pfizer Inc. – Value Analysis (NYSE:PFE) : February 8, 2017"
PFE,PFE:US,BBG000BR2B91,4 Dow Stocks Every Retiree Should Own,2017-02-08 18:30:01 +0000,http://portal.kiplinger.com/slideshow/investing/T018-S001-4-dow-stocks-every-retiree-should-own/index.html?rid=SYN-yahoo&rpageid=16036,4 Dow Stocks Every Retiree Should Own
PFE,PFE:US,BBG000BR2B91,Gilead: Where's the Bottom?,2017-02-08 18:28:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/08/gilead-wheres-the-bottom/?mod=yahoobarrons&ru=yahoo,Gilead: Where's the Bottom?
PFE,PFE:US,BBG000BR2B91,[$$] Sanofi points to lower profit for 2017,2017-02-08 14:48:04 +0000,"http://www.ft.com/cms/s/e4044b74-edea-11e6-930f-061b01e23655,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - French drugmaker Sanofi said on Wednesday that profits for 2017 would be flat or slightly lower as it looks to compensate for a slowdown in sales of its blockbuster insulin medication, Lantus. Its diabetes ..."
PFE,PFE:US,BBG000BR2B91,"Hexavest Inc. Buys Lennar, Bristol-Myers Squibb Company, Apple, Sells Procter & Gamble Co, ...",2017-02-08 14:17:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9UifxK_BnD0/hexavest-inc-buys-lennar-bristol-myers-squibb-company-apple-sells-procter-gamble-co-cm744739,Hexavest Inc New Purchases LEN LYB NKE TWTR MCHI CIFAF CCJ CCORF CMLEF ELEEF Added Positions BMY AAPL DG CAA DLTR WFC WBA SPY T VZ Reduced Positions PG MCD ABX PM IAG PEP AUY MET AIG NEM Sold Out EWJ PRU ADM
PFE,PFE:US,BBG000BR2B91,"Should I Buy Valeant Pharmaceuticals Intl Inc (VRX) Stock? 3 Pros, 3 Cons",2017-02-07 22:17:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P31fDpXeEGk/should-i-buy-valeant-pharmaceuticals-intl-inc-vrx-stock-3-pros-3-cons-cm744551,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips When writing a pros cons article 160 on Valeant Pharmaceuticals Intl Inc NYSE VRX I admittedly 160 did not have much trouble coming up with the cons Let s face it the company has been an
PFE,PFE:US,BBG000BR2B91,"Model N (MODN) Q1 Loss Narrower than Expected, Guides Well",2017-02-07 21:17:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DY9heVqG82U/model-n-modn-q1-loss-narrower-than-expected-guides-well-cm744463,Model N Inc MODN started fiscal 2017 on a strong note reporting better than expected results for the first quarter Although the company posted adjusted loss including all one time expenses but excluding stock based compensation of 21 cents per share it was narrower than the Zacks
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Shares Cross 4% Yield Mark,2017-02-07 21:17:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xjBKHKaIH0U/pfizer-pfe-shares-cross-4-yield-mark-cm744475,Looking at the universe of stocks we cover at Dividend Channel in trading on Tuesday shares of Pfizer Inc Symbol PFE were yielding above the 4 mark based on its quarterly dividend annualized to 1 28 with the stock changing hands as low as 31 94 on the day Dividends are
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. (PFE) And Citibank To Work Together On $5 Billion Share Repurchase Program,2017-02-07 17:28:35 +0000,http://www.insidermonkey.com/blog/pfizer-inc-pfe-and-citibank-to-work-together-on-5-billion-share-repurchase-program-533376/,Pfizer Inc. (PFE) And Citibank To Work Together On $5 Billion Share Repurchase Program
PFE,PFE:US,BBG000BR2B91,"Fishman Jay A Ltd Buys Arconic, The Home Depot, Alcoa, Sells Allergan PLC, Level 3 ...",2017-02-07 17:16:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p8K8IEq3ZY0/fishman-jay-a-ltd-buys-arconic-the-home-depot-alcoa-sells-allergan-plc-level-3-cm744331,Fishman Jay A Ltd New Purchases ARNC AA SHW AMZN DHR PJT VFFIF VWO MSFT WAL Added Positions HD RTN WHR CHKP PFE BRK B XPO MON SYK NWL Reduced Positions AGN AAPL IEP ORCL NKE LVLT CELG BX HEES JNJ Sold Out DAL M CIM
PFE,PFE:US,BBG000BR2B91,ARIAD Files for EU Approval of Lung Cancer Drug Brigatinib,2017-02-07 14:19:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zqNI3ifI6zE/ariad-files-for-eu-approval-of-lung-cancer-drug-brigatinib-cm744117,ARIAD Pharmaceuticals Inc ARIA announced the submission of a Marketing Authorisation Application MAA for its experimental ALK inhibitor brigatinib with the European Medicines Agency EMA ARIAD is looking to get brigatinib approved for the treatment of adult patients with
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. breached its 50 day moving average in a Bullish Manner : PFE-US : February 7, 2017",2017-02-07 12:22:54 +0000,http://www.capitalcube.com/blog/index.php/pfizer-inc-breached-its-50-day-moving-average-in-a-bullish-manner-pfe-us-february-7-2017/,"Pfizer Inc. breached its 50 day moving average in a Bullish Manner : PFE-US : February 7, 2017"
PFE,PFE:US,BBG000BR2B91,Agilent (A) Announces Expanded Use of Diagnostic Assay (revised),2017-02-06 23:18:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k58QtC1nw80/agilent-a-announces-expanded-use-of-diagnostic-assay-revised-cm743877,Agilent Technologies A recently announced the expanded use of its diagnostic assay Dako PD L1 IHC 22C3 pharmDx This marks the company s efforts to expand in the growing companion diagnostics market This assay will help in assessing the PD L1 expression status for both untreated and
PFE,PFE:US,BBG000BR2B91,Pfizer CEO: 'Misinformation About Drug Pricing Is Far Greater Than I've Ever Seen',2017-02-06 17:56:00 +0000,https://www.thestreet.com/story/13972689/1/pfizer-will-stick-to-pricing-strategy-as-m-amp-a-window-remains-open.html?puc=yahoo&cm_ven=YAHOO,Pfizer CEO: 'Misinformation About Drug Pricing Is Far Greater Than I've Ever Seen'
PFE,PFE:US,BBG000BR2B91,Q4 Earnings Faring Well for Pharma ETFs,2017-02-06 17:19:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2oG8p1Qtx2o/q4-earnings-faring-well-for-pharma-etfs-cm743689,The Q4 earnings season is faring better than the last few years with not only earnings growth on track to reach the highest level in two years but also total earnings set to create a new quarterly record Most sectors are coming up with good results with healthcare being no exception The
PFE,PFE:US,BBG000BR2B91,"Drug Stocks Reporting Earnings on Feb 7: GILD, MNK & More",2017-02-06 16:22:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ilur_ld5S1U/drug-stocks-reporting-earnings-on-feb-7-gild-mnk-more-cm743617,2017 seems to have started on an encouraging note for investors when compared to the year ago periods Earnings growth turned positive in the last quarter and things are surely looking up as we stand in the middle of the earnings season As per our Earnings Preview report approximately
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Apple, Exxon Mobil, Merck, Pfizer and Intel",2017-02-06 16:20:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fMVyv1tz8yA/the-zacks-analyst-blog-highlights-apple-exxon-mobil-merck-pfizer-and-intel-cm743564,For Immediate Release Chicago IL February 06 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
PFE,PFE:US,BBG000BR2B91,Q4 Earnings Faring Well for Pharma ETFs,2017-02-06 14:55:02 +0000,http://finance.yahoo.com/news/q4-earnings-faring-well-pharma-145502433.html,Q4 Earnings Faring Well for Pharma ETFs
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Apple, Exxon Mobil, Merck, Pfizer and Intel",2017-02-06 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-apple-143002778.html,"The Zacks Analyst Blog Highlights: Apple, Exxon Mobil, Merck, Pfizer and Intel"
PFE,PFE:US,BBG000BR2B91,"Portola, HealthCare Royalty Partners Ink $150 Million Deal",2017-02-06 14:18:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fuj7zzZeASg/portola-healthcare-royalty-partners-ink-150-million-deal-cm743499,Portola Pharmaceuticals Inc s PTLA shares were up 2 7 after the company announced that it has signed a royalty agreement with HealthCare Royalty Partners HCR a private investment firm for 150 million A look at Portola s share price movement over the past one year shows that
PFE,PFE:US,BBG000BR2B91,Merck???s Keytruda Gets Priority Review for Bladder Cancer,2017-02-06 14:17:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SkPm72X343I/mercks-keytruda-gets-priority-review-for-bladder-cancer-cm743496,Merck amp Co Inc s MRK two supplemental Biologics License Applications sBLA for its anti PD 1 therapy Keytruda have been accepted under priority review by the FDA This time the company is looking to expand the label of Keytruda for the treatment of patients with locally advanced
PFE,PFE:US,BBG000BR2B91,Blog Coverage Pfizer Signs Agreement with Citibank to Repurchase $5 Billion Worth of Shares,2017-02-06 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-pfizer-signs-agreement-131500396.html,"[Accesswire] - Upcoming AWS Coverage on Immune Pharmaceuticals LONDON, UK / ACCESSWIRE / February 6, 2017 / Active Wall St. blog coverage looks at the headline from Pfizer, Inc. (NYSE: PFE ) as the Company announced ..."
PFE,PFE:US,BBG000BR2B91,ICU Medical Completes the Acquisition of Hospira Infusion Systems from Pfizer,2017-02-06 12:45:00 +0000,http://finance.yahoo.com/news/icu-medical-completes-acquisition-hospira-124500417.html,"[GlobeNewswire] - SAN CLEMENTE, Calif., Feb. 06, 2017-- ICU Medical Inc. today announced that it has completed its acquisition of the Hospira Infusion Systems business from Pfizer Inc.. The Hospira Infusion Systems business ..."
PFE,PFE:US,BBG000BR2B91,"Palouse Capital Management, Inc. Buys MetLife, Mattel, Nucor, Sells JPMorgan Chase, Regions ...",2017-02-04 18:57:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BKN1BxQjQ6k/palouse-capital-management-inc-buys-metlife-mattel-nucor-sells-jpmorgan-chase-regions-cm743310,Palouse Capital Management Inc New Purchases MET MAT NUE HCN DOW ZBH PPG AMN OCLR APOG Added Positions ANTM WFC SPY T MO AJG GM UFS HPT INTC Reduced Positions UMPQ BAC GILD AMGN F DLPH PRU FDX CBS UNH Sold Out JPM RF
PFE,PFE:US,BBG000BR2B91,Pfizer's New Biosimilar Is Off and Running,2017-02-04 12:57:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6cup1wiaYYs/pfizers-new-biosimilar-is-off-and-running-cm743241,Pfizer Inc NYSE PFE launched Inflectra its biosimilar to Johnson amp Johnson s NYSE JNJ Remicade late last year and fourth quarter earnings reports from the two companies provide us with insight into Inflectra s market potential Can Inflectra become a top seller Read
PFE,PFE:US,BBG000BR2B91,Pfizer's New Biosimilar Is Off and Running,2017-02-04 11:41:05 +0000,http://www.fool.com/investing/2017/02/04/pfizers-new-biosimilar-is-off-and-running.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Pfizer's New Biosimilar Is Off and Running
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: Apple, Intel, Exxon Beat; Merck, Pfizer, Chevron Miss on Revenues",2017-02-03 23:57:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SCAbr4KnZj0/dow-30-stock-roundup-apple-intel-exxon-beat-merck-pfizer-chevron-miss-on-revenues-cm743185,The Dow suffered losses over the week as optimism over Trump s election gave way to apprehension over his actions as President Newly introduced immigration rules led to protests criticism and legal challenges Additionally the tech sector expressed concerns over the impact these
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Feb 3, 2017 :  ETE, EPD, PFE, WPZ, ENLK, AAPL, BAC, INTC, MSFT, CTXS, CSCO, YHOO",2017-02-03 21:57:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KGsgVRnR3eA/after-hours-most-active-for-feb-3-2017-ete-epd-pfe-wpz-enlk-aapl-bac-intc-msft-ctxs-csco-yhoo-cm743159,The NASDAQ 100 After Hours Indicator is down 1 81 to 5 159 79 The total After hours volume is currently 35 316 329 shares traded The following are the most active stocks for the after hours session Energy Transfer Equity L P ETE is 0 04 at 19 09 with 2 979
PFE,PFE:US,BBG000BR2B91,MACD: Learn to Recognize Trade Setups,2017-02-03 18:00:59 +0000,http://finance.yahoo.com/news/macd-learn-recognize-trade-setups-180059719.html,MACD: Learn to Recognize Trade Setups
PFE,PFE:US,BBG000BR2B91,"Notable ETF Inflow Detected - XLV, PFE, MRK, UNH",2017-02-03 17:31:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IwQIHv4v_qM/notable-etf-inflow-detected-xlv-pfe-mrk-unh-cm742939,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the XLV Health Care Select Sector SPDR Fund US Equities Symbol XLV where we have detected an approximate 380 2 million dollar inflow that s a 2 8 increase
PFE,PFE:US,BBG000BR2B91,Pfizer Is Returning Even More Cash to Shareholders,2017-02-03 16:19:00 +0000,https://www.thestreet.com/story/13977980/1/pfizer-is-returning-more-capital-to-shareholders.html?puc=yahoo&cm_ven=YAHOO,Pfizer Is Returning Even More Cash to Shareholders
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. (PFE)’s Breast Cancer Drug Too Expensive: Says NICE,2017-02-03 15:50:31 +0000,http://www.insidermonkey.com/blog/pfizer-inc-pfes-breast-cancer-drug-too-expensive-says-nice-531138/,Pfizer Inc. (PFE)’s Breast Cancer Drug Too Expensive: Says NICE
PFE,PFE:US,BBG000BR2B91,What Alicia Keys and Daft Punk are bringing home after the Grammys,2017-02-03 14:48:19 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=B0A89DE4-E989-11E6-AED6-5495A9969352&siteid=yhoof2,What Alicia Keys and Daft Punk are bringing home after the Grammys
PFE,PFE:US,BBG000BR2B91,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-02-03 13:48:28 +0000,http://biz.yahoo.com/e/170203/pfe8-k.html,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
PFE,PFE:US,BBG000BR2B91,"Stock Futures Hold Higher After U.S. Economy Adds 227,000 Jobs",2017-02-03 13:37:00 +0000,https://www.thestreet.com/story/13977055/1/stock-futures-edge-higher-ahead-of-u-s-jobs-report.html?puc=yahoo&cm_ven=YAHOO,"Stock Futures Hold Higher After U.S. Economy Adds 227,000 Jobs"
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Pfizer, Merck, LLY Report Results, Teva Hit by Copaxone Ruling",2017-02-03 13:33:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3s3hs5m8cow/pharma-stock-roundup-pfizer-merck-lly-report-results-teva-hit-by-copaxone-ruling-cm742674,Major pharma companies like Pfizer PFE Merck MRK and Lilly LLY reported fourth quarter results this week Meanwhile Teva TEVA was hit by an unfavorable ruling in the Copaxone patent infringement lawsuit Recap of the Week s Most Important Stories A Look at Earnings
PFE,PFE:US,BBG000BR2B91,Pfizer to buyback $5 billion of its common stock,2017-02-03 13:16:24 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=D56B5B72-06E2-4158-8CC7-E19BD3AA6183&siteid=yhoof2,Pfizer to buyback $5 billion of its common stock
PFE,PFE:US,BBG000BR2B91,Pfizer Commences $5 Billion Accelerated Share Repurchase,2017-02-03 13:10:00 +0000,http://finance.yahoo.com/news/pfizer-commences-5-billion-accelerated-131000979.html,[Business Wire] - Pfizer Inc. today announced that it has entered into an accelerated share repurchase agreement with Citibank N.A. to repurchase $5 billion of Pfizer’s common stock.
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Pfizer, Merck, LLY Report Results, Teva Hit by Copaxone Ruling",2017-02-03 11:54:11 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-pfizer-merck-115411134.html,"Pharma Stock Roundup: Pfizer, Merck, LLY Report Results, Teva Hit by Copaxone Ruling"
PFE,PFE:US,BBG000BR2B91,Pfizer Enters $5 Bln Accelerated Share Repurchase Agreement With Citibank,2017-02-03 08:28:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bIydjPJgbwE/pfizer-enters-5-bln-accelerated-share-repurchase-agreement-with-citibank-20170203-00437,Pfizer Enters $5 Bln Accelerated Share Repurchase Agreement With Citibank
PFE,PFE:US,BBG000BR2B91,UK agency says Pfizer breast cancer drug too expensive,2017-02-03 00:26:05 +0000,http://sg.finance.yahoo.com/news/uk-agency-says-pfizer-breast-002605923.html,UK agency says Pfizer breast cancer drug too expensive
PFE,PFE:US,BBG000BR2B91,PFE May Reportedly Sell Part of its Portfolio,2017-02-02 20:13:00 +0000,http://www.investopedia.com/news/pfizer-reportedly-considering-sale-portfolio-pfe/?partner=YahooSA,PFE May Reportedly Sell Part of its Portfolio
PFE,PFE:US,BBG000BR2B91,Pfizer hires JPMorgan to weigh sale of some drugs - Bloomberg,2017-02-02 18:17:10 +0000,http://sg.finance.yahoo.com/news/pfizer-hires-jpmorgan-weigh-sale-181710543.html,Pfizer hires JPMorgan to weigh sale of some drugs - Bloomberg
PFE,PFE:US,BBG000BR2B91,Pfizer hires JPMorgan to weigh sale of some drugs: Bloomberg,2017-02-02 18:03:31 +0000,http://finance.yahoo.com/news/pfizer-hires-jpmorgan-weigh-sale-180331285.html,Pfizer hires JPMorgan to weigh sale of some drugs: Bloomberg
PFE,PFE:US,BBG000BR2B91,Pfizer hires JPMorgan to weigh sale of some drugs - Bloomberg,2017-02-02 17:59:13 +0000,http://finance.yahoo.com/news/pfizer-hires-jpmorgan-weigh-sale-175913739.html,Pfizer hires JPMorgan to weigh sale of some drugs - Bloomberg
PFE,PFE:US,BBG000BR2B91,Agilent (A) Announces Expanded Use of Diagnostic Assay,2017-02-02 17:35:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vmMn92zgcnQ/agilent-a-announces-expanded-use-of-diagnostic-assay-cm742337,Agilent Technologies A recently announced the expanded use of its diagnostic assay Dako PD L1 IHC 28 8 22C3 pharmDx This marks the company s efforts to expand in the growing companion diagnostics market This assay will help in assessing the PD L1 expression status for both untreated
PFE,PFE:US,BBG000BR2B91,Pfizer Said to Hire JPMorgan to Weigh $2 Billion Portfolio Sale,2017-02-02 17:03:30 +0000,http://www.bloomberg.com/news/articles/2017-02-02/pfizer-said-to-hire-jpmorgan-to-weigh-2-billion-portfolio-sale?cmpid=yhoo.headline,Pfizer Said to Hire JPMorgan to Weigh $2 Billion Portfolio Sale
PFE,PFE:US,BBG000BR2B91,Merck (MRK) Tops Q4 Earnings; Pharmaceutical Sales Down,2017-02-02 16:36:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1fKnkk-5Qok/merck-mrk-tops-q4-earnings-pharmaceutical-sales-down-cm742200,Merck amp Co Inc MRK reported fourth quarter 2016 earnings of 89 cents per share which beat the Zacks Consensus Estimate of 88 cents by a penny However earnings declined 4 3 from the year ago period FindTheCompany Graphiq Merck s shares were up 5 5 so far
PFE,PFE:US,BBG000BR2B91,"The 10 cheapest, fastest-growing and most beloved Dow stocks",2017-02-02 16:21:10 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=3B0247C4-E313-11E6-9F0C-C196D45BAA51&siteid=yhoof2,"The 10 cheapest, fastest-growing and most beloved Dow stocks"
PFE,PFE:US,BBG000BR2B91,Ignore Gilead Sciences Inc.: Here Are 2 Better Stocks,2017-02-02 15:53:56 +0000,http://www.fool.com/investing/2017/02/02/ignore-gilead-sciences-inc-here-are-2-better-stock.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Ignore Gilead Sciences Inc.: Here Are 2 Better Stocks
PFE,PFE:US,BBG000BR2B91,Ignore Gilead Sciences Inc.: Here Are 2 Better Stocks,2017-02-02 15:35:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uOBVjTxW5s8/ignore-gilead-sciences-inc-here-are-2-better-stocks-cm742147,Because of the anemic outlook for its hepatitis C franchise and recent clinical setbacks Gilead Sciences NASDAQ GILD may not be the outright bargain that its rock bottom forward price to earnings ratio of about seven would seem to indicate In fact Pfizer NYSE PFE
PFE,PFE:US,BBG000BR2B91,US Market Indexes Regain Some of Their Losses on Wednesday,2017-02-02 14:53:18 +0000,http://finance.yahoo.com/news/us-market-indexes-regain-losses-145318250.html,US Market Indexes Regain Some of Their Losses on Wednesday
PFE,PFE:US,BBG000BR2B91,Novartis a Top Ranked SAFE Dividend Stock With 3.7% Yield (NVS),2017-02-02 14:33:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a3PsiBQOibI/novartis-a-top-ranked-safe-dividend-stock-with-37-yield-nvs-cm741999,Novartis Symbol NVS has been named to the Dividend Channel International S A F E 10 list signifying an international stock with above average DividendRank statistics including a strong 3 7 yield as well as a superb track record of at least five years of dividend growth
PFE,PFE:US,BBG000BR2B91,3 Pharmaceutical Stocks With Bigger Dividends Than Johnson & Johnson,2017-02-02 12:00:48 +0000,http://www.fool.com/investing/2017/02/01/3-pharmaceutical-stocks-with-bigger-dividends-than.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Pharmaceutical Stocks With Bigger Dividends Than Johnson & Johnson
PFE,PFE:US,BBG000BR2B91,[$$] Reckitt Benckiser in talks over $16.7bn baby milk deal,2017-02-02 08:55:00 +0000,"http://www.ft.com/cms/s/0675ed20-e8e6-11e6-893c-082c54a7f539,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Reckitt Benckiser, the UK-based maker of Nurofen painkillers and Durex condoms, is in advanced talks to acquire Mead Johnson in a deal that could value the US baby milk group at about $16.7bn. Reckitt ..."
PFE,PFE:US,BBG000BR2B91,3 Pharmaceutical Stocks With Bigger Dividends Than Johnson & Johnson,2017-02-01 22:33:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6lkQFKWZFOE/3-pharmaceutical-stocks-with-bigger-dividends-than-johnson-johnson-cm741862,If there were such a thing as the dividend stock hall of fame Johnson amp Johnson NYSE JNJ would be in it After all the company increased its dividend for a whopping 54 years in a row But if you re looking for high dividend yields there are better options Here are
PFE,PFE:US,BBG000BR2B91,3 Big Mergers & Acquisitions That We Could See in 2017,2017-02-01 22:31:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OAB8Tc8p5dE/3-big-mergers-acquisitions-that-we-could-see-in-2017-cm741892,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips It looks like 2017 is likely to be a big year for mergers amp acquisitions Several factors have come together over the past few months that have made the coming year ripe for consolidation Industries
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Feb 1, 2017 :  FB, LOGM, TGI, GE, QQQ, PFE, WFT, BIVVV, CSCO, AAPL, ABT, SYF",2017-02-01 22:01:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fuQwRfbARlU/after-hours-most-active-for-feb-1-2017-fb-logm-tgi-ge-qqq-pfe-wft-bivvv-csco-aapl-abt-syf-cm741881,The NASDAQ 100 After Hours Indicator is up 4 28 to 5 156 97 The total After hours volume is currently 47 904 385 shares traded The following are the most active stocks for the after hours session Facebook Inc FB is 2 87 at 136 10 with 6 766 935 shares traded
PFE,PFE:US,BBG000BR2B91,5 Things Pfizer's Management Wants You to Know,2017-02-01 21:00:28 +0000,http://www.fool.com/investing/2017/02/01/5-things-pfizers-management-wants-you-to-know.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Things Pfizer's Management Wants You to Know
PFE,PFE:US,BBG000BR2B91,How to Play Pfizer's Fourth-Quarter Results With ETFs,2017-02-01 18:10:00 +0000,https://www.thestreet.com/story/13971244/1/how-to-play-pfizer-s-fourth-quarter-results-with-etfs.html?puc=yahoo&cm_ven=YAHOO,How to Play Pfizer's Fourth-Quarter Results With ETFs
PFE,PFE:US,BBG000BR2B91,5 Things Pfizer's Management Wants You to Know,2017-02-01 16:34:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ftkjJelC0zM/5-things-pfizers-management-wants-you-to-know-cm741574,Pfizer NYSE PFE might have fallen short of expectations with its fourth quarter earnings results but the market didn t seem to mind The big drugmaker s shares were up slightly on Tuesday following the fourth quarter update Investors were probably much more focused on the
PFE,PFE:US,BBG000BR2B91,Drug Stocks to Report Q4 Earnings on Feb 2: MRK & AMGN,2017-02-01 15:34:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qERKto41_a4/drug-stocks-to-report-q4-earnings-on-feb-2-mrk-amgn-cm741446,With the Q4 earnings season well underway approximately 170 S amp P 500 members representing 33 9 of the index s total market capitalization have reported quarterly results as of Jan 27 An impressive 64 1 of these companies managed to post an earnings beat while 54 7
PFE,PFE:US,BBG000BR2B91,SanofiRegeneron Sarilumab Approved in Canada for Arthritis,2017-02-01 13:31:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UVo9XOCUgRQ/sanofiregeneron-sarilumab-approved-in-canada-for-arthritis-cm741327,Sanofi SNY and Regeneron Pharmaceuticals Inc REGN announced that their pipeline candidate sarilumab has been approved in Canada for the treatment of adult patients with moderate to severely active rheumatoid arthritis RA who have had an inadequate response or intolerance to one or
PFE,PFE:US,BBG000BR2B91,Merck Keytruda Gets EU Approval for First-Line Lung Cancer,2017-02-01 13:31:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_AHtvJrgM6s/merck-keytruda-gets-eu-approval-for-first-line-lung-cancer-cm741323,Merck amp Co Inc MRK announced that its anti PD 1 therapy Keytruda has been approved by the European Commission for the first line treatment of adult patients with metastatic non small cell lung cancer NSCLC In Aug 2016 Keytruda was approved in the EU for the second line treatment
PFE,PFE:US,BBG000BR2B91,Top Healthcare Stocks to Buy in 2017,2017-02-01 13:14:27 +0000,http://www.fool.com/investing/2017/01/31/top-healthcare-stocks-to-buy-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Top Healthcare Stocks to Buy in 2017
PFE,PFE:US,BBG000BR2B91,[$$] Trump’s Criticism of Imports Adds to Drugmakers’ Headaches,2017-02-01 05:51:08 +0000,https://www.wsj.com/articles/trumps-criticism-of-imports-adds-to-drugmakers-headaches-1485871207?ru=yahoo?mod=yahoo_itp,[$$] Trump’s Criticism of Imports Adds to Drugmakers’ Headaches
PFE,PFE:US,BBG000BR2B91,[$$] Trump Inauguration Drew More Than 18 Corporate Donors,2017-02-01 04:58:02 +0000,https://www.wsj.com/articles/donald-trump-inauguration-drew-more-than-18-corporate-donors-1485924877?mod=yahoo_hs,[$$] Trump Inauguration Drew More Than 18 Corporate Donors
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer Revenue Falls As Full-Year Sales Seen Below Wall Street Estimates,2017-02-01 03:57:08 +0000,http://www.wsj.com/articles/pfizer-revenue-falls-full-year-sales-seen-below-wall-street-expectations-1485868955?ru=yahoo?mod=yahoo_itp,[$$] Pfizer Revenue Falls As Full-Year Sales Seen Below Wall Street Estimates
PFE,PFE:US,BBG000BR2B91,Edited Transcript of PFE earnings conference call or presentation 31-Jan-17 3:00pm GMT,2017-02-01 02:53:20 +0000,http://finance.yahoo.com/news/edited-transcript-pfe-earnings-conference-025320336.html,Edited Transcript of PFE earnings conference call or presentation 31-Jan-17 3:00pm GMT
PFE,PFE:US,BBG000BR2B91,[$$] Trump’s Criticism of Imports Adds to Drugmakers’ Headaches,2017-02-01 01:49:30 +0000,http://www.wsj.com/articles/trumps-criticism-of-imports-adds-to-drugmakers-headaches-1485871207?ru=yahoo?mod=yahoo_itp,[$$] Trump’s Criticism of Imports Adds to Drugmakers’ Headaches
PFE,PFE:US,BBG000BR2B91,[$$] Trump's Criticism of Imports Adds to Drugmakers' Headaches,2017-01-31 23:47:04 +0000,http://www.wsj.com/articles/trumps-criticism-of-imports-adds-to-drugmakers-headaches-1485871207?mod=yahoo_hs,[$$] Trump's Criticism of Imports Adds to Drugmakers' Headaches
PFE,PFE:US,BBG000BR2B91,Dow Jones Industrial Average Nabs Monthly Win,2017-01-31 23:30:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AFq1ZYfsOcQ/dow-jones-industrial-average-nabs-monthly-win-cm741185,The 160 Dow Jones Industrial Average DJIA shed triple digits for a second straight session as a round of disappointing earnings and concerns over President Donald Trump s immigration ban continued to weigh on the market though some drug stocks saw a boost following Trump s comments
PFE,PFE:US,BBG000BR2B91,"Final Trade: FDX, FCX & more",2017-01-31 22:59:00 +0000,http://finance.yahoo.com/video/final-trade-fdx-fcx-more-225900028.html,"Final Trade: FDX, FCX & more"
PFE,PFE:US,BBG000BR2B91,Pfizer's 3 Fastest-Growing Drugs,2017-01-31 22:32:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QCId65D-kBM/pfizers-3-fastest-growing-drugs-cm741151,Pfizer Inc NYSE PFE is turning an important corner After years of declining sales due to patent expiration on its megablockbuster cholesterol drug Lipitor the company finally appears to be on a path back to reporting year over year growth Investments in mergers
PFE,PFE:US,BBG000BR2B91,Business Highlights,2017-01-31 22:26:56 +0000,http://sg.finance.yahoo.com/news/business-highlights-222656284.html,Business Highlights
PFE,PFE:US,BBG000BR2B91,"Pfizer swings to 4Q profit after rough year, hikes 2017 view",2017-01-31 22:08:51 +0000,http://sg.finance.yahoo.com/news/pfizer-misses-4q-profit-forecasts-115244544.html,"Pfizer swings to 4Q profit after rough year, hikes 2017 view"
PFE,PFE:US,BBG000BR2B91,"Market Close Report: NASDAQ trading volume joins the top ten ranking for the year. NASDAQ Composite Index closes at 5,614.79",2017-01-31 21:48:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yIaslSvltT8/market-close-report-nasdaq-trading-volume-joins-the-top-ten-ranking-for-the-year-nasdaq-composite-index-closes-at-561479-cm741172,Today s session closes with the NASDAQ Composite Index volume reaching the 10th place in the top ten list for this year The last time the index closed above 2 11 billion shares was on Jan 06 2017 The total shares traded for the NASDAQ was over 2 27 billion Today s session closes with the
PFE,PFE:US,BBG000BR2B91,Pfizer's 3 Fastest-Growing Drugs,2017-01-31 21:21:05 +0000,http://www.fool.com/investing/2017/01/31/pfizers-3-fastest-growing-drugs.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Pfizer's 3 Fastest-Growing Drugs
PFE,PFE:US,BBG000BR2B91,Fmr. Onyx CEO: Responsibility to find and research cures ...,2017-01-31 21:17:00 +0000,http://finance.yahoo.com/video/fmr-onyx-ceo-responsibility-research-211700370.html,Fmr. Onyx CEO: Responsibility to find and research cures ...
PFE,PFE:US,BBG000BR2B91,Pfizer Reports Lagging Q4 EPS; Rebounds On Trump Commentary,2017-01-31 21:11:40 +0000,http://www.investors.com/news/technology/pfizer-reports-lagging-q4-2016-eps-rebounds-on-trump-commentary/,Pfizer Reports Lagging Q4 EPS; Rebounds On Trump Commentary
PFE,PFE:US,BBG000BR2B91,Pfizer Needs to Keep Dealing,2017-01-31 20:37:31 +0000,http://www.bloomberg.com/gadfly/articles/2017-01-31/pfizer-earnings-more-deals-needed?cmpid=yhoo.headline,Pfizer Needs to Keep Dealing
PFE,PFE:US,BBG000BR2B91,[$$] Trump Tells Pharmaceutical CEOs He Wants Prices Down,2017-01-31 20:21:45 +0000,http://www.wsj.com/articles/trump-tells-pharmaceutical-ceos-he-wants-prices-down-1485875553?mod=yahoo_hs,[$$] Trump Tells Pharmaceutical CEOs He Wants Prices Down
PFE,PFE:US,BBG000BR2B91,Pfizer CEO says no need to alter its drug pricing practices,2017-01-31 20:01:48 +0000,http://finance.yahoo.com/news/pfizer-quarterly-profit-misses-estimates-121613486.html,"[Reuters] - Pfizer Inc Chief Executive Ian Read said on Tuesday the company would not change its philosophy on pricing of its medicines or when it takes price increases, bucking a recent trend by some rivals of the largest U.S. drugmaker. The comments, made on a conference call after Pfizer reported slightly lower than expected fourth-quarter profit, came as several of Read's industry peers met with U.S. President Donald Trump, who has insisted prescription drug prices must come down. Discussions with Trump included some ideas on how that goal might be accomplished, including tax reform and undoing regulations that slow entry of new drugs and generics to the market."
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. (PFE) Stock Makes Big Moves After Q4 Earnings Miss,2017-01-31 19:32:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tzrWExgXEFc/pfizer-inc-pfe-stock-makes-big-moves-after-q4-earnings-miss-cm741093,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Pfizer Inc NYSE PFE stock was on the move Tuesday following the release of its earnings report for the fourth quarter of 2016 Source Kojach Via Flickr Revenue reported by 160 Pfizer
PFE,PFE:US,BBG000BR2B91,Tuesday's ETF with Unusual Volume: PPH,2017-01-31 19:31:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/autjheTRc_A/tuesdays-etf-with-unusual-volume-pph-cm741029,The Pharmaceutical ETF PPH is seeing unusually high volume in afternoon trading Tuesday with over 2 2 million shares traded versus three month average volume of about 193 000 Shares of PPH were up about 0 6 on the day Components of that ETF with the highest volume on Tuesday
PFE,PFE:US,BBG000BR2B91,Pfizer Shares Look Undervalued,2017-01-31 19:12:00 +0000,http://finance.yahoo.com/news/pfizer-shares-look-undervalued-191200331.html,Pfizer Shares Look Undervalued
PFE,PFE:US,BBG000BR2B91,Pfizer Still Looking For Growth,2017-01-31 19:05:00 +0000,http://www.investopedia.com/news/pfizer-delivered-q4-and-fy-mixed-results-pfe/?partner=YahooSA,Pfizer Still Looking For Growth
PFE,PFE:US,BBG000BR2B91,7 Things You Might Have Missed in Pfizer's Q4 Earnings Slip,2017-01-31 18:33:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qeKK6vw_zFo/7-things-you-might-have-missed-in-pfizers-q4-earnings-slip-cm740997,Wall Street expected Pfizer NYSE PFE to report fourth quarter revenue of 13 63 billion and earnings of 0 50 per share The big drugmaker met the revenue expectation but fell short of the consensus earnings estimate reporting adjusted diluted earnings per share of 0 47
PFE,PFE:US,BBG000BR2B91,"Early movers: UAA, XOM, UPS, MA, LLY, HOG, PFE & more",2017-01-31 18:24:55 +0000,http://www.cnbc.com/id/104251508?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104251508,"Early movers: UAA, XOM, UPS, MA, LLY, HOG, PFE & more"
PFE,PFE:US,BBG000BR2B91,7 Things You Might Have Missed in Pfizer's Q4 Earnings Slip,2017-01-31 17:44:35 +0000,http://www.fool.com/investing/2017/01/31/7-things-you-might-have-missed-in-pfizers-q4-earni.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,7 Things You Might Have Missed in Pfizer's Q4 Earnings Slip
PFE,PFE:US,BBG000BR2B91,Trade War Concerns Coming Home to Roost,2017-01-31 17:35:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4REJwiug1Mk/trade-war-concerns-coming-home-to-roost-cm740976,Tuesday January 31 2017 We d gone more than two months on a Trump Rally that had favorably priced in things like corporate tax cuts and deregulation opening a clear path toward market gains Eventually we saw a bid up to the coveted Dow 20 000 something that had been considered a
PFE,PFE:US,BBG000BR2B91,"Tuesday’s Vital Data: Rite Aid Corporation (RAD), Bank of America Corp (BAC) and Pfizer Inc. (PFE)",2017-01-31 17:32:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3xuSa2veTyY/tuesdays-vital-data-rite-aid-corporation-rad-bank-of-america-corp-bac-and-pfizer-inc-pfe-cm741002,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are pointing toward another round of losses as Wall Street continues to fret over President Donald Trump s immigration policies after he fired acting Attorney General
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Q4 Earnings Lag, Sales Top; '17 Sales View Soft",2017-01-31 16:36:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/odtPMmItYy0/pfizer-pfe-q4-earnings-lag-sales-top-17-sales-view-soft-cm740880,Pfizer Inc PFE reported fourth quarter adjusted earnings per share of 47 cents missing the Zacks Consensus Estimate of 50 cents by 6 Earnings also declined 11 year over year due to lower revenues than year ago quarter On the other hand revenues beat expectations The pharma
PFE,PFE:US,BBG000BR2B91,Healthcare Names Rally as Pharma Meets with Trump,2017-01-31 16:29:00 +0000,http://www.investopedia.com/news/trump-meets-pharma-ceos-stocks-pop-pfe-lly/?partner=YahooSA,Healthcare Names Rally as Pharma Meets with Trump
PFE,PFE:US,BBG000BR2B91,S&P 500 Falls for a Fourth Day as 'Rose-Tinted Glasses' of Trump Presidency Come Off,2017-01-31 15:40:00 +0000,https://www.thestreet.com/story/13972706/1/wall-street-s-losing-streak-continues-after-trump-s-travel-ban.html?puc=yahoo&cm_ven=YAHOO,S&P 500 Falls for a Fourth Day as 'Rose-Tinted Glasses' of Trump Presidency Come Off
PFE,PFE:US,BBG000BR2B91,Trump says drug prices are 'astronomical',2017-01-31 14:48:07 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=A18FAF41-1B41-4FB3-A3D2-8DA9D94CCCC3&siteid=yhoof2,Trump says drug prices are 'astronomical'
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Misses on Q4 Earnings; Tops Sales Estimate,2017-01-31 14:35:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7uKwD7CE0QE/pfizer-pfe-misses-on-q4-earnings-tops-sales-estimate-cm740792,Pfizer Inc s PFE is one of the most well known names in the pharmaceutical sector not just for its medicines and vaccines but also for its consumer healthcare products This New York based company is well known for products like Prevnar Lyrica Lipitor and Celebrex among others However
PFE,PFE:US,BBG000BR2B91,Top Healthcare Stocks to Buy in 2017,2017-01-31 14:33:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BeuMLYuZmEc/top-healthcare-stocks-to-buy-in-2017-cm740641,The S amp P 500 gained double digits in 2016 but healthcare investors were largely left out in the cold Shares of the Vanguard Health Care ETF NYSEMKT VHT a widely held index fund that focuses on the sector actually declined by more than 2 during the
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Q4 Earnings Lag, Sales Top; '17 Sales View Soft",2017-01-31 14:29:02 +0000,http://finance.yahoo.com/news/pfizer-pfe-q4-earnings-lag-142902960.html,"Pfizer (PFE) Q4 Earnings Lag, Sales Top; '17 Sales View Soft"
PFE,PFE:US,BBG000BR2B91,"Pfizer Misses on Earnings, Forecasts 2017 Sales Below Analysts' Estimates",2017-01-31 14:27:00 +0000,http://www.thestreet.com/video/13972549/pfizer-misses-on-earnings-forecasts-2017-sales-below-analysts-estimates.html?puc=yahoov&cm_ven=YAHOOV,"Pfizer Misses on Earnings, Forecasts 2017 Sales Below Analysts' Estimates"
PFE,PFE:US,BBG000BR2B91,"Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for February 01, 2017",2017-01-31 14:12:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3Y9VZN4wAXY/pfizer-inc-pfe-ex-dividend-date-scheduled-for-february-01-2017-cm740692,Pfizer Inc PFE will begin trading ex dividend on February 01 2017 A cash dividend payment of 0 32 per share is scheduled to be paid on March 01 2017 Shareholders who purchased PFE prior to the ex dividend date are eligible for the cash dividend payment This represents an 6 67
PFE,PFE:US,BBG000BR2B91,"Pfizer's profit misses as Prevnar sales lag, costs rise",2017-01-31 14:09:12 +0000,http://in.finance.yahoo.com/news/pfizer-quarterly-revenue-slips-3-120239374.html,"Pfizer's profit misses as Prevnar sales lag, costs rise"
PFE,PFE:US,BBG000BR2B91,"Healthcare Q4: Eli Lilly Beats, Pfizer Misses",2017-01-31 13:57:14 +0000,http://finance.yahoo.com/news/healthcare-q4-eli-lilly-beats-135714133.html,"Healthcare Q4: Eli Lilly Beats, Pfizer Misses"
PFE,PFE:US,BBG000BR2B91,Are Pfizer’s Acquisitions Holding Back Its Bottom Line?,2017-01-31 13:55:43 +0000,http://finance.yahoo.com/news/pfizer-acquisitions-holding-back-bottom-135543539.html,Are Pfizer’s Acquisitions Holding Back Its Bottom Line?
PFE,PFE:US,BBG000BR2B91,"Stock Futures Slip as Trump's Travel Ban Continues to Rock Markets, Fed Meets",2017-01-31 13:43:00 +0000,https://www.thestreet.com/story/13971344/1/stock-futures-slip-as-fed-meets-trump-s-travel-ban-continues-to-rock-markets.html?puc=yahoo&cm_ven=YAHOO,"Stock Futures Slip as Trump's Travel Ban Continues to Rock Markets, Fed Meets"
PFE,PFE:US,BBG000BR2B91,Pfizer Lets Investors Down in Two New Ways,2017-01-31 13:30:00 +0000,https://www.thestreet.com/story/13972222/1/pfizer-misses-4q-earnings-estimate-sees-2017-sales-below-forecasts.html?puc=yahoo&cm_ven=YAHOO,Pfizer Lets Investors Down in Two New Ways
PFE,PFE:US,BBG000BR2B91,Pfizer swings to a 4Q profit after rough year,2017-01-31 13:25:05 +0000,http://finance.yahoo.com/news/pfizer-misses-4q-profit-forecasts-115244063.html,Pfizer swings to a 4Q profit after rough year
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Misses on Q4 Earnings; Tops Sales Estimate,2017-01-31 13:16:01 +0000,http://finance.yahoo.com/news/pfizer-pfe-misses-q4-earnings-131601362.html,Pfizer (PFE) Misses on Q4 Earnings; Tops Sales Estimate
PFE,PFE:US,BBG000BR2B91,Q4 2016 Pfizer Inc Earnings Release - Time Not Supplied,2017-01-31 12:07:07 +0000,http://biz.yahoo.com/research/earncal/20170131.html?t=pfe,Q4 2016 Pfizer Inc Earnings Release - Time Not Supplied
PFE,PFE:US,BBG000BR2B91,"Pfizer's stock drops after profit miss, downbeat sales outlook",2017-01-31 11:57:35 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=6C92527C-8A71-4646-AA68-60A193F0D10C&siteid=yhoof2,"Pfizer's stock drops after profit miss, downbeat sales outlook"
PFE,PFE:US,BBG000BR2B91,Pfizer quarterly revenue slips 3 percent,2017-01-31 11:57:04 +0000,http://finance.yahoo.com/news/pfizer-quarterly-revenue-slips-3-115704205.html,Pfizer quarterly revenue slips 3 percent
PFE,PFE:US,BBG000BR2B91,"Pfizer Profit, Forecast Fall Short as Generics to Hurt Sales",2017-01-31 11:54:21 +0000,http://www.bloomberg.com/news/articles/2017-01-31/pfizer-earnings-forecast-fall-short-as-generics-to-hurt-sales?cmpid=yhoo.headline,"Pfizer Profit, Forecast Fall Short as Generics to Hurt Sales"
PFE,PFE:US,BBG000BR2B91,"Earnings Reaction History: Pfizer Inc, 45.5% Follow-Through Indicator, 1.3% Sensitive",2017-01-31 11:51:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tm5y5iox5sI/earnings-reaction-history-pfizer-inc-455-follow-through-indicator-13-sensitive-cm740599,Expected Earnings Release 01 31 2017 PremarketExpected Earnings Release 01 31 2017 Premarket Avg Extended Hours Dollar Volume 9 728 522Avg Extended Hours Dollar Volume 9 728 522 Pfizer Inc PFE is due to issue its quarterly earnings report in the upcoming extended hours session
PFE,PFE:US,BBG000BR2B91,PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2016 RESULTS,2017-01-31 11:45:00 +0000,http://finance.yahoo.com/news/pfizer-reports-fourth-quarter-full-114500713.html,[Business Wire] - Pfizer Inc. reported financial results for fourth-quarter and full-year 2016 and provided 2017 financial guidance.
PFE,PFE:US,BBG000BR2B91,"Stocks to Watch: January 31, 2017",2017-01-31 11:38:00 +0000,http://finance.yahoo.com/video/stocks-watch-january-31-2017-113800091.html,"Stocks to Watch: January 31, 2017"
PFE,PFE:US,BBG000BR2B91,Pfizer Q4 16 Earnings Conference Call At 10:00 AM ET,2017-01-31 08:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5NKz84CBVIM/pfizer-q4-16-earnings-conference-call-at-1000-am-et-20170131-00561,Pfizer Q4 16 Earnings Conference Call At 10:00 AM ET
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. Q4 Profit Retreats 13%,2017-01-31 06:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/exIntvhbM-w/pfizer-inc-q4-profit-retreats-13-20170131-00305,Pfizer Inc. Q4 Profit Retreats 13%
PFE,PFE:US,BBG000BR2B91,All Eyes on Growth Plans as Pfizer Gears Up for Fourth Quarter Earnings,2017-01-31 00:41:00 +0000,https://www.thestreet.com/story/13970965/1/what-will-you-hear-on-pfizer-s-fourth-quarter-call-tuesday.html?puc=yahoo&cm_ven=YAHOO,All Eyes on Growth Plans as Pfizer Gears Up for Fourth Quarter Earnings
PFE,PFE:US,BBG000BR2B91,Apple earnings on deck — What you need to know in markets on Tuesday,2017-01-30 23:40:48 +0000,http://finance.yahoo.com/news/apple-earnings-on-deck-what-you-need-to-know-in-markets-on-tuesday-234048204.html,Apple earnings on deck — What you need to know in markets on Tuesday
PFE,PFE:US,BBG000BR2B91,Better Buy: AbbVie Inc. vs. Pfizer,2017-01-30 22:32:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BiEOKgmZWKU/better-buy-abbvie-inc-vs-pfizer-cm740472,AbbVie NYSE ABBV and Pfizer NYSE PFE have a lot in common Both big drugmakers have a cancer drug with soaring sales Both pay great dividends And both stocks have turned in nearly identical performances over the past 12 months But which is the better buy now Here s
PFE,PFE:US,BBG000BR2B91,"Apple, MasterCard, Exxon, EA, AMD, Fed: Investing Action Plan",2017-01-30 21:52:53 +0000,http://www.investors.com/research/investing-action-plan/apple-mastercard-exxon-ea-amd-fed-investing-action-plan/,"Apple, MasterCard, Exxon, EA, AMD, Fed: Investing Action Plan"
PFE,PFE:US,BBG000BR2B91,Better Buy: AbbVie Inc. vs. Pfizer,2017-01-30 21:28:05 +0000,http://www.fool.com/investing/2017/01/30/better-buy-abbvie-inc-vs-pfizer.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: AbbVie Inc. vs. Pfizer
PFE,PFE:US,BBG000BR2B91,"Pre-Market Earnings Report for January 31, 2017 :  XOM, PFE, MA, LLY, UPS, TMO, SPG, DHR, AET, S, VLO, HCA",2017-01-30 21:11:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qmAOdReUxPs/pre-market-earnings-report-for-january-31-2017-xom-pfe-ma-lly-ups-tmo-spg-dhr-aet-s-vlo-hca-cm740464,The following companies are expected to report earnings prior to market open on 01 31 2017 Visit our Earnings Calendar for a full list of expected earnings releases Exxon Mobil Corporation XOM is reporting for the quarter ending December 31 2016 The
PFE,PFE:US,BBG000BR2B91,Dow Analyst Moves: PFE,2017-01-30 18:32:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fRygyvr6gGk/dow-analyst-moves-pfe-cm740330,The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average Pfizer Inc PFE is the 11 analyst pick Pfizer also comes in above the median of analyst picks among the broader S amp P 500 index
PFE,PFE:US,BBG000BR2B91,Broker Darlings of the Dow: Pfizer Ranks As a Top 15 Analyst Pick,2017-01-30 18:31:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L96T7i0jK_Y/broker-darlings-of-the-dow-pfizer-ranks-as-a-top-15-analyst-pick-cm740310,A study of analyst recommendations at the major brokerages shows that Pfizer Inc Symbol PFE is the 11 broker pick on average out of the 30 stocks making up the Dow Jones Industrial Average according to ETF Channel Pfizer Inc also comes in above the median of analyst picks among
PFE,PFE:US,BBG000BR2B91,Interesting September Stock Options for PFE,2017-01-30 18:31:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YrH2m2qXX1I/interesting-september-stock-options-for-pfe-cm740306,Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the September expiration for PFE The put contract
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 01/30/2017: JNJ, PFE, ABT, MRK, AMGN, OCRX, CALA, EYEG",2017-01-30 17:33:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3Xz4hRsvs9s/health-care-sector-update-for-01302017-jnj-pfe-abt-mrk-amgn-ocrx-cala-eyeg-cm740298,Top Health Care stocks Top Health Care stocks JNJ 0 3 JNJ 0 3 PFE 0 7 PFE 0 7 ABT 0 1 ABT 0 1 MRK 1 MRK 1 AMGN 1 7 AMGN 1 7 Health care shares were lower at mid day Monday Health care shares were lower at mid day Monday In health care stocks news Calithera
PFE,PFE:US,BBG000BR2B91,"A Mixed Bag of Earnings Ahead: Eli Lilly, Pfizer, Exxon Mobil, And Under Armour",2017-01-30 17:26:00 +0000,http://finance.yahoo.com/news/mixed-bag-earnings-ahead-eli-172600301.html,"A Mixed Bag of Earnings Ahead: Eli Lilly, Pfizer, Exxon Mobil, And Under Armour"
PFE,PFE:US,BBG000BR2B91,Top 7 Earnings Reports to Look For Tuesday,2017-01-30 16:45:35 +0000,http://finance.yahoo.com/news/top-7-earnings-reports-look-164535286.html,Top 7 Earnings Reports to Look For Tuesday
PFE,PFE:US,BBG000BR2B91,"Ex-Dividend Reminder: D.R. Horton, CMS Energy Corp and Pfizer",2017-01-30 16:33:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pmAUGDDQltU/ex-dividend-reminder-dr-horton-cms-energy-corp-and-pfizer-cm740152,Looking at the universe of stocks we cover at Dividend Channel on 2 1 17 D R Horton Inc Symbol DHI CMS Energy Corp Symbol CMS and Pfizer Inc Symbol PFE will all trade ex dividend for their respective upcoming dividends D R Horton Inc will pay its quarterly dividend of 0 10
PFE,PFE:US,BBG000BR2B91,What Are Analysts’ Future Estimates for Johnson & Johnson?,2017-01-30 15:35:59 +0000,http://marketrealist.com/2017/01/what-are-analysts-future-estimates-for-johnson-johnson/?utm_source=yahoo&utm_medium=feed,What Are Analysts’ Future Estimates for Johnson & Johnson?
PFE,PFE:US,BBG000BR2B91,Exploring JNJ’s 2017 Profitability and Financial Guidance,2017-01-30 14:06:06 +0000,http://marketrealist.com/2017/01/exploring-jnjs-2017-profitability-and-financial-guidance/?utm_source=yahoo&utm_medium=feed,Exploring JNJ’s 2017 Profitability and Financial Guidance
PFE,PFE:US,BBG000BR2B91,What to expect from Pfizer earnings: competition on two fronts,2017-01-30 13:44:48 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=49BD9A2E-E4AE-11E6-8855-08962D199CE8&siteid=yhoof2,What to expect from Pfizer earnings: competition on two fronts
PFE,PFE:US,BBG000BR2B91,Drug Stocks Reporting Q4 Earnings on Jan 31: LLY and PFE,2017-01-30 13:33:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8OwP6JmTR8U/drug-stocks-reporting-q4-earnings-on-jan-31-lly-and-pfe-cm739957,As the Q4 earnings season picks up pace we believe this quarter is witnessing the highest growth momentum in the last eight quarters As of Jan 27 2017 170 S amp P 500 members accounting for 33 9 of the index s total market capitalization have reported results according to the
PFE,PFE:US,BBG000BR2B91,3 Top Pharmaceutical Stocks to Buy in February,2017-01-30 13:22:06 +0000,http://www.fool.com/investing/2017/01/30/3-top-pharmaceutical-stocks-to-buy-in-february.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Pharmaceutical Stocks to Buy in February
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Gets Positive CHMP Opinion for Arthritis Drug,2017-01-30 12:37:12 +0000,http://finance.yahoo.com/news/pfizer-pfe-gets-positive-chmp-123712742.html,Pfizer (PFE) Gets Positive CHMP Opinion for Arthritis Drug
PFE,PFE:US,BBG000BR2B91,Can Merck And Pfizer Beat Low Expectations?,2017-01-30 12:16:54 +0000,http://finance.yahoo.com/news/merck-pfizer-beat-low-expectations-121654554.html,Can Merck And Pfizer Beat Low Expectations?
PFE,PFE:US,BBG000BR2B91,Drug Stocks Reporting Q4 Earnings on Jan 31: LLY and PFE,2017-01-30 11:06:11 +0000,http://finance.yahoo.com/news/drug-stocks-reporting-q4-earnings-110611159.html,Drug Stocks Reporting Q4 Earnings on Jan 31: LLY and PFE
PFE,PFE:US,BBG000BR2B91,[$$] Looking for a new chief? Let the office 'Hunger Games' begin,2017-01-30 05:00:27 +0000,"http://www.ft.com/cms/s/e8f2eeb6-e30d-11e6-9645-c9357a75844a,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Chief executive is a highly paid, high-profile role, for which highly motivated pretenders have prepared for years. The only surprise is why anyone is surprised that recruiting a new one often descends ..."
PFE,PFE:US,BBG000BR2B91,Drugmakers Plan Huge Deals in 2017 -- and Banks Will Collect Big Fees,2017-01-29 23:43:00 +0000,https://www.thestreet.com/story/13964281/1/drugmakers-plan-big-deals-in-2017-and-banks-will-collect-big-fees.html?puc=yahoo&cm_ven=YAHOO,Drugmakers Plan Huge Deals in 2017 -- and Banks Will Collect Big Fees
PFE,PFE:US,BBG000BR2B91,3 Reasons to Buy Pfizer Stock and Never Sell,2017-01-29 15:43:47 +0000,http://www.fool.com/investing/2017/01/29/3-reasons-to-buy-pfizer-stock-and-never-sell.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Reasons to Buy Pfizer Stock and Never Sell
PFE,PFE:US,BBG000BR2B91,3 Reasons to Buy Pfizer Stock and Never Sell,2017-01-29 13:31:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tv5lXUGZ134/3-reasons-to-buy-pfizer-stock-and-never-sell-cm739854,Buy and hold really hasn t been great advice in the past when it comes to owning Pfizer NYSE PFE stock Although the big drugmaker s stock has posted decent gains over the last six years Pfizer s share price still hasn t regained where it was in 2000 But things are different
PFE,PFE:US,BBG000BR2B91,This Promising Prostate Cancer Treatment Could Be a Game-Changer,2017-01-28 18:31:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hEc_HaTMJCg/this-promising-prostate-cancer-treatment-could-be-a-game-changer-cm739816,Image source Getty Images Cancer is among the scariest diagnosis a person can receive According to the American Cancer Society s Cancer Facts amp Figures 2016 report there were an estimated 1 69 million new cases of cancer diagnosed in 2016 along with a projected 595 690
PFE,PFE:US,BBG000BR2B91,This Promising Prostate Cancer Treatment Could Be a Game-Changer,2017-01-28 16:41:06 +0000,http://www.fool.com/investing/2017/01/28/this-promising-prostate-cancer-treatment-could-be.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,This Promising Prostate Cancer Treatment Could Be a Game-Changer
PFE,PFE:US,BBG000BR2B91,You Better Not Behave Like an Over-Caffeinated Day Trader Right Now,2017-01-28 16:05:00 +0000,https://www.thestreet.com/story/13970325/1/investor-euphoria-lasting-momentum-or-sugar-high.html?puc=yahoo&cm_ven=YAHOO,You Better Not Behave Like an Over-Caffeinated Day Trader Right Now
PFE,PFE:US,BBG000BR2B91,"Earnings Growth Returns, Will it Continue?",2017-01-28 06:30:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VQrXaufF75o/earnings-growth-returns-will-it-continue-cm739733,Corporate earnings have started growing again with growth in the ongoing Q4 earnings season on track to reach its highest level in 8 quarters Growth is still modest the Q4 earnings growth is currently on track to reach 5 2 and the final growth tally for the quarter will at best be a couple
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. Johnson & Johnson,2017-01-27 21:31:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9HUemFoQXww/better-buy-pfizer-inc-vs-johnson-johnson-cm739583,Choosing between Pfizer NYSE PFE and Johnson amp Johnson NYSE JNJ based on past performance is an easy decision J amp J s stock performance trounced Pfizer s over the past year three years five years and 10 years But that s the past Which stock is the better pick
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. Johnson & Johnson,2017-01-27 19:58:14 +0000,http://www.fool.com/investing/2017/01/27/better-buy-pfizer-inc-vs-johnson-johnson.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Pfizer Inc. vs. Johnson & Johnson
PFE,PFE:US,BBG000BR2B91,Will a Pending EU Approval Help XELJANZ Growth?,2017-01-27 17:51:00 +0000,http://www.investopedia.com/news/pfe-gets-positive-review-arthritis-drug-pfe/?partner=YahooSA,Will a Pending EU Approval Help XELJANZ Growth?
PFE,PFE:US,BBG000BR2B91,Will Amgen (AMGN) Keep the Earnings Streak Alive in Q4?,2017-01-27 16:36:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EWjzfYpdrD8/will-amgen-amgn-keep-the-earnings-streak-alive-in-q4-cm739399,We expect biotech major Amgen Inc AMGN to beat expectations when it reports fourth quarter 2016 and full year results on Feb 2 after the market closes Amgen had delivered a positive earnings surprise of 8 24 in the last quarter Amgen s shares were up 4 6 so far this year This
PFE,PFE:US,BBG000BR2B91,Merck (MRK): Stock to Gain on Likely Earnings Beat in Q4?,2017-01-27 16:35:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q7tnTQxQd3U/merck-mrk-stock-to-gain-on-likely-earnings-beat-in-q4-cm739358,We expect pharma heavyweight Merck amp Co Inc MRK to beat expectations when it reports fourth quarter 2016 and full year earnings results on Feb 2 before the market opens Last quarter the company delivered a positive earnings surprise of 9 18 Merck s shares rose 3 9 so far this
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) C. Difficile Vaccine Positive in Phase II Study,2017-01-27 16:35:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6M_jyQpEsgk/pfizer-pfe-c-difficile-vaccine-positive-in-phase-ii-study-cm739355,Pfizer Inc PFE announced positive top line results from a phase II study on its investigational vaccine candidate PF 06425090 for the prevention of clostridium difficile infection which includes life threatening diarrhea and pseudomembranous colitis The phase II
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) C. Difficile Vaccine Positive in Phase II Study,2017-01-27 14:35:02 +0000,http://finance.yahoo.com/news/pfizer-pfe-c-difficile-vaccine-143502685.html,Pfizer (PFE) C. Difficile Vaccine Positive in Phase II Study
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: J&J to Buy Actelion, Bristol-Myers' 4Q Results Disappoint",2017-01-27 13:33:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kLuU7W2doGg/pharma-stock-roundup-jj-to-buy-actelion-bristol-myers-4q-results-disappoint-cm739155,Healthcare giant Johnson amp Johnson JNJ and Swiss company Actelion finally announced an agreement under which J amp J will acquire Actelion for about 30 billion Meanwhile companies like J amp J Read more J amp J Q4 Earnings Top Seeks Options for Diabetes Unit Novartis Read
PFE,PFE:US,BBG000BR2B91,Blog Coverage Pfizer Reported Positive Results for Mid-stage Trial for C. difficile Vaccine,2017-01-27 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-pfizer-reported-positive-131500697.html,"[Accesswire] - Upcoming AWS Coverage on Impax Laboratories Post-Earnings Results LONDON, UK / ACCESSWIRE / January 27, 2017 / Active Wall St. blog coverage looks at the headline from Pfizer Inc. (NYSE: PFE ) as the Company ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Receives Positive CHMP Opinion in Europe for XELJANZ® (tofacitinib citrate) for the Treatment of Moderate to Severe Active Rheumatoid Arthritis,2017-01-27 12:00:00 +0000,http://uk.finance.yahoo.com/news/pfizer-receives-positive-chmp-opinion-120000230.html,Pfizer Receives Positive CHMP Opinion in Europe for XELJANZ® (tofacitinib citrate) for the Treatment of Moderate to Severe Active Rheumatoid Arthritis
PFE,PFE:US,BBG000BR2B91,Pfizer Gets Positive CHMP Opinion In Europe For XELJANZ,2017-01-27 07:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_TZaO_-D648/pfizer-gets-positive-chmp-opinion-in-europe-for-xeljanz-20170127-00260,Pfizer Gets Positive CHMP Opinion In Europe For XELJANZ
PFE,PFE:US,BBG000BR2B91,Earnings Preview: What To Expect From Pfizer,2017-01-27 01:55:00 +0000,http://www.forbes.com/sites/adamsarhan/2017/01/26/earnings-preview-what-to-expect-from-pfizer/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Earnings Preview: What To Expect From Pfizer
PFE,PFE:US,BBG000BR2B91,"IMGN Marches Forward, FDA Nod For ZLTQ, Knight Lends Shine To PLX",2017-01-26 23:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_t39jshIaXo/imgn-marches-forward-fda-nod-for-zltq-knight-lends-shine-to-plx-20170126-01848,"IMGN Marches Forward, FDA Nod For ZLTQ, Knight Lends Shine To PLX"
PFE,PFE:US,BBG000BR2B91,"Bristol-Myers (BMY) Misses on Q4 Earnings, Beats on Sales",2017-01-26 22:33:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D4IOHm32e_Y/bristol-myers-bmy-misses-on-q4-earnings-beats-on-sales-cm739045,Bristol Myers Squibb Company s BMY reported a mixed fourth quarter with earnings missing expectations while sales beating the same Shares declined around 2 in pre market trading In the past one year Bristol Myers share price was down 21 compared unfavorably with the 4 6
PFE,PFE:US,BBG000BR2B91,"XLV, MLN: Big ETF Outflows",2017-01-26 17:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/angF5FAYMSo/xlv-mln-big-etf-outflows-cm738785,Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel the biggest outflow was seen in the XLV where 9 500 000 units were destroyed or a 4 7 decrease week over week Among the largest underlying components of XLV in morning trading
PFE,PFE:US,BBG000BR2B91,"Noteworthy ETF Inflows: IWD, BAC, PFE, MRK",2017-01-26 17:32:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SWtBEF67BtA/noteworthy-etf-inflows-iwd-bac-pfe-mrk-cm738767,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 Value ETF Symbol IWD where we have detected an approximate 455 2 million dollar inflow that s a 1 3 increase week over week in
PFE,PFE:US,BBG000BR2B91,Could New Vaccine Help Pfizer Grow its Revenue?,2017-01-26 17:25:00 +0000,http://www.investopedia.com/news/pfizer-sees-positive-results-new-vaccine-pfe/?partner=YahooSA,Could New Vaccine Help Pfizer Grow its Revenue?
PFE,PFE:US,BBG000BR2B91,J&J to spend $30 billion on Swiss drugmaker Actelion,2017-01-26 16:47:12 +0000,http://sg.finance.yahoo.com/news/j-j-buy-swiss-biopharma-101604724.html,J&J to spend $30 billion on Swiss drugmaker Actelion
PFE,PFE:US,BBG000BR2B91,J&J to spend $30 billion on Swiss drugmaker Actelion,2017-01-26 16:47:12 +0000,http://finance.yahoo.com/news/j-j-buy-swiss-biopharma-firm-actelion-30-101604197--finance.html,J&J to spend $30 billion on Swiss drugmaker Actelion
PFE,PFE:US,BBG000BR2B91,11 Largest Pharmaceutical Companies In The World,2017-01-26 14:28:39 +0000,http://www.insidermonkey.com/blog/11-largest-pharmaceutical-companies-in-the-world-523960/,11 Largest Pharmaceutical Companies In The World
PFE,PFE:US,BBG000BR2B91,Pfizer says mid-stage trial for C. difficile vaccine had positive results,2017-01-26 13:13:39 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=63C699E4-6BAA-411D-BD57-C3E5E80F22DB&siteid=yhoof2,Pfizer says mid-stage trial for C. difficile vaccine had positive results
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Positive Top-Line Results from Phase 2 Study of Investigational Clostridium difficile Vaccine for the Prevention of C. difficile Infection,2017-01-26 13:00:00 +0000,http://finance.yahoo.com/news/pfizer-announces-positive-top-line-130000414.html,"[Business Wire] - Pfizer Inc. announced today that the Phase 2 study evaluating the Company’s Clostridium difficile vaccine candidate, PF-06425090, provided positive data, based on a pre-planned interim analysis."
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Results From Phase 2 Study Of C. Difficile Vaccine,2017-01-26 08:29:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-9eBtM_hXQA/pfizer-announces-results-from-phase-2-study-of-c-difficile-vaccine-20170126-00662,Pfizer Announces Results From Phase 2 Study Of C. Difficile Vaccine
PFE,PFE:US,BBG000BR2B91,"Eli Lilly, Novartis Challenge Pfizer's Potential $8 Billion Breast Cancer Drug",2017-01-25 21:34:39 +0000,http://www.investors.com/news/technology/eli-lilly-novartis-challenge-pfizers-8-billion-breast-cancer-drug/,"Eli Lilly, Novartis Challenge Pfizer's Potential $8 Billion Breast Cancer Drug"
PFE,PFE:US,BBG000BR2B91,"Q4 Earnings Scorecard and Analyst Reports for Tesla, Verizon & Others",2017-01-25 19:31:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QQEOTFRZU68/q4-earnings-scorecard-and-analyst-reports-for-tesla-verizon-others-cm738263,Wednesday January 25 2017 Today s Research Daily features an updated scorecard for the ongoing Q4 earnings season and fresh research reports on 16 major stocks including Verizon VZ and Tesla TSLA To see of all of the 70 or so research reports issued by our analyst team
PFE,PFE:US,BBG000BR2B91,What Lies in Store for Pfizer (PFE) this Earnings Season?,2017-01-25 17:35:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9o6-j0c3Tt0/what-lies-in-store-for-pfizer-pfe-this-earnings-season-cm738132,Pfizer Inc PFE will be reporting fourth quarter and full year 2016 earnings results on Jan 31 before market open Last quarter the company delivered a negative earnings surprise of 1 61 Nonetheless the pharma giant has been consistently beating earnings expectations The company s
PFE,PFE:US,BBG000BR2B91,"Q4 Earnings Scorecard and Analyst Reports for Tesla, Verizon & Others",2017-01-25 17:08:05 +0000,http://finance.yahoo.com/news/q4-earnings-scorecard-analyst-reports-170805595.html,"Q4 Earnings Scorecard and Analyst Reports for Tesla, Verizon & Others"
PFE,PFE:US,BBG000BR2B91,What Lies in Store for Pfizer (PFE) this Earnings Season?,2017-01-25 15:17:03 +0000,http://finance.yahoo.com/news/lies-store-pfizer-pfe-earnings-151703650.html,What Lies in Store for Pfizer (PFE) this Earnings Season?
PFE,PFE:US,BBG000BR2B91,Analyzing Bristol-Myers Squibb’s Other Segments in 4Q16,2017-01-25 14:06:35 +0000,http://marketrealist.com/2017/01/analyzing-bristol-myers-squibbs-other-segments-in-4q16/?utm_source=yahoo&utm_medium=feed,Analyzing Bristol-Myers Squibb’s Other Segments in 4Q16
PFE,PFE:US,BBG000BR2B91,US Market Indexes Lower on Monday,2017-01-25 11:30:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NWzl3bDqbxk/us-market-indexes-lower-on-monday-cm737759,U S market indexes were lower on Monday For the day the Dow Jones Industrial Average closed at 19799 85 for a loss of 27 40 points or 0 14 The S amp P 500 closed at 2265 20 for a loss of 6 11 points or 0 27 The Nasdaq Composite closed at 5552 94 for a loss of 2 39 points or 0 04
PFE,PFE:US,BBG000BR2B91,Uh-Oh: This Could Be Johnson & Johnson's Biggest Risk in 2017,2017-01-25 00:31:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ab1L-5zHkIQ/uh-oh-this-could-be-johnson-johnsons-biggest-risk-in-2017-cm737710,Johnson amp Johnson NYSE JNJ released its fourth quarter 2016 financials and the numbers show that the launch of a Remicade biosimilar by Pfizer Inc NYSE PFE could pose a big threat to the company s growth in 2017 Image source Getty Images A massive
PFE,PFE:US,BBG000BR2B91,Uh-Oh: This Could Be Johnson & Johnson's Biggest Risk in 2017,2017-01-24 23:21:06 +0000,http://www.fool.com/investing/2017/01/24/uh-oh-this-could-be-johnson-johnsons-biggest-risk.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Uh-Oh: This Could Be Johnson & Johnson's Biggest Risk in 2017
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb Earnings Preview: The Company Has To Reassure Investors,2017-01-24 22:01:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5Yeem7hJcgk/bristol-myers-squibb-earnings-preview-the-company-has-to-reassure-investors-cm737667,Bristol Myers Squibb 160 BMY will report its Q4 2016 and full year results on January 26th We expect strong performance from key drugs including Opdivo and Eliquis On the other hand Yervoy s sales are likely to decline and Hepatitis C franchise may feel the impact of growing
PFE,PFE:US,BBG000BR2B91,A Would-Be Dividend Aristocrat With a 3.5% Dividend Yield,2017-01-24 22:01:18 +0000,http://finance.yahoo.com/news/dividend-aristocrat-3-5-dividend-220118456.html,A Would-Be Dividend Aristocrat With a 3.5% Dividend Yield
PFE,PFE:US,BBG000BR2B91,Tuesday's ETF with Unusual Volume: XRLV,2017-01-24 20:31:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pNga3cBuW-Y/tuesdays-etf-with-unusual-volume-xrlv-cm737581,The PowerShares S amp P 500 ex Rate Sensitive Low Volatility Portfolio ETF XRLV is seeing unusually high volume in afternoon trading Tuesday with over 343 000 shares traded versus three month average volume of about 43 000 Shares of XRLV were up about 0 5 on the day Components
PFE,PFE:US,BBG000BR2B91,"Northeast Financial Consultants Inc Buys Vanguard Growth ETF - DNQ, Vanguard High Dividend ...",2017-01-24 19:30:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uohaQlACvWg/northeast-financial-consultants-inc-buys-vanguard-growth-etf-dnq-vanguard-high-dividend-cm737569,Northeast Financial Consultants Inc New Purchases VFH AGR DOW PKW Added Positions VUG VYM VIG CVS XLK WM JNJ ADP PEP MMM Reduced Positions VMC EZM PJP SPY XOM KMI DFE VTI IDV WFC Sold Out IR FMC ALLE CR PAA TLT MRO IWD
PFE,PFE:US,BBG000BR2B91,[$$] J&J disappoints on 2017 forecasts due to strong dollar,2017-01-24 17:17:54 +0000,"http://www.ft.com/cms/s/34d1bffa-e24c-11e6-8405-9e5580d6e5fb,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Johnson & Johnson, the world's largest healthcare company, blamed a stronger dollar as it forecast that 2017 profits and sales would fall below Wall Street expectations, sending the group's shares down ..."
PFE,PFE:US,BBG000BR2B91,"Johnson & Johnson cautious in outlook, shops diabetes care",2017-01-24 17:07:25 +0000,http://sg.finance.yahoo.com/news/johnson-johnson-tops-4q-profit-115055748.html,"Johnson & Johnson cautious in outlook, shops diabetes care"
PFE,PFE:US,BBG000BR2B91,J&J (JNJ) Q4 Earnings Top; Seeks Options for Diabetes Unit,2017-01-24 16:35:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vkYy5aL-ThY/jj-jnj-q4-earnings-top-seeks-options-for-diabetes-unit-cm737341,Johnson amp Johnson JNJ reported a rather mixed fourth quarter with earnings beating expectations while sales missing the same Moreover the healthcare giant issued guidance for 2017 and announced that it is looking for strategic options for its diabetes care division Shares declined
PFE,PFE:US,BBG000BR2B91,US Market Indexes Lower on Monday,2017-01-24 14:52:38 +0000,http://finance.yahoo.com/news/us-market-indexes-lower-monday-145238630.html,US Market Indexes Lower on Monday
PFE,PFE:US,BBG000BR2B91,On Experiencing The Failure Of A Billion-Dollar Clinical Program,2017-01-24 13:04:00 +0000,http://www.forbes.com/sites/johnlamattina/2017/01/24/on-experiencing-the-failure-of-a-billion-dollar-clinical-program/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,On Experiencing The Failure Of A Billion-Dollar Clinical Program
PFE,PFE:US,BBG000BR2B91,What Do Analysts Recommend for Johnson & Johnson?,2017-01-24 12:36:01 +0000,http://marketrealist.com/2017/01/what-do-analysts-recommend-for-johnson-johnson/?utm_source=yahoo&utm_medium=feed,What Do Analysts Recommend for Johnson & Johnson?
PFE,PFE:US,BBG000BR2B91,Here's the Price Where Fallen Angel Bristol-Myers Becomes an Attractive Takeover Target,2017-01-23 20:04:00 +0000,https://www.thestreet.com/story/13962537/1/bristol-myers-squibb-reiterated-buy-at-jefferies-analysts-respond.html?puc=yahoo&cm_ven=YAHOO,Here's the Price Where Fallen Angel Bristol-Myers Becomes an Attractive Takeover Target
PFE,PFE:US,BBG000BR2B91,Interesting January 2018 Stock Options for PFE,2017-01-23 18:31:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E-W-Y2q6Zl8/interesting-january-2018-stock-options-for-pfe-cm736831,Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the January 2018 expiration for PFE The put
PFE,PFE:US,BBG000BR2B91,Can Q4 Earnings Revitalize Healthcare ETFs?,2017-01-23 18:31:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CzcaOx8F4AI/can-q4-earnings-revitalize-healthcare-etfs-cm736826,The healthcare sector has long been a victim of concerns over increased regulatory scrutiny related to high drug prices While the worries cooled down after Trump s victory the biotech and pharma stocks were again troubled by the President s non friendly plan to lower drug prices read
PFE,PFE:US,BBG000BR2B91,5 Stupendously Expensive Cancer Drugs,2017-01-23 17:35:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rhdPWhi5drg/5-stupendously-expensive-cancer-drugs-cm736699,Some of the most expensive drugs on the market are used to treat cancer and those drugs are getting increasingly costlier as they get more complex Over the past five years IMS Health reports that 70 new cancer drugs have been launched and while their prices vary the vast majority
PFE,PFE:US,BBG000BR2B91,5 Stupendously Expensive Cancer Drugs,2017-01-23 16:27:28 +0000,http://www.fool.com/investing/2017/01/23/5-stupendously-expensive-cancer-drugs.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Stupendously Expensive Cancer Drugs
PFE,PFE:US,BBG000BR2B91,10 Questions That Need to Be Asked Ahead of Johnson & Johnson's Q4 Report,2017-01-23 16:05:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4S5b7CjHka8/10-questions-that-need-to-be-asked-ahead-of-johnson-johnsons-q4-report-cm736527,Image source Getty Images Though it technically never ends earnings season is about to kick into high gear For about a six week stretch a vast majority of S amp P 500 companies are set to report their performance from the previous quarter Conglomerate Johnson amp
PFE,PFE:US,BBG000BR2B91,What’s New with Johnson & Johnson?,2017-01-23 15:36:07 +0000,http://marketrealist.com/2017/01/whats-new-with-johnson-johnson/?utm_source=yahoo&utm_medium=feed,What’s New with Johnson & Johnson?
PFE,PFE:US,BBG000BR2B91,10 Questions That Need to Be Asked Ahead of Johnson & Johnson's Q4 Report,2017-01-23 13:31:08 +0000,http://www.fool.com/investing/2017/01/23/10-questions-that-need-to-be-asked-ahead-of-johnso.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,10 Questions That Need to Be Asked Ahead of Johnson & Johnson's Q4 Report
PFE,PFE:US,BBG000BR2B91,Better Buy: Merck & Co. Inc. vs. Pfizer,2017-01-23 12:11:43 +0000,http://www.fool.com/investing/2017/01/22/better-buy-merck-co-inc-vs-pfizer.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Merck & Co. Inc. vs. Pfizer
PFE,PFE:US,BBG000BR2B91,[$$] Theresa May to unveil 10 'pillars' of industrial strategy,2017-01-22 22:43:25 +0000,"http://www.ft.com/cms/s/22971970-e0b2-11e6-8405-9e5580d6e5fb,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Theresa May will set out her vision for Britain's industrial future on Monday, promising to boost ""world-leading"" sectors while ""closing the gap"" between the most productive industries ..."
PFE,PFE:US,BBG000BR2B91,What to Watch for When PFE Reports Q4 Results,2017-01-22 21:49:00 +0000,http://www.investopedia.com/news/where-will-growth-come-pfizers-q4-pfe/?partner=YahooSA,What to Watch for When PFE Reports Q4 Results
PFE,PFE:US,BBG000BR2B91,BioCorRx Receives New Funding for Opioid Drug,2017-01-22 18:13:55 +0000,http://finance.yahoo.com/news/biocorrx-receives-funding-opioid-drug-181355512.html,BioCorRx Receives New Funding for Opioid Drug
PFE,PFE:US,BBG000BR2B91,Better Buy: Merck & Co. Inc. vs. Pfizer,2017-01-22 13:37:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lbHDgn6T0cM/better-buy-merck-co-inc-vs-pfizer-cm736408,Merck NYSE MRK and Pfizer NYSE PFE compete against each other in several markets from cancer to vaccines The big drugmakers also work together from time to time But which of these big pharma stocks is the better pick for long term investors Here s how Merck and
PFE,PFE:US,BBG000BR2B91,How Will Pfizer Inc. Fare Under President Trump?,2017-01-21 18:37:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PmaqHXlKRWo/how-will-pfizer-inc-fare-under-president-trump-cm736369,President Trump could shake up the pharmaceutical world If he delivers on his promises it means that Pfizer NYSE PFE one of the biggest of the big pharma companies is in for some significant changes How might Pfizer fare in a Trump Administration
PFE,PFE:US,BBG000BR2B91,How Will Pfizer Inc. Fare Under President Trump?,2017-01-21 17:12:36 +0000,http://www.fool.com/investing/2017/01/21/how-will-pfizer-inc-fare-under-president-trump.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,How Will Pfizer Inc. Fare Under President Trump?
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Jan 20, 2017 :  VCIT, CUZ, BAC, TLT, ODP, P, MSFT, PFE, GE, F, QQQ, AAPL",2017-01-20 21:57:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/59JypCGEVCw/after-hours-most-active-for-jan-20-2017-vcit-cuz-bac-tlt-odp-p-msft-pfe-ge-f-qqq-aapl-cm736255,The NASDAQ 100 After Hours Indicator is down 88 to 5 062 32 The total After hours volume is currently 41 010 511 shares traded The following are the most active stocks for the after hours session Vanguard Intermediate Term Corporate Bond ETF VCIT is 0 025 at 85
PFE,PFE:US,BBG000BR2B91,Amgen Could Gouge 'Top Pick' AbbVie With Humira Biosimilar: Jefferies,2017-01-20 21:30:52 +0000,http://www.investors.com/news/technology/amgen-could-gouge-top-pick-abbvie-with-humira-biosimilar-jefferies/,Amgen Could Gouge 'Top Pick' AbbVie With Humira Biosimilar: Jefferies
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Gilead Sciences, Las Vegas Sands, Illinois Tool Works, Pfizer and Lockheed Martin",2017-01-20 16:40:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yS6mqPNSk9c/the-zacks-analyst-blog-highlights-gilead-sciences-las-vegas-sands-illinois-tool-works-pfizer-and-lockheed-martin-cm736022,For Immediate Release Chicago IL January 20 2017 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the
PFE,PFE:US,BBG000BR2B91,5 Worst Performing Dow Stocks of 2017,2017-01-20 16:25:38 +0000,http://finance.yahoo.com/news/5-worst-performing-dow-stocks-162538802.html,5 Worst Performing Dow Stocks of 2017
PFE,PFE:US,BBG000BR2B91,"Lawson Kroeker Investment Management Inc Buys Anheuser-Busch InBev SA/NV, Crimson Wine Group ...",2017-01-20 15:36:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Lh8MTwF5qMc/lawson-kroeker-investment-management-inc-buys-anheuser-busch-inbev-sanv-crimson-wine-group-cm735979,Lawson Kroeker Investment Management Inc New Purchases BUD CWGL AAPL Added Positions OPB DIS WFC BAM CMREPRC T XOM MDT KO DEO Reduced Positions TPL LECO MSFT BRK A PFE CBI JNJ COP VZ PG Sold Out CFRUY New Purchases
PFE,PFE:US,BBG000BR2B91,Are You Undervaluing These 3 Biopharmas' Pipelines?,2017-01-20 14:40:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VgOU1JyH6cI/are-you-undervaluing-these-3-biopharmas-pipelines-cm735869,Biopharma companies are continously investing in new development projects to offset the risks of competition and patent expirations but sometimes the nature of business landscape can keep investors from seeing opportunities that may be lurking in research and development pipelines
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Gilead Sciences, Las Vegas Sands, Illinois Tool Works, Pfizer and Lockheed Martin",2017-01-20 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-gilead-143002351.html,"The Zacks Analyst Blog Highlights: Gilead Sciences, Las Vegas Sands, Illinois Tool Works, Pfizer and Lockheed Martin"
PFE,PFE:US,BBG000BR2B91,Why Johnson & Johnson’s 4Q16 Revenues Could Grow,2017-01-20 12:38:49 +0000,http://marketrealist.com/2017/01/why-johnson-johnsons-4q16-revenues-could-grow/?utm_source=yahoo&utm_medium=feed,Why Johnson & Johnson’s 4Q16 Revenues Could Grow
PFE,PFE:US,BBG000BR2B91,Sanofi's M&A misses frustrate some investors in drugmaker,2017-01-20 07:06:38 +0000,http://sg.finance.yahoo.com/news/sanofis-m-misses-frustrate-investors-070535808.html,Sanofi's M&A misses frustrate some investors in drugmaker
PFE,PFE:US,BBG000BR2B91,INSIGHT: Sanofi's M&A misses frustrate some investors in drugmaker,2017-01-20 07:06:06 +0000,http://in.finance.yahoo.com/news/insight-sanofis-m-misses-frustrate-070606290.html,INSIGHT: Sanofi's M&A misses frustrate some investors in drugmaker
PFE,PFE:US,BBG000BR2B91,What Lies Ahead for Pharma ETFs?,2017-01-19 21:06:09 +0000,http://finance.yahoo.com/news/lies-ahead-pharma-etfs-210609720.html,What Lies Ahead for Pharma ETFs?
PFE,PFE:US,BBG000BR2B91,"Exxon Mobil, Merck Weigh on DJIA Thursday",2017-01-19 21:01:32 +0000,http://finance.yahoo.com/news/exxon-mobil-merck-weigh-djia-210132184.html,"Exxon Mobil, Merck Weigh on DJIA Thursday"
PFE,PFE:US,BBG000BR2B91,"Top Analyst Reports for Gilead Sciences, Las Vegas Sands & Illinois Tool Works",2017-01-19 20:36:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SwlLKT5CD_Q/top-analyst-reports-for-gilead-sciences-las-vegas-sands-illinois-tool-works-cm735649,Thursday January 19 2017 Today s Research Daily features new research reports on 16 major stocks including Gilead Sciences GILD Las Vegas Sands LVS and Illinois Tool Works ITW Also featured today is our updated Earnings Trends report Bank Earnings amp the Trump
PFE,PFE:US,BBG000BR2B91,"Top Analyst Reports for Gilead Sciences, Las Vegas Sands & Illinois Tool Works",2017-01-19 17:56:05 +0000,http://finance.yahoo.com/news/top-analyst-reports-gilead-sciences-175605309.html,"Top Analyst Reports for Gilead Sciences, Las Vegas Sands & Illinois Tool Works"
PFE,PFE:US,BBG000BR2B91,Pfizer Continues to Tank -- Get Ready to Buy on the Dip,2017-01-19 16:58:00 +0000,https://www.thestreet.com/story/13956342/1/pfizer-continues-to-fade-get-ready-to-buy-on-the-dip.html?puc=yahoo&cm_ven=YAHOO,Pfizer Continues to Tank -- Get Ready to Buy on the Dip
PFE,PFE:US,BBG000BR2B91,Lilly to Boost Migraine Pipeline with $960M CoLucid Buyout,2017-01-19 15:41:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HuTTxIy3wBA/lilly-to-boost-migraine-pipeline-with-960m-colucid-buyout-cm735316,Eli Lilly and Company LLY announced that it plans to buy Cambridge MA based biotech firm CoLucid Pharmaceuticals Inc CLCD for approximately 960 million in cash The deal will enhance Lilly s pain management portfolio for migraine The announcement sent CoLucid s soaring over 32
PFE,PFE:US,BBG000BR2B91,Teva's (TEVA) Pain Drug Vantrela ER Receives FDA Approval,2017-01-19 15:40:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tq63KL0w5Ww/tevas-teva-pain-drug-vantrela-er-receives-fda-approval-cm735298,Teva Pharmaceutical Industries Ltd TEVA announced that the FDA has approved Vantrela ER for the treatment of pain which is severe enough to require daily around the clock long term opioid treatment and for which alternative treatment options are inadequate Teva s share price has declined
PFE,PFE:US,BBG000BR2B91,Milner Therapeutics Institute Announces New Partnership with US Pharmaceutical Company Pfizer,2017-01-19 13:00:00 +0000,http://finance.yahoo.com/news/milner-therapeutics-institute-announces-partnership-130000739.html,"[PR Newswire] - The Milner Therapeutics Institute today announces Pfizer Inc. (PFE) as a partner to the Milner Therapeutics Consortium. Pfizer has agreed to join the Consortium, which enables the efficient transfer of materials between industry and academia and allocation of funds for partnering opportunities in Cambridge."
PFE,PFE:US,BBG000BR2B91,"[$$] Gormley's Take: In Role Reversal, Pharmaceutical Giants Turn to Biotech Startups for Help",2017-01-19 12:30:09 +0000,http://www.wsj.com/articles/gormleys-take-in-role-reversal-pharmaceutical-giants-turn-to-biotech-startups-for-help-1484829005?mod=yahoo_hs,"[$$] Gormley's Take: In Role Reversal, Pharmaceutical Giants Turn to Biotech Startups for Help"
PFE,PFE:US,BBG000BR2B91,5 Expensive Drugs That Could End Up in Trump's Crosshairs,2017-01-18 23:37:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oblDGAE3opo/5-expensive-drugs-that-could-end-up-in-trumps-crosshairs-cm735129,Donald Trump s taking aim at drug companies that have increasingly found themselves in the hot seat because of sky high drug price increases in the past Last week Trump likened the industry s history of price hikes as akin to getting away with murder and he hinted that
PFE,PFE:US,BBG000BR2B91,5 Most Important Drugs to Johnson & Johnson in 2017,2017-01-18 23:37:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h6IqziSEcPE/5-most-important-drugs-to-johnson-johnson-in-2017-cm735120,Johnson amp Johnson NYSE JNJ generates billions of dollars by selling consumer goods and medical devices but its pharmaceuticals business is the one that s most likely to drive the company s growth in the coming year Here s why Remicade Xarelto Imbruvica Darzalex and
PFE,PFE:US,BBG000BR2B91,How to improve your sex life without breaking the bank,2017-01-18 23:31:40 +0000,http://sg.finance.yahoo.com/news/improve-sex-drive-without-breaking-222138221.html,How to improve your sex life without breaking the bank
PFE,PFE:US,BBG000BR2B91,5 Expensive Drugs That Could End Up in Trump's Crosshairs,2017-01-18 21:41:08 +0000,http://www.fool.com/investing/2017/01/18/5-expensive-drugs-that-could-end-up-in-trumps-cros.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Expensive Drugs That Could End Up in Trump's Crosshairs
PFE,PFE:US,BBG000BR2B91,"Noteworthy ETF Inflows: XLV, PFE, MRK, UNH",2017-01-18 17:37:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kj1CTmFKNx8/noteworthy-etf-inflows-xlv-pfe-mrk-unh-cm734873,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Health Care Select Sector SPDR Fund Symbol XLV where we have detected an approximate 123 5 million dollar inflow that s a 0 9 increase week over week
PFE,PFE:US,BBG000BR2B91,There May Be a Buying Opportunity When Pfizer Shares Hit This Important Level,2017-01-18 15:45:00 +0000,http://www.thestreet.com/video/13957698/there-may-be-a-buying-opportunity-when-pfizer-shares-hit-this-important-level.html?puc=yahoov&cm_ven=YAHOOV,There May Be a Buying Opportunity When Pfizer Shares Hit This Important Level
PFE,PFE:US,BBG000BR2B91,What???s Ahead for Johnson & Johnson (JNJ) in Q4 Earnings?,2017-01-18 15:41:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HbQ5ENfrYgM/whats-ahead-for-johnson-johnson-jnj-in-q4-earnings-cm734731,Johnson amp Johnson JNJ the bellwether of healthcare companies is scheduled to report fourth quarter 2016 and full year results on Jan 24 before the opening bell Last quarter the company reported a positive earnings surprise of 1 82 J amp J s share price was up 17 9 in the past
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. breached its 50 day moving average in a Bearish Manner : PFE-US : January 18, 2017",2017-01-18 14:54:19 +0000,http://www.capitalcube.com/blog/index.php/pfizer-inc-breached-its-50-day-moving-average-in-a-bearish-manner-pfe-us-january-18-2017/,"Pfizer Inc. breached its 50 day moving average in a Bearish Manner : PFE-US : January 18, 2017"
PFE,PFE:US,BBG000BR2B91,"Allergan Rebounding With Strong Product Pipeline, Smart Acquisitions",2017-01-18 12:25:00 +0000,https://www.thestreet.com/story/13954895/1/allergan-rebounding-with-strong-product-pipeline-smart-acquisitions.html?puc=yahoo&cm_ven=YAHOO,"Allergan Rebounding With Strong Product Pipeline, Smart Acquisitions"
PFE,PFE:US,BBG000BR2B91,Drugmakers in Davos shift focus to chronic diseases of poor,2017-01-18 11:06:43 +0000,http://uk.finance.yahoo.com/news/drugmakers-davos-shift-focus-chronic-110643780.html,Drugmakers in Davos shift focus to chronic diseases of poor
PFE,PFE:US,BBG000BR2B91,Trump's health pick set to defend investments at U.S. Senate hearing,2017-01-18 11:00:01 +0000,http://finance.yahoo.com/news/trumps-health-pick-set-defend-110001339.html,"[Reuters] - President-elect Donald Trump's nominee for health secretary was expected to face hard questions from a U.S. Senate panel on Wednesday about his personal stock investments and proposals to dismantle Obamacare. Representative Tom Price, a Georgia orthopedic surgeon who has been in politics for more than 20 years, was chosen by fellow Republican Trump, who will become president on Friday, to head an agency that manages scores of healthcare programs. The Department of Health and Human Services runs the Medicare program for the elderly, Medicaid for the poor and President Barack Obama's Affordable Care Act, which was enacted in 2010 and brought health insurance coverage to millions of Americans who previously lacked it."
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer warns of 'big challenge' ahead from strong dollar,2017-01-18 10:40:26 +0000,"http://www.ft.com/cms/s/f7437cc8-dcf1-11e6-86ac-f253db7791c6,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Pfizer, the world's top drugmaker by revenues, has warned that a strengthening dollar would be ""a very big challenge"" for the company in 2017, raising concerns for US corporations that generate ..."
PFE,PFE:US,BBG000BR2B91,Pfizer CEO: This is what Trump doesn’t understand about the pharma industry,2017-01-17 23:02:55 +0000,http://www.cnbc.com/id/104223901?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104223901,Pfizer CEO: This is what Trump doesn’t understand about the pharma industry
PFE,PFE:US,BBG000BR2B91,AARP CEO: Trumpcare needs these 4 basic principles,2017-01-17 22:33:22 +0000,http://finance.yahoo.com/news/aarp-ceo-trumpcare-needs-these-4-basic-principles-223322163.html,AARP CEO: Trumpcare needs these 4 basic principles
PFE,PFE:US,BBG000BR2B91,"JPMorgan, Goldman Sachs Sink DJIA on Tuesday",2017-01-17 21:01:57 +0000,http://finance.yahoo.com/news/jpmorgan-goldman-sachs-sink-djia-210157433.html,"JPMorgan, Goldman Sachs Sink DJIA on Tuesday"
PFE,PFE:US,BBG000BR2B91,"Should Pfizer, Inc. Be on Your Stock Watchlist?",2017-01-17 18:37:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jrJ-bKLucHA/should-pfizer-inc-be-on-your-stock-watchlist-cm734346,Pfizer Inc NYSE PFE is one of the largest drugmakers in the world and management is making solid progress in kick starting sales and profit growth following years of declining results tied to the loss of patent protection on Lipitor Is Pfizer worthy of adding to your stock
PFE,PFE:US,BBG000BR2B91,"Should Pfizer, Inc. Be on Your Stock Watchlist?",2017-01-17 17:27:34 +0000,http://www.fool.com/investing/2017/01/17/should-pfizer-inc-be-on-your-stock-watchlist.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Should Pfizer, Inc. Be on Your Stock Watchlist?"
PFE,PFE:US,BBG000BR2B91,5 Trump-Proof Pharma Dividend Stocks to Buy,2017-01-17 16:38:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C0k6xbz5rvs/5-trump-proof-pharma-dividend-stocks-to-buy-cm734299,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Donald Trump needed just 20 minutes to knock 24 6 billion in value from the nine biggest Big Pharma companies That was the statistic bandied about recently when the president elect at
PFE,PFE:US,BBG000BR2B91,Why Bristol-Myers Squibb May Be a Merger Target Soon,2017-01-17 14:59:00 +0000,https://www.thestreet.com/story/13955786/1/why-bristol-myers-squibb-may-be-a-merger-target-soon.html?puc=yahoo&cm_ven=YAHOO,Why Bristol-Myers Squibb May Be a Merger Target Soon
PFE,PFE:US,BBG000BR2B91,Double Down On Dividends With These 2 Covered Calls,2017-01-17 14:45:41 +0000,http://www.insidermonkey.com/blog/double-down-on-dividends-with-these-2-covered-calls-519156/,Double Down On Dividends With These 2 Covered Calls
PFE,PFE:US,BBG000BR2B91,One Simple Step to Building a Smarter Portfolio,2017-01-17 14:38:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pKhuotSvdM8/one-simple-step-to-building-a-smarter-portfolio-cm734073,If you invest in growth stocks value stocks income stocks or any other category of stocks then watch lists can improve your process and keep you on track to building a well rounded and profit friendly portfolio In this episode of The Motley Fool s Industry Focus
PFE,PFE:US,BBG000BR2B91,"Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for January 18, 2017",2017-01-17 14:17:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qAXJbwRDTUo/zoetis-inc-zts-ex-dividend-date-scheduled-for-january-18-2017-cm734096,Zoetis Inc ZTS will begin trading ex dividend on January 18 2017 A cash dividend payment of 0 105 per share is scheduled to be paid on March 01 2017 Shareholders who purchased ZTS prior to the ex dividend date are eligible for the cash dividend payment This represents an 10 53
PFE,PFE:US,BBG000BR2B91,One Simple Step to Building a Smarter Portfolio,2017-01-17 13:11:03 +0000,http://www.fool.com/investing/2017/01/17/one-simple-step-to-building-a-smarter-portfolio.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,One Simple Step to Building a Smarter Portfolio
PFE,PFE:US,BBG000BR2B91,[$$] OncoImmune Picks Up $15 Million for Immune-Based Disease Treatments,2017-01-17 12:30:06 +0000,http://www.wsj.com/articles/oncoimmune-picks-up-15-million-series-a-for-immune-based-disease-treatments-1484656202?mod=yahoo_hs,[$$] OncoImmune Picks Up $15 Million for Immune-Based Disease Treatments
PFE,PFE:US,BBG000BR2B91,These 5 Drug Patents Will Expire in 2017,2017-01-16 15:14:00 +0000,http://www.investopedia.com/news/5-drug-patents-expiring-2017-nvs-gsk-lly/?partner=YahooSA,These 5 Drug Patents Will Expire in 2017
PFE,PFE:US,BBG000BR2B91,Lilly-Incyte Rheumatoid Arthritis Drug PDUFA Date Extended,2017-01-16 14:39:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J0q2VXUFt7o/lilly-incyte-rheumatoid-arthritis-drug-pdufa-date-extended-cm733817,Eli Lilly and Company LLY and partner Incyte Corporation INCY announced that the FDA has extended the time to review the company s New Drug Application NDA seeking approval of its pipeline candidate baricitinib for the treatment of rheumatoid arthritis RA Previously the FDA was
PFE,PFE:US,BBG000BR2B91,5 Trump-Proof Pharma Dividends Up To 5.3%,2017-01-16 13:38:00 +0000,http://www.forbes.com/sites/brettowens/2017/01/16/5-trump-proof-pharma-dividends-up-to-5-3/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,5 Trump-Proof Pharma Dividends Up To 5.3%
PFE,PFE:US,BBG000BR2B91,Lilly-Incyte Rheumatoid Arthritis Drug PDUFA Date Extended,2017-01-16 12:39:12 +0000,http://finance.yahoo.com/news/lilly-incyte-rheumatoid-arthritis-drug-123912305.html,Lilly-Incyte Rheumatoid Arthritis Drug PDUFA Date Extended
PFE,PFE:US,BBG000BR2B91,How Does Novartis’s Valuation Compare to Peers?,2017-01-16 12:37:38 +0000,http://marketrealist.com/2017/01/how-does-novartiss-valuation-compare-to-peers/?utm_source=yahoo&utm_medium=feed,How Does Novartis’s Valuation Compare to Peers?
PFE,PFE:US,BBG000BR2B91,Is Donald Trump Big Pharma's Worst Nightmare?,2017-01-16 12:27:51 +0000,http://www.fool.com/investing/2017/01/15/is-donald-trump-big-pharmas-worst-nightmare.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Donald Trump Big Pharma's Worst Nightmare?
PFE,PFE:US,BBG000BR2B91,[$$] Ireland: Brexit vote forces Dublin to seek new EU friends,2017-01-15 15:20:42 +0000,"http://www.ft.com/cms/s/3d0fdb18-d97b-11e6-944b-e7eb37a6aa8e,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - One of the most explosive moments in the recent history of Anglo-Irish relations took place not in Dublin or London, but in Milan in 1985. A summit of European leaders was debating how to proceed with ..."
PFE,PFE:US,BBG000BR2B91,Is Donald Trump Big Pharma's Worst Nightmare?,2017-01-15 13:37:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Dc75tPdP0iw/is-donald-trump-big-pharmas-worst-nightmare-cm733700,President elect Donald Trump pulled no punches when it came to big pharma in a press conference on Wednesday He said that pharmaceutical companies are getting away with murder Trump also promised that he would do something about the problem when he takes office During the 20
PFE,PFE:US,BBG000BR2B91,Options Insight: How to Play Pfizer,2017-01-13 20:44:14 +0000,http://finance.yahoo.com/video/options-insight-play-pfizer-204414154.html,Options Insight: How to Play Pfizer
PFE,PFE:US,BBG000BR2B91,It's Full Speed Ahead for Opko Health After Pipeline Stumble,2017-01-13 20:24:57 +0000,http://www.fool.com/investing/2017/01/12/its-full-speed-ahead-for-opko-health-after-pipelin.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,It's Full Speed Ahead for Opko Health After Pipeline Stumble
PFE,PFE:US,BBG000BR2B91,Versartis' Pipeline Holds Big Promise,2017-01-13 16:00:00 +0000,http://realmoney.thestreet.com/articles/01/13/2017/versartis-pipeline-holds-big-promise?puc=yahoo&cm_ven=YAHOO,Versartis' Pipeline Holds Big Promise
PFE,PFE:US,BBG000BR2B91,5 Stocks With Bigger Dividends Than ExxonMobil,2017-01-13 15:39:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ecqQOl5WL-g/5-stocks-with-bigger-dividends-than-exxonmobil-cm733234,Steady income is within reach with these five stocks Image source Getty Images ExxonMobil Corporation NYSE XOM has an enviable track record of paying and growing its dividend for many years But at the same time there are plenty of reasons to skip this biggest of the big
PFE,PFE:US,BBG000BR2B91,Will This Be a Genius or Foolish Move for Johnson & Johnson?,2017-01-13 15:39:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D14FvKnin5g/will-this-be-a-genius-or-foolish-move-for-johnson-johnson-cm733232,Image source Johnson amp Johnson For quite a few investors healthcare conglomerate Johnson amp Johnson NYSE JNJ is a portfolio staple Johnson amp Johnson is comprised of more than 250 different subsidiaries and three primary operating segments healthcare
PFE,PFE:US,BBG000BR2B91,"ARIAD: Acquisition by Takeda Bodes Well, Competition a Risk",2017-01-13 14:40:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bIoRW1Pndw0/ariad-acquisition-by-takeda-bodes-well-competition-a-risk-cm733158,On Jan 13 we issued an updated report on ARIAD Pharmaceuticals Inc ARIA ARIAD s one month share price movement shows that the stock has significantly outperformed the Zacks classified Medical Drugs industry Specifically the company gained 89 2 during this period while the industry
PFE,PFE:US,BBG000BR2B91,5 Stocks With Bigger Dividends Than ExxonMobil,2017-01-13 13:40:06 +0000,http://www.fool.com/investing/2017/01/13/5-stocks-with-bigger-dividends-than-exxon-mobil.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Stocks With Bigger Dividends Than ExxonMobil
PFE,PFE:US,BBG000BR2B91,​Trump’s HHS nominee has promised to divest from these Mass. companies,2017-01-12 22:10:08 +0000,http://www.bizjournals.com/boston/news/2017/01/12/trump-s-hhs-nominee-has-promised-to-divest-from.html?ana=yahoo,​Trump’s HHS nominee has promised to divest from these Mass. companies
PFE,PFE:US,BBG000BR2B91,It's Full Speed Ahead for Opko Health After Pipeline Stumble,2017-01-12 21:57:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ClMMmYqwv1I/its-full-speed-ahead-for-opko-health-after-pipeline-stumble-cm732979,Mark Twain and an experimental human growth hormone Opko Health NASDAQ OPK executive vice president Steve Rubin managed to combine this unlikely pair at the J P Morgan Healthcare Conference on Wednesday Rubin talked about the recent clinical failure of a human
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Jan 12, 2017 :  PDBC, AKS, PFE, QQQ, SBRA, VNQI, ABEV, GFI, BAC, RF, CTSH, HAIN",2017-01-12 21:56:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kfBgc0l6klY/after-hours-most-active-for-jan-12-2017-pdbc-aks-pfe-qqq-sbra-vnqi-abev-gfi-bac-rf-ctsh-hain-cm733013,The NASDAQ 100 After Hours Indicator is down 74 to 5 040 69 The total After hours volume is currently 17 675 964 shares traded The following are the most active stocks for the after hours session PowerShares Optimum Yield Diversified Commodity Strategy No K PDBC
PFE,PFE:US,BBG000BR2B91,3 Surprises From Pfizer at the J. P. Morgan Healthcare Conference,2017-01-12 21:25:50 +0000,http://www.fool.com/investing/2017/01/11/3-surprises-from-pfizer-at-the-j-p-morgan-healthca.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Surprises From Pfizer at the J. P. Morgan Healthcare Conference
PFE,PFE:US,BBG000BR2B91,"Disney, Microsoft Lead DJIA Drop Thursday",2017-01-12 21:01:23 +0000,http://finance.yahoo.com/news/disney-microsoft-lead-djia-drop-210123755.html,"Disney, Microsoft Lead DJIA Drop Thursday"
PFE,PFE:US,BBG000BR2B91,"Investors in big pharma, biotech look to ride out Trump storm",2017-01-12 20:22:50 +0000,http://finance.yahoo.com/news/investors-big-pharma-biotech-look-202250238.html,"Investors in big pharma, biotech look to ride out Trump storm"
PFE,PFE:US,BBG000BR2B91,Bank of America Corp (BAC) Stock Could Take Flight Tomorrow,2017-01-12 17:59:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MpWjHyxPxX8/bank-of-america-corp-bac-stock-could-take-flight-tomorrow-cm732904,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips On Friday Bank of America Corp NYSE BAC effectively even if not officially gets the first quarter earnings season started with a report of its fiscal Q4 numbers And all signs point toward
PFE,PFE:US,BBG000BR2B91,Trump Attacks Biotech & Pharma: ETFs Bleed,2017-01-12 16:57:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FXC6m2w_ZhQ/trump-attacks-biotech-pharma-etfs-bleed-cm732747,The pharma and biotech industry is a victim of concerns over increased regulatory scrutiny on high drug prices over the past two years The worries cooled down after Trump s victory and gave biotech stocks a shot in the arm But the trend has reversed again following Trump s first press
PFE,PFE:US,BBG000BR2B91,"Stock Market News for January 12, 2017",2017-01-12 16:57:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XOeQ4SMalGg/stock-market-news-for-january-12-2017-cm732743,Benchmarks ended a volatile trading session in the green on Wednesday following President elect Donald Trump s first news conference in months Energy shares were among the day s biggest gainers thanks to rise in oil prices OPEC to trim production levels along with expectations of
PFE,PFE:US,BBG000BR2B91,"Merck KGaA, Vertex Announce Tie-Up for Oncology Programs",2017-01-12 16:02:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QoUywuSfh2I/merck-kgaa-vertex-announce-tie-up-for-oncology-programs-cm732689,Germany based Merck KGaA MKGAF announced that it has entered into a licensing agreement with Vertex Pharmaceuticals Incorporated VRTX for the global development and commercialization of four research and development programs for the treatment of cancer A look at Merck KGaA s share
PFE,PFE:US,BBG000BR2B91,Double Down on Dividends with These 3 Covered Calls,2017-01-12 16:01:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YG0fcqHEnRw/double-down-on-dividends-with-these-3-covered-calls-cm732817,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips One of the best options strategies as far as income is concerned is using covered calls This strategy involves first buying or already owning a stock in round lots of 100 shares You then enter into
PFE,PFE:US,BBG000BR2B91,Analysts Forecast 13% Gains Ahead For The Holdings of FXH,2017-01-12 15:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/38SRQqXL0T4/analysts-forecast-13-gains-ahead-for-the-holdings-of-fxh-cm732654,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
PFE,PFE:US,BBG000BR2B91,Mylan/Biocon's Herceptin Biosimilar under Review in the U.S.,2017-01-12 15:01:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lmZry9rnr7g/mylanbiocons-herceptin-biosimilar-under-review-in-the-us-cm732735,Mylan N V MYL and partner Biocon Ltd announced that the FDA had accepted their Biologics License Application BLA for a biosimilar version of Roche Holding AG s RHHBY cancer drug Herceptin trastuzumab MYL 1401O Shares of Mylan have outperformed the Zacks categorized Medical
PFE,PFE:US,BBG000BR2B91,Donald Trump Puts Humana Inc (HUM) Stock on My Buy Radar,2017-01-12 15:01:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i2riezTMYJw/donald-trump-puts-humana-inc-hum-stock-on-my-buy-radar-cm732732,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips President elect Donald Trump on Wednesday held his first press conference since July and investors paid close attention The biotechnology sector and some other parts of the healthcare
PFE,PFE:US,BBG000BR2B91,"Merck KGaA, Vertex Announce Tie-Up for Oncology Programs",2017-01-12 13:43:01 +0000,http://finance.yahoo.com/news/merck-kgaa-vertex-announce-tie-134301180.html,"Merck KGaA, Vertex Announce Tie-Up for Oncology Programs"
PFE,PFE:US,BBG000BR2B91,Understanding Mylan’s Revenues,2017-01-12 12:37:39 +0000,http://marketrealist.com/2017/01/understanding-mylans-revenues/?utm_source=yahoo&utm_medium=feed,Understanding Mylan’s Revenues
PFE,PFE:US,BBG000BR2B91,"Tokyo stocks, dollar hit as Asia stumbles on Trump woe",2017-01-12 08:42:42 +0000,http://uk.finance.yahoo.com/news/tokyo-stocks-dollar-hit-asia-084242422.html,"[AFP] - Pharma stocks in Asia took a hit after US President-elect Donald Trump lashed out at companies for offshore production and overcharging, January 12, 2017"
PFE,PFE:US,BBG000BR2B91,Most Asia stocks up but Tokyo hit by Trump worries,2017-01-12 07:25:51 +0000,http://uk.finance.yahoo.com/news/most-asia-stocks-tokyo-hit-030519278.html,"[AFP] - Pharma stocks in Asia took a hit after US President-elect Donald Trump lashed out at companies for offshore production and overcharging, January 12, 2017"
PFE,PFE:US,BBG000BR2B91,Trump Attacks Drugmakers on Pricing,2017-01-12 06:43:46 +0000,http://www.wsj.com/articles/trump-attacks-drugmakers-on-pricing-1484167641?ru=yahoo?mod=yahoo_itp,Trump Attacks Drugmakers on Pricing
PFE,PFE:US,BBG000BR2B91,Stock Market Roundup Jan. 11: Health Sector Lower on Trump &quot;Murder&quot; Comment,2017-01-11 23:57:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VJQIhtaVNHs/stock-market-roundup-jan-11-health-sector-lower-on-trump-murder-comment-cm732485,After President elect Donald Trump said pharmaceutical companies were getting away with murder in how much they charge the government for medicines health sector stocks began to slide The iShares Nasdaq Biotech ETF IBB closed the day down 2 99 while Pfizer PFE Johnson amp Johnson
PFE,PFE:US,BBG000BR2B91,3 Surprises From Pfizer at the J. P. Morgan Healthcare Conference,2017-01-11 22:58:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DSG816m4T2Y/3-surprises-from-pfizer-at-the-j-p-morgan-healthcare-conference-cm732475,It s always fun to hear what pharmaceutical company executives might say at the J P Morgan NYSE JPM Healthcare Conference This year Pfizer NYSE PFE was represented by three top members of its management team at the conference Here are three things the Pfizer
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. (PFE), Lockheed Martin (LMT) Get “Trumped”",2017-01-11 22:56:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HXTdXbnchnU/pfizer-inc-pfe-lockheed-martin-lmt-get-trumped-cm732459,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips U S equities are suffering another bout of volatility on Wednesday after intense fireworks were seen at president elect Donald Trump s first press conference in months Issues such as Russian hacking of
PFE,PFE:US,BBG000BR2B91,Dow Jones Industrial Average Ends Choppy Session Higher After Trump,2017-01-11 22:56:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kTQVutiB28Y/dow-jones-industrial-average-ends-choppy-session-higher-after-trump-cm732454,The 160 Dow Jones Industrial Average DJIA 160 explored both sides of breakeven today as traders reacted to President elect Donald Trump s highly watched press conference Biotech stocks were among the biggest movers taking a hit after Trump slammed the drug industry as a
PFE,PFE:US,BBG000BR2B91,"Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,563.65.",2017-01-11 21:48:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v5emdqq_GBg/market-close-report-historical-high-reached-as-nasdaq-composite-index-closes-at-556365-cm732452,Wednesday s session closes with the NASDAQ Composite Index reaching a historical high The index closed at 5 563 65 up 11 83 for the day The index first reached the 5000 mark on 01 10 2017 The total shares traded for the NASDAQ was over 2 1 billion Wednesday s session closes with the
PFE,PFE:US,BBG000BR2B91,"Trump Says Drugmakers 'Getting Away With Murder', Cites F-35, Ford, Fiat",2017-01-11 21:19:08 +0000,http://www.investors.com/news/trump-says-drugmakers-getting-away-with-murder-cites-f-35-ford-fiat/,"Trump Says Drugmakers 'Getting Away With Murder', Cites F-35, Ford, Fiat"
PFE,PFE:US,BBG000BR2B91,Trump Attacks Drugmakers on Pricing,2017-01-11 21:16:40 +0000,http://www.wsj.com/articles/trump-attacks-drugmakers-on-pricing-1484167641?mod=yahoo_hs,Trump Attacks Drugmakers on Pricing
PFE,PFE:US,BBG000BR2B91,Markets Right Now: Stocks end a wobbly day with solid gains,2017-01-11 21:10:31 +0000,http://sg.finance.yahoo.com/news/markets-now-stocks-little-changed-144054315.html,Markets Right Now: Stocks end a wobbly day with solid gains
PFE,PFE:US,BBG000BR2B91,Pisani: Market's a tightly-coiled spring right now,2017-01-11 20:58:00 +0000,http://finance.yahoo.com/video/pisani-markets-tightly-coiled-spring-205800218.html,Pisani: Market's a tightly-coiled spring right now
PFE,PFE:US,BBG000BR2B91,Wednesday’s Top Biopharma Movers,2017-01-11 20:22:17 +0000,http://finance.yahoo.com/news/wednesday-top-biopharma-movers-202217751.html,Wednesday’s Top Biopharma Movers
PFE,PFE:US,BBG000BR2B91,"Trump Shoots Down Biotechs, Lockheed; Apple, Nvidia Weigh On Nasdaq",2017-01-11 18:41:37 +0000,http://www.investors.com/market-trend/stock-market-today/trump-shoots-down-biotechs-lockheed-apple-nvidia-weigh-on-nasdaq/,"Trump Shoots Down Biotechs, Lockheed; Apple, Nvidia Weigh On Nasdaq"
PFE,PFE:US,BBG000BR2B91,Markets Right Now: US stocks give back most of an early gain,2017-01-11 16:59:59 +0000,http://finance.yahoo.com/news/markets-now-stocks-little-changed-144054104.html,Markets Right Now: US stocks give back most of an early gain
PFE,PFE:US,BBG000BR2B91,See Which Of The Latest 13F Filers Holds Pfizer,2017-01-11 14:56:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/C2_RVdZLyOE/see-which-of-the-latest-13f-filers-holds-pfizer-cm732076,At Holdings Channel we have reviewed the latest batch of the 21 most recent 13F filings for the 12 31 2016 reporting period and noticed that Pfizer Inc Symbol PFE was held by 14 of these funds When hedge fund managers appear to be thinking alike we find it is a good idea to take a
PFE,PFE:US,BBG000BR2B91,US warns of unusual cybersecurity flaw in heart devices,2017-01-11 00:07:25 +0000,http://finance.yahoo.com/news/us-warns-unusual-cybersecurity-flaw-230049798.html,US warns of unusual cybersecurity flaw in heart devices
PFE,PFE:US,BBG000BR2B91,US warns of unusual cybersecurity flaw in heart devices,2017-01-11 00:07:19 +0000,http://sg.finance.yahoo.com/news/us-warns-unusual-cybersecurity-flaw-230038694.html,US warns of unusual cybersecurity flaw in heart devices
PFE,PFE:US,BBG000BR2B91,Celebrate One Debacle of a Merger With Another -- ICYMI,2017-01-10 23:15:00 +0000,https://www.thestreet.com/story/13949617/1/celebrate-one-debacle-of-a-merger-with-another-icymi.html?puc=yahoo&cm_ven=YAHOO,Celebrate One Debacle of a Merger With Another -- ICYMI
PFE,PFE:US,BBG000BR2B91,How a Bust Caused Opko Health Shares to Tumble in 2016,2017-01-10 20:41:29 +0000,http://www.fool.com/investing/2017/01/10/how-a-bust-caused-opko-health-shares-to-tumble-in.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,How a Bust Caused Opko Health Shares to Tumble in 2016
PFE,PFE:US,BBG000BR2B91,1 Perfect Stock to Invest in the Pharmaceutical Industry,2017-01-10 18:40:27 +0000,http://www.fool.com/investing/2017/01/10/1-perfect-stock-to-invest-in-the-pharmaceutical-in.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,1 Perfect Stock to Invest in the Pharmaceutical Industry
PFE,PFE:US,BBG000BR2B91,Todd Hagopian's Top Biotech Takeover Targets For 2017,2017-01-10 17:59:00 +0000,http://www.forbes.com/sites/kenkam/2017/01/10/todd-hagopians-top-biotech-takeover-targets-for-2017/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Todd Hagopian's Top Biotech Takeover Targets For 2017
PFE,PFE:US,BBG000BR2B91,"Notable ETF Inflow Detected - VOO, BAC, PFE, MRK",2017-01-10 17:53:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zyN7nudrpSg/notable-etf-inflow-detected-voo-bac-pfe-mrk-cm731763,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard S amp P 500 ETF Symbol VOO where we have detected an approximate 798 2 million dollar inflow that s a 1 4 increase week over week in outstanding
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Clovis Oncology, Pfizer, Roche's, Sanofi and Regeneron Pharmaceuticals",2017-01-10 16:55:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nl9UeYCPzZI/the-zacks-analyst-blog-highlights-clovis-oncology-pfizer-roches-sanofi-and-regeneron-pharmaceuticals-cm731692,For Immediate Release Chicago IL January 10 2017 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the
PFE,PFE:US,BBG000BR2B91,"3 “Dogs of the Dow” Paying Up to 4.3% (CVX, PFE, VZ)",2017-01-10 16:52:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RRZESVXoTzc/3-dogs-of-the-dow-paying-up-to-43-cvx-pfe-vz-cm731756,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The Dogs of the Dow are back And this year the biggest dogs are not just generous yielders 160 they re cash cows with price upside to boot For the uninitiated the Dogs of the
PFE,PFE:US,BBG000BR2B91,Best Dividend Stocks For Retirement Income In 2017,2017-01-10 16:36:00 +0000,http://www.forbes.com/sites/robertlaura/2017/01/10/best-dividend-stocks-for-retirement-income-in-2017/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Best Dividend Stocks For Retirement Income In 2017
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. : PFE-US: Dividend Analysis : November 11th, 2016 (record date) : By the numbers : January 10, 2017",2017-01-10 16:32:56 +0000,http://www.capitalcube.com/blog/index.php/pfizer-inc-pfe-us-dividend-analysis-november-11th-2016-record-date-by-the-numbers-january-10-2017/,"Pfizer Inc. : PFE-US: Dividend Analysis : November 11th, 2016 (record date) : By the numbers : January 10, 2017"
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. (PFE) Challenges Businessmen To Come Up With Breast Cancer Solutions,2017-01-10 15:42:00 +0000,http://www.insidermonkey.com/blog/pfizer-inc-pfe-challenges-businessmen-to-come-up-with-breast-cancer-solutions-515960/,Pfizer Inc. (PFE) Challenges Businessmen To Come Up With Breast Cancer Solutions
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 01/10/2017: IMNP, VRX, JNJ, PFE, ABT, MRK, AMGN",2017-01-10 14:29:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FqfzK9eh-GE/health-care-sector-update-for-01102017-imnp-vrx-jnj-pfe-abt-mrk-amgn-cm731492,Top Health Care stocks Top Health Care stocks JNJ flatJNJ flat PFE 1 1 PFE 1 1 ABT flatABT flat MRK flatMRK flat AMGN flatAMGN flat Health care shares were mostly unchanged in pre market trade Tuesday Health care shares were mostly unchanged in pre market trade Tuesday In health
PFE,PFE:US,BBG000BR2B91,"Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for January 11, 2017",2017-01-10 14:21:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lGrJwHquSmk/abbott-laboratories-abt-ex-dividend-date-scheduled-for-january-11-2017-cm731541,Abbott Laboratories ABT will begin trading ex dividend on January 11 2017 A cash dividend payment of 0 265 per share is scheduled to be paid on February 15 2017 Shareholders who purchased ABT prior to the ex dividend date are eligible for the cash dividend payment This represents
PFE,PFE:US,BBG000BR2B91,"AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for January 11, 2017",2017-01-10 14:19:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PBvEJa1xdnU/abbvie-inc-abbv-ex-dividend-date-scheduled-for-january-11-2017-cm731502,AbbVie Inc ABBV will begin trading ex dividend on January 11 2017 A cash dividend payment of 0 64 per share is scheduled to be paid on February 15 2017 Shareholders who purchased ABBV prior to the ex dividend date are eligible for the cash dividend payment This represents an 12
PFE,PFE:US,BBG000BR2B91,3 'Dogs of the Dow' Paying Up To 4.3%,2017-01-10 13:24:00 +0000,http://www.forbes.com/sites/brettowens/2017/01/10/3-dogs-of-the-dow-paying-up-to-4-3/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,3 'Dogs of the Dow' Paying Up To 4.3%
PFE,PFE:US,BBG000BR2B91,Pfizer To Present At  J.P. Morgan Healthcare Conference; Webcast At 1:30 PM ET,2017-01-10 12:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T9PsqmiDT1c/pfizer-to-present-at--jp-morgan-healthcare-conference-webcast-at-130-pm-et-20170110-00781,Pfizer To Present At  J.P. Morgan Healthcare Conference; Webcast At 1:30 PM ET
PFE,PFE:US,BBG000BR2B91,Cramer names the 'humanization of pets' as the greatest investing theme in the market,2017-01-09 23:51:42 +0000,http://www.cnbc.com/id/104208149?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104208149,Cramer names the 'humanization of pets' as the greatest investing theme in the market
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Jan 9, 2017 :  BAC, PFE, ELY, ABBV, GE, PENN, MSFT, MPEL, CTXS, AAPL, C, CTSH",2017-01-09 21:59:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gm-FX3zcbDI/after-hours-most-active-for-jan-9-2017-bac-pfe-ely-abbv-ge-penn-msft-mpel-ctxs-aapl-c-ctsh-cm731341,The NASDAQ 100 After Hours Indicator is up 37 to 5 025 27 The total After hours volume is currently 44 219 567 shares traded The following are the most active stocks for the after hours session Bank of America Corporation BAC is unchanged at 22 55 with 4 820
PFE,PFE:US,BBG000BR2B91,Piper Bullish On Pfizer and Eli Lilly,2017-01-09 19:19:00 +0000,http://www.investopedia.com/news/piper-likes-pfizer-and-eli-lilly-pfe-jnj/?partner=YahooSA,Piper Bullish On Pfizer and Eli Lilly
PFE,PFE:US,BBG000BR2B91,2 Reasons Pfizer's Stock Beat the Field in 2016,2017-01-09 18:51:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IDWTVYoZD20/2-reasons-pfizers-stock-beat-the-field-in-2016-cm731192,What happened According to data from S amp P Global Market Intelligence Pfizer s NYSE PFE shares gained 1 66 in 2016 While such a modest gain may not seem impressive at first glance the drugmaker s shares markedly outperformed the broader field of pharma stocks
PFE,PFE:US,BBG000BR2B91,2 Reasons Pfizer's Stock Beat the Field in 2016,2017-01-09 17:24:02 +0000,http://www.fool.com/investing/2017/01/09/2-reasons-pfizers-stock-beat-the-field-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,2 Reasons Pfizer's Stock Beat the Field in 2016
PFE,PFE:US,BBG000BR2B91,The FDA Approved Fewer Drugs in 2016: Here's Why,2017-01-09 15:53:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S6bh6xEdhV0/the-fda-approved-fewer-drugs-in-2016-heres-why-cm730975,There was a notable dip in FDA novel drug approvals in 2016 with the agency giving its nod to 22 treatments during the year Compare this to 45 approvals in 2015 and 41 in 2014 and the 2016 numbers look really disappointing It s not like a fewer number of applications were submitted in
PFE,PFE:US,BBG000BR2B91,"Bristol-Myers, GeneCentric Tie Up for Opdivo Biomarker Study",2017-01-09 14:52:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EsOt2GXfvik/bristol-myers-genecentric-tie-up-for-opdivo-biomarker-study-cm730896,Bristol Myers Squibb Company BMY inked a biomarker research collaboration with GeneCentric Diagnostics Inc under which application of the latter s proprietary core technology Cancer Subtype Platform CSP will be explored for the identification of translational biomarkers for Bristol
PFE,PFE:US,BBG000BR2B91,2 Top Stocks in Biotech,2017-01-09 14:52:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IyhrE5lM7ns/2-top-stocks-in-biotech-cm730928,In 2016 the FDA approved less than half as many new drugs as the previous year An increasingly strict regulatory environment might not be great for investing in the broad based industry tracking iShares Nasdaq Biotechnology ETF NASDAQ IBB but it has made shares of
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 01/09/2017: ARWR, EXAS, JNJ, PFE, ABT, MRK, AMGN",2017-01-09 14:29:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VSSQ8tsQet8/health-care-sector-update-for-01092017-arwr-exas-jnj-pfe-abt-mrk-amgn-cm730945,Top Health Care stocks Top Health Care stocks JNJ 0 1 JNJ 0 1 PFE 0 1 PFE 0 1 ABT 0 1 ABT 0 1 MRK 0 4 MRK 0 4 AMGN 0 5 AMGN 0 5 Health care shares were mostly higher in pre market trade Monday Health care shares were mostly higher in pre market trade Monday In health
PFE,PFE:US,BBG000BR2B91,This Stock Prevented The Dow From Hitting Key Milestone,2017-01-09 13:51:00 +0000,http://www.forbes.com/sites/investor/2017/01/09/this-stock-prevented-the-dow-from-hitting-key-milestone/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,This Stock Prevented The Dow From Hitting Key Milestone
PFE,PFE:US,BBG000BR2B91,Pfizer's Humira Biosimilar Meets Primary Endpoint in Study (Revised),2017-01-09 12:48:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5kavqWL1sCo/pfizers-humira-biosimilar-meets-primary-endpoint-in-study-revised-cm730869,Pfizer Inc PFE announced positive top line results from the comparative REFLECTIONS B538 02 study on its investigational compound PF 06410293 a potential biosimilar to AbbVie Inc s ABBV Humira adalimumab approved for the treatment of patients with rheumatoid arthritis Pfizer
PFE,PFE:US,BBG000BR2B91,Pfizer's Humira Biosimilar Meets Primary Endpoint in Study (Revised),2017-01-09 11:09:11 +0000,http://finance.yahoo.com/news/pfizers-humira-biosimilar-meets-primary-110911089.html,Pfizer's Humira Biosimilar Meets Primary Endpoint in Study (Revised)
PFE,PFE:US,BBG000BR2B91,"5 Trade Ideas for Monday: AIG, CME, Honeywell, McDonald's and Pfizer",2017-01-08 19:18:13 +0000,http://finance.yahoo.com/tumblr/blog-5-trade-ideas-for-monday-aig-cme-honeywell-191820491.html,"5 Trade Ideas for Monday: AIG, CME, Honeywell, McDonald's and Pfizer"
PFE,PFE:US,BBG000BR2B91,"Better Buy: Regeneron Pharmaceuticals, Inc. vs. Pfizer",2017-01-07 16:13:00 +0000,http://www.fool.com/investing/2017/01/07/better-buy-regeneron-pharmaceuticals-inc-vs-pfizer.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Better Buy: Regeneron Pharmaceuticals, Inc. vs. Pfizer"
PFE,PFE:US,BBG000BR2B91,"Better Buy: Regeneron Pharmaceuticals, Inc. vs. Pfizer",2017-01-07 12:48:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tKDlDhqaA80/better-buy-regeneron-pharmaceuticals-inc-vs-pfizer-cm730677,Last year a handful of setbacks led shares of Regeneron Pharmaceuticals NASDAQ REGN about 29 lower while Pfizer NYSE PFE stock ended 2016 about 2 higher than it began Sales of Regeneron s lead product have been tapering off but a handful of potential blockbusters
PFE,PFE:US,BBG000BR2B91,Close Update: Labor Market Report Powers S&P 500 and Nasdaq to Record Highs,2017-01-06 22:08:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o2RL41KqHH4/close-update-labor-market-report-powers-sp-500-and-nasdaq-to-record-highs-cm730606,The S amp P 500 and Nasdaq closed at record highs Friday after buying erupted mid morning on the heels of the December non farm payroll report The better than expected increase in average hourly earnings powered the Dow Jones Industrial Average to within one point of the elusive 20 000 level
PFE,PFE:US,BBG000BR2B91,Midday Update: Stocks Regain Upward Momentum After Mixed Jobs Report,2017-01-06 18:17:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A7irE6L3jt0/midday-update-stocks-regain-upward-momentum-after-mixed-jobs-report-cm730503,Stocks were back on the move after idling in neutral for much of Friday s morning session as the Dow Jones Industrial Average inches closer to the 20 000 milestone and the S amp P 500 and Nasdaq set new record highs Stocks were back on the move after idling in neutral for much of Friday s
PFE,PFE:US,BBG000BR2B91,It Was CheckMate for Bristol-Myers Squibb Company in 2016,2017-01-06 17:40:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TXjScInokNA/it-was-checkmate-for-bristol-myers-squibb-company-in-2016-cm730455,Image source Getty Images What happened According to data from S amp P Global Market Intelligence shares of global drug giant Bristol Myers Squibb NYSE BMY tumbled 15 in 2016 160 meaning it underperformed the broad based S amp P 500 by nearly 25
PFE,PFE:US,BBG000BR2B91,ICU Medical Wins Big Price Cut to Buy Pfizer's Hospira Unit,2017-01-06 16:37:00 +0000,https://www.thestreet.com/story/13945291/1/icu-medical-wins-big-cut-in-price-for-pfizer-s-hospira.html?puc=yahoo&cm_ven=YAHOO,ICU Medical Wins Big Price Cut to Buy Pfizer's Hospira Unit
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: PCSK9 Inhibitor Praluent in News, Allergan's Preliminary 2017 View",2017-01-06 14:41:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CVGADu1vf3U/pharma-stock-roundup-pcsk9-inhibitor-praluent-in-news-allergans-preliminary-2017-view-cm730250,French pharma giant Sanofi SNY and partner Regeneron were hit by a court injunction blocking the sale of their PCSK9 inhibitor Praluent in the U S Meanwhile Allergan AGN provided a preliminary look at its expectations for 2017 Recap of the Week s Most Important Stories Sanofi
PFE,PFE:US,BBG000BR2B91,Pfizer's Humira Biosimilar Meets Primary Endpoint in Study,2017-01-06 14:40:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mq38JQm1pYE/pfizers-humira-biosimilar-meets-primary-endpoint-in-study-cm730334,Pfizer Inc PFE announced positive top line results from the comparative REFLECTIONS B538 02 study on its investigational compound PF 06410293 a potential biosimilar to AbbVie Inc s ABBV Humira adalimumab approved for the treatment of patients with rheumatoid arthritis Pfizer
PFE,PFE:US,BBG000BR2B91,[$$] Carlyle looks to sell health business Nature's Bounty,2017-01-06 13:48:29 +0000,"http://www.ft.com/cms/s/5ef18008-d401-11e6-b06b-680c49b4b4c0,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Nature's Bounty, the parent company of retailer Holland & Barrett, could be sold for as much as $6bn after Carlyle Group, its private equity owner, started looking at selling the health food and vitamins ..."
PFE,PFE:US,BBG000BR2B91,Pfizer's Humira Biosimilar Meets Primary Endpoint in Study,2017-01-06 13:21:01 +0000,http://finance.yahoo.com/news/pfizers-humira-biosimilar-meets-primary-132101767.html,Pfizer's Humira Biosimilar Meets Primary Endpoint in Study
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: PCSK9 Inhibitor Praluent in News, Allergan's Preliminary 2017 View",2017-01-06 12:24:12 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-pcsk9-inhibitor-122412444.html,"Pharma Stock Roundup: PCSK9 Inhibitor Praluent in News, Allergan's Preliminary 2017 View"
PFE,PFE:US,BBG000BR2B91,Bullish Two Hundred Day Moving Average Cross - PFE,2017-01-05 22:37:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FfbeY3uBPi4/bullish-two-hundred-day-moving-average-cross-pfe-cm730121,In trading on Thursday shares of Pfizer Inc Symbol PFE crossed above their 200 day moving average of 33 53 changing hands as high as 33 69 per share Pfizer Inc shares are currently trading up about 1 1 on the day The chart below shows the one year performance of PFE shares versus its
PFE,PFE:US,BBG000BR2B91,Pfizer Unveils Positive Results from Study of Potential Humira Biosimilar,2017-01-05 22:26:00 +0000,https://www.thestreet.com/story/13944236/1/pfizer-unveils-positive-results-from-study-of-potential-humira-biosimilar.html?puc=yahoo&cm_ven=YAHOO,Pfizer Unveils Positive Results from Study of Potential Humira Biosimilar
PFE,PFE:US,BBG000BR2B91,"ICU Medical, Inc. Provides Update on Hospira Infusion Systems Transaction",2017-01-05 21:55:10 +0000,http://www.publicnow.com/view/7A8D0F91BF36D22A5D1CC1733262E9A788AC69BD,"[at noodls] - January 5, 2017 U.S. and Other Required Antitrust Clearances for Transaction Received Company Expects Deal to Close in February 2017 Terms of the Deal Modified for Value-Creating and Risk Mitigated Structure ..."
PFE,PFE:US,BBG000BR2B91,Spark Gets A Check From Pfizer And A Downgrade From Vetr,2017-01-05 21:39:33 +0000,http://finance.yahoo.com/news/spark-gets-check-pfizer-downgrade-213933976.html,Spark Gets A Check From Pfizer And A Downgrade From Vetr
PFE,PFE:US,BBG000BR2B91,"ICU Medical, Inc. Provides Update on Hospira Infusion Systems Transaction",2017-01-05 21:05:00 +0000,http://finance.yahoo.com/news/icu-medical-inc-provides-hospira-210500510.html,[GlobeNewswire] - U.S. and Other Required Antitrust Clearances for Transaction Received Company Expects Deal to Close in February 2017 Terms of the Deal Modified for Value-Creating and Risk Mitigated Structure ICU Medical ...
PFE,PFE:US,BBG000BR2B91,Spark Therapeutics Gets $15M Milestone Payment from Pfizer,2017-01-05 17:39:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hKwpmkvrZBk/spark-therapeutics-gets-15m-milestone-payment-from-pfizer-cm729886,Spark Therapeutics ONCE received a 15 million milestone payment from partner Pfizer Inc PFE for achieving a pre specified safety and efficacy profile in the phase I II study on SPK 9001 which is being evaluated for the treatment of hemophilia B Spark Therapeutics share price has gained
PFE,PFE:US,BBG000BR2B91,"Senate Dems, D.C. Watchdog Call for Investigation Into Trump HHS Pick Tom Price's Stock Portfolio",2017-01-05 17:36:00 +0000,https://www.thestreet.com/story/13944072/1/senate-dems-d-c-watchdog-call-for-ethics-investigation-into-trump-hhs-pick-tom-price.html?puc=yahoo&cm_ven=YAHOO,"Senate Dems, D.C. Watchdog Call for Investigation Into Trump HHS Pick Tom Price's Stock Portfolio"
PFE,PFE:US,BBG000BR2B91,"The 4 Building Blocks That Pushed Exelixis, Inc. Higher by 164% in 2016",2017-01-05 16:44:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8ZaocuxPYdk/the-4-building-blocks-that-pushed-exelixis-inc-higher-by-164-in-2016-cm729849,Image source Getty Images What happened Shares of Exelixis NASDAQ EXEL a mid cap biotech company primarily focused on developing therapies to treat cancer surged 164 during 2016 according to S amp P Global Market Intelligence There appear to be four key reasons
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Verizon Communications, Pfizer, Chevron, Caterpillar and ExxonMobil",2017-01-05 16:40:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oqKq3dNk4yA/the-zacks-analyst-blog-highlights-verizon-communications-pfizer-chevron-caterpillar-and-exxonmobil-cm729926,For Immediate Release Chicago IL January 05 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
PFE,PFE:US,BBG000BR2B91,"2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth",2017-01-05 16:05:19 +0000,http://finance.yahoo.com/news/2017-bull-bear-case-health-160519439.html,"2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth"
PFE,PFE:US,BBG000BR2B91,Spark Therapeutics Gets $15M Milestone Payment from Pfizer,2017-01-05 15:09:03 +0000,http://finance.yahoo.com/news/spark-therapeutics-gets-15m-milestone-150903751.html,Spark Therapeutics Gets $15M Milestone Payment from Pfizer
PFE,PFE:US,BBG000BR2B91,What Pharma and Health Care Investors Should Watch for at JPM,2017-01-05 14:41:00 +0000,https://www.thestreet.com/story/13942732/1/what-pharma-and-healthcare-investors-should-watch-for-at-jpm-next-week.html?puc=yahoo&cm_ven=YAHOO,What Pharma and Health Care Investors Should Watch for at JPM
PFE,PFE:US,BBG000BR2B91,Bayer's sNDA for Stivarga Granted Priority Review in the U.S.,2017-01-05 14:40:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vyh7uxA3U_M/bayers-snda-for-stivarga-granted-priority-review-in-the-us-cm729786,Bayer AG BAYRY announced that the FDA has granted priority review designation to the company s supplemental New Drug Application sNDA for its cancer drug Stivarga for the second line treatment of patients with unresectable hepatocellular carcinoma uHCC Bayer s share price movement
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 01/05/2017: CTIC, HRTX, JNJ, PFE, ABT, MRK, AMGN",2017-01-05 14:37:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fyiEvdNbps4/health-care-sector-update-for-01052017-ctic-hrtx-jnj-pfe-abt-mrk-amgn-cm729709,Top Health Care stocks Top Health Care stocks JNJ flatJNJ flat PFE 0 3 PFE 0 3 ABT flatABT flat MRK flatMRK flat AMGN flatAMGN flat Health care shares were mostly unchanged in pre market trade Thursday Health care shares were mostly unchanged in pre market trade Thursday In
PFE,PFE:US,BBG000BR2B91,"Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B538-02 Study for PF-06410293, a Potential Biosimilar to Humira®1 (adalimumab)",2017-01-05 14:34:09 +0000,http://www.publicnow.com/view/C24F38E4FC10EE907E97A68DCADCF289C31AA1B9,"[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the comparative, confirmatory REFLECTIONS B538-02 study met its primary objective by demonstrating equivalent efficacy as measured ..."
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Verizon Communications, Pfizer, Chevron, Caterpillar and ExxonMobil",2017-01-05 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-verizon-143002863.html,"The Zacks Analyst Blog Highlights: Verizon Communications, Pfizer, Chevron, Caterpillar and ExxonMobil"
PFE,PFE:US,BBG000BR2B91,AbCellera Announces Multi-Target Research Collaboration with Pfizer,2017-01-05 14:02:01 +0000,http://finance.yahoo.com/news/abcellera-announces-multi-target-research-140201688.html,"[GlobeNewswire] - Multi-year collaboration aims to generate lead antibody candidates against membrane targets using AbCellera`s mAb discovery platform. VANCOUVER, British Columbia, Jan. 05, 2017 (GLOBE NEWSWIRE) -- AbCellera ..."
PFE,PFE:US,BBG000BR2B91,AbCellera Announces Multi-Target Research Collaboration with Pfizer,2017-01-05 14:00:00 +0000,http://finance.yahoo.com/news/abcellera-announces-multi-target-research-140000944.html,"[GlobeNewswire] - VANCOUVER, British Columbia, Jan. 05, 2017-- AbCellera Biologics, Inc. announced today a new therapeutic antibody discovery collaboration with Pfizer Inc.. AbCellera will apply its proprietary monoclonal ..."
PFE,PFE:US,BBG000BR2B91,BAT quits nicotine inhaler to focus on vaping,2017-01-05 13:30:31 +0000,http://sg.finance.yahoo.com/news/bat-quits-nicotine-inhaler-focus-114553947.html,BAT quits nicotine inhaler to focus on vaping
PFE,PFE:US,BBG000BR2B91,"Pfizer Announces Positive Top-Line Results from the Comparative REFLECTIONS B538-02 Study for PF-06410293, a Potential Biosimilar to Humira®1 (adalimumab)",2017-01-05 13:30:00 +0000,http://finance.yahoo.com/news/pfizer-announces-positive-top-line-133000596.html,"[Business Wire] - Pfizer Inc. today announced that the comparative, confirmatory REFLECTIONS B538-02 study met its primary objective by demonstrating equivalent efficacy as measured by the American College of Rheumatology 20 response rate at Week 12."
PFE,PFE:US,BBG000BR2B91,"Here's When to Buy Chevron, IBM, 3 More High-Yielding Dow 'Dogs'",2017-01-05 11:02:00 +0000,https://www.thestreet.com/story/13942814/1/here-s-when-to-buy-chevron-ibm-3-more-high-yielding-dow-dogs.html?puc=yahoo&cm_ven=YAHOO,"Here's When to Buy Chevron, IBM, 3 More High-Yielding Dow 'Dogs'"
PFE,PFE:US,BBG000BR2B91,"For People With Disabilities, ABLE Accounts a Step Toward Independence",2017-01-05 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=787269&SR=Yahoo,"For People With Disabilities, ABLE Accounts a Step Toward Independence"
PFE,PFE:US,BBG000BR2B91,Molecular Stethoscope Completes $8.2M Seed Financing to Advance Circulating Cell-Free RNA Liquid Biopsy Platform; Announces Research Collaboration with Pfizer,2017-01-05 11:00:00 +0000,http://finance.yahoo.com/news/molecular-stethoscope-completes-8-2m-110000758.html,"[PR Newswire] - SAN DIEGO, Jan. 5, 2017 /PRNewswire/ -- Molecular Stethoscope, Inc., a biotechnology company developing novel blood-based early detection and disease monitoring tests, announced today that it has completed ..."
PFE,PFE:US,BBG000BR2B91,Pfizer's Potential Biosimilar To Humira Reveals Positive Data - Quick Facts,2017-01-05 08:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bYVFOWJ4wbc/pfizers-potential-biosimilar-to-humira-reveals-positive-data--quick-facts-20170105-00547,Pfizer's Potential Biosimilar To Humira Reveals Positive Data - Quick Facts
PFE,PFE:US,BBG000BR2B91,"Why Encana, Acadia Pharmaceuticals, and Tenet Healthcare Jumped Today",2017-01-05 00:37:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LlN5h8WL298/why-encana-acadia-pharmaceuticals-and-tenet-healthcare-jumped-today-cm729594,The stock market continued to perform well on Wednesday sending the S amp P 500 to within a point of a new all time record closing high The Dow remained stubbornly below 20 000 but major market benchmarks posted gains of around half a percent as the latest release of minutes from
PFE,PFE:US,BBG000BR2B91,Here's Why Acadia Pharmaceuticals Inc. Stock Is Up Today,2017-01-04 23:37:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CbCwZqXYfu8/heres-why-acadia-pharmaceuticals-inc-stock-is-up-today-cm729584,Image source Getty Images What happened Shares of ACADIA Pharmaceuticals Inc NASDAQ ACAD popped just ahead of lunch on Wednesday and have risen about 12 6 as of 3 31 p m EST An unconfirmed rumor that Pfizer is interested in acquiring its set to explode
PFE,PFE:US,BBG000BR2B91,"Why Encana, Acadia Pharmaceuticals, and Tenet Healthcare Jumped Today",2017-01-04 23:17:00 +0000,http://www.fool.com/investing/2017/01/04/why-encana-acadia-pharmaceuticals-and-tenet-health.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,"Why Encana, Acadia Pharmaceuticals, and Tenet Healthcare Jumped Today"
PFE,PFE:US,BBG000BR2B91,What's Next for Opko Health After Its Recent Clinical Setback?,2017-01-04 22:37:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e6ONXRMHpT4/whats-next-for-opko-health-after-its-recent-clinical-setback-cm729561,Things seemed to be moving along nicely for Opko Health NASDAQ OPK until the bottom fell out The biotech s shares plunged more than 20 in the aftermath of disappointing late stage results for a human growth hormone product that Opko has already licensed to Pfizer NYSE
PFE,PFE:US,BBG000BR2B91,Exploring an Apple Inc. (AAPL) Takeover of Sirius and Pandora,2017-01-04 22:37:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nUI56dWkTkA/exploring-an-apple-inc-aapl-takeover-of-sirius-and-pandora-cm729567,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Apple Inc NASDAQ AAPL stock improved 10 in 2016 despite posting its first revenue decline since 2001 Last week it emerged that Apple would cut iPhone 7 production 10 amid
PFE,PFE:US,BBG000BR2B91,Here's Why Acadia Pharmaceuticals Inc. Stock Is Up Today,2017-01-04 21:43:52 +0000,http://www.fool.com/investing/2017/01/04/heres-why-acadia-pharmaceuticals-inc-stock-is-up-t.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why Acadia Pharmaceuticals Inc. Stock Is Up Today
PFE,PFE:US,BBG000BR2B91,Acadia Pharmaceuticals Inc. (ACAD) Flirts With a Pfizer Inc. (PFE) Buyout,2017-01-04 21:37:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jM8VZLSiCQE/acadia-pharmaceuticals-inc-acad-flirts-with-a-pfizer-inc-pfe-buyout-cm729528,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Acadia Pharmaceuticals Inc 160 NASDAQ ACAD is having a Happy New Year as ACAD stock 160 sets the second trading day of the year ablaze with 12 plus gains It won
PFE,PFE:US,BBG000BR2B91,What's Next for Opko Health After Its Recent Clinical Setback?,2017-01-04 20:56:16 +0000,http://www.fool.com/investing/2017/01/04/whats-next-for-opko-health-after-its-recent-clinic.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What's Next for Opko Health After Its Recent Clinical Setback?
PFE,PFE:US,BBG000BR2B91,3 Reasons to Buy Pfizer Stock for Retirement,2017-01-04 20:30:01 +0000,http://portal.kiplinger.com/slideshow/investing/T052-S001-3-reasons-to-buy-pfizer-stock-for-retirement/index.html?rid=SYN-yahoo&rpageid=16024,3 Reasons to Buy Pfizer Stock for Retirement
PFE,PFE:US,BBG000BR2B91,Spark reels in second $15M payment from Pfizer,2017-01-04 18:40:14 +0000,http://www.bizjournals.com/philadelphia/news/2017/01/04/spark-therapeutics-pfier-payment-once-gene-spk.html?ana=yahoo,Spark reels in second $15M payment from Pfizer
PFE,PFE:US,BBG000BR2B91,Shining A Spotlight On Ailing Health Care ETFs,2017-01-04 17:56:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P9VUrF-mG28/shining-a-spotlight-on-ailing-health-care-etfs-cm729460,"When looking over the last decade of sector returns on a year-by-year basis, it’s rare to see health care fall to the bottom of the stack.  Yet that unusual event is exactly what occurred in calendar year 2016.   Over the last twelve month, the  Health Care Select Sector SPDR  ( XLV ) posted a total return of"
PFE,PFE:US,BBG000BR2B91,5 Dogs of the Dow Stocks for 2017,2017-01-04 16:42:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D_E6YU3ilJs/5-dogs-of-the-dow-stocks-for-2017-cm729300,After a dismal 2015 during which it lost 2 3 the Dow has just completed a spectacular year The blue chip index soared in 2016 gaining 13 4 even as all the other benchmarks recorded spectacular gains Markets survived early blues from slowing growth in China s economy as well as the
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: UnitedHealth, Pfizer, Lockheed Martin, 3M and TripAdvisor",2017-01-04 16:42:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UOSExFBC5i8/the-zacks-analyst-blog-highlights-unitedhealth-pfizer-lockheed-martin-3m-and-tripadvisor-cm729421,For Immediate Release Chicago IL January 04 2017 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
PFE,PFE:US,BBG000BR2B91,Inotek (ITEK) Down on Poor Phase III Glaucoma Drug Data,2017-01-04 14:41:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OSvDpXm7kUQ/inotek-itek-down-on-poor-phase-iii-glaucoma-drug-data-cm729232,Shares of Inotek Pharmaceuticals Corporation ITEK plunged 71 3 after the company announced that a phase III trial on lead candidate trabodenoson failed to meet the primary endpoint We note that Inotek has underperformed the Zacks classified Medical Biomed Genetics industry in the
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: UnitedHealth, Pfizer, Lockheed Martin, 3M and TripAdvisor",2017-01-04 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-unitedhealth-143002433.html,"The Zacks Analyst Blog Highlights: UnitedHealth, Pfizer, Lockheed Martin, 3M and TripAdvisor"
PFE,PFE:US,BBG000BR2B91,"Pfizer Is Cheap, but Is Still a Dog Stock",2017-01-04 14:30:00 +0000,https://www.thestreet.com/story/13941229/1/why-does-pfizer-trade-at-a-discount.html?puc=yahoo&cm_ven=YAHOO,"Pfizer Is Cheap, but Is Still a Dog Stock"
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 01/04/2017: NVLS, JNJ, PFE, ABT, MRK, AMGN",2017-01-04 14:16:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aIhYsv-ojiM/health-care-sector-update-for-01042017-nvls-jnj-pfe-abt-mrk-amgn-cm729129,Top Health Care stocks Top Health Care stocks JNJ 0 9 JNJ 0 9 PFE 0 5 PFE 0 5 ABT flatABT flat MRK 0 1 MRK 0 1 AMGN 0 3 AMGN 0 3 Health care shares were mostly higher in pre market trade Wednesday Health care shares were mostly higher in pre market trade Wednesday In
PFE,PFE:US,BBG000BR2B91,5 Dogs of the Dow Stocks for 2017,2017-01-04 14:12:02 +0000,http://finance.yahoo.com/news/5-dogs-dow-stocks-2017-141202727.html,5 Dogs of the Dow Stocks for 2017
PFE,PFE:US,BBG000BR2B91,4 Reasons Why Pfizer (PFE) Could be a Great Pick in 2017,2017-01-04 13:38:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5WHf6QhBzvY/4-reasons-why-pfizer-pfe-could-be-a-great-pick-in-2017-cm729081,Pfizer Inc PFE is one of the most prominent names in the pharmaceutical sector not just for its medicines and vaccines but also for its consumer healthcare products This New York based company is known for products like Prevnar Lyrica Lipitor and Celebrex among others Pfizer s
PFE,PFE:US,BBG000BR2B91,Spark Therapeutics Announces $15 Million Milestone Payment from Pfizer for Progress in Hemophilia B Gene Therapy Program,2017-01-04 12:30:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-announces-15-million-123000647.html,"[GlobeNewswire] - PHILADELPHIA, Jan. 04, 2017-- Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that it has earned a $15 million ..."
PFE,PFE:US,BBG000BR2B91,The price of a lifesaving drug that reverses opioid overdoses is soaring,2017-01-04 11:54:29 +0000,http://www.cnbc.com/id/104197118?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104197118,The price of a lifesaving drug that reverses opioid overdoses is soaring
PFE,PFE:US,BBG000BR2B91,4 Reasons Why Pfizer (PFE) Could be a Great Pick in 2017,2017-01-04 11:25:11 +0000,http://finance.yahoo.com/news/4-reasons-why-pfizer-pfe-112511393.html,4 Reasons Why Pfizer (PFE) Could be a Great Pick in 2017
PFE,PFE:US,BBG000BR2B91,Spark Therapeutics Announces Milestone Payment From Pfizer - Quick Facts,2017-01-04 07:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2JKX7gWFces/spark-therapeutics-announces-milestone-payment-from-pfizer--quick-facts-20170104-00260,Spark Therapeutics Announces Milestone Payment From Pfizer - Quick Facts
PFE,PFE:US,BBG000BR2B91,My Worst Predictions for Biotech in 2016,2017-01-04 00:37:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LkRSCAzdKpU/my-worst-predictions-for-biotech-in-2016-cm729008,It s never fun to admit you re wrong but anyone who has been involved in the markets for years knows that much like in baseball failure is more common than success Last year my 5 Biotech Predictions for 2016 was filled with failure including a doozy of a prediction that
PFE,PFE:US,BBG000BR2B91,From Bamboo Therapeutics to Undercover Colors: Top Triangle fundraises in 2016,2017-01-03 23:00:08 +0000,http://www.bizjournals.com/triangle/news/2017/01/03/from-bamboo-therapeutics-to-undercover-colors-top.html?ana=yahoo,From Bamboo Therapeutics to Undercover Colors: Top Triangle fundraises in 2016
PFE,PFE:US,BBG000BR2B91,"Stock Research Reports for Pfizer, Lockheed Martin & UnitedHealth",2017-01-03 20:37:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yym6cX-MJG8/stock-research-reports-for-pfizer-lockheed-martin-unitedhealth-cm728920,Tuesday January 3 2016 Today s Research Daily features new research reports on 16 major stocks including UnitedHealth UNH Pfizer PFE and Lockheed Martin LMT Shares of Buy rated UnitedHealth have gained more than 37 4 over 2016 outperforming the medical health
PFE,PFE:US,BBG000BR2B91,2017 stock picker's playbook,2017-01-03 19:09:00 +0000,http://finance.yahoo.com/video/2017-stock-pickers-playbook-190900991.html,2017 stock picker's playbook
PFE,PFE:US,BBG000BR2B91,"Stock Research Reports for Pfizer, Lockheed Martin & UnitedHealth",2017-01-03 17:48:05 +0000,http://finance.yahoo.com/news/stock-research-reports-pfizer-lockheed-174805223.html,"Stock Research Reports for Pfizer, Lockheed Martin & UnitedHealth"
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts,2017-01-03 16:13:09 +0000,http://www.publicnow.com/view/6C4A660CED979E96735CD2D3118E60A65B9DA1BA,"[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, January ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public To View And Listen To Webcast Of January 31 Conference Call With Analysts,2017-01-03 16:00:00 +0000,http://finance.yahoo.com/news/pfizer-invites-public-view-listen-160000908.html,"[Business Wire] - Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, January 31, 2017."
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference,2017-01-03 15:00:00 +0000,http://finance.yahoo.com/news/pfizer-invites-public-listen-webcast-150000937.html,"[Business Wire] - Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Group President, Pfizer Innovative Health, Frank D’Amelio, Executive Vice President, Business Operations, and Chief Financial Officer, and Mikael Dolsten, President, Worldwide Research and Development, and at the 35th Annual J.P."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 01/03/2017: AGN, ITEK, JNJ, PFE, ABT, MRK, AMGN",2017-01-03 14:37:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Sb1mzHFP7K4/health-care-sector-update-for-01032017-agn-itek-jnj-pfe-abt-mrk-amgn-cm728543,Top Health Care stocks Top Health Care stocks JNJ 0 2 JNJ 0 2 PFE 0 5 PFE 0 5 ABT 2 2 ABT 2 2 MRK 0 03 MRK 0 03 AMGN 0 6 AMGN 0 6 Health care shares were mostly higher in pre market trade Tuesday Health care shares were mostly higher in pre market trade Tuesday In
PFE,PFE:US,BBG000BR2B91,"Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for January 04, 2017",2017-01-03 14:19:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UdIA7V8ApF8/bristol-myers-squibb-company-bmy-ex-dividend-date-scheduled-for-january-04-2017-cm728536,Bristol Myers Squibb Company BMY will begin trading ex dividend on January 04 2017 A cash dividend payment of 0 39 per share is scheduled to be paid on February 01 2017 Shareholders who purchased BMY prior to the ex dividend date are eligible for the cash dividend payment This
PFE,PFE:US,BBG000BR2B91,SNY Named Top 10 SAFE International Dividend Stock,2017-01-03 13:57:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DXw5uWOPcTI/sny-named-top-10-safe-international-dividend-stock-cm728468,Sanofi Symbol SNY has been named to the Dividend Channel International S A F E 10 list signifying an international stock with above average DividendRank statistics including a strong 4 0 yield as well as a superb track record of at least five years of dividend growth according
PFE,PFE:US,BBG000BR2B91,[$$] Will 2017 Be the Year of the Deal?,2017-01-03 04:47:53 +0000,http://www.wsj.com/articles/will-2017-be-the-year-of-the-deal-1483093808?ru=yahoo?mod=yahoo_itp,[$$] Will 2017 Be the Year of the Deal?
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Dec 30, 2016 :  CMCSA, BAC, QQQ, GE, MSFT, AAPL, JPM, T, CSCO, PFE, INTC, WFC",2017-01-02 21:48:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Dc5O4IcLSOA/after-hours-most-active-for-dec-30-2016-cmcsa-bac-qqq-ge-msft-aapl-jpm-t-csco-pfe-intc-wfc-cm728401,The NASDAQ 100 After Hours Indicator is down 2 35 to 4 861 27 The total After hours volume is currently 47 135 805 shares traded The following are the most active stocks for the after hours session Comcast Corporation CMCSA is 0 29 at 68 76 with 4 122 919
PFE,PFE:US,BBG000BR2B91,Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside,2016-12-31 16:14:23 +0000,http://247wallst.com/investing/2016/12/31/meet-the-2017-dogs-of-the-dow-massive-dividends-and-expected-upside/,Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Dec 30, 2016 :  BAC, QQQ, GE, MSFT, AAPL, JPM, T, PFE, CSCO, INTC, WFC, FB",2016-12-30 21:58:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0t9vriWJZRc/after-hours-most-active-for-dec-30-2016-bac-qqq-ge-msft-aapl-jpm-t-pfe-csco-intc-wfc-fb-cm728127,The NASDAQ 100 After Hours Indicator is up 91 to 4 864 53 The total After hours volume is currently 41 283 483 shares traded The following are the most active stocks for the after hours session Bank of America Corporation BAC is unchanged at 22 10 with 3 731
PFE,PFE:US,BBG000BR2B91,2016: Biotech’s Tumultuous Year,2016-12-30 19:30:11 +0000,http://finance.yahoo.com/video/2016-biotech-tumultuous-193011571.html,2016: Biotech’s Tumultuous Year
PFE,PFE:US,BBG000BR2B91,Why Opko Health Inc. Stock Is Sinking Today,2016-12-30 18:58:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-G0KtFSZsPM/why-opko-health-inc-stock-is-sinking-today-cm728044,Image source Getty Images What happened Shares of Opko Health Inc NASDAQ OPK a multinational pharmaceutical and diagnostics company are down 16 1 as of 11 18 a m EST Friday An announcement that its human growth hormone candidate which is partnered with
PFE,PFE:US,BBG000BR2B91,These 3 Stocks Just Raised Their Dividends,2016-12-30 17:59:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZMSztNcd-8Y/these-3-stocks-just-raised-their-dividends-cm728020,Unlike many others income investors will probably remember 2016 fondly After all the year was stuffed full of dividend raises True to form its final weeks saw a clutch of companies hike their payouts Here are three notables that upped their distributions as the year came to a
PFE,PFE:US,BBG000BR2B91,Growth hormone deficiency drug from OPKO and Pfizer fails study,2016-12-30 17:39:08 +0000,http://in.finance.yahoo.com/news/growth-hormone-deficiency-drug-opko-173908069.html,Growth hormone deficiency drug from OPKO and Pfizer fails study
PFE,PFE:US,BBG000BR2B91,Why Opko Health Inc. Stock Is Sinking Today,2016-12-30 17:19:14 +0000,http://www.fool.com/investing/2016/12/30/why-opko-health-inc-stock-is-sinking-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Opko Health Inc. Stock Is Sinking Today
PFE,PFE:US,BBG000BR2B91,"ARIAD Stock Beats Industry in 2016, Iclusig Sales Strong",2016-12-30 17:01:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iRoJFeP1ZcM/ariad-stock-beats-industry-in-2016-iclusig-sales-strong-cm727981,ARIAD Pharmaceuticals Inc ARIA remains focused on the discovery development and commercialization of breakthrough treatments for cancer This year was a tough one for the pharma sector which had to grapple with media and political focus on the high prices of drugs Shares of ARIAD
PFE,PFE:US,BBG000BR2B91,Mylan (MYL) Announces Multiple Generic Launches in the U.S.,2016-12-30 17:01:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b80iKhZ8Zzs/mylan-myl-announces-multiple-generic-launches-in-the-us-cm727975,The final month of 2016 saw several important initiatives being undertaken by generic drug maker Mylan N V MYL The company announced quite a few generic launches in the U S in December However the one that drew the maximum attention was the roll out of the first generic version of
PFE,PFE:US,BBG000BR2B91,These 3 Stocks Just Raised Their Dividends,2016-12-30 16:12:06 +0000,http://www.fool.com/investing/2016/12/30/these-3-stocks-just-raised-their-dividends.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,These 3 Stocks Just Raised Their Dividends
PFE,PFE:US,BBG000BR2B91,Opko Health's Phase 3 Data Sends Stock Plunging,2016-12-30 15:12:38 +0000,http://finance.yahoo.com/news/opko-healths-phase-3-data-151238026.html,Opko Health's Phase 3 Data Sends Stock Plunging
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 12/30/2016: CO, JNJ, PFE, ABT, MRK, AMGN",2016-12-30 14:37:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mw0TGHjXXlE/health-care-sector-update-for-12302016-co-jnj-pfe-abt-mrk-amgn-cm727812,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 0 4 PFE 0 4 ABT 0 1 ABT 0 1 MRK 0 7 MRK 0 7 AMGN 0 1 AMGN 0 1 Health care shares were higher in pre market trade Friday Health care shares were higher in pre market trade Friday In health care stocks
PFE,PFE:US,BBG000BR2B91,How GlaxoSmithKline’s Pharmaceuticals Segment Has Performed,2016-12-30 14:07:11 +0000,http://marketrealist.com/2016/12/how-glaxosmithklines-pharmaceuticals-segment-has-performed/?utm_source=yahoo&utm_medium=feed,How GlaxoSmithKline’s Pharmaceuticals Segment Has Performed
PFE,PFE:US,BBG000BR2B91,Merck (MRK) Does Well in 2016: Reasons for Outperformance,2016-12-30 14:00:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XKoQqVV0l3g/merck-mrk-does-well-in-2016-reasons-for-outperformance-cm727759,New Jersey based leading pharma company Merck amp Co Inc s MRK share price is up 11 8 so far this year This is impressive given that the year was fraught with challenges for the pharma biotech sector which faced immense flak for steep drug prices The company s price movement
PFE,PFE:US,BBG000BR2B91,Growth hormone deficiency drug from OPKO and Pfizer fails study,2016-12-30 13:51:14 +0000,http://finance.yahoo.com/news/growth-hormone-deficiency-drug-opko-135114853.html,"[Reuters] - OPKO Health Inc said on Friday its experimental drug for growth hormone deficiency did not provide a statistically significant benefit over a placebo in a late-stage study. The drug, hGH-CTP, is being ..."
PFE,PFE:US,BBG000BR2B91,Exploring GlaxoSmithKline’s Business Segments,2016-12-30 12:38:05 +0000,http://marketrealist.com/2016/12/exploring-glaxosmithklines-business-segments/?utm_source=yahoo&utm_medium=feed,Exploring GlaxoSmithKline’s Business Segments
PFE,PFE:US,BBG000BR2B91,[$$] Will 2017 Be the Year of the Deal?,2016-12-30 11:01:50 +0000,http://www.wsj.com/articles/will-2017-be-the-year-of-the-deal-1483093808?mod=yahoo_hs,[$$] Will 2017 Be the Year of the Deal?
PFE,PFE:US,BBG000BR2B91,Kevin O'Leary's Top 10 Quality Dividend Stocks,2016-12-29 23:20:18 +0000,http://finance.yahoo.com/news/kevin-olearys-top-10-quality-232018903.html,Kevin O'Leary's Top 10 Quality Dividend Stocks
PFE,PFE:US,BBG000BR2B91,"Watch Beaten-Down Drug Companies, Hospitals in 2017",2016-12-29 21:00:00 +0000,http://realmoney.thestreet.com/articles/12/29/2016/watch-beaten-down-drug-companies-hospitals-2017?puc=yahoo&cm_ven=YAHOO,"Watch Beaten-Down Drug Companies, Hospitals in 2017"
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson's 4 Biggest Catalysts in 2017,2016-12-29 17:01:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-SDrEipjw_k/johnson-johnsons-4-biggest-catalysts-in-2017-cm727489,Image source Getty Images Though it was a very difficult year for drugmakers with the SPDR S amp P Pharmaceuticals ETF 160 losing just shy of a quarter of its value the same can t be said of healthcare conglomerate Johnson amp Johnson NYSE JNJ a company that
PFE,PFE:US,BBG000BR2B91,These 2 'Dogs of the Dow' Will Have Their Day in 2017,2016-12-29 16:46:00 +0000,https://www.thestreet.com/story/13938663/1/these-2-dogs-of-the-dow-will-have-their-day-in-2017.html?puc=yahoo&cm_ven=YAHOO,These 2 'Dogs of the Dow' Will Have Their Day in 2017
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 12/29/2016: ETRM, CEMP, JNJ, PFE, ABT, MRK, AMGN",2016-12-29 14:37:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o7iQSQmCxeI/health-care-sector-update-for-12292016-etrm-cemp-jnj-pfe-abt-mrk-amgn-cm727331,Top Health care stocks Top Health care stocks JNJ 0 1 JNJ 0 1 PFE 1 1 PFE 1 1 ABT 0 03 ABT 0 03 MRK flatMRK flat AMGN flatAMGN flat Health care shares were mixed in pre market trade Thursday Health care shares were mixed in pre market trade Thursday In health care stocks
PFE,PFE:US,BBG000BR2B91,Will Keytruda’s Position Strengthen in the Lung Cancer Market?,2016-12-29 12:36:11 +0000,http://marketrealist.com/2016/12/increased-pd-l1-testing-expected-strengthen-keytrudas-position-lung-cancer-market/?utm_source=yahoo&utm_medium=feed,Will Keytruda’s Position Strengthen in the Lung Cancer Market?
PFE,PFE:US,BBG000BR2B91,"5 Companies That Will Kill the Dow’s Move to 20,000",2016-12-29 12:35:27 +0000,http://247wallst.com/investing/2016/12/29/5-companies-that-will-kill-the-dows-move-to-20000/,"5 Companies That Will Kill the Dow’s Move to 20,000"
PFE,PFE:US,BBG000BR2B91,2 Top High-Yield Dividend Stocks to Buy Now,2016-12-28 23:57:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h5FW5AR1TPE/2-top-high-yield-dividend-stocks-to-buy-now-cm727198,One of the easiest ways to find quality companies that pay better than average dividends is to focus on industries that have multiple tailwinds at their proverbial backs The pharmaceutical industry for example is experiencing a renaissance of sorts due to the aging and ever
PFE,PFE:US,BBG000BR2B91,2 Top High-Yield Dividend Stocks to Buy Now,2016-12-28 22:38:11 +0000,http://www.fool.com/investing/2016/12/28/2-top-high-yield-dividend-stocks-to-buy-now-2.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,2 Top High-Yield Dividend Stocks to Buy Now
PFE,PFE:US,BBG000BR2B91,These 2 'Dogs of Dow' Are Set to Be Unleashed,2016-12-28 21:30:00 +0000,http://realmoney.thestreet.com/articles/12/28/2016/these-2-dogs-dow-are-set-be-unleashed?puc=yahoo&cm_ven=YAHOO,These 2 'Dogs of Dow' Are Set to Be Unleashed
PFE,PFE:US,BBG000BR2B91,Expensive Breakups In 2016 Surpass GDPs Of Dozens Of Developing Nations,2016-12-28 20:00:44 +0000,http://finance.yahoo.com/news/expensive-breakups-2016-surpass-gdps-200044288.html,Expensive Breakups In 2016 Surpass GDPs Of Dozens Of Developing Nations
PFE,PFE:US,BBG000BR2B91,Why Is Enbrel So Important for Amgen?,2016-12-28 15:36:54 +0000,http://marketrealist.com/2016/12/why-is-enbrel-so-important-for-amgen/?utm_source=yahoo&utm_medium=feed,Why Is Enbrel So Important for Amgen?
PFE,PFE:US,BBG000BR2B91,Short Interest Rises in Major Pharma,2016-12-28 15:25:59 +0000,http://finance.yahoo.com/news/short-interest-rises-major-pharma-152559380.html,Short Interest Rises in Major Pharma
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 12/28/2016: SNY, ANTH, JNJ, PFE, ABT, MRK, AMGN",2016-12-28 14:17:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Qm94dSq6N6I/health-care-sector-update-for-12282016-sny-anth-jnj-pfe-abt-mrk-amgn-cm726775,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 0 3 PFE 0 3 ABT flatABT flat MRK 0 5 MRK 0 5 AMGN 1 2 AMGN 1 2 Health care shares were mixed in pre market trade Wednesday Health care shares were mixed in pre market trade Wednesday In health care stocks
PFE,PFE:US,BBG000BR2B91,'Dogs of the Dow' unleashed for 2017,2016-12-28 13:47:17 +0000,http://finance.yahoo.com/news/dogs-of-the-dow-unleashed-for-2017-134717531.html,'Dogs of the Dow' unleashed for 2017
PFE,PFE:US,BBG000BR2B91,Eight Milestones Of 2016 In The War On Cancer,2016-12-28 13:35:00 +0000,http://www.forbes.com/sites/arleneweintraub/2016/12/28/eight-milestones-of-2016-in-the-war-on-cancer/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Eight Milestones Of 2016 In The War On Cancer
PFE,PFE:US,BBG000BR2B91,The 3 Biggest Risks for Pfizer in 2017,2016-12-28 12:23:22 +0000,http://www.fool.com/investing/2016/12/27/3-biggest-risks-for-pfizer-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The 3 Biggest Risks for Pfizer in 2017
PFE,PFE:US,BBG000BR2B91,[$$] Donald Trump Dogs Dow Strategy,2016-12-28 04:45:04 +0000,http://www.wsj.com/articles/donald-trump-dogs-dow-strategy-1482872516?ru=yahoo?mod=yahoo_itp,[$$] Donald Trump Dogs Dow Strategy
PFE,PFE:US,BBG000BR2B91,International Segment: Key Driver of VRX’s Revenue Growth in 2016,2016-12-27 23:05:35 +0000,http://marketrealist.com/2016/12/international-segment-key-driver-valeant-pharmaceuticals-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,International Segment: Key Driver of VRX’s Revenue Growth in 2016
PFE,PFE:US,BBG000BR2B91,[$$] Donald Trump Dogs Dow Strategy,2016-12-27 21:19:11 +0000,http://www.wsj.com/articles/donald-trump-dogs-dow-strategy-1482872516?mod=yahoo_hs,[$$] Donald Trump Dogs Dow Strategy
PFE,PFE:US,BBG000BR2B91,"ETFs with exposure to Pfizer Inc. : December 27, 2016",2016-12-27 18:38:18 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-pfizer-inc-december-27-2016/,"ETFs with exposure to Pfizer Inc. : December 27, 2016"
PFE,PFE:US,BBG000BR2B91,3 Best Stocks for Retirees,2016-12-27 18:08:51 +0000,http://www.fool.com/investing/2016/12/27/3-best-stocks-for-retirees.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Best Stocks for Retirees
PFE,PFE:US,BBG000BR2B91,Halftime traders' 2017 playbook: Jim & Sarat,2016-12-27 17:24:00 +0000,http://finance.yahoo.com/video/halftime-traders-2017-playbook-jim-172400437.html,Halftime traders' 2017 playbook: Jim & Sarat
PFE,PFE:US,BBG000BR2B91,Donald Trump Dogs Dow Strategy -- Ahead of the Tape,2016-12-27 16:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nF5j9MsPfjg/donald-trump-dogs-dow-strategy--ahead-of-the-tape-20161227-00349,Donald Trump Dogs Dow Strategy -- Ahead of the Tape
PFE,PFE:US,BBG000BR2B91,"Portola Betrixaban Accepted for Review in U.S. & EU, Stock Up",2016-12-27 16:01:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1I0Qa_PZBpg/portola-betrixaban-accepted-for-review-in-us-eu-stock-up-cm726398,Shares of Portola Pharmaceuticals Inc PTLA surged 33 8 after the company s new drug application for its oral once daily Factor Xa inhibitor anticoagulant betrixaban was accepted under priority review by the FDA Note that Portola is looking to get betrixaban approved for extended
PFE,PFE:US,BBG000BR2B91,Aerie (AERI) Rhopressa Regulatory Application Delayed Again,2016-12-27 16:01:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SKx5Cownu_I/aerie-aeri-rhopressa-regulatory-application-delayed-again-cm726396,Aerie Pharmaceuticals Inc AERI announced that the manufacturing facility for its lead candidate Rhopressa will not be ready for pre approval inspection by the FDA until the end of Feb 2017 We note that Aerie has outperformed the Zacks classified Medical Drugs industry in the last
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 12/27/2016: SGEN, IONS, JNJ, PFE, ABT, MRK, AMGN",2016-12-27 15:17:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FONYCDmnwe0/health-care-sector-update-for-12272016-sgen-ions-jnj-pfe-abt-mrk-amgn-cm726382,Top Health care stocks Top Health care stocks JNJ 0 6 JNJ 0 6 PFE 0 5 PFE 0 5 ABT 0 5 ABT 0 5 MRK 0 3 MRK 0 3 AMGN 1 AMGN 1 Health care shares were higher as Tuesday s regular session commencedHealth care shares were higher as Tuesday s regular session commenced In
PFE,PFE:US,BBG000BR2B91,3 Best Stocks for Retirees,2016-12-27 14:58:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FkUUbBaTVVk/3-best-stocks-for-retirees-cm726175,Retirees are living longer than ever which means they will depend on their stock portfolios for income for an extended period of time That s why we Fools believe that nearly every retiree should invest at least a portion of their nest egg in the stock market Of course not every
PFE,PFE:US,BBG000BR2B91,"Portola Betrixaban Accepted for Review in U.S. & EU, Stock Up",2016-12-27 14:07:02 +0000,http://finance.yahoo.com/news/portola-betrixaban-accepted-review-u-140702838.html,"Portola Betrixaban Accepted for Review in U.S. & EU, Stock Up"
PFE,PFE:US,BBG000BR2B91,The 3 Biggest Risks for Pfizer in 2017,2016-12-27 13:57:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BfG7UnLCm8k/the-3-biggest-risks-for-pfizer-in-2017-cm726141,Pfizer NYSE PFE appears to be on track to end 2016 with its stock price at roughly the same level as it began the year Could the new year present better opportunities for the big pharma Yes but challenges remain Here are three of Pfizer s biggest risks in
PFE,PFE:US,BBG000BR2B91,How Ugly Can the Bond Rout Get?,2016-12-26 18:57:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LGcefzxF6Hk/how-ugly-can-the-bond-rout-get-cm726098,The beauty of bonds comes from the predictability of their payment schedules That predictability is maintained through the threat of default if the bond payer doesn t pay on schedule the bond holder has recourse that often includes taking control of the defaulting bond 160 issuer
PFE,PFE:US,BBG000BR2B91,How Ugly Can the Bond Rout Get?,2016-12-26 17:01:10 +0000,http://www.fool.com/retirement/2016/12/26/how-ugly-can-the-bond-rout-get.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,How Ugly Can the Bond Rout Get?
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. :PFE-US: Earnings Analysis: Q3, 2016 By the Numbers : December 26, 2016",2016-12-26 13:51:58 +0000,http://www.capitalcube.com/blog/index.php/pfizer-inc-pfe-us-earnings-analysis-q3-2016-by-the-numbers-december-26-2016/,"Pfizer Inc. :PFE-US: Earnings Analysis: Q3, 2016 By the Numbers : December 26, 2016"
PFE,PFE:US,BBG000BR2B91,Financial Metrics of Baxter’s Acquisition of Claris Injectables,2016-12-26 12:36:19 +0000,http://marketrealist.com/2016/12/financial-metrics-of-baxters-acquisition-of-claris-injectables/?utm_source=yahoo&utm_medium=feed,Financial Metrics of Baxter’s Acquisition of Claris Injectables
PFE,PFE:US,BBG000BR2B91,The Year That Was: Novel Drug Approvals Of 2016,2016-12-25 02:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eutJfQ074C8/the-year-that-was-novel-drug-approvals-of-2016-20161225-00001,The Year That Was: Novel Drug Approvals Of 2016
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: Nike Beats, Coca-Cola to Buy AB InBev's Stake in CCBA",2016-12-23 23:57:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wnb9ZfBBt40/dow-30-stock-roundup-nike-beats-coca-cola-to-buy-ab-inbevs-stake-in-ccba-cm725904,The Dow endured a turbulent week as the postelection rally encountered several roadblocks Sectors which had fallen out of favor recently such as technology regained their popularity among investors However financials continued to gain on hopes that deregulation measures would be undertaken
PFE,PFE:US,BBG000BR2B91,Why Portola Pharmaceuticals Inc Stock Surged Higher Today,2016-12-23 23:57:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UcIyicNfP6o/why-portola-pharmaceuticals-inc-stock-surged-higher-today-cm725903,Image source Getty Images What happened Shares of clinical stage anticoagulant specialist Portola Pharmaceuticals Inc NASDAQ PTLA 160 rose 33 5 at the end of Friday s session 160 Announcements that key regulatory agencies have officially accepted new drug applications
PFE,PFE:US,BBG000BR2B91,Why Portola Pharmaceuticals Inc Stock Surged Higher Today,2016-12-23 22:35:48 +0000,http://www.fool.com/investing/2016/12/23/why-portola-pharmaceuticals-is-up-27-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Portola Pharmaceuticals Inc Stock Surged Higher Today
PFE,PFE:US,BBG000BR2B91,"Gilead Sciences, Inc. (GILD) Is A Hail Mary: 3 Better Stocks To Consider",2016-12-23 19:32:32 +0000,http://www.insidermonkey.com/blog/gilead-sciences-inc-gild-is-a-hail-mary-3-better-stocks-to-consider-513001/,"Gilead Sciences, Inc. (GILD) Is A Hail Mary: 3 Better Stocks To Consider"
PFE,PFE:US,BBG000BR2B91,"Noteworthy ETF Inflows: IWD, BAC, PFE, C",2016-12-23 16:58:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3oi6wvdlRX0/noteworthy-etf-inflows-iwd-bac-pfe-c-cm725711,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 Value ETF Symbol IWD where we have detected an approximate 220 1 million dollar inflow that s a 0 6 increase week over week in
PFE,PFE:US,BBG000BR2B91,Does Pfizer Acquisition From AZN Help The Stock?,2016-12-23 16:19:00 +0000,http://www.investopedia.com/news/pfe-completes-acquisition-azn-pfe/?partner=YahooSA,Does Pfizer Acquisition From AZN Help The Stock?
PFE,PFE:US,BBG000BR2B91,"Stocks Open Tightly Mixed; Pfizer Climbs, Fred's Surges Again",2016-12-23 14:45:10 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-lull-pfizer-climbs-on-astrazeneca-deal/,"Stocks Open Tightly Mixed; Pfizer Climbs, Fred's Surges Again"
PFE,PFE:US,BBG000BR2B91,Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca,2016-12-23 10:08:14 +0000,http://www.publicnow.com/view/0CC8887EB8CC75DE047CD1E583945A2DDC870B4D,"[at noodls] - Pfizer Inc. (NYSE:PFE) today announced that it has completed the acquisition of the development and commercialization rights to AstraZeneca's late-stage small molecule anti-infective business, primarily ..."
PFE,PFE:US,BBG000BR2B91,The 3 Best New ETFs That Will Keep Your Wallet Stuffed,2016-12-22 21:58:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RA2XUfxFj9Y/the-3-best-new-etfs-that-will-keep-your-wallet-stuffed-cm725422,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips This has been another brisk year in terms of launches of new exchange traded funds As of Dec 20 nearly 200 new ETFs have come to the market this year with 15 coming to market in just the first half
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Dec 22, 2016 :  NAVI, BAC, CMCSA, GLW, GNTX, PFE, DOW, MU, MOS, MPEL, TSM, QQQ",2016-12-22 21:57:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mK9KrxcnSFY/after-hours-most-active-for-dec-22-2016-navi-bac-cmcsa-glw-gntx-pfe-dow-mu-mos-mpel-tsm-qqq-cm725391,The NASDAQ 100 After Hours Indicator is down 1 06 to 4 933 33 The total After hours volume is currently 39 297 781 shares traded The following are the most active stocks for the after hours session Navient Corporation NAVI is unchanged at 16 63 with 4 857 926
PFE,PFE:US,BBG000BR2B91,Donald Trump's Pick for Health Secretary Traded Medical Stocks While in House,2016-12-22 19:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y-SvAjAW02s/donald-trumps-pick-for-health-secretary-traded-medical-stocks-while-in-house-20161222-00836,Donald Trump's Pick for Health Secretary Traded Medical Stocks While in House
PFE,PFE:US,BBG000BR2B91,FDA Agrees To Review IBRANCE (palbociclib) From Pfizer Inc. (PFE),2016-12-22 19:02:04 +0000,http://www.insidermonkey.com/blog/fda-agrees-to-review-ibrance-palbociclib-from-pfizer-inc-pfe-512811/,FDA Agrees To Review IBRANCE (palbociclib) From Pfizer Inc. (PFE)
PFE,PFE:US,BBG000BR2B91,Roche Holding Ltd. (RHHBY) Still Has a Few Tricks Up its Sleeve,2016-12-22 18:00:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wld5UB8r74g/roche-holding-ltd-rhhby-still-has-a-few-tricks-up-its-sleeve-cm725293,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips With a market cap of 160 196 160 billion Roche Holding Ltd ADR OTCMKTS RHHBY is certainly a Big Pharma player slightly ahead of 160 Pfizer Inc NYSE
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Pfizer, Microsoft, Bank of America, Oracle and Nike",2016-12-22 17:01:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5UBM-XnvGIE/the-zacks-analyst-blog-highlights-pfizer-microsoft-bank-of-america-oracle-and-nike-cm725127,For Immediate Release Chicago IL December 22 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
PFE,PFE:US,BBG000BR2B91,"Dow Movers: PFE, CVX",2016-12-22 17:00:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i78rv5C_FwY/dow-movers-pfe-cvx-cm725170,In early trading on Thursday shares of Chevron CVX topped the list of the day s best performing Dow Jones Industrial Average components trading up 0 3 Year to date Chevron registers a 31 5 gain And the worst performing Dow component thus far on the day is Pfizer PFE
PFE,PFE:US,BBG000BR2B91,J&J Resumes Talks with Actelion: Did Sanofi Just Lose Out?,2016-12-22 15:00:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/luxFElckqKI/jj-resumes-talks-with-actelion-did-sanofi-just-lose-out-cm725008,In an interesting turn of events Johnson amp Johnson JNJ announced that it is once again discussing a possible transaction with Swiss biotechnology company Actelion Ltd ALIOF Note that this announcement comes just a week after the two companies disclosed that they have ended earlier
PFE,PFE:US,BBG000BR2B91,Pfizer Ibrance sNDA Accepted by FDA under Priority Review,2016-12-22 15:00:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7OzIiB83onM/pfizer-ibrance-snda-accepted-by-fda-under-priority-review-cm725000,Pfizer Inc s PFE supplemental new drug application sNDA to convert accelerated approval for its breast cancer drug Ibrance to regular approval was accepted by the FDA under priority review Note that Ibrance is approved in the U S for the treatment of HR HER2 advanced or
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Pfizer, Microsoft, Bank of America, Oracle and Nike",2016-12-22 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-pfizer-143002389.html,"The Zacks Analyst Blog Highlights: Pfizer, Microsoft, Bank of America, Oracle and Nike"
PFE,PFE:US,BBG000BR2B91,Pfizer Ibrance sNDA Accepted by FDA under Priority Review,2016-12-22 13:01:01 +0000,http://finance.yahoo.com/news/pfizer-ibrance-snda-accepted-fda-130101715.html,Pfizer Ibrance sNDA Accepted by FDA under Priority Review
PFE,PFE:US,BBG000BR2B91,"5 Stocks That Will Keep the Dow Under 20,000",2016-12-22 11:40:01 +0000,http://247wallst.com/investing/2016/12/22/5-stocks-that-will-keep-dow-under-20000/,"5 Stocks That Will Keep the Dow Under 20,000"
PFE,PFE:US,BBG000BR2B91,"Stock Research Reports for Pfizer, Microsft & Bank of America",2016-12-22 06:56:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TpHtYgtSPJo/stock-research-reports-for-pfizer-microsft-bank-of-america-cm724923,Wednesday December 21 2016 Today s Research Daily features new research reports on 16 major stocks including Pfizer PFE Microsoft MSFT and Bank of America BAC Pfizer shares have gained 9 5 since results of the presidential election were declared on Nov 8 outperforming the
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Nimenrix Vaccine's Label Expanded in the EU,2016-12-22 00:56:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F3VpTj81UQQ/pfizer-pfe-nimenrix-vaccines-label-expanded-in-the-eu-cm724871,Pfizer Inc PFE announced that the European Commission EC has approved an expanded indication for its meningococcal vaccine Nimenrix We note that Pfizer has outperformed the Zacks classified Large Cap Pharmaceuticals industry year to date In fact the company has gained 1 8 so
PFE,PFE:US,BBG000BR2B91,US Market Indexes Lower on Wednesday,2016-12-21 23:42:55 +0000,http://finance.yahoo.com/news/us-market-indexes-lower-wednesday-234255722.html,US Market Indexes Lower on Wednesday
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Nimenrix Vaccine's Label Expanded in the EU,2016-12-21 23:19:11 +0000,http://finance.yahoo.com/news/pfizer-pfe-nimenrix-vaccines-label-231911251.html,Pfizer (PFE) Nimenrix Vaccine's Label Expanded in the EU
PFE,PFE:US,BBG000BR2B91,"Stock Research Reports for Pfizer, Microsft & Bank of America",2016-12-21 22:35:10 +0000,http://finance.yahoo.com/news/stock-research-reports-pfizer-microsft-223510146.html,"Stock Research Reports for Pfizer, Microsft & Bank of America"
PFE,PFE:US,BBG000BR2B91,Dividends key to beating market?,2016-12-21 22:28:00 +0000,http://finance.yahoo.com/video/dividends-key-beating-market-222800871.html,Dividends key to beating market?
PFE,PFE:US,BBG000BR2B91,3 Stocks That Could Get Pounded by Tax Loss Selling,2016-12-21 21:56:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PgMD04mWNwA/3-stocks-that-could-get-pounded-by-tax-loss-selling-cm724800,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips This year has been a pretty good one for most stock investors Unfortunately for stocks that have lagged the market in 2016 tis the season for tax loss selling Source Pictures of Money via
PFE,PFE:US,BBG000BR2B91,Markets Right Now: Health care stocks lead US indexes lower,2016-12-21 21:07:36 +0000,http://sg.finance.yahoo.com/news/markets-now-stock-indexes-edge-144440133.html,Markets Right Now: Health care stocks lead US indexes lower
PFE,PFE:US,BBG000BR2B91,"Merck, Pfizer Weigh on DJIA Wednesday",2016-12-21 21:01:58 +0000,http://finance.yahoo.com/news/merck-pfizer-weigh-djia-wednesday-210158139.html,"Merck, Pfizer Weigh on DJIA Wednesday"
PFE,PFE:US,BBG000BR2B91,Markets Right Now: Stock indexes edge lower in midday trade,2016-12-21 17:03:05 +0000,http://finance.yahoo.com/news/markets-now-stock-indexes-edge-144440160.html,Markets Right Now: Stock indexes edge lower in midday trade
PFE,PFE:US,BBG000BR2B91,Allergan to Buy LifeCell to Boost Regenerative Medicine Suite,2016-12-21 14:59:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yzdaDHK4aVQ/allergan-to-buy-lifecell-to-boost-regenerative-medicine-suite-cm724428,Allergan plc AGN announced that it has signed a definitive agreement to acquire LifeCell the regenerative medicine unit of Texas based privately held company Acelity for 2 9 billion in cash Allergan s share price was up 1 3 in the past one month outperforming the 0 6 increase for the
PFE,PFE:US,BBG000BR2B91,"FDA Accepts Supplemental New Drug Application for Pfizer’s IBRANCE® (palbociclib) in HR+, HER2- Metastatic Breast Cancer",2016-12-21 13:12:10 +0000,http://www.publicnow.com/view/CAF84C90F3E64CEB314CC94FEAF056B26308B531,[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental New Drug Application (sNDA) for its first-in-class ...
PFE,PFE:US,BBG000BR2B91,Artificial leaf copies nature to manufacture medicine,2016-12-21 12:00:01 +0000,http://uk.finance.yahoo.com/news/artificial-leaf-copies-nature-manufacture-120001400.html,Artificial leaf copies nature to manufacture medicine
PFE,PFE:US,BBG000BR2B91,Actelion shares gain on report of progress in Sanofi talks,2016-12-21 09:39:56 +0000,http://sg.finance.yahoo.com/news/actelion-shares-gain-report-progress-093956971.html,Actelion shares gain on report of progress in Sanofi talks
PFE,PFE:US,BBG000BR2B91,Pfizer: FDA To Review SNDA For IBRANCE Inhibitor - Quick Facts,2016-12-21 08:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9UMPrLDcUwo/pfizer-fda-to-review-snda-for-ibrance-inhibitor--quick-facts-20161221-00301,Pfizer: FDA To Review SNDA For IBRANCE Inhibitor - Quick Facts
PFE,PFE:US,BBG000BR2B91,BioInvent announces Cancer Immunotherapy Research Collaboration and License Agreement with Pfizer and issues new shares to Pfizer,2016-12-21 07:12:06 +0000,http://www.publicnow.com/view/EF6BBBBE01B50150EC1ED16679A07925AF5087EC,"[at noodls] - Pfizer makes a $6 million equity investment in new shares in BioInvent Lund, Sweden - 21 December 2016 - BioInvent International AB ('BioInvent') (OMXS: BINV), a biotech company focused on the discovery ..."
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb Expects Strong Revenue Growth in 2016,2016-12-20 22:31:27 +0000,http://marketrealist.com/2016/12/bristol-myers-squibb-expects-strong-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,Bristol-Myers Squibb Expects Strong Revenue Growth in 2016
PFE,PFE:US,BBG000BR2B91,3 Dividend Stocks to Put on Your Shopping List,2016-12-20 21:57:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3Z38Qwsd8Dw/3-dividend-stocks-to-put-on-your-shopping-list-cm724277,There s just something nice about stocks that pay you to own them Dividends make a huge difference in overall investing returns especially over long periods of time Few dividend stocks are are as attractive right now as AbbVie NYSE ABBV Pfizer NYSE PFE
PFE,PFE:US,BBG000BR2B91,"Cramer: I'm Already Sick of Dow 20,000, and We're Not Even There Yet",2016-12-20 21:10:00 +0000,http://realmoney.thestreet.com/articles/12/20/2016/cramer-im-already-sick-dow-20000-and-were-not-even-there-yet?puc=yahoo&cm_ven=YAHOO,"Cramer: I'm Already Sick of Dow 20,000, and We're Not Even There Yet"
PFE,PFE:US,BBG000BR2B91,3 Dividend Stocks to Put on Your Shopping List,2016-12-20 20:06:10 +0000,http://www.fool.com/investing/2016/12/20/3-dividend-stocks-to-put-on-your-shopping-list.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Dividend Stocks to Put on Your Shopping List
PFE,PFE:US,BBG000BR2B91,Sanofi's takeover talks with Actelion progressing - source,2016-12-20 19:18:14 +0000,http://sg.finance.yahoo.com/news/sanofis-takeover-talks-actelion-progressing-190159195.html,Sanofi's takeover talks with Actelion progressing - source
PFE,PFE:US,BBG000BR2B91,Gilead Sciences: How Bad is the Glaxo News?,2016-12-20 16:25:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/20/gilead-sciences-how-bad-is-the-glaxo-news/?mod=yahoobarrons&ru=yahoo,Gilead Sciences: How Bad is the Glaxo News?
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb Co (BMY) And Pfizer Inc. (PFE) Agree To $50 Million Loan To Portola Pharmaceuticals Inc (PTLA),2016-12-20 15:36:13 +0000,http://www.insidermonkey.com/blog/bristol-myers-squibb-co-bmy-and-pfizer-inc-pfe-agree-to-50-million-loan-to-portola-pharmaceuticals-inc-ptla-512239/,Bristol-Myers Squibb Co (BMY) And Pfizer Inc. (PFE) Agree To $50 Million Loan To Portola Pharmaceuticals Inc (PTLA)
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 12/20/2016: BMY, ACAD, JNJ, PFE, ABT, MRK, AMGN",2016-12-20 14:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FaAJRv6k-Kw/health-care-sector-update-for-12202016-bmy-acad-jnj-pfe-abt-mrk-amgn-cm723794,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 0 2 PFE 0 2 ABT flatABT flat MRK 0 2 MRK 0 2 AMGN 1 7 AMGN 1 7 Health care shares were mixed in pre market trade Tuesday Health care shares were mixed in pre market trade Tuesday In health care stocks
PFE,PFE:US,BBG000BR2B91,Draper to Build Preclinical Microphysiological Systems with Pfizer to Help Predict Clinical Outcomes,2016-12-20 12:00:00 +0000,http://finance.yahoo.com/news/draper-build-preclinical-microphysiological-systems-120000020.html,[Marketwired] - Draper today announces a three-year agreement with Pfizer Inc. under which the companies will collaborate to create unique versions of Draper's Microphysiological Systems technology with the aim of improving ...
PFE,PFE:US,BBG000BR2B91,Surprise! Clovis Oncology Nabs Early OK,2016-12-20 02:56:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z20T9RlN8yk/surprise-clovis-oncology-nabs-early-ok-cm723690,The FDA has given a green light to Clovis Oncology s NASDAQ CLVS ovarian cancer drug Rubraca Its approval offers new hope to ovarian cancer patients who have seen their disease progress despite prior treatment and it positions Clovis Oncology to compete against
PFE,PFE:US,BBG000BR2B91,"Close Update: Geopolitical Events Trim Early Gains; Dow Misses 20,000 For Fifth Day",2016-12-19 21:56:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fqDda3Vqi_c/close-update-geopolitical-events-trim-early-gains-dow-misses-20000-for-fifth-day-cm723609,Stocks closed modestly higher on Monday but off their session highs as geopolitical events spooked investors ahead of the holiday weekend The assassination of the Russian ambassador to Turkey followed by a vehicle attack on Berliners that killed nine people tugged the benchmark averages lower
PFE,PFE:US,BBG000BR2B91,"CLVS Gets FDA Nod, PBYI Leaves Big Board, LOXO Hits All-time High, CNAT On Watch",2016-12-19 20:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9I2-LeJFKKM/clvs-gets-fda-nod-pbyi-leaves-big-board-loxo-hits-alltime-high-cnat-on-watch-20161219-01000,"CLVS Gets FDA Nod, PBYI Leaves Big Board, LOXO Hits All-time High, CNAT On Watch"
PFE,PFE:US,BBG000BR2B91,Pfizer May Be Happy With Anacor,2016-12-19 19:59:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5xdNG6_wV-I/pfizer-may-be-happy-with-anacor-cm723532,It is no secret that 160 Pfizer 160 PFE has traditionally relied on acquisitions to a great extent to bolster its growth and drug pipeline The company acquired Hospira last year and this year completed the acquisition of Anacor and Medivation Additionally it attempted to merge
PFE,PFE:US,BBG000BR2B91,European Regulator Approves Pfizer Vaccine,2016-12-19 19:05:00 +0000,http://www.investopedia.com/news/european-regulator-approves-pfizer-vaccine-pfe/?partner=YahooSA,European Regulator Approves Pfizer Vaccine
PFE,PFE:US,BBG000BR2B91,Three Appealing Micro-Cap Stocks,2016-12-19 19:00:00 +0000,http://realmoney.thestreet.com/articles/12/19/2016/three-appealing-micro-cap-stocks?puc=yahoo&cm_ven=YAHOO,Three Appealing Micro-Cap Stocks
PFE,PFE:US,BBG000BR2B91,Midday Update: Stocks Hold Gains As Wall Street Waits For Reassurances From Yellen,2016-12-19 18:36:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w5J4NjSeD20/midday-update-stocks-hold-gains-as-wall-street-waits-for-reassurances-from-yellen-cm723485,The benchmark averages were holding onto modest gains midday Monday but are off their session highs following reports that the Russian ambassador to Turkey was killed in an attack tied to Russia s military involvement in the Syrian city of Aleppo The benchmark averages were holding onto
PFE,PFE:US,BBG000BR2B91,4 Stocks Insiders Are Loading Up On – and You Should Too,2016-12-19 17:58:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ht16CuG_i54/4-stocks-insiders-are-loading-up-on-and-you-should-too-cm723349,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips If you re cutting back on stocks because interest rates are rising you re making a mistake But don t just take my word for it after all I am a dyed in the wool dividend stock fan
PFE,PFE:US,BBG000BR2B91,Boom and Bust: The 2016 M&A Deals Report,2016-12-19 17:42:56 +0000,http://finance.yahoo.com/video/boom-bust-2016-m-deals-174256133.html,Boom and Bust: The 2016 M&A Deals Report
PFE,PFE:US,BBG000BR2B91,Portola Pharma Wins on Pfizer and Bristol-Myers Loan Agreement,2016-12-19 17:20:55 +0000,http://finance.yahoo.com/news/portola-pharma-wins-pfizer-bristol-172055438.html,Portola Pharma Wins on Pfizer and Bristol-Myers Loan Agreement
PFE,PFE:US,BBG000BR2B91,Merck Keytruda Gets CHMP Nod for First-Line Lung Cancer,2016-12-19 16:02:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tOrdc2H6TkI/merck-keytruda-gets-chmp-nod-for-first-line-lung-cancer-cm723243,Merck amp Co Inc MRK announced that its anti PD 1 therapy Keytruda was rendered a positive opinion in the EU for the first line treatment of metastatic lung cancer The European Medicines Agency s EMA Committee for Medicinal Products for Human Use CHMP recommended marketing
PFE,PFE:US,BBG000BR2B91,Pfizer Chantix Label Warning Lifted in U.S.; to Add New Data,2016-12-19 15:00:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tOqzHAb24EE/pfizer-chantix-label-warning-lifted-in-us-to-add-new-data-cm723249,Pfizer Inc PFE announced that the FDA has lifted a boxed warning about neuropsychiatric side effects from the label of its smoking cessation drug Chantix We remind investors that Chantix s label included a boxed warning regarding serious neuropsychiatric adverse events reported in
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Lilly Up on Guidance, Merck Awarded $2.54B in HCV Case",2016-12-19 13:58:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kl0cHeX8hw8/pharma-stock-roundup-lilly-up-on-guidance-merck-awarded-254b-in-hcv-case-cm723128,Lilly LLY provided better than expected guidance for 2017 leaving investors happy with the numbers Merck MRK also had some good news with a jury awarding the company 2 54 billion in its patent infringement case against Gilead Meanwhile drug pricing remains in the news with 20 states
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 12/19/2016: BCLI, JNJ, PFE, ABT, MRK, AMGN",2016-12-19 13:57:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mRfWCRMMR3g/health-care-sector-update-for-12192016-bcli-jnj-pfe-abt-mrk-amgn-cm723098,Top Health Care stocks Top Health Care stocks JNJ flatJNJ flat PFE 1 2 PFE 1 2 ABT 1 2 ABT 1 2 MRK 0 9 MRK 0 9 AMGN flatAMGN flat Health care shares were mixed in pre market trade Monday Health care shares were mixed in pre market trade Monday In health care stocks news
PFE,PFE:US,BBG000BR2B91,Pfizer Chantix Label Warning Lifted in U.S.; to Add New Data,2016-12-19 13:26:01 +0000,http://finance.yahoo.com/news/pfizer-chantix-label-warning-lifted-132601817.html,Pfizer Chantix Label Warning Lifted in U.S.; to Add New Data
PFE,PFE:US,BBG000BR2B91,Portola Pharmaceuticals Enters into $50 Million Loan Agreement with Bristol-Myers Squibb and Pfizer for Continued Development of AndexXa™ (andexanet alfa),2016-12-19 13:00:00 +0000,http://finance.yahoo.com/news/portola-pharmaceuticals-enters-50-million-130000639.html,"[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif., Dec. 19, 2016-- Portola Pharmaceuticals Inc. ® today announced it has signed a $50 million loan agreement with Bristol-Myers Squibb Company and Pfizer Inc. that provides additional ..."
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Lilly Up on Guidance, Merck Awarded $2.54B in HCV Case",2016-12-19 12:33:12 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-lilly-guidance-123312897.html,"Pharma Stock Roundup: Lilly Up on Guidance, Merck Awarded $2.54B in HCV Case"
PFE,PFE:US,BBG000BR2B91,"Pfizer Receives Approval in the European Union for Nimenrix™ (Meningococcal Group A, C, W-135, and Y Conjugate Vaccine) in Infants Six Weeks of Age and Older",2016-12-19 12:11:06 +0000,http://www.publicnow.com/view/0564C3BFE28F0D727111FBE2652818B36EA64453,"[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today the European Commission (EC) has approved an expanded indication for Nimenrix™ (meningococcal group A, C, W-135, and Y conjugate vaccine) ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Gets EU Nod For Nimenrix To Treat Invasive Meningococcal Disease,2016-12-19 07:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2CTiR6ys2VQ/pfizer-gets-eu-nod-for-nimenrix-to-treat-invasive-meningococcal-disease-20161219-00207,Pfizer Gets EU Nod For Nimenrix To Treat Invasive Meningococcal Disease
PFE,PFE:US,BBG000BR2B91,4 Must-Have Dividend-Growth Stocks For 2017,2016-12-17 14:23:00 +0000,http://www.forbes.com/sites/brettowens/2016/12/17/4-must-have-dividend-growth-stocks-for-2017/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,4 Must-Have Dividend-Growth Stocks For 2017
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: Boeing, GE Raise Dividends; ExxonMobil Gets New CEO",2016-12-16 21:57:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xqrjy_aeWvQ/dow-30-stock-roundup-boeing-ge-raise-dividends-exxonmobil-gets-new-ceo-cm722736,The Dow enjoyed a week of strong gains on rising expectations about the likely industry friendly policies of the Trump administration Economic data released this week continued to be largely positive in nature Meanwhile the Fed raised rates for the first time this year Though the move
PFE,PFE:US,BBG000BR2B91,"US drops bold warning from anti-smoking pills Chantix, Zyban",2016-12-16 21:56:56 +0000,http://sg.finance.yahoo.com/news/pfizer-says-us-drops-bold-194944573.html,"US drops bold warning from anti-smoking pills Chantix, Zyban"
PFE,PFE:US,BBG000BR2B91,Pfizer get OK to remove 'black box' warning on smoking cessation drug,2016-12-16 21:20:08 +0000,http://www.bizjournals.com/philadelphia/news/2016/12/16/pfizer-get-ok-to-remove-black-box-warning-on.html?ana=yahoo,Pfizer get OK to remove 'black box' warning on smoking cessation drug
PFE,PFE:US,BBG000BR2B91,[$$] FDA Drops Stringent Warning on Smoking-Cessation Drug Chantix,2016-12-16 20:28:17 +0000,http://www.wsj.com/articles/fda-drops-stringent-warning-on-smoking-cessation-drug-chantix-1481918026?mod=yahoo_hs,[$$] FDA Drops Stringent Warning on Smoking-Cessation Drug Chantix
PFE,PFE:US,BBG000BR2B91,White House Kills Plan for Drug Price Cap,2016-12-16 20:12:00 +0000,https://www.thestreet.com/story/13929151/1/white-house-kills-plan-for-drug-price-cap.html?puc=yahoo&cm_ven=YAHOO,White House Kills Plan for Drug Price Cap
PFE,PFE:US,BBG000BR2B91,FDA drops black box warning on Pfizer's anti-smoking drug,2016-12-16 19:26:35 +0000,http://finance.yahoo.com/news/fda-drops-black-box-warning-192635502.html,"[Reuters] - U.S. health regulators on Friday allowed Pfizer Inc to remove a serious warning from the label of its smoking cessation treatment, Chantix, giving a new lease of life to the controversial drug that was ..."
PFE,PFE:US,BBG000BR2B91,FDA Approves Removal Of Boxed Warning Regarding Serious Neuropsychiatric Events From CHANTIX® (varenicline) Labeling,2016-12-16 19:20:10 +0000,http://www.publicnow.com/view/C337E41573D154CB37EA21D0EFFCA57832711646,"[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer announced today that the U.S. Food and Drug Administration (FDA) approved updates to the CHANTIX (varenicline) labeling, including removal of the boxed warning regarding ..."
PFE,PFE:US,BBG000BR2B91,Actavis UK accused of overcharging hydrocortisone drug,2016-12-16 17:10:28 +0000,http://sg.finance.yahoo.com/news/actavis-uk-accused-overcharging-hydrocortisone-165335692.html,Actavis UK accused of overcharging hydrocortisone drug
PFE,PFE:US,BBG000BR2B91,The bizarre connection between Pfizer and the synthetic drug turning people into ‘zombies’,2016-12-16 16:28:00 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=0C4AC64A-C2D4-11E6-BB09-47C32D1B660C&siteid=yhoof2,The bizarre connection between Pfizer and the synthetic drug turning people into ‘zombies’
PFE,PFE:US,BBG000BR2B91,Correction to FDA Chantix Warning Story,2016-12-16 15:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tbUczRELrvU/correction-to-fda-chantix-warning-story-20161216-00612,Correction to FDA Chantix Warning Story
PFE,PFE:US,BBG000BR2B91,FDA Drops Stringent Warning on Smoking-Cessation Drug Chantix,2016-12-16 15:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Smc_WFAHLiQ/fda-drops-stringent-warning-on-smokingcessation-drug-chantix-20161216-00596,FDA Drops Stringent Warning on Smoking-Cessation Drug Chantix
PFE,PFE:US,BBG000BR2B91,Is This Gilead Sciences' Biggest Mistake in 2016?,2016-12-16 15:00:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y2wyVpchH_4/is-this-gilead-sciences-biggest-mistake-in-2016-cm722368,Enjoying windfall in revenue from its highly successful hepatitis C program in 2015 Gilead Sciences NASDAQ GILD decided to return money to investors via a dividend and share buybacks As a result the company s handed back billions of dollars to investors through the first
PFE,PFE:US,BBG000BR2B91,Stocks With the Potential to Propel Dow Beyond 20K,2016-12-16 14:03:00 +0000,https://www.thestreet.com/story/13928741/1/stocks-with-the-potential-to-propel-dow-beyond-20k.html?puc=yahoo&cm_ven=YAHOO,Stocks With the Potential to Propel Dow Beyond 20K
PFE,PFE:US,BBG000BR2B91,"Firm accused of overcharging NHS by hiking life-saving drug price by 12,000%",2016-12-16 13:35:00 +0000,http://uk.finance.yahoo.com/news/firm-accused-overcharging-nhs-hiking-074400573.html,"Firm accused of overcharging NHS by hiking life-saving drug price by 12,000%"
PFE,PFE:US,BBG000BR2B91,Mega stocks' mega potential,2016-12-16 13:04:00 +0000,http://finance.yahoo.com/video/mega-stocks-mega-potential-130400943.html,Mega stocks' mega potential
PFE,PFE:US,BBG000BR2B91,Is This Gilead Sciences' Biggest Mistake in 2016?,2016-12-16 13:03:13 +0000,http://www.fool.com/investing/2016/12/16/is-this-gilead-sciences-biggest-mistake-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is This Gilead Sciences' Biggest Mistake in 2016?
PFE,PFE:US,BBG000BR2B91,Big Pharma Face Off: Is Merck More Attractive than J&J?,2016-12-15 23:57:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hxdmlUydiwg/big-pharma-face-off-is-merck-more-attractive-than-jj-cm722243,The year has been fraught with challenges for the pharma biotech sector which has faced immense flak for steep drug prices Democratic presidential candidate Hillary Clinton had pledged to find ways to curb drug prices and lower prescription drug costs for all Americans Naturally with Trump
PFE,PFE:US,BBG000BR2B91,3 Top Big Pharma Stocks to Buy Now,2016-12-15 22:22:09 +0000,http://www.fool.com/investing/2016/12/15/3-top-big-pharma-stocks-to-buy-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Big Pharma Stocks to Buy Now
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 12/15/2016: ATHN,CBIO,PFE,PACB",2016-12-15 21:36:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GWZiQi6eGuk/health-care-sector-update-for-12152016-athncbiopfepacb-cm722187,Top Health Care StocksTop Health Care Stocks JNJ 0 62 JNJ 0 62 PFE 0 27 PFE 0 27 MRK 0 33 MRK 0 33 ABT 0 91 ABT 0 91 AMGN 1 03 AMGN 1 03 Health care stocks were moderately higher in late afternoon trade with the NYSE Health Care Index rising about 0 5 while shares of health
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 12/15/2016: FOLD,CBIO,PFE,PACB",2016-12-15 19:36:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U1O1ArTpQD4/health-care-sector-update-for-12152016-foldcbiopfepacb-cm722138,Top Health Care StocksTop Health Care Stocks Health care stocks were moderately higher in early afternoon trade with the NYSE Health Care Index rising about 0 4 while shares of health care companies in the S amp P 500 were up about 0 4 as a group Health care stocks were moderately higher
PFE,PFE:US,BBG000BR2B91,3 Top Big Pharma Stocks to Buy Now,2016-12-15 17:00:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yiSR7jBMlbs/3-top-big-pharma-stocks-to-buy-now-cm722000,A well rounded investment portfolio should arguably always include a couple of Big Pharma stocks These companies after all sport some of the highest profit margins and steady free cash flows and they often reward shareholder richly With this in mind I think investors may want
PFE,PFE:US,BBG000BR2B91,"VOO, PFE, BAC, KO: ETF Inflow Alert",2016-12-15 16:58:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wYhNAw717q8/voo-pfe-bac-ko-etf-inflow-alert-cm721961,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard S amp P 500 ETF Symbol VOO where we have detected an approximate 784 6 million dollar inflow that s a 1 4 increase week over week in outstanding
PFE,PFE:US,BBG000BR2B91,What Were Pfizer’s Major Achievements in 2016?,2016-12-15 15:05:28 +0000,http://marketrealist.com/2016/12/what-were-pfizers-major-achievements-in-2016/?utm_source=yahoo&utm_medium=feed,What Were Pfizer’s Major Achievements in 2016?
PFE,PFE:US,BBG000BR2B91,[$$] Drug Company Lonza to Buy Capsule Maker From KKR,2016-12-15 14:19:03 +0000,http://www.wsj.com/articles/lonza-agrees-to-buy-capsugel-from-kkr-in-multibillion-dollar-deal-1481782518?mod=yahoo_hs,[$$] Drug Company Lonza to Buy Capsule Maker From KKR
PFE,PFE:US,BBG000BR2B91,Pfizer Has Strong Track Record since 2010,2016-12-15 13:15:57 +0000,http://marketrealist.com/2016/12/pfizer-has-strong-track-record-since-2010/?utm_source=yahoo&utm_medium=feed,Pfizer Has Strong Track Record since 2010
PFE,PFE:US,BBG000BR2B91,What Do Analysts Recommend for Pfizer?,2016-12-15 13:05:32 +0000,http://marketrealist.com/2016/12/what-do-analysts-recommend-for-pfizer/?utm_source=yahoo&utm_medium=feed,What Do Analysts Recommend for Pfizer?
PFE,PFE:US,BBG000BR2B91,Trending: Transportation and Steel Industries Prepare for Trumponomics,2016-12-15 13:00:00 +0000,http://finance.yahoo.com/news/trending-transportation-steel-industries-prepare-130000236.html,Trending: Transportation and Steel Industries Prepare for Trumponomics
PFE,PFE:US,BBG000BR2B91,Pfizer: FDA Approves Eczema Ointment; Xtandi Fails Study,2016-12-15 12:58:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dLr7fK1IuNo/pfizer-fda-approves-eczema-ointment-xtandi-fails-study-cm721732,Pfizer Inc PFE announced that it received FDA approval for crisaborole topical ointment to treat mild to moderate eczema or atopic dermatitis in patients two years and older The ointment will be sold under the brand name Eucrisa Pfizer shares have risen 2 1 this month so far lower
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson Looks for New Deal That's Just Right,2016-12-15 12:30:00 +0000,https://www.thestreet.com/story/13926493/1/johnson-amp-johnson-looks-for-new-deal-that-s-just-right.html?puc=yahoo&cm_ven=YAHOO,Johnson & Johnson Looks for New Deal That's Just Right
PFE,PFE:US,BBG000BR2B91,Pfizer: FDA Approves Eczema Ointment; Xtandi Fails Study,2016-12-15 11:16:11 +0000,http://finance.yahoo.com/news/pfizer-fda-approves-eczema-ointment-111611232.html,Pfizer: FDA Approves Eczema Ointment; Xtandi Fails Study
PFE,PFE:US,BBG000BR2B91,Drugmakers set to gain as taxpayers foot new opioid costs,2016-12-15 11:10:23 +0000,http://finance.yahoo.com/news/drugmakers-set-gain-taxpayers-foot-opioid-costs-094755518.html,Drugmakers set to gain as taxpayers foot new opioid costs
PFE,PFE:US,BBG000BR2B91,Drugmakers set to gain as taxpayers foot new opioid costs,2016-12-15 11:10:22 +0000,http://sg.finance.yahoo.com/news/drugmakers-set-gain-taxpayers-foot-111022865.html,Drugmakers set to gain as taxpayers foot new opioid costs
PFE,PFE:US,BBG000BR2B91,"Drugmakers push profitable, but unproven, opioid solution",2016-12-15 11:06:52 +0000,http://finance.yahoo.com/news/drugmakers-push-profitable-unproven-opioid-solution-093334227.html,"Drugmakers push profitable, but unproven, opioid solution"
PFE,PFE:US,BBG000BR2B91,"Drugmakers push profitable, but unproven, opioid solution",2016-12-15 11:06:42 +0000,http://sg.finance.yahoo.com/news/drugmakers-push-profitable-unproven-opioid-095402647.html,"Drugmakers push profitable, but unproven, opioid solution"
PFE,PFE:US,BBG000BR2B91,Lonza to Buy Capsugel from KKR in Multibillion-Dollar Deal-- 2nd Update,2016-12-15 09:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3w_wijYOMjk/lonza-to-buy-capsugel-from-kkr-in-multibilliondollar-deal-2nd-update-20161215-00596,Lonza to Buy Capsugel from KKR in Multibillion-Dollar Deal-- 2nd Update
PFE,PFE:US,BBG000BR2B91,"CORRECTING and REPLACING Pfizer Receives FDA Approval for EUCRISA™ (crisaborole), a Novel Non-Steroidal Topical Ointment for Mild to Moderate Atopic Dermatitis (Eczema)",2016-12-15 02:15:00 +0000,http://finance.yahoo.com/news/pfizer-receives-fda-approval-eucrisatm-003400926.html,[Business Wire] - Please replace the release with the following corrected version due to multiple revisions.
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. Merck,2016-12-14 22:57:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9KtyN3bZQDE/better-buy-pfizer-inc-vs-merck-cm721588,This year is turning out quite differently for two of the biggest pharmaceutical companies Pfizer s NYSE PFE stock is barely above where it started at the beginning of 2016 Merck s NYSE MRK shares though are up nearly 20 for the year But which of these two drug stocks
PFE,PFE:US,BBG000BR2B91,Pfizer's Xtandi fails in progression trial vs J&J's Zytiga,2016-12-14 22:22:32 +0000,http://finance.yahoo.com/news/pfizers-xtandi-fails-progression-trial-222232924.html,"[Reuters] - A late-stage trial found that continuing treatment with Pfizer Inc's cancer drug Xtandi in addition to a regimen of Zytiga and a steroid worked no better than the two other drugs alone in patients with advanced prostate cancer whose disease had worsened, the company said on Wednesday. Zytiga, or abiraterone acetate, is sold by Johnson & Johnson . Xtandi, currently approved in the United States for patients with advanced prostate cancer that has spread, is sold by Pfizer in partnership Astellas Pharma Inc."
PFE,PFE:US,BBG000BR2B91,FDA approves Pfizer ointment for chronic itchy skin condition,2016-12-14 22:07:59 +0000,http://finance.yahoo.com/news/fda-approves-pfizer-ointment-itchy-190355622.html,"[Reuters] - A Pfizer Inc ointment to treat mild to moderate cases of the itchy skin condition eczema, or atopic dermatitis, won U.S. approval for use in patients aged two years and older, the Food and Drug Administration said on Wednesday. Atopic dermatitis, a chronic inflammatory skin disease, is the most common of the many types of eczema, typically beginning in childhood and possibly lasting through adulthood. The topical drug, crisaborole, will be sold under the brand name Eucrisa, the FDA said."
PFE,PFE:US,BBG000BR2B91,Will Buyback ETFs Gain Big on Overseas Cash Repatriation?,2016-12-14 21:57:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1JcL_Q7CGpw/will-buyback-etfs-gain-big-on-overseas-cash-repatriation-cm721542,The performance of Buyback ETFs has been lackluster in 2016 owing to subdued buyback activity in the year As per a TrimTabs report stock buyback announcements fell to a nine quarter low of 115 billion in the third quarter of 2016 and the figure 160 would have been much lower
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Dec 14, 2016 :  V, ORCL, MDLZ, QQQ, SYF, ITUB, WFC, PFE, MSFT, INTC, MENT, QCOM",2016-12-14 21:56:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ia5fwv6TS8Y/after-hours-most-active-for-dec-14-2016-v-orcl-mdlz-qqq-syf-itub-wfc-pfe-msft-intc-ment-qcom-cm721571,The NASDAQ 100 After Hours Indicator is up 12 1 to 4 933 32 The total After hours volume is currently 38 501 075 shares traded The following are the most active stocks for the after hours session Visa Inc V is 0 5163 at 79 65 with 6 877 793 shares traded As
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. Merck,2016-12-14 21:49:53 +0000,http://www.fool.com/investing/2016/12/14/better-buy-pfizer-inc-vs-merck.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Pfizer Inc. vs. Merck
PFE,PFE:US,BBG000BR2B91,Sheridan Memorial Hospital First to Implement Interoperable Alarm Technology Between Cerner and Hospira,2016-12-14 21:30:00 +0000,http://finance.yahoo.com/news/sheridan-memorial-hospital-first-implement-213000839.html,"[GlobeNewswire] - KANSAS CITY, Mo., Dec. 14, 2016-- Cerner, a global leader in health care technology, and Hospira, a Pfizer company and leading provider of infusion technologies, today announced that Sheridan Memorial ..."
PFE,PFE:US,BBG000BR2B91,Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI® (enzalutamide) Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer,2016-12-14 21:15:00 +0000,http://au.finance.yahoo.com/news/pfizer-astellas-announce-top-line-211500002.html,"[Business Wire] - NEW YORK & TOKYO--(BUSINESSWIRE)-- Pfizer Inc. (NYSE:PFE - News) and Astellas Pharma Inc. (TSE:4503) today announced the Phase 4 PLATO study, evaluating the efficacy and safety of continued treatment with XTANDI® (enzalutamide), plus abiraterone acetate and prednisone as compared to treatment with abiraterone acetate and prednisone alone, did not meet its primary endpoint of improvement in progression-free survival (PFS) in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer (CRPC) whose prostate-specific antigen (PSA) has previously progressed on XTANDI. “While the PLATO trial did not meet its primary endpoint, it is critical that we continue to focus on addressing the unmet needs of men with metastatic CRPC, who have a poor prognosis despite treatment advances,” said Mohammad Hirmand, M.D., interim chief medical officer at Medivation, Inc., which is now part of Pfizer."
PFE,PFE:US,BBG000BR2B91,FDA Approves Pfizer's Eucrisa For Eczema,2016-12-14 20:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rjrZzbpDBaI/fda-approves-pfizers-eucrisa-for-eczema-20161214-01106,FDA Approves Pfizer's Eucrisa For Eczema
PFE,PFE:US,BBG000BR2B91,Eli Lilly In 2017: Boom Or Bust?,2016-12-14 18:50:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/14/eli-lilly-in-2017-boom-or-bust/?mod=yahoobarrons&ru=yahoo,Eli Lilly In 2017: Boom Or Bust?
PFE,PFE:US,BBG000BR2B91,FDA approves Pfizer's eczema ointment,2016-12-14 18:25:40 +0000,http://finance.yahoo.com/news/fda-approves-pfizers-eczema-ointment-182540373.html,"[Reuters] - The U.S. Food and Drug Administration said on Wednesday it had approved Pfizer Inc's Eucrisa ointment to treat mild-to-moderate eczema, or atopic dermatitis, in patients two years and older. Atopic dermatitis ..."
PFE,PFE:US,BBG000BR2B91,"How to Trade Wednesday's Most Active Stocks -- Wells Fargo, Apple and More",2016-12-14 17:20:00 +0000,https://www.thestreet.com/story/13925865/1/how-to-trade-wednesday-s-most-active-stocks-wells-fargo-apple-and-more.html?puc=yahoo&cm_ven=YAHOO,"How to Trade Wednesday's Most Active Stocks -- Wells Fargo, Apple and More"
PFE,PFE:US,BBG000BR2B91,"Dow Movers: BA, MRK",2016-12-14 16:57:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zK5KfLh6in4/dow-movers-ba-mrk-cm721372,In early trading on Wednesday shares of Merck amp Co MRK topped the list of the day s best performing Dow Jones Industrial Average components trading up 1 4 Year to date Merck amp Co registers a 18 6 gain And the worst performing Dow component thus far on the day is
PFE,PFE:US,BBG000BR2B91,Actelion talking to Sanofi after J&J exit,2016-12-14 16:54:46 +0000,http://sg.finance.yahoo.com/news/j-j-ends-takeover-talks-001756229.html,Actelion talking to Sanofi after J&J exit
PFE,PFE:US,BBG000BR2B91,How Much Could Pfizer Grow beyond 2016?,2016-12-14 16:05:37 +0000,http://marketrealist.com/2016/12/how-much-could-pfizer-grow-beyond-2016/?utm_source=yahoo&utm_medium=feed,How Much Could Pfizer Grow beyond 2016?
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. – Value Analysis (NYSE:PFE) : December 14, 2016",2016-12-14 16:05:05 +0000,http://www.capitalcube.com/blog/index.php/pfizer-inc-value-analysis-nysepfe-december-14-2016/,"Pfizer Inc. – Value Analysis (NYSE:PFE) : December 14, 2016"
PFE,PFE:US,BBG000BR2B91,Blockchain Technology Can Help Reduce Flow Of Counterfeit Drugs,2016-12-14 16:03:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0vO34HgMIso/blockchain-technology-can-help-reduce-flow-of-counterfeit-drugs-cm721230,"Biotech (Shutterstock photo)    The global pharmaceutical industry is faced with a thriving counterfeit drugs market, a source of unfair competition that harms innovative and generic industries, and most importantly, puts millions of lives at risk. Despite strict enforcement efforts and policies, the problem of"
PFE,PFE:US,BBG000BR2B91,J&J (JNJ) Ends Deal Talks with Actelion: Will Sanofi Gain?,2016-12-14 15:01:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2ySFWZYSBeo/jj-jnj-ends-deal-talks-with-actelion-will-sanofi-gain-cm721177,On Tuesday Johnson amp Johnson JNJ announced that it has ended talks regarding a possible transaction with Swiss biotechnology company Actelion Ltd ALIOF reportedly for a disagreement over the purchase price Last month J amp J confirmed that it had approached Actelion with a
PFE,PFE:US,BBG000BR2B91,Lyrica to Lose Patent Protection in the US in 2018,2016-12-14 14:35:36 +0000,http://marketrealist.com/2016/12/lyrica-to-lose-patent-protection-in-the-us-in-2018/?utm_source=yahoo&utm_medium=feed,Lyrica to Lose Patent Protection in the US in 2018
PFE,PFE:US,BBG000BR2B91,Loss of Patent Protection to Drag Pfizer’s Top Line,2016-12-14 13:05:41 +0000,http://marketrealist.com/2016/12/loss-of-patent-protection-to-drag-pfizers-top-line/?utm_source=yahoo&utm_medium=feed,Loss of Patent Protection to Drag Pfizer’s Top Line
PFE,PFE:US,BBG000BR2B91,Asian stocks mostly higher ahead of Fed's rate decision,2016-12-14 04:01:12 +0000,http://sg.finance.yahoo.com/news/stock-indexes-open-record-highs-150950417.html,Asian stocks mostly higher ahead of Fed's rate decision
PFE,PFE:US,BBG000BR2B91,US Market Indexes Mixed on Monday,2016-12-13 18:56:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m0oqRnqAc4c/us-market-indexes-mixed-on-monday-cm720909,U S market indexes were mixed on Monday with the Dow Jones reaching a new high For the day the Dow Jones Industrial Average closed at 9796 4 for a gain of 9 58 points or The S amp P 5 closed at 56 96 for a loss of 57 points or The Nasdaq Composite closed at 54 54 for
PFE,PFE:US,BBG000BR2B91,Ab Initio Announces Strategic Collaboration with Pfizer to Discover GPCR Activating Antibodies,2016-12-13 18:03:00 +0000,http://finance.yahoo.com/news/ab-initio-announces-strategic-collaboration-180300971.html,"[Business Wire] - Ab Initio Biotherapeutics, Inc., today announced a collaborative research and license agreement with Pfizer Inc. that aims to discover novel therapeutic antibodies against an undisclosed target in the G-protein coupled receptor superfamily."
PFE,PFE:US,BBG000BR2B91,Pfizer Just Channeled Its Inner Martin Shkreli (and Paid for It),2016-12-13 17:22:04 +0000,http://www.fool.com/investing/2016/12/13/pfizer-just-channeled-its-inner-martin-shkreli-and.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Pfizer Just Channeled Its Inner Martin Shkreli (and Paid for It)
PFE,PFE:US,BBG000BR2B91,Pfizer Just Channeled Its Inner Martin Shkreli (and Paid for It),2016-12-13 17:00:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-3mrpGBbiuI/pfizer-just-channeled-its-inner-martin-shkreli-and-paid-for-it-cm720855,Image source Getty Images This is a point that probably doesn t need to be stated but prescription drug prices are generally expensive and they re seemingly growing pricier by the day 160 particularly if we re talking about branded or specialty drugs Drug developers are
PFE,PFE:US,BBG000BR2B91,3 Tempting Stocks to Avoid,2016-12-13 16:58:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9uQqUHwl6Ts/3-tempting-stocks-to-avoid-cm720839,It is remarkable how much long term advantage people like us have gotten by trying to be consistently not stupid instead of trying to be very intelligent Charlie Munger There are a lot of stocks out there that look to be tempting investments Perhaps there is some sort
PFE,PFE:US,BBG000BR2B91,How Did Pfizer’s Essential Health Business Perform in 3Q16?,2016-12-13 16:05:57 +0000,http://marketrealist.com/2016/12/how-did-pfizers-essential-health-business-perform-in-3q16/?utm_source=yahoo&utm_medium=feed,How Did Pfizer’s Essential Health Business Perform in 3Q16?
PFE,PFE:US,BBG000BR2B91,Pfizer Raises Dividend; Now Yields Near 4%,2016-12-13 15:11:00 +0000,http://blogs.barrons.com/incomeinvesting/2016/12/13/pfizer-raises-dividend-now-yields-near-4/?mod=yahoobarrons&ru=yahoo,Pfizer Raises Dividend; Now Yields Near 4%
PFE,PFE:US,BBG000BR2B91,Exploring Avelumab’s Opportunities in the PD-1/PD-L1 Space,2016-12-13 14:36:01 +0000,http://marketrealist.com/2016/12/exploring-avelumabs-opportunities-in-the-pd-1pd-l1-space/?utm_source=yahoo&utm_medium=feed,Exploring Avelumab’s Opportunities in the PD-1/PD-L1 Space
PFE,PFE:US,BBG000BR2B91,"China’s Go-Go Momentum Is Pointing to Momo, Inc. (ADR) Stock",2016-12-13 13:56:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ObL4m-aPRh8/chinas-go-go-momentum-is-pointing-to-momo-inc-adr-stock-cm720533,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The momentum isn t back just yet in Momo Inc ADR NASDAQ MOMO Reasons for traders to pick up shares of MOMO however are building And for bulls seeking a stronger
PFE,PFE:US,BBG000BR2B91,Avelumab: The First US Treatment for Metastatic Skin Cancer?,2016-12-13 13:06:09 +0000,http://marketrealist.com/2016/12/avelumab-the-first-us-treatment-for-metastatic-skin-cancer/?utm_source=yahoo&utm_medium=feed,Avelumab: The First US Treatment for Metastatic Skin Cancer?
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. breached its 50 day moving average in a Bullish Manner : PFE-US : December 13, 2016",2016-12-13 12:18:48 +0000,http://www.capitalcube.com/blog/index.php/pfizer-inc-breached-its-50-day-moving-average-in-a-bullish-manner-pfe-us-december-13-2016/,"Pfizer Inc. breached its 50 day moving average in a Bullish Manner : PFE-US : December 13, 2016"
PFE,PFE:US,BBG000BR2B91,Monday's ETF with Unusual Volume: SPYG,2016-12-12 21:56:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N6XK6TTVNH0/mondays-etf-with-unusual-volume-spyg-cm720368,The SPDR S amp P 500 Growth ETF SPYG is seeing unusually high volume in afternoon trading Monday with over 592 000 shares traded versus three month average volume of about 35 000 Shares of SPYG were off about 0 2 on the day Components of that ETF with the highest volume on
PFE,PFE:US,BBG000BR2B91,"Close Update: S&P, Nasdaq Halt Winning Streak But Dow Floats to Record High",2016-12-12 21:56:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CbT9sitE2Ls/close-update-sp-nasdaq-halt-winning-streak-but-dow-floats-to-record-high-cm720388,The S amp P 500 and the Nasdaq Composite halted six day stretches of gains as financial and consumer discretionary stocks gave back ground while a surge in oil prices kept the Dow Jones Industrial Average in the green as it closed at another record high The S P 500 and the Nasdaq Composite
PFE,PFE:US,BBG000BR2B91,"Daily Dividend Report: PFE, MORN, STJ, AWK, XHR",2016-12-12 21:56:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v5belYURQbU/daily-dividend-report-pfe-morn-stj-awk-xhr-cm720363,Pfizer declared a 32 cent first quarter 2017 dividend on the company s common stock payable March 1 2017 to shareholders of record at the close of business on February 3 2017 Pfizer increased the dividend by approximately 7 percent to 32 cents from 30 cents per share Morningstar
PFE,PFE:US,BBG000BR2B91,This Isn't a Bearish Pause in the Market,2016-12-12 21:25:00 +0000,http://realmoney.thestreet.com/articles/12/12/2016/isnt-bearish-pause-market?puc=yahoo&cm_ven=YAHOO,This Isn't a Bearish Pause in the Market
PFE,PFE:US,BBG000BR2B91,"J&J, Wal-Mart Lift Dow Higher Monday",2016-12-12 21:01:42 +0000,http://finance.yahoo.com/news/j-j-wal-mart-lift-210142117.html,"J&J, Wal-Mart Lift Dow Higher Monday"
PFE,PFE:US,BBG000BR2B91,Regeneron Pharmaceuticals Inc (REGN) Stock Gains on Opthotech’s Loss,2016-12-12 19:56:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IcBZj96v3MI/regeneron-pharmaceuticals-inc-regn-stock-gains-on-opthotechs-loss-cm720316,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips It has been a horrible year for biotechs with the iShares NASDAQ Biotechnology Index ETF NASDAQ IBB down 21 but 160 Ophthotech Corp s
PFE,PFE:US,BBG000BR2B91,3 Big Risks for Johnson & Johnson in 2017,2016-12-12 18:57:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fzX2bus3k4Y/3-big-risks-for-johnson-johnson-in-2017-cm720242,Johnson amp Johnson NYSE JNJ shareholders can t complain too much about the stock s performance in 2016 However there s certainly room for improvement when a member of the S amp P 500 SNPINDEX GSPC 160 trails the broader index s results as J amp J did this
PFE,PFE:US,BBG000BR2B91,3 Big Risks for Johnson & Johnson in 2017,2016-12-12 17:50:17 +0000,http://www.fool.com/investing/2016/12/12/3-big-risks-for-johnson-johnson-in-2017.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Big Risks for Johnson & Johnson in 2017
PFE,PFE:US,BBG000BR2B91,"Pfizer's Dividend Rate Hike 'More Important' Than a Trump Tweet, Analyst Says",2016-12-12 17:35:00 +0000,https://www.thestreet.com/story/13922468/1/pfizer-s-dividend-rate-hike-more-important-than-a-trump-tweet-analyst-says.html?puc=yahoo&cm_ven=YAHOO,"Pfizer's Dividend Rate Hike 'More Important' Than a Trump Tweet, Analyst Says"
PFE,PFE:US,BBG000BR2B91,Pfizer raises dividend 7%; stock surges,2016-12-12 17:03:23 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=52B49C6C-97D8-416F-A277-55323A440B2B&siteid=yhoof2,Pfizer raises dividend 7%; stock surges
PFE,PFE:US,BBG000BR2B91,"Value Battle: Pfizer Inc. (PFE) vs. Merck & Co., Inc. (MRK)",2016-12-12 16:57:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0WNm1Eg5Q6I/value-battle-pfizer-inc-pfe-vs-merck-co-inc-mrk-cm720205,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips James Montier is one of the premier value investors of our times His 2009 book Value Investing Tools and Techniques for Intelligent Investment is a must for anyone serious about this style
PFE,PFE:US,BBG000BR2B91,Pfizer Declares First-Quarter 2017 Dividend,2016-12-12 16:53:00 +0000,http://finance.yahoo.com/news/pfizer-declares-first-quarter-2017-165300910.html,"[Business Wire] - The board of directors of Pfizer Inc. today declared a 32-cent first-quarter 2017 dividend on the company’s common stock, payable March 1, 2017, to shareholders of record at the close of business on February 3, 2017."
PFE,PFE:US,BBG000BR2B91,Meet the Preliminary 2017 Dogs of the Dow for Massive Dividends,2016-12-12 16:10:07 +0000,http://247wallst.com/investing/2016/12/12/meet-the-preliminary-2017-dogs-of-the-dow-for-massive-dividends/,Meet the Preliminary 2017 Dogs of the Dow for Massive Dividends
PFE,PFE:US,BBG000BR2B91,How Could Pfizer Drive Growth for Ibrance?,2016-12-12 16:06:08 +0000,http://marketrealist.com/2016/12/how-could-pfizer-drive-growth-for-ibrance/?utm_source=yahoo&utm_medium=feed,How Could Pfizer Drive Growth for Ibrance?
PFE,PFE:US,BBG000BR2B91,Lilly/AstraZeneca Expand Alzheimer Disease Collaboration,2016-12-12 16:00:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ot5Bf4-IUi4/lillyastrazeneca-expand-alzheimer-disease-collaboration-cm719999,Eli Lilly and Company LLY and AstraZeneca plc AZN expanded their existing collaboration to develop the second treatment for Alzheimer s disease MEDI1814 Incidentally failure of Lilly s high profile investigational Alzheimer disease candidate solanezumab hurt the company s share price
PFE,PFE:US,BBG000BR2B91,Analysts Expect IWY To Hit $63,2016-12-12 15:56:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AjzTPhLvrUg/analysts-expect-iwy-to-hit-63-cm720006,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
PFE,PFE:US,BBG000BR2B91,Ibrance Is the Only Registered CDK 4/6 Inhibitor for Breast Cancer,2016-12-12 14:36:34 +0000,http://marketrealist.com/2016/12/ibrance-is-the-only-registered-cdk-46-inhibitor-for-breast-cancer/?utm_source=yahoo&utm_medium=feed,Ibrance Is the Only Registered CDK 4/6 Inhibitor for Breast Cancer
PFE,PFE:US,BBG000BR2B91,Lilly/AstraZeneca Expand Alzheimer Disease Collaboration,2016-12-12 14:19:02 +0000,http://finance.yahoo.com/news/lilly-astrazeneca-expand-alzheimer-disease-141902194.html,Lilly/AstraZeneca Expand Alzheimer Disease Collaboration
PFE,PFE:US,BBG000BR2B91,Short Sellers Back Way Off Major Pharma Stocks,2016-12-12 13:44:06 +0000,http://247wallst.com/healthcare-business/2016/12/12/short-sellers-back-way-off-major-pharma-stocks/,Short Sellers Back Way Off Major Pharma Stocks
PFE,PFE:US,BBG000BR2B91,How Did Pfizer’s Innovative Health Business Perform in 3Q16?,2016-12-12 13:06:15 +0000,http://marketrealist.com/2016/12/how-did-pfizers-innovative-health-business-perform-in-3q16/?utm_source=yahoo&utm_medium=feed,How Did Pfizer’s Innovative Health Business Perform in 3Q16?
PFE,PFE:US,BBG000BR2B91,My Biggest Investing Regret of 2016,2016-12-12 11:49:40 +0000,http://www.fool.com/investing/2016/12/11/my-biggest-investing-regret-of-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,My Biggest Investing Regret of 2016
PFE,PFE:US,BBG000BR2B91,Lonza Group Confirms Interest In Capsugel,2016-12-12 09:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xbl_W-So978/lonza-group-confirms-interest-in-capsugel-20161212-00518,Lonza Group Confirms Interest In Capsugel
PFE,PFE:US,BBG000BR2B91,Pfizer To Collaborate On IGNITE's Research Program On Novel Vaccinia Viruses,2016-12-12 08:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EEQ23XHufWQ/pfizer-to-collaborate-on-ignites-research-program-on-novel-vaccinia-viruses-20161212-00345,Pfizer To Collaborate On IGNITE's Research Program On Novel Vaccinia Viruses
PFE,PFE:US,BBG000BR2B91,[$$] Lonza Nears Deal to Buy KKR’s Capsugel,2016-12-12 04:22:01 +0000,http://www.wsj.com/articles/lonza-nears-deal-to-buy-kkrs-capsugel-1481499732?ru=yahoo?mod=yahoo_itp,[$$] Lonza Nears Deal to Buy KKR’s Capsugel
PFE,PFE:US,BBG000BR2B91,Lonza Confirms Talks to Buy Capsugel,2016-12-12 04:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SvP74UY7L2s/lonza-confirms-talks-to-buy-capsugel-20161212-00078,Lonza Confirms Talks to Buy Capsugel
PFE,PFE:US,BBG000BR2B91,Lonza Confirms Talks to Buy Capsugel From KKR,2016-12-12 04:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zv0oD28wHLU/lonza-confirms-talks-to-buy-capsugel-from-kkr-20161212-00095,Lonza Confirms Talks to Buy Capsugel From KKR
PFE,PFE:US,BBG000BR2B91,Asian stocks mixed ahead of Fed rates decision; oil soars,2016-12-12 04:09:05 +0000,http://sg.finance.yahoo.com/news/asian-stocks-mixed-ahead-fed-035605833.html,Asian stocks mixed ahead of Fed rates decision; oil soars
PFE,PFE:US,BBG000BR2B91,[$$] Lonza Nears Deal to Buy KKR's Capsugel,2016-12-12 03:47:34 +0000,http://www.wsj.com/articles/lonza-nears-deal-to-buy-kkrs-capsugel-1481499732?mod=yahoo_hs,[$$] Lonza Nears Deal to Buy KKR's Capsugel
PFE,PFE:US,BBG000BR2B91,KKR Closes In on $5 Billion Deal -- WSJ,2016-12-12 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QjaS2EZfPoU/kkr-closes-in-on-5-billion-deal--wsj-20161212-00055,KKR Closes In on $5 Billion Deal -- WSJ
PFE,PFE:US,BBG000BR2B91,KKR Reportedly Nears Deal To Sell Capsugel To Lonza Group For More Than $5 Bln,2016-12-11 23:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IO49f1w9BQA/kkr-reportedly-nears-deal-to-sell-capsugel-to-lonza-group-for-more-than-5-bln-20161211-00081,KKR Reportedly Nears Deal To Sell Capsugel To Lonza Group For More Than $5 Bln
PFE,PFE:US,BBG000BR2B91,"Lonza Nears Deal to Buy KKR's Capsugel for More Than $5 Billion, Sources Say -- Update",2016-12-11 23:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xtq91iS0pjg/lonza-nears-deal-to-buy-kkrs-capsugel-for-more-than-5-billion-sources-say--update-20161211-00063,"Lonza Nears Deal to Buy KKR's Capsugel for More Than $5 Billion, Sources Say -- Update"
PFE,PFE:US,BBG000BR2B91,Lonza Nears Deal to Buy KKR's Capsugel,2016-12-11 19:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yDIS7DLAdt0/lonza-nears-deal-to-buy-kkrs-capsugel-20161211-00064,Lonza Nears Deal to Buy KKR's Capsugel
PFE,PFE:US,BBG000BR2B91,Lonza Nears Deal to Buy KKR's Capsugel for More Than $5 Billion -- Sources,2016-12-11 18:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/noOnjl8ELDI/lonza-nears-deal-to-buy-kkrs-capsugel-for-more-than-5-billion--sources-20161211-00037,Lonza Nears Deal to Buy KKR's Capsugel for More Than $5 Billion -- Sources
PFE,PFE:US,BBG000BR2B91,"Just 4 DJIA Stocks Trading Down This Year: Nike, Coke, Pfizer, Disneydow",2016-12-11 14:18:28 +0000,http://finance.yahoo.com/news/just-4-djia-stocks-trading-141828449.html,"Just 4 DJIA Stocks Trading Down This Year: Nike, Coke, Pfizer, Disneydow"
PFE,PFE:US,BBG000BR2B91,My Biggest Investing Regret of 2016,2016-12-11 13:56:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DMJ3aDO8CZ8/my-biggest-investing-regret-of-2016-cm719814,In buying businesses I ve made some terrible mistakes both of commission and omission Warren Buffett 2003 letter to shareholders Even the smartest investors make mistakes We Fools are certainly no exception While we try our hardest to make the best
PFE,PFE:US,BBG000BR2B91,Should Big Pharma Be Worried About a Trump Trade War?,2016-12-11 11:50:12 +0000,http://www.fool.com/investing/2016/12/10/should-big-pharma-be-worried-about-a-trump-trade-w.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Should Big Pharma Be Worried About a Trump Trade War?
PFE,PFE:US,BBG000BR2B91,Pfizer likely to announce dividend increase,2016-12-10 13:06:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gb7gfRxj5b8/pfizer-likely-to-announce-dividend-increase-cm719713,What s Happening Drug maker Pfizer PFE is likely to announce a dividend increase this week The stock trended lower in the months ahead of the presidential election but rallied a bit after Trump s unexpected victory The stock has lost of its post election gains and is currently down 1
PFE,PFE:US,BBG000BR2B91,Should Big Pharma Be Worried About a Trump Trade War?,2016-12-10 12:55:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wpUGMMDSRaI/should-big-pharma-be-worried-about-a-trump-trade-war-cm719705,With one phone call with the leader of Taiwan and several tweets President elect Donald Trump has stirred concerns about a potential trade war between the U S and China It s not just industrial and consumer products companies that could be impacted if the two countries
PFE,PFE:US,BBG000BR2B91,Dow Jones Industrial Average Ends Week With Record Win; S&P Nabs Best Win Streak Since '14,2016-12-09 22:56:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OgA_4O4Lgfg/dow-jones-industrial-average-ends-week-with-record-win-sp-nabs-best-win-streak-since-14-cm719634,The 160 Dow Jones Industrial Average DJIA 160 climbed steadily throughout the day notching a fresh record high and a fifth straight daily and weekly win The 160 S amp P 500 Index SPX 160 and 160 Nasdaq Composite COMP 160 followed suit stretching their daily win
PFE,PFE:US,BBG000BR2B91,US Market Indexes End the Week Higher,2016-12-09 21:57:17 +0000,http://finance.yahoo.com/news/us-market-indexes-end-week-215717174.html,US Market Indexes End the Week Higher
PFE,PFE:US,BBG000BR2B91,Markets Right Now: Stocks extend rally to new highs,2016-12-09 21:06:45 +0000,http://sg.finance.yahoo.com/news/markets-now-us-indexes-open-144059446.html,Markets Right Now: Stocks extend rally to new highs
PFE,PFE:US,BBG000BR2B91,Stocks poised for records as S&P 500 on pace for longest streak since 2014,2016-12-09 20:07:54 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=F03CFA06-BDF4-11E6-A55C-7986D69D84E4&siteid=yhoof2,Stocks poised for records as S&P 500 on pace for longest streak since 2014
PFE,PFE:US,BBG000BR2B91,"Stock Market Indexes Rally To New Highs; Apple, Microsoft Boost Dow",2016-12-09 20:00:43 +0000,http://www.investors.com/market-trend/stock-market-today/stock-market-indexes-rally-to-new-highs-apple-microsoft-boost-dow/,"Stock Market Indexes Rally To New Highs; Apple, Microsoft Boost Dow"
PFE,PFE:US,BBG000BR2B91,Pfizer Up Along with Other Healthcare Stocks,2016-12-09 19:46:00 +0000,http://www.investopedia.com/news/pfe-bounces-it-just-dead-cat-pfe-xlv/?partner=YahooSA,Pfizer Up Along with Other Healthcare Stocks
PFE,PFE:US,BBG000BR2B91,Pfizer’s Eighth Consecutive Quarter of Revenue Growth,2016-12-09 19:35:28 +0000,http://marketrealist.com/2016/12/pfizers-eighth-consecutive-quarter-of-revenue-growth/?utm_source=yahoo&utm_medium=feed,Pfizer’s Eighth Consecutive Quarter of Revenue Growth
PFE,PFE:US,BBG000BR2B91,Understanding Pfizer’s 3Q16 Performance,2016-12-09 18:05:28 +0000,http://marketrealist.com/2016/12/understanding-pfizers-3q16-performance/?utm_source=yahoo&utm_medium=feed,Understanding Pfizer’s 3Q16 Performance
PFE,PFE:US,BBG000BR2B91,"Stocks Up Again; Apple Strengthens, Reclaims 50-Day Line",2016-12-09 17:04:07 +0000,http://www.investors.com/market-trend/stock-market-today/stocks-up-again-apple-strengthens-reclaims-50-day-line/,"Stocks Up Again; Apple Strengthens, Reclaims 50-Day Line"
PFE,PFE:US,BBG000BR2B91,"Dow Movers: WMT, KO",2016-12-09 16:59:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KkPHBqMEfh8/dow-movers-wmt-ko-cm719339,In early trading on Friday shares of Coca Cola KO topped the list of the day s best performing Dow Jones Industrial Average components trading up 2 1 Year to date Coca Cola has lost about 2 6 of its value And the worst performing Dow component thus far on the day is Wal
PFE,PFE:US,BBG000BR2B91,Can Trump Solve Pfizer's $80 Billion Problem?,2016-12-09 16:57:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fTYqP7_eCtI/can-trump-solve-pfizers-80-billion-problem-cm719306,Among publicly traded U S based companies pharma giant Pfizer NYSE PFE 160 has outshined nearly all of its peers in terms of stockpiling cash overseas 160 Specifically the drugmaker divulged in its 2015 annual report that it had a staggering 80 billion 160 of
PFE,PFE:US,BBG000BR2B91,Listing the Reasons behind Pfizer’s Discounted Price-to-Earnings,2016-12-09 16:24:00 +0000,http://marketrealist.com/2016/12/listing-the-reasons-behind-pfizers-discounted-price-to-earnings/?utm_source=yahoo&utm_medium=feed,Listing the Reasons behind Pfizer’s Discounted Price-to-Earnings
PFE,PFE:US,BBG000BR2B91,Can Trump Solve Pfizer's $80 Billion Problem?,2016-12-09 15:48:57 +0000,http://www.fool.com/investing/2016/12/09/can-trump-solve-pfizers-80-billion-problem.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Can Trump Solve Pfizer's $80 Billion Problem?
PFE,PFE:US,BBG000BR2B91,Should You Buy Drug Stocks on Their Post-Election Drop?,2016-12-09 15:19:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hMGviIAT390/should-you-buy-drug-stocks-on-their-post-election-drop-cm719282,"We have seen a strong rally in stocks since the U.S Presidential election, based on the assumption that, as a businessperson, the President elect will usher in a business-friendly era. The general feeling seems to be that some of the things said on the campaign trail, things like restricting trade, deporting millions"
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Drug Pricing Heat Back on Sector, Endo, Mylan, AZN to Cut Jobs",2016-12-09 14:59:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z4k6ihoe7Kw/pharma-stock-roundup-drug-pricing-heat-back-on-sector-endo-mylan-azn-to-cut-jobs-cm719273,Drug pricing is back in focus with President elect Donald Trump making it clear that he does not like price increases In an interview with TIME magazine which has named him 2016 Person of the Year Trump said that his intentions may have been misread by some stock analysts and that his
PFE,PFE:US,BBG000BR2B91,Drug-Research Firm PPD Explores Sale,2016-12-09 14:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/99s7WiG1VaY/drugresearch-firm-ppd-explores-sale-20161209-00513,Drug-Research Firm PPD Explores Sale
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Drug Pricing Heat Back on Sector, Endo, Mylan, AZN to Cut Jobs",2016-12-09 13:28:01 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-drug-pricing-132801721.html,"Pharma Stock Roundup: Drug Pricing Heat Back on Sector, Endo, Mylan, AZN to Cut Jobs"
PFE,PFE:US,BBG000BR2B91,Pfizer May Be Setting Up as a Low-Risk Buy,2016-12-09 10:57:00 +0000,https://www.thestreet.com/story/13920181/1/pfizer-may-be-setting-up-as-a-low-risk-buy.html?puc=yahoo&cm_ven=YAHOO,Pfizer May Be Setting Up as a Low-Risk Buy
PFE,PFE:US,BBG000BR2B91,Asian shares meander as ECB-inspired rally fades,2016-12-09 03:05:17 +0000,http://sg.finance.yahoo.com/news/us-indexes-back-away-record-150920558.html,Asian shares meander as ECB-inspired rally fades
PFE,PFE:US,BBG000BR2B91,Better Buy: Johnson & Johnson vs. Pfizer Inc.,2016-12-08 21:56:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N6AXfdYz7rM/better-buy-johnson-johnson-vs-pfizer-inc-cm718894,Johnson amp Johnson NYSE JNJ and Pfizer NYSE PFE have several things in common They re two of the biggest drugmakers in the world The stocks are popular among dividend seeking investors Both companies have been very successful through the years But which stock is
PFE,PFE:US,BBG000BR2B91,Health care sector suffers: Time to buy the dip?,2016-12-08 21:18:00 +0000,http://finance.yahoo.com/video/health-care-sector-suffers-time-211800961.html,Health care sector suffers: Time to buy the dip?
PFE,PFE:US,BBG000BR2B91,"Dow Movers: PFE, GS",2016-12-08 16:59:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oNImrJE7H5A/dow-movers-pfe-gs-cm718700,In early trading on Thursday shares of Goldman Sachs Group GS topped the list of the day s best performing Dow Jones Industrial Average components trading up 1 2 Year to date Goldman Sachs Group registers a 32 3 gain And the worst performing Dow component thus far on the day
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Fined for Price Hike of Anti-Epilepsy Drug in UK,2016-12-08 16:57:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MAimRKI2pk4/pfizer-pfe-fined-for-price-hike-of-anti-epilepsy-drug-in-uk-cm718656,Leading pharma company Pfizer Inc PFE was levied a fine of 107 million 84 2 million by the Competition and Markets Authority CMA of the UK upon finding that it had violated competition laws by charging excessive and unfair prices for its anti epilepsy drug phenytoin sodium capsules
PFE,PFE:US,BBG000BR2B91,"U.S. Stocks Climb, Extending Rally",2016-12-08 16:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F5Ii-nshTns/us-stocks-climb-extending-rally-20161208-00811,"U.S. Stocks Climb, Extending Rally"
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Fined for Price Hike of Anti-Epilepsy Drug in UK,2016-12-08 15:08:03 +0000,http://finance.yahoo.com/news/pfizer-pfe-fined-price-hike-150803342.html,Pfizer (PFE) Fined for Price Hike of Anti-Epilepsy Drug in UK
PFE,PFE:US,BBG000BR2B91,Should Biotech Investors Worry About Donald Trump?,2016-12-08 15:01:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kPsuChBg-A8/should-biotech-investors-worry-about-donald-trump-cm718499,The biotech sector got a major wake up call yesterday President elect Donald Trump does not like price increases Biotech stocks which enjoy huge profit margins under current law had jumped 9 the day after Trump s election reflecting relief that the price controls that Hillary Clinton
PFE,PFE:US,BBG000BR2B91,Blog Coverage Pfizer Fined $107 Million for Overcharging Through an Antiepileptic Drug,2016-12-08 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-pfizer-fined-107-131500967.html,"[Accesswire] - Upcoming AWS Coverage on Rockwell Medical Post-Earnings Results LONDON, UK / ACCESSWIRE / December 8, 2016 / Active Wall St. blog coverage looks at the headline from Pfizer Inc. (NYSE: PFE ). US lawmakers ..."
PFE,PFE:US,BBG000BR2B91,Patients' Right To Try Should Not Be A License To Fleece Them,2016-12-08 13:15:00 +0000,http://www.forbes.com/sites/bernardmunos/2016/12/08/patients-right-to-try-should-not-be-a-license-to-fleece-them/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Patients' Right To Try Should Not Be A License To Fleece Them
PFE,PFE:US,BBG000BR2B91,Pfizer To Present At Citi Global Healthcare Conference; Webcast At 2:10 PM ET,2016-12-08 13:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jX5CT3T91p4/pfizer-to-present-at-citi-global-healthcare-conference-webcast-at-210-pm-et-20161208-00783,Pfizer To Present At Citi Global Healthcare Conference; Webcast At 2:10 PM ET
PFE,PFE:US,BBG000BR2B91,Stocks Advance After Wall Street Highs,2016-12-08 08:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a9FlUXQzMqw/stocks-advance-after-wall-street-highs-20161208-00082,Stocks Advance After Wall Street Highs
PFE,PFE:US,BBG000BR2B91,Pfizer Fined $107 Million for Overcharging U.K. for Epilepsy Drug,2016-12-08 05:08:22 +0000,http://www.wsj.com/articles/pfizer-fined-107-million-for-epilepsy-drug-price-hike-1481104073?ru=yahoo?mod=yahoo_itp,Pfizer Fined $107 Million for Overcharging U.K. for Epilepsy Drug
PFE,PFE:US,BBG000BR2B91,U.S. Stocks Climb; Euro Slides,2016-12-08 04:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GMuVccSx8Zs/us-stocks-climb-euro-slides-20161208-00800,U.S. Stocks Climb; Euro Slides
PFE,PFE:US,BBG000BR2B91,U.S. Stocks Little Changed; Euro Slides,2016-12-08 04:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c-jy4vysmfI/us-stocks-little-changed-euro-slides-20161208-00686,U.S. Stocks Little Changed; Euro Slides
PFE,PFE:US,BBG000BR2B91,Stocks Advance as ECB Extends Asset Purchases,2016-12-08 04:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RXPlBMHOToM/stocks-advance-as-ecb-extends-asset-purchases-20161208-00440,Stocks Advance as ECB Extends Asset Purchases
PFE,PFE:US,BBG000BR2B91,Asian stocks advance ahead of ECB decision,2016-12-08 03:41:24 +0000,http://sg.finance.yahoo.com/news/losses-drugmakers-pull-us-stocks-150340249.html,"[AP] - U.S. indexes are leaping to all-time highs in a broad rally Wednesday afternoon. Investors are buying stocks that do well in times of faster economic growth, like technology and industrial companies, but ..."
PFE,PFE:US,BBG000BR2B91,Dow Jones Industrial Average Jumps 298 Points; Trump Derails Drug Stocks,2016-12-07 22:55:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Eas1Eu1RqbQ/dow-jones-industrial-average-jumps-298-points-trump-derails-drug-stocks-cm718298,The 160 Dow Jones Industrial Average DJIA shrugged off a slow start to settle up nearly 298 points notching a record high once again The S amp P 500 Index SPX 160 followed suit with an all time high of its own as stocks rallied ahead of tomorrow s European Central Bank
PFE,PFE:US,BBG000BR2B91,Business Highlights,2016-12-07 22:12:05 +0000,http://sg.finance.yahoo.com/news/business-highlights-221205901.html,Business Highlights
PFE,PFE:US,BBG000BR2B91,Close Update: Dow Closes At Another Record High as Trump-Rally Continues; Drug Makers Under Pressure,2016-12-07 21:56:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zZoNsUdiCZs/close-update-dow-closes-at-another-record-high-as-trump-rally-continues-drug-makers-under-pressure-cm718294,Wall Street continued its meteoric rise on Wednesday with the Dow Jones Industrial Average and S amp P 500 setting new all time highs as sizable gains in interest rate sensitive sectors upstaged a selling spree in stocks of drug makers Wall Street continued its meteoric rise on Wednesday with
PFE,PFE:US,BBG000BR2B91,"NASDAQ Composite Index closes up 24.11 points for the week, rising for the 4th straight day",2016-12-07 21:49:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oQrywPCM2TU/nasdaq-composite-index-closes-up-2411-points-for-the-week-rising-for-the-4th-straight-day-cm718295,Wednesday s session closes with the NASDAQ Composite Index 60 76 This is the 4th straight day of increase for the index The total shares traded for the NASDAQ was over 2 15 billion Wednesday s session closes with the NASDAQ Composite Index 60 76 This is the 4th straight day of increase for
PFE,PFE:US,BBG000BR2B91,"Trump Targets Drug Prices And Apple, Seeks '5 Minutes' With Offshoring Firms",2016-12-07 21:33:10 +0000,http://www.investors.com/news/time-person-of-the-year-trump-wants-lower-drug-costs-yuge-apple-factory/,"Trump Targets Drug Prices And Apple, Seeks '5 Minutes' With Offshoring Firms"
PFE,PFE:US,BBG000BR2B91,Ariad Pharma Could Draw M&A Fire Ahead Of Second Cancer Drug Win,2016-12-07 21:32:38 +0000,http://www.investors.com/news/technology/ariad-pharma-could-draw-ma-fire-ahead-of-second-cancer-drug-win/,Ariad Pharma Could Draw M&A Fire Ahead Of Second Cancer Drug Win
PFE,PFE:US,BBG000BR2B91,"Markets Right Now: Dow, S&P 500 surge to record high closes",2016-12-07 21:07:18 +0000,http://sg.finance.yahoo.com/news/markets-now-us-stocks-open-144100367.html,"Markets Right Now: Dow, S&P 500 surge to record high closes"
PFE,PFE:US,BBG000BR2B91,The UK Has Fined PFE For Unfair Drug Pricing (PFE),2016-12-07 20:00:00 +0000,http://www.investopedia.com/news/pfe-lower-after-record-fine-uk-pfe/?partner=YahooSA,The UK Has Fined PFE For Unfair Drug Pricing (PFE)
PFE,PFE:US,BBG000BR2B91,Britain fines Pfizer record 84.2 million pounds for huge drug price hike,2016-12-07 18:13:43 +0000,http://sg.finance.yahoo.com/news/britain-fines-pfizer-record-107-072336649.html,Britain fines Pfizer record 84.2 million pounds for huge drug price hike
PFE,PFE:US,BBG000BR2B91,"US STOCKS-Dow, S&P hit highs; Trump comment hammers drug stocks",2016-12-07 17:57:15 +0000,http://finance.yahoo.com/news/us-stocks-dow-p-hit-175715580.html,"US STOCKS-Dow, S&P hit highs; Trump comment hammers drug stocks"
PFE,PFE:US,BBG000BR2B91,Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares,2016-12-07 17:40:08 +0000,http://247wallst.com/healthcare-business/2016/12/07/trumps-drug-price-comments-weigh-on-biotech-and-pharma-etfs-and-shares/,Trump’s Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares
PFE,PFE:US,BBG000BR2B91,"Dow Movers: PFE, WMT",2016-12-07 16:58:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/moY3SeTaxMA/dow-movers-pfe-wmt-cm718043,In early trading on Wednesday shares of Wal Mart Stores WMT topped the list of the day s best performing Dow Jones Industrial Average components trading up 1 1 Year to date Wal Mart Stores registers a 14 4 gain And the worst performing Dow component thus far on the day is
PFE,PFE:US,BBG000BR2B91,"Notable ETF Inflow Detected - VOO, PFE, KO, PEP",2016-12-07 16:56:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dEl7EGR0jhY/notable-etf-inflow-detected-voo-pfe-ko-pep-cm718012,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard S amp P 500 ETF Symbol VOO where we have detected an approximate 454 8 million dollar inflow that s a 0 8 increase week over week in outstanding
PFE,PFE:US,BBG000BR2B91,Pfizer at the Mercy of Trump's Tweets: More Squawk From Jim Cramer,2016-12-07 16:37:00 +0000,https://www.thestreet.com/story/13917749/1/pfizer-at-the-mercy-of-trump-s-tweets-more-squawk-from-jim-cramer.html?puc=yahoo&cm_ven=YAHOO,Pfizer at the Mercy of Trump's Tweets: More Squawk From Jim Cramer
PFE,PFE:US,BBG000BR2B91,"US STOCKS-Dow, S&P hit highs but Trump comments slam drug stocks",2016-12-07 16:26:01 +0000,http://finance.yahoo.com/news/us-stocks-dow-p-hit-162601808.html,"US STOCKS-Dow, S&P hit highs but Trump comments slam drug stocks"
PFE,PFE:US,BBG000BR2B91,Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study,2016-12-07 16:00:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GpJtBczOatE/novartis-nvs-zykadia-positive-in-phase-iii-ascend-4-study-cm717962,Novartis AG NVS announced results from the phase III ASCEND 4 study on its oncology drug Zykadia for the treatment of patients with advanced anaplastic lymphoma kinase positive ALK non small cell lung cancer NSCLC A look at Novartis year to date share price movement shows that
PFE,PFE:US,BBG000BR2B91,Is Pfizer's New PD-L1 Drug a Game-Changer?,2016-12-07 15:57:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Dq_Io3-w7jQ/is-pfizers-new-pd-l1-drug-a-game-changer-cm717925,The Food and Drug Administration has agreed to review Pfizer Inc s NYSE PFE PD L1 checkpoint inhibitor avelumab under an accelerated approval pathway If it s given the go ahead avelumab will join the previously approved PD 1 PD L1 drugs Opdivo Keytruda and Tecentriq
PFE,PFE:US,BBG000BR2B91,Dividend-paying stocks pull US indexes up; drugmakers drop,2016-12-07 15:52:40 +0000,http://finance.yahoo.com/news/losses-drugmakers-pull-us-stocks-mostly-lower-150350322--finance.html,Dividend-paying stocks pull US indexes up; drugmakers drop
PFE,PFE:US,BBG000BR2B91,"Dow, S&P 500 set intraday records, but health-care slumps on Trump",2016-12-07 15:37:12 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=F5A5DBF2-BC64-11E6-B2C4-457F0A421E12&siteid=yhoof2,"Dow, S&P 500 set intraday records, but health-care slumps on Trump"
PFE,PFE:US,BBG000BR2B91,Drug Stocks Tumble After Trump Vows to Pressure Prices,2016-12-07 15:36:58 +0000,http://blogs.wsj.com/moneybeat/2016/12/07/drug-stocks-tumble-after-trump-vows-to-pressure-drug-prices/?mod=yahoo_hs,Drug Stocks Tumble After Trump Vows to Pressure Prices
PFE,PFE:US,BBG000BR2B91,US STOCKS-Wall St flat as investors test post-election rally,2016-12-07 14:57:58 +0000,http://finance.yahoo.com/news/us-stocks-wall-st-flat-145758408.html,US STOCKS-Wall St flat as investors test post-election rally
PFE,PFE:US,BBG000BR2B91,Better Buy: Amgen Inc. vs. Pfizer,2016-12-07 14:57:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tN48QV8derk/better-buy-amgen-inc-vs-pfizer-cm717857,Image source Getty Images Over the past five years Amgen NASDAQ AMGN investors have enjoyed a market thumping 166 1 gain During the same period Pfizer NYSE PFE shares rose just 71 8 underperforming the broad market S amp P 500 benchmark by double digits
PFE,PFE:US,BBG000BR2B91,Is Pfizer's New PD-L1 Drug a Game-Changer?,2016-12-07 14:49:51 +0000,http://www.fool.com/investing/2016/12/07/is-pfizers-new-pd-l1-drug-a-game-changer.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Pfizer's New PD-L1 Drug a Game-Changer?
PFE,PFE:US,BBG000BR2B91,Britain fines Pfizer record $107 million for huge drug price hike,2016-12-07 14:22:15 +0000,http://finance.yahoo.com/news/britain-fines-pfizer-record-107-092934878.html,"[Reuters] - Britain's competition watchdog has fined Pfizer a record 84.2 million pounds for its role in ramping up the cost of an epilepsy drug by as much as 2,600 percent. The Competition and Markets Authority also ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Takes $106 Million Fine From U.K. for Price Hike of Epilepsy Drug,2016-12-07 14:21:00 +0000,https://www.thestreet.com/story/13917037/1/pfizer-takes-106-million-fine-from-u-k-for-price-hike-of-epilepsy-drug.html?puc=yahoo&cm_ven=YAHOO,Pfizer Takes $106 Million Fine From U.K. for Price Hike of Epilepsy Drug
PFE,PFE:US,BBG000BR2B91,Britain fines Pfizer record $107 mln for huge drug price hike,2016-12-07 14:19:48 +0000,http://uk.finance.yahoo.com/news/britain-fines-pfizer-record-107-080838120.html,"[Reuters - UK Focus] - LONDON, Dec (Shanghai: 600875.SS - news) 7 (Reuters) - Britain's competition watchdog has fined Pfizer a record 84.2 million pounds ($107 million) for its role in ramping up the cost of an epilepsy drug by as much as 2,600 percent. The Competition and Markets Authority (CMA) also fined Flynn Pharma 5.2 million pounds for overcharging for phenytoin sodium capsules, following a dramatic price hike in 2012."
PFE,PFE:US,BBG000BR2B91,Pfizer Fined $107 Million for Overcharging U.K. for Epilepsy Drug,2016-12-07 14:13:00 +0000,http://www.wsj.com/articles/pfizer-fined-107-million-for-epilepsy-drug-price-hike-1481104073?mod=yahoo_hs,Pfizer Fined $107 Million for Overcharging U.K. for Epilepsy Drug
PFE,PFE:US,BBG000BR2B91,Pfizer fined $107M because of epilepsy drug price hike in U.K.,2016-12-07 14:00:08 +0000,http://www.bizjournals.com/philadelphia/news/2016/12/07/pfizer-fined-107m-epilepsy-epan-price-flynn.html?ana=yahoo,Pfizer fined $107M because of epilepsy drug price hike in U.K.
PFE,PFE:US,BBG000BR2B91,Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study,2016-12-07 14:00:02 +0000,http://finance.yahoo.com/news/novartis-nvs-zykadia-positive-phase-140002227.html,Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
PFE,PFE:US,BBG000BR2B91,"Pfizer and Flynn Pharma fined over 2,600% NHS price hike",2016-12-07 13:58:00 +0000,http://uk.finance.yahoo.com/news/pfizer-flynn-pharma-fined-over-091600876.html,"Pfizer and Flynn Pharma fined over 2,600% NHS price hike"
PFE,PFE:US,BBG000BR2B91,"Pfizer fined for hiking epilepsy drug price 2,600 pct in UK",2016-12-07 13:29:54 +0000,http://finance.yahoo.com/news/uk-fines-companies-hiking-epilepsy-090428116.html,"Pfizer fined for hiking epilepsy drug price 2,600 pct in UK"
PFE,PFE:US,BBG000BR2B91,"Pfizer fined for hiking epilepsy drug price 2,600 pct in UK",2016-12-07 13:29:54 +0000,http://sg.finance.yahoo.com/news/uk-fines-companies-hiking-epilepsy-090428251.html,"Pfizer fined for hiking epilepsy drug price 2,600 pct in UK"
PFE,PFE:US,BBG000BR2B91,Britain fines Pfizer $107M for drug price hike,2016-12-07 13:28:00 +0000,http://finance.yahoo.com/video/britain-fines-pfizer-107m-drug-132800589.html,Britain fines Pfizer $107M for drug price hike
PFE,PFE:US,BBG000BR2B91,Better Buy: Amgen Inc. vs. Pfizer,2016-12-07 13:18:18 +0000,http://www.fool.com/investing/2016/12/07/better-buy-amgen-inc-vs-pfizer.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Amgen Inc. vs. Pfizer
PFE,PFE:US,BBG000BR2B91,Pfizer Fined $106 Million For Anti-Epilepsy Drug,2016-12-07 12:56:26 +0000,http://finance.yahoo.com/news/pfizer-fined-106-million-anti-125626229.html,Pfizer Fined $106 Million For Anti-Epilepsy Drug
PFE,PFE:US,BBG000BR2B91,5 Things You Must Know Before the Market Opens Wednesday,2016-12-07 12:06:00 +0000,https://www.thestreet.com/story/13915256/1/5-things-you-must-know-before-the-market-opens-wednesday.html?puc=yahoo&cm_ven=YAHOO,5 Things You Must Know Before the Market Opens Wednesday
PFE,PFE:US,BBG000BR2B91,"MARKET SNAPSHOT: Dow, S&P 500 Set Intraday Records, But Health-care Slumps On Trump",2016-12-07 11:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8s2VTtWN9xo/market-snapshot-dow-sp-500-set-intraday-records-but-healthcare-slumps-on-trump-20161207-00663,"MARKET SNAPSHOT: Dow, S&P 500 Set Intraday Records, But Health-care Slumps On Trump"
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer fined £84m for charging 'unfair' price for epilepsy drug,2016-12-07 10:05:48 +0000,"http://www.ft.com/cms/s/0a1d0f6e-bc5c-11e6-8b45-b8b81dd5d080,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Britain's competition watchdog has fined Pfizer more than £84m and UK pharmaceuticals distributor Flynn Pharma more than £5m for ""charging excessive and unfair prices"" for a drug used to treat ..."
PFE,PFE:US,BBG000BR2B91,Britain fines Pfizer record $107 mln for huge drug price hike,2016-12-07 09:27:18 +0000,http://in.finance.yahoo.com/news/britain-fines-pfizer-record-107-072258969.html,Britain fines Pfizer record $107 mln for huge drug price hike
PFE,PFE:US,BBG000BR2B91,"Drug firms fined over 2,600% NHS price hike for epilepsy treatment",2016-12-07 09:15:00 +0000,http://uk.finance.yahoo.com/news/drug-firms-fined-over-2-081300803.html,"Drug firms fined over 2,600% NHS price hike for epilepsy treatment"
PFE,PFE:US,BBG000BR2B91,Pfizer Fined $107 Million for Overcharging U.K. for Epilepsy Drug,2016-12-07 08:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vLx7qa_kQHc/pfizer-fined-107-million-for-overcharging-uk-for-epilepsy-drug-20161207-00438,Pfizer Fined $107 Million for Overcharging U.K. for Epilepsy Drug
PFE,PFE:US,BBG000BR2B91,Pfizer Fined $107 Million for Overcharging U.K. for Epilepsy Drug -- 2nd Update,2016-12-07 08:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IBlv_BqrH1o/pfizer-fined-107-million-for-overcharging-uk-for-epilepsy-drug--2nd-update-20161207-00384,Pfizer Fined $107 Million for Overcharging U.K. for Epilepsy Drug -- 2nd Update
PFE,PFE:US,BBG000BR2B91,Drug firms fined £90m for 'excessive' price hike to NHS,2016-12-07 08:03:00 +0000,http://uk.finance.yahoo.com/news/drug-firms-fined-90m-excessive-071700727.html,Drug firms fined £90m for 'excessive' price hike to NHS
PFE,PFE:US,BBG000BR2B91,"Pfizer, Flynn Pharma Fined Record $106 Million by U.K. Regulator",2016-12-07 07:36:22 +0000,http://finance.yahoo.com/news/pfizer-flynn-pharma-fined-record-073622654.html,"Pfizer, Flynn Pharma Fined Record $106 Million by U.K. Regulator"
PFE,PFE:US,BBG000BR2B91,"Pfizer, Flynn Fined Record $113 Million Over Epilepsy Drug",2016-12-07 07:36:22 +0000,http://www.bloomberg.com/news/articles/2016-12-07/pfizer-flynn-pharma-fined-record-106-million-by-u-k-regulator?cmpid=yhoo.headline,"Pfizer, Flynn Fined Record $113 Million Over Epilepsy Drug"
PFE,PFE:US,BBG000BR2B91,Pfizer Fined In UK For Charging Unfair Prices For Anti-epilepsy Drug,2016-12-07 05:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RKDpLFzIYDw/pfizer-fined-in-uk-for-charging-unfair-prices-for-antiepilepsy-drug-20161207-00114,Pfizer Fined In UK For Charging Unfair Prices For Anti-epilepsy Drug
PFE,PFE:US,BBG000BR2B91,Pfizer Fined $107 Million for Epilepsy Drug Price Hike in UK -- Update,2016-12-07 05:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/opNaFMwFDNY/pfizer-fined-107-million-for-epilepsy-drug-price-hike-in-uk--update-20161207-00100,Pfizer Fined $107 Million for Epilepsy Drug Price Hike in UK -- Update
PFE,PFE:US,BBG000BR2B91,"Dow, S&P 500 on Track to Set New Highs",2016-12-07 04:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9QjODalEmps/dow-sp-500-on-track-to-set-new-highs-20161207-00861,"Dow, S&P 500 on Track to Set New Highs"
PFE,PFE:US,BBG000BR2B91,Health-Care Selloff Pressures Stocks,2016-12-07 04:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/caxnNEG9O0U/healthcare-selloff-pressures-stocks-20161207-00671,Health-Care Selloff Pressures Stocks
PFE,PFE:US,BBG000BR2B91,Stocks Pressured by Health-Care Selloff,2016-12-07 04:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HBGrOMK7b7Q/stocks-pressured-by-healthcare-selloff-20161207-00707,Stocks Pressured by Health-Care Selloff
PFE,PFE:US,BBG000BR2B91,Health-Care Stocks Slide,2016-12-07 04:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OlvSh3TkZxQ/healthcare-stocks-slide-20161207-00658,Health-Care Stocks Slide
PFE,PFE:US,BBG000BR2B91,"Stocks Rise, Despite Slide in Health-Care Shares",2016-12-07 04:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tE1fCvC9lBc/stocks-rise-despite-slide-in-healthcare-shares-20161207-00786,"Stocks Rise, Despite Slide in Health-Care Shares"
PFE,PFE:US,BBG000BR2B91,U.S. Stocks Post Biggest One-Day Rally Since Election,2016-12-07 04:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0dOM0SIYWFE/us-stocks-post-biggest-oneday-rally-since-election-20161207-01039,U.S. Stocks Post Biggest One-Day Rally Since Election
PFE,PFE:US,BBG000BR2B91,"Dow, S&P 500 Set New Highs",2016-12-07 04:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GOO97GRIBR8/dow-sp-500-set-new-highs-20161207-01024,"Dow, S&P 500 Set New Highs"
PFE,PFE:US,BBG000BR2B91,Pfizer Fined $107 Million by UK Regulator Over Drug Prices,2016-12-07 02:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dlb4XheUkLY/pfizer-fined-107-million-by-uk-regulator-over-drug-prices-20161207-00047,Pfizer Fined $107 Million by UK Regulator Over Drug Prices
PFE,PFE:US,BBG000BR2B91,Sanofi May Battle Johnson & Johnson For European Biotech Actelion,2016-12-06 21:49:03 +0000,http://www.investors.com/news/technology/sanofi-pressures-johnsons-27-billion-on-european-biotech-actelion/,Sanofi May Battle Johnson & Johnson For European Biotech Actelion
PFE,PFE:US,BBG000BR2B91,Pfizer Leukemia Drug Meets Primary Endpoint in Phase III,2016-12-06 21:27:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hZ-Axg8XSvY/pfizer-leukemia-drug-meets-primary-endpoint-in-phase-iii-cm717610,Pfizer Inc PFE and partner Avillion LLP announced that a phase III study BFORE evaluating its marketed drug Bosulif in the first line setting met the primary endpoint Results from the BFORE study demonstrated superiority of Bosulif bosutinib over Glivec for the first line treatment
PFE,PFE:US,BBG000BR2B91,The Latest Buzz in Biotech,2016-12-06 21:26:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EpVsy00YKRg/the-latest-buzz-in-biotech-cm717591,In this week s episode of Industry Focus Healthcare Motley Fool analyst Michael Douglass and Fool contributor Todd Campbell go over three of the biggest recent stories in healthcare Shares in Juno Therapeutics NASDAQ JUNO and 160 Amicus Therapeutics
PFE,PFE:US,BBG000BR2B91,Interesting March 2017 Stock Options for PFE,2016-12-06 21:19:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ntJjksDou7w/interesting-march-2017-stock-options-for-pfe-cm717383,Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the March 2017 expiration for PFE The put contract
PFE,PFE:US,BBG000BR2B91,The Latest Buzz in Biotech,2016-12-06 21:19:34 +0000,http://www.fool.com/investing/2016/12/06/the-latest-buzz-in-biotech.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Latest Buzz in Biotech
PFE,PFE:US,BBG000BR2B91,Pfizer Leukemia Drug Meets Primary Endpoint in Phase III,2016-12-06 15:12:03 +0000,http://finance.yahoo.com/news/pfizer-leukemia-drug-meets-primary-151203064.html,Pfizer Leukemia Drug Meets Primary Endpoint in Phase III
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference,2016-12-06 15:00:00 +0000,http://finance.yahoo.com/news/pfizer-invites-public-listen-webcast-150000002.html,"[Business Wire] - Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Ian Read, Chairman and CEO, at the Guggenheim 4th Annual Boston Healthcare Conference on Tuesday, December 13, 2016 at 12:00 p.m."
PFE,PFE:US,BBG000BR2B91,Trump's corporate tax holiday could spur pharma M&A,2016-12-06 12:05:18 +0000,http://finance.yahoo.com/news/trumps-corporate-tax-holiday-could-120518802.html,[Reuters] - U.S. President-elect Donald Trump's plan to incentivize U.S. companies to repatriate their swelling overseas cash piles could spur a new wave of dealmaking in a pharmaceutical industry seeking to buy its ...
PFE,PFE:US,BBG000BR2B91,What a Dividend Payout Ratio Can (and Can't) Tell You,2016-12-06 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=783506&SR=Yahoo,What a Dividend Payout Ratio Can (and Can't) Tell You
PFE,PFE:US,BBG000BR2B91,Dealtalk: Trump's corporate tax holiday could spur pharma M&A,2016-12-06 08:44:46 +0000,http://in.finance.yahoo.com/news/dealtalk-trumps-corporate-tax-holiday-084446521.html,Dealtalk: Trump's corporate tax holiday could spur pharma M&A
PFE,PFE:US,BBG000BR2B91,Can't buy love? Drug price hikes put sex beyond reach,2016-12-06 06:30:23 +0000,http://sg.finance.yahoo.com/news/cant-buy-love-drug-price-150148727.html,Can't buy love? Drug price hikes put sex beyond reach
PFE,PFE:US,BBG000BR2B91,Can't buy love? Drug price hikes put sex beyond reach,2016-12-06 04:58:44 +0000,http://finance.yahoo.com/news/cant-buy-love-drug-price-150148751.html,Can't buy love? Drug price hikes put sex beyond reach
PFE,PFE:US,BBG000BR2B91,U.S. 'Disappointed' by Japan's Plan to Cut Drug Costs,2016-12-06 02:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/poTbgndJTLE/us-disappointed-by-japans-plan-to-cut-drug-costs-20161206-00047,U.S. 'Disappointed' by Japan's Plan to Cut Drug Costs
PFE,PFE:US,BBG000BR2B91,Sanofi exploring bid for Actelion amid J&J talks - Bloomberg,2016-12-05 22:53:21 +0000,http://sg.finance.yahoo.com/news/sanofi-exploring-bid-actelion-amid-225321751.html,Sanofi exploring bid for Actelion amid J&J talks - Bloomberg
PFE,PFE:US,BBG000BR2B91,Sanofi to Explore Counterbid for Actelion Amid J&J Talks,2016-12-05 21:07:06 +0000,http://www.bloomberg.com/news/articles/2016-12-05/sanofi-said-to-explore-counterbid-for-actelion-amid-j-j-talks?cmpid=yhoo.headline,Sanofi to Explore Counterbid for Actelion Amid J&J Talks
PFE,PFE:US,BBG000BR2B91,Bloomberg : Sanofi To Explore Counterbid For Actelion Amid J&J Talks,2016-12-05 20:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1Y7NzYi8umA/bloomberg--sanofi-to-explore-counterbid-for-actelion-amid-jj-talks-20161205-01153,Bloomberg : Sanofi To Explore Counterbid For Actelion Amid J&J Talks
PFE,PFE:US,BBG000BR2B91,Robust Pipeline Supports 5.5% Dividend Yield,2016-12-05 15:33:23 +0000,http://finance.yahoo.com/news/robust-pipeline-supports-5-5-153323430.html,Robust Pipeline Supports 5.5% Dividend Yield
PFE,PFE:US,BBG000BR2B91,2 Stocks That Could Soar Under a Donald Trump Presidency,2016-12-05 14:48:38 +0000,http://www.fool.com/investing/2016/12/05/2-stocks-that-could-soar-under-a-donald-trump-pres.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,2 Stocks That Could Soar Under a Donald Trump Presidency
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Presents Favorable Data on Leukemia Candidate,2016-12-05 14:08:02 +0000,http://finance.yahoo.com/news/pfizer-pfe-presents-favorable-data-140802574.html,Pfizer (PFE) Presents Favorable Data on Leukemia Candidate
PFE,PFE:US,BBG000BR2B91,Pfizer's blood cancer drug Bosulif effective in untreated patients,2016-12-05 13:43:25 +0000,http://finance.yahoo.com/news/pfizers-blood-cancer-drug-bosulif-134325801.html,"[Reuters] - Pfizer Inc said on Monday its cancer drug, Bosulif, was found effective in a late-stage study on previously untreated patients with a form of blood and bone marrow cancer that is characterized by the abnormal production of white blood cells. Most people with chronic myeloid leukemia (CML) have a genetic mutation, called the Philadelphia chromosome, which causes the bone marrow to make an enzyme that triggers the development of abnormal and unhealthy white blood cells."
PFE,PFE:US,BBG000BR2B91,Pfizer and Avillion Announce Positive Top-Line Results for Phase 3 BFORE Study of BOSULIF for First-Line Treatment of Philadelphia Chromosome Positive Chronic Myeloid Leukemia,2016-12-05 13:00:00 +0000,http://finance.yahoo.com/news/pfizer-avillion-announce-positive-top-130000633.html,"[Business Wire] - Today, Pfizer Inc. and its partner Avillion LLP announced results from the Phase 3 BFORE trial demonstrating superiority of BOSULIF® over imatinib as a first-line treatment for patients with chronic phase Philadelphia chromosome positive chronic myeloid leukemia ."
PFE,PFE:US,BBG000BR2B91,Pfizer Reports Positive Top-Line Results For Phase 3 BFORE Study Of BOSULIF,2016-12-05 08:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GIYK02L1RaM/pfizer-reports-positive-topline-results-for-phase-3-bfore-study-of-bosulif-20161205-00385,Pfizer Reports Positive Top-Line Results For Phase 3 BFORE Study Of BOSULIF
PFE,PFE:US,BBG000BR2B91,Does Pfizer Pass Warren Buffett’s Test?,2016-12-04 14:48:29 +0000,http://www.fool.com/investing/2016/12/04/does-pfizer-pass-warren-buffetts-test.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Does Pfizer Pass Warren Buffett’s Test?
PFE,PFE:US,BBG000BR2B91,Spark's Hemophilia Gene Therapy Remains Effective Despite Immune Reactions,2016-12-03 18:04:00 +0000,https://www.thestreet.com/story/13913098/1/spark-s-hemophilia-gene-therapy-remains-effective-despite-immune-reactions.html?puc=yahoo&cm_ven=YAHOO,Spark's Hemophilia Gene Therapy Remains Effective Despite Immune Reactions
PFE,PFE:US,BBG000BR2B91,New Phase 2 Results Show Investigational Compound Glasdegib Improved Overall Survival in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome,2016-12-03 18:00:00 +0000,http://finance.yahoo.com/news/phase-2-results-show-investigational-180000146.html,"[Business Wire] - Today, Pfizer Inc. announced new data from a randomized Phase 2 study of glasdegib , an oral, smoothened inhibitor, showing the addition of glasdegib to low-dose cytarabine significantly increased overall survival when compared to LDAC alone in patients with acute myeloid leukemia or high-risk myelodysplastic syndrome who were ineligible for intensive chemotherapy ."
PFE,PFE:US,BBG000BR2B91,Spark Therapeutics and Pfizer Present Updated Preliminary Data from Hemophilia B Phase 1/2 Trial Suggesting Consistent and Sustained Levels of Factor IX Activity at Annual ASH Meeting,2016-12-03 16:00:00 +0000,http://finance.yahoo.com/news/spark-therapeutics-pfizer-present-updated-160000142.html,"[GlobeNewswire] - Together, all nine participants have reduced infusions of factor IX concentrates by 99 percent over cumulative 1,650 days. Seven infused participants who have progressed to at least 12 weeks post-vector ..."
PFE,PFE:US,BBG000BR2B91,[$$] New Tax Rules on Corporate Inversions Face Uncertain Future,2016-12-03 05:03:00 +0000,http://www.wsj.com/articles/new-tax-rules-on-corporate-inversions-face-uncertain-future-1480680003?ru=yahoo?mod=yahoo_itp,[$$] New Tax Rules on Corporate Inversions Face Uncertain Future
PFE,PFE:US,BBG000BR2B91,Forget Pfizer: Here Are 3 Better Dividend Stocks,2016-12-02 21:41:06 +0000,http://www.fool.com/investing/2016/12/02/forget-pfizer-here-are-3-better-dividend-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Forget Pfizer: Here Are 3 Better Dividend Stocks
PFE,PFE:US,BBG000BR2B91,$50 Billion Quant Fund Is Making New Bets On These Stocks,2016-12-02 20:35:20 +0000,http://www.insidermonkey.com/blog/50-billion-quant-fund-is-making-new-bets-on-these-stocks-488040/,$50 Billion Quant Fund Is Making New Bets On These Stocks
PFE,PFE:US,BBG000BR2B91,Regeneron's CEO Blasts Peers on Innovation,2016-12-02 20:02:00 +0000,http://www.fool.com/investing/2016/12/02/regenerons-ceo-blasts-peers-on-innovation.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,Regeneron's CEO Blasts Peers on Innovation
PFE,PFE:US,BBG000BR2B91,The Numbers Behind a Pharma CEO Shouting Match,2016-12-02 19:42:53 +0000,http://www.bloomberg.com/gadfly/articles/2016-12-02/pharma-ceos-fighting-about-drug-prices-follow-the-numbers?cmpid=yhoo.headline,The Numbers Behind a Pharma CEO Shouting Match
PFE,PFE:US,BBG000BR2B91,"Morgan Stanley Wealth Management: Chevron, Pfizer May be Big Winners in 2017",2016-12-02 18:08:00 +0000,http://www.thestreet.com/video/13912635/morgan-stanley-chevron-pfizer-will-be-big-winners-in-2017.html?puc=yahoov&cm_ven=YAHOOV,"Morgan Stanley Wealth Management: Chevron, Pfizer May be Big Winners in 2017"
PFE,PFE:US,BBG000BR2B91,[$$] Tax Rules on Corporate Inversions Face Uncertain Future,2016-12-02 16:41:24 +0000,http://www.wsj.com/articles/new-tax-rules-on-corporate-inversions-face-uncertain-future-1480680003?mod=yahoo_hs,[$$] Tax Rules on Corporate Inversions Face Uncertain Future
PFE,PFE:US,BBG000BR2B91,Pfizer Offers Positive Phase III Data on Pediatric Epilesy Drug,2016-12-02 14:33:02 +0000,http://finance.yahoo.com/news/pfizer-offers-positive-phase-iii-143302456.html,Pfizer Offers Positive Phase III Data on Pediatric Epilesy Drug
PFE,PFE:US,BBG000BR2B91,5 Best Dividend Stocks To Buy Right Now,2016-12-02 14:15:09 +0000,http://www.insidermonkey.com/blog/5-best-dividend-stocks-to-buy-right-now-490698/,5 Best Dividend Stocks To Buy Right Now
PFE,PFE:US,BBG000BR2B91,The Word on the Street: What Analysts Are Estimating for Pfizer Now,2016-12-02 13:04:11 +0000,http://marketrealist.com/2016/11/the-word-on-the-street-what-analysts-are-estimating-for-pfizer-now/?utm_source=yahoo&utm_medium=feed,The Word on the Street: What Analysts Are Estimating for Pfizer Now
PFE,PFE:US,BBG000BR2B91,Coverage initiated on Pfizer by Guggenheim,2016-12-02 12:15:49 +0000,http://finance.yahoo.com/q/ud?s=PFE,Coverage initiated on Pfizer by Guggenheim
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytruda",2016-12-02 11:40:11 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-nivalis-falls-114011277.html,"Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytruda"
PFE,PFE:US,BBG000BR2B91,New Tax Rules on Corporate Inversions Face Uncertain Future,2016-12-02 07:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_Qa6m6VlxBw/new-tax-rules-on-corporate-inversions-face-uncertain-future-20161202-00157,New Tax Rules on Corporate Inversions Face Uncertain Future
PFE,PFE:US,BBG000BR2B91,"ARDM Out Of Orbit, CLSN To Report Data In Q1, MRK Seeks New Use For Old Drug",2016-12-02 00:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4z1zwlFqxWk/ardm-out-of-orbit-clsn-to-report-data-in-q1-mrk-seeks-new-use-for-old-drug-20161202-00002,"ARDM Out Of Orbit, CLSN To Report Data In Q1, MRK Seeks New Use For Old Drug"
PFE,PFE:US,BBG000BR2B91,Pharma execs weigh in on possible changes under Trump,2016-12-01 23:36:25 +0000,http://sg.finance.yahoo.com/news/allergan-ceo-expects-drug-industry-192405801.html,Pharma execs weigh in on possible changes under Trump
PFE,PFE:US,BBG000BR2B91,Here's the Best Dividend Stock in Big Pharma,2016-12-01 23:34:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iavayLtxyM0/heres-the-best-dividend-stock-in-big-pharma-cm716721,When looking for the best pharma dividend stocks there are a few metrics investors should look for High dividend yield Reasonable dividend payout ratio History of dividend increases High likelihood of increase in share price All four categories are
PFE,PFE:US,BBG000BR2B91,Here's the Best Dividend Stock in Big Pharma,2016-12-01 21:48:37 +0000,http://www.fool.com/investing/2016/12/01/heres-the-best-dividend-stock-in-big-pharma.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's the Best Dividend Stock in Big Pharma
PFE,PFE:US,BBG000BR2B91,"IBM, Pfizer Announce Partnership (IBM, PFE)",2016-12-01 20:42:00 +0000,http://www.investopedia.com/news/ibm-pfizer-announce-partnership-ibm-pfe/?partner=YahooSA,[at Investopedia] - International Business Machines Corp. and Pfizer Inc. have announced a partnership to accelerate immuno-oncology research.
PFE,PFE:US,BBG000BR2B91,5 Top Performing S&P 500 Stocks of November,2016-12-01 17:22:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PHm024JLYfw/5-top-performing-sp-500-stocks-of-november-cm716422,President elect Donald Trump has proposed a raft of fiscal stimulus measures which has pushed the S amp P 500 to almost an all time high in November OPEC s decision to cut oil production for the first time since 2008 also added to the euphoria while holiday season sales gained ground Amid
PFE,PFE:US,BBG000BR2B91,Pfizer's Herceptin Biosimilar Meets Primary Endpoint in Study,2016-12-01 16:20:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Psbol1EiE_c/pfizers-herceptin-biosimilar-meets-primary-endpoint-in-study-cm716308,Pfizer Inc PFE recently announced that its experimental biosimilar of Roche Holding AG s RHHBY breast cancer drug Herceptin has reached the primary endpoint in a pivotal study Pfizer shares rose 1 4 in November comparing favorably with a decline of 0 3 for the Zacks
PFE,PFE:US,BBG000BR2B91,US Market Indexes Higher on Tuesday,2016-12-01 16:15:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UE8uszGQelo/us-market-indexes-higher-on-tuesday-cm715928,U S market indexes were higher on Monday with gains slowed by uncertainty from a potential OPEC agreement For the day the Dow Jones Industrial Average closed at 9 6 for a gain of 7 points or The S amp P 5 closed at 4 66 for a gain of 94 points or The
PFE,PFE:US,BBG000BR2B91,Recent R&D Developments from Merck You Won’t Want to Miss,2016-12-01 16:05:29 +0000,http://marketrealist.com/2016/11/recent-rd-developments-from-merck-you-wont-want-to-miss/?utm_source=yahoo&utm_medium=feed,Recent R&D Developments from Merck You Won’t Want to Miss
PFE,PFE:US,BBG000BR2B91,Inside Pfizer’s Recent Corporate and Pipeline Developments,2016-12-01 16:04:13 +0000,http://marketrealist.com/2016/11/inside-pfizers-recent-corporate-and-pipeline-developments/?utm_source=yahoo&utm_medium=feed,Inside Pfizer’s Recent Corporate and Pipeline Developments
PFE,PFE:US,BBG000BR2B91,"Pfizer Announces Positive Top-Line Results from the Pivotal Comparative REFLECTIONS B3271002 Study for PF-05280014, a Potential Biosimilar to Herceptin®1 (trastuzumab)",2016-12-01 15:22:40 +0000,http://www.publicnow.com/view/7BE7AB6388309568F6E48AAD8483BDAD478FB1EF,"[at noodls] - Pfizer Inc. (NYSE:PFE) today announced that the pivotal REFLECTIONS B3271002 study, a comparative safety and efficacy study of PF-05280014 versus Herceptin® (trastuzumab), met its primary endpoint. PF-05280014 ..."
PFE,PFE:US,BBG000BR2B91,LYRICA® (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint,2016-12-01 15:21:25 +0000,http://www.publicnow.com/view/9F7DD318E3649685387598B4AAC3640F21B7E3B2,[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today positive top-line results of a study that evaluated the use of LYRICA® (pregabalin) Capsules CV and Oral Solution CV as adjunctive therapy ...
PFE,PFE:US,BBG000BR2B91,IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery,2016-12-01 15:21:22 +0000,http://www.publicnow.com/view/5772D620ECEDE28B99BFB8A31B6B6AB632AB4E7A,"[at noodls] - ARMONK, New York and NEW YORK - 01 Dec 2016: IBM (NYSE: IBM) Watson Health and Pfizer Inc. (NYSE: PFE) today announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate ..."
PFE,PFE:US,BBG000BR2B91,Major Product Developments for Pfizer,2016-12-01 15:04:19 +0000,http://marketrealist.com/2016/11/major-product-developments-for-pfizer-3/?utm_source=yahoo&utm_medium=feed,Major Product Developments for Pfizer
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference,2016-12-01 15:00:00 +0000,http://finance.yahoo.com/news/pfizer-invites-public-view-listen-150000812.html,"[Business Wire] - Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Mikael Dolsten, President, Worldwide Research and Development, at the Citi 2016 Global Healthcare Conference on Thursday, December 8, 2016 at 2:10 p.m."
PFE,PFE:US,BBG000BR2B91,Lyrica Showed Efficacy in Children With Epilesey (PFE),2016-12-01 14:27:00 +0000,http://www.investopedia.com/news/pfizer-reports-positive-lyrica-study-pfe/?partner=YahooSA,Lyrica Showed Efficacy in Children With Epilesey (PFE)
PFE,PFE:US,BBG000BR2B91,Tiger Cub Lee Ainslie’s Top Stock Picks,2016-12-01 14:21:55 +0000,http://www.insidermonkey.com/blog/tiger-cub-lee-ainslies-top-stock-picks-489906/,Tiger Cub Lee Ainslie’s Top Stock Picks
PFE,PFE:US,BBG000BR2B91,Pfizer's Herceptin Biosimilar Meets Primary Endpoint in Study,2016-12-01 14:08:02 +0000,http://finance.yahoo.com/news/pfizers-herceptin-biosimilar-meets-primary-140802844.html,Pfizer's Herceptin Biosimilar Meets Primary Endpoint in Study
PFE,PFE:US,BBG000BR2B91,Pfizer to use IBM Watson supercomputing to find new drugs,2016-12-01 13:50:08 +0000,http://www.bizjournals.com/boston/news/2016/12/01/pfizer-to-use-ibm-watson-supercomputing-to-find.html?ana=yahoo,Pfizer to use IBM Watson supercomputing to find new drugs
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 12/01/2016: JNJ, PFE, ABT, MRK, AMGN, ARDM, HTBX",2016-12-01 13:35:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LpLjrxfB--Y/health-care-sector-update-for-12012016-jnj-pfe-abt-mrk-amgn-ardm-htbx-cm716194,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 0 6 PFE 0 6 ABT flatABT flat MRK flatMRK flat AMGN 1 3 AMGN 1 3 Health care shares were mostly unchanged in pre market trade Thursday Health care shares were mostly unchanged in pre market trade Thursday In
PFE,PFE:US,BBG000BR2B91,Pfizer’s Profitability and Financial Guidance,2016-12-01 13:04:22 +0000,http://marketrealist.com/2016/11/pfizers-profitability-and-financial-guidance/?utm_source=yahoo&utm_medium=feed,Pfizer’s Profitability and Financial Guidance
PFE,PFE:US,BBG000BR2B91,Pfizer Partners With IBM Watson To Advance Cancer Drug Discovery,2016-12-01 13:00:00 +0000,http://www.forbes.com/sites/brucejapsen/2016/12/01/pfizer-partners-with-ibm-watson-to-advance-cancer-drug-discovery/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Pfizer Partners With IBM Watson To Advance Cancer Drug Discovery
PFE,PFE:US,BBG000BR2B91,Pfizer Reports Positive Results From LYRICA Study In Pediatric Epilepsy Patients,2016-12-01 08:16:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0dVPxFrSMfI/pfizer-reports-positive-results-from-lyrica-study-in-pediatric-epilepsy-patients-20161201-00459,Pfizer Reports Positive Results From LYRICA Study In Pediatric Epilepsy Patients
PFE,PFE:US,BBG000BR2B91,"It's All Green For BLUE, HTBX Plunges On Failed Study, Watch Out For BPMC",2016-12-01 00:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tDge2q3p8Iw/its-all-green-for-blue-htbx-plunges-on-failed-study-watch-out-for-bpmc-20161201-00015,"It's All Green For BLUE, HTBX Plunges On Failed Study, Watch Out For BPMC"
PFE,PFE:US,BBG000BR2B91,What's Pfizer's Excuse for Not Buying Exelixis?,2016-11-30 23:18:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bCXPOLmgFgk/whats-pfizers-excuse-for-not-buying-exelixis-cm716068,Exelixis Inc NASDAQ EXEL 160 reported in October that its kidney cancer drug Cabometyx outperformed Pfizer Inc s NYSE PFE 160 top selling Sutent in first line advanced kidney cancer patients Exelixis management plans to use this data to convince regulators to
PFE,PFE:US,BBG000BR2B91,What's Pfizer's Excuse for Not Buying Exelixis?,2016-11-30 21:41:08 +0000,http://www.fool.com/investing/2016/11/30/whats-pfizers-excuse-for-not-buying-exelixis.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What's Pfizer's Excuse for Not Buying Exelixis?
PFE,PFE:US,BBG000BR2B91,Omnicell's Performance Center Integrates with Hospira's Infusion Pump Software,2016-11-30 21:01:00 +0000,http://finance.yahoo.com/news/omnicells-performance-center-integrates-hospiras-210100377.html,"[PR Newswire] - MOUNTAIN VIEW, Calif., Nov. 30, 2016 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management and supply chain solutions for healthcare systems and pharmacies, and Hospira ..."
PFE,PFE:US,BBG000BR2B91,Avelumab Granted Priority Review: One Of The Many Milestones That Pfizer Needs,2016-11-30 20:24:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NH2dZBmAC6c/avelumab-granted-priority-review-one-of-the-many-milestones-that-pfizer-needs-cm715986,Pfizer 160 PFE has been co developing an anti PD L1 cancer drug Avelumab with Merck KGaA which has now been granted priority review status by the FDA This puts the drug on track to hit the market somewhere in 2017 which is in line with our expectations Avelumab is under review for
PFE,PFE:US,BBG000BR2B91,Allergan's CEO Signals Confidence With $1 Million Purchase Of Stock,2016-11-30 17:06:00 +0000,http://www.forbes.com/sites/kenkam/2016/11/30/allergans-ceo-signals-confidence-with-1-million-purchase-of-stock/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Allergan's CEO Signals Confidence With $1 Million Purchase Of Stock
PFE,PFE:US,BBG000BR2B91,ARIAD's Leukemia Drug Iclusig Gets Full Approval in U.S.,2016-11-30 16:58:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z8cY7ZeXyuQ/ariads-leukemia-drug-iclusig-gets-full-approval-in-us-cm715746,ARIAD Pharmaceuticals Inc ARIA announced that the FDA has granted a full approval to its leukemia drug Iclusig ponatinib following its successful completion of the commitments made on the receipt of accelerated approval in Dec 2012 Iclusig is approved for the treatment of
PFE,PFE:US,BBG000BR2B91,3 High-Yield Dividend Stocks to Buy in December,2016-11-30 16:55:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2fXgfo9If3I/3-high-yield-dividend-stocks-to-buy-in-december-cm715709,High yield dividend stocks tend to be a mixed bag On the one hand above average payouts can really boost a portfolio s return on capital In the same breath high yields are often the unwanted by products of a stock s poor performance over a short period of time Keeping
PFE,PFE:US,BBG000BR2B91,These Pfizer Products Saw Falling Revenues in 3Q16,2016-11-30 16:04:32 +0000,http://marketrealist.com/2016/11/these-pfizer-products-saw-falling-revenues-in-3q16/?utm_source=yahoo&utm_medium=feed,These Pfizer Products Saw Falling Revenues in 3Q16
PFE,PFE:US,BBG000BR2B91,J&J (JNJ) Stands Tall in 2016: Reasons for Outperformance,2016-11-30 15:59:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/646g1EeOt2Y/jj-jnj-stands-tall-in-2016-reasons-for-outperformance-cm715680,Johnson amp Johnson JNJ the bellwether among healthcare companies has a strong presence in the pharmaceutical medical devices and consumer care markets across the world This New Jersey based company is well known for its baby care products and brands like Tylenol in addition to drugs
PFE,PFE:US,BBG000BR2B91,Pfizer/Merck KGaA: Priority Review for Cancer Drug Avelumab,2016-11-30 15:58:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/azoB8r5KXfM/pfizermerck-kgaa-priority-review-for-cancer-drug-avelumab-cm715674,Pfizer Inc PFE and German partner Merck KGaA MKGAF announced that the Biologics License Application sBLA for their experimental anti PD L1 monoclonal antibody avelumab has been accepted for priority review by the FDA Pfizer shares rose 0 7 in the past one month comparing favorably
PFE,PFE:US,BBG000BR2B91,3 High-Yield Dividend Stocks to Buy in December,2016-11-30 15:49:07 +0000,http://www.fool.com/investing/2016/11/30/3-high-yield-dividend-stocks-to-buy-in-december.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 High-Yield Dividend Stocks to Buy in December
PFE,PFE:US,BBG000BR2B91,10 Undervalued High-Yield Dividend Stocks Worth Buying Today,2016-11-30 15:27:00 +0000,https://www.thestreet.com/story/13905366/1/10-undervalued-high-yield-dividend-stocks-worth-buying-today.html?puc=yahoo&cm_ven=YAHOO,10 Undervalued High-Yield Dividend Stocks Worth Buying Today
PFE,PFE:US,BBG000BR2B91,Pfizer reports positive REFLECTIONS data (PFE),2016-11-30 15:22:00 +0000,http://www.investopedia.com/news/does-pfizer-have-answer-herceptin-pfe/?partner=YahooSA,Pfizer reports positive REFLECTIONS data (PFE)
PFE,PFE:US,BBG000BR2B91,Understanding Pfizer’s Growth Contributors,2016-11-30 15:04:51 +0000,http://marketrealist.com/2016/11/understanding-pfizers-growth-contributors-2/?utm_source=yahoo&utm_medium=feed,Understanding Pfizer’s Growth Contributors
PFE,PFE:US,BBG000BR2B91,"Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for December 01, 2016",2016-11-30 14:14:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0fUCDRKhl2I/teva-pharmaceutical-industries-limited-teva-ex-dividend-date-scheduled-for-december-01-2016-cm715609,Teva Pharmaceutical Industries Limited TEVA will begin trading ex dividend on December 01 2016 A cash dividend payment of 0 289 per share is scheduled to be paid on December 20 2016 Shareholders who purchased TEVA prior to the ex dividend date are eligible for the cash dividend
PFE,PFE:US,BBG000BR2B91,Pfizer's Herceptin biosimilar succeeds in key breast cancer study,2016-11-30 13:58:28 +0000,http://finance.yahoo.com/news/pfizers-herceptin-biosimilar-succeeds-key-135828893.html,Pfizer's Herceptin biosimilar succeeds in key breast cancer study
PFE,PFE:US,BBG000BR2B91,Pfizer/Merck KGaA: Priority Review for Cancer Drug Avelumab,2016-11-30 13:38:01 +0000,http://finance.yahoo.com/news/pfizer-merck-kgaa-priority-review-133801037.html,Pfizer/Merck KGaA: Priority Review for Cancer Drug Avelumab
PFE,PFE:US,BBG000BR2B91,"Pfizer Announces Positive Top-Line Results from the Pivotal Comparative REFLECTIONS B3271002 Study for PF-05280014, a Potential Biosimilar to Herceptin®1 (trastuzumab)",2016-11-30 13:30:00 +0000,http://finance.yahoo.com/news/pfizer-announces-positive-top-line-133000188.html,"[Business Wire] - Pfizer Inc. today announced that the pivotal REFLECTIONS B3271002 study, a comparative safety and efficacy study of PF-05280014 versus Herceptin® , met its primary endpoint."
PFE,PFE:US,BBG000BR2B91,Pfizer’s Innovative and Essential Health Businesses,2016-11-30 13:04:47 +0000,http://marketrealist.com/2016/11/pfizers-innovative-and-essential-health-businesses/?utm_source=yahoo&utm_medium=feed,Pfizer’s Innovative and Essential Health Businesses
PFE,PFE:US,BBG000BR2B91,"[$$] Pfizer: Easy to Swallow With Low P/E, 3.8% Yield",2016-11-30 11:17:00 +0000,http://www.barrons.com/articles/pfizer-easy-pill-to-swallow-with-low-p-e-3-8-yield-1480504676?mod=yahoobarrons&ru=yahoo,"[$$] Pfizer: Easy to Swallow With Low P/E, 3.8% Yield"
PFE,PFE:US,BBG000BR2B91,10 Cheap High-Quality Dividend Payers,2016-11-30 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=782513&SR=Yahoo,10 Cheap High-Quality Dividend Payers
PFE,PFE:US,BBG000BR2B91,Pfizer: PF-05280014 Versus Herceptin Study Meets Primary Endpoint,2016-11-30 08:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EvV_Nk9ZEHA/pfizer-pf05280014-versus-herceptin-study-meets-primary-endpoint-20161130-00464,Pfizer: PF-05280014 Versus Herceptin Study Meets Primary Endpoint
PFE,PFE:US,BBG000BR2B91,"Arrowhead Blunted, CERC Depressed, It's All Clear For NOVN, CPHR Leaves Nasdaq",2016-11-30 01:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7J1NgBDHevE/arrowhead-blunted-cerc-depressed-its-all-clear-for-novn-cphr-leaves-nasdaq-20161130-00022,"Arrowhead Blunted, CERC Depressed, It's All Clear For NOVN, CPHR Leaves Nasdaq"
PFE,PFE:US,BBG000BR2B91,"In Case You Missed It Tuesday: Self-Driving Cars, Soy, Slumping Commodities Take Markets for a Ride",2016-11-29 22:24:00 +0000,https://www.thestreet.com/story/13908313/1/in-case-you-missed-it-tuesday-self-driving-cars-soy-slumping-commodities-take-markets-for-a-ride.html?puc=yahoo&cm_ven=YAHOO,"In Case You Missed It Tuesday: Self-Driving Cars, Soy, Slumping Commodities Take Markets for a Ride"
PFE,PFE:US,BBG000BR2B91,US Market Indexes Higher on Tuesday,2016-11-29 22:20:56 +0000,http://finance.yahoo.com/news/us-market-indexes-higher-tuesday-222056969.html,US Market Indexes Higher on Tuesday
PFE,PFE:US,BBG000BR2B91,"Goldman Sachs, Pfizer Are Buys; J&J, Wendy's Downgraded",2016-11-29 21:17:02 +0000,http://www.investors.com/news/goldman-sachs-pfizer-are-buys-jj-wendys-downgraded/,"Goldman Sachs, Pfizer Are Buys; J&J, Wendy's Downgraded"
PFE,PFE:US,BBG000BR2B91,"Boeing, UnitedHealth Dominate DJIA Tuesday",2016-11-29 21:01:24 +0000,http://finance.yahoo.com/news/boeing-unitedhealth-dominate-djia-tuesday-210124174.html,"Boeing, UnitedHealth Dominate DJIA Tuesday"
PFE,PFE:US,BBG000BR2B91,Pfizer Upgraded at Barclays,2016-11-29 20:18:00 +0000,http://www.thestreet.com/video/13908067/pfizer-upgraded-at-barclays.html?puc=yahoov&cm_ven=YAHOOV,Pfizer Upgraded at Barclays
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Stock Rating Upgraded at Barclays,2016-11-29 19:18:00 +0000,https://www.thestreet.com/story/13908006/1/pfizer-pfe-stock-rating-upgraded-at-barclays.html?puc=yahoo&cm_ven=YAHOO,Pfizer (PFE) Stock Rating Upgraded at Barclays
PFE,PFE:US,BBG000BR2B91,J&J raises Actelion takeover pressure with higher price - source,2016-11-29 18:52:10 +0000,http://sg.finance.yahoo.com/news/j-j-raising-offer-actelion-154625191.html,J&J raises Actelion takeover pressure with higher price - source
PFE,PFE:US,BBG000BR2B91,Does Procter & Gamble Co (PG) Represent a Good Addition to Your Portfolio?,2016-11-29 18:30:58 +0000,http://www.insidermonkey.com/blog/does-procter-gamble-co-pg-represent-a-good-addition-to-your-portfolio-489828/,Does Procter & Gamble Co (PG) Represent a Good Addition to Your Portfolio?
PFE,PFE:US,BBG000BR2B91,"VOO, PFE, KO, PEP: Large Inflows Detected at ETF",2016-11-29 17:56:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RhWvruT01GU/voo-pfe-ko-pep-large-inflows-detected-at-etf-cm715227,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard S amp P 500 ETF Symbol VOO where we have detected an approximate 63 9 million dollar inflow that s a 0 1 increase week over week in outstanding
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. (PFE), Eli Lilly And Co (LLY) Impotence Drugs Price Increases Leave Patients Disgruntled",2016-11-29 17:50:29 +0000,http://www.insidermonkey.com/blog/pfizer-inc-pfe-eli-lilly-and-co-lly-impotence-drugs-price-increases-leave-patients-disgruntled-494753/,"Pfizer Inc. (PFE), Eli Lilly And Co (LLY) Impotence Drugs Price Increases Leave Patients Disgruntled"
PFE,PFE:US,BBG000BR2B91,"The Pfizer-Medivation Deal, Completed in 3Q16",2016-11-29 16:05:15 +0000,http://marketrealist.com/2016/11/the-pfizer-medivation-deal-completed-in-3q16/?utm_source=yahoo&utm_medium=feed,"The Pfizer-Medivation Deal, Completed in 3Q16"
PFE,PFE:US,BBG000BR2B91,Pfizer Shares up in Early Trading (PFE),2016-11-29 16:00:00 +0000,http://www.investopedia.com/news/pfizer-shares-gain-after-upgrade-pfe/?partner=YahooSA,Pfizer Shares up in Early Trading (PFE)
PFE,PFE:US,BBG000BR2B91,Pfizer Divests Hospira’s Infusion System Business to ICU Medical,2016-11-29 15:05:42 +0000,http://marketrealist.com/2016/11/pfizer-divests-hospiras-infusion-system-business-to-icu-medical/?utm_source=yahoo&utm_medium=feed,Pfizer Divests Hospira’s Infusion System Business to ICU Medical
PFE,PFE:US,BBG000BR2B91,Pfizer: Be Happy With the Dividend for Now,2016-11-29 14:52:00 +0000,http://realmoney.thestreet.com/articles/11/29/2016/pfizer-be-happy-dividend-now?puc=yahoo&cm_ven=YAHOO,Pfizer: Be Happy With the Dividend for Now
PFE,PFE:US,BBG000BR2B91,FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review,2016-11-29 14:28:00 +0000,http://finance.yahoo.com/news/fda-accepts-biologics-license-application-142800829.html,[CNW Group] - FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review
PFE,PFE:US,BBG000BR2B91,"Stock Futures Turn Mixed as U.S. Economy Grows, Oil Prices Slump",2016-11-29 14:09:00 +0000,https://www.thestreet.com/story/13907076/1/stock-futures-tiptoe-higher-despite-crude-oil-s-slump.html?puc=yahoo&cm_ven=YAHOO,"Stock Futures Turn Mixed as U.S. Economy Grows, Oil Prices Slump"
PFE,PFE:US,BBG000BR2B91,"Early movers: TIF, UNH, MNK, PFE, AAPL, T, TIVO, C, ALL & more",2016-11-29 13:17:13 +0000,http://www.cnbc.com/id/104134567?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104134567,"Early movers: TIF, UNH, MNK, PFE, AAPL, T, TIVO, C, ALL & more"
PFE,PFE:US,BBG000BR2B91,Pfizer’s Valuation Compared to Peers,2016-11-29 13:06:50 +0000,http://marketrealist.com/2016/11/pfizers-valuation-compared-to-peers/?utm_source=yahoo&utm_medium=feed,Pfizer’s Valuation Compared to Peers
PFE,PFE:US,BBG000BR2B91,"German Merck, Pfizer get FDA priority review for cancer drug",2016-11-29 13:06:36 +0000,http://finance.yahoo.com/news/german-merck-pfizer-fda-priority-130636773.html,"[Reuters] - German drugmaker Merck KGaA and U.S. partner Pfizer have been granted priority review status in the United States as they seek approval to fight a rare and aggressive form of skin cancer with immunotherapy drug avelumab. The U.S. Food and Drug Administration has accepted the request for approval and will review the trial data for the drug against metastatic Merkel cell carcinoma within six months instead of the usual 10, Merck said on Tuesday. Avelumab belongs to a new generation of biotech drugs that stop some tumours from hiding from the immune system, similar to Merck & Co's Keytruda or Roche's Tecentriq."
PFE,PFE:US,BBG000BR2B91,Merck: Keytruda's Priority Review for New Cancer Indication,2016-11-29 12:53:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YZgnHQ10nVs/merck-keytrudas-priority-review-for-new-cancer-indication-cm714874,Merck amp Co Inc s MRK yet another supplemental Biologics License Application sBLA for its anti PD 1 therapy Keytruda has been accepted for priority review by the FDA This time the company is looking to expand the label for the treatment of previously treated patients with
PFE,PFE:US,BBG000BR2B91,Clifton on Trump trade: Financials good place to be,2016-11-29 11:25:00 +0000,http://finance.yahoo.com/video/clifton-trump-trade-financials-good-112500156.html,Clifton on Trump trade: Financials good place to be
PFE,PFE:US,BBG000BR2B91,"Stocks to Watch: November 29, 2016",2016-11-29 11:16:00 +0000,http://finance.yahoo.com/video/stocks-watch-november-29-2016-111600077.html,"Stocks to Watch: November 29, 2016"
PFE,PFE:US,BBG000BR2B91,Pfizer : FDA Accepts BLA For Avelumab For Treatment Of MMCC For Priority Review,2016-11-29 08:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x4HPXATEZvA/pfizer--fda-accepts-bla-for-avelumab-for-treatment-of-mmcc-for-priority-review-20161129-00449,Pfizer : FDA Accepts BLA For Avelumab For Treatment Of MMCC For Priority Review
PFE,PFE:US,BBG000BR2B91,Which companies will benefit from Cuban biotech?,2016-11-28 21:19:00 +0000,http://finance.yahoo.com/video/companies-benefit-cuban-biotech-211900189.html,Which companies will benefit from Cuban biotech?
PFE,PFE:US,BBG000BR2B91,"XLV, DXJF: Big ETF Inflows",2016-11-28 19:54:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BO0t7JwMtMY/xlv-dxjf-big-etf-inflows-cm714656,Comparing units outstanding versus one week ago at the coverage universe of ETFs at ETF Channel the biggest inflow was seen in the Health Care Select Sector SPDR Fund XLV which added 5 050 000 units or a 2 7 increase week over week Among the largest underlying components of XLV
PFE,PFE:US,BBG000BR2B91,5 Healthcare Stocks Hedge Funds Are Dumping Like Crazy,2016-11-28 18:11:26 +0000,http://www.insidermonkey.com/blog/5-healthcare-stocks-hedge-funds-are-dumping-like-crazy-492511/,5 Healthcare Stocks Hedge Funds Are Dumping Like Crazy
PFE,PFE:US,BBG000BR2B91,Pfizer Nixes 350-Job Expansion After Drug Fails (PFE),2016-11-28 16:45:00 +0000,http://www.investopedia.com/news/pfizer-scraps-425m-dublin-plant-expansion-pfe/?partner=YahooSA,Pfizer Nixes 350-Job Expansion After Drug Fails (PFE)
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Pfizer, Microsoft, Priceline, Expedia and United Continental",2016-11-28 16:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RnmoBAHVEPc/the-zacks-analyst-blog-highlights-pfizer-microsoft-priceline-expedia-and-united-continental-cm714506,For Immediate Release Chicago IL November 28 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
PFE,PFE:US,BBG000BR2B91,J&J (JNJ) Confirms it Approached Actelion for Possible Deal,2016-11-28 14:33:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zCLu1PRkfY4/jj-jnj-confirms-it-approached-actelion-for-possible-deal-cm714346,Johnson amp Johnson JNJ confirmed that it approached Swiss biotechnology company Actelion Ltd ALIOF with a takeover offer J amp J stated in a press release that it is engaged in preliminary discussions with Actelion regarding a possible transaction However both J amp J and
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Pfizer, Microsoft, Priceline, Expedia and United Continental",2016-11-28 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-pfizer-143002272.html,"The Zacks Analyst Blog Highlights: Pfizer, Microsoft, Priceline, Expedia and United Continental"
PFE,PFE:US,BBG000BR2B91,Actelion's ambitious independent-minded CEO will drive up takeover price,2016-11-28 12:45:18 +0000,http://sg.finance.yahoo.com/news/actelions-ambitious-independent-minded-ceo-124518400.html,Actelion's ambitious independent-minded CEO will drive up takeover price
PFE,PFE:US,BBG000BR2B91,Short Sellers Hike Their Bets in Most Major Pharma Stocks,2016-11-28 12:15:13 +0000,http://finance.yahoo.com/news/short-sellers-hike-bets-most-121513877.html,Short Sellers Hike Their Bets in Most Major Pharma Stocks
PFE,PFE:US,BBG000BR2B91,Tandem Drug-Price Increases Take Toll on Some Patients,2016-11-28 05:07:58 +0000,http://www.wsj.com/articles/tandem-drug-price-increases-take-toll-on-some-patients-1480248000?ru=yahoo?mod=yahoo_itp,Tandem Drug-Price Increases Take Toll on Some Patients
PFE,PFE:US,BBG000BR2B91,Drugmakers Find Competition Doesn’t Keep a Lid on Prices,2016-11-28 05:07:52 +0000,http://www.wsj.com/articles/drugmakers-find-competition-doesnt-keep-a-lid-on-prices-1480248003?ru=yahoo?mod=yahoo_itp,Drugmakers Find Competition Doesn’t Keep a Lid on Prices
PFE,PFE:US,BBG000BR2B91,Where Else Have We Seen Mallinckrodt’s ‘Acquire to Invest’ Strategy?,2016-11-27 21:54:53 +0000,http://marketrealist.com/2016/03/else-seen-mallinckrodts-acquire-invest-strategy/?utm_source=yahoo&utm_medium=feed,Where Else Have We Seen Mallinckrodt’s ‘Acquire to Invest’ Strategy?
PFE,PFE:US,BBG000BR2B91,[$$] Drugmakers Find Competition Doesn't Keep a Lid on Prices,2016-11-27 12:05:39 +0000,http://www.wsj.com/articles/drugmakers-find-competition-doesnt-keep-a-lid-on-prices-1480248003?mod=yahoo_hs,[$$] Drugmakers Find Competition Doesn't Keep a Lid on Prices
PFE,PFE:US,BBG000BR2B91,[$$] Tandem Drug-Price Increases Take Toll on Some Patients,2016-11-27 12:00:04 +0000,http://www.wsj.com/articles/tandem-drug-price-increases-take-toll-on-some-patients-1480248000?mod=yahoo_hs,[$$] Tandem Drug-Price Increases Take Toll on Some Patients
PFE,PFE:US,BBG000BR2B91,Drugmakers Find Competition Doesn’t Keep a Lid on Prices,2016-11-27 12:00:00 +0000,http://finance.yahoo.com/news/drugmakers-competition-doesn-t-keep-120000679.html,Drugmakers Find Competition Doesn’t Keep a Lid on Prices
PFE,PFE:US,BBG000BR2B91,Drugmakers Find Competition Doesn't Keep a Lid on Prices,2016-11-27 07:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BnsS0Wg6MWo/drugmakers-find-competition-doesnt-keep-a-lid-on-prices-20161127-00007,Drugmakers Find Competition Doesn't Keep a Lid on Prices
PFE,PFE:US,BBG000BR2B91,Tandem Drug-Price Increases Take Toll on Some Patients,2016-11-27 07:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Bbe6qwGkNYQ/tandem-drugprice-increases-take-toll-on-some-patients-20161127-00006,Tandem Drug-Price Increases Take Toll on Some Patients
PFE,PFE:US,BBG000BR2B91,J&J Stalks Swiss Drug Company -- WSJ,2016-11-26 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hS26PM684rg/jj-stalks-swiss-drug-company--wsj-20161126-00004,J&J Stalks Swiss Drug Company -- WSJ
PFE,PFE:US,BBG000BR2B91,Top Research Reports for Black Friday 2016,2016-11-25 18:02:06 +0000,http://finance.yahoo.com/news/top-research-reports-black-friday-180206109.html,Top Research Reports for Black Friday 2016
PFE,PFE:US,BBG000BR2B91,"Stocks Open Modestly Higher; Early Risers: Wal-Mart, Pfizer, Ctrip.com",2016-11-25 14:50:01 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-steer-higher-early-risers-pfizer-disney-ctrip-com/,"Stocks Open Modestly Higher; Early Risers: Wal-Mart, Pfizer, Ctrip.com"
PFE,PFE:US,BBG000BR2B91,"Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for November 28, 2016",2016-11-25 14:15:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K2tNZUahlHU/phibro-animal-health-corporation-pahc-ex-dividend-date-scheduled-for-november-28-2016-cm713819,Phibro Animal Health Corporation PAHC will begin trading ex dividend on November 28 2016 A cash dividend payment of 0 1 per share is scheduled to be paid on December 21 2016 Shareholders who purchased PAHC prior to the ex dividend date are eligible for the cash dividend payment
PFE,PFE:US,BBG000BR2B91,J&J Approaches Swiss Firm Actelion About Potential Deal,2016-11-25 12:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Dl4xlWGL1co/jj-approaches-swiss-firm-actelion-about-potential-deal-20161125-00208,J&J Approaches Swiss Firm Actelion About Potential Deal
PFE,PFE:US,BBG000BR2B91,A Deeper Look into Eli Lilly’s New Products Portfolio,2016-11-24 15:04:17 +0000,http://marketrealist.com/2016/11/a-deeper-look-into-eli-lillys-new-products-portfolio/?utm_source=yahoo&utm_medium=feed,A Deeper Look into Eli Lilly’s New Products Portfolio
PFE,PFE:US,BBG000BR2B91,"Lilly's Alzheimer Drug Fails Phase III Study, Stock Down",2016-11-24 13:06:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SV-ZlB57ots/lillys-alzheimer-drug-fails-phase-iii-study-stock-down-cm713614,Lilly s Eli Lilly and Company LLY announced that its key pipeline candidate solanezumab failed to meet the primary endpoint in a phase III study EXPEDITION3 in patients with mild Alzheimer s dementia The drugmaker s shares declined almost 11 on Wednesday following the disappointing
PFE,PFE:US,BBG000BR2B91,What Happened in Biotech in 2016?,2016-11-23 21:44:34 +0000,http://www.fool.com/investing/2016/11/22/what-happened-in-biotech-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What Happened in Biotech in 2016?
PFE,PFE:US,BBG000BR2B91,Lilly's drug for Alzheimer's fails big trial; shares drop,2016-11-23 21:25:38 +0000,http://sg.finance.yahoo.com/news/lillys-drug-alzheimers-fails-big-190703746.html,Lilly's drug for Alzheimer's fails big trial; shares drop
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. (PFE): Are Hedge Funds Right About This Stock?,2016-11-23 21:20:00 +0000,http://www.insidermonkey.com/blog/pfizer-inc-pfe-are-hedge-funds-right-about-this-stock-489778/,Pfizer Inc. (PFE): Are Hedge Funds Right About This Stock?
PFE,PFE:US,BBG000BR2B91,Eli Lilly and Co (LLY) Drug Failure Doesn’t Answer the Bigger Question,2016-11-23 20:05:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KUePqSjdx6k/eli-lilly-and-co-lly-drug-failure-doesnt-answer-the-bigger-question-cm713492,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips A tough break for Eli Lilly and Co NYSE LLY shareholders today reports of another failed drug trial have sent LLY shares 12 lower as of this writing The current price near 67 is a two year
PFE,PFE:US,BBG000BR2B91,Eli Lilly Alzheimer''s Drug Fails Trial; Shares Plunge,2016-11-23 07:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h3Nid7pkXD0/eli-lilly-alzheimers-drug-fails-trial-shares-plunge-20161123-00393,Eli Lilly Alzheimer''s Drug Fails Trial; Shares Plunge
PFE,PFE:US,BBG000BR2B91,Eli Lilly Alzheimer's Drug Fails Trial; Shares Plunge,2016-11-23 07:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yEDUkOEyy10/eli-lilly-alzheimers-drug-fails-trial-shares-plunge-20161123-00715,Eli Lilly Alzheimer's Drug Fails Trial; Shares Plunge
PFE,PFE:US,BBG000BR2B91,What Happened in Biotech in 2016?,2016-11-22 23:19:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Jc0QNGC1rY8/what-happened-in-biotech-in-2016-cm713018,Image source Getty Images It s been a rollercoaster of a year for the biotech industry with the decline that started in the middle of last year continuing into this year a recovery from those lows after a few gyrations a pre election decline on fears of price controls and
PFE,PFE:US,BBG000BR2B91,"Lilly Poised For Big December On Alzheimer's Data, Diabetes Ruling",2016-11-22 21:01:57 +0000,http://www.investors.com/news/technology/lilly-poised-for-holly-december-on-alzheimers-data-diabetes-ruling/,"Lilly Poised For Big December On Alzheimer's Data, Diabetes Ruling"
PFE,PFE:US,BBG000BR2B91,Small-Cap Biotech Is on Front Lines of Fight Against Depression,2016-11-22 20:22:47 +0000,http://finance.yahoo.com/news/small-cap-biotech-front-lines-202247344.html,Small-Cap Biotech Is on Front Lines of Fight Against Depression
PFE,PFE:US,BBG000BR2B91,7 Stocks That Are Ridiculously Cheap Right Now,2016-11-22 19:43:53 +0000,http://www.fool.com/investing/2016/11/22/7-stocks-that-are-ridiculously-cheap-right-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,7 Stocks That Are Ridiculously Cheap Right Now
PFE,PFE:US,BBG000BR2B91,Is Donald Trump a Blessing or a Curse for Big Pharma?,2016-11-22 19:19:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eHXI5jlkzPA/is-donald-trump-a-blessing-or-a-curse-for-big-pharma-cm712872,The pharmaceutical industry is breathing a sigh of relief after Donald Trump s insurgent victory earlier this month thanks to his arguably more favorable stances on prescription drug prices corporate tax rates and regulatory reform at the FDA as compared to his former
PFE,PFE:US,BBG000BR2B91,Pfizer to consolidate offices at new $200 million Chesterfield campus,2016-11-22 17:29:19 +0000,http://www.bizjournals.com/stlouis/news/2016/11/22/pfizer-to-build-chesterfield-campus.html?ana=yahoo,Pfizer to consolidate offices at new $200 million Chesterfield campus
PFE,PFE:US,BBG000BR2B91,Is Donald Trump a Blessing or a Curse for Big Pharma?,2016-11-22 17:27:40 +0000,http://www.fool.com/investing/2016/11/22/is-donald-trump-a-blessing-or-a-curse-for-big-phar.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Donald Trump a Blessing or a Curse for Big Pharma?
PFE,PFE:US,BBG000BR2B91,Where Does Eli Lilly’s Valuation Stand Next to Peers?,2016-11-22 16:54:12 +0000,http://marketrealist.com/2016/11/where-does-eli-lillys-valuation-stand-next-to-peers/?utm_source=yahoo&utm_medium=feed,Where Does Eli Lilly’s Valuation Stand Next to Peers?
PFE,PFE:US,BBG000BR2B91,Novartis Buys Selexys on Favorable Phase II Data on SelG1,2016-11-22 16:21:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/foGvRZBHge8/novartis-buys-selexys-on-favorable-phase-ii-data-on-selg1-cm712677,Swiss drug maker Novartis AG NVS announced that it has acquired Selexys Pharmaceuticals Corporation a privately held company specializing in the development of therapeutics for certain hematologic and inflammatory disorders following the receipt of results from the phase II SUSTAIN study
PFE,PFE:US,BBG000BR2B91,What Do the Analysts Recommend for Bristol-Myers Squibb’s Stock?,2016-11-22 16:04:18 +0000,http://marketrealist.com/2016/11/what-do-the-analysts-recommend-for-bristol-myers-squibbs-stock/?utm_source=yahoo&utm_medium=feed,What Do the Analysts Recommend for Bristol-Myers Squibb’s Stock?
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. (PFE) Files Lawsuit Against Texas HHSC,2016-11-22 15:27:18 +0000,http://www.insidermonkey.com/blog/pfizer-inc-pfe-files-lawsuit-against-texas-hhsc-489538/,Pfizer Inc. (PFE) Files Lawsuit Against Texas HHSC
PFE,PFE:US,BBG000BR2B91,7 Stocks That Are Ridiculously Cheap Right Now,2016-11-22 15:19:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pFPPsI5R6V0/7-stocks-that-are-ridiculously-cheap-right-now-cm712555,The only thing that is better than buying the stock of a great company is buying a stock of a great company at a low price While there aren t a whole lot of companies out there selling at decent discounted prices these days the market is hitting all time highs after all there
PFE,PFE:US,BBG000BR2B91,"The Latest on Fasinumab, a Teva-Regeneron Collaborative Drug",2016-11-22 15:04:52 +0000,http://marketrealist.com/2016/11/teva-pharmaceutical-regeneron-continue-develop-ngf-antibody-fasinumab-2016/?utm_source=yahoo&utm_medium=feed,"The Latest on Fasinumab, a Teva-Regeneron Collaborative Drug"
PFE,PFE:US,BBG000BR2B91,"Currency drop hits Egypt's medicine supplies, angering public",2016-11-22 13:27:14 +0000,http://uk.finance.yahoo.com/news/currency-drop-hits-egypts-medicine-132714769.html,"[Reuters - UK Focus] - Pharmacies across Egypt are running short of medicines, some of them life-savers, as a plunge in the value of the Egyptian pound coupled with strict government price caps has made scores of products unprofitable to produce or import. Unable to raise prices above levels set by the Health Ministry but now paying roughly twice as much to import drugs or active ingredients, pharmaceutical firms say they have been forced to phase out certain medicine to stay in business. Out of insulin for weeks, Ali Etman said he was recently forced to turn away eight diabetes patients from his Cairo pharmacy in a single day."
PFE,PFE:US,BBG000BR2B91,"Can DJIA Still Rise to 19,700 by End of 2016?",2016-11-22 13:26:27 +0000,http://247wallst.com/investing/2016/11/22/can-djia-still-rise-to-19700-by-end-of-2016/,"Can DJIA Still Rise to 19,700 by End of 2016?"
PFE,PFE:US,BBG000BR2B91,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-11-21 22:09:52 +0000,http://biz.yahoo.com/e/161121/pfe8-k.html,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Nov 21, 2016 :  PRXL, WMB, C, AAPL, YHOO, PFE, PG, GRPN, IVC, FTR, QQQ, ZAYO",2016-11-21 21:57:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pLLhO_-E8_Y/after-hours-most-active-for-nov-21-2016-prxl-wmb-c-aapl-yhoo-pfe-pg-grpn-ivc-ftr-qqq-zayo-cm712352,The NASDAQ 100 After Hours Indicator is down 49 to 4 858 51 The total After hours volume is currently 31 575 489 shares traded The following are the most active stocks for the after hours session PAREXEL International Corporation PRXL is unchanged at 57 51
PFE,PFE:US,BBG000BR2B91,Cloud M&A: Oracle Corporation (ORCL) to Buy DNS Provider Dyn,2016-11-21 20:57:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jza8SnSeFZ0/cloud-ma-oracle-corporation-orcl-to-buy-dns-provider-dyn-cm712308,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Oracle Corporation NYSE ORCL is planning to purchase DNS provider Dyn Source Flickr Oracle Corporation didn t say how much it would be spending to acquire Dyn or when the deal will
PFE,PFE:US,BBG000BR2B91,"Stock Market News for November 21, 2016",2016-11-21 18:23:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MunfDnJLPjU/stock-market-news-for-november-21-2016-cm712136,Rising rate hike possibilities boosted the dollar to its best settlement in 13 years which in turn dragged the benchmarks into the red on Friday Following his victory it is widely expected that Donald Trump will boost infrastructure spending and cut taxes which will result in higher
PFE,PFE:US,BBG000BR2B91,"Notable ETF Outflow Detected - PPH, SNY, BMY, PFE",2016-11-21 18:09:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y9dpIg15o70/notable-etf-outflow-detected-pph-sny-bmy-pfe-cm712104,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Pharmaceutical ETF Symbol PPH where we have detected an approximate 42 2 million dollar outflow that s a 14 1 decrease week over week from 5 688 138
PFE,PFE:US,BBG000BR2B91,Pfizer Files 8K - Other Events,2016-11-21 17:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rhVoOYaj8LA/pfizer-files-8k--other-events-20161121-01089,Pfizer Files 8K - Other Events
PFE,PFE:US,BBG000BR2B91,Pfizer Files 8K - Other Events,2016-11-21 17:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NnU-EmBhwqk/pfizer-files-8k--other-events-20161121-01088,Pfizer Files 8K - Other Events
PFE,PFE:US,BBG000BR2B91,"Pfizer Announces Expiration And Results Of Tender Offer For Any And All Of Its 6.200% Senior Notes Due March 15, 2019",2016-11-21 17:00:29 +0000,http://www.publicnow.com/view/FD959B986FD197C81938850AA07F2AAC95E60BC5,[at noodls] - Pfizer Inc. (NYSE:PFE) (the 'Company') today announced the expiration and results of the previously announced tender offer (the 'Tender Offer') to purchase for cash any and all of its outstanding 6.200% ...
PFE,PFE:US,BBG000BR2B91,"Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply to Retire",2016-11-21 17:00:29 +0000,http://www.publicnow.com/view/8C9790A36B259FDAB572E51324A29C5695008E87,"[at noodls] - Pfizer Inc. (NYSE:PFE) today announced that Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply will retire from the company after more than 41 years with Pfizer. ... This ..."
PFE,PFE:US,BBG000BR2B91,How a 15% Decline Is a Gift to Income Investors,2016-11-21 16:45:01 +0000,http://finance.yahoo.com/news/15-decline-gift-income-investors-164501907.html,How a 15% Decline Is a Gift to Income Investors
PFE,PFE:US,BBG000BR2B91,"Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply to Retire",2016-11-21 15:11:00 +0000,http://finance.yahoo.com/news/anthony-j-maddaluna-executive-vice-151100272.html,"[Business Wire] - Pfizer Inc. today announced that Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply will retire from the company after more than 41 years with Pfizer."
PFE,PFE:US,BBG000BR2B91,"Perrigo Company (PRGO) Ex-Dividend Date Scheduled for November 22, 2016",2016-11-21 14:20:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_ShWCfQK5hY/perrigo-company-prgo-ex-dividend-date-scheduled-for-november-22-2016-cm711844,Perrigo Company PRGO will begin trading ex dividend on November 22 2016 A cash dividend payment of 0 145 per share is scheduled to be paid on December 13 2016 Shareholders who purchased PRGO prior to the ex dividend date are eligible for the cash dividend payment This marks the
PFE,PFE:US,BBG000BR2B91,3 Stocks You Can Safely Own Until 2030,2016-11-21 12:53:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4rViGH4FAlc/3-stocks-you-can-safely-own-until-2030-cm711725,Image source Getty Images Any investment novice knows that stocks are risky investments However it s important for investors to know how risks affect the portfolio Every stock has two sources of risk Systemic risk the first type is mostly unavoidable when investing in
PFE,PFE:US,BBG000BR2B91,"Pfizer Announces Expiration And Results Of Tender Offer For Any And All Of Its 6.200% Senior Notes Due March 15, 2019",2016-11-21 11:45:00 +0000,http://finance.yahoo.com/news/pfizer-announces-expiration-results-tender-114500244.html,"[Business Wire] - Pfizer Inc. today announced the expiration and results of the previously announced tender offer to purchase for cash any and all of its outstanding 6.200% Senior Notes due March 15, 2019 ."
PFE,PFE:US,BBG000BR2B91,3 Stocks You Can Safely Own Until 2030,2016-11-20 22:06:00 +0000,http://www.fool.com/investing/2016/11/20/3-stocks-you-can-safely-own-until-2030.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,3 Stocks You Can Safely Own Until 2030
PFE,PFE:US,BBG000BR2B91,"3 Stocks That Turned $7,000 Into $145,600 (or More)",2016-11-20 13:49:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BflqUs2qAjc/3-stocks-that-turned-7000-into-145600-or-more-cm711668,Image source Getty Images You don t need to own the next big information technology stock to see eye popping returns Sometimes the most obvious long term opportunities are hiding in plain sight the mistake is that the boring can be overlooked for the flashy But in
PFE,PFE:US,BBG000BR2B91,"3 Stocks That Turned $7,000 Into $145,600 (or More)",2016-11-20 12:43:34 +0000,http://www.fool.com/investing/2016/11/20/3-stocks-that-turned-7000-into-145600-or-more.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"3 Stocks That Turned $7,000 Into $145,600 (or More)"
PFE,PFE:US,BBG000BR2B91,"Pfizer Announces Pricing of Tender Offer for Any and All of its 6.200% Senior Notes Due March 15, 2019",2016-11-18 22:50:05 +0000,http://www.publicnow.com/view/6F3C752AF8B0D4EF8D45CAF1524F99C9D4749A29,[at noodls] - Pfizer Inc. (NYSE:PFE) (the 'Company') today announced the pricing of the previously announced tender offer (the 'Tender Offer') to purchase for cash any and all of its outstanding 6.200% Senior Notes ...
PFE,PFE:US,BBG000BR2B91,The 10 Best Pharma Stocks Under President Donald Trump,2016-11-18 21:50:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Rr-p2ujnig0/the-10-best-pharma-stocks-under-president-donald-trump-cm710889,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips It s been a little over a week yet the news has yet to fully sink in for many folks Donald Trump the mogul the mastermind the most interesting man in the world according to Donald Trump will be
PFE,PFE:US,BBG000BR2B91,"Donald Trump, Republicans Won't Ease Drug-Pricing Debate: Pfizer",2016-11-18 21:01:45 +0000,http://www.investors.com/news/technology/donald-trump-republicans-wont-ease-drug-pricing-debate-pfizer/,"Donald Trump, Republicans Won't Ease Drug-Pricing Debate: Pfizer"
PFE,PFE:US,BBG000BR2B91,Is Pfizer Rethinking a Company Spin-Off?,2016-11-18 16:52:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oGU8y39JMHU/is-pfizer-rethinking-a-company-spin-off-cm711253,Image source Getty Images Pfizer s NYSE PFE stock jumped last week based on a Reuters report that the company could be planning to unload its consumer health unit for 14 billion The potential spin off would be great news for shareholders helping to refocus Pfizer on
PFE,PFE:US,BBG000BR2B91,Innovative Research in Vaccines May Boost Pfizer’s Revenues,2016-11-18 15:04:40 +0000,http://marketrealist.com/2016/11/innovative-research-programs-vaccines-segment-may-boost-pfizers-revenues-future-years/?utm_source=yahoo&utm_medium=feed,Innovative Research in Vaccines May Boost Pfizer’s Revenues
PFE,PFE:US,BBG000BR2B91,Is Pfizer Rethinking a Company Spin-Off?,2016-11-18 15:02:17 +0000,http://www.fool.com/investing/2016/11/18/is-pfizer-rethinking-a-company-spin-off.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Pfizer Rethinking a Company Spin-Off?
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal",2016-11-18 13:51:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rzqSEN84ZPw/pharma-stock-roundup-data-presented-at-acr-bristol-myers-inks-immuno-oncology-deal-cm711052,Several companies were present at the annual meeting of the American College of Rheumatology ACR presenting data on approved as well as pipeline candidates Meanwhile Bristol Myers BMY announced an immune oncology deal and also provided updates on some of its cancer treatments Recap of
PFE,PFE:US,BBG000BR2B91,"Pfizer’s Metabolic, Rare Disease Segments: Hope for the Future?",2016-11-18 13:04:47 +0000,http://marketrealist.com/2016/11/metabolic-rare-disease-segments-expected-boost-pfizers-revenues-future-years/?utm_source=yahoo&utm_medium=feed,"Pfizer’s Metabolic, Rare Disease Segments: Hope for the Future?"
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal",2016-11-18 11:22:11 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-data-presented-112211338.html,"Pharma Stock Roundup: Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal"
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Ibrance Positive in Phase III Breast Cancer Study,2016-11-18 05:51:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FX5TAO-dTIE/pfizer-pfe-ibrance-positive-in-phase-iii-breast-cancer-study-cm710964,Pfizer Inc PFE announced that detailed results of phase III PALOMA 2 study evaluating the combination of its breast cancer drug Ibrance palbociclib and Novartis AG s NVS Femara letrozole for the treatment of first line ER HER2 metastatic breast cancer were published in The New
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Ibrance Positive in Phase III Breast Cancer Study,2016-11-18 03:58:03 +0000,http://finance.yahoo.com/news/pfizer-pfe-ibrance-positive-phase-035803537.html,Pfizer (PFE) Ibrance Positive in Phase III Breast Cancer Study
PFE,PFE:US,BBG000BR2B91,Money in Medicine: The 30 drug and device makers who paid Oregon doctors the most,2016-11-18 00:27:41 +0000,http://www.bizjournals.com/portland/news/2016/11/17/money-in-medicine-the-top-30-drug-and-device.html?ana=yahoo,Money in Medicine: The 30 drug and device makers who paid Oregon doctors the most
PFE,PFE:US,BBG000BR2B91,AnacorAcquisition Added Crisaborole to Pfizer’s Portfolio,2016-11-17 23:04:11 +0000,http://marketrealist.com/2016/11/acquisition-anacor-added-promising-investigational-drug-crisaborole-pfizers-portfolio/?utm_source=yahoo&utm_medium=feed,AnacorAcquisition Added Crisaborole to Pfizer’s Portfolio
PFE,PFE:US,BBG000BR2B91,10 Pharma Stocks That Are Prescribed Under President Trump,2016-11-17 22:51:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w2zuywKHp48/10-pharma-stocks-that-are-prescribed-under-president-trump-cm710889,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips It s been a little over a week yet the news has yet to fully sink in for many folks Donald Trump the mogul the mastermind the most interesting man in the world according to Donald Trump will be
PFE,PFE:US,BBG000BR2B91,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-11-17 22:05:06 +0000,http://biz.yahoo.com/e/161117/pfe8-k.html,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
PFE,PFE:US,BBG000BR2B91,Pfizer’s Xeljanz Expected to See Strong Growth Trends in 2016,2016-11-17 21:01:46 +0000,http://marketrealist.com/2016/11/xeljanz-expected-witness-strong-growth-trends-2016/?utm_source=yahoo&utm_medium=feed,Pfizer’s Xeljanz Expected to See Strong Growth Trends in 2016
PFE,PFE:US,BBG000BR2B91,Pfizer Files 8K - Other Events,2016-11-17 17:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ziP70OYEgRU/pfizer-files-8k--other-events-20161117-01288,Pfizer Files 8K - Other Events
PFE,PFE:US,BBG000BR2B91,3 Things Exelixis Must Do to Survive and Thrive in 2017,2016-11-17 15:52:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FPpwwYqZXB8/3-things-exelixis-must-do-to-survive-and-thrive-in-2017-cm710577,Few stocks have performed as well as Exelixis NASDAQ EXEL has in 2016 The biotech s share price has nearly tripled this year Will Exelixis be able to carry this tremendous momentum in to 2017 Mike Morrissey Exelixis CEO spoke at the Stifel Healthcare Conference this week
PFE,PFE:US,BBG000BR2B91,3 Stocks to Add to Your Portfolio as Biotech M&A Hopes Rise,2016-11-17 15:51:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/haGDFsP1dtc/3-stocks-to-add-to-your-portfolio-as-biotech-ma-hopes-rise-cm710528,2016 has not been a great year for mergers and acquisitions M amp As in the pharma and biotech sector although some headline deals like the Pfizer PFE Medivation and the Teva Actavis Generics acquisitions were completed this year While expectations were high that this year too the pharma
PFE,PFE:US,BBG000BR2B91,"Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for November 18, 2016",2016-11-17 14:19:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CPco2Kvl7Z4/johnson-johnson-jnj-ex-dividend-date-scheduled-for-november-18-2016-cm710495,Johnson amp Johnson JNJ will begin trading ex dividend on November 18 2016 A cash dividend payment of 0 8 per share is scheduled to be paid on December 06 2016 Shareholders who purchased JNJ prior to the ex dividend date are eligible for the cash dividend payment This marks the
PFE,PFE:US,BBG000BR2B91,"Roche, Bristol-Myers cut cancer drug prices to win UK approval",2016-11-17 00:03:17 +0000,http://sg.finance.yahoo.com/news/roche-bristol-myers-cut-cancer-000317295.html,"Roche, Bristol-Myers cut cancer drug prices to win UK approval"
PFE,PFE:US,BBG000BR2B91,The Scariest Thing About Pfizer's Dividend,2016-11-16 22:50:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FMcQXNfGl8U/the-scariest-thing-about-pfizers-dividend-cm710305,For Pfizer NYSE PFE shareholders who have come to count on steady dividends there s one frightening thing that jumps out at anyone who looks the dividend payout ratio of well over 100 Pfizer s dividend payments are considerably higher than its earnings Should shareholders
PFE,PFE:US,BBG000BR2B91,"PALOMA-2 Phase 3 Study Published In The New England Journal Of Medicine Demonstrates Clinical Benefit Of Pfizer’s IBRANCE® (palbociclib) In First-Line ER+, HER2- Metastatic Breast Cancer",2016-11-16 22:09:00 +0000,http://finance.yahoo.com/news/paloma-2-phase-3-study-220900658.html,"[Business Wire] - Pfizer Inc. today announced that detailed results from the Phase 3 PALOMA-2 trial were published in The New England Journal of Medicine. These data, presented at the 52nd American Society of Clinical Oncology Annual Meeting in June, further demonstrate the clinical benefit of IBRANCE® as initial therapy for postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor ..."
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Nov 16, 2016 :  COMT, YHOO, ACWI, VNQI, CSCO, CHK, SYMC, BAC, PFE, DHR, VZ, WFC",2016-11-16 21:59:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WPKiCbrDvuE/after-hours-most-active-for-nov-16-2016-comt-yhoo-acwi-vnqi-csco-chk-symc-bac-pfe-dhr-vz-wfc-cm710308,The NASDAQ 100 After Hours Indicator is down 6 98 to 4 785 29 The total After hours volume is currently 49 957 932 shares traded The following are the most active stocks for the after hours session iShares Commodities Select Strategy ETF COMT is 0 0631 at 31 89
PFE,PFE:US,BBG000BR2B91,The Scariest Thing About Pfizer's Dividend,2016-11-16 21:28:10 +0000,http://www.fool.com/investing/2016/11/16/the-scariest-thing-about-pfizers-dividend.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Scariest Thing About Pfizer's Dividend
PFE,PFE:US,BBG000BR2B91,Pfizer Reports Phase III Psoriatic Arthritis Data on Xeljanz,2016-11-16 15:53:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fODPPtQOSeI/pfizer-reports-phase-iii-psoriatic-arthritis-data-on-xeljanz-cm710017,Pfizer Inc PFE announced detailed data from the two phase III OPAL O ral P soriatic A rthritis Tria L studies Broaden and Beyond on Xeljanz The data will be presented at the ACR ARHP annual meeting OPAL Broaden and OPAL Beyond evaluated the efficacy and safety of Xeljanz in
PFE,PFE:US,BBG000BR2B91,Merck KGaA's (MKGAF) Q3 Earnings and Sales Increase Y/Y,2016-11-16 15:52:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hC9f8PRERmc/merck-kgaas-mkgaf-q3-earnings-and-sales-increase-yy-cm710000,Merck KGaA MKGAF reported third quarter 2016 earnings of 1 20 per American Depositary Share higher than the year ago tally of 90 cents Net sales in the reported quarter came in at 4 1 billion 3 7 billion up 19 7 primarily due to portfolio changes following the Sigma
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. (PFE) Signs Agreement With NCI To Explore Immunotherapy,2016-11-16 15:41:23 +0000,http://www.insidermonkey.com/blog/pfizer-inc-pfe-signs-agreement-with-nci-to-explore-immunotherapy-488471/,Pfizer Inc. (PFE) Signs Agreement With NCI To Explore Immunotherapy
PFE,PFE:US,BBG000BR2B91,Pfizer Reports Phase III Psoriatic Arthritis Data on Xeljanz,2016-11-16 13:20:01 +0000,http://finance.yahoo.com/news/pfizer-reports-phase-iii-psoriatic-132001729.html,Pfizer Reports Phase III Psoriatic Arthritis Data on Xeljanz
PFE,PFE:US,BBG000BR2B91,Macron: the fresh-faced prodigy who would be president,2016-11-16 10:43:32 +0000,http://uk.finance.yahoo.com/news/macron-fresh-faced-prodigy-president-104332692.html,Macron: the fresh-faced prodigy who would be president
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. (PFE) Teams Up With NIH NCI CCR On Immunotherapy,2016-11-15 20:06:37 +0000,http://www.insidermonkey.com/blog/pfizer-inc-pfe-teams-up-with-nih-nci-ccr-on-immunotherapy-488254/,Pfizer Inc. (PFE) Teams Up With NIH NCI CCR On Immunotherapy
PFE,PFE:US,BBG000BR2B91,"ETFs with exposure to Pfizer Inc. : November 15, 2016",2016-11-15 19:11:21 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-pfizer-inc-november-15-2016/,"ETFs with exposure to Pfizer Inc. : November 15, 2016"
PFE,PFE:US,BBG000BR2B91,Dow Analyst Moves: PFE,2016-11-15 18:27:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bMrh1MLtZu4/dow-analyst-moves-pfe-cm709531,The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average Pfizer PFE is the 13 analyst pick Within the broader S amp P 500 when components were ranked in terms of analyst favorites PFE claims the
PFE,PFE:US,BBG000BR2B91,Pfizer Makes Progress with Its 2016 Immuno-Oncology Programs,2016-11-15 16:04:41 +0000,http://marketrealist.com/2016/11/pfizer-continues-progress-immuno-oncology-programs-2016/?utm_source=yahoo&utm_medium=feed,Pfizer Makes Progress with Its 2016 Immuno-Oncology Programs
PFE,PFE:US,BBG000BR2B91,Xtandi Is Expected to Witness Strong Growth Trends Going Forward,2016-11-15 15:04:47 +0000,http://marketrealist.com/2016/11/xtandi-expected-witness-strong-growth-trends-future-years/?utm_source=yahoo&utm_medium=feed,Xtandi Is Expected to Witness Strong Growth Trends Going Forward
PFE,PFE:US,BBG000BR2B91,"Stocks Open Mixed; Oil Jumps; Airlines, Shipping Fleets Rally",2016-11-15 14:42:50 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-mixed-oil-jumps-advanced-auto-netease-climb/,"Stocks Open Mixed; Oil Jumps; Airlines, Shipping Fleets Rally"
PFE,PFE:US,BBG000BR2B91,Pfizer and NCI Ink Research Deal Targeting Multiple Cancers,2016-11-15 14:31:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/koKZjnGEmv0/pfizer-and-nci-ink-research-deal-targeting-multiple-cancers-cm709180,Pfizer Inc PFE announced that it has struck a research and development agreement with the National Cancer Institute NCI to study three immunotherapy agents targeting multiple cancers The three immunotherapy agents include Pfizer s proprietary immunotherapy agonistic monoclonal
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Results from Phase 3 OPAL Clinical Development Program Investigating XELJANZ® (Tofacitinib Citrate) for Psoriatic Arthritis,2016-11-15 13:18:07 +0000,http://www.publicnow.com/view/6972A8FF26DDB38B32FD5A48D2A37AA5C38BE6A2,"[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that new results from the Phase 3 Oral Psoriatic Arthritis TriaL (OPAL) studies, Broaden and Beyond, will be presented at the 2016 ACR/ARHP ..."
PFE,PFE:US,BBG000BR2B91,PRECISION Results Open The Door For OTC Celebrex,2016-11-15 13:05:00 +0000,http://www.forbes.com/sites/johnlamattina/2016/11/15/precision-results-open-the-door-for-otc-celebrex/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,PRECISION Results Open The Door For OTC Celebrex
PFE,PFE:US,BBG000BR2B91,Ibrance May Continue to Dominate Breast Cancer Space in 2016,2016-11-15 13:04:58 +0000,http://marketrealist.com/2016/11/ibrance-may-continue-dominate-breast-cancer-space-2016/?utm_source=yahoo&utm_medium=feed,Ibrance May Continue to Dominate Breast Cancer Space in 2016
PFE,PFE:US,BBG000BR2B91,Pfizer and NCI Ink Research Deal Targeting Multiple Cancers,2016-11-15 12:36:12 +0000,http://finance.yahoo.com/news/pfizer-nci-ink-research-deal-123612082.html,Pfizer and NCI Ink Research Deal Targeting Multiple Cancers
PFE,PFE:US,BBG000BR2B91,Pfizer Says Phase 3 OPAL Studies For Xeljanz Met Primary Efficacy Endpoints,2016-11-15 08:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v_vvonlkB8A/pfizer-says-phase-3-opal-studies-for-xeljanz-met-primary-efficacy-endpoints-20161115-00493,Pfizer Says Phase 3 OPAL Studies For Xeljanz Met Primary Efficacy Endpoints
PFE,PFE:US,BBG000BR2B91,"Pfizer Prices $6,000,000,000 Debt Offering",2016-11-15 06:27:08 +0000,http://www.publicnow.com/view/3893A821852DD148652CA6CE6E54C1A9AE0391D5,"[at noodls] - Pfizer Inc. (NYSE:PFE) today announced the pricing of a debt offering consisting of five tranches of notes: $1,000,000,000 aggregate principal amount of 1.700% notes due 2019 $1,000,000,000 aggregate principal ..."
PFE,PFE:US,BBG000BR2B91,[$$] Medicare Identifies Which Prescription Drugs Were Costliest in 2015,2016-11-15 05:23:10 +0000,http://www.wsj.com/articles/medicare-identifies-which-prescription-drugs-were-costliest-in-2015-1479156606?ru=yahoo?mod=yahoo_itp,[$$] Medicare Identifies Which Prescription Drugs Were Costliest in 2015
PFE,PFE:US,BBG000BR2B91,[$$] Corporate bond sell-off tests investor appetite,2016-11-15 02:25:23 +0000,"http://www.ft.com/cms/s/aa28de6e-aaca-11e6-9cb3-bb8207902122,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - A sell-off reverberating through sovereign bond markets tested investor appetite on Monday for a multibillion-dollar corporate bond sale, as money managers wait for volatile price swings to subside. Pfizer ..."
PFE,PFE:US,BBG000BR2B91,Medicare Identifies Which Prescription Drugs Were Costliest in 2015,2016-11-15 00:08:00 +0000,http://finance.yahoo.com/news/medicare-identifies-prescription-drugs-were-000800333.html,Medicare Identifies Which Prescription Drugs Were Costliest in 2015
PFE,PFE:US,BBG000BR2B91,"Pfizer Prices $6,000,000,000 Debt Offering",2016-11-14 23:55:00 +0000,http://finance.yahoo.com/news/pfizer-prices-6-000-000-235500744.html,[Business Wire] - Pfizer Inc. today announced the pricing of a debt offering consisting of five tranches of notes:
PFE,PFE:US,BBG000BR2B91,"Go for It, Pfizer -- Sell Your Consumer Healthcare Business",2016-11-14 23:28:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O6PeY9bCsXg/go-for-it-pfizer-sell-your-consumer-healthcare-business-cm709040,If at first you don t sell or spin off try try again In September Pfizer NYSE PFE announced that it had decided not to split its legacy drug business off from its higher growth innovative health segment Now Reuters has reported that the healthcare giant is
PFE,PFE:US,BBG000BR2B91,Analysts’ Recommendations for Pfizer and Its Peers in 2016,2016-11-14 23:04:08 +0000,http://marketrealist.com/2016/11/analyst-recommendations-pfizer-peers-2016-2/?utm_source=yahoo&utm_medium=feed,Analysts’ Recommendations for Pfizer and Its Peers in 2016
PFE,PFE:US,BBG000BR2B91,"Go for It, Pfizer -- Sell Your Consumer Healthcare Business",2016-11-14 21:40:42 +0000,http://www.fool.com/investing/2016/11/14/go-for-it-pfizer-sell-your-consumer-products-busin.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Go for It, Pfizer -- Sell Your Consumer Healthcare Business"
PFE,PFE:US,BBG000BR2B91,Why Is Pfizer Trading at Discounted Valuation Multiples?,2016-11-14 21:25:19 +0000,http://marketrealist.com/2016/11/pfizer-trading-discounted-valuation-multiples/?utm_source=yahoo&utm_medium=feed,Why Is Pfizer Trading at Discounted Valuation Multiples?
PFE,PFE:US,BBG000BR2B91,Pfizer Pneumonia Drug Price Slashed for Charity (PFA),2016-11-14 20:17:00 +0000,http://www.investopedia.com/news/pfizer-cuts-pneumonia-vaccine-price-ngos-pfe/?partner=YahooSA,Pfizer Pneumonia Drug Price Slashed for Charity (PFA)
PFE,PFE:US,BBG000BR2B91,5 Reasons to Buy 5 Low P/E Biotech ETFs,2016-11-14 18:29:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m-WpRAqTBCc/5-reasons-to-buy-5-low-pe-biotech-etfs-cm708807,With Trump winning the U S presidential election the biotech and pharma sectors have regained their lost ground Since Clinton who has long been vocal against the price gouging issue in the pharma sector is no more threat to the sector pharma and biotech stocks should get a break
PFE,PFE:US,BBG000BR2B91,"Pfizer Announces Tender Offer for Any and All of its 6.200% Senior Notes Due March 15, 2019",2016-11-14 17:47:06 +0000,http://www.publicnow.com/view/FB5A4F3415CE76AB1C32158904B26B277E6E6C8B,"[at noodls] - Pfizer Inc. (NYSE:PFE) today announced the commencement of a tender offer (the 'Tender Offer') to purchase for cash any and all of its outstanding 6.200% Senior Notes due March 15, 2019 (the 'Notes'). ..."
PFE,PFE:US,BBG000BR2B91,"PFIZER INC Files SEC form 8-K/A, Other Events, Financial Statements and Exhibits",2016-11-14 17:01:00 +0000,http://biz.yahoo.com/e/161114/pfe8-k_a.html,"PFIZER INC Files SEC form 8-K/A, Other Events, Financial Statements and Exhibits"
PFE,PFE:US,BBG000BR2B91,Clarification: Pfizer-Vaccine Price story,2016-11-14 16:51:38 +0000,http://sg.finance.yahoo.com/news/pfizer-lowers-cost-prevnar-vaccine-183437310.html,Clarification: Pfizer-Vaccine Price story
PFE,PFE:US,BBG000BR2B91,5 Pharma Stocks in Focus on World Diabetes Day,2016-11-14 16:31:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/axy_v9iMQTc/5-pharma-stocks-in-focus-on-world-diabetes-day-cm708687,Every year World Diabetes Day is celebrated on Nov 14 This year the theme is eyes on diabetes with a focus on promoting the importance of screening to ensure early diagnosis of type II diabetes and reduce the risk of serious complications According to information provided by
PFE,PFE:US,BBG000BR2B91,Medicare Identifies Which Prescription Drugs Were Costliest in 2015,2016-11-14 16:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KLAbpdENvhA/medicare-identifies-which-prescription-drugs-were-costliest-in-2015-20161114-01209,Medicare Identifies Which Prescription Drugs Were Costliest in 2015
PFE,PFE:US,BBG000BR2B91,"CORRECTING and REPLACING Pfizer Announces Tender Offer for Any and All of its 6.200% Senior Notes Due March 15, 2019",2016-11-14 15:31:00 +0000,http://finance.yahoo.com/news/pfizer-announces-tender-offer-6-134700286.html,"[Business Wire] - Under Information Relating to the Tender Offer, third paragraph, fourth sentence should read: The Tender Offer Documents may be downloaded from Global Bondholder Services Corporation’s website at http://www.gbsc-usa.com/pfizer/ ."
PFE,PFE:US,BBG000BR2B91,Which Of The Latest 13F Filers Holds Pfizer?,2016-11-14 15:28:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IjxlU86a8h4/which-of-the-latest-13f-filers-holds-pfizer-cm708513,At Holdings Channel we have reviewed the latest batch of the 48 most recent 13F filings for the 09 30 2016 reporting period and noticed that Pfizer Inc Symbol PFE was held by 15 of these funds When hedge fund managers appear to be thinking alike we find it is a good idea to take a
PFE,PFE:US,BBG000BR2B91,"Dow Hits Fresh High; Early Risers: Harman, Mentor Graphics",2016-11-14 14:48:44 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-turn-positive-early-risers-pfizer-harman-mentor-graphics/,"Dow Hits Fresh High; Early Risers: Harman, Mentor Graphics"
PFE,PFE:US,BBG000BR2B91,5 Pharma Stocks in Focus on World Diabetes Day,2016-11-14 14:19:02 +0000,http://finance.yahoo.com/news/5-pharma-stocks-focus-world-141902784.html,5 Pharma Stocks in Focus on World Diabetes Day
PFE,PFE:US,BBG000BR2B91,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-11-14 14:05:08 +0000,http://biz.yahoo.com/e/161114/pfe8-k.html,"PFIZER INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. breached its 50 day moving average in a Bearish Manner : PFE-US : November 14, 2016",2016-11-14 13:37:22 +0000,http://www.capitalcube.com/blog/index.php/pfizer-inc-breached-its-50-day-moving-average-in-a-bearish-manner-pfe-us-november-14-2016/,"Pfizer Inc. breached its 50 day moving average in a Bearish Manner : PFE-US : November 14, 2016"
PFE,PFE:US,BBG000BR2B91,Should Biopharma Companies Buy Innovation?,2016-11-14 13:26:34 +0000,http://www.fool.com/investing/2016/11/13/should-biopharma-companies-buy-innovation.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Should Biopharma Companies Buy Innovation?
PFE,PFE:US,BBG000BR2B91,Pfizer to Collaborate with National Cancer Institute to Study Three Immunotherapy Agents Targeting Multiple Cancers,2016-11-14 13:00:00 +0000,http://finance.yahoo.com/news/pfizer-collaborate-national-cancer-institute-130000456.html,"[Business Wire] - Pfizer Inc. today announced that it has entered into a Cooperative Research and Development Agreement with the National Cancer Institute , part of the National Institutes of Health ."
PFE,PFE:US,BBG000BR2B91,Correction to Celebrex Article on Sunday,2016-11-14 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AoOsfWxQVG4/correction-to-celebrex-article-on-sunday-20161114-00841,Correction to Celebrex Article on Sunday
PFE,PFE:US,BBG000BR2B91,Pfizer Files 8K - Other Events,2016-11-14 09:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3I7Z7_tl0Yg/pfizer-files-8k--other-events-20161114-00710,Pfizer Files 8K - Other Events
PFE,PFE:US,BBG000BR2B91,Study Suggests Celebrex Isn't Riskier Than Rivals,2016-11-14 06:50:15 +0000,http://www.wsj.com/articles/study-suggests-celebrex-isnt-riskier-than-rival-pain-drugs-1479073501?mod=yahoo_hs,Study Suggests Celebrex Isn't Riskier Than Rivals
PFE,PFE:US,BBG000BR2B91,Study Suggests Celebrex Isn’t Riskier Than Rival Pain Drugs,2016-11-14 05:50:54 +0000,http://www.wsj.com/articles/study-suggests-celebrex-isnt-riskier-than-rival-pain-drugs-1479073501?ru=yahoo?mod=yahoo_itp,Study Suggests Celebrex Isn’t Riskier Than Rival Pain Drugs
PFE,PFE:US,BBG000BR2B91,Study Suggests Celebrex Isn''t Riskier Than Rival Pain Drugs,2016-11-14 02:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZlKjM9JcJGM/study-suggests-celebrex-isnt-riskier-than-rival-pain-drugs-20161114-00047,Study Suggests Celebrex Isn''t Riskier Than Rival Pain Drugs
PFE,PFE:US,BBG000BR2B91,[$$] Big pharma is failing to do enough for poor countries,2016-11-14 00:34:40 +0000,"http://www.ft.com/cms/s/937eac86-a979-11e6-809d-c9f98a0cf216,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Some of the world's biggest drug companies are failing to do enough to provide medicines to poor countries, and the industry as a whole has made almost no progress in making treatments more affordable, ..."
PFE,PFE:US,BBG000BR2B91,Landmark Study Demonstrates Pfizer’s Celebrex (Celecoxib)Has Similar Cardiovascular Risk As Compared To Prescription Doses Of Ibuprofen and Naproxen,2016-11-13 21:57:00 +0000,http://finance.yahoo.com/news/landmark-study-demonstrates-pfizer-celebrex-215700688.html,"[Business Wire] - Results of the landmark Prospective Randomized Evaluation of Celecoxib Integrated Safety vs. Ibuprofen Or Naproxen demonstrated similar rates of cardiovascular risk in patients treated with prescription doses of celecoxib, ibuprofen and naproxen who had a clinical diagnosis of osteoarthritis or rheumatoid arthritis , were at high risk for cardiovascular disease, and required daily treatment with non-steroidal ..."
PFE,PFE:US,BBG000BR2B91,Pfizer's Celebrex shown to be as safe as ibuprofen or naproxen -study,2016-11-13 21:45:02 +0000,http://finance.yahoo.com/news/pfizers-celebrex-shown-safe-ibuprofen-214502683.html,"[Reuters] - Pfizer Inc's Celebrex arthritis drug was shown to be at least as safe as the widely used prescription-strength versions of painkillers ibuprofen and naproxen, and does not appear to cause heart problems that spurred the withdrawal of rival Vioxx, according to a large 10-year study presented on Sunday. Some 100 million prescriptions were written in the United States in 2013 alone for the type of painkiller known as non-steroidal anti-inflammatory drugs, or NSAIDS, to which all three drugs belong. Celebrex, or celecoxib, belongs to a class of NSAID called Cox-2 inhibitors that were designed to prevent gastrointestinal bleeding common with many NSAIDs."
PFE,PFE:US,BBG000BR2B91,Study Suggests Celebrex Isn't Riskier Than Rival Pain Drugs,2016-11-13 16:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zcQoLfVN5WY/study-suggests-celebrex-isnt-riskier-than-rival-pain-drugs-20161113-00029,Study Suggests Celebrex Isn't Riskier Than Rival Pain Drugs
PFE,PFE:US,BBG000BR2B91,Six Thoughts on President Trump and the Durability of the Biotech Stock Rally,2016-11-13 16:20:00 +0000,https://www.thestreet.com/story/13887750/1/six-thoughts-on-president-trump-and-the-durability-of-the-biotech-stock-rally.html?puc=yahoo&cm_ven=YAHOO,Six Thoughts on President Trump and the Durability of the Biotech Stock Rally
PFE,PFE:US,BBG000BR2B91,Should Biopharma Companies Buy Innovation?,2016-11-13 14:27:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WqjtM0RHnHw/should-biopharma-companies-buy-innovation-cm708320,Pfizer NYSE PFE and Astellas NASDAQOTH ALPMY share profit on the blockbuster prostate cancer drug Xtandi and AbbVie NYSE ABBV and Johnson amp Johnson NYSE JNJ split profit 160 on the blockbuster lymphoma and leukemia drug Imbruvica However these
PFE,PFE:US,BBG000BR2B91,The Shot Heard ‘Round the World: First Inning of Global Reflation,2016-11-12 14:44:22 +0000,http://finance.yahoo.com/tumblr/blog-the-shot-heard-round-the-world-first-inning-of-144429291.html,The Shot Heard ‘Round the World: First Inning of Global Reflation
PFE,PFE:US,BBG000BR2B91,"Pfizer May Sell, Spin Off Consumer Health Op (PFE)",2016-11-11 23:20:00 +0000,http://www.investopedia.com/news/pfizer-may-sell-consumer-health-business-pfe/?partner=YahooSA,"Pfizer May Sell, Spin Off Consumer Health Op (PFE)"
PFE,PFE:US,BBG000BR2B91,"Market Close Report: NASDAQ Composite index closes at 5,237.11 up 28.31 points",2016-11-11 21:49:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pXK4Xx9G3CE/market-close-report-nasdaq-composite-index-closes-at-523711-up-2831-points-cm708160,Friday s session closes with the NASDAQ Composite Index at 5 237 11 The total shares traded for the NASDAQ was over 2 23 billion Friday s session closes with the NASDAQ Composite Index at 5 237 11 The total shares traded for the NASDAQ was over 2 23 billion Advancers stocks led declining by 2
PFE,PFE:US,BBG000BR2B91,"Thursday’s Vital Data: Bank of America Corp (BAC), Apple Inc. (AAPL) and Pfizer Inc. (PFE)",2016-11-11 20:30:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DKfHpB0IDgE/thursdays-vital-data-bank-of-america-corp-bac-apple-inc-aapl-and-pfizer-inc-pfe-cm707194,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are sharply higher once again this morning as Wall Street debates the impact of a Donald Trump presidency Banking stocks especially Bank of America Corp
PFE,PFE:US,BBG000BR2B91,The 7 Best Dividend Stocks to Buy for 2017,2016-11-11 20:28:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uNMlhwlY92E/the-7-best-dividend-stocks-to-buy-for-2017-cm707496,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The surprising result of the presidential election has large implications for dividend stocks First let s stipulate this As an asset class stocks that pay dividends always look good Yes they
PFE,PFE:US,BBG000BR2B91,A massive nonprofit rejected a bunch of donated vaccines from Pfizer — and now the drug giant is offering them at a lower price,2016-11-11 19:09:00 +0000,http://finance.yahoo.com/news/massive-nonprofit-rejected-bunch-donated-181800481.html,A massive nonprofit rejected a bunch of donated vaccines from Pfizer — and now the drug giant is offering them at a lower price
PFE,PFE:US,BBG000BR2B91,Pfizer offers cut-price pneumonia shot for humanitarian crises,2016-11-11 19:08:12 +0000,http://uk.finance.yahoo.com/news/pfizer-offers-cut-price-pneumonia-190812891.html,Pfizer offers cut-price pneumonia shot for humanitarian crises
PFE,PFE:US,BBG000BR2B91,Pfizer lowers cost of Prevnar vaccine for some charity use,2016-11-11 18:34:41 +0000,http://finance.yahoo.com/news/pfizer-lowers-cost-prevnar-vaccine-183437285.html,Pfizer lowers cost of Prevnar vaccine for some charity use
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Pharma Stocks Rally on Trump Win, Pfizer to Divest Consumer Unit?",2016-11-11 16:16:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HGKETbDBVSU/pharma-stock-roundup-pharma-stocks-rally-on-trump-win-pfizer-to-divest-consumer-unit-cm707773,Although some big names like AstraZeneca AZN and Mylan MYL reported Q3 results this week earnings reports were overshadowed by the run up to the Presidential election and the surprise win of Donald Trump In fact the pharma sector responded favorably to Trump s victory on hopes that there
PFE,PFE:US,BBG000BR2B91,"Dow Movers: PFE, DIS",2016-11-11 16:14:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UrBeKXUPMgo/dow-movers-pfe-dis-cm707764,In early trading on Friday shares of Walt Disney DIS topped the list of the day s best performing Dow Jones Industrial Average components trading up 2 8 Year to date Walt Disney has lost about 7 1 of its value And the worst performing Dow component thus far on the day is
PFE,PFE:US,BBG000BR2B91,"Drug Stocks' Q3 Earnings to Watch on Nov 14: ARGS, AST",2016-11-11 14:16:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8zvFArW39Zc/drug-stocks-q3-earnings-to-watch-on-nov-14-args-ast-cm707722,With 89 of the S amp P 500 members having already reported their results the Q3 reporting cycle is soon to wrap up Though earnings and revenue growth for the reported index members is still low an improvement over other recent periods is palpable In fact it is being said that the
PFE,PFE:US,BBG000BR2B91,Pfizer Finds Breaking Up Is Hard to Do,2016-11-11 14:06:00 +0000,https://www.thestreet.com/story/13889746/1/pfizer-finds-breaking-up-is-hard-to-do.html?puc=yahoo&cm_ven=YAHOO,Pfizer Finds Breaking Up Is Hard to Do
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Pharma Stocks Rally on Trump Win, Pfizer to Divest Consumer Unit?",2016-11-11 13:55:01 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-pharma-stocks-135501273.html,"Pharma Stock Roundup: Pharma Stocks Rally on Trump Win, Pfizer to Divest Consumer Unit?"
PFE,PFE:US,BBG000BR2B91,Pfizer offers cut-price pneumonia shot for humanitarian crises,2016-11-11 11:17:34 +0000,http://uk.finance.yahoo.com/news/pfizer-offers-cut-price-pneumonia-111734711.html,"[Reuters - UK Focus] - U.S. pharmaceuticals giant Pfizer is to offer its pneumococcal vaccine at the lowest possible price to non-governmental organisations seeking to protect vulnerable people from illness in humanitarian crises. In what it called a major expansion of its humanitarian assistance work, the drugmaker said its Prevenar 13 shot, which protects babies and children against pneumonia and other diseases, would be offered in a new multi-dose vial at the lowest prevailing global price, currently $3.10 per dose. ""In addition, given the acute need for aid on the ground, Pfizer will donate all sales proceeds for the first year of this program to humanitarian groups undertaking the difficult work of reaching vulnerable populations in emergency settings,"" the company said in a statement."
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Major Expansion of Humanitarian Assistance Program,2016-11-11 11:07:09 +0000,http://www.publicnow.com/view/083C52DE907EB734405C37410C56E9341FB57882,"[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today a major expansion of its humanitarian assistance program enabling broader access to its vaccine, Prevenar 13, in humanitarian emergency ..."
PFE,PFE:US,BBG000BR2B91,Pfizer: Prevenar 13 To Be Available At Lowest Price For Humanitarian Emergencies,2016-11-11 06:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zaSdjZNPN0Y/pfizer-prevenar-13-to-be-available-at-lowest-price-for-humanitarian-emergencies-20161111-00114,Pfizer: Prevenar 13 To Be Available At Lowest Price For Humanitarian Emergencies
PFE,PFE:US,BBG000BR2B91,Trump presidency could prove a salve for pharma merger deals,2016-11-11 06:12:19 +0000,http://sg.finance.yahoo.com/news/trump-presidency-could-prove-salve-061219360.html,Trump presidency could prove a salve for pharma merger deals
PFE,PFE:US,BBG000BR2B91,What's in Store for Merck KGaA (MKGAF) in Q3 Earnings?,2016-11-11 00:13:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sv-qMGDtF4Q/whats-in-store-for-merck-kgaa-mkgaf-in-q3-earnings-cm707516,Merck KGaA MKGAF is scheduled to report third quarter 2016 earnings results on Nov 15 Let s see how things are shaping up for this quarter The company reports results under three business sectors Healthcare Life Science and Performance Materials Strong performance at Life Science
PFE,PFE:US,BBG000BR2B91,Pfizer Spikes On Report It's Mulling $14 Billion Consumer Care Sale,2016-11-10 22:19:33 +0000,http://www.investors.com/news/technology/pfizer-spikes-on-report-its-mulling-14-billion-consumer-care-sale/,Pfizer Spikes On Report It's Mulling $14 Billion Consumer Care Sale
PFE,PFE:US,BBG000BR2B91,"PFIZER INC Files SEC form 10-Q, Quarterly Report",2016-11-10 22:19:03 +0000,http://biz.yahoo.com/e/161110/pfe10-q.html,"PFIZER INC Files SEC form 10-Q, Quarterly Report"
PFE,PFE:US,BBG000BR2B91,Trump Election Lights A Firecracker Under Key Stocks,2016-11-10 22:17:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wtJBaUjXMPg/trump-election-lights-a-firecracker-under-key-stocks-cm706846,After acting like it yearned for a Hillary 160 Clinton victory in the weeks leading up to the election the stock market appeared to relish Donald Trump s 160 presidential victory And investors boosted 160 sectors and some 160 stocks that could benefit from Trump
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Nov 10, 2016 :  LW, ASNA, KKR, WFT, CHK, NVDA, SPLS, PFE, BAC, SOXX, QQQ, MSFT",2016-11-10 22:02:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zv_4WfhPodg/after-hours-most-active-for-nov-10-2016-lw-asna-kkr-wft-chk-nvda-spls-pfe-bac-soxx-qqq-msft-cm707501,The NASDAQ 100 After Hours Indicator is up 5 39 to 4 752 42 The total After hours volume is currently 51 485 424 shares traded The following are the most active stocks for the after hours session Lamb Weston Holdings Inc LW is 0 22 at 30 11 with 15 513 413
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 11/10/2016: JNJ, PFE, MRK, ABT, AMGN, VRML, MNKD, ANTH",2016-11-10 21:33:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J16f84SYLKU/health-care-sector-update-for-11102016-jnj-pfe-mrk-abt-amgn-vrml-mnkd-anth-cm707468,Top Health Care StocksTop Health Care Stocks JNJ 0 5 JNJ 0 5 PFE 4 3 PFE 4 3 MRK 1 1 MRK 1 1 ABT 1 5 ABT 1 5 AMGN 3 6 AMGN 3 6 Health care stocks were mostly higher before the close continuing their post election advance with the NYSE Health Care Index NYP up 0
PFE,PFE:US,BBG000BR2B91,"Goldman, JPMorgan Boost Dow on Thursday",2016-11-10 21:01:03 +0000,http://247wallst.com/investing/2016/11/10/363108/,"Goldman, JPMorgan Boost Dow on Thursday"
PFE,PFE:US,BBG000BR2B91,"Dow Holds Near Record High But Alphabet, Facebook, Other Techs Sag",2016-11-10 18:34:18 +0000,http://www.investors.com/market-trend/stock-market-today/dow-holds-near-record-high-but-alphabet-facebook-other-techs-sag/,"Dow Holds Near Record High But Alphabet, Facebook, Other Techs Sag"
PFE,PFE:US,BBG000BR2B91,Here's Which Pharma Giants Might Want to Buy Pfizer's Consumer Health Unit,2016-11-10 17:04:00 +0000,https://www.thestreet.com/story/13888690/1/here-s-which-pharma-giants-might-want-to-buy-pfizer-s-consumer-health-unit.html?puc=yahoo&cm_ven=YAHOO,Here's Which Pharma Giants Might Want to Buy Pfizer's Consumer Health Unit
PFE,PFE:US,BBG000BR2B91,"Dow Hits All-Time High; Financials Lead Again; Macy's, Kohl's Up Big",2016-11-10 15:30:34 +0000,http://www.investors.com/market-trend/stock-market-today/dow-hits-all-time-high-financials-lead-again-macys-kohls-up-big/,"Dow Hits All-Time High; Financials Lead Again; Macy's, Kohl's Up Big"
PFE,PFE:US,BBG000BR2B91,Dow hits new record as Trump victory drives up blue chips,2016-11-10 15:21:57 +0000,http://uk.finance.yahoo.com/news/dow-hits-record-trump-victory-152157923.html,Dow hits new record as Trump victory drives up blue chips
PFE,PFE:US,BBG000BR2B91,[$$] AstraZeneca: Trump lifts it up,2016-11-10 15:11:16 +0000,"http://www.ft.com/cms/s/e73f4848-a740-11e6-8b69-02899e8bd9d1,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - AstraZeneca has base-jumped off a cliff. Quarterly operating profits crashed 29 per cent at constant exchange rates to about $1bn on patent expiries. The pharmaceuticals group is yanking hard on its parachute ...
PFE,PFE:US,BBG000BR2B91,"Why Allergan, Horizon Pharma plc, and Pfizer All Spiked Wednesday",2016-11-10 14:56:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Nt0jXMlZqJU/why-allergan-horizon-pharma-plc-and-pfizer-all-spiked-wednesday-cm706980,What happened Shares of Allergan NYSE AGN Horizon Pharma plc NASDAQ HZNP and Pfizer NYSE PFE all surged higher yesterday on the news that Donald Trump would become the next president of the United States of America AGN Price
PFE,PFE:US,BBG000BR2B91,President-elect Trump puts Obamacare’s future up in the air,2016-11-10 14:46:02 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=637CA30C-A68C-11E6-8356-610B01C9B6FE&siteid=yhoof2,President-elect Trump puts Obamacare’s future up in the air
PFE,PFE:US,BBG000BR2B91,"Stocks Open With Dow At Record High; Pfizer, Taser, Kohl's Climb",2016-11-10 14:44:47 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-up-off-highs-early-risers-pfizer-taser-kohls/,"Stocks Open With Dow At Record High; Pfizer, Taser, Kohl's Climb"
PFE,PFE:US,BBG000BR2B91,IBRANCE® (palbociclib) Receives Approval in European Union for the Treatment of Women with HR+/HER2- Metastatic Breast Cancer,2016-11-10 14:41:03 +0000,http://www.publicnow.com/view/522518C73CE4A59AC5151B31087654887DA467EF,"[at noodls] - Pfizer Inc. (NYSE:PFE) today announced that the European Commission (EC) has approved IBRANCE®(palbociclib) for the treatment of women with hormone receptor-positive, human epidermal growth factor receptor ..."
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb and Pfizer to Deliver 12 New Eliquis® (apixaban) Presentations at American Heart Association (AHA) Scientific Sessions 2016,2016-11-10 14:41:03 +0000,http://www.publicnow.com/view/23AD6D0DB39377393F4C063CB3405798DE0EB37F,"[at noodls] - Bristol-Myers Squibb Company(link is external) (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) announced today that 12 Eliquis abstracts will be presented at the AHA Scientific Sessions 2016, to be held November ..."
PFE,PFE:US,BBG000BR2B91,"Trending Stocks: Lockheed Martin to Get Trump Boost? Plus the Latest on ConocoPhillips, Netflix, Pfizer, and More",2016-11-10 14:02:03 +0000,http://www.insidermonkey.com/blog/trending-stocks-lockheed-martin-to-get-trump-boost-plus-the-latest-on-conocophillips-netflix-pfizer-and-more-486665/,"Trending Stocks: Lockheed Martin to Get Trump Boost? Plus the Latest on ConocoPhillips, Netflix, Pfizer, and More"
PFE,PFE:US,BBG000BR2B91,Peek Into Drug Stocks' Q3 Earnings on Nov 11: XBIT & REPH,2016-11-10 13:55:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jtFY2BiQwkc/peek-into-drug-stocks-q3-earnings-on-nov-11-xbit-reph-cm706952,The Q3 earnings season has almost come to an end with 445 S amp P 500 members as of Nov 9 accounting for 89 of the index s total market capitalization having reported results according to the latest Earnings Preview While total earnings for these index members were up 4 0 from
PFE,PFE:US,BBG000BR2B91,Here Are 3 Ways to Play the Growing Market for Vaccines Right Now,2016-11-10 13:21:00 +0000,https://www.thestreet.com/story/13887217/1/here-are-3-ways-to-play-the-growing-market-for-vaccines-right-now.html?puc=yahoo&cm_ven=YAHOO,Here Are 3 Ways to Play the Growing Market for Vaccines Right Now
PFE,PFE:US,BBG000BR2B91,"Why Allergan, Horizon Pharma plc, and Pfizer All Spiked Wednesday",2016-11-10 13:14:31 +0000,http://www.fool.com/investing/2016/11/10/why-allergan-horizon-pharma-plc-and-pfizer-all-spi.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Allergan, Horizon Pharma plc, and Pfizer All Spiked Wednesday"
PFE,PFE:US,BBG000BR2B91,Short Interest Bets Increase on Major Pharma,2016-11-10 12:40:14 +0000,http://finance.yahoo.com/news/short-interest-bets-increase-major-124014934.html,Short Interest Bets Increase on Major Pharma
PFE,PFE:US,BBG000BR2B91,Pfizer wins EU's approval for Ibrance as Novartis readies rival drug,2016-11-10 08:05:47 +0000,http://finance.yahoo.com/news/pfizer-wins-eus-approval-ibrance-080547701.html,"[Reuters] - U.S. drugmaker Pfizer said on Wednesday it had won approval from the European Union for its best-selling breast cancer drug Ibrance, making it the first medicine of its kind to reach the European market. The decision, which had been expected following a positive recommendation from the European Medicines Agency in September, comes as Novartis readies a rival treatment called ribociclib. Novartis plans to file its rival medicine for approval worldwide this year, following promising clinical trial results."
PFE,PFE:US,BBG000BR2B91,IBRANCE® (palbociclib) Receives Approval in European Union for the Treatment of Women with HR+/HER2- Metastatic Breast Cancer,2016-11-10 07:00:00 +0000,http://uk.finance.yahoo.com/news/ibrance-palbociclib-receives-approval-european-070000796.html,IBRANCE® (palbociclib) Receives Approval in European Union for the Treatment of Women with HR+/HER2- Metastatic Breast Cancer
PFE,PFE:US,BBG000BR2B91,The top Trump victory trades,2016-11-10 06:01:00 +0000,http://finance.yahoo.com/video/top-trump-victory-trades-060100351.html,The top Trump victory trades
PFE,PFE:US,BBG000BR2B91,AstraZeneca Profit Lifted by Tax Gain,2016-11-10 03:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RcJhVpwXRC8/astrazeneca-profit-lifted-by-tax-gain-20161110-00150,AstraZeneca Profit Lifted by Tax Gain
PFE,PFE:US,BBG000BR2B91,Markets Right Now: S&P backs US rating after Trump win,2016-11-10 01:18:15 +0000,http://sg.finance.yahoo.com/news/markets-now-european-stocks-open-081925085.html,Markets Right Now: S&P backs US rating after Trump win
PFE,PFE:US,BBG000BR2B91,"Novartis, Pfizer cut prices to win UK approval for cancer drugs",2016-11-10 00:06:28 +0000,http://sg.finance.yahoo.com/news/novartis-pfizer-cut-prices-win-000628489.html,"Novartis, Pfizer cut prices to win UK approval for cancer drugs"
PFE,PFE:US,BBG000BR2B91,"Novartis, Pfizer cut prices to win UK approval for cancer drugs",2016-11-10 00:01:01 +0000,http://uk.finance.yahoo.com/news/novartis-pfizer-cut-prices-win-000101381.html,"Novartis, Pfizer cut prices to win UK approval for cancer drugs"
PFE,PFE:US,BBG000BR2B91,Exclusive: Pfizer weighs sale or spin-off of consumer health unit - sources,2016-11-09 23:46:32 +0000,http://finance.yahoo.com/news/exclusive-pfizer-weighs-sale-spin-234632094.html,"[Reuters] - A Pfizer exit from the consumer health business, which includes lip balm Chapstick and painkiller Advil, would be one of its biggest corporate moves since abandoning a $160 billion deal to buy Irish drugmaker Allergan Inc earlier this year. The deliberations are still in a preliminary stage and the New York-based pharmaceutical company may opt to retain the business, the people said. Pfizer declined to comment."
PFE,PFE:US,BBG000BR2B91,Better Buy: Gilead Sciences Inc. vs. Pfizer Inc.,2016-11-09 22:54:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DnuqqxHxF2U/better-buy-gilead-sciences-inc-vs-pfizer-inc-cm706820,Your time horizon matters when picking a stock Gilead Sciences NASDAQ GILD for example gave investors five times the returns of Pfizer NYSE PFE over the past five years In 2016 though Pfizer has handily outperformed Gilead Which of these two stocks is the
PFE,PFE:US,BBG000BR2B91,Trump Election Lights A Firecracker Under Key Stocks,2016-11-09 22:52:07 +0000,http://www.investors.com/etfs-and-funds/mutual-funds/trump-election-lights-a-firecracker-under-key-stocks/,Trump Election Lights A Firecracker Under Key Stocks
PFE,PFE:US,BBG000BR2B91,[$$] US stocks defy fears of panic after Trump win,2016-11-09 22:52:02 +0000,"http://www.ft.com/cms/s/3ce1a2fa-a633-11e6-8898-79a99e2a4de6,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - US stock markets climbed in New York on Wednesday, confounding earlier fears that a victory for Republican Donald Trump in Tuesday's presidential election would spell panic among investors. The benchmark ..."
PFE,PFE:US,BBG000BR2B91,Close Update: Stocks Rally as Wall Street Warms Up to Trump Presidency,2016-11-09 22:13:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LRiHqR5dmMo/close-update-stocks-rally-as-wall-street-warms-up-to-trump-presidency-cm706805,Wall Street orchestrated a stunning comeback Wednesday turning a 750 points loss in Dow futures into a 300 point gain as investors reconsidered Donald Trump s election victory and what his presidency could mean to Federal Reserve monetary policy and the U S economy Wall Street orchestrated
PFE,PFE:US,BBG000BR2B91,Drugmakers soar after Trump victory; hospital operators sink,2016-11-09 21:47:38 +0000,http://sg.finance.yahoo.com/news/drugmakers-soar-trump-victory-hospital-214738923.html,Drugmakers soar after Trump victory; hospital operators sink
PFE,PFE:US,BBG000BR2B91,Dow ends near record highs following election of Trump,2016-11-09 21:41:44 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=71DC69E2-A63B-11E6-9FB3-ED22A22D76AF&siteid=yhoof2,"[at MarketWatch] - U.S. stocks rally Wednesday, with the Dow industrials jumping 257 points, led by a surge in financial, health-care and industrial stocks, as investors bet on the infrastructure spending policy promised ..."
PFE,PFE:US,BBG000BR2B91,Better Buy: Gilead Sciences Inc. vs. Pfizer Inc.,2016-11-09 21:23:59 +0000,http://www.fool.com/investing/2016/11/09/better-buy-gilead-sciences-inc-vs-pfizer.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Gilead Sciences Inc. vs. Pfizer Inc.
PFE,PFE:US,BBG000BR2B91,Health-care stocks skyrocket after Donald Trump stuns market with White House win,2016-11-09 21:20:52 +0000,http://www.cnbc.com/id/104092679?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104092679,Health-care stocks skyrocket after Donald Trump stuns market with White House win
PFE,PFE:US,BBG000BR2B91,Drug Stocks Rally On Relief Clinton Didn't Win White House,2016-11-09 21:19:53 +0000,http://www.investors.com/news/technology/drug-stocks-rally-on-relief-clinton-didnt-win-white-house/,Drug Stocks Rally On Relief Clinton Didn't Win White House
PFE,PFE:US,BBG000BR2B91,Pharma surges on Trump win,2016-11-09 20:21:00 +0000,http://finance.yahoo.com/video/pharma-surges-trump-win-202100382.html,Pharma surges on Trump win
PFE,PFE:US,BBG000BR2B91,"Pharma, biotech shares soar as Trump win calms pricing talk",2016-11-09 19:36:19 +0000,http://uk.finance.yahoo.com/news/trump-win-boosts-drug-stocks-114828108.html,"Pharma, biotech shares soar as Trump win calms pricing talk"
PFE,PFE:US,BBG000BR2B91,"Trump Victory, Agenda Likely To Spur Lasting Stock Market Rally",2016-11-09 18:47:32 +0000,http://www.investors.com/news/after-diving-on-trump-victory-markets-may-reconsider/,"Trump Victory, Agenda Likely To Spur Lasting Stock Market Rally"
PFE,PFE:US,BBG000BR2B91,Stocks Pare Gains As Market Adjusts To Trump Victory; Banking Stocks Rise,2016-11-09 18:38:25 +0000,http://www.investors.com/market-trend/stock-market-today/stocks-pare-gains-as-market-adjusts-to-trump-victory-banking-stocks-rise/,Stocks Pare Gains As Market Adjusts To Trump Victory; Banking Stocks Rise
PFE,PFE:US,BBG000BR2B91,Midday Update: Stocks Snap Back as Financial and Healthcare Sectors Rally,2016-11-09 18:13:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CgwE0a-RIc4/midday-update-stocks-snap-back-as-financial-and-healthcare-sectors-rally-cm706630,Wall Street made an impressive comeback from Wednesday s ugly open with the major benchmark indices all solidly in the plus column led by gains in the financial healthcare and industrial sectors Wall Street made an impressive comeback from Wednesday s ugly open with the major benchmark indices
PFE,PFE:US,BBG000BR2B91,Stocks Rally As Market Digests Trump's Surprise Win; Why Is Apple Down?,2016-11-09 17:23:49 +0000,http://www.investors.com/market-trend/stock-market-today/stocks-rally-as-market-digests-trumps-surprise-win-why-is-apple-down/,Stocks Rally As Market Digests Trump's Surprise Win; Why Is Apple Down?
PFE,PFE:US,BBG000BR2B91,"How to Trade the Most Active Stocks After Trump's Win -- Pfizer, BofA, Facebook",2016-11-09 17:23:00 +0000,https://www.thestreet.com/story/13886813/1/how-to-trade-the-most-active-stocks-after-trump-s-win-pfizer-bofa-facebook.html?puc=yahoo&cm_ven=YAHOO,"How to Trade the Most Active Stocks After Trump's Win -- Pfizer, BofA, Facebook"
PFE,PFE:US,BBG000BR2B91,Drug stocks rip higher after Trump's upset victory signals easing pressure on prices,2016-11-09 17:21:00 +0000,http://finance.yahoo.com/news/drug-company-stocks-soaring-144847328.html,Drug stocks rip higher after Trump's upset victory signals easing pressure on prices
PFE,PFE:US,BBG000BR2B91,"Dow Movers: TRV, PFE",2016-11-09 16:55:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BhWQTaPCTlY/dow-movers-trv-pfe-cm706486,In early trading on Wednesday shares of Pfizer PFE topped the list of the day s best performing Dow Jones Industrial Average components trading up 8 4 Year to date Pfizer registers a 0 7 gain And the worst performing Dow component thus far on the day is Travelers Companies
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. (PFE) To Close 2 Britain Facilities, To Present New Xeljanz Data",2016-11-09 16:07:05 +0000,http://www.insidermonkey.com/blog/pfizer-inc-pfe-to-close-2-britain-facilities-to-present-new-xeljanz-data-486181/,"Pfizer Inc. (PFE) To Close 2 Britain Facilities, To Present New Xeljanz Data"
PFE,PFE:US,BBG000BR2B91,US STOCKS-Wall St swings in post-U.S. election rollercoaster,2016-11-09 15:36:14 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-swings-153614185.html,US STOCKS-Wall St swings in post-U.S. election rollercoaster
PFE,PFE:US,BBG000BR2B91,US stocks mixed in early trade; bond prices tumble,2016-11-09 15:33:05 +0000,http://sg.finance.yahoo.com/news/us-stocks-mixed-early-trade-153305454.html,US stocks mixed in early trade; bond prices tumble
PFE,PFE:US,BBG000BR2B91,"Stocks Rethink Trump Win, Pare Losses; Pfizer, CAT Lead Dow",2016-11-09 15:28:44 +0000,http://www.investors.com/market-trend/stock-market-today/stocks-rethink-trump-win-pare-losses-pfizer-cat-lead-dow/,"Stocks Rethink Trump Win, Pare Losses; Pfizer, CAT Lead Dow"
PFE,PFE:US,BBG000BR2B91,Trump’s victory is just the beginning of the shocks for stocks,2016-11-09 15:09:33 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=01370D16-A5CB-11E6-9FB3-ED22A22D76AF&siteid=yhoof2,Trump’s victory is just the beginning of the shocks for stocks
PFE,PFE:US,BBG000BR2B91,"Drug Stocks Q3 Earnings Roster for Nov 10: AVXS, GBT & BPMC",2016-11-09 14:56:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MPshT4BFZf4/drug-stocks-q3-earnings-roster-for-nov-10-avxs-gbt-bpmc-cm706265,The bulk of the Q3 earnings season is over with 423 S amp P 500 members as of Nov 4 accounting for 87 1 of the index s total market capitalization having already reported results according to the latest Earnings Preview While total earnings for these index members were up 3 6 from
PFE,PFE:US,BBG000BR2B91,Is a Donald Trump Presidency a Black Swan Event for Pharma Stocks?,2016-11-09 14:55:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DPiXyH2VncA/is-a-donald-trump-presidency-a-black-swan-event-for-pharma-stocks-cm706264,Pharma stocks so far are reacting positively to the news the Donald Trump has upended Hillary Clinton to become the 44th President of the United States of America However a Donald Trump presidency may in fact be a black swan for this multi billion industry Here are 3 reasons
PFE,PFE:US,BBG000BR2B91,"Stocks Open Lower After Stunning Trump Win; Drugs Up, Hospitals Dive",2016-11-09 14:46:41 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-down-trim-losses-pfizer-consol-energy-jump-tenet-hca-dive/,"Stocks Open Lower After Stunning Trump Win; Drugs Up, Hospitals Dive"
PFE,PFE:US,BBG000BR2B91,Markets Right Now: US stocks open broadly lower,2016-11-09 14:42:41 +0000,http://finance.yahoo.com/news/markets-now-european-stocks-open-081925508.html,Markets Right Now: US stocks open broadly lower
PFE,PFE:US,BBG000BR2B91,Is a Donald Trump Presidency a Black Swan Event for Pharma Stocks?,2016-11-09 14:22:25 +0000,http://www.fool.com/investing/2016/11/09/is-a-donald-trump-presidency-a-black-swan-event-fo.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is a Donald Trump Presidency a Black Swan Event for Pharma Stocks?
PFE,PFE:US,BBG000BR2B91,"Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for November 10, 2016",2016-11-09 14:15:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-BmUrU7ZKBo/eli-lilly-and-company-lly-ex-dividend-date-scheduled-for-november-10-2016-cm706375,Eli Lilly and Company LLY will begin trading ex dividend on November 10 2016 A cash dividend payment of 0 51 per share is scheduled to be paid on December 09 2016 Shareholders who purchased LLY prior to the ex dividend date are eligible for the cash dividend payment This marks the
PFE,PFE:US,BBG000BR2B91,"Pre-Market Most Active for Nov 9, 2016 :  BAC, XIV, CX, QQQ, VALE, TVIX, AAPL, VRX, PFE, AZN, ARWR, FB",2016-11-09 13:53:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XFMFFbKhuuw/pre-market-most-active-for-nov-9-2016-bac-xiv-cx-qqq-vale-tvix-aapl-vrx-pfe-azn-arwr-fb-cm706238,The NASDAQ 100 Pre Market Indicator is down 64 46 to 4 740 46 The total Pre Market volume is currently 31 588 977 shares traded The following are the most active stocks for the pre market session Bank of America Corporation BAC is 0 42 at 17 42 with 5 827 880
PFE,PFE:US,BBG000BR2B91,Teva Pharmaceutical Industries a Top Ranked SAFE Dividend Stock With 3.5% Yield (TEVA),2016-11-09 13:52:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RmCAD4Es1Ks/teva-pharmaceutical-industries-a-top-ranked-safe-dividend-stock-with-35-yield-teva-cm706190,Teva Pharmaceutical Industries Ltd Symbol TEVA has been named to the Dividend Channel International S A F E 10 list signifying an international stock with above average DividendRank statistics including a strong 3 5 yield as well as a superb track record of at least five years
PFE,PFE:US,BBG000BR2B91,Pharma Stocks Gain on U.S. Election Result,2016-11-09 08:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f1S-IrJZIDQ/pharma-stocks-gain-on-us-election-result-20161109-00570,Pharma Stocks Gain on U.S. Election Result
PFE,PFE:US,BBG000BR2B91,California drug pricing initiative headed for defeat,2016-11-09 08:01:21 +0000,http://finance.yahoo.com/news/california-drug-pricing-initiative-headed-080121490.html,"[Reuters] - A California ballot initiative aimed at reining in rising prices for prescription drugs was headed for defeat on Tuesday after pharmaceutical companies spent more than $100 million to fight it. The California Drug Price Relief Act, also known as Proposition 61, sought to limit state health programs from paying more for medications than the U.S. Department of Veterans Affairs (VA), which receives the steepest discounts in the country. As of late Tuesday night, with 47 percent of precincts partially reporting, the vote was 46 percent in support of the measure and 54 percent opposed, according to California's Secretary of State."
PFE,PFE:US,BBG000BR2B91,Corporate Winners and Losers Emerge After Trump Win,2016-11-09 05:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cA3T8MbGHwQ/corporate-winners-and-losers-emerge-after-trump-win-20161109-00161,Corporate Winners and Losers Emerge After Trump Win
PFE,PFE:US,BBG000BR2B91,California's drug price showdown,2016-11-08 22:35:00 +0000,http://finance.yahoo.com/video/californias-drug-price-showdown-223500658.html,California's drug price showdown
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Shares Cross 4% Yield Mark,2016-11-08 22:03:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CXSXr9dROTY/pfizer-pfe-shares-cross-4-yield-mark-cm705936,Looking at the universe of stocks we cover at Dividend Channel in trading on Tuesday shares of Pfizer Inc Symbol PFE were yielding above the 4 mark based on its quarterly dividend annualized to 1 20 with the stock changing hands as low as 29 96 on the day Dividends are
PFE,PFE:US,BBG000BR2B91,"Market Close Report: NASDAQ Composite index closes at 5,193.49 up 27.32 points",2016-11-08 21:48:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dGVOpq5Zyzs/market-close-report-nasdaq-composite-index-closes-at-519349-up-2732-points-cm705989,Tuesday s session closes with the NASDAQ Composite Index at 5 193 49 The total shares traded for the NASDAQ was over 1 75 billion Tuesday s session closes with the NASDAQ Composite Index at 5 193 49 The total shares traded for the NASDAQ was over 1 75 billion Advancers stocks led declining
PFE,PFE:US,BBG000BR2B91,"Stock Market News for November 08, 2016",2016-11-08 21:32:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Cya3pdCW_go/stock-market-news-for-november-08-2016-cm705847,Benchmarks ended higher on Monday after the FBI said that it would not press criminal charges against Democratic nominee Hillary Clinton Financial markets in general view a Clinton win as the better outcome in today s election as it presents more stability for markets than a Trump presidency
PFE,PFE:US,BBG000BR2B91,Viagra maker Pfizer denies Brexit link to two UK site closures,2016-11-08 17:45:00 +0000,http://uk.finance.yahoo.com/news/viagra-maker-pfizer-denies-brexit-174500355.html,Viagra maker Pfizer denies Brexit link to two UK site closures
PFE,PFE:US,BBG000BR2B91,Pfizer denies Brexit link to two UK site closures,2016-11-08 17:39:00 +0000,http://uk.finance.yahoo.com/news/pfizer-denies-brexit-two-uk-173900691.html,Pfizer denies Brexit link to two UK site closures
PFE,PFE:US,BBG000BR2B91,"Pfizer says closing two British sites, not Brexit-related",2016-11-08 17:11:31 +0000,http://sg.finance.yahoo.com/news/pfizer-says-closing-two-british-171131619.html,"Pfizer says closing two British sites, not Brexit-related"
PFE,PFE:US,BBG000BR2B91,"Pfizer says closing two British sites, not Brexit-related",2016-11-08 17:09:15 +0000,http://uk.finance.yahoo.com/news/pfizer-says-closing-two-british-170915593.html,"Pfizer says closing two British sites, not Brexit-related"
PFE,PFE:US,BBG000BR2B91,"2 Reasons Exelixis, Inc. Dove 17% in October, and 1 Excuse to Be Excited",2016-11-08 16:06:40 +0000,http://www.fool.com/investing/2016/11/07/2-reasons-exelixis-inc-dove-17-in-october-and-1-ex.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"2 Reasons Exelixis, Inc. Dove 17% in October, and 1 Excuse to Be Excited"
PFE,PFE:US,BBG000BR2B91,Pfizer’s 3Q16 Earnings: Changes in Valuations,2016-11-08 16:04:22 +0000,http://marketrealist.com/2016/11/pfizers-3q16-earnings-changes-in-valuations/?utm_source=yahoo&utm_medium=feed,Pfizer’s 3Q16 Earnings: Changes in Valuations
PFE,PFE:US,BBG000BR2B91,Pfizer’s 3Q16 Earnings: Profitability and Financial Guidance,2016-11-08 15:04:29 +0000,http://marketrealist.com/2016/11/pfizers-3q16-earnings-profitability-and-financial-guidance/?utm_source=yahoo&utm_medium=feed,Pfizer’s 3Q16 Earnings: Profitability and Financial Guidance
PFE,PFE:US,BBG000BR2B91,5 Healthcare Stocks Kahn Brothers Is Bullish On,2016-11-08 13:44:21 +0000,http://www.insidermonkey.com/blog/5-healthcare-stocks-kahn-brothers-is-bullish-on-485758/,5 Healthcare Stocks Kahn Brothers Is Bullish On
PFE,PFE:US,BBG000BR2B91,Understanding Pfizer’s Products with Declining Sales,2016-11-08 13:04:37 +0000,http://marketrealist.com/2016/11/understanding-pfizers-products-with-declining-sales/?utm_source=yahoo&utm_medium=feed,Understanding Pfizer’s Products with Declining Sales
PFE,PFE:US,BBG000BR2B91,"Bonuses on Wall Street to Take a Dive (DOW, PFE)",2016-11-08 01:25:00 +0000,http://www.investopedia.com/news/bonuses-wall-street-take-dive-dow-pfe/?partner=YahooSA,"Bonuses on Wall Street to Take a Dive (DOW, PFE)"
PFE,PFE:US,BBG000BR2B91,"2 Reasons Exelixis, Inc. Dove 17% in October, and 1 Excuse to Be Excited",2016-11-07 19:15:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UyaOMP7ePR0/2-reasons-exelixis-inc-dove-17-in-october-and-1-excuse-to-be-excited-cm705153,Image source Getty Images What happened Shares of Exelixis NASDAQ EXEL a mid cap biopharmaceutical company focused on the development of oncology drugs dipped 17 in October based on data from S amp P Global Market Intelligence The reason for the drop can likely
PFE,PFE:US,BBG000BR2B91,Is Pfizer Inc.'s 6.4% Drop in October the Beginning of a Long Downtrend?,2016-11-07 18:13:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q0wtpKW7Zq4/is-pfizer-incs-64-drop-in-october-the-beginning-of-a-long-downtrend-cm705089,Image source Getty Images What happened Shares of global drug giant Pfizer NYSE PFE had a pretty miserable October ending lower by 6 4 based on data from S amp P Global Market Intelligence and things haven t improved through the first few days of November
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: General Electric, Baker Hughes, Facebook, Pfizer and Procter & Gamble",2016-11-07 17:22:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nkCj-rAXTDc/the-zacks-analyst-blog-highlights-general-electric-baker-hughes-facebook-pfizer-and-procter-gamble-cm705019,For Immediate Release Chicago IL November 07 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
PFE,PFE:US,BBG000BR2B91,Is Pfizer Inc.'s 6.4% Drop in October the Beginning of a Long Downtrend?,2016-11-07 16:23:07 +0000,http://www.fool.com/investing/2016/11/07/is-pfizer-incs-64-drop-in-october-the-beginning-of.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Pfizer Inc.'s 6.4% Drop in October the Beginning of a Long Downtrend?
PFE,PFE:US,BBG000BR2B91,This Contributed to Pfizer’s Growth in 3Q16,2016-11-07 16:05:07 +0000,http://marketrealist.com/2016/11/this-contributed-to-pfizers-growth-in-3q16/?utm_source=yahoo&utm_medium=feed,This Contributed to Pfizer’s Growth in 3Q16
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Pfizer, Allergan Q3 Results Fall Short, Insulin Drugmakers under Pricing Pressure",2016-11-07 16:02:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wGjCdid42RA/pharma-stock-roundup-pfizer-allergan-q3-results-fall-short-insulin-drugmakers-under-pricing-pressure-cm704894,This week key earnings updates came from companies like Pfizer PFE and Allergan AGN while pharma stocks remained under drug pricing pressure with lawmakers questioning the prices of insulin drugs Recap of the Week s Most Important Stories Pfizer Allergan Disappoint in
PFE,PFE:US,BBG000BR2B91,"Monday’s Vital Data: Apple Inc. (AAPL), Facebook Inc (FB) and Pfizer Inc. (PFE)",2016-11-07 15:57:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/86pIk5BtjdE/mondays-vital-data-apple-inc-aapl-facebook-inc-fb-and-pfizer-inc-pfe-cm704877,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures are pointed sharply higher this morning as Wall Street looks to end its longest losing streak since 1980 The Trump Effect slammed stocks lower for nine
PFE,PFE:US,BBG000BR2B91,"Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for November 08, 2016",2016-11-07 15:22:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N2pY8OMkrMA/pfizer-inc-pfe-ex-dividend-date-scheduled-for-november-08-2016-cm704812,Pfizer Inc PFE will begin trading ex dividend on November 08 2016 A cash dividend payment of 0 3 per share is scheduled to be paid on December 01 2016 Shareholders who purchased PFE prior to the ex dividend date are eligible for the cash dividend payment This marks the 4th quarter
PFE,PFE:US,BBG000BR2B91,Pfizer’s 3Q16 Earnings: Revenue Stream,2016-11-07 15:05:21 +0000,http://marketrealist.com/2016/11/pfizers-3q16-earnings-revenue-stream/?utm_source=yahoo&utm_medium=feed,Pfizer’s 3Q16 Earnings: Revenue Stream
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: General Electric, Baker Hughes, Facebook, Pfizer and Procter & Gamble",2016-11-07 14:30:02 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-general-143002416.html,"The Zacks Analyst Blog Highlights: General Electric, Baker Hughes, Facebook, Pfizer and Procter & Gamble"
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Pfizer, Allergan Q3 Results Fall Short, Insulin Drugmakers under Pricing Pressure",2016-11-07 13:39:01 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-pfizer-allergan-133901017.html,"Pharma Stock Roundup: Pfizer, Allergan Q3 Results Fall Short, Insulin Drugmakers under Pricing Pressure"
PFE,PFE:US,BBG000BR2B91,Pfizer’s 3Q16 Earnings: An Overview,2016-11-07 13:07:20 +0000,http://marketrealist.com/2016/11/pfizers-3q16-earnings-an-overview/?utm_source=yahoo&utm_medium=feed,Pfizer’s 3Q16 Earnings: An Overview
PFE,PFE:US,BBG000BR2B91,"Pfizer to Present Additional Research For XELJANZ® (Tofacitinib Citrate) In Rheumatologic Diseases, Including Rheumatoid Arthritis and Psoriatic Arthritis",2016-11-07 11:54:10 +0000,http://www.publicnow.com/view/2C9E474585CE0EB422CA687043D14AD53645A497,"[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that 20 abstracts for XELJANZ (tofacitinib citrate) will be presented at the upcoming 2016 ACR/ARHP Annual Meeting (November 11-16, Washington, ..."
PFE,PFE:US,BBG000BR2B91,Six Late Stage Drugs That Bit The Dust Recently,2016-11-07 07:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7HZ5JOx7e_Y/six-late-stage-drugs-that-bit-the-dust-recently-20161107-00317,Six Late Stage Drugs That Bit The Dust Recently
PFE,PFE:US,BBG000BR2B91,Stocks Slip in Uncertain Start to November Amid Election Uncertainty,2016-11-05 17:00:00 +0000,https://www.thestreet.com/story/13875190/1/stocks-rise-on-upbeat-china-data-kellogg-and-shell-top-earnings-estimates.html?puc=yahoo&cm_ven=YAHOO,Stocks Slip in Uncertain Start to November Amid Election Uncertainty
PFE,PFE:US,BBG000BR2B91,Donald Trump's Corporate Tax Repatriation Plan Would Benefit These 5 Companies the Most,2016-11-05 12:52:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D__Obk-KFKQ/donald-trumps-corporate-tax-repatriation-plan-would-benefit-these-5-companies-the-most-cm704494,Image source Flickr user Michael Candelori If there s one thing that can be said about the election process in 2016 it s that it s been unique In just a matter of days we re going to find out whether the United States will be run by the first female president ever or the first
PFE,PFE:US,BBG000BR2B91,Donald Trump's Corporate Tax Repatriation Plan Would Benefit These 5 Companies the Most,2016-11-05 11:23:07 +0000,http://www.fool.com/retirement/2016/11/05/donald-trumps-corporate-tax-repatriation-plan-woul.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Donald Trump's Corporate Tax Repatriation Plan Would Benefit These 5 Companies the Most
PFE,PFE:US,BBG000BR2B91,Regeneron Bounds On EPS Beat; Stock Muzzled On Amgen Drug Brouhaha,2016-11-04 20:11:12 +0000,http://www.investors.com/news/technology/regeneron-bounds-on-eps-beat-stock-muzzled-on-amgen-drug-brouhaha/,Regeneron Bounds On EPS Beat; Stock Muzzled On Amgen Drug Brouhaha
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Allergan, Gilead Sciences, Pfizer, Regeneron Pharmaceuticals and Lion Biotechnologies",2016-11-04 16:26:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/N9s-8nwy3Pg/the-zacks-analyst-blog-highlights-allergan-gilead-sciences-pfizer-regeneron-pharmaceuticals-and-lion-biotechnologies-cm704183,For Immediate Release Chicago IL November 04 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
PFE,PFE:US,BBG000BR2B91,"Dow Movers: XOM, NKE",2016-11-04 16:23:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k9uh8lC8pvc/dow-movers-xom-nke-cm704154,In early trading on Friday shares of Nike NKE topped the list of the day s best performing Dow Jones Industrial Average components trading up 1 3 Year to date Nike has lost about 19 4 of its value And the worst performing Dow component thus far on the day is Exxon Mobil
PFE,PFE:US,BBG000BR2B91,"Zacks Industry Outlook Highlights: Mylan, Lilly, Pfizer, Novartis and Amgen",2016-11-04 15:12:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h2S-ZpUH7RI/zacks-industry-outlook-highlights-mylan-lilly-pfizer-novartis-and-amgen-cm703967,For Immediate Release Chicago IL November 01 2016 Today Zacks Equity Research discusses the Pharmaceuticals part 1 including Mylan NASDAQ MYL Free Report Lilly NYSE LLY Free Report Pfizer NYSE PFE Free Report Novartis NYSE NVS Free
PFE,PFE:US,BBG000BR2B91,"Noteworthy ETF Inflows: IVE, JPM, WMT, PFE",2016-11-04 15:08:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LZT_P1_SlOI/noteworthy-etf-inflows-ive-jpm-wmt-pfe-cm704127,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares S amp P 500 Value ETF Symbol IVE where we have detected an approximate 133 8 million dollar inflow that s a 1 3 increase week over week in
PFE,PFE:US,BBG000BR2B91,"Stock Indexes Edge Up, Russell 2000 Up 0.5%; Starbucks Pops 3.5%",2016-11-04 14:26:06 +0000,http://www.investors.com/market-trend/stock-market-today/stock-indexes-flat-but-starbucks-pops-3-5/,"Stock Indexes Edge Up, Russell 2000 Up 0.5%; Starbucks Pops 3.5%"
PFE,PFE:US,BBG000BR2B91,"Drug Stocks Earnings Roster for Nov 7: HZNP, ACAD & More",2016-11-04 14:15:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ybyP7kU5h3I/drug-stocks-earnings-roster-for-nov-7-hznp-acad-more-cm704072,The bulk of the Q3 earnings season is over with 364 S amp P 500 members as of Nov 2 accounting for 72 6 of the index s total market capitalization having already reported results according to the latest Earnings Outlook While total earnings for these index members were up 1 6 from
PFE,PFE:US,BBG000BR2B91,How Does Pfizer's Dividend Stack Up?,2016-11-04 14:14:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hzHw1WyEIeU/how-does-pfizers-dividend-stack-up-cm703861,Image source Getty Images After the company reported disappointing third quarter results Pfizer s NYSE PFE dividend is starting to look like the primary reason to buy or hold this megacap pharma stock After all the drugmaker s earnings release was
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Allergan, Gilead Sciences, Pfizer, Regeneron Pharmaceuticals and Lion Biotechnologies",2016-11-04 13:46:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-allergan-134601929.html,"The Zacks Analyst Blog Highlights: Allergan, Gilead Sciences, Pfizer, Regeneron Pharmaceuticals and Lion Biotechnologies"
PFE,PFE:US,BBG000BR2B91,"Zacks Industry Outlook Highlights: Mylan, Lilly, Pfizer, Novartis and Amgen",2016-11-04 13:30:01 +0000,http://finance.yahoo.com/news/zacks-industry-outlook-highlights-mylan-133001635.html,"Zacks Industry Outlook Highlights: Mylan, Lilly, Pfizer, Novartis and Amgen"
PFE,PFE:US,BBG000BR2B91,How Does Pfizer's Dividend Stack Up?,2016-11-04 12:05:11 +0000,http://www.fool.com/investing/2016/11/04/how-does-pfizers-dividend-stack-up.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,How Does Pfizer's Dividend Stack Up?
PFE,PFE:US,BBG000BR2B91,Regeneron Revenue Growth Slows,2016-11-04 08:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4YO7Ty8Zts0/regeneron-revenue-growth-slows-20161104-00701,Regeneron Revenue Growth Slows
PFE,PFE:US,BBG000BR2B91,Pharma Industry Outlook - November 2016,2016-11-04 08:18:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-E90rqxFwkw/pharma-industry-outlook-november-2016-cm703807,It s been a rough year for pharma and biotech stocks with several factors weighing on the sector including media and political focus on the high price of drugs mixed performance results slower than expected new product launches and increasing competition The impact of these issues is
PFE,PFE:US,BBG000BR2B91,"ACHN Tanks, INNL''s Acts Fail, LCI In The Crosshair Of Law, ONCE Loses Its Spark",2016-11-04 03:44:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WBMAZAXetGU/achn-tanks-innls-acts-fail-lci-in-the-crosshair-of-law-once-loses-its-spark-20161104-00065,"ACHN Tanks, INNL''s Acts Fail, LCI In The Crosshair Of Law, ONCE Loses Its Spark"
PFE,PFE:US,BBG000BR2B91,Spark Therapeutics Inc. Tumbled as Much as 25% on Thursday -- Here's Why,2016-11-03 21:08:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UMEPoe80Y84/spark-therapeutics-inc-tumbled-as-much-as-25-on-thursday-heres-why-cm703620,Image source Getty Images What happened Shares of Spark Therapeutics NASDAQ ONCE a clinical stage gene therapy company plunged as much as 25 during Thursday afternoon s trading session after Spark and its development partner Pfizer NYSE PFE released an abstract
PFE,PFE:US,BBG000BR2B91,Pharma Industry Outlook - November 2016,2016-11-03 21:08:09 +0000,http://finance.yahoo.com/news/pharma-industry-outlook-november-2016-210809481.html,Pharma Industry Outlook - November 2016
PFE,PFE:US,BBG000BR2B91,"Close Update: S&P 500 and Nasdaq Poised for Eighth Day of Declines as Facebook, Election Jitters Weigh",2016-11-03 21:07:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0ssPd6bmJZs/close-update-sp-500-and-nasdaq-poised-for-eighth-day-of-declines-as-facebook-election-jitters-weigh-cm703661,Wall Street extended losses on Thursday with the S amp P 500 and the Nasdaq Composite marking eight straight days of declines and the Dow Jones Industrial Average in its sixth consecutive retreat as Facebook s FB warning of slower revenue and jitters about next week s election weighed
PFE,PFE:US,BBG000BR2B91,Health Sector Down As Report of Industry Price Collusion Surfaces,2016-11-03 21:03:00 +0000,https://www.thestreet.com/story/13880341/1/health-sector-down-as-report-of-industry-price-collusion-surfaces.html?puc=yahoo&cm_ven=YAHOO,Health Sector Down As Report of Industry Price Collusion Surfaces
PFE,PFE:US,BBG000BR2B91,"Market Close Report: NASDAQ Composite index closes at 5,058.41 down -47.16 points",2016-11-03 20:48:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fnAlRODWGiQ/market-close-report-nasdaq-composite-index-closes-at-505841-down-4716-points-cm703660,Thursday s session closes with the NASDAQ Composite Index at 5 058 41 The total shares traded for the NASDAQ was over 2 11 billion Declining stocks led advancers by 1 9 to 1 ratio There were 986 advancers and 1876 decliners for the day On the NASDAQ Stock Exchange 26 stocks reached a 52
PFE,PFE:US,BBG000BR2B91,Stock market falls for 8th straight session,2016-11-03 20:34:14 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=D3600E24-A110-11E6-A1DB-8713B4B92290&siteid=yhoof2,Stock market falls for 8th straight session
PFE,PFE:US,BBG000BR2B91,"S&P 500 and Nasdaq Poised for Eighth Day of Declines as Facebook, Election Jitters Weigh",2016-11-03 20:27:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y8DzTu5Pf2A/sp-500-and-nasdaq-poised-for-eighth-day-of-declines-as-facebook-election-jitters-weigh-cm703637,Wall Street extended losses on Thursday with the S amp P 500 and the Nasdaq Composite poised to mark eight straight days of declines and the Dow Jones Industrial Average set for its sixth consecutive retreat as Facebook FB hampered technology shares and jitters about next week s
PFE,PFE:US,BBG000BR2B91,Spark Therapeutics Inc. Tumbled as Much as 25% on Thursday -- Here's Why,2016-11-03 19:57:02 +0000,http://www.fool.com/investing/2016/11/03/spark-therapeutics-inc-tumbled-as-much-as-25-on-th.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Spark Therapeutics Inc. Tumbled as Much as 25% on Thursday -- Here's Why
PFE,PFE:US,BBG000BR2B91,Pharma's Woes Go Beyond Election,2016-11-03 16:04:55 +0000,http://blogs.wsj.com/moneybeat/2016/11/03/pharmas-woes-go-beyond-election/?mod=yahoo_hs,Pharma's Woes Go Beyond Election
PFE,PFE:US,BBG000BR2B91,Drug Stocks to Watch for Earnings on Nov 4; REGN & More,2016-11-03 15:10:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8Z9jy-dH23s/drug-stocks-to-watch-for-earnings-on-nov-4-regn-more-cm703210,The bulk of the Q3 earnings season is over with 364 S amp P 500 members as of Nov 2 accounting for 72 6 of the index s total market capitalization having already reported results according to the latest Earnings Outlook While total earnings for these index members were up 1 6 from
PFE,PFE:US,BBG000BR2B91,Novartis Takes Aim at Pfizer,2016-11-03 15:09:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6dYoolo24qU/novartis-takes-aim-at-pfizer-cm703249,Novartis NYSE NVS application for FDA approval of ribociclib for first line use alongside letrozole in patients who have advanced breast cancer with an amenable genetic makeup has been accepted by regulators under priority review The priority review timeline accelerates a
PFE,PFE:US,BBG000BR2B91,Roche's Haemophilia Drug Difficulties Has Rivals Looking for an Edge,2016-11-03 15:09:00 +0000,https://www.thestreet.com/story/13879423/1/roche-s-haemophilia-drug-difficulties-has-rivals-looking-for-an-edge.html?puc=yahoo&cm_ven=YAHOO,Roche's Haemophilia Drug Difficulties Has Rivals Looking for an Edge
PFE,PFE:US,BBG000BR2B91,Spark Therapeutics and Pfizer Announce Updated Data from Hemophilia B Phase 1/2 Trial Suggesting Sustained Therapeutic Levels of Factor IX Activity,2016-11-03 15:08:02 +0000,http://www.publicnow.com/view/A185B142C005D02485FC2F51E2ABAE76A6AF78CD,"[at noodls] - PHILADELPHIA and NEW YORK, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE) and Pfizer Inc. (NYSE:PFE) announced today that Lindsey A. George, M.D., a hematologist and attending physician ..."
PFE,PFE:US,BBG000BR2B91,Novartis Takes Aim at Pfizer,2016-11-03 13:10:03 +0000,http://www.fool.com/investing/2016/11/03/novartis-takes-aim-at-pfizer.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Novartis Takes Aim at Pfizer
PFE,PFE:US,BBG000BR2B91,It’s time to prepare your portfolio for the Fed’s next move — here’s how,2016-11-03 11:00:00 +0000,http://www.cnbc.com/id/104073711?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104073711,It’s time to prepare your portfolio for the Fed’s next move — here’s how
PFE,PFE:US,BBG000BR2B91,"Look to Pfizer (PFE), Church & Dwight if Interest Rates Increase, Stifel Nicolaus' Morganlander Says",2016-11-02 19:22:00 +0000,https://www.thestreet.com/story/13878088/1/look-to-pfizer-pfe-church-amp-dwight-if-interest-rates-increase-stifel-nicolaus-morganlander-says.html?puc=yahoo&cm_ven=YAHOO,"Look to Pfizer (PFE), Church & Dwight if Interest Rates Increase, Stifel Nicolaus' Morganlander Says"
PFE,PFE:US,BBG000BR2B91,"Pfizer Q3 Earnings Review: Performance On Expected Lines, Future Outlook Is Stable",2016-11-02 19:08:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FsUoBSvLPQM/pfizer-q3-earnings-review-performance-on-expected-lines-future-outlook-is-stable-cm702749,Pfizer Inc 160 PFE recently reported its Q3 16 earnings and posted operational revenue growth of 3 excluding legacy Hospira which was on expected lines For the next quarter we believe Pfizer will maintain low single digit growth as the Immuno Oncology 160 offering led by Ibrance
PFE,PFE:US,BBG000BR2B91,Novartis AG (ADR) (NVS) And Pfizer Inc. (PFE) Are In A Race To Gain Favor In Breast Cancer,2016-11-02 17:37:03 +0000,http://www.insidermonkey.com/blog/novartis-ag-adr-nvs-and-pfizer-inc-pfe-are-in-a-race-to-gain-favor-in-breast-cancer-484619/,Novartis AG (ADR) (NVS) And Pfizer Inc. (PFE) Are In A Race To Gain Favor In Breast Cancer
PFE,PFE:US,BBG000BR2B91,US Market Indexes Lower on Tuesday,2016-11-02 16:13:21 +0000,http://finance.yahoo.com/news/us-market-indexes-lower-tuesday-222802956.html,US Market Indexes Lower on Tuesday
PFE,PFE:US,BBG000BR2B91,"Pfizer Scraps New Cholesterol Drug (PFE, AMGN)",2016-11-02 15:40:00 +0000,http://www.investopedia.com/news/pfizer-sees-4q-charge-dumping-drug-pfe-amgn/?partner=YahooSA,"Pfizer Scraps New Cholesterol Drug (PFE, AMGN)"
PFE,PFE:US,BBG000BR2B91,Pfizer: Don't Buy the Dip,2016-11-02 15:35:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/02/pfizer-dont-buy-the-dip/?mod=yahoobarrons&ru=yahoo,Pfizer: Don't Buy the Dip
PFE,PFE:US,BBG000BR2B91,Pfizer Delivers Another Solid Quarter Of Organic Growth,2016-11-02 15:09:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bMfpSqVQl6A/pfizer-delivers-another-solid-quarter-of-organic-growth-cm702359,Image source Pfizer Inc Pfizer Inc s NYSE PFE third quarter performance shows that the company s finally overcoming the multiyear drag on sales caused by the patent expiration of Lipitor back in 2011 Pfizer s quarterly sales of 13 billion were up 8 year over year and
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Stock Lower, BMO Capital Downgrades on Q3 Results",2016-11-02 15:05:00 +0000,https://www.thestreet.com/story/13877577/1/pfizer-pfe-stock-lower-bmo-capital-downgrades-on-q3-results.html?puc=yahoo&cm_ven=YAHOO,"Pfizer (PFE) Stock Lower, BMO Capital Downgrades on Q3 Results"
PFE,PFE:US,BBG000BR2B91,"Stock Market News for November 02, 2016",2016-11-02 14:04:02 +0000,http://finance.yahoo.com/news/stock-market-news-november-02-140402642.html,"Stock Market News for November 02, 2016"
PFE,PFE:US,BBG000BR2B91,Pfizer Delivers Another Solid Quarter Of Organic Growth,2016-11-02 13:20:05 +0000,http://www.fool.com/investing/2016/11/02/pfizer-delivers-another-solid-quarter-of-organic-g.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Pfizer Delivers Another Solid Quarter Of Organic Growth
PFE,PFE:US,BBG000BR2B91,Pfizer’s Prevenar 13® Receives Approval For Use in Infants and Children in China,2016-11-02 13:20:05 +0000,http://www.publicnow.com/view/58DD9C8E9202F5905DBD594B96484F7856FC1310,"[at noodls] - Pfizer China announced today that it has received approval from the Chinese Food and Drug Administration (CFDA) to market its pneumococcal 13-valent conjugate vaccine, Prevenar 13®, in China for active ..."
PFE,PFE:US,BBG000BR2B91,"Drug Stocks Q3 Earnings Roster for Nov 3; ICPT, EXEL, AKRX",2016-11-02 13:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-bcqNT1wDlU/drug-stocks-q3-earnings-roster-for-nov-3-icpt-exel-akrx-cm702314,The Q3 earnings season moves into the last leg of its reporting cycle with 332 S amp P 500 members as of Nov 1 accounting for 74 1 of the index s total market capitalization having already reported results according to the Earnings Outlook report While total earnings for these
PFE,PFE:US,BBG000BR2B91,"Corcept (CORT) Beats on Q3 Earnings, Lifts Sales Guidance",2016-11-02 13:16:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B-jeXkaeGNc/corcept-cort-beats-on-q3-earnings-lifts-sales-guidance-cm702305,Corcept Therapeutics Incorporated s CORT adjusted third quarter 2016 earnings including stock based compensation expense of 2 cents per share beating the Zacks Consensus Estimate of a penny Excluding stock based compensation expenses adjusted earnings amounted to 4 cents per
PFE,PFE:US,BBG000BR2B91,"Top Analyst Upgrades and Downgrades: Brookdale Senior Living, Frontier Communications, Nike, Norfolk Southern, Pfizer, Nucor, Xylem and More",2016-11-02 13:05:42 +0000,http://247wallst.com/investing/2016/11/02/top-analyst-upgrades-and-downgrades-brookdale-senior-living-frontier-communications-nike-norfolk-southern-pfizer-nucor-xylem-and-more/,"Top Analyst Upgrades and Downgrades: Brookdale Senior Living, Frontier Communications, Nike, Norfolk Southern, Pfizer, Nucor, Xylem and More"
PFE,PFE:US,BBG000BR2B91,Merck’s 3Q16 Valuation Cheat Sheet,2016-11-02 12:04:14 +0000,http://marketrealist.com/2016/10/mercks-3q16-valuation-cheat-sheet/?utm_source=yahoo&utm_medium=feed,Merck’s 3Q16 Valuation Cheat Sheet
PFE,PFE:US,BBG000BR2B91,Pfizer Soft Earnings the Latest Reason to Avoid Big Pharma Stocks,2016-11-02 11:03:00 +0000,https://www.thestreet.com/story/13876128/1/pfizer-soft-earnings-the-latest-reason-to-avoid-big-pharma-stocks.html?puc=yahoo&cm_ven=YAHOO,Pfizer Soft Earnings the Latest Reason to Avoid Big Pharma Stocks
PFE,PFE:US,BBG000BR2B91,Global Blood Therapeutics: Incredible Value At This Price,2016-11-02 08:18:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XP0skoMpVtc/global-blood-therapeutics-incredible-value-at-this-price-cm698712,By Decision Analytics ByDecision Analytics Every once in a while I come across a biotech stock that seems so incredibly undervalued I think it has to be wrong So I try to make sense of it Often I find a big red flag like increasing competition market decline or a high likelihood
PFE,PFE:US,BBG000BR2B91,China approves Pfizer vaccine Prevenar,2016-11-02 07:11:05 +0000,http://finance.yahoo.com/news/china-approves-pfizer-vaccine-prevenar-071105321.html,"[Reuters] - Chinese regulators have approved Pfizer Inc's blockbuster vaccine Prevenar 13, the U.S. drugmaker said on Wednesday, a breakthrough for the firm after it was forced to shut its vaccine business in China last year. Prevenar - one of Pfizer's top selling products - is used primarily for infants to help prevent pneumococcal disease, a bacterial infection that can lead to illnesses such as pneumonia, meningitis and sepsis. Pfizer shuttered its China vaccines business after a license for an earlier version of Prevenar was not renewed in 2015."
PFE,PFE:US,BBG000BR2B91,Pfizer vaccine Prevenar gains approval in China,2016-11-02 06:22:17 +0000,http://finance.yahoo.com/news/pfizer-vaccine-prevenar-gains-approval-062217099.html,"[Reuters] - Chinese regulators have approved Pfizer Inc's blockbuster vaccine Prevenar 13, the U.S. drugmaker said in a statement on Wednesday, a breakthrough for the firm after it was forced to shut its vaccine business ..."
PFE,PFE:US,BBG000BR2B91,"PTN Surges On Trial Data, PFE Dumps Cholesterol Drug, Watch Out For PRTA",2016-11-02 04:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z38L-536a5M/ptn-surges-on-trial-data-pfe-dumps-cholesterol-drug-watch-out-for-prta-20161102-00006,"PTN Surges On Trial Data, PFE Dumps Cholesterol Drug, Watch Out For PRTA"
PFE,PFE:US,BBG000BR2B91,[$$] Big Pharma Sales Need a Booster Shot​,2016-11-02 04:14:15 +0000,http://www.wsj.com/articles/big-pharma-sales-need-a-booster-shot-1478012385?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Slowing sales, rather than election worries, are pressuring pharmaceutical stocks."
PFE,PFE:US,BBG000BR2B91,"[$$] Pfizer Cuts Outlook, Ends Development of Cholesterol Drug",2016-11-02 04:12:46 +0000,http://www.wsj.com/articles/pfizer-cuts-outlook-ends-development-of-cholesterol-drug-1478000457?ru=yahoo?mod=yahoo_itp,"[$$] Pfizer Cuts Outlook, Ends Development of Cholesterol Drug"
PFE,PFE:US,BBG000BR2B91,Edited Transcript of PFE earnings conference call or presentation 1-Nov-16 2:00pm GMT,2016-11-02 03:38:30 +0000,http://finance.yahoo.com/news/edited-transcript-pfe-earnings-conference-033830624.html,Edited Transcript of PFE earnings conference call or presentation 1-Nov-16 2:00pm GMT
PFE,PFE:US,BBG000BR2B91,Asian shares languish as jittery investors eye 2016 election,2016-11-02 03:08:37 +0000,http://sg.finance.yahoo.com/news/investors-focused-election-stocks-remain-141324629.html,Asian shares languish as jittery investors eye 2016 election
PFE,PFE:US,BBG000BR2B91,Pfizer Ends Cholesterol-Drug Chase -- WSJ,2016-11-02 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y96kZVREuBE/pfizer-ends-cholesteroldrug-chase--wsj-20161102-01348,Pfizer Ends Cholesterol-Drug Chase -- WSJ
PFE,PFE:US,BBG000BR2B91,Cramer Remix: The most negative thing this earnings seaso...,2016-11-01 23:00:00 +0000,http://finance.yahoo.com/video/cramer-remix-most-negative-thing-230000164.html,Cramer Remix: The most negative thing this earnings seaso...
PFE,PFE:US,BBG000BR2B91,Business Highlights,2016-11-01 21:10:16 +0000,http://sg.finance.yahoo.com/news/business-highlights-211016334.html,Business Highlights
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Nov 1, 2016 :  YUMC, QCP, AA, GES, BAC, CSCO, PFE, AAPL, INTC, MENT, MSFT, GILD",2016-11-01 21:04:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NN1XuJqr2tc/after-hours-most-active-for-nov-1-2016-yumc-qcp-aa-ges-bac-csco-pfe-aapl-intc-ment-msft-gild-cm702062,The NASDAQ 100 After Hours Indicator is down 2 47 to 4 764 47 The total After hours volume is currently 29 934 898 shares traded The following are the most active stocks for the after hours session Yum China Holdings Inc YUMC is 0 16 at 26 35 with 28 377 144
PFE,PFE:US,BBG000BR2B91,"Market Close Report: NASDAQ Composite index closes at 5,153.58 down -35.56 points",2016-11-01 20:48:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YBNEHTllpQQ/market-close-report-nasdaq-composite-index-closes-at-515358-down-3556-points-cm702061,Tuesday s session closes with the NASDAQ Composite Index at 5 153 58 The total shares traded for the NASDAQ was over 1 89 billion Declining stocks led advancers by 2 25 to 1 ratio There were 872 advancers and 1963 decliners for the day On the NASDAQ Stock Exchange 12 stocks reached a 52
PFE,PFE:US,BBG000BR2B91,"Stocks Drop As Fed Meeting Starts; Apple, Pfizer Biggest Losers On Dow",2016-11-01 20:41:00 +0000,http://www.investors.com/market-trend/stock-market-today/stocks-drop-as-fed-meeting-starts-apple-pfizer-biggest-losers-on-dow/,"Stocks Drop As Fed Meeting Starts; Apple, Pfizer Biggest Losers On Dow"
PFE,PFE:US,BBG000BR2B91,"US STOCKS-U.S. election, rate uncertainty rattle Wall Street",2016-11-01 20:36:20 +0000,http://uk.finance.yahoo.com/news/us-stocks-u-election-rate-203620203.html,"US STOCKS-U.S. election, rate uncertainty rattle Wall Street"
PFE,PFE:US,BBG000BR2B91,"Pfizer cholesterol drug fizzles, hitting shares",2016-11-01 20:28:23 +0000,http://finance.yahoo.com/news/pfizer-quarterly-profit-falls-38-110306486.html,"Pfizer cholesterol drug fizzles, hitting shares"
PFE,PFE:US,BBG000BR2B91,"Pfizer cholesterol drug fizzles, hitting shares",2016-11-01 20:28:20 +0000,http://sg.finance.yahoo.com/news/pfizer-cholesterol-drug-fizzles-hitting-202820724.html,"Pfizer cholesterol drug fizzles, hitting shares"
PFE,PFE:US,BBG000BR2B91,"Pfizer cholesterol drug fizzles, hitting shares",2016-11-01 20:23:51 +0000,http://in.finance.yahoo.com/news/pfizer-quarterly-profit-falls-38-112011601.html,"Pfizer cholesterol drug fizzles, hitting shares"
PFE,PFE:US,BBG000BR2B91,3 Things You Really Need to Know About Pfizer's Q3 Results,2016-11-01 20:16:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0lSMBldkOGA/3-things-you-really-need-to-know-about-pfizers-q3-results-cm701998,Investors had gotten used to Pfizer NYSE PFE beating earnings estimates each quarter But all good things come to an end The big drugmaker announced its third quarter results before the market opened on Tuesday This time Pfizer didn t satisfy Wall Street s earnings
PFE,PFE:US,BBG000BR2B91,"Pfizer Ends Cholesterol Drug Development, Lowers EPS Guidance",2016-11-01 20:10:41 +0000,http://www.investors.com/news/technology/pfizer-ends-cholesterol-drug-development-lowers-eps-guidance/,"Pfizer Ends Cholesterol Drug Development, Lowers EPS Guidance"
PFE,PFE:US,BBG000BR2B91,Markets Right Now: Stocks end lower ahead of US election,2016-11-01 20:06:04 +0000,http://sg.finance.yahoo.com/news/markets-now-stocks-open-higher-133814297.html,Markets Right Now: Stocks end lower ahead of US election
PFE,PFE:US,BBG000BR2B91,"Pfizer Bails on Boco, Better Late Than Never",2016-11-01 19:58:37 +0000,http://www.bloomberg.com/gadfly/articles/2016-11-01/pfizer-s-bococizumab-ditch-better-late-than-never?cmpid=yhoo.headline,"Pfizer Bails on Boco, Better Late Than Never"
PFE,PFE:US,BBG000BR2B91,"US STOCKS-Wall St shaken by U.S. election, rate uncertainty",2016-11-01 19:36:02 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-shaken-193602896.html,"US STOCKS-Wall St shaken by U.S. election, rate uncertainty"
PFE,PFE:US,BBG000BR2B91,"Pfizer's Ian Read Sees No Size Limit to M&A, But Says Industry Is on Pause",2016-11-01 19:08:00 +0000,https://www.thestreet.com/story/13875576/1/pfizer-s-ian-read-sees-no-size-limit-to-m-amp-a-but-says-industry-is-on-pause.html?puc=yahoo&cm_ven=YAHOO,"Pfizer's Ian Read Sees No Size Limit to M&A, But Says Industry Is on Pause"
PFE,PFE:US,BBG000BR2B91,"US STOCKS-Wall St rattled by U.S. election, rate uncertainty",2016-11-01 19:01:29 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-rattled-190129999.html,"US STOCKS-Wall St rattled by U.S. election, rate uncertainty"
PFE,PFE:US,BBG000BR2B91,3 Things You Really Need to Know About Pfizer's Q3 Results,2016-11-01 18:57:28 +0000,http://www.fool.com/investing/2016/11/01/3-things-you-really-need-to-know-about-pfizers-q3.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Things You Really Need to Know About Pfizer's Q3 Results
PFE,PFE:US,BBG000BR2B91,"Stocks Extend Losses Amid Election Uncertainty, Crude Falls",2016-11-01 18:29:00 +0000,https://www.thestreet.com/story/13875678/1/stocks-hold-lower-in-uncertain-start-to-november-amid-election-uncertainty.html?puc=yahoo&cm_ven=YAHOO,"Stocks Extend Losses Amid Election Uncertainty, Crude Falls"
PFE,PFE:US,BBG000BR2B91,Pfizer's Surprising News Upends the Market for Next-Gen Cholesterol Busters,2016-11-01 18:16:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NtbDMFU_hwA/pfizers-surprising-news-upends-the-market-for-next-gen-cholesterol-busters-cm701933,Image source Getty Images Pfizer Inc NYSE PFE has unexpectedly shuttered development of a high profile cholesterol lowering drug that works similarly to Amgen Inc s NASDAQ AMGN Repatha and Regeneron Pharmaceuticals Inc s NASDAQ REGN Praluent two next
PFE,PFE:US,BBG000BR2B91,Tuesday's ETF with Unusual Volume: DHS,2016-11-01 18:14:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cRU36nzLy9M/tuesdays-etf-with-unusual-volume-dhs-cm701905,The WisdomTree High Dividend Fund ETF DHS is seeing unusually high volume in afternoon trading Tuesday with over 454 000 shares traded versus three month average volume of about 56 000 Shares of DHS were down about 0 9 on the day Components of that ETF with the highest volume
PFE,PFE:US,BBG000BR2B91,"Midday Update: Wall Street Stays Negative as Focus Shifts to Election, NFP",2016-11-01 17:34:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q8ureSxuY2k/midday-update-wall-street-stays-negative-as-focus-shifts-to-election-nfp-cm701926,Stocks were trading lower in Tuesday s midday trade with the S amp P 500 extending its losing streak to a sixth consecutive trading day as Wall Street remains defensive leading into Friday s payroll report and next week s presidential election Stocks were also derailed by an unexpected drop
PFE,PFE:US,BBG000BR2B91,[$$] Shire Hit by Fall in Sales of Hemophilia Drugs,2016-11-01 17:34:25 +0000,http://www.wsj.com/articles/shire-cuts-guidance-after-posting-third-quarter-loss-1478004376?mod=yahoo_hs,[$$] Shire Hit by Fall in Sales of Hemophilia Drugs
PFE,PFE:US,BBG000BR2B91,"Pfizer net plunges 38 pct., misses Street 3Q forecasts",2016-11-01 17:33:07 +0000,http://sg.finance.yahoo.com/news/pfizer-net-plunges-38-pct-135658705.html,"Pfizer net plunges 38 pct., misses Street 3Q forecasts"
PFE,PFE:US,BBG000BR2B91,PFE Stock: Ignore Pfizer Inc.’s Earnings Miss at Your Own Peril,2016-11-01 17:16:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tZc7FXHMDvI/pfe-stock-ignore-pfizer-incs-earnings-miss-at-your-own-peril-cm701879,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips When an industry bellwether fails the first question must be is the problem with the industry or the bellwether 160 There are clues in the case of Pfizer Inc NYSE PFE Source Kojach Via
PFE,PFE:US,BBG000BR2B91,US STOCKS-Wall St extends losses on election jitters,2016-11-01 17:06:37 +0000,http://finance.yahoo.com/news/us-stocks-wall-st-extends-170637343.html,US STOCKS-Wall St extends losses on election jitters
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer cancels cholesterol drug trial and cuts earnings forecast,2016-11-01 17:00:05 +0000,"http://www.ft.com/cms/s/62a8c0d0-a044-11e6-891e-abe238dee8e2,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - Drugmaker Pfizer cut its earnings outlook on the back of bad news about two potential blockbusters: a new cholesterol-lowering treatment fell short in late-stage trials and a breast cancer drug that saw ...
PFE,PFE:US,BBG000BR2B91,Pfizer's Surprising News Upends the Market for Next-Gen Cholesterol Busters,2016-11-01 16:39:07 +0000,http://www.fool.com/investing/2016/11/01/pfizers-surprising-news-upends-the-market-for-next.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Pfizer's Surprising News Upends the Market for Next-Gen Cholesterol Busters
PFE,PFE:US,BBG000BR2B91,"Pfizer earnings tumble on lost patents, higher costs",2016-11-01 16:23:19 +0000,http://uk.finance.yahoo.com/news/pfizer-earnings-tumble-lost-patents-115807300.html,"Pfizer earnings tumble on lost patents, higher costs"
PFE,PFE:US,BBG000BR2B91,Stocks Kick Off November With Declines,2016-11-01 16:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EQ1_iLTx1PQ/stocks-kick-off-november-with-declines-20161101-00591,Stocks Kick Off November With Declines
PFE,PFE:US,BBG000BR2B91,"Fed Meets, Q3 Earnings Continue, Election Uncertainty Rules",2016-11-01 16:18:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nIMxI0avmq8/fed-meets-q3-earnings-continue-election-uncertainty-rules-cm701804,Tuesday November 1 2016 Members of the Federal Open Market Committee FOMC or The Fed are meeting today and tomorrow to discuss U S policy regarding interest rates With the presidential election one week from today it is highly unlikely the Fed will make a move lest they get caught
PFE,PFE:US,BBG000BR2B91,Pfizer: It's Never Just the Earnings,2016-11-01 16:05:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/01/pfizer-its-never-just-the-earnings/?mod=yahoobarrons&ru=yahoo,Pfizer: It's Never Just the Earnings
PFE,PFE:US,BBG000BR2B91,Pfizer Unexpectedly Ends Cholesterol Drug Trial,2016-11-01 15:58:43 +0000,http://finance.yahoo.com/video/pfizer-unexpectedly-ends-cholesterol-drug-155843067.html,Pfizer Unexpectedly Ends Cholesterol Drug Trial
PFE,PFE:US,BBG000BR2B91,Pfizer Unexpectedly Ends Cholesterol Drug Trial,2016-11-01 15:58:31 +0000,http://www.bloomberg.com/news/videos/2016-11-01/pfizer-unexpectedly-ends-cholesterol-drug-trial?cmpid=yhoo.headline,Pfizer Unexpectedly Ends Cholesterol Drug Trial
PFE,PFE:US,BBG000BR2B91,"[$$] Pfizer Cuts Outlook, Ends Development of Cholesterol Drug",2016-11-01 15:48:25 +0000,http://www.wsj.com/articles/pfizer-cuts-outlook-ends-development-of-cholesterol-drug-1478000457?mod=yahoo_hs,"[$$] Pfizer Cuts Outlook, Ends Development of Cholesterol Drug"
PFE,PFE:US,BBG000BR2B91,"US STOCKS-Wall St lower amid election jitters, tepid data",2016-11-01 15:35:00 +0000,http://finance.yahoo.com/news/us-stocks-wall-st-lower-153500542.html,"US STOCKS-Wall St lower amid election jitters, tepid data"
PFE,PFE:US,BBG000BR2B91,"Dow Movers: PFE, CVX",2016-11-01 15:14:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sVsMPg90N4Y/dow-movers-pfe-cvx-cm701623,In early trading on Tuesday shares of Chevron CVX topped the list of the day s best performing Dow Jones Industrial Average components trading up 1 1 Year to date Chevron registers a 17 8 gain And the worst performing Dow component thus far on the day is Pfizer PFE
PFE,PFE:US,BBG000BR2B91,"Tuesday’s Vital Data: Facebook Inc (FB), Alibaba Group Holding Ltd (BABA) and Pfizer Inc. (PFE)",2016-11-01 15:14:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wz9y-nJitvo/tuesdays-vital-data-facebook-inc-fb-alibaba-group-holding-ltd-baba-and-pfizer-inc-pfe-cm701640,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips U S stock futures were up sharply for a good portion of this morning following positive economic data out of China Specifically China s manufacturing purchasing managers index PMI
PFE,PFE:US,BBG000BR2B91,[$$] Big Pharma Sales Need a Booster Shot​,2016-11-01 14:59:49 +0000,http://www.wsj.com/articles/big-pharma-sales-need-a-booster-shot-1478012385?mod=yahoo_hs,[$$] Big Pharma Sales Need a Booster Shot​
PFE,PFE:US,BBG000BR2B91,"Pfizer Q3 'Wasn't Great, Wasn't Bad': More Squawk From Jim Cramer",2016-11-01 14:43:00 +0000,https://www.thestreet.com/story/13875271/1/pfizer-q3-wasn-t-great-wasn-t-bad-more-squawk-from-jim-cramer.html?puc=yahoo&cm_ven=YAHOO,"Pfizer Q3 'Wasn't Great, Wasn't Bad': More Squawk From Jim Cramer"
PFE,PFE:US,BBG000BR2B91,Pfizer Caught In Drug Price Maelstrom (PFE),2016-11-01 14:41:00 +0000,http://www.investopedia.com/stock-analysis/cotd/110116/pfizer-caught-drug-price-maelstrom-pfe-pfe.aspx?partner=YahooSA,Pfizer Caught In Drug Price Maelstrom (PFE)
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Misses on Q3 Earnings and Sales; Lowers View,2016-11-01 14:18:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wYW0WRby-TY/pfizer-pfe-misses-on-q3-earnings-and-sales-lowers-view-cm701559,Pfizer Inc s PFE is one of the most well known names in the pharmaceutical sector not just for its medicines and vaccines but also for its consumer healthcare products This New York based company is well known for products like Prevnar Lyrica Lipitor and Celebrex among others However
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Q3 Earnings Lag; Cuts View, Sheds Bococizumab",2016-11-01 14:17:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YOOB9yux1Xk/pfizer-pfe-q3-earnings-lag-cuts-view-sheds-bococizumab-cm701670,Pfizer Inc s PFE third quarter adjusted earnings per share came in at 61 cents a penny below the Zacks Consensus Estimate of 62 cents The pharma giant s earnings were 2 above the year ago quarter as inclusion of Hospira operations a lower tax rate and a lower share count offset
PFE,PFE:US,BBG000BR2B91,What Will Be Pfizer’s Profitability in 3Q16?,2016-11-01 14:04:42 +0000,http://marketrealist.com/2016/10/what-will-be-pfizers-profitability-in-3q16/?utm_source=yahoo&utm_medium=feed,What Will Be Pfizer’s Profitability in 3Q16?
PFE,PFE:US,BBG000BR2B91,US STOCKS-Wall St little changed; Fed in focus,2016-11-01 13:52:27 +0000,http://finance.yahoo.com/news/us-stocks-wall-st-little-135227092.html,US STOCKS-Wall St little changed; Fed in focus
PFE,PFE:US,BBG000BR2B91,Stock Futures Trade Higher on Chinese Manufacturing Data,2016-11-01 13:34:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0KYsoHlo0m0/stock-futures-trade-higher-on-chinese-manufacturing-data-cm701568,Stocks were set to open higher on Tuesday with modest gains in the futures market attributed to upbeat Chinese manufacturing data and a slight uptick in West Texas intermediate crude oil futures Wall Street is also buoyed by a slightly weaker dollar and the expectation that the Federal
PFE,PFE:US,BBG000BR2B91,"Pfizer Cuts Outlook, Ends Development of Cholesterol Drug -- 2nd Update",2016-11-01 12:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/65wlWHy1TWQ/pfizer-cuts-outlook-ends-development-of-cholesterol-drug--2nd-update-20161101-01169,"Pfizer Cuts Outlook, Ends Development of Cholesterol Drug -- 2nd Update"
PFE,PFE:US,BBG000BR2B91,"Stocks, Bonds Kick Off November With Declines",2016-11-01 11:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TxvAXvm6LeE/stocks-bonds-kick-off-november-with-declines-20161101-00443,"Stocks, Bonds Kick Off November With Declines"
PFE,PFE:US,BBG000BR2B91,Pfizer third quarter earnings tumble 38% to $1.3 bn,2016-11-01 11:21:29 +0000,http://uk.finance.yahoo.com/news/pfizer-third-quarter-earnings-tumble-112129133.html,Pfizer third quarter earnings tumble 38% to $1.3 bn
PFE,PFE:US,BBG000BR2B91,Pfizer Reports Third-Quarter 2016 Results,2016-11-01 11:03:07 +0000,http://www.publicnow.com/view/AC747938588C05EE5181C38ED289B88E55AA404C,"[at noodls] - PFIZER REPORTS THIRD-QUARTER 2016 RESULTS‌‌‌ Third-Quarter 2016 Revenues of $13.0 Billion, Reflecting 10% Operational Growth Third-Quarter 2016 Revenues for Pfizer Standalone (Excluding Legacy Hospira) ..."
PFE,PFE:US,BBG000BR2B91,"Earnings Reaction History: Pfizer Inc, 40.0% Follow-Through Indicator, 1.4% Sensitive",2016-11-01 10:54:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gM_swg7yzqQ/earnings-reaction-history-pfizer-inc-400-follow-through-indicator-14-sensitive-cm701501,Expected Earnings Release 11 01 2016 PremarketExpected Earnings Release 11 01 2016 Premarket Avg Extended Hours Dollar Volume 8 927 340Avg Extended Hours Dollar Volume 8 927 340 Pfizer Inc PFE is due to issue its quarterly earnings report in the upcoming extended hours session
PFE,PFE:US,BBG000BR2B91,Shire Cuts Guidance After Posting Third-Quarter Loss--Update,2016-11-01 10:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xviJADgHaPk/shire-cuts-guidance-after-posting-thirdquarter-lossupdate-20161101-01126,Shire Cuts Guidance After Posting Third-Quarter Loss--Update
PFE,PFE:US,BBG000BR2B91,"Pfizer Discontinues Global Development of Bococizumab, Its Investigational PCSK9 Inhibitor",2016-11-01 10:33:04 +0000,http://www.publicnow.com/view/E5352DB3F5833F4CD63DC7D28C97C0C6E9645235,"[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. announced today the discontinuation of the global clinical development program for bococizumab, its investigational Proprotein Convertase Subtilisin Kexin type 9 ..."
PFE,PFE:US,BBG000BR2B91,Positive China Data Buoy Global Stocks,2016-11-01 09:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-Ti2z82U74I/positive-china-data-buoy-global-stocks-20161101-00317,Positive China Data Buoy Global Stocks
PFE,PFE:US,BBG000BR2B91,Three things to watch in Pfizer's earnings,2016-11-01 09:38:00 +0000,http://finance.yahoo.com/video/three-things-watch-pfizers-earnings-093800715.html,Three things to watch in Pfizer's earnings
PFE,PFE:US,BBG000BR2B91,U.S. Hot Stocks: Hot Stocks to Watch,2016-11-01 09:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pvN3VyjBBKA/us-hot-stocks-hot-stocks-to-watch-20161101-00260,U.S. Hot Stocks: Hot Stocks to Watch
PFE,PFE:US,BBG000BR2B91,Shire Cuts Guidance After Posting Third-Quarter Loss,2016-11-01 09:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FbhSmY9AV3Q/shire-cuts-guidance-after-posting-thirdquarter-loss-20161101-01127,Shire Cuts Guidance After Posting Third-Quarter Loss
PFE,PFE:US,BBG000BR2B91,"Pfizer Cuts Outlook, Ends Development of Cholesterol Drug -- Update",2016-11-01 08:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zHScC9LBguM/pfizer-cuts-outlook-ends-development-of-cholesterol-drug--update-20161101-01718,"Pfizer Cuts Outlook, Ends Development of Cholesterol Drug -- Update"
PFE,PFE:US,BBG000BR2B91,"Pfizer Cuts Outlook, Ends Development of Cholesterol Drug",2016-11-01 07:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DyZ3RcP2GjQ/pfizer-cuts-outlook-ends-development-of-cholesterol-drug-20161101-00079,"Pfizer Cuts Outlook, Ends Development of Cholesterol Drug"
PFE,PFE:US,BBG000BR2B91,Pfizer Q3 16 Earnings Conference Call At 10:00 AM ET,2016-11-01 07:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZeKUCfVaGGQ/pfizer-q3-16-earnings-conference-call-at-1000-am-et-20161101-00223,Pfizer Q3 16 Earnings Conference Call At 10:00 AM ET
PFE,PFE:US,BBG000BR2B91,Pfizer Q3 Profit Falls; To Discontinue Bococizumab Development Program,2016-11-01 07:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0EZIXxrDTBI/pfizer-q3-profit-falls-to-discontinue-bococizumab-development-program-20161101-01567,Pfizer Q3 Profit Falls; To Discontinue Bococizumab Development Program
PFE,PFE:US,BBG000BR2B91,Positive China Data Buoys Global Stocks,2016-11-01 05:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lRGxFYSdgj4/positive-china-data-buoys-global-stocks-20161101-00034,Positive China Data Buoys Global Stocks
PFE,PFE:US,BBG000BR2B91,Stocks Open Month With a Thud,2016-11-01 05:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QxDYhI7vbtc/stocks-open-month-with-a-thud-20161101-01091,Stocks Open Month With a Thud
PFE,PFE:US,BBG000BR2B91,3 Top Earnings Charts in a Busy Week,2016-11-01 00:14:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z9HYrDV6sBc/3-top-earnings-charts-in-a-busy-week-cm701439,Earnings season is still going strong with some of the biggest names about to report These three companies have good earnings track records even though they ve each missed one time in the last 5 years That s still an impressive earnings surprise record Here are three you should be
PFE,PFE:US,BBG000BR2B91,Win-win election plays,2016-10-31 21:01:00 +0000,http://finance.yahoo.com/video/win-win-election-plays-210100908.html,Win-win election plays
PFE,PFE:US,BBG000BR2B91,"Pfizer Q3 Sales Challenged By Eli Lilly, Novartis Amid Breakup Bust",2016-10-31 20:19:51 +0000,http://www.investors.com/news/technology/pfizer-q3-sales-challenged-by-eli-lilly-novartis-amid-breakup-bust/,"Pfizer Q3 Sales Challenged By Eli Lilly, Novartis Amid Breakup Bust"
PFE,PFE:US,BBG000BR2B91,"Pre-Market Earnings Report for November 1, 2016 :  PFE, OXY, SHPG, ECL, LYB, BP, EMR, ICE, AEP, TRI, ETN, K",2016-10-31 20:14:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pNM_6gWvW78/pre-market-earnings-report-for-november-1-2016-pfe-oxy-shpg-ecl-lyb-bp-emr-ice-aep-tri-etn-k-cm701355,The following companies are expected to report earnings prior to market open on 11 01 2016 Visit our Earnings Calendar for a full list of expected earnings releases Pfizer Inc PFE is reporting for the quarter ending September 30 2016 The large
PFE,PFE:US,BBG000BR2B91,"Amgen, Gilead, Eli Lilly Eat Into AbbVie's Humira Sales: Analyst",2016-10-31 20:01:58 +0000,http://www.investors.com/news/technology/amgen-gilead-eli-lilly-champ-at-abbvies-humira-sales-analyst/,"Amgen, Gilead, Eli Lilly Eat Into AbbVie's Humira Sales: Analyst"
PFE,PFE:US,BBG000BR2B91,5 Stocks to Watch Before the Market Opens Tomorrow,2016-10-31 20:00:34 +0000,http://finance.yahoo.com/tumblr/blog-5-stocks-to-watch-before-the-market-opens-tomorrow-200037935.html,5 Stocks to Watch Before the Market Opens Tomorrow
PFE,PFE:US,BBG000BR2B91,European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma,2016-10-31 16:43:09 +0000,http://www.publicnow.com/view/D51743FC70664C1842DAFCD8C1CE656DFA926EE0,"[at noodls] - Merck KGaA, Darmstadt, Germany, and Pfizer Inc. (NYSE: PFE(link is external)) today announced that the European Medicines Agency (EMA) has validated for review Merck KGaA, Darmstadt, Germany's Marketing ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Opens The Books And The Medicine Cabinets,2016-10-31 15:19:00 +0000,http://www.forbes.com/sites/jjkinahan/2016/10/31/pfizer-opens-the-books-and-the-medicine-cabinets/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Pfizer Opens The Books And The Medicine Cabinets
PFE,PFE:US,BBG000BR2B91,Products Offsetting Growth in Pfizer’s 3Q16 Estimates,2016-10-31 15:05:14 +0000,http://marketrealist.com/2016/10/products-offsetting-growth-in-pfizers-3q16-estimates/?utm_source=yahoo&utm_medium=feed,Products Offsetting Growth in Pfizer’s 3Q16 Estimates
PFE,PFE:US,BBG000BR2B91,What Analysts Are Recommending for Pfizer and Other Major Oncology Players in 2016,2016-10-31 15:04:05 +0000,http://marketrealist.com/2016/10/analysts-recommending-pfizer-major-oncology-players-2016/?utm_source=yahoo&utm_medium=feed,What Analysts Are Recommending for Pfizer and Other Major Oncology Players in 2016
PFE,PFE:US,BBG000BR2B91,What to Expect From Pfizer Earnings,2016-10-31 14:25:49 +0000,http://247wallst.com/healthcare-business/2016/10/31/what-to-expect-from-pfizer-earnings-4/,What to Expect From Pfizer Earnings
PFE,PFE:US,BBG000BR2B91,Understanding the Growth Contributors in Pfizer’s 3Q16 Estimates,2016-10-31 14:05:17 +0000,http://marketrealist.com/2016/10/understanding-the-growth-contributors-in-pfizers-3q16-estimates/?utm_source=yahoo&utm_medium=feed,Understanding the Growth Contributors in Pfizer’s 3Q16 Estimates
PFE,PFE:US,BBG000BR2B91,Talazoparib and Pidilizumab May Prove Complementary to Pfizer’s Existing Oncology Drugs,2016-10-31 14:04:15 +0000,http://marketrealist.com/2016/10/talazoparib-pidilizumab-may-prove-complementary-pfizers-existing-oncology-drugs/?utm_source=yahoo&utm_medium=feed,Talazoparib and Pidilizumab May Prove Complementary to Pfizer’s Existing Oncology Drugs
PFE,PFE:US,BBG000BR2B91,Can Pfizer Recover Growth in 3Q16 Earnings?,2016-10-31 12:06:08 +0000,http://marketrealist.com/2016/10/can-pfizer-recover-growth-in-3q16-earnings/?utm_source=yahoo&utm_medium=feed,Can Pfizer Recover Growth in 3Q16 Earnings?
PFE,PFE:US,BBG000BR2B91,Pfizer’s Xtandi Researched as a Therapy for Early Stage Prostate Cancer,2016-10-31 12:04:16 +0000,http://marketrealist.com/2016/10/xtandi-researched-therapy-early-stage-prostate-cancer/?utm_source=yahoo&utm_medium=feed,Pfizer’s Xtandi Researched as a Therapy for Early Stage Prostate Cancer
PFE,PFE:US,BBG000BR2B91,European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma,2016-10-31 07:00:00 +0000,http://finance.yahoo.com/news/european-medicines-agency-validates-marketing-070000300.html,[CNW Group] - European Medicines Agency Validates the Marketing Authorization Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
PFE,PFE:US,BBG000BR2B91,Wall Street May Bounce Back,2016-10-31 06:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QZ4sWPMwbls/wall-street-may-bounce-back-20161031-00255,Wall Street May Bounce Back
PFE,PFE:US,BBG000BR2B91,Wall Street May Bounce Back,2016-10-31 06:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iJxkvmfmI_A/wall-street-may-bounce-back-20161031-00254,Wall Street May Bounce Back
PFE,PFE:US,BBG000BR2B91,EMA To Review Merck's Avelumab For Treatment Of Metastatic Merkel Cell Carcinoma,2016-10-31 03:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L3O8IyQZNB8/ema-to-review-mercks-avelumab-for-treatment-of-metastatic-merkel-cell-carcinoma-20161031-00087,EMA To Review Merck's Avelumab For Treatment Of Metastatic Merkel Cell Carcinoma
PFE,PFE:US,BBG000BR2B91,EMA To Review Merck's Avelumab For Treatment Of Metastatic Merkel Cell Carcinoma,2016-10-31 03:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U9cQnPY-o3A/ema-to-review-mercks-avelumab-for-treatment-of-metastatic-merkel-cell-carcinoma-20161031-00088,EMA To Review Merck's Avelumab For Treatment Of Metastatic Merkel Cell Carcinoma
PFE,PFE:US,BBG000BR2B91,Reflation Alert!,2016-10-30 17:01:15 +0000,http://finance.yahoo.com/tumblr/blog-reflation-alert-170123613.html,Reflation Alert!
PFE,PFE:US,BBG000BR2B91,8 Top Earnings for the Week Ahead,2016-10-30 14:05:25 +0000,http://247wallst.com/investing/2016/10/30/8-top-earnings-for-the-week-ahead/,8 Top Earnings for the Week Ahead
PFE,PFE:US,BBG000BR2B91,What Can We Expect of Pfizer’s 3Q16 Earnings?,2016-10-28 22:02:41 +0000,http://marketrealist.com/2016/10/what-can-we-expect-of-pfizers-3q16-earnings/?utm_source=yahoo&utm_medium=feed,What Can We Expect of Pfizer’s 3Q16 Earnings?
PFE,PFE:US,BBG000BR2B91,ARIAD (ARIA): Is a Beat in the Cards this Earnings Season?,2016-10-28 19:34:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L4xyDL6EDxo/ariad-aria-is-a-beat-in-the-cards-this-earnings-season-cm700305,ARIAD Pharmaceuticals Inc ARIA is expected to report third quarter 2016 results on Nov 1 In the last reported quarter the company recorded a positive earnings surprise of 670 Overall ARIAD has posted an average positive earnings surprise of 153 54 in the four trailing quarters Let
PFE,PFE:US,BBG000BR2B91,Should You Buy Pfizer (PFE) Ahead of Earnings?,2016-10-28 16:36:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PqE_-k_D4XQ/should-you-buy-pfizer-pfe-ahead-of-earnings-cm700330,Investors are always looking for stocks that are poised to beat at earnings season and Pfizer Inc PFE may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Pfizer is seeing favorable earnings
PFE,PFE:US,BBG000BR2B91,3 ETFs to Buy if You Think Pfizer Will Beat Earnings,2016-10-28 16:07:00 +0000,https://www.thestreet.com/story/13865877/1/3-etfs-to-buy-if-you-think-pfizer-will-beat-earnings.html?puc=yahoo&cm_ven=YAHOO,3 ETFs to Buy if You Think Pfizer Will Beat Earnings
PFE,PFE:US,BBG000BR2B91,Medivation Adds Leading Prostate Cancer Drug Xtandi to Pfizer’s Oncology Portfolio,2016-10-28 15:04:12 +0000,http://marketrealist.com/2016/10/medivation-adds-leading-prostate-cancer-drug-xtandi-pfizers-oncology-portfolio/?utm_source=yahoo&utm_medium=feed,Medivation Adds Leading Prostate Cancer Drug Xtandi to Pfizer’s Oncology Portfolio
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Bristol-Myers, Merck Top Estimates, Merck Wins Key FDA Nod",2016-10-28 14:34:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_mEm4L1No38/pharma-stock-roundup-bristol-myers-merck-top-estimates-merck-wins-key-fda-nod-cm700213,Third quarter earnings season is in full flow with several large cap pharma companies like Lilly LLY Merck MRK Bristol Myers BMY Novartis and others reporting results this week While companies like Merck and Bristol Myers surpassed expectations others like Lilly fell short Recap
PFE,PFE:US,BBG000BR2B91,Should You Buy Pfizer (PFE) Ahead of Earnings?,2016-10-28 14:10:02 +0000,http://finance.yahoo.com/news/buy-pfizer-pfe-ahead-earnings-141002084.html,Should You Buy Pfizer (PFE) Ahead of Earnings?
PFE,PFE:US,BBG000BR2B91,Pfizer Aims to Position Avelumab as Backbone Immuno-Oncology Therapy,2016-10-28 14:04:20 +0000,http://marketrealist.com/2016/10/pfizer-aims-position-avelumab-backbone-immuno-oncology-therapy/?utm_source=yahoo&utm_medium=feed,Pfizer Aims to Position Avelumab as Backbone Immuno-Oncology Therapy
PFE,PFE:US,BBG000BR2B91,Pfizer calls piling up before earnings,2016-10-28 13:16:06 +0000,http://finance.yahoo.com/news/pfizer-calls-piling-earnings-131606212.html,Pfizer calls piling up before earnings
PFE,PFE:US,BBG000BR2B91,New Label Expansion May Help Boost Sutent’s Growth Prospects,2016-10-28 12:04:33 +0000,http://marketrealist.com/2016/10/new-label-expansion-may-help-boost-sutents-growth-prospects-future-years/?utm_source=yahoo&utm_medium=feed,New Label Expansion May Help Boost Sutent’s Growth Prospects
PFE,PFE:US,BBG000BR2B91,Sanofi Lifts Profit Outlook,2016-10-28 02:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mDlfHYDzu0w/sanofi-lifts-profit-outlook-20161028-00102,Sanofi Lifts Profit Outlook
PFE,PFE:US,BBG000BR2B91,Using VIX In A Stock Portfolio,2016-10-27 20:44:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xJ5gVSmtxWU/using-vix-in-a-stock-portfolio-cm695756,By Stuart Barton PhD CFA ByStuart Barton PhD CFA Some of the strongest demand for VIX exposure comes from traders and portfolio managers looking for diversifying instruments that are uncorrelated to their present portfolios Given that the VIX Index is ultimately an S amp P 500
PFE,PFE:US,BBG000BR2B91,The Woman At The Center Of The Biggest Biotech IPO Of The Year,2016-10-27 20:08:00 +0000,http://www.forbes.com/sites/nathanvardi/2016/10/27/the-woman-at-the-center-of-the-biggest-biotech-ipo-of-the-year/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,The Woman At The Center Of The Biggest Biotech IPO Of The Year
PFE,PFE:US,BBG000BR2B91,"Bristol-Myers (BMY) Beats on Q3 Earnings, Ups 2016 View",2016-10-27 17:44:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-eBxuF7vS0k/bristol-myers-bmy-beats-on-q3-earnings-ups-2016-view-cm699608,Bristol Myers Squibb Company s BMY third quarter 2016 earnings of 77 cents per share beat the Zacks Consensus Estimate of 65 cents and surged 97 from the year ago period FindTheCompany Graphiq Total revenue of 4 92 billion was also above the Zacks Consensus Estimate
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) to Post Q3 Earnings: How Will the Stock React?,2016-10-27 17:43:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bA9cu08wUk4/pfizer-pfe-to-post-q3-earnings-how-will-the-stock-react-cm699576,Pfizer Inc PFE will be reporting third quarter 2016 earnings on Nov 1 before market open Last quarter the company delivered a positive earnings surprise of 3 23 The pharma giant has been consistently beating earnings expectations The company s earnings surpassed expectations in each
PFE,PFE:US,BBG000BR2B91,Pfizer Files 8K - Changes Executive Management,2016-10-27 16:28:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d4pCv0DXcMU/pfizer-files-8k--changes-executive-management-20161027-01501,Pfizer Files 8K - Changes Executive Management
PFE,PFE:US,BBG000BR2B91,These 3 Dividend Stocks Are the Place To Be Today,2016-10-27 15:44:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2tmz3AbSYsw/these-3-dividend-stocks-are-the-place-to-be-today-cm699391,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips I m the lucky dad of teenage boys Financial markets remind me of teenage boys brilliant rewarding inspiring at times and other times frustrating erratic and just plain stupid I ve
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) to Post Q3 Earnings: How Will the Stock React?,2016-10-27 15:37:03 +0000,http://finance.yahoo.com/news/pfizer-pfe-post-q3-earnings-153703357.html,Pfizer (PFE) to Post Q3 Earnings: How Will the Stock React?
PFE,PFE:US,BBG000BR2B91,Inlyta Expected to Witness Competitive Pressures in 2016,2016-10-27 15:04:51 +0000,http://marketrealist.com/2016/10/inlyta-expected-witness-competitive-pressures-2016/?utm_source=yahoo&utm_medium=feed,Inlyta Expected to Witness Competitive Pressures in 2016
PFE,PFE:US,BBG000BR2B91,Xalkori Label Expansion May Boost Pfizer’s Sales in 2016,2016-10-27 14:05:08 +0000,http://marketrealist.com/2016/10/xalkori-label-expansion-may-boost-drugs-sales-2016/?utm_source=yahoo&utm_medium=feed,Xalkori Label Expansion May Boost Pfizer’s Sales in 2016
PFE,PFE:US,BBG000BR2B91,AstraZeneca Suspends Recruitment in Two Cancer Clinical Trials,2016-10-27 13:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7G4mIjOcqYs/astrazeneca-suspends-recruitment-in-two-cancer-clinical-trials-20161027-01157,AstraZeneca Suspends Recruitment in Two Cancer Clinical Trials
PFE,PFE:US,BBG000BR2B91,Biggest Biotech IPO Of 2016 Is Launched By 31 Year Old,2016-10-27 12:56:00 +0000,http://www.forbes.com/sites/nathanvardi/2016/10/27/biggest-biotech-ipo-of-2016-is-launched-by-31-year-old/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Biggest Biotech IPO Of 2016 Is Launched By 31 Year Old
PFE,PFE:US,BBG000BR2B91,Pfizer Continues to Work on Ibrance Label Expansion in 2016,2016-10-27 12:05:38 +0000,http://marketrealist.com/2016/10/pfizer-continues-work-ibrance-label-expansion-2016/?utm_source=yahoo&utm_medium=feed,Pfizer Continues to Work on Ibrance Label Expansion in 2016
PFE,PFE:US,BBG000BR2B91,Pfizer Expects Ibrance to Become a Blockbuster Therapy,2016-10-27 12:04:05 +0000,http://marketrealist.com/2016/10/pfizer-expects-ibrance-become-blockbuster-therapy/?utm_source=yahoo&utm_medium=feed,Pfizer Expects Ibrance to Become a Blockbuster Therapy
PFE,PFE:US,BBG000BR2B91,Better Buy: Eli Lilly and Co vs. Pfizer,2016-10-27 11:02:45 +0000,http://www.fool.com/investing/2016/10/26/better-buy-eli-lilly-and-co-vs-pfizer.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Eli Lilly and Co vs. Pfizer
PFE,PFE:US,BBG000BR2B91,'Mad Money' Lightning Round: Dollar Tree Has 'Been in Free Fall',2016-10-27 10:00:00 +0000,https://www.thestreet.com/story/13741646/1/mad-money-lightning-round-dollar-tree-has-been-in-free-fall.html?puc=yahoo&cm_ven=YAHOO,'Mad Money' Lightning Round: Dollar Tree Has 'Been in Free Fall'
PFE,PFE:US,BBG000BR2B91,Better Buy: Eli Lilly and Co vs. Pfizer,2016-10-26 22:51:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3H0Upmrp2Bg/better-buy-eli-lilly-and-co-vs-pfizer-cm699001,Eli Lilly NYSE LLY and Pfizer NYSE PFE are two of the most widely recognized dividend paying Big Pharma stocks in the world However these two elite drugmakers appear to be on drastically different trajectories thanks to their varying strategies in dealing with a spate
PFE,PFE:US,BBG000BR2B91,How Do Pfizer’s Valuation Multiples Compare with Those of Other Oncology Players in 2016?,2016-10-26 22:16:12 +0000,http://marketrealist.com/2016/10/pfizers-valuation-multiples-compare-oncology-players-2016/?utm_source=yahoo&utm_medium=feed,How Do Pfizer’s Valuation Multiples Compare with Those of Other Oncology Players in 2016?
PFE,PFE:US,BBG000BR2B91,Xeljanz ER Is Driving Growth for Pfizer This Year,2016-10-26 15:04:05 +0000,http://marketrealist.com/2016/10/xeljanz-er-expected-key-growth-driver-pfizer-2016/?utm_source=yahoo&utm_medium=feed,Xeljanz ER Is Driving Growth for Pfizer This Year
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: AT&T, General Mills, Pfizer and Time Warner",2016-10-26 14:52:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HEGcPvJfSWk/the-zacks-analyst-blog-highlights-att-general-mills-pfizer-and-time-warner-cm698561,For Immediate Release Chicago IL October 26 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
PFE,PFE:US,BBG000BR2B91,Enbrel Facing Competition from Biosimilar Versions of the Drug,2016-10-26 14:04:05 +0000,http://marketrealist.com/2016/10/enbrel-witnesses-biosimilar-competition-2016/?utm_source=yahoo&utm_medium=feed,Enbrel Facing Competition from Biosimilar Versions of the Drug
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: AT&T, General Mills, Pfizer and Time Warner",2016-10-26 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-t-133001083.html,"The Zacks Analyst Blog Highlights: AT&T, General Mills, Pfizer and Time Warner"
PFE,PFE:US,BBG000BR2B91,Interesting Trend Developing for Pfizer’s Pneumococcal Franchise,2016-10-26 12:04:09 +0000,http://marketrealist.com/2016/10/prevnar-13-franchise-may-witness-slight-decline-revenues-2016/?utm_source=yahoo&utm_medium=feed,Interesting Trend Developing for Pfizer’s Pneumococcal Franchise
PFE,PFE:US,BBG000BR2B91,Short Sellers Grow More Selective on Major Pharma Stocks,2016-10-26 11:40:58 +0000,http://247wallst.com/healthcare-business/2016/10/26/short-sellers-grow-more-selective-on-major-pharma-stocks/,Short Sellers Grow More Selective on Major Pharma Stocks
PFE,PFE:US,BBG000BR2B91,Ex-Oppenheimer & Co. worker pleads guilty to insider trading,2016-10-25 23:22:08 +0000,http://sg.finance.yahoo.com/news/ex-oppenheimer-co-worker-pleads-231413744.html,Ex-Oppenheimer & Co. worker pleads guilty to insider trading
PFE,PFE:US,BBG000BR2B91,Ex-Oppenheimer adviser pleads guilty to U.S. insider trading charges,2016-10-25 21:48:55 +0000,http://finance.yahoo.com/news/ex-oppenheimer-adviser-pleads-guilty-214855234.html,Ex-Oppenheimer adviser pleads guilty to U.S. insider trading charges
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Oct 25, 2016 :  EPD, AAPL, RAI, NRG, ETE, CHK, PFE, QQQ, EBAY, KHC, ADI, MSFT",2016-10-25 21:04:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q3mf_XDrb5A/after-hours-most-active-for-oct-25-2016-epd-aapl-rai-nrg-ete-chk-pfe-qqq-ebay-khc-adi-msft-cm698217,The NASDAQ 100 After Hours Indicator is down 15 02 to 4 876 43 The total After hours volume is currently 33 417 339 shares traded The following are the most active stocks for the after hours session Enterprise Products Partners L P EPD is 0 02 at 26 26
PFE,PFE:US,BBG000BR2B91,"Analyst Reports for AT&T, Pfizer & General Mills",2016-10-25 20:25:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Kgh_9mbA6Po/analyst-reports-for-att-pfizer-general-mills-cm698176,Tuesday October 25 2016 Today s Research Daily features new research reports on 16 major stocks including AT amp T T General Mills GIS and Pfizer PFE AT amp T is in the headlines because of the Time Warner TWX deal which will likely get plenty of regulatory scrutiny The
PFE,PFE:US,BBG000BR2B91,Ex-Oppenheimer adviser to plead guilty in U.S. to insider trading,2016-10-25 20:06:17 +0000,http://finance.yahoo.com/news/ex-oppenheimer-adviser-plead-guilty-200617116.html,Ex-Oppenheimer adviser to plead guilty in U.S. to insider trading
PFE,PFE:US,BBG000BR2B91,"Analyst Reports for AT&T, Pfizer & General Mills",2016-10-25 16:36:04 +0000,http://finance.yahoo.com/news/analyst-reports-t-pfizer-general-163604477.html,"Analyst Reports for AT&T, Pfizer & General Mills"
PFE,PFE:US,BBG000BR2B91,5 Healthcare Stocks to Buy Despite a Clinton Victory,2016-10-25 16:27:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z7WuhrvyqPM/5-healthcare-stocks-to-buy-despite-a-clinton-victory-cm697884,As the race for the presidency enters its last lap Hillary Clinton has emerged as the clear favorite Going by the Real Clear Politics poll average Clinton is leading Donald Trump by more than six points as of now Market watchers and analysts alike are now examining the implications of a
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb’s 3Q16 Earnings: What’s Expected,2016-10-25 15:45:42 +0000,http://marketrealist.com/2016/10/bristol-myers-squibbs-3q16-earnings-whats-expected/?utm_source=yahoo&utm_medium=feed,Bristol-Myers Squibb’s 3Q16 Earnings: What’s Expected
PFE,PFE:US,BBG000BR2B91,Viagra May Witness a Decline in Revenues in 2016,2016-10-25 15:04:16 +0000,http://marketrealist.com/2016/10/viagra-may-witness-decline-revenues-2016/?utm_source=yahoo&utm_medium=feed,Viagra May Witness a Decline in Revenues in 2016
PFE,PFE:US,BBG000BR2B91,Merck Keytruda Gets FDA Approval for First-Line Lung Cancer,2016-10-25 14:27:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FKUGu8s5ZTY/merck-keytruda-gets-fda-approval-for-first-line-lung-cancer-cm697709,Merck amp Co Inc MRK announced that the FDA has approved a label expansion of its PD 1 therapy Keytruda to include the first line treatment of patients whose tumors have high PD L1 expression with no EGFR or ALK genomic tumor aberrations Keytruda is approved for the treatment
PFE,PFE:US,BBG000BR2B91,Update on Roche’s Analyst Recommendations,2016-10-25 14:04:59 +0000,http://marketrealist.com/2016/10/update-on-roches-analyst-recommendations/?utm_source=yahoo&utm_medium=feed,Update on Roche’s Analyst Recommendations
PFE,PFE:US,BBG000BR2B91,Pfizer Has a Revenue-Boosting Treatment to Help Smokers Quit,2016-10-25 14:04:26 +0000,http://marketrealist.com/2016/10/chantix-expected-boost-pfizers-revenues-2016/?utm_source=yahoo&utm_medium=feed,Pfizer Has a Revenue-Boosting Treatment to Help Smokers Quit
PFE,PFE:US,BBG000BR2B91,Toviaz Expected to Report Stable Revenues in 2016,2016-10-25 12:04:27 +0000,http://marketrealist.com/2016/10/toviaz-expected-report-stable-revenues-2016/?utm_source=yahoo&utm_medium=feed,Toviaz Expected to Report Stable Revenues in 2016
PFE,PFE:US,BBG000BR2B91,Ariad Could Follow Gilead's — Or Mylan's — Route In Drug Price Battle,2016-10-24 20:19:18 +0000,http://www.investors.com/news/technology/ariad-could-follow-gileads-or-mylans-route-in-drug-price-battle/,Ariad Could Follow Gilead's — Or Mylan's — Route In Drug Price Battle
PFE,PFE:US,BBG000BR2B91,What Presidential Election? Deal Making Has Biggest Week Since 1999,2016-10-24 18:56:53 +0000,http://blogs.wsj.com/moneybeat/2016/10/24/what-presidential-election-deal-making-has-biggest-week-since-1999/?mod=yahoo_hs,What Presidential Election? Deal Making Has Biggest Week Since 1999
PFE,PFE:US,BBG000BR2B91,Healthcare ETFs: Gain or Pain Ahead in Q3 Earnings?,2016-10-24 16:26:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lGd9FKvfjkU/healthcare-etfs-gain-or-pain-ahead-in-q3-earnings-cm697191,The Q3 earnings season is in full swing with the healthcare sector showing the third highest growth at this stage trailing materials and business services Earnings from 22 of the sector s market capitalization that have reported so far are up 15 9 with a beat ratio of 83 3 on revenue growth
PFE,PFE:US,BBG000BR2B91,Eliquis Proving to Be a Major Growth Driver for Pfizer This Year,2016-10-24 15:04:56 +0000,http://marketrealist.com/2016/10/eliquis-may-prove-major-growth-driver-pfizer-2016/?utm_source=yahoo&utm_medium=feed,Eliquis Proving to Be a Major Growth Driver for Pfizer This Year
PFE,PFE:US,BBG000BR2B91,Healthcare ETFs: Gain or Pain Ahead in Q3 Earnings?,2016-10-24 14:28:02 +0000,http://finance.yahoo.com/news/healthcare-etfs-gain-pain-ahead-142802745.html,Healthcare ETFs: Gain or Pain Ahead in Q3 Earnings?
PFE,PFE:US,BBG000BR2B91,Treating Epilepsy Is One of Pfizer’s Solid Growth Prospects,2016-10-24 14:05:33 +0000,http://marketrealist.com/2016/10/lyrica-expected-report-modest-revenue-growth-till-2017/?utm_source=yahoo&utm_medium=feed,Treating Epilepsy Is One of Pfizer’s Solid Growth Prospects
PFE,PFE:US,BBG000BR2B91,Analyst Recommendations for Pfizer and Its Peers in 2016,2016-10-24 12:06:20 +0000,http://marketrealist.com/2016/10/analyst-recommendations-pfizer-peers-2016/?utm_source=yahoo&utm_medium=feed,Analyst Recommendations for Pfizer and Its Peers in 2016
PFE,PFE:US,BBG000BR2B91,[$$] A CEO's primer on how to manage under pressure,2016-10-24 04:00:13 +0000,"http://www.ft.com/cms/s/50125bbe-96af-11e6-a1dc-bdf38d484582,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Leaders often define themselves by bold acts: a takeover, a corporate rescue. Success, though, is determined by a trait less obvious to outsiders their ability to handle pressure. Dennis Kozlowski told ..."
PFE,PFE:US,BBG000BR2B91,The Biggest Mergers & Acquisitions In The U.S.,2016-10-23 14:23:00 +0000,http://www.investopedia.com/articles/investing/102314/biggest-mergers-acquisitions-us.asp?rp=y&partner=YahooSA,The Biggest Mergers & Acquisitions In The U.S.
PFE,PFE:US,BBG000BR2B91,FDA Approves Supplemental New Drug Application for XTANDI® (enzalutamide) Capsules in Advanced Prostate Cancer,2016-10-21 20:39:02 +0000,http://www.publicnow.com/view/33F6D3CE6F312A8883824BBAA70DF188A4554A12,[at noodls] - Astellas Pharma Inc. (TSE: 4503) and Pfizer Inc. (NYSE: PFE(link is external)) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) to update ...
PFE,PFE:US,BBG000BR2B91,Billionaire Ken Fisher Loves These Dividend Stocks,2016-10-21 20:26:15 +0000,http://www.insidermonkey.com/blog/billionaire-ken-fisher-loves-these-dividend-stocks-482524/,Billionaire Ken Fisher Loves These Dividend Stocks
PFE,PFE:US,BBG000BR2B91,FDA Approves Supplemental New Drug Application for XTANDI® (enzalutamide) Capsules in Advanced Prostate Cancer,2016-10-21 15:55:00 +0000,http://finance.yahoo.com/news/fda-approves-supplemental-drug-application-155500472.html,"[PR Newswire] - TOKYO and NEW YORK, Oct. 21, 2016 /PRNewswire/ -- Astellas Pharma Inc. (TSE:4503) and Pfizer Inc. (PFE) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) to update the U.S. product labeling for XTANDI® (enzalutamide) capsules to include new clinical data versus bicalutamide from the TERRAIN study. The data demonstrate improvement in radiographic progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (CRPC) who were treated with enzalutamide compared to patients who were treated with bicalutamide."
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Pfizer, Novartis AG, Amgen, Merck and Momenta Pharmaceuticals",2016-10-21 15:27:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aanaJa6VeUU/the-zacks-analyst-blog-highlights-pfizer-novartis-ag-amgen-merck-and-momenta-pharmaceuticals-cm696583,For Immediate Release Chicago IL October 21 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
PFE,PFE:US,BBG000BR2B91,"XLV, ZSL: Big ETF Outflows",2016-10-21 15:24:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o6n7VMrm3Yo/xlv-zsl-big-etf-outflows-cm696545,Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel the biggest outflow was seen in the Health Care Select Sector SPDR Fund XLV where 5 900 000 units were destroyed or a 3 3 decrease week over week Among the largest underlying
PFE,PFE:US,BBG000BR2B91,"Advent, Bain gain edge in bid for Pfizer's Brazil venture - sources",2016-10-21 14:10:07 +0000,http://in.finance.yahoo.com/news/advent-bain-gain-edge-bid-141007181.html,"Advent, Bain gain edge in bid for Pfizer's Brazil venture - sources"
PFE,PFE:US,BBG000BR2B91,"Advent, Bain gain edge in bid for Pfizer's Brazil venture -sources",2016-10-21 14:08:46 +0000,http://finance.yahoo.com/news/advent-bain-gain-edge-bid-140846395.html,"Advent, Bain gain edge in bid for Pfizer's Brazil venture -sources"
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Pfizer, Novartis AG, Amgen, Merck and Momenta Pharmaceuticals",2016-10-21 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-pfizer-133001778.html,"The Zacks Analyst Blog Highlights: Pfizer, Novartis AG, Amgen, Merck and Momenta Pharmaceuticals"
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Oct 20, 2016 :  BAC, BBVA, MSFT, CA, CTSH, QQQ, ALKS, PYPL, VZ, PBR, KKR, PFE",2016-10-20 21:05:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/asE1Mjlw-7A/after-hours-most-active-for-oct-20-2016-bac-bbva-msft-ca-ctsh-qqq-alks-pypl-vz-pbr-kkr-pfe-cm696209,The NASDAQ 100 After Hours Indicator is up 22 19 to 4 854 9 The total After hours volume is currently 35 991 458 shares traded The following are the most active stocks for the after hours session Bank of America Corporation BAC is unchanged at 16 56 with 7 126
PFE,PFE:US,BBG000BR2B91,7 Drug Stocks to Consider as Biosimilars Pick Up Pace,2016-10-20 16:28:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fPImImuLMiY/7-drug-stocks-to-consider-as-biosimilars-pick-up-pace-cm696033,Interest in biosimilars has picked up considerably with Pfizer Inc s PFE announcement this week regarding its plans to launch a biosimilar version of Johnson amp Johnson s blockbuster drug Remicade in late November What are Biosimilars A biosimilar is a biologic product
PFE,PFE:US,BBG000BR2B91,"Zacks Market Edge Highlights: Pfizer, Netflix, Baidu, Johnson & Johnson and Domino's Pizza",2016-10-20 15:30:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZMBbOWnCnDM/zacks-market-edge-highlights-pfizer-netflix-baidu-johnson-johnson-and-dominos-pizza-cm695972,For Immediate Release Chicago IL October 20 2016 Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec Every week Tracey will be joined by guests to discuss the hottest investing topics in stocks bonds and ETFs and how it impacts your life To listen to
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. GlaxoSmithKline plc,2016-10-20 14:51:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HLX0hoH3a_E/better-buy-pfizer-inc-vs-glaxosmithkline-plc-cm695872,Image source Getty Images You don t want to go buy just any big pharma stock Some are definitely better than others But figuring out which big pharma stock to go with requires checking out the companies product lineups pipelines and financial health Digging into those details
PFE,PFE:US,BBG000BR2B91,7 Drug Stocks to Consider as Biosimilars Pick Up Pace,2016-10-20 14:29:02 +0000,http://finance.yahoo.com/news/7-drug-stocks-consider-biosimilars-142902130.html,7 Drug Stocks to Consider as Biosimilars Pick Up Pace
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. GlaxoSmithKline plc,2016-10-20 14:24:39 +0000,http://www.fool.com/investing/2016/10/20/better-buy-pfizer-inc-vs-glaxosmithkline.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Pfizer Inc. vs. GlaxoSmithKline plc
PFE,PFE:US,BBG000BR2B91,The 3 Biggest Stories From Johnson & Johnson's Third-Quarter Report,2016-10-20 13:50:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OiNCD8VOikw/the-3-biggest-stories-from-johnson-johnsons-third-quarter-report-cm695772,Johnson amp Johnson CEO Alex Gorsky Image source Johnson amp Johnson The largest publicly traded healthcare company in the world Johnson amp Johnson NYSE JNJ reported its third quarter earnings results before the opening bell on Tuesday Oct 18 As has become
PFE,PFE:US,BBG000BR2B91,"Debiopharm International SA Announces Clinical Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer in Cancer Immunotherapy",2016-10-20 12:00:00 +0000,http://finance.yahoo.com/news/debiopharm-international-sa-announces-clinical-120000611.html,"[PR Newswire] - LAUSANNE, Switzerland, October 20, 2016 /PRNewswire/ -- This joint effort will initially focus on a Phase I/Ib trial in patients with Lung Cancer to assess safety and preliminary efficacy of Debio 1143 ..."
PFE,PFE:US,BBG000BR2B91,CDC Advisory Committee on Immunization Practices Votes to Recommend New Dosing Schedule for Vaccination with TRUMENBA® (Meningococcal Group B Vaccine),2016-10-19 22:18:06 +0000,http://www.publicnow.com/view/A70374118C6482121454A1FF0C84148AD4678C38,[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend ...
PFE,PFE:US,BBG000BR2B91,Seven New Stocks in My Purloined Portfolio,2016-10-19 21:38:56 +0000,http://finance.yahoo.com/news/seven-stocks-purloined-portfolio-213856019.html,Seven New Stocks in My Purloined Portfolio
PFE,PFE:US,BBG000BR2B91,"Stock Market News for October 19, 2016",2016-10-19 16:51:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3S_PFXoJWOQ/stock-market-news-for-october-19-2016-cm695454,Upbeat earnings results led the benchmarks to close in the green on Tuesday Better than expected earnings results from UnitedHealth Netflix Goldman Sachs and Johnson amp Johnson had a positive impact on investor sentiment Gains in UnitedHealth boosted the healthcare sector Meanwhile pick
PFE,PFE:US,BBG000BR2B91,"Noteworthy ETF Inflows: VYM, PFE, WMT, LLY",2016-10-19 16:49:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tMnNh8z-kZA/noteworthy-etf-inflows-vym-pfe-wmt-lly-cm695426,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the Vanguard High Dividend Yield ETF Symbol VYM where we have detected an approximate 49 8 million dollar inflow that s a 0 3 increase week over week
PFE,PFE:US,BBG000BR2B91,WHO seeks new mechanism for crisis vaccine supplies at low cost,2016-10-19 14:27:59 +0000,http://finance.yahoo.com/news/seeks-mechanism-crisis-vaccine-supplies-142759913.html,"[Reuters] - The World Health Organization, drugmakers and humanitarian groups are hammering out details of a new vaccine supply system aimed at getting vital shots to vulnerable people in crises such as wars or natural disasters. The mechanism, which so far has British drugmaker GlaxoSmithKline signed up to provide its pneumonia vaccine at the lowest possible price, will ask other major pharmaceutical firms including Pfizer and Merck to make similar cut-price agreements for emergencies only. ""The idea is that this will set a model in place for other manufacturers to put their vaccines on the table,"" said Greg Elder, a medical coordinator with the international charity Medecins Sans Frontieres (MSF) which joined talks on the issue at the WHO's Geneva headquarters last week."
PFE,PFE:US,BBG000BR2B91,"Key Takeaways from JNJ's Q3 Call: Remicade, Pipeline, Acquisitions",2016-10-19 13:49:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DXdEu__NxR8/key-takeaways-from-jnjs-q3-call-remicade-pipeline-acquisitions-cm695292,Healthcare giant and industry bellwether Johnson amp Johnson JNJ reported third quarter 2016 results before the market opened yesterday with both earnings and revenues surpassing expectations Read more J amp J Outshines in Q3 Earnings on Strong Pharma Sales However shares were down 2
PFE,PFE:US,BBG000BR2B91,Health Care Sector Update for 10/19/2016: PFE,2016-10-19 13:47:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KaKB-6jf0Qg/health-care-sector-update-for-10192016-pfe-cm695220,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 0 9 PFE 0 9 ABT 2 2 ABT 2 2 MRK flatMRK flat AMGN flatAMGN flat Health care shares were mainly unchanged in pre market trade on Wednesday Health care shares were mainly unchanged in pre market trade on Wednesday
PFE,PFE:US,BBG000BR2B91,Pfizer Awarded Grant to Evaluate Vaccine to Protect Newborns Against Group B Streptococcus Infection,2016-10-19 12:00:00 +0000,http://finance.yahoo.com/news/pfizer-awarded-grant-evaluate-vaccine-120000629.html,"[Business Wire] - Pfizer Inc. today announced an award of a grant from the Bill & Melinda Gates Foundation to conduct a Phase 1/2 clinical trial of Pfizer’s vaccine candidate against group B Streptococcus infection, a leading cause of neonatal sepsis, a serious life-threatening blood infection."
PFE,PFE:US,BBG000BR2B91,Pfizer Awarded Grant From Bill & Melinda Gates Foundation - Quick Facts,2016-10-19 08:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_Ocsguz4Qp8/pfizer-awarded-grant-from-bill--melinda-gates-foundation--quick-facts-20161019-00284,Pfizer Awarded Grant From Bill & Melinda Gates Foundation - Quick Facts
PFE,PFE:US,BBG000BR2B91,"[$$] Johnson & Johnson Brushes Off Looming Biosimilar Competition, Posts Solid Results",2016-10-19 04:11:08 +0000,http://www.wsj.com/articles/johnson-johnson-again-buoyed-by-pharmaceuticals-1476789542?ru=yahoo?mod=yahoo_itp,"[$$] Johnson & Johnson Brushes Off Looming Biosimilar Competition, Posts Solid Results"
PFE,PFE:US,BBG000BR2B91,J&J Brushes Off Pfizer's Challenge -- WSJ,2016-10-19 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lRhv80_G7F4/jj-brushes-off-pfizers-challenge--wsj-20161019-00053,J&J Brushes Off Pfizer's Challenge -- WSJ
PFE,PFE:US,BBG000BR2B91,How to Trade Stocks in the After-Hours,2016-10-19 01:46:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zcU0roNiP9U/how-to-trade-stocks-in-the-after-hours-cm695098,Welcome to Episode 54 of the Zacks Market Edge Podcast Every week host and Zacks stock strategist Tracey Ryniec will be joined by guests to discuss the hottest investing topics in stocks bonds and ETFs and how it impacts your life In this episode Tracey is joined by Jeremy Mullin
PFE,PFE:US,BBG000BR2B91,Eli Lilly’s 3Q16 Earnings: What to Expect,2016-10-18 21:21:03 +0000,http://marketrealist.com/2016/10/eli-lillys-3q16-earnings-what-to-expect/?utm_source=yahoo&utm_medium=feed,Eli Lilly’s 3Q16 Earnings: What to Expect
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 10/18/2016: JNJ,PFE,ABEO,ICCC",2016-10-18 20:47:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/t2FdsnCcp3Y/health-care-sector-update-for-10182016-jnjpfeabeoiccc-cm695017,Top Health Care StocksTop Health Care Stocks JNJ 2 70 JNJ 2 70 PFE 0 58 PFE 0 58 MRK 0 93 MRK 0 93 ABT 1 43 ABT 1 43 AMGN 0 11 AMGN 0 11 Health care stocks were broadly higher in afternoon trade with the NYSE Health Care Index climbing almost 1 2 while shares of health
PFE,PFE:US,BBG000BR2B91,Pfizer's Remicade Rudeness Shouldn't Faze J&J,2016-10-18 18:19:01 +0000,http://www.bloomberg.com/gadfly/articles/2016-10-18/pfizer-remicade-biosimilar-rudeness-shouldn-t-faze-j-j?cmpid=yhoo.headline,Pfizer's Remicade Rudeness Shouldn't Faze J&J
PFE,PFE:US,BBG000BR2B91,J&J shares lose ground on fears of Pfizer's answer to Remicade,2016-10-18 18:15:48 +0000,http://sg.finance.yahoo.com/news/johnson-johnson-quarterly-sales-rise-111402144.html,J&J shares lose ground on fears of Pfizer's answer to Remicade
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson: 3 Reasons the Selloff is Overblown,2016-10-18 18:15:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/18/johnson-johnson-3-reasons-the-selloff-is-overblown/?mod=yahoobarrons&ru=yahoo,Johnson & Johnson: 3 Reasons the Selloff is Overblown
PFE,PFE:US,BBG000BR2B91,[$$] J&J Brushes Off Looming Biosimilar Competition,2016-10-18 16:13:11 +0000,http://www.wsj.com/articles/johnson-johnson-again-buoyed-by-pharmaceuticals-1476789542?mod=yahoo_hs,[$$] J&J Brushes Off Looming Biosimilar Competition
PFE,PFE:US,BBG000BR2B91,[$$] J&J prepares for drug price war with Pfizer,2016-10-18 16:06:41 +0000,"http://www.ft.com/cms/s/0f1db736-9540-11e6-a1dc-bdf38d484582,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Johnson & Johnson set the stage for a price war in one of the most lucrative segments of the pharmaceuticals industry, as it announced its intention to discount its top-selling arthritis drug following ..."
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson tops 3Q Street view but shares decline,2016-10-18 15:59:10 +0000,http://sg.finance.yahoo.com/news/johnson-johnson-tops-street-3q-104823871.html,Johnson & Johnson tops 3Q Street view but shares decline
PFE,PFE:US,BBG000BR2B91,Pfizer to Launch Remicade Biosimilar in U.S. in November,2016-10-18 15:50:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZxFOpmTNv_M/pfizer-to-launch-remicade-biosimilar-in-us-in-november-cm694736,Pfizer Inc PFE announced that its Inflectra injection a biosimilar version of Johnson amp Johnson s JNJ blockbuster drug Remicade will be available in the U S in late November Inflectra is the first and only biosimilar monoclonal antibody mAb therapy and only the second biosimilar
PFE,PFE:US,BBG000BR2B91,J&J (JNJ) Outshines in Q3 Earnings on Strong Pharma Sales,2016-10-18 15:50:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ir8EQZrt_0A/jj-jnj-outshines-in-q3-earnings-on-strong-pharma-sales-cm694705,Johnson amp Johnson JNJ reported another strong quarter with both earnings and sales beating expectations Moreover the company raised the lower end of its earnings outlook for the year The healthcare giant s third quarter 2016 earnings came in at 1 68 per share beating the Zacks
PFE,PFE:US,BBG000BR2B91,Why Johnson & Johnson is Tanking,2016-10-18 15:49:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/18/why-johnson-johnson-is-tanking/?mod=yahoobarrons&ru=yahoo,Why Johnson & Johnson is Tanking
PFE,PFE:US,BBG000BR2B91,"Why Visa, Johnson and Johnson, Pfizer, and Two Other Stocks Are in Spotlight Today",2016-10-18 14:54:45 +0000,http://www.insidermonkey.com/blog/why-visa-johnson-and-johnson-pfizer-and-two-other-stocks-are-in-spotlight-today-481782/,"Why Visa, Johnson and Johnson, Pfizer, and Two Other Stocks Are in Spotlight Today"
PFE,PFE:US,BBG000BR2B91,Pharma giants poised to battle over biosimilar medicine,2016-10-18 14:42:27 +0000,http://www.bizjournals.com/philadelphia/news/2016/10/18/pfizer-jannsen-remicade-biosimilar-crohns-disease.html?ana=yahoo,Pharma giants poised to battle over biosimilar medicine
PFE,PFE:US,BBG000BR2B91,"J&J says pharma future bright, despite threat to Remicade",2016-10-18 13:56:00 +0000,http://finance.yahoo.com/news/j-j-quarterly-revenue-profit-111238665.html,"J&J says pharma future bright, despite threat to Remicade"
PFE,PFE:US,BBG000BR2B91,Pfizer to Launch Remicade Biosimilar in U.S. in November,2016-10-18 13:41:01 +0000,http://finance.yahoo.com/news/pfizer-launch-remicade-biosimilar-u-134101334.html,Pfizer to Launch Remicade Biosimilar in U.S. in November
PFE,PFE:US,BBG000BR2B91,Pharma giants poised for biosimilar battle,2016-10-18 12:31:48 +0000,http://www.bizjournals.com/philadelphia/news/2016/10/18/pharma-giants-poised-for-biosimilar-battle.html?ana=yahoo,Pharma giants poised for biosimilar battle
PFE,PFE:US,BBG000BR2B91,Alzheimer's Remains a Top Priority for Big Pharma,2016-10-18 11:37:36 +0000,http://www.fool.com/investing/2016/10/17/alzheimers-remains-a-top-priority-for-big-pharma.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Alzheimer's Remains a Top Priority for Big Pharma
PFE,PFE:US,BBG000BR2B91,J&J Brushes Off Looming Biosimilar Competition,2016-10-18 07:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OXmvlujCgoA/jj-brushes-off-looming-biosimilar-competition-20161018-00632,J&J Brushes Off Looming Biosimilar Competition
PFE,PFE:US,BBG000BR2B91,Pfizer To Begin Shipment Of Biosimilar INFLECTRA To Wholesalers In Nov,2016-10-17 23:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZSZyrXnUuR8/pfizer-to-begin-shipment-of-biosimilar-inflectra-to-wholesalers-in-nov-20161017-00983,Pfizer To Begin Shipment Of Biosimilar INFLECTRA To Wholesalers In Nov
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer Plans to Launch Remicade Biosimilar in November,2016-10-17 22:50:22 +0000,http://www.wsj.com/articles/pfizer-plans-to-launch-remicade-biosimilar-in-november-1476740161?mod=yahoo_hs,[$$] Pfizer Plans to Launch Remicade Biosimilar in November
PFE,PFE:US,BBG000BR2B91,Pfizer to launch cheaper version of J&J immune drug Remicade,2016-10-17 22:16:06 +0000,http://sg.finance.yahoo.com/news/pfizer-launch-cheaper-version-j-202221529.html,Pfizer to launch cheaper version of J&J immune drug Remicade
PFE,PFE:US,BBG000BR2B91,Pfizer to start shipping biosimilar version of J&J's Remicade in November,2016-10-17 22:01:14 +0000,http://finance.yahoo.com/news/pfizer-set-start-shipping-remicade-211215296.html,"[Reuters] - Pfizer Inc said on Monday it will begin shipping its biosimilar version of Johnson & Johnson's blockbuster rheumatoid arthritis drug Remicade in late November at a 15 percent discount to current wholesale prices. The Pfizer drug, to be sold under the name Inflectra, is already available in Europe and other overseas markets and would be the second biosimilar medicine available in the United States. As it is not possible to produce exact copies of biotech drugs made from living cells, the cheaper versions - referred to as biosimilars rather than generics - are intended to provide cost savings compared with pricey biologic medicines."
PFE,PFE:US,BBG000BR2B91,Alzheimer's Remains a Top Priority for Big Pharma,2016-10-17 21:47:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fpPqR__TpuM/alzheimers-remains-a-top-priority-for-big-pharma-cm694462,Alzheimer s disease AD has been a graveyard for experimental medications A recent study for instance reported that a whopping 99 6 of experimental AD drugs 160 failed to improve patient outcomes over the course of 2002 to 2012 Despite this sky high failure rate
PFE,PFE:US,BBG000BR2B91,Pfizer set to start shipping Remicade biosimilar next month,2016-10-17 20:49:28 +0000,http://finance.yahoo.com/news/pfizer-set-start-shipping-remicade-204928893.html,"[Reuters] - Pfizer Inc said on Monday it plans to begin shipping its biosimilar version of Johnson & Johnson's blockbuster rheumatoid arthritis drug Remicade in late November at a 15 percent discount to current wholesale prices. The Pfizer drug, to be sold under the name Inflectra, is already available in Europe and other overseas markets and would be the second biosimilar available in the United States. Remicade is J&J's biggest selling drug with U.S. sales of about $5 billion a year."
PFE,PFE:US,BBG000BR2B91,Pfizer Announces The U.S. Availability Of Biosimilar INFLECTRA® (infliximab-dyyb),2016-10-17 20:33:07 +0000,http://www.publicnow.com/view/ABCBEBD832F1C85E84213B6CE9BA1096BE025A19,"[at noodls] - Pfizer Inc. (NYSE:PFE) announced today that the company will begin shipment of INFLECTRA® (infliximab-dyyb)for injection, a biosimilar of REMICADE®1(infliximab) to wholesalers in the United States (U.S.) ..."
PFE,PFE:US,BBG000BR2B91,"Eli Lilly, AbbVie Top 2017 Rankings; Pfizer, AstraZeneca Flailing",2016-10-17 20:13:21 +0000,http://www.investors.com/news/technology/eli-lilly-abbvie-top-2017-rankings-pfizer-astrazeneca-flailing/,"Eli Lilly, AbbVie Top 2017 Rankings; Pfizer, AstraZeneca Flailing"
PFE,PFE:US,BBG000BR2B91,Pfizer Plans to Launch Remicade Biosimilar in November -- Update,2016-10-17 19:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/56M57p3FOvI/pfizer-plans-to-launch-remicade-biosimilar-in-november--update-20161017-00947,Pfizer Plans to Launch Remicade Biosimilar in November -- Update
PFE,PFE:US,BBG000BR2B91,Pfizer Refuses to Go the Spinoff Route,2016-10-17 18:58:10 +0000,http://finance.yahoo.com/news/pfizer-refuses-spinoff-route-185810716.html,Pfizer Refuses to Go the Spinoff Route
PFE,PFE:US,BBG000BR2B91,Pfizer Plans to Launch Remicade Biosimilar in November,2016-10-17 18:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HH9fPvu2JkY/pfizer-plans-to-launch-remicade-biosimilar-in-november-20161017-00939,Pfizer Plans to Launch Remicade Biosimilar in November
PFE,PFE:US,BBG000BR2B91,What to expect from Johnson & Johnson earnings,2016-10-17 17:56:30 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=C53FF7FE-921B-11E6-8EDD-5BF0DE03C406&siteid=yhoof2,What to expect from Johnson & Johnson earnings
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Mylan, Pfizer, Roche, Merck and Bristol-Myers",2016-10-17 15:43:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k7mz-8RlIHc/the-zacks-analyst-blog-highlights-mylan-pfizer-roche-merck-and-bristol-myers-cm694137,For Immediate Release Chicago IL October 17 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
PFE,PFE:US,BBG000BR2B91,Johnson & Johnson’s Expected Profitability in 3Q16,2016-10-17 15:04:21 +0000,http://marketrealist.com/2016/10/johnson-johnsons-expected-profitability-in-3q16/?utm_source=yahoo&utm_medium=feed,Johnson & Johnson’s Expected Profitability in 3Q16
PFE,PFE:US,BBG000BR2B91,Pfizer and Bristol-Myers Squibb Could Face a Big Threat from Small Biotech Exelixis,2016-10-17 13:43:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Jh4i_SRDlLc/pfizer-and-bristol-myers-squibb-could-face-a-big-threat-from-small-biotech-exelixis-cm694003,Image source Getty Images Only 12 of patients with advanced kidney cancer survive five years or more Exelixis NASDAQ EXEL hopes to increase that number and based on its latest clinical trial results the small biotech appears to be on the right track That s great news
PFE,PFE:US,BBG000BR2B91,What to Expect from J&J's (JNJ) Pharmaceutical Segment in Q3?,2016-10-17 13:42:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4nK4vBdrQpY/what-to-expect-from-jjs-jnj-pharmaceutical-segment-in-q3-cm694060,Healthcare giant Johnson amp Johnson JNJ will be reporting third quarter results tomorrow before the market opens The company has a pretty good earnings track record having surpassed expectations in each of the last four quarters While J amp J has three segments
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: Mylan, Pfizer, Roche, Merck and Bristol-Myers",2016-10-17 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-mylan-133001275.html,"The Zacks Analyst Blog Highlights: Mylan, Pfizer, Roche, Merck and Bristol-Myers"
PFE,PFE:US,BBG000BR2B91,Pfizer and Bristol-Myers Squibb Could Face a Big Threat from Small Biotech Exelixis,2016-10-17 12:36:56 +0000,http://www.fool.com/investing/2016/10/17/pfizer-faces-a-big-threat-from-small-biotech-exeli.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Pfizer and Bristol-Myers Squibb Could Face a Big Threat from Small Biotech Exelixis
PFE,PFE:US,BBG000BR2B91,Making Sense of Merger-Arbitrage Funds,2016-10-17 10:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=774331&SR=Yahoo,Making Sense of Merger-Arbitrage Funds
PFE,PFE:US,BBG000BR2B91,Pfizer to Present New Data on XELJANZ® (Tofacitinib Citrate) for Ulcerative Colitis at UEG Week 2016,2016-10-15 15:00:05 +0000,http://www.publicnow.com/view/6E97AD515527AE2BB57E09D2FE43E87307E10DAB,"[at noodls] - Pfizer Inc. (NYSE:PFE) announced that three abstracts for XELJANZ (tofacitinib citrate), being investigated in moderate to severe ulcerative colitis (UC), will be presented at the upcoming United European ..."
PFE,PFE:US,BBG000BR2B91,Pfizer to Present New Data on XELJANZ® (Tofacitinib Citrate) for Ulcerative Colitis at UEG Week 2016,2016-10-15 14:30:00 +0000,http://uk.finance.yahoo.com/news/pfizer-present-data-xeljanz-tofacitinib-143000124.html,Pfizer to Present New Data on XELJANZ® (Tofacitinib Citrate) for Ulcerative Colitis at UEG Week 2016
PFE,PFE:US,BBG000BR2B91,Is Opko Health On the Cusp of a Big Year?,2016-10-14 22:42:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GMOm-jsTdFI/is-opko-health-on-the-cusp-of-a-big-year-cm693720,Image source Getty Images Opko Health s NASDAQ OPK billionaire CEO Phillip Frost has been busy The legendary healthcare entrepreneur best known for selling his IVAX Labs to Teva Pharmaceutical for 7 4 billion in 2006 160 is 160 on a spending spree that he
PFE,PFE:US,BBG000BR2B91,How Will Johnson & Johnson Fare Revenue-Wise in 3Q16?,2016-10-14 22:04:19 +0000,http://marketrealist.com/2016/10/how-will-johnson-johnson-fare-revenue-wise-in-3q16/?utm_source=yahoo&utm_medium=feed,How Will Johnson & Johnson Fare Revenue-Wise in 3Q16?
PFE,PFE:US,BBG000BR2B91,Is Opko Health On the Cusp of a Big Year?,2016-10-14 20:42:06 +0000,http://www.fool.com/investing/2016/10/14/is-opko-health-on-the-cusp-of-a-big-year.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Opko Health On the Cusp of a Big Year?
PFE,PFE:US,BBG000BR2B91,3 Big-Cap Stocks That Are Growing Again,2016-10-14 16:43:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-gXFpmOc3Jg/3-big-cap-stocks-that-are-growing-again-cm693521,Image source Getty Images A long haul investing approach has been proven time and time again to outperform short term trading and with sales and profit ticking higher again at these large capitalization companies today may be the perfect time to stash them away in forever
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Mylan in EpiPen Medicaid Settlement, ESMO Data in Focus",2016-10-14 15:44:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f6ID7EEIvRU/pharma-stock-roundup-mylan-in-epipen-medicaid-settlement-esmo-data-in-focus-cm693441,Mylan MYL was in the news again with the company agreeing to a settlement related to Medicaid rebate classification for EpiPen Meanwhile several pharma companies were present at the congress of the European Society for Medical Oncology ESMO with data on their cancer treatments Recap
PFE,PFE:US,BBG000BR2B91,Merck KGaA Offers Portfolio Updates at Market Day Event,2016-10-14 15:43:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mv1PBQZkjqY/merck-kgaa-offers-portfolio-updates-at-market-day-event-cm693418,Germany based Merck KGaA MKGAF provided an update on its objectives up to 2018 at the company s 2016 Capital Market Day At the Healthcare business the company aims to obtain approval of one medicine or indication every year starting 2017 Through 2022 Merck expects to generate sales of
PFE,PFE:US,BBG000BR2B91,How Much Is Pfizer’s Return Potential?,2016-10-14 15:04:38 +0000,http://marketrealist.com/2016/10/much-pfizers-return-potential/?utm_source=yahoo&utm_medium=feed,How Much Is Pfizer’s Return Potential?
PFE,PFE:US,BBG000BR2B91,3 Big-Cap Stocks That Are Growing Again,2016-10-14 15:00:09 +0000,http://www.fool.com/investing/2016/10/14/3-big-cap-stocks-that-are-growing-again.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Big-Cap Stocks That Are Growing Again
PFE,PFE:US,BBG000BR2B91,Pfizer’s Divestment of Hospira Infusion Systems,2016-10-14 14:04:37 +0000,http://marketrealist.com/2016/10/pfizers-divestment-hospira-infusion-systems/?utm_source=yahoo&utm_medium=feed,Pfizer’s Divestment of Hospira Infusion Systems
PFE,PFE:US,BBG000BR2B91,A Guide to Conservative Income Producing Option Strategies for Dividend Stocks,2016-10-14 13:43:21 +0000,http://www.insidermonkey.com/blog/a-guide-to-conservative-income-producing-option-strategies-for-dividend-stocks-481156/,A Guide to Conservative Income Producing Option Strategies for Dividend Stocks
PFE,PFE:US,BBG000BR2B91,3 Figures That Matter Most When Johnson & Johnson Reports Its 3rd-Quarter Results,2016-10-14 13:42:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E39veQWgZCA/3-figures-that-matter-most-when-johnson-johnson-reports-its-3rd-quarter-results-cm693300,Image source Getty Images Did you blink If you did you probably missed the kickoff to earnings season for the third quarter Although earnings season never officially ends the vast majority of S amp P 500 companies report their results within a matter of six weeks
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Mylan in EpiPen Medicaid Settlement, ESMO Data in Focus",2016-10-14 13:22:01 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-mylan-epipen-132201020.html,"Pharma Stock Roundup: Mylan in EpiPen Medicaid Settlement, ESMO Data in Focus"
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 10/14/2016: NHTC, EGLT, JNJ, PFE, ABT, MRK, AMGN",2016-10-14 13:01:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J_Ptg6TMZtA/health-care-sector-update-for-10142016-nhtc-eglt-jnj-pfe-abt-mrk-amgn-cm693296,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 0 4 PFE 0 4 ABT flatABT flat MRK 1 6 MRK 1 6 AMGN flatAMGN flat Health care shares were mostly unchanged in pre market trade Friday Health care shares were mostly unchanged in pre market trade Friday In health
PFE,PFE:US,BBG000BR2B91,Four Key Deals: Analyzing Pfizer’s Impending Growth,2016-10-14 12:04:53 +0000,http://marketrealist.com/2016/10/four-key-deals-analyzing-pfizers-impending-growth/?utm_source=yahoo&utm_medium=feed,Four Key Deals: Analyzing Pfizer’s Impending Growth
PFE,PFE:US,BBG000BR2B91,Exelixis Goes for It,2016-10-13 22:41:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bMPLMjZsnXs/exelixis-goes-for-it-cm693190,Image source Exelixis Exelixis NASDAQ EXEL started the marketing stage of its company life with a whimper Last year in its third full year on the market the biotech managed sales of just 37 2 million for Cometriq not surprising given the drug is only approved
PFE,PFE:US,BBG000BR2B91,US Market Indexes Lower on Thursday,2016-10-13 22:08:54 +0000,http://finance.yahoo.com/news/us-market-indexes-lower-thursday-220854142.html,US Market Indexes Lower on Thursday
PFE,PFE:US,BBG000BR2B91,Treasury takes its latest step to keep corporate taxes in the US,2016-10-13 21:32:36 +0000,http://www.cnbc.com/id/104017976?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104017976,Treasury takes its latest step to keep corporate taxes in the US
PFE,PFE:US,BBG000BR2B91,Exelixis Goes for It,2016-10-13 21:00:03 +0000,http://www.fool.com/investing/2016/10/13/exelixis-goes-for-it.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Exelixis Goes for It
PFE,PFE:US,BBG000BR2B91,Pfizer Will Likely Overpay For M&A Post-Allergan Breakup Flop: Jeffries,2016-10-13 20:29:13 +0000,http://www.investors.com/news/technology/pfizer-will-likely-overpay-for-ma-post-allergan-breakup-flop-jefferies/,Pfizer Will Likely Overpay For M&A Post-Allergan Breakup Flop: Jeffries
PFE,PFE:US,BBG000BR2B91,"Apple Price Target Raised; Gigamon, GrubHub Rated Buys",2016-10-13 20:17:11 +0000,http://www.investors.com/news/apple-price-target-raised-gigamon-grubhub-rated-buys/,"Apple Price Target Raised; Gigamon, GrubHub Rated Buys"
PFE,PFE:US,BBG000BR2B91,Prothena Slammed On Politics; Could Win Eli Lilly Or Pfizer Partnership,2016-10-13 20:09:21 +0000,http://www.investors.com/news/technology/prothena-slammed-on-politics-could-win-eli-lilly-or-pfizer-partnership/,Prothena Slammed On Politics; Could Win Eli Lilly Or Pfizer Partnership
PFE,PFE:US,BBG000BR2B91,Did Pfizer’s Top Line Growth Beat Its Peers?,2016-10-13 20:04:11 +0000,http://marketrealist.com/2016/10/pfizers-top-line-growth-beat-peers/?utm_source=yahoo&utm_medium=feed,Did Pfizer’s Top Line Growth Beat Its Peers?
PFE,PFE:US,BBG000BR2B91,What Are Pfizer’s Major Growth Concerns?,2016-10-13 18:04:14 +0000,http://marketrealist.com/2016/10/pfizers-major-growth-concerns/?utm_source=yahoo&utm_medium=feed,What Are Pfizer’s Major Growth Concerns?
PFE,PFE:US,BBG000BR2B91,Lack of Catalysts Keeps Analysts Away From Pfizer,2016-10-13 18:04:00 +0000,https://www.thestreet.com/story/13852648/1/lack-of-catalysts-keeps-analysts-away-from-pfizer.html?puc=yahoo&cm_ven=YAHOO,Lack of Catalysts Keeps Analysts Away From Pfizer
PFE,PFE:US,BBG000BR2B91,"Street Talk: AAPL, HCA & more",2016-10-13 17:49:00 +0000,http://finance.yahoo.com/video/street-talk-aapl-hca-more-174900321.html,"Street Talk: AAPL, HCA & more"
PFE,PFE:US,BBG000BR2B91,Does Pfizer Deserve a Better Valuation?,2016-10-13 16:30:31 +0000,http://marketrealist.com/2016/10/pfizer-deserve-better-valuation/?utm_source=yahoo&utm_medium=feed,Does Pfizer Deserve a Better Valuation?
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer vows to persist in court battle over Lyrica,2016-10-13 16:08:48 +0000,"http://www.ft.com/cms/s/2e03c62e-9151-11e6-8df8-d3778b55a923,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - US drugmaker Pfizer plans to continue a legal battle with rival Actavis over the way its blockbuster drug Lyrica is sold in the UK after the Court of Appeal on Thursday rejected a claim of patent infringement. ...
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 10/13/2016: FLKS, TGTX, JNJ, PFE, ABT, MRK, AMGN",2016-10-13 13:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CCzVMjz_9SQ/health-care-sector-update-for-10132016-flks-tgtx-jnj-pfe-abt-mrk-amgn-cm692715,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 1 3 PFE 1 3 ABT flatABT flat MRK 0 5 MRK 0 5 AMGN 1 AMGN 1 Health care shares were mostly mixed in pre market trade Thursday Health care shares were mostly mixed in pre market trade Thursday In health
PFE,PFE:US,BBG000BR2B91,"Morning Movers: WFC, PFE, AMZN, GS, MS",2016-10-13 12:30:00 +0000,http://realmoney.thestreet.com/articles/10/13/2016/morning-movers-wfc-pfe-amzn-gs-ms?puc=yahoo&cm_ven=YAHOO,"Morning Movers: WFC, PFE, AMZN, GS, MS"
PFE,PFE:US,BBG000BR2B91,"This Drug Stock's Pattern Says, 'Sell Now!'",2016-10-13 12:30:00 +0000,http://finance.yahoo.com/news/drug-stocks-pattern-says-sell-123000385.html,"This Drug Stock's Pattern Says, 'Sell Now!'"
PFE,PFE:US,BBG000BR2B91,Pfizer Loses U.K. Patent Appeal Over $4.8 Billion Lyrica Drug,2016-10-13 12:10:52 +0000,http://www.bloomberg.com/news/articles/2016-10-13/pfizer-loses-u-k-patent-appeal-over-4-8-billion-lyrica-drug?cmpid=yhoo.headline,Pfizer Loses U.K. Patent Appeal Over $4.8 Billion Lyrica Drug
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Stock Slides, Jefferies Cuts to 'Hold'",2016-10-13 12:04:00 +0000,https://www.thestreet.com/story/13851657/1/pfizer-pfe-stock-slides-jefferies-cuts-to-hold.html?puc=yahoo&cm_ven=YAHOO,"Pfizer (PFE) Stock Slides, Jefferies Cuts to 'Hold'"
PFE,PFE:US,BBG000BR2B91,Pfizer loses appeal in UK patent case over use of Lyrica drug for pain,2016-10-13 11:06:38 +0000,http://finance.yahoo.com/news/pfizer-loses-appeal-uk-patent-110638434.html,Pfizer loses appeal in UK patent case over use of Lyrica drug for pain
PFE,PFE:US,BBG000BR2B91,Pfizer Loses UK Appeal Court Patent Case Over Lyrica,2016-10-13 07:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z4aeQHGA_wU/pfizer-loses-uk-appeal-court-patent-case-over-lyrica-20161013-00287,Pfizer Loses UK Appeal Court Patent Case Over Lyrica
PFE,PFE:US,BBG000BR2B91,"Better Buy: Regeneron Pharmaceuticals, Inc. vs. Roche Holding AG",2016-10-13 02:40:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wj-5r1lAJJU/better-buy-regeneron-pharmaceuticals-inc-vs-roche-holding-ag-cm692636,Image source Getty Images Nearly everyone likes a matchup between the little guy and the big guy David vs Goliath Ant Man vs Godzilla What about Regeneron Pharmaceuticals NASDAQ REGN vs Roche NASDAQOTH RHHBY Regeneron isn t tiny but its market cap is
PFE,PFE:US,BBG000BR2B91,"Fed Hawks Are Gaining Sway, September Meeting Minutes Show",2016-10-12 20:13:24 +0000,http://www.investors.com/news/economy/fed-hawks-are-gaining-sway-september-meeting-minutes-show/,"Fed Hawks Are Gaining Sway, September Meeting Minutes Show"
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. (PFE): Safe And Steady Dividends,2016-10-12 18:55:49 +0000,http://www.insidermonkey.com/blog/pfizer-inc-pfe-safe-and-steady-dividends-480889/,Pfizer Inc. (PFE): Safe And Steady Dividends
PFE,PFE:US,BBG000BR2B91,Is Pfizer Beginning to Hit Bottom?,2016-10-12 13:07:00 +0000,https://www.thestreet.com/story/13850316/1/is-pfizer-beginning-to-hit-bottom.html?puc=yahoo&cm_ven=YAHOO,Is Pfizer Beginning to Hit Bottom?
PFE,PFE:US,BBG000BR2B91,Is Biopharma Productivity In A Sharp Decline?,2016-10-12 11:56:00 +0000,http://www.forbes.com/sites/johnlamattina/2016/10/12/is-biopharma-productivity-in-a-sharp-decline/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Is Biopharma Productivity In A Sharp Decline?
PFE,PFE:US,BBG000BR2B91,Major Pharma Short Sellers Grow More Selective,2016-10-12 11:35:07 +0000,http://247wallst.com/healthcare-business/2016/10/12/major-pharma-short-sellers-grow-more-selective/,Major Pharma Short Sellers Grow More Selective
PFE,PFE:US,BBG000BR2B91,PFE Makes Notable Cross Below Critical Moving Average,2016-10-12 01:17:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vd6P7V9bwkQ/pfe-makes-notable-cross-below-critical-moving-average-cm692128,In trading on Tuesday shares of Pfizer Inc Symbol PFE crossed below their 200 day moving average of 33 04 changing hands as low as 32 94 per share Pfizer Inc shares are currently trading down about 1 4 on the day The chart below shows the one year performance of PFE shares versus its
PFE,PFE:US,BBG000BR2B91,[$$] The Health-Care Sector Is Anything but Healthy,2016-10-11 21:20:00 +0000,http://www.barrons.com/articles/the-health-care-sector-is-anything-but-healthy-1476220819?mod=yahoobarrons&ru=yahoo,[$$] The Health-Care Sector Is Anything but Healthy
PFE,PFE:US,BBG000BR2B91,Investors Are Finally Getting With The Fed's Program — Are You?,2016-10-11 21:17:12 +0000,http://www.investors.com/news/economy/stocks-falls-as-markets-start-believing-the-fed/,Investors Are Finally Getting With The Fed's Program — Are You?
PFE,PFE:US,BBG000BR2B91,Why Doctors Without Borders is turning down a million free pneumonia vaccines from Pfizer,2016-10-11 17:36:22 +0000,http://finance.yahoo.com/news/why-doctors-without-borders-turning-173622188.html,Why Doctors Without Borders is turning down a million free pneumonia vaccines from Pfizer
PFE,PFE:US,BBG000BR2B91,"Pfizer's Kidney Drug Faces a New Rival (EXEL, PFE)",2016-10-11 17:25:00 +0000,http://www.investopedia.com/news/pfizers-kidney-drug-faces-new-rival-exel-pfe/?partner=YahooSA,"Pfizer's Kidney Drug Faces a New Rival (EXEL, PFE)"
PFE,PFE:US,BBG000BR2B91,"VLUE, WMT, PFE, GM: ETF Inflow Alert",2016-10-11 16:18:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9Vd3CdBXuHY/vlue-wmt-pfe-gm-etf-inflow-alert-cm691851,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Edge MSCI USA Value Factor ETF Symbol VLUE where we have detected an approximate 82 0 million dollar inflow that s a 9 5 increase week over week
PFE,PFE:US,BBG000BR2B91,"October 11, 2016 - Transgene Announces Collaboration with Merck and Pfizer to Evaluate the Combination of TG4001 with Avelumab in HPV-Positive Head & Neck Cancer in a Phase 1/2 Study",2016-10-11 16:05:09 +0000,http://www.publicnow.com/view/9BF85F133AE2339372BC0FF3960F0416B180FB24,"[at noodls] - Transgene Announces Collaboration with Merck and Pfizer to Evaluate the Combination of TG4001 with Avelumab in HPV-Positive Head & Neck Cancer in a Phase 1/2 Study Strasbourg, France, October 11, 2016, ..."
PFE,PFE:US,BBG000BR2B91,"Abbott Laboratories (ABT) Ex-Dividend Date Scheduled for October 12, 2016",2016-10-11 13:26:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ndpdPKsG5mw/abbott-laboratories-abt-ex-dividend-date-scheduled-for-october-12-2016-cm691674,Abbott Laboratories ABT will begin trading ex dividend on October 12 2016 A cash dividend payment of 0 26 per share is scheduled to be paid on November 15 2016 Shareholders who purchased ABT prior to the ex dividend date are eligible for the cash dividend payment This marks the
PFE,PFE:US,BBG000BR2B91,"AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for October 12, 2016",2016-10-11 13:21:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xwmxA3RtfGY/abbvie-inc-abbv-ex-dividend-date-scheduled-for-october-12-2016-cm691530,AbbVie Inc ABBV will begin trading ex dividend on October 12 2016 A cash dividend payment of 0 57 per share is scheduled to be paid on November 15 2016 Shareholders who purchased ABBV prior to the ex dividend date are eligible for the cash dividend payment This marks the 4th
PFE,PFE:US,BBG000BR2B91,Tesaro Inc. Is Flying High Today (and Could Go Higher From Here),2016-10-11 12:21:32 +0000,http://www.fool.com/investing/2016/10/10/could-tesaro-inc-be-ready-to-fly.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Tesaro Inc. Is Flying High Today (and Could Go Higher From Here)
PFE,PFE:US,BBG000BR2B91,What Do Analysts Have to Say about Bristol-Myers Squibb?,2016-10-11 12:04:43 +0000,http://marketrealist.com/2016/10/what-do-analysts-have-to-say-about-bristol-myers-squibb/?utm_source=yahoo&utm_medium=feed,What Do Analysts Have to Say about Bristol-Myers Squibb?
PFE,PFE:US,BBG000BR2B91,Merck Topples Bristol-Myers On Lung Cancer Drug Win,2016-10-10 20:20:21 +0000,http://www.investors.com/research/ibd-industry-themes/esmo-2016-merck-topples-bristol-myers-on-lung-cancer-drug-win/,Merck Topples Bristol-Myers On Lung Cancer Drug Win
PFE,PFE:US,BBG000BR2B91,Tesaro Inc. Is Flying High Today (and Could Go Higher From Here),2016-10-10 18:19:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zXQ4Z0K8RMg/tesaro-inc-is-flying-high-today-and-could-go-higher-from-here-cm691201,Image source Getty Images If you re looking for a biotech 160 to 160 add high flying gains to 160 your portfolio 160 check out Tesaro Inc NASDAQ TSRO Tesaro 160 could be headed for lift off 160 after 160 rival Clovis Oncology NASDAQ CLVS 160
PFE,PFE:US,BBG000BR2B91,"Tesaro Inc (TSRO) Soars on Trial Data, Analyst Upgrades",2016-10-10 17:18:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tVC4sQQJTOM/tesaro-inc-tsro-soars-on-trial-data-analyst-upgrades-cm691161,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Tesaro Inc 160 NASDAQ TSRO has kept investors salivating waiting for the markets to open all weekend as the small oncology focused biotech posted solid results in
PFE,PFE:US,BBG000BR2B91,3 Cheap Dividend Stocks That Could Rally Higher,2016-10-10 11:13:13 +0000,http://www.fool.com/investing/2016/10/09/3-cheap-dividend-stocks-that-could-rally-higher.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Cheap Dividend Stocks That Could Rally Higher
PFE,PFE:US,BBG000BR2B91,Exelixis and Pfizer drugs compete in kidney cancer trial,2016-10-10 07:32:33 +0000,http://uk.finance.yahoo.com/news/exelixis-pfizer-drugs-compete-kidney-073233035.html,Exelixis and Pfizer drugs compete in kidney cancer trial
PFE,PFE:US,BBG000BR2B91,Pfizer Says Kidney Drug Extends Disease-Free Survival in Adjuvant Setting,2016-10-10 07:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Gy3cQn3qheo/pfizer-says-kidney-drug-extends-diseasefree-survival-in-adjuvant-setting-20161010-00175,Pfizer Says Kidney Drug Extends Disease-Free Survival in Adjuvant Setting
PFE,PFE:US,BBG000BR2B91,First Positive Phase 3 Results In Adjuvant Setting For Renal Cell Carcinoma Show SUTENT® (sunitinib) Extended Disease Free Survival After Surgical Removal,2016-10-10 06:53:04 +0000,http://www.publicnow.com/view/7420E629E38A8DFAA3A20337876AD1349BDC5815,[at noodls] - Pfizer Inc. (NYSE:PFE) today announced results from the Phase 3 S-TRAC clinical trial (Sunitinib Trial as Adjuvant Treatment of Renal Cancer) investigating SUTENT®(sunitinib) as adjuvant therapy. The trial ...
PFE,PFE:US,BBG000BR2B91,Exelixis and Pfizer drugs face off in kidney cancer,2016-10-10 06:15:01 +0000,http://uk.finance.yahoo.com/news/exelixis-pfizer-drugs-face-off-061501472.html,Exelixis and Pfizer drugs face off in kidney cancer
PFE,PFE:US,BBG000BR2B91,First Positive Phase 3 Results in Adjuvant Setting for Renal Cell Carcinoma Show SUTENT® (sunitinib) Extended Disease Free Survival After Surgical Removal,2016-10-10 06:15:00 +0000,http://finance.yahoo.com/news/first-positive-phase-3-results-061500640.html,[Business Wire] - Pfizer Inc. today announced results from the Phase 3 S-TRAC clinical trial investigating SUTENT® as adjuvant therapy.
PFE,PFE:US,BBG000BR2B91,Pfizer: Positive Results From SUTENT Trial As Adjuvant Therapy In Renal Cancer,2016-10-10 03:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MFLfCtMsutc/pfizer-positive-results-from-sutent-trial-as-adjuvant-therapy-in-renal-cancer-20161010-00061,Pfizer: Positive Results From SUTENT Trial As Adjuvant Therapy In Renal Cancer
PFE,PFE:US,BBG000BR2B91,Encouraging Results For Ribociclib In Advanced Breast Cancer,2016-10-09 20:15:00 +0000,http://www.forbes.com/sites/elaineschattner/2016/10/09/encouraging-results-for-ribociclib-in-advanced-breast-cancer/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Encouraging Results For Ribociclib In Advanced Breast Cancer
PFE,PFE:US,BBG000BR2B91,Mindset Shifts Take Time,2016-10-09 19:30:55 +0000,http://finance.yahoo.com/tumblr/blog-mindset-shifts-take-time-193102164.html,Mindset Shifts Take Time
PFE,PFE:US,BBG000BR2B91,3 Cheap Dividend Stocks That Could Rally Higher,2016-10-09 18:18:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kP1Esd8tgFg/3-cheap-dividend-stocks-that-could-rally-higher-cm690790,Image source Getty Images Dividend stocks have been shown to outperform non dividend paying stocks so it s not too surprising that investors have been tucking more dividend paying companies into their portfolios While many dividend stocks are trading at historically high
PFE,PFE:US,BBG000BR2B91,3 Cancer Drugs That Could Get an FDA OK Next Year,2016-10-09 16:20:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PW6HQYKqJMg/3-cancer-drugs-that-could-get-an-fda-ok-next-year-cm690778,Image source Getty Images Significant spending on cancer research and development could be about to pay off for Clovis Oncology NASDAQ CLVS Array BioPharma NASDAQ ARRY and Ariad Pharmaceuticals NASDAQ ARIA All three of these companies are preparing for
PFE,PFE:US,BBG000BR2B91,3 Cancer Drugs That Could Get an FDA OK Next Year,2016-10-09 15:13:33 +0000,http://www.fool.com/investing/2016/10/09/3-cancer-drugs-that-could-get-a-fda-ok-next-year.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Cancer Drugs That Could Get an FDA OK Next Year
PFE,PFE:US,BBG000BR2B91,Pfizer Presents Promising New Immunotherapy Combination Data With INLYTA® (axitinib) In Advanced Renal Cell Carcinoma (RCC),2016-10-09 14:53:02 +0000,http://www.publicnow.com/view/61B40B43D27915C1B04895A075C8BD633CBC26EE,"[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced data from an ongoing, investigational Phase 1b study of INLYTA (axitinib) combined with the checkpoint inhibitor pembrolizumab (A4061079, ..."
PFE,PFE:US,BBG000BR2B91,3 Tax Loopholes Hillary Clinton Wants to Close,2016-10-09 12:43:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TYQHbKiXbMQ/3-tax-loopholes-hillary-clinton-wants-to-close-cm690751,Image source Hillary Clinton for President With about a month left in the 2016 Presidential election campaign Donald Trump and Hillary Clinton have started to hammer home their stances on important policies Few issues inspire more controversy than taxes and the
PFE,PFE:US,BBG000BR2B91,3 Tax Loopholes Hillary Clinton Wants to Close,2016-10-09 11:05:06 +0000,http://www.fool.com/retirement/2016/10/09/3-tax-loopholes-hillary-clinton-wants-to-close.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Tax Loopholes Hillary Clinton Wants to Close
PFE,PFE:US,BBG000BR2B91,The trillion-dollar reason why Wall Street should take gender diversity more seriously,2016-10-08 15:45:00 +0000,http://finance.yahoo.com/news/trillion-dollar-reason-why-wall-154500749.html,The trillion-dollar reason why Wall Street should take gender diversity more seriously
PFE,PFE:US,BBG000BR2B91,Novartis challenges Pfizer with strong breast cancer drug data,2016-10-08 06:15:01 +0000,http://finance.yahoo.com/news/novartis-challenges-pfizer-strong-breast-061501508.html,"[Reuters] - An experimental Novartis pill given with an older drug kept advanced breast cancer in check far longer than standard treatment alone, putting it on track to challenge Pfizer's blockbuster Ibrance, data showed on Saturday. Novartis' ribociclib works in a similar way to Ibrance and is set to be second to market in the category, since it could go on sale next year, ahead of rivals like Eli Lilly's abemaciclib. The 44 percent reduction in progression-free survival seen with ribociclib, which is also known as LEE011, compared with a 42 percent fall reported in a comparable late-stage trial involving Ibrance."
PFE,PFE:US,BBG000BR2B91,Novartis Targets Breast Cancer Drug Approval to Take on Pfizer,2016-10-08 06:15:00 +0000,http://www.bloomberg.com/news/articles/2016-10-08/novartis-targets-breast-cancer-drug-approval-to-take-on-pfizer?cmpid=yhoo.headline,Novartis Targets Breast Cancer Drug Approval to Take on Pfizer
PFE,PFE:US,BBG000BR2B91,Did Pfizer's No-Split Decision Cost Investors a Lot of Money?,2016-10-07 19:43:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-IHYlsOItjU/did-pfizers-no-split-decision-cost-investors-a-lot-of-money-cm690506,Image source Getty Images Pfizer NYSE PFE 160 announced on Sept 26 that it would remain as one company rather than split into two The decision was made to maximize future shareholder value creation the company said 160 But could the choice to stay united end up
PFE,PFE:US,BBG000BR2B91,Did Pfizer's No-Split Decision Cost Investors a Lot of Money?,2016-10-07 18:28:24 +0000,http://www.fool.com/investing/2016/10/07/did-pfizers-no-split-decision-cost-investors-a-lot.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Did Pfizer's No-Split Decision Cost Investors a Lot of Money?
PFE,PFE:US,BBG000BR2B91,Pfizer to Sell Hospira Infusion Unit to ICU Medical for $1B,2016-10-07 16:44:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/giU54Mmt8u0/pfizer-to-sell-hospira-infusion-unit-to-icu-medical-for-1b-cm690382,Pfizer Inc PFE has entered into a definitive agreement to sell its Hospira infusion systems business to medical device maker ICU Medical Inc ICUI for 1 billion in cash and stock Shares of ICU Medical were up almost 15 on Thursday With the addition of Hospira infusion systems
PFE,PFE:US,BBG000BR2B91,Pfizer to Sell Hospira Infusion Unit to ICU Medical for $1B,2016-10-07 14:36:02 +0000,http://finance.yahoo.com/news/pfizer-sell-hospira-infusion-unit-143602979.html,Pfizer to Sell Hospira Infusion Unit to ICU Medical for $1B
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer to Sell New York City Headquarters By End of Next Year,2016-10-07 04:11:29 +0000,http://www.wsj.com/articles/pfizer-to-sell-new-york-city-headquarters-by-end-of-next-year-1475766972?ru=yahoo?mod=yahoo_itp,[$$] Pfizer to Sell New York City Headquarters By End of Next Year
PFE,PFE:US,BBG000BR2B91,"Why ICU Medical, Big 5 Sporting Goods, and Caesars Acquisition Jumped Today",2016-10-06 23:43:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P9ECf5wYVEw/why-icu-medical-big-5-sporting-goods-and-caesars-acquisition-jumped-today-cm690092,Image source ICU Medical Thursday was a quiet day for the stock market with mixed performance from major market benchmarks The Dow and the Nasdaq Composite fell slightly from yesterday s close while the S amp P 500 added a single point Investors appeared content to wait and see
PFE,PFE:US,BBG000BR2B91,Why Opko Health Shares Rallied 14% in September,2016-10-06 22:44:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tRHLPTdj8wA/why-opko-health-shares-rallied-14-in-september-cm690068,Image source Getty Images What happened Following the completion of a planned acquisition and the report of an upcoming phase 3 trial for its long lasting human growth hormone and ahead of key late stage trial data later this year shares in Opko Health NASDAQ OPK jumped
PFE,PFE:US,BBG000BR2B91,"Why ICU Medical, Big 5 Sporting Goods, and Caesars Acquisition Jumped Today",2016-10-06 22:14:00 +0000,http://www.fool.com/investing/2016/10/06/why-icu-medical-big-5-sporting-goods-and-caesars-a.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,"Why ICU Medical, Big 5 Sporting Goods, and Caesars Acquisition Jumped Today"
PFE,PFE:US,BBG000BR2B91,Why Opko Health Shares Rallied 14% in September,2016-10-06 21:28:02 +0000,http://www.fool.com/investing/general/2016/10/06/why-opko-health-shares-rallied-14-in-september.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Opko Health Shares Rallied 14% in September
PFE,PFE:US,BBG000BR2B91,ICU Medical (ICUI) Stock Closed Higher on $1 Billion Pfizer Deal,2016-10-06 21:15:00 +0000,https://www.thestreet.com/story/13844899/1/icu-medical-icui-stock-closed-higher-on-1-billion-pfizer-deal.html?puc=yahoo&cm_ven=YAHOO,ICU Medical (ICUI) Stock Closed Higher on $1 Billion Pfizer Deal
PFE,PFE:US,BBG000BR2B91,Pfizer to seek more modern headquarters in Manhattan,2016-10-06 21:11:32 +0000,http://finance.yahoo.com/news/pfizer-seek-more-modern-manhattan-164624865.html,"[Reuters] - Pfizer Inc, the largest U.S. drugmaker, said on Thursday it aims to sell its world headquarters buildings in midtown Manhattan by the end of 2017 and begin moving into more modern facilities in Manhattan no sooner than the first half of 2019. ""This move is being driven by the significant investment that would be required to bring the buildings to modern standards,"" Pfizer said in a statement. Pfizer spokeswoman Joan Campion said the company notified employees of the plans on Wednesday."
PFE,PFE:US,BBG000BR2B91,Pfizer to Sell Its Aging Headquarters (PFE),2016-10-06 20:45:00 +0000,http://www.investopedia.com/news/pfizer-sell-its-aging-headquarters-pfe/?partner=YahooSA,Pfizer to Sell Its Aging Headquarters (PFE)
PFE,PFE:US,BBG000BR2B91,7 Top Stocks to Buy in October,2016-10-06 20:43:40 +0000,http://www.fool.com/investing/2016/10/05/7-top-stocks-to-buy-in-october.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,7 Top Stocks to Buy in October
PFE,PFE:US,BBG000BR2B91,Twitter and Wal-Mart fall; ICU Medical and Lam Research jump,2016-10-06 20:41:54 +0000,http://sg.finance.yahoo.com/news/twitter-wal-mart-fall-icu-204154798.html,Twitter and Wal-Mart fall; ICU Medical and Lam Research jump
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 10/06/2016: PFE,PHMD,ALNY",2016-10-06 20:23:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MJR-Hkvecgg/health-care-sector-update-for-10062016-pfephmdalny-cm690025,Top Health Care StocksTop Health Care Stocks JNJ 0 57 JNJ 0 57 PFE 1 08 PFE 1 08 MRK 0 30 MRK 0 30 ABT 0 79 ABT 0 79 AMGN 0 35 AMGN 0 35 Health care stocks and in particular shares of drug companies continued to lose ground this afternoon dragging on the broader U S
PFE,PFE:US,BBG000BR2B91,"American Express, Wal-Mart Weigh on DJIA Thursday",2016-10-06 20:01:52 +0000,http://247wallst.com/investing/2016/10/06/american-express-wal-mart-weigh-on-djia-thursday/,"American Express, Wal-Mart Weigh on DJIA Thursday"
PFE,PFE:US,BBG000BR2B91,Pfizer Sells Infusion Therapy Business (PFE),2016-10-06 19:22:00 +0000,http://www.investopedia.com/news/pfizer-sells-infusion-therapy-business-pfe/?partner=YahooSA,Pfizer Sells Infusion Therapy Business (PFE)
PFE,PFE:US,BBG000BR2B91,[$$] The Designer Shoebox: Studio Apartments That Use Every Inch,2016-10-06 17:25:28 +0000,http://www.wsj.com/articles/the-designer-shoebox-studio-apartments-that-use-every-inch-1475774725?mod=yahoo_hs,[$$] The Designer Shoebox: Studio Apartments That Use Every Inch
PFE,PFE:US,BBG000BR2B91,Pfizer says to seek more modern Manhattan headquarters,2016-10-06 16:03:18 +0000,http://finance.yahoo.com/news/pfizer-says-seek-more-modern-160318488.html,Pfizer says to seek more modern Manhattan headquarters
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer to Sell New York Headquarters By End of 2017,2016-10-06 16:02:51 +0000,http://www.wsj.com/articles/pfizer-to-sell-new-york-city-headquarters-by-end-of-next-year-1475766972?mod=yahoo_hs,[$$] Pfizer to Sell New York Headquarters By End of 2017
PFE,PFE:US,BBG000BR2B91,3 Reasons Pfizer's Recent Drop Could Make It a Buying Opportunity,2016-10-06 15:43:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LjipMvX2WJw/3-reasons-pfizers-recent-drop-could-make-it-a-buying-opportunity-cm689529,Image source Getty Images Drug giant Pfizer NYSE PFE is back full circle After years of Wall Street speculation about whether the company would split into stand alone parts CEO Ian Read recently announced management s decision no split You could almost hear the
PFE,PFE:US,BBG000BR2B91,Pfizer to sell Hospira infusion therapy business to ICU Medical,2016-10-06 15:30:26 +0000,http://sg.finance.yahoo.com/news/icu-medical-buy-pfizers-infusion-125253647.html,Pfizer to sell Hospira infusion therapy business to ICU Medical
PFE,PFE:US,BBG000BR2B91,"Here’s Why Traders Are Watching Tesla, ICU Medical, Pfizer, and Two Other Stocks Today",2016-10-06 15:24:07 +0000,http://www.insidermonkey.com/blog/heres-why-traders-are-watching-tesla-icu-medical-pfizer-and-two-other-stocks-today-479044/,"Here’s Why Traders Are Watching Tesla, ICU Medical, Pfizer, and Two Other Stocks Today"
PFE,PFE:US,BBG000BR2B91,How Will Pfizer (PFE) Stock React to $1 Billion ICU Medical Deal?,2016-10-06 15:03:00 +0000,https://www.thestreet.com/story/13844274/1/how-will-pfizer-pfe-stock-react-to-1-billion-icu-medical-deal.html?puc=yahoo&cm_ven=YAHOO,How Will Pfizer (PFE) Stock React to $1 Billion ICU Medical Deal?
PFE,PFE:US,BBG000BR2B91,US STOCKS-Wall St falls as health stocks drag,2016-10-06 13:57:51 +0000,http://finance.yahoo.com/news/us-stocks-wall-st-falls-135751025.html,US STOCKS-Wall St falls as health stocks drag
PFE,PFE:US,BBG000BR2B91,[$$] ICU Medical To Buy Pfizer Unit in $1 Billion Deal,2016-10-06 13:38:07 +0000,http://www.wsj.com/articles/icu-medical-to-buy-pfizer-unit-in-1-billion-deal-1475761083?mod=yahoo_hs,[$$] ICU Medical To Buy Pfizer Unit in $1 Billion Deal
PFE,PFE:US,BBG000BR2B91,ICU Medical Inc. To Acquire The Hospira Infusion Systems Business From Pfizer Inc. For $1 Billion In Cash And Stock,2016-10-06 12:09:04 +0000,http://www.publicnow.com/view/671082DFAC88F2FBB8A1E823D854B6106CEC67A5,[at noodls] - ICU Medical Inc.(link is external) (NASDAQ:ICUI(link is external)) and Pfizer Inc.(link is external) (NYSE:PFE(link is external)) today announced that they have entered into a definitive agreement under ...
PFE,PFE:US,BBG000BR2B91,ICU Medical to buy Pfizer's infusion therapy business for $1 bln,2016-10-06 12:02:33 +0000,http://finance.yahoo.com/news/icu-medical-buy-pfizers-infusion-120233310.html,"[Reuters] - Medical device maker ICU Medical Inc said it would buy Pfizer Inc's global infusion therapy business, Hospira Infusion Systems , for $1 billion in cash and stock. Pfizer will receive $600 million in cash ..."
PFE,PFE:US,BBG000BR2B91,ICU Medical Inc. to Acquire the Hospira Infusion Systems Business from Pfizer Inc. for $1 Billion in Cash and Stock,2016-10-06 11:59:04 +0000,http://www.publicnow.com/view/E9DDE2A83DAA04D09FD7C9B4B2B6FAE1DCC2C130,"[at noodls] - October 6, 2016 Creates an integrated pure-play infusion therapy company with focus and scale Combined business to compete in the US market with a unified organization and a complementary portfolio Extends ..."
PFE,PFE:US,BBG000BR2B91,ICU Medical to Buy Pfizer’s Infusion Unit for $1 Billion,2016-10-06 11:54:47 +0000,http://www.bloomberg.com/news/articles/2016-10-06/icu-medical-to-acquire-pfizer-s-hospira-unit-for-1-billion?cmpid=yhoo.headline,ICU Medical to Buy Pfizer’s Infusion Unit for $1 Billion
PFE,PFE:US,BBG000BR2B91,Pfizer to Sell New York Headquarters By End of 2017,2016-10-06 11:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9f-TocSDZho/pfizer-to-sell-new-york-headquarters-by-end-of-2017-20161006-00707,Pfizer to Sell New York Headquarters By End of 2017
PFE,PFE:US,BBG000BR2B91,Pfizer To Sell New York City Headquarters By End Of Next Year -- Update,2016-10-06 11:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uWFZRM3MTyM/pfizer-to-sell-new-york-city-headquarters-by-end-of-next-year--update-20161006-00675,Pfizer To Sell New York City Headquarters By End Of Next Year -- Update
PFE,PFE:US,BBG000BR2B91,Pfizer To Sell New York City Headquarters By End Of Next Year,2016-10-06 11:28:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RJOtNuBJJF8/pfizer-to-sell-new-york-city-headquarters-by-end-of-next-year-20161006-00656,Pfizer To Sell New York City Headquarters By End Of Next Year
PFE,PFE:US,BBG000BR2B91,ICU Medical To Buy Pfizer Unit in $1 Billion Deal,2016-10-06 10:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jacGfDnxXVA/icu-medical-to-buy-pfizer-unit-in-1-billion-deal-20161006-00544,ICU Medical To Buy Pfizer Unit in $1 Billion Deal
PFE,PFE:US,BBG000BR2B91,ICU Medical Inc. (ICUI) Has Broken Out To A New High After Acquisition,2016-10-06 09:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CbXo-wG0sI8/icu-medical-inc-icui-has-broken-out-to-a-new-high-after-acquisition-20161006-00527,ICU Medical Inc. (ICUI) Has Broken Out To A New High After Acquisition
PFE,PFE:US,BBG000BR2B91,ICU Medical To Acquire Pfizer's Hospira In $1 Bln Deal - Quick Facts,2016-10-06 08:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QiEkB07G1H4/icu-medical-to-acquire-pfizers-hospira-in-1-bln-deal--quick-facts-20161006-00337,ICU Medical To Acquire Pfizer's Hospira In $1 Bln Deal - Quick Facts
PFE,PFE:US,BBG000BR2B91,ICU Medical Investor Conference Call At 8:30 AM ET,2016-10-06 08:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M5hP21FFoNE/icu-medical-investor-conference-call-at-830-am-et-20161006-00334,ICU Medical Investor Conference Call At 8:30 AM ET
PFE,PFE:US,BBG000BR2B91,3 Reasons Pfizer's Recent Drop Could Make It a Buying Opportunity,2016-10-06 01:57:11 +0000,http://www.fool.com/investing/2016/10/05/3-reasons-pfizers-recent-drop-could-make-it-a-buyi.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Reasons Pfizer's Recent Drop Could Make It a Buying Opportunity
PFE,PFE:US,BBG000BR2B91,7 Top Stocks to Buy in October,2016-10-05 22:43:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kuvb8RkHHOM/7-top-stocks-to-buy-in-october-cm689484,Image source Getty Images Great stocks come in many shapes and sizes and finding the best ones to buy now can be tricky To help investors home in on the top stocks on the market today we asked some of our top contributors for their best ideas Their picks span healthcare
PFE,PFE:US,BBG000BR2B91,Eli Lilly Looks To Corral More Animal-Health Business Vs. Zoetis,2016-10-05 20:04:55 +0000,http://www.investors.com/news/technology/eli-lilly-looks-to-corral-more-animal-health-business-vs-zoetis/,Eli Lilly Looks To Corral More Animal-Health Business Vs. Zoetis
PFE,PFE:US,BBG000BR2B91,Three Cancer Plays For The Fourth Quarter Of 2016,2016-10-05 18:42:20 +0000,http://www.insidermonkey.com/blog/three-cancer-plays-for-the-fourth-quarter-of-2016-478857/,Three Cancer Plays For The Fourth Quarter Of 2016
PFE,PFE:US,BBG000BR2B91,"If You're in Your 60s, Consider Buying These 3 Stocks",2016-10-05 16:45:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/niij46sjocY/if-youre-in-your-60s-consider-buying-these-3-stocks-cm689165,Image source Getty Some investors believe that it is a mistake to own stocks as their retirement draws near However the Social Security Administration estimates that today s average 65 year old will live for 20 more years which is why we Fools think that it is a mistake to forgo
PFE,PFE:US,BBG000BR2B91,"Pfizer Inc. : PFE-US: Dividend Analysis : August 05th, 2016 (record date) : By the numbers : October 5, 2016",2016-10-05 16:28:57 +0000,http://www.capitalcube.com/blog/index.php/pfizer-inc-pfe-us-dividend-analysis-august-05th-2016-record-date-by-the-numbers-october-5-2016/,"Pfizer Inc. : PFE-US: Dividend Analysis : August 05th, 2016 (record date) : By the numbers : October 5, 2016"
PFE,PFE:US,BBG000BR2B91,3 Insights FuelCell Energy's Management Is Sharing With Investors,2016-10-05 15:45:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tr3GC5L6zOc/3-insights-fuelcell-energys-management-is-sharing-with-investors-cm689102,Image source Getty Images When a company reports its quarterly earnings management often presents just a sketch of how the company performed But equally important for investors is the conference call where management s commentary colors in the sketch providing the full picture
PFE,PFE:US,BBG000BR2B91,"If You're in Your 60s, Consider Buying These 3 Stocks",2016-10-05 15:22:52 +0000,http://www.fool.com/investing/2016/10/05/if-youre-in-your-60s-consider-buying-these-3-stock.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"If You're in Your 60s, Consider Buying These 3 Stocks"
PFE,PFE:US,BBG000BR2B91,Biotech Mergers Run the Show: 5 Small-Cap Stocks for Q4,2016-10-05 13:49:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/REB_8Ifg5zA/biotech-mergers-run-the-show-5-small-cap-stocks-for-q4-cm688679,Healthcare merger and acquisition activity has gathered steam over the past few years A few big mergers in the recent past include that of Pfizer Inc PFE and Wyeth Pfizer and Hospira Novartis AG NVS and Alcon Sanofi SNY and Genzyme Roche Holding AG RHHBY and Genentech and
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: VIVUS, Geron, Achillion Pharmaceuticals, Anika Therapeutics and ANI Pharmaceuticals",2016-10-05 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-vivus-133001958.html,"The Zacks Analyst Blog Highlights: VIVUS, Geron, Achillion Pharmaceuticals, Anika Therapeutics and ANI Pharmaceuticals"
PFE,PFE:US,BBG000BR2B91,"How Merck & Co., Inc. Ranks As a Top Analyst Pick (MRK)",2016-10-05 12:43:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bEaDo6o84yI/how-merck-co-inc-ranks-as-a-top-analyst-pick-mrk-cm688945,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips A study of analyst recommendations at the major brokerages shows that Merck amp Co Inc MRK is the 12 broker pick on average out of the 30 stocks making up the
PFE,PFE:US,BBG000BR2B91,[$$] Samsung BioLogics IPO Could Value Firm at $8.2 Billion,2016-10-05 04:51:45 +0000,http://www.wsj.com/articles/samsung-affiliate-seeks-european-approval-for-near-replica-of-herceptin-1475546455?ru=yahoo?mod=yahoo_itp,[$$] Samsung BioLogics IPO Could Value Firm at $8.2 Billion
PFE,PFE:US,BBG000BR2B91,Samsung Group Furthers Drug Push -- WSJ,2016-10-05 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2tEzh_LOljA/samsung-group-furthers-drug-push--wsj-20161005-00079,Samsung Group Furthers Drug Push -- WSJ
PFE,PFE:US,BBG000BR2B91,"Nope, Gilead Sciences Won’t Get Bought out",2016-10-04 21:27:58 +0000,http://www.fool.com/investing/2016/10/04/nope-gilead-sciences-wont-get-bought-out.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Nope, Gilead Sciences Won’t Get Bought out"
PFE,PFE:US,BBG000BR2B91,Dynavax Technologies Corporation (DVAX) Steals Back Gains on Pending Heplisav Treatment,2016-10-04 20:47:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wNmjNKz8Dbk/dynavax-technologies-corporation-dvax-steals-back-gains-on-pending-heplisav-treatment-cm688089,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Dynavax Technologies Corporation 160 NASDAQ DVAX a clinical stage biotech in the field of autoimmunology is surging 20 plus for the second time in less than a
PFE,PFE:US,BBG000BR2B91,[$$] Samsung BioLogics IPO Could Value Firm at $8.2 Billion,2016-10-04 16:56:47 +0000,http://www.wsj.com/articles/samsung-affiliate-seeks-european-approval-for-near-replica-of-herceptin-1475546455?mod=yahoo_hs,[$$] Samsung BioLogics IPO Could Value Firm at $8.2 Billion
PFE,PFE:US,BBG000BR2B91,J&J Warns Insulin Pump Vulnerable to Cyber Hacking,2016-10-04 16:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fcE2ViKvZj4/jj-warns-insulin-pump-vulnerable-to-cyber-hacking-20161004-00695,J&J Warns Insulin Pump Vulnerable to Cyber Hacking
PFE,PFE:US,BBG000BR2B91,Roche Alecensa Wins Second Breakthrough Status in the U.S.,2016-10-04 15:46:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-VQNI-mxShY/roche-alecensa-wins-second-breakthrough-status-in-the-us-cm688435,Roche Holding AG RHHBY announced that its lung cancer drug Alecensa was granted a second breakthrough therapy designation in the U S for the treatment of advanced anaplastic lymphoma kinase ALK positive non small cell lung cancer NSCLC in adult patients who have not received
PFE,PFE:US,BBG000BR2B91,"Nope, Gilead Sciences Won’t Get Bought out",2016-10-04 14:44:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5x5yXaNUrXo/nope-gilead-sciences-wont-get-bought-out-cm688365,Image Source Getty Images Rumors have been swirling around the internet that Gilead Sciences NASDAQ GILD is going to get bought by a big pharma Heck my Foolish colleague Sean Williams has entertained the possibility Lots of smart people are discussing this With all
PFE,PFE:US,BBG000BR2B91,Roche Alecensa Wins Second Breakthrough Status in the U.S.,2016-10-04 14:05:02 +0000,http://finance.yahoo.com/news/roche-alecensa-wins-second-breakthrough-140502633.html,Roche Alecensa Wins Second Breakthrough Status in the U.S.
PFE,PFE:US,BBG000BR2B91,5 FDA Decisions to Watch Out for in October 2016,2016-10-04 13:45:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VcF0rpyLWrY/5-fda-decisions-to-watch-out-for-in-october-2016-cm688404,The drug development process is often lengthy and time consuming and involves a lot of funds and resources It could take a drug anything between 10 12 years to be successfully developed and reach the market In such a scenario key pipeline events including data readouts and regulatory updates
PFE,PFE:US,BBG000BR2B91,"Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for October 05, 2016",2016-10-04 13:14:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZI0umfBAeN4/bristol-myers-squibb-company-bmy-ex-dividend-date-scheduled-for-october-05-2016-cm688330,Bristol Myers Squibb Company BMY will begin trading ex dividend on October 05 2016 A cash dividend payment of 0 38 per share is scheduled to be paid on November 01 2016 Shareholders who purchased BMY prior to the ex dividend date are eligible for the cash dividend payment This marks
PFE,PFE:US,BBG000BR2B91,5 FDA Decisions to Watch Out for in October 2016,2016-10-04 12:42:12 +0000,http://finance.yahoo.com/news/5-fda-decisions-watch-october-124212646.html,5 FDA Decisions to Watch Out for in October 2016
PFE,PFE:US,BBG000BR2B91,Correction to Samsung BioLogics story,2016-10-04 05:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v_ojdRExK7Y/correction-to-samsung-biologics-story-20161004-00125,Correction to Samsung BioLogics story
PFE,PFE:US,BBG000BR2B91,AstraZeneca's Brilinta Fails Arterial Disease Drug Trial,2016-10-04 05:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9kvhI3eGVmo/astrazenecas-brilinta-fails-arterial-disease-drug-trial-20161004-00110,AstraZeneca's Brilinta Fails Arterial Disease Drug Trial
PFE,PFE:US,BBG000BR2B91,Corrections & Amplifications,2016-10-04 04:02:37 +0000,http://www.wsj.com/articles/corrections-amplifications-1475536386?ru=yahoo?mod=yahoo_itp,Corrections & Amplifications
PFE,PFE:US,BBG000BR2B91,Samsung BioLogics IPO Could Value Firm at $8.2 Billion -- 2nd Update,2016-10-04 01:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5WNOVkq6xC4/samsung-biologics-ipo-could-value-firm-at-82-billion--2nd-update-20161004-00037,Samsung BioLogics IPO Could Value Firm at $8.2 Billion -- 2nd Update
PFE,PFE:US,BBG000BR2B91,Samsung BioLogics IPO Could Value Firm at $8.2 Billion,2016-10-03 22:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qO4yZY97U7U/samsung-biologics-ipo-could-value-firm-at-82-billion-20161003-01301,Samsung BioLogics IPO Could Value Firm at $8.2 Billion
PFE,PFE:US,BBG000BR2B91,Samsung Affiliate Seeks European Approval for Herceptin Copy,2016-10-03 22:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ev-KibnLbHk/samsung-affiliate-seeks-european-approval-for-herceptin-copy-20161003-01293,Samsung Affiliate Seeks European Approval for Herceptin Copy
PFE,PFE:US,BBG000BR2B91,US Market Indexes Lower on Monday,2016-10-03 22:41:57 +0000,http://finance.yahoo.com/news/us-market-indexes-lower-monday-224157462.html,US Market Indexes Lower on Monday
PFE,PFE:US,BBG000BR2B91,Samsung Affiliate Seeks European Approval for Near-Replica of Herceptin,2016-10-03 22:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WpPo5lO3KUs/samsung-affiliate-seeks-european-approval-for-nearreplica-of-herceptin-20161003-01290,Samsung Affiliate Seeks European Approval for Near-Replica of Herceptin
PFE,PFE:US,BBG000BR2B91,Allergan PLC’s Charm-and-Merger Offensive (AGN),2016-10-03 19:44:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/itzx__LEK3E/allergan-plcs-charm-and-merger-offensive-agn-cm688064,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Since losing in his effort to take out Pfizer Inc NYSE PFE in a huge tax inversion deal this past spring Allergan Plc NYSE AGN CEO Brent Saunders has hatched a new strategy with the
PFE,PFE:US,BBG000BR2B91,"Noteworthy ETF Inflows: VLUE, PFE, GM, JPM",2016-10-03 16:44:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vUihahwQmMo/noteworthy-etf-inflows-vlue-pfe-gm-jpm-cm687854,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Edge MSCI USA Value Factor ETF Symbol VLUE where we have detected an approximate 78 3 million dollar inflow that s a 10 0 increase week over week
PFE,PFE:US,BBG000BR2B91,"Dow Movers: PFE, DD",2016-10-03 15:44:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OIBbdflENZI/dow-movers-pfe-dd-cm687721,In early trading on Monday shares of DuPont DD topped the list of the day s best performing Dow Jones Industrial Average components trading up 0 9 Year to date DuPont registers a 1 5 gain And the worst performing Dow component thus far on the day is Pfizer PFE trading
PFE,PFE:US,BBG000BR2B91,What’s the Outlook for Pfizer?,2016-10-03 15:05:05 +0000,http://marketrealist.com/2016/09/whats-the-outlook-for-pfizer/?utm_source=yahoo&utm_medium=feed,What’s the Outlook for Pfizer?
PFE,PFE:US,BBG000BR2B91,Argus Slightly Disappointed With Pfizer's Decision Not To Split The Company,2016-10-03 14:37:07 +0000,http://finance.yahoo.com/news/argus-slightly-disappointed-pfizers-decision-143707290.html,Argus Slightly Disappointed With Pfizer's Decision Not To Split The Company
PFE,PFE:US,BBG000BR2B91,Recent Corporate and Pipeline Developments for Pfizer,2016-10-03 14:04:49 +0000,http://marketrealist.com/2016/09/recent-corporate-and-pipeline-developments-for-pfizer-2/?utm_source=yahoo&utm_medium=feed,Recent Corporate and Pipeline Developments for Pfizer
PFE,PFE:US,BBG000BR2B91,Major Product Developments for Pfizer,2016-10-03 12:04:58 +0000,http://marketrealist.com/2016/09/major-product-developments-for-pfizer-2/?utm_source=yahoo&utm_medium=feed,Major Product Developments for Pfizer
PFE,PFE:US,BBG000BR2B91,Stock Market Outlook: A Little Too Buoyant?,2016-10-03 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=771403&SR=Yahoo,Stock Market Outlook: A Little Too Buoyant?
PFE,PFE:US,BBG000BR2B91,Vanguard Windsor II: Vanguard’s Oddball,2016-10-01 18:21:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_a3J4hdFDWs/vanguard-windsor-ii-vanguards-oddball-cm687485,Logo source Vanguard The Vanguard Windsor II Fund NASDAQMUTFUND VWNFX was launched in 1985 after the original Windsor fund managed by the legendary manager John Neff was closed to new investors Today the Windsor II is one of the firm s largest actively managed
PFE,PFE:US,BBG000BR2B91,Deutsche Bank's Losses Affecting the Market on Thursday,2016-10-01 15:20:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gwqegXj4N7s/deutsche-banks-losses-affecting-the-market-on-thursday-cm687272,U S market indexes were lower Thursday For the day the Dow Jones Industrial Average closed at 8 4 45 for a loss of 95 79 points or 7 The S amp P 5 was also lower closing at 5 for a loss of 4 points or 9 The Nasdaq Composite closed lower at 5 69 5 for a loss
PFE,PFE:US,BBG000BR2B91,Why Pfizer's Scrapped Merger May Ultimately Benefit the Company and Investors,2016-10-01 12:23:00 +0000,https://www.thestreet.com/story/13837829/1/why-pfizer-s-scrapped-merger-may-ultimately-benefit-the-company-and-investors.html?puc=yahoo&cm_ven=YAHOO,Why Pfizer's Scrapped Merger May Ultimately Benefit the Company and Investors
PFE,PFE:US,BBG000BR2B91,US Market Indexes Gain on Friday,2016-09-30 23:24:05 +0000,http://finance.yahoo.com/news/us-market-indexes-gain-friday-232328005.html,US Market Indexes Gain on Friday
PFE,PFE:US,BBG000BR2B91,3 Top Healthcare Stocks to Buy Now,2016-09-30 20:22:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6aZIqzIYYEM/3-top-healthcare-stocks-to-buy-now-cm687338,Because of an aging global population an unprecedented amount of innovation and wider access to medical services in the United States the healthcare sector should continue to push higher in the coming years To take advantage of this rising tide investors may want to grab shares
PFE,PFE:US,BBG000BR2B91,3 Top Healthcare Stocks to Buy Now,2016-09-30 18:45:00 +0000,http://www.fool.com/investing/2016/09/30/3-top-healthcare-stocks-to-buy-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Healthcare Stocks to Buy Now
PFE,PFE:US,BBG000BR2B91,The Highest-Yielding Drug Stocks,2016-09-30 17:25:20 +0000,http://www.fool.com/investing/2016/09/29/the-highest-yielding-drug-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Highest-Yielding Drug Stocks
PFE,PFE:US,BBG000BR2B91,"Midday Update: Deutsche Bank Takes Pressure off Wall Street, Dow Races Higher",2016-09-30 17:21:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o0P8l4cCmck/midday-update-deutsche-bank-takes-pressure-off-wall-street-dow-races-higher-cm687242,Stocks have reversed Thursday s losses and were gaining altitude in Friday s midday trade as concerns about Germany s Deutsche Bank faded following reports of a settlement with the U S government Agence France tweeted earlier this morning that the bank is nearing a 5 4 billion settlement
PFE,PFE:US,BBG000BR2B91,"Kite, Anavex, G.W. Pharma Help Revive Biotech Sector Chemistry",2016-09-30 16:56:03 +0000,http://www.investors.com/research/industry-snapshot/kite-anavex-g-w-pharma-revive-biotech-sector-chemistry/,"Kite, Anavex, G.W. Pharma Help Revive Biotech Sector Chemistry"
PFE,PFE:US,BBG000BR2B91,"Exelixis, Inc. (EXEL) Crushed on CaboNivo Drug Trial Results",2016-09-30 16:24:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MCZ95b0VkVg/exelixis-inc-exel-crushed-on-cabonivo-drug-trial-results-cm687199,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Look up the term volatility and you re likely to find several biotech stocks that have posted wild price swings over the past several weeks Among them Exelixis Inc
PFE,PFE:US,BBG000BR2B91,ARIAD (ARIA) Leukemia Drug Iclusig Gets Approval in Japan,2016-09-30 16:24:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kDxR7UD1Fho/ariad-aria-leukemia-drug-iclusig-gets-approval-in-japan-cm687182,ARIAD Pharmaceuticals Inc ARIA announced that its partner Otsuka Pharmaceutical Co Ltd has gained approval from the Japanese Pharmaceuticals and Medical Devices Agency for leukemia drug Iclusig Iclusig is approved for the treatment of patients with chronic myeloid leukemia CML
PFE,PFE:US,BBG000BR2B91,Which Pfizer Products Reported Declining Sales?,2016-09-30 15:05:21 +0000,http://marketrealist.com/2016/09/which-pfizer-products-reported-declining-sales/?utm_source=yahoo&utm_medium=feed,Which Pfizer Products Reported Declining Sales?
PFE,PFE:US,BBG000BR2B91,Which Products Were Key Contributors to Pfizer’s Revenue Growth?,2016-09-30 14:05:31 +0000,http://marketrealist.com/2016/09/which-products-were-key-contributors-to-pfizers-revenue-growth/?utm_source=yahoo&utm_medium=feed,Which Products Were Key Contributors to Pfizer’s Revenue Growth?
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 09/30/2016: JNJ, PFE, ABT, MRK, AMGN, AUPH, THLD",2016-09-30 13:41:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/89G0AfCsppI/health-care-sector-update-for-09302016-jnj-pfe-abt-mrk-amgn-auph-thld-cm687033,Top Health care stocks Top Health care stocks JNJ 0 5 JNJ 0 5 PFE 0 2 PFE 0 2 ABT flatABT flat MRK 1 7 MRK 1 7 AMGN flatAMGN flat Health care shares were mostly higher in pre market trade Friday Health care shares were mostly higher in pre market trade Friday In health
PFE,PFE:US,BBG000BR2B91,Pfizer’s Innovative Health and Essential Health Businesses,2016-09-30 12:06:02 +0000,http://marketrealist.com/2016/09/pfizers-innovative-health-and-essential-health-businesses/?utm_source=yahoo&utm_medium=feed,Pfizer’s Innovative Health and Essential Health Businesses
PFE,PFE:US,BBG000BR2B91,"Why Exelixis, Inc. Continued Its Downfall Today",2016-09-29 23:22:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wxlEGT9125U/why-exelixis-inc-continued-its-downfall-today-cm686882,Image source Getty Images What happened Exelixis NASDAQ EXEL continued its fall today down as much as 12 and ending the day down 8 after falling 14 yesterday So what Today s move seems to be a continuation of yesterday The momentum down shouldn t come as
PFE,PFE:US,BBG000BR2B91,Deutsche Bank's Losses Affecting the Market on Thursday,2016-09-29 22:59:51 +0000,http://finance.yahoo.com/news/deutsche-banks-losses-affecting-market-225951163.html,Deutsche Bank's Losses Affecting the Market on Thursday
PFE,PFE:US,BBG000BR2B91,The Pfizer-Anacor Deal: A Review,2016-09-29 22:04:12 +0000,http://marketrealist.com/2016/09/the-pfizer-anacor-deal-a-review/?utm_source=yahoo&utm_medium=feed,The Pfizer-Anacor Deal: A Review
PFE,PFE:US,BBG000BR2B91,"Why Exelixis, Inc. Continued Its Downfall Today",2016-09-29 21:20:45 +0000,http://www.fool.com/investing/2016/09/29/why-exelixis-inc-continued-its-downfall-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Exelixis, Inc. Continued Its Downfall Today"
PFE,PFE:US,BBG000BR2B91,A Look at the Pfizer-Medivation Deal,2016-09-29 21:04:11 +0000,http://marketrealist.com/2016/09/a-look-at-the-pfizer-medivation-deal/?utm_source=yahoo&utm_medium=feed,A Look at the Pfizer-Medivation Deal
PFE,PFE:US,BBG000BR2B91,"U.S. Stocks Sell Off On Deutsche Bank Worries, But Oil Plays Surge",2016-09-29 20:23:22 +0000,http://www.investors.com/market-trend/stock-market-today/u-s-stocks-sell-off-on-deutsche-bank-worries-but-oil-plays-surge/,"U.S. Stocks Sell Off On Deutsche Bank Worries, But Oil Plays Surge"
PFE,PFE:US,BBG000BR2B91,"Troubles for Deutsche Bank, Wells Fargo Drag Down Wall Street",2016-09-29 20:03:00 +0000,https://www.thestreet.com/story/13836645/1/troubles-for-deutsche-bank-wells-fargo-drag-down-wall-street.html?puc=yahoo&cm_ven=YAHOO,"Troubles for Deutsche Bank, Wells Fargo Drag Down Wall Street"
PFE,PFE:US,BBG000BR2B91,"Goldman, Merck Lead DJIA Thursday Plunge",2016-09-29 20:01:09 +0000,http://finance.yahoo.com/news/goldman-merck-lead-djia-thursday-200109639.html,"Goldman, Merck Lead DJIA Thursday Plunge"
PFE,PFE:US,BBG000BR2B91,How Does Pfizer’s Valuation Compare?,2016-09-29 18:42:36 +0000,http://marketrealist.com/2016/09/how-does-pfizers-valuation-compare/?utm_source=yahoo&utm_medium=feed,How Does Pfizer’s Valuation Compare?
PFE,PFE:US,BBG000BR2B91,7 Healthcare Stocks in Focus on World Heart Day,2016-09-29 16:24:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a05pILds2Pk/7-healthcare-stocks-in-focus-on-world-heart-day-cm686605,Every year on Sep 29 World Heart Day is observed to raise awareness about cardiovascular CV diseases including heart disease and stroke The focus is on creating heart healthy environments that will help reduce cardiovascular risk be it at work or at home According to the World
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: Nike Earnings Impress, Boeing Wins $8B Saudi Order",2016-09-29 16:23:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GD-wWBC4RTQ/dow-30-stock-roundup-nike-earnings-impress-boeing-wins-8b-saudi-order-cm686568,The Dow chalked up gains this week boosted by encouraging consumer related data and OPEC s landmark production control agreement Consumer confidence touched a nine year high leading to significant gains for consumer discretionary stocks on Tuesday Meanwhile the world s largest oil
PFE,PFE:US,BBG000BR2B91,Why Apple Inc. Could Slide 20% This Year (AAPL),2016-09-29 15:24:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z65o8AYPPu0/why-apple-inc-could-slide-20-this-year-aapl-cm686533,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Apple Inc 160 AAPL 160 stock is surging to new heights and is up 18 this quarter on expectations that its new devices will sell in great 160
PFE,PFE:US,BBG000BR2B91,How Oncology Could Move the Needle for Johnson & Johnson's Stock,2016-09-29 14:24:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZKTg6Wg5OAA/how-oncology-could-move-the-needle-for-johnson-johnsons-stock-cm686441,Image source Getty Images Johnson amp Johnson s NYSE JNJ stock has nearly doubled 160 in the past five years 160 with 160 the healthcare giant s 160 pharmaceuticals division creating enough growth to keep 160 investors 160 happily squirreling away 160
PFE,PFE:US,BBG000BR2B91,7 Healthcare Stocks in Focus on World Heart Day,2016-09-29 14:03:02 +0000,http://finance.yahoo.com/news/7-healthcare-stocks-focus-world-140302072.html,7 Healthcare Stocks in Focus on World Heart Day
PFE,PFE:US,BBG000BR2B91,Trade extends bearish position in Pfizer,2016-09-29 12:45:06 +0000,http://finance.yahoo.com/news/trade-extends-bearish-position-pfizer-124506106.html,Trade extends bearish position in Pfizer
PFE,PFE:US,BBG000BR2B91,"Why Exelixis, Inc. Got Hammered Today",2016-09-28 22:21:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J6ZVYPUa1gQ/why-exelixis-inc-got-hammered-today-cm686251,Image source Getty Images What happened Exelixis NASDAQ EXEL fell 14 today after abstracts from the European Society for Medical Oncology ESMO meeting were released today So what Data from Exelixis s most important clinical trial the CABOSUN trial testing
PFE,PFE:US,BBG000BR2B91,Opko Health Has Big News on Deck,2016-09-28 20:35:37 +0000,http://www.fool.com/investing/general/2016/09/27/opko-health-has-big-news-on-deck.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Opko Health Has Big News on Deck
PFE,PFE:US,BBG000BR2B91,"Why Oracle, SolarCity, Tesla and Two Other Stocks Are Making Headlines Today",2016-09-28 15:43:35 +0000,http://www.insidermonkey.com/blog/why-oracle-solarcity-tesla-and-two-other-stocks-are-making-headlines-today-477377/,"Why Oracle, SolarCity, Tesla and Two Other Stocks Are Making Headlines Today"
PFE,PFE:US,BBG000BR2B91,Battle of the Pharmaceutical Bigwigs: GlaxoSmithKline vs. Pfizer,2016-09-28 13:29:00 +0000,https://www.thestreet.com/story/13753462/1/battle-of-the-pharmaceutical-bigwigs-glaxosmithkline-vs-pfizer.html?puc=yahoo&cm_ven=YAHOO,Battle of the Pharmaceutical Bigwigs: GlaxoSmithKline vs. Pfizer
PFE,PFE:US,BBG000BR2B91,Pfizer Completes Acquisition of Medivation,2016-09-28 13:09:09 +0000,http://www.publicnow.com/view/988CFFEAB2F1EBC16BB9BE6EE04E2B8CF45D16AB,"[at noodls] - Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Medivation, Inc.(NASDAQ: MDVN). As of the tender offer expiration, 115,574,041 shares of Medivation common stock ..."
PFE,PFE:US,BBG000BR2B91,"Today's Top 5 Stock Picks: Pfizer, Apple, GE, More",2016-09-28 11:51:00 +0000,http://www.barrons.com/articles/todays-top-5-stock-picks-pfizer-apple-ge-more-1475063469?mod=yahoobarrons&ru=yahoo,"Today's Top 5 Stock Picks: Pfizer, Apple, GE, More"
PFE,PFE:US,BBG000BR2B91,Pfizer to Showcase Progress of Broad-Based Oncology Portfolio at European Society for Medical Oncology (ESMO) 2016 Congress,2016-09-28 10:00:00 +0000,http://finance.yahoo.com/news/pfizer-showcase-progress-broad-based-100000242.html,"[Business Wire] - Pfizer Inc. today announced that it will be presenting data from 20 abstracts, including three late-breakers, at the European Society for Medical Oncology 2016 Congress in Copenhagen from October 7-11, 2016."
PFE,PFE:US,BBG000BR2B91,Pfizer Completes Acquisition Of Medivation,2016-09-28 09:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AwY73hG58jQ/pfizer-completes-acquisition-of-medivation-20160928-00372,Pfizer Completes Acquisition Of Medivation
PFE,PFE:US,BBG000BR2B91,Opko Health Has Big News on Deck,2016-09-27 22:22:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dJbDIt2bI8E/opko-health-has-big-news-on-deck-cm685665,Image source Getty Images Results from a phase 3 study of Opko Health s NASDAQ OPK long lasting human growth hormone hGH CTP are expected before the end of the fourth quarter and if results are positive then it could result in a big payday for this burgeoning biotech
PFE,PFE:US,BBG000BR2B91,What Gives With Biosimilars?,2016-09-27 18:22:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8Hr-7dqyX7g/what-gives-with-biosimilars-cm685505,Pfizer Inc s NYSE PFE plans to launch its biosimilar to Johnson amp Johnson s NYSE JNJ multibillion dollar rheumatoid arthritis drug Remicade before the end of 2016 but that s not the only biosimilar on its way that could reshape the drug market Biosimilars
PFE,PFE:US,BBG000BR2B91,Markets In Monotone Mode Despite Post-Debate Rally,2016-09-27 18:12:22 +0000,http://finance.yahoo.com/news/markets-monotone-mode-despite-post-181222962.html,Markets In Monotone Mode Despite Post-Debate Rally
PFE,PFE:US,BBG000BR2B91,Eli Lilly Stock Upgraded: What You Need to Know,2016-09-27 17:21:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ebH7jEgHR-A/eli-lilly-stock-upgraded-what-you-need-to-know-cm685417,Flat across the past 52 weeks and down 3 since the year began Eli Lilly and Co NYSE LLY has had a hard time keeping up with the rest of the stock market lately But according to one analyst that s all about to change and Lilly doesn t even need a blockbuster to prove
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) to Stay Together as a Single Company After All,2016-09-27 16:24:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iSyZA5gjw2w/pfizer-pfe-to-stay-together-as-a-single-company-after-all-cm685345,Drug maker Pfizer Inc PFE has finally decided not to split its two segments Innovative Health IH and Essential Health EH into two publicly traded companies For years the company has been facing pressure from investors and analysts alike to split into two separate companies in
PFE,PFE:US,BBG000BR2B91,What Gives With Biosimilars?,2016-09-27 16:22:00 +0000,http://www.fool.com/investing/2016/09/27/what-gives-with-biosimilars.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What Gives With Biosimilars?
PFE,PFE:US,BBG000BR2B91,Eli Lilly Stock Upgraded: What You Need to Know,2016-09-27 16:06:27 +0000,http://www.fool.com/investing/2016/09/27/eli-lilly-stock-upgraded-what-you-need-to-know.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Eli Lilly Stock Upgraded: What You Need to Know
PFE,PFE:US,BBG000BR2B91,Is This Pfizer's Next Mega-Blockbuster Cancer Drug?,2016-09-27 15:22:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3fWlEKP9lF8/is-this-pfizers-next-mega-blockbuster-cancer-drug-cm685288,Now that Pfizer 160 has NYSE PFE decided to call off its proposed split all eyes are squarely focused on the pharma giant s growth prospects as a single entity The good news is that Pfizer is forecast to post modest single digit top line growth next year and this
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) to Stay Together as a Single Company After All,2016-09-27 14:44:02 +0000,http://finance.yahoo.com/news/pfizer-pfe-stay-together-single-144402448.html,Pfizer (PFE) to Stay Together as a Single Company After All
PFE,PFE:US,BBG000BR2B91,Is This Pfizer's Next Mega-Blockbuster Cancer Drug?,2016-09-27 13:49:00 +0000,http://www.fool.com/investing/2016/09/27/is-this-pfizers-next-mega-blockbuster-drug.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is This Pfizer's Next Mega-Blockbuster Cancer Drug?
PFE,PFE:US,BBG000BR2B91,Pfizer's Latest Immunotherapy Deal Could Be Great News for This Tiny Company,2016-09-27 13:21:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jGdoosCLakE/pfizers-latest-immunotherapy-deal-could-be-great-news-for-this-tiny-company-cm684985,Image source Getty Images Last week Pfizer NYSE PFE agreed to a deal with privately held biopharma company OncoImmune It could be worth up to 250 million in up front and milestone payments if the monoclonal antibody at the center of the licensing agreement succeeds
PFE,PFE:US,BBG000BR2B91,Blog Coverage US Pharma Giant Pfizer to Whole as one Complete Unit,2016-09-27 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-us-pharma-giant-131500938.html,"[Accesswire] - LONDON, UK / ACCESSWIRE / September 27, 2016 / Active Wall St. blog coverage looks at the headline from Pfizer Inc. (NYSE: PFE ) as the company announced on September 26, 2016, that in its own financial ..."
PFE,PFE:US,BBG000BR2B91,Pfizer's Latest Immunotherapy Deal Could Be Great News for This Tiny Company,2016-09-27 12:06:00 +0000,http://www.fool.com/investing/2016/09/27/pfizers-latest-immunotherapy-deal-could-be-great-n.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Pfizer's Latest Immunotherapy Deal Could Be Great News for This Tiny Company
PFE,PFE:US,BBG000BR2B91,Major Pharma Continues to See Rising Tide in Short Interest,2016-09-27 11:40:49 +0000,http://247wallst.com/healthcare-business/2016/09/27/major-pharma-continues-to-see-rising-tide-in-short-interest/,Major Pharma Continues to See Rising Tide in Short Interest
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer Throws Out Plan to Split Into Two Companies,2016-09-27 10:59:22 +0000,http://www.wsj.com/articles/pfizer-wont-pursue-a-split-1474887987?ru=yahoo?mod=yahoo_itp,[$$] Pfizer Throws Out Plan to Split Into Two Companies
PFE,PFE:US,BBG000BR2B91,PRESS DIGEST - Wall Street Journal - Sept 27,2016-09-27 04:59:51 +0000,http://finance.yahoo.com/news/press-digest-wall-street-journal-045951268.html,[Reuters] - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - Chinese billionaire Wang Jianlin is in discussions to buy Dick ...
PFE,PFE:US,BBG000BR2B91,[$$] Overheard,2016-09-27 01:37:49 +0000,http://online.wsj.com/article/SB21530136595012353762404582337932718209826.html?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Pfizer’s decision not to split into two companies came as a disappointment to Wall Street, but investment bankers are likely to get a consolation prize."
PFE,PFE:US,BBG000BR2B91,Presidential Debate a Factor for the Market This Week,2016-09-26 23:23:36 +0000,http://finance.yahoo.com/news/presidential-debate-factor-market-week-232336013.html,Presidential Debate a Factor for the Market This Week
PFE,PFE:US,BBG000BR2B91,"Regeneron, Sanofi Skin Disease Drug Under Priority Review",2016-09-26 22:21:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/831enhIiZ_M/regeneron-sanofi-skin-disease-drug-under-priority-review-cm684876,Regeneron Pharmaceuticals Inc REGN and partner Sanofi SNY received encouraging news after their biologics license application for experimental skin disease treatment dupilumab was accepted for priority review by the FDA The companies are looking to get dupilumab approved for the
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer Won't Split and Neither Should Investors,2016-09-26 22:05:00 +0000,http://www.barrons.com/articles/pfizer-wont-split-and-neither-should-investors-1474927542?mod=yahoobarrons&ru=yahoo,[$$] Pfizer Won't Split and Neither Should Investors
PFE,PFE:US,BBG000BR2B91,How the Dow Jones industrial average fared on Monday,2016-09-26 22:00:02 +0000,http://sg.finance.yahoo.com/news/dow-jones-industrial-average-fared-205803836.html,How the Dow Jones industrial average fared on Monday
PFE,PFE:US,BBG000BR2B91,Business Highlights,2016-09-26 21:57:07 +0000,http://sg.finance.yahoo.com/news/business-highlights-215707425.html,Business Highlights
PFE,PFE:US,BBG000BR2B91,US STOCKS-Wall St drops as investors brace for presidential debate,2016-09-26 21:15:00 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-drops-211500732.html,US STOCKS-Wall St drops as investors brace for presidential debate
PFE,PFE:US,BBG000BR2B91,"Regeneron-Sanofi Could Beat Pfizer, Roche, AstraZeneca On Eczema",2016-09-26 20:32:02 +0000,http://www.investors.com/news/technology/regeneron-sanofi-could-beat-pfizer-roche-astrazeneca-on-eczema/,"Regeneron-Sanofi Could Beat Pfizer, Roche, AstraZeneca On Eczema"
PFE,PFE:US,BBG000BR2B91,Unexpected Twist: Pfizer Scraps Breakup Following Dead Allergen Merger,2016-09-26 20:30:48 +0000,http://www.investors.com/news/technology/unexpected-twist-pfizer-scraps-breakup-following-dead-allergen-merger/,Unexpected Twist: Pfizer Scraps Breakup Following Dead Allergen Merger
PFE,PFE:US,BBG000BR2B91,Pfizer decides against split-up; more deals seen likely,2016-09-26 20:04:54 +0000,http://sg.finance.yahoo.com/news/pfizer-abandons-plan-split-two-121949969.html,Pfizer decides against split-up; more deals seen likely
PFE,PFE:US,BBG000BR2B91,Wall Street Sells Off on Worries Over Clinton-Trump Showdown,2016-09-26 20:03:00 +0000,https://www.thestreet.com/story/13752207/1/wall-street-sells-off-on-worries-over-clinton-trump-showdown.html?puc=yahoo&cm_ven=YAHOO,Wall Street Sells Off on Worries Over Clinton-Trump Showdown
PFE,PFE:US,BBG000BR2B91,"Goldman Sachs, JPMorgan Sink DJIA Monday",2016-09-26 20:01:11 +0000,http://247wallst.com/investing/2016/09/26/goldman-sachs-jpmorgan-sink-djia-monday/,"Goldman Sachs, JPMorgan Sink DJIA Monday"
PFE,PFE:US,BBG000BR2B91,Pfizer decides against split-up; more deals seen likely,2016-09-26 19:39:38 +0000,http://in.finance.yahoo.com/news/pfizer-abandons-plan-split-two-114456195.html,Pfizer decides against split-up; more deals seen likely
PFE,PFE:US,BBG000BR2B91,Drugmaker Pfizer decides not to break up business,2016-09-26 19:12:06 +0000,http://sg.finance.yahoo.com/news/drugmaker-pfizer-decides-not-break-115352233.html,Drugmaker Pfizer decides not to break up business
PFE,PFE:US,BBG000BR2B91,These Investors Are Glad Pfizer Has Decided Not to Split,2016-09-26 18:48:00 +0000,http://blogs.barrons.com/incomeinvesting/2016/09/26/these-investors-are-glad-pfizer-has-decided-not-to-split/?mod=yahoobarrons&ru=yahoo,These Investors Are Glad Pfizer Has Decided Not to Split
PFE,PFE:US,BBG000BR2B91,"For Pfizer, Bigger as One May Be Better Than Smaller With Two",2016-09-26 18:46:05 +0000,http://www.bloomberg.com/news/articles/2016-09-26/for-pfizer-bigger-as-one-may-be-better-than-smaller-with-two?cmpid=yhoo.headline,"For Pfizer, Bigger as One May Be Better Than Smaller With Two"
PFE,PFE:US,BBG000BR2B91,US STOCKS-Wall St falls as investors brace for presidential debate,2016-09-26 18:43:56 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-falls-184356922.html,US STOCKS-Wall St falls as investors brace for presidential debate
PFE,PFE:US,BBG000BR2B91,"One Put, One Call Option To Know About for Pfizer",2016-09-26 16:22:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lyFu_HieGGU/one-put-one-call-option-to-know-about-for-pfizer-cm684628,Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the March 2017 expiration for PFE The put contract
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Stock Declines, Bernstein: More Deals Seem Likely",2016-09-26 15:57:00 +0000,https://www.thestreet.com/story/13751877/1/pfizer-pfe-stock-declines-bernstein-more-deals-seem-likely.html?puc=yahoo&cm_ven=YAHOO,"Pfizer (PFE) Stock Declines, Bernstein: More Deals Seem Likely"
PFE,PFE:US,BBG000BR2B91,Drugmaker Pfizer decides not to break up business,2016-09-26 15:35:29 +0000,http://finance.yahoo.com/news/drugmaker-pfizer-decides-not-break-business-115353624--finance.html,Drugmaker Pfizer decides not to break up business
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer Throws Out Plan to Split Into Two Companies,2016-09-26 15:35:28 +0000,http://www.wsj.com/articles/pfizer-wont-pursue-a-split-1474887987?mod=yahoo_hs,[$$] Pfizer Throws Out Plan to Split Into Two Companies
PFE,PFE:US,BBG000BR2B91,Pfizer: Split Decision,2016-09-26 15:24:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/26/pfizer-split-decision/?mod=yahoobarrons&ru=yahoo,Pfizer: Split Decision
PFE,PFE:US,BBG000BR2B91,Pfizer Can Conquer by Not Dividing,2016-09-26 15:22:36 +0000,http://www.bloomberg.com/gadfly/articles/2016-09-26/pfizer-decides-not-to-split-and-it-s-the-right-call?cmpid=yhoo.headline,Pfizer Can Conquer by Not Dividing
PFE,PFE:US,BBG000BR2B91,"Dow Movers: PFE, AAPL",2016-09-26 15:21:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R7VN2Otpceo/dow-movers-pfe-aapl-cm684430,In early trading on Monday shares of Apple AAPL topped the list of the day s best performing Dow Jones Industrial Average components trading up 0 3 Year to date Apple registers a 7 4 gain And the worst performing Dow component thus far on the day is Pfizer PFE trading
PFE,PFE:US,BBG000BR2B91,US STOCKS-Wall St drops as Pfizer falls; presidential debate eyed,2016-09-26 15:20:21 +0000,http://finance.yahoo.com/news/us-stocks-wall-st-drops-152021261.html,US STOCKS-Wall St drops as Pfizer falls; presidential debate eyed
PFE,PFE:US,BBG000BR2B91,Stocks Fall as Health Care Slumps Ahead of Presidential Debate,2016-09-26 15:20:00 +0000,https://www.thestreet.com/story/13751469/1/stocks-fall-as-clinton-trump-presidential-debate-looms.html?puc=yahoo&cm_ven=YAHOO,Stocks Fall as Health Care Slumps Ahead of Presidential Debate
PFE,PFE:US,BBG000BR2B91,Pfizer Decides Against the Split,2016-09-26 15:10:22 +0000,http://finance.yahoo.com/news/pfizer-decides-against-split-151022598.html,Pfizer Decides Against the Split
PFE,PFE:US,BBG000BR2B91,Pfizer Decides Not to Split Business,2016-09-26 14:52:00 +0000,http://www.thestreet.com/video/13751691/pfizer-decides-not-to-split-business.html?puc=yahoov&cm_ven=YAHOOV,Pfizer Decides Not to Split Business
PFE,PFE:US,BBG000BR2B91,"Why Pfizer, Netflix, Amazon.com, Deutsche Bank, and Cal-Maine Foods Are Trending",2016-09-26 14:28:15 +0000,http://www.insidermonkey.com/blog/why-pfizer-netflix-amazon-com-deutsche-bank-and-cal-maine-foods-are-trending-476855/,"Why Pfizer, Netflix, Amazon.com, Deutsche Bank, and Cal-Maine Foods Are Trending"
PFE,PFE:US,BBG000BR2B91,Can You Guess Which Big Pharma Has Raised Its Drug Prices 5 Times Since June 2014?,2016-09-26 14:24:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RSiQpnt4TAk/can-you-guess-which-big-pharma-has-raised-its-drug-prices-5-times-since-june-2014-cm684421,Image source Getty Images This is probably far from breaking news or in any way shocking but prescription drug prices are soaring If you ve filled a prescription recently you probably don t need that affirmation According to an analysis conducted by healthcare data
PFE,PFE:US,BBG000BR2B91,US shares open lower on profit-taking,2016-09-26 14:08:07 +0000,http://sg.finance.yahoo.com/news/us-shares-open-lower-profit-140807768.html,US shares open lower on profit-taking
PFE,PFE:US,BBG000BR2B91,"US STOCKS-Wall St drops as Pfizer falls, Deutsche Bank drags financials",2016-09-26 14:05:03 +0000,http://finance.yahoo.com/news/us-stocks-wall-st-drops-140503806.html,"US STOCKS-Wall St drops as Pfizer falls, Deutsche Bank drags financials"
PFE,PFE:US,BBG000BR2B91,"Stocks to Watch: Chemtura, Deutsche Bank, Array BioPharma",2016-09-26 13:20:44 +0000,http://blogs.wsj.com/moneybeat/2016/09/26/stocks-to-watch-chemtura-deutsche-bank-array-biopharma/?mod=yahoo_hs,"Stocks to Watch: Chemtura, Deutsche Bank, Array BioPharma"
PFE,PFE:US,BBG000BR2B91,US STOCKS-Wall St set to open lower as presidential debate looms,2016-09-26 13:03:17 +0000,http://finance.yahoo.com/news/us-stocks-wall-st-set-130317479.html,US STOCKS-Wall St set to open lower as presidential debate looms
PFE,PFE:US,BBG000BR2B91,Stock Futures Fall With Clinton-Trump Showdown Looming,2016-09-26 12:23:00 +0000,https://www.thestreet.com/story/13751114/1/stock-futures-fall-with-clinton-trump-showdown-looming.html?puc=yahoo&cm_ven=YAHOO,Stock Futures Fall With Clinton-Trump Showdown Looming
PFE,PFE:US,BBG000BR2B91,Pfizer Throws Out Plan to Split Into Two Companies -- 2nd Update,2016-09-26 11:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xRLl3qmU01g/pfizer-throws-out-plan-to-split-into-two-companies--2nd-update-20160926-00743,Pfizer Throws Out Plan to Split Into Two Companies -- 2nd Update
PFE,PFE:US,BBG000BR2B91,Pfizer Decides Remaining One Company Best Positions Company To Maximize Future Value Creation,2016-09-26 11:09:04 +0000,http://www.publicnow.com/view/B87E7E35E72F5EAD56E1FAB9167F9CEB162DD347,"[at noodls] - Pfizer Inc. (NYSE:PFE) announced that, after an extensive evaluation, the company's Board of Directors and Executive Leadership Team have determined the company is best positioned to maximize future shareholder ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Throws Out Plan to Split Into Two Companies,2016-09-26 10:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5guaYSe2st0/pfizer-throws-out-plan-to-split-into-two-companies-20160926-00758,Pfizer Throws Out Plan to Split Into Two Companies
PFE,PFE:US,BBG000BR2B91,Pfizer Won't Pursue a Split of Established and New Medical Lines,2016-09-26 10:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S-8KpAlvaEs/pfizer-wont-pursue-a-split-of-established-and-new-medical-lines-20160926-00683,Pfizer Won't Pursue a Split of Established and New Medical Lines
PFE,PFE:US,BBG000BR2B91,Pfizer Won''t Pursue a Split of Established and New Medical Lines -- Update,2016-09-26 07:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vorw_GplH_8/pfizer-wont-pursue-a-split-of-established-and-new-medical-lines--update-20160926-00308,Pfizer Won''t Pursue a Split of Established and New Medical Lines -- Update
PFE,PFE:US,BBG000BR2B91,Pfizer Won't Pursue a Split,2016-09-26 07:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7yC_zdbQzCU/pfizer-wont-pursue-a-split-20160926-00272,Pfizer Won't Pursue a Split
PFE,PFE:US,BBG000BR2B91,"Pfizer Says Not To Pursue Splitting Innovative Health, Essential Health Into Two",2016-09-26 06:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y4iw5EPOw44/pfizer-says-not-to-pursue-splitting-innovative-health-essential-health-into-two-20160926-00199,"Pfizer Says Not To Pursue Splitting Innovative Health, Essential Health Into Two"
PFE,PFE:US,BBG000BR2B91,Apple iPhone Calling Big Pharma: We Can Help You Develop Better Drugs,2016-09-25 19:20:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OPiBdXoDZYc/apple-iphone-calling-big-pharma-we-can-help-you-develop-better-drugs-cm684253,Image source Getty Images Apple s NASDAQ AAPL iPhone just scored its first big drug deal Okay I m kidding but not really Through an app called PARADE short for Pa tient R heumatoid A rthritis D ata from the R e al World global
PFE,PFE:US,BBG000BR2B91,“Don’t fire until you see the whites of their eyes”,2016-09-25 17:04:26 +0000,http://finance.yahoo.com/tumblr/blog-dont-fire-until-you-see-the-whites-of-their-170432457.html,“Don’t fire until you see the whites of their eyes”
PFE,PFE:US,BBG000BR2B91,Generics or Specialty: Which Mylan Segment Is Growing Fastest?,2016-09-23 23:04:05 +0000,http://marketrealist.com/2016/09/generics-or-specialty-which-mylan-segment-is-growing-fastest/?utm_source=yahoo&utm_medium=feed,Generics or Specialty: Which Mylan Segment Is Growing Fastest?
PFE,PFE:US,BBG000BR2B91,The 5 Highest Dividend Payout Ratios on the Dow,2016-09-23 22:21:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CGrr9TWWxq8/the-5-highest-dividend-payout-ratios-on-the-dow-cm684078,Image source Getty Images For income investors there s a certain Goldilocks quality to judging a dividend payout ratio If the number is too small say 10 it implies that the company doesn t prioritize returning cash to shareholders through steadily increasing payouts But a
PFE,PFE:US,BBG000BR2B91,Teva’s Valuation Multiples Compared to Other Generic Drug Players,2016-09-23 21:25:53 +0000,http://marketrealist.com/2016/09/teva-pharmaceuticals-valuation-multiples-compare-generic-pharmaceutical-players/?utm_source=yahoo&utm_medium=feed,Teva’s Valuation Multiples Compared to Other Generic Drug Players
PFE,PFE:US,BBG000BR2B91,Dow 30 Stock Roundup: Microsoft Rewards Shareholders; GE Wins $1.9B Nuclear Power Contract,2016-09-23 20:20:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7Okj_skKjTc/dow-30-stock-roundup-microsoft-rewards-shareholders-ge-wins-19b-nuclear-power-contract-cm684014,The Dow experienced a strong week of gains buoyed by the Fed s decision to leave rates unchanged in September Japan s central bank s decision to control the yield curve also provided a flip to stocks Additionally gains arising from developments related to major healthcare deals also
PFE,PFE:US,BBG000BR2B91,The 5 Highest Dividend Payout Ratios on the Dow,2016-09-23 20:17:00 +0000,http://www.fool.com/investing/2016/09/23/the-highest-dividend-payout-ratios-on-the-dow.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,The 5 Highest Dividend Payout Ratios on the Dow
PFE,PFE:US,BBG000BR2B91,Axovant Confidence 'Not Swayed' After Rival Alzheimer's Drug Fails,2016-09-23 20:07:24 +0000,http://www.investors.com/news/technology/axovant-confidence-not-swayed-after-rival-alzheimers-drug-fails/,Axovant Confidence 'Not Swayed' After Rival Alzheimer's Drug Fails
PFE,PFE:US,BBG000BR2B91,Dow 30 Stock Roundup: Microsoft Rewards Shareholders; GE Wins $1.9B Nuclear Power Contract,2016-09-23 18:12:06 +0000,http://finance.yahoo.com/news/dow-30-stock-roundup-microsoft-181206787.html,Dow 30 Stock Roundup: Microsoft Rewards Shareholders; GE Wins $1.9B Nuclear Power Contract
PFE,PFE:US,BBG000BR2B91,Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study,2016-09-23 16:25:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xvaHY886C0Y/novartis-nvs-zykadia-positive-in-phase-iii-ascend-4-study-cm683849,Novartis AG NVS announced positive top line data from a phase III study ASCEND 4 on its oncology drug Zykadia for the treatment of patients with advanced anaplastic lymphoma kinase positive ALK non small cell lung cancer NSCLC We expect investors to react positively to the news
PFE,PFE:US,BBG000BR2B91,Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study,2016-09-23 14:01:02 +0000,http://finance.yahoo.com/news/novartis-nvs-zykadia-positive-phase-140102801.html,Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
PFE,PFE:US,BBG000BR2B91,[video]Takeover Chatter Around Clovis May Be Overdone,2016-09-23 13:28:00 +0000,https://www.thestreet.com/story/13750094/1/takeover-chatter-around-clovis-may-be-overdone.html?puc=yahoo&cm_ven=YAHOO,[video]Takeover Chatter Around Clovis May Be Overdone
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. Johnson & Johnson,2016-09-23 13:22:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0q7qOCFQQ-A/better-buy-pfizer-inc-vs-johnson-johnson-cm683628,The pharmaceutical industry is big business for many companies and the giants of the industry have found ways to make huge profits Among the top participants in big pharma are Pfizer NYSE PFE and Johnson amp Johnson NYSE JNJ and although J amp J s business has a
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Expiration of HSR Waiting Period For Proposed Acquisition of Medivation,2016-09-23 12:42:05 +0000,http://www.publicnow.com/view/B650E6698688837E0CC16BC1BB931263226EC8A8,"[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended has expired with respect to Pfizer's ..."
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. Johnson & Johnson,2016-09-23 12:03:06 +0000,http://www.fool.com/investing/2016/09/23/better-buy-pfizer-inc-vs-johnson-johnson.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Pfizer Inc. vs. Johnson & Johnson
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO",2016-09-23 12:00:12 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-allergan-acquisitions-120012919.html,"Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO"
PFE,PFE:US,BBG000BR2B91,"UPDATE 1-Novartis's Zykadia gets positive results, faces Roche pressure",2016-09-23 11:29:56 +0000,http://finance.yahoo.com/news/novartiss-zykadia-gets-positive-results-111251277.html,"[Reuters] - Novartis's Zykadia drug performed well against a rare form of lung cancer, the Swiss company said on Friday, citing a study it hopes will help it win expanded regulatory approval for the use of the drug. Novartis released results of a phase III clinical trial of Zykadia, or ceritinib, on previously untreated patients with advanced anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer. Patients treated with Zykadia showed a significant improvement in their chances of surviving without the cancer spreading compared with standard chemotherapy, the firm said."
PFE,PFE:US,BBG000BR2B91,Pfizer Gets U.S. Regulatory Approval For Medivation Takeover,2016-09-23 08:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GdUpcBOs8tM/pfizer-gets-us-regulatory-approval-for-medivation-takeover-20160923-00042,Pfizer Gets U.S. Regulatory Approval For Medivation Takeover
PFE,PFE:US,BBG000BR2B91,"Why Axovant Sciences Ltd (AXON), Jabil Circuit, Inc. (JBL) and Virgin America Inc (VA) Are 3 of Today’s Worst Stocks",2016-09-22 23:21:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/U7c8pbvheRQ/why-axovant-sciences-ltd-axon-jabil-circuit-inc-jbl-and-virgin-america-inc-va-are-3-of-todays-worst-stocks-cm683513,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Following through on yesterday s decision from the Federal Reserve to not raise interest rates and despite a disappointing existing home sales figure for August stocks moved
PFE,PFE:US,BBG000BR2B91,"Market Close Report: Historical high reached as NASDAQ Composite Index closes at 5,339.52.",2016-09-22 21:59:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9JfY8gIvjbI/market-close-report-historical-high-reached-as-nasdaq-composite-index-closes-at-533952-cm683457,Thursday s session closes with the NASDAQ Composite Index reaching a historical high The index closed at 5 339 52 up 44 34 for the day The index first reached the 5000 mark on 09 21 2016 The total shares traded for the NASDAQ was over 1 87 billion Thursday s session closes with the
PFE,PFE:US,BBG000BR2B91,Lundbeck says Alzheimer's late-stage study fails,2016-09-22 17:43:49 +0000,http://finance.yahoo.com/news/lundbeck-says-alzheimers-stage-study-174349101.html,[Reuters] - Danish drugmaker H Lundbeck A/S said its late-stage study testing an experimental drug to treat mild to moderate Alzheimer's disease failed. The company said both doses of its drug idalopirdine failed to improve symptoms of the disease measured on a scale called ADAS-cog in the study named Starshine. Lundbeck added that idalopirdine was safe and well-tolerated.
PFE,PFE:US,BBG000BR2B91,Pfizer Declares 30-Cent Fourth-Quarter 2016 Dividend,2016-09-22 16:41:04 +0000,http://www.publicnow.com/view/610B9516C5FD10C201000819C8A3A12FE89AF38D,"[at noodls] - The board of directors of Pfizer Inc. today declared a 30-cent fourth-quarter 2016 dividend on the company's common stock, payable December 1, 2016, to shareholders of record at the close of business on ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public To View And Listen To Webcast Of November 1 Conference Call With Analysts,2016-09-22 16:41:04 +0000,http://www.publicnow.com/view/B5705A63426143DFF3B0D7CB420BAA53BD737A0E,"[at noodls] - Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, November 1, 2016. The purpose of the call is ..."
PFE,PFE:US,BBG000BR2B91,"Dow Movers: V, UTX",2016-09-22 16:22:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uOb8keBEH74/dow-movers-v-utx-cm683229,In early trading on Thursday shares of United Technologies topped the list of the day s best performing Dow Jones Industrial Average components trading up 1 2 Year to date United Technologies registers a 7 4 gain And the worst performing Dow component thus far on the day is
PFE,PFE:US,BBG000BR2B91,Pfizer Declares 30-Cent Fourth-Quarter 2016 Dividend,2016-09-22 15:56:00 +0000,http://finance.yahoo.com/news/pfizer-declares-30-cent-fourth-155600506.html,"[Business Wire] - The board of directors of Pfizer Inc. today declared a 30-cent fourth-quarter 2016 dividend on the company’s common stock, payable December 1, 2016, to shareholders of record at the close of business on November 11, 2016."
PFE,PFE:US,BBG000BR2B91,"'Blockbuster Franchises' Spark M&A Fever For Sarepta, Ariad, Biotechs",2016-09-21 20:32:58 +0000,http://www.investors.com/news/technology/blockbuster-franchises-spark-ma-fever-for-sarepta-ariad-biotechs/,"'Blockbuster Franchises' Spark M&A Fever For Sarepta, Ariad, Biotechs"
PFE,PFE:US,BBG000BR2B91,Sanofi Sues Merck Over Patent Infringement,2016-09-21 17:20:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FmXlYyXbWIk/sanofi-sues-merck-over-patent-infringement-cm682487,French pharmaceutical giant Sanofi SA SNY filed a lawsuit against Merck amp Co MRK for supposed patent infringements last Friday The company has taken action in an attempt to prevent its American rival from releasing a competing version of its best selling insulin
PFE,PFE:US,BBG000BR2B91,How Procysbi Fits into Horizon’s Existing Orphan Drug Portfolio,2016-09-21 14:04:59 +0000,http://marketrealist.com/2016/09/how-procysbi-fits-into-horizons-existing-orphan-drug-portfolio/?utm_source=yahoo&utm_medium=feed,How Procysbi Fits into Horizon’s Existing Orphan Drug Portfolio
PFE,PFE:US,BBG000BR2B91,This ETF bets that companies with female leadership will outperform,2016-09-20 21:09:43 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=3F4C97E2-7C36-11E6-B9F7-409A1DD77891&siteid=yhoof2,This ETF bets that companies with female leadership will outperform
PFE,PFE:US,BBG000BR2B91,This Hated Pharma Stock Has A Bright Future,2016-09-20 17:30:00 +0000,http://finance.yahoo.com/news/drug-company-could-cure-hiv-173000664.html,This Hated Pharma Stock Has A Bright Future
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public To View And Listen To Webcast Of November 1 Conference Call With Analysts,2016-09-20 14:00:00 +0000,http://finance.yahoo.com/news/pfizer-invites-public-view-listen-140000044.html,"[Business Wire] - Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, November 1, 2016. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Third Quarter 2016 Performance Report, to be issued that morning."
PFE,PFE:US,BBG000BR2B91,5 Dividend Paying Stocks Deutsche Bank Likes If Trump Wins in November,2016-09-20 13:50:16 +0000,http://247wallst.com/investing/2016/09/20/5-dividend-paying-stocks-deutsche-bank-likes-if-trump-wins-in-november/,5 Dividend Paying Stocks Deutsche Bank Likes If Trump Wins in November
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Breast Cancer Drug Ibrance Wins CHMP Backing,2016-09-20 13:24:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mSpbTun2iss/pfizer-pfe-breast-cancer-drug-ibrance-wins-chmp-backing-cm681729,Pfizer Inc PFE came up with a couple of announcements related to its breast cancer drug Ibrance and PF 06438179 a biosimilar version of Johnson amp Johnson s JNJ blockbuster drug Remicade infliximab Ibrance a Step Closer to EU Approval Pfizer announced that the European
PFE,PFE:US,BBG000BR2B91,[$$] Big pharma targets drug-resistant superbugs,2016-09-20 12:08:02 +0000,"http://www.ft.com/cms/s/4289275e-7ec0-11e6-bc52-0c7211ef3198,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Big pharmaceutical companies have signed an agreement to tackle the spread of superbugs as the UN prepares to discuss the growing problem of antimicrobial resistance. Drugmakers including Johnson & Johnson, ..."
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Breast Cancer Drug Ibrance Wins CHMP Backing,2016-09-20 10:50:10 +0000,http://finance.yahoo.com/news/pfizer-pfe-breast-cancer-drug-105010824.html,Pfizer (PFE) Breast Cancer Drug Ibrance Wins CHMP Backing
PFE,PFE:US,BBG000BR2B91,Stocks Trade Lower Monday With Global Central Bank Uncertainty,2016-09-19 23:26:08 +0000,http://finance.yahoo.com/news/stocks-trade-lower-monday-global-232608263.html,Stocks Trade Lower Monday With Global Central Bank Uncertainty
PFE,PFE:US,BBG000BR2B91,How To Predict The Next Sarepta (FDA Approval Stock) And Win Big,2016-09-19 22:56:00 +0000,http://www.forbes.com/sites/bryanrich/2016/09/19/how-to-predict-the-next-sarepta-fda-approval-stock-and-win-big/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,How To Predict The Next Sarepta (FDA Approval Stock) And Win Big
PFE,PFE:US,BBG000BR2B91,A Breakdown Here In This Sector Would Not Be Healthy,2016-09-19 22:50:37 +0000,http://finance.yahoo.com/tumblr/blog-a-breakdown-here-in-this-sector-would-not-be-225043635.html,A Breakdown Here In This Sector Would Not Be Healthy
PFE,PFE:US,BBG000BR2B91,Pfizer: Hospira Is Future; Xtandi Is Today's Meal,2016-09-19 19:57:45 +0000,http://finance.yahoo.com/news/pfizer-hospira-future-xtandi-todays-195745343.html,Pfizer: Hospira Is Future; Xtandi Is Today's Meal
PFE,PFE:US,BBG000BR2B91,"Pfizer’s on a Roll, Netflix Earns the Ire of Fox, Plus 2 Other Trending Stories",2016-09-19 13:25:17 +0000,http://www.insidermonkey.com/blog/pfizers-on-a-roll-netflix-earns-the-ire-of-fox-plus-2-other-trending-stories-475389/,"Pfizer’s on a Roll, Netflix Earns the Ire of Fox, Plus 2 Other Trending Stories"
PFE,PFE:US,BBG000BR2B91,"GSK cuts vaccine price for refugees, bowing to pressure",2016-09-19 12:39:08 +0000,http://sg.finance.yahoo.com/news/gsk-cuts-vaccine-price-refugees-113811247.html,"GSK cuts vaccine price for refugees, bowing to pressure"
PFE,PFE:US,BBG000BR2B91,"GSK cuts vaccine price for refugees, bowing to pressure",2016-09-19 11:34:05 +0000,http://uk.finance.yahoo.com/news/gsk-cuts-vaccine-price-refugees-113405124.html,"GSK cuts vaccine price for refugees, bowing to pressure"
PFE,PFE:US,BBG000BR2B91,Sanofi Files Suit Against Merck,2016-09-19 08:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/99WoS74zfzU/sanofi-files-suit-against-merck-20160919-00313,Sanofi Files Suit Against Merck
PFE,PFE:US,BBG000BR2B91,GE brings off-the-shelf biotech drug factories to Ireland,2016-09-18 23:12:56 +0000,http://sg.finance.yahoo.com/news/ge-brings-off-shelf-biotech-231256784.html,GE brings off-the-shelf biotech drug factories to Ireland
PFE,PFE:US,BBG000BR2B91,"GoPro, Oracle, Pfizer, and More: Traders Can’t Stop Watching These Stocks This Weekend",2016-09-18 16:38:49 +0000,http://www.insidermonkey.com/blog/gopro-oracle-pfizer-and-more-traders-cant-stop-watching-these-stocks-this-weekend-475289/,"GoPro, Oracle, Pfizer, and More: Traders Can’t Stop Watching These Stocks This Weekend"
PFE,PFE:US,BBG000BR2B91,Is This New Market the Biggest Investment Idea of the Decade?,2016-09-17 17:20:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o9nhQMEtSno/is-this-new-market-the-biggest-investment-idea-of-the-decade-cm680951,Image source Stockmonkeys com via Flickr Over 100 billion in annual sales for top selling biologic medicines will soon be up for grabs and that s leading to a gold rush to develop biosimilars With the biosimilar market poised to eclipse 20 billion as early as 2020 you might
PFE,PFE:US,BBG000BR2B91,Is This New Market the Biggest Investment Idea of the Decade?,2016-09-17 15:41:06 +0000,http://www.fool.com/investing/2016/09/17/is-this-new-market-the-biggest-investment-idea-of.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is This New Market the Biggest Investment Idea of the Decade?
PFE,PFE:US,BBG000BR2B91,"Forget Novavax, Buy These 4 Biotech Stocks Instead",2016-09-16 22:18:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J58VFJ7gzxU/forget-novavax-buy-these-4-biotech-stocks-instead-cm680788,Shares of Novavax Inc NVAX plunged around 82 in pre market trading on Friday after the biopharmaceutical company announced a day before that its key vaccine candidate unexpectedly failed to meet the primary endpoint in a phase III trial What Went Wrong at Novavax Top line
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Positive Top-Line Results from REFLECTIONS B537-02 Study for PF-06438179 (infliximab-Pfizer) a Potential Biosimilar to Remicade® (infliximab),2016-09-16 22:08:04 +0000,http://www.publicnow.com/view/BD57695DC0C71FC168B9989119C1212CDA034DC4,"[at noodls] - Pfizer Inc. (NYSE:PFE) announced the confirmatory study (REFLECTIONS B537-02) evaluating the efficacy, safety, and immunogenicity of PF-06438179 (infliximab-Pfizer) compared to Remicade® (infliximab) met ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Positive Top-Line Results from REFLECTIONS B537-02 Study for PF-06438179 (infliximab-Pfizer) a Potential Biosimilar to Remicade® (infliximab),2016-09-16 21:24:00 +0000,http://finance.yahoo.com/news/pfizer-announces-positive-top-line-212400946.html,"[Business Wire] - Pfizer Inc. announced the confirmatory study evaluating the efficacy, safety, and immunogenicity of PF-06438179 compared to Remicade® met its primary endpoint."
PFE,PFE:US,BBG000BR2B91,VLUE: Isolate the Value Factor With This ETF,2016-09-16 20:18:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/k20iwO_j6ts/vlue-isolate-the-value-factor-with-this-etf-cm679373,For the first time in several years the value factor is being embraced by advisors and investors That is prompting renewed attention on and inflows to exchange traded funds emphasizing this widely followed factor including the iShares MSCI USA Value Factor ETF NYSEArca
PFE,PFE:US,BBG000BR2B91,"Kahn Brothers Trims Pfizer, Citigroup",2016-09-16 18:08:10 +0000,http://finance.yahoo.com/news/kahn-brothers-trims-pfizer-citigroup-180810045.html,"Kahn Brothers Trims Pfizer, Citigroup"
PFE,PFE:US,BBG000BR2B91,"Inside the FDA: Why The Pfizer, Inc. (PFE) Boxed Warning On Chantix Is Unlikely To Be Removed",2016-09-16 17:28:15 +0000,http://www.insidermonkey.com/blog/inside-the-fda-why-the-pfizer-inc-pfe-boxed-warning-on-chantix-is-unlikely-to-be-removed-475130/,"Inside the FDA: Why The Pfizer, Inc. (PFE) Boxed Warning On Chantix Is Unlikely To Be Removed"
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. May Get FDA Ok to Remove ‘Black Box’ Warning From Chantix,2016-09-16 17:18:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OcPb1ManIdY/pfizer-inc-may-get-fda-ok-to-remove-black-box-warning-from-chantix-cm680280,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Pfizer Inc NYSE PFE may garner approval to remove its black box warning from anti smoking product Chantix The Food and Drug Administration
PFE,PFE:US,BBG000BR2B91,Merck/Pfizer Diabetes Drug Ertugliflozin Positive in Phase III,2016-09-16 15:22:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gycWqkS0h2E/merckpfizer-diabetes-drug-ertugliflozin-positive-in-phase-iii-cm680519,Merck amp Co Inc MRK in partnership with Pfizer Inc PFE announced that their diabetes pipeline candidate ertugliflozin MK 8835 has met the primary endpoint in a phase III study The double blind randomized placebo controlled study VERTIS SITA2 showed that ertugliflozin
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Acquisitions & Deals Pick Up Pace, Aerie Up on Positive Data",2016-09-16 15:22:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TqdC7YLSoCo/pharma-stock-roundup-acquisitions-deals-pick-up-pace-aerie-up-on-positive-data-cm680517,Acquisitions as well as collaborations are picking up pace with Bayer BAYRY finally signing a merger agreement with Monsanto and Allergan AGN announcing its decision to acquire Vitae Moreover companies like Teva TEVA and Sanofi SNY announced collaborations that involve the use of
PFE,PFE:US,BBG000BR2B91,CEOs say consumers are less confident,2016-09-16 15:21:18 +0000,http://finance.yahoo.com/tumblr/blog-ceos-say-consumers-are-less-confident-152125777.html,CEOs say consumers are less confident
PFE,PFE:US,BBG000BR2B91,Blog Coverage Aerie Pharma Glaucoma Drug Roclatan Surpasses Primary Goals at End Phase III Trials,2016-09-16 13:19:25 +0000,http://news.investornetwork.com/2016/09/16/blog-coverage-aerie-pharma-glaucoma-drug-roclatan-surpasses-primary-goals-at-end-phase-iii-trials/?1=1&1474031965,Blog Coverage Aerie Pharma Glaucoma Drug Roclatan Surpasses Primary Goals at End Phase III Trials
PFE,PFE:US,BBG000BR2B91,EMA panel recommends nod for Pfizer's breast cancer drug,2016-09-16 13:10:46 +0000,http://finance.yahoo.com/news/ema-panel-recommends-nod-pfizers-131046234.html,"[Reuters] - U.S. drugmaker Pfizer Inc's breast cancer drug, Ibrance, should be given marketing approval, an advisory committee at the European Medicines Agency recommended. The CHMP's opinion will now be reviewed by the EMA, Pfizer said in a statement on Friday. Novartis is also testing an experimental breast cancer pill which belongs to same drug class as Pfizer's Ibrance."
PFE,PFE:US,BBG000BR2B91,"Pharma Stock Roundup: Acquisitions & Deals Pick Up Pace, Aerie Up on Positive Data",2016-09-16 13:04:01 +0000,http://finance.yahoo.com/news/pharma-stock-roundup-acquisitions-deals-130401877.html,"Pharma Stock Roundup: Acquisitions & Deals Pick Up Pace, Aerie Up on Positive Data"
PFE,PFE:US,BBG000BR2B91,Merck/Pfizer Diabetes Drug Ertugliflozin Positive in Phase III,2016-09-16 13:03:01 +0000,http://finance.yahoo.com/news/merck-pfizer-diabetes-drug-ertugliflozin-130301757.html,Merck/Pfizer Diabetes Drug Ertugliflozin Positive in Phase III
PFE,PFE:US,BBG000BR2B91,The Top 10 S&P 500 Dividend Stocks to Buy Now,2016-09-16 12:50:01 +0000,http://portal.kiplinger.com/article/investing/T018-C000-S015-the-top-10-s-p-500-dividend-stocks-to-buy-now.html?rid=SYN-yahoo&rpageid=15491,The Top 10 S&P 500 Dividend Stocks to Buy Now
PFE,PFE:US,BBG000BR2B91,Pfizer Receives Positive CHMP Opinion For IBRANCE® (palbociclib) In Combination With Endocrine Therapy For The Treatment Of HR+/HER2- Metastatic Breast Cancer In Europe,2016-09-16 11:58:03 +0000,http://www.publicnow.com/view/222BB847061FE986299D90DCC00581CCB87AEBE4,[at noodls] - Pfizer Inc. (NYSE:PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending that IBRANCE (palbociclib) ...
PFE,PFE:US,BBG000BR2B91,Pfizer Receives Positive CHMP Opinion For IBRANCE,2016-09-16 07:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9Z4awjOhwuE/pfizer-receives-positive-chmp-opinion-for-ibrance-20160916-00171,Pfizer Receives Positive CHMP Opinion For IBRANCE
PFE,PFE:US,BBG000BR2B91,"ARLZ Gets FDA Nod, ACRX Scores Hat Trick, OTIC On Watch, No Relief For NVAX",2016-09-16 02:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_-b5Ef8NgOE/arlz-gets-fda-nod-acrx-scores-hat-trick-otic-on-watch-no-relief-for-nvax-20160916-00036,"ARLZ Gets FDA Nod, ACRX Scores Hat Trick, OTIC On Watch, No Relief For NVAX"
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Sep 15, 2016 :  QQQ, MSFT, AAPL, PFE, YHOO, ACAS, FTR, ORCL, FCX, BAC, GE, OXY",2016-09-15 21:06:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/evuZwJrIZGw/after-hours-most-active-for-sep-15-2016-qqq-msft-aapl-pfe-yhoo-acas-ftr-orcl-fcx-bac-ge-oxy-cm680260,The NASDAQ 100 After Hours Indicator is down 82 to 4 819 08 The total After hours volume is currently 26 048 383 shares traded The following are the most active stocks for the after hours session PowerShares QQQ Trust Series 1 QQQ is 0 11 at 117 53 with 2 131
PFE,PFE:US,BBG000BR2B91,"Merck (MRK) Stock Higher, Joint Pfizer Diabetes Drug Meets Primary Endpoint",2016-09-15 19:39:00 +0000,https://www.thestreet.com/story/13742038/1/merck-mrk-stock-higher-joint-pfizer-diabetes-drug-meets-primary-endpoint.html?puc=yahoo&cm_ven=YAHOO,"Merck (MRK) Stock Higher, Joint Pfizer Diabetes Drug Meets Primary Endpoint"
PFE,PFE:US,BBG000BR2B91,FDA Panel Suggests Removing Warning from Pfizer's Chantix,2016-09-15 17:16:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rFEzTKSezbw/fda-panel-suggests-removing-warning-from-pfizers-chantix-cm680084,Pfizer Inc PFE announced that the FDA advisory panels have recommended removing a serious warning about neuropsychiatric side effects on the label of its smoking cessation therapy Chantix We remind investors that Chantix s label includes a boxed warning regarding serious
PFE,PFE:US,BBG000BR2B91,"Noteworthy ETF Inflows: IWD, JPM, PFE, MRK",2016-09-15 16:16:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TNIK3LihfhU/noteworthy-etf-inflows-iwd-jpm-pfe-mrk-cm680006,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the iShares Russell 1000 Value ETF Symbol IWD where we have detected an approximate 327 4 million dollar inflow that s a 1 1 increase week over week in
PFE,PFE:US,BBG000BR2B91,FDA Panel Suggests Removing Warning from Pfizer's Chantix,2016-09-15 15:32:03 +0000,http://finance.yahoo.com/news/fda-panel-suggests-removing-warning-153203496.html,FDA Panel Suggests Removing Warning from Pfizer's Chantix
PFE,PFE:US,BBG000BR2B91,FDA AdCom Votes on Pfizer and Spectrum Drugs - What Next?,2016-09-15 15:20:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YZF00y_bXfc/fda-adcom-votes-on-pfizer-and-spectrum-drugs-what-next-cm679963,Yesterday a couple of drugs came up before FDA advisory panels for review large cap pharma Pfizer Inc s PFE Chantix and biotech company Spectrum Pharmaceuticals Inc s SPPI Qapzola Chantix amp Qapzola under Review Data on Pfizer s smoking cessation product Chantix from
PFE,PFE:US,BBG000BR2B91,Aerie (AERI) Stock Up on Positive Phase III Data on Roclatan,2016-09-15 15:20:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PJgwXxyEzYY/aerie-aeri-stock-up-on-positive-phase-iii-data-on-roclatan-cm679959,Aerie Pharmaceuticals Inc s AERI shares gained 7 5 after the company announced successful 90 day primary efficacy data from the first phase III registration study Mercury 1 on Roclatan Roclatan is a fixed dose combination of Aerie s lead candidate Rhopressa netarsudil
PFE,PFE:US,BBG000BR2B91,"Dow Movers: PFE, AAPL",2016-09-15 15:17:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FRpmHL4b9Sg/dow-movers-pfe-aapl-cm679925,In early trading on Thursday shares of Apple AAPL topped the list of the day s best performing Dow Jones Industrial Average components trading up 2 5 Year to date Apple registers a 8 9 gain And the worst performing Dow component thus far on the day is Pfizer PFE trading
PFE,PFE:US,BBG000BR2B91,Merck and Pfizer Announce Investigational Ertugliflozin Met Primary Endpoint of A1C Reduction When Added to Sitagliptin and Metformin in People with Type 2 Diabetes,2016-09-15 14:18:09 +0000,http://www.publicnow.com/view/9C6399AB40C0495EC08E73725BD3005D29AA43EC,"[at noodls] - Merck (NYSE: MRK), known as MSD outside the United States and Canada, in partnership with Pfizer Inc. (NYSE: PFE) today announced that a Phase 3 study (VERTIS SITA2) of ertugliflozin, an investigational ..."
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. AbbVie Inc.,2016-09-15 14:17:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3xra5rHGxZs/better-buy-pfizer-inc-vs-abbvie-inc-cm679884,IMAGE SOURCE GETTY IMAGES Big pharma is on a roll Several of the largest drugmakers stocks are up by double digit percentages over the past six months Count AbbVie NYSE ABBV and Pfizer NYSE PFE among big pharma s best performers in 2016 AbbVie s shares are up
PFE,PFE:US,BBG000BR2B91,Better Buy: Pfizer Inc. vs. AbbVie Inc.,2016-09-15 13:13:22 +0000,http://www.fool.com/investing/2016/09/15/better-buy-pfizer-inc-vs-abbvie.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Pfizer Inc. vs. AbbVie Inc.
PFE,PFE:US,BBG000BR2B91,Pfizer's (PFE) Chantix Warning Could Be Removed After FDA Recommendation,2016-09-15 13:07:00 +0000,https://www.thestreet.com/story/13741168/1/pfizer-s-pfe-chantix-warning-could-be-removed-after-fda-recommendation.html?puc=yahoo&cm_ven=YAHOO,Pfizer's (PFE) Chantix Warning Could Be Removed After FDA Recommendation
PFE,PFE:US,BBG000BR2B91,FDA AdCom Votes on Pfizer and Spectrum Drugs - What Next?,2016-09-15 12:56:12 +0000,http://finance.yahoo.com/news/fda-adcom-votes-pfizer-spectrum-125612589.html,FDA AdCom Votes on Pfizer and Spectrum Drugs - What Next?
PFE,PFE:US,BBG000BR2B91,Merck and Pfizer's diabetes treatment meets primary endpoint of late-stage trial,2016-09-15 12:41:12 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=FA703705-7B8F-4E68-A7BF-674DDA5AB763&siteid=yhoof2,Merck and Pfizer's diabetes treatment meets primary endpoint of late-stage trial
PFE,PFE:US,BBG000BR2B91,PARP Wars: Biotech M&A's New Hope,2016-09-15 12:00:37 +0000,http://www.bloomberg.com/gadfly/articles/2016-09-15/parp-inhibitors-biotech-m-a-s-new-hope?cmpid=yhoo.headline,PARP Wars: Biotech M&A's New Hope
PFE,PFE:US,BBG000BR2B91,"Wells Fargo, Twitter, Pfizer and More: Why Investors Are Yammering About These 5 Stocks",2016-09-15 11:58:26 +0000,http://www.insidermonkey.com/blog/wells-fargo-twitter-pfizer-and-more-why-investors-are-yammering-about-these-5-stocks-474717/,"Wells Fargo, Twitter, Pfizer and More: Why Investors Are Yammering About These 5 Stocks"
PFE,PFE:US,BBG000BR2B91,"Merck, Pfizer Diabetes Therapy Meets Late-Stage Study Goals",2016-09-15 09:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jlxwqDDukUE/merck-pfizer-diabetes-therapy-meets-latestage-study-goals-20160915-00616,"Merck, Pfizer Diabetes Therapy Meets Late-Stage Study Goals"
PFE,PFE:US,BBG000BR2B91,OncoImmune Reaches Option And License Agreement With Pfizer,2016-09-15 09:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S1N-MhRHIco/oncoimmune-reaches-option-and-license-agreement-with-pfizer-20160915-00560,OncoImmune Reaches Option And License Agreement With Pfizer
PFE,PFE:US,BBG000BR2B91,"Merck, Pfizer Announce Ertugliflozin Meets Primary Endpoint In Phase 3 Study",2016-09-15 08:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JpZlIs6Kl-w/merck-pfizer-announce-ertugliflozin-meets-primary-endpoint-in-phase-3-study-20160915-00465,"Merck, Pfizer Announce Ertugliflozin Meets Primary Endpoint In Phase 3 Study"
PFE,PFE:US,BBG000BR2B91,"Data Boosts AERI, FDA Panel Snubs SPPI, D-Day For ACRX Today, VTAE Abuzz",2016-09-15 02:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TKeSj7mxQ1A/data-boosts-aeri-fda-panel-snubs-sppi-dday-for-acrx-today-vtae-abuzz-20160915-00082,"Data Boosts AERI, FDA Panel Snubs SPPI, D-Day For ACRX Today, VTAE Abuzz"
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer Moves Closer to FDA Removal of Suicide Warning on Chantix,2016-09-14 23:47:26 +0000,http://www.wsj.com/articles/pfizer-moves-closer-to-fda-removing-suicide-warning-from-smoking-cessation-pill-chantix-1473896843?mod=yahoo_hs,[$$] Pfizer Moves Closer to FDA Removal of Suicide Warning on Chantix
PFE,PFE:US,BBG000BR2B91,FDA panel recommends dropping serious warning on Pfizer's Chantix,2016-09-14 23:35:05 +0000,http://finance.yahoo.com/news/fda-panel-recommends-dropping-serious-213821051.html,"[Reuters] - Pfizer's Chantix was approved about a decade ago, but thousands of reports of mental health problems in users led to the FDA imposing the ""black box"" warning - the most severe available - in 2009. On Wednesday, four of the 19 panelists voted to update the language in the box warning - of neuropsychiatric risks including suicidal thoughts, hostility and agitation - while five recommended retaining it. The 10 who voted in favor of removal stressed that the benefits of quitting smoking far outweighed the potential severe side-effects of the drug, and that the evidence of causality between Chantix and the side-effects was not clear enough to warrant a black box."
PFE,PFE:US,BBG000BR2B91,FDA panel recommends dropping serious warning on Pfizer's Chantix,2016-09-14 23:32:31 +0000,http://uk.finance.yahoo.com/news/fda-panel-recommends-dropping-serious-233231086.html,"[Reuters - UK Focus] - A serious warning on Pfizer Inc (NYSE: PFE - news) 's quit smoking drug should be removed, 10 of 19 independent panelists to the U.S. Food and Drug Administration recommended on Wednesday, after reviewing additional trial data on the controversial treatment. Pfizer's Chantix was approved about a decade ago, but thousands of reports of mental health problems in users led to the FDA imposing the ""black box"" warning - the most severe available - in 2009. On Wednesday, four of the 19 panelists voted to update the language in the box warning - of neuropsychiatric risks including suicidal thoughts, hostility and agitation - while five recommended retaining it."
PFE,PFE:US,BBG000BR2B91,"FDA Advisory Committees Recommend to Remove Boxed Warning in Labeling for Pfizer’s Smoking Cessation Therapy, CHANTIX® (varenicline)",2016-09-14 22:28:08 +0000,http://www.publicnow.com/view/7A6A1363BE7AED80364F68AF4A2C9CBE569FA090,"[at noodls] - NEW YORK--(BUSINESS WIRE)--Today, a joint meeting of the U.S. Food and Drug Administration's (FDA) Psychopharmacologic Drugs Advisory Committee and Drug Safety Risk Management Advisory Committee reviewed ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Moves Closer to FDA Removal of Suicide Warning on Chantix,2016-09-14 21:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bhoIFQdI2Nk/pfizer-moves-closer-to-fda-removal-of-suicide-warning-on-chantix-20160914-01127,Pfizer Moves Closer to FDA Removal of Suicide Warning on Chantix
PFE,PFE:US,BBG000BR2B91,Pfizer Moves Closer to FDA Removal of Suicide Warning on Chantix,2016-09-14 21:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9GfYDd-d5UM/pfizer-moves-closer-to-fda-removal-of-suicide-warning-on-chantix-20160914-01124,Pfizer Moves Closer to FDA Removal of Suicide Warning on Chantix
PFE,PFE:US,BBG000BR2B91,Pfizer Moves Closer to FDA Removing Suicide Warning From Smoking Cessation Pill Chantix,2016-09-14 20:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gvWFMwpUxHs/pfizer-moves-closer-to-fda-removing-suicide-warning-from-smoking-cessation-pill-chantix-20160914-01110,Pfizer Moves Closer to FDA Removing Suicide Warning From Smoking Cessation Pill Chantix
PFE,PFE:US,BBG000BR2B91,Why Pfizer's Stock Is a Big Gamble Right Now,2016-09-14 12:42:59 +0000,http://www.fool.com/investing/2016/09/13/why-pfizers-stock-is-a-big-gamble-right-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Pfizer's Stock Is a Big Gamble Right Now
PFE,PFE:US,BBG000BR2B91,Fed Won’t Raise Until December: Buy These 4 Dividend Blue Chips On Sale,2016-09-14 12:25:16 +0000,http://247wallst.com/investing/2016/09/14/fed-wont-raise-until-december-buy-these-4-dividend-blue-chips-on-sale/,[at 24/7 Wall St.] - The volatility in the markets have shaken some of the top dividend leaders and may be giving long-term investors a great buying opportunity.
PFE,PFE:US,BBG000BR2B91,Here's Why Pfizer Is Headed Lower Before It Can Head Higher,2016-09-14 10:01:00 +0000,https://www.thestreet.com/story/13727958/1/here-s-why-pfizer-is-headed-lower-before-it-can-head-higher.html?puc=yahoo&cm_ven=YAHOO,Here's Why Pfizer Is Headed Lower Before It Can Head Higher
PFE,PFE:US,BBG000BR2B91,Allergan to Buy Vitae Pharmaceuticals for $639 Million,2016-09-14 09:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e7s8CNbCObc/allergan-to-buy-vitae-pharmaceuticals-for-639-million-20160914-00567,Allergan to Buy Vitae Pharmaceuticals for $639 Million
PFE,PFE:US,BBG000BR2B91,[$$] Takeda earmarks $15bn for US pharma acquisitions,2016-09-14 01:57:03 +0000,"http://www.ft.com/cms/s/5c8e5c50-79c5-11e6-97ae-647294649b28,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Takeda, Japan's largest pharmaceuticals group, is on the hunt for acquisitions in the US and has earmarked up to $15bn to spend on takeovers to boost its presence in the world's largest healthcare market, ..."
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Sep 13, 2016 :  WFT, ACAS, MSFT, WFC, GE, ARCC, MTU, PFE, AAPL, AMAT, BAC, ON",2016-09-13 21:05:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-6eAifjCwAM/after-hours-most-active-for-sep-13-2016-wft-acas-msft-wfc-ge-arcc-mtu-pfe-aapl-amat-bac-on-cm679084,The NASDAQ 100 After Hours Indicator is up 2 21 to 4 725 05 The total After hours volume is currently 35 266 453 shares traded The following are the most active stocks for the after hours session Weatherford International plc WFT is 0 05 at 6 31 with 2 549 135
PFE,PFE:US,BBG000BR2B91,3 Dividend Stocks to Buy in a Market Crash,2016-09-13 20:52:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0fEFqha6m_o/3-dividend-stocks-to-buy-in-a-market-crash-cm679011,Image source Getty Images Market uncertainty is climbing ahead of November s elections and that could provide investors with an opportunity to scoop up bargains on top dividend paying stocks Historically dividend paying stocks have outperformed non dividend paying stocks and
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Stock Falls, Jefferies Drops Price Target",2016-09-13 19:27:00 +0000,https://www.thestreet.com/story/13727498/1/pfizer-pfe-stock-falls-jefferies-drops-price-target.html?puc=yahoo&cm_ven=YAHOO,"Pfizer (PFE) Stock Falls, Jefferies Drops Price Target"
PFE,PFE:US,BBG000BR2B91,3 Dividend Stocks to Buy in a Market Crash,2016-09-13 19:01:07 +0000,http://www.fool.com/investing/2016/09/13/3-dividend-stocks-to-buy-in-a-market-crash.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Dividend Stocks to Buy in a Market Crash
PFE,PFE:US,BBG000BR2B91,Insight from Ray Dalio and Tim Geithner on the Credit Market,2016-09-13 17:46:23 +0000,http://finance.yahoo.com/news/insight-ray-dalio-tim-geithner-174623191.html,Insight from Ray Dalio and Tim Geithner on the Credit Market
PFE,PFE:US,BBG000BR2B91,Why Gilead Sciences Loves PARP…And You Should Too,2016-09-13 17:32:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/13/why-gilead-sciences-loves-parp-and-you-should-too/?mod=yahoobarrons&ru=yahoo,Why Gilead Sciences Loves PARP…And You Should Too
PFE,PFE:US,BBG000BR2B91,Big Pharma Spends Millions to Keep Prices High for California Agencies,2016-09-13 17:20:00 +0000,https://www.thestreet.com/story/13726935/1/big-pharma-spends-millions-to-keep-prices-high-for-california-agencies.html?puc=yahoo&cm_ven=YAHOO,Big Pharma Spends Millions to Keep Prices High for California Agencies
PFE,PFE:US,BBG000BR2B91,Biotech Stocks Bounce Back in Monday Trading: 3 Picks,2016-09-13 15:49:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kjcnaOB1Djo/biotech-stocks-bounce-back-in-monday-trading-3-picks-cm678799,The healthcare sector has been choppy since the beginning of 2016 continuing the volatile trend from the second half of 2015 Media and political focus on the high prices of drugs have made things difficult for the pharma biotech sector since the past one year Democratic presidential
PFE,PFE:US,BBG000BR2B91,5 Biotech Stocks That Are Broker Favorites,2016-09-13 15:49:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mKm6hf3UY1g/5-biotech-stocks-that-are-broker-favorites-cm678780,It s been a pretty rough year for the biotech sector with the NASDAQ Biotechnology index tumbling 18 7 over the last 12 months and 12 3 year to date YTD Factors like a changing competitive scenario and more importantly the drug pricing issue have been weighing on the sector The
PFE,PFE:US,BBG000BR2B91,Why Pfizer's Stock Is a Big Gamble Right Now,2016-09-13 14:48:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1Y12r4uSihQ/why-pfizers-stock-is-a-big-gamble-right-now-cm678632,Image source Getty Images Since the failure of Pfizer s NYSE PFE 160 160 billion megadeal to buy Allergan and move its headquarters on paper to lower tax Ireland 160 shares of the pharmaceutical giant have been moving upward In fact 160 the 160 stock
PFE,PFE:US,BBG000BR2B91,Doctors Downplaying Drug’s Suicide Risks Attract FDA’s Scrutiny,2016-09-13 14:46:48 +0000,http://www.bloomberg.com/news/articles/2016-09-13/pfizer-money-may-have-clouded-doctor-judgment-of-risks-fda-says?cmpid=yhoo.headline,Doctors Downplaying Drug’s Suicide Risks Attract FDA’s Scrutiny
PFE,PFE:US,BBG000BR2B91,Pfizer To Present At Morgan Stanley Conference; Webcast At 3:30 PM ET,2016-09-13 14:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0G45V6iI29o/pfizer-to-present-at-morgan-stanley-conference-webcast-at-330-pm-et-20160913-00973,Pfizer To Present At Morgan Stanley Conference; Webcast At 3:30 PM ET
PFE,PFE:US,BBG000BR2B91,"Pfizer Launches New “Moodivator” App to Help Support, Encourage and Motivate People with Depression",2016-09-13 14:28:04 +0000,http://www.publicnow.com/view/B6AF2E0E1DCBE1397D2D119F85F75FA3C4D538D7,"[at noodls] - Today, Pfizer Inc announced it has launched a new app, Moodivator, to help motivate and encourage the millions of adults who experience depression. Depression is one of the most common mental health disorders ..."
PFE,PFE:US,BBG000BR2B91,5 Quality Dividend Names On The Cheap,2016-09-13 13:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vLC9oU0URJs/5-quality-dividend-names-on-the-cheap-cm678459,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips With more than a third of the global sovereign bonds market offering negative yields it s no surprise that investors have flocked to any source for cash yield The global hunt for yield
PFE,PFE:US,BBG000BR2B91,Major Pharma Continues to See Significant Drop in Short Interest,2016-09-13 11:25:00 +0000,http://247wallst.com/healthcare-business/2016/09/13/major-pharma-continues-to-see-significant-drop-in-short-interest/,Major Pharma Continues to See Significant Drop in Short Interest
PFE,PFE:US,BBG000BR2B91,Interesting January 2018 Stock Options for PFE,2016-09-12 17:30:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WZqEAF7uTbU/interesting-january-2018-stock-options-for-pfe-cm678096,Consistently one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc Symbol PFE So this week we highlight one interesting put contract and one interesting call contract from the January 2018 expiration for PFE The put
PFE,PFE:US,BBG000BR2B91,5 Undervalued Dividend Stocks To Protect Your Portfolio,2016-09-12 17:30:00 +0000,http://finance.yahoo.com/news/5-quality-dividend-names-cheap-173000166.html,5 Undervalued Dividend Stocks To Protect Your Portfolio
PFE,PFE:US,BBG000BR2B91,Is Clovis Oncology Still a Strong Buy?,2016-09-12 16:33:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7D3Nsx2kBFk/is-clovis-oncology-still-a-strong-buy-cm678058,Image source Getty Images What happened Shares of Clovis Oncology NASDAQ CLVS a cancer focused biophama gained more than 64 for the month of August 160 according to data from S amp P Global Market Intelligence CLVS data
PFE,PFE:US,BBG000BR2B91,Is Clovis Oncology Still a Strong Buy?,2016-09-12 15:59:47 +0000,http://www.fool.com/investing/2016/09/12/is-clovis-oncology-still-a-strong-buy.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Clovis Oncology Still a Strong Buy?
PFE,PFE:US,BBG000BR2B91,This Forbes 'Most Innovative' Growth Stock Remains Near Buy Point,2016-09-12 15:49:05 +0000,http://www.investors.com/research/ibd-stock-analysis/forbes-most-innovative-growth-stocks-tyler-technologies-near-buy-zone/,This Forbes 'Most Innovative' Growth Stock Remains Near Buy Point
PFE,PFE:US,BBG000BR2B91,"Better Buy: Merck & Co., Inc. vs. Pfizer",2016-09-12 15:34:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e83yx3j472A/better-buy-merck-co-inc-vs-pfizer-cm677959,Pharmaceutical companies have been in the news lately and political pressure attacking the profits that drug makers have earned over the decades is rising rapidly as the 2016 election approaches For pharma giants Merck NYSE MRK and Pfizer NYSE PFE however the fear
PFE,PFE:US,BBG000BR2B91,"2 Biotech Stocks that Turned $8,000 into over $250,000",2016-09-12 15:34:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1NmDSjtia4Y/2-biotech-stocks-that-turned-8000-into-over-250000-cm677955,Image source Getty Images Investing in small biotech stocks is terribly risky but once in a while a few stocks produce astounding gains An 8 000 investment in AxoGen NASDAQ AXGN 160 10 years ago for example would be worth about 258 400 today The biggest long
PFE,PFE:US,BBG000BR2B91,Will Pfizer (PFE) Stock Be Affected by FDA Chantix Study Scrutiny?,2016-09-12 15:26:00 +0000,https://www.thestreet.com/story/13708341/1/will-pfizer-pfe-stock-be-affected-by-fda-chantix-study-scrutiny.html?puc=yahoo&cm_ven=YAHOO,Will Pfizer (PFE) Stock Be Affected by FDA Chantix Study Scrutiny?
PFE,PFE:US,BBG000BR2B91,FDA Staff Question Pfizer’s Psychiatric Data on Chantix,2016-09-12 14:29:46 +0000,http://www.bloomberg.com/news/articles/2016-09-12/fda-staff-question-pfizer-study-of-chantix-psychiatric-effects?cmpid=yhoo.headline,FDA Staff Question Pfizer’s Psychiatric Data on Chantix
PFE,PFE:US,BBG000BR2B91,"Better Buy: Merck & Co., Inc. vs. Pfizer",2016-09-12 14:13:50 +0000,http://www.fool.com/investing/2016/09/12/better-buy-merck-co-inc-vs-pfizer.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Better Buy: Merck & Co., Inc. vs. Pfizer"
PFE,PFE:US,BBG000BR2B91,"2 Biotech Stocks that Turned $8,000 into over $250,000",2016-09-12 14:13:49 +0000,http://www.fool.com/investing/2016/09/12/4-stocks-that-turned-8000-into-18000.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"2 Biotech Stocks that Turned $8,000 into over $250,000"
PFE,PFE:US,BBG000BR2B91,How Can Pfizer Revive Its Essential Health Business?,2016-09-12 14:04:53 +0000,http://marketrealist.com/2016/09/how-can-pfizer-revive-its-essential-health-business/?utm_source=yahoo&utm_medium=feed,How Can Pfizer Revive Its Essential Health Business?
PFE,PFE:US,BBG000BR2B91,"Gilead Sciencs, Inc. a Takeover Target? It's Not as Crazy As It Sounds",2016-09-12 13:33:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cK2jt7CqFfo/gilead-sciencs-inc-a-takeover-target-its-not-as-crazy-as-it-sounds-cm677557,Image source Getty Images Gilead Sciences NASDAQ GILD may not be a household name but it s been a true game changer among biotech s elite for years Gilead s biggest medical contribution is its trio of hepatitis C drugs Sovaldi Harvoni and the most recently
PFE,PFE:US,BBG000BR2B91,"Merck & Company, Inc. (MRK) Ex-Dividend Date Scheduled for September 13, 2016",2016-09-12 13:28:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CL6jSsziM_0/merck-company-inc-mrk-ex-dividend-date-scheduled-for-september-13-2016-cm677771,Merck amp Company Inc MRK will begin trading ex dividend on September 13 2016 A cash dividend payment of 0 46 per share is scheduled to be paid on October 07 2016 Shareholders who purchased MRK prior to the ex dividend date are eligible for the cash dividend payment This marks
PFE,PFE:US,BBG000BR2B91,FDA staff flags concerns about Pfizer's quit-smoking drug study,2016-09-12 13:10:24 +0000,http://finance.yahoo.com/news/fda-staff-flags-concerns-pfizers-131024122.html,"[Reuters] - U.S. Food and Drug Administration scientists have expressed concerns about a post-marketing study of Pfizer Inc's drug Chantix, which is aimed at helping smokers quit, according to documents posted on the regulator's website on Monday. The concerns are related to the trial design and data interpretation of the study, called Eagles, in more than 8,000 adult smokers. The trial compared the effects of Chantix or GlaxoSmithKline Plc's Zyban with a placebo or a nicotine patch in patients with and without a history of psychiatric disorders."
PFE,PFE:US,BBG000BR2B91,"Gilead Sciencs, Inc. a Takeover Target? It's Not as Crazy As It Sounds",2016-09-12 12:18:06 +0000,http://www.fool.com/investing/2016/09/12/gilead-sciencs-inc-a-takeover-target-its-not-as-cr.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Gilead Sciencs, Inc. a Takeover Target? It's Not as Crazy As It Sounds"
PFE,PFE:US,BBG000BR2B91,Pfizer’s Hospira Deal: Catching Up a Year Later,2016-09-12 12:05:10 +0000,http://marketrealist.com/2016/09/pfizers-hospira-deal-catching-up-a-year-later/?utm_source=yahoo&utm_medium=feed,Pfizer’s Hospira Deal: Catching Up a Year Later
PFE,PFE:US,BBG000BR2B91,"Reads For The Weed-Kend: Marijuana Roadside Testing, Pregnancy And Depression",2016-09-11 21:09:48 +0000,http://finance.yahoo.com/news/reads-weed-kend-marijuana-roadside-210948912.html,"Reads For The Weed-Kend: Marijuana Roadside Testing, Pregnancy And Depression"
PFE,PFE:US,BBG000BR2B91,Two Things You Must Understand About Biotech Investing,2016-09-11 16:30:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2HKTCcBLieM/two-things-you-must-understand-about-biotech-investing-cm677459,A multibillion dollar market for drugs that work similarly to branded biologics is emerging and investors might not want to miss out on the opportunity Over 100 billion in brand name sales of biologic drugs will lose patent protection over the next five to 10 years and
PFE,PFE:US,BBG000BR2B91,Pfizer Takes Aim at Johnson & Johnson,2016-09-10 13:30:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BctFPkS33As/pfizer-takes-aim-at-johnson-johnson-cm677374,Image source Getty Images Johnson amp Johnson NYSE JNJ is a global healthcare giant that s well known for top selling consumer brands like Band Aid but it also generates billions of dollars in sales annually from the rheumatoid arthritis drug Remicade In fact Remicade
PFE,PFE:US,BBG000BR2B91,Pfizer Takes Aim at Johnson & Johnson,2016-09-10 12:01:06 +0000,http://www.fool.com/investing/2016/09/10/pfizer-takes-aim-at-johnson-johnson.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Pfizer Takes Aim at Johnson & Johnson
PFE,PFE:US,BBG000BR2B91,5 Dow Jones Titans Getting Pulled Into the Selloff,2016-09-09 22:32:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uHA1IhGddFY/5-dow-jones-titans-getting-pulled-into-the-selloff-cm677276,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips U S equities are being hit with their worst selloff in months on Friday as long term government bonds around the world are being hit hard The catalyst Source GotCredit via Flickr Indications that
PFE,PFE:US,BBG000BR2B91,Why Is Pfizer’s Legacy Brand Portfolio Falling?,2016-09-09 22:04:32 +0000,http://marketrealist.com/2016/09/why-is-pfizers-legacy-brand-portfolio-falling/?utm_source=yahoo&utm_medium=feed,Why Is Pfizer’s Legacy Brand Portfolio Falling?
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Sep 9, 2016 :  BAC, MSFT, T, GE, AAPL, XOM, PFE, JPM, XIV, CSCO, QQQ, FLEX",2016-09-09 21:09:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eaHxQBJ6VyM/after-hours-most-active-for-sep-9-2016-bac-msft-t-ge-aapl-xom-pfe-jpm-xiv-csco-qqq-flex-cm677231,The NASDAQ 100 After Hours Indicator is up 1 45 to 4 682 98 The total After hours volume is currently 37 498 224 shares traded The following are the most active stocks for the after hours session Bank of America Corporation BAC is 0 01 at 15 75 with 3 997 511
PFE,PFE:US,BBG000BR2B91,Five Dividend Stocks Billionaires Like,2016-09-09 21:00:02 +0000,http://www.insidermonkey.com/blog/five-dividend-stocks-billionaires-like-472608/,Five Dividend Stocks Billionaires Like
PFE,PFE:US,BBG000BR2B91,Teva Discusses EpiPen Comps as Host of Generics Unveiled,2016-09-09 20:34:00 +0000,https://www.thestreet.com/slideshow/13700288/1/teva-discusses-epipen-comps-as-host-of-generics-unveiled.html?puc=yahoo&cm_ven=YAHOO,Teva Discusses EpiPen Comps as Host of Generics Unveiled
PFE,PFE:US,BBG000BR2B91,Pfizer’s Essential Health Business: What You Need to Know,2016-09-09 20:19:00 +0000,http://marketrealist.com/2016/09/pfizers-essential-health-business-what-you-need-to-know/?utm_source=yahoo&utm_medium=feed,Pfizer’s Essential Health Business: What You Need to Know
PFE,PFE:US,BBG000BR2B91,Gilead Sciences: What is PARP?,2016-09-09 19:46:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/09/gilead-sciences-what-is-parp/?mod=yahoobarrons&ru=yahoo,Gilead Sciences: What is PARP?
PFE,PFE:US,BBG000BR2B91,Medivation (MDVN) Scales New 52-Week High on Pfizer Deal,2016-09-09 16:33:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xnFikL9fyxA/medivation-mdvn-scales-new-52-week-high-on-pfizer-deal-cm676945,Shares of Medivation Inc MDVN hit a 52 week high of 80 99 on Thursday Sep 9 Shares of the biopharmaceutical company have been up more than 20 ever since pharmaceutical giant Pfizer Inc PFE announced its intention to buy it MEDIVATION INC
PFE,PFE:US,BBG000BR2B91,Clinton spokeswoman defends drug plan after Pfizer comments,2016-09-09 15:28:05 +0000,http://finance.yahoo.com/news/clinton-spokeswoman-defends-drug-plan-152805927.html,Clinton spokeswoman defends drug plan after Pfizer comments
PFE,PFE:US,BBG000BR2B91,Pfizer CEO: Clinton's plan to curb high drug prices would be 'very negative for innovation',2016-09-09 14:58:58 +0000,http://finance.yahoo.com/news/pfizer-ceo-clintons-plan-curb-145858531.html,Pfizer CEO: Clinton's plan to curb high drug prices would be 'very negative for innovation'
PFE,PFE:US,BBG000BR2B91,Medivation (MDVN) Scales New 52-Week High on Pfizer Deal,2016-09-09 14:25:02 +0000,http://finance.yahoo.com/news/medivation-mdvn-scales-52-week-142502055.html,Medivation (MDVN) Scales New 52-Week High on Pfizer Deal
PFE,PFE:US,BBG000BR2B91,The Biotech ETF With The Unusual Investment Strategy,2016-09-09 13:48:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LzdJHyilsgk/the-biotech-etf-with-the-unusual-investment-strategy-cm676816,"With most of the investable universe covered by an ETF in some form or another, fund providers are targeting increasingly narrow spaces for new product launches.     Management style tactics are also veering from the norm, as evidenced by the boom in smart beta products. While many of the ETFs are perfectly"
PFE,PFE:US,BBG000BR2B91,Clovis Oncology Up As FDA Skips Review Panel For New Drug,2016-09-08 20:49:15 +0000,http://www.investors.com/news/technology/clovis-oncology-up-as-fda-skips-review-panel-for-new-drug/,Clovis Oncology Up As FDA Skips Review Panel For New Drug
PFE,PFE:US,BBG000BR2B91,[$$] Chrono Therapeutics Raises $47.6M Series B for Smoking-Cessation Tech,2016-09-08 19:28:36 +0000,http://www.wsj.com/articles/chrono-therapeutics-raises-47-6m-series-b-for-smoking-cessation-tech-1473362912?mod=yahoo_hs,[$$] Chrono Therapeutics Raises $47.6M Series B for Smoking-Cessation Tech
PFE,PFE:US,BBG000BR2B91,Is Pfizer About to Slash Its Dividend?,2016-09-08 18:18:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RHAjVq4vMKY/is-pfizer-about-to-slash-its-dividend-cm676397,It s no secret that Pfizer NYSE PFE has been gearing up for a possible split for several years now And in its most recent efforts to this effect the drugmaker has already split its operating model into two distinct businesses 160 Pfizer Innovative Health and Pfizer
PFE,PFE:US,BBG000BR2B91,Pfizer CEO says Clinton plan to curb drug prices would hurt consumers,2016-09-08 18:18:29 +0000,http://finance.yahoo.com/news/pfizer-ceo-says-clinton-plan-181829671.html,"[Reuters] - Pfizer Inc's chief executive on Thursday said recent proposals by Democratic presidential candidate Hillary Clinton to curb ""unjustified"" U.S. drug prices would dampen investment in innovative new drugs and ultimately hurt consumers. ""(They) would be very negative for innovation,"" Ian Read said in webcast from the annual Wells Fargo healthcare conference in Boston. Read said he did not believe price controls like those seen in Europe would occur in the United States."
PFE,PFE:US,BBG000BR2B91,Merck's Lung Cancer Drug Keytruda Under Priority Review,2016-09-08 18:17:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rXMSGbQNjG0/mercks-lung-cancer-drug-keytruda-under-priority-review-cm676345,Merck amp Co Inc s MRK supplemental Biologics License Application sBLA for its anti PD 1 therapy Keytruda has been accepted for priority review by the FDA The company is looking to expand the label into the first line treatment of patients with advanced non small cell lung
PFE,PFE:US,BBG000BR2B91,5 Dividend Stocks to Put on Your Shopping List,2016-09-08 17:18:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JbxdgXDO2x0/5-dividend-stocks-to-put-on-your-shopping-list-cm676366,Image source Getty Images Finding a high quality company that pays a dividend is easy The hard part is finding one that offers exceptional value with an above average yield and an attractive valuation With the market near all time highs finding attractive dividend stocks
PFE,PFE:US,BBG000BR2B91,Is Pfizer About to Slash Its Dividend?,2016-09-08 17:08:48 +0000,http://www.fool.com/investing/2016/09/08/is-pfizer-about-to-slash-its-dividend.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Pfizer About to Slash Its Dividend?
PFE,PFE:US,BBG000BR2B91,"Clinton’s Drug Proposals ‘Very Negative,’ Pfizer CEO Says",2016-09-08 16:46:38 +0000,http://finance.yahoo.com/news/clinton-drug-proposals-very-negative-164638805.html,"Clinton’s Drug Proposals ‘Very Negative,’ Pfizer CEO Says"
PFE,PFE:US,BBG000BR2B91,5 Dividend Stocks to Put on Your Shopping List,2016-09-08 15:39:10 +0000,http://www.fool.com/investing/2016/09/08/5-dividend-stocks-to-put-on-your-shopping-list.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Dividend Stocks to Put on Your Shopping List
PFE,PFE:US,BBG000BR2B91,Merck's Lung Cancer Drug Keytruda Under Priority Review,2016-09-08 15:29:03 +0000,http://finance.yahoo.com/news/mercks-lung-cancer-drug-keytruda-152903026.html,Merck's Lung Cancer Drug Keytruda Under Priority Review
PFE,PFE:US,BBG000BR2B91,[$$] Funding Snapshot: Immune-Drug Developer AnTolRx Raises $4M Series A,2016-09-08 14:45:32 +0000,http://www.wsj.com/articles/funding-snapshot-immune-drug-developer-antolrx-raises-4m-series-a-1473345930?mod=yahoo_hs,[$$] Funding Snapshot: Immune-Drug Developer AnTolRx Raises $4M Series A
PFE,PFE:US,BBG000BR2B91,One Of Forbes' 'Most Innovative Growth Companies' Nears Breakout,2016-09-08 13:49:06 +0000,http://www.investors.com/research/ibd-stock-analysis/top-rated-tech-stock-tyler-technologies-near-buy-zone/,One Of Forbes' 'Most Innovative Growth Companies' Nears Breakout
PFE,PFE:US,BBG000BR2B91,"AnTolRx, Inc. Announces Series A Equity Funding from Pfizer, JDRF and Orion Equity Partners, LLC to Develop Targeted Nanoparticle Tolerance Therapeutics",2016-09-08 13:07:00 +0000,http://finance.yahoo.com/news/antolrx-inc-announces-series-equity-130700211.html,"[PR Newswire] - CAMBRIDGE, Mass., Sept. 8, 2016 /PRNewswire/ -- AnTolRx, Inc. announced today that it has signed a Series A funding agreement with Pfizer Inc. (PFE), Orion Equity Partners LLC and JDRF, the leading global organization funding type 1 diabetes (T1D) research. The funding parties will provide $4 million over two years to fund research and development of AnTolRx's antigen-specific Targeted Nanoparticle Tolerance Therapeutics (TNTT) to treat immune disorders including T1D. The company's technology is based on the work of Dr. Francisco Quintana, Associate Scientist at Brigham and Women's Hospital and Associate Professor of Neurology at Harvard Medical School. ""AnTolRx's nanoparticles aim to co-deliver targeted antigens and a tolerogenic factor to suppress pathogenic antigen-specific immune responses and thereby restore more normal immunoregulation in a variety of autoimmune disorders,"" said Mark Carthy, AnTolRx's Chief Executive Officer."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 09/08/2016: BLRX, APRI, JNJ, PFE, ABT, MRK, AMGN",2016-09-08 12:57:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YIKESgQGFcs/health-care-sector-update-for-09082016-blrx-apri-jnj-pfe-abt-mrk-amgn-cm676089,Top Health care stocks Top Health care stocks JNJ 0 3 JNJ 0 3 PFE flatPFE flat ABT flatABT flat MRK flatMRK flat AMGN flatAMGN flat Health care shares were mostly unchanged in pre market trade Thursday Health care shares were mostly unchanged in pre market trade Thursday In
PFE,PFE:US,BBG000BR2B91,Pfizer To Present At Wells Fargo Healthcare Conference; Webcast At 12:15 PM ET,2016-09-08 11:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fy-k_blMEx0/pfizer-to-present-at-wells-fargo-healthcare-conference-webcast-at-1215-pm-et-20160908-00802,Pfizer To Present At Wells Fargo Healthcare Conference; Webcast At 12:15 PM ET
PFE,PFE:US,BBG000BR2B91,Forget Gilead Sciences Inc.: These 3 Stocks Are Better Buys,2016-09-07 22:18:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DcUaGPB4Zvc/forget-gilead-sciences-inc-these-3-stocks-are-better-buys-cm675929,If you re a growth oriented investor Gilead Sciences NASDAQ GILD may no longer be a particularly good fit for your portfolio This blue chip biotech after all has seen the sales of its top selling hepatitis C drug Harvoni fall dramatically in the last quarter and its top line
PFE,PFE:US,BBG000BR2B91,Volatile September Likely After August Losses,2016-09-07 15:17:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x0WRtwuNGxc/volatile-september-likely-after-august-losses-cm675341,Stocks ended August lower as a few factors affected trading For the month the Dow Jones Industrial Average was down 7 and the S amp P 5 was down Stocks leading gains and losses in the DJIA for the month included the following Losses Pfizer PFE down 5
PFE,PFE:US,BBG000BR2B91,Pfizer Appoints Chief Scientific Officer for Neuroscience Research,2016-09-07 12:09:10 +0000,http://www.publicnow.com/view/4F7B10248D5B55729E1D4625C504128FEDEE7E54,"[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. announced today that Dr. Ole Isacson, a world-renowned scientist and thought leader in neurology, will become Chief Scientific Officer of the Neuroscience Research ..."
PFE,PFE:US,BBG000BR2B91,3 Cheap Dividend-Paying Stocks to Buy Now,2016-09-06 21:13:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/szN-d8iiLgQ/3-cheap-dividend-paying-stocks-to-buy-now-cm674720,Image source Getty Images Buying stocks that pay market beating dividend yields can give your annual performance some extra pop but not every company with a high dividend yield deserves to be in your income portfolio The dividend yield of some companies are high because
PFE,PFE:US,BBG000BR2B91,3 Hottest Cancer Biotech Acquisition Targets After Medivation,2016-09-06 20:00:00 +0000,http://www.forbes.com/sites/kenkam/2016/09/06/3-hottest-cancer-biotech-acquisition-targets-after-medivation/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,3 Hottest Cancer Biotech Acquisition Targets After Medivation
PFE,PFE:US,BBG000BR2B91,Understanding Pfizer's Capital Structure (PFE),2016-09-06 15:00:00 +0000,http://www.investopedia.com/articles/financial-analysis/090616/understanding-pfizers-capital-structure-pfe.asp?partner=YahooSA,Understanding Pfizer's Capital Structure (PFE)
PFE,PFE:US,BBG000BR2B91,"Out With The Old, In With The New: State Agencies Seem To Prefer Marijuana Over Opioids",2016-09-06 14:26:59 +0000,http://finance.yahoo.com/news/old-state-agencies-seem-prefer-142659881.html,"Out With The Old, In With The New: State Agencies Seem To Prefer Marijuana Over Opioids"
PFE,PFE:US,BBG000BR2B91,3 Cheap Dividend-Paying Stocks to Buy Now,2016-09-06 14:08:57 +0000,http://www.fool.com/investing/2016/09/05/3-cheap-dividend-paying-stocks-to-buy-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Cheap Dividend-Paying Stocks to Buy Now
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Morgan Stanley Global Healthcare Conference,2016-09-06 14:00:00 +0000,http://finance.yahoo.com/news/pfizer-invites-public-listen-webcast-140000063.html,"[Business Wire] - Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Frank D’Amelio, Executive Vice President, Business Operations, and Chief Financial Officer, at the Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2016 at 3:30 p.m."
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 09/06/2016: TNXP, KPTI, JNJ, PFE, ABT, MRK, AMGN",2016-09-06 13:37:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QFoPQFojdAI/health-care-sector-update-for-09062016-tnxp-kpti-jnj-pfe-abt-mrk-amgn-cm674908,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 0 1 PFE 0 1 ABT flatABT flat MRK flatMRK flat AMGN flatAMGN flat Health care shares were mostly unchanged in pre market trade Tuesday Health care shares were mostly unchanged in pre market trade Tuesday In health
PFE,PFE:US,BBG000BR2B91,"Shire plc (SHPG) Ex-Dividend Date Scheduled for September 07, 2016",2016-09-06 13:21:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CSKiA6Q8UKY/shire-plc-shpg-ex-dividend-date-scheduled-for-september-07-2016-cm674877,Shire plc SHPG will begin trading ex dividend on September 07 2016 A cash dividend payment of 0 1389 per share is scheduled to be paid on October 07 2016 Shareholders who purchased SHPG prior to the ex dividend date are eligible for the cash dividend payment This represents an 79
PFE,PFE:US,BBG000BR2B91,Volatile September Likely After August Losses,2016-09-06 11:51:51 +0000,http://finance.yahoo.com/news/volatile-september-likely-august-losses-115151345.html,Volatile September Likely After August Losses
PFE,PFE:US,BBG000BR2B91,Five Dividend Stocks You Should Look Into,2016-09-06 11:48:33 +0000,http://www.insidermonkey.com/blog/five-dividend-stocks-you-should-look-into-472245/,Five Dividend Stocks You Should Look Into
PFE,PFE:US,BBG000BR2B91,Low taxes at dozens of firms in spotlight after Apple ruling,2016-09-06 10:28:15 +0000,http://sg.finance.yahoo.com/news/low-taxes-dozens-firms-spotlight-070203678.html,Low taxes at dozens of firms in spotlight after Apple ruling
PFE,PFE:US,BBG000BR2B91,Why Are Revenues from Pfizer’s Rare Disease Portfolio Falling?,2016-09-05 15:04:05 +0000,http://marketrealist.com/2016/08/why-are-revenues-from-pfizers-rare-disease-portfolio-falling/?utm_source=yahoo&utm_medium=feed,Why Are Revenues from Pfizer’s Rare Disease Portfolio Falling?
PFE,PFE:US,BBG000BR2B91,3 Retirement Stocks to Buy in September,2016-09-05 14:19:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9jFYFXCKBYE/3-retirement-stocks-to-buy-in-september-cm674638,Image source Getty Images Retirees should be on a constant search for stocks that offer a combination of good long term growth prospects solid dividend 160 yields and low risk While finding 160 companies with all of these characteristics isn t easy they do exist if you to
PFE,PFE:US,BBG000BR2B91,3 Retirement Stocks to Buy in September,2016-09-05 14:09:34 +0000,http://www.fool.com/investing/2016/09/05/3-retirement-stocks-to-buy-in-september.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Retirement Stocks to Buy in September
PFE,PFE:US,BBG000BR2B91,How Are Eli Lilly’s New Products Performing?,2016-09-05 14:04:15 +0000,http://marketrealist.com/2016/09/eli-lillys-new-products-performing/?utm_source=yahoo&utm_medium=feed,How Are Eli Lilly’s New Products Performing?
PFE,PFE:US,BBG000BR2B91,Will Sales of Xeljanz Offset Falling Sales of Enbrel?,2016-09-05 14:04:05 +0000,http://marketrealist.com/2016/08/will-sales-of-xeljanz-offset-falling-sales-of-enbrel/?utm_source=yahoo&utm_medium=feed,Will Sales of Xeljanz Offset Falling Sales of Enbrel?
PFE,PFE:US,BBG000BR2B91,Why Pfizer’s Enbrel Faces a Sales Decline,2016-09-05 12:04:05 +0000,http://marketrealist.com/2016/08/why-pfizers-enbrel-faces-a-sales-decline/?utm_source=yahoo&utm_medium=feed,Why Pfizer’s Enbrel Faces a Sales Decline
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: EC Asks Apple to Pay $14.5B, Cisco to Buy Software Management Startup, ContainerX",2016-09-02 17:17:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V-JQBWWzZfo/dow-30-stock-roundup-ec-asks-apple-to-pay-145b-cisco-to-buy-software-management-startup-containerx-cm674172,The Dow swung between gains and losses over the week even as investors waited for further indications about the timing of a rate hike Hawkish comments from the Fed chair helped financial shares gain toward the beginning of the week However favorable consumer data raised familiar fears about
PFE,PFE:US,BBG000BR2B91,Traders see limit to downside in Pfizer,2016-09-02 15:32:16 +0000,http://finance.yahoo.com/news/traders-see-limit-downside-pfizer-153216279.html,Traders see limit to downside in Pfizer
PFE,PFE:US,BBG000BR2B91,"Dow Movers: PFE, BA",2016-09-02 15:19:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hk6mKlHNGxg/dow-movers-pfe-ba-cm673999,In early trading on Friday shares of Boeing BA topped the list of the day s best performing Dow Jones Industrial Average components trading up 1 4 Year to date Boeing has lost about 8 9 of its value And the worst performing Dow component thus far on the day is Pfizer
PFE,PFE:US,BBG000BR2B91,How Pfizer Plans to Extend Ibrance beyond Breast Cancer Treatment,2016-09-02 15:04:05 +0000,http://marketrealist.com/2016/08/how-pfizer-plans-to-extend-ibrance-beyond-breast-cancer-treatment/?utm_source=yahoo&utm_medium=feed,How Pfizer Plans to Extend Ibrance beyond Breast Cancer Treatment
PFE,PFE:US,BBG000BR2B91,PFE to Enjoy Being Sole Provider of Key Breast Cancer Treatment,2016-09-02 14:04:10 +0000,http://marketrealist.com/2016/08/pfe-to-enjoy-being-sole-provider-of-key-breast-cancer-treatment/?utm_source=yahoo&utm_medium=feed,PFE to Enjoy Being Sole Provider of Key Breast Cancer Treatment
PFE,PFE:US,BBG000BR2B91,An Overview of Pfizer’s Oncology Business,2016-09-02 12:04:21 +0000,http://marketrealist.com/2016/08/an-overview-of-pfizers-oncology-business/?utm_source=yahoo&utm_medium=feed,An Overview of Pfizer’s Oncology Business
PFE,PFE:US,BBG000BR2B91,Pfizer's Lung Cancer Drug Xalkori Label Expanded in the EU,2016-09-01 15:25:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LrVofY951bY/pfizers-lung-cancer-drug-xalkori-label-expanded-in-the-eu-cm673421,Pfizer Inc PFE announced that its lung cancer drug Xalkori has been approved for an additional indication by the European Commission EC The EC has approved Xalkori for the treatment of adult patients with advanced NSCLC whose tumors are ROS1 positive We note that Xalkori is
PFE,PFE:US,BBG000BR2B91,"Clovis Oncology Speeds Toward Possible Launch in Ovarian Cancer, but Red Flags Remain",2016-09-01 15:23:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2g5WihjsHa0/clovis-oncology-speeds-toward-possible-launch-in-ovarian-cancer-but-red-flags-remain-cm673404,Image Source Getty Images Shares of Clovis Oncology NASDAQ CLVS shot up more than 30 last week 160 on news that the Food and Drug Administration had accepted a New Drug Application or NDA for accelerated approval of rucaparib an ovarian cancer drug Rucaparib s fast
PFE,PFE:US,BBG000BR2B91,Why Pfizer’s Vaccines Business Is Declining,2016-09-01 15:04:13 +0000,http://marketrealist.com/2016/08/why-pfizers-vaccines-business-is-declining/?utm_source=yahoo&utm_medium=feed,Why Pfizer’s Vaccines Business Is Declining
PFE,PFE:US,BBG000BR2B91,How Pfizer’s Internal Medicine Core Drugs Are Performing,2016-09-01 14:04:16 +0000,http://marketrealist.com/2016/08/how-pfizers-internal-medicine-core-drugs-are-performing/?utm_source=yahoo&utm_medium=feed,How Pfizer’s Internal Medicine Core Drugs Are Performing
PFE,PFE:US,BBG000BR2B91,Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference,2016-09-01 14:00:00 +0000,http://finance.yahoo.com/news/pfizer-invites-public-listen-webcast-140000118.html,"[Business Wire] - Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Ian Read, Chairman and Chief Executive Officer, at the 2016 Wells Fargo Healthcare Conference on Thursday, September 8, 2016 at 12:15 p.m."
PFE,PFE:US,BBG000BR2B91,Options Activity Shows Traders are Betting on a Recovery for This Health Care ETF,2016-09-01 13:49:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UjNGVarUjXw/options-activity-shows-traders-are-betting-on-a-recovery-for-this-health-care-etf-cm673347,"Health Care stocks have gotten beaten up a bit in the latter part of August, with the benchmark Health Care SPDR ETF (   XLV  ) (Expense Ratio 0.15%) plunging below its 50 day MA five trading sessions ago, and failing to get back above this level.     Trading volume in the ETF has been about average lately, but"
PFE,PFE:US,BBG000BR2B91,"Phibro Animal Health Corporation (PAHC) Ex-Dividend Date Scheduled for September 02, 2016",2016-09-01 13:19:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/07QNTOPQbwQ/phibro-animal-health-corporation-pahc-ex-dividend-date-scheduled-for-september-02-2016-cm673287,Phibro Animal Health Corporation PAHC will begin trading ex dividend on September 02 2016 A cash dividend payment of 0 1 per share is scheduled to be paid on September 28 2016 Shareholders who purchased PAHC prior to the ex dividend date are eligible for the cash dividend payment
PFE,PFE:US,BBG000BR2B91,Blog Coverage FDA Approves Novartis Erelzi as Biosimilar to Amgens Enbrel,2016-09-01 13:17:34 +0000,http://news.investornetwork.com/2016/09/01/blog-coverage-fda-approves-novartis-erelzi-as-biosimilar-to-amgens-enbrel/?1=1&1472735854,Blog Coverage FDA Approves Novartis Erelzi as Biosimilar to Amgens Enbrel
PFE,PFE:US,BBG000BR2B91,Pfizer's Lung Cancer Drug Xalkori Label Expanded in the EU,2016-09-01 12:42:12 +0000,http://finance.yahoo.com/news/pfizers-lung-cancer-drug-xalkori-124212683.html,Pfizer's Lung Cancer Drug Xalkori Label Expanded in the EU
PFE,PFE:US,BBG000BR2B91,Is Eli Lilly’s Valuation Higher than Its Peers?,2016-09-01 12:06:12 +0000,http://marketrealist.com/2016/09/eli-lillys-valuation-higher-peers/?utm_source=yahoo&utm_medium=feed,Is Eli Lilly’s Valuation Higher than Its Peers?
PFE,PFE:US,BBG000BR2B91,A Look at Pfizer’s Innovative Health Business,2016-09-01 12:04:33 +0000,http://marketrealist.com/2016/08/a-look-at-pfizers-innovative-health-business/?utm_source=yahoo&utm_medium=feed,A Look at Pfizer’s Innovative Health Business
PFE,PFE:US,BBG000BR2B91,[$$] Bidding War for Medivation Is Good News for Biotech,2016-09-01 05:04:05 +0000,http://www.wsj.com/articles/bidding-war-for-medivation-is-good-news-for-biotech-1472663100?ru=yahoo?mod=yahoo_itp,"[at The Wall Street Journal] - Pfizer had stiff competition in the chase for Medivation, which bodes well for biotech."
PFE,PFE:US,BBG000BR2B91,"CYNA Snapped Up For $624 Mln, AMRN On Track, Genmab Gets FDA Nod",2016-08-31 23:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r3ontxmEK5k/cyna-snapped-up-for-624-mln-amrn-on-track-genmab-gets-fda-nod-20160831-01178,"CYNA Snapped Up For $624 Mln, AMRN On Track, Genmab Gets FDA Nod"
PFE,PFE:US,BBG000BR2B91,Merck Will Hold Steady on Div Increase Despite Flat Revenue Growth,2016-08-31 22:14:30 +0000,http://finance.yahoo.com/news/merck-hold-steady-div-increase-221430916.html,Merck Will Hold Steady on Div Increase Despite Flat Revenue Growth
PFE,PFE:US,BBG000BR2B91,Is Pfizer Paying Too Much to Buy Medivation?,2016-08-31 21:05:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ETdANr27fKw/is-pfizer-paying-too-much-to-buy-medivation-cm673157,The fact that there was a bidding war to buy Medivation NASDAQ MDVN isn t surprising but the 14 billion price tag that 160 Pfizer Inc NYSE PFE agreed to pay is a bit shocking It s a massive premium to Medivation s share price earlier this year and it s more than
PFE,PFE:US,BBG000BR2B91,Is Pfizer Paying Too Much to Buy Medivation?,2016-08-31 20:49:40 +0000,http://www.fool.com/investing/2016/08/31/is-pfizer-paying-too-much-to-buy-medivation.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Pfizer Paying Too Much to Buy Medivation?
PFE,PFE:US,BBG000BR2B91,Novartis Closing Cell Therapy Unit; CAR-T Stocks Tumble,2016-08-31 20:43:44 +0000,http://www.investors.com/news/technology/novartis-closing-cell-therapy-unit-car-t-stocks-tumble/,Novartis Closing Cell Therapy Unit; CAR-T Stocks Tumble
PFE,PFE:US,BBG000BR2B91,[$$] Bidding War for Medivation Is Good News for Biotech,2016-08-31 17:28:12 +0000,http://www.wsj.com/articles/bidding-war-for-medivation-is-good-news-for-biotech-1472663100?mod=yahoo_hs,[$$] Bidding War for Medivation Is Good News for Biotech
PFE,PFE:US,BBG000BR2B91,Medivation Proxy Shows Pfizer Battled Four Bidders to Seal a Deal,2016-08-31 16:43:00 +0000,https://www.thestreet.com/story/13690770/1/medivation-proxy-shows-pfizer-battled-four-bidders-to-seal-a-deal.html?puc=yahoo&cm_ven=YAHOO,Medivation Proxy Shows Pfizer Battled Four Bidders to Seal a Deal
PFE,PFE:US,BBG000BR2B91,"Merck: Lung Cancer Lead Depends On ""How Smart It Plays Its Hand""",2016-08-31 16:25:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/31/merck-lung-cancer-lead-depends-on-how-smart-it-plays-its-hand/?mod=yahoobarrons&ru=yahoo,"Merck: Lung Cancer Lead Depends On ""How Smart It Plays Its Hand"""
PFE,PFE:US,BBG000BR2B91,3 Dividend Stocks to Make Your Retirement Sweeter,2016-08-31 15:20:36 +0000,http://www.fool.com/investing/2016/08/31/3-dividend-stocks-that-could-make-your-retirement.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Dividend Stocks to Make Your Retirement Sweeter
PFE,PFE:US,BBG000BR2B91,Novartis (NVS) Gets FDA Nod for Biosimilar Version of Enbrel,2016-08-31 15:16:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Sw4WvC6NwMg/novartis-nvs-gets-fda-nod-for-biosimilar-version-of-enbrel-cm672792,"Novartis AGNVS received a major boost when its generic arm, Sandoz obtained FDA approval for Erelzi, the biosimilar version of Amgen's AMGN blockbuster drug Enbrel (etanercept).  The FDA has approved Erelzi for all indications stated in"
PFE,PFE:US,BBG000BR2B91,ARIAD Finishes Rolling NDA for Lung Cancer Drug Brigatinib,2016-08-31 15:15:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6V9-m0xPbhk/ariad-finishes-rolling-nda-for-lung-cancer-drug-brigatinib-cm672773,"ARIAD Pharmaceuticals, Inc.ARIA announced the completion of the rolling submission of the new drug application (NDA) for its experimental ALK inhibitor, brigatinib, to the FDA. ARIAD is looking to get brigatinib approved for the treatment of patients"
PFE,PFE:US,BBG000BR2B91,3 Dividend Stocks to Make Your Retirement Sweeter,2016-08-31 15:13:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n3lcUXTan90/3-dividend-stocks-to-make-your-retirement-sweeter-cm672766,"Image source  Getty Images.  In America, death rates have been dropping for nearly all leading causes of death, according to a government report. That means you could easily have several decades to think"
PFE,PFE:US,BBG000BR2B91,Here's a Reason Why Clovis Oncology (CLVS) Stock Is Gaining Today,2016-08-31 15:06:00 +0000,https://www.thestreet.com/story/13690575/1/here-s-a-reason-why-clovis-oncology-clvs-stock-is-gaining-today.html?puc=yahoo&cm_ven=YAHOO,Here's a Reason Why Clovis Oncology (CLVS) Stock Is Gaining Today
PFE,PFE:US,BBG000BR2B91,Will Xtandi Fuel Pfizer’s Top-Line Growth?,2016-08-31 15:05:02 +0000,http://marketrealist.com/2016/08/will-xtandi-fuel-pfizers-top-line-growth/?utm_source=yahoo&utm_medium=feed,Will Xtandi Fuel Pfizer’s Top-Line Growth?
PFE,PFE:US,BBG000BR2B91,Why Pfizer Is Trading at a Discount on an Earnings Basis,2016-08-31 14:05:13 +0000,http://marketrealist.com/2016/08/why-pfizer-is-trading-at-a-discount-on-an-earnings-basis/?utm_source=yahoo&utm_medium=feed,Why Pfizer Is Trading at a Discount on an Earnings Basis
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/31/2016: VEEV,CLVS,PFE",2016-08-31 12:47:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cE2uoMnTqFk/health-care-sector-update-for-08312016-veevclvspfe-cm672664,"Top Health Care Stocks JNJ Unchanged PFE +1.3% MRK Unchanged ABT Unchanged AMGN Unchanged Health care stocks were little changed in Wednesday's early session, with shares of health care companies in the S&P 500 tracked by the Health Care"
PFE,PFE:US,BBG000BR2B91,What's Up With Mylan's EpiPen Pricing?,2016-08-31 12:35:11 +0000,http://www.fool.com/investing/2016/08/30/whats-up-with-mylans-epipen-pricing.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What's Up With Mylan's EpiPen Pricing?
PFE,PFE:US,BBG000BR2B91,Morning Movers: Clovis Amends Pfizer Agreement; H&R Block Tumbles,2016-08-31 12:23:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/31/morning-movers-clovis-amends-pfizer-agreement-hr-block-tumbles/?mod=yahoobarrons&ru=yahoo,Morning Movers: Clovis Amends Pfizer Agreement; H&R Block Tumbles
PFE,PFE:US,BBG000BR2B91,"Pfizer Gets European Approval For XALKORI, A Cell Lung Cancer Treatment",2016-08-31 12:10:09 +0000,http://finance.yahoo.com/news/pfizer-gets-european-approval-xalkori-121009233.html,"Pfizer Gets European Approval For XALKORI, A Cell Lung Cancer Treatment"
PFE,PFE:US,BBG000BR2B91,Why Pfizer’s Valuation Is Suffering,2016-08-31 12:05:39 +0000,http://marketrealist.com/2016/08/why-pfizers-valuation-is-suffering/?utm_source=yahoo&utm_medium=feed,Why Pfizer’s Valuation Is Suffering
PFE,PFE:US,BBG000BR2B91,XALKORI® (Crizotinib) Receives Approval In European Union For The Treatment Of Patients With ROS1-Positive Advanced Non-Small Cell Lung Cancer,2016-08-31 11:13:04 +0000,http://www.publicnow.com/view/66BEF0261548D163D3FA5EFB54913370493AC0A5,[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the European Commission has approved XALKORI (crizotinib) for the treatment of adults with ROS1-positive advanced non-small cell lung ...
PFE,PFE:US,BBG000BR2B91,XALKORI® (Crizotinib) Receives Approval In European Union For The Treatment Of Patients With ROS1-Positive Advanced Non-Small Cell Lung Cancer,2016-08-31 11:00:00 +0000,http://finance.yahoo.com/news/xalkori-crizotinib-receives-approval-european-110000494.html,[Business Wire] - Pfizer Inc. today announced that the European Commission has approved XALKORI® for the treatment of adults with ROS1-positive advanced non-small cell lung cancer .
PFE,PFE:US,BBG000BR2B91,There’s More to Johnson & Johnson (JNJ) Than Meets the Eye,2016-08-30 23:07:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0N0BmstcXWM/theres-more-to-johnson-johnson-jnj-than-meets-the-eye-cm672518,"For most investors, Johnson & Johnson (NYSE  JNJ ) is perceived as one of the old guards of healthcare industry. Afterall, it is the"
PFE,PFE:US,BBG000BR2B91,Novartis wins US OK for biosimilar version of Amgen's Enbrel,2016-08-30 22:29:47 +0000,http://finance.yahoo.com/news/novartis-wins-us-ok-biosimilar-version-amgens-enbrel-212144648.html,Novartis wins US OK for biosimilar version of Amgen's Enbrel
PFE,PFE:US,BBG000BR2B91,Novartis wins US OK for biosimilar version of Amgen's Enbrel,2016-08-30 22:29:44 +0000,http://sg.finance.yahoo.com/news/novartis-wins-us-ok-biosimilar-212136216.html,Novartis wins US OK for biosimilar version of Amgen's Enbrel
PFE,PFE:US,BBG000BR2B91,How StrataGraft Could Benefit Mallinckrodt’s Hospital Portfolio,2016-08-30 22:04:19 +0000,http://marketrealist.com/2016/08/how-stratagraft-could-benefit-mallinckrodts-hospital-portfolio/?utm_source=yahoo&utm_medium=feed,How StrataGraft Could Benefit Mallinckrodt’s Hospital Portfolio
PFE,PFE:US,BBG000BR2B91,Could Pfizer Face An Apple-Like Tax Surprise in the EU?,2016-08-30 20:12:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TVdS5PPe1ig/could-pfizer-face-an-apple-like-tax-surprise-in-the-eu-cm672435,"Image source  Pfizer, Inc.  The European Commission has told Apple Inc. (NASDAQ  AAPL) that it needs to pay $14.5 billion, plus interest, for a tax savings deal it cut with Ireland over"
PFE,PFE:US,BBG000BR2B91,Dow Analyst Moves: PFE,2016-08-30 19:12:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-92vJBQ88Uo/dow-analyst-moves-pfe-cm672400,"The latest tally of analyst opinions from the major brokerage houses shows that among the 30 stocks making up the Dow Jones Industrial Average, Pfizer ( PFE ) is the #9 analyst pick."
PFE,PFE:US,BBG000BR2B91,Could Pfizer Face An Apple-Like Tax Surprise in the EU?,2016-08-30 19:01:00 +0000,http://www.fool.com/investing/2016/08/30/could-pfizer-be-on-the-hook-for-an-apple-size-tax.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,Could Pfizer Face An Apple-Like Tax Surprise in the EU?
PFE,PFE:US,BBG000BR2B91,FDA Approves Novartis's Biosimilar to Amgen's Enbrel,2016-08-30 18:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1nO2erjNphw/fda-approves-novartiss-biosimilar-to-amgens-enbrel-20160830-00969,FDA Approves Novartis's Biosimilar to Amgen's Enbrel
PFE,PFE:US,BBG000BR2B91,FDA Approves Novartis''s Biosimilar to Amgen''s Enbrel,2016-08-30 18:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I7v2ie5hIXg/fda-approves-novartiss-biosimilar-to-amgens-enbrel-20160830-00968,FDA Approves Novartis''s Biosimilar to Amgen''s Enbrel
PFE,PFE:US,BBG000BR2B91,Analyzing Johnson & Johnson’s Business Segments,2016-08-30 18:04:19 +0000,http://marketrealist.com/2016/08/analyzing-johnson-johnsons-business-segments/?utm_source=yahoo&utm_medium=feed,Analyzing Johnson & Johnson’s Business Segments
PFE,PFE:US,BBG000BR2B91,This Pharma Company Is Leading The Race For A Zika Vaccine,2016-08-30 17:30:00 +0000,http://finance.yahoo.com/news/pharma-company-leading-race-zika-173000684.html,This Pharma Company Is Leading The Race For A Zika Vaccine
PFE,PFE:US,BBG000BR2B91,U.S. Chamber of Commerce Files Suit Over Anti-Inversion Regs,2016-08-30 16:38:00 +0000,http://www.forbes.com/sites/taxanalysts/2016/08/30/u-s-chamber-of-commerce-files-suit-over-anti-inversion-regs/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,U.S. Chamber of Commerce Files Suit Over Anti-Inversion Regs
PFE,PFE:US,BBG000BR2B91,"XLV, IELG: Big ETF Outflows",2016-08-30 16:11:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lnrJZZt3ySo/xlv-ielg-big-etf-outflows-cm672246,"Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel, the biggest outflow was seen in the Health Care Select Sector SPDR Fund, where"
PFE,PFE:US,BBG000BR2B91,British tech champion ARM's sale to Japan's SoftBank wins shareholder nod,2016-08-30 15:18:58 +0000,http://uk.finance.yahoo.com/news/british-tech-champion-arms-sale-151858450.html,British tech champion ARM's sale to Japan's SoftBank wins shareholder nod
PFE,PFE:US,BBG000BR2B91,3 Bargain Stocks With Great Upside Potential,2016-08-30 15:08:00 +0000,http://www.forbes.com/sites/wallaceforbes/2016/08/30/3-bargain-stocks-with-great-upside-potential/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,3 Bargain Stocks With Great Upside Potential
PFE,PFE:US,BBG000BR2B91,What's Up With Mylan's EpiPen Pricing?,2016-08-30 14:13:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9vAe9dR7J4k/whats-up-with-mylans-epipen-pricing-cm672070,"If you're diagnosed with a severe allergy that could lead to life threatening anaphylaxis, then you're probably carrying around one of Mylan N.V. 's(NASDAQ  MYL) EpiPens. Even if you don't own an EpiPen yourself, you've likely"
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/30/2016: PTLA, RIGL, JNJ, PFE, ABT, MRK, AMGN",2016-08-30 13:13:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JFmhtoWYltU/health-care-sector-update-for-08302016-ptla-rigl-jnj-pfe-abt-mrk-amgn-cm672041,"Top Health care stocks JNJ flat PFE flat ABT 1.1% MRK flat AMGN flat Health care shares were mostly unchanged in pre market trade Tuesday. In health care stocks news, Rigel Pharmaceuticals ( RIGL ) was up 5.3% as"
PFE,PFE:US,BBG000BR2B91,Mylan To Launch Its Own EpiPen Generic Rival At Half Price,2016-08-29 20:21:43 +0000,http://www.investors.com/news/technology/mylan-to-launch-its-own-generic-rival-to-epipen-at-half-price/,Mylan To Launch Its Own EpiPen Generic Rival At Half Price
PFE,PFE:US,BBG000BR2B91,Analyst Recommendations for Akorn in 2016,2016-08-29 19:04:10 +0000,http://marketrealist.com/2016/08/analyst-recommendations-akorn-inc-2016/?utm_source=yahoo&utm_medium=feed,Analyst Recommendations for Akorn in 2016
PFE,PFE:US,BBG000BR2B91,Gilead Was Smart to Let Medivation Slip Through its Fingers,2016-08-29 17:28:17 +0000,http://finance.yahoo.com/news/gilead-smart-let-medivation-slip-172817037.html,Gilead Was Smart to Let Medivation Slip Through its Fingers
PFE,PFE:US,BBG000BR2B91,Mondelez Walks Away After Hershey Spurns Raised Bid,2016-08-29 16:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mwbCskVkyEw/mondelez-walks-away-after-hershey-spurns-raised-bid-20160829-00815,Mondelez Walks Away After Hershey Spurns Raised Bid
PFE,PFE:US,BBG000BR2B91,Five Healthcare Stocks Hedge Funds Like,2016-08-29 16:53:26 +0000,http://www.insidermonkey.com/blog/five-healthcare-stocks-hedge-funds-like-471117/,Five Healthcare Stocks Hedge Funds Like
PFE,PFE:US,BBG000BR2B91,"In Wake Of Medivation Deal, Argus Thinks Pfizer's Existing Business Is Underrated",2016-08-29 15:21:52 +0000,http://finance.yahoo.com/news/wake-medivation-deal-argus-thinks-152152007.html,"In Wake Of Medivation Deal, Argus Thinks Pfizer's Existing Business Is Underrated"
PFE,PFE:US,BBG000BR2B91,Ibrance and Xtandi Could Be in the Top 10 Oncology Drugs by 2021,2016-08-29 15:05:02 +0000,http://marketrealist.com/2016/08/ibrance-xtandi-top-10-oncology-drugs-2021/?utm_source=yahoo&utm_medium=feed,Ibrance and Xtandi Could Be in the Top 10 Oncology Drugs by 2021
PFE,PFE:US,BBG000BR2B91,What’s the Story behind the Pfizer-Medivation Deal?,2016-08-29 14:05:17 +0000,http://marketrealist.com/2016/08/whats-story-behind-pfizer-medivation-deal/?utm_source=yahoo&utm_medium=feed,What’s the Story behind the Pfizer-Medivation Deal?
PFE,PFE:US,BBG000BR2B91,[$$] Mylan to launch cut-price generic version of EpiPen,2016-08-29 14:00:59 +0000,"http://www.ft.com/cms/s/b3a63228-6de6-11e6-a0c9-1365ce54b926,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - The maker of a $300 injection for severe allergic shock bowed to a week of public pressure over the high price of the medicine and said it would introduce a copycat generic version that costs half as much. ...
PFE,PFE:US,BBG000BR2B91,Why Pfizer Remains Attractively Valued With Medivation,2016-08-29 13:44:00 +0000,http://www.forbes.com/sites/genemarcial/2016/08/29/why-pfizer-remains-attractively-valued-with-medivation/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Why Pfizer Remains Attractively Valued With Medivation
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/29/2016: MYL, TNXP, JNJ, PFE, ABT, MRK, AMGN",2016-08-29 13:12:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VDrONhpQHg4/health-care-sector-update-for-08292016-myl-tnxp-jnj-pfe-abt-mrk-amgn-cm671418,"Top Health care stocks JNJ flat PFE flat ABT flat MRK flat AMGN flat Health care shares were unchanged in pre market trade Monday. In health care stocks news, Tonix Pharmaceuticals Holding ( TNXP ) was up 13% after"
PFE,PFE:US,BBG000BR2B91,What Investors Should Know about the Pfizer-Anacor Deal,2016-08-29 12:05:46 +0000,http://marketrealist.com/2016/08/investors-know-pfizer-anacor-deal/?utm_source=yahoo&utm_medium=feed,What Investors Should Know about the Pfizer-Anacor Deal
PFE,PFE:US,BBG000BR2B91,Glaxo Bets It Can Shake Up HIV Treatment,2016-08-29 04:09:48 +0000,http://www.wsj.com/articles/glaxo-bets-it-can-shake-up-hiv-treatment-1472409636?ru=yahoo?mod=yahoo_itp,Glaxo Bets It Can Shake Up HIV Treatment
PFE,PFE:US,BBG000BR2B91,[$$] Glaxo Bets It Can Shake Up HIV Treatment,2016-08-28 18:40:40 +0000,http://www.wsj.com/articles/glaxo-bets-it-can-shake-up-hiv-treatment-1472409636?mod=yahoo_hs,[$$] Glaxo Bets It Can Shake Up HIV Treatment
PFE,PFE:US,BBG000BR2B91,"3 Stocks Up Over 1,000% in the Past 5 Years",2016-08-28 12:11:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ctsOQzD6Oio/3-stocks-up-over-1000-in-the-past-5-years-cm671276,"Image source  Getty Images.  Past performance doesn't guarantee supersize gains (or losses) in the future, but investors who took the risk and socked these three darlings into their portfolios five years ago are"
PFE,PFE:US,BBG000BR2B91,"3 Stocks Up Over 1,000% in the Past 5 Years",2016-08-28 10:49:39 +0000,http://www.fool.com/investing/2016/08/28/3-stocks-up-over-1000-in-the-past-5-years.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"3 Stocks Up Over 1,000% in the Past 5 Years"
PFE,PFE:US,BBG000BR2B91,Here Are All The Big Biotech Mergers In 2016,2016-08-27 22:36:10 +0000,http://finance.yahoo.com/news/big-biotech-mergers-2016-223610312.html,Here Are All The Big Biotech Mergers In 2016
PFE,PFE:US,BBG000BR2B91,Can Novartis Tide Over the Alcon Crisis?,2016-08-26 22:18:44 +0000,http://finance.yahoo.com/news/novartis-tide-over-alcon-crisis-221844366.html,Can Novartis Tide Over the Alcon Crisis?
PFE,PFE:US,BBG000BR2B91,6 More Pharma Companies Selling Overpriced Drugs,2016-08-26 17:30:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p4yb8i3lp6k/6-more-pharma-companies-selling-overpriced-drugs-cm670871,Kudos to Mylan NV (NASDAQ  MYL ) for offering discounts on the exorbitant price on EpiPen for patients with a high out of pocket
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: Pfizer's Big Buy, Boeing's Big Win",2016-08-26 15:32:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZSYMJatO5T8/dow-30-stock-roundup-pfizers-big-buy-boeings-big-win-cm670750,"The Dow suffered losses over the week, weighed down by a number of factors. The specter of falling crude prices returned to haunt investors, following the release of data which raised concerns about oversupply. Meanwhile, a major"
PFE,PFE:US,BBG000BR2B91,"Game On for Pfizer With $14 Billion Medivation Buyout (or, Why Pfizer's Buyout of Medivation Could Be a Smart Move)",2016-08-26 14:48:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A0xTlHfqZv4/game-on-for-pfizer-with-14-billion-medivation-buyout-or-why-pfizers-buyout-of-medivation-could-be-a-smart-move-cm670668,"Image source  Getty Images.  It's game on time for Pfizer (NYSE  PFE)    finally. On Monday, the giant pharma surprised the market by speeding past Sanofi (NYSE  SNY) to nab cancer"
PFE,PFE:US,BBG000BR2B91,3 Top Stocks For Retirees,2016-08-26 14:48:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XLX0gwQlY-4/3-top-stocks-for-retirees-cm670642,"Retirees can benefit from owning top tier stocks generating steady eddy income, but with thousands of stocks to choose from it can be tough figuring out which companies are best to include in portfolios. With that in"
PFE,PFE:US,BBG000BR2B91,"Dow 30 Stock Roundup: Pfizer's Big Buy, Boeing's Big Win",2016-08-26 13:24:01 +0000,http://finance.yahoo.com/news/dow-30-stock-roundup-pfizers-132401661.html,"Dow 30 Stock Roundup: Pfizer's Big Buy, Boeing's Big Win"
PFE,PFE:US,BBG000BR2B91,3 Top Stocks For Retirees,2016-08-26 13:20:00 +0000,http://www.fool.com/investing/2016/08/26/3-top-stocks-for-retirees.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Top Stocks For Retirees
PFE,PFE:US,BBG000BR2B91,"Game On for Pfizer With $14 Billion Medivation Buyout (or, Why Pfizer's Buyout of Medivation Could Be a Smart Move)",2016-08-26 12:02:00 +0000,http://www.fool.com/investing/2016/08/26/game-on-for-pfizer-with-14-billion-medivation-buyo.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Game On for Pfizer With $14 Billion Medivation Buyout (or, Why Pfizer's Buyout of Medivation Could Be a Smart Move)"
PFE,PFE:US,BBG000BR2B91,Biotech Funds Are Routine Casualty As Political Rhetoric Ratchets Up,2016-08-25 21:45:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fn8BU-8sWCg/biotech-funds-are-routine-casualty-as-political-rhetoric-ratchets-up-cm670147,"Flagship ETFs tracking the major indexes opened lower Thursday morning as a weekend conclave of policymakers in Wyoming looms. However, the S&P 500 and Dow Jones industrial average attempted to gain in early trade as oil prices reversed higher."
PFE,PFE:US,BBG000BR2B91,Mylan NV (MYL): Stop Rewarding Big Pharma Greed!,2016-08-25 20:47:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4J8u-QE_i1g/mylan-nv-myl-stop-rewarding-big-pharma-greed-cm670291,A 5.5% fall in shares of  Mylan NV  (NASDAQ  MYL ) on Aug. 24 trade was quickly followed by a 2% gain for MYL
PFE,PFE:US,BBG000BR2B91,Healthcare Drug Pricing a Factor for the Market on Wednesday,2016-08-25 19:45:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B4KoPRnA9IE/healthcare-drug-pricing-a-factor-for-the-market-on-wednesday-cm669883,"U.S. market indexes were lower on Wednesday. For the day, the Dow Jones Industrial Average closed at 18481.48 for a loss of  65.82 points, or  0.35%. The S&P 500 was also lower, closing at 2175.44"
PFE,PFE:US,BBG000BR2B91,Will Pfizer Take a Beating After Its Celebrex Settlement?,2016-08-25 19:41:06 +0000,http://finance.yahoo.com/news/pfizer-beating-celebrex-settlement-194106808.html,Will Pfizer Take a Beating After Its Celebrex Settlement?
PFE,PFE:US,BBG000BR2B91,Elliott Management Reduced Its Holding in Interpublic Group of Companies,2016-08-25 19:19:08 +0000,http://marketrealist.com/2016/08/elliott-management-reduced-holding-interpublic-group-companies/?utm_source=yahoo&utm_medium=feed,Elliott Management Reduced Its Holding in Interpublic Group of Companies
PFE,PFE:US,BBG000BR2B91,Pfizer (PFE) Stock Earnings Estimates Raised at Jefferies on $14 Billion Medivation Deal,2016-08-25 19:18:00 +0000,https://www.thestreet.com/story/13685907/1/pfizer-pfe-stock-earnings-estimates-raised-at-jefferies-on-14-billion-medivation-deal.html?puc=yahoo&cm_ven=YAHOO,Pfizer (PFE) Stock Earnings Estimates Raised at Jefferies on $14 Billion Medivation Deal
PFE,PFE:US,BBG000BR2B91,Pfizer Inks a $1.6 Billion Deal with AstraZeneca,2016-08-25 17:18:03 +0000,http://www.investopedia.com/stock-analysis/082516/pfizer-inks-16-billion-deal-astrazeneca-azn-pfe.aspx?partner=YahooSA,Pfizer Inks a $1.6 Billion Deal with AstraZeneca
PFE,PFE:US,BBG000BR2B91,"Biotech Funds Bounce After Another Steep, Hillary-Induced Sell-Off",2016-08-25 16:45:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X8MrMusKFz4/biotech-funds-bounce-after-another-steep-hillary-induced-sell-off-cm670147,"Flagship ETFs tracking the major indexes opened lower Thursday morning as a weekend conclave of policymakers in Wyoming looms. However, the S&P 500 and Dow Jones industrial average attempted to gain in early trade as oil prices reversed higher."
PFE,PFE:US,BBG000BR2B91,Why Roche Might Be Interested in BioMarin,2016-08-25 16:04:30 +0000,http://marketrealist.com/2016/08/roche-might-interested-biomarin/?utm_source=yahoo&utm_medium=feed,Why Roche Might Be Interested in BioMarin
PFE,PFE:US,BBG000BR2B91,"Company News for August 25, 2016",2016-08-25 15:45:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UI0gN0F87rk/company-news-for-august-25-2016-cm670085,"• Shares of Intuit Inc. ( INTU ) fell 3.5% after forecasting fiscal first quarter revenues in the range of $740 million to $760 million, lower than the Zacks Consensus Estimate of $780 million  • Pfizer"
PFE,PFE:US,BBG000BR2B91,AstraZeneca’s Recent Product Developments,2016-08-25 15:04:05 +0000,http://marketrealist.com/2016/08/astrazenecas-recent-product-developments/?utm_source=yahoo&utm_medium=feed,AstraZeneca’s Recent Product Developments
PFE,PFE:US,BBG000BR2B91,Pfizer Can Stall the Decision to Split — Thanks to Medivation,2016-08-25 14:35:59 +0000,http://finance.yahoo.com/tumblr/blog-pfizer-can-stall-the-decision-to-split-thanks-to-143606562.html,Pfizer Can Stall the Decision to Split — Thanks to Medivation
PFE,PFE:US,BBG000BR2B91,"Company News for August 25, 2016",2016-08-25 13:53:01 +0000,http://finance.yahoo.com/news/company-news-august-25-2016-135301154.html,"Company News for August 25, 2016"
PFE,PFE:US,BBG000BR2B91,"Allergan, Humana, Biogen: Billionaires’ Favorite Healthcare Stocks For Q3",2016-08-25 13:30:16 +0000,http://www.insidermonkey.com/blog/allergan-humana-biogen-billionaires-favorite-healthcare-stocks-for-q3-470339/,"Allergan, Humana, Biogen: Billionaires’ Favorite Healthcare Stocks For Q3"
PFE,PFE:US,BBG000BR2B91,Major Pharma Short Interest Faces Significant Drop,2016-08-25 12:45:54 +0000,http://247wallst.com/healthcare-business/2016/08/25/major-pharma-short-interest-faces-significant-drop/,Major Pharma Short Interest Faces Significant Drop
PFE,PFE:US,BBG000BR2B91,How Mylan And Pfizer Could Cause A Major Biotech Backlash,2016-08-25 12:31:00 +0000,http://www.forbes.com/sites/stephenbrozak/2016/08/25/how-mylan-and-pfizer-could-cause-a-major-biotech-backlash/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,How Mylan And Pfizer Could Cause A Major Biotech Backlash
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer Buys Part of AstraZeneca’s Antibiotics Business,2016-08-25 04:28:34 +0000,http://www.wsj.com/articles/astrazeneca-sells-part-of-antibiotics-business-to-pfizer-for-up-to-1-575-billion-1472021239?ru=yahoo?mod=yahoo_itp,[$$] Pfizer Buys Part of AstraZeneca’s Antibiotics Business
PFE,PFE:US,BBG000BR2B91,Pfizer to Buy Some Of Astra's Antibiotics -- WSJ,2016-08-25 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rmPI1PaT9pk/pfizer-to-buy-some-of-astras-antibiotics--wsj-20160825-00055,Pfizer to Buy Some Of Astra's Antibiotics -- WSJ
PFE,PFE:US,BBG000BR2B91,"HEB Gets Some Relief, ITEK Awaits Data In Dec., NYMX Abuzz, FDA Snubs AMGN",2016-08-25 01:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BleN1x1kLZI/heb-gets-some-relief-itek-awaits-data-in-dec-nymx-abuzz-fda-snubs-amgn-20160825-00026,"HEB Gets Some Relief, ITEK Awaits Data In Dec., NYMX Abuzz, FDA Snubs AMGN"
PFE,PFE:US,BBG000BR2B91,"HEB Gets Some Relief, ITEK Awaits Data In Dec., NYMX Abuzz, FDA Snubs AMGN",2016-08-25 01:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PXGZ1N-BZvM/heb-gets-some-relief-itek-awaits-data-in-dec-nymx-abuzz-fda-snubs-amgn-20160825-00025,"HEB Gets Some Relief, ITEK Awaits Data In Dec., NYMX Abuzz, FDA Snubs AMGN"
PFE,PFE:US,BBG000BR2B91,"HEB Gets Some Respite, ITEK Awaits Data In Dec., NYMX Abuzz, FDA Snubs AMGN",2016-08-25 01:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VwNapvPad8E/heb-gets-some-respite-itek-awaits-data-in-dec-nymx-abuzz-fda-snubs-amgn-20160825-00024,"HEB Gets Some Respite, ITEK Awaits Data In Dec., NYMX Abuzz, FDA Snubs AMGN"
PFE,PFE:US,BBG000BR2B91,Which Criteria Best Determine the Success of Mergers?,2016-08-25 00:41:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1oCpLErAors/which-criteria-best-determine-the-success-of-mergers-cm669847,"Throughout the past three months, several mergers, including the $14 billion merger between Pfizer Inc. ( PFE ) and Medivation Inc. ( MDVN ), were announced. In part one of our study , we discussed how the"
PFE,PFE:US,BBG000BR2B91,"Trade of the Day: Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)",2016-08-24 22:46:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tbofCaVtjVg/trade-of-the-day-achillion-pharmaceuticals-inc-nasdaqachn-cm669718,"To receive further information on this Achillion Pharmaceuticals, Inc. (NASDAQ  ACHN ) trade or any of  Profit Scanner's  trading opportunities ,  sign up for a risk"
PFE,PFE:US,BBG000BR2B91,"PFE, AZN: Pfizer Inc. to Buy AstraZeneca plc (ADR)’s Antibiotic Business",2016-08-24 22:46:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r0ZfP6ogCvA/pfe-azn-pfizer-inc-to-buy-astrazeneca-plc-adrs-antibiotic-business-cm669799,Pfizer Inc. (NYSE  PFE ) has announced that it will be acquiring part of  AstraZeneca plc (ADR)'s (NYSE  AZN ) antibiotic business.
PFE,PFE:US,BBG000BR2B91,"Merck & Co., Inc. Features Slow and Steady Dividend Growth (MRK)",2016-08-24 22:45:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f8_bd9vlJi8/merck-co-inc-features-slow-and-steady-dividend-growth-mrk-cm669813,"Merck & Co., Inc. ( MRK ) is a blue chip dividend stock that has paid a consistent dividend since 1970 and has grown its"
PFE,PFE:US,BBG000BR2B91,U.S. Market Indexes Higher on Tuesday,2016-08-24 22:41:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/85kkLjf7Qoc/us-market-indexes-higher-on-tuesday-cm669302,"U.S. market indexes were higher on Tuesday. For the day, the Dow Jones Industrial Average closed at 18547.30 for a gain of 17.88 points, or 0.10%. The S&P 500 was also higher, closing at 2186.90 for a"
PFE,PFE:US,BBG000BR2B91,"Dear Pfizer, Stop Overpaying for Acquisitions!",2016-08-24 21:45:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GOUg-HeNGsg/dear-pfizer-stop-overpaying-for-acquisitions-cm669797,"Image source  Getty Images.  If you've ever taken the time to sit down and listen to one of Pfizer 's(NYSE  PFE) quarterly conference calls or investor day updates, you'll catch many of"
PFE,PFE:US,BBG000BR2B91,Portfolio Manager: Is Pfizer Acquiring Too Quickly?,2016-08-24 21:27:00 +0000,http://realmoney.thestreet.com/articles/08/24/2016/portfolio-manager-pfizer-acquiring-too-quickly?puc=yahoo&cm_ven=YAHOO,Portfolio Manager: Is Pfizer Acquiring Too Quickly?
PFE,PFE:US,BBG000BR2B91,Business Highlights,2016-08-24 21:24:40 +0000,http://sg.finance.yahoo.com/news/business-highlights-212440159.html,Business Highlights
PFE,PFE:US,BBG000BR2B91,Pfizer on buying spree with AstraZeneca antibiotics deal,2016-08-24 21:11:59 +0000,http://sg.finance.yahoo.com/news/pfizer-buying-spree-astrazeneca-antibiotics-175437812.html,Pfizer on buying spree with AstraZeneca antibiotics deal
PFE,PFE:US,BBG000BR2B91,AstraZeneca Sells Antibiotics Business; Mallinckrodt Sheds Imaging Unit,2016-08-24 20:52:57 +0000,http://www.investors.com/news/technology/astrazeneca-sells-antibiotics-biz-mallinkcrodt-sheds-imaging-unit/,AstraZeneca Sells Antibiotics Business; Mallinckrodt Sheds Imaging Unit
PFE,PFE:US,BBG000BR2B91,Biotech Stocks Seesaw As M&A Hopes Meet New Pricing Fears,2016-08-24 20:50:18 +0000,http://www.investors.com/news/technology/biotech-stocks-seesaw-as-ma-hopes-meet-new-pricing-fears/,Biotech Stocks Seesaw As M&A Hopes Meet New Pricing Fears
PFE,PFE:US,BBG000BR2B91,"Crude Oil, Health Care Team Up to Pull Wall Street Lower",2016-08-24 20:03:00 +0000,https://www.thestreet.com/story/13684482/1/crude-oil-health-care-team-up-to-pull-wall-street-lower.html?puc=yahoo&cm_ven=YAHOO,"Crude Oil, Health Care Team Up to Pull Wall Street Lower"
PFE,PFE:US,BBG000BR2B91,"Dear Pfizer, Stop Overpaying for Acquisitions!",2016-08-24 19:41:00 +0000,http://www.fool.com/investing/2016/08/24/dear-pfizer-stop-overpaying-for-acquisitions.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Dear Pfizer, Stop Overpaying for Acquisitions!"
PFE,PFE:US,BBG000BR2B91,Stocks Extend Decline as Crude Falls to One-Week Low,2016-08-24 18:50:00 +0000,https://www.thestreet.com/story/13684168/1/stocks-decline-as-crude-slides-fed-summit-ticks-closer.html?puc=yahoo&cm_ven=YAHOO,Stocks Extend Decline as Crude Falls to One-Week Low
PFE,PFE:US,BBG000BR2B91,Pfizer's $1.5 Billion Antibiotics Buy: Strategic Long-Term Planning Or Pre-Split Prep?,2016-08-24 18:42:24 +0000,http://finance.yahoo.com/news/pfizers-1-5-billion-antibiotics-184224882.html,Pfizer's $1.5 Billion Antibiotics Buy: Strategic Long-Term Planning Or Pre-Split Prep?
PFE,PFE:US,BBG000BR2B91,Which Criteria Best Determine the Success of Mergers?,2016-08-24 18:39:14 +0000,http://finance.yahoo.com/news/criteria-best-determine-success-mergers-183914832.html,Which Criteria Best Determine the Success of Mergers?
PFE,PFE:US,BBG000BR2B91,AstraZeneca to sell antibiotic pills business to Pfizer,2016-08-24 17:25:46 +0000,http://sg.finance.yahoo.com/news/astrazeneca-sell-antibiotic-pills-business-172546403.html,AstraZeneca to sell antibiotic pills business to Pfizer
PFE,PFE:US,BBG000BR2B91,"Top trades for the 2nd half: Lending Club, Amgen & more",2016-08-24 16:59:00 +0000,http://finance.yahoo.com/video/top-trades-2nd-half-lending-165900973.html,"Top trades for the 2nd half: Lending Club, Amgen & more"
PFE,PFE:US,BBG000BR2B91,"Market News Over Summer Vacation: PFE, AZN, TSLA, LZB",2016-08-24 16:47:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gbnVHJ2ljjA/market-news-over-summer-vacation-pfe-azn-tsla-lzb-cm669631,"Wednesday, August 24, 2016  You know you're in the middle of a market slow down period when before the bell ""news"" focuses on the 2016 Economic Symposium in Jackson Hole, WY when Fed Chair Janet Yellen"
PFE,PFE:US,BBG000BR2B91,Pfizer to Buy Rival's Antibiotics Business (PFN),2016-08-24 16:00:00 +0000,http://www.investopedia.com/news/pfizer-buy-rivals-antibiotics-business-pfn/?partner=YahooSA,Pfizer to Buy Rival's Antibiotics Business (PFN)
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer Buys Part of AstraZeneca's Antibiotics Business,2016-08-24 15:39:54 +0000,http://www.wsj.com/articles/astrazeneca-sells-part-of-antibiotics-business-to-pfizer-for-up-to-1-575-billion-1472021239?mod=yahoo_hs,[$$] Pfizer Buys Part of AstraZeneca's Antibiotics Business
PFE,PFE:US,BBG000BR2B91,[$$] Smaller Biotech Buyout Targets After Medivation,2016-08-24 15:17:00 +0000,http://www.barrons.com/articles/smaller-biotech-buyout-targets-after-medivation-1472051871?mod=yahoobarrons&ru=yahoo,[$$] Smaller Biotech Buyout Targets After Medivation
PFE,PFE:US,BBG000BR2B91,Medivation: The Latest Analyst Recommendations,2016-08-24 15:04:05 +0000,http://marketrealist.com/2016/08/medivation-the-latest-analyst-recommendations/?utm_source=yahoo&utm_medium=feed,Medivation: The Latest Analyst Recommendations
PFE,PFE:US,BBG000BR2B91,Risk Arbitrage Trading Strategies,2016-08-24 14:56:04 +0000,http://finance.yahoo.com/news/risk-arbitrage-trading-strategies-145604981.html,Risk Arbitrage Trading Strategies
PFE,PFE:US,BBG000BR2B91,[$$] AstraZeneca and Pfizer strike $1.6bn antibiotics deal,2016-08-24 14:19:56 +0000,"http://www.ft.com/cms/s/c7ca348a-69e9-11e6-ae5b-a7cc5dd5a28c,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Anglo-Swedish pharmaceuticals group AstraZeneca has agreed to sell part of its antibiotics business to former US suitor Pfizer in a deal worth up to $1.6bn. The sale, unveiled on Wednesday, sees Pfizer ..."
PFE,PFE:US,BBG000BR2B91,"Market News Over Summer Vacation: PFE, AZN, TSLA, LZB",2016-08-24 14:11:02 +0000,http://finance.yahoo.com/news/market-news-over-summer-vacation-141102398.html,"Market News Over Summer Vacation: PFE, AZN, TSLA, LZB"
PFE,PFE:US,BBG000BR2B91,Write A Prescription For More Pharma M&A With This ETF,2016-08-24 14:00:38 +0000,http://finance.yahoo.com/news/write-prescription-more-pharma-m-140038698.html,Write A Prescription For More Pharma M&A With This ETF
PFE,PFE:US,BBG000BR2B91,"Stock Market News for August 24, 2016",2016-08-24 13:56:01 +0000,http://finance.yahoo.com/news/stock-market-news-august-24-135601214.html,"Stock Market News for August 24, 2016"
PFE,PFE:US,BBG000BR2B91,Pfizer to Acquire Rights to AstraZeneca's Antibiotics Business,2016-08-24 13:48:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Fxwfa9Sb7wM/pfizer-to-acquire-rights-to-astrazenecas-antibiotics-business-cm669407,"Pfizer Inc.PFE announced that it has entered into an agreement to acquire the rights to AstraZeneca plc's AZN late stage small molecule anti infectives business, primarily in the ex U.S. markets.  The transaction will give Pfizer"
PFE,PFE:US,BBG000BR2B91,AstraZeneca to sell molecule antibiotics business to Pfizer,2016-08-24 13:45:18 +0000,http://sg.finance.yahoo.com/news/astrazeneca-sell-molecule-antibiotics-business-104259172.html,AstraZeneca to sell molecule antibiotics business to Pfizer
PFE,PFE:US,BBG000BR2B91,"Stocks Open Flat To Lower As Oil Dips; Lannett Surges, Intuit, Express Dive",2016-08-24 13:40:34 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-narrowly-higher-lannett-rockets-intuit-express-cave/,"Stocks Open Flat To Lower As Oil Dips; Lannett Surges, Intuit, Express Dive"
PFE,PFE:US,BBG000BR2B91,"Deals of the Day: Pfizer Does Another Deal, Bracing for a September IPO Spike",2016-08-24 13:07:02 +0000,http://blogs.wsj.com/moneybeat/2016/08/24/deals-of-the-day-pfizer-does-another-deal-bracing-for-a-september-ipo-spike/?mod=yahoo_hs,"Deals of the Day: Pfizer Does Another Deal, Bracing for a September IPO Spike"
PFE,PFE:US,BBG000BR2B91,Why Pfizer's Latest Deal Could Send Its Shares Soaring,2016-08-24 13:04:00 +0000,https://www.thestreet.com/story/13683180/1/why-pfizer-s-latest-deal-could-send-its-shares-soaring.html?puc=yahoo&cm_ven=YAHOO,Why Pfizer's Latest Deal Could Send Its Shares Soaring
PFE,PFE:US,BBG000BR2B91,"Apple, McDonald’s, Yahoo: 5 Stocks Hedge Funds Were Getting Rid of During Q2",2016-08-24 13:00:22 +0000,http://www.insidermonkey.com/blog/apple-mcdonalds-yahoo-5-stocks-hedge-funds-were-getting-rid-of-during-q2-470315/,"Apple, McDonald’s, Yahoo: 5 Stocks Hedge Funds Were Getting Rid of During Q2"
PFE,PFE:US,BBG000BR2B91,Stock Futures Little Changed in Wait for Friday's Yellen Speech,2016-08-24 12:51:00 +0000,https://www.thestreet.com/story/13682827/1/stock-futures-little-changed-in-wait-for-friday-s-yellen-speech.html?puc=yahoo&cm_ven=YAHOO,Stock Futures Little Changed in Wait for Friday's Yellen Speech
PFE,PFE:US,BBG000BR2B91,AstraZeneca selling antibiotic unit to Pfizer for $725M,2016-08-24 12:50:11 +0000,http://www.bizjournals.com/philadelphia/news/2016/08/24/astrazeneca-antibiotic-pfizer.html?ana=yahoo,AstraZeneca selling antibiotic unit to Pfizer for $725M
PFE,PFE:US,BBG000BR2B91,Jacobs Wins Pfizer's Chinese Bio-Facility Project Contract,2016-08-24 12:47:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SM-F8WY3oyE/jacobs-wins-pfizers-chinese-bio-facility-project-contract-cm669372,Jacobs Engineering Group Inc.JEC recently received a contract from Pfizer Inc. PFE to develop a new state of the art biotechnology centre in China. The new contract would not only boost Jacobs' organic growth but is also
PFE,PFE:US,BBG000BR2B91,"Early movers: FIT, TSLA, PFE, LZB, CLVS, NMBL & more",2016-08-24 12:08:53 +0000,http://www.cnbc.com/id/103889463?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103889463,"Early movers: FIT, TSLA, PFE, LZB, CLVS, NMBL & more"
PFE,PFE:US,BBG000BR2B91,Pfizer: Let's Stay Together,2016-08-24 12:00:29 +0000,http://www.bloomberg.com/gadfly/articles/2016-08-24/pfizer-split-looking-less-likely-with-every-deal-it-does?cmpid=yhoo.headline,Pfizer: Let's Stay Together
PFE,PFE:US,BBG000BR2B91,Forget About That Pfizer Mega-Merger,2016-08-24 12:00:23 +0000,http://www.bloomberg.com/gadfly/articles/2016-08-24/pfizer-mega-merger-not-as-likely-as-smaller-deals?cmpid=yhoo.headline,Forget About That Pfizer Mega-Merger
PFE,PFE:US,BBG000BR2B91,"U.S. stock futures search for firm direction, marooned in wait for Yellen",2016-08-24 11:27:00 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=7E7E4D06-69D6-11E6-933B-8BAFB8E4E1DA&siteid=yhoof2,"[at MarketWatch] - U.S. stock futures wander between small gains and losses Wednesday, suggesting a muted open for Wall Street as investors keep up their wait for the Federal Reserve’s summer summit."
PFE,PFE:US,BBG000BR2B91,Pfizer to Acquire Rights to AstraZeneca's Antibiotics Business,2016-08-24 11:14:11 +0000,http://finance.yahoo.com/news/pfizer-acquire-rights-astrazenecas-antibiotics-111411833.html,Pfizer to Acquire Rights to AstraZeneca's Antibiotics Business
PFE,PFE:US,BBG000BR2B91,Pfizer Picks Up AstraZeneca's Antibiotics Business,2016-08-24 11:01:00 +0000,https://www.thestreet.com/story/13683495/1/pfizer-picks-up-astrazeneca-s-antibiotics-business.html?puc=yahoo&cm_ven=YAHOO,Pfizer Picks Up AstraZeneca's Antibiotics Business
PFE,PFE:US,BBG000BR2B91,10 things you need to know today,2016-08-24 10:50:00 +0000,http://finance.yahoo.com/news/10-things-know-opening-bell-105000599.html,10 things you need to know today
PFE,PFE:US,BBG000BR2B91,AstraZeneca to sell molecule antibiotics business to Pfizer,2016-08-24 10:42:59 +0000,http://finance.yahoo.com/news/astrazeneca-sell-molecule-antibiotics-business-104259357.html,AstraZeneca to sell molecule antibiotics business to Pfizer
PFE,PFE:US,BBG000BR2B91,Jacobs Wins Pfizer's Chinese Bio-Facility Project Contract,2016-08-24 10:32:10 +0000,http://finance.yahoo.com/news/jacobs-wins-pfizers-chinese-bio-103210901.html,Jacobs Wins Pfizer's Chinese Bio-Facility Project Contract
PFE,PFE:US,BBG000BR2B91,5 Things You Must Know Before the Market Opens Wednesday,2016-08-24 10:02:00 +0000,https://www.thestreet.com/story/13682214/1/5-things-you-must-know-before-the-market-opens-wednesday.html?puc=yahoo&cm_ven=YAHOO,5 Things You Must Know Before the Market Opens Wednesday
PFE,PFE:US,BBG000BR2B91,What does AstraZeneca plc’s deal with Pfizer mean for shareholders?,2016-08-24 09:56:08 +0000,http://uk.finance.yahoo.com/news/does-astrazeneca-plc-deal-pfizer-095608782.html,What does AstraZeneca plc’s deal with Pfizer mean for shareholders?
PFE,PFE:US,BBG000BR2B91,AstraZeneca sells part of antibiotics unit to Pfizer,2016-08-24 08:32:58 +0000,http://uk.finance.yahoo.com/news/astrazeneca-sells-part-antibiotics-unit-083258293.html,AstraZeneca sells part of antibiotics unit to Pfizer
PFE,PFE:US,BBG000BR2B91,Pfizer to buy antibiotics business from AstraZeneca,2016-08-24 07:48:21 +0000,http://sg.finance.yahoo.com/news/astrazeneca-sell-antibiotics-business-pfizer-061644642.html,Pfizer to buy antibiotics business from AstraZeneca
PFE,PFE:US,BBG000BR2B91,Pfizer to buy antibiotics business from AstraZeneca,2016-08-24 07:44:07 +0000,http://uk.finance.yahoo.com/news/pfizer-buy-antibiotics-business-astrazeneca-074407334.html,"[Reuters - UK Focus] - Pharmaceutical company AstraZeneca has agreed to sell its small molecule antibiotics business to Pfizer Inc in a deal that could be valued at more than $1.5 billion. AstraZeneca, which saw off a $120 billion ..."
PFE,PFE:US,BBG000BR2B91,Pfizer To Acquire Small Molecule Anti-Infective Business From AstraZeneca,2016-08-24 06:38:01 +0000,http://www.publicnow.com/view/A3552E7E14C06E9913223306E763344637535BD3,"[at noodls] - Pfizer Inc. (NYSE:PFE) today announced that it has entered into an agreement with AstraZeneca to acquire the development and commercialization rights to its late-stage small molecule anti-infectives business, ..."
PFE,PFE:US,BBG000BR2B91,AstraZeneca to sell antibiotics business to Pfizer,2016-08-24 06:15:05 +0000,http://uk.finance.yahoo.com/news/astrazeneca-sell-antibiotics-business-pfizer-061505107.html,[Reuters - UK Focus] - Pharmaceutical company AstraZeneca said it had agreed to sell its small molecule antibiotics business to Pfizer in a deal that could reach more than $1.5 billion. The portfolio includes approved antibiotics ...
PFE,PFE:US,BBG000BR2B91,Pfizer to Buy Antibiotics From AstraZeneca for $725 Million,2016-08-24 06:09:54 +0000,http://www.bloomberg.com/news/articles/2016-08-24/pfizer-to-buy-small-molecule-antibiotics-unit-from-astrazeneca?cmpid=yhoo.headline,Pfizer to Buy Antibiotics From AstraZeneca for $725 Million
PFE,PFE:US,BBG000BR2B91,Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca,2016-08-24 06:00:00 +0000,http://finance.yahoo.com/news/pfizer-acquire-small-molecule-anti-060000749.html,"[Business Wire] - Pfizer Inc. today announced that it has entered into an agreement with AstraZeneca to acquire the development and commercialization rights to its late-stage small molecule anti-infectives business, primarily outside the United States."
PFE,PFE:US,BBG000BR2B91,Pfizer Buys Part of AstraZeneca''s Antibiotics Business -- 2nd Update,2016-08-24 05:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DVjoVy1QA5w/pfizer-buys-part-of-astrazenecas-antibiotics-business--2nd-update-20160824-00074,Pfizer Buys Part of AstraZeneca''s Antibiotics Business -- 2nd Update
PFE,PFE:US,BBG000BR2B91,AstraZeneca Sells Part of its Antibiotics Business to Pfizer -- Update,2016-08-24 04:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QHEATQsPW6Y/astrazeneca-sells-part-of-its-antibiotics-business-to-pfizer--update-20160824-00061,AstraZeneca Sells Part of its Antibiotics Business to Pfizer -- Update
PFE,PFE:US,BBG000BR2B91,AstraZeneca Sells Part of its Antibiotics Business to Pfizer,2016-08-24 04:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y7m0aXZPEWg/astrazeneca-sells-part-of-its-antibiotics-business-to-pfizer-20160824-00062,AstraZeneca Sells Part of its Antibiotics Business to Pfizer
PFE,PFE:US,BBG000BR2B91,Pfizer Buys Part of AstraZeneca''s Antibiotics Business,2016-08-24 04:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UjyXaj3rYnY/pfizer-buys-part-of-astrazenecas-antibiotics-business-20160824-00075,Pfizer Buys Part of AstraZeneca''s Antibiotics Business
PFE,PFE:US,BBG000BR2B91,AstraZeneca Sells Part of Antibiotics Business to Pfizer,2016-08-24 04:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HKYuK-sGVok/astrazeneca-sells-part-of-antibiotics-business-to-pfizer-20160824-00056,AstraZeneca Sells Part of Antibiotics Business to Pfizer
PFE,PFE:US,BBG000BR2B91,Pfizer Buys Part of AstraZeneca's Antibiotics Business,2016-08-24 04:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VzprFIAXXwk/pfizer-buys-part-of-astrazenecas-antibiotics-business-20160824-00076,Pfizer Buys Part of AstraZeneca's Antibiotics Business
PFE,PFE:US,BBG000BR2B91,AstraZeneca Sells Part of Antibiotics Business to Pfizer for Up to $1.575 Billion,2016-08-24 03:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y0e7LOmdS7Y/astrazeneca-sells-part-of-antibiotics-business-to-pfizer-for-up-to-1575-billion-20160824-00048,AstraZeneca Sells Part of Antibiotics Business to Pfizer for Up to $1.575 Billion
PFE,PFE:US,BBG000BR2B91,Pfizer Acquires Rights Of AstraZeneca's Small Molecule Anti-infectives Business,2016-08-24 02:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a5IQtWUlUHs/pfizer-acquires-rights-of-astrazenecas-small-molecule-antiinfectives-business-20160824-00025,Pfizer Acquires Rights Of AstraZeneca's Small Molecule Anti-infectives Business
PFE,PFE:US,BBG000BR2B91,U.S. Market Indexes Higher on Tuesday,2016-08-23 23:21:31 +0000,http://finance.yahoo.com/news/u-market-indexes-higher-tuesday-231614775.html,U.S. Market Indexes Higher on Tuesday
PFE,PFE:US,BBG000BR2B91,"Pfizer Acquires Medivation, Renews Biotech M&A Bets",2016-08-23 22:47:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aW2rSRnWQCs/pfizer-acquires-medivation-renews-biotech-ma-bets-cm668631,"Pfizer ( PFE ) announced a $14 billion deal to acquire cancer drug developer Medivation (NasdaqGS  MDVN), propelling the broader biotechnology exchange traded funds higher on speculation of more deals in the sector.  Biopharmaceutical giant"
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Aug 23, 2016 :  ESRX, AAPL, LMT, WIX, CSCO, MSFT, EMC, AMAT, WFT, PFE, BAC, C",2016-08-23 21:09:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zg8XlSKpm7g/after-hours-most-active-for-aug-23-2016-esrx-aapl-lmt-wix-csco-msft-emc-amat-wft-pfe-bac-c-cm669240,"The NASDAQ 100 After Hours Indicator is down 1.39 to 4,817.09. The total After hours volume is currently 25,228,394 shares traded. The following are the most active stocks for the after hours session Express Scripts Holding Company ( ESRX"
PFE,PFE:US,BBG000BR2B91,The 3 Best Fidelity ETFs … No Matter Who Wins the Election!,2016-08-23 20:48:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wr_WmjCJOFA/the-3-best-fidelity-etfs-no-matter-who-wins-the-election-cm668750,One of Wall Street's favorite games right now is gaming the 2016 election. What stocks will soar if Hillary Clinton enters the White House? What
PFE,PFE:US,BBG000BR2B91,"Why Intersil Corp (ISIL), Medivation Inc (MDVN) and United States Steel Corporation (X) Are 3 of Today’s Best Stocks",2016-08-23 20:47:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W3286-wlAu4/why-intersil-corp-isil-medivation-inc-mdvn-and-united-states-steel-corporation-x-are-3-of-todays-best-stocks-cm668795,It was a quiet start to the week for stocks as investors appeared pensive about what could come of the Federal Reserve's meeting in Jackson
PFE,PFE:US,BBG000BR2B91,Stocks Finish Mixed Amid Summer Doldrums,2016-08-23 20:47:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RiVMkA7DHOg/stocks-finish-mixed-amid-summer-doldrums-cm668804,"U.S. equities finished mixed on Monday amid quiet, late summer trading.  In the end, the Dow Jones Industrial Average lost 0.1%, the S&P 500"
PFE,PFE:US,BBG000BR2B91,"S&P 500, Nasdaq near records as housing data boosts stocks",2016-08-23 18:51:27 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=6F18A0F2-6907-11E6-9466-B35C1E3D9BB5&siteid=yhoof2,"S&P 500, Nasdaq near records as housing data boosts stocks"
PFE,PFE:US,BBG000BR2B91,Pfizer & Medivation: A Big Win Like Gilead-Pharmasset or a Big Bust Like Bristol-Inhibitex?,2016-08-23 18:39:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/23/pfizer-medivation-a-big-win-like-gilead-pharmasset-or-a-big-bust-like-bristol-inhibitex/?mod=yahoobarrons&ru=yahoo,Pfizer & Medivation: A Big Win Like Gilead-Pharmasset or a Big Bust Like Bristol-Inhibitex?
PFE,PFE:US,BBG000BR2B91,"Dow Movers: XOM, PFE",2016-08-23 15:46:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zwZ90Flf9BA/dow-movers-xom-pfe-cm668954,"In early trading on Tuesday, shares of Pfizer topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.2%. Year to date, Pfizer registers a 9.2% gain."
PFE,PFE:US,BBG000BR2B91,3 Value Stocks Senior Citizens Could Buy Right Now,2016-08-23 14:47:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l-SKdp6f0qk/3-value-stocks-senior-citizens-could-buy-right-now-cm668922,"Image Source  Getty Images.  Retirement is certainly not the time to take on undue amounts of risk. Even so, there's a lot to be said about owning at least a few high quality dividend stocks"
PFE,PFE:US,BBG000BR2B91,"Stock Market News for August 23, 2016",2016-08-23 14:10:02 +0000,http://finance.yahoo.com/news/stock-market-news-august-23-141002044.html,"Stock Market News for August 23, 2016"
PFE,PFE:US,BBG000BR2B91,Top 10 Shareholders of Pfizer (PFE),2016-08-23 14:00:00 +0000,http://www.investopedia.com/articles/company-insights/082316/top-10-shareholders-pfizer-pfe.asp?partner=YahooSA,Top 10 Shareholders of Pfizer (PFE)
PFE,PFE:US,BBG000BR2B91,"Tiger Cub Lee Ainslie Warns About Valuations, Reveals Major Q2 Moves",2016-08-23 13:38:49 +0000,http://www.insidermonkey.com/blog/tiger-cub-lee-ainslie-warns-about-valuations-reveals-major-q2-moves-470173/,"Tiger Cub Lee Ainslie Warns About Valuations, Reveals Major Q2 Moves"
PFE,PFE:US,BBG000BR2B91,"Deals of the Day: Apple Gets a Gliimpse, Pfizer's Steep Price",2016-08-23 13:30:18 +0000,http://blogs.wsj.com/moneybeat/2016/08/23/deals-of-the-day-apple-gets-a-gliimpse-pfizers-steep-price/?mod=yahoo_hs,"Deals of the Day: Apple Gets a Gliimpse, Pfizer's Steep Price"
PFE,PFE:US,BBG000BR2B91,Pfizer Expands Cancer Drug Portfolio with the Acquisition of Medivation,2016-08-23 13:16:18 +0000,http://news.investornetwork.com/2016/08/23/pfizer-expands-cancer-drug-portfolio-with-the-acquisition-of-medivation-latest-report-on-pfizer/?1=1&1471958178,Pfizer Expands Cancer Drug Portfolio with the Acquisition of Medivation
PFE,PFE:US,BBG000BR2B91,Pfizer’s Medivation Acquisition: What You Need to Know,2016-08-23 13:04:05 +0000,http://marketrealist.com/2016/08/pfizers-medivation-acquisition-what-you-need-to-know/?utm_source=yahoo&utm_medium=feed,Pfizer’s Medivation Acquisition: What You Need to Know
PFE,PFE:US,BBG000BR2B91,"Your first trade for Tuesday, August 23",2016-08-23 13:03:31 +0000,http://www.cnbc.com/id/103887061?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103887061,"Your first trade for Tuesday, August 23"
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/23/2016: CEMP, BSPM, JNJ, PFE, ABT, MRK, AMGN",2016-08-23 13:00:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PdO914FwSp0/health-care-sector-update-for-08232016-cemp-bspm-jnj-pfe-abt-mrk-amgn-cm668888,"Top Health care stocks JNJ flat PFE +0.7% ABT flat MRK flat AMGN flat Health care shares were mostly unchanged in pre market trade Tuesday. In health care stocks news, Biostar Pharmaceuticals ( BSPM ) was down 31% in"
PFE,PFE:US,BBG000BR2B91,Pfizer Has Had A Busy M&A Year...Or Has It?,2016-08-23 12:58:07 +0000,http://finance.yahoo.com/news/pfizer-had-busy-m-125807635.html,Pfizer Has Had A Busy M&A Year...Or Has It?
PFE,PFE:US,BBG000BR2B91,Medivation (MDVN) Stock Downgraded After Pfizer Deal,2016-08-23 12:47:00 +0000,https://www.thestreet.com/story/13682438/1/medivation-mdvn-stock-downgraded-after-pfizer-deal.html?puc=yahoo&cm_ven=YAHOO,Medivation (MDVN) Stock Downgraded After Pfizer Deal
PFE,PFE:US,BBG000BR2B91,What Pfizer Gets in Its $14 Billion Medivation Deal,2016-08-23 12:45:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OddFBnwUk0Q/what-pfizer-gets-in-its-14-billion-medivation-deal-cm668860,"Image source  Getty Images.  After spurning multiple public offers to be bought by drug giant Sanofi SA , Medivation 's(NASDAQ  MDVN) board of directors has agreed to sell to Pfizer, Inc. (NYSE"
PFE,PFE:US,BBG000BR2B91,3 Value Stocks Senior Citizens Could Buy Right Now,2016-08-23 12:41:00 +0000,http://www.fool.com/retirement/2016/08/23/3-value-stocks-senior-citizens-could-buy-right-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Value Stocks Senior Citizens Could Buy Right Now
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb and Pfizer to Present New Eliquis (apixaban) Analyses at ESC Congress 2016,2016-08-23 12:08:04 +0000,http://www.publicnow.com/view/44D817B3D267775DA01C80533CC9D4FDB2189B7F,"[at noodls] - Bristol-Myers Squibb Company(link is external)(NYSE: BMY) and Pfizer Inc.(NYSE: PFE) announced today that 19 abstracts (late-breaking, rapid-fire, oral and poster presentations) will be presented at ESC ..."
PFE,PFE:US,BBG000BR2B91,Jacobs Awarded Design Contract for Pfizer Global Biotechnology Center in China,2016-08-23 11:45:00 +0000,http://au.finance.yahoo.com/news/jacobs-awarded-design-contract-pfizer-114500493.html,"[Business Wire] - PASADENA, Calif.--(BUSINESSWIRE)-- Jacobs Engineering Group Inc. (NYSE:JEC - News) announced today it was awarded a contract to lead design and provide engineering services, procurement and construction support for Pfizer, Inc.’s new $350 million Global Biotechnology Center investment in the Hangzhou Economic Development Area in China. The facility is being built to produce monoclonal antibodies and also serve as a process development and clinical supply site for biologic medicines in China. In making the announcement, Jacobs Senior Vice President Life Sciences Robert Norfleet stated, “This is an exciting opportunity for our Life Sciences business."
PFE,PFE:US,BBG000BR2B91,Bristol-Myers Squibb and Pfizer to Present New Eliquis (apixaban) Analyses at ESC Congress 2016,2016-08-23 11:08:03 +0000,http://www.publicnow.com/view/C81A06B81A77A0FE6B9AC9DEA0FB3F377446D166,"[at noodls] - PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced today that 19 abstracts (late-breaking, rapid-fire, oral and poster presentations) ..."
PFE,PFE:US,BBG000BR2B91,What Pfizer Gets in Its $14 Billion Medivation Deal,2016-08-23 11:01:00 +0000,http://www.fool.com/investing/2016/08/23/what-pfizer-gets-in-its-14-billion-medivation-deal.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What Pfizer Gets in Its $14 Billion Medivation Deal
PFE,PFE:US,BBG000BR2B91,"Pfizer to Buy Medivation for $14B, Boost Cancer Franchise (revised)",2016-08-23 10:40:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W_ppGfTGkTQ/pfizer-to-buy-medivation-for-14b-boost-cancer-franchise-revised-cm668842,"Putting rumors to rest, Pfizer Inc.PFE and Medivation, Inc. MDVN announced that they have entered into a definitive merger agreement under which Pfizer will acquire Medivation for $81.50 per share in cash or a total enterprise value"
PFE,PFE:US,BBG000BR2B91,"Pfizer to Buy Medivation for $14B, Boost Cancer Franchise (revised)",2016-08-23 08:50:08 +0000,http://finance.yahoo.com/news/pfizer-buy-medivation-14b-boost-085008468.html,"Pfizer to Buy Medivation for $14B, Boost Cancer Franchise (revised)"
PFE,PFE:US,BBG000BR2B91,"GLOBAL MARKETS-Stocks creep up amid Fed limbo, dollar dips",2016-08-23 08:41:24 +0000,http://uk.finance.yahoo.com/news/global-markets-stocks-creep-amid-084124136.html,[Reuters - UK Focus] - World shares crept up on Tuesday while the dollar lost ground as investors awaited further clues on whether the Federal Reserve will raise U.S (Other OTC: UBGXF - news) . A quarter-point hike is not fully priced in until September 2017.
PFE,PFE:US,BBG000BR2B91,Jacobs Wins Contract For Pfizer Global Biotechnology Center In China,2016-08-23 07:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vuOtvxf1ibg/jacobs-wins-contract-for-pfizer-global-biotechnology-center-in-china-20160823-00220,Jacobs Wins Contract For Pfizer Global Biotechnology Center In China
PFE,PFE:US,BBG000BR2B91,PRESS DIGEST- New York Times business news - Aug 23,2016-08-23 04:23:40 +0000,http://finance.yahoo.com/news/press-digest-york-times-business-042340604.html,PRESS DIGEST- New York Times business news - Aug 23
PFE,PFE:US,BBG000BR2B91,PRESS DIGEST - Wall Street Journal - Aug 23,2016-08-23 04:18:41 +0000,http://finance.yahoo.com/news/press-digest-wall-street-journal-041841114.html,[Reuters] - The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy. - A federal judge prodded the U.S. State Department to quickly ...
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer’s Medivation Deal Latest in Long Line of Similar Acquisitions,2016-08-23 04:09:26 +0000,http://www.wsj.com/articles/pfizers-medivation-deal-latest-in-long-line-of-similar-acquisitions-1471882973?ru=yahoo?mod=yahoo_itp,[$$] Pfizer’s Medivation Deal Latest in Long Line of Similar Acquisitions
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer to Buy Medivation for $14 Billion,2016-08-23 04:09:24 +0000,http://www.wsj.com/articles/pfizer-to-buy-medivation-for-14-billion-1471864168?ru=yahoo?mod=yahoo_itp,[$$] Pfizer to Buy Medivation for $14 Billion
PFE,PFE:US,BBG000BR2B91,[$$] Medivation Ovation: Pfizer Pays the Price for Growth,2016-08-23 04:07:16 +0000,http://www.wsj.com/articles/pfizer-pays-the-price-for-growth-1471884546?ru=yahoo?mod=yahoo_itp,[at The Wall Street Journal] - Pfizer’s $14 billion acquisition shows quality midsize biotechs are in short supply.
PFE,PFE:US,BBG000BR2B91,Asian stocks in summer lull as markets await Yellen speech,2016-08-23 03:45:36 +0000,http://sg.finance.yahoo.com/news/stocks-fall-early-trading-oil-140542948.html,Asian stocks in summer lull as markets await Yellen speech
PFE,PFE:US,BBG000BR2B91,M&A is key to Pfizer's sales growth: Strategist,2016-08-23 03:36:00 +0000,http://finance.yahoo.com/video/m-key-pfizers-sales-growth-033600371.html,M&A is key to Pfizer's sales growth: Strategist
PFE,PFE:US,BBG000BR2B91,The $150 million winner — and the losers — in Pfizer's $14 billion takeout of Medivation,2016-08-23 03:05:11 +0000,http://www.bizjournals.com/sanfrancisco/blog/biotech/2016/08/medivation-pfizer-mdvn-pfe-winners-losers.html?ana=yahoo,The $150 million winner — and the losers — in Pfizer's $14 billion takeout of Medivation
PFE,PFE:US,BBG000BR2B91,Deal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ,2016-08-23 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jUi2B1Mc-2E/deal-for-medivation-is-the-latest-in-a-line-of-similar-acquisitions--wsj-20160823-00038,Deal for Medivation Is the Latest In a Line of Similar Acquisitions -- WSJ
PFE,PFE:US,BBG000BR2B91,Pfizer to Acquire Key Drug -- WSJ,2016-08-23 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JH2xr-_Ey3g/pfizer-to-acquire-key-drug--wsj-20160823-00037,Pfizer to Acquire Key Drug -- WSJ
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer Adds Key Cancer Drug With $14 Billion Medivation Deal,2016-08-23 00:56:44 +0000,http://www.wsj.com/articles/pfizer-to-buy-medivation-for-14-billion-1471864168?mod=yahoo_hs,[$$] Pfizer Adds Key Cancer Drug With $14 Billion Medivation Deal
PFE,PFE:US,BBG000BR2B91,"BPMX Scores A Facelift, MDVN Says ""I Do"" To PFE, Europe Gets Its 1st HIV PrEP",2016-08-23 00:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tExakLQQTgs/bpmx-scores-a-facelift-mdvn-says-i-do-to-pfe-europe-gets-its-1st-hiv-prep-20160823-00007,"BPMX Scores A Facelift, MDVN Says ""I Do"" To PFE, Europe Gets Its 1st HIV PrEP"
PFE,PFE:US,BBG000BR2B91,"BPMX Scores A Facelift, MDVN Says ""I Do"" To PFE, Europe Gets Its 1st HIV PrEP",2016-08-23 00:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mKGe1WE9SJ0/bpmx-scores-a-facelift-mdvn-says-i-do-to-pfe-europe-gets-its-1st-hiv-prep-20160823-00006,"BPMX Scores A Facelift, MDVN Says ""I Do"" To PFE, Europe Gets Its 1st HIV PrEP"
PFE,PFE:US,BBG000BR2B91,PRESS DIGEST- British Business - August 23,2016-08-23 00:04:30 +0000,http://finance.yahoo.com/news/press-digest-british-business-august-000430628.html,"[Reuters] - The following are the top stories on the business pages of British newspapers. ** Senior Conservatives reacted with anger last night after a European leader warned Theresa May that handing a tax cut to businesses would make Brexit negotiations ""more difficult"". ** The chairman of the parliamentary committee investigating Philip Green's handling of the BHS pension deficit is seeking talks with an American investor who owns a minority stake in the entrepreneur's Topshop chain."
PFE,PFE:US,BBG000BR2B91,Business Highlights,2016-08-22 23:24:05 +0000,http://finance.yahoo.com/news/business-highlights-232405978.html,Business Highlights
PFE,PFE:US,BBG000BR2B91,Business Highlights,2016-08-22 23:24:05 +0000,http://sg.finance.yahoo.com/news/business-highlights-232405235.html,Business Highlights
PFE,PFE:US,BBG000BR2B91,Pfizer-Medivation cash deal is hard to justify: Analyst,2016-08-22 23:19:00 +0000,http://finance.yahoo.com/video/pfizer-medivation-cash-deal-hard-231900810.html,Pfizer-Medivation cash deal is hard to justify: Analyst
PFE,PFE:US,BBG000BR2B91,Cramer: Forget biotech! THIS is the next red-hot takeover group,2016-08-22 23:02:48 +0000,http://www.cnbc.com/id/103885025?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103885025,Cramer: Forget biotech! THIS is the next red-hot takeover group
PFE,PFE:US,BBG000BR2B91,Cramer: A Bunch of Semis Are Ripe for the Picking,2016-08-22 23:01:00 +0000,http://realmoney.thestreet.com/articles/08/22/2016/cramer-bunch-semis-are-ripe-picking?puc=yahoo&cm_ven=YAHOO,Cramer: A Bunch of Semis Are Ripe for the Picking
PFE,PFE:US,BBG000BR2B91,Stocks Calm As Crude Plunges; Busy Day For Medical Sector,2016-08-22 22:54:24 +0000,http://finance.yahoo.com/video/stocks-calm-crude-plunges-busy-225424193.html,Stocks Calm As Crude Plunges; Busy Day For Medical Sector
PFE,PFE:US,BBG000BR2B91,Pfizer Acquires Medivation,2016-08-22 22:51:11 +0000,http://finance.yahoo.com/news/pfizer-acquires-medivation-225111831.html,Pfizer Acquires Medivation
PFE,PFE:US,BBG000BR2B91,Is Microsoft Corporation (MSFT) the Next Apple?,2016-08-22 22:46:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sGpvyQ2TKpg/is-microsoft-corporation-msft-the-next-apple-cm668731,"Five years after the tragic death of Steve Jobs, everyone wants to talk about Tim Cook, and whether his reign at Apple Inc. (NASDAQ  AAPL"
PFE,PFE:US,BBG000BR2B91,Pfizer-Medivation Close to Signing $14B Acquisition Deal? (revised),2016-08-22 22:46:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T6pT31Qb4WQ/pfizer-medivation-close-to-signing-14b-acquisition-deal-revised-cm668723,"According to a Financial Times article, Pfizer Inc. ( PFE ) and Medivation, Inc. ( MDVN ) are close to signing a deal under which Pfizer will acquire Medivation for more than $80 per share (approximately $14 billion). Medivation"
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Bought Medivation (MDVN), but is it a Good Deal?",2016-08-22 22:45:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Do39CU3_aHI/pfizer-pfe-bought-medivation-mdvn-but-is-it-a-good-deal-cm668721,"Today, Pfizer PFEhas announced that it will be acquiring Medivation Inc. MDVN in an all cash offer for $81.50 per share.  This comes out to a transaction value of approximately $14 billion.  Shares were trading for about"
PFE,PFE:US,BBG000BR2B91,What Happened in the Stock Market Today,2016-08-22 22:45:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ni008qsuXF0/what-happened-in-the-stock-market-today-cm668722,"Stocks stuck around breakeven during Monday's trading session, lurching between slight gains and minor losses throughout the day. By the closing bell, the Dow Jones Industrial Average (DJINDICES   DJI) and the S&P 500 (SNPINDEX"
PFE,PFE:US,BBG000BR2B91,Pfizer boosts cancer drug roster with $14 billion Medivation deal,2016-08-22 22:39:52 +0000,http://finance.yahoo.com/news/pfizer-buy-medivation-14-billion-105833819.html,"[Reuters] - Medivation shares jumped nearly 20 percent to close at $80.42, just shy of the offer price of $81.50 per share. Shares of Pfizer, the largest U.S. drugmaker, were down 0.4 percent at $34.84. The offer is a 55-percent premium to Sanofi SA's (SASY.PA) initial bid to buy Medivation for $52.50 per share in April, which pushed the San Francisco-based company to put itself up for sale."
PFE,PFE:US,BBG000BR2B91,"Final Trade: PFE, XRT, JCP & TGT",2016-08-22 21:59:00 +0000,http://finance.yahoo.com/video/final-trade-pfe-xrt-jcp-215900724.html,"Final Trade: PFE, XRT, JCP & TGT"
PFE,PFE:US,BBG000BR2B91,Pfizer Inc. (PFE) Adds Oncology Muscle With Medivation Inc (MDVN),2016-08-22 21:46:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6MthIQdAJMg/pfizer-inc-pfe-adds-oncology-muscle-with-medivation-inc-mdvn-cm668704,Pfizer Inc. 's (NYSE  PFE ) $14 billion acquisition of star cancer biotech Medivation Inc (NASDAQ  MDVN ) bolsters the long term bull
PFE,PFE:US,BBG000BR2B91,Markets focus on big mergers as global stocks are quiet,2016-08-22 21:43:51 +0000,http://uk.finance.yahoo.com/news/markets-focus-big-mergers-global-214351413.html,Markets focus on big mergers as global stocks are quiet
PFE,PFE:US,BBG000BR2B91,"In possible $14 billion ending, Medivation goes back to early days",2016-08-22 21:32:13 +0000,http://www.bizjournals.com/sanfrancisco/blog/biotech/2016/08/medivation-pfizer-mdvn-pfe-sanofi-sny-xtandi.html?ana=yahoo,"In possible $14 billion ending, Medivation goes back to early days"
PFE,PFE:US,BBG000BR2B91,Biotech's next big deal?,2016-08-22 21:25:00 +0000,http://finance.yahoo.com/video/biotechs-next-big-deal-212500006.html,Biotech's next big deal?
PFE,PFE:US,BBG000BR2B91,"Close Update: Dow, S&P Close Lower On Oil While Nasdaq Buoyed by Biotechs",2016-08-22 21:20:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-LfHdyQS2WM/close-update-dow-sp-close-lower-on-oil-while-nasdaq-buoyed-by-biotechs-cm668716,"The Dow Jones Industrial Average and S&P 500 closed on Monday marginally lower as oil traded in the red for the first time in eight days, while the Nasdaq clung to a slim gain thanks to strength in the"
PFE,PFE:US,BBG000BR2B91,"Pfizer (PFE) Bought Medivation (MDVN), but is it a Good Deal?",2016-08-22 21:06:09 +0000,http://finance.yahoo.com/news/pfizer-pfe-bought-medivation-mdvn-210609372.html,"Pfizer (PFE) Bought Medivation (MDVN), but is it a Good Deal?"
PFE,PFE:US,BBG000BR2B91,Pfizer boosts cancer drug roster with $14 billion Medivation deal,2016-08-22 21:06:08 +0000,http://sg.finance.yahoo.com/news/pfizer-buy-medivation-14-billion-113218132.html,Pfizer boosts cancer drug roster with $14 billion Medivation deal
PFE,PFE:US,BBG000BR2B91,What Happened in the Stock Market Today,2016-08-22 21:04:00 +0000,http://www.fool.com/investing/2016/08/22/what-happened-in-the-stock-market-today.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,What Happened in the Stock Market Today
PFE,PFE:US,BBG000BR2B91,Pfizer boosts cancer drug roster with $14 billion Medivation deal,2016-08-22 21:01:47 +0000,http://in.finance.yahoo.com/news/pfizer-boosts-cancer-drug-roster-180100684.html,Pfizer boosts cancer drug roster with $14 billion Medivation deal
PFE,PFE:US,BBG000BR2B91,What's Driving the M&A in Health Care?,2016-08-22 20:58:39 +0000,http://finance.yahoo.com/video/whats-driving-m-health-care-205839270.html,What's Driving the M&A in Health Care?
PFE,PFE:US,BBG000BR2B91,"S&P 500, Dow industrials book a loss as oil snaps win streak",2016-08-22 20:57:17 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=FC57CAAE-683C-11E6-AF2A-021016061ED1&siteid=yhoof2,"S&P 500, Dow industrials book a loss as oil snaps win streak"
PFE,PFE:US,BBG000BR2B91,[$$] Marathon Oil slips on broad sector fall,2016-08-22 20:56:26 +0000,"http://www.ft.com/cms/s/622edd7a-6871-11e6-a0b1-d87a9fea034f,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Marathon Oil led a broad decline in the oil sector's stocks as crude prices fell back after a bumper seven-session rally. West Texas Intermediate, the US benchmark, fell 3 per cent to $47.05 on Monday, ..."
PFE,PFE:US,BBG000BR2B91,Bernie Sanders Just Called Out Pfizer and Medivation on Twitter,2016-08-22 20:43:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dS7OgPutO3E/bernie-sanders-just-called-out-pfizer-and-medivation-on-twitter-cm668656,"After much speculation, Pfizer Inc.PFE announced today that it will acquire Medivation, Inc.MDVN in a deal worth about $14 billion. The acquisition is slated to close in the third or fourth quarter, and early predictions suggest that"
PFE,PFE:US,BBG000BR2B91,Medivation surges on Pfizer takeover as US markets stay flat,2016-08-22 20:31:54 +0000,http://uk.finance.yahoo.com/news/medivation-surges-pfizer-takeover-us-203154222.html,Medivation surges on Pfizer takeover as US markets stay flat
PFE,PFE:US,BBG000BR2B91,Stocks End Little-Changed; Zoe's Kitchen Plunges After Hours,2016-08-22 20:31:07 +0000,http://www.investors.com/market-trend/stock-market-today/stocks-end-little-changed-zoes-kitchen-plunges-after-hours/,Stocks End Little-Changed; Zoe's Kitchen Plunges After Hours
PFE,PFE:US,BBG000BR2B91,Medivation shares leap on Pfizer's $14 billion offer,2016-08-22 20:31:03 +0000,http://www.cnbc.com/id/103883982?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103883982,Medivation shares leap on Pfizer's $14 billion offer
PFE,PFE:US,BBG000BR2B91,Pfizer-Medivation Deal Reignites Biotech Buyout Speculation,2016-08-22 20:29:12 +0000,http://www.investors.com/news/technology/pfizer-medivation-deal-reignites-biotech-buyout-speculation/,Pfizer-Medivation Deal Reignites Biotech Buyout Speculation
PFE,PFE:US,BBG000BR2B91,Pfizer's Medivation buy seen prescribing more biotech M&A,2016-08-22 20:27:59 +0000,http://finance.yahoo.com/news/pfizers-medivation-buy-seen-prescribing-202759352.html,"[Reuters] - Medivation's $14 billion sale to U.S. drug giant Pfizer Inc for a hefty premium, the largest U.S. biotechnology acquisition so far this year, had investors on Monday speculating about more dealmaking in the sector. Shares of Incyte Corp and Seattle Genetics , rose as much as 11 percent and 4 percent, respectively. Incyte and Seattle Genetics, which have respective market capitalizations of $15.4 billion and $6.7 billion, focus on innovative cancer treatments and, like Medivation, are already producing revenue."
PFE,PFE:US,BBG000BR2B91,Pfizer-Medivation Deal Headlines Busy Merger Monday,2016-08-22 20:27:43 +0000,http://www.investors.com/news/ma-pace-quickens-pfizer-medivation-cst-renesas-intersil-deals/,Pfizer-Medivation Deal Headlines Busy Merger Monday
PFE,PFE:US,BBG000BR2B91,Stocks end mostly lower in quiet trade; oil prices decline,2016-08-22 20:26:16 +0000,http://finance.yahoo.com/news/stocks-fall-early-trading-oil-140534701.html,Stocks end mostly lower in quiet trade; oil prices decline
PFE,PFE:US,BBG000BR2B91,Pfizer-Medivation Close to Signing $14B Acquisition Deal? (revised),2016-08-22 20:13:08 +0000,http://finance.yahoo.com/news/pfizer-medivation-close-signing-14b-201308491.html,Pfizer-Medivation Close to Signing $14B Acquisition Deal? (revised)
PFE,PFE:US,BBG000BR2B91,Here's a Reason Why Tesaro (TSRO) Stock Climbed Today,2016-08-22 20:10:00 +0000,https://www.thestreet.com/story/13681864/1/here-s-a-reason-why-tesaro-tsro-stock-climbed-today.html?puc=yahoo&cm_ven=YAHOO,Here's a Reason Why Tesaro (TSRO) Stock Climbed Today
PFE,PFE:US,BBG000BR2B91,"Valeant Stock Jumps On CFO Appointment, As M&A Hopes Rise",2016-08-22 20:05:36 +0000,http://www.investors.com/news/technology/valeant-stock-up-on-cfo-appointment-as-ma-hopes-rise/,"Valeant Stock Jumps On CFO Appointment, As M&A Hopes Rise"
PFE,PFE:US,BBG000BR2B91,Stocks Waver as Investors Wait for Fed Clarity,2016-08-22 20:02:00 +0000,https://www.thestreet.com/story/13681869/1/stocks-waver-as-investors-wait-for-fed-clarity.html?puc=yahoo&cm_ven=YAHOO,Stocks Waver as Investors Wait for Fed Clarity
PFE,PFE:US,BBG000BR2B91,STOCKS SEESAW: Here's what you need to know,2016-08-22 20:00:11 +0000,http://finance.yahoo.com/news/stocks-seesaw-heres-know-200011366.html,STOCKS SEESAW: Here's what you need to know
PFE,PFE:US,BBG000BR2B91,"New Research Reports for Pfizer, Cisco & Visa",2016-08-22 19:46:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MDofkBtDifM/new-research-reports-for-pfizer-cisco-visa-cm668640,"Monday, August 22, 2016  Today's Research Daily write up features fresh analyst reports on 16 major companies, including Pfizer (PFE), Cisco (CSCO) and Visa (V). These 16 reports have been handpicked from the roughly 80 research"
PFE,PFE:US,BBG000BR2B91,"After Medivation, These 6 Biotech Stocks Could Be M&A Targets Next",2016-08-22 18:57:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/22/after-medivation-these-6-biotech-stocks-could-be-ma-targets-next/?mod=yahoobarrons&ru=yahoo,"After Medivation, These 6 Biotech Stocks Could Be M&A Targets Next"
PFE,PFE:US,BBG000BR2B91,Stocks Struggle for Direction as Jackson Hole Conference Looms,2016-08-22 18:47:00 +0000,https://www.thestreet.com/story/13681613/1/stocks-fall-back-into-red-on-crude-selloff.html?puc=yahoo&cm_ven=YAHOO,Stocks Struggle for Direction as Jackson Hole Conference Looms
PFE,PFE:US,BBG000BR2B91,Bernie Sanders Just Called Out Pfizer and Medivation on Twitter,2016-08-22 18:35:06 +0000,http://finance.yahoo.com/news/bernie-sanders-just-called-pfizer-183506248.html,Bernie Sanders Just Called Out Pfizer and Medivation on Twitter
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer swallows Medivation in effort to conquer cancer,2016-08-22 17:57:55 +0000,"http://www.ft.com/cms/s/1fd54b5a-687e-11e6-ae5b-a7cc5dd5a28c,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - When Dr Mace Rothenberg, Pfizer's top cancer scientist, joined the company in 2008, the drugmaker concentrated almost exclusively on selling ""primary care"" medicines prescribed by family doctors, ..."
PFE,PFE:US,BBG000BR2B91,Mid-Day Market Update: Crude Oil Down 2.8%; Intersil Shares Spike Higher,2016-08-22 17:54:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BkO2-kEfPrc/mid-day-market-update-crude-oil-down-28-intersil-shares-spike-higher-cm668615,"Midway through trading Monday, the Dow traded up 0.02 percent to 18,556.55 while the NASDAQ rose 0.06 percent to 5,241.33. The S&P also rose, gaining 0.01 percent to 2,183.90.  Leading and Lagging Sectors"
PFE,PFE:US,BBG000BR2B91,Medivation's Shares Soar on Confirmation of a Pfizer Buyout,2016-08-22 17:47:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g7mbBVvPllw/medivations-shares-soar-on-confirmation-of-a-pfizer-buyout-cm668546,Image source  Getty Images.  What   Investors in Medivation (NASDAQ  MDVN) are having a pleasant start to the trading week. Shares of the cancer focused biopharma are soaring 19% higher as of
PFE,PFE:US,BBG000BR2B91,ETFs in Focus on Pfizer's Medivation Acquisition,2016-08-22 17:42:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eFjK215lNmY/etfs-in-focus-on-pfizers-medivation-acquisition-cm668570,"The biotech giant, Pfizer Inc. PFE and Xtandi manufacturer, Medivation, Inc. MDVN entered into a definitive merger agreement under which Pfizer will acquire Medivation for $81.50 per share in cash or a total enterprise value of about"
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer makes $14bn bet on cancer drugmaker Medivation,2016-08-22 17:24:11 +0000,"http://www.ft.com/cms/s/2a6693de-687f-11e6-ae5b-a7cc5dd5a28c,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev",[at Financial Times] - Pfizer unveiled its biggest takeover of a cancer company in its 167-year history on Monday - the $14bn acquisition of Californian biotech Medivation - following a hotly-contested auction of the sought-after ...
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer/Medivation: combination therapy,2016-08-22 17:23:15 +0000,"http://www.ft.com/cms/s/fc0c1f3a-6875-11e6-a0b1-d87a9fea034f,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - There is a grim symmetry between the challenges pharmaceutical companies face and the treatments they sell. Both are often about staving off decline. Whereas cancer drugs measure ""progression free ..."
PFE,PFE:US,BBG000BR2B91,Biotechs Rise on Bet Medivation Losers Will Look to Next Deal,2016-08-22 17:14:52 +0000,http://finance.yahoo.com/news/biotechs-rise-bet-medivation-losers-171452706.html,Biotechs Rise on Bet Medivation Losers Will Look to Next Deal
PFE,PFE:US,BBG000BR2B91,Pfizer to buy Medivation,2016-08-22 17:08:00 +0000,http://finance.yahoo.com/video/pfizer-buy-medivation-170800807.html,Pfizer to buy Medivation
PFE,PFE:US,BBG000BR2B91,[$$] Medivation Ovation: Pfizer Pays the Price for Growth,2016-08-22 16:52:31 +0000,http://www.wsj.com/articles/pfizer-pays-the-price-for-growth-1471884546?mod=yahoo_hs,[$$] Medivation Ovation: Pfizer Pays the Price for Growth
PFE,PFE:US,BBG000BR2B91,Medivation shareholders should be ‘thrilled’ about price of Pfizer deal: analysts,2016-08-22 16:46:16 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=28D64570-6873-11E6-AF2A-021016061ED1&siteid=yhoof2,Medivation shareholders should be ‘thrilled’ about price of Pfizer deal: analysts
PFE,PFE:US,BBG000BR2B91,European stocks dip awaiting clear US rate outlook,2016-08-22 16:37:05 +0000,http://uk.finance.yahoo.com/news/european-stocks-dip-awaiting-clear-144658288.html,"[AFP] - In mid-afternoon trading, London's benchmark FTSE 100 had lost 0.65 percent compared with Friday's close while in the eurozone both Frankfurt and Paris gave up early minor gains"
PFE,PFE:US,BBG000BR2B91,Monday links: work and drudgery,2016-08-22 16:36:14 +0000,http://finance.yahoo.com/tumblr/blog-monday-links-work-and-drudgery-163618457.html,Monday links: work and drudgery
PFE,PFE:US,BBG000BR2B91,Pfizer Claims Pharmaceutical's Latest Big Prize,2016-08-22 16:33:48 +0000,http://finance.yahoo.com/video/pfizer-claims-pharmaceuticals-latest-big-163348442.html,Pfizer Claims Pharmaceutical's Latest Big Prize
PFE,PFE:US,BBG000BR2B91,"New Research Reports for Pfizer, Cisco & Visa",2016-08-22 16:30:04 +0000,http://finance.yahoo.com/news/research-reports-pfizer-cisco-visa-163004789.html,"New Research Reports for Pfizer, Cisco & Visa"
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer's Medivation Deal Latest in Long Line of Similar Acquisitions,2016-08-22 16:22:57 +0000,http://www.wsj.com/articles/pfizers-medivation-deal-latest-in-long-line-of-similar-acquisitions-1471882973?mod=yahoo_hs,[$$] Pfizer's Medivation Deal Latest in Long Line of Similar Acquisitions
PFE,PFE:US,BBG000BR2B91,The takeover pipeline: Who will be next?,2016-08-22 16:22:00 +0000,http://finance.yahoo.com/video/takeover-pipeline-next-162200209.html,The takeover pipeline: Who will be next?
PFE,PFE:US,BBG000BR2B91,Pfizer's Deal to Buy Medivation May Give the Company Its Groove Back,2016-08-22 16:12:00 +0000,http://www.thestreet.com/video/13681451/pfizer-s-deal-to-buy-medivation-may-give-the-company-its-groove-back.html?puc=yahoov&cm_ven=YAHOOV,Pfizer's Deal to Buy Medivation May Give the Company Its Groove Back
PFE,PFE:US,BBG000BR2B91,"Incyte (INCY) Stock Rises on Takeover Speculation After $14 Billion Pfizer, Medivation Deal",2016-08-22 16:07:00 +0000,https://www.thestreet.com/story/13681606/1/incyte-incy-stock-rises-on-takeover-speculation-after-14-billion-pfizer-medivation-deal.html?puc=yahoo&cm_ven=YAHOO,"Incyte (INCY) Stock Rises on Takeover Speculation After $14 Billion Pfizer, Medivation Deal"
PFE,PFE:US,BBG000BR2B91,Biotech stocks rally as investors bet on the next big tie-up,2016-08-22 15:57:44 +0000,http://www.cnbc.com/id/103884606?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103884606,Biotech stocks rally as investors bet on the next big tie-up
PFE,PFE:US,BBG000BR2B91,"M&A Boosts Intersil, Syngenta and Medivation in Pre-Market",2016-08-22 15:48:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g4OSWLQ8STw/ma-boosts-intersil-syngenta-and-medivation-in-pre-market-cm668417,"Monday, August 22, 2016  Futures are down again ahead of the market open this morning, following a Friday that was awash in red until climbing toward unched in the closing minutes of the trading week. The"
PFE,PFE:US,BBG000BR2B91,Pfizer spends $14B on Medivation in cancer fight,2016-08-22 15:46:45 +0000,http://sg.finance.yahoo.com/news/pfizer-buying-medivation-deal-valued-110146084.html,Pfizer spends $14B on Medivation in cancer fight
PFE,PFE:US,BBG000BR2B91,Mid-Morning Market Update: Markets Mostly Lower; Pfizer To Buy Medivation For $14 Billion,2016-08-22 15:46:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6cmDavzThro/mid-morning-market-update-markets-mostly-lower-pfizer-to-buy-medivation-for-14-billion-cm668476,"Following the market opening Monday, the Dow traded down 0.09 percent to 18,535.86 while the NASDAQ rose 0.11 percent to 5,244.30. The S&P also fell, dropping 0.05 percent to 2,182.77.  Leading and Lagging Sectors"
PFE,PFE:US,BBG000BR2B91,Pfizer to acquire Medivation for $14 billion,2016-08-22 15:23:36 +0000,http://uk.finance.yahoo.com/news/pfizer-acquire-medivation-14-billion-152336882.html,Pfizer to acquire Medivation for $14 billion
PFE,PFE:US,BBG000BR2B91,"Crude Selloff, Health Care Rally Split Wall Street",2016-08-22 15:16:00 +0000,https://www.thestreet.com/story/13681271/1/crude-oil-drags-on-stocks-as-hopes-for-opec-deal-fade.html?puc=yahoo&cm_ven=YAHOO,"Crude Selloff, Health Care Rally Split Wall Street"
PFE,PFE:US,BBG000BR2B91,Medivation's Shares Soar on Confirmation of a Pfizer Buyout,2016-08-22 15:16:00 +0000,http://www.fool.com/investing/2016/08/22/medivations-shares-soar-on-confirmation-of-a-pfize.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Medivation's Shares Soar on Confirmation of a Pfizer Buyout
PFE,PFE:US,BBG000BR2B91,Upstart banks just yanked another big deal away from Wall Street,2016-08-22 14:50:26 +0000,http://www.cnbc.com/id/103884236?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103884236,Upstart banks just yanked another big deal away from Wall Street
PFE,PFE:US,BBG000BR2B91,"Pfizer to Buy Medivation for $14B, Boost Cancer Franchise",2016-08-22 14:48:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gdmHFc_G3YY/pfizer-to-buy-medivation-for-14b-boost-cancer-franchise-cm668384,"Putting rumors to rest, Pfizer Inc.PFE and Medivation, Inc. MDVN announced that they have entered into a definitive merger agreement under which Pfizer will acquire Medivation for $81.50 per share in cash or a total enterprise value"
PFE,PFE:US,BBG000BR2B91,Understanding Medivation’s Premium Valuation,2016-08-22 14:39:37 +0000,http://marketrealist.com/2016/08/understanding-medivations-premium-valuation/?utm_source=yahoo&utm_medium=feed,Understanding Medivation’s Premium Valuation
PFE,PFE:US,BBG000BR2B91,Wall Street lower as investors react to Pfizer deal,2016-08-22 14:28:48 +0000,http://uk.finance.yahoo.com/news/wall-street-lower-investors-react-142848444.html,Wall Street lower as investors react to Pfizer deal
PFE,PFE:US,BBG000BR2B91,Pfizer spent $14 billion on a company with just one approved drug — here's why that's a game-changer,2016-08-22 14:28:39 +0000,http://finance.yahoo.com/news/heres-why-pfizer-just-spent-142839435.html,Pfizer spent $14 billion on a company with just one approved drug — here's why that's a game-changer
PFE,PFE:US,BBG000BR2B91,More Squawk from Jim Cramer: Pfizer Buys Medivation (MDVN) for $14 Billion,2016-08-22 14:26:00 +0000,https://www.thestreet.com/story/13681376/1/more-squawk-from-jim-cramer-pfizer-buys-medivation-mdvn-for-14-billion.html?puc=yahoo&cm_ven=YAHOO,More Squawk from Jim Cramer: Pfizer Buys Medivation (MDVN) for $14 Billion
PFE,PFE:US,BBG000BR2B91,"Nasdaq Turns Up; Medivation, Syngenta, Intersil Soar On Merger News",2016-08-22 14:21:32 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-down-small-caps-lag-medivation-syngenta-soar-on-mergers-news/,"Nasdaq Turns Up; Medivation, Syngenta, Intersil Soar On Merger News"
PFE,PFE:US,BBG000BR2B91,Pfizer Won the Bidding War for Medivation But Is It Really a Win?,2016-08-22 14:20:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/22/pfizer-won-the-bidding-war-for-medivation-but-is-it-really-a-win/?mod=yahoobarrons&ru=yahoo,Pfizer Won the Bidding War for Medivation But Is It Really a Win?
PFE,PFE:US,BBG000BR2B91,"Stock Market News for August 22, 2016",2016-08-22 14:10:02 +0000,http://finance.yahoo.com/news/stock-market-news-august-22-141002935.html,"Stock Market News for August 22, 2016"
PFE,PFE:US,BBG000BR2B91,Pfizer buys Medivation $14 billion cash,2016-08-22 14:06:00 +0000,http://finance.yahoo.com/video/pfizer-buys-medivation-14-billion-140600586.html,Pfizer buys Medivation $14 billion cash
PFE,PFE:US,BBG000BR2B91,"M&A Boosts Intersil, Syngenta and Medivation in Pre-Market",2016-08-22 14:01:02 +0000,http://finance.yahoo.com/news/m-boosts-intersil-syngenta-medivation-140102483.html,"M&A Boosts Intersil, Syngenta and Medivation in Pre-Market"
PFE,PFE:US,BBG000BR2B91,Wall Street opens lower as Pfizer seals Medivation deal,2016-08-22 13:57:25 +0000,http://uk.finance.yahoo.com/news/wall-street-opens-lower-pfizer-135725930.html,Wall Street opens lower as Pfizer seals Medivation deal
PFE,PFE:US,BBG000BR2B91,Pfizer Will Buy Cancer Drugmaker Medivation For $14 Billion,2016-08-22 13:53:11 +0000,http://www.investors.com/news/technology/pfizer-near-14-billion-deal-for-medivation/,Pfizer Will Buy Cancer Drugmaker Medivation For $14 Billion
PFE,PFE:US,BBG000BR2B91,Pfizer's (PFE) Pain Drug Troxyca ER Receives FDA Approval,2016-08-22 13:48:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2Lu2H8LTits/pfizers-pfe-pain-drug-troxyca-er-receives-fda-approval-cm668304,"Pfizer Inc.PFE announced that the FDA has approved Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) extended release capsules, for oral use, CII, for the management of pain severe enough to require daily, around the clock, long term"
PFE,PFE:US,BBG000BR2B91,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Medivation, Inc. to Pfizer Inc. is Fair to Shareholders -- MDVN",2016-08-22 13:45:00 +0000,http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-134500787.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / August 22, 2016 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Medivation, Inc. (""Medivation"") (NASDAQ: ..."
PFE,PFE:US,BBG000BR2B91,"U.S. Futures Defensive on Lower Oil, Hawkish Fed; Pfizer to Buy Medivation for $14 Bln",2016-08-22 13:44:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/exKIElqFBtE/us-futures-defensive-on-lower-oil-hawkish-fed-pfizer-to-buy-medivation-for-14-bln-cm668341,"Stock futures are trading lower into Monday's open as losses in the energy sector and hawkish comments from Fed Vice Chairman Stanley Fischer upstage a multi billion dollar deal in the pharmaceutical sector. On Sunday, Fischer told a Colorado"
PFE,PFE:US,BBG000BR2B91,"Deals of the Day: Pfizer Nabs Medivation, Syngenta Deal Gets U.S. Approval",2016-08-22 13:20:43 +0000,http://blogs.wsj.com/moneybeat/2016/08/22/deals-of-the-day-pfizer-nabs-medivation-syngenta-deal-gets-u-s-approval/?mod=yahoo_hs,"[at The Wall Street Journal] - Deals of the Day is your one-stop-shop for the morning’s biggest merger news. We've also got a peek at the latest IPOs, the loudest activist investors and the newest private equity transactions."
PFE,PFE:US,BBG000BR2B91,"Stocks Futures Trade Lower as Fischer, Oil Weighs on Wall Street",2016-08-22 13:20:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5tSkvZCYAPw/stocks-futures-trade-lower-as-fischer-oil-weighs-on-wall-street-cm668322,"Stock futures are trading lower into Monday's open as losses in the energy sector and hawkish comments from Fed Vice Chairman Stanley Fischer upstage a multi billion dollar deal in the pharmaceutical sector. On Sunday, Fischer told a Colorado"
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/22/2016: FMS, MDVN, JNJ, PFE, ABT, MRK, AMGN",2016-08-22 13:20:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wy7mnV61SnQ/health-care-sector-update-for-08222016-fms-mdvn-jnj-pfe-abt-mrk-amgn-cm668321,"Top Health care stocks JNJ flat PFE 0.5% ABT flat MRK flat AMGN flat Health care shares were mostly unchanged in pre market trade Monday. In health care stocks news, Medivation ( MDVN ) rose 20% after Pfizer ("
PFE,PFE:US,BBG000BR2B91,Blog Coverage Pfizer Gets Negative News from UKs MHRA and Positive News from US FDA,2016-08-22 13:20:17 +0000,http://news.investornetwork.com/2016/08/22/blog-coverage-pfizer-gets-negative-news-from-uks-mhra-and-positive-news-from-us-fda/?1=1&1471872017,Blog Coverage Pfizer Gets Negative News from UKs MHRA and Positive News from US FDA
PFE,PFE:US,BBG000BR2B91,Pfizer To Buy Cancer Drug Firm Medivation For £10bn,2016-08-22 13:17:00 +0000,http://uk.finance.yahoo.com/news/pfizer-buy-cancer-drug-firm-131700118.html,Pfizer To Buy Cancer Drug Firm Medivation For £10bn
PFE,PFE:US,BBG000BR2B91,"Why Pfizer, Medivation, GM, and 2 Other Stocks Have Investors Talking",2016-08-22 13:16:17 +0000,http://www.insidermonkey.com/blog/why-pfizer-medivation-gm-and-2-other-stocks-have-investors-talking-469965/,"Why Pfizer, Medivation, GM, and 2 Other Stocks Have Investors Talking"
PFE,PFE:US,BBG000BR2B91,Pfizer Is Buying Medivation for $14 Billion,2016-08-22 13:11:00 +0000,http://www.thestreet.com/video/13681162/pfizer-is-buying-medivation-for-14-billion.html?puc=yahoov&cm_ven=YAHOOV,Pfizer Is Buying Medivation for $14 Billion
PFE,PFE:US,BBG000BR2B91,Pfizer boosts cancer drug pipeline with $14 bln Medivation deal,2016-08-22 13:09:50 +0000,http://finance.yahoo.com/news/pfizer-buy-medivation-14-bln-112403965.html,Pfizer boosts cancer drug pipeline with $14 bln Medivation deal
PFE,PFE:US,BBG000BR2B91,"McDonald's, Verizon And 3 Others That May Drag Down The Dow",2016-08-22 13:07:00 +0000,http://www.forbes.com/sites/investor/2016/08/22/mcdonalds-verizon-and-3-others-that-may-drag-the-dow-down/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,"McDonald's, Verizon And 3 Others That May Drag Down The Dow"
PFE,PFE:US,BBG000BR2B91,BOUTIQUE BLOWOUT: 3 tiny firms will make a killing on a $14 billion pharma deal,2016-08-22 12:53:32 +0000,http://finance.yahoo.com/news/boutique-blowout-3-tiny-firms-125332547.html,BOUTIQUE BLOWOUT: 3 tiny firms will make a killing on a $14 billion pharma deal
PFE,PFE:US,BBG000BR2B91,Pfizer''s Medivation Deal Latest in Long Line of Similar Acquisitions,2016-08-22 12:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gtUKJNqLib4/pfizers-medivation-deal-latest-in-long-line-of-similar-acquisitions-20160822-00530,Pfizer''s Medivation Deal Latest in Long Line of Similar Acquisitions
PFE,PFE:US,BBG000BR2B91,Morning Movers: Medivation Soars as Pfizer Wins Bidding War; Valeant Jumps,2016-08-22 12:36:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/22/morning-movers-medivation-soars-as-pfizer-wins-bidding-war-valeant-jumps/?mod=yahoobarrons&ru=yahoo,Morning Movers: Medivation Soars as Pfizer Wins Bidding War; Valeant Jumps
PFE,PFE:US,BBG000BR2B91,Pfizer buying biopharm firm focused on oncology for $14B,2016-08-22 12:30:11 +0000,http://www.bizjournals.com/philadelphia/news/2016/08/22/pfizer-buying-medivation-oncology-14-billion.html?ana=yahoo,Pfizer buying biopharm firm focused on oncology for $14B
PFE,PFE:US,BBG000BR2B91,"Sanofi says talked with Medivation, but will be ""disciplined"" acquirer",2016-08-22 12:28:02 +0000,http://finance.yahoo.com/news/sanofi-says-talked-medivation-disciplined-122802188.html,"Sanofi says talked with Medivation, but will be ""disciplined"" acquirer"
PFE,PFE:US,BBG000BR2B91,Pfizer to buy Medivation in $US14b deal,2016-08-22 12:14:04 +0000,http://au.finance.yahoo.com/news/pfizer-buy-medivation-us14b-deal-121005253.html,[AAP] - Pfizer is buying the cancer drug company Medivation in a deal valued at about $US14 billion ($A18 billion). Pfizer Inc. will pay $US81.50 ($A107.05) per Medivation share. That's a 21 percent premium to ...
PFE,PFE:US,BBG000BR2B91,"PFIZER INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exh",2016-08-22 12:13:15 +0000,http://biz.yahoo.com/e/160822/pfe8-k.html,"PFIZER INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exh"
PFE,PFE:US,BBG000BR2B91,Pfizer says acquiring Medivation for $14 billion,2016-08-22 12:01:25 +0000,http://uk.finance.yahoo.com/news/pfizer-says-acquiring-medivation-14-120125594.html,Pfizer says acquiring Medivation for $14 billion
PFE,PFE:US,BBG000BR2B91,Pfizer Pays a Big Premium for Medivation,2016-08-22 11:55:16 +0000,http://247wallst.com/healthcare-business/2016/08/22/pfizer-pays-a-big-premium-for-medivation/,Pfizer Pays a Big Premium for Medivation
PFE,PFE:US,BBG000BR2B91,"Early movers: MDVN, PFE, CST, ISIL, SYT, FB, VIAB, VLKAY, JPM, MAT & more",2016-08-22 11:48:54 +0000,http://www.cnbc.com/id/103883872?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103883872,"Early movers: MDVN, PFE, CST, ISIL, SYT, FB, VIAB, VLKAY, JPM, MAT & more"
PFE,PFE:US,BBG000BR2B91,Pfizer says acquiring Medivation for $14 bn,2016-08-22 11:48:33 +0000,http://uk.finance.yahoo.com/news/pfizer-says-acquiring-medivation-14-114833990.html,Pfizer says acquiring Medivation for $14 bn
PFE,PFE:US,BBG000BR2B91,Pfizer's (PFE) Pain Drug Troxyca ER Receives FDA Approval,2016-08-22 11:45:11 +0000,http://finance.yahoo.com/news/pfizers-pfe-pain-drug-troxyca-114511107.html,Pfizer's (PFE) Pain Drug Troxyca ER Receives FDA Approval
PFE,PFE:US,BBG000BR2B91,Pfizer buying Medivation in deal valued at about $14B,2016-08-22 11:41:19 +0000,http://finance.yahoo.com/news/pfizer-buying-medivation-deal-valued-14b-110137332--finance.html,Pfizer buying Medivation in deal valued at about $14B
PFE,PFE:US,BBG000BR2B91,Pfizer agrees to buy cancer behemoth Medivation for $14 billion,2016-08-22 11:38:47 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=EE8E5BF8-685B-11E6-AF2A-021016061ED1&siteid=yhoof2,Pfizer agrees to buy cancer behemoth Medivation for $14 billion
PFE,PFE:US,BBG000BR2B91,"Global stocks, oil turn lower ahead of Fed meeting",2016-08-22 11:38:42 +0000,http://sg.finance.yahoo.com/news/asian-stocks-mixed-ahead-fed-064831377.html,"Global stocks, oil turn lower ahead of Fed meeting"
PFE,PFE:US,BBG000BR2B91,Pfizer Tops Sanofi in $14 Billion Medivation Deal,2016-08-22 11:25:20 +0000,http://finance.yahoo.com/video/pfizer-tops-sanofi-14-billion-112520475.html,Pfizer Tops Sanofi in $14 Billion Medivation Deal
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer agrees $14bn takeover of Medivation,2016-08-22 11:20:45 +0000,"http://www.ft.com/cms/s/0b556924-67e5-11e6-a0b1-d87a9fea034f,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Pfizer has reached a deal worth $14bn to acquire California biotechnology company Medivation, beating a handful of its biggest rivals to win the auction for the sought-after cancer drugmaker. Pfizer, the ..."
PFE,PFE:US,BBG000BR2B91,Pfizer To Acquire Medivation,2016-08-22 11:08:02 +0000,http://www.publicnow.com/view/35477B187A7A1A8A1F39E612F626A88B324F0606,"[at noodls] - Pfizer Inc. (NYSE:PFE) and Medivation, Inc. (NASDAQ:MDVN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Medivation, a biopharmaceutical company ..."
PFE,PFE:US,BBG000BR2B91,Five Things You Need to Know to Start Your Day,2016-08-22 11:06:49 +0000,http://finance.yahoo.com/news/five-things-know-start-day-110649917.html,Five Things You Need to Know to Start Your Day
PFE,PFE:US,BBG000BR2B91,Medivation's stock soars after Pfizer buyout deal,2016-08-22 11:00:20 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=50BCD542-4F4D-4A36-80CE-2B4FB4C20B0B&siteid=yhoof2,Medivation's stock soars after Pfizer buyout deal
PFE,PFE:US,BBG000BR2B91,Pfizer has one-upped the competition with a $14 billion bid for a cancer drugmaker,2016-08-22 10:58:30 +0000,http://finance.yahoo.com/news/pfizer-buying-cancer-drugmaker-medivation-105830001.html,Pfizer has one-upped the competition with a $14 billion bid for a cancer drugmaker
PFE,PFE:US,BBG000BR2B91,Sanofi's Hostility Backfires,2016-08-22 10:58:21 +0000,http://www.bloomberg.com/gadfly/articles/2016-08-22/sanofi-s-hostility-backfires-in-failing-medivation-deal?cmpid=yhoo.headline,Sanofi's Hostility Backfires
PFE,PFE:US,BBG000BR2B91,Pfizer to buy Medivation in $14 bln deal,2016-08-22 10:54:39 +0000,http://finance.yahoo.com/news/pfizer-buy-medivation-14-bln-105439727.html,Pfizer to buy Medivation in $14 bln deal
PFE,PFE:US,BBG000BR2B91,Pfizer Trumps Sanofi With Medivation Deal for $14 Billion,2016-08-22 10:54:12 +0000,http://finance.yahoo.com/news/pfizer-trumps-sanofi-medivation-deal-105412518.html,Pfizer Trumps Sanofi With Medivation Deal for $14 Billion
PFE,PFE:US,BBG000BR2B91,Pfizer will pay about $14 billion to acquire the cancer drug company Medivation,2016-08-22 10:50:48 +0000,http://sg.finance.yahoo.com/news/pfizer-pay-14-billion-acquire-105048802.html,Pfizer will pay about $14 billion to acquire the cancer drug company Medivation
PFE,PFE:US,BBG000BR2B91,Pfizer to Acquire Medivation,2016-08-22 10:46:00 +0000,http://finance.yahoo.com/news/pfizer-acquire-medivation-104600375.html,"[Marketwired] - Medivation, Inc. -Propels Pfizer into a leading position in oncologyMedivation agrees to transaction valued at $81.50 per Medivation share in cash, for a total enterprise value of approximately $14 billionExpected ..."
PFE,PFE:US,BBG000BR2B91,Pfizer To Acquire Medivation,2016-08-22 10:45:00 +0000,http://finance.yahoo.com/news/pfizer-acquire-medivation-104500290.html,"[Business Wire] - Pfizer Inc. and Medivation, Inc. today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Medivation, a biopharmaceutical company focused on developing and commercializing small molecules for oncology, for $81.50 a share in cash for a total enterprise value of approximately $14 billion."
PFE,PFE:US,BBG000BR2B91,Pfizer buys Medivation for $14B cash,2016-08-22 10:43:00 +0000,http://finance.yahoo.com/video/pfizer-buys-medivation-14b-cash-104300246.html,Pfizer buys Medivation for $14B cash
PFE,PFE:US,BBG000BR2B91,Pfizer to Acquire Medivation in Deal Worth $14 Billion -- 4th Update,2016-08-22 10:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L6tXOezV8oo/pfizer-to-acquire-medivation-in-deal-worth-14-billion--4th-update-20160822-00432,Pfizer to Acquire Medivation in Deal Worth $14 Billion -- 4th Update
PFE,PFE:US,BBG000BR2B91,Pfizer near deal to buy Medivation,2016-08-22 10:03:00 +0000,http://finance.yahoo.com/video/pfizer-near-deal-buy-medivation-100300246.html,Pfizer near deal to buy Medivation
PFE,PFE:US,BBG000BR2B91,Pfizer-Medivation Close to Signing $14B Acquisition Deal?,2016-08-22 09:40:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QfryMp-CPxQ/pfizer-medivation-close-to-signing-14b-acquisition-deal-cm668236,"According to a Financial Times article, Pfizer Inc.PFE and Medivation, Inc.MDVN are close to signing a deal under which Pfizer will acquire Medivation for more than $80 per share (approximately $14 billion).  Medivation has been a"
PFE,PFE:US,BBG000BR2B91,Pfizer to Acquire Medivation in Deal Worth $14 Billion -- 3rd Update,2016-08-22 08:44:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nIxgURbmSYA/pfizer-to-acquire-medivation-in-deal-worth-14-billion--3rd-update-20160822-00308,Pfizer to Acquire Medivation in Deal Worth $14 Billion -- 3rd Update
PFE,PFE:US,BBG000BR2B91,Pfizer Adds Key Drug for Cancer in $14 Billion Deal,2016-08-22 08:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TAn5fmFfuxI/pfizer-adds-key-drug-for-cancer-in-14-billion-deal-20160822-00434,Pfizer Adds Key Drug for Cancer in $14 Billion Deal
PFE,PFE:US,BBG000BR2B91,Pfizer Adds Key Cancer Drug in $14 Billion Biotech Deal,2016-08-22 08:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oxs4TbrNtn8/pfizer-adds-key-cancer-drug-in-14-billion-biotech-deal-20160822-00297,Pfizer Adds Key Cancer Drug in $14 Billion Biotech Deal
PFE,PFE:US,BBG000BR2B91,Pfizer Adds Key Cancer Drug in $14 Billion Biotech Deal,2016-08-22 08:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KihbsWcp3RM/pfizer-adds-key-cancer-drug-in-14-billion-biotech-deal-20160822-00298,Pfizer Adds Key Cancer Drug in $14 Billion Biotech Deal
PFE,PFE:US,BBG000BR2B91,Pfizer Files 8K - Other Events,2016-08-22 08:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HD9KtC0gayo/pfizer-files-8k--other-events-20160822-00251,Pfizer Files 8K - Other Events
PFE,PFE:US,BBG000BR2B91,Pfizer Files 8K - Entry Into Definitive Agreement,2016-08-22 08:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tUaS7uJe4rI/pfizer-files-8k--entry-into-definitive-agreement-20160822-00250,Pfizer Files 8K - Entry Into Definitive Agreement
PFE,PFE:US,BBG000BR2B91,Pfizer to Acquire Medivation in Deal Worth $14 Billion -- 2nd Update,2016-08-22 08:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fRp73Boi-uI/pfizer-to-acquire-medivation-in-deal-worth-14-billion--2nd-update-20160822-00241,Pfizer to Acquire Medivation in Deal Worth $14 Billion -- 2nd Update
PFE,PFE:US,BBG000BR2B91,Pfizer to Acquire Medivation in Deal Worth $14 Billion -- 2nd Update,2016-08-22 08:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/551_XxBNlAo/pfizer-to-acquire-medivation-in-deal-worth-14-billion--2nd-update-20160822-00242,Pfizer to Acquire Medivation in Deal Worth $14 Billion -- 2nd Update
PFE,PFE:US,BBG000BR2B91,Pfizer Investors Conference Call At 9:00 AM ET,2016-08-22 08:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/29ydafqo9vc/pfizer-investors-conference-call-at-900-am-et-20160822-00222,Pfizer Investors Conference Call At 9:00 AM ET
PFE,PFE:US,BBG000BR2B91,Pfizer-Medivation Close to Signing $14B Acquisition Deal?,2016-08-22 07:54:07 +0000,http://finance.yahoo.com/news/pfizer-medivation-close-signing-14b-075407053.html,Pfizer-Medivation Close to Signing $14B Acquisition Deal?
PFE,PFE:US,BBG000BR2B91,Pfizer To Buy Prostate-cancer Drug Maker Medivation For $14 Bln,2016-08-22 07:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n0hkcUXTFE0/pfizer-to-buy-prostatecancer-drug-maker-medivation-for-14-bln-20160822-00158,Pfizer To Buy Prostate-cancer Drug Maker Medivation For $14 Bln
PFE,PFE:US,BBG000BR2B91,Pfizer To Buy Prostate-cancer Drug Maker Medivation For $14 Bln,2016-08-22 07:53:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mxnnKAERrV8/pfizer-to-buy-prostatecancer-drug-maker-medivation-for-14-bln-20160822-00159,Pfizer To Buy Prostate-cancer Drug Maker Medivation For $14 Bln
PFE,PFE:US,BBG000BR2B91,Pfizer to Acquire Medivation in Deal Worth $14 Billion -- Update,2016-08-22 07:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b7Q5gvBGVGU/pfizer-to-acquire-medivation-in-deal-worth-14-billion--update-20160822-00146,Pfizer to Acquire Medivation in Deal Worth $14 Billion -- Update
PFE,PFE:US,BBG000BR2B91,Pfizer to Buy Medivation for $14 Billion,2016-08-22 07:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ayyQv7-XA3Y/pfizer-to-buy-medivation-for-14-billion-20160822-00129,Pfizer to Buy Medivation for $14 Billion
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer Nears Agreement to Buy Medivation,2016-08-22 07:16:00 +0000,http://www.wsj.com/articles/pfizer-nears-agreement-to-buy-medivation-1471827217?mod=yahoo_hs,[$$] Pfizer Nears Agreement to Buy Medivation
PFE,PFE:US,BBG000BR2B91,Pfizer To Buy Medivation For Total Enterprise Value Of About $14 Bln,2016-08-22 06:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4zFrmyeFgjI/pfizer-to-buy-medivation-for-total-enterprise-value-of-about-14-bln-20160822-00099,Pfizer To Buy Medivation For Total Enterprise Value Of About $14 Bln
PFE,PFE:US,BBG000BR2B91,Pfizer nears agreement to buy Medivation for $14 bn: reports,2016-08-22 05:42:19 +0000,http://uk.finance.yahoo.com/news/pfizer-nears-agreement-buy-medivation-054219200.html,Pfizer nears agreement to buy Medivation for $14 bn: reports
PFE,PFE:US,BBG000BR2B91,[$$] Pfizer Nears Agreement to Buy Medivation,2016-08-22 04:34:37 +0000,http://www.wsj.com/articles/pfizer-nears-agreement-to-buy-medivation-1471827217?ru=yahoo?mod=yahoo_itp,[$$] Pfizer Nears Agreement to Buy Medivation
PFE,PFE:US,BBG000BR2B91,PRESS DIGEST - Wall Street Journal - Aug 22,2016-08-22 04:27:50 +0000,http://finance.yahoo.com/news/press-digest-wall-street-journal-042750640.html,"[Reuters] - The following are the top stories in the Wall Street Journal. - Pfizer Inc is nearing a deal to buy biotech company Medivation Inc in a move that would add one of the crown jewels of the multibillion-dollar market for cancer drugs to Pfizer's portfolio, people familiar with the matter said. - Turkey's president blamed Islamic State for turning a youth into a human bomb at a crowded outdoor wedding party in southeast Turkey's largest city, killing at least 51 people in a weekend attack that underscored how the war in neighboring Syria is destabilizing the region."
PFE,PFE:US,BBG000BR2B91,U.S. Stock Futures Slip on Rate Concerns,2016-08-22 04:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Wl088H24Nik/us-stock-futures-slip-on-rate-concerns-20160822-00246,U.S. Stock Futures Slip on Rate Concerns
PFE,PFE:US,BBG000BR2B91,Pfizer Near $14 Billion Deal for Biotech -- WSJ,2016-08-22 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mrxtMw8pinw/pfizer-near-14-billion-deal-for-biotech--wsj-20160822-00024,Pfizer Near $14 Billion Deal for Biotech -- WSJ
PFE,PFE:US,BBG000BR2B91,Pfizer Reportedly Nears $14 Bln Deal To Acquire Medivation,2016-08-22 01:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9dklLZSptco/pfizer-reportedly-nears-14-bln-deal-to-acquire-medivation-20160822-00012,Pfizer Reportedly Nears $14 Bln Deal To Acquire Medivation
PFE,PFE:US,BBG000BR2B91,"PFE, SUPN Get FDA Nod, SNY Will Have To Wait Till Nov., Xenetic On The Move",2016-08-22 01:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ySRJ_42CrKg/pfe-supn-get-fda-nod-sny-will-have-to-wait-till-nov-xenetic-on-the-move-20160822-00008,"PFE, SUPN Get FDA Nod, SNY Will Have To Wait Till Nov., Xenetic On The Move"
PFE,PFE:US,BBG000BR2B91,Pfizer Said to Be Close to $14B Deal for Medivation,2016-08-22 00:09:22 +0000,http://finance.yahoo.com/video/pfizer-said-close-14b-deal-000922626.html,Pfizer Said to Be Close to $14B Deal for Medivation
PFE,PFE:US,BBG000BR2B91,Pfizer is reportedly close to spending $14 billion on cancer drugmaker Medivation,2016-08-21 23:52:57 +0000,http://finance.yahoo.com/news/pfizer-reportedly-close-spending-14-235257120.html,Pfizer is reportedly close to spending $14 billion on cancer drugmaker Medivation
PFE,PFE:US,BBG000BR2B91,Pfizer nears deal to acquire Medivation for close to $14 billion,2016-08-21 23:27:35 +0000,http://finance.yahoo.com/news/pfizer-nears-14-billion-deal-221228489.html,Pfizer nears deal to acquire Medivation for close to $14 billion
PFE,PFE:US,BBG000BR2B91,Pfizer nears deal to acquire Medivation for close to $14 billion - sources,2016-08-21 23:18:05 +0000,http://sg.finance.yahoo.com/news/pfizer-nears-14-billion-deal-221145161.html,Pfizer nears deal to acquire Medivation for close to $14 billion - sources
PFE,PFE:US,BBG000BR2B91,Pfizer’s Medivation Win; ’Ben-Hur’ Throws a Wheel: Sunday Wrap,2016-08-21 23:16:23 +0000,http://www.bloomberg.com/news/articles/2016-08-21/pfizer-s-medivation-win-ben-hur-throws-a-wheel-sunday-wrap?cmpid=yhoo.headline,Pfizer’s Medivation Win; ’Ben-Hur’ Throws a Wheel: Sunday Wrap
PFE,PFE:US,BBG000BR2B91,Pfizer nears deal to acquire Medivation for close to $14 bln -sources,2016-08-21 23:15:37 +0000,http://finance.yahoo.com/news/pfizer-nears-deal-acquire-medivation-231537681.html,Pfizer nears deal to acquire Medivation for close to $14 bln -sources
PFE,PFE:US,BBG000BR2B91,"Pfizer Nears Agreement to Buy Medivation, Sources Say -- Update",2016-08-21 22:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pSTQ7GTSFbk/pfizer-nears-agreement-to-buy-medivation-sources-say--update-20160821-00059,"Pfizer Nears Agreement to Buy Medivation, Sources Say -- Update"
PFE,PFE:US,BBG000BR2B91,Pfizer said to be near $14 billion acquisition of Medivation,2016-08-21 22:39:16 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=9B8E03C7-CC7D-4114-AD1C-FC82117CE53C&siteid=yhoof2,Pfizer said to be near $14 billion acquisition of Medivation
PFE,PFE:US,BBG000BR2B91,Pfizer nears $14 billion deal for Medivation-source,2016-08-21 22:09:41 +0000,http://finance.yahoo.com/news/pfizer-nears-14-billion-deal-220941105.html,Pfizer nears $14 billion deal for Medivation-source
PFE,PFE:US,BBG000BR2B91,Pfizer Reportedly Nears Agreement To Buy Medivation For About $14 Bln,2016-08-21 22:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d8hiLQhMhP0/pfizer-reportedly-nears-agreement-to-buy-medivation-for-about-14-bln-20160821-00053,Pfizer Reportedly Nears Agreement To Buy Medivation For About $14 Bln
PFE,PFE:US,BBG000BR2B91,Pfizer Said Close to $14 Billion Deal to Acquire Medivation,2016-08-21 22:03:06 +0000,http://www.bloomberg.com/news/articles/2016-08-21/pfizer-nears-deal-to-buy-medivation-financial-times-says?cmpid=yhoo.headline,Pfizer Said Close to $14 Billion Deal to Acquire Medivation
PFE,PFE:US,BBG000BR2B91,Pfizer Nears Agreement to Buy Medivation,2016-08-21 21:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7Gi_gLh3HiU/pfizer-nears-agreement-to-buy-medivation-20160821-00050,Pfizer Nears Agreement to Buy Medivation
PFE,PFE:US,BBG000BR2B91,Pfizer Nears Agreement To Buy Medivation -- Sources,2016-08-21 21:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4qbNK-dRQk0/pfizer-nears-agreement-to-buy-medivation--sources-20160821-00036,Pfizer Nears Agreement To Buy Medivation -- Sources
PFE,PFE:US,BBG000BR2B91,3 Reasons Medivation Is the Juiciest Target in Biotech,2016-08-21 17:45:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9ePy8qcEXEY/3-reasons-medivation-is-the-juiciest-target-in-biotech-cm668201,"Image source  Getty Images.  When the going gets tough, the tough go shopping    especially when the tough run a major drug company. And given how many big pharmas are facing"
PFE,PFE:US,BBG000BR2B91,Curbing Excessive Exuberance May be Premature,2016-08-21 16:33:34 +0000,http://finance.yahoo.com/tumblr/blog-curbing-excessive-exuberance-may-be-premature-163340785.html,Curbing Excessive Exuberance May be Premature
PFE,PFE:US,BBG000BR2B91,[$$] US doctors waste millions on branded medicines,2016-08-21 16:04:14 +0000,"http://www.ft.com/cms/s/e2a44bf6-6647-11e6-a08a-c7ac04ef00aa,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev","[at Financial Times] - Doctors in the US are wasting hundreds of millions of dollars a year prescribing expensive branded medicines even when cheaper generic alternatives are available, according to an analysis by the Financial ..."
PFE,PFE:US,BBG000BR2B91,Here's the Best Dividend Stock in Big Pharma,2016-08-21 12:45:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CodigGIpPpM/heres-the-best-dividend-stock-in-big-pharma-cm668163,"Image source  Getty Images.  After taking it on the chin to begin the year, Big Pharma stocks have staged a comeback. The iShares U.S. Pharmaceuticals ETF had given up almost 20% near the"
PFE,PFE:US,BBG000BR2B91,Here's the Best Dividend Stock in Big Pharma,2016-08-21 10:45:00 +0000,http://www.fool.com/investing/2016/08/21/heres-the-best-dividend-stock-in-big-pharma.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's the Best Dividend Stock in Big Pharma
PFE,PFE:US,BBG000BR2B91,Is Pfizer on Its Way Up?,2016-08-21 08:01:23 +0000,http://finance.yahoo.com/news/pfizer-way-080123952.html,Is Pfizer on Its Way Up?
PFE,PFE:US,BBG000BR2B91,"Big Sell-Off of Pfizer Amid Merger Collapse (PFE, AGN)",2016-08-19 23:25:00 +0000,http://www.investopedia.com/news/big-selloff-pfizer-amid-merger-collapse-pfe-agn/?partner=YahooSA,"Big Sell-Off of Pfizer Amid Merger Collapse (PFE, AGN)"
PFE,PFE:US,BBG000BR2B91,FDA Approves TROXYCA® ER (oxycodone hydrochloride and naltrexone hydrochloride) Extended-Release Capsules CII with Abuse-Deterrent Properties for the Management of Pain,2016-08-19 22:41:06 +0000,http://www.publicnow.com/view/E72AA045EFF1202BEF8AF26227687F998972DB87,"[at noodls] - Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved TROXYCA®ER (oxycodone hydrochloride and naltrexone hydrochloride) extended-release capsules, for oral ..."
PFE,PFE:US,BBG000BR2B91,"After Hours Most Active for Aug 19, 2016 :  LDOS, NI, PFE, YHOO, CMCSA, QQQ, MSFT, PYPL, IDTI",2016-08-19 21:09:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dnakaqWrTWg/after-hours-most-active-for-aug-19-2016-ldos-ni-pfe-yhoo-cmcsa-qqq-msft-pypl-idti-cm667994,"The NASDAQ 100 After Hours Indicator is down .15 to 4,805.99. The total After hours volume is currently 22,967,678 shares traded. The following are the most active stocks for the after hours session Leidos Holdings, Inc. ( LDOS )"
PFE,PFE:US,BBG000BR2B91,Who Is Driving Pfizer's Management Team? (PFE),2016-08-19 19:00:00 +0000,http://www.investopedia.com/articles/company-insights/081916/who-driving-pfizers-management-team-pfe.asp?partner=YahooSA,Who Is Driving Pfizer's Management Team? (PFE)
PFE,PFE:US,BBG000BR2B91,"Noteworthy ETF Inflows: HDV, PFE, MRK, INTC",2016-08-19 16:45:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kmbgVwr4PrI/noteworthy-etf-inflows-hdv-pfe-mrk-intc-cm667792,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the iShares Core High Dividend ETF (Symbol HDV) where we have detected an approximate $99.3 million dollar"
PFE,PFE:US,BBG000BR2B91,Teva Pharmaceutical’s 2016 Valuation Compared to Peers,2016-08-19 15:25:24 +0000,http://marketrealist.com/2016/08/teva-pharmaceuticals-valuation-multiples-compare-peers-2016-2/?utm_source=yahoo&utm_medium=feed,Teva Pharmaceutical’s 2016 Valuation Compared to Peers
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/19/2016: JNJ, PFE, ABT, MRK, AMGN, XLV, ALR, CUTR, CERU",2016-08-19 13:19:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Md4aYF04Meo/health-care-sector-update-for-08192016-jnj-pfe-abt-mrk-amgn-xlv-alr-cutr-ceru-cm667589,"Top Health care stocks JNJ 0.3% PFE unchanged ABT unchanged MRK unchanged AMGN unchanged Health care stocks were practically unchanged in Friday's pre market session, with shares of health care companies in the S&P 500 holding steady as a"
PFE,PFE:US,BBG000BR2B91,Employers Slowly Adopt Value-Based Health Benefit Designs,2016-08-19 12:30:00 +0000,http://www.forbes.com/sites/brucejapsen/2016/08/19/employers-slowly-adopt-value-based-health-benefit-designs/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Employers Slowly Adopt Value-Based Health Benefit Designs
PFE,PFE:US,BBG000BR2B91,"No Pain, Potential for Lots of Gain",2016-08-19 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=765787&SR=Yahoo,"No Pain, Potential for Lots of Gain"
PFE,PFE:US,BBG000BR2B91,Is It &quot;Game Over&quot; After Portola's FDA Rejection?,2016-08-18 22:45:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6erSrWzjtyg/is-it-game-over-after-portolas-fda-rejection-cm667401,Image source  Getty Images.  Investors will have to wait to find out if Portola Pharmaceuticals '(NASDAQ  PTLA) first generation antidote to factor Xa anticoagulants will be as big of a hit as
PFE,PFE:US,BBG000BR2B91,US Stocks Higher after July FOMC Minutes,2016-08-18 22:44:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/trRAZDap9Ag/us-stocks-higher-after-july-fomc-minutes-cm666902,"U.S. market indexes were higher on Wednesday, after the Fed released its July Federal Open Market Committee meeting minutes. For the day, the Dow Jones Industrial Average closed at 18573.94 for a gain of 21.92 points, or"
PFE,PFE:US,BBG000BR2B91,10 Highest Healthcare Dividend Stocks,2016-08-18 21:45:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1iHzH4rqzDo/10-highest-healthcare-dividend-stocks-cm667368,"Image source  Getty Images.  Healthcare's stable revenue and growing demand due to aging baby boomers makes it a hit with income investors, but not every healthcare stock with a big dividend yield is"
PFE,PFE:US,BBG000BR2B91,"Is It ""Game Over"" After Portola's FDA Rejection?",2016-08-18 20:40:00 +0000,http://www.fool.com/investing/2016/08/18/is-it-game-over-after-portolas-fda-rejection.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Is It ""Game Over"" After Portola's FDA Rejection?"
PFE,PFE:US,BBG000BR2B91,10 Highest Healthcare Dividend Stocks,2016-08-18 20:21:00 +0000,http://www.fool.com/investing/2016/08/18/10-highest-healthcare-dividend-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,10 Highest Healthcare Dividend Stocks
PFE,PFE:US,BBG000BR2B91,Why Did We Update Our Price Estimate For Bristol-Myers Squibb?,2016-08-18 19:11:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DURxJpaZ6UA/why-did-we-update-our-price-estimate-for-bristol-myers-squibb-cm667299,"Bristol Myers Squibb ( BMY ) announced earlier this month that the Phase III trial for the use of its Opdivo as monotherapy for patients with non small cell lung cancer had failed to produce adequate results, despite its success treating"
PFE,PFE:US,BBG000BR2B91,Deutsche Takes A Look At Johnson & Johnson's Patent Woes,2016-08-18 18:53:36 +0000,http://finance.yahoo.com/news/deutsche-takes-look-johnson-johnsons-185336537.html,Deutsche Takes A Look At Johnson & Johnson's Patent Woes
PFE,PFE:US,BBG000BR2B91,"Activist Keith Meister Unloads Large Pfizer (PFE) Position, Takes Stakes in B/E Aerospace (BEAV), Johnson Controls (JCI)",2016-08-18 18:34:21 +0000,http://www.insidermonkey.com/blog/activist-keith-meister-unloads-large-pfizer-pfe-position-takes-stakes-in-be-aerospace-beav-johnson-controls-jci-469616/,"Activist Keith Meister Unloads Large Pfizer (PFE) Position, Takes Stakes in B/E Aerospace (BEAV), Johnson Controls (JCI)"
PFE,PFE:US,BBG000BR2B91,Recent Patent Ruling A Positive For Pfizer,2016-08-18 18:26:20 +0000,http://finance.yahoo.com/news/recent-patent-ruling-positive-pfizer-182620542.html,Recent Patent Ruling A Positive For Pfizer
PFE,PFE:US,BBG000BR2B91,How Much Medivation Can Really Fetch in a Buyout,2016-08-18 16:50:49 +0000,http://247wallst.com/healthcare-business/2016/08/18/how-much-medivation-can-really-fetch-in-a-buyout/,How Much Medivation Can Really Fetch in a Buyout
PFE,PFE:US,BBG000BR2B91,Why Portola Pharmaceuticals Inc Is Plunging Today,2016-08-18 16:47:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kB9SkNhQNIo/why-portola-pharmaceuticals-inc-is-plunging-today-cm667189,"Image source  Getty Images.  What   Shares of Portola Pharmaceuticals (NASDAQ  PTLA) , a clinical stage biotech focused primarily on hematologic diseases, are down by more than 18% as of 10 40 a.m. EDT"
PFE,PFE:US,BBG000BR2B91,Why I Hate Johnson & Johnson Right Now (But I'll Never Sell),2016-08-18 15:18:00 +0000,http://www.fool.com/investing/2016/08/18/why-i-hate-johnson-johnson-right-now-but-ill-never.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why I Hate Johnson & Johnson Right Now (But I'll Never Sell)
PFE,PFE:US,BBG000BR2B91,Why Pfizer's Acquisition of Anacor Is a Great Fit,2016-08-18 14:47:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F4mCc8JsHUw/why-pfizers-acquisition-of-anacor-is-a-great-fit-cm667038,Image source  Getty Images.  Zero for two isn't a great record    but that's the score Pfizer 's(NYSE  PFE) CEO Ian Read has when it comes
PFE,PFE:US,BBG000BR2B91,"J&J (JNJ) Remicade Patent Invalid, Pfizer to Launch Inflectra?",2016-08-18 13:49:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EoGnsa53kpE/jj-jnj-remicade-patent-invalid-pfizer-to-launch-inflectra-cm666979,"Johnson & JohnsonJNJ suffered a setback in its patent infringement lawsuit against Celltrion and Pfizer, Inc.'s PFE Hospira regarding the launch of a biosimilar version of its blockbuster drug, Remicade (infliximab), in the U.S.  The District"
PFE,PFE:US,BBG000BR2B91,"Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for August 19, 2016",2016-08-18 13:19:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DAKWJGpK3Wc/johnson-johnson-jnj-ex-dividend-date-scheduled-for-august-19-2016-cm666992,"Johnson & Johnson ( JNJ ) will begin trading ex dividend on August 19, 2016. A cash dividend payment of $0.8 per share is scheduled to be paid on September 06, 2016. Shareholders who purchased JNJ prior to the"
PFE,PFE:US,BBG000BR2B91,Why Pfizer's Acquisition of Anacor Is a Great Fit,2016-08-18 13:06:00 +0000,http://www.fool.com/investing/2016/08/18/why-pfizers-acquisition-of-anacor-is-a-great-fit.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Pfizer's Acquisition of Anacor Is a Great Fit
PFE,PFE:US,BBG000BR2B91,"J&J (JNJ) Remicade Patent Invalid, Pfizer to Launch Inflectra?",2016-08-18 11:39:11 +0000,http://finance.yahoo.com/news/j-j-jnj-remicade-patent-113911732.html,"J&J (JNJ) Remicade Patent Invalid, Pfizer to Launch Inflectra?"
PFE,PFE:US,BBG000BR2B91,Pfizer’s Lyrica Fuels Endowment Growth at Northwestern: Chart,2016-08-18 09:00:00 +0000,http://www.bloomberg.com/news/articles/2016-08-18/pfizer-s-lyrica-fuels-endowment-growth-at-northwestern-chart?cmpid=yhoo.headline,Pfizer’s Lyrica Fuels Endowment Growth at Northwestern: Chart
PFE,PFE:US,BBG000BR2B91,"Patent for J&J's Remicade invalidated, cheaper version looms",2016-08-17 23:16:25 +0000,http://sg.finance.yahoo.com/news/patent-j-js-remicade-invalidated-212307223.html,"Patent for J&J's Remicade invalidated, cheaper version looms"
PFE,PFE:US,BBG000BR2B91,Glaxo/Pfizer ViiV Healthcare Starts HIV Drug Combo Study,2016-08-17 22:47:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cth52lAZsdA/glaxopfizer-viiv-healthcare-starts-hiv-drug-combo-study-cm666638,"GlaxoSmithKlineGSK announced that its HIV focused company, ViiV Healthcare has initiated a phase III program to support regulatory filings for a two drug regimen of Tivicay and Epivir for the treatment for HIV 1 infection in adults who have"
PFE,PFE:US,BBG000BR2B91,US Stocks Higher after July FOMC Minutes,2016-08-17 22:45:29 +0000,http://finance.yahoo.com/news/us-stocks-higher-july-fomc-224529940.html,US Stocks Higher after July FOMC Minutes
PFE,PFE:US,BBG000BR2B91,[$$] Court Says Pfizer's Biosimilar of J&J's Remicade Doesn't Infringe Patent,2016-08-17 22:10:36 +0000,http://www.wsj.com/articles/court-says-pfizers-biosimilar-of-j-js-remicade-doesnt-infringe-patent-1471471280?mod=yahoo_hs,[$$] Court Says Pfizer's Biosimilar of J&J's Remicade Doesn't Infringe Patent
PFE,PFE:US,BBG000BR2B91,"Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for August 18, 2016",2016-08-17 22:02:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PJQpOE7-Ldw/teva-pharmaceutical-industries-limited-teva-ex-dividend-date-scheduled-for-august-18-2016-cm666416,"Teva Pharmaceutical Industries Limited ( TEVA ) will begin trading ex dividend on August 18, 2016. A cash dividend payment of $0.34 per share is scheduled to be paid on September 08, 2016. Shareholders who purchased TEVA prior to"
PFE,PFE:US,BBG000BR2B91,Billionaire Money Managers Sold off This Stock in the 2nd Quarter,2016-08-17 22:01:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fhDQckwW0oQ/billionaire-money-managers-sold-off-this-stock-in-the-2nd-quarter-cm666652,"Image source  Getty Images.  Ready or not, here come the 13F filings with the Securities and Exchange Commission.  Once every quarter institutional money managers with more than $100 million in qualifying assets"
PFE,PFE:US,BBG000BR2B91,"Merck Among Drug Giants Looking To Buy Medivation, Says Report",2016-08-17 20:32:01 +0000,http://www.investors.com/news/technology/merck-among-companies-looking-to-buy-medivation-says-report/,"Merck Among Drug Giants Looking To Buy Medivation, Says Report"
PFE,PFE:US,BBG000BR2B91,Stocks close slightly higher as Fed rate-hike debate rages on,2016-08-17 20:11:40 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=23385A86-6454-11E6-A91B-CC094CD5E4A5&siteid=yhoof2,Stocks close slightly higher as Fed rate-hike debate rages on
PFE,PFE:US,BBG000BR2B91,"3M, Chevron Pull Dow Higher Wednesday",2016-08-17 20:01:15 +0000,http://247wallst.com/investing/2016/08/17/3m-chevron-pull-dow-higher-wednesday/,"3M, Chevron Pull Dow Higher Wednesday"
PFE,PFE:US,BBG000BR2B91,What Are Analysts’ Recommendations for Mylan and Its Peers?,2016-08-17 19:10:13 +0000,http://marketrealist.com/2016/08/analysts-recommendations-mylan-peers-2016/?utm_source=yahoo&utm_medium=feed,What Are Analysts’ Recommendations for Mylan and Its Peers?
PFE,PFE:US,BBG000BR2B91,Court Says Pfizer's Biosimilar of J&J's Remicade Doesn't Infringe Patent,2016-08-17 18:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mqG5YMZcv8U/court-says-pfizers-biosimilar-of-jjs-remicade-doesnt-infringe-patent-20160817-00889,Court Says Pfizer's Biosimilar of J&J's Remicade Doesn't Infringe Patent
PFE,PFE:US,BBG000BR2B91,Court Says Pfizer''s Biosimilar of J&J''s Remicade Doesn''t Infringe Patent,2016-08-17 18:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LPfKvEFI6Q8/court-says-pfizers-biosimilar-of-jjs-remicade-doesnt-infringe-patent-20160817-00884,Court Says Pfizer''s Biosimilar of J&J''s Remicade Doesn''t Infringe Patent
PFE,PFE:US,BBG000BR2B91,Billionaire Money Managers Sold off This Stock in the 2nd Quarter,2016-08-17 16:03:00 +0000,http://www.fool.com/investing/2016/08/17/billionaire-money-managers-sold-off-this-stock-in.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,Billionaire Money Managers Sold off This Stock in the 2nd Quarter
PFE,PFE:US,BBG000BR2B91,"Dow Movers: CSCO, PFE",2016-08-17 15:33:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kxU0psZ2nJA/dow-movers-csco-pfe-cm666518,"In early trading on Wednesday, shares of Pfizer ( PFE ) topped the list of the day's best performing Dow Jones Industrial Average components, trading up 0.3%. Year to date, Pfizer registers a 8.1% gain. And the worst performing"
PFE,PFE:US,BBG000BR2B91,Jason Karp’s Biggest Contributors in Q2 Amid Tourbillon’s Disappointing Performance,2016-08-17 14:57:56 +0000,http://www.insidermonkey.com/blog/jason-karps-biggest-contributors-in-q2-amid-tourbillons-disappointing-performance-469421/,Jason Karp’s Biggest Contributors in Q2 Amid Tourbillon’s Disappointing Performance
PFE,PFE:US,BBG000BR2B91,"With new president and focus on big investors, Cellceutix aims for the Nasdaq",2016-08-17 12:13:22 +0000,http://www.bizjournals.com/boston/blog/bioflash/2016/08/with-new-president-and-focus-on-big-investors.html?ana=yahoo,"With new president and focus on big investors, Cellceutix aims for the Nasdaq"
PFE,PFE:US,BBG000BR2B91,U.S. Market Indexes Lower on Tuesday,2016-08-16 23:22:50 +0000,http://finance.yahoo.com/news/u-market-indexes-lower-tuesday-232250701.html,U.S. Market Indexes Lower on Tuesday
PFE,PFE:US,BBG000BR2B91,Novartis Needs to Stem the Bleeding From Gleevec Decline,2016-08-16 22:48:24 +0000,http://finance.yahoo.com/news/novartis-needs-stem-bleeding-gleevec-224824879.html,Novartis Needs to Stem the Bleeding From Gleevec Decline
PFE,PFE:US,BBG000BR2B91,Pfizer's Bold Bid to Conquer Cancer,2016-08-16 22:33:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zsRAAG10x44/pfizers-bold-bid-to-conquer-cancer-cm666252,"Image source  Getty Images.  Pfizer Inc. (NYSE  PFE) came up strong last quarter, topping analysts' estimates by a hefty margin. In particular, the world's second biggest drugmaker by revenue is gaining traction"
PFE,PFE:US,BBG000BR2B91,Pfizer's Bold Bid to Conquer Cancer,2016-08-16 20:26:00 +0000,http://www.fool.com/investing/2016/08/16/pfizers-bold-bid-to-conquer-cancer.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Pfizer's Bold Bid to Conquer Cancer
PFE,PFE:US,BBG000BR2B91,"For Value Investors, Arbiter Partners Knows How to Pick 'Em",2016-08-16 18:00:00 +0000,http://realmoney.thestreet.com/articles/08/16/2016/value-investors-arbiter-partners-knows-how-pick-em?puc=yahoo&cm_ven=YAHOO,"For Value Investors, Arbiter Partners Knows How to Pick 'Em"
PFE,PFE:US,BBG000BR2B91,Abraxane Still Leads the US Metastatic Pancreatic Cancer Segment,2016-08-16 15:04:37 +0000,http://marketrealist.com/2016/08/abraxane-continues-leader-metastatic-pancreatic-cancer-segment-u-s/?utm_source=yahoo&utm_medium=feed,Abraxane Still Leads the US Metastatic Pancreatic Cancer Segment
PFE,PFE:US,BBG000BR2B91,Ackman: Pershing Square Slashes Zoetis Stake,2016-08-16 13:35:00 +0000,http://blogs.barrons.com/focusonfunds/2016/08/16/ackman-pershing-square-slashes-zoetis-stake/?mod=yahoobarrons&ru=yahoo,Ackman: Pershing Square Slashes Zoetis Stake
PFE,PFE:US,BBG000BR2B91,ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment,2016-08-16 13:14:00 +0000,http://finance.yahoo.com/news/viiv-healthcare-launches-phase-iii-131400032.html,[CNW Group] - ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/16/2016: REPH, OGXI, JNJ, PFE, ABT, MRK, AMGN",2016-08-16 13:11:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ljOb_Cl_TZo/health-care-sector-update-for-08162016-reph-ogxi-jnj-pfe-abt-mrk-amgn-cm665752,"Top Health care stocks JNJ flat PFE 0.2% ABT 0.5% MRK flat AMGN flat Health care shares were mostly unchanged in pre market trade Tuesday. In health care stocks news, OncoGenex Pharmaceuticals ( OGXI ) fell 24.3% after the"
PFE,PFE:US,BBG000BR2B91,Analyzing the Future Estimates for Pfizer,2016-08-16 13:04:13 +0000,http://marketrealist.com/2016/08/analyzing-the-future-estimates-for-pfizer/?utm_source=yahoo&utm_medium=feed,Analyzing the Future Estimates for Pfizer
PFE,PFE:US,BBG000BR2B91,ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment,2016-08-16 12:55:00 +0000,http://finance.yahoo.com/news/viiv-healthcare-launches-phase-iii-125500352.html,"[PR Newswire] - LONDON, August 16, 2016 /PRNewswire/ -- ViiV Healthcare today announced the start of a phase III programme to support regulatory filings for a two-drug regimen of dolutegravir (Tivicay®) and lamivudine ..."
PFE,PFE:US,BBG000BR2B91,"Paulson Shifts Health-Care Stakes, Adds FedEx",2016-08-15 22:37:07 +0000,http://blogs.wsj.com/moneybeat/2016/08/15/paulson-shifts-health-care-stakes-adds-fedex/?mod=yahoo_hs,"Paulson Shifts Health-Care Stakes, Adds FedEx"
PFE,PFE:US,BBG000BR2B91,Hedge funds made big changes at drug companies in 2nd qtr -filings,2016-08-15 20:25:30 +0000,http://finance.yahoo.com/news/hedge-funds-made-big-changes-202530271.html,Hedge funds made big changes at drug companies in 2nd qtr -filings
PFE,PFE:US,BBG000BR2B91,Why is Time (TIME) Stock Popping Today?,2016-08-15 19:35:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5zA1Xgcs6tE/why-is-time-time-stock-popping-today-cm665504,"On Monday, shares of magazine publisher Time Inc. TIME are popping, up over 6% in late morning trading after Jana Partners LLC, a New York based hedge fund, announced a new, 5 million share position in the media company."
PFE,PFE:US,BBG000BR2B91,Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis,2016-08-15 17:05:26 +0000,http://247wallst.com/healthcare-business/2016/08/15/credit-suisse-issues-top-pharma-picks-in-bullbear-upside-analysis/,Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis
PFE,PFE:US,BBG000BR2B91,What CVS and Express Scripts' Drug Exclusion Lists Means for Your Portfolio,2016-08-15 16:58:00 +0000,https://www.thestreet.com/story/13675249/1/what-cvs-and-express-scripts-drug-exclusion-lists-means-for-your-portfolio.html?puc=yahoo&cm_ven=YAHOO,What CVS and Express Scripts' Drug Exclusion Lists Means for Your Portfolio
PFE,PFE:US,BBG000BR2B91,GlycoMimetics Initiated At Outperform By Cowen And Company,2016-08-15 16:01:49 +0000,http://finance.yahoo.com/news/glycomimetics-initiated-outperform-cowen-company-160149274.html,GlycoMimetics Initiated At Outperform By Cowen And Company
PFE,PFE:US,BBG000BR2B91,Rosenstein's Jana Partners: Walgreens Stake Gets Slashed 60%; Trims ConAgra; Adds AutoNation,2016-08-15 15:41:00 +0000,http://blogs.barrons.com/focusonfunds/2016/08/15/rosensteins-jana-partners-walgreens-stake-gets-slashed-60-trims-conagra-adds-autonation/?mod=yahoobarrons&ru=yahoo,Rosenstein's Jana Partners: Walgreens Stake Gets Slashed 60%; Trims ConAgra; Adds AutoNation
PFE,PFE:US,BBG000BR2B91,Pfizer’s 2Q16 Profitability and Financial Guidance,2016-08-15 15:04:13 +0000,http://marketrealist.com/2016/08/pfizers-2q16-profitability-and-financial-guidance/?utm_source=yahoo&utm_medium=feed,Pfizer’s 2Q16 Profitability and Financial Guidance
PFE,PFE:US,BBG000BR2B91,Recent Corporate and Pipeline Developments for Pfizer,2016-08-15 13:04:20 +0000,http://marketrealist.com/2016/08/recent-corporate-and-pipeline-developments-for-pfizer/?utm_source=yahoo&utm_medium=feed,Recent Corporate and Pipeline Developments for Pfizer
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/15/2016: ACRX, ADK, JNJ, PFE, ABT, MRK, AMGN",2016-08-15 12:51:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sw4ftUGbgV8/health-care-sector-update-for-08152016-acrx-adk-jnj-pfe-abt-mrk-amgn-cm665183,"Top Health care stocks JNJ flat PFE +0.1% ABT 0.1% MRK +0.3% AMGN flat Health care shares were mixed in pre market trade Monday. In health care stocks news, Adcare Health Systems Inc ( ADK ) was up 7.2%"
PFE,PFE:US,BBG000BR2B91,"Mark Your Calendar For Aug.17, TRIL To Report Data In Q4, FLML Launches Akova",2016-08-14 23:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gve17BIXunc/mark-your-calendar-for-aug17-tril-to-report-data-in-q4-flml-launches-akova-20160814-00049,"Mark Your Calendar For Aug.17, TRIL To Report Data In Q4, FLML Launches Akova"
PFE,PFE:US,BBG000BR2B91,Valeant Pharmaceuticals (VRX) Stock: The Philidor Nightmare Isn’t Over,2016-08-12 20:24:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/shAS8OsO3yA/valeant-pharmaceuticals-vrx-stock-the-philidor-nightmare-isnt-over-cm664277,"The U.S. Attorney for the Southern District of New York, which often prosecutes Wall Street cases, has opened an investigation into Valeant Pharmaceuticals Intl Inc (NYSE VRX ). The topic Valeant's"
PFE,PFE:US,BBG000BR2B91,How To YieldBoost PFE To 5.2% Using Options,2016-08-12 16:48:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oE6y73RzI4I/how-to-yieldboost-pfe-to-52-using-options-cm664713,"Shareholders of Pfizer Inc (Symbol PFE) looking to boost their income beyond the stock's 3.4% annualized dividend yield can sell the January 2018 covered call at the $40 strike and collect the premium based on the 91 cents bid,"
PFE,PFE:US,BBG000BR2B91,Major Product Developments for Pfizer,2016-08-12 15:04:29 +0000,http://marketrealist.com/2016/08/major-product-developments-for-pfizer/?utm_source=yahoo&utm_medium=feed,Major Product Developments for Pfizer
PFE,PFE:US,BBG000BR2B91,Pfizer-Anacor Deal Completed in June 2016,2016-08-12 13:04:39 +0000,http://marketrealist.com/2016/08/pfizer-anacor-deal-completed-in-june-2016/?utm_source=yahoo&utm_medium=feed,Pfizer-Anacor Deal Completed in June 2016
PFE,PFE:US,BBG000BR2B91,Five Healthcare Stocks Billionaires Are Bullish On,2016-08-11 23:14:23 +0000,http://www.insidermonkey.com/blog/five-healthcare-stocks-billionaires-are-bullish-on-459931/,Five Healthcare Stocks Billionaires Are Bullish On
PFE,PFE:US,BBG000BR2B91,"PFIZER INC Files SEC form 10-Q, Quarterly Report",2016-08-11 21:03:30 +0000,http://biz.yahoo.com/e/160811/pfe10-q.html,"PFIZER INC Files SEC form 10-Q, Quarterly Report"
PFE,PFE:US,BBG000BR2B91,5 DJIA Stocks That Really Missed Out on the All-Time High Rally Thursday,2016-08-11 20:33:59 +0000,http://247wallst.com/investing/2016/08/11/5-djia-stocks-that-really-missed-out-on-the-all-time-high-rally-thursday/,5 DJIA Stocks That Really Missed Out on the All-Time High Rally Thursday
PFE,PFE:US,BBG000BR2B91,Put sale sees limited downside for Pfizer,2016-08-11 15:36:53 +0000,http://finance.yahoo.com/news/pfizer-put-sale-sees-limited-153653643.html,Put sale sees limited downside for Pfizer
PFE,PFE:US,BBG000BR2B91,Pfizer’s Products with Decreasing Revenues,2016-08-11 15:04:54 +0000,http://marketrealist.com/2016/08/pfizers-products-with-decreasing-revenues/?utm_source=yahoo&utm_medium=feed,Pfizer’s Products with Decreasing Revenues
PFE,PFE:US,BBG000BR2B91,Post Earnings Coverage as Allergan Tops Earnings Expectation Bolstered By Botox,2016-08-11 13:31:34 +0000,http://news.investornetwork.com/2016/08/11/post-earnings-coverage-as-allergan-tops-earnings-expectation-bolstered-by-botox/?1=1&1470922294,Post Earnings Coverage as Allergan Tops Earnings Expectation Bolstered By Botox
PFE,PFE:US,BBG000BR2B91,Understanding Growth Contributors for Pfizer,2016-08-11 13:06:07 +0000,http://marketrealist.com/2016/08/understanding-growth-contributors-for-pfizer/?utm_source=yahoo&utm_medium=feed,Understanding Growth Contributors for Pfizer
PFE,PFE:US,BBG000BR2B91,More Good News from Ireland,2016-08-11 12:54:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xUmeNUy4WXY/more-good-news-from-ireland-cm663927,"Remember the acronym PIIGS from not very long ago? Which in turn gave way to headlines such as, “Which PIIG Won’t Fly” and “PIIGS Don’t Fly”? Obviously implying that the five countries that made up the silly acronym, Portugal, Italy, Ireland, Greece, and Spain were doomed.  It’s been eight years since that term was"
PFE,PFE:US,BBG000BR2B91,"[$$] Lawyer, Adviser Charged With Insider Trading",2016-08-11 04:51:58 +0000,http://www.wsj.com/articles/former-law-partner-adviser-arrested-for-insider-trading-1470850605?ru=yahoo?mod=yahoo_itp,[at The Wall Street Journal] - A former partner at Hunton & Williams and his investment adviser are accused of illegal trades ahead of Pfizer’s 2010 acquisition of King Pharmaceuticals.
PFE,PFE:US,BBG000BR2B91,Two charged with insider trading over 2010 Pfizer acquisition,2016-08-10 23:05:35 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=44357108-5F4D-11E6-BA69-1FAA450B70CD&siteid=yhoof2,Two charged with insider trading over 2010 Pfizer acquisition
PFE,PFE:US,BBG000BR2B91,Mylan's Time Leaning on EpiPens Is Rapidly Approaching an End,2016-08-10 20:58:00 +0000,https://www.thestreet.com/story/13646012/1/mylan-s-time-leaning-on-epipens-is-rapidly-approaching-an-end.html?puc=yahoo&cm_ven=YAHOO,Mylan's Time Leaning on EpiPens Is Rapidly Approaching an End
PFE,PFE:US,BBG000BR2B91,"Lilly Breast Cancer Drug Study Rolls On, Pushing Back Launch Date",2016-08-10 20:41:49 +0000,http://www.investors.com/news/technology/lilly-breast-cancer-drug-study-goes-on-pushing-back-launch-date/,"Lilly Breast Cancer Drug Study Rolls On, Pushing Back Launch Date"
PFE,PFE:US,BBG000BR2B91,"IWD, JNJ, JPM, PFE: ETF Inflow Alert",2016-08-10 16:52:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j-PtvVflOh8/iwd-jnj-jpm-pfe-etf-inflow-alert-cm663506,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the iShares Russell 1000 Value ETF (Symbol IWD) where we have detected an approximate $413.7 million dollar"
PFE,PFE:US,BBG000BR2B91,Pfizer’s Business Segments and Their Performance,2016-08-10 16:04:05 +0000,http://marketrealist.com/2016/08/pfizers-business-segments-and-their-performance/?utm_source=yahoo&utm_medium=feed,Pfizer’s Business Segments and Their Performance
PFE,PFE:US,BBG000BR2B91,Why Ariad Pharmaceuticals Gained 26.9% in July,2016-08-10 15:53:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hx6qONbrA6c/why-ariad-pharmaceuticals-gained-269-in-july-cm663400,"Image Source  Getty Images  What   Shares of Ariad Pharmaceuticals (NASDAQ  ARIA) , a mid cap oncology company, gained close to 27% in July, according to data from S&P Global Market Intelligence"
PFE,PFE:US,BBG000BR2B91,"Lawyer, Adviser Charged With Insider Trading",2016-08-10 14:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g8b6D4jT2-E/lawyer-adviser-charged-with-insider-trading-20160810-01104,"Lawyer, Adviser Charged With Insider Trading"
PFE,PFE:US,BBG000BR2B91,"Former Law Partner, Adviser Arrested For Insider Trading",2016-08-10 14:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UeKawlHpc8Q/former-law-partner-adviser-arrested-for-insider-trading-20160810-00784,"Former Law Partner, Adviser Arrested For Insider Trading"
PFE,PFE:US,BBG000BR2B91,"Eli Lilly and Company (LLY) Ex-Dividend Date Scheduled for August 11, 2016",2016-08-10 13:29:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/l2cGitfSmzU/eli-lilly-and-company-lly-ex-dividend-date-scheduled-for-august-11-2016-cm663161,"Eli Lilly and Company ( LLY ) will begin trading ex dividend on August 11, 2016. A cash dividend payment of $0.51 per share is scheduled to be paid on September 09, 2016. Shareholders who purchased LLY prior to"
PFE,PFE:US,BBG000BR2B91,"Novo Nordisk A/S (NVO) Ex-Dividend Date Scheduled for August 11, 2016",2016-08-10 13:27:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xP43Z8sU714/novo-nordisk-as-nvo-ex-dividend-date-scheduled-for-august-11-2016-cm663125,"Novo Nordisk A S ( NVO ) will begin trading ex dividend on August 11, 2016. A cash dividend payment of $0.446847 per share is scheduled to be paid on August 23, 2016. Shareholders who purchased NVO prior to"
PFE,PFE:US,BBG000BR2B91,Gilead Sciences Inc. Stock in 3 Charts,2016-08-09 19:56:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hEzcfD3jnf0/gilead-sciences-inc-stock-in-3-charts-cm662791,"Image source  Getty Images.  Leading antiviral treatments have made Gilead Sciences (NASDAQ  GILD) more profitable than any of its Big Pharma peers, but the stock is trading at bargain bin prices. Sales"
PFE,PFE:US,BBG000BR2B91,"Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for August 10, 2016",2016-08-09 13:18:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/auBjveZZ6Yo/astrazeneca-plc-azn-ex-dividend-date-scheduled-for-august-10-2016-cm662333,"Astrazeneca PLC ( AZN ) will begin trading ex dividend on August 10, 2016. A cash dividend payment of $0.45 per share is scheduled to be paid on September 12, 2016. Shareholders who purchased AZN prior to the ex"
PFE,PFE:US,BBG000BR2B91,Cardinal Health a Top Ranked SAFE Dividend Stock With 2.1% Yield (CAH),2016-08-09 12:33:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rMDrF9jbaRY/cardinal-health-a-top-ranked-safe-dividend-stock-with-21-yield-cah-cm662271,"Cardinal Health, Inc. (Symbol CAH) has been named to the Dividend Channel ''S.A.F.E. 25'' list, signifying a stock with above average ''DividendRank'' statistics including a strong 2.1% yield, as well as a superb track record of at least two"
PFE,PFE:US,BBG000BR2B91,"MESO Gains After Hours, PFNX Gets It Back, CHRS' Humira Biosimilar Meets Goals",2016-08-09 02:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DHGRjpICogE/meso-gains-after-hours-pfnx-gets-it-back-chrs-humira-biosimilar-meets-goals-20160809-00041,"MESO Gains After Hours, PFNX Gets It Back, CHRS' Humira Biosimilar Meets Goals"
PFE,PFE:US,BBG000BR2B91,Monday's ETF with Unusual Volume: PPH,2016-08-08 19:11:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Br8Ar5-1tvU/mondays-etf-with-unusual-volume-pph-cm662012,"The Pharmaceutical ETF ( PPH ) is seeing unusually high volume in afternoon trading Monday, with over 232,000 shares traded versus three month average volume of about 47,000. Shares of PPH were down about 1.1% on the day. Components"
PFE,PFE:US,BBG000BR2B91,"Dow Movers: MRK, CAT",2016-08-08 16:16:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lbL0VNk5P1E/dow-movers-mrk-cat-cm661860,"In early trading on Monday, shares of Caterpillar ( CAT ) topped the list of the day's best performing Dow Jones Industrial Average components, trading up 0.8%. Year to date, Caterpillar registers a 22.4% gain. And the worst performing"
PFE,PFE:US,BBG000BR2B91,"The Zacks Analyst Blog Highlights: ExxonMobil, Chevron, Merck, Pfizer and Procter & Gamble",2016-08-08 15:18:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8VOychpAtFk/the-zacks-analyst-blog-highlights-exxonmobil-chevron-merck-pfizer-and-procter-gamble-cm661769,"For Immediate Release Chicago, IL August 08, 2016 Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks"
PFE,PFE:US,BBG000BR2B91,"Health Care Sector Update for 08/08/2016: JNJ, PFE, ABT, MRK, AMGN",2016-08-08 14:28:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s8C1pQmbjRM/health-care-sector-update-for-08082016-jnj-pfe-abt-mrk-amgn-cm661766,"Top Health care stocks AMGN +0.2% ABT 0.4% JNJ 0.6% PFE 1.5% MRK 2.1% Health care shares were mostly lower in pre market trade Monday. In health care stocks news, Allergan ( AGN ) reported Q2 EPS of $3.35"
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Publication of New Analysis Showing Long-Term Therapy with VYNDAQEL (tafamidis) Slowed Progression of Rare Neurodegenerative Disease,2016-08-08 12:08:04 +0000,http://www.publicnow.com/view/88B1E0FE5F1982492736E7BACFEB61EA9D65B088,[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced the publication of a new post-hoc analysis of data from three studies of VYNDAQEL in patients with mild transthyretin familial amyloid polyneuropathy ...
PFE,PFE:US,BBG000BR2B91,"Allergan Revenue Increases, Though Loss Widens",2016-08-08 08:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8l0xeZ_HrgQ/allergan-revenue-increases-though-loss-widens-20160808-00413,"Allergan Revenue Increases, Though Loss Widens"
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Publication Of New Data From Studies Of Vyndaqel - Quick Facts,2016-08-08 08:19:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jenFT8maAOo/pfizer-announces-publication-of-new-data-from-studies-of-vyndaqel--quick-facts-20160808-00362,Pfizer Announces Publication Of New Data From Studies Of Vyndaqel - Quick Facts
PFE,PFE:US,BBG000BR2B91,"Pfizer Limited revenue up by 3.4 % for the Quarter ended June 30, 2016",2016-08-06 09:08:02 +0000,http://www.publicnow.com/view/873810D61D9DE599192996D1531C445901B7A748,"[at noodls] - Pfizer Limited revenue up by 3.4 % for the Quarter ended June 30, 2016 The text version of this document is not available at the moment. The original content was posted at original link . Pfizer Ltd. published ..."
PFE,PFE:US,BBG000BR2B91,"AstraZeneca hits 2014 Pfizer bid price, helped by Bristol's woes",2016-08-05 14:50:09 +0000,http://sg.finance.yahoo.com/news/astrazeneca-hits-2014-pfizer-bid-145009783.html,"AstraZeneca hits 2014 Pfizer bid price, helped by Bristol's woes"
PFE,PFE:US,BBG000BR2B91,Business Groups Sue Over Inversion Rules -- WSJ,2016-08-05 02:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Vj_rLoAkdVQ/business-groups-sue-over-inversion-rules--wsj-20160805-00034,Business Groups Sue Over Inversion Rules -- WSJ
PFE,PFE:US,BBG000BR2B91,US industry bodies sue over Obama corporate tax rules,2016-08-05 01:51:36 +0000,http://uk.finance.yahoo.com/news/us-industry-bodies-sue-over-015136965.html,US industry bodies sue over Obama corporate tax rules
PFE,PFE:US,BBG000BR2B91,Business groups sue over new U.S. limit on tax-driven foreign buyouts,2016-08-04 20:00:54 +0000,http://sg.finance.yahoo.com/news/business-groups-sue-over-u-184815883.html,Business groups sue over new U.S. limit on tax-driven foreign buyouts
PFE,PFE:US,BBG000BR2B91,Business Groups Sue U.S. Government Over Tax-Inversion Rules -- 2nd Update,2016-08-04 16:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X7pV9NU2-6k/business-groups-sue-us-government-over-taxinversion-rules--2nd-update-20160804-01540,Business Groups Sue U.S. Government Over Tax-Inversion Rules -- 2nd Update
PFE,PFE:US,BBG000BR2B91,Business Groups Sue U.S. Government Over Tax-Inversion Rules -- Update,2016-08-04 15:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8D8-x_su8Hc/business-groups-sue-us-government-over-taxinversion-rules--update-20160804-01162,Business Groups Sue U.S. Government Over Tax-Inversion Rules -- Update
PFE,PFE:US,BBG000BR2B91,U.S. Government Sued Over Tax-Inversion Rules,2016-08-04 14:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DLHO-eaf_pg/us-government-sued-over-taxinversion-rules-20160804-01103,U.S. Government Sued Over Tax-Inversion Rules
PFE,PFE:US,BBG000BR2B91,Business Groups Sue U.S. Government Over Tax-Inversion Rules,2016-08-04 13:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AYgcuPrf8A4/business-groups-sue-us-government-over-taxinversion-rules-20160804-01093,Business Groups Sue U.S. Government Over Tax-Inversion Rules
PFE,PFE:US,BBG000BR2B91,Pfizer Hit As Sales Of Older Drugs Fall -- WSJ,2016-08-03 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wpgtYKlLpIQ/pfizer-hit-as-sales-of-older-drugs-fall--wsj-20160803-00060,Pfizer Hit As Sales Of Older Drugs Fall -- WSJ
PFE,PFE:US,BBG000BR2B91,"In Quest to Grow, Rivals Woo Biogen -- WSJ",2016-08-03 02:48:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6uWr2Ug4SF8/in-quest-to-grow-rivals-woo-biogen--wsj-20160803-00055,"In Quest to Grow, Rivals Woo Biogen -- WSJ"
PFE,PFE:US,BBG000BR2B91,Business Highlights,2016-08-02 21:19:57 +0000,http://sg.finance.yahoo.com/news/business-highlights-211957792.html,Business Highlights
PFE,PFE:US,BBG000BR2B91,Wall Street falls as weak auto sales spur growth jitters,2016-08-02 20:32:39 +0000,http://in.finance.yahoo.com/news/wall-st-opens-lower-pfizer-142735539.html,Wall Street falls as weak auto sales spur growth jitters
PFE,PFE:US,BBG000BR2B91,Biogen Draws Takeover Interest from Rival Drugmakers--2nd Update,2016-08-02 19:44:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JQZ0wh9GuTo/biogen-draws-takeover-interest-from-rival-drugmakers2nd-update-20160802-01135,Biogen Draws Takeover Interest from Rival Drugmakers--2nd Update
PFE,PFE:US,BBG000BR2B91,CVS Drops Coverage of 2 Branded Biotech Drugs in Favor of Copies,2016-08-02 19:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/veVrvXp-qXM/cvs-drops-coverage-of-2-branded-biotech-drugs-in-favor-of-copies-20160802-01620,CVS Drops Coverage of 2 Branded Biotech Drugs in Favor of Copies
PFE,PFE:US,BBG000BR2B91,"Pfizer beats estimates, but branded drugs disappoint",2016-08-02 17:06:39 +0000,http://sg.finance.yahoo.com/news/pfizer-revenue-rises-11-percent-105927432.html,"Pfizer beats estimates, but branded drugs disappoint"
PFE,PFE:US,BBG000BR2B91,Pfizer beats Street 2Q forecasts despite big drop in profit,2016-08-02 17:02:35 +0000,http://sg.finance.yahoo.com/news/pfizer-beats-street-2q-forecasts-105923276.html,Pfizer beats Street 2Q forecasts despite big drop in profit
PFE,PFE:US,BBG000BR2B91,Pfizer earnings top estimates on higher sales,2016-08-02 13:23:00 +0000,http://uk.finance.yahoo.com/news/pfizer-earnings-top-estimates-higher-132300963.html,Pfizer earnings top estimates on higher sales
PFE,PFE:US,BBG000BR2B91,PFIZER REPORTS SECOND-QUARTER 2016 RESULTS,2016-08-02 11:11:04 +0000,http://www.publicnow.com/view/A3DC5A17814C86368525B8C2C0035936296D7C9A,"[at noodls] - ‌‌‌ Second-Quarter 2016 Revenues of $13.1 Billion, Reflecting 13% Operational Growth Driven by the Inclusion of Legacy Hospira Operations and 9% Operational Growth from Pfizer Innovative Health Second-Quarter ..."
PFE,PFE:US,BBG000BR2B91,"PFIZER AIMS TO BECOME INDUSTRY LEADER IN GENE THERAPY WITH AQUISITION OF BAMBOO THERAPEUTICS, INC.",2016-08-01 14:41:03 +0000,http://www.publicnow.com/view/76784D145F9247E0CB41598C3299778DE810B97F,"[at noodls] - Pfizer Inc. (NYSE:PFE) today announced that it has acquired Bamboo Therapeutics, Inc., a privately held biotechnology company based in Chapel Hill, N.C., focused on developing gene therapies for the potential ..."
PFE,PFE:US,BBG000BR2B91,"Pfizer Aims to Become Industry Leader in Gene Therapy with Acquisition of Bamboo Therapeutics, Inc.",2016-08-01 14:11:03 +0000,http://www.publicnow.com/view/CD42F3E1ADC71095034115B513B09D91ED9F0B8C,"[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that it has acquired Bamboo Therapeutics, Inc., a privately held biotechnology company based in Chapel Hill, N.C., focused on developing ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of Oral XELJANZ® (Tofacitinib Citrate) in Ulcerative Colitis,2016-07-28 20:38:17 +0000,http://www.publicnow.com/view/6B625E16952FC1C59A7F81F1BECCB5CEBE0B30F7,"[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today top-line results from Oral Clinical Trials for tofAcitinib in ulceratiVE colitis (OCTAVE) Sustain, the third Phase 3 study of XELJANZ (tofacitinib ..."
PFE,PFE:US,BBG000BR2B91,Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to Investigate Novel Oncolytic Virus Technology,2016-07-28 14:08:08 +0000,http://www.publicnow.com/view/9FE7E96C97459BC38342E142F235B5FE5CAD1D30,"[at noodls] - NEW YORK & CLEVELAND--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) and Western Oncolytics announced today that they have entered into a development collaboration, license and option agreement to advance Western ..."
PFE,PFE:US,BBG000BR2B91,AstraZeneca a takeover target again? CEO not commenting,2016-07-28 09:43:43 +0000,http://uk.finance.yahoo.com/news/astrazeneca-takeover-target-again-ceo-094343937.html,AstraZeneca a takeover target again? CEO not commenting
PFE,PFE:US,BBG000BR2B91,Legislator: Pfizer can't complain about execution drug,2016-07-26 23:11:17 +0000,http://sg.finance.yahoo.com/news/legislator-pfizer-cant-complain-execution-215551933.html,Legislator: Pfizer can't complain about execution drug
PFE,PFE:US,BBG000BR2B91,BIND Therapeutics Determines Pfizer's $40 Million Bid Is Highest and Best in 363 Auction for Substantially All of BIND's Assets,2016-07-26 21:48:09 +0000,http://www.publicnow.com/view/E0C6BD7A9D2EF86F40EBFBE64D341DBF3EBE2A43,"[at noodls] - July 26, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- BIND Therapeutics, Inc. (NASDAQ: BIND), a biotechnology company developing targeted and programmable therapeutics called ACCURINS®, today announced that ..."
PFE,PFE:US,BBG000BR2B91,"Exclusive - Teva, Mylan eye Pfizer's Brazil venture, sources say",2016-07-26 13:51:47 +0000,http://sg.finance.yahoo.com/news/exclusive-teva-mylan-eye-pfizers-134409051.html,"Exclusive - Teva, Mylan eye Pfizer's Brazil venture, sources say"
PFE,PFE:US,BBG000BR2B91,"Teva, Mylan eye Pfizer's Brazil venture, sources say",2016-07-26 13:41:56 +0000,http://in.finance.yahoo.com/news/teva-mylan-eye-pfizers-brazil-134156506.html,"Teva, Mylan eye Pfizer's Brazil venture, sources say"
PFE,PFE:US,BBG000BR2B91,APNewsBreak: Pfizer: Arkansas execution would 'misuse' drug,2016-07-25 23:14:47 +0000,http://sg.finance.yahoo.com/news/apnewsbreak-arkansas-execution-drug-made-210806864.html,APNewsBreak: Pfizer: Arkansas execution would 'misuse' drug
PFE,PFE:US,BBG000BR2B91,Germany plans to extend price brake for drugs under statutory insurance,2016-07-25 15:09:25 +0000,http://uk.finance.yahoo.com/news/germany-plans-extend-price-brake-150925469.html,"[Reuters - UK Focus] - Germany wants to extend a price brake for drugs covered by statutory health insurance for five years beyond 2017, stretching out the measure introduced in 2009, a draft law seen by Reuters shows. The health ..."
PFE,PFE:US,BBG000BR2B91,"Spark Therapeutics and Pfizer Announce Updated Data from First Cohort in Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels of Factor IX Activity",2016-07-25 12:48:02 +0000,http://www.publicnow.com/view/36D6F2B42AC0C4A0DD4086A0427769A28CB890C6,"[at noodls] - PHILADELPHIA and NEW YORK, July 25, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE) and Pfizer Inc. (NYSE:PFE) announced today updated results of the first cohort from the ongoing Phase 1/2 clinical ..."
PFE,PFE:US,BBG000BR2B91,BIND Therapeutics Announces Two Bidders Join Pfizer's Stalking Horse Bid in Auction for BIND's Assets,2016-07-25 11:58:08 +0000,http://www.publicnow.com/view/BD5B5411E6C4A109290CB7F5750BDF9E105805D3,"[at noodls] - July 25, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- BIND Therapeutics, Inc. (NASDAQ:BIND), a biotechnology company developing targeted and programmable therapeutics called ACCURINS®, today announced that ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Announces the Publication of Final Results from Two Pivotal Phase 3 Studies of Crisaborole Topical Ointment in Patients with Mild to Moderate Atopic Dermatitis,2016-07-13 12:23:01 +0000,http://www.publicnow.com/view/10DA5FCC1996FC88D5191E6C51743476E4390542,[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today the publication of findings from two pivotal Phase 3 studies of investigational crisaborole topical ointment 2% (formerly AN2728) in the ...
PFE,PFE:US,BBG000BR2B91,Lower-cost biotech drug gets thumbs up from FDA panel,2016-07-12 21:39:00 +0000,http://sg.finance.yahoo.com/news/lower-cost-biotech-drug-gets-210612526.html,Lower-cost biotech drug gets thumbs up from FDA panel
PFE,PFE:US,BBG000BR2B91,Pfizer Receives FDA Approval for Prevnar 13® in Adults Age 18 Through 49,2016-07-12 20:33:11 +0000,http://www.publicnow.com/view/4474194CE247D100464AB6D6E332C50B83C68313,[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine ) received U.S. Food and Drug Administration (FDA) ...
PFE,PFE:US,BBG000BR2B91,Pfizer Announces Positive Top-Line Results From Phase 3 S-TRAC Trial of SUTENT® (sunitinib) as Adjuvant Therapy in Patients at High Risk of Recurrent Renal Cell Carcinoma,2016-07-08 12:11:05 +0000,http://www.publicnow.com/view/B581425978265DA0E1456DA863A1BDED88BB76C2,"[at noodls] - NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the S-TRAC clinical trial (Sunitinib Trial in Adjuvant Renal Cancer), a Phase 3 study of SUTENT versus placebo in the adjuvant setting, ..."
PFE,PFE:US,BBG000BR2B91,Pfizer agrees to note addiction risks in opioid marketing,2016-07-06 18:48:20 +0000,http://sg.finance.yahoo.com/news/chicago-says-pfizer-agrees-disclose-172142293.html,Pfizer agrees to note addiction risks in opioid marketing
PFE,PFE:US,BBG000BR2B91,"Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer",2016-07-06 12:21:02 +0000,http://www.publicnow.com/view/6ED15A56E16975F501B6FA9B5AC3FA7C9D9BDC93,"[at noodls] - DARMSTADT, Germany & NEW YORK--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, and Pfizer (NYSE: PFE) today announced the initiation of a Phase III study, JAVELIN Ovarian 100, to evaluate the efficacy ..."
PFE,PFE:US,BBG000BR2B91,Merck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer,2016-07-06 12:11:09 +0000,http://www.publicnow.com/view/B683FFD25DC9953F7185025F8EF941B98CE572BD,[at noodls] - Press Release Template News Release Merck Media: Gangolf Schrimpf +49 6151 72 9591 Investor Relations: +49 6151 72 3321 Pfizer Media:... This is an abstract of the original noodl. To continue reading this ...
PFE,PFE:US,BBG000BR2B91,Medivation agrees to open its books to Sanofi,2016-07-05 21:24:43 +0000,http://sg.finance.yahoo.com/news/exclusive-medivation-discusses-potential-sale-185006662.html,Medivation agrees to open its books to Sanofi
PFE,PFE:US,BBG000BR2B91,UK plans lower corporation tax to cushion hit from Brexit,2016-07-04 14:31:10 +0000,http://sg.finance.yahoo.com/news/osborne-slash-corporation-tax-cushion-021226172.html,UK plans lower corporation tax to cushion hit from Brexit
PFE,PFE:US,BBG000BR2B91,BIND Therapeutics Files Motion for Sale of Assets After Accepting Stalking Horse Bid from Pfizer Inc.,2016-07-01 21:51:01 +0000,http://www.publicnow.com/view/183071800CDE8D73E7D060B06288AFD26F79B999,"[at noodls] - July 1, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- BIND Therapeutics, Inc. (NASDAQ: BIND), a biotechnology company developing targeted and programmable therapeutics called ACCURINS, today announced it has ..."
PFE,PFE:US,BBG000BR2B91,Two Additional Phase 3 Lipid-Lowering Studies of Bococizumab Deliver Positive Topline Results,2016-06-28 12:51:03 +0000,http://www.publicnow.com/view/B5BB25462ADB3FF0496502E754B69B70F0CA827F,"[at noodls] - Pfizer Inc. announced two additional Phase 3 bococizumab trials, SPIRE-HR (HighRisk) and SPIRE-FH (Familial Hypercholesterolemia), met their primary endpoint, demonstrating a significant reduction in the ..."
PFE,PFE:US,BBG000BR2B91,Pfizer Advances Biosimilars Leadership with Investment in a New World-Class Global Biotechnology Center in China,2016-06-28 10:41:04 +0000,http://www.publicnow.com/view/3353D7A47DB24A592D779731719897EC178722A7,[at noodls] - Pfizer Inc. today announced that it will invest approximately USD$350 million in the development of a state-of-the-art Global Biotechnology Center at a ground-breaking ceremony in the Hangzhou Economic ...
PFE,PFE:US,BBG000BR2B91,Rx pizza: 1 free meal can sway doctor prescribing,2016-06-20 19:16:04 +0000,http://sg.finance.yahoo.com/news/rx-pizza-1-free-meal-191604918.html,Rx pizza: 1 free meal can sway doctor prescribing
PFE,PFE:US,BBG000BR2B91,Shire buys bowel drug rights from Pfizer,2016-06-14 12:57:02 +0000,http://sg.finance.yahoo.com/news/drugmaker-shire-buys-bowel-drug-115151777.html,Shire buys bowel drug rights from Pfizer
PFE,PFE:US,BBG000BR2B91,"Fresenius, Smiths in two-way race for Pfizer infusion pumps - sources",2016-06-06 16:00:02 +0000,http://uk.finance.yahoo.com/news/fresenius-smiths-two-way-race-160002232.html,"Fresenius, Smiths in two-way race for Pfizer infusion pumps - sources"
PFE,PFE:US,BBG000BR2B91,"Fresenius, Smiths in 2-way race for Pfizer infusion pumps-sources",2016-06-06 15:28:11 +0000,http://uk.finance.yahoo.com/news/fresenius-smiths-2-way-race-152811741.html,"Fresenius, Smiths in 2-way race for Pfizer infusion pumps-sources"
PFE,PFE:US,BBG000BR2B91,Ex-Oppenheimer & Co. employee faces insider trading charges,2016-06-04 02:28:13 +0000,http://sg.finance.yahoo.com/news/ex-oppenheimer-co-employee-faces-231957703.html,Ex-Oppenheimer & Co. employee faces insider trading charges
PFE,PFE:US,BBG000BR2B91,GSK's modern HIV drug to be rolled out in Botswana,2016-06-03 07:22:18 +0000,http://uk.finance.yahoo.com/news/gsks-modern-hiv-drug-rolled-072218051.html,GSK's modern HIV drug to be rolled out in Botswana
PFE,PFE:US,BBG000BR2B91,"Pharma sector set for wave of mergers, acquisitions: study",2016-05-30 13:05:26 +0000,http://uk.finance.yahoo.com/news/pharma-sector-set-wave-mergers-130526415.html,"Pharma sector set for wave of mergers, acquisitions: study"
PFE,PFE:US,BBG000BR2B91,Anacor received rival bid before Pfizer deal - filing,2016-05-26 21:29:00 +0000,http://sg.finance.yahoo.com/news/anacor-reveals-receiving-rival-bid-194047801.html,Anacor received rival bid before Pfizer deal - filing
PFE,PFE:US,BBG000BR2B91,EU lifts suicide warning on Pfizer's smoking-cessation pill,2016-05-23 21:53:23 +0000,http://sg.finance.yahoo.com/news/eu-lifts-suicide-warning-pfizers-193515874.html,EU lifts suicide warning on Pfizer's smoking-cessation pill
PFE,PFE:US,BBG000BR2B91,U.S. FDA approves Roche's immunotherapy for bladder cancer,2016-05-18 20:52:43 +0000,http://uk.finance.yahoo.com/news/u-fda-approves-roches-immunotherapy-205243412.html,U.S. FDA approves Roche's immunotherapy for bladder cancer
PFE,PFE:US,BBG000BR2B91,Pascal Soriot's big experiment: reinventing AstraZeneca,2016-05-18 06:41:40 +0000,http://uk.finance.yahoo.com/news/pascal-soriots-big-experiment-reinventing-064130927.html,Pascal Soriot's big experiment: reinventing AstraZeneca
PFE,PFE:US,BBG000BR2B91,"AstraZeneca asthma drug hits goal, to enter competitive market",2016-05-17 09:36:21 +0000,http://sg.finance.yahoo.com/news/astrazeneca-boosted-good-results-biotech-063709832.html,"AstraZeneca asthma drug hits goal, to enter competitive market"
PFE,PFE:US,BBG000BR2B91,"Asian stocks mixed as crude oil rises, Chinese shares fall",2016-05-17 03:36:27 +0000,http://sg.finance.yahoo.com/news/us-stocks-gain-early-trading-143317154.html,"Asian stocks mixed as crude oil rises, Chinese shares fall"
PFE,PFE:US,BBG000BR2B91,Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel,2016-05-16 17:46:19 +0000,http://in.finance.yahoo.com/news/pfizer-buy-anacor-pharma-5-110811765.html,Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel
PFE,PFE:US,BBG000BR2B91,Pfizer to buy eczema specialist for $5.2 billion,2016-05-16 13:53:22 +0000,http://uk.finance.yahoo.com/news/pfizer-buy-eczema-specialist-5-135322892.html,Pfizer to buy eczema specialist for $5.2 billion
PFE,PFE:US,BBG000BR2B91,Pfizer takes 'significant' move to restrict lethal injection drugs,2016-05-14 20:08:43 +0000,http://uk.finance.yahoo.com/news/pfizer-takes-significant-move-restrict-185838607.html,Pfizer takes 'significant' move to restrict lethal injection drugs
PFE,PFE:US,BBG000BR2B91,EXCLUSIVE: Pfizer approaches Medivation about potential takeover -sources,2016-05-04 03:10:49 +0000,http://in.finance.yahoo.com/news/exclusive-pfizer-approaches-medivation-potential-031049833.html,EXCLUSIVE: Pfizer approaches Medivation about potential takeover -sources
PFE,PFE:US,BBG000BR2B91,"US STOCKS-Wall St declines on growth fears, oil slide",2016-05-03 19:26:45 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-declines-192645773.html,"US STOCKS-Wall St declines on growth fears, oil slide"
PFE,PFE:US,BBG000BR2B91,"Pfizer earnings rise, boosted by Hospira assets",2016-05-03 12:33:10 +0000,http://uk.finance.yahoo.com/news/pfizer-earnings-rise-boosted-hospira-123310683.html,"Pfizer earnings rise, boosted by Hospira assets"
PFE,PFE:US,BBG000BR2B91,Pfizer to pay $785 mn for overcharging US government on drugs,2016-04-27 20:07:53 +0000,http://uk.finance.yahoo.com/news/pfizer-pay-785-mn-overcharging-200753033.html,Pfizer to pay $785 mn for overcharging US government on drugs
PFE,PFE:US,BBG000BR2B91,Pfizer to pay $785 million for overcharging US government on drugs,2016-04-27 18:36:26 +0000,http://uk.finance.yahoo.com/news/pfizer-pay-785-million-overcharging-183626504.html,Pfizer to pay $785 million for overcharging US government on drugs
PFE,PFE:US,BBG000BR2B91,Pfizer to pay $784.6 million to resolve Wyeth false claims lawsuit,2016-04-27 16:05:59 +0000,http://uk.finance.yahoo.com/news/pfizer-pay-784-6-million-160559571.html,Pfizer to pay $784.6 million to resolve Wyeth false claims lawsuit
PFE,PFE:US,BBG000BR2B91,INVESTMENT FOCUS-Investors favour European drug stocks in spite of M&A crackdown,2016-04-08 13:55:38 +0000,http://uk.finance.yahoo.com/news/investment-focus-investors-favour-european-135538897.html,INVESTMENT FOCUS-Investors favour European drug stocks in spite of M&A crackdown
PFE,PFE:US,BBG000BR2B91,Investors stick with Pfizer CEO after Allergan deal scrapped,2016-04-07 23:20:27 +0000,http://in.finance.yahoo.com/news/investors-stick-pfizer-ceo-allergan-232027481.html,Investors stick with Pfizer CEO after Allergan deal scrapped
PFE,PFE:US,BBG000BR2B91,"US and European stocks gain as oil, pharma shares rally",2016-04-06 21:47:47 +0000,http://uk.finance.yahoo.com/news/us-european-stocks-gain-oil-214747585.html,"US and European stocks gain as oil, pharma shares rally"
PFE,PFE:US,BBG000BR2B91,US STOCKS-Wall St rises with healthcare; oil rallies,2016-04-06 20:57:11 +0000,http://uk.finance.yahoo.com/news/us-stocks-wall-st-rises-205711337.html,US STOCKS-Wall St rises with healthcare; oil rallies
PFE,PFE:US,BBG000BR2B91,"Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change",2016-04-06 18:20:35 +0000,http://in.finance.yahoo.com/news/pfizer-allergan-scrap-160-bln-105613100.html,"Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change"
PFE,PFE:US,BBG000BR2B91,Obama's inversion curbs kill Pfizer's $160 bln Allergan deal,2016-04-06 12:46:21 +0000,http://in.finance.yahoo.com/news/obamas-inversion-curbs-kill-pfizers-062325568.html,Obama's inversion curbs kill Pfizer's $160 bln Allergan deal
PFE,PFE:US,BBG000BR2B91,Obama's inversion curbs kill Pfizer's $160 billion Allergan deal,2016-04-06 05:51:34 +0000,http://in.finance.yahoo.com/news/obamas-inversion-curbs-kill-pfizers-055134446.html,Obama's inversion curbs kill Pfizer's $160 billion Allergan deal
PFE,PFE:US,BBG000BR2B91,"Pfizer, Allergan to mutually terminate merger on Wednesday morning, source says",2016-04-06 02:52:07 +0000,http://in.finance.yahoo.com/news/pfizers-allergan-deal-teeters-u-002720378.html,"Pfizer, Allergan to mutually terminate merger on Wednesday morning, source says"
PFE,PFE:US,BBG000BR2B91,Delhi High Court grants Pfizer temporary relief on cough syrup ban,2016-03-15 02:34:23 +0000,http://in.finance.yahoo.com/news/delhi-high-court-grants-pfizer-023422890.html,Delhi High Court grants Pfizer temporary relief on cough syrup ban
PFE,PFE:US,BBG000BR2B91,Delhi High Court stays government ban on Pfizer's Corex cough syrup - TV,2016-03-14 13:56:07 +0000,http://in.finance.yahoo.com/news/delhi-high-court-stays-government-114338936.html,Delhi High Court stays government ban on Pfizer's Corex cough syrup - TV
PFE,PFE:US,BBG000BR2B91,Medecins Sans Frontieres files to block Pfizer patent on pneumonia vaccine in India,2016-03-11 13:19:04 +0000,http://in.finance.yahoo.com/news/medecins-sans-frontieres-files-block-131709859.html,Medecins Sans Frontieres files to block Pfizer patent on pneumonia vaccine in India
PFE,PFE:US,BBG000BR2B91,Pfizer 2016 forecasts disappoint; shares fall,2016-02-02 14:48:58 +0000,http://in.finance.yahoo.com/news/pfizer-forecasts-2016-revenue-earnings-125059659.html,Pfizer 2016 forecasts disappoint; shares fall
PFE,PFE:US,BBG000BR2B91,"Pfizer, IIT-Delhi collaborate for healthcare incubation",2015-11-24 18:00:05 +0000,http://in.finance.yahoo.com/news/pfizer-iit-delhi-collaborate-healthcare-180005588.html,"Pfizer, IIT-Delhi collaborate for healthcare incubation"
PFE,PFE:US,BBG000BR2B91,U.S. politicians slam tax-avoiding Pfizer-Allergan deal,2015-11-24 03:15:02 +0000,http://in.finance.yahoo.com/news/u-politicians-slam-tax-avoiding-031502091.html,U.S. politicians slam tax-avoiding Pfizer-Allergan deal
PFE,PFE:US,BBG000BR2B91,Pfizer to buy Allergan in $160 billion deal,2015-11-24 03:15:02 +0000,http://in.finance.yahoo.com/news/pfizer-buy-allergan-160-billion-031502366.html,Pfizer to buy Allergan in $160 billion deal
PFE,PFE:US,BBG000BR2B91,U.S. Republican Trump calls Pfizer deal to move tax base overseas 'disgusting',2015-11-23 23:14:14 +0000,http://in.finance.yahoo.com/news/u-republican-trump-calls-pfizer-231414619.html,U.S. Republican Trump calls Pfizer deal to move tax base overseas 'disgusting'
PFE,PFE:US,BBG000BR2B91,Politicians slam tax-avoiding Pfizer-Allergan mega-deal,2015-11-23 22:32:12 +0000,http://in.finance.yahoo.com/news/politicians-slam-tax-avoiding-pfizer-223212273.html,Politicians slam tax-avoiding Pfizer-Allergan mega-deal
